PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	MANDEL, JL; MONACO, AP; NELSON, DL; SCHLESSINGER, D; WILLARD, H				MANDEL, JL; MONACO, AP; NELSON, DL; SCHLESSINGER, D; WILLARD, H			GENOME ANALYSIS AND THE HUMAN X-CHROMOSOME	SCIENCE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; YEAST ARTIFICIAL CHROMOSOMES; FIELD GEL-ELECTROPHORESIS; GENETIC-LINKAGE MAP; HUMAN XQ24-XQ28 DNA; FRAGILE-X; SHORT ARM; INACTIVATION CENTER; CAENORHABDITIS-ELEGANS	A unified genetic, physical, and functional map of the human X chromosome is being built through a concerted, international effort. About 40 percent of the 160 million base pairs of the X chromosome DNA have been cloned in overlapping, ordered contigs derived from yeast artificial chromosomes. This rapid progress toward a physical map is accelerating the identification of inherited disease genes, 26 of which are already cloned and more than 50 others regionally localized by linkage analysis. This article summarizes the mapping strategies now used and the impact of genome research on the understanding of X chromosome inactivation and X-linked diseases.	JOHN RADCLIFFE HOSP,IMPERIAL CANC RES FUND,HUMAN GENET LAB,OXFORD OX3 9DU,ENGLAND; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110	University of Oxford; Baylor College of Medicine; Washington University (WUSTL)	MANDEL, JL (corresponding author), CNRS,INSERM,GENET MOLEC EUCARYOTES LAB,F-67085 STRASBOURG,FRANCE.		Gilna, Paul/I-3608-2016; Monaco, Anthony P/A-4495-2010	Gilna, Paul/0000-0002-6542-0191; Monaco, Anthony P/0000-0001-7480-3197				ABBS S, 1990, GENOMICS, V7, P602, DOI 10.1016/0888-7543(90)90205-9; ABIDI FE, 1990, GENOMICS, V7, P363, DOI 10.1016/0888-7543(90)90170-Y; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALITALO T, 1991, HUM GENET, V86, P599, DOI 10.1007/BF00201548; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; ARCHIDIACONO N, 1991, HUM GENET, V86, P604; ARVEILER B, 1990, AM J HUM GENET, V46, P906; ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BACH I, IN PRESS HUM GENET; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; Ballabio A, 1991, CURR OPIN GENET DEV, V1, P25, DOI 10.1016/0959-437X(91)80036-L; BARKER DF, 1991, HUM GENET, V88, P189; BARLOW DP, 1987, TRENDS GENET, V3, P167, DOI 10.1016/0168-9525(87)90219-8; BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BENHAM F, 1989, GENOMICS, V4, P509, DOI 10.1016/0888-7543(89)90274-7; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BERGER W, 1992, NAT GENET, V1, P204; BLONDEN LAJ, 1991, GENOMICS, V10, P631, DOI 10.1016/0888-7543(91)90445-K; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P839; BOYD Y, 1990, GENOMICS, V7, P182, DOI 10.1016/0888-7543(90)90539-7; BROCKDORFF N, 1991, MAMM GENOME, V1, P152, DOI 10.1007/BF00351061; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, IN PRESS CELL; BROWN CJ, 1989, SOMAT CELL MOLEC GEN, V15, P173, DOI 10.1007/BF01535079; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1989, CYTOGENET CELL GENET, V51, P970; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, IN PRESS CELL; BROWN S, IN PRESS MAMM GENOME; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CANGIANO G, 1990, NUCLEIC ACIDS RES, V18, P5077, DOI 10.1093/nar/18.17.5077; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CATTANACH BM, 1991, CYTOGENET CELL GENET, V56, P137, DOI 10.1159/000133070; CLARKE TR, 1992, AM J HUM GENET, V51, P316; COFFEY AJ, 1992, GENOMICS, V12, P474, DOI 10.1016/0888-7543(92)90437-W; COHEN D, 1992, COLD SPRING HARBOR M, P32; COLE CG, 1991, GENOMICS, V10, P816, DOI 10.1016/0888-7543(91)90468-T; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7826; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; CREMERS FP, 1990, NATURE, V347, P347; CREMERS FPM, 1988, AM J HUM GENET, V43, P452; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; ELVIN P, 1990, NUCLEIC ACIDS RES, V18, P3913, DOI 10.1093/nar/18.13.3913; FAIN P, 1992, 3RD X CHROM WORKSH A; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; FU YH, 1991, NEW ENGL J MED, V65, P905; GEDEON AK, 1992, AM J MED GENET, V43, P255, DOI 10.1002/ajmg.1320430140; GIANNELLI F, 1991, NUCLEIC ACIDS RES, V19, P2193, DOI 10.1093/nar/19.suppl.2193; GOLEMAN MP, 1991, GENOMICS, V11, P991; GORSKI JL, 1991, AM J HUM GENET, V48, P53; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; Green E D, 1991, PCR Methods Appl, V1, P77; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HADANO S, 1991, GENOMICS, V11, P364, DOI 10.1016/0888-7543(91)90144-4; HENDRIKS RW, 1992, HUM MOL GENET, V1, P187, DOI 10.1093/hmg/1.3.187; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P8307, DOI 10.1073/pnas.88.19.8307; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P405; HIRST MC, 1991, GENOMICS, V10, P243, DOI 10.1016/0888-7543(91)90506-A; HO M, 1991, CYTOGENET CELL GENET, V58, P2067; HO MF, 1992, AM J HUM GENET, V50, P317; HU XY, 1990, AM J HUM GENET, V46, P682; HUANG THM, 1992, GENOMICS, V13, P375, DOI 10.1016/0888-7543(92)90256-R; KERE J, IN PRESS GENOMICS; KERR B, 1991, J MED GENET, V28, P378, DOI 10.1136/jmg.28.6.378; KOENIG M, 1989, AM J HUM GENET, V45, P489; KORN B, 1991, HUM MOL GENET, V1, P235; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUPKE KG, 1992, AM J HUM GENET, V50, P808; LAFRENIERE RG, 1991, GENOMICS, V11, P352, DOI 10.1016/0888-7543(91)90143-3; LAFRENIERE RG, 1992, COLD SPRING HARBOR M; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEE JT, 1992, GENOMICS, V12, P526, DOI 10.1016/0888-7543(92)90444-W; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEHRACH H, 1990, CENOME ANAL, V1, P39; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LITT M, 1989, AM J HUM GENET, V44, P397; LITTLE RD, 1992, P NATL ACAD SCI USA, V89, P177, DOI 10.1073/pnas.89.1.177; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; LLISON KA, 1992, AM J HUM GENET, V50, P278; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; LUDECKE HJ, 1989, NATURE, V338, P348, DOI 10.1038/338348a0; LYON MF, 1988, AM J HUM GENET, V42, P8; MAESTRINI E, 1990, GENOMICS, V8, P664, DOI 10.1016/0888-7543(90)90253-Q; MAESTRINI E, 1992, HUM MOL GENET, V1, P2775; MAHTANI MM, 1991, GENOMICS, V10, P849, DOI 10.1016/0888-7543(91)90172-B; MAZZARELLA R, 1992, P NATL ACAD SCI USA, V89, P3681, DOI 10.1073/pnas.89.9.3681; McKusick V.A., 1992, MENDELIAN INHERITANC; MIGEON BR, 1990, GENET RES, V56, P91, DOI 10.1017/S0016672300035151; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MONACO AP, 1992, GENOMICS, V12, P465, DOI 10.1016/0888-7543(92)90436-V; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; MONACO AP, 1991, NUCLEIC ACIDS RES, V19, P3315, DOI 10.1093/nar/19.12.3315; MONACO AP, 1986, NATURE, V322, P32; MONACO AP, UNPUB; MONTANARO V, 1991, AM J HUM GENET, V48, P183; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MUSARELLA MA, 1991, GENOMICS, V11, P263, DOI 10.1016/0888-7543(91)90132-X; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NELSON DL, 1991, P NATL ACAD SCI USA, V88, P6157, DOI 10.1073/pnas.88.14.6157; NERI G, 1992, AM J MED GENET, V43, P373, DOI 10.1002/ajmg.1320430158; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Ohno S., 1967, SEX CHROMOSOMES SEX; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; OUDET C, IN PRESS HUM MOL GEN; PALAZZOLO MJ, 1991, P NATL ACAD SCI USA, V88, P8034, DOI 10.1073/pnas.88.18.8034; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; PETIT C, 1990, P NATL ACAD SCI USA, V87, P3680, DOI 10.1073/pnas.87.10.3680; PETIT C, 1991, P NATL ACAD SCI USA, V88, P8302; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; RASTAN S, 1990, GENET RES, V56, P99, DOI 10.1017/S0016672300035163; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; ROSS MT, 1992, NAT GENET, V1, P284, DOI 10.1038/ng0792-284; ROUSSEAU F, 1991, AM J HUM GENET, V48, P108; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; ROYLE NJ, 1988, GENOMICS, V3, P325; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SCHLESSINGER D, 1991, GENOMICS, V11, P783, DOI 10.1016/0888-7543(91)90001-U; SCHMIDT M, 1992, AM J MED GENET, V43, P279, DOI 10.1002/ajmg.1320430143; SEFIANI A, 1991, HUM GENET, V86, P297; SINKALA EM, 1989, HUM GENET, V84, P66; SUTHERS GK, 1991, GENOMICS, V9, P37, DOI 10.1016/0888-7543(91)90218-4; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; TUDDENHAM EGD, 1991, NUCLEIC ACIDS RES, V19, P4821, DOI 10.1093/nar/19.18.4821; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VERGA V, 1992, HUM GENET, V88, P668; VIDAUD D, IN PRESS EUR J HUM G; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; VULLIAMY P, 1992, TRENDS GENET, V8, P138; WADA M, 1990, AM J HUM GENET, V46, P95; WARREN ST, 1990, P NATL ACAD SCI USA, V87, P3856, DOI 10.1073/pnas.87.10.3856; WATSON JM, 1991, P NATL ACAD SCI USA, V88, P11256, DOI 10.1073/pnas.88.24.11256; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLARD HF, 1985, HUM GENET, V71, P138; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; ZONANA J, IN PRESS AM J HUM GE; ZUCCHI I, 1992, GENOMICS, V12, P264, DOI 10.1016/0888-7543(92)90373-Z	161	48	51	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 2	1992	258	5079					103	109		10.1126/science.1439756	http://dx.doi.org/10.1126/science.1439756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ619	1439756				2022-12-28	WOS:A1992JQ61900027
J	EUVRARD, S; NOBLE, CP; KANITAKIS, J; FFRENCH, M; BERGER, F; DELECLUSE, HJ; DINCAN, M; THIVOLET, J; TOURAINE, JL				EUVRARD, S; NOBLE, CP; KANITAKIS, J; FFRENCH, M; BERGER, F; DELECLUSE, HJ; DINCAN, M; THIVOLET, J; TOURAINE, JL			BRIEF REPORT - SUCCESSIVE OCCURRENCE OF T-CELL AND B-CELL LYMPHOMAS AFTER RENAL-TRANSPLANTATION IN A PATIENT WITH MULTIPLE CUTANEOUS SQUAMOUS-CELL CARCINOMAS	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							BARR VIRUS-INFECTIONS; MYCOSIS-FUNGOIDES; LESIONS; SKIN; DNA		EDOUARD HERRIOT HOSP, TRANSPLANTAT UNIT, CNRS, URA 1177, INSERM, U80, F-69437 LYON 03, FRANCE; EDOUARD HERRIOT HOSP, DEPT HEMATOL, F-69437 LYON 03, FRANCE; EDOUARD HERRIOT HOSP, DEPT PATHOL, F-69437 LYON 03, FRANCE	Centre National de la Recherche Scientifique (CNRS); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon	EUVRARD, S (corresponding author), EDOUARD HERRIOT HOSP, DEPT DERMATOL, F-69437 LYON 03, FRANCE.		Kanitakis, Jean/Q-3450-2019	Delecluse, Henri-Jacques/0000-0002-1744-6274; Kanitakis, Jean/0000-0003-0469-257X				ALLUE L, 1990, J AM ACAD DERMATOL, V23, P677, DOI 10.1016/0190-9622(90)70272-J; COIFFIER B, 1989, J CLIN ONCOL, V7, P1018, DOI 10.1200/JCO.1989.7.8.1018; CRANE GA, 1991, ARCH DERMATOL, V127, P989, DOI 10.1001/archderm.127.7.989; DINEHART SM, 1989, J AM ACAD DERMATOL, V21, P241, DOI 10.1016/S0190-9622(89)70168-7; Euvrard S., 1991, EUR J DERMATOL, V1, P175; HALL WW, 1991, SCIENCE, V253, P317, DOI 10.1126/science.1857968; HO M, 1985, J INFECT DIS, V152, P876, DOI 10.1093/infdis/152.5.876; JONES JF, 1988, NEW ENGL J MED, V318, P733, DOI 10.1056/NEJM198803243181203; NAHASS GT, 1991, ARCH DERMATOL, V127, P1020, DOI 10.1001/archderm.127.7.1020; PENN I, 1991, TRANSPLANT P, V23, P1101; PENN I, 1987, TRANSPLANTATION, V43, P32, DOI 10.1097/00007890-198701000-00008; PENN I, 1988, ANNU REV MED, V39, P63, DOI 10.1146/annurev.me.39.020188.000431; RAFTERY MJ, 1988, TRANSPLANTATION, V46, P475; SHEIBANI K, 1983, BLOOD, V62, P1176; TOURAINE JL, 1991, CANCER IN ORGAN TRANSPLANT RECIPIENTS, P27	15	50	50	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	1992	327	27					1924	1926		10.1056/NEJM199212313272706	http://dx.doi.org/10.1056/NEJM199212313272706			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KE505	1454087				2022-12-28	WOS:A1992KE50500006
J	CHEN, YCJ; GUO, YL; HSU, CC; ROGAN, WJ				CHEN, YCJ; GUO, YL; HSU, CC; ROGAN, WJ			COGNITIVE-DEVELOPMENT OF YU-CHENG (OIL DISEASE) CHILDREN PRENATALLY EXPOSED TO HEAT-DEGRADED PCBS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; BIRTH-DEFECTS; DIBENZOFURANS; CONTAMINANTS; DIOXINS; TAIWAN; BLOOD	Objective.-To compare the cognitive development in Taiwanese children who had been exposed prenatally to high levels of heat-degraded polychlorinated biphenyls (PCBs) with control children who were exposed to background levels. The disorder was called Yu-Cheng, "oil disease," in Taiwan. Design.-Matched-pair cohort study. Setting.-Communities in central Taiwan in which there had been a cooking-oil contamination and mass poisoning by heat-degraded PCBs in 1978 through 1979. Participants.-One hundred eighteen children born between June 1978 and March 1985 during or after their mothers' consumption of contaminated rice oil; 118 children matched for age, sex, neighborhood, maternal age, and parental education and occupational class; and 15 older siblings of exposed children, born before the poisoning. Main Outcome Measures.-Cognitive development measured from 1985 through 1990 using the Chinese versions of the Stanford-Binet test and the Wechsler Intelligence Scale for Children, Revised. Results.-The exposed children scored approximately 5 points lower on the Stanford-Binet test at the ages of 4 and 5 years and approximately 5 points lower on the Wechsler Intelligence Scale for Children, Revised, at the ages of 6 and 7 years. Children born up to 6 years after their mothers' exposure were as affected as children born within a year or two after exposure when examined at 6 and 7 years of age. Older siblings resembled the control children. Conclusion.-Children prenatally exposed to heat-degraded PCBs had poorer cognitive development than their matched controls. The effect persisted in the children up to the age of 7 years, and children born long after the exposure were still affected.	NATL CHENG KUNG UNIV,COLL MED,DEPT ENVIRONM HLTH,TAINAN,TAIWAN; NIEHS,RES TRIANGLE PK,NC 27709	National Cheng Kung University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	CHEN, YCJ (corresponding author), NATL CHENG KUNG UNIV,COLL MED,DEPT PSYCHIAT,138 SHENG LI RD,TAINAN 70428,TAIWAN.		Rogan, Walter/I-6034-2012	Rogan, Walter/0000-0002-9302-0160; GUO, Yue Leon/0000-0002-8530-4809				Anastasi A., 1982, PSYCHOL TESTING, V5th; CHEN CC, 1988, CHIN PSYCHIATRY, V2, P257; CHEN JH, 1979, MANUAL CHINESE VERSI; CHEN PH, 1981, CLIN MED TAIPEI, V7, P71; CHEN YC, 1989, CHIN PSYCHIATRY, V3, P89; CHEN YC, 1990, CHIN PSYCHIATRY, V4, P40; CHEN YCJ, IN PRESS J FORMOSAN; Crow K D, 1970, Trans St Johns Hosp Dermatol Soc, V56, P79; DEVOOGT P, 1989, TOPICS ENV HLTH, V4, P3; DYMENT PG, 1971, B ENVIRON CONTAM TOX, V6, P532, DOI 10.1007/BF01796861; ERICKSON JD, 1984, JAMA-J AM MED ASSOC, V252, P903, DOI 10.1001/jama.252.7.903; FUNATSU I, 1972, Kurume Medical Journal, V19, P43; GLADEN BC, 1991, J PEDIATR-US, V119, P58, DOI 10.1016/S0022-3476(05)81039-X; HARA I, 1985, ENVIRON HEALTH PERSP, V59, P85, DOI 10.2307/3429879; Harada M., 1976, B I CONSTITUTIONAL S, V25, P1; HSU CC, 1988, CHIN PSYCH, V2, P26; HSU CC, 1989, CHIN PSYCHIATRY S1, V3, P101; HSU ST, 1985, ENVIRON HEALTH PERSP, V59, P5, DOI 10.2307/3429867; JACOBSON JL, 1990, J PEDIATR-US, V116, P38, DOI 10.1016/S0022-3476(05)81642-7; JENSEN AA, 1989, TOPICS ENV HLTH, V4, P345; KURATSUNE M, 1989, TOPICS ENV HLTH, V4, P381; LAN CF, 1981, CLIN MED TAIPEI, V7, P96; LIU SH, 1985, ANN REP BUREAU HLTH, V1, P269; MASTROIACOVO P, 1988, JAMA-J AM MED ASSOC, V259, P1668, DOI 10.1001/jama.259.11.1668; MASUDA Y, 1985, ENVIRON HEALTH PERSP, V59, P53, DOI 10.2307/3429874; NICHOLSON WJ, 1987, REV HUMAN HLTH EFFEC; ROGAN WJ, 1988, SCIENCE, V241, P334, DOI 10.1126/science.3133768; ROGAN WJ, 1989, TOPICS ENV HLTH, V4, P401; SAFE S, 1990, CRIT REV TOXICOL, V21, P51, DOI 10.3109/10408449009089873; SAMUELSSON B, 1989, Neurofibromatosis, V2, P78; SHALAT SL, 1989, BRIT J IND MED, V46, P823; SVENSSON BG, 1991, NEW ENGL J MED, V324, P8, DOI 10.1056/NEJM199101033240102; TILSON HA, 1990, NEUROTOXICOL TERATOL, V12, P239, DOI 10.1016/0892-0362(90)90095-T; YEH TL, 1988, CHIN PSYCHIATRY, V2, P172; YU ML, 1991, NEUROTOXICOL TERATOL, V13, P195, DOI 10.1016/0892-0362(91)90011-K; 1977, MANUAL CHINESE 4TH V	36	208	217	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3213	3218		10.1001/jama.268.22.3213	http://dx.doi.org/10.1001/jama.268.22.3213			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433761				2022-12-28	WOS:A1992KA65400027
J	HEDBERG, CW; LEVINE, WC; WHITE, KE; CARLSON, RH; WINSOR, DK; CAMERON, DN; MACDONALD, KL; OSTERHOLM, MT				HEDBERG, CW; LEVINE, WC; WHITE, KE; CARLSON, RH; WINSOR, DK; CAMERON, DN; MACDONALD, KL; OSTERHOLM, MT			AN INTERNATIONAL FOODBORNE OUTBREAK OF SHIGELLOSIS ASSOCIATED WITH A COMMERCIAL AIRLINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMID	Objective.-To determine the source of an international outbreak of shigellosis associated with consumption of food served by a Minnesota-based airline. Design.-Cohort studies of players and staff of a Minnesota-based professional football team and passengers on flights with a confirmed case of outbreak-associated Shigella sonnei infection. Setting.-Community- and industry-based studies conducted from October through November 1988. Participants.-Sixty-five football team players and staff, and 725 airline passengers in the cohort studies. Results.-Twenty-one (32%) of 65 football players and staff developed shigellosis that was associated with consumption of cold sandwiches prepared at the airline flight kitchen (relative risk [RR], 17.1; 95% confidence interval [CI], 2.4 to 120; P<.001). Confirmed or probable shigellosis was identified among 240 passengers on 219 flights to 24 states, the District of Columbia, and four countries between September 14 and October 13. An outbreak-associated strain of S sonnei was isolated from football players and staff, airline passengers, and flight attendants. Thirty (4.1%) of 725 passengers on 13 flights with confirmed cases had confirmed or probable shigellosis. Illness was associated with consumption of cold food items served on the flights and prepared by hand at the airline flight kitchen (RR, 5.7; 95% CI, 1.4 to 23.5; P<.01). Conclusions.-This international outbreak of shigellosis was identified only because of the occurrence of an index outbreak involving a professional football team. Prevention of Shigella transmission in mass catering establishments may require reduction of hand contact in the preparation of cold food items or elimination of these items from menus.	CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV BACTERIAL & MYCOT DIS,ENTER DIS BRANCH,ATLANTA,GA; HENNEPIN CTY COMMUNITY HLTH DEPT,MINNEAPOLIS,MN; UNIV TEXAS,SCH MED,HOUSTON,TX 77025	Centers for Disease Control & Prevention - USA; University of Texas System	HEDBERG, CW (corresponding author), MINNESOTA DEPT HLTH,ACUTE DIS EPIDEMIOL SECT,717 DELAWARE ST SE,POB 9441,MINNEAPOLIS,MN 55440, USA.							BARRY AL, 1985, MANUAL CLIN MICROBIO, pCH102; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Breslow N.E., 1980, STAT METHODS CANC RE, P192; BRYAN FL, 1981, FOOD TECHNOL-CHICAGO, V35, P78; LEE LA, 1991, J INFECT DIS, V164, P894, DOI 10.1093/infdis/164.5.894; MEYERS JA, 1976, J BACTERIOL, V127, P1529, DOI 10.1128/JB.127.3.1529-1537.1976; ROTHMAN KJ, 1979, EPIDEMIOLOGIC ANAL P, P5; TAUXE RV, 1987, AM J EPIDEMIOL, V125, P150, DOI 10.1093/oxfordjournals.aje.a114498; WINSOR DK, 1988, J INFECT DIS, V158, P1108, DOI 10.1093/infdis/158.5.1108	9	67	67	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3208	3212		10.1001/jama.268.22.3208	http://dx.doi.org/10.1001/jama.268.22.3208			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433760				2022-12-28	WOS:A1992KA65400026
J	MOON, RT; CHRISTIAN, JL				MOON, RT; CHRISTIAN, JL			COMPETENCE MODIFIERS SYNERGIZE WITH GROWTH-FACTORS DURING MESODERM INDUCTION AND PATTERNING IN XENOPUS	CELL			English	Article											MOON, RT (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195, USA.		Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408				ALTABA ARI, 1991, GENE DEV, V5, P175, DOI 10.1101/gad.5.2.175; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; CHRISTIAN JL, 1993, IN PRESS GENES DEV; DALE L, 1992, DEVELOPMENT, V115, P573; GERHART J, 1991, GASTRULATION MOVEMEN, P57; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; JONES CM, 1992, DEVELOPMENT, V115, P639; KAGEURA H, 1990, DEV BIOL, V142, P432, DOI 10.1016/0012-1606(90)90365-P; KIMELMAN D, 1992, DEVELOPMENT, V116, P1; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; SOKOL S, 1991, NATURE, V351, P409, DOI 10.1038/351409a0	13	51	51	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 27	1992	71	5					709	712		10.1016/0092-8674(92)90545-N	http://dx.doi.org/10.1016/0092-8674(92)90545-N			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423626				2022-12-28	WOS:A1992JZ63300001
J	SAMPSON, HA; METCALFE, DD				SAMPSON, HA; METCALFE, DD			FOOD ALLERGIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE REACTIONS; NATURAL-HISTORY; ATOPIC-DERMATITIS; DIAGNOSIS; HYPERSENSITIVITY; ADDITIVES; CHALLENGE; CHILDREN; INFANCY		NIAID, CLIN INVEST LAB, MAST CELL PHYSIOL SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	SAMPSON, HA (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, PEDIAT CLIN RES UNIT, BALTIMORE, MD 21205 USA.							ANDERSON JA, 1986, J ALLERGY CLIN IMMUN, V78, P140, DOI 10.1016/0091-6749(86)90004-7; BARNESKOERNER C, 1991, FOOD ALLERGY ADVERSE, P332; BOCK SA, 1982, J ALLERGY CLIN IMMUN, V69, P173, DOI 10.1016/0091-6749(82)90096-3; BOCK SA, 1989, J ALLERGY CLIN IMMUN, V83, P900, DOI 10.1016/0091-6749(89)90103-6; BOCK SA, 1987, PEDIATRICS, V79, P683; BOCK SA, 1988, J ALLERGY CLIN IMMUN, V82, P986; BRUCE MG, 1986, IMMUNOLOGY, V57, P627; BUSINCO L, 1985, ANN ALLERGY, V55, P844; DOHI M, 1991, J ALLERGY CLIN IMMUN, V87, P34, DOI 10.1016/0091-6749(91)90210-F; ELSAYED S, 1983, ALLERGY, V38, P449, DOI 10.1111/j.1398-9995.1983.tb02353.x; ENBERG RN, 1991, IMMUNOL ALLERGY CLIN, V11, P767; GRYBOSKI JD, 1967, PEDIATRICS, V40, P354; HALL RP, 1987, J AM ACAD DERMATOL, V16, P1129, DOI 10.1016/S0190-9622(87)70148-0; HEINER DC, 1960, AM J DIS CHILD, V100, P500; JOHANSSON SGO, 1984, ANN ALLERGY, V53, P665; Kettlehut B., 1988, ALLERGY PRINCIPLES P, V3, P1481; KUITUNEN P, 1975, ARCH DIS CHILD, V50, P351, DOI 10.1136/adc.50.5.351; May C D, 1972, Clin Allergy, V2, P335, DOI 10.1111/j.1365-2222.1972.tb01298.x; MCNEISH AS, 1979, ARCH DIS CHILD, V54, P783, DOI 10.1136/adc.54.10.783; METCALFE DD, 1990, J ALLERGY CLIN IMMUN, V86, P421, DOI 10.1016/S0091-6749(05)80252-0; MOWAT AM, 1987, IMMUNOL TODAY, V8, P93, DOI 10.1016/0167-5699(87)90853-X; PASTORELLO EA, 1989, J ALLERGY CLIN IMMUN, V84, P475, DOI 10.1016/0091-6749(89)90360-6; POWELL GK, 1978, J PEDIATR-US, V93, P553, DOI 10.1016/S0022-3476(78)80887-7; SAMPSON HA, 1988, ANN ALLERGY, V60, P262; SAMPSON HA, 1988, J ALLERGY CLIN IMMUN, V81, P635, DOI 10.1016/0091-6749(88)91033-0; SAMPSON HA, 1986, J ALLERGY CLIN IMMUN, V78, P212, DOI 10.1016/0091-6749(86)90014-X; SAMPSON HA, 1989, J PEDIATR-US, V115, P23, DOI 10.1016/S0022-3476(89)80323-3; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405; SAMPSON HA, 1991, FOOD ALLERGY ADVERSE, P99; SOGN D, 1986, J ALLERGY CLIN IMMUN, V78, P238, DOI 10.1016/0091-6749(86)90017-5; Walzer M, 1941, J LAB CLIN MED, V26, P1867; WEBER RW, 1991, IMMUNOL ALLERGY CLIN, V11, P831	33	87	89	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2840	2844		10.1001/jama.268.20.2840	http://dx.doi.org/10.1001/jama.268.20.2840			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433699				2022-12-28	WOS:A1992JY66800007
J	GREGANTI, MA				GREGANTI, MA			LIFE CARE AT GOLDEN ACRES	ANNALS OF INTERNAL MEDICINE			English	Editorial Material						HOUSING FOR THE ELDERLY; LIFE CHANGE EVENTS; NURSING HOMES; SOCIAL SUPPORT		Life care communities offer an increasingly popular option for the elderly. They offer an attractive setting that assures optimal care when dependence on others becomes unavoidable. But is there another side? This essay illustrates what I have from one of my wisest teachers, an elderly life care community resident.			GREGANTI, MA (corresponding author), UNIV N CAROLINA, SCH MED,DEPT MED,3029 OLD CLIN BLDG,226H, CB 7005, CHAPEL HILL, NC 27599 USA.								0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					867	868		10.7326/0003-4819-117-10-867	http://dx.doi.org/10.7326/0003-4819-117-10-867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416563				2022-12-28	WOS:A1992JX83800011
J	KADLUBAR, FF				KADLUBAR, FF			DETECTION OF HUMAN DNA CARCINOGEN ADDUCTS	NATURE			English	Article							SENSITIVITY				KADLUBAR, FF (corresponding author), US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA.							Carson Rachel, 1994, SILENT SPRING; GAYLOR DW, IN PRESS ENV HLTH PE; GUPTA RC, 1982, CARCINOGENESIS, V3, P1081, DOI 10.1093/carcin/3.9.1081; GUPTA RC, 1985, CANCER RES, V45, P5656; MILLER JA, 1983, ENVIRON HEALTH PERSP, V49, P3, DOI 10.2307/3429574; RANDERATH K, 1981, P NATL ACAD SCI-BIOL, V78, P6126, DOI 10.1073/pnas.78.10.6126; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	8	6	6	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 12	1992	360	6400					189	189		10.1038/360189a0	http://dx.doi.org/10.1038/360189a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX752	1436097				2022-12-28	WOS:A1992JX75200070
J	LASKY, LA				LASKY, LA			SELECTINS - INTERPRETERS OF CELL-SPECIFIC CARBOHYDRATE INFORMATION DURING INFLAMMATION	SCIENCE			English	Article							LEUKOCYTE ADHESION MOLECULE-1; LYMPHOCYTE HOMING RECEPTOR; HIGH-ENDOTHELIAL VENULES; GRANULE MEMBRANE-PROTEIN; SIALYL-LEWIS-X; CUTANEOUS INFLAMMATION; VASCULAR ENDOTHELIUM; ACTIVATED PLATELETS; NEUTROPHIL ADHESION; CHEMOTACTIC FACTORS	Although a bewildering array of cell surface carbohydrate structures have been described, the physiological relevance of any of these complex molecules has often eluded biologists. A family of cell surface glycoproteins, the "selectins," has a characteristic ability to use some of these carbohydrate structures in adhesive mechanisms that help localize leukocytes to regions of inflammation. This article will review the biology of these carbohydrate-binding adhesive proteins and discuss the potential for developing anti-inflammatory antagonists that could inhibit binding events that are selectin-mediated.			LASKY, LA (corresponding author), GENENTECH INC, DEPT IMMUNOL, San Francisco, CA 94080 USA.							ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; ANDREWS P, 1982, J CELL SCI, V57, P277; ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; BERG EL, 1991, J BIOL CHEM, V266, P14869; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; BEVILACQUA M, 1991, CELL, V67, P233, DOI 10.1016/0092-8674(91)90174-W; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BONFANTI R, 1989, BLOOD, V73, P1109; BOWEN BR, 1989, J CELL BIOL, V109, P421, DOI 10.1083/jcb.109.1.421; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CARLOS TM, 1990, IMMUNOL REV, V114, P5, DOI 10.1111/j.1600-065X.1990.tb00559.x; COLLINS T, 1991, J BIOL CHEM, V266, P2466; CORRAL L, 1990, BIOCHEM BIOPH RES CO, V172, P1349, DOI 10.1016/0006-291X(90)91598-M; DOWBENKO DJ, 1991, GENOMICS, V9, P270, DOI 10.1016/0888-7543(91)90252-A; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; ERBE D, IN PRESS J CELL BIOL; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GROVES RW, 1991, BRIT J DERMATOL, V124, P117, DOI 10.1111/j.1365-2133.1991.tb00419.x; GUNDEL RH, 1991, J CLIN INVEST, V88, P1407, DOI 10.1172/JCI115447; HARDING SE, 1989, ADV CARBOHYD CHEM BI, V47, P345; HATTORI R, 1989, J BIOL CHEM, V264, P7768; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IMAI Y, 1991, J CELL BIOL, V113, P1213, DOI 10.1083/jcb.113.5.1213; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; JOHNSTON GI, 1990, J BIOL CHEM, V265, P21381; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JUNG TM, 1990, J IMMUNOL, V144, P3130; JUTILA MA, 1989, J IMMUNOL, V143, P3318; KAMEYAMA A, 1991, CARBOHYD RES, V209, pC1, DOI 10.1016/0008-6215(91)80171-I; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KYANAUNG U, 1991, J IMMUNOL, V146, P521; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LARSEN E, 1990, CELL, V63, P467, DOI 10.1016/0092-8674(90)90443-I; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; LEY K, 1991, BLOOD, V77, P2553; LOWE JB, 1991, J BIOL CHEM, V266, P17467; LOWE JB, 1990, CELL, V63, P475, DOI 10.1016/0092-8674(90)90444-J; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; MOORE KL, 1991, J CELL BIOL, V112, P491, DOI 10.1083/jcb.112.3.491; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; MOUNTZ JD, 1988, J IMMUNOL, V140, P2943; MULLIGAN MS, 1991, J CLIN INVEST, V88, P1396, DOI 10.1172/JCI115446; NICOLAOU KC, 1990, J AM CHEM SOC, V112, P3693, DOI 10.1021/ja00165a084; ORD DC, 1990, J BIOL CHEM, V265, P7760; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; PICKER LJ, 1991, NATURE, V349, P796, DOI 10.1038/349796a0; PICKER LJ, 1991, CELL, V66, P921, DOI 10.1016/0092-8674(91)90438-5; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; ROSEN SD, 1989, J IMMUNOL, V142, P1895; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SHIMIZU Y, 1991, NATURE, V349, P799, DOI 10.1038/349799a0; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SMITH CW, 1991, J CLIN INVEST, V87, P609, DOI 10.1172/JCI115037; SPERTINI O, 1991, NATURE, V349, P691, DOI 10.1038/349691a0; SPERTINI O, 1991, J IMMUNOL, V147, P2565; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STOOLMAN LM, 1983, J CELL BIOL, V96, P722, DOI 10.1083/jcb.96.3.722; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; STOOLMAN LM, 1984, J CELL BIOL, V99, P1535, DOI 10.1083/jcb.99.4.1535; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; TIEMEYER M, 1991, P NATL ACAD SCI USA, V88, P1138, DOI 10.1073/pnas.88.4.1138; TRUE DD, 1990, J CELL BIOL, V111, P2757, DOI 10.1083/jcb.111.6.2757; TYRRELL D, 1991, P NATL ACAD SCI USA, V88, P10372, DOI 10.1073/pnas.88.22.10372; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; WATSON ML, 1990, J EXP MED, V172, P263, DOI 10.1084/jem.172.1.263; WATSON SR, 1990, J CELL BIOL, V110, P2221, DOI 10.1083/jcb.110.6.2221; WATSON SR, 1991, NATURE, V349, P164, DOI 10.1038/349164a0; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; YEDNOCK TA, 1987, J CELL BIOL, V104, P713, DOI 10.1083/jcb.104.3.713; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725; ZHOU Q, 1991, J CELL BIOL, V115, P557, DOI 10.1083/jcb.115.2.557	90	1228	1288	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	1992	258	5084					964	969		10.1126/science.1439808	http://dx.doi.org/10.1126/science.1439808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439808				2022-12-28	WOS:A1992JW79600026
J	EZZAT, S; SNYDER, PJ; YOUNG, WF; BOYAJY, LD; NEWMAN, C; KLIBANSKI, A; MOLITCH, ME; BOYD, AE; SHEELER, L; COOK, DM; MALARKEY, WB; JACKSON, I; VANCE, ML; THORNER, MO; BARKAN, A; FROHMAN, LA; MELMED, S				EZZAT, S; SNYDER, PJ; YOUNG, WF; BOYAJY, LD; NEWMAN, C; KLIBANSKI, A; MOLITCH, ME; BOYD, AE; SHEELER, L; COOK, DM; MALARKEY, WB; JACKSON, I; VANCE, ML; THORNER, MO; BARKAN, A; FROHMAN, LA; MELMED, S			OCTREOTIDE TREATMENT OF ACROMEGALY - A RANDOMIZED, MULTICENTER STUDY	ANNALS OF INTERNAL MEDICINE			English	Article						OCTREOTIDE; ACROMEGALY; SOMATOTROPIN; INSULIN-LIKE GROWTH FACTOR-I; PITUITARY NEOPLASMS	SOMATOSTATIN ANALOG SMS-201-995; LONG-TERM TREATMENT; GROWTH-HORMONE; SMS 201-995; PITUITARY-ADENOMAS; TUMORS	Objective: To determine the effects of the somatostatin analog, octreotide acetate, in patients with acromegaly. Design: Double-blind, randomized trial. Setting: Fourteen university-affiliated medical centers. Patients: One hundred fifteen acromegalic patients, 70% of whom had persistent disease after pituitary surgery or radiotherapy. Intervention: Subcutaneous octreotide, 100 mug, or placebo every 8 hours for 4 weeks. Four weeks after the end of treatment, patients were randomized to receive 100 or 250 mug octreotide subcutaneously every 8 hours for 6 months. Results: After 2 weeks of treatment, a single 100-mug injection reduced mean serum growth hormone (GH) to 30% of the pretreatment concentration within 2 hours. The integrated mean GH level was reduced over 8 hours from 39 +/- 11 mug/L to 9 +/- 2 mug/L (P < 0.001). Mean plasma insulin-like growth factor-1 (IGF-1) was reduced from 5100 +/- 400 U/L to 2400 +/- 400 U/L (P < 0.001). After 6 months, the mean GH was reduced from 39 +/- 13 to 15 +/- 4 mug/L by 300 mug of octreotide and from 29 +/- 5 mug/L to 9 +/- 2 mug/L by 750 mug of octreotide daily. The mean IGF-1 concentration was suppressed to 2100 +/- 300 and 2500+/-400 U/L after 300 and 750 mug octreotide, respectively. Integrated mean GH levels were reduced to less than 5 mug/L in 53% (95% Cl, 39% to 67%) and 49% (Cl, 35% to 63%), and IGF-1 levels were normal in 68% (Cl, 54% to 82%) and 55% (Cl, 40% to 70%) of patients receiving low- and high-dose octreotide, respectively. A substantial decrease in headache, amount of perspiration, joint pain, and finger circumference occurred in two thirds of the patients. The pituitary size was reduced in 19% (Cl, 5% to 33%) and 37% (Cl, 22% to 52%) of patients receiving 6 months of low- and high-dose octreotide, respectively. Ten percent and 13% of patients in each treatment group developed transient diarrhea; 10% and 14%, biliary sludge; and 6% and 18%, cholelithiasis, respectively. Conclusion: Octreotide effectively decreased GH and IGF-1 concentrations in 53% and 68% of patients, respectively. The higher dose resulted in increased frequency of tumor shrinkage but added no biochemical or clinical benefit.	CEDARS SINAI MED CTR, 8700 BEVERLY BLVD, LOS ANGELES, CA 90048 USA	Cedars Sinai Medical Center								BARKAN AL, 1988, J CLIN ENDOCR METAB, V67, P1040, DOI 10.1210/jcem-67-5-1040; BARNARD LB, 1986, ANN INTERN MED, V105, P856, DOI 10.7326/0003-4819-105-6-856; BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X; BESSER GM, 1974, BMJ-BRIT MED J, V4, P622, DOI 10.1136/bmj.4.5945.622; CLEMMONS DR, 1979, NEW ENGL J MED, V301, P1138, DOI 10.1056/NEJM197911223012102; DAUGHADAY WH, 1989, ENDOCRINOLOGY, P318; EASTMAN RC, 1979, J CLIN ENDOCR METAB, V48, P931, DOI 10.1210/jcem-48-6-931; FREDSTORP L, 1990, J CLIN ENDOCR METAB, V71, P1189, DOI 10.1210/jcem-71-5-1189; FROHMAN LA, 1991, J CLIN ENDOCR METAB, V72, P1175, DOI 10.1210/jcem-72-6-1175; GORDEN P, 1989, ANN INTERN MED, V110, P35, DOI 10.7326/0003-4819-110-1-35; HERMAN V, 1990, J CLIN ENDOCR METAB, V71, P1427, DOI 10.1210/jcem-71-6-1427; HOFLAND LJ, 1989, J CLIN ENDOCR METAB, V68, P613, DOI 10.1210/jcem-68-3-613; HOPMAN WPM, 1990, DIGESTION, V45, P72, DOI 10.1159/000200266; KOHLER PO, 1987, NEW ENGL J MED, V317, P45, DOI 10.1056/NEJM198707023170109; LAMBERTS SWJ, 1988, ENDOCR REV, V9, P417, DOI 10.1210/edrv-9-4-417; LAMBERTS SWJ, 1985, NEW ENGL J MED, V313, P1576, DOI 10.1056/NEJM198512193132504; MELMED S, 1990, NEW ENGL J MED, V322, P966, DOI 10.1056/NEJM199004053221405; MOLITCH ME, 1985, J CLIN ENDOCR METAB, V60, P698, DOI 10.1210/jcem-60-4-698; REICHLIN S, 1983, NEW ENGL J MED, V309, P1495, DOI 10.1056/NEJM198312153092406; REICHLIN S, 1983, NEW ENGL J MED, V309, P1556, DOI 10.1056/NEJM198312223092506; REICHLIN S, 1991, INT CONGR SER, V961, P113; REUBI JC, 1989, J CLIN ENDOCR METAB, V68, P844, DOI 10.1210/jcem-68-4-844; ROSS DA, 1988, J NEUROSURG, V68, P854, DOI 10.3171/jns.1988.68.6.0854; SASSOLAS G, 1990, J CLIN ENDOCR METAB, V71, P391, DOI 10.1210/jcem-71-2-391; THORNER MO, 1988, J CLIN INVEST, V82, P745, DOI 10.1172/JCI113673; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; VANCE ML, 1991, ARCH INTERN MED, V151, P1573; VANLIESSUM PA, 1989, J CLIN ENDOCR METAB, V69, P557, DOI 10.1210/jcem-69-3-557; WANG C, 1989, J CLIN ENDOCR METAB, V69, P670, DOI 10.1210/jcem-69-3-670; WASS JAH, 1989, BRIT MED J, V299, P1162, DOI 10.1136/bmj.299.6708.1162-c; WILLIAMS G, 1987, BMJ-BRIT MED J, V295, P247, DOI 10.1136/bmj.295.6592.247	31	244	248	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					711	718		10.7326/0003-4819-117-9-711	http://dx.doi.org/10.7326/0003-4819-117-9-711			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416572				2022-12-28	WOS:A1992JV42400002
J	GOLDFARB, LG; PETERSEN, RB; TABATON, M; BROWN, P; LEBLANC, AC; MONTAGNA, P; CORTELLI, P; JULIEN, J; VITAL, C; PENDELBURY, WW; HALTIA, M; WILLS, PR; HAUW, JJ; MCKEEVER, PE; MONARI, L; SCHRANK, B; SWERGOLD, GD; AUTILIOGAMBETTI, L; GAJDUSEK, DC; LUGARESI, E; GAMBETTI, P				GOLDFARB, LG; PETERSEN, RB; TABATON, M; BROWN, P; LEBLANC, AC; MONTAGNA, P; CORTELLI, P; JULIEN, J; VITAL, C; PENDELBURY, WW; HALTIA, M; WILLS, PR; HAUW, JJ; MCKEEVER, PE; MONARI, L; SCHRANK, B; SWERGOLD, GD; AUTILIOGAMBETTI, L; GAJDUSEK, DC; LUGARESI, E; GAMBETTI, P			FATAL FAMILIAL INSOMNIA AND FAMILIAL CREUTZFELDT-JAKOB DISEASE - DISEASE PHENOTYPE DETERMINED BY A DNA POLYMORPHISM	SCIENCE			English	Article							PRECURSOR PROTEIN GENE; HUMAN PRION PROTEIN; ALZHEIMERS-DISEASE; SPONGIFORM ENCEPHALOPATHY; SICKLING HEMOGLOBIN; MUTATION; BIOLOGY; VARIANT	Fatal familial insomnia (FFI) and a subtype of familial Creutzfeldt-Jakob disease (CJD), two clinically and pathologically distinct diseases, are linked to the same mutation at codon 178 (Asn178) of the prion protein gene. The possibility that a second genetic component modified the phenotypic expression of the Asn178 mutation was investigated. FFI and the familial CJD subtype segregated with different genotypes determined by the Asn178 mutation and the methionine-valine polymorphism at codon 129. The Met129, Asn178 allele segregated with FFI in all 15 affected members of five kindreds whereas the Val129, Asn178 allele segregated with the familial CJD subtype in all 15 affected members of six kindreds. Thus, two distinct disease phenotypes linked to a single pathogenic mutation can be determined by a common polymorphism.	CASE WESTERN RESERVE UNIV,INST PATHOL,DIV NEUROPATHOL,CLEVELAND,OH 44106; NINCDS,CENT NERVOUS SYST STUDIES LAB,BETHESDA,MD 20892; NCI,BIOCHEM LAB,BETHESDA,MD 20892; UNIV BOLOGNA,INST NEUROL,I-40126 BOLOGNA,ITALY; UNIV BORDEAUX,SCH MED,DEPT NEUROL,BORDEAUX,FRANCE; UNIV BORDEAUX,SCH MED,DEPT PATHOL,BORDEAUX,FRANCE; UNIV VERMONT,DEPT PATHOL,BURLINGTON,VT 05405; UNIV HELSINKI,DEPT PATHOL,SF-00100 HELSINKI 10,FINLAND; UNIV AUCKLAND,DEPT PHYS,AUCKLAND,NEW ZEALAND; LAB NEUROPATHOL R ESCOUROLLE,PARIS,FRANCE; UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48104; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110	Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bologna; UDICE-French Research Universities; Universite de Bordeaux; Universite de Franche-Comte; UDICE-French Research Universities; Universite de Bordeaux; Universite de Franche-Comte; University of Vermont; University of Helsinki; University of Auckland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; University of Michigan System; University of Michigan; Washington University (WUSTL)			Petersen, Robert/B-5075-2011; Wills, Peter R./B-9611-2012; Cortelli, Pietro/K-6063-2016	Petersen, Robert/0000-0002-3154-0072; Wills, Peter R./0000-0002-2670-7624; Cortelli, Pietro/0000-0002-3633-8818	NIA NIH HHS [1 R01 AGNS08155-02, AG-08012-02] Funding Source: Medline; NINDS NIH HHS [NS 14509-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008012] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAKER HF, 1991, LANCET, V337, P1286, DOI 10.1016/0140-6736(91)92953-Y; BOOKCHIN RM, 1967, J BIOL CHEM, V242, P248; BROWN P, 1992, ANN NEUROL, V31, P282, DOI 10.1002/ana.410310309; BROWN P, 1991, LANCET, V337, P1019, DOI 10.1016/0140-6736(91)92670-W; BROWN PN, UNPUB; BUGE A, 1978, REV NEUROL, V134, P165; CASTANO EM, 1988, LAB INVEST, V58, P122; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; DLOUHY SR, 1992, NAT GENET, V1, P64, DOI 10.1038/ng0492-64; GAJDUSEK DC, 1990, VIROLOGY; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDFARB L G, 1989, American Journal of Human Genetics, V45, pA189; GOLDFARB LG, 1991, LANCET, V337, P425, DOI 10.1016/0140-6736(91)91198-4; GOLDFARB LG, 1992, ANN NEUROL, V31, P274, DOI 10.1002/ana.410310308; GOOSSENS M, 1975, FEBS LETT, V58, P149, DOI 10.1016/0014-5793(75)80246-8; GUIDON G, 1978, THESIS U RENNES; HALTIA M, 1979, Journal of the Neurological Sciences, V42, P381, DOI 10.1016/0022-510X(79)90171-0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HSAIO K, 1992, NAT GENET, V1, P68; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; LANGDOWN JV, 1989, BRIT J HAEMATOL, V71, P443; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LITTLE BW, 1986, ANN NEUROL, V20, P231, DOI 10.1002/ana.410200209; MANETTO V, 1992, NEUROLOGY, V42, P312, DOI 10.1212/WNL.42.2.312; MASTERS CL, 1978, BRAIN, V101, P333, DOI 10.1093/brain/101.2.333; MASTERS CL, 1981, BRAIN, V104, P559, DOI 10.1093/brain/104.3.559; MAY WW, 1968, ARCH NEUROL-CHICAGO, V19, P137, DOI 10.1001/archneur.1968.00480020023002; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; MEDORI R, 1992, NEUROLOGY, V42, P669, DOI 10.1212/WNL.42.3.669; MONPLAISIR N, 1986, P NATL ACAD SCI USA, V83, P9363, DOI 10.1073/pnas.83.24.9363; MOOPENN WF, 1977, EUR J BIOCHEM, V77, P561, DOI 10.1111/j.1432-1033.1977.tb11699.x; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PENDLEBURY W, UNPUB; PETERSEN RB, 1992, PRION DISEASE HUMANS; PETERSEN RB, IN PRESS NEUROLOGY; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; TANAKA MT, 1992, ACTA NEUROL SCAND, V85, P327; YSOHIDA K, 1992, ANN NEUROL, V31, P328	40	589	617	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					806	808		10.1126/science.1439789	http://dx.doi.org/10.1126/science.1439789			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439789				2022-12-28	WOS:A1992JV69200040
J	SHULL, MM; ORMSBY, I; KIER, AB; PAWLOWSKI, S; DIEBOLD, RJ; YIN, MY; ALLEN, R; SIDMAN, C; PROETZEL, G; CALVIN, D; ANNUNZIATA, N; DOETSCHMAN, T				SHULL, MM; ORMSBY, I; KIER, AB; PAWLOWSKI, S; DIEBOLD, RJ; YIN, MY; ALLEN, R; SIDMAN, C; PROETZEL, G; CALVIN, D; ANNUNZIATA, N; DOETSCHMAN, T			TARGETED DISRUPTION OF THE MOUSE TRANSFORMING GROWTH FACTOR-BETA-1 GENE RESULTS IN MULTIFOCAL INFLAMMATORY DISEASE	NATURE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MUCOSAL IMMUNE-SYSTEM; NECROSIS FACTOR-ALPHA; FACTOR-BETA; EXPRESSION PATTERNS; LYMPHOCYTES-B; TGF BETA-1; CELLS; INHIBITION; EMBRYO	Transforming growth factor-beta1 (TGF-beta1) is a multifunctional growth factor that has profound regulatory effects on many developmental and physiological processes. Disruption of the TGF-beta1 gene by homologous recombination in murine embryonic stem cells enables mice to be generated that carry the disrupted allele. Animals homozygous for the mutated TGF-beta1 allele show no gross developmental abnormalities, but about 20 days after birth they succumb to a wasting syndrome accompanied by a multifocal, mixed inflammatory cell response and tissue necrosis, leading to organ failure and death. TGF-beta1-deficient mice may be valuable models for human immune and inflammatory disorders, including autoimmune diseases, transplant rejection and graft versus host reactions.	UNIV CINCINNATI, COLL MED, DEPT PATHOL & LAB MED, DIV COMPARAT PATHOL, CINCINNATI, OH 45267 USA	University System of Ohio; University of Cincinnati	SHULL, MM (corresponding author), UNIV CINCINNATI, COLL MED, DEPT MOLEC GENET BIOCHEM & MICROBIOL, CINCINNATI, OH 45267 USA.				NICHD NIH HHS [R01 HD026471] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026471] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARNARD JA, 1990, BIOCHIM BIOPHYS ACTA, V1032, P79, DOI 10.1016/0304-419X(90)90013-Q; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOTTAZZO GF, 1983, LANCET, V2, P1115; BRANDES ME, 1991, J CLIN INVEST, V87, P1108, DOI 10.1172/JCI115073; BRANDTZAEG P, 1989, CURR TOP MICROBIOL, V146, P13; CHIN YH, 1992, J IMMUNOL, V148, P1106; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; COX DA, 1991, EUR J BIOCHEM, V197, P353, DOI 10.1111/j.1432-1033.1991.tb15918.x; CRONIN ME, 1988, PRIMER RHEUMATIC DIS, P120; CZARNIECKI CW, 1988, J IMMUNOL, V140, P4217; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; ESPEVIK T, 1987, J EXP MED, V166, P571, DOI 10.1084/jem.166.2.571; ESPEVIK T, 1988, J IMMUNOL, V140, P2312; FROLIK CA, 1983, P NATL ACAD SCI-BIOL, V80, P3676, DOI 10.1073/pnas.80.12.3676; GAMBLE JR, 1988, SCIENCE, V242, P97; GATHERER D, 1990, DEVELOPMENT, V110, P445; GLODE LM, 1976, J IMMUNOL, V117, P2061; HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861; JOHNS LD, 1991, J IMMUNOL, V147, P1792; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; KEHRL JH, 1991, J IMMUNOL, V146, P4016; KILSHAW PJ, 1991, EUR J IMMUNOL, V21, P2591, DOI 10.1002/eji.1830211041; KURUVILLA AP, 1991, P NATL ACAD SCI USA, V88, P2918, DOI 10.1073/pnas.88.7.2918; LEBMAN DA, 1990, J IMMUNOL, V144, P952; LEHNERT SA, 1988, DEVELOPMENT, V104, P263; LONDEI M, 1984, NATURE, V312, P639, DOI 10.1038/312639a0; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MATTHYS P, 1991, INT J CANCER, V49, P77, DOI 10.1002/ijc.2910490115; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; ORTALDO JR, 1991, J IMMUNOL, V146, P3791; PARKER CM, 1992, P NATL ACAD SCI USA, V89, P1924, DOI 10.1073/pnas.89.5.1924; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PELTON RW, 1990, DEVELOPMENT, V110, P609; RACKE MK, 1991, J IMMUNOL, V146, P3012; RANGES GE, 1987, J EXP MED, V166, P991, DOI 10.1084/jem.166.4.991; RISTOW HJ, 1986, P NATL ACAD SCI USA, V83, P5531, DOI 10.1073/pnas.83.15.5531; ROBERTS AB, 1909, PEPTIDE GROWTH FACTO, V1, P419; ROOK AH, 1986, J IMMUNOL, V136, P3916; SCHMID P, 1991, DEVELOPMENT, V111, P117; SCHWARTZ RS, 1989, FUNDAMENTAL IMMUNOLO, P819; TALAL N, 1988, PRIMER RHEUMATIC DIS, P136; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMPSON NL, 1989, J CELL BIOL, V108, P661, DOI 10.1083/jcb.108.2.661; TOKUYAMA H, 1989, CELL BIOL INT REP, V13, P251, DOI 10.1016/0309-1651(89)90147-1; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; WAHL SM, 1988, J IMMUNOL, V140, P3026; WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007/BF00918135; WILCOX JN, 1988, MOL CELL BIOL, V8, P3415, DOI 10.1128/MCB.8.8.3415	52	2550	2656	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	1992	359	6397					693	699		10.1038/359693a0	http://dx.doi.org/10.1038/359693a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436033	Green Accepted			2022-12-28	WOS:A1992JU65000045
J	GOODE, HF; BURNS, E; WALKER, BE				GOODE, HF; BURNS, E; WALKER, BE			VITAMIN-C DEPLETION AND PRESSURE SORES IN ELDERLY PATIENTS WITH FEMORAL-NECK FRACTURE	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; DIETARY SUPPLEMENTATION; PLASMA; ZINC; FEMUR	Objective-To evaluate the contribution of specific nutritional deficiencies (as indicated by zinc; vitamin A, C, and E; albumin; and haemoglobin concentrations) to the risk of pressure sores. Design-Observational cohort study. Setting-St James's University Hospital, Leeds. Subjects-21 elderly patients presenting consecutively to the orthopaedic unit with femoral neck fracture. Main outcome measure-Full thickness epidermal break over a pressure bearing surface. Results-10 patients (48%) developed a pressure sore during their hospital stay. Indices of zinc status and concentrations of albumin, haemoglobin, and vitamins A and E were similar in patients who developed a pressure sore and those who did not. Mean leucocyte vitamin C concentration, however, was 6.3 (SD 2.2) mug/10(8) cells in patients who developed a pressure sore as compared with 12.8 (4.6) mug/10(8) cells in patients who did not. Conclusions-Low concentrations of leucocyte vitamin C appear to be associated with subsequent development of pressure sores in elderly patients with femoral neck fractures.	GEN INFIRM,DEPT MED ELDERLY,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND	Leeds General Infirmary	GOODE, HF (corresponding author), ST JAMES UNIV HOSP,MED,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND.							AGREN MS, 1990, THESIS LINKOPING U L; Allman R M, 1989, Decubitus, V2, P30; BARRETT JD, 1988, J HYPERTENS, V6, P49; BASTOW MD, 1983, BRIT MED J, V287, P1589, DOI 10.1136/bmj.287.6405.1589; Breslow R, 1991, Decubitus, V4, P16; BROWN KM, IN PRESS P NUTR SOC; CATIGNANI GL, 1983, CLIN CHEM, V29, P708; DELMI M, 1990, LANCET, V335, P1013, DOI 10.1016/0140-6736(90)91073-J; DENSON KW, 1961, CLIN SCI, V21, P157; GOODE HF, 1991, AGE AGEING, V20, P345, DOI 10.1093/ageing/20.5.345; GOODE HF, 1990, CLIN SCI, V79, P247, DOI 10.1042/cs0790247; GOODE HF, 1989, ANN CLIN BIOCHEM, V26, P89, DOI 10.1177/000456328902600114; HUGHES AW, 1986, INJURY, V17, P19, DOI 10.1016/0020-1383(86)90007-0; MACHLIN LJ, 1984, HDB VITAMINS NUTRITI; MORGAN AG, 1975, INT J VITAM NUTR RES, V45, P448; PENN ND, 1991, AGE AGEING, V20, P169, DOI 10.1093/ageing/20.3.169; SCHORAH CJ, 1986, ANN CLIN BIOCHEM, V23, P566, DOI 10.1177/000456328602300513; TAYLOR TV, 1974, LANCET, V2, P544; VERSLUYSEN M, 1986, BRIT MED J, V292, P1311, DOI 10.1136/bmj.292.6531.1311; 1990, LANCET, V335, P1311	20	40	39	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 17	1992	305	6859					925	927		10.1136/bmj.305.6859.925	http://dx.doi.org/10.1136/bmj.305.6859.925			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JU649	1458073	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JU64900021
J	NEVINS, JR				NEVINS, JR			E2F - A LINK BETWEEN THE RB TUMOR SUPPRESSOR PROTEIN AND VIRAL ONCOPROTEINS	SCIENCE			English	Article							RETINOBLASTOMA GENE-PRODUCT; ADENOVIRUS E1A PROTEINS; CELLULAR TRANSCRIPTION FACTOR; DNA-BINDING ACTIVITY; HUMAN MYC PROMOTER; HUMAN CYCLIN-A; TRANS-ACTIVATION; CARCINOMA-CELLS; INFECTED CELLS; T-ANTIGEN	The cellular transcription factor E2F, previously identified as a component of early adenovirus transcription, has now been shown to be important in cell proliferation control. E2F appears to be a functional target for the action of the tumor suppressor protein Rb that is encoded by the retinoblastoma susceptibility gene. The disruption of this E2F-Rb interaction, as well as a complex involving E2F in association with the cell cycle-regulated cyclin A-cdk2 kinase complex, may be a common mechanism of action for the oncoproteins encoded by the DNA tumor viruses.			NEVINS, JR (corresponding author), DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, GENET SECT, DURHAM, NC 27710 USA.							BAGCHI S, 1990, CELL, V62, P659, DOI 10.1016/0092-8674(90)90112-R; BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BERK AJ, 1979, CELL, V17, P935, DOI 10.1016/0092-8674(79)90333-7; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; COBRINIK D, COMMUNICATION; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DEPINHO RA, 1986, P NATL ACAD SCI USA, V83, P1827, DOI 10.1073/pnas.83.6.1827; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DULBECCO R, 1965, P NATL ACAD SCI USA, V53, P403, DOI 10.1073/pnas.53.2.403; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; FAHA B, 1992, SCIENCE, V255, P87, DOI 10.1126/science.1532458; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FREARSON PM, 1965, CANCER RES, V25, P737; GALLIMORE PH, 1974, J MOL BIOL, V89, P49, DOI 10.1016/0022-2836(74)90162-4; GIORDANO A, 1991, ONCOGENE, V6, P481; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; GRAHAM FL, 1974, COLD SPRING HARB SYM, V39, P637, DOI 10.1101/SQB.1974.039.01.077; HAMEL PA, 1992, MOL CELL BIOL, V12, P3431, DOI 10.1128/MCB.12.8.3431; HARDY S, 1989, MOL CELL BIOL, V9, P4495, DOI 10.1128/MCB.9.10.4495; HARDY S, 1989, GENE DEV, V3, P1062, DOI 10.1101/gad.3.7.1062; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HIEBERT S, UNPUB; HIEBERT SW, 1991, J VIROL, V65, P3547, DOI 10.1128/JVI.65.7.3547-3552.1991; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HOUWELING A, 1980, VIROLOGY, V105, P537, DOI 10.1016/0042-6822(80)90054-9; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; HUANG MM, 1989, GENE DEV, V3, P1699, DOI 10.1101/gad.3.11.1699; HUANG S, 1991, NATURE, V350, P160, DOI 10.1038/350160a0; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KIM YK, 1991, MOL CELL BIOL, V11, P2296, DOI 10.1128/MCB.11.4.2296; KIMELMAN D, 1985, J VIROL, V53, P399, DOI 10.1128/JVI.53.2.399-409.1985; KIT S, 1965, VIROLOGY, V27, P453, DOI 10.1016/0042-6822(65)90133-9; KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; KRAUS VB, IN PRESS MOL CELL BI; KRAUS VB, UNPUB; LEDINKO N, 1967, CANCER RES, V27, P1459; LEES E, IN PRESS GENES DEV; LEES JA, UNPUB; LOEKEN MR, 1989, J BIOL CHEM, V264, P6572; MARTON MJ, 1990, J VIROL, V64, P2345, DOI 10.1128/JVI.64.5.2345-2359.1990; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; MUDRYJ M, 1990, EMBO J, V9, P2179, DOI 10.1002/j.1460-2075.1990.tb07387.x; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; NEILL SD, 1990, P NATL ACAD SCI USA, V87, P2008, DOI 10.1073/pnas.87.5.2008; NEILL SD, 1991, J VIROL, V65, P5364, DOI 10.1128/JVI.65.10.5364-5373.1991; Nevins J R, 1990, Semin Cancer Biol, V1, P59; NEVINS JR, 1981, CELL, V26, P213, DOI 10.1016/0092-8674(81)90304-4; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PEARSON BE, 1991, MOL CELL BIOL, V11, P2081, DOI 10.1128/MCB.11.4.2081; PHELPS WC, 1991, J VIROL, V65, P6922, DOI 10.1128/JVI.65.12.6922-6930.1991; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RAYCHAUDHURI P, 1991, GENE DEV, V5, P1200, DOI 10.1101/gad.5.7.1200; RAYCHAUDHURI P, 1990, J VIROL, V64, P2702, DOI 10.1128/JVI.64.6.2702-2710.1990; REICHEL R, 1989, J VIROL, V63, P3643, DOI 10.1128/JVI.63.9.3643-3650.1989; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SCHWARZ JH, UNPUB; SHENK T, 1991, ADV CANCER RES, V57, P47; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; TAKAHASH.M, 1966, P SOC EXP BIOL MED, V122, P740; TAKAHASHI R, 1991, P NATL ACAD SCI USA, V88, P5257, DOI 10.1073/pnas.88.12.5257; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; TOOZE J, 1984, DNA TUMOR VIRUSES; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; WALKER DH, 1991, NATURE, V354, P314, DOI 10.1038/354314a0; WATSON RJ, 1987, EMBO J, V6, P1643, DOI 10.1002/j.1460-2075.1987.tb02413.x; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YEE AS, 1987, EMBO J, V6, P2061, DOI 10.1002/j.1460-2075.1987.tb02471.x; YEE AS, 1989, MOL CELL BIOL, V9, P578, DOI 10.1128/MCB.9.2.578; YEE SP, 1985, VIROLOGY, V147, P142, DOI 10.1016/0042-6822(85)90234-X; YODER SS, 1983, MOL CELL BIOL, V3, P819, DOI 10.1128/MCB.3.5.819; ZIMMERMAN JE, 1970, VIROLOGY, V42, P1147, DOI 10.1016/0042-6822(70)90365-X	100	1540	1586	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	1992	258	5081					424	429						6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411535				2022-12-28	WOS:A1992JT77500025
J	DIXON, J				DIXON, J			UNITED-STATES HEALTH-CARE .2. THE COST PROBLEM	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INSURANCE; PHYSICIANS; SYSTEM				DIXON, J (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED, HLTH SERV RES UNIT, LONDON WC1E 7HT, ENGLAND.							Bailit H L, 1991, Health Care Financ Rev Annu Suppl, P87; BLENDON RJ, 1991, HEALTH AFFAIR, V10, P170, DOI 10.1377/hlthaff.10.4.170; COTTON P, 1991, JAMA-J AM MED ASSOC, V265, P2451; Coulam R F, 1991, Health Care Financ Rev Annu Suppl, P45; DIXON J, 1991, LANCET, V337, P891, DOI 10.1016/0140-6736(91)90213-9; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; FALTERMAYER E, 1992, FORTUNE         0323, P46; FEDER J, 1985, HOSPITALS UNINSURED, P3; FREUDENHEIM M, 1991, NY TIMES        0129, pD9; FREUDENHEIM M, 1991, NW TIMES, pD1; GABEL J, 1990, HEALTH AFFAIR, V9, P161, DOI 10.1377/hlthaff.9.3.161; GLASER WA, 1989, HEALTH AFFAIR, V8, P129, DOI 10.1377/hlthaff.8.3.129; HOLAHAN J, 1991, J HEALTH POLIT POLIC, V16, P335, DOI 10.1215/03616878-16-2-335; HOY EW, 1991, HEALTH AFFAIR, V10, P18, DOI 10.1377/hlthaff.10.4.18; HSIAO WC, 1988, NEW ENGL J MED, V319, P835, DOI 10.1056/NEJM198809293191305; INGLEHART JK, 1992, NEW ENGL J MED, V326, P1715; Jencks S F, 1991, Health Care Financ Rev Annu Suppl, P1; KANE NM, 1989, NEW ENGL J MED, V321, P1378, DOI 10.1056/NEJM198911163212006; Levit K R, 1991, Health Care Financ Rev, V13, P29; LEWIN T, 1991, NY TIMES        0208, pA9; LEWIN T, 1991, NY TIMES        0323, pA1; LONG SH, 1988, HEALTH AFFAIR, V7, P113, DOI 10.1377/hlthaff.7.4.113; LUFT HS, 1978, NEW ENGL J MED, V298, P1336, DOI 10.1056/NEJM197806152982404; MCCOMBS JS, 1990, HEALTH SERV RES, V25, P593; MEYER J, 1990, CRITICAL CHOICES CON; Pollack Andrew, 1991, N Y Times Web, pB8; SCHENKLER RE, 1991, HLTH CARE FINANCING, V13, P93; SCHROEDER SA, 1992, HEALTH AFFAIR, V11, P235, DOI 10.1377/hlthaff.11.1.235; SIPRESS A, 1991, WASHINGTON POST 0430; SULLIVAN CB, 1991, HEALTH AFFAIR, V10, P104, DOI 10.1377/hlthaff.10.2.104; SULLIVAN JF, 1991, NY TIMES        0430, pB2; Sullivan Joseph F, 1991, N Y Times Web, pB2; Sulvetta M B, 1991, Health Care Financ Rev Annu Suppl, P95; WILENSKY GR, 1991, HEALTH AFFAIR, V10, P62, DOI 10.1377/hlthaff.10.4.62; WILENSKY GR, 1985, HOSPITALS UNINSURED, P33; WOOLHANDLER S, 1991, NEW ENGL J MED, V324, P1253, DOI 10.1056/NEJM199105023241805; DATA HELD COMPUTERIS; 1988, HLTH INSURANCE UNINS; 1990, MED TREATMENT EFFECT; 1902, SOURCES HLTH INSURAN; 1990, DIRECT FINANCING UNC; [No title captured]	42	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	1992	305	6858					878	880		10.1136/bmj.305.6858.878	http://dx.doi.org/10.1136/bmj.305.6858.878			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422406	Green Submitted, Green Published, Bronze			2022-12-28	WOS:A1992JT77700034
J	DESIMONE, R				DESIMONE, R			THE PHYSIOLOGY OF MEMORY - RECORDINGS OF THINGS PAST	SCIENCE			English	Editorial Material							INFERIOR TEMPORAL CORTEX; SHORT-TERM-MEMORY; HIPPOCAMPAL-FORMATION; RECOGNITION MEMORY; NEURONS; LESIONS; ASSOCIATION; RESPONSES; MACAQUE; PRIMATE				DESIMONE, R (corresponding author), NIMH,NEUROPSYCHOL LAB,BETHESDA,MD 20892, USA.		Desimone, Robert/G-1121-2018					BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; COLOMBO M, 1990, SCIENCE, V247, P336, DOI 10.1126/science.2296723; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; ESKANDAR EN, IN PRESS J NEUROPHYS; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; GALFAN D, 1992, BEHAV NEUROSCI, V106, P30; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1990, COLD SPRING HARB SYM, V55, P1025; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; MERZENICH MM, 1990, COLD SPRING HARB SYM, V55, P873; MIHASHITA Y, 1988, NATURE, V335, P817; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MISHKIN M, 1991, 1990 YAK INT S PERC, P7; MISHKIN M, 1982, PHILOS T R SOC LOND, V298, P83; MITZ AR, 1991, J NEUROSCI, V11, P1855; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MURRAY EA, 1985, SCIENCE, V228, P604, DOI 10.1126/science.3983648; NADEL L, 1992, J COGNITIVE NEUROSCI, V4, P179, DOI 10.1162/jocn.1992.4.3.179; PACKARD MG, 1989, J NEUROSCI, V9, P1465; POLSTER MR, 1991, J COGNITIVE NEUROSCI, V3, P95, DOI 10.1162/jocn.1991.3.2.95; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; THOMPSON RF, 1991, NEUROPSYCHOLOGIA, V29, P571, DOI 10.1016/0028-3932(91)90011-V; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355; ZOLAMORGAN S, IN PRESS J NEUROSCI	32	59	60	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					245	246		10.1126/science.1411523	http://dx.doi.org/10.1126/science.1411523			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	1411523				2022-12-28	WOS:A1992JR86000021
J	HYMAN, AA; MIDDLETON, K; CENTOLA, M; MITCHISON, TJ; CARBON, J				HYMAN, AA; MIDDLETON, K; CENTOLA, M; MITCHISON, TJ; CARBON, J			MICROTUBULE-MOTOR ACTIVITY OF A YEAST CENTROMERE-BINDING PROTEIN COMPLEX	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC DYNEIN; KINETOCHORES; SPINDLE; MITOSIS; INVITRO; CELLS	DURING cell division, sister chromosomes segregate from each other on a microtubule-based structure called the mitotic spindle. Proteins bind to the centromere, a region of chromosomal DNA, to form the kinetochore, which mediates chromosome attachment to the mitotic spindle microtubules1,2. In the budding yeast Saccharomyces cerevisiae, genetic analysis has shown that the 28-base-pair (bp) CDEIII region of the 125-bp centromere DNA sequence (CEN sequence) is the main region controlling chromosome segregation in vivo3,4. Therefore it is likely that proteins binding to the CDEIII region link the centromeres to the microtubules during mitosis. A complex of proteins (CBF3) that binds specifically to the CDEIII DNA sequence has been isolated by affinity chromatography5. Here we describe kinetochore function in vitro. The CBF3 complex can link DNA to microtubules, and the complex contains a minus-end-directed microtubule-based motor. We suggest that microtubule-based motors form the fundamental link between microtubules and chromosomes at mitosis.	UNIV CALIF SANTA BARBARA, DEPT BIOL SCI, SANTA BARBARA, CA 93106 USA	University of California System; University of California Santa Barbara	HYMAN, AA (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA.		Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017	Hyman, Anthony A/0000-0003-3664-154X				BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; CLARKE L, 1990, TRENDS GENET, V6, P150, DOI 10.1016/0168-9525(90)90149-Z; EUTENEUER U, 1982, J CELL BIOL, V94, P644, DOI 10.1083/jcb.94.3.644; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; HYMAN AA, 1991, J CELL SCI, P125; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; MCGREW J, 1986, MOL CELL BIOL, V6, P530, DOI 10.1128/MCB.6.2.530; NG R, 1987, MOL CELL BIOL, V7, P4522, DOI 10.1128/MCB.7.12.4522; PALMER RE, 1989, J CELL BIOL, V109, P3355, DOI 10.1083/jcb.109.6.3355; PETERSON JB, 1976, J CELL SCI, V22, P219; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; ROOS UP, 1973, CHROMOSOMA, V41, P195, DOI 10.1007/BF00319696; SHIMIZU T, 1991, J CELL BIOL, V112, P1189, DOI 10.1083/jcb.112.6.1189; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; YAMAMOTO A, 1990, CELL STRUCT FUNCT, V15, P221, DOI 10.1247/csf.15.221	20	104	104	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	1992	359	6395					533	536		10.1038/359533a0	http://dx.doi.org/10.1038/359533a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406970				2022-12-28	WOS:A1992JR85900059
J	SAWIN, KE; LEGUELLEC, K; PHILIPPE, M; MITCHISON, TJ				SAWIN, KE; LEGUELLEC, K; PHILIPPE, M; MITCHISON, TJ			MITOTIC SPINDLE ORGANIZATION BY A PLUS-END-DIRECTED MICROTUBULE MOTOR	NATURE			English	Article							KINESIN-LIKE PROTEIN; CHROMOSOME SEGREGATION; DROSOPHILA; INVITRO; GENE; EXTRACTS; FLUX; IDENTIFICATION; MOTILITY; ENCODES	INTRACELLULAR microtubule motor proteins1,2 may direct the motile properties and/or morphogenesis of the mitotic spindle (reviewed in ref. 3). The recent identification of kinesin-like proteins important for mitosis or meiosis4-9 indicates that kinesin-related proteins may play a universal role in eukaryotic cell division, but the precise function of such proteins in mitosis remains unknown. Here we use an in vitro assay for spindle assembly, derived from Xenopus egg extracts10,11, to investigate the role of Eg5, a kinesin-like protein in Xenopus eggs12. Eg5 is localized along spindle microtubules, and particularly enriched near spindle poles. Immunodepletion of Eg5 from egg extracts markedly reduces the extent of spindle formation in extracts, as does direct addition of anti-Eg5 antibodies. We also demonstrate that Eg5 is a plus-end-directed microtubule motor in vitro. Our results suggest a novel mechanism for the dynamic self-organization of spindle poles in mitosis.	UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143; UNIV RENNES 1,CNRS,URA 256,DEPT BIOL & GENET DEV,F-35042 RENNES,FRANCE	University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	SAWIN, KE (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA.			Sawin, Kenneth/0000-0002-2607-2219	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039565] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HYMAN AA, 1991, J CELL SCI S, V14, P125; KITANISHIYUMURA T, 1987, CELL MOTIL CYTOSKEL, V8, P106, DOI 10.1002/cm.970080203; LEGUELLEC R, 1991, MOL CELL BIOL, V11, P3395, DOI 10.1128/MCB.11.6.3395; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; MACKETT M, 1990, NUCLEIC ACIDS RES, V18, P1082, DOI 10.1093/nar/18.4.1082; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MCINTOSH JR, 1981, INT CELLBIOL 1980 19; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; MITCHISON TJ, 1990, CELL MOTIL CYTOSKEL, V16, P93, DOI 10.1002/cm.970160202; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; MURRAY AW, 1952, METHOD CELL BIOL, P581; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PICKETTHEAPS JD, 1982, CELL, V29, P729, DOI 10.1016/0092-8674(82)90435-4; REBHUN LI, 1988, CELL MOTIL CYTOSKEL, V10, P197, DOI 10.1002/cm.970100124; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Sawin K E, 1991, Trends Cell Biol, V1, P122, DOI 10.1016/0962-8924(91)90117-R; SAWIN KE, 1992, J CELL SCI, V101, P303; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; WOLF KW, 1991, EUR J CELL BIOL, V55, P235; YANG CH, 1992, J CELL BIOL, V116, P1303, DOI 10.1083/jcb.116.6.1303; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	38	550	561	2	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 8	1992	359	6395					540	543		10.1038/359540a0	http://dx.doi.org/10.1038/359540a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406972				2022-12-28	WOS:A1992JR85900061
J	STEINHART, R; REINGOLD, AL; TAYLOR, F; ANDERSON, G; WENGER, JD				STEINHART, R; REINGOLD, AL; TAYLOR, F; ANDERSON, G; WENGER, JD			INVASIVE HAEMOPHILUS-INFLUENZAE INFECTIONS IN MEN WITH HIV-INFECTION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNE-DEFICIENCY SYNDROME; INTRAVENOUS DRUG-USERS; HEMOPHILUS-INFLUENZAE; BACTERIAL PNEUMONIA; AIDS; BACTEREMIA; ADULTS; SURVEILLANCE; DISEASE	Objective.-To determine the incidence of invasive Haemophilus influenzae disease in men with the acquired immunodeficiency syndrome (AIDS) or human immunodeficiency virus (HIV) infection and the proportion of disease due to serotype b. Design.-Population-based, active surveillance. Setting.-San Francisco (Calif) Department of Health. Participants.-All men 20 to 49 years of age with invasive H influenzae disease. Results.-The cumulative incidences of invasive H influenzae disease in men 20 to 49 years of age with AIDS and in HIV-infected men 20 to 49 years of age without AIDS were 79.2 and 14.6 per 100 000, respectively, but only 33% of cases were due to serotype b. The corresponding rates for invasive H influenzae b disease were 11.3 and 7.6 per 100 000. Conclusions.-Men with AIDS or HIV infection are at increased risk of invasive H influenzae infections, including H influenzae b, but such infections are still infrequent in this population.	UNIV CALIF BERKELEY,SCH PUBL HLTH,EPIDEMIOL PROGRAM,140 WARREN HALL,BERKELEY,CA 94720; BUR EPIDEMIOL & DIS CONTROL,SAN FRANCISCO,CA; CTR DIS CONTROL,NATL CTR INFECT DIS,DIV BACTERIAL & MYCOT DIS,ATLANTA,GA 30333; CTR DIS CONTROL,DEPT HLTH,ATLANTA,GA 30333	University of California System; University of California Berkeley; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA								BERNSTEIN LJ, 1985, PEDIATR INFECT DIS J, V4, P472, DOI 10.1097/00006454-198509000-00005; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; GRANOFF DM, 1980, J INFECT DIS, V141, P40, DOI 10.1093/infdis/141.1.40; HECHT FM, 1991, NEW ENGL J MED, V326, P1569; MUSHER DM, 1983, ANN INTERN MED, V99, P444, DOI 10.7326/0003-4819-99-4-444; PELTOLA H, 1990, REV INFECT DIS, V12, P708; POLSKY B, 1986, ANN INTERN MED, V104, P38, DOI 10.7326/0003-4819-104-1-38; REDD SC, 1990, J INFECT DIS, V162, P1012, DOI 10.1093/infdis/162.5.1012; ROLSTON KVI, 1987, AM J MED, V83, P604, DOI 10.1016/0002-9343(87)90789-3; SCHLAMM HT, 1989, AM J MED, V86, P11, DOI 10.1016/0002-9343(89)90222-2; SCHRAGER LK, 1988, AIDS, V2, pS183, DOI 10.1097/00002030-198800001-00027; SCHUCHAT A, 1991, JAMA-J AM MED ASSOC, V265, P3275, DOI 10.1001/jama.265.24.3275; SELWYN PA, 1988, AIDS, V2, P267, DOI 10.1097/00002030-198808000-00005; SELWYN PA, 1989, AM J PUBLIC HEALTH, V79, P1358, DOI 10.2105/AJPH.79.10.1358; SIMBERKOFF M, 1989, 29TH INT C ANT AG CH, P174; SIMBERKOFF MS, 1984, AM REV RESPIR DIS, V130, P1174; STEINHOFF MC, 1991, NEW ENGL J MED, V325, P1837, DOI 10.1056/NEJM199112263252603; TROLLFORS B, 1984, EUR J CLIN MICROBIOL, V3, P180, DOI 10.1007/BF02014874; WALLACE RJ, 1981, J INFECT DIS, V144, P101, DOI 10.1093/infdis/144.2.101; WENGER JD, 1990, J INFECT DIS, V162, P1316, DOI 10.1093/infdis/162.6.1316; WHIMBEY E, 1986, ANN INTERN MED, V104, P511, DOI 10.7326/0003-4819-104-4-511; WHITE S, 1985, CHEST, V87, P486, DOI 10.1378/chest.87.4.486; WITT DJ, 1987, AM J MED, V82, P900, DOI 10.1016/0002-9343(87)90150-1; 1988, MMWR, V37, P593	24	74	75	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3350	3352						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB732	1453528				2022-12-28	WOS:A1992KB73200028
J	PEREZSTABLE, EJ; SABOGAL, F; OTEROSABOGAL, R; HIATT, RA; MCPHEE, SJ				PEREZSTABLE, EJ; SABOGAL, F; OTEROSABOGAL, R; HIATT, RA; MCPHEE, SJ			MISCONCEPTIONS ABOUT CANCER AMONG LATINOS AND ANGLOS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEXICAN-AMERICANS; UNITED-STATES; BREAST-CANCER; ACCULTURATION; HISPANICS; POPULATION; BEHAVIOR; SYMPTOMS; SMOKING; HEALTH	Objective.-To collect information regarding knowledge about and attitudes toward cancer in a sample of adult health plan members, self-identified as Latino or Anglo. Design.-Cross-sectional survey. Setting.-Prepaid health plan. Respondents.-A random sample of 844 Latinos (mean age, 50.5 years) and 510 Anglos (51.8 years) completed the interview. Main Outcome Measures and Results.-Latinos were significantly more likely than Anglos to think that sugar substitutes (58% vs 42%), bruises from being hit (53% vs 34%), microwave ovens (47% vs 23%), eating pork (31% vs 11%), eating spicy foods (15% vs 8%), breast-feeding (14% vs 6%), and antibiotics (32% vs 12%) could cause cancer (P<.001 for each). Compared with Anglos, Latinos more often misidentified constant dizziness (39% vs 25%) and arthralgias (35% vs 20%) as being symptoms of cancer. A higher proportion of Latinos believed that having cancer is like getting a death sentence (46% vs 26%), that cancer is God's punishment (7% vs 2%), that there is very little one can do to prevent getting cancer (26% vs 18%), that it is uncomfortable to touch someone with cancer (13% vs 8%), and that they would rather not know if they had incurable cancer (35% vs 23%; P<.001 for each). Latino ethnicity was a significant predictor of these knowledge and attitude items in multivariate logistic regression models adjusted for sex, education, age, employment, marital status, county of residence, and self-perceived health status. Conclusions.-We conclude that misconceptions about cancer are more prevalent among Latinos than Anglos and that selected attitudes about cancer among Latinos fit a cultural theme of fatalismo. These data can enable development of culturally appropriate cancer control interventions for Latinos.	KAISER PERMANENTE MED CARE PROGRAM, DIV RES, OAKLAND, CA USA; UNIV CALIF SAN FRANCISCO, DEPT MED, DIV GEN INTERNAL MED, SAN FRANCISCO, CA 94143 USA	Kaiser Permanente; University of California System; University of California San Francisco			Hiatt, Robert/AAQ-1537-2021		NCI NIH HHS [CA 50030] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050030] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ajzen I., 1980, UNDERSTANDING ATTITU; [Anonymous], 1980, ACCULTURATION THEORY; Brislin RW., 1973, CROSS CULTURAL RES M; DALY MB, 1985, JNCI-J NATL CANCER I, V74, P753; HAFFNER SM, 1985, AM J CLIN NUTR, V42, P1266, DOI 10.1093/ajcn/42.6.1266; JEPSON C, 1991, AM J PUBLIC HEALTH, V81, P501, DOI 10.2105/AJPH.81.4.501; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; MARCUS AC, 1985, AM J PUBLIC HEALTH, V75, P169, DOI 10.2105/AJPH.75.2.169; MARIN G, 1989, AM J PUBLIC HEALTH, V79, P196, DOI 10.2105/AJPH.79.2.196; MARIN G, 1987, HISPANIC J BEHAV SCI, V9, P183, DOI 10.1177/07399863870092005; MARIN G, 1991, APPLIED SOCIAL RES M, V23, P130; MAURER JD, 1990, VITAL HLTH STAT, V20, P1; OTT L, 1988, INTRO STATISTICAL ME, P220; ROOT RK, 1987, WESTERN J MED, V146, P213; ROSENWAIKE I, 1987, AM J PUBLIC HEALTH, V77, P603, DOI 10.2105/AJPH.77.5.603; SABOGAL F, 1987, HISPANIC J BEHAV SCI, V9, P397, DOI 10.1177/07399863870094003; SAMET JM, 1988, J NATL CANCER I, V80, P432, DOI 10.1093/jnci/80.6.432; Sandoval M. C., 1986, CROSS CULTURAL TRAIN, P151; SIMON R, 1986, ANN INTERN MED, V105, P429, DOI 10.7326/0003-4819-105-3-429; TREVINO FM, 1991, JAMA-J AM MED ASSOC, V265, P233, DOI 10.1001/jama.265.2.233; TRIANDIS HC, 1984, J PERS SOC PSYCHOL, V47, P1363, DOI 10.1037/0022-3514.47.6.1363; VERNON SW, 1985, CANCER-AM CANCER SOC, V55, P1563, DOI 10.1002/1097-0142(19850401)55:7<1563::AID-CNCR2820550726>3.0.CO;2-1; 1980, 1980 CENSUS POPULATI; 1986, SPSSX USERS GUIDE; 1992, MMWR, V41, P354; 1985, STUDY HISPANICS ATTI; 1984, CONDITIONS HISPANICS	27	223	223	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3219	3223		10.1001/jama.268.22.3219	http://dx.doi.org/10.1001/jama.268.22.3219			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433762				2022-12-28	WOS:A1992KA65400028
J	ANNAS, GJ				ANNAS, GJ			HEALTH WARNINGS, SMOKING, AND CANCER - THE CIPOLLONE CASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Annas, George/0000-0001-5836-7831				GOSTIN LO, 1991, JAMA-J AM MED ASSOC, V266, P3178, DOI 10.1001/jama.266.22.3178; GREENHOUSE L, 1992, NY TIMES        0301, P1; GREENHOUSE L, 1992, NY TIMES        0505, pB10; SLADE J, 1992, JAMA-J AM MED ASSOC, V268, P524, DOI 10.1001/jama.268.4.524; 1989, DHHS CDC898411 DEP H; 1991, DHHS PHS9150213 DEP	6	2	2	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1604	1607		10.1056/NEJM199211263272219	http://dx.doi.org/10.1056/NEJM199211263272219			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435897				2022-12-28	WOS:A1992JZ43200027
J	VENES, DJ				VENES, DJ			CONTINUED ZIDOVUDINE OR DIDANOSINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											VENES, DJ (corresponding author), SPARTANBURG REG MED CTR,SPARTANBURG,SC 29303, USA.							KAHN JO, 1992, NEW ENGL J MED, V327, P581, DOI 10.1056/NEJM199208273270901	1	0	0	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1598	1598						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435892				2022-12-28	WOS:A1992JZ43200016
J	BUCKLEY, RH				BUCKLEY, RH			IMMUNODEFICIENCY DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; DEFICIENCY; PATHOGENESIS; COMPLEMENT; INFECTION; GLOBULIN; IGA				BUCKLEY, RH (corresponding author), DUKE UNIV,MED CTR,DIV ALLERGY IMMUNOL,DURHAM,NC 27710, USA.		Buckley, Rebecca/AAB-1578-2019					AKAHORI Y, 1990, J CLIN INVEST, V85, P1722, DOI 10.1172/JCI114627; ARNAIZVILLENA A, 1992, NEW ENGL J MED, V327, P529, DOI 10.1056/NEJM199208203270805; BASILE GD, 1991, IMMUNOL TODAY, V12, P456; BUCKLEY RH, 1991, NEW ENGL J MED, V325, P110, DOI 10.1056/NEJM199107113250207; BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; BUCKLEY RH, IN PRESS TXB RHEUMAT; BUCKLEY RH, 1981, CLIN IMMUNOLOGY UPDA, P147; BUCKLEY RH, 1992, CECIL TXB MED, P1446; BUCKLEY RH, 1992, ZINSSER MICROBIOLOGY, P327; BURKS AW, 1986, NEW ENGL J MED, V314, P560, DOI 10.1056/NEJM198602273140907; CUNNINGHAMRUNDLES C, 1989, J CLIN IMMUNOL, V9, P22, DOI 10.1007/BF00917124; FAUCI AS, 1991, ANN INTERN MED, V114, P678, DOI 10.7326/0003-4819-114-8-678; Fischer A, 1988, Immunodefic Rev, V1, P39; FRANK MM, 1987, NEW ENGL J MED, V316, P1525, DOI 10.1056/NEJM198706113162407; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; Griscelli C, 1989, Immunodefic Rev, V1, P135; HIRSCHHORN R, 1990, Immunodeficiency Reviews, V2, P175; LEFRANC M-P, 1991, Immunodeficiency Reviews, V2, P265; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; MCKINNEY RE, 1987, REV INFECT DIS, V9, P334; REMOLD-O'DONNELL E, 1990, Immunodeficiency Reviews, V2, P151; ROSS SC, 1984, MEDICINE, V63, P243, DOI 10.1097/00005792-198409000-00001; SCHAFFER FM, 1989, P NATL ACAD SCI USA, V86, P8015, DOI 10.1073/pnas.86.20.8015; Sullivan J L, 1989, Immunodefic Rev, V1, P325; 1992, IMMUNODEF REV, V3, P195	26	34	35	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2797	2806		10.1001/jama.268.20.2797	http://dx.doi.org/10.1001/jama.268.20.2797			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433695				2022-12-28	WOS:A1992JY66800003
J	CONDEMI, JJ				CONDEMI, JJ			THE AUTOIMMUNE-DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; SCLERODERMA; PATHOPHYSIOLOGY; FEATURES; THERAPY				CONDEMI, JJ (corresponding author), UNIV ROCHESTER,SCH MED & DENT,DEPT MED,CLIN IMMUNOL RHEUMATOL UNIT,ROCHESTER,NY 14642, USA.							ANSELL BM, 1991, RHEUM DIS CLIN N AM, V17, P931; ATHREYA BH, 1991, RHEUM DIS CLIN N AM, V17, P871; BLOMGREN SE, 1972, AM J MED, V52, P338, DOI 10.1016/0002-9343(72)90021-6; BOWLES CA, 1990, RHEUM DIS CLIN N AM, V16, P471; DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107; FOX RI, 1984, SEMIN ARTHRITIS RHEU, V14, P77, DOI 10.1016/0049-0172(84)90001-5; FOX RI, 1991, CURRENT THERAPY ALLE, P175; FRITZLER MJ, 1980, AM J MED, V69, P520, DOI 10.1016/0002-9343(80)90462-3; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; KAYE BR, 1989, ANN INTERN MED, V111, P158, DOI 10.7326/0003-4819-111-2-158; KLIPPEL JH, 1992, CURRENT THERAPY ALLE, P189; KREMER JM, 1988, ARTHRITIS RHEUM-US, V31, P577, DOI 10.1002/art.1780310501; LIPNICK RN, 1991, RHEUM DIS CLIN N AM, V17, P843; MARIETTE X, 1991, AM J MED, V90, P286, DOI 10.1016/0002-9343(91)80007-9; MARTIN RW, 1990, ANN INTERN MED, V113, P124, DOI 10.7326/0003-4819-113-2-124; Mongey A B, 1991, Adv Intern Med, V36, P151; NEMELSTEIN SH, 1980, MEDICINE, V59, P239; POSTLETHWAITE AE, 1990, RHEUM DIS CLIN N AM, V16, P125; REIMER G, 1990, RHEUMATIC DISEASE CL, V16, P109; SCOTT DGI, 1981, CLIN EXP IMMUNOL, V43, P54; SOUDAH HC, 1991, NEW ENGL J MED, V325, P1461, DOI 10.1056/NEJM199111213252102; STEINBERG AD, 1991, BASIC CLIN IMMUNOL, P432; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TRAUB YM, 1983, MEDICINE, V62, P335, DOI 10.1097/00005792-198311000-00001; ZVAIFLER NJ, 1988, AM J MED, V85, P12, DOI 10.1016/0002-9343(88)90356-7	25	29	30	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2882	2892		10.1001/jama.268.20.2882	http://dx.doi.org/10.1001/jama.268.20.2882			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433704				2022-12-28	WOS:A1992JY66800012
J	BERKY, ZT; LUCIANO, WJ; JAMES, WD				BERKY, ZT; LUCIANO, WJ; JAMES, WD			LATEX GLOVE ALLERGY - A SURVEY OF THE UNITED-STATES-ARMY-DENTAL-CORPS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							CONTACT URTICARIA; RUBBER GLOVES; HOSPITAL PERSONNEL; ANAPHYLAXIS; DERMATITIS; HEALTH; VINYL	Objective.-To assess the prevalence of latex glove allergy in a population of health care providers (dentists) with a high occupational exposure to latex gloves. Design.-A survey instrument was distributed to all active-duty dental officers in the US Army (n=1628). The survey was designed to identify those individuals who had symptoms of allergy to latex gloves. Setting.-US Army dental facilities worldwide. Results.-The response rate to the survey was 64% (n=1043). There were 143 (13.7%) responses indicating latex glove allergy. If nonrespondents were assumed to be allergy-free, the prevalence rate would be 8.8%. Conclusion.-Latex allergy, as ascertained by self-report in this survey, appears to have a substantial prevalence in this health care provider population.	USA,DENT CLIN,FT RICHIE,MD; WALTER REED ARMY MED CTR,DERMATOL SERV,WASHINGTON,DC 20307	United States Department of Defense; United States Army; Walter Reed National Military Medical Center	BERKY, ZT (corresponding author), CRAVEN DENT CLIN,FT KNOX,KY 40121, USA.							BAUER X, 1990, LANCET, V335, P912; BELSITO DV, 1990, DERMATOL CLIN, V8, P61, DOI 10.1016/S0733-8635(18)30523-0; CONDESALAZAR L, 1990, DERMATOL CLIN, V8, P49, DOI 10.1016/S0733-8635(18)30521-7; DOOMSGOOSSENS A, 1988, J AM ACAD DERMATOL, V18, P1360, DOI 10.1016/S0190-9622(88)80116-6; FISHER AA, 1991, CUTIS, V47, P301; GOLD M, 1991, J ALLERGY CLIN IMMUN, V87, P662, DOI 10.1016/0091-6749(91)90385-2; GONZALEZ E, 1988, J AM DENT ASSOC, V117, P467, DOI 10.1016/S0002-8177(88)73019-6; HEALEY MP, 1990, J AM DENT ASSOC, V121, P672, DOI 10.14219/jada.archive.1990.0273; KORNIEWICZ DM, 1990, J CLIN MICROBIOL, V28, P787, DOI 10.1128/JCM.28.4.787-788.1990; KOTILAINEN HR, 1989, ARCH INTERN MED, V149, P2749; LAWLOR K, IN PRESS CUTANEOUS S; MARCH PJ, 1988, J AM DENT ASSOC, V117, P590, DOI 10.14219/jada.archive.1988.0046; MASO MJ, 1990, J AM ACAD DERMATOL, V23, P733, DOI 10.1016/0190-9622(90)70283-N; MAYER R, 1988, JAMA-J AM MED ASSOC, V259, P3184; MORALES C, 1989, CLIN EXP ALLERGY, V19, P425, DOI 10.1111/j.1365-2222.1989.tb02409.x; NUTTER AF, 1979, BRIT J DERMATOL, V101, P597, DOI 10.1111/j.1365-2133.1979.tb15107.x; PALMER C, 1989, ADA NEWS, V20, P1; RICH P, 1991, J AM ACAD DERMATOL, V24, P37, DOI 10.1016/0190-9622(91)70006-N; RUDZKI E, 1989, CONTACT DERMATITIS, V20, P247, DOI 10.1111/j.1600-0536.1989.tb03140.x; SHAW FE, 1986, JAMA-J AM MED ASSOC, V255, P3260, DOI 10.1001/jama.255.23.3260; SOCKIN S M, 1991, Journal of Allergy and Clinical Immunology, V87, P269, DOI 10.1016/0091-6749(91)91803-2; SPANER D, 1989, J ALLERGY CLIN IMMUN, V83, P1135, DOI 10.1016/0091-6749(89)90457-0; SUSSMAN GL, 1991, JAMA-J AM MED ASSOC, V265, P2844, DOI 10.1001/jama.265.21.2844; TARLO SM, 1990, J ALLERGY CLIN IMMUN, V85, P626, DOI 10.1016/0091-6749(90)90103-B; TAYLOR JS, 1986, CONTACT DERMATITIS, P604; TURJANMAA K, 1988, CONTACT DERMATITIS, V19, P241, DOI 10.1111/j.1600-0536.1988.tb02920.x; TURJANMAA K, 1988, DERMATOL CLIN, V6, P47, DOI 10.1016/S0733-8635(18)30688-0; TURJANMAA K, 1988, CONTACT DERMATITIS, V19, P362, DOI 10.1111/j.1600-0536.1988.tb02953.x; TURJANMAA K, 1987, CONTACT DERMATITIS, V17, P270, DOI 10.1111/j.1600-0536.1987.tb01476.x; TURJANMAA K, 1988, BRIT MED J, V297, P1029, DOI 10.1136/bmj.297.6655.1029; TURJANMAA K, 1989, CONTACT DERMATITIS, V20, P360, DOI 10.1111/j.1600-0536.1989.tb03173.x; TURJANMAA K, 1984, ALLERGY S2, V40, pS35; WARPINSKI JR, 1991, ALLERGY PROC, V12, P95, DOI 10.2500/108854191779011846; WRANGSJO K, 1986, CONTACT DERMATITIS, V15, P79, DOI 10.1111/j.1600-0536.1986.tb01281.x; WRANGSJO K, 1988, CONTACT DERMATITIS, V19, P264, DOI 10.1111/j.1600-0536.1988.tb02925.x; 1990, ARMY DEFENSE MATERIA; 1990, FDA DRUG B, V20, P2; 1988, FACTS AIDS DENTAL TE; 1988, MMWR, V379, P377	39	78	79	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	1992	268	19					2695	2697						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX680	1433688				2022-12-28	WOS:A1992JX68000032
J	WEIDNER, G; CONNOR, SL; HOLLIS, JF; CONNOR, WE				WEIDNER, G; CONNOR, SL; HOLLIS, JF; CONNOR, WE			IMPROVEMENTS IN HOSTILITY AND DEPRESSION IN RELATION TO DIETARY CHANGE AND CHOLESTEROL LOWERING - THE FAMILY HEART-STUDY	ANNALS OF INTERNAL MEDICINE			English	Article						CHOLESTEROL, DIETARY; DIET THERAPY; DEPRESSION; HOSTILITY; DIETARY FATS	RANDOMLY SELECTED FAMILIES; BODY-WEIGHT; MEN; WOMEN; BEHAVIOR; CHILDREN; DISEASE; TRIALS; LIPIDS; AGE	Objective: To describe changes in negative emotions among participants of a cholesterol-lowering study. Design: Cohort study. Quantitative evaluation of changes in negative emotions in relation to diet and plasma cholesterol levels before and after a 5-year dietary intervention program aimed at reducing plasma cholesterol levels. Setting: Community-dwelling families of the Family Heart Study, Portland, Oregon. Participants: One hundred forty-nine men and 156 women from 233 families (mean age, 37.7 years). Measurements: Changes in negative emotions including depression and aggressive hostility as measured by the Hopkins Symptom Checklist (SCL-90). Results: Improvement in overall emotional state was noted for the entire sample. Those who consumed a low-fat, high complex-carbohydrate diet at the end of the study showed significantly greater improvements in depression (P = 0.044; difference in improvement, 2.9 points) and aggressive hostility (P = 0.035; difference in improvement, 3.3 points) as well as a reduction in their plasma cholesterol levels (P = 0.024; difference in improvement, 2.7%) compared with those who ate a high-fat "American diet." Conclusions: Participation in a cholesterol-lowering program may not be associated with a worsening in emotional state. To the contrary, improvements in diet appear to be associated with reductions in depression and aggressive hostility as well as with lowered plasma cholesterol levels.	OREGON HLTH SCI UNIV, DEPT MED, PORTLAND, OR 97201 USA	Oregon Health & Science University	WEIDNER, G (corresponding author), SUNY STONY BROOK, DEPT PSYCHOL, STONY BROOK, NY 11794 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025687, R01HL040368, R01HL020910] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL25687, HL20910, HL40368] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BECK AT, 1985, AM J PSYCHIAT, V142, P559; CONNOR SL, 1982, CIRCULATION, V65, P1290, DOI 10.1161/01.CIR.65.7.1290; CONNOR SL, 1984, CIRCULATION, V70, P76, DOI 10.1161/01.CIR.70.1.76; CONNOR SL, 1992, J AM DIET ASSOC, V92, P41; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; DEROGATIS LR, 1977, SCL 90 VERSION MANUA, V1; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; HOLLIS JF, 1984, PREV MED, V13, P276, DOI 10.1016/0091-7435(84)90084-7; KAPLAN JR, 1991, PSYCHOSOM MED, V53, P634, DOI 10.1097/00006842-199111000-00005; MULDOON MF, 1990, BMJ-BRIT MED J, V301, P309, DOI 10.1136/bmj.301.6747.309; MURPHY CM, 1989, J CONSULT CLIN PSYCH, V57, P579, DOI 10.1037/0022-006X.57.5.579; PIERCE DK, 1984, PREV MED, V13, P390, DOI 10.1016/0091-7435(84)90030-6; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; WEIDNER G, 1987, PSYCHOSOM MED, V49, P136, DOI 10.1097/00006842-198703000-00004; WYSOWSKI DK, 1990, ARCH INTERN MED, V150, P2169, DOI 10.1001/archinte.150.10.2169; [No title captured]	18	111	112	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					820	823		10.7326/0003-4819-117-10-820	http://dx.doi.org/10.7326/0003-4819-117-10-820			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416556				2022-12-28	WOS:A1992JX83800004
J	WERTMAN, KF; DRUBIN, DG				WERTMAN, KF; DRUBIN, DG			ACTIN CONSTITUTION - GUARANTEEING THE RIGHT TO ASSEMBLE	SCIENCE			English	Editorial Material							TETRAHYMENA ACTIN		UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley					NIGMS NIH HHS [GM42759] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042759, R37GM042759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARLIER MF, 1989, INT REV CYTOL, V115, P1339; HENNESSEY ES, 1992, J MUSCLE RES CELL M, V13, P127, DOI 10.1007/BF01874149; HIRONO M, 1990, J BIOCHEM-TOKYO, V107, P32, DOI 10.1093/oxfordjournals.jbchem.a123007; HIRONO M, 1987, J MOL BIOL, V194, P181, DOI 10.1016/0022-2836(87)90367-6; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; WERTMAN KF, 1992, GENETICS, V132, P337	9	19	20	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					759	760		10.1126/science.1439782	http://dx.doi.org/10.1126/science.1439782			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439782				2022-12-28	WOS:A1992JV69200024
J	HAHN, K; DEBIASIO, R; TAYLOR, DL				HAHN, K; DEBIASIO, R; TAYLOR, DL			PATTERNS OF ELEVATED FREE CALCIUM AND CALMODULIN ACTIVATION IN LIVING CELLS	NATURE			English	Article							SWISS 3T3 FIBROBLASTS; FLUORESCENT ANALOG; LEADING-EDGE; MYOSIN; ACTIN; STIMULATION; TRANSPORT; BINDING	THE temporal and spatial dynamics of intracellular signals and protein effectors are being defined as a result of imaging using fluorescent reagents within living cells1-5. We have described a new class of fluorescent analogues2 termed optical biosensors6, which sense chemical or molecular events through their effects on protein transducers7. One example of this new class of indicators is MeroCaM, an environmentally sensitive fluorophore which when it is attached to calmodulin reflects the activation of calmodulin by calcium in vitro2. We report here that the rise in free calcium and MeroCaM activation occur in the same period during serum stimulation of quiescent fibroblasts. MeroCaM activation also correlates with the spatial pattern of increased free calcium and the contraction of transverse fibres during wound healing1,8-10. Finally, migrating fibroblasts in the later stages of wound-healing exhibit an increasing gradient of free calcium and MeroCaM activation from the front to the rear.	CARNEGIE MELLON UNIV, CTR LIGHT MICROSCOPE IMAGING & BIOTECHNOL, PITTSBURGH, PA 15213 USA; CARNEGIE MELLON UNIV, DEPT BIOL SCI, PITTSBURGH, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University				Hahn, Klaus/0000-0002-1970-7562; Taylor, D. Lansing/0000-0001-6947-1343				ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; BRIGHT GR, 1989, J CELL PHYSIOL, V141, P410, DOI 10.1002/jcp.1041410223; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; BYRON KL, 1989, J BIOL CHEM, V264, P18234; Cohen P, 1988, CALMODULIN; CONRAD PA, 1989, CELL MOTIL CYTOSKEL, V14, P527, DOI 10.1002/cm.970140410; DEBIASIO RL, 1988, J CELL BIOL, V107, P2631, DOI 10.1083/jcb.107.6.2631; FISHER GW, 1988, CELL MOTIL CYTOSKEL, V11, P235, DOI 10.1002/cm.970110403; GIULIANO KA, 1990, CELL MOTIL CYTOSKEL, V16, P14, DOI 10.1002/cm.970160104; HAHN KM, 1990, J BIOL CHEM, V265, P20335; HAHN KM, IN PRESS FLUORESCENT; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KOLEGA J, 1991, CURR TOP MEMBR, V38, P187; LUBYPHELPS K, 1985, J CELL BIOL, V101, P1245, DOI 10.1083/jcb.101.4.1245; MCNEIL PL, 1985, J CELL BIOL, V101, P372, DOI 10.1083/jcb.101.2.372; MILLS JS, 1988, BIOCHEMISTRY-US, V27, P991, DOI 10.1021/bi00403a023; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; Sellers JR, 1987, ENZYMES, V18, ppp381, DOI 10.1016/S1874-6047(08)60264-4; TAYLOR DL, 1992, AM SCI, V80, P322; TAYLOR DL, 1980, J CELL BIOL, V86, P599, DOI 10.1083/jcb.86.2.599; TAYLOR DL, 1989, CELL STRUCT FUNCT, P297; TSIEN RY, 1989, METHOD CELL BIOL, V30, P127; TUCKER RW, 1990, EUR J CELL BIOL, V51, P120; ZAVORTINK M, 1983, EXP CELL RES, V149, P375, DOI 10.1016/0014-4827(83)90350-6	26	156	164	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	1992	359	6397					736	738		10.1038/359736a0	http://dx.doi.org/10.1038/359736a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436037				2022-12-28	WOS:A1992JU65000058
J	KOKAME, K; FUKADA, Y; YOSHIZAWA, T; TAKAO, T; SHIMONISHI, Y				KOKAME, K; FUKADA, Y; YOSHIZAWA, T; TAKAO, T; SHIMONISHI, Y			LIPID MODIFICATION AT THE N-TERMINUS OF PHOTORECEPTOR G-PROTEIN ALPHA-SUBUNIT	NATURE			English	Article							NH2-TERMINAL BLOCKING GROUP; AMINO-ACID-SEQUENCE; ROD OUTER SEGMENTS; MYRISTIC ACID; BETA-GAMMA; SUBSTRATE-SPECIFICITY; CDNA SEQUENCE; TRANSDUCIN; MYRISTOYLTRANSFERASE; BINDING	MYRISTATE is a fatty acid (fourteen-carbon chain with no double bonds, C14:0) linked to the amino-terminal glycine of several proteins 1-7, including alpha-subunits of heterotrimeric (alpha/betagamma) G proteins8,9. We report here a novel modification at the N terminus of the alpha-subunit of the photoreceptor G protein transducin, Talpha, with heterogeneous fatty acids composed of laurate (C12:0), unsaturated C14:2 and C14:1 fatty acids, and a small amount (approximately 5%) of myristate. Both the GTPase activity of Talpha/Tbetagamma and the Tbetagamma-dependent ADP-ribosylation of Talpha catalysed by pertussis toxin were inhibited by the lauroylated and myristoylated N-terminal peptide of Talpha. The myristoylated peptide gave 50% inhibition at a 3.5 to approximately 4.5-fold lower concentration than the lauroylated peptide in each assay, indicating that the strength of the interaction between Talpha and Tbetagamma is altered by heterogeneous fatty acids linked to Talpha. This suggests that a looser subunit interaction in transducin which is due to an abundance of N-linked fatty acids other than myristate would favour the rapid turnover and catalysis essential for the visual excitation in photoreceptor cells.	KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 60601,JAPAN; UNIV ELECTROCOMMUN,DEPT APPL PHYS & CHEM,CHOFU,TOKYO 182,JAPAN; OSAKA UNIV,INST PROT RES,SUITA,OSAKA 565,JAPAN	Kyoto University; University of Electro-Communications - Japan; Osaka University			吉孝, 深田/G-5090-2014	Kokame, Koichi/0000-0002-9654-6299				AITKEN A, 1982, FEBS LETT, V150, P314, DOI 10.1016/0014-5793(82)80759-X; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0; DENKER BM, 1992, J BIOL CHEM, V267, P6272; DURONIO RJ, 1991, J BIOL CHEM, V266, P10498; FUKADA Y, 1989, J BIOL CHEM, V264, P5937; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; HENDERSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P339, DOI 10.1073/pnas.80.2.339; HEUCKEROTH RO, 1988, P NATL ACAD SCI USA, V85, P8795, DOI 10.1073/pnas.85.23.8795; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; JOURNOT L, 1991, J BIOL CHEM, V266, P9009; KISHORE NS, 1991, J BIOL CHEM, V266, P8835; LINDER ME, 1991, J BIOL CHEM, V266, P4654; LOCHRIE MA, 1985, SCIENCE, V228, P96, DOI 10.1126/science.3856323; MARCHILDON GA, 1984, P NATL ACAD SCI-BIOL, V81, P7679, DOI 10.1073/pnas.81.24.7679; MEDYNSKI DC, 1985, P NATL ACAD SCI USA, V82, P4311, DOI 10.1073/pnas.82.13.4311; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEER EJ, 1988, J BIOL CHEM, V263, P8996; OZOLS J, 1984, J BIOL CHEM, V259, P3349; SCHULTZ AM, 1987, BIOCHEM BIOPH RES CO, V146, P1234, DOI 10.1016/0006-291X(87)90780-7; SHULTZ AM, 1985, SCIENCE, V227, P427; TANABE T, 1985, NATURE, V315, P242, DOI 10.1038/315242a0; TOMER KB, 1983, J AM CHEM SOC, V105, P5487, DOI 10.1021/ja00354a055; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; VUONG TM, 1984, NATURE, V311, P659, DOI 10.1038/311659a0; WATKINS PA, 1985, J BIOL CHEM, V260, P3478; YATSUNAMI K, 1985, P NATL ACAD SCI USA, V82, P4316, DOI 10.1073/pnas.82.13.4316	29	189	192	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 22	1992	359	6397					749	752		10.1038/359749a0	http://dx.doi.org/10.1038/359749a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436039				2022-12-28	WOS:A1992JU65000063
J	CHAUHAN, A; MULLINS, PA; THURAISINGHAM, ST; SCHOFIELD, PM				CHAUHAN, A; MULLINS, PA; THURAISINGHAM, ST; SCHOFIELD, PM			INTRACORONARY PAPAVERINE AND COMPLETE ATRIOVENTRICULAR-BLOCK	BRITISH MEDICAL JOURNAL			English	Letter											CHAUHAN, A (corresponding author), PAPWORTH HOSP,CAMBRIDGE CB3 8RE,ENGLAND.							MAHOMED Y, 1984, ANESTHESIOLOGY, V61, P350, DOI 10.1097/00000542-198409000-00027; TALMAN CL, 1990, J AM COLL CARDIOL, V15, P275, DOI 10.1016/S0735-1097(10)80048-8; VROLIX M, 1991, EUR HEART J, V12, P273, DOI 10.1093/oxfordjournals.eurheartj.a059880; WIJLSTRA F, 1986, CATHET CARDIOVASC DI, V12, P298; WILSON RF, 1988, AM J CARDIOL, V62, P1301, DOI 10.1016/0002-9149(88)90281-0; WILSON RF, 1986, CIRCULATION, V73, P444, DOI 10.1161/01.CIR.73.3.444	6	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					870	870		10.1136/bmj.305.6858.870	http://dx.doi.org/10.1136/bmj.305.6858.870			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422403	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JT77700027
J	MITCHELL, MJ; WOODS, DR; WILCOX, SA; GRAVES, JAM; BISHOP, CE				MITCHELL, MJ; WOODS, DR; WILCOX, SA; GRAVES, JAM; BISHOP, CE			MARSUPIAL Y-CHROMOSOME ENCODES A HOMOLOG OF THE MOUSE Y-LINKED CANDIDATE SPERMATOGENESIS GENE UBE1Y	NATURE			English	Article							HUMAN X-CHROMOSOME; UBIQUITIN-ACTIVATING ENZYME-E1; HIGHLY CONSERVED REGION; SEX-DETERMINING REGION; INACTIVATION; PROTEIN; MONOTREMES; EVOLUTION; SUGGESTS; DEFECT	THE mammalian subclass Theria consists of infraclasses Metatheria (marsupials) and Eutheria ('placentals') which diverged from each other 120-150 million years before present1 (Myr BP). Both infraclasses have Y chromosome-dependent testis determination but direct molecular evidence linking the Metatherian and Eutherian Y chromosomes is lacking. Comparative analyses indicate that three mammalian genes have remained Y-linked for at least 80 Myr, since the divergence of the Eutherian orders from a common ancestor. These are Zfy, a gene encoding a transcription factor of the zinc-finger type2; Sry, the putative primary testis-determining gene3; and Ube1y (formerly Sby or A1s9Y-1), a candidate for the mouse spermatogenesis gene Spy, encoding a ubiquitin-activating enzyme E1 homologue4,5. Although in marspials Zfy homologues are autosomal6, a Y homologue of Sry has recently been isolated. We report here the identification of a functional marsupial Y-linked homologue of the murine Ube1y gene establishing that Metatherian and Eutherian Y chromosomes diverged from a common ancestor. This extreme conservation indicates that Ube1y plays a critical role in male development.	LA TROBE UNIV,DEPT GENET & HUMAN VARIAT,BUNDOORA,VIC 3083,AUSTRALIA	La Trobe University	MITCHELL, MJ (corresponding author), UNIV TENNESSEE,DEPT OBSTET & GYNECOL,DIV REPROD GENET,MOLEC GENET LAB,MEMPHIS,TN 38105, USA.		Mitchell, Michael/I-3987-2016; Graves, Jennifer A.M./A-1387-2008	Mitchell, Michael/0000-0003-2052-7347; Graves, Jennifer/0000-0001-6480-7856				ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EWENS WJ, 1992, GENOMICS, V12, P675, DOI 10.1016/0888-7543(92)90293-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; HAMVAS RMJ, 1992, GENOMICS, V12, P363, DOI 10.1016/0888-7543(92)90386-7; KAY GF, 1991, NATURE, V354, P486, DOI 10.1038/354486a0; MITCHELL MJ, 1992, GENOMICS, V12, P26, DOI 10.1016/0888-7543(92)90402-E; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SINCLAIR AH, 1987, GENET RES, V50, P131, DOI 10.1017/S0016672300023533; SINCLAIR AH, 1988, NATURE, V336, P780, DOI 10.1038/336780a0; SPENCER JA, 1991, GENOMICS, V9, P598, DOI 10.1016/0888-7543(91)90352-F; SPENCER JA, 1991, GENOMICS, V11, P339, DOI 10.1016/0888-7543(91)90141-Z; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; WATSON JM, 1990, P NATL ACAD SCI USA, V87, P7125, DOI 10.1073/pnas.87.18.7125; WATSON JM, 1991, P NATL ACAD SCI USA, V88, P11256, DOI 10.1073/pnas.88.24.11256; ZACKSENHAUS E, 1990, CYTOGENET CELL GENET, V53, P20, DOI 10.1159/000132887; [No title captured]	23	40	42	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 8	1992	359	6395					528	531		10.1038/359528a0	http://dx.doi.org/10.1038/359528a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406968				2022-12-28	WOS:A1992JR85900057
J	ALLEN, S; SERUFILIRA, A; BOGAERTS, J; VANDEPERRE, P; NSENGUMUREMYI, F; LINDAN, C; CARAEL, M; WOLF, W; COATES, T; HULLEY, S				ALLEN, S; SERUFILIRA, A; BOGAERTS, J; VANDEPERRE, P; NSENGUMUREMYI, F; LINDAN, C; CARAEL, M; WOLF, W; COATES, T; HULLEY, S			CONFIDENTIAL HIV TESTING AND CONDOM PROMOTION IN AFRICA - IMPACT ON HIV AND GONORRHEA RATES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REPRESENTATIVE SAMPLE; CHILDBEARING WOMEN; AIDS; RISK; KNOWLEDGE; RWANDA; ATTITUDES; INFECTION; BEHAVIOR	Objective.-We evaluated the impact of human immunodeficiency virus (HIV) testing and counseling on self-reported condom and spermicide use and on corresponding HIV seroconversion and gonorrhea rates in urban Rwandan women. Design.-Prospective cohort study with 2 years of follow-up, comparison of outcome variables before and after an intervention, and condom use measured in a control group that did not receive the intervention. Setting.-Outpatient research clinic in Kigali, the capital of Rwanda. Participants.-One thousand four hundred fifty-eight childbearing women, 32% of whom were infected with HIV, were enrolled in a prospective study in 1988, and followed at 3- to 6-month intervals for 2 years. Follow-up was available for 95% of subjects at year 1 and 92% at year 2. Interventions.-An acquired immunodeficiency syndrome (AIDS) educational videotape, HIV testing and counseling, and free condoms and spermicide were provided to all participants and interested sexual partners. Main Outcome Measures.-Self-report of compliance with condom-spermicide use and observed incidence of HIV and gonorrhea. Results.-Only 7% of the women reported ever trying condoms before the intervention, but 22% reported condom use with good compliance 1 year later. Women who were HIV-positive were more likely to adopt condom use than HIV-negative women (36% vs 16%; P<.05). Independent predictors of condom use, both in HIV-positive and in HIV-negative women, included HIV testing and counseling of the male partner, having a nonmonogamous relationship, and believing condoms were not dangerous. Human immunodeficiency virus seroconversion rates decreased significantly (from 4.1 to 1.8 per 100 person-years; P<.04) in women whose partners were tested and counseled. The prevalence of gonorrhea decreased substantially (13% to 6%; P<.05) among HIV-positive women, with the greatest reduction among condom users (16% to 4%; P<.05). Conclusion.-A confidential HIV testing and counseling program was associated with increased use of condoms and reduced rates of gonorrhea and HIV in urban Rwandan women. The lack of risk reduction in HIV-negative women whose partner's serostatus was unknown was of concern. Interventions that promote HIV testing and counseling for both members of a couple should be considered in other high-prevalence areas.	WHO,GLOBAL PROGRAMME AIDS,CH-1211 GENEVA 27,SWITZERLAND; PROJET SAN FRANCISCO,SAN FRANCISCO,CA; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT EPIDEMIOL & BIOSTAT,DIV CLIN EPIDEMIOL,SAN FRANCISCO,CA 94143; BELGIAN RWANDAN,KIGALI,RWANDA; MINIST HLTH,NATL AIDS CONTROL PROGRAM,KIGALI,RWANDA	World Health Organization; University of California System; University of California San Francisco; University of California System; University of California San Francisco	ALLEN, S (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MED,DIV GEN INTERNAL MED,CTR AIDS PREVENT STUDIES,SAN FRANCISCO,CA 94105, USA.		Van de Perre, Philippe/B-9692-2008	Van de Perre, Philippe/0000-0002-3912-0427	NIAID NIH HHS [R01 AI23980] Funding Source: Medline; NIMH NIH HHS [MH 42459] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMCHAK DJ, 1990, AIDS, V4, P245, DOI 10.1097/00002030-199003000-00011; ALLEN S, 1991, JAMA-J AM MED ASSOC, V266, P1657, DOI 10.1001/jama.266.12.1657; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN S, 1991, J INFECT DIS, V164, P67, DOI 10.1093/infdis/164.1.67; ALLEN S, 1988, 14TH INT C AIDS STOC; BAJOS N, 1989, BEH, V11, P42; BECKER MH, 1988, AM J PUBLIC HEALTH, V78, P394, DOI 10.2105/AJPH.78.4.394; BOGAERTS J, 1989, SEX TRANSM DIS, V16, P123, DOI 10.1097/00007435-198907000-00001; Bradbeer C, 1990, Int J STD AIDS, V1, P233; CARAEL M, 1988, AIDS, V2, P201; CARAEL M, 1988, AIDS HLTH PROMOTION, P6; CARBALLO M, 1989, J SEX RES, V26, P287, DOI 10.1080/00224498909551516; CLEARY PD, 1991, AM J PUBLIC HEALTH, V81, P1586, DOI 10.2105/AJPH.81.12.1586; COATES TJ, 1988, AM PSYCHOL, V43, P859, DOI 10.1037/0003-066X.43.11.859; COATES TJ, 1988, AIDS, V2, pS239, DOI 10.1097/00002030-198800001-00037; COCHRAN SD, 1991, SOC SCI MED, V33, P25, DOI 10.1016/0277-9536(91)90447-K; FORSTER SJ, 1989, AIDS, V3, P147, DOI 10.1097/00002030-198903000-00005; GILLIES P, 1990, AIDS, V4, P943, DOI 10.1097/00002030-199010000-00001; GOLDBERG HI, 1989, B WORLD HEALTH ORGAN, V67, P85; HEARST N, 1988, JAMA-J AM MED ASSOC, V259, P2428, DOI 10.1001/jama.259.16.2428; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; KEGELES SM, 1990, AIDS, V4, P585, DOI 10.1097/00002030-199006000-00016; Kizer K. W., 1990, AIDS and Public Policy Journal, V5, P24; KONDELULE JK, 1989, AIDS, V3, P513, DOI 10.1097/00002030-198908000-00005; KREISS J, 1989, 5TH INT C AIDS MONTR; LINDAN C, 1991, AIDS, V5, P993, DOI 10.1097/00002030-199108000-00011; MANN J, 1987, NEW ENGL J MED, V316, P345; MAY JF, 1990, STUD FAMILY PLANN, V21, P20, DOI 10.2307/1966588; MBIZVO MT, 1989, CENT AFR J MED, V35, P519; MCKUSICK L, 1990, AM J PUBLIC HEALTH, V80, P978, DOI 10.2105/AJPH.80.8.978; MUSKA S, 1990, 6TH INT C AIDS SAN F; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; RWANDAN HIV, 1989, LANCET, V1, P941; SHEON A, 1989, 4TH INT C AIDS ASS C; SOLOMON MZ, 1989, AM J PUBLIC HEALTH, V79, P453, DOI 10.2105/AJPH.79.4.453; VANDEPERRE P, 1987, AIDS, V1, P207; Vermund Sten H., 1990, Annals of Epidemiology, V1, P141, DOI 10.1016/1047-2797(90)90005-D; WENGER NS, 1991, AM J PUBLIC HEALTH, V81, P1580, DOI 10.2105/AJPH.81.12.1580; WILSON D, 1990, SOC SCI MED, V31, P609, DOI 10.1016/0277-9536(90)90097-C; WILSON D, 1988, CENT AFR J MED, V34, P95; WOFSY CB, 1988, WESTERN J MED, V149, P687; WORTH D, 1989, STUD FAMILY PLANN, V20, P297, DOI 10.2307/1966433; ZUNZUNEGUI MV, 1986, AM J EPIDEMIOL, V123, P302, DOI 10.1093/oxfordjournals.aje.a114238; 1990, MMWR, V39, P137; 1990, WHO AIDS SERIES, V8	45	199	199	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3338	3343		10.1001/jama.268.23.3338	http://dx.doi.org/10.1001/jama.268.23.3338			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KB732	1453526				2022-12-28	WOS:A1992KB73200026
J	MACKERROW, SD; OSBORN, LA; LEVY, H; EATON, RP; ECONOMOU, P				MACKERROW, SD; OSBORN, LA; LEVY, H; EATON, RP; ECONOMOU, P			MYXEDEMA-ASSOCIATED CARDIOGENIC-SHOCK TREATED WITH INTRAVENOUS TRIIODOTHYRONINE	ANNALS OF INTERNAL MEDICINE			English	Note						MYXEDEMA; SHOCK, CARDIOGENIC; TRIIODOTHYRONINE; HYPOTHYROIDISM	HYPOTHYROIDISM	Some patients with hypothyroidism have impaired conversion of thyroxine (T4) to triiodothyronine (T3) and gastrointestinal absorption. We report a case of cardiogenic shock resulting from secondary hypothyroidism that was successfully treated with intravenous T3. Parenteral T3 is now commercially available and should be used in medically unstable hypothyroid patients with appropriate indications.	UNIV NEW MEXICO, SCH MED, DEPT INTERNAL MED, ALBUQUERQUE, NM 87131 USA	University of New Mexico								BECKER KL, 1990, PRINCIPLES PRACTICE, P275; KLEIN I, 1990, AM J MED, V88, P631, DOI 10.1016/0002-9343(90)90531-H; LADENSON PW, 1983, J CLIN ENDOCR METAB, V56, P1252, DOI 10.1210/jcem-56-6-1252; LADENSON PW, 1990, AM J MED, V88, P638, DOI 10.1016/0002-9343(90)90532-I; REZA MJ, 1975, WESTERN J MED, V123, P228; SANTOS AD, 1980, AM J MED, V68, P675, DOI 10.1016/0002-9343(80)90253-3; VORA J, 1985, J CLIN ENDOCR METAB, V61, P269, DOI 10.1210/jcem-61-2-269	7	24	25	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1992	117	12					1014	1015		10.7326/0003-4819-117-12-1014	http://dx.doi.org/10.7326/0003-4819-117-12-1014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB980	1443970				2022-12-28	WOS:A1992KB98000007
J	MENDELSON, NH				MENDELSON, NH			PRODUCTION AND INITIAL CHARACTERIZATION OF BIONITES - MATERIALS FORMED ON A BACTERIAL BACKBONE	SCIENCE			English	Article							BACILLUS-SUBTILIS; CELL-WALLS; BIOTECHNOLOGY; PRECIPITATION; GROWTH; THREAD	The addition of soluble metal salts of calcium, iron, or copper to cultures of Bacillus subtilis grown in web form nucleated precipitation at the surface of the bacterial cell walls. The mineralized cell filaments can be drawn into a fiber that when dried consists of a bacterial thread backbone carrying an inorganic solid. The ratios of organic to inorganic components (by weight) in the stiff brittle materials, called bionites, were: 1.08 for fe(2) bactonite, 1.8 for calbactonite, 2.3 for fe(3)bactonite, and 5 for cu(2)bactonite. X-ray photoelectron spectra suggest that the fe(3)bactonite contains Fe2O3, that calbactonite contains calcium carbonate, and that cu(2)bactonite contains CuCl (Cu I). Acid-base reactions of the bionites are compatible with these identifications. Burning out the organic phase of the febactonites yields a black magnetic material, presumably magnetite. The burnt cubactonite appears to yield elemental Cu(s). Calbactonite upon hydration was able to retain a genetically engineered enzymatic activity.			MENDELSON, NH (corresponding author), UNIV ARIZONA, DEPT MOLEC & CELLULAR BIOL, TUCSON, AZ 85721 USA.							ABELSON PH, 1983, SCIENCE, V219, P611, DOI 10.1126/science.6572016; BEVERIDGE TJ, 1980, J BACTERIOL, V141, P876, DOI 10.1128/JB.141.2.876-887.1980; BEVERIDGE TJ, 1989, SPEC PUBL SOC GEN MI, V26, P65; BEVERIDGE TJ, 1976, J BACTERIOL, V127, P1502, DOI 10.1128/JB.127.3.1502-1518.1976; CALVERT P, 1988, J MATER SCI, V23, P3801, DOI 10.1007/BF01106796; CHALOUPKA J, 1964, FOLIA MICROBIOL, V9, P9, DOI 10.1007/BF02875894; Doyle R.J., 1989, METAL IONS BACTERIA, P275; FERRIS FG, 1988, GEOLOGY, V16, P149, DOI 10.1130/0091-7613(1988)016<0149:MIBBBS>2.3.CO;2; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; HUGHES MN, 1989, METALS MICROORGANISM, P337; KOSHLAND DE, 1991, SCIENCE, V252, P1593, DOI 10.1126/science.252.5013.1593; Krumbein WE, 1986, BIOMINERALIZATION LO, P55; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; MANN S, 1986, BIOMINERALIZATION LO, P39; MARQUIS RE, 1976, CAN J MICROBIOL, V22, P975, DOI 10.1139/m76-142; MENDELSON NH, 1976, P NATL ACAD SCI USA, V73, P1740, DOI 10.1073/pnas.73.5.1740; MENDELSON NH, 1989, J BACTERIOL, V171, P1055, DOI 10.1128/jb.171.2.1055-1062.1989; MENDELSON NH, 1990, SCI PROG, V74, P425; MENDELSON NH, 1977, MICROBIOLOGY 1977, P5; MORITA RY, 1980, GEOMICROBIOL J, V2, P63, DOI 10.1080/01490458009377751; PAUTARD FGE, 1970, BIOL CALCIFICATION, P106; POOLEY HM, 1976, J BACTERIOL, V125, P1127, DOI 10.1128/JB.125.3.1127-1138.1976; POOLEY HM, 1976, J BACTERIOL, V125, P1139, DOI 10.1128/JB.125.3.1139-1147.1976; Rouxhet PG, 1991, MICROBIAL CELL SURFA, P173; SALHI B, 1991, THESIS U ARIZONA TUC; SWAISGOOD HE, 1985, ENZYMES IMMOBILIZED, P1; THWAITES JJ, 1991, ADV MICROB PHYSIOL, V32, P173, DOI 10.1016/S0065-2911(08)60008-9; THWAITES JJ, 1985, P NATL ACAD SCI USA, V82, P2163, DOI 10.1073/pnas.82.7.2163; ZIOLO RF, 1992, SCIENCE, V257, P219, DOI 10.1126/science.257.5067.219	29	27	27	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	1992	258	5088					1633	1636		10.1126/science.1455245	http://dx.doi.org/10.1126/science.1455245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA896	1455245				2022-12-28	WOS:A1992KA89600031
J	VANVOORHIES, WA				VANVOORHIES, WA			PRODUCTION OF SPERM REDUCES NEMATODE LIFE-SPAN	NATURE			English	Article							CAENORHABDITIS-ELEGANS; DEFECTIVE MUTANTS; REPRODUCTION; FERTILIZATION; GENETICS; COSTS	SEX and death are two fundamental but poorly understood aspects of life1-3. They are often thought to be linked because reproduction requires the diversion of limited resources from somatic growth and maintenance4-9. This diversion of resources in mated animals, often called a cost of reproduction, is usually expressed as a reduction of lifespan in mated animals, although some debate exists on the best way to measure this cost4-6,9,10. I report here that in the soil nematode, Caenorhabditis elegans, sex significantly decreases male lifespan without reducing hermaphrodite lifespan. The reduction of mated male lifespan seems to be caused by additional sperm production and not by the physical activity of mating. This conclusion is supported by observations that a mutation reducing sperm production increased mean lifespan by about 65% in both mated males and hermaphrodites. This suggests that spermatogenesis, rather than oogenesis or the physical act of mating, is a major factor reducing lifespan in C. elegans. This contradicts the traditional biological assumption that large oocytes are much costlier to produce than small sperm11-14.			VANVOORHIES, WA (corresponding author), UNIV ARIZONA, DEPT ECOL & EVOLUT BIOL, TUCSON, AZ 85721 USA.							Bell G., 1986, Oxford Surveys in Evolutionary Biology, V3, P83; BOGGS CL, 1981, OECOLOGIA, V50, P320, DOI 10.1007/BF00344970; BRENNER S, 1974, GENETICS, V77, P71; CALOW P, 1979, BIOL REV, V54, P23, DOI 10.1111/j.1469-185X.1979.tb00866.x; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Finch CE, 1990, LONGEVITY SENESCENCE; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Friedman D.B., 1988, Journals of Gerontology, V43, P102; FRIEDMAN DB, 1988, GENETICS, V118, P75; GIESS MC, 1980, EXP GERONTOL, V15, P503, DOI 10.1016/0531-5565(80)90002-9; Hennig W, 1990, Int Rev Cytol, V123, P129, DOI 10.1016/S0074-7696(08)60673-7; HIRSHFIELD MF, 1980, ECOLOGY, V61, P282, DOI 10.2307/1935187; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; HODGKIN J, 1979, GENETICS, V91, P67; ICHOD RE, 1988, EVOLUTION SEX EXAMIN; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; KREBS JR, 1981, INTRO BEHAVIOURAL EC; LHERNAULT SW, 1988, GENETICS, V120, P435; Partridge L, 1987, FUNCT ECOL, V1, P317, DOI 10.2307/2389786; PARTRIDGE L, 1985, NATURE, V316, P20, DOI 10.1038/316020a0; PARTRIDGE L, 1981, NATURE, V294, P580, DOI 10.1038/294580a0; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; SCHAFFER WM, 1979, P NATL ACAD SCI USA, V76, P3567, DOI 10.1073/pnas.76.7.3567; SIMMONS LW, 1992, NATURE, V358, P61, DOI 10.1038/358061a0; Smith M, 1978, EVOLUTION SEX; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WARD S, 1978, GENETICS, V88, P285; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Wood W.B., 1988, Cold Spring Harbor Monograph Series, V17, P1; [No title captured]	31	232	236	0	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	1992	360	6403					456	458		10.1038/360456a0	http://dx.doi.org/10.1038/360456a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448167				2022-12-28	WOS:A1992KA79700057
J	HOWARD, PK; SEFTON, BM; FIRTEL, RA				HOWARD, PK; SEFTON, BM; FIRTEL, RA			ANALYSIS OF A SPATIALLY REGULATED PHOSPHOTYROSINE PHOSPHATASE IDENTIFIES TYROSINE PHOSPHORYLATION AS A KEY REGULATORY PATHWAY IN DICTYOSTELIUM	CELL			English	Article							LEUKOCYTE-COMMON ANTIGEN; ANTERIOR-LIKE CELLS; PROTEIN-KINASE; SIGNAL TRANSDUCTION; ESCHERICHIA-COLI; GENE-EXPRESSION; RAS GENE; DISCOIDEUM; RECEPTOR; ENCODES	We have cloned a Dictyostelium phosphotyrosine phosphatase (PTP1) with a catalytic domain showing approximately 38%-50% amino acid identity to those of other PTPs. PTP1 contains an approximately 99 amino acid insert and bacterially produced PTP1 possesses PTP activity. PTP1 is expressed at a very low level in vegetative cells, induced by 4 hr, and maximally expressed at the tight aggregate stage. PTP1-lacZ studies indicate that PTP1 is spatially localized to prestalk and anterior-like cell types. PTP1 gene disruptants show accelerated development, whereas strains overexpressing PTP1 to a high level fail to aggregate. Strains overexpressing moderate levels exhibit severe morphological defects following aggregation, including multiply tipped aggregates and morphologically aberrant fruiting bodies. Western blot analysis using anti-phosphotyrosine antibodies shows specific changes in the mutant strains when compared with wild-type cells. The results indicate that reversible protein-tyrosine phosphorylation and PTP1 play important regulatory roles during Dictyostelium development.	SALK INST BIOL SCI,SAN DIEGO,CA 92186	Salk Institute	HOWARD, PK (corresponding author), UNIV CALIF SAN DIEGO,CTR MOLEC GENET,DEPT BIOL,LA JOLLA,CA 92093, USA.							AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; BURKI E, 1991, GENE, V102, P57, DOI 10.1016/0378-1119(91)90538-M; CECCARELLI A, 1991, CELL, V65, P983, DOI 10.1016/0092-8674(91)90550-I; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; DEVINE KM, 1985, DEV BIOL, V107, P364, DOI 10.1016/0012-1606(85)90318-5; DINGERMANN T, 1990, DEV GENET, V11, P410, DOI 10.1002/dvg.1020110514; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; ESCH RK, 1991, GENE DEV, V5, P9, DOI 10.1101/gad.5.1.9; FIRTEL RA, 1991, TRENDS GENET, V7, P381, DOI 10.1016/0168-9525(91)90260-W; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HABERSTROH L, 1990, GENE DEV, V4, P596, DOI 10.1101/gad.4.4.596; HADWIGER JA, 1992, GENE DEV, V6, P38, DOI 10.1101/gad.6.1.38; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; KAMPS MP, 1988, ONCOGENE, V2, P305; Kimmel AR, 1991, CURR OPIN GENET DEV, V1, P383, DOI 10.1016/S0959-437X(05)80304-1; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; KUSPA A, 1992, GENOMICS, V13, P49, DOI 10.1016/0888-7543(92)90201-3; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MANN SKO, 1991, MECH DEVELOP, V35, P89, DOI 10.1016/0925-4773(91)90060-J; MANN SKO, 1992, IN PRESS P NATL ACAD; MEHDY MC, 1983, CELL, V32, P763, DOI 10.1016/0092-8674(83)90062-4; NELLEN W, 1985, GENE, V39, P155, DOI 10.1016/0378-1119(85)90309-9; NELLEN W, 1987, METHOD CELL BIOL, V28, P67; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; OTTILIE S, 1991, P NATL ACAD SCI USA, V88, P3455, DOI 10.1073/pnas.88.8.3455; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; RALPH SJ, 1987, EMBO J, V6, P1251, DOI 10.1002/j.1460-2075.1987.tb02361.x; REYMOND CD, 1986, NATURE, V323, P340, DOI 10.1038/323340a0; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sambrook J, 1989, MOL CLONING LABORATO; SCHWEIGER A, 1990, FEBS LETT, V268, P199, DOI 10.1016/0014-5793(90)81007-B; SEFTON BM, 1991, ANNU REV CELL BIOL, V7, P257, DOI 10.1146/annurev.cellbio.7.1.257; STERNFELD J, 1982, DEV BIOL, V93, P111, DOI 10.1016/0012-1606(82)90244-5; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; TAN JL, 1990, MOL CELL BIOL, V10, P3578, DOI 10.1128/MCB.10.7.3578; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Williams JG, 1991, CURR OPIN GENET DEV, V1, P358, DOI 10.1016/S0959-437X(05)80300-4; WILLIAMS JG, 1989, CELL, V59, P1157, DOI 10.1016/0092-8674(89)90771-X; WILLIAMS JG, 1989, DEVELOPMENT, V7, P91; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949	55	66	67	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					637	647		10.1016/0092-8674(92)90597-6	http://dx.doi.org/10.1016/0092-8674(92)90597-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423620				2022-12-28	WOS:A1992JY67600011
J	ADE, H; ZHANG, X; CAMERON, S; COSTELLO, C; KIRZ, J; WILLIAMS, S				ADE, H; ZHANG, X; CAMERON, S; COSTELLO, C; KIRZ, J; WILLIAMS, S			CHEMICAL CONTRAST IN X-RAY MICROSCOPY AND SPATIALLY RESOLVED XANES SPECTROSCOPY OF ORGANIC SPECIMENS	SCIENCE			English	Article							POLYMER BLENDS; RUBBER BLENDS; ELECTRONS; DAMAGE; NYLON	The scanning transmission x-ray microscope at the National Synchrotron Light Source has been used to record x-ray absorption near-edge structure (XANES) spectra from 0.01-square-micrometer regions of organic specimens. The spectral features observed reflect the molecular structure of the dominant absorbing atoms and provide the contrast mechanism for high-resolution imaging with chemical sensitivity. This technique was used with x-ray energies near the carbon K absorption edge to identify and map separate phases in various polymer blends and to map the DNA distribution in chromosomes with a spatial resolution of 55 nanometers.	SUNY STONY BROOK,DEPT PHYS,STONY BROOK,NY 11794; EXXON RES & ENGN CO,ANNANDALE,NJ 08801	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Exxon Mobil Corporation			Kirz, Janos/AHE-9085-2022; Ade, Harald W/E-7471-2011	Zhang, Xiaodong/0000-0001-9786-7038; Ade, Harald/0000-0002-1853-5471; Williams, Shawn/0000-0001-8311-2638				ANDERSON E, 1992, XRAY MICROSCOPY, V3; BORGGREVE RJM, 1987, POLYMER, V28, P1489, DOI 10.1016/0032-3861(87)90348-X; BRIBER PM, 1988, J POLYM SCI PP, V26, P621; CAZAUX J, 1985, APPL SURF SCI, V20, P457, DOI 10.1016/0378-5963(85)90167-9; CIMMINO S, 1984, POLYM ENG SCI, V24, P48, DOI 10.1002/pen.760240106; HIRAYAMA K, 1990, BIOCHEM BIOPH RES CO, V173, P639, DOI 10.1016/S0006-291X(05)80083-X; ISAACSON M, 1972, J CHEM PHYS, V56, P1813, DOI 10.1063/1.1677457; JACOBSEN C, 1991, OPT COMMUN, V86, P351, DOI 10.1016/0030-4018(91)90016-7; KIRTLEY SM, IN PRESS BIOCH BIOPH; LAIBINIS PE, 1991, SCIENCE, V254, P981, DOI 10.1126/science.254.5034.981; LEAPMAN RD, 1992, J MICROSC-OXFORD, V165, P225, DOI 10.1111/j.1365-2818.1992.tb01482.x; RARBACK H, 1990, J XRAY SCI TECHNOL, V2, P273; REIMER L, 1988, TRANSMISSION ELECTRO; SOLEM JC, 1982, SCIENCE, V218, P229, DOI 10.1126/science.218.4569.229; SOLEM JC, 1984, OPT ENG, V23, P193, DOI 10.1117/12.7973410; STOHR J, 1992, NEXAFS SPECTROSCOPY, V25; WILLIAMS S, IN PRESS J MICROSC; WU S, 1987, POLYMER, V26, P1855; WU SH, 1987, POLYM ENG SCI, V27, P335, DOI 10.1002/pen.760270506; WU SH, 1983, J POLYM SCI POL PHYS, V21, P699, DOI 10.1002/pol.1983.180210503	20	299	310	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 6	1992	258	5084					972	975		10.1126/science.1439809	http://dx.doi.org/10.1126/science.1439809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439809				2022-12-28	WOS:A1992JW79600028
J	CHAN, JCN; COCKRAM, CS; NICHOLLS, MG; CHEUNG, CK; SWAMINATHAN, R				CHAN, JCN; COCKRAM, CS; NICHOLLS, MG; CHEUNG, CK; SWAMINATHAN, R			COMPARISON OF ENALAPRIL AND NIFEDIPINE IN TREATING NON-INSULIN-DEPENDENT DIABETES ASSOCIATED WITH HYPERTENSION - ONE YEAR ANALYSIS	BRITISH MEDICAL JOURNAL			English	Article							CONVERTING ENZYME-INHIBITOR; CONTROLLED TRIAL; HEART-FAILURE; CAPTOPRIL; MICROALBUMINURIA; NEPHROPATHY; ANTAGONIST; METABOLISM; MELLITUS; GLUCOSE	Objectives-To compare the efficacy, safety, and tolerance of enalapril and nifedipine in hypertensive patients with non-insulin dependent diabetes. Design-One year double blind follow up of patients randomly allocated to either enalapril or nifedipine with matching placebos for the alternative drug. Setting-Metabolic Investigation Unit, Hong Kong. Subjects-102 patients were randomised: 52 to nifedipine and 50 to enalapril. At baseline 44 patients had normoalbuminuria, 36 microalbuminuria, and 22 macroalbuminuria. Main outcome measures-Blood pressure, albuminuria, and parameters of renal function and glycaemic control. Results-In patients who completed one year's treatment the median dose required by the nifedipine group (n=49) was 60 mg/day; seven (14%) required additional diuretics. Of 41 patients given enalapril, 37 required the maximum dose (40 mg/day) and 27 (76%) required diuretics. At one year mean arterial blood pressures were similar in both groups. Albuminuria fell by 54% in the enalapril group and 11% in the nifedipine group (p=0.006). Fractional albumin clearance ratio fell by 47% in the enalapril group and increased by 3% in the nifedipine group (p=0.009). Creatinine clearance fell similarly in both groups but plasma creatinine concentration was increased by 20% in the enalapril group versus 8% in the nifedipine group (p=0.001). Conclusion-Patients taking enalapril often required diuretics to control blood pressure. Enalapril reduced proteinuria significantly more than nifedipine in the microalbuminuric and macroalbuminuric patients but increased plasma creatinine concentrations. Longer follow up is required to clarify the importance of enalapril's antiproteinuric effect.	CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT CHEM PATHOL,SHA TIN,HONG KONG; CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT MED,SHA TIN,HONG KONG	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	CHAN, JCN (corresponding author), CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT CLIN PHARMACOL,SHA TIN,HONG KONG.		Chan, Juliana/B-7918-2016	Chan, Juliana/0000-0003-1325-1194				ARAUZPACHECO C, 1990, AM J MED, V89, P811, DOI 10.1016/0002-9343(90)90227-5; BABA T, 1989, DIABETOLOGIA, V32, P40; BJORCK S, 1992, BMJ-BRIT MED J, V304, P339, DOI 10.1136/bmj.304.6823.339; CHAN JCN, 1991, ADVERSE DRUG REACT T, V10, P1; CHEUNG CK, 1989, CLIN BIOCHEM, V22, P425, DOI 10.1016/S0009-9120(89)80092-X; CLELAND JGF, 1984, BRIT HEART J, V52, P530; FERDER L, 1992, HYPERTENSION, V19, P237, DOI 10.1161/01.HYP.19.2_Suppl.II237; FERRIER C, 1991, DIABETES CARE, V14, P911, DOI 10.2337/diacare.14.10.911; FERRIERE M, 1985, ANN INTERN MED, V102, P134, DOI 10.7326/0003-4819-102-1-134_3; GAMBARDELLA S, 1991, AM HEART J, V122, P1232, DOI 10.1016/0002-8703(91)90946-F; GILCHRIST NL, 1988, J HUM HYPERTENS, V2, P33; HELLER J, 1986, RENAL PHYSIOL BIOCH, V9, P357; JACKSON B, 1988, J HYPERTENS, V6, P495, DOI 10.1097/00004872-198806000-00010; JAUCH KW, 1987, EUR J CLIN INVEST, V17, P448, DOI 10.1111/j.1365-2362.1987.tb01141.x; KAMPER AL, 1990, SCAND J CLIN LAB INV, V50, P611, DOI 10.3109/00365519009089178; LAI KN, IN PRESS RENIN ANGIO; MACDONALD D, 1987, CLIN CHIM ACTA, V168, P247, DOI 10.1016/0009-8981(87)90294-4; MATTHEWS DM, 1987, J HUM HYPERTENS, V1, P19; MCGUIRE GA, 1985, ANN CLIN BIOCHEM, V22, P204; MOGENSEN CE, 1992, BRIT MED J, V304, P327, DOI 10.1136/bmj.304.6823.327; MUJAIS SK, 1984, BRIT HEART J, V52, P63; MYERS BD, 1989, AM J KIDNEY DIS, V13, P20, DOI 10.1016/S0272-6386(89)80109-X; NICHOLLS MG, 1987, KIDNEY INT, V31, pS200; PARVING HH, 1983, LANCET, V1, P1175; PAYNE RB, 1986, ANN CLIN BIOCHEM, V23, P243, DOI 10.1177/000456328602300304; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; ROWE DJF, 1990, ANN CLIN BIOCHEM, V27, P297, DOI 10.1177/000456329002700404; STORNELLO M, 1992, CLIN SCI, V82, P19, DOI 10.1042/cs0820019; STORNELLO M, 1989, J HYPERTENS        S, V7, pPS65; UEDA Y, 1990, NEPHRON, V55, P85; VALVO E, 1988, AM J MED, V85, P344, DOI 10.1016/0002-9343(88)90584-0; ZIMMET P, 1982, DIABETOLOGIA, V22, P399, DOI 10.1007/BF00282581; 1991, BMJ, V302, P210; 1982, JAMA-J AM MED ASSOC, V248, P1996	34	140	142	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 24	1992	305	6860					981	985		10.1136/bmj.305.6860.981	http://dx.doi.org/10.1136/bmj.305.6860.981			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV776	1458144	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JV77600024
J	KEYSE, SM; EMSLIE, EA				KEYSE, SM; EMSLIE, EA			OXIDATIVE STRESS AND HEAT-SHOCK INDUCE A HUMAN GENE ENCODING A PROTEIN-TYROSINE PHOSPHATASE	NATURE			English	Article							SIGNAL TRANSDUCTION; IONIZING-RADIATION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; SKIN FIBROBLASTS; POSITIVE CONTROL; HEME OXYGENASE; ACTIVATION; CELLS; PURIFICATION	REACTIVE oxygen species have been implicated both in the ageing process and in degenerative diseases, including arthritis and cancer1,2. Bacteria adapt to the lethal effects of oxidants such as hydrogen peroxide by inducing the expression of protective stress genes3,4 . Analogous responses have been identified in human cells. For example, haem oxygenase is a major stress protein in human cells treated with oxidants5, and reactive oxygen intermediates activate NF-kappaB, a transcriptional regulator of genes involved in inflammatory and acute-phase responses6. We report here the isolation and characterization of a novel complementary DNA (CL100) corresponding to a messenger RNA that is highly inducible by oxidative stress and heat shock in human skin cells. The cDNA contains an open reading frame specifying a protein of M(r) 39.3K with the structural features of a non-receptor-type protein-tyrosine phosphatase7 and which has significant amino-acid sequence similarity to a Tyr/Ser-protein phosphatase encoded by the late gene H1 of vaccinia virus8. The purified protein encoded by the CL100 open reading frame expressed in bacteria has intrinsic phosphatase activity. Given the relationship between the levels of protein-tyrosine phosphorylation, receptor activity, cellular proliferation and cell-cycle control, the induction of this gene may play an important regulatory role in the human cellular response to environmental stress.			KEYSE, SM (corresponding author), UNIV EDINBURGH,IMPERIAL CANC RES FUND,DEPT BIOCHEM,MOLEC PHARMACOL UNIT,HUGH ROBSON BLDG,EDINBURGH EH8 9XD,SCOTLAND.		Keyse, Stephen M./B-9575-2009	Keyse, Stephen M./0000-0002-5150-8221	Cancer Research UK [12053] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		AMES BN, 1985, GENETIC TOXICOLOGY E, P11; BAIROCH A, 1991, PROSITE DICT PROTEIN; BUSCHER M, 1988, ONCOGENE, V3, P301; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHARLES CH, 1992, ONCOGENE, V7, P187; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; CLAASSEN LA, 1991, J BIOL CHEM, V266, P11380; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FORNACE AJ, 1989, MOL CELL BIOL, V9, P851, DOI 10.1128/MCB.9.2.851; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUTCHINSON F, 1985, PROG NUCLEIC ACID RE, V32, P115, DOI 10.1016/S0079-6603(08)60347-5; KEYSE SM, 1990, MOL CELL BIOL, V10, P4967, DOI 10.1128/MCB.10.9.4967; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; Maniatis T., 1982, MOL CLONING; MILLAR BA, 1992, CELL, V68, P407; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHERMAN ML, 1990, P NATL ACAD SCI USA, V87, P5663, DOI 10.1073/pnas.87.15.5663; TYRRELL RM, 1986, CANCER RES, V46, P2665; ZIEGLERSKYLAKAKIS K, 1987, MUTAT RES, V192, P65, DOI 10.1016/0165-7992(87)90127-8	31	591	618	0	20	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 15	1992	359	6396					644	647		10.1038/359644a0	http://dx.doi.org/10.1038/359644a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	1406996				2022-12-28	WOS:A1992JT82400060
J	[Anonymous]				[Anonymous]			SEMIPRIVATE RESEARCH - BEST OF BOTH WORLDS	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	1992	359	6396					577	577						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	1406989				2022-12-28	WOS:A1992JT82400022
J	BEGUN, DR				BEGUN, DR			MIOCENE FOSSIL HOMINIDS AND THE CHIMP-HUMAN CLADE	SCIENCE			English	Article							AUSTRALOPITHECUS-AFARENSIS; SKULL MATERIAL; EVOLUTION; ENAMEL; PHYLOGENY; HOMINOIDS; PROCONSUL; PAKISTAN; DNA	Miocene hominoids from Europe are among the earliest members of the great ape and human clade (the Hominidae). One of these forms, represented by well-preserved cranial remains from Rudabanya, Hungary, sheds new light on the question of the evolutionary relations among living hominids. This new evidence supports the view that humans have a specific evolutionary relation with chimpanzees, to the exclusion of all other apes.			BEGUN, DR (corresponding author), UNIV TORONTO,DEPT ANTHROPOL,TORONTO M5S 1A1,ONTARIO,CANADA.		Klein, Richard G/B-5910-2009					ANDREWS P, 1982, NATURE, V297, P541, DOI 10.1038/297541a0; Andrews P., 1987, P23; ANDREWS P, 1987, J HUM EVOL, V16, P101, DOI 10.1016/0047-2484(87)90062-5; ANDREWS P, 1991, PHILOS T R SOC LON B, V333, P307; Ashley-Montagu MF, 1935, Q REV BIOL, V10, P32, DOI 10.1086/394475; BEARD KC, 1986, FOLIA PRIMATOL, V47, P97; BEGUN DR, 1992, AM J PHYS ANTHROPOL, V87, P291, DOI 10.1002/ajpa.1330870306; BEGUN DR, 1987, REV GENUS DRYOPITHEC; BEYNON AD, 1991, AM J PHYS ANTHROPOL, V86, P295, DOI 10.1002/ajpa.1330860216; BOYDE A, 1987, SCANNING MICROSCOPY, V1, P1935; DEBONIS L, 1987, CR ACAD SCI II, V304, P767; DEBONIS L, 1990, NATURE, V345, P712, DOI 10.1038/345712a0; Delson E., 1975, P405; GOODMAN M, 1975, PHYLOGENY PRIMATES, P219; GOODMAN M, 1992, AM J PHYS ANTHR S, V14, P82; Groves C.P., 1986, P187; HAYASAKA K, 1988, MOL BIOL EVOL, V5, P626; IYAMOTO MM, 1992, AM J PHYS ANTHR S, V14, P126; KIMBEL WH, 1984, AM J PHYS ANTHROPOL, V64, P337, DOI 10.1002/ajpa.1330640403; KORDOS L, 1987, Annales Historico-Naturales Musei Nationalis Hungarici, V79, P77; KRETZOI L, 1969, S BIOL HUNG, V9, P3; Krogman WM, 1930, AM J ANAT, V46, P315, DOI 10.1002/aja.1000460206; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; PERRINPECONTAL P, 1992, J MOL EVOL, V34, P17, DOI 10.1007/BF00163849; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; Robinson J.T., 1972, EARLY HOMINID POSTUR; ROGERS J, 1992, AM J PHYS ANTHR S, V14, P140; ROSE MD, 1984, J HUM EVOL, V13, P503, DOI 10.1016/S0047-2484(84)80004-4; RUVOLO M, 1992, AM J PHYS ANTHR S, V14, P144; SCHWARTZ JH, 1984, NATURE, V308, P501, DOI 10.1038/308501a0; SHEA BT, 1988, BIOL ORANGUTAN, P233; SIMPSON SW, 1992, AM J PHYS ANTHROPOL, V87, P29, DOI 10.1002/ajpa.1330870104; SPOOR CF, 1991, J HUM EVOL, V21, P413, DOI 10.1016/0047-2484(91)90092-A; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Tattersall I., 1988, ENCY HUMAN EVOLUTION; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; Virchow H., 1929, GEGENBAURS MORPHOL J, V63, P480; WALKER A, 1989, SCI AM, V260, P76, DOI 10.1038/scientificamerican0189-76; Ward S.C., 1983, P211; [No title captured]	41	121	123	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 25	1992	257	5078					1929	1933		10.1126/science.1411507	http://dx.doi.org/10.1126/science.1411507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JP594	1411507				2022-12-28	WOS:A1992JP59400027
J	ANDERSON, CHM; RAJU, SK; FORSLING, ML; WHEELER, MJ				ANDERSON, CHM; RAJU, SK; FORSLING, ML; WHEELER, MJ			ESTROGEN REPLACEMENT AFTER OOPHORECTOMY - COMPARISON OF PATCHES AND IMPLANTS	BRITISH MEDICAL JOURNAL			English	Article							POSTMENOPAUSAL WOMEN; ESTRADIOL		UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT OBSTET & GYNAECOL,ST THOMAS CAMPUS,LONDON SE1 7EH,ENGLAND; UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT CHEM PATHOL,LONDON,ENGLAND	University of London; King's College London; University of London; King's College London								CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; KAMEL EM, 1991, OBSTET GYNECOL, V78, P98; SELBY PL, 1986, BRIT MED J, V293, P1337, DOI 10.1136/bmj.293.6558.1337; STANCZYK FZ, 1988, AM J OBSTET GYNECOL, V159, P1540, DOI 10.1016/0002-9378(88)90591-1; THOM MH, 1981, BRIT J OBSTET GYNAEC, V88, P426, DOI 10.1111/j.1471-0528.1981.tb01008.x	5	5	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 11	1992	305	6845					90	91		10.1136/bmj.305.6845.90	http://dx.doi.org/10.1136/bmj.305.6845.90			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD850	1449552	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JD85000023
J	MASUR, H				MASUR, H			DRUG-THERAPY - PREVENTION AND TREATMENT OF PNEUMOCYSTIS PNEUMONIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; CARINII DIHYDROFOLATE-REDUCTASE; TRIMETHOPRIM-SULFAMETHOXAZOLE; AIDS PATIENTS; RANDOMIZED TRIAL; PENTAMIDINE ISETHIONATE; INTRAVENOUS PENTAMIDINE; AEROSOLIZED PENTAMIDINE; MARROW TRANSPLANTATION; HEART-TRANSPLANTATION				MASUR, H (corresponding author), NIMH, CTR CLIN, DEPT CRIT CARE MED, BETHESDA, MD 20892 USA.							ALLEGRA CJ, 1987, NEW ENGL J MED, V317, P978, DOI 10.1056/NEJM198710153171602; ALLEGRA CJ, 1987, J EXP MED, V165, P926, DOI 10.1084/jem.165.3.926; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; ARMSTRONG MYK, 1991, J PROTOZOOL, V38, pS88; BARTLETT MS, 1991, ANTIMICROB AGENTS CH, V35, P277, DOI 10.1128/AAC.35.2.277; BARTLETT MS, 1987, J CLIN MICROBIOL, V25, P480, DOI 10.1128/JCM.25.3.480-484.1987; BASKIN MI, 1990, ANN INTERN MED, V113, P677, DOI 10.7326/0003-4819-113-9-677; BOYLAN CJ, 1991, J PROTOZOOL, V38, pS138; BOZZETTE SA, 1990, NEW ENGL J MED, V323, P1451, DOI 10.1056/NEJM199011223232104; BRENNER M, 1987, AM REV RESPIR DIS, V136, P1199, DOI 10.1164/ajrccm/136.5.1199; BURKE BA, 1973, MEDICINE, V52, P23, DOI 10.1097/00005792-197301000-00002; CARR A, 1992, ANN INTERN MED, V117, P106, DOI 10.7326/0003-4819-117-2-106; CHAVE JP, 1991, AIDS, V5, P927, DOI 10.1097/00002030-199108000-00002; CHECHANI V, 1992, CHEST, V101, P375, DOI 10.1378/chest.101.2.375; CONTE JE, 1991, J INFECT DIS, V163, P169, DOI 10.1093/infdis/163.1.169; CONTE JE, 1990, ANN INTERN MED, V113, P203, DOI 10.7326/0003-4819-113-3-203; CONTE JE, 1986, J INFECT DIS, V154, P923, DOI 10.1093/infdis/154.6.923; CUSHION MT, 1985, ANTIMICROB AGENTS CH, V28, P796, DOI 10.1128/AAC.28.6.796; CUSHION MT, 1985, EXP PARASITOL, V60, P43, DOI 10.1016/S0014-4894(85)80021-7; DYKSTRA CC, 1991, J PROTOZOOL, V38, pS78; EDMAN JC, 1989, P NATL ACAD SCI USA, V86, P8625, DOI 10.1073/pnas.86.22.8625; EDMAN U, 1989, P NATL ACAD SCI USA, V86, P6503, DOI 10.1073/pnas.86.17.6503; ELSADR W, 1988, AM REV RESPIR DIS, V137, P1264, DOI 10.1164/ajrccm/137.6.1264; FALLOON J, 1991, NEW ENGL J MED, V325, P1534, DOI 10.1056/NEJM199111283252202; FRANSON TR, 1987, ARCH SURG-CHICAGO, V122, P1034; FRENKEL JK, 1966, LAB INVEST, V15, P1559; GAGNON S, 1990, NEW ENGL J MED, V323, P1444, DOI 10.1056/NEJM199011223232103; Gajdusek D C, 1976, Natl Cancer Inst Monogr, V43, P1; GARAY SM, 1989, CHEST, V95, P769, DOI 10.1378/chest.95.4.769; GIGLIOTTI F, 1988, J CLIN INVEST, V81, P1666, DOI 10.1172/JCI113503; GIGLIOTTI F, 1986, J INFECT DIS, V154, P315, DOI 10.1093/infdis/154.2.315; GIRARD PM, 1989, LANCET, V1, P1348; GOLDEN JA, 1984, WESTERN J MED, V141, P613; GORDIN FM, 1984, ANN INTERN MED, V100, P495, DOI 10.7326/0003-4819-100-4-495; GRYZAN S, 1988, AM REV RESPIR DIS, V137, P1268, DOI 10.1164/ajrccm/137.6.1268; HARDY R, 1987, J NATL MED ASSOC, V79, P1205; HARDY WD, 1992, NEW ENGL J MED, V327, P1842, DOI 10.1056/NEJM199212243272604; HARMSEN AG, 1990, J EXP MED, V172, P937, DOI 10.1084/jem.172.3.937; HENSON JW, 1991, ARCH NEUROL-CHICAGO, V48, P406, DOI 10.1001/archneur.1991.00530160074017; HIRSCHEL B, 1991, NEW ENGL J MED, V324, P1079, DOI 10.1056/NEJM199104183241602; HOO GWS, 1990, ANN INTERN MED, V113, P195, DOI 10.7326/0003-4819-113-3-195; HUGHES WT, 1990, ANTIMICROB AGENTS CH, V34, P225, DOI 10.1128/AAC.34.2.225; HUGHES WT, 1977, NEW ENGL J MED, V297, P1419, DOI 10.1056/NEJM197712292972602; HUGHES WT, 1987, NEW ENGL J MED, V316, P1627, DOI 10.1056/NEJM198706253162604; HUGHES WT, 1978, J PEDIATR-US, V92, P285, DOI 10.1016/S0022-3476(78)80028-6; HUGHES WT, 1990, LANCET, V336, P1066, DOI 10.1016/0140-6736(90)92533-N; HUGHES WT, 1974, ANTIMICROB AGENTS CH, V5, P289, DOI 10.1128/AAC.5.3.289; HUGHES WT, 1975, CAN MED ASSOC J, V112, pS47; HUGHES WT, 1987, PNEUMOCYSTIS CARINII; IVADY G, 1967, LANCET, V1, P616; JOHNSON MP, 1990, PHARMACOTHERAPY, V10, P413; KIRBY HB, 1971, ANN INTERN MED, V75, P505, DOI 10.7326/0003-4819-75-4-505; KOVACS JA, 1989, J INFECT DIS, V160, P312, DOI 10.1093/infdis/160.2.312; KOVACS JA, 1990, EXP PARASITOL, V71, P60, DOI 10.1016/0014-4894(90)90008-Z; KOVACS JA, 1984, ANN INTERN MED, V100, P663, DOI 10.7326/0003-4819-100-5-663; KOVACS JA, 1988, J IMMUNOL, V140, P2023; KOVACS JA, 1989, J INFECT DIS, V159, P60, DOI 10.1093/infdis/159.1.60; KROWKA MJ, 1985, CHEST, V87, P237, DOI 10.1378/chest.87.2.237; LATORRE CR, 1977, APPL ENVIRON MICROB, V33, P1204, DOI 10.1128/AEM.33.5.1204-1206.1977; LAVELLE J, 1991, 7TH INT C AIDS FLOR, V2, P233; LEE BL, 1989, ANN INTERN MED, V110, P606, DOI 10.7326/0003-4819-110-8-606; LEFF RL, 1990, ANN INTERN MED, V112, P716, DOI 10.7326/0003-4819-112-9-716_1; LEGGIADRO RJ, 1981, J PEDIATR-US, V99, P96, DOI 10.1016/S0022-3476(81)80967-5; LEOUNG GS, 1990, NEW ENGL J MED, V323, P769, DOI 10.1056/NEJM199009203231201; LIPSCHIK GY, 1991, J INFECT DIS, V163, P1121, DOI 10.1093/infdis/163.5.1121; MALLORY DL, 1987, CRIT CARE MED, V15, P503, DOI 10.1097/00003246-198705000-00010; MASUR H, 1990, NEW ENGL J MED, V323, P1500, DOI 10.1056/NEJM199011223232131; MEYERS JD, 1982, REV INFECT DIS, V4, P1119; MILLIGAN DW, 1987, LANCET, V1, P867; MILLS J, 1988, ANTIMICROB AGENTS CH, V32, P1057, DOI 10.1128/AAC.32.7.1057; MONTANER JSG, 1990, ANN INTERN MED, V113, P14, DOI 10.7326/0003-4819-113-1-14; MONTANER JSG, 1991, ANN INTERN MED, V114, P948, DOI 10.7326/0003-4819-114-11-948; MURPHY RL, 1991, AM J MED, V90, P418, DOI 10.1016/0002-9343(91)80080-6; NAVIN TR, 1984, NEW ENGL J MED, V311, P1701; NOSKIN GA, 1992, CLIN INFECT DIS, V14, P183, DOI 10.1093/clinids/14.1.183; ODOHERTY MJ, 1990, CHEST, V97, P1343, DOI 10.1378/chest.97.6.1343; ODOHERTY MJ, 1988, LANCET, V2, P1283; PAULSON YJ, 1992, CHEST, V101, P67, DOI 10.1378/chest.101.1.67; PEARSON RD, 1985, ANN INTERN MED, V103, P782, DOI 10.7326/0003-4819-103-5-782; PESANTI EL, 1991, J INFECT DIS, V163, P611, DOI 10.1093/infdis/163.3.611; PIFER LL, 1977, PEDIATR RES, V11, P305, DOI 10.1203/00006450-197704000-00010; POST C, 1964, ARCH DIS CHILD, V39, P35, DOI 10.1136/adc.39.203.35; POTTRATZ ST, 1990, J CLIN INVEST, V85, P351, DOI 10.1172/JCI114445; QUEENER SF, 1988, ANTIMICROB AGENTS CH, V32, P807, DOI 10.1128/AAC.32.6.807; QUEENER SF, 1987, ANTIMICROB AGENTS CH, V31, P1323, DOI 10.1128/AAC.31.9.1323; RICHARDSON JD, 1989, J PROTOZOOL, V36, pS27, DOI 10.1111/j.1550-7408.1989.tb05817.x; RUBIN RH, 1980, NEW ENGL J MED, V303, P426, DOI 10.1056/NEJM198008213030804; RUF B, 1989, LANCET, V2, P626; SAIGENJI H, 1991, ANN THORAC SURG, V52, P107, DOI 10.1016/0003-4975(91)91429-Y; SATTLER FR, 1988, ANN INTERN MED, V109, P280, DOI 10.7326/0003-4819-109-4-280; SCHMATZ DM, 1990, P NATL ACAD SCI USA, V87, P5950, DOI 10.1073/pnas.87.15.5950; SCHNEIDER MME, 1992, NEW ENGL J MED, V327, P1836, DOI 10.1056/NEJM199212243272603; SEPKOWITZ KA, 1992, JAMA-J AM MED ASSOC, V267, P832, DOI 10.1001/jama.267.6.832; SHEAR HL, 1990, J ACQ IMMUN DEF SYND, V3, P943; SHELLITO J, 1990, J CLIN INVEST, V85, P1686, DOI 10.1172/JCI114621; SILVESTRI RC, 1987, AM REV RESPIR DIS, V136, P1003, DOI 10.1164/ajrccm/136.4.1003; SMITH RM, 1987, ANN INTERN MED, V106, P335, DOI 10.7326/0003-4819-106-2-335_1; TALSETH T, 1988, TRANSPLANT P, V20, P400; TOMA E, 1989, LANCET, V1, P1046, DOI 10.1016/S0140-6736(89)92446-X; VANDERVEN AJAM, 1991, LANCET, V338, P431, DOI 10.1016/0140-6736(91)91046-W; WACHTER RM, 1992, JAMA-J AM MED ASSOC, V267, P541, DOI 10.1001/jama.267.4.541; WALLIS PJW, 1989, ANN RHEUM DIS, V48, P247, DOI 10.1136/ard.48.3.247; WALZER PD, 1988, ANTIMICROB AGENTS CH, V32, P96, DOI 10.1128/AAC.32.1.96; WALZER PD, 1974, ANN INTERN MED, V80, P83, DOI 10.7326/0003-4819-80-1-83; WALZER PD, 1988, ANTIMICROB AGENTS CH, V32, P896, DOI 10.1128/AAC.32.6.896; WALZER PD, 1987, EXP PARASITOL, V63, P319, DOI 10.1016/0014-4894(87)90179-2; WASKIN H, 1988, JAMA-J AM MED ASSOC, V260, P345, DOI 10.1001/jama.260.3.345; WELLER R, 1955, Z Kinderheilkd, V76, P366, DOI 10.1007/BF00440251; WHARTON JM, 1986, ANN INTERN MED, V105, P37, DOI 10.7326/0003-4819-105-1-37; Whisnant J K, 1976, Natl Cancer Inst Monogr, V43, P211; 1989, MMWR MORB MORTAL SS5, V38, P1	111	195	199	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	1992	327	26					1853	1860						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KD714	1448123				2022-12-28	WOS:A1992KD71400006
J	ROSENBERG, IH				ROSENBERG, IH			FOLIC-ACID AND NEURAL-TUBE DEFECTS - TIME FOR ACTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERICONCEPTIONAL USE; SUPPLEMENTATION; EXPERIENCE; PREVENTION; FOLATE				ROSENBERG, IH (corresponding author), TUFTS UNIV,USDA,HUMAN NUTR CTR AGING,BOSTON,MA 02111, USA.							BOWER C, 1989, MED J AUSTRALIA, V150, P613, DOI 10.5694/j.1326-5377.1989.tb136723.x; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; HIBBARD ED, 1965, LANCET, V1, P1254; LAURENCE KM, 1981, BRIT MED J, V282, P1509, DOI 10.1136/bmj.282.6275.1509; MILLS JL, 1989, NEW ENGL J MED, V321, P430, DOI 10.1056/NEJM198908173210704; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; MULINARE J, 1988, JAMA-J AM MED ASSOC, V260, P3141, DOI 10.1001/jama.260.21.3141; SMITHELLS RW, 1983, LANCET, V1, P1027; VERGEL RG, 1990, PRENATAL DIAG, V10, P149, DOI 10.1002/pd.1970100303; 1991, LANCET, V338, P131; 1992, MMWR MORB MORTAL WKL, V41	11	41	42	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	1992	327	26					1875	1877		10.1056/NEJM199212243272609	http://dx.doi.org/10.1056/NEJM199212243272609			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KD714	1448126				2022-12-28	WOS:A1992KD71400009
J	BALLEM, PJ; BELZBERG, A; DEVINE, DV; LYSTER, D; SPRUSTON, B; CHAMBERS, H; DOUBROFF, P; MIKULASH, K				BALLEM, PJ; BELZBERG, A; DEVINE, DV; LYSTER, D; SPRUSTON, B; CHAMBERS, H; DOUBROFF, P; MIKULASH, K			KINETIC-STUDIES OF THE MECHANISM OF THROMBOCYTOPENIA IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOMOSEXUAL MEN; HEMATOLOGIC MANIFESTATIONS; PATHO-PHYSIOLOGY; GLYCOPROTEIN-IB; HIV INFECTION; PURPURA; MEGAKARYOCYTES; PLATELETS; AUTOANTIBODIES; INTERLEUKIN-6	Background. Isolated thrombocytopenia accompanied by increased amounts of platelet-associated antibody is a common manifestation of human immunodeficiency virus (HIV) infection, and the thrombocytopenia often improves with zidovudine. It is not clear whether the mechanism of HIV-related thrombocytopenia primarily involves autoimmune destruction of platelets or reduced platelet production by megakaryocytes. Methods. We studied the survival of In-111-labeled autologous platelets and performed platelet imaging in 24 men with isolated HIV-related thrombocytopenia (1 6 who received no treatment and 8 who received zidovudine). We also studied 20 HIV-infected men with normal platelet counts (10 who received no treatment and 10 who received zidovudine) and studied 12 healthy seronegative men as controls. Results. Mean(+/-SD) platelet survival was significantly decreased in both the untreated and the zidovudine-treated patients with HIV-related thrombocytopenia (to 92+/-33 and 129+/-44 hours, respectively; both P<0.001), as compared with the normal controls (198+/-15 hours). Mean platelet survival was also significantly decreased in the HIV-infected patients with normal platelet counts (untreated, 162+/-23 hours, P<0.01; zidovudine-treated, 166+/-35 hours, P<0.05). Imaging studies, however, revealed no evidence of increased clearance of autologous platelets in the liver or spleen in any of these groups. Mean platelet production was significantly depressed in the untreated patients with thrombocytopenia (23,000+/-11,000 platelets per cubic millimeter per day, P<0.001) as compared with the healthy controls (45,000+/-6,000 per cubic millimeter per day). Mean platelet production was significantly increased, however, in the men treated with zidovudine, both in those with thrombocytopenia (60,000+/-31,000 platelets per cubic millimeter per day, P<0.01 vs. controls) and in those without thrombocytopenia (68,000+/-22,000 per cubic millimeter per day, P<0.01). Conclusions. Although there was a moderate reduction in platelet survival in HIV-infected persons, these patients, regardless of platelet counts, also had decreased production of platelets, possibly due to viral infection of the megakaryocytes. Zidovudine appears to improve platelet production.	ST PAULS HOSP, DEPT MED, VANCOUVER V6Z 1Y6, BC, CANADA; ST PAULS HOSP, DEPT NUCL MED, VANCOUVER V6Z 1Y6, BC, CANADA; ST PAULS HOSP, DEPT PATHOL, VANCOUVER V6Z 1Y6, BC, CANADA; CANADIAN RED CROSS SOC, BLOOD TRANSFUS SERV, VANCOUVER, BC, CANADA; UNIV BRITISH COLUMBIA, VANCOUVER V6T 1W5, BC, CANADA	St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of British Columbia								ABRAMS DI, 1984, AM J CLIN PATHOL, V81, P13, DOI 10.1093/ajcp/81.1.13; ABRAMS DI, 1986, ANN INTERN MED, V104, P47, DOI 10.7326/0003-4819-104-1-47; ASANO S, 1990, BLOOD, V75, P1602; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; BALLEM PJ, 1989, BLUT, V59, P111, DOI 10.1007/BF00320260; BASCH RS, 1990, P NATL ACAD SCI USA, V87, P8085, DOI 10.1073/pnas.87.20.8085; BEARDSLEY DS, 1984, J CLIN INVEST, V74, P1701, DOI 10.1172/JCI111587; BETTAIEB A, 1989, BRIT J HAEMATOL, V73, P241, DOI 10.1111/j.1365-2141.1989.tb00259.x; BIK T, 1982, BLOOD, V59, P482; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P334; CHOW FPR, 1991, BLOOD S, V78, pA148; COX LH, 1991, BLOOD, V77, P286; GERNSHEIMER T, 1989, NEW ENGL J MED, V320, P974, DOI 10.1056/NEJM198904133201505; HANSON SR, 1985, BLOOD, V66, P1105; HARKER LA, 1969, J CLIN INVEST, V48, P963, DOI 10.1172/JCI106077; HEYNS AP, 1985, PLATELET KINETICS IM, V2, P97; HILL RJ, 1990, J CLIN INVEST, V85, P1242, DOI 10.1172/JCI114559; HIRSCHEL B, 1988, ANN INTERN MED, V109, P718, DOI 10.7326/0003-4819-109-9-718; HIRSH J, 1966, BRIT J HAEMATOL, V12, P44, DOI 10.1111/j.1365-2141.1966.tb00125.x; HYMES KB, 1988, NEW ENGL J MED, V318, P516, DOI 10.1056/NEJM198802253180812; JERUSHALMY Z, 1963, P SOC EXP BIOL MED, V114, P687, DOI 10.3181/00379727-114-28771; KARPATKIN S, 1988, P NATL ACAD SCI USA, V85, P9763, DOI 10.1073/pnas.85.24.9763; KLAASSEN RJL, 1989, BLUT, V59, P75, DOI 10.1007/BF00320253; LEIDERMAN IZ, 1987, BLOOD, V70, P1267; LIPSON RL, 1959, AM J CLIN PATHOL, V32, P526; LOUACHE F, 1991, BLOOD, V78, P1697; MATHIAS CJ, 1984, SEMIN NUCL MED, V14, P118, DOI 10.1016/S0001-2998(84)80025-2; MONTANER JSG, 1990, J ACQ IMMUN DEF SYND, V3, P565; MONTE D, 1992, BLOOD, V79, P2670; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; MURPHY EA, 1971, THROMB DIATH HAEMOST, V25, P53, DOI 10.1055/s-0038-1654280; PENA JM, 1990, ACTA HAEMATOL-BASEL, V83, P86; PERKOCHA LA, 1988, AM J HEMATOL, V29, P94, DOI 10.1002/ajh.2830290207; POTTAGE JC, 1988, JAMA-J AM MED ASSOC, V260, P3045, DOI 10.1001/jama.260.20.3045; SAVONA S, 1985, ANN INTERN MED, V102, P737, DOI 10.7326/0003-4819-102-6-737; SCADDEN DT, 1989, BLOOD, V74, P1455; SCOTT S, 1978, BLOOD, V52, P47; STELLA CC, 1987, J CLIN INVEST, V80, P286, DOI 10.1172/JCI113071; STELLA CC, 1988, HAEMATOLOGICA, V73, P25; STRATTON JR, 1989, J NUCL MED, V30, P629; SZATKOWSKI NS, 1986, BLOOD, V67, P310; TERADA H, 1966, BLOOD-J HEMATOL, V28, P213, DOI 10.1182/blood.V28.2.213.213; VANDERLELIE J, 1987, BRIT J HAEMATOL, V67, P109, DOI 10.1111/j.1365-2141.1987.tb02304.x; WALSH CM, 1984, NEW ENGL J MED, V311, P635, DOI 10.1056/NEJM198409063111004; WOODS VL, 1984, BLOOD, V63, P368; WOODS VL, 1984, BLOOD, V64, P156; ZAULI G, 1992, BLOOD, V79, P2680; ZON LI, 1987, BRIT J HAEMATOL, V66, P251, DOI 10.1111/j.1365-2141.1987.tb01307.x; ZUCKERFRANKLIN D, 1989, P NATL ACAD SCI USA, V86, P5595, DOI 10.1073/pnas.86.14.5595; ZUCKERFRANKLIN D, 1989, AM J PATHOL, V134, P1295; 1987, MMWR MORB MORTAL S1, V36, pS3	51	162	169	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	1992	327	25					1779	1784		10.1056/NEJM199212173272503	http://dx.doi.org/10.1056/NEJM199212173272503			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB975	1435932	Bronze			2022-12-28	WOS:A1992KB97500003
J	JAY, ME; SILVER, MT				JAY, ME; SILVER, MT			ACUTE BACTERIAL-ENDOCARDITIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Note									MASSACHUSETTS GEN HOSP,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital	JAY, ME (corresponding author), BROCKTON W ROXBURY VET AFFAIRS MED CTR,BOSTON,MA 02132, USA.								0	0	0	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	1992	327	24					1734	1734						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA897	1435918				2022-12-28	WOS:A1992KA89700007
J	CREWS, JR; HARRISON, JK; COREY, GR; STEENBERGEN, C; BASHORE, TM				CREWS, JR; HARRISON, JK; COREY, GR; STEENBERGEN, C; BASHORE, TM			STUNNED MYOCARDIUM IN THE TOXIC SHOCK SYNDROME	ANNALS OF INTERNAL MEDICINE			English	Note						SHOCK, SEPTIC; MYOCARDIAL DISEASES; VENTRICULAR FUNCTION, LEFT; MYOCARDIAL CONTRACTION; EXOTOXINS	PATHOLOGIC FINDINGS	A 17-year-old woman with the toxic shock syndrome developed acute, life-threatening cardiac dysfunction (ejection fraction, 0.15). After aggressive supportive measures and antibiotic treatment, she regained normal cardiac function (ejection fraction, 0.60). We describe the first premortem cardiac histologic findings in a patient with a severe acute cardiomyopathy caused by the toxic shock syndrome. Percutaneous endomyocardial biopsies showed a scarcity of necrotic myocytes, with a few small aggregates of macrophages involved in myophagocytosis. Scattered-T lymphocytes were also noted. The lack of severe inflammation and paucity of necrotic myocytes suggest that the myocardial dysfunction associated with the toxic shock syndrome is caused by acute suppression of myocardial function by staphylococcal exotoxin. Complete return of left ventricular function can be expected if the patient is supported through the critical stages of the illness.	DUKE UNIV, MED CTR, BOX 31108, DURHAM, NC 27710 USA	Duke University			Harrison, Jennifer/GVS-9022-2022					CHESNEY PJ, 1989, REV INFECT DIS, V11, pS1; FISHER CJ, 1985, CRIT CARE MED, V13, P160, DOI 10.1097/00003246-198503000-00004; KLONER RA, 1989, AM J MED, V86, P14, DOI 10.1016/0002-9343(89)90005-3; LARKIN SM, 1982, ANN INTERN MED, V96, P858, DOI 10.7326/0003-4819-96-6-858; OLSON RD, 1989, REV INFECT DIS, V11, pS313; PARIS AL, 1982, ANN INTERN MED, V96, P852, DOI 10.7326/0003-4819-96-6-852; STEVENS DL, 1988, J INFECT DIS, V157, P272, DOI 10.1093/infdis/157.2.272	7	9	9	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					912	913		10.7326/0003-4819-117-11-912	http://dx.doi.org/10.7326/0003-4819-117-11-912			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443952				2022-12-28	WOS:A1992JZ27600006
J	HUPP, TR; MEEK, DW; MIDGLEY, CA; LANE, DP				HUPP, TR; MEEK, DW; MIDGLEY, CA; LANE, DP			REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53	CELL			English	Article							CASEIN-KINASE-II; CELLULAR TUMOR-ANTIGEN; HEAT-SHOCK PROTEINS; EPIDERMAL GROWTH-FACTOR; VIRUS-40 T-ANTIGEN; ESCHERICHIA-COLI; WILD-TYPE; TRANSCRIPTIONAL ACTIVATION; SV40-TRANSFORMED CELLS; NUCLEAR-LOCALIZATION	The DNA binding activity of p53 is required for its tumor suppressor function; we show here that this activity is cryptic but can be activated by cellular factors acting on a C-terminal regulatory domain of p53. A gel mobility shift assay demonstrated that recombinant wild-type human p53 binds DNA sequence specifically only weakly, but a monoclonal antibody binding near the C terminus activated the cryptic DNA binding activity stoichiometrically. p53 DNA binding could be activated by a C-terminal deletion of p53, mild proteolysis of full-length p53, E. coli dnaK (which disrupts protein-protein complexes), or casein kinase II (and coincident phosphorylation of a C-terminal site on p53). Activation of p53 DNA binding may be critical in regulation of its ability to arrest cell growth and thus its tumor suppressor function.			HUPP, TR (corresponding author), UNIV DUNDEE,DEPT BIOCHEM,MRC,PROT PHOSPHORYLAT UNIT,CANC RES CAMPAIGN LABS,DUNDEE DD1 4HN,SCOTLAND.		Lane, David P/C-4920-2008	Lane, David/0000-0003-0551-3545				ACKERMAN P, 1989, J BIOL CHEM, V264, P11958; ACKERMAN P, 1988, J BIOL CHEM, V263, P12653; ADDISON C, 1990, ONCOGENE, V5, P423; ALFANO C, 1989, J BIOL CHEM, V264, P10709; ARAI N, 1986, MOL CELL BIOL, V6, P3232, DOI 10.1128/MCB.6.9.3232; BARAK Y, 1992, EMBO J, V11, P2115, DOI 10.1002/j.1460-2075.1992.tb05270.x; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; BISCHOFF JR, 1992, MOL CELL BIOL, V12, P1405, DOI 10.1128/MCB.12.4.1405; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; CARROLL D, 1988, COLD SPRING HARB SYM, V53, P91, DOI 10.1101/SQB.1988.053.01.014; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CLARKE CF, 1988, MOL CELL BIOL, V8, P1206, DOI 10.1128/MCB.8.3.1206; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FOORD OS, 1991, NUCLEIC ACIDS RES, V19, P5191, DOI 10.1093/nar/19.19.5191; FRIEDMAN PN, 1990, P NATL ACAD SCI USA, V87, P9275, DOI 10.1073/pnas.87.23.9275; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GANNON JV, 1991, NATURE, V349, P802; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GINSBERG D, 1991, MOL CELL BIOL, V11, P582, DOI 10.1128/MCB.11.1.582; HALL PA, 1992, IN PRESS ONCOGENE; HARLOW E, 1988, ANTIBODIES LABORATOR; Hoekstra M F, 1992, Trends Cell Biol, V2, P153, DOI 10.1016/0962-8924(92)90022-F; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUBBARD TJP, 1991, PROTEIN ENG, V4, P711, DOI 10.1093/protein/4.7.711; HWANG DS, 1991, J BIOL CHEM, V266, P7537; HWANG DS, 1990, J BIOL CHEM, V265, P19244; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; KASTAN MB, 1991, CANCER RES, V51, P6304; KATO S, 1992, CELL, V68, P731, DOI 10.1016/0092-8674(92)90148-6; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LU X, 1992, CELL, V70, P153, DOI 10.1016/0092-8674(92)90541-J; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Maniatis T., 1982, MOL CLONING; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; MIDGLEY CA, 1992, J CELL SCI, V101, P183; MILARSKI KL, 1989, J CELL BIOL, V109, P1947, DOI 10.1083/jcb.109.5.1947; MILNE DM, 1992, ONCOGENE, V7, P1361; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NAKIELNY S, 1991, EUR J BIOCHEM, V199, P713, DOI 10.1111/j.1432-1033.1991.tb16175.x; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; OROURKE RW, 1990, ONCOGENE, V5, P1829; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; PRIGENT C, 1992, EMBO J, V11, P2925, DOI 10.1002/j.1460-2075.1992.tb05362.x; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; REIHSAUS E, 1990, ONCOGENE, V5, P137; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SAKAKIBARA Y, 1988, J BACTERIOL, V170, P972, DOI 10.1128/jb.170.2.972-979.1988; SAMAD A, 1991, MOL CELL BIOL, V11, P1598, DOI 10.1128/MCB.11.3.1598; SCHARER E, 1992, NUCLEIC ACIDS RES, V20, P1539, DOI 10.1093/nar/20.7.1539; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; SOUSSI T, 1990, ONCOGENE, V5, P945; STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X; STURZBECHER HW, 1988, ONCOGENE, V3, P405; STURZBECHER HW, 1992, ONCOGENE, V7, P1515; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; WANG Y, 1992, P NATL ACAD SCI USA, V89, P4231, DOI 10.1073/pnas.89.10.4231; WICKNER S, 1991, NATURE, V350, P165, DOI 10.1038/350165a0; ZAMBETTI GP, 1992, GENE DEV, V6, P1143, DOI 10.1101/gad.6.7.1143; ZYLICZ M, 1988, BIOCHIM BIOPHYS ACTA, V951, P344, DOI 10.1016/0167-4781(88)90105-4; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437	92	968	994	0	40	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 27	1992	71	5					875	886		10.1016/0092-8674(92)90562-Q	http://dx.doi.org/10.1016/0092-8674(92)90562-Q			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423635				2022-12-28	WOS:A1992JZ63300016
J	WIDNER, H; TETRUD, J; REHNCRONA, S; SNOW, B; BRUNDIN, P; GUSTAVII, B; BJORKLUND, A; LINDVALL, O; LANGSTON, JW				WIDNER, H; TETRUD, J; REHNCRONA, S; SNOW, B; BRUNDIN, P; GUSTAVII, B; BJORKLUND, A; LINDVALL, O; LANGSTON, JW			BILATERAL FETAL MESENCEPHALIC GRAFTING IN 2 PATIENTS WITH PARKINSONISM INDUCED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON EMISSION TOMOGRAPHY; SUBSTANTIA-NIGRA; VENTRAL MESENCEPHALON; DOPAMINERGIC-NEURONS; DISEASE; STRIATUM; TRANSPLANTATION; DESTRUCTION; HUMANS	Background. Intracerebral transplantation of fetal dopaminergic neurons is a promising new approach for the treatment of Parkinson's disease. Patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) have a relatively stable lesion limited to the nigrostriatal system, rendering them ideal candidates for transplantation. Improvement of motor function after neural grafting has previously been observed in nonhuman primates with MPTP-induced parkinsonism. Methods. We grafted human fetal tissue from the ventral mesencephalon (obtained six to eight weeks after conception) bilaterally to the caudate and putamen in two immunosuppressed patients with severe MPTP-induced parkinsonism, using a stereotaxic technique. The patients were assessed regularly with clinical rating scales, timed tests of motor performance, and [F-18]fluorodopa positron-emission tomography during the 18 months before the operation and the 22 to 24 months after the operation. Results. Both patients had substantial, sustained improvement in motor function and became much more independent. Postoperatively, the second patient's maintenance dose of levodopa was decreased to 150 mg daily, which was 30 percent of the original dose. Striatal uptake of fluorodopa was unchanged 5 to 6 months postoperatively but was markedly and bilaterally increased at 12 to 13 and 22 to 24 months in both patients, closely paralleling the patients' clinical improvement. There were no serious complications. Conclusions. Bilateral implantation of fetal mesencephalic tissue can induce substantial long-term functional improvement in patients with parkinsonism and severe dopamine depletion and is accompanied by increased uptake of fluorodopa by the striatum. The results in these patients resemble those obtained in MPTP-treated primates and suggest that this will be a useful model for the assessment of transplantation therapies in Parkinson's disease.	UNIV LUND HOSP, DEPT NEUROSURG, S-22185 LUND, SWEDEN; UNIV LUND HOSP, DEPT OBSTET & GYNECOL, S-22185 LUND, SWEDEN; HUDDINGE HOSP, KAROLINSKA INST, DEPT CLIN IMMUNOL, S-14186 HUDDINGE, SWEDEN; CALIF PARKINSONS FDN, SAN JOSE, CA USA; UNIV BRITISH COLUMBIA, DIV NEUROL, VANCOUVER V6T 1W5, BC, CANADA; UNIV LUND, DEPT MED CELL RES, S-22101 LUND, SWEDEN	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Karolinska Institutet; University of British Columbia; Lund University	WIDNER, H (corresponding author), UNIV LUND HOSP, DEPT NEUROL, RESTORAT NEUROL UNIT, S-22185 LUND, SWEDEN.		Björklund, Anders/ABA-1326-2020	Bjorklund, Anders/0000-0002-5676-6203				BAKAY RAE, 1987, ANN NY ACAD SCI, V495, P623, DOI 10.1111/j.1749-6632.1987.tb23705.x; BALLARD PA, 1985, NEUROLOGY, V35, P949, DOI 10.1212/WNL.35.7.949; BANKIEWICZ KS, 1990, J NEUROSURG, V72, P231, DOI 10.3171/jns.1990.72.2.0231; BJORKLUND A, 1987, TRENDS NEUROSCI, V10, P509, DOI 10.1016/0166-2236(87)90131-7; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BOYES BE, 1986, LIFE SCI, V39, P2243, DOI 10.1016/0024-3205(86)90403-0; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; DUNNETT SB, 1991, INTRACEREBRAL TRANSP, V4, P27; Elsworth JD, 1989, FUNCTION DYSFUNCTION, P161; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fahn S., 1987, RECENT DEV PARK DIS, V2, P293; FINE A, 1988, PROG BRAIN RES, V78, P479; Freed C. R., 1988, PHARM FUNCTIONAL REG, P353; FREED CR, 1990, ARCH NEUROL-CHICAGO, V47, P505, DOI 10.1001/archneur.1990.00530050021007; FREED WJ, 1991, RESTOR NEUROL NEUROS, V3, P109, DOI 10.3233/RNN-1991-3301; HENDERSON BTH, 1991, ARCH NEUROL-CHICAGO, V48, P822, DOI 10.1001/archneur.1991.00530200062020; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LANGSTON JW, 1984, BRAIN RES, V292, P390; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206; LOPEZLOZANO JJ, 1991, INTRACEREBRAL TRANSP, V4, P87; MADRAZO I, 1990, ARCH NEUROL-CHICAGO, V47, P1281, DOI 10.1001/archneur.1990.00530120025005; MARTIN WRW, 1989, ANN NEUROL, V26, P535, DOI 10.1002/ana.410260407; MOLINA H, 1991, INTRACEREBRAL TRANSP, V4, P99; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; SAWLE GV, 1992, ANN NEUROL, V31, P166, DOI 10.1002/ana.410310207; TAYLOR JR, 1991, EXP BRAIN RES, V85, P335; 1983, ACTA PHYSL SCAND S, V522, P1; 1976, ECDEU ASSESSMENT MAN, P534	32	430	469	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1556	1563		10.1056/NEJM199211263272203	http://dx.doi.org/10.1056/NEJM199211263272203			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435882	Bronze			2022-12-28	WOS:A1992JZ43200003
J	FINK, JN; KELLY, KJ				FINK, JN; KELLY, KJ			IMMUNOLOGICAL ASPECTS OF GRANULOMATOUS AND INTERSTITIAL LUNG-DISEASES AND OF CYSTIC-FIBROSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; INDUCED PULMONARY-DISEASE; LOWER RESPIRATORY-TRACT; CHRONIC INFLAMMATION; IMMUNE-COMPLEXES; UNKNOWN CAUSE; TOMOGRAPHY; ACTIVATION; FARMERS; DRUGS				FINK, JN (corresponding author), MED COLL WISCONSIN,ALLERGY IMMUNOL,MILWAUKEE,WI 53226, USA.			Kelly, Kevin/0000-0002-2954-6117				BANKS DE, 1986, ANN ALLERGY, V57, P389; CANLIN A, 1988, J LEUKOCYTE BIOL, V43, P299; CARRINGT.CB, 1969, NEW ENGL J MED, V280, P787, DOI 10.1056/NEJM196904102801501; CARROLL JL, 1989, IMMUNOLOGIC DISORDER, P475; COOPER JAD, 1986, AM REV RESPIR DIS, V133, P488; COOPER JAD, 1986, AM REV RESPIR DIS, V133, P321; CRYSTAL RG, 1984, NEW ENGL J MED, V310, P235, DOI 10.1056/NEJM198401263100406; CRYSTAL RG, 1984, NEW ENGL J MED, V310, P154, DOI 10.1056/NEJM198401193100304; DOLL NJ, 1981, J ALLERGY CLIN IMMUN, V68, P281; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; FEW F, 1986, J CLIN IMMUNOL, V6, P225; FINK JN, 1991, IMMUNOLOGICALLY MEDI, P399; FORMAN SR, 1978, J ALLERGY CLIN IMMUN, V62, P131, DOI 10.1016/0091-6749(78)90096-9; GHOSE T, 1974, CLIN ALLERGY, V4, P119, DOI 10.1111/j.1365-2222.1974.tb01369.x; Gocke D J, 1971, J Exp Med, V134, P330; GREENBERGER PA, 1988, ALLERGY PRINCIPLES P, P1219; Hamman L, 1935, Trans Am Clin Climatol Assoc, V51, P154; HASLAM P, 1975, CLIN EXP IMMUNOL, V20, P379; KASAHARA K, 1989, CLIN IMMUNOL IMMUNOP, V51, P419, DOI 10.1016/0090-1229(89)90040-8; KATZENSTEIN AL, 1975, AM REV RESPIR DIS, V111, P497; KRAUSEHOOYMAN L, 1983, INT ARCH ALLER A IMM, V71, P245, DOI 10.1159/000233398; KUNKEL SL, 1984, J CLIN INVEST, V74, P514, DOI 10.1172/JCI111449; Liebow A, 1969, FRONTIERS PULMONARY, P102; LYNCH JP, 1991, IMMUNOLOGICALLY MEDI, P189; MARX JJ, 1990, AM J IND MED, V18, P263, DOI 10.1002/ajim.4700180304; MARX JJ, 1973, J IMMUNOL, V111, P590; MOSS RB, 1986, AM REV RESPIR DIS, V133, P648; MULLER NL, 1990, AM REV RESPIR DIS, V142, P1206; NEELD DA, 1990, AM REV RESPIR DIS, V142, P1200, DOI 10.1164/ajrccm/142.5.1200; OLIVEIRA DBG, 1989, KIDNEY INT, V35, P923, DOI 10.1038/ki.1989.76; Parrillo J E, 1977, Trans Assoc Am Physicians, V90, P135; Pepys J, 1969, HYPERSENSITIVITY DIS; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; ROSSMAN MD, 1991, IMMUNOLOGICALLY MEDI, P217; SALVAGGIO JE, 1992, ADVANCES IN ALLERGOLOGY AND CLINICAL IMMUNOLOGY, P435; SANS J, 1988, J BIOL CHEM, V263, P1374; Stankus RP, 1988, INTERSTITIAL LUNG DI, P111; WILSON MR, 1977, J ALLERGY CLIN IMMUN, V60, P218, DOI 10.1016/0091-6749(77)90133-6	38	7	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2874	2881		10.1001/jama.268.20.2874	http://dx.doi.org/10.1001/jama.268.20.2874			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433703				2022-12-28	WOS:A1992JY66800011
J	LOPEZ, M; FLEISHER, T; DESHAZO, RD				LOPEZ, M; FLEISHER, T; DESHAZO, RD			USE AND INTERPRETATION OF DIAGNOSTIC IMMUNOLOGICAL LABORATORY TESTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIBODIES; AUTOANTIBODIES; HEPATITIS; NEUTROPHILS; RELEVANCE; DISORDERS; ONTOGENY; CELLS		NIH,WARREN GRANT MAGNUSON CLIN CTR,IMMUNOL SERV,BETHESDA,MD 20892; TULANE UNIV,SCH MED,DEPT MED,DIV RHEUMATOL,NEW ORLEANS,LA 70112	National Institutes of Health (NIH) - USA; Tulane University	LOPEZ, M (corresponding author), TULANE UNIV,SCH MED,DEPT MED,DIV ALLERGY & CLIN IMMUNOL,NEW ORLEANS,LA 70112, USA.							ALTENBURGER KM, 1983, PRIMARY SECONDARY IM, P113; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; ALTER HJ, 1990, J GASTROEN HEPATOL, V1, P78; [Anonymous], [No title captured]; BEDELL SE, 1985, AM J MED, V78, P1001, DOI 10.1016/0002-9343(85)90224-4; BERTOLI LF, 1988, CLIN LAB MED, V8, P15, DOI 10.1016/S0272-2712(18)30695-4; Bigazzi PE, 1992, MANUAL CLIN LAB IMMU, V4th, P765; BRARD TJT, 1987, ARCH PATHOL LAB MED, V111, P120; CARON J, 1992, MANUAL CLIN LABORATO, P84; CHECK LJ, 1992, MANUAL CLIN LABORATO, P71; COATES TD, 1992, MANUAL CLIN LAB IMMU, P409; COOPER NR, 1984, BASIC CLIN IMMUNOL, P119; DIAMOND BA, 1981, NEW ENGL J MED, V304, P1344, DOI 10.1056/NEJM198105283042208; DOUGAL JS, 1982, J LAB CLIN MED, V69, P287; FAHEY JL, 1965, J IMMUNOL, V94, P84; FRANK MM, 1989, FUNDAMENTAL IMMUNOLO, P679; Giorgi J. V., 1990, Clinical Immunology, V10, P55, DOI 10.1016/0197-1859(90)90024-3; HARDIN JA, 1985, CLIN RHEUM DIS, V11, P485; HARMON CE, 1985, MED CLIN N AM, V69, P547, DOI 10.1016/S0025-7125(16)31032-X; HAYNES BF, 1989, IMMUNOL TODAY, V10, P87, DOI 10.1016/0167-5699(89)90232-6; HOLLINGER BF, 1992, MANUAL CLIN LABORATO, P634; HONG R, 1987, IMMUNOL INVEST, V16, P453, DOI 10.3109/08820138709087098; HOOFNAGLE JH, 1989, JAMA-J AM MED ASSOC, V261, P1321, DOI 10.1001/jama.261.9.1321; HOOFNAGLE JH, 1985, DIGEST DIS SCI, V30, P1022, DOI 10.1007/BF01315598; Jackson A, 1990, CLIN IMMUNOL NEWSL, V10, P43; JOHNSON AM, 1986, MANUAL CLIN LABORATO, P14; Kaufman L, 1992, MANUAL CLIN LAB IMMU, V4th, P506; KELSO JM, 1991, ALLERGEN IMMUNOTHERA, P145; KOHLER G, 1975, NATURE, V256, P445; LANIER LL, 1992, MANUAL CLIN LABORATO, P157; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127; LOIZOU S, 1985, CLIN EXP IMMUNOL, V62, P738; LOPEZ M, 1991, IMMUNOLOGICALLY MEDI, P413; LOVE PE, 1990, ANN INTERN MED, V112, P682, DOI 10.7326/0003-4819-112-9-682; MAKGOBA MW, 1989, IMMUNOL TODAY, V10, P417, DOI 10.1016/0167-5699(89)90039-X; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MCKENDRY RJR, 1982, AM J CLIN PATHOL, V78, P517, DOI 10.1093/ajcp/78.4.517; Nakamura RM, 1984, LAB MED, V15, P190; NORMAN PS, 1983, ALLERGY PRINCIPLES P, P295; NOSSAL GJV, 1987, NEW ENGL J MED, V316, P1320, DOI 10.1056/NEJM198705213162107; Petz L. D., 1983, METHODS HEMATOLOGY I, V9, P9; ROYER HD, 1987, NEW ENGL J MED, V317, P1136, DOI 10.1056/NEJM198710293171807; RUDDY S, 1985, LABORATORY DIAGNOSTI, P137; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; Sandler SG, 1988, AIDS ETIOLOGY DIAGNO, P121; SMITH DL, 1992, MANUAL CLIN LABORATO, P202; SPECKS U, 1989, MAYO CLIN PROC, V64, P28, DOI 10.1016/S0025-6196(12)65300-2; TAN EM, 1982, ADV IMMUNOL, V33, P167, DOI 10.1016/S0065-2776(08)60836-6; VECCHIO TJ, 1966, NEW ENGL J MED, V274, P1171, DOI 10.1056/NEJM196605262742104; WEEKE B, 1976, MANUAL QUANTITATIVE, P47; WELLER PF, 1984, J ALLERGY CLIN IMMUN, V73, P1, DOI 10.1016/0091-6749(84)90474-3; Winchester RJ, 1986, MANUAL CLIN IMMUNOLO, P212; YALOW RS, 1961, J CLIN INVEST, V40, P2190, DOI 10.1172/JCI104445; 1988, CLIN IMMUNOL IMMUNOP, V49, P478; [No title captured]	56	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2970	2990		10.1001/jama.268.20.2970	http://dx.doi.org/10.1001/jama.268.20.2970			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433717				2022-12-28	WOS:A1992JY66800026
J	MARTIN, P; LEWIS, J				MARTIN, P; LEWIS, J			ACTIN CABLES AND EPIDERMAL MOVEMENT IN EMBRYONIC WOUND-HEALING	NATURE			English	Article							SCANNING ELECTRON-MICROSCOPY; EPITHELIAL-CELLS; GENE-EXPRESSION; MIGRATION; XENOPUS; VISUALIZATION; MICROFILAMENT; MORPHOGENESIS; CULTURE	SKIN wounds in embryos heal rapidly and perfectly. Even though the epidermis appears to be stretched taut over the surface of a structure such as a growing limb bud, its response to wounding is to close over the lesion, rather than to gape more widely. In adult wounds, the epidermis seems to migrate by means of lamellipodia, crawling over the exposed connective tissue1-5. But in embryonic wounds we do not see lamellipodia. The epidermis at the edge of the wound looks smooth, as though under a circumferential tension. Here we show that a cable of filamentous actin appears to run continuously around most of the wound margin. It is confined to the single row of basal cells at the free edge of the epidermis. We suggest that the actin cable acts as a contractile 'purse string' to close up the embryonic wound.	UNIV OXFORD,DEPT ZOOL,IMPERIAL CANC RES FUND,DEV BIOL UNIT,OXFORD OX1 3PS,ENGLAND	University of Oxford	MARTIN, P (corresponding author), UNIV OXFORD,DEPT HUMAN ANAT,OXFORD OX1 3QX,ENGLAND.		Lewis, Julian H/E-8733-2010	Martin, Paul/0000-0002-2665-5086				Bard J. B. L., 1990, MORPHOGENESIS CELLUL; BELOUSSOV LV, 1975, J EMBRYOL EXP MORPH, V34, P559; BENZEEV A, 1991, BIOESSAYS, V13, P207, DOI 10.1002/bies.950130502; Bereiter-Hahn J., 1986, P443; BUCK RC, 1979, INVEST OPHTH VIS SCI, V18, P767; DIPASQUALE A, 1975, EXP CELL RES, V94, P191, DOI 10.1016/0014-4827(75)90545-5; FRISTROM D, 1988, TISSUE CELL, V20, P645, DOI 10.1016/0040-8166(88)90015-8; Gabbiani G, 1977, Int Rev Cytol, V48, P187, DOI 10.1016/S0074-7696(08)61745-3; GEIGER B, 1987, J CELL SCI S, V8, P251; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; KOMURO I, 1991, J BIOL CHEM, V266, P1265; KRAWCZYK WS, 1971, J CELL BIOL, V49, P247, DOI 10.1083/jcb.49.2.247; MARTIN P, 1992, MECH DEVELOP, V38, P209, DOI 10.1016/0925-4773(92)90054-N; MAUPINSZAMIER P, 1978, J CELL BIOL, V77, P738; MCDONALD K, 1984, J ULTRA MOL STRUCT R, V86, P107, DOI 10.1016/S0022-5320(84)80051-9; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; ODLAND G, 1968, J CELL BIOL, V39, P135, DOI 10.1083/jcb.39.1.135; PANG SC, 1978, AM J ANAT, V153, P177, DOI 10.1002/aja.1001530202; RADICE GP, 1980, DEV BIOL, V76, P26, DOI 10.1016/0012-1606(80)90360-7; SHERRATT JA, IN PRESS B MATH BIOL; SMEDLEY MJ, 1984, J EMBRYOL EXP MORPH, V83, P109; STANISSTREET M, 1982, J EMBRYOL EXP MORPH, V67, P195; STANISSTREET M, 1980, J EMBRYOL EXP MORPH, V59, P341; THEVENET A, 1981, ARCH ANAT MICROSC MO, V70, P227; Trinkaus J.P., 1984, CELLS ORGANS; VAUGHAN RB, 1966, J CELL SCI, V1, P407; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498	28	349	355	5	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 12	1992	360	6400					179	183		10.1038/360179a0	http://dx.doi.org/10.1038/360179a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX752	1436096				2022-12-28	WOS:A1992JX75200067
J	LAMPL, M; VELDHUIS, JD; JOHNSON, ML				LAMPL, M; VELDHUIS, JD; JOHNSON, ML			SALTATION AND STASIS - A MODEL OF HUMAN GROWTH	SCIENCE			English	Article							LONGITUDINAL BONE-GROWTH; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; LINEAR GROWTH; FACTOR-I; CHILDREN; HORMONE; PROTEIN; CHONDROCYTES; VELOCITY	Human growth has been viewed as a continuous process characterized by changing velocity with age. Serial length measurements of normal infants were assessed weekly (n = 10), semiweekly (n = 18), and daily (n = 3) (19 females and 12 males) during their first 21 months. Data show that growth in length occurs by discontinuous, aperiodic saltatory spurts. These bursts were 0.5 to 2.5 centimeters in amplitude during intervals separated by no measurable growth (2 to 63 days duration). These data suggest that 90 to 95 percent of normal development during infancy is growth-free and length accretion is a distinctly saltatory process of incremental bursts punctuating background stasis.	UNIV VIRGINIA, HLTH SCI CTR, NATL SCI FDN, CTR BIOL TIMING, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT INTERNAL MED, DIV ENDOCRINOL & METAB, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT PHARMACOL, CHARLOTTESVILLE, VA 22908 USA	National Science Foundation (NSF); NSF - Center for Biological Timing; University of Virginia; University of Virginia; University of Virginia	LAMPL, M (corresponding author), UNIV PENN, DEPT ANTHROPOL, PHILADELPHIA, PA 19104 USA.		Lampl, Michelle L/B-1619-2013		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK038942] Funding Source: NIH RePORTER; NICHD NIH HHS [KO4HD00634] Funding Source: Medline; NIDDK NIH HHS [DK 38942] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERTSSONWIKLAND K, 1988, J CLIN ENDOCR METAB, V67, P493, DOI 10.1210/jcem-67-3-493; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; BORTELL R, 1990, J CELL BIOCHEM, V44, P81, DOI 10.1002/jcb.240440203; BREUR GJ, 1991, J ORTHOPAED RES, V9, P348, DOI 10.1002/jor.1100090306; BUTLER GE, 1990, ANN HUM BIOL, V17, P177, DOI 10.1080/03014469000000952; Cameron N., 1986, HUMAN GROWTH, V3, P3; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Gordon CC, 1988, ANTHR STAND REF MANU, P3; Hamill PV, 1977, VITAL HLTH STAT 11, V11, P1; HARRISON GA, 1990, ANN HUM BIOL, V17, P407, DOI 10.1080/03014469000001182; HEALY MJR, 1988, NESTLE NUTRITION WOR, V14, P41; HERMANUSSEN M, 1988, ANN HUM BIOL, V15, P103, DOI 10.1080/03014468800009521; HERMANUSSEN M, 1986, ACTA PAEDIATR SCAND, V75, P601, DOI 10.1111/j.1651-2227.1986.tb10258.x; HUNZIKER EB, 1989, J PHYSIOL-LONDON, V414, P55, DOI 10.1113/jphysiol.1989.sp017676; KARLBERG J, 1987, STAT MED, V6, P185, DOI 10.1002/sim.4780060210; LAMPL M, UNPUB; LLOYD D, 1986, CELL CYCLE CLOCKS, P27; MARSHALL WA, 1971, ARCH DIS CHILD, V46, P414, DOI 10.1136/adc.46.248.414; MARTHA PM, 1989, J CLIN ENDOCR METAB, V69, P563, DOI 10.1210/jcem-69-3-563; MARTORELL R, 1975, AM J PHYS ANTHROPOL, V43, P347, DOI 10.1002/ajpa.1330430308; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MAURAS N, 1987, J CLIN ENDOCR METAB, V64, P596, DOI 10.1210/jcem-64-3-596; Meredith HV, 1936, CHILD DEV, V7, P262; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; POLYCHRONAKOS C, 1988, EUR J PEDIATR, V147, P582, DOI 10.1007/BF00442467; ROCHE AF, 1980, AM J CLIN NUTR, V33, P2041, DOI 10.1093/ajcn/33.9.2041; Scammon RE, 1927, AM J PHYS ANTHROPOL, V10, P329, DOI 10.1002/ajpa.1330100303; SCHEVEN BAA, 1991, ACTA ENDOCRINOL-COP, V124, P602, DOI 10.1530/acta.0.1240602; SCHOLL D. A., 1954, DYNAMICS GROWTH PROC, P224; SMITH DW, 1976, J PEDIATR-US, V89, P225, DOI 10.1016/S0022-3476(76)80453-2; STEVENSON S, 1990, J ORTHOPAED RES, V8, P132, DOI 10.1002/jor.1100080117; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; TANNER JM, 1990, FETUS MAN PHYSICAL G; TOGO M, 1982, ANN HUM BIOL, V9, P425, DOI 10.1080/03014468200005961; VALK IM, 1983, GROWTH, V47, P53; VANDERLINDEN FP, 1970, GROWTH, V34, P385; VELDHUIS JD, 1992, METHOD ENZYMOL, V210, P539; WALES JKH, 1987, ARCH DIS CHILD, V62, P166, DOI 10.1136/adc.62.2.166; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WIT JM, 1987, ACTA PAEDIATR SCAND, P40; [No title captured]	46	233	238	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	1992	258	5083					801	803		10.1126/science.1439787	http://dx.doi.org/10.1126/science.1439787			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439787				2022-12-28	WOS:A1992JV69200038
J	OH, VMS				OH, VMS			IRON DEXTRAN AND SYSTEMIC LUPUS-ERYTHEMATOSUS	BRITISH MEDICAL JOURNAL			English	Letter											OH, VMS (corresponding author), NATL UNIV SINGAPORE HOSP,SINGAPORE 0511,SINGAPORE.								0	12	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 24	1992	305	6860					1000	1000		10.1136/bmj.305.6860.1000-a	http://dx.doi.org/10.1136/bmj.305.6860.1000-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV776	1458107	Bronze, Green Submitted, Green Published			2022-12-28	WOS:A1992JV77600032
J	IKEGAMI, N				IKEGAMI, N			THE ECONOMICS OF HEALTH-CARE IN JAPAN	SCIENCE			English	Article								Japan's health care system balances universal coverage at reasonable cost. The government has taken on the responsibility of acting as insurer and subsidizing health care spending for the employees of small enterprises and the self-employed. Despite the fee-for-service form of payment, costs have been contained by the use of a nationally uniform fee schedule that is mandatory for all providers. However, the increasingly affluent and aging population is making new demands on the system that can only be met by a major restructuring.	KEIO UNIV,SCH MED,DEPT HOSP & MED ADM,SHINJUKU KU,TOKYO 160,JAPAN	Keio University	IKEGAMI, N (corresponding author), KEIO UNIV,SCH MED,FAC POLICY MANAGEMENT,SHINJUKU KU,TOKYO 160,JAPAN.							IGLEHART JK, 1988, NEW ENGL J MED, V319, P1166, DOI 10.1056/NEJM198810273191731; Ikegami N, 1988, Int J Technol Assess Health Care, V4, P239; Ikegami N, 1989, Int J Health Plann Manage, V4, P181, DOI 10.1002/hpm.4740040305; IKEGAMI N, 1991, HEALTH AFFAIR, V10, P88; KOYOKAI KT, 1991, KOUSEI NO SHIHYOU, V38, P95; KOYOKAI KT, 1991, KOUSEI NO SHIHYOU, V38, P237; KYOKAI KT, 1991, KOUSEI NO SHIHYOU, V38, P67; KYOKAI KT, 1992, 1990 IRYOU SHISETU C, P45; KYOKAI KT, 1991, KOUSEI NO SHIHYOU, V38; MARMOT MG, 1989, BRIT MED J, V299, P1547, DOI 10.1136/bmj.299.6715.1547; NIKI R, 1992, SHAKAIHOKEN YJUNPOU, V1770, P19; NIKI R, 1985, SOC SCI MED, V12, P113; NIKI R, 1992, SHAKAIHOKEN YJUNPOU, V1768, P6; SAGUCHI T, 1982, IRYOU NO SHAKAIKA; 1992, 1990 POPULATION CENS, V2, P400; 1989, 1987 KANJYA CHOUSA, P319; 1985, IRYOUKEIZAIGAKU, P131; 1986, KOKUMIN KENKOU CHOUS, P168; 1990, HLTH CARE SYSTEMS TR, P129; 1992, 1990 IRYOU SHISETU C, P35; 1989, BASIC STUDY TOKYOS N; 1989, 1987 SHAKAIFUKUSHI G; 1987, 1987 KANJA CHOUSA; 1992, SHAKAI IRYOU SHINRYO, P24; 1992, SHUKAN IGAKUKAI SHIN, V1	25	24	24	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 23	1992	258	5082					614	618		10.1126/science.1411572	http://dx.doi.org/10.1126/science.1411572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JU745	1411572				2022-12-28	WOS:A1992JU74500049
J	MENGER, FM; HAIM, A				MENGER, FM; HAIM, A			STRUGGLES TO CORRECT PUBLISHED ERRORS	NATURE			English	Editorial Material							CLEAVAGE		SUNY STONY BROOK,DEPT CHEM,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	MENGER, FM (corresponding author), EMORY UNIV,DEPT CHEM,ATLANTA,GA 30322, USA.							ANSLYN E, 1989, J AM CHEM SOC, V111, P4473, DOI 10.1021/ja00194a050; BRESLOW R, 1990, J AM CHEM SOC, V112, P9621, DOI 10.1021/ja00182a022; HAIM A, IN PRESS J AM CHEM S; HILTS PJ, 1991, NEW REPUBLIC    0518, P24; MENGER FM, 1991, J ORG CHEM, V56, P6251, DOI 10.1021/jo00022a001; 1992, J ORG CHEM, V56, P6960	6	7	7	0	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 22	1992	359	6397					666	668		10.1038/359666a0	http://dx.doi.org/10.1038/359666a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436025				2022-12-28	WOS:A1992JU65000017
J	LOPEZDELEON, A; LIBRIZZI, M; PUGLIA, K; WILLIS, IM				LOPEZDELEON, A; LIBRIZZI, M; PUGLIA, K; WILLIS, IM			PCF4 ENCODES AN RNA POLYMERASE-III TRANSCRIPTION FACTOR WITH HOMOLOGY TO TFIIB	CELL			English	Article							HUMAN U6 GENE; SACCHAROMYCES-CEREVISIAE; INVITRO TRANSCRIPTION; INITIATION; BINDING; DNA; PURIFICATION; COMPONENTS; INTERACT; SUBUNIT	A dominant mutation in the PCF4 gene of S. cerevisiae was isolated as a suppressor of a tRNA gene A block promoter mutation. In vitro studies indicate that PCF4 is a stoichiometrically-required RNA polymerase III (pol III) transcription initiation factor. We show that the PCF4-1 mutation increases the number of transcriptionally competent preinitiation complexes by affecting a limiting activity in yeast cell extracts that is squelched by excess TFIIIC. The PCF4 gene encodes a TFIIB homolog whose size, biochemical, and genetic properties are consistent with those of the 70 kd subunit of TFIIIB. The TFIIB homology of PCF4 suggests a means for determining the polymerase specificity of a gene.			LOPEZDELEON, A (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT BIOCHEM,JACK & PEARL RESNICK CAMPUS,BRONX,NY 10461, USA.			Willis, Ian/0000-0001-6599-2395	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042728] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42728] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER RE, 1986, J BIOL CHEM, V261, P5275; BARTHOLOMEW B, 1991, MOL CELL BIOL, V11, P5181, DOI 10.1128/MCB.11.10.5181; BARTHOLOMEW B, 1990, EMBO J, V9, P2197, DOI 10.1002/j.1460-2075.1990.tb07389.x; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; GABRIELSEN OS, 1989, J BIOL CHEM, V264, P7505; GABRIELSEN OS, 1991, TRENDS BIOCHEM SCI, V16, P412, DOI 10.1016/0968-0004(91)90166-S; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GIARDINA CA, 1990, J BIOL CHEM, V265, P9121; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; KALB VF, 1977, ANAL BIOCHEM, V82, P362, DOI 10.1016/0003-2697(77)90173-7; KASSAVETIS GA, 1991, P NATL ACAD SCI USA, V88, P7308, DOI 10.1073/pnas.88.16.7308; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KLEKAMP MS, 1986, J BIOL CHEM, V261, P2819; LOBO SM, 1991, GENE DEV, V5, P1477, DOI 10.1101/gad.5.8.1477; MARGOTTIN F, 1991, SCIENCE, V251, P424, DOI 10.1126/science.1989075; PARSONS MC, 1990, J BIOL CHEM, V265, P5095; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; SCHULTZ MC, 1992, IN PRESS CELL, V69; Sherman F., 1986, METHODS YEAST GENETI; SIMCHEN G, 1984, P NATL ACAD SCI-BIOL, V81, P2431, DOI 10.1073/pnas.81.8.2431; SIMMEN KA, 1991, EMBO J, V10, P1853, DOI 10.1002/j.1460-2075.1991.tb07711.x; WHITE RJ, 1992, P NATL ACAD SCI USA, V89, P1949, DOI 10.1073/pnas.89.5.1949; WILLIS I, 1992, NUCLEIC ACIDS RES, V20, P3725, DOI 10.1093/nar/20.14.3725; WILLIS I, 1989, EMBO J, V8, P4281, DOI 10.1002/j.1460-2075.1989.tb08614.x; YAMASHITA S, 1992, P NATL ACAD SCI USA, V89, P2839, DOI 10.1073/pnas.89.7.2839	32	132	134	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					211	220		10.1016/0092-8674(92)90350-L	http://dx.doi.org/10.1016/0092-8674(92)90350-L			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423589				2022-12-28	WOS:A1992JU39500007
J	NITSCH, RM; SLACK, BE; WURTMAN, RJ; GROWDON, JH				NITSCH, RM; SLACK, BE; WURTMAN, RJ; GROWDON, JH			RELEASE OF ALZHEIMER AMYLOID PRECURSOR DERIVATIVES STIMULATED BY ACTIVATION OF MUSCARINIC ACETYLCHOLINE-RECEPTORS	SCIENCE			English	Article							PROTEIN KINASE-C; DISEASE; DOMAIN; PHOSPHORYLATION; LOCALIZATION; CLEAVAGE; SUBTYPES; PEPTIDE	Altered processing of the amyloid precursor protein (APP) is a central event in the formation of amyloid deposits in the brains of individuals with Alzheimer's disease. To investigate whether cellular APP processing is controlled by cell-surface neurotransmitter receptors, human embryonic kidney (293) cell lines were transfected with the genes for human brain muscarinic acetylcholine receptors. Stimulation of m1 and m3 receptor subtypes with carbachol increased the basal release of APP derivatives within minutes of treatment, indicating that preexisting APP is released in response to receptor activation. Receptor-activated APP release was blocked by staurosporine, suggesting that protein kinases mediate neurotransmitter receptor-controlled APP processing.	MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	NITSCH, RM (corresponding author), MIT,DEPT BRAIN & COGNIT SCI,E25-604,CAMBRIDGE,MA 02139, USA.		Slack, Barbara/AAU-9917-2021	Slack, Barbara/0000-0002-7619-410X				ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1991, J NEUROSCI, V11, P3783; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KONIG G, 1992, J BIOL CHEM, V267, P10804; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NITSCH RM, UNPUB; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; SANDMANN J, 1991, J BIOL CHEM, V266, P6031; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SUZUKI T, 1992, NEUROSCIENCE, V48, P755, DOI 10.1016/0306-4522(92)90264-3; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; 1989, TRENDS PHARM SCI S, pR7	33	846	880	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					304	307		10.1126/science.1411529	http://dx.doi.org/10.1126/science.1411529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	1411529				2022-12-28	WOS:A1992JR86000036
J	MONTEIRO, CA; TORRES, AM				MONTEIRO, CA; TORRES, AM			CAN SECULAR TRENDS IN CHILD GROWTH BE ESTIMATED FROM A SINGLE CROSS-SECTIONAL SURVEY	BRITISH MEDICAL JOURNAL			English	Article							HEIGHT; BOYS	Objective-To formulate and evaluate a new method to measure secular trends in child growth based on the cross sectional collection of heights of children and young adults. Design-Trends in child growth obtained from comparison of two national surveys made with an interval of 15 years were compared with estimates obtained from comparison of height deficits of children and young adults in the more recent survey. Setting-Brazil. Subjects-Random sample of children (6 and 7 years old) and young adults (21 and 22 years old) living in Brazil in 1974 and 1989 (a total of 23 271 subjects in 1974 and 5479 in 1989). Main outcome measures-Increments in average heights of 6 and 7 year old children in a 15 year period. Results-Mean height of 6 year old children increased 4.0 cm (boys) and 3.3 cm (girls) from 1974 to 1989. Similar results were obtained by subtracting, in the 1989 survey, mean height deficits found at ages 21 and 6 (3.8 cm for males and 3.5 cm for females). Positive changes in the mean height of 7 year old children could also be predicted by subtracting, in the 1989 survey, height deficits found at ages 7 and 22. Conclusions-Findings of this study support the hypothesis that secular trends in child growth can be estimated by comparing height deficits observed in children and young adults.	WHO,NUTR UNIT,CH-1211 GENEVA 27,SWITZERLAND; UNIV GENEVA,COMMUNITY HLTH UNIT,CH-1211 GENEVA 4,SWITZERLAND	World Health Organization; University of Geneva			Monteiro, Carlos Augusto/F-9892-2012	Monteiro, Carlos Augusto/0000-0002-3777-1533; Torres-Cantero, Alberto M./0000-0001-5402-1016				BILLEWICZ WZ, 1982, ANN HUM BIOL, V9, P309, DOI 10.1080/03014468200005811; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P749, DOI 10.1093/ajcn/46.5.749; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; HAUSPIE RC, 1980, ANN HUM BIOL, V7, P429, DOI 10.1080/03014468000004541; Martorell R., 1990, ANN NESTLE, V48, P85; MONTEIRO CA, 1989, IN PRESS B WHO; SATYANARAYANA K, 1989, ANN HUM BIOL, V16, P289, DOI 10.1080/03014468900000422; Van Wieringen J., 1978, HUMAN GROWTH, P445, DOI [10.1007/978-1-4684-2622-9_16, DOI 10.1007/978-1-4684-2622-9_16]; WATERLOW JC, 1988, NUTRITION WORKSHOP S, V14; 1989, PERFIL ESTATISTICO C; 1989, GLOBAL NUTRITION STA; 1990, APPROPRIATE USES ANT	12	7	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 3	1992	305	6857					797	799		10.1136/bmj.305.6857.797	http://dx.doi.org/10.1136/bmj.305.6857.797			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT256	1422358	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JT25600018
J	HENDERSON, E; HAYDON, PG; SAKAGUCHI, DS				HENDERSON, E; HAYDON, PG; SAKAGUCHI, DS			ACTIN FILAMENT DYNAMICS IN LIVING GLIAL-CELLS IMAGED BY ATOMIC FORCE MICROSCOPY	SCIENCE			English	Article							LANGMUIR-BLODGETT-FILMS; MOLECULAR-RESOLUTION; DNA	Observation of filamentous actin (F-actin) in living cells is currently limited to the resolution of the light microscope. Higher resolution procedures require sample fixation and preclude dynamic studies. The atomic force microscope (AFM) can image and manipulate samples at very high, sometimes atomic resolution by scanning a fine tip over the surface of interest and detecting physical interactions between the tip and sample. This study demonstrates that F-actin can be readily resolved in living cells with the AFM and that the dynamic properties of F-actin are easily observed.			HENDERSON, E (corresponding author), IOWA STATE UNIV SCI & TECHNOL,DEPT ZOOL & GENET,SIGNAL TRANSDUCT TRAINING GRP,AMES,IA 50011, USA.			Sakaguchi, Donald/0000-0003-4537-0972				BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BUSTAMANTE C, 1992, BIOCHEMISTRY-US, V31, P22, DOI 10.1021/bi00116a005; BUTT HJ, 1990, BIOPHYS J, V58, P1473, DOI 10.1016/S0006-3495(90)82492-9; BUTT HJ, 1990, J STRUCT BIOL, V105, P54, DOI 10.1016/1047-8477(90)90098-W; DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794; EDSTROM RD, 1990, FASEB J, V4, P3144, DOI 10.1096/fasebj.4.13.2120098; GOULD SAC, 1990, J VAC SCI TECHNOL A, V8, P369, DOI 10.1116/1.576398; HENDERSON E, 1992, NUCLEIC ACIDS RES, V20, P445, DOI 10.1093/nar/20.3.445; HOH J H, 1992, Trends in Cell Biology, V2, P208, DOI 10.1016/0962-8924(92)90248-L; HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206; KELLER D, 1992, SPIE P, V1639, P91; MARTI O, 1988, J MICROSC-OXFORD, V152, P803, DOI 10.1111/j.1365-2818.1988.tb01452.x; OMIE J, 1991, SCIENCE, V252, P691; PARPURA V, COMMUNICATION; PUTMAN CAJ, IN PRESS ULTRAMICROS; PUTNAM CAJ, 1992, REV SCI INSTRUM, V63, P1914; RADMACHER M, 1992, STRUCTURE CONFORMATI, V66, P24; SAKAGUCHI DS, 1989, DEV BIOL, V134, P158, DOI 10.1016/0012-1606(89)90086-9; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; VESENKA J, IN PRESS ULTRAMICROS; VESENKA J, 1992, SPIE P, V1639, P38; WEISENHORN AL, 1990, BIOPHYS J, V58, P1251, DOI 10.1016/S0006-3495(90)82465-6; WEISENHORN AL, 1990, SCANNING MICROSCOPY, V4, P511; WEISENHORN AL, 1991, LANGMUIR, V7, P8, DOI 10.1021/la00049a003	24	375	393	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 25	1992	257	5078					1944	1946		10.1126/science.1411511	http://dx.doi.org/10.1126/science.1411511			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP594	1411511				2022-12-28	WOS:A1992JP59400031
J	WOLFF, SP				WOLFF, SP			TRYING TIMES FOR HUMAN INSULIN	NATURE			English	Editorial Material							PORCINE INSULIN; HYPOGLYCEMIA; UNAWARENESS				WOLFF, SP (corresponding author), UNIV COLL & MIDDLESEX SCH MED,DEPT CLIN PHARMACOL,5 UNIV ST,LONDON WC1E 6JJ,ENGLAND.							BERGER W, 1989, LANCET, V1, P1041, DOI 10.1016/S0140-6736(89)92444-6; EGGER M, 1991, BMJ-BRIT MED J, V303, P617, DOI 10.1136/bmj.303.6803.617; EGGER M, 1991, BMJ-BRIT MED J, V303, P622, DOI 10.1136/bmj.303.6803.622; EGGER M, 1991, LANCET, V338, P950, DOI 10.1016/0140-6736(91)91820-K; FINEBERG SE, 1983, DIABETOLOGIA, V25, P465; FRIER BM, 1989, LANCET, V2, P1269; HEINE RJ, 1990, LANCET, V335, P62, DOI 10.1016/0140-6736(90)90203-H; HEINE RJ, 1989, LANCET, V2, P946; HEPBURN DA, 1989, LANCET, V1, P1394; HILSTED J, 1989, LANCET, V2, P1268; HOME P, 1991, DIABETIC MED, V8, P799, DOI 10.1111/j.1464-5491.1991.tb02115.x; KERR D, 1989, LANCET, V1, P836; LEAN MEJ, 1987, LANCET, V2, P748; MUHLHAUSER I, 1989, LANCET, V1, P1394; PATRICK AW, 1991, LANCET, V338, P528, DOI 10.1016/0140-6736(91)91098-F; PATRICK AW, 1991, BRIT MED J, V303, P1266, DOI 10.1136/bmj.303.6812.1266-a; PICKUP J, 1989, BRIT MED J, V299, P991, DOI 10.1136/bmj.299.6706.991; SONNENBERG GE, 1983, DIABETOLOGIA, V25, P457; TATTERSALL RB, 1991, DIABETIC MED, V8, P49, DOI 10.1111/j.1464-5491.1991.tb01516.x; TEUSCHER A, 1987, LANCET, V2, P382; THORSTEINSSON B, 1991, BRIT MED J, V303, P1267, DOI 10.1136/bmj.303.6812.1267; TURNER TA, 1988, LANCET, V2, P1150; WOLFF SP, 1991, BIOCHEM MED METAB B, V46, P129, DOI 10.1016/0885-4505(91)90060-X	23	10	9	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 2	1992	356	6368					375	376		10.1038/356375a0	http://dx.doi.org/10.1038/356375a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL830	1445519				2022-12-28	WOS:A1992HL83000020
J	BARRETTCONNOR, E; HOLBROOK, TL				BARRETTCONNOR, E; HOLBROOK, TL			SEX-DIFFERENCES IN OSTEOPOROSIS IN OLDER ADULTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; ISCHEMIC-HEART-DISEASE; POSTMENOPAUSAL WOMEN; RISK-FACTORS; MEN; MASS; CALCIUM; STEROIDS; HORMONES; PREMENOPAUSAL	Objective.-To describe the association of non-insulin-dependent diabetes mellitus (NIDDM) with bone mineral density (BMD). Design.-A survey of men and women from an established epidemiologic cohort who were separately screened for diabetes by oral glucose tolerance test between 1984 and 1987 and for osteopenia by BMD measured in 1988-1989. Setting.-A community-based population of older adults, Rancho Bernardo, Calif. Participants.-The first 627 consecutively seen white men and women aged 55 to 88 years. Main Outcome Measures.-Bone density measured by single photon absorptiometry at the ultradistal wrist and midradius and by dual x-ray absorptiometry at the femoral neck and lumbar spine. Main Results.-Among the 236 men and 391 women, whose average age was 72 years, 41 men and 39 women had NIDDM, 56 men and 110 women had impaired glucose tolerance, and 139 men and 242 women had normal glucose tolerance. Men with diabetes had BMD levels similar to those men with normal glucose tolerance, whereas women with diabetes had significantly higher BMD levels at all sites than women with normal glucose tolerance. The increased bone density in diabetic women was unexplained by age, obesity, cigarette smoking, alcohol intake, regular physical activity, and the use of diuretics and estrogen. The multiply adjusted mean BMD in women with NIDDM compared with normoglycemic women was 0.600 g/cm2 vs 0.548 g/cm2 at the midradius; 0.265 g/cm2 vs 0.230 g/cm2 at the ultradistal wrist; 0.654 g/cm2 vs 0.610 g/cm2 at the femoral neck; and 0.962 g/cm2 vs 0.859 g/cm2 at the spine. The sex differences were unexplained by survivor bias, prior obesity, or duration of diabetes. Differences were seen in women (but not men) whose diabetes was first detected at the screening evaluation, ie, before drug or dietary treatment. Similarly, in women (but not men) without diabetes increasing BMD levels at all four sites were associated with increasing postchallenge glucose levels independent of age and body mass index. Conclusions.-Older women with NIDDM or hyperglycemia had better BMD than women with normal glucose tolerance, independent of differences in obesity and many other risk factors. No differences in bone density by diabetic status were observed in men. We hypothesize that the sex differences may be explained by the greater androgenicity reported in women with hyperglycemic and hyperinsulinemic conditions.			BARRETTCONNOR, E (corresponding author), UNIV CALIF SAN DIEGO,DEPT COMMUNITY & FAMILY MED,9500 GILLMAN DR,LA JOLLA,CA 92093, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007181, R37AG007181] Funding Source: NIH RePORTER; NIA NIH HHS [AG07181] Funding Source: Medline; NIDDK NIH HHS [DK31801] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALOIA JF, 1985, AM J MED, V78, P95, DOI 10.1016/0002-9343(85)90468-1; ANDO S, 1984, J ENDOCRINOL INVEST, V7, P21, DOI 10.1007/BF03348370; AUWERX J, 1988, DIABETES, V37, P8, DOI 10.2337/diabetes.37.1.8; BARRETTCONNOR E, 1990, AM J EPIDEMIOL, V132, P895, DOI 10.1093/oxfordjournals.aje.a115732; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; BENNETT AE, 1984, J CLIN ENDOCR METAB, V59, P70; BRODY S, 1987, ACTA OBSTET GYN SCAN, V66, P357, DOI 10.3109/00016348709103653; DAVIDSON BJ, 1983, OBSTET GYNECOL, V61, P275; DELEEUW I, 1977, DIABETES, V26, P1130, DOI 10.2337/diabetes.26.12.1130; DEUTSCH S, 1987, INT J GYNECOL OBSTET, V25, P217, DOI 10.1016/0020-7292(87)90238-4; EVANS DJ, 1983, J CLIN ENDOCR METAB, V57, P304, DOI 10.1210/jcem-57-2-304; FORESTA C, 1984, HORM RES, V19, P18, DOI 10.1159/000179855; FRANCIS RM, 1986, BONE, V7, P261, DOI 10.1016/8756-3282(86)90205-X; GARG A, 1990, J CLIN ENDOCR METAB, V70, P1007, DOI 10.1210/jcem-70-4-1007; GIACCA A, 1988, BONE, V9, P29, DOI 10.1016/8756-3282(88)90024-5; GREENSPAN SL, 1989, ANN INTERN MED, V110, P526, DOI 10.7326/0003-4819-110-7-526; HAFFNER SM, 1988, METABOLISM, V37, P683, DOI 10.1016/0026-0495(88)90091-1; HEATH H, 1979, J CLIN ENDOCR METAB, V49, P462, DOI 10.1210/jcem-49-3-462; HEATH H, 1980, NEW ENGL J MED, V303, P567, DOI 10.1056/NEJM198009043031008; HOLBROOK TL, 1989, INT J OBESITY, V13, P723; ISAIA G, 1987, ACTA DIABETOL LAT, V24, P305, DOI 10.1007/BF02742962; JOHNSTON CC, 1985, METABOLISM, V34, P544, DOI 10.1016/0026-0495(85)90192-1; KELLY PJ, 1990, BRIT MED J, V300, P1361, DOI 10.1136/bmj.300.6736.1361; KHAW KT, 1991, CLIN SCI, V80, P199, DOI 10.1042/cs0800199; Kissebah AHK, 1985, METABOLIC COMPLICATI, P115; LEVIN ME, 1976, NEW ENGL J MED, V294, P241, DOI 10.1056/NEJM197601292940502; LEVY J, 1986, CALCIFIED TISSUE INT, V39, P316, DOI 10.1007/BF02555197; LICHTENSTEIN MJ, 1987, AM J EPIDEMIOL, V126, P647, DOI 10.1093/oxfordjournals.aje.a114704; MARSHALL DH, 1977, BRIT MED J, V2, P1177, DOI 10.1136/bmj.2.6096.1177; MCNAIR P, 1988, DAN MED BULL, V35, P109; MEEMA HE, 1967, CAN MED ASSOC J, V96, P132; MEIER DE, 1987, J AM GERIATR SOC, V35, P189, DOI 10.1111/j.1532-5415.1987.tb02308.x; PEDRAZZONI M, 1989, CALCIFIED TISSUE INT, V45, P331, DOI 10.1007/BF02556002; RICO H, 1989, CALCIFIED TISSUE INT, V45, P71, DOI 10.1007/BF02561404; RIGGS BL, 1986, J CLIN INVEST, V77, P1487, DOI 10.1172/JCI112462; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; RINGE JD, 1976, AM J ROENTGENOL, V126, P1300, DOI 10.2214/ajr.126.6.1300; SCHEIDTNAVE C, 1991, MAY SAN DIEG EP RES; SEEMAN E, 1983, AM J MED, V75, P977, DOI 10.1016/0002-9343(83)90878-1; SELBY PL, 1988, DIABETIC MED, V5, P423, DOI 10.1111/j.1464-5491.1988.tb01021.x; SLEMENDA C, 1987, J CLIN INVEST, V80, P1261, DOI 10.1172/JCI113201; SORENSEN OH, 1986, DIABETES 1985, P754; STANLEY HL, 1991, J AM GERIATR SOC, V39, P766, DOI 10.1111/j.1532-5415.1991.tb02698.x; STEINBERG KK, 1989, J CLIN ENDOCR METAB, V69, P533, DOI 10.1210/jcem-69-3-533; Verstraeten A, 1991, CLIN ORTHOP RELAT R, V264, P169; WEINSTOCK RS, 1989, J BONE MINER RES, V4, P97; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WINGARD D L, 1990, Diabetes Care, V13, P3; World Health Organization, 1985, DIAB MELL REP WHO ST, V727	49	147	155	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3333	3337						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB732	1453525				2022-12-28	WOS:A1992KB73200025
J	ESKOLA, J; TAKALA, AK; KELA, E; PEKKANEN, E; KALLIOKOSKI, R; LEINONEN, M				ESKOLA, J; TAKALA, AK; KELA, E; PEKKANEN, E; KALLIOKOSKI, R; LEINONEN, M			EPIDEMIOLOGY OF INVASIVE PNEUMOCOCCAL INFECTIONS IN CHILDREN IN FINLAND	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAPSULAR POLYSACCHARIDE VACCINE; STREPTOCOCCUS-PNEUMONIAE; ANTIBODY-RESPONSE; CONJUGATE VACCINE; B DISEASE; CHARLESTON COUNTY; SOUTH-CAROLINA; NEW-GUINEA; BACTEREMIA; INFANTS	Objective.-To study the epidemiologic characteristics of invasive infections in children caused by Streptococcus pneumoniae to provide background data for vaccination programs. Design.-A nationwide laboratory-based prospective surveillance of all invasive pneumococcal infections in children during 1985 through 1989. Setting.-A network of all microbiologic laboratories and pediatric wards in Finland. Patients.-Children aged 0 to 15 years who were admitted to a hospital with S pneumoniae isolated from blood, cerebrospinal fluid, or deep aspirate sample. Results.-Four hundred fifty-two invasive pneumococcal infections were diagnosed in 1985 through 1989. The annual incidence rate was 8.9 per 100 000 children less than 16 years of age (24.2 per 100 000 among children less than 5 years of age and 45.3 per 100 000 among those less than 2 years of age). The most common clinical entities were bacteremia without focus (310 cases), pneumonia (66 cases), and meningitis (51 cases), with other focal infections seen in 25 cases. The pneumococcal groups/types 14, 6, 19, 7, 18, and 23 comprised 78% of all invasive infections. Conclusions.-Streptococcus pneumoniae is a common cause of invasive infections in children in Finland. A pneumococcal conjugate vaccine containing the six most common groups/types could prevent up to 70% of invasive pneumococcal infections of children in Finland if fully protective in infancy.	NATL PUBL HLTH INST,DEPT BACTERIAL & RESP INFECT,SF-00280 HELSINKI 28,FINLAND	Finland National Institute for Health & Welfare	ESKOLA, J (corresponding author), NATL PUBL HLTH INST,DEPT INFECT DIS EPIDEMIOL,SF-00280 HELSINKI 28,FINLAND.							ANDERSEN AH, 1989, IEEE T MED IMAGING, V8, P50, DOI 10.1109/42.20361; BARKER J, 1989, J INFECT DIS, V159, P348, DOI 10.1093/infdis/159.2.348; BARRY MA, 1984, J INFECT DIS, V149, P449, DOI 10.1093/infdis/149.3.449; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; BURKE JP, 1971, AM J DIS CHILD, V121, P353, DOI 10.1001/archpedi.1971.02100150127021; BURMAN LA, 1985, REV INFECT DIS, V7, P133; DAVIDSON M, 1989, JAMA-J AM MED ASSOC, V261, P715, DOI 10.1001/jama.261.5.715; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; ENGELHARD D, 1991, 31ST INT C ANT AG CH; ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004; FATTOM A, 1990, INFECT IMMUN, V58, P2309, DOI 10.1128/IAI.58.7.2309-2312.1990; FILICE GA, 1980, AM J EPIDEMIOL, V112, P828, DOI 10.1093/oxfordjournals.aje.a113055; GRAY BM, 1986, PEDIATR INFECT DIS J, V5, P201, DOI 10.1097/00006454-198603000-00009; GUIRGUIS N, 1983, B WORLD HEALTH ORGAN, V61, P517; HANSMAN D, 1977, AUST NZ J MED, V7, P267, DOI 10.1111/j.1445-5994.1977.tb03684.x; KLEIN JO, 1981, REV INFECT DIS, V3, P246; KOSKELA M, 1986, PEDIATR INFECT DIS J, V5, P45, DOI 10.1097/00006454-198601000-00009; LEINONEN M, 1986, PEDIATR INFECT DIS J, V5, P39, DOI 10.1097/00006454-198601000-00008; LUOTONEN J, 1981, SCAND J INFECT DIS, V13, P177, DOI 10.3109/inf.1981.13.issue-3.04; MURPHY TV, 1991, 31ST INT C ANT AG CH; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; NOHYNEK H, 1991, AM J DIS CHILD, V145, P618, DOI 10.1001/archpedi.1991.02160060036016; ONYEMELUKWE GC, 1982, J INFECTION, V5, P157, DOI 10.1016/S0163-4453(82)91772-8; RILEY ID, 1986, LANCET, V2, P877; RILEY ID, 1977, LANCET, V1, P1338; RILEY ID, 1991, REV INFECT DIS, V13, P535; ROBBINS JB, 1990, J INFECT DIS, V161, P821, DOI 10.1093/infdis/161.5.821; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; SARNAIK S, 1990, PEDIATR INFECT DIS J, V9, P181, DOI 10.1097/00006454-199003000-00007; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; TAKALA AK, 1989, PEDIATR INFECT DIS J, V8, P297; TAKALA AK, 1991, J INFECT DIS, V164, P982, DOI 10.1093/infdis/164.5.982; WEINBERG GA, 1988, J PEDIATR-US, V113, P621, DOI 10.1016/S0022-3476(88)80369-X; 1989, PEDIATR INFECT DIS J, V8, P21; 1985, NEW VACCINE DEV ESTA, V2, P44	36	201	214	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3323	3327		10.1001/jama.268.23.3323	http://dx.doi.org/10.1001/jama.268.23.3323			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB732	1453524				2022-12-28	WOS:A1992KB73200023
J	GINSBURG, KS; LIANG, MH; NEWCOMER, L; GOLDHABER, SZ; SCHUR, PH; HENNEKENS, CH; STAMPFER, MJ				GINSBURG, KS; LIANG, MH; NEWCOMER, L; GOLDHABER, SZ; SCHUR, PH; HENNEKENS, CH; STAMPFER, MJ			ANTICARDIOLIPIN ANTIBODIES AND THE RISK FOR ISCHEMIC STROKE AND VENOUS THROMBOSIS	ANNALS OF INTERNAL MEDICINE			English	Article						ANTIBODIES, ANTICARDIOLIPIN; CEREBROVASCULAR DISORDERS; THROMBOPHLEBITIS; PULMONARY EMBOLISM; LUPUS ERYTHEMATOSUS, SYSTEMIC	SYSTEMIC LUPUS-ERYTHEMATOSUS; ANTI-CARDIOLIPIN ANTIBODIES; PRIMARY ANTIPHOSPHOLIPID SYNDROME; RETINAL VASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CEREBROVASCULAR-DISEASE; CLINICAL-SIGNIFICANCE; ANTICOAGULANT; ASSOCIATION; SLE	Objective: To determine whether the presence of anticardiolipin antibodies is a risk factor for ischemic stroke and venous thrombosis in healthy adult men. Design: A nested, case-control study in a prospective cohort. Setting. A nationwide study of physicians. Participants: The study sample was drawn from the Physicians' Health Study, a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene in 22 071 male physicians. At entry, 68% of the participants submitted plasma samples that were subsequently frozen at -80-degrees-C. During 60.2 months of follow-up, follow-up for nonfatal outcomes was 99.7% complete and ascertainment of fatal outcomes was 100% complete. We identified men with documented ischemic stroke, deep venous thrombosis of the leg, or pulmonary embolus and for whom a plasma sample was available. A control was matched by age, smoking history, and length of follow-up to each of the 100 patients with ischemic stroke and the 90 patients with deep venous thrombosis or pulmonary embolus. Measurements: Plasma samples were assessed for IgG anticardiolipin antibodies by enzyme-linked immunosorbent assay. The mean anticardiolipin antibody titers of the case patients in the two diagnostic groups (ischemic stroke; venous thrombosis or pulmonary embolus) were compared with those of the control groups, and relative risks were calculated for patients in increasing percentile categories of anticardiolipin antibodies by conditional logistic regression. Results: The anticardiolipin antibody titers were higher in case patients with deep venous thrombosis and pulmonary embolus than in their matched controls (P = 0.01). Persons with anticardiolipin antibody titers above the 95th percentile had a relative risk for developing deep venous thrombosis or pulmonary embolus of 5.3 (95% Cl, 1.55 to 18.3; P = 0.01). The anticardiolipin antibody titers in case patients with ischemic stroke and controls were not significantly different (P > 0.2), and no clear trend of higher risks among those with elevated levels of anticardiolipin antibodies was observed. Conclusion: An anticardiolipin antibody level above the 95th percentile is an important risk factor for deep venous thrombosis or pulmonary embolus but not for ischemic stroke in healthy adult men.	BRIGHAM & WOMENS HOSP, CHANNING LAB, 180 LONGWOOD AVE, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital					NCI NIH HHS [CA42182] Funding Source: Medline; NIAMS NIH HHS [AR36308, AR07530] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR036308, T32AR007530] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALARCONSEGOVIA D, 1989, MEDICINE, V68, P353, DOI 10.1097/00005792-198911000-00003; [Anonymous], 1988, NEW ENGL J MED; ASHERSON RA, 1989, MEDICINE, V68, P366, DOI 10.1097/00005792-198911000-00004; ASHERSON RA, 1989, AM J MED, V86, P391, DOI 10.1016/0002-9343(89)90335-5; ASHERSON RA, 1986, ARTHRITIS RHEUM, V29, P1292, DOI 10.1002/art.1780291019; ASHERSON RA, 1989, Q J MED, V73, P1103; ASHERSON RA, 1987, ANN RHEUM DIS, V46, P605, DOI 10.1136/ard.46.8.605; ASHERSON RA, 1989, ANN RHEUM DIS, V48, P358, DOI 10.1136/ard.48.5.358; BOEY ML, 1983, BMJ-BRIT MED J, V287, P1021, DOI 10.1136/bmj.287.6398.1021; CARRERAS LO, 1981, LANCET, V1, P244; COLACO CB, 1983, ANN RHEUM DIS, V42, P228; COLACO CB, 1985, CLIN EXP IMMUNOL, V59, P449; COLDITZ GA, 1988, NEW ENGL J MED, V318, P937, DOI 10.1056/NEJM198804143181501; COON WW, 1976, SURG GYNECOL OBSTET, V143, P385; COOPER RC, 1989, BRIT J RHEUMATOL, V28, P379; COULL BM, 1990, STROKE, V21, P1370, DOI 10.1161/01.STR.21.9.1370; CRONIN ME, 1988, J RHEUMATOL, V15, P795; DECATERINA R, 1990, AM J CARDIOL, V65, P922, DOI 10.1016/0002-9149(90)91439-D; DERKSEN RHWM, 1986, ARTHRITIS RHEUM, V29, P1295, DOI 10.1002/art.1780291021; DONALDSON MC, 1990, J VASC SURG, V11, P825, DOI 10.1067/mva.1990.20120; DREW P, 1987, ANN RHEUM DIS, V46, P612, DOI 10.1136/ard.46.8.612; FORT JG, 1987, ARTHRITIS RHEUM, V30, P752, DOI 10.1002/art.1780300705; GERSTMAN BB, 1991, AM J EPIDEMIOL, V133, P32, DOI 10.1093/oxfordjournals.aje.a115799; HALL S, 1984, J RHEUMATOL, V11, P846; HAMSTEN A, 1986, LANCET, V1, P113; HARRIS EN, 1987, CLIN EXP IMMUNOL, V68, P215; HARRIS EN, 1983, LANCET, V2, P1211; HARRIS EN, 1986, ARCH INTERN MED, V146, P2153, DOI 10.1001/archinte.146.11.2153; HARRIS EN, 1985, J CLIN LAB IMMUNOL, V16, P1; HARRIS EN, 1988, ANNU REV MED, V39, P261, DOI 10.1146/annurev.med.39.1.261; HASSELAAR P, 1990, J RHEUMATOL, V17, P186; ISENBERG DA, 1986, MEDICINE, V65, P46, DOI 10.1097/00005792-198601000-00003; KALUNIAN KC, 1988, AM J MED, V85, P602; KHAMASHTA MA, 1988, ANN RHEUM DIS, V47, P849, DOI 10.1136/ard.47.10.849; KLEMP P, 1988, CLIN EXP IMMUNOL, V74, P254; KUSHNER M, 1989, STROKE, V20, P225, DOI 10.1161/01.STR.20.2.225; LAVALLE C, 1990, J RHEUMATOL, V17, P34; LEVINE SR, 1987, ARCH NEUROL-CHICAGO, V44, P876, DOI 10.1001/archneur.1987.00520200078024; LOCKSHIN M D, 1991, Current Opinion in Rheumatology, V3, P797, DOI 10.1097/00002281-199110000-00008; LOIZOU S, 1985, CLIN EXP IMMUNOL, V62, P738; LOVE PE, 1990, ANN INTERN MED, V112, P682, DOI 10.7326/0003-4819-112-9-682; MCNEIL HP, 1990, CLIN EXP RHEUMATOL, V8, P525; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; MEYER O, 1987, J RHEUMATOL, V14, P502; MORTON KE, 1986, LANCET, V2, P1353; MOULTON AW, 1991, AM J MED, V91, P156, DOI 10.1016/0002-9343(91)90008-L; OUT HJ, 1989, ANN RHEUM DIS, V48, P1023, DOI 10.1136/ard.48.12.1023; POPE JM, 1991, AM J MED, V90, P299, DOI 10.1016/0002-9343(91)90569-J; RUIZARGUELLES GJ, 1989, J RHEUMATOL, V16, P381; SAMMARITANO LR, 1990, SEMIN ARTHRITIS RHEU, V20, P81, DOI 10.1016/0049-0172(90)90021-7; SLETNES KE, 1992, LANCET, V339, P451, DOI 10.1016/0140-6736(92)91057-F; STURFELT G, 1987, ARTHRITIS RHEUM, V30, P382, DOI 10.1002/art.1780300404	52	453	464	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1992	117	12					997	1002		10.7326/0003-4819-117-12-997	http://dx.doi.org/10.7326/0003-4819-117-12-997			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB980	1443986				2022-12-28	WOS:A1992KB98000004
J	SWAN, HJC				SWAN, HJC			KATH	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		GINSBURG KS, 1992, ANN INTERN MED, V117, P997, DOI 10.7326/0003-4819-117-12-997; 1992, ANN INTERN MED, V117, P1049	2	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1992	117	12					1049	1050		10.7326/0003-4819-117-12-1049	http://dx.doi.org/10.7326/0003-4819-117-12-1049			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB980	1443973				2022-12-28	WOS:A1992KB98000011
J	CARITIS, SN				CARITIS, SN			TREATMENT OF PRETERM LABOR WITH THE BETA-ADRENERGIC AGONIST RITODRINE	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							TERBUTALINE				CARITIS, SN (corresponding author), UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15213, USA.							CARITIS SN, 1990, AM J OBSTET GYNECOL, V162, P429, DOI 10.1016/0002-9378(90)90401-R; CARITIS SN, 1984, AM J OBSTET GYNECOL, V150, P7, DOI 10.1016/S0002-9378(84)80101-5; INGEMARSSON I, 1985, OBSTET GYNECOL, V66, P176; SMIT DA, 1984, GYNECOL OBSTET INVES, V18, P105, DOI 10.1159/000299058; 1992, NEW ENGL J MED, V327, P308	5	1	1	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	1992	327	24					1758	1758						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA897	1435924				2022-12-28	WOS:A1992KA89700018
J	MCINTYRE, KM; VITA, JA; LAMBREW, CT; FREEMAN, J; LOSCALZO, J				MCINTYRE, KM; VITA, JA; LAMBREW, CT; FREEMAN, J; LOSCALZO, J			A NONINVASIVE METHOD OF PREDICTING PULMONARY-CAPILLARY WEDGE PRESSURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BALLOON-TIPPED CATHETER; VALSALVA MANEUVER; HEART-FAILURE; ARTERY	Background. The noninvasive prediction of pulmonary-capillary wedge pressure (PCWP) is important for the recognition and treatment of a variety of cardiovascular disorders. The response of the arterial pressure to the Valsalva maneuver has been shown to correlate with the PCWP. We therefore devised a noninvasive method to measure this pressure response at the bedside and correlated these measurements with the PCWP measured directly with a pulmonary-artery catheter. Methods. Simultaneous, blinded, noninvasive measurements of the ratio of the final amplitude to the initial amplitude of the pulse wave form during the stress phase of the Valsalva maneuver (pulse-amplitude ratio) and direct measurements of the PCWP were obtained in 20 clinically stable patients and in 14 clinically unstable patients who were receiving vasoactive agents, 12 of whom also had endotracheal tubes in place. Results. Using linear regression analysis, we found that the pulse-amplitude ratio strongly correlated with the measured PCWP over a range of base-line values from 4 to 32 mm Hg for the 20 clinically stable patients (R2 = 0.80) and the 14 clinically unstable patients (R2 = 0.85). The method also correctly predicted changes in the PCWP after the administration of nitroglycerin or furosemide and after expansion of the intravascular volume (R2 = 0.79). Conclusions. These preliminary data indicate that a simple noninvasive method can accurately predict the PCWP and changes in the PCWP in response to medical therapy.	BROCKTON W ROXBURY VET AFFAIRS MED CTR,DEPT MED,CARDIOL SECT,BOSTON,MA; BROCKTON W ROXBURY VET AFFAIRS MED CTR,RES & DEV SERV,BOSTON,MA; BROCKTON W ROXBURY VET AFFAIRS MED CTR,DEPT SURG,BOSTON,MA; HARVARD UNIV,SCH MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT SURG,BOSTON,MA 02115; MAINE MED CTR,DEPT CARDIOL,PORTLAND,ME 04102; MAINE MED CTR,DEPT RES,PORTLAND,ME 04102; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115	Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Maine Medical Center; Maine Medical Center; Harvard University; Harvard T.H. Chan School of Public Health			Loscalzo, Joseph/ABD-8980-2021	Vita, Joseph/0000-0001-5607-1797				ASKENAZI J, 1981, NEW ENGL J MED, V305, P1566, DOI 10.1056/NEJM198112243052606; BRAUNWALD E, 1984, HEART DISEASE TXB CA, V1, P500; BROOKER JZ, 1974, BRIT HEART J, V36, P713; CHAKKO S, 1991, AM J MED, V90, P353, DOI 10.1016/0002-9343(91)90576-J; CHEVALIER PA, 1972, P SOC EXP BIOL MED, V139, P1429, DOI 10.3181/00379727-139-36378; FOOTE GA, 1974, NEW ENGL J MED, V290, P927, DOI 10.1056/NEJM197404252901702; GILL JB, 1988, J INTENSIVE CARE MED, V2, P121; GORLIN R, 1957, AM J MED, V22, P197, DOI 10.1016/0002-9343(57)90004-9; Hamilton WF, 1944, AM J PHYSIOL, V141, P0042, DOI 10.1152/ajplegacy.1944.141.1.42; JUDSON WE, 1955, CIRCULATION, V11, P889, DOI 10.1161/01.CIR.11.6.889; KORNER PI, 1976, J APPL PHYSIOL, V40, P434, DOI 10.1152/jappl.1976.40.3.434; LEE GD, 1954, BRIT HEART J, V16, P311; MATTHAY MA, 1988, ANN INTERN MED, V109, P826, DOI 10.7326/0003-4819-109-10-826; MCINTYRE KM, 1987, J APPL CARDIOL, V2, P137; PARISI AF, 1976, CIRCULATION, V54, P921, DOI 10.1161/01.CIR.54.6.921; RAHKO PS, 1985, CARDIOVASC REV REPS, V6, P428; ROBERTSON D, 1977, CIRCULATION, V55, P596, DOI 10.1161/01.CIR.55.4.596; SHARPEY-SCHAFER E. P., 1965, HANDBOOK PHYSIOL, V3, P1875; SHARPEYSCHAFER EP, 1955, BRIT MED J, V1, P693, DOI 10.1136/bmj.1.4915.693; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; STUCKI P, 1955, CIRCULATION, V11, P900, DOI 10.1161/01.CIR.11.6.900; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; WILKINSON PL, 1977, AM J PHYSIOL, V233, pH93, DOI 10.1152/ajpheart.1977.233.1.H93; ZEMA MJ, 1980, BRIT HEART J, V44, P560; 1988, SAS STAT USERS GUIDE, P193; 1991, NEW ENGL J MED, V325, P293	26	53	61	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	1992	327	24					1715	1720		10.1056/NEJM199212103272404	http://dx.doi.org/10.1056/NEJM199212103272404			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA897	1435916				2022-12-28	WOS:A1992KA89700004
J	THEOBALD, M; NIERLE, T; BUNJES, D; ARNOLD, R; HEIMPEL, H				THEOBALD, M; NIERLE, T; BUNJES, D; ARNOLD, R; HEIMPEL, H			HOST-SPECIFIC INTERLEUKIN-2-SECRETING DONOR T-CELL PRECURSORS AS PREDICTORS OF ACUTE GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANTATION BETWEEN HLA-IDENTICAL SIBLINGS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; LYMPHOCYTES-T; EFFECTOR MECHANISMS; FREQUENCY-ANALYSIS; INVITRO; HELPER; INDUCTION; LEUKEMIA; INVIVO; SKIN	Background. Acute graft-versus-host disease (GVHD) is a serious complication of allogeneic bone marrow transplantation from an HLA-identical sibling. There is no practical test before transplantation that gives sufficient information to predict the degree of allogeneic reactivity between HLA-identical siblings. Methods. We determined the frequency with which host-specific interleukin-2-secreting donor T-cell precursors occurred in 16 consecutive pairs of HLA-identical siblings before they underwent marrow grafting. The results were correlated with the development of acute GVHD after transplantation. Results. High frequencies of host-specific T-cell precursors (greater-than-or-equal-to 1 per 100,000) were detectable before transplantation in eight donors whose siblings later had severe (grade II or III) acute GVHD. Among the donors to eight patients with mild (grade 0 or I) acute GVHD, low frequencies (<1 per 100,000) were found. Conclusions. Analysis of the frequency of such cells before transplantation may be a useful predictor of severe acute GVHD in allogeneic bone marrow transplantation between HLA-identical siblings. It is possible that the patients at risk for serious acute GVHD after marrow grafting may benefit from some alternative form of immunosuppressive therapy.	UNIV HOSP ULM, DEPT INTERNAL MED 3, BONE MARROW TRANSPLANTAT UNIT, ULM, GERMANY	Ulm University								ALDACCAK R, 1990, LEUKEMIA, V4, P222; CHAMPLIN R, 1990, BLOOD, V76, P418; CLEVELAND MG, 1988, J IMMUNOL, V141, P3349; DEBUEGER M, 1991, EUR J IMMUNOL, V21, P2839, DOI 10.1002/eji.1830211127; DELMONTE L, 1982, TRANSPLANTATION, V34, P100; EIERMANN TH, 1991, TISSUE ANTIGENS, V38, P193; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GOULMY E, 1988, TRANSPLANT REV, V2, P29, DOI DOI 10.1016/S0955-470X(88)80005-3; HAMILTON BL, 1987, J IMMUNOL, V139, P2511; Hansen J A, 1984, Prog Clin Biol Res, V149, P299; HOLLER E, 1990, BLOOD, V75, P1011; JOHNSEN HE, 1992, SCAND J IMMUNOL, V35, P353, DOI 10.1111/j.1365-3083.1992.tb02868.x; KAMINSKI E, 1988, BONE MARROW TRANSPL, V3, P149; KAMINSKI E, 1989, TRANSPLANTATION, V48, P608; KORNGOLD R, 1987, TRANSPLANTATION, V44, P335, DOI 10.1097/00007890-198709000-00002; MCCARTHY PL, 1991, BLOOD, V78, P1915; PERREAULT C, 1990, BLOOD, V76, P1269; PIGUET PF, 1987, J EXP MED, V166, P1280, DOI 10.1084/jem.166.5.1280; PIGUET PF, 1990, GRAFT VS HOST DISEAS, P255; SHARROCK CEM, 1990, IMMUNOL TODAY, V11, P281, DOI 10.1016/0167-5699(90)90113-N; SPRENT J, 1986, IMMUNOL REV, V91, P195, DOI 10.1111/j.1600-065X.1986.tb01489.x; STORB R, 1989, BLOOD, V73, P1729; SYMINGTON FW, 1990, TRANSPLANTATION, V50, P518, DOI 10.1097/00007890-199009000-00033; TASWELL C, 1981, J IMMUNOL, V126, P1614; THEOBALD M, 1989, J IMMUNOL METHODS, V121, P19, DOI 10.1016/0022-1759(89)90415-8; THEOBALD M, 1990, TRANSPLANTATION, V50, P850, DOI 10.1097/00007890-199011000-00021; TRUITT RL, 1991, BONE MARROW TRANSPL, V8, P51; VANELS CACM, 1990, HUM IMMUNOL, V28, P39, DOI 10.1016/0198-8859(90)90101-T; VANELS CACM, 1990, TRANSPLANTATION, V50, P67, DOI 10.1097/00007890-199007000-00012; VANELS CACM, 1990, TRANSPLANTATION, V50, P62, DOI 10.1097/00007890-199007000-00011; VOGELSANG GB, 1985, NEW ENGL J MED, V313, P645, DOI 10.1056/NEJM198509123131101; Waldmann H., 1979, LIMITING DILUTION AN	33	162	165	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	1992	327	23					1613	1617		10.1056/NEJM199212033272301	http://dx.doi.org/10.1056/NEJM199212033272301			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA260	1435898				2022-12-28	WOS:A1992KA26000001
J	DOOREY, AJ; MICHELSON, EL; TOPOL, EJ				DOOREY, AJ; MICHELSON, EL; TOPOL, EJ			THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION - KEEPING THE UNFULFILLED PROMISES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE PLASMINOGEN-ACTIVATOR; CARDIOPULMONARY-RESUSCITATION; EMERGENCY ROOM; INTRAVENOUS STREPTOKINASE; CORONARY THROMBOLYSIS; CHEST PAIN; PHASE-II; INTRACORONARY STREPTOKINASE; INTRACEREBRAL HEMORRHAGE; VENTRICULAR-FUNCTION	Objective.-To assess the use of thrombolytic therapy for acute myocardial infarction, evaluating whether inclusion and exclusion criteria should be altered as well as the public health implications of any such alterations. Data Sources.-Data obtained were from English-language articles on the use of thrombolytic therapy in acute myocardial infarction. Articles that reported on inclusion and exclusion criteria as well as specific complications of this therapy were specifically sought. The review included articles under the terms thrombolytic therapy and acute myocardial infarction in the National Library of Medicine's MEDLINE database. Study Selection.-Studies selected for detailed review were those reporting specifics about inclusion and exclusion criteria and efficacy. Data extraction guidelines for assessing data quality included study size, patient population, detail of patient information acquired, and consecutive patient enrollment. Data Synthesis.-Thrombolytic therapy can provide substantial decrements of morbidity and mortality of acute myocardial infarction in the subset of patients who receive this therapy, but is underused in the United States. Advanced age per se should not be an exclusion criterion. Improvements can be made in electrocardiographic diagnosis of acute myocardial infarction. Many of the clinical conditions initially excluded from thrombolytic consideration, such as hypertension or having received cardiopulmonary resuscitation, are only relative contraindications. The benefit/risk ratio in treatment of these patients is often acceptable. Several well-documented points of delay from onset of symptoms to treatment can be minimized, and accelerated therapy can result in a reduction in mortality rates. Conclusion.-Significant public health benefits will result from greater use of thrombolytic therapy in acute myocardial infarction.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, PHILADELPHIA, PA 19107 USA; HAHNEMANN UNIV, DEPT MED, DIV CARDIOVASC DIS, PHILADELPHIA, PA 19102 USA; CLEVELAND CLIN EDUC FDN, DEPT CARDIOL, CLEVELAND, OH 44106 USA	Jefferson University; Drexel University; Cleveland Clinic Foundation	DOOREY, AJ (corresponding author), CARDIOL CONSULTANTS PA, MED CTR DELAWARE,DEPT MED,DIV CARDIOL, 4745 OGLETOWN STANTON RD, SUITE 220, NEWARK, DE 19713 USA.							ADOLPH RJ, 1990, J AM COLL CARDIOL, V16, P793, DOI 10.1016/S0735-1097(10)80323-7; ALTHOUSE R, 1990, AM J CARDIOL, V66, P1298, DOI 10.1016/0002-9149(90)91157-2; ANDERSON JL, 1991, AM J CARDIOL, V68, P166, DOI 10.1016/0002-9149(91)90738-7; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, Lancet, V1, P397; BARBASH GI, 1990, AM J CARDIOL, V66, P261, DOI 10.1016/0002-9149(90)90832-L; BATTLE R, 1991, Journal of the American College of Cardiology, V17, p311A; BAYER AJ, 1986, J AM GERIATR SOC, V34, P263, DOI 10.1111/j.1532-5415.1986.tb04221.x; BEDELL SE, 1983, NEW ENGL J MED, V309, P569, DOI 10.1056/NEJM198309083091001; BEHAR S, 1991, AM J CARDIOL, V68, P1291, DOI 10.1016/0002-9149(91)90233-B; BEHAR S, 1991, CIRCULATION, V84, P63; BLOHM M, 1992, AM J CARDIOL, V69, P411, DOI 10.1016/0002-9149(92)90244-S; BOVILL EG, 1991, ANN INTERN MED, V115, P256, DOI 10.7326/0003-4819-115-4-256; BRAUNWALD E, 1989, J AM COLL CARDIOL, V14, P1570, DOI 10.1016/0735-1097(89)90400-2; BRAUNWALD E, 1990, CIRCULATION, V82, P1510, DOI 10.1161/01.CIR.82.4.1510; BUSH HS, 1991, AM HEART J, V121, P1591, DOI 10.1016/0002-8703(91)90001-X; CALIFF RM, 1990, J AM COLL CARDIOL, V15, P937, DOI 10.1016/0735-1097(90)90220-J; CALIFF RM, 1992, AM J CARDIOL, V69, pA12, DOI 10.1016/0002-9149(92)91168-4; CHAITMAN BR, 1989, J AM COLL CARDIOL, V14, P1159, DOI 10.1016/0735-1097(89)90410-5; CHAITMAN BR, 1988, J AM COLL CARDIOL, V12, P1167, DOI 10.1016/0735-1097(88)92595-8; CHAMBERLAIN DA, 1990, LANCET, V335, P427; CHAMBERLAIN DA, 1992, THROMBOLYSIS CAN WE; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; CHOP WM, 1991, J FAM PRACTICE, V33, P79; COLLINS R, 1991, CIRCULATION, V84, P230; CRAGG DR, 1991, ANN INTERN MED, V115, P173, DOI 10.7326/0003-4819-115-3-173; CROSS SJ, 1991, BMJ-BRIT MED J, V303, P1242, DOI 10.1136/bmj.303.6812.1242; DEGREGORIO B, 1985, AM HEART J, V109, P908, DOI 10.1016/0002-8703(85)90660-X; DEJAEGERE PP, 1992, J AM COLL CARDIOL, V19, P289, DOI 10.1016/0735-1097(92)90480-B; DOOREY AJ, 1987, J AM COLL CARDIOL, V10, P1357, DOI 10.1016/S0735-1097(87)80141-9; EISENBERG MS, 1989, ANN EMERG MED, V18, P838, DOI 10.1016/S0196-0644(89)80207-0; FEIRING AJ, 1987, CIRCULATION, V75, P980, DOI 10.1161/01.CIR.75.5.980; FRANZOSI MG, 1992, CHEST, V101, pS116, DOI 10.1378/chest.101.4_Supplement.116S; GIBLER WB, 1991, AM HEART J, V121, P1, DOI 10.1016/0002-8703(91)90948-H; GLIKSON M, 1991, AM HEART J, V121, P1542, DOI 10.1016/0002-8703(91)90164-D; GONZALEZ E R, 1991, Journal of the American College of Cardiology, V17, p247A; GORE JM, 1991, CIRCULATION, V83, P448, DOI 10.1161/01.CIR.83.2.448; GRINES CL, 1990, J AM COLL CARDIOL, V16, P223, DOI 10.1016/0735-1097(90)90482-5; GURWITZ JH, 1991, JAMA-J AM MED ASSOC, V265, P1720, DOI 10.1001/jama.265.13.1720; HERLITZ J, 1989, AM J CARDIOL, V64, P90, DOI 10.1016/0002-9149(89)90659-0; HLATKY MA, 1988, AM J CARDIOL, V61, P510, DOI 10.1016/0002-9149(88)90755-2; HO MT, 1989, ANN EMERG MED, V18, P727, DOI 10.1016/S0196-0644(89)80004-6; Ho MT, 1990, J AM COLL CARDIOL, V15, p192A; HOLMBERG S, 1990, AM J CARDIOL, V65, P401; HUEY BL, 1988, J AM COLL CARDIOL, V12, P1156, DOI 10.1016/0735-1097(88)92594-6; KARLSON BW, 1990, AM HEART J, V120, P1213, DOI 10.1016/0002-8703(90)90138-N; KASE CS, 1990, ANN INTERN MED, V112, P17, DOI 10.7326/0003-4819-112-1-17; KENNEDY JW, 1990, ANN INTERN MED, V113, P907, DOI 10.7326/0003-4819-113-12-907; KENNEDY JW, 1985, NEW ENGL J MED, V312, P1073, DOI 10.1056/NEJM198504253121701; KENNEDY JW, 1988, J AM COLL CARDIOL, V11, P446, DOI 10.1016/0735-1097(88)90114-3; KEREIAKES DJ, 1990, AM HEART J, V120, P773, DOI 10.1016/0002-8703(90)90192-Z; KOWALENKO T, 1992, AM HEART J, V123, P181, DOI 10.1016/0002-8703(92)90764-M; KRUMHOLZ H M, 1992, Journal of the American College of Cardiology, V19, p378A; KRUMHOLZ HM, 1992, NEW ENGL J MED, V327, P7, DOI 10.1056/NEJM199207023270102; KUDENCHUK PJ, 1991, J AM COLL CARDIOL, V17, P1486, DOI 10.1016/0735-1097(91)90636-N; LEE TH, 1989, ANN INTERN MED, V110, P957, DOI 10.7326/0003-4819-110-12-957; LEIZOROVICZ A, 1990, CIRCULATION, V82, P255; LEW AS, 1987, AM J CARDIOL, V59, P1, DOI 10.1016/S0002-9149(87)80059-0; MACCALLUM AG, 1990, EUR HEART J, V11, P48, DOI 10.1093/eurheartj/11.suppl_F.48; MAGGIONI A, 1991, BMJ-BRIT MED J, V302, P1428, DOI 10.1136/bmj.302.6790.1428; MAGGIONI AP, 1992, NEW ENGL J MED, V327, P1, DOI 10.1056/NEJM199207023270101; MARK DB, 1988, J AM COLL CARDIOL, V12, pA32, DOI 10.1016/0735-1097(88)92639-3; MAYNARD C, 1989, AM J CARDIOL, V63, P1296, DOI 10.1016/0002-9149(89)91038-2; MITIC WR, 1984, CAN J PUBLIC HEALTH, V75, P414; MOHR JP, 1983, HARRISONS PRINCIPLES, P2050; MOLINA JE, 1992, AM J SURG, V163, P375, DOI 10.1016/0002-9610(92)90036-Q; MONTAGUE TJ, 1991, AM J CARDIOL, V68, P843, DOI 10.1016/0002-9149(91)90397-4; MOSES HW, 1991, AM J CARDIOL, V68, P251, DOI 10.1016/0002-9149(91)90754-9; MULLER DWM, 1990, ANN INTERN MED, V113, P949, DOI 10.7326/0003-4819-113-12-949; MURRAY N, 1987, BRIT HEART J, V57, P144; NECHES RB, 1991, CLIN CARDIOL, V14, P616, DOI 10.1002/clc.4960140715; NEUHAUS KL, 1989, J AM COLL CARDIOL, V14, P1566, DOI 10.1016/0735-1097(89)90399-9; O'CONNOR C M, 1990, Journal of the American College of Cardiology, V15, p34A; OCONNOR CM, 1990, J AM COLL CARDIOL, V16, P533, DOI 10.1016/0735-1097(90)90338-P; PASTERNAK RC, 1992, HEART DISEASE TXB CA, P1200; PEPINE CJ, 1990, CLIN CARDIOL, V13, P12; PEPINE CJ, 1991, J MYOCARDIAL ISCHEMI, V3, P10; PETO R, 1991, 40TH ANN SCI SESS AM; PFEFFER MA, 1991, JAMA-J AM MED ASSOC, V266, P528, DOI 10.1001/jama.266.4.528; RICH MW, 1990, CARDIO, V7, P79; RIDKER PM, 1992, AM J CARDIOL, V70, P10, DOI 10.1016/0002-9149(92)91381-D; SCHMIDT SB, 1990, AM J CARDIOL, V65, P1411, DOI 10.1016/0002-9149(90)91345-7; SCHOLZ KH, 1992, AM J CARDIOL, V69, P724, DOI 10.1016/0002-9149(92)90494-J; SCHROEDER JS, 1978, AM J MED, V64, P742, DOI 10.1016/0002-9343(78)90512-0; SCHWEITZER P, 1990, AM HEART J, V119, P642, DOI 10.1016/S0002-8703(05)80288-1; SHARKEY SW, 1989, JAMA-J AM MED ASSOC, V262, P3171, DOI 10.1001/jama.262.22.3171; SHERRY S, 1980, ANN INTERN MED, V93, P141, DOI 10.7326/0003-4819-93-1-141; SLEIGHT P, 1991, 7TH INT WORKSH THROM; SLOAN MA, 1992, AM J CARDIOL, V69, pA21, DOI 10.1016/0002-9149(92)91169-5; SMITH M, 1987, ANN EMERG MED, V16, P592, DOI 10.1016/S0196-0644(87)80698-4; SMITH SC, 1990, J AM COLL CARDIOL, V16, P784, DOI 10.1016/S0735-1097(10)80322-5; TENAGLIA AN, 1991, AM J CARDIOL, V68, P1015, DOI 10.1016/0002-9149(91)90488-7; TIEFENBRUNN AJ, 1989, JAMA-J AM MED ASSOC, V261, P2107; TIEFENBRUNN AJ, 1992, AM J CARDIOL, V69, pA3, DOI 10.1016/0002-9149(92)91167-3; TJOE SL, 1972, CHEST, V61, P617, DOI 10.1378/chest.61.7.617; TOPOL EJ, 1987, J AM COLL CARDIOL, V10, P1173, DOI 10.1016/S0735-1097(87)80114-6; TOPOL EJ, 1990, J AM COLL CARDIOL, V15, P922, DOI 10.1016/0735-1097(90)90217-D; TOPOL EJ, 1992, NEW ENGL J MED, V327, P45, DOI 10.1056/NEJM199207023270109; VERHEUGT FWA, 1989, AM HEART J, V117, P1018, DOI 10.1016/0002-8703(89)90856-9; VERSTRAETE M, 1988, CIRCULATION, V77, P353, DOI 10.1161/01.CIR.77.2.353; VONDERLEYEN H, 1991, CIRCULATION, V84, P62; WASSERMAN AG, 1989, AM J CARDIOL, V64, pB17, DOI 10.1016/S0002-9149(89)80004-9; WEAVER WD, 1990, J AM COLL CARDIOL, V15, P925, DOI 10.1016/0735-1097(90)90218-E; WEAVER WD, 1991, J AM COLL CARDIOL, V18, P657, DOI 10.1016/0735-1097(91)90784-7; WEAVER WD, 1992, 41ST SCI SESS AM COL; WILCOX RG, 1990, LANCET, V335, P1175; WILELRSON JT, 1991, NEW ENGL J MED, V325, P1166; WITTRY MD, 1989, GERIATRICS-US, V44, P28; 1991, 1991 HEART STROKE FA	109	54	54	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	1992	268	21					3108	3114		10.1001/jama.268.21.3108	http://dx.doi.org/10.1001/jama.268.21.3108			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA002	1433742				2022-12-28	WOS:A1992KA00200035
J	MADHANI, HD; GUTHRIE, C				MADHANI, HD; GUTHRIE, C			A NOVEL BASE-PAIRING INTERACTION BETWEEN U2 AND U6 SNRNAS SUGGESTS A MECHANISM FOR THE CATALYTIC ACTIVATION OF THE SPLICEOSOME	CELL			English	Article							PRE-MESSENGER-RNA; SMALL NUCLEAR-RNA; GROUP-II INTRON; RIBONUCLEOPROTEIN-PARTICLES; SACCHAROMYCES-CEREVISIAE; SPLICING REACTION; SITE SELECTION; YEAST; U4; MUTATION	Prior to the chemical steps of mRNA splicing, the extensive base-pairing interaction between the U4 and U6 spliceosomal snRNAs is disrupted. Here, we use a mutational analysis in yeast to demonstrate a conserved base-pairing interaction between the U6 and U2 snRNAs that is mutually exclusive with the U4-U6 interaction. In this novel pairing, conserved sequences in U6 interact with a sequence in U2 that is immediately upstream of the branch point recognition region. Remarkably, the residues in U6 that can be consequently juxtaposed with the intron substrate include those that have been proposed previously to be catalytic. Both the first and second steps of splicing are inhibited when this base-paired structure is mutated. These observations, together with the high conservation of the U2-U6 structure, lead us to propose that it might be a component of the spliceosomal active site.			MADHANI, HD (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA.			Madhani, Hiten/0000-0001-7400-6657	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021119, R01GM021119] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM21119] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BINDEREIF A, 1987, EMBO J, V6, P2415, DOI 10.1002/j.1460-2075.1987.tb02520.x; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BORDONNE R, 1992, NUCLEIC ACIDS RES, V20, P479, DOI 10.1093/nar/20.3.479; BRINGMANN P, 1984, EMBO J, V3, P1357, DOI 10.1002/j.1460-2075.1984.tb01977.x; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; BROW DA, 1989, NATURE, V337, P14, DOI 10.1038/337014a0; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; DATTA B, 1991, NATURE, V352, P821, DOI 10.1038/352821a0; ELLEDGE SJ, 1988, GENE, V70, P303, DOI 10.1016/0378-1119(88)90202-8; FABRIZIO P, 1989, GENE DEV, V3, P2137, DOI 10.1101/gad.3.12b.2137; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; Guthrie C, 1991, GUIDE YEAST GENETICS; HAMM J, 1989, EMBO J, V8, P4179, DOI 10.1002/j.1460-2075.1989.tb08603.x; HASHIMOTO C, 1984, NUCLEIC ACIDS RES, V12, P3283, DOI 10.1093/nar/12.7.3283; HAUSNER TP, 1990, GENE DEV, V4, P2146, DOI 10.1101/gad.4.12a.2146; JACQUIER A, 1991, J MOL BIOL, V219, P415, DOI 10.1016/0022-2836(91)90183-7; JACQUIER A, 1987, CELL, V50, P17, DOI 10.1016/0092-8674(87)90658-1; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; KELLER EB, 1985, NUCLEIC ACIDS RES, V13, P4971, DOI 10.1093/nar/13.13.4971; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; LAMOND AI, 1988, P NATL ACAD SCI USA, V85, P411, DOI 10.1073/pnas.85.2.411; LAMOND AI, 1989, CELL, V58, P383, DOI 10.1016/0092-8674(89)90852-0; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MIRAGLIA L, 1991, P NATL ACAD SCI USA, V88, P7061, DOI 10.1073/pnas.88.16.7061; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; MYSLINSKI E, 1990, SCIENCE, V247, P1213, DOI 10.1126/science.1690452; NEWMAN A, 1991, CELL, V65, P115, DOI 10.1016/0092-8674(91)90413-S; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; PATTERSON B, 1987, CELL, V49, P613, DOI 10.1016/0092-8674(87)90537-X; PATTERSON B, 1991, CELL, V64, P181, DOI 10.1016/0092-8674(91)90219-O; PIKIELNY CW, 1986, NATURE, V324, P341, DOI 10.1038/324341a0; RINKE J, 1985, J MOL BIOL, V185, P721, DOI 10.1016/0022-2836(85)90057-9; ROIHA H, 1989, GENE, V82, P137, DOI 10.1016/0378-1119(89)90038-3; SAWA H, 1992, GENE DEV, V6, P244, DOI 10.1101/gad.6.2.244; SCHMELZER C, 1986, CELL, V46, P557, DOI 10.1016/0092-8674(86)90881-0; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; SCHNEIDER JC, 1991, METHOD ENZYMOL, V194, P373; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SHANNON KW, 1991, GENE DEV, V5, P773, DOI 10.1101/gad.5.5.773; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; SHUSTER EO, 1990, NATURE, V345, P270, DOI 10.1038/345270a0; SHUSTER EO, 1988, CELL, V55, P41, DOI 10.1016/0092-8674(88)90007-4; SILICIANO PG, 1987, CELL, V50, P585, DOI 10.1016/0092-8674(87)90031-6; TANI T, 1991, GENE DEV, V5, P1022, DOI 10.1101/gad.5.6.1022; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; TEEM JL, 1983, P NATL ACAD SCI-BIOL, V80, P4403, DOI 10.1073/pnas.80.14.4403; VANKAN P, 1990, EMBO J, V9, P3397, DOI 10.1002/j.1460-2075.1990.tb07541.x; VANKAN P, 1992, EMBO J, V11, P335, DOI 10.1002/j.1460-2075.1992.tb05056.x; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; WOLFF T, 1992, EMBO J, V11, P345, DOI 10.1002/j.1460-2075.1992.tb05057.x; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; WU J, 1991, NATURE, V352, P818, DOI 10.1038/352818a0; YEAN SL, 1991, MOL CELL BIOL, V11, P5571, DOI 10.1128/MCB.11.11.5571; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	63	383	393	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	1992	71	5					803	817		10.1016/0092-8674(92)90556-R	http://dx.doi.org/10.1016/0092-8674(92)90556-R			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423631				2022-12-28	WOS:A1992JZ63300010
J	ABOULELA, F; MURCHIE, AIH; LILLEY, DMJ				ABOULELA, F; MURCHIE, AIH; LILLEY, DMJ			NMR-STUDY OF PARALLEL-STRANDED TETRAPLEX FORMATION BY THE HEXADEOXYNUCLEOTIDE D(TG4T)	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; TELOMERIC DNA; PROTON RESONANCES; OLIGONUCLEOTIDES; SPECTROSCOPY; ASSIGNMENT; MISMATCH	MULTISTRANDED DNA structures based upon guanine association have been proposed to be important in the structure of chromosome telomeres1 and in immunoglobulin class switching2. Nucleic acids containing runs of guanine bases form a number of structures in vitro3-6, including fold-back structures (Fig. 1a)7-9 and parallel-stranded quadruplex structures in DNA2,10 and RNA11. The features of fold-back structures have now been determined at high-resolution12-14. The different structures are probably based on a tetrad of hydrogen-bonded guanine bases (Fig. 1b), with buffer conditions and sequence effects mediating isomerization between the different forms4,15-18. Here we use NMR spectroscopy to investigate the solution structure of the complex formed by the hexadeoxynucleotide d(TG4T) in the presence of sodium ions. We have observed the formation of a parallel-stranded quadruplex containing hydrogen-bonded tetrads of guanine. The parallel-stranded form differs significantly from the fold-back form, with individual nucleotide conformations being closer to those of B-form DNA.			ABOULELA, F (corresponding author), UNIV DUNDEE,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND.		aboul-ela, fareed/C-2887-2011					BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BOELENS R, 1985, J MAGN RESON, V62, P378, DOI 10.1016/0022-2364(85)90207-0; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; FAZEKERLY GV, 1984, NUCLEIC ACIDS RES, V12, P8269; FORSTER M, 1989, J MOL GRAPHICS, V7, P196, DOI 10.1016/0263-7855(89)80002-5; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; GUSCHLBAUER W, 1990, J BIOMOL STRUCT DYN, V8, P491, DOI 10.1080/07391102.1990.10507825; HARDIN CC, 1992, BIOCHEMISTRY-US, V31, P833, DOI 10.1021/bi00118a028; HARDIN CC, 1991, BIOCHEMISTRY-US, V30, P4460, DOI 10.1021/bi00232a013; HARE DR, 1983, J MOL BIOL, V171, P319, DOI 10.1016/0022-2836(83)90096-7; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HENDERSON ER, 1990, BIOCHEMISTRY-US, V29, P732, DOI 10.1021/bi00455a020; KIM J, 1991, NATURE, V351, P331, DOI 10.1038/351331a0; LANE AN, 1991, BIOCHEM J, V279, P269, DOI 10.1042/bj2790269; LI Y, 1991, P NATL ACAD SCI USA, V88, P26, DOI 10.1073/pnas.88.1.26; LU M, 1992, BIOCHEMISTRY-US, V31, P2455, DOI 10.1021/bi00124a003; MURCHIE AIH, 1992, NUCLEIC ACIDS RES, V20, P49, DOI 10.1093/nar/20.1.49; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P5263, DOI 10.1093/nar/19.19.5263; OKA Y, 1987, NUCLEIC ACIDS RES, V15, P8877, DOI 10.1093/nar/15.21.8877; PINNAVAIA TJ, 1975, J AM CHEM SOC, V97, P7198, DOI 10.1021/ja00857a059; RINKEL LJ, 1987, J BIOMOL STRUCT DYN, V4, P621, DOI 10.1080/07391102.1987.10507665; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SKLENAR V, 1986, FEBS LETT, V208, P94, DOI 10.1016/0014-5793(86)81539-3; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Sundquist W. I., 1991, Nucleic Acids and Molecular Biology, V5, P1; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; WANG Y, 1991, J MOL BIOL, V222, P819, DOI 10.1016/0022-2836(91)90513-6; WANG Y, 1992, NATURE, V356, P126; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Wuthrich K., 1986, NMR PROTEINS NUCL AC	31	193	200	0	29	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 19	1992	360	6401					280	282		10.1038/360280a0	http://dx.doi.org/10.1038/360280a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY960	1436110				2022-12-28	WOS:A1992JY96000059
J	CANNONALBRIGHT, LA; GOLDGAR, DE; MEYER, LJ; LEWIS, CM; ANDERSON, DE; FOUNTAIN, JW; HEGI, ME; WISEMAN, RW; PETTY, EM; BALE, AE; OLOPADE, OI; DIAZ, MO; KWIATKOWSKI, DJ; PIEPKORN, MW; ZONE, JJ; SKOLNICK, MH				CANNONALBRIGHT, LA; GOLDGAR, DE; MEYER, LJ; LEWIS, CM; ANDERSON, DE; FOUNTAIN, JW; HEGI, ME; WISEMAN, RW; PETTY, EM; BALE, AE; OLOPADE, OI; DIAZ, MO; KWIATKOWSKI, DJ; PIEPKORN, MW; ZONE, JJ; SKOLNICK, MH			ASSIGNMENT OF A LOCUS FOR FAMILIAL MELANOMA, MLM, TO CHROMOSOME-9P13-P22	SCIENCE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; DYSPLASTIC NEVUS SYNDROME; CYTOGENETIC ANALYSIS; SYNDROME DNS; HIGH-RISK; INHERITANCE; LINKAGE; CANCER; UPDATE	Linkage analysis of ten Utah kindreds and one Texas kindred with multiple cases of cutaneous malignant melanoma (CMM) provided evidence that a locus for familial melanoma susceptibility is in the chromosomal region 9p13-p22. The genetic markers analyzed reside in a candidate region on chromosome 9p21, previously implicated by the presence of homozygous deletions in melanoma tumors and by the presence of a germline deletion in an individual with eight independent melanomas. Multipoint linkage analysis was performed between the familial melanoma susceptibility locus (MLM) and two short tandem repeat markers, D9S126 and the interferon-alpha (IFNA) gene, which reside in the region of somatic loss in melanoma tumors. An analysis incorporating a partially penetrant dominant melanoma susceptibility locus places MLM near IFNA and D9S126 with a maximum location score of 12.71. Therefore, the region frequently deleted in melanoma tumors on 9p21 presumably contains a locus that plays a critical role in predisposition to familial melanoma.	UNIV UTAH,SCH MED,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,HOUSTON,TX 77030; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; NIEHS,MOLEC CARCINOGENESIS LAB,RES TRIANGLE PK,NC 27709; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; UNIV CHICAGO,MED CTR,DEPT MED,CHICAGO,IL 60637; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,BOSTON,MA 02115; UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT PATHOL,SEATTLE,WA 98195	Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Yale University; University of Chicago; University of Chicago Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	CANNONALBRIGHT, LA (corresponding author), UNIV UTAH,SCH MED,DEPT INTERNAL MED,SALT LAKE CITY,UT 84112, USA.		Lewis, Cathryn/M-8766-2019; Hegi, Monika/O-4796-2015; Lewis, Cathryn M/A-5225-2010	Lewis, Cathryn/0000-0002-8249-8476; Hegi, Monika/0000-0003-0855-6495; Lewis, Cathryn M/0000-0002-8249-8476; albright, lisa/0000-0003-2602-3668	NATIONAL CANCER INSTITUTE [P30CA042014, P01CA048711] Funding Source: NIH RePORTER; NCI NIH HHS [CA 42014, CA 48711] Funding Source: Medline; NCRR NIH HHS [RR 00064] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON DE, 1991, ANTICANCER RES, V11, P433; BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; BALE SJ, 1989, J NATL CANCER I, V81, P70, DOI 10.1093/jnci/81.1.70; CANNONALBRIGHT LA, 1990, AM J HUM GENET, V46, P912; CLARK WH, 1978, ARCH DERMATOL, V114, P732, DOI 10.1001/archderm.114.5.732; CLAUS EB, 1991, AM J HUM GENET, V48, P232; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COWAN JM, 1988, J NATL CANCER I, V80, P1159, DOI 10.1093/jnci/80.14.1159; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; EASTON D, 1990, CANCER SURV, V9, P395; EASTON DF, COMMUNICATION; FOUNTAIN JW, 1990, CANCER SURV, V9, P645; FOUNTAIN JW, 1992, GENOMICS, V14, P105, DOI 10.1016/S0888-7543(05)80290-3; FOUNTAIN JW, IN PRESS P NATL ACAD; FOUNTAIN JW, 1991, AM J HUM GENET, V49, P223; FREY C, 1991, J NATL CANCER I, V83, P170; GOLDGAR DE, 1991, J NATL CANCER I, V83, P1726, DOI 10.1093/jnci/83.23.1726; GREENE MH, 1985, ANN INTERN MED, V102, P458, DOI 10.7326/0003-4819-102-4-458; GREENE MH, 1983, P NATL ACAD SCI-BIOL, V80, P6071, DOI 10.1073/pnas.80.19.6071; Greene MH., 1979, HEREDITARY VARIANT M; GRUIS NA, 1990, NEW ENGL J MED, V322, P853; HAPPLE R, 1982, J AM ACAD DERMATOL, V6, P540, DOI 10.1016/S0190-9622(82)80369-1; Hayward N., COMMUNICATION; JONASSON J, 1977, J CELL SCI, V24, P217; KEFFORD RF, 1991, CANCER GENET CYTOGEN, V51, P45, DOI 10.1016/0165-4608(91)90007-H; KWIATKOWSKI DJ, IN PRESS HUM MOL GEN; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUKEIS R, 1990, GENE CHROMOSOME CANC, V2, P116, DOI 10.1002/gcc.2870020207; LYNCH HT, 1978, J MED GENET, V15, P352, DOI 10.1136/jmg.15.5.352; MACCLUER JW, 1992, CYTOGENET CELL GENET, V59, P148; NANCARROW DJ, 1992, GENOMICS, V12, P18, DOI 10.1016/0888-7543(92)90401-D; OLOPADE OI, 1992, GENOMICS, V14, P437, DOI 10.1016/S0888-7543(05)80238-1; OLOPADE OI, 1992, CANCER RES, V52, P2523; OLOPADE OI, 1991, P AM ASSOC CANC RES, V52, P1814; OLOPADE OI, 1990, P AM ASSOC CANC RES, V31, P1883; OTT J, 1985, ANAL HUMAN GENETIC L; PASCOE L, 1987, AM J HUM GENET, V40, P464; PETTY EM, UNPUB; PETTY EM, IN PRESS AM J MED GE; RODERICK TH, 1984, MOUSE NEWS LETT, V71, P8; Skolnick M, 1980, BANBURY REPORT, P285; SOBER AJ, 1991, DERMATOL CLIN, V9, P617; SWERDLOW AJ, 1984, LANCET, V2, P168; TRAUPE H, 1989, AM J MED GENET, V32, P155, DOI 10.1002/ajmg.1320320203; VANHAERINGEN A, 1989, GENOMICS, V5, P61, DOI 10.1016/0888-7543(89)90086-4; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WISEMAN RW, UNPUB; 1992, JAMA-J AM MED ASSOC, V268, P1314; 1988, 1987 ANN CANCER STAT; 1988, CANCER UTAH STATISTI	51	482	500	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1148	1152		10.1126/science.1439824	http://dx.doi.org/10.1126/science.1439824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439824				2022-12-28	WOS:A1992JX85200032
J	CATANIA, JA; COATES, TJ; STALL, R; TURNER, H; PETERSON, J; HEARST, N; DOLCINI, MM; HUDES, E; GAGNON, J; WILEY, J; GROVES, R				CATANIA, JA; COATES, TJ; STALL, R; TURNER, H; PETERSON, J; HEARST, N; DOLCINI, MM; HUDES, E; GAGNON, J; WILEY, J; GROVES, R			PREVALENCE OF AIDS-RELATED RISK-FACTORS AND CONDOM USE IN THE UNITED-STATES	SCIENCE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; SEXUAL-BEHAVIOR; TRANSMISSION; WOMEN; PREVENTION; FREQUENCY; PROMOTION; BIAS	A national probability survey of human immunodeficiency virus (HIV)-related risk factors among the general heterosexual population, the National AIDS (acquired immunodeficiency syndrome) Behavioral Surveys, has obtained data from 10,630 respondents. Data are presented on the prevalence of HIV-related risks in the general heterosexual population, on the distribution of the three largest risk groups across social strata, and on the prevalence and distribution of condom use among heterosexuals reporting a risk factor. Between 15 and 31 percent of heterosexuals nationally and 20 and 41 percent in cities with a high prevalence of AIDS reported an HIV risk factor. Condom use was relatively low. Only 17 percent of those with multiple sexual partners, 12.6 percent of those with risky sexual partners, and 10.8 percent of untested transfusion recipients used condoms all the time. Overall, the results suggest that current HIV prevention programs have, to a very limited extent, reached those heterosexuals with multiple sexual partners but have failed to reach many other groups of the heterosexual population at risk for HIV. New public health strategies may be needed for these specific risk groups.	UNIV CALIF SAN FRANCISCO, DEPT MED, DIV GEN INTERNAL MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT EPIDEMIOL & BIOSTAT, DIV CLIN EPIDEMIOL, SAN FRANCISCO, CA 94143 USA; UNIV NEW HAMPSHIRE, DEPT SOCIOL & ANTHROPOL, DURHAM, NH 03824 USA; SUNY STONY BROOK, DEPT SOCIOL, STONY BROOK, NY 11794 USA; UNIV CALIF BERKELEY, SURVEY RES CTR, BERKELEY, CA 94720 USA; UNIV MICHIGAN, DEPT SOCIOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, INST SOCIAL RES, ANN ARBOR, MI 48109 USA; US BUR CENSUS, WASHINGTON, DC 20233 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System Of New Hampshire; University of New Hampshire; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	CATANIA, JA (corresponding author), UNIV CALIF SAN FRANCISCO, CTR AIDS PREVENT STUDIES, SAN FRANCISCO, CA 94143 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046240, R01MH043892] Funding Source: NIH RePORTER; NIMH NIH HHS [MH43892, MH46240] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTER MJ, 1986, JAMA-J AM MED ASSOC, V256, P1307, DOI 10.1001/jama.256.10.1307; BAJOS N, 1991, SEXUAL BEHAVIOR FRAN, P405; BRADBURN NM, 1979, IMPROVING INTERVIEW, V42; CATANIA JA, 1992, AM J PUBLIC HEALTH, V82, P284, DOI 10.2105/AJPH.82.2.284; CATANIA JA, 1990, EVAL PROGRAM PLANN, V13, P19, DOI 10.1016/0149-7189(90)90005-H; CATANIA JA, 1989, GERONTOLOGIST, V29, P373, DOI 10.1093/geront/29.3.373; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; CATANIA JA, UNPUB; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P565; COATES T, 1990, AIDS 2ND DECADE; COATES T, 1989, 1989 AIDS CLIN REV; DONEGAN E, 1988, JAMA-J AM MED ASSOC, V260, P922; ECHENBERG D, 1985, MMWR-MORBID MORTAL W, V34, P573; FELDBLUM PJ, 1991, AIDS, V5, P1265, DOI 10.1097/00002030-199110000-00020; Fowler F. J., 1988, SURVEY RES METHODS; FULLILOVE MT, 1992, WESTERN J MED, V157, P32; GOEDERT JJ, 1984, LANCET, V2, P711; GUYDISH J, 1991, PREVENTING AIDS DRUG, P28; GUYDISH JR, 1990, AM J PUBLIC HEALTH, V80, P995, DOI 10.2105/AJPH.80.8.995; HANDSFIELD HH, 1986, JAMA-J AM MED ASSOC, V255, P1730, DOI 10.1001/jama.255.13.1730; HANNAN J, 1991, HEMOPHILIA HIV RISK; HEARST N, 1988, JAMA-J AM MED ASSOC, V259, P2428, DOI 10.1001/jama.259.16.2428; HINGSON R, 1989, PREV MED, V18, P806, DOI 10.1016/0091-7435(89)90016-9; HOLMES KK, 1990, AM J PUBLIC HEALTH, V80, P858, DOI 10.2105/AJPH.80.7.858; KANOUSE D, 1991, AIDS RELATED KNOWLED; KEETER S, 1988, AM J PREV MED, V4, P146, DOI 10.1016/S0749-3797(18)31187-5; KINSEY AC, 1953, SEXUAL BEHAVIOR HUMA; LANGE WR, 1988, AM J PUBLIC HEALTH, V78, P443, DOI 10.2105/AJPH.78.4.443; LAVRAKAS PJ, 1987, TELEPHONE SURVEY MET; LINDENBAUM S, 1991, EVALUATING AIDS PREV, P223; MCQUEEN D, 1989, STUDY LIFESTYLE HLTH; MILLER HG, 1990, AIDS 2 DECADE; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; PADIAN N, 1990, CONRAD W S, P25; SELIK RM, 1988, AM J PUBLIC HEALTH, V78, P1539, DOI 10.2105/AJPH.78.12.1539; SHELTON JD, 1990, CONRAD W S, P327; SMITH TW, 1991, FAM PLANN PERSPECT, V23, P102, DOI 10.2307/2135820; SORENSEN J, 1991, PREVENTING AIDS DRUG, P62; STALL R, 1989, AIDS AGING SOC WHAT, P77; SYRJANEN K, 1984, BRIT J VENER DIS, V60, P243; THORNBERRY OT, 1988, WILEY S PRO, P25; TURNER CF, 1989, AIDS SEXUAL BEHAVIOR; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; WATKINS JD, 1988, REPORT PRESIDENTIAL; WEDDINGTON W, 1990, MMWR-MORBID MORTAL W, V39, P274; WINKELSTEIN W, 1987, AM J PUBLIC HEALTH, V77, P685, DOI 10.2105/AJPH.77.6.685; WORTH D, 1989, STUD FAMILY PLANN, V20, P297, DOI 10.2307/1966433; 1991, HIV AIDS SURVEILLANC; 1982, COUNCIL AM SURVEY RE	49	273	274	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	1992	258	5085					1101	1106		10.1126/science.1439818	http://dx.doi.org/10.1126/science.1439818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439818				2022-12-28	WOS:A1992JX85200018
J	FUCHS, EJ; MATZINGER, P				FUCHS, EJ; MATZINGER, P			B-CELLS TURN OFF VIRGIN BUT NOT MEMORY T-CELLS	SCIENCE			English	Article							ANTIGEN-PRESENTING CELLS; MIXED LEUKOCYTE REACTION; DENDRITIC CELLS; LYMPHOCYTES-B; BLOOD-TRANSFUSIONS; ACTIVE ENHANCEMENT; PRIMING INVIVO; SKIN-GRAFT; TOLERANCE; INDUCTION	There are three possible outcomes when a T cell recognizes a cell bearing a self or foreign antigen. (i) The T cell is not sufficiently signaled and is unaffected. (ii) The T cell is activated. (iii) The T cell is turned off. The differentiation state of the T cell is critical to the outcome. Although both virgin and memory T cells can be activated by antigens presented by "professional" antigen-presenting cells such as dendritic cells, they differ in their responses to B cells. Experienced T cells respond to antigen presented by B cells, whereas virgin T cells are rendered tolerant. These findings may relate to the phenomena of low- and high-zone tolerance, neonatal tolerance, and the beneficial effect of blood transfusions on allograft survival.	NIH,CELLULAR & MOLEC IMMUNOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA								ASHWELL JD, 1988, J IMMUNOL, V141, P2536; ASHWELL JD, 1984, J EXP MED, V159, P881, DOI 10.1084/jem.159.3.881; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; BIKOFF E, 1986, J IMMUNOL, V137, P28; BILLINGHAM RE, 1956, PHILOS T R SOC B, V239, P357, DOI 10.1098/rstb.1956.0006; BOOG CJP, 1985, NATURE, V318, P59, DOI 10.1038/318059a0; BURAKOFF SJ, 1978, J EXP MED, V148, P1414, DOI 10.1084/jem.148.5.1414; CHESNUT RW, 1981, J IMMUNOL, V126, P1075; CHESNUT RW, 1982, J IMMUNOL, V128, P1764; CLAVERIE JM, 1986, ANN INST PASTEUR IMM, VD137, P425; COBBOLD SP, 1990, EUR J IMMUNOL, V20, P2747, DOI 10.1002/eji.1830201232; EYNON EE, 1991, TRANSPLANT P, V23, P729; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; GOLOB K, UNPUB; GORDON RD, 1975, J EXP MED, V142, P1108, DOI 10.1084/jem.142.5.1108; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; GUERDER S, 1989, COLD SPRING HARB SYM, V54, P799; HAWRYLOWICZ CM, 1988, J IMMUNOL, V141, P4083; HORI S, 1989, J IMMUNOL, V143, P1447; INABA K, 1984, J EXP MED, V160, P1717, DOI 10.1084/jem.160.6.1717; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JENKINSON EJ, 1985, TRANSPLANTATION, V39, P331, DOI 10.1097/00007890-198503000-00030; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KAKIUCHI T, 1983, J IMMUNOL, V131, P109; KRIEGER JI, 1986, J IMMUNOL, V137, P3117; KRIEGER JI, 1985, J IMMUNOL, V135, P2937; KURTJONES EA, 1988, J IMMUNOL, V140, P3773; LAFFERTY KJ, 1980, IMMUNOL REV, V51, P279, DOI 10.1111/j.1600-065X.1980.tb00325.x; LAGAAIJ EL, 1989, NEW ENGL J MED, V321, P701, DOI 10.1056/NEJM198909143211101; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LASSILA O, 1988, NATURE, V334, P253, DOI 10.1038/334253a0; LAUCHART W, 1980, TRANSPLANTATION, V29, P259, DOI 10.1097/00007890-198003000-00020; LIU Y, 1991, INT IMMUNOL, V3, P323, DOI 10.1093/intimm/3.4.323; MATZINGER P, 1989, NATURE, V338, P74, DOI 10.1038/338074a0; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; MCKEAN DJ, 1981, J EXP MED, V154, P1419, DOI 10.1084/jem.154.5.1419; METLAY JP, 1989, J EXP MED, V169, P239, DOI 10.1084/jem.169.1.239; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; OPELZ G, 1973, TRANSPLANT P, V5, P253; PIRCHER H, 1987, EUR J IMMUNOL, V17, P159, DOI 10.1002/eji.1830170202; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; RAMMENSEE HG, 1991, BONE MARROW TRANSPL, V7, P26; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; RON Y, 1987, J IMMUNOL, V138, P2848; RYAN JJ, 1984, J IMMUNOL, V133, P2343; SHIMONKEVITZ RP, 1988, J EXP MED, V168, P143, DOI 10.1084/jem.168.1.143; STROM TB, 1977, TRANSPL P, V9, P965; TONY HP, 1985, J EXP MED, V161, P223, DOI 10.1084/jem.161.1.223; VANROOD JJ, 1990, SCIENCE, V248, P1388, DOI 10.1126/science.1972596; WEBB SR, 1985, EUR J IMMUNOL, V15, P92, DOI 10.1002/eji.1830150118; WEBB SR, 1989, J EXP MED, V169, P1, DOI 10.1084/jem.169.1.1; WEISS S, 1989, P NATL ACAD SCI USA, V86, P282, DOI 10.1073/pnas.86.1.282	56	545	558	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1156	1159		10.1126/science.1439825	http://dx.doi.org/10.1126/science.1439825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439825	Green Submitted			2022-12-28	WOS:A1992JX85200034
J	WEIS, WI; DRICKAMER, K; HENDRICKSON, WA				WEIS, WI; DRICKAMER, K; HENDRICKSON, WA			STRUCTURE OF A C-TYPE MANNOSE-BINDING PROTEIN COMPLEXED WITH AN OLIGOSACCHARIDE	NATURE			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; ASPARAGINE-LINKED OLIGOSACCHARIDES; PULMONARY SURFACTANT APOPROTEIN; SOLUTION CONFORMATION; 3-DIMENSIONAL STRUCTURES; CELL-ADHESION; LECTIN DOMAIN; RECEPTOR; RAT; REFINEMENT	C-type (Ca2+-dependent) animal lectins such as mannose-binding proteins mediate many cell-surface carbohydrate-recognition events. The crystal structure at 1.7 angstrom resolution of the carbohydrate-recognition domain of rat mannose-binding protein complexed with an oligomannose asparaginyl-oligosaccharide reveals that Ca2+ forms coordination bonds with the carbohydrate ligand. Carbohydrate specificity is determined by a network of coordination and hydrogen bonds that stabilizes the ternary complex of protein, Ca2+ and sugar. Two branches of the oligosaccharide crosslink neighbouring carbohydrate-recognition domains in the crystal, enabling multivalent binding to a single oligosaccharide chain to be visualized directly.	COLUMBIA UNIV, DEPT BIOCHEM & MOLEC BIOPHYS, NEW YORK, NY 10032 USA; COLUMBIA UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute			Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150				ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BILDERBACK D, 1988, NUCL INSTRUM METH A, V266, P636, DOI 10.1016/0168-9002(88)90457-3; BOURNE Y, 1990, J BIOL CHEM, V265, P18161; BOURNE Y, 1992, J BIOL CHEM, V267, P197; BOURNE Y, 1990, PROTEINS, V8, P365, DOI 10.1002/prot.340080410; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; BRISSON JR, 1983, BIOCHEMISTRY-US, V22, P3680, DOI 10.1021/bi00284a022; BRISSON JR, 1983, BIOCHEMISTRY-US, V22, P3671, DOI 10.1021/bi00284a021; BRISSON JR, 1983, BIOCHEMISTRY-US, V22, P1362, DOI 10.1021/bi00275a007; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNGER AT, 1992, XPLOR MANUAL; BRUNGER AT, 1992, ANTURE, V355, P472; DEREWENDA Z, 1989, EMBO J, V8, P2189, DOI 10.1002/j.1460-2075.1989.tb08341.x; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; HALBERG DF, 1988, J BIOL CHEM, V263, P9486; HOMANS SW, 1986, BIOCHEMISTRY-US, V25, P6342, DOI 10.1021/bi00368a076; HOMANS SW, 1987, BIOCHEMISTRY-US, V26, P6649, DOI 10.1021/bi00395a014; IKEDA K, 1987, J BIOL CHEM, V262, P7451; IMBERTY A, 1990, GLYCOCONJUGATE J, V7, P27, DOI 10.1007/BF01050401; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEE RT, 1991, J BIOL CHEM, V266, P4810; LEE YC, 1982, GLYCOCONJUGATES, V4, P57; PETERS D, 1981, J MOL STRUCT, V85, P107; QUESENBERRY MS, 1992, J BIOL CHEM, V267, P10831; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; SHAANAN B, 1991, SCIENCE, V254, P862, DOI 10.1126/science.1948067; SHERIFF S, 1987, ACTA CRYSTALLOGR A, V43, P118, DOI 10.1107/S010876738709977X; SIEGELMAN M, 1991, Current Biology, V1, P125, DOI 10.1016/0960-9822(91)90299-C; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SPIESS M, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00495a001; SPRINGER TA, 1991, ANTURE, V349, P196; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D; WEIS WI, 1991, J BIOL CHEM, V266, P20678; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; WRIGHT CS, 1992, J BIOL CHEM, V267, P14345; 1979, SUITE PROGRAMS PROTE	49	853	891	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	1992	360	6400					127	134		10.1038/360127a0	http://dx.doi.org/10.1038/360127a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX752	1436090				2022-12-28	WOS:A1992JX75200049
J	GREGORY, MW				GREGORY, MW			THE INFECTIOUSNESS OF POMPOUS PROSE	NATURE			English	Editorial Material											GREGORY, MW (corresponding author), FOREIGN & COMMONWEALTH OFF,KING CHARLES ST,LONDON SW1A 2AH,ENGLAND.							AARONSON S, 1977, CC/LIFE SCI, P10; Arnold G.W., 1978, ETHOLOGY FREE RANGIN; CHAPMAN B, 1973, GUT, V6, P905; GAAFAR SM, 1981, VET PARASITOL, V8, P199, DOI 10.1016/0304-4017(81)90050-9; HILLABY J, 1976, NEW SCI         0506; HUXLEY TH, 1881, SCIENCE, V2; RICHARDS T, 1985, BRIT MED J, V291, P1220, DOI 10.1136/bmj.291.6504.1220; ROWLEY PT, 1986, CURR HEMATOL ONCOL, V4, P1; SHEEN AP, 1987, BREATHING LIFE MED W; Sprat Thomas, 1667, HIST ROYAL SOC LONDO; STRUNK W, 1919, ELEMENTS STYLE; UNANUE ER, 1980, NEW ENGL J MED, V303, P977, DOI 10.1056/NEJM198010233031706; WHALE J, 1984, PUT WRITING; WHITE EB, 1959, ELEMENTS STYLE, V13; 1980, SCIENCE, V207, P750	15	18	18	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 5	1992	360	6399					11	12		10.1038/360011a0	http://dx.doi.org/10.1038/360011a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	JW717	1436065				2022-12-28	WOS:A1992JW71700024
J	STCLAIR, EW; ODDONE, EZ; WAUGH, RA; COREY, GR; FEUSSNER, JR				STCLAIR, EW; ODDONE, EZ; WAUGH, RA; COREY, GR; FEUSSNER, JR			ASSESSING HOUSESTAFF DIAGNOSTIC SKILLS USING A CARDIOLOGY PATIENT SIMULATOR	ANNALS OF INTERNAL MEDICINE			English	Article						INTERNSHIP AND RESIDENCY; PATIENT SIMULATION; PHYSICAL EXAMINATION; CLINICAL COMPETENCE; HEART VALVE DISEASES	PHYSICAL-EXAMINATION	Objective: To assess the cardiovascular physical examination skills of internal medicine housestaff. Design: Cross-sectional assessment of housestaff performance on three valvular abnormality simulations conducted on the cardiology patient simulator, "Harvey." Evaluations were done at the beginning (session I) and end (session II) of the academic year. Setting: Duke University Medical Center internal medicine training program. Subjects: Sixty-three (59%) of 107 eligible internal medicine housestaff (postgraduate years 1 through 3) agreed to participate and completed session I; 60 (95%) completed session II. Measurements: All volunteers were tested on three preprogrammed simulations (mitral regurgitation, mitral stenosis, and aortic regurgitation). Results: The overall correct response rates for all housestaff were 52% for mitral regurgitation, 37% for mitral stenosis, and 54% for aortic regurgitation. No difference was noted in correct response rates between sessions I and II. For mitral regurgitation, correct assessment of the contour of the holosystolic murmur predicted a correct diagnosis (P = 0.002). For mitral stenosis, identification of an opening snap and proper characterization of the mitral area diastolic murmur predicted a correct diagnosis (P < 0.0001). No individual observations were noted for the aortic regurgitation simulation, whose identification by the housestaff was associated with a correct diagnosis. Conclusions: Housestaff had difficulty establishing a correct diagnosis for simulations of three common valvular heart diseases. Accurate recognition of a few "key" observations was associated with a correct diagnosis in two of the three diseases. Teaching housestaff to elicit and interpret a few critical signs accurately may improve their physical diagnosis abilities.	VET AFFAIRS MED CTR, CTR HLTH SERV RES PRIMARY CARE, DURHAM, NC 27705 USA; DUKE UNIV, MED CTR, DIV CARDIOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DIV GEN INTERNAL MED, DURHAM, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University								ALOIA JF, 1976, J MED EDUC, V51, P410; EWY GA, 1987, J MED EDUC, V62, P738; GORDON MS, 1974, AM J CARDIOL, V34, P350, DOI 10.1016/0002-9149(74)90038-1; GORDON MS, 1980, AM J CARDIOL, V45, P791, DOI 10.1016/0002-9149(80)90123-X; GORDON MS, 1983, JAMA-J AM MED ASSOC, V244, P1035; JOHNSON JE, 1986, ARCH INTERN MED, V146, P937, DOI 10.1001/archinte.146.5.937; KORAN LM, 1975, NEW ENGL J MED, V293, P642, DOI 10.1056/NEJM197509252931307; WIENER S, 1976, JAMA-J AM MED ASSOC, V236, P852, DOI 10.1001/jama.236.7.852	8	118	119	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					751	756		10.7326/0003-4819-117-9-751	http://dx.doi.org/10.7326/0003-4819-117-9-751			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416578				2022-12-28	WOS:A1992JV42400008
J	WEISSENBACH, J; GYAPAY, G; DIB, C; VIGNAL, A; MORISSETTE, J; MILLASSEAU, P; VAYSSEIX, G; LATHROP, M				WEISSENBACH, J; GYAPAY, G; DIB, C; VIGNAL, A; MORISSETTE, J; MILLASSEAU, P; VAYSSEIX, G; LATHROP, M			A 2ND-GENERATION LINKAGE MAP OF THE HUMAN GENOME	NATURE			English	Article							INVITRO AMPLIFICATION; DNA; GENE; OLIGONUCLEOTIDES; REPEAT; SINGLE	A linkage map of the human genome has been constructed based on the segregation analysis of 814 newly characterized polymorphic loci containing short tracts of (C-A)n repeats in a panel of DNAs from eight large families. Statistical linkage analysis placed 813 of the markers into 23 linkage groups corresponding to the 22 autosomes and the X chromosome; 605 show a heterozygosity above 0.7 and 553 could be ordered with odds ratios above 1,000:1. The distance spanned corresponds to approximately 90% of the estimated length of the human genome.	INST PASTEUR,UNITE GENET MOLEC HUMAINE,CNRS,URA 1445,F-75724 PARIS,FRANCE; CHU LAVAL,CTR ETUD POLYMORPHISME HUMAIN,QUEBEC CITY G1V 4G2,QUEBEC,CANADA; CHU LAVAL,RESEAU MED GENET,QUEBEC CITY G1V 4G2,QUEBEC,CANADA; INSERM,U358,F-75010 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Laval University; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm)	WEISSENBACH, J (corresponding author), GENETHON,1 RUE INT,F-91000 EVRY,FRANCE.		Vignal, Alain/I-6253-2017	Vignal, Alain/0000-0002-6797-2125				BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BISHOP DT, 1990, AM J HUM GENET, V46, P254; CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; DIETRICH W, 1992, GENETICS, V131, P423; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1991, STAT METH BIOL MED S, V8, P81; LATHROP GM, 1988, GENOMICS, V2, P157; LITT M, 1989, AM J HUM GENET, V44, P397; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OTT J, 1992, AM J HUM GENET, V51, P283; RISCH N, 1990, AM J HUM GENET, V46, P242; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SALUZ H, 1989, P NATL ACAD SCI USA, V86, P2602, DOI 10.1073/pnas.86.8.2602; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; VERGNAUD G, 1991, ELECTROPHORESIS, V12, P134, DOI 10.1002/elps.1150120207; VIGINAL A, IN PRESS METHODS MOL, V1; WEBER JL, 1989, AM J HUM GENET, V44, P388; WHITE R, 1990, GENETICS MAPS LOCUS; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; 1991, CYTOGENET CELL GENET, V58, P1	24	1914	2000	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 29	1992	359	6398					794	801		10.1038/359794a0	http://dx.doi.org/10.1038/359794a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV777	1436057				2022-12-28	WOS:A1992JV77700053
J	TULINIUS, H; EGILSSON, V; OLAFSDOTTIR, GH; SIGVALDASON, H				TULINIUS, H; EGILSSON, V; OLAFSDOTTIR, GH; SIGVALDASON, H			RISK OF PROSTATE, OVARIAN, AND ENDOMETRIAL CANCER AMONG RELATIVES OF WOMEN WITH BREAST-CANCER	BRITISH MEDICAL JOURNAL			English	Article							FAMILIAL ASSOCIATION; CARCINOMA; LOCUS	Objective-To investigate the risk of prostate, ovarian, and endometrial cancer among relatives of patients with breast cancer. Design-Cohort study of 947 pedigrees in which the proband had breast cancer, linked with the Icelandic cancer registry. Setting-Iceland. Subjects-The 947 pedigrees included 29725 people, of whom 1539 had breast cancer, 467 had prostate cancer, 135 ovarian cancer, and 105 endometrial cancer. Main outcome measures-Risk of prostate, ovarian, and endometrial cancer among blood relatives of women with breast cancer compared with risk in spouses. Results-The risk of prostate cancer was significantly raised for all relatives (1.5), first degree relatives (1.4), and second degree relatives (1.3) of women with breast cancer. Risk of ovarian cancer was raised for all relatives (1.9) and first degree relatives (1.9) and risk of endometrial cancer was raised for all relatives only (1.9). The risk of prostate cancer was raised if the proband with breast cancer had a first degree relative with prostate cancer. Conclusions-Coaggreption exists between breast cancer and cancers of the prostate, ovaries, and endometrium. This risk relation is probably based on genes which act by increasing the risk for cancer at these sites. Environmental factors that are common among relatives may also play a part. Continued research is required into pathophysiological mechanisms that could explain these observations.	UNIV ICELAND,DEPT PATHOL,REYKJAVIK,ICELAND	University of Iceland	TULINIUS, H (corresponding author), ICELAND CANC REGISTRY,SKOGARHLID 8,IS-125 REYKJAVIK,ICELAND.							Cannon L., 1982, CANCER SURV, V1, P47; FERRELL RE, 1989, CANCER GENET CYTOGEN, V38, P241, DOI 10.1016/0165-4608(89)90665-1; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KING MC, 1980, SCIENCE, V208, P406, DOI 10.1126/science.7367867; LYNCH HT, 1978, CANCER-AM CANCER SOC, V41, P1543, DOI 10.1002/1097-0142(197804)41:4<1543::AID-CNCR2820410444>3.0.CO;2-Y; LYNCH HT, 1982, OBSTET GYNECOL, V59, P589; NAROD SA, 1991, LANCET, V338, P82; NOMURA AMY, 1991, EPIDEMIOL REV, V13, P200, DOI 10.1093/oxfordjournals.epirev.a036069; SCHILDKRAUT JM, 1989, AM J HUM GENET, V45, P521; THIESSEN EU, 1974, CANCER, V34, P1102, DOI 10.1002/1097-0142(197410)34:4<1102::AID-CNCR2820340421>3.0.CO;2-5; THOMPSON WD, 1991, INT J EPIDEMIOL, V20, P595, DOI 10.1093/ije/20.3.595; TULINIUS H, 1992, J MED GENET, V29, P158, DOI 10.1136/jmg.29.3.158; TULINIUS H, 1985, INT C SERIES, V685; TULINIUS H, 1985, NARINGSFORSKNING, V29, P17; VATTEN LJ, 1990, INT J CANCER, V45, P440, DOI 10.1002/ijc.2910450311; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104; 1990, EGRET REFERENCE MANU	17	149	152	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					855	857		10.1136/bmj.305.6858.855	http://dx.doi.org/10.1136/bmj.305.6858.855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422397	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JT77700021
J	BROWN, GE				BROWN, GE			RATIONAL SCIENCE, IRRATIONAL REALITY - A CONGRESSIONAL PERSPECTIVE ON BASIC RESEARCH AND SOCIETY	SCIENCE			English	Editorial Material											BROWN, GE (corresponding author), US HOUSE REPRESENTAT,COMM SCI SPACE & TECHNOL,WASHINGTON,DC 20515, USA.							BRANSCOMB LM, 1992, HARVARD BUS REV, V24; Eisenhower DD., 1961, MILITARY IND COMPLEX; HAVEL E, 1992, NY TIMES        0301, pE15; LEDERMAN LM, 1991, SCIENCE          JAN; McClellan James E., 1985, SCI REORGANIZED SCI; 1991, COMPETITING EC AM EU; 1991, SCI ENG INDICATORS 1; 1991, FEDERALLY FUNDED RES	8	11	11	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					200	201		10.1126/science.1411514	http://dx.doi.org/10.1126/science.1411514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JR860	1411514				2022-12-28	WOS:A1992JR86000002
J	FANIDI, A; HARRINGTON, EA; EVAN, GI				FANIDI, A; HARRINGTON, EA; EVAN, GI			COOPERATIVE INTERACTION BETWEEN C-MYC AND BCL-2 PROTOONCOGENES	NATURE			English	Article							PROGRAMMED CELL-DEATH; APOPTOSIS; MICE; GENE	THE bcl-2 proto-oncogene is activated by translocation in a variety of B-lymphoid tumours and synergizes with the c-myc oncogene in tumour progression1. The mechanism of synergy is unclear but bcl-2 expression inhibits apoptosis2-6, a property presumably pertinent to its proto-oncogenic mode of action4. We have shown that the c-myc gene is a potent inducer of apoptosis, in addition to its established role in mitogenesis7. Here we show that expression of the bcl-2 protein, Bcl-2, specifically abrogates c-myc-induced apoptosis without affecting the c-myc mitogenic function. This provides a novel mechanism for oncogene cooperation, of potential importance both in carcinogenesis and in the evolution of drug resistance in tumours.	IMPERIAL CANC RES FUND, BIOCHEM CELL NUCLEUS LAB, 44 LINCOLNS INN FIELDS, LONDON WC2A 3PX, ENGLAND	Cancer Research UK								ASKEW DS, 1991, ONCOGENE, V6, P1915; BURSCH W, 1990, BIOCHEM CELL BIOL, V68, P1071, DOI 10.1139/o90-160; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; LENNON SV, 1990, BIOCHEM SOC T, V18, P343, DOI 10.1042/bst0180343; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; PEZZELLA F, 1990, AM J PATHOL, V137, P225; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WYLLIE AH, 1987, J PATHOL, V153, P313, DOI 10.1002/path.1711530404	16	765	802	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	1992	359	6395					554	556		10.1038/359554a0	http://dx.doi.org/10.1038/359554a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406976				2022-12-28	WOS:A1992JR85900066
J	LITTLE, P				LITTLE, P			MAPPING THE WAY AHEAD	NATURE			English	Editorial Material											LITTLE, P (corresponding author), UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,DEPT BIOCHEM,PRINCE CONSORT RD,LONDON SW7 2AZ,ENGLAND.							CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769	4	6	6	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 1	1992	359	6394					367	368		10.1038/359367a0	http://dx.doi.org/10.1038/359367a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406946				2022-12-28	WOS:A1992JQ62400034
J	SOMERS, WS; PHILLIPS, SEV				SOMERS, WS; PHILLIPS, SEV			CRYSTAL-STRUCTURE OF THE MET REPRESSOR-OPERATOR COMPLEX AT 2.8 A-ANGSTROM RESOLUTION REVEALS DNA RECOGNITION BY BETA-STRANDS	NATURE			English	Article							ESCHERICHIA-COLI; METHIONINE BIOSYNTHESIS; ARC REPRESSOR; PROTEIN; BINDING; COREPRESSOR; PHAGE-434; PROGRAM; REGION; FAMILY	The crystal structure of the met repressor-operator complex shows two dimeric repressor molecules bound to adjacent sites 8 base pairs apart on an 18-base-pair DNA fragment. Sequence specificity is achieved by insertion of double-stranded antiparallel protein beta-ribbons into the major groove of B-form DNA, with direct hydrogen-bonding between amino-acid side chains and the base pairs. The repressor also recognizes sequence-dependent distortion or flexibility of the operator phosphate backbone, conferring specificity even for inaccessible base pairs.	UNIV LEEDS,DEPT BIOCHEM & MOLEC BIOL,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND	University of Leeds				Phillips, Simon/0000-0001-8922-0250				AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; BELFAIZA J, 1986, P NATL ACAD SCI USA, V83, P867, DOI 10.1073/pnas.83.4.867; BOWIE JU, 1990, J MOL BIOL, V211, P5, DOI 10.1016/0022-2836(90)90004-6; BREG JN, 1990, NATURE, V346, P586, DOI 10.1038/346586a0; BRENNAN RG, 1990, P NATL ACAD SCI USA, V87, P8165, DOI 10.1073/pnas.87.20.8165; Brennan RG, 1991, CURR OPIN STRUC BIOL, V1, P80, DOI 10.1016/0959-440X(91)90015-L; BROWN BM, 1990, BIOCHEMISTRY-US, V29, P11189, DOI 10.1021/bi00503a006; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CARTER CW, 1974, P NATL ACAD SCI USA, V71, P283, DOI 10.1073/pnas.71.2.283; CHURCH GM, 1977, P NATL ACAD SCI USA, V74, P1458, DOI 10.1073/pnas.74.4.1458; CLARKE ND, 1991, SCIENCE, V254, P267, DOI 10.1126/science.1833818; DAVIDSON BE, 1989, MOL MICROBIOL, V3, P1639, DOI 10.1111/j.1365-2958.1989.tb00149.x; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299; FLOWER DR, 1991, J MOL GRAPHICS, V9, P257, DOI 10.1016/0263-7855(91)80021-Q; FREEMONT PS, 1991, BIOCHEM J, V278, P1; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HARRISON SC, 1990, REV BIOCH, V59, P933; HE YY, 1992, NATURE, V359, P431, DOI 10.1038/359431a0; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KLUG A, 1979, J MOL BIOL, V131, P669, DOI 10.1016/0022-2836(79)90196-7; KNIGHT KL, 1989, J BIOL CHEM, V264, P3639; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; LUISI BF, 1990, BIOCHIM BIOPHYS ACTA, V1048, P113, DOI 10.1016/0167-4781(90)90047-6; MONDRAGON A, 1991, J MOL BIOL, V219, P321, DOI 10.1016/0022-2836(91)90568-Q; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PHILLIPS SEV, 1989, NATURE, V341, P711, DOI 10.1038/341711a0; PRIESTLE JP, 1988, J APPL CRYSTALLOGR, V21, P572, DOI 10.1107/S0021889888005746; QUINTANA JR, 1992, J MOL BIOL, V225, P379, DOI 10.1016/0022-2836(92)90928-D; RAFFERTY JB, 1989, NATURE, V341, P705, DOI 10.1038/341705a0; RHODES D, 1980, NATURE, V286, P573, DOI 10.1038/286573a0; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P226; SAINTGIRONS I, 1986, J BIOL CHEM, V261, P936; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SIM GA, 1960, ACTA CRYSTALLOGR, V13, P511, DOI 10.1107/S0365110X60001266; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; YOON C, 1988, P NATL ACAD SCI USA, V85, P6332, DOI 10.1073/pnas.85.17.6332; 1979, 4 DAR LAB SERC COLL	46	284	290	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 1	1992	359	6394					387	393		10.1038/359387a0	http://dx.doi.org/10.1038/359387a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406951				2022-12-28	WOS:A1992JQ62400046
J	SHELDRICK, JH; VERNON, SA; WILSON, A				SHELDRICK, JH; VERNON, SA; WILSON, A			STUDY OF DIAGNOSTIC ACCORD BETWEEN GENERAL-PRACTITIONERS AND AN OPHTHALMOLOGIST	BRITISH MEDICAL JOURNAL			English	Article							EYE; DISEASE	Objectives - To identify diagnostic accord and disagreement between general practitioners and an ophthalmologist and thereby determine how undergraduate and non-specialist postgraduate ophthalmic training could be improved. Design - Comparison of diagnosis of presenting conditions by general practitioners and one ophthalmologist in patients consulting general practitioners for ophthalmic problems during March 1989 to February 1990. Setting - 12 general practices in west Nottingham. Patients - 1474 patients presenting to the study general practitioners with new ophthalmic conditions or new episodes of recurrent conditions. Main outcome measures - Diagnoses of general practitioners and ophthalmologist. Results - 1121 (76%) of patients with eye problems agreed to see the ophthalmologist and most were seen within three days. Sufficient data for comparison were available on 1103 patients. Diagnostic agreement was found in 638 cases (58%), but potentially serious misdiagnosis was found in only 15 cases; management in three of these cases would have ensured later identification. Most commonly confused conditions were infective and allergic conjunctivitis, blepharitis, and dry eyes. General practitioners assessed visual acuity in only 114 cases yet eight of the 15 patients seriously misdiagnosed had reduced acuity, an important diagnostic sign. Conclusions - Most ophthalmic disease seen in general practice does not require specialised equipment for diagnosis. Most cases of misdiagnosis have no serious consequences for the patient. Undergraduate and postgraduate training in ophthalmology should ensure that common conditions can be easily differentiated and more serious conditions identified and referred.	UNIV NOTTINGHAM,DEPT GEN PRACTICE,NOTTINGHAM NG7 2RD,ENGLAND; UNIV NOTTINGHAM,ACAD UNIT OPHTHALMOL,NOTTINGHAM NG7 2RD,ENGLAND	University of Nottingham; University of Nottingham								Brittain G P, 1988, Health Trends, V20, P43; CLAOUE CMP, 1986, BMJ-BRIT MED J, V292, P1450, DOI 10.1136/bmj.292.6533.1450; DART JKG, 1986, BRIT MED J, V293, P1477, DOI 10.1136/bmj.293.6560.1477; FEATHERSTONE PI, 1992, BRIT J GEN PRACT, V42, P21; HARRISON RJ, 1988, BRIT MED J, V297, P1162, DOI 10.1136/bmj.297.6657.1162; JONES NP, 1990, J ROY SOC MED, V83, P770, DOI 10.1177/014107689008301207; LAVIN MJ, 1986, BRIT MED J, V292, P1448, DOI 10.1136/bmj.292.6533.1448; MACKEAN JM, 1982, BRIT MED J, V285, P1093, DOI 10.1136/bmj.285.6348.1093; MORRELL DC, 1971, BRIT MED J, V2, P454, DOI 10.1136/bmj.2.5759.454; VERNON SA, 1988, J ROY SOC MED, V81, P335, DOI 10.1177/014107688808100612; VERNON SA, 1983, J ROYAL SOC MED, V76, P79; WILSON A, 1987, J ROY COLL GEN PRACT, V37, P62	12	32	33	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 25	1992	304	6834					1096	1098		10.1136/bmj.304.6834.1096	http://dx.doi.org/10.1136/bmj.304.6834.1096			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR136	1445527	Bronze, Green Published			2022-12-28	WOS:A1992HR13600022
J	HANNAN, EL; ARANI, DT; JOHNSON, LW; KEMP, HG; LUKACIK, G				HANNAN, EL; ARANI, DT; JOHNSON, LW; KEMP, HG; LUKACIK, G			PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN NEW-YORK-STATE - RISK-FACTORS AND OUTCOMES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECURRENT RESTENOSIS; DISEASE; COMPLICATIONS; DETERMINANTS; MORTALITY; REGISTRY; TERM	Objective.-To identify significant independent risk factors for major percutaneous transluminal coronary angioplasty outcomes. Design.-Retrospective analysis using univariate and logistic regression analysis to identify significant independent risk factors for adverse outcomes. Setting.-All 31 hospitals performing percutaneous transluminal coronary angioplasty in New York State in 1991. Patients.-All 5827 patients undergoing percutaneous transluminal coronary angioplasty between January 1, 1991, and June 30, 1991, in New York State. Main Outcome Measures.-In-hospital mortality, major complication(s) (in-hospital mortality, myocardial infarction, and/or emergency coronary artery bypass graft), and absence of angiographic success (stenosis reduction of less than 20% on any attempted lesion or residual stenosis of at least 50% on any attempted lesion). Main Results.-Before discharge from the hospital, a total of 37 patients (0.63%) died; 67 patients (1.1%) suffered a myocardial infarction, with a mortality rate of 4.5%; and 97 patients (1.7%) underwent emergency coronary artery bypass graft surgery, with a mortality rate of 2.1% (no deaths in 85 patients who were hemodynamically stable and two deaths among 12 patients who were hemodynamically unstable). A total of 187 patients (3.2%) experienced a major complication. Angiographic success was achieved for 88% of all patients. Multivariate analysis found four independent preprocedural variables related to death: female gender, hemodynamic instability, shock, and ejection fraction. Conclusions.-Percutaneous transluminal coronary angioplasty outcomes in New York compare favorably with other recent results reported in the literature. Several preprocedural variables markedly increase the incidence of adverse events.	SUNY ALBANY,DEPT HLTH POLICY & MANAGEMENT,ALBANY,NY 12222; SUNY ALBANY,DEPT BIOSTAT,ALBANY,NY 12222; SUNY BUFFALO,DEPT MED,BUFFALO,NY 14260; BUFFALO GEN HOSP,BUFFALO,NY 14203; SUNY HLTH SCI CTR,DEPT MED,SYRACUSE,NY; ST JOSEPHS HOSP,CARDIOVASC LAB,SYRACUSE,NY 13203; ST LUKES ROOSEVELT HOSP,NEW YORK,NY 10025; COLUMBIA UNIV COLL PHYS & SURG,DEPT CLIN MED,NEW YORK,NY 10032	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Mount Sinai St. Luke's; Mount Sinai West; Columbia University	HANNAN, EL (corresponding author), NEW YORK STATE DEPT HLTH,2019 CORNING TOWER BLDG,ALBANY,NY 12237, USA.				AHRQ HHS [HS06503] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ALFONSO F, 1990, AM HEART J, V119, P237, DOI 10.1016/S0002-8703(05)80010-9; BREDLAU CE, 1985, CIRCULATION, V72, P1044, DOI 10.1161/01.CIR.72.5.1044; COOK C, 1989, AGE AGEING, V18, P219, DOI 10.1093/ageing/18.4.219; DETRE K, 1988, NEW ENGL J MED, V318, P265, DOI 10.1056/NEJM198802043180501; DORROS G, 1988, CLIN CARDIOL, V11, P601, DOI 10.1002/clc.4960110904; ELLIS SG, 1988, J AM COLL CARDIOL, V11, P211, DOI 10.1016/0735-1097(88)90082-4; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; FINCI L, 1987, INT J CARDIOL, V15, P165, DOI 10.1016/0167-5273(87)90311-1; GLAZIER JJ, 1989, BRIT HEART J, V61, P485; Harrell F. E., 1986, SUGI SUPPLEMENTAL LI, P269; HOLMES DR, 1988, J AM COLL CARDIOL, V12, P1149, DOI 10.1016/0735-1097(88)92593-4; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; MEIER B, 1984, J AM COLL CARDIOL, V4, P463, DOI 10.1016/S0735-1097(84)80088-1; QUIGLEY PJ, 1989, AM J CARDIOL, V63, P409, DOI 10.1016/0002-9149(89)90309-3; RAIZNER AE, 1986, AM J CARDIOL, V57, P29, DOI 10.1016/0002-9149(86)90946-X; RAPOLD H, 1987, EUR HEART J, V8, P755; SAHNI R, 1989, CLIN CARDIOL, V12, P427, DOI 10.1002/clc.4960120805; SAVAGE MP, 1991, J AM COLL CARDIOL, V17, P22, DOI 10.1016/0735-1097(91)90700-J; SHIMIZU Y, 1984, JPN CIRC J, V48, P457, DOI 10.1253/jcj.48.457; SIMPFENDORFER C, 1988, CLEV CLIN J MED, V55, P299, DOI 10.3949/ccjm.55.4.299; STEFFENINO G, 1988, BRIT HEART J, V59, P151; TALLEY JD, 1988, CIRCULATION, V77, P820, DOI 10.1161/01.CIR.77.4.820; VALENTINE PA, 1987, MED J AUSTRALIA, V147, P344, DOI 10.5694/j.1326-5377.1987.tb133517.x; 1988, J AM COLL CARDIOL, V12, P529	24	89	93	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	1992	268	21					3092	3097		10.1001/jama.268.21.3092	http://dx.doi.org/10.1001/jama.268.21.3092			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA002	1433740				2022-12-28	WOS:A1992KA00200032
J	BARLOGIE, B; ALEXANIAN, R; JAGANNATH, S				BARLOGIE, B; ALEXANIAN, R; JAGANNATH, S			PLASMA-CELL DYSCRASIAS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY SYSTEMIC AMYLOIDOSIS; HEAVY-CHAIN DISEASE; MULTIPLE-MYELOMA; SURVIVAL; MACROGLOBULINEMIA; COLCHICINE; LEUKEMIA; THERAPY; BONE; AL		UNIV TEXAS, MD ANDERSON CANC CTR, DEPT HEMATOL, GEN HEMATOL SECT, HOUSTON, TX 77025 USA	University of Texas System; UTMD Anderson Cancer Center	BARLOGIE, B (corresponding author), UNIV ARKANSAS MED SCI HOSP, ARKANSAS CANC RES CTR, DIV HEMATOL ONCOL, LITTLE ROCK, AR 72205 USA.							ALEXANIAN R, 1980, BLOOD, V56, P521; ALEXANIAN R, 1990, ARCH INTERN MED, V150, P1693; BARLOGIE B, 1989, BLOOD, V73, P865; BARLOGIE B, 1984, NEW ENGL J MED, V310, P1353, DOI 10.1056/NEJM198405243102104; BARLOGIE B, 1991, BONE MARROW TRANSPL, V7, P71; BARLOGIE B, 1986, MULTIPLE MYELOMA OTH, P154; BATAILLE R, 1992, HEMATOL ONCOL CLIN N, V6, P285, DOI 10.1016/S0889-8588(18)30345-9; BUSKARD NA, 1977, CAN MED ASSOC J, V117, P135; CALIGARISCAPPIO F, 1992, HEMATOL ONCOL CLIN N, V6, P257, DOI 10.1016/S0889-8588(18)30343-5; CHAK LY, 1987, J CLIN ONCOL, V5, P1811, DOI 10.1200/JCO.1987.5.11.1811; DAUEL TF, 1985, LANCET, V2, P311; EPSTEIN J, 1990, NEW ENGL J MED, V322, P664, DOI 10.1056/NEJM199003083221005; FORTE FA, 1970, BLOOD-J HEMATOL, V36, P137, DOI 10.1182/blood.V36.2.137.137; FRANKLIN EC, 1983, HARVEY LECT, V78, P1; GERTZ MA, 1991, BLOOD, V77, P257; GERTZ MA, 1990, AM J MED, V89, P609, DOI 10.1016/0002-9343(90)90179-H; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GORE ME, 1989, LANCET, V2, P879; GOULD J, 1988, BLOOD, V71, P453; GREIL R, 1991, BLOOD, V78, P180; GREIPP PR, 1984, ARCH INTERN MED, V144, P2145, DOI 10.1001/archinte.144.11.2145; JACOBSON DR, 1986, SEMIN ONCOL, V13, P282; KLEIN B, 1989, BLOOD, V73, P517; KLEIN B, 1991, BLOOD, V78, P1198; KYLE RA, 1983, MAYO CLIN PROC, V58, P665; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; KYLE RA, 1985, AM J MED, V79, P708, DOI 10.1016/0002-9343(85)90521-2; KYLE RA, 1980, NEW ENGL J MED, V302, P1347, DOI 10.1056/NEJM198006123022405; KYLE RA, 1981, MAYO CLIN PROC, V56, P439; KYLE RA, 1983, NEW ENGL J MED, V308, P314, DOI 10.1056/NEJM198302103080604; MACKENZIE MR, 1972, BLOOD-J HEMATOL, V39, P874, DOI 10.1182/blood.V39.6.874.874; OSSERMAN EF, 1959, NEW ENGL J MED, V261, P952, DOI 10.1056/NEJM195911052611906; RANDALL RE, 1976, AM J MED, V60, P293, DOI 10.1016/0002-9343(76)90440-X; RAVID M, 1977, ANN INTERN MED, V87, P568, DOI 10.7326/0003-4819-87-5-568; SELIGMANN M, 1986, MULTIPLE MYELOMA OTH, P263; Somer T, 1987, Baillieres Clin Haematol, V1, P695, DOI 10.1016/S0950-3536(87)80021-5	36	43	46	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2946	2951		10.1001/jama.268.20.2946	http://dx.doi.org/10.1001/jama.268.20.2946			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433713				2022-12-28	WOS:A1992JY66800022
J	CHAN, AC; IWASHIMA, M; TURCK, CW; WEISS, A				CHAN, AC; IWASHIMA, M; TURCK, CW; WEISS, A			ZAP-70 - A 70 KD PROTEIN-TYROSINE KINASE THAT ASSOCIATES WITH THE TCR ZETA-CHAIN	CELL			English	Article							CELL ANTIGEN RECEPTOR; AMINO-ACID SEQUENCE; T-CELL; PHOSPHOLIPASE C-GAMMA-1; SIGNAL TRANSDUCTION; ETA-CHAIN; PHYSICAL ASSOCIATION; POLYACRYLAMIDE GELS; MOLECULAR-CLONING; GAMMA-CHAIN	Protein-tyrosine kinases (PTKs) play an integral role in T cell activation. Stimulation of the T cell antigen receptor (TCR) results in tyrosine phosphorylation of a number of cellular substrates. One of these is the TCR zeta chain, which can mediate the transduction of extracellular stimuli into cellular effector functions. We have recently identified a 70 kd tyrosine phosphoprotein (ZAP-70) that associates with zeta and undergoes tyrosine phosphorylation following TCR stimulation. Here we report the isolation of a cDNA clone encoding ZAP-70. ZAP-70 represents a novel PTK and is expressed in T and natural killer cells. Moreover, tyrosine phosphorylation and association of ZAP-70 with zeta require the presence of src family PTKs and provide a potential mechanism by which the src family PTKs and ZAP-70 may interact to mediate TCR signal transduction.	UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	CHAN, AC (corresponding author), UNIV CALIF SAN FRANCISCO, DIV RHEUMATOL, SAN FRANCISCO, CA 94143 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020684] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR20684] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BANIYASH M, 1989, J BIOL CHEM, V264, P13252; BANIYASH M, 1988, J BIOL CHEM, V263, P9874; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BUFERNE M, 1992, J IMMUNOL, V148, P657; BURGESS KE, 1991, EUR J IMMUNOL, V21, P1663, DOI 10.1002/eji.1830210712; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; CASNELLIE JE, 1982, J BIOL CHEM, V257, P3877; CLAYTON LK, 1991, P NATL ACAD SCI USA, V88, P5202, DOI 10.1073/pnas.88.12.5202; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; DASGUPTA JD, 1992, J EXP MED, V175, P285, DOI 10.1084/jem.175.1.285; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Frank S J, 1990, Semin Immunol, V2, P89; GASSMANN M, 1992, EUR J IMMUNOL, V22, P283, DOI 10.1002/eji.1830220142; GEISLER C, 1992, J IMMUNOL, V148, P2437; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HARLOW E, 1988, ANTIBODIES LAB MANUA, P53; HSI ED, 1989, J BIOL CHEM, V264, P10836; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; JUNE CH, 1990, J IMMUNOL, V144, P1591; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KESSLER SW, 1975, J IMMUNOL, V115, P1617; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LITTMAN DR, 1987, NATURE, V326, P85, DOI 10.1038/326085a0; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MITTLER RS, 1989, P NATL ACAD SCI USA, V86, P8531, DOI 10.1073/pnas.86.21.8531; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NORMENT AM, 1989, J IMMUNOL, V142, P3312; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; ORLOFF DG, 1989, J BIOL CHEM, V264, P14812; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; PERLMUTTER RM, 1988, J CELL BIOCHEM, V38, P117, DOI 10.1002/jcb.240380206; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; RUDD CE, 1990, IMMUNOL TODAY, V11, P400, DOI 10.1016/0167-5699(90)90159-7; SAIZAWA K, 1987, NATURE, V328, P260, DOI 10.1038/328260a0; Sambrook J, 1989, MOL CLONING LABORATO; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; SEFTON BM, 1980, CELL, V20, P807, DOI 10.1016/0092-8674(80)90327-X; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; WEISSMAN AM, 1988, SCIENCE, V239, P1018, DOI 10.1126/science.3278377; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	77	965	997	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	1992	71	4					649	662		10.1016/0092-8674(92)90598-7	http://dx.doi.org/10.1016/0092-8674(92)90598-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423621				2022-12-28	WOS:A1992JY67600012
J	GLAZER, AN; RYE, HS				GLAZER, AN; RYE, HS			STABLE DYE-DNA INTERCALATION COMPLEXES AS REAGENTS FOR HIGH-SENSITIVITY FLUORESCENCE DETECTION	NATURE			English	Article							ACRIDINE ETHIDIUM HETERODIMER; DOUBLE-STRANDED DNA; BIFUNCTIONAL INTERCALATORS; THIAZOLE ORANGE; GEL SCANNER; HOMODIMER				GLAZER, AN (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720, USA.			Rye, Hays/0000-0002-9420-3137				BECKER MM, 1979, J AM CHEM SOC, V101, P3664, DOI 10.1021/ja00507a046; CROTHERS DM, 1968, BIOPOLYMERS, V6, P575, DOI 10.1002/bip.1968.360060411; GAO Q, 1991, P NATL ACAD SCI USA, V88, P2422, DOI 10.1073/pnas.88.6.2422; GAUGAIN B, 1978, BIOCHEMISTRY-US, V17, P5078, DOI 10.1021/bi00617a002; GAUGAIN B, 1978, BIOCHEMISTRY-US, V17, P5071, DOI 10.1021/bi00617a001; GLAZER AN, 1990, P NATL ACAD SCI USA, V87, P3851, DOI 10.1073/pnas.87.10.3851; HAUGLAND RP, 1992, MOL PROBES HDB FLUOR, P221; HUANG CH, 1983, CANCER RES, V43, P2718; HUANG XHC, 1992, ANAL CHEM, V64, P2149, DOI 10.1021/ac00042a021; HURLEY LH, 1989, J MED CHEM, V32, P2027, DOI 10.1021/jm00129a001; LEE LG, 1986, CYTOMETRY, V7, P508, DOI 10.1002/cyto.990070603; LEMAN LS, 1961, J MOL BIOL, V3, P18; MARKOVITS J, 1979, ANAL BIOCHEM, V94, P259, DOI 10.1016/0003-2697(79)90357-9; MATHIES RA, 1992, NATURE, V359, P167, DOI 10.1038/359167a0; NIELSEN PE, 1988, BIOCHEMISTRY-US, V27, P67, DOI 10.1021/bi00401a012; QUESADA MA, 1991, BIOTECHNIQUES, V10, P616; RYE HS, 1991, NUCLEIC ACIDS RES, V19, P327, DOI 10.1093/nar/19.2.327; RYE HS, 1992, NUCLEIC ACIDS RES, V20, P2803, DOI 10.1093/nar/20.11.2803; RYE HS, IN PRESS METH ENZYM, V217; RYE HS, IN PRESS ANAL BIOCH; SCHWARTZ HE, 1992, ANAL CHEM, V64, P1737, DOI 10.1021/ac00039a019; WAKELIN LPG, 1986, MED RES REV, V6, P275, DOI 10.1002/med.2610060303	22	338	369	1	76	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 29	1992	359	6398					859	861		10.1038/359859a0	http://dx.doi.org/10.1038/359859a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV777	1436062				2022-12-28	WOS:A1992JV77700073
J	SWAMINATHAN, S; FUREY, W; PLETCHER, J; SAX, M				SWAMINATHAN, S; FUREY, W; PLETCHER, J; SAX, M			CRYSTAL-STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN-B, A SUPERANTIGEN	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; USE PREDICTS REACTIVITY; MLSA-ENCODED ANTIGENS; T-CELL RECOGNITION; CLASS-II MOLECULES; BINDING SITE; TOLERANCE; CRYSTALLOGRAPHY; STIMULATION; REQUIREMENT	The three-dimensional structure of staphylococcal enterotoxin B, which is both a toxin and a super-antigen, has been determined to a resolution of 2.5 angstrom. The unusual main-chain fold containing two domains may represent a general motif adopted by all staphylococcal enterotoxins. The T-cell receptor binding site encompasses a shallow cavity formed by both domains. The MHCII molecule binds to an adjacent site. Another cavity with possible biological activity was also identified.			SWAMINATHAN, S (corresponding author), VET AFFAIRS MED CTR,BIOCRYSTALLOG LAB,POB 12055,UNIV DR C,PITTSBURGH,PA 15240, USA.							BERDOLL MS, 1985, STAPHYLOCOCCI, P247; Bergdoll M.S., 1979, FOOD BORNE INFECTION, P443; BERGDOLL MS, 1970, MICROBIAL TOXINS, P265; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BLANCO L, 1990, INFECT IMMUN, V58, P3020, DOI 10.1128/IAI.58.9.3020-3028.1990; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CARLSSON R, 1988, J IMMUNOL, V140, P2484; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEREWENDA Z, 1989, J APPL CRYSTALLOGR, V22, P123, DOI 10.1107/S0021889888012348; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; FUREY W, 1990, AM CRYSTALLOGR ASS M; HERMAN A, 1991, P NATL ACAD SCI USA, V88, P9954, DOI 10.1073/pnas.88.22.9954; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; IRWIN MJ, 1992, NATURE, V359, P841, DOI 10.1038/359841a0; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; JOHNSON HM, 1992, SCI AM           APR, P92; JONES CL, 1986, J BACTERIOL, V166, P29, DOI 10.1128/jb.166.1.29-33.1986; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KARP DR, 1992, J EXP MED, V175, P415, DOI 10.1084/jem.175.2.415; LANGFORD MP, 1978, INFECT IMMUN, V22, P62, DOI 10.1128/IAI.22.1.62-68.1978; LESLIE AGW, 1987, ACTA CRYSTALLOGR A, V43, P134, DOI 10.1107/S0108767387099720; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; RICHARDSON JS, 1976, P NATL ACAD SCI USA, V73, P2619, DOI 10.1073/pnas.73.8.2619; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUSSELL JK, 1991, P NATL ACAD SCI USA, V88, P7228, DOI 10.1073/pnas.88.16.7228; SCHEUBER PH, 1985, INFECT IMMUN, V50, P869, DOI 10.1128/IAI.50.3.869-876.1985; SPERO L, 1978, J BIOL CHEM, V253, P8787; STEIMA GN, 1982, BIOCHEM BIOPH RES CO, V105, P121; SWAMINATHAN S, 1988, J MOL BIOL, V199, P397, DOI 10.1016/0022-2836(88)90326-9; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WEISSMAN L, 1982, COMPUTATIONAL CRYSTA, P56; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X	45	292	317	1	15	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 29	1992	359	6398					801	806		10.1038/359801a0	http://dx.doi.org/10.1038/359801a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV777	1436058				2022-12-28	WOS:A1992JV77700054
J	HUGHES, JR; HIGGINS, EM; DUVIVIER, AWP				HUGHES, JR; HIGGINS, EM; DUVIVIER, AWP			ACNE ASSOCIATED WITH INHALED GLUCOCORTICOSTEROIDS	BRITISH MEDICAL JOURNAL			English	Letter							CORTICOSTEROIDS				HUGHES, JR (corresponding author), UNIV LONDON KINGS COLL HOSP,DEPT DERMATOL,LONDON SE5 9RS,ENGLAND.							CAPEWELL S, 1990, BRIT MED J, V300, P1548, DOI 10.1136/bmj.300.6739.1548; HIGGINS EM, 1991, CLIN EXP DERMATOL, V16, P244, DOI 10.1111/j.1365-2230.1991.tb00366.x; KAIDBEY KH, 1974, J INVEST DERMATOL, V62, P31, DOI 10.1111/1523-1747.ep12676716; PLEWIG G, 1973, ARCH DERMATOL FORSCH, V247, P29, DOI 10.1007/BF00595699; SNEDDON I, 1969, BRIT MED J, V4, P49, DOI 10.1136/bmj.4.5674.49-a; STEAD RJ, 1989, BRIT MED J, V298, P403, DOI 10.1136/bmj.298.6671.403	6	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 24	1992	305	6860					1000	1000		10.1136/bmj.305.6860.1000	http://dx.doi.org/10.1136/bmj.305.6860.1000			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV776	1458105	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JV77600031
J	AKIHITO				AKIHITO			EARLY CULTIVATORS OF SCIENCE IN JAPAN	SCIENCE			English	Editorial Material													P., Akihito/M-1268-2015					GENETSU, 1765, SANRON; GENPAKU, KEIEI YAWA; GENPAKU, RANGAKU KOTO HAJIME; GENPAKU, FLORA JAPONICA FAUNA; KAEMPFER E, HIST JAPAN; KULMUS JA, 1934, ONTLEEDKUNDIGE TAFEL	6	3	3	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 23	1992	258	5082					578	580		10.1126/science.1411568	http://dx.doi.org/10.1126/science.1411568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU745	1411568				2022-12-28	WOS:A1992JU74500036
J	NISHIZUKA, Y				NISHIZUKA, Y			INTRACELLULAR SIGNALING BY HYDROLYSIS OF PHOSPHOLIPIDS AND ACTIVATION OF PROTEIN-KINASE-C	SCIENCE			English	Article							EPIDERMAL-GROWTH-FACTOR; UNSATURATED FATTY-ACIDS; GROUP-II PHOSPHOLIPASE-A2; MOLECULAR-SPECIES ANALYSIS; HAMSTER OVARY CELLS; CA2+-SENSITIVE CYTOSOLIC PHOSPHOLIPASE-A2; MOUSE PERITONEAL-MACROPHAGES; STIMULATED HUMAN-PLATELETS; LYMPHOCYTE-T ACTIVATION; MESSENGER-RNA SYNTHESIS	Hydrolysis of inositol phospholipids by phospholipase C is initiated by either receptor stimulation or opening of Ca2+ channels. This was once thought to be the sole mechanism to produce the diacylglycerol that links extracellular signals to intracellular events through activation of protein kinase C. It is becoming clear that agonist-induced hydrolysis of other membrane phospholipids, particularly choline phospholipids, by phospholipase D and phospholipase A2 may also take part in cell signaling. The products of hydrolysis of these phospholipids may enhance and prolong the activation of protein kinase C. Such prolonged activation of protein kinase C is essential for long-term cellular responses such as cell proliferation and differentiation.	KOBE UNIV,BIOSIGNAL RES CTR,KOBE 657,JAPAN	Kobe University	NISHIZUKA, Y (corresponding author), KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN.							ADAMS PD, 1991, FEBS LETT, V290, P77, DOI 10.1016/0014-5793(91)81230-6; AGWU DE, 1989, J BIOL CHEM, V264, P1405; AHN NG, 1990, J BIOL CHEM, V265, P11487; AIHARA H, 1991, P NATL ACAD SCI USA, V88, P11062, DOI 10.1073/pnas.88.24.11062; AKIMOTO K, UNPUB; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANTHES JC, 1989, BIOCHEM BIOPH RES CO, V163, P657, DOI 10.1016/0006-291X(89)92187-6; ASAOKA Y, 1991, BIOCHEM BIOPH RES CO, V178, P1378, DOI 10.1016/0006-291X(91)91046-F; ASAOKA Y, 1992, P NATL ACAD SCI USA, V89, P6447, DOI 10.1073/pnas.89.14.6447; ASAOKA Y, 1991, P NATL ACAD SCI USA, V88, P8681, DOI 10.1073/pnas.88.19.8681; ASAOKA Y, IN PRESS P NATL ACAD; ASAOKA Y, UNPUB; AUGERT G, 1989, J BIOL CHEM, V264, P21689; AXELROD J, 1988, TRENDS NEUROSCI, V11, P117, DOI 10.1016/0166-2236(88)90157-9; BACHER N, 1991, MOL CELL BIOL, V11, P126, DOI 10.1128/MCB.11.1.126; BAKER RR, 1972, BIOCHIM BIOPHYS ACTA, V270, P489, DOI 10.1016/0005-2760(72)90114-2; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BELL RM, 1991, J BIOL CHEM, V266, P4661; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; BERRY N, 1990, EUR J BIOCHEM, V189, P205, DOI 10.1111/j.1432-1033.1990.tb15478.x; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P6785, DOI 10.1073/pnas.83.18.6785; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Bird G. A., UNPUB; BISHOP WR, 1988, ONCOGENE RES, V2, P205; BISHOP WR, 1990, BIOCHEM J, V269, P465, DOI 10.1042/bj2690465; BLISS TVP, 1989, BRAIN SIGNAL TRANSDU, P185; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BONVENTRE JV, 1990, J BIOL CHEM, V265, P4934; BUDAY L, 1990, FEBS LETT, V276, P223, DOI 10.1016/0014-5793(90)80547-V; BURCH RM, 1986, P NATL ACAD SCI USA, V83, P7201, DOI 10.1073/pnas.83.19.7201; CHALIFA V, 1990, J BIOL CHEM, V265, P17512; CHALIFOUR R, 1982, J NEUROCHEM, V39, P299, DOI 10.1111/j.1471-4159.1982.tb03946.x; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CHEN SG, 1992, BIOCHEM J, V282, P33, DOI 10.1042/bj2820033; CHOUDHURY GG, 1991, J BIOL CHEM, V266, P23147; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; CLARK MA, 1991, P NATL ACAD SCI USA, V88, P5418, DOI 10.1073/pnas.88.12.5418; CLARK MA, 1986, BIOCHEM BIOPH RES CO, V140, P114, DOI 10.1016/0006-291X(86)91065-X; COCKCROFT S, 1985, FEBS LETT, V181, P259, DOI 10.1016/0014-5793(85)80271-4; CONQUER J, 1991, J LIPID MEDIATOR, V3, P113; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; COOK SJ, 1990, BIOCHEM J, V265, P617, DOI 10.1042/bj2650617; CUTHBERTSON KSR, 1991, CELL CALCIUM, V12, P61, DOI 10.1016/0143-4160(91)90008-3; DANIEL LW, 1988, BIOCHEM BIOPH RES CO, V151, P291, DOI 10.1016/0006-291X(88)90592-X; DANIEL LW, 1986, J BIOL CHEM, V261, P9128; DAVIS LS, 1989, CELL IMMUNOL, V118, P208, DOI 10.1016/0008-8749(89)90370-5; DENNIS EA, 1991, FASEB J, V5, P2068, DOI 10.1096/fasebj.5.7.1901288; DOMINO SE, 1989, J BIOL CHEM, V264, P9412; EBELING JG, 1985, P NATL ACAD SCI USA, V82, P815, DOI 10.1073/pnas.82.3.815; EMILSSON A, 1986, BIOCHIM BIOPHYS ACTA, V876, P533, DOI 10.1016/0005-2760(86)90041-X; EXTON JH, 1988, FASEB J, V2, P2670, DOI 10.1096/fasebj.2.11.2456243; EXTON JH, 1990, J BIOL CHEM, V265, P1; FALLMAN M, 1992, J BIOL CHEM, V267, P2656; FARESE RV, 1989, BIOCHEM J, V261, P927, DOI 10.1042/bj2610927; FLESCH I, 1986, BIOCHIM BIOPHYS ACTA, V889, P6, DOI 10.1016/0167-4889(86)90003-0; FORD DA, 1989, J BIOL CHEM, V264, P13818; FUKAMI K, 1989, J BIOL CHEM, V264, P14985; GANONG BR, 1986, P NATL ACAD SCI USA, V83, P1184, DOI 10.1073/pnas.83.5.1184; GO M, 1987, BIOCHEM BIOPH RES CO, V144, P598; GOLDBERG HJ, 1990, BIOCHEM J, V267, P461, DOI 10.1042/bj2670461; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GORACCI G, 1981, BIOCHIM BIOPHYS ACTA, V664, P373, DOI 10.1016/0005-2760(81)90059-X; GRIENDLING KK, 1986, J BIOL CHEM, V261, P5901; GRILLONE LR, 1988, J BIOL CHEM, V263, P2658; GRONICH JH, 1990, BIOCHEM J, V271, P37, DOI 10.1042/bj2710037; GRONICH JH, 1988, J BIOL CHEM, V263, P16645; HALENDA SP, 1985, J BIOL CHEM, V260, P2484; HARA S, IN PRESS J BIOCH TOK; HATTORI H, 1985, J NEUROCHEM, V45, P1578, DOI 10.1111/j.1471-4159.1985.tb07229.x; HATTORI S, 1992, IN PRESS J BIOL CHEM, V267; HAYAKAWA M, 1988, J BIOCHEM-TOKYO, V104, P767, DOI 10.1093/oxfordjournals.jbchem.a122547; HO AK, 1987, J BIOL CHEM, V262, P11764; HOFFMAN RD, 1982, P NATL ACAD SCI-BIOL, V79, P3285, DOI 10.1073/pnas.79.10.3285; HOLBROOK PG, 1992, J BIOL CHEM, V267, P16834; HOLUB BJ, 1970, J LIPID RES, V11, P558; JEREMY JY, 1987, EUR J PHARMACOL, V136, P311, DOI 10.1016/0014-2999(87)90303-7; KAIBUCHI K, 1983, J BIOL CHEM, V258, P6701; KANFER JN, 1980, CAN J BIOCHEM CELL B, V58, P1370, DOI 10.1139/o80-186; KATER LA, 1976, J CLIN INVEST, V57, P1173, DOI 10.1172/JCI108385; KAWAHARA Y, 1980, BIOCHEM BIOPH RES CO, V97, P309, DOI 10.1016/S0006-291X(80)80169-0; KENNERLY DA, 1990, J IMMUNOL, V144, P3912; KENNERLY DA, 1987, J BIOL CHEM, V262, P16305; KHAN WA, 1992, J BIOL CHEM, V267, P3605; KIM DK, 1991, BIOCHIM BIOPHYS ACTA, V1083, P80; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; KOIDE H, 1992, P NATL ACAD SCI USA, V89, P1149, DOI 10.1073/pnas.89.4.1149; KOJIMA I, 1984, J BIOL CHEM, V259, P4448; KOMADA M, 1990, BIOCHEM BIOPH RES CO, V168, P1059, DOI 10.1016/0006-291X(90)91137-H; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; KUDO I, 1989, DERMATOLOGICA, V179, P72, DOI 10.1159/000248454; KUGE O, 1986, J BIOL CHEM, V261, P5790; KUGE O, 1986, J BIOL CHEM, V261, P5795; KUGE O, 1985, P NATL ACAD SCI USA, V82, P1926, DOI 10.1073/pnas.82.7.1926; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; LEACH KL, 1991, J BIOL CHEM, V266, P3215; LEIBERSPERGER H, 1990, J BIOL CHEM, V265, P16108; LESTER DS, 1991, BIOCHEM BIOPH RES CO, V179, P1522, DOI 10.1016/0006-291X(91)91745-X; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LISCOVITCH M, 1991, BIOCHEM SOC T, V19, P402, DOI 10.1042/bst0190402; LIYANAGE M, 1992, BIOCHEM J, V283, P781, DOI 10.1042/bj2830781; MARTIN TW, 1989, J BIOL CHEM, V264, P8847; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; MATSUZAWA A, UNPUB; MCCOLL SR, 1986, BIOCHEM BIOPH RES CO, V141, P399, DOI 10.1016/S0006-291X(86)80186-3; MCINTYRE TM, 1987, J BIOL CHEM, V262, P15370; MCKEAN ML, 1981, J BIOL CHEM, V256, P1522; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MIZUSHIMA H, 1989, J BIOCHEM-TOKYO, V105, P520, DOI 10.1093/oxfordjournals.jbchem.a122699; MORI T, 1982, J BIOCHEM, V91, P427, DOI 10.1093/oxfordjournals.jbchem.a133714; MUELLER HW, 1984, J LIPID RES, V25, P383; MUIR JG, 1987, J CELL PHYSIOL, V130, P382, DOI 10.1002/jcp.1041300311; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; MURAKAMI K, 1985, FEBS LETT, V192, P189, DOI 10.1016/0014-5793(85)80105-8; MURAKAMI M, 1991, FEBS LETT, V294, P247, DOI 10.1016/0014-5793(91)81440-J; NAKAMURA S, UNPUB; NAKANISHI H, IN PRESS; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; NAKANO T, 1990, J BIOL CHEM, V265, P12745; NAKANO T, 1990, FEBS LETT, V273, P23, DOI 10.1016/0014-5793(90)81042-M; NAKANO T, 1989, J BIOL CHEM, V264, P5400; NAOR Z, 1988, MOL ENDOCRINOL, V2, P1043, DOI 10.1210/mend-2-11-1043; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; NISHIKAWA M, 1988, BIOCHEM PHARMACOL, V37, P3079, DOI 10.1016/0006-2952(88)90304-8; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OGITA K, 1992, P NATL ACAD SCI USA, V89, P1592, DOI 10.1073/pnas.89.5.1592; OISHI K, 1988, J BIOL CHEM, V263, P6865; OKA S, 1991, J BIOL CHEM, V266, P9956; OLSON SC, 1991, J BIOL CHEM, V266, P17236; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OSADA S, 1990, J BIOL CHEM, V265, P22434; OSADA S, IN PRESS; PACHTER JA, 1992, J BIOL CHEM, V267, P9826; PAI JK, 1988, J BIOL CHEM, V263, P12472; PARKER J, 1987, J BIOL CHEM, V262, P5385; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; PESSIN MS, 1990, J BIOL CHEM, V265, P7959; PESSIN MS, 1989, J BIOL CHEM, V264, P8729; PETTIT TR, 1992, IN PRESS BIOCH J; PFEFFER LM, 1990, P NATL ACAD SCI USA, V87, P6537, DOI 10.1073/pnas.87.17.6537; PFEFFER LM, 1991, P NATL ACAD SCI USA, V88, P7988, DOI 10.1073/pnas.88.18.7988; PORCELLATI G, 1979, P EUR SOC NEUROCHEM, V1, P285; PRESCOTT SM, 1981, J BIOL CHEM, V256, P579; PRICE BD, 1989, J BIOL CHEM, V264, P16638; QIAN Z, 1990, J BIOL CHEM, V265, P3607; QIAN Z, 1989, J BIOL CHEM, V264, P21720; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; RASUMUSSEN H, 1984, PHYSL EV, V64, P938; REHFELDT W, 1991, BIOCHEM J, V276, P631, DOI 10.1042/bj2760631; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; ROSSOMANDO A, 1992, P NATL ACAD SCI USA, V89, P5221, DOI 10.1073/pnas.89.12.5221; ROUTTENBERG A, 1989, BRAIN SIGNAL TRANSDU, P213; SAITO M, 1975, ARCH BIOCHEM BIOPHYS, V169, P318, DOI 10.1016/0003-9861(75)90346-X; SAITO M, 1974, ARCH BIOCHEM BIOPHYS, V164, P420, DOI 10.1016/0003-9861(74)90051-4; SAITO T, 1988, P NATL ACAD SCI USA, V85, P8246, DOI 10.1073/pnas.85.21.8246; SANO K, 1983, J BIOL CHEM, V258, P2010; Sasaki Y., UNPUB; SCHAAP D, 1990, J BIOL CHEM, V265, P7301; SCHALKWIJK CG, 1990, BIOCHIM BIOPHYS ACTA, V1044, P139, DOI 10.1016/0005-2760(90)90229-Q; SEIFERT R, 1988, BIOCHEM BIOPH RES CO, V154, P20, DOI 10.1016/0006-291X(88)90643-2; SEKIGUCHI K, 1987, BIOCHEM BIOPH RES CO, V145, P797, DOI 10.1016/0006-291X(87)91035-7; SHARIFF A, 1992, SCIENCE, V256, P245, DOI 10.1126/science.1373523; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SHEARMAN MS, 1989, FEBS LETT, V243, P177, DOI 10.1016/0014-5793(89)80125-5; SHEARMAN MS, 1991, FEBS LETT, V279, P261, DOI 10.1016/0014-5793(91)80163-W; SHEIKHNEJAD RG, 1986, J BIOL CHEM, V261, P7544; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; SIDDIQUI RA, 1992, J BIOL CHEM, V267, P5755; SSAIDO TC, 1990, BIOCHEMISTRY-US, V31, P482; STROSZNAJDER J, 1980, NEUROCHEM RES, V6, P767; SZAMEL M, 1989, J IMMUNOL, V143, P2806; TAKAYAMA K, 1991, FEBS LETT, V282, P326, DOI 10.1016/0014-5793(91)80506-X; TAKI T, 1979, J BIOL CHEM, V254, P976; TENCE M, 1985, THROMB RES, V38, P207, DOI 10.1016/0049-3848(85)90148-3; TETTENBORN CS, 1988, BIOCHEM BIOPH RES CO, V155, P249, DOI 10.1016/S0006-291X(88)81076-3; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; UHING RJ, 1989, J BIOL CHEM, V264, P9224; UINGS IJ, 1992, BIOCHEM J, V281, P597, DOI 10.1042/bj2810597; VANDENBOSCH H, 1980, BIOCHIM BIOPHYS ACTA, V604, P191; VANDERMEULEN J, 1990, BIOCHEM J, V271, P693, DOI 10.1042/bj2710693; VOLPI M, 1985, BIOCHEM BIOPH RES CO, V128, P594, DOI 10.1016/0006-291X(85)90087-7; WAITE M, 1985, J LIPID RES, V26, P1379; WAITE M, 1987, HDB LIPID RES, V5, P1; WANG P, 1991, J BIOL CHEM, V266, P14877; WATANABE T, IN PRESS P NATL ACAD; WATSON SP, 1985, P NATL ACAD SCI USA, V82, P2623, DOI 10.1073/pnas.82.9.2623; WAYS DK, 1992, J BIOL CHEM, V267, P4799; WEISS BA, 1991, J BIOL CHEM, V266, P2126; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; WERNER MH, 1992, BIOCHEM J, V282, P815, DOI 10.1042/bj2820815; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WHATLEY RE, 1989, J BIOL CHEM, V264, P6325; WIJKANDER J, 1991, EUR J BIOCHEM, V202, P873, DOI 10.1111/j.1432-1033.1991.tb16445.x; WIJKANDER J, 1989, FEBS LETT, V244, P51, DOI 10.1016/0014-5793(89)81160-3; WIJKANDER J, 1992, THESIS LUND U LUND; WILLIAM F, 1990, J BIOL CHEM, V265, P18166; WOLF RA, 1985, J BIOL CHEM, V260, P7295; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; WOODS NM, 1987, BIOCHEM J, V246, P619, DOI 10.1042/bj2460619; WRIGHT TM, 1988, J BIOL CHEM, V263, P9374; YOSHIDA K, 1992, P NATL ACAD SCI USA, V89, P6443, DOI 10.1073/pnas.89.14.6443; YOSHIHARA Y, 1990, BIOCHEM BIOPH RES CO, V170, P484, DOI 10.1016/0006-291X(90)92117-I	211	4432	4534	4	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 23	1992	258	5082					607	614		10.1126/science.1411571	http://dx.doi.org/10.1126/science.1411571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU745	1411571				2022-12-28	WOS:A1992JU74500048
J	BLATTER, EE; EBRIGHT, YW; EBRIGHT, RH				BLATTER, EE; EBRIGHT, YW; EBRIGHT, RH			IDENTIFICATION OF AN AMINO ACID-BASE CONTACT IN THE GCN4-DNA COMPLEX BY BROMOURACIL-MEDIATED PHOTO-CROSS-LINKING	NATURE			English	Article							LAC REPRESSOR PROTEIN; GENE-CONTROL REGIONS; LEUCINE ZIPPER; DNA-BINDING; GEL-ELECTROPHORESIS; ACTIVATOR PROTEIN; OPERATOR DNA; RECOGNITION; SITE; BROMODEOXYURIDINE	THE bZIP DNA-binding proteins are characterized by a 50-amino-acid DNA binding and dimerization motif, consisting of a highly basic DNA-binding region ('b') followed by a leucine zipper dimerization region ('ZIP')1. The best characterized bZIP DNA-binding protein is GCN4, a yeast transcriptional activator2-6. GCN4 binds to a 9-base-pair two-fold-symmetric DNA site, 5'-A-4T-3G-2A-1C0T+1C+2A+3T+4-3' (refs 7-10). A detailed model known as the 'induced helical fork' model has been proposed for the structure of the GCN4-DNA complex4. Using a site-specific bromouracil-mediated photocrosslinking method, we show here that the alanine at position 238 of GCN4 contacts, or is close to, the thymine 5-methyl of A.T at position +3 of the DNA site in the GCN4-DNA complex. Our results strongly support the induced helical fork model4. Our site-specific bromouracil-mediated photocrosslinking method requires no prior information regarding the structure of the protein or the structure of the protein-DNA complex and should be generalizable to DNA-binding proteins that interact with the DNA major groove11,12.	RUTGERS STATE UNIV,DEPT CHEM,NEW BRUNSWICK,NJ 08855; RUTGERS STATE UNIV,WAKSMAN INST,NEW BRUNSWICK,NJ 08855	Rutgers State University New Brunswick; Rutgers State University New Brunswick			Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140				ALLEN TD, 1991, J BIOL CHEM, V266, P6113; BRENNAN CA, 1986, J BIOL CHEM, V261, P7270; EBRIGHT RH, 1989, NUCLEIC ACIDS RES, V17, P10295, DOI 10.1093/nar/17.24.10295; FISHER EF, 1979, NUCLEIC ACIDS RES, V7, P401, DOI 10.1093/nar/7.2.401; FLIESS A, 1988, NUCLEIC ACIDS RES, V16, P11781, DOI 10.1093/nar/16.24.11781; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GARTENBERG MR, 1990, P NATL ACAD SCI USA, V87, P6034, DOI 10.1073/pnas.87.16.6034; GOEDDEL DV, 1978, J MOL BIOL, V123, P661, DOI 10.1016/0022-2836(78)90211-5; GUNASEKERA A, 1992, J BIOL CHEM, V267, P14713; HAYAKAWA T, 1988, NUCLEIC ACIDS RES, V16, P4761, DOI 10.1093/nar/16.11.4761; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; HUTCHINSON F, 1973, Q REV BIOPHYS, V6, P201, DOI 10.1017/S0033583500001141; LIN SY, 1974, P NATL ACAD SCI USA, V71, P947, DOI 10.1073/pnas.71.3.947; MAVROTHALASSITIS G, 1990, DNA CELL BIOL, V9, P783, DOI 10.1089/dna.1990.9.783; OGATA R, 1977, P NATL ACAD SCI USA, V74, P4973, DOI 10.1073/pnas.74.11.4973; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PU WT, 1992, NUCLEIC ACIDS RES, V20, P771, DOI 10.1093/nar/20.4.771; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P1310, DOI 10.1021/bi00219a022; SIMPSON RB, 1979, CELL, V18, P277, DOI 10.1016/0092-8674(79)90047-3; STRUHL K, IN PRESS TRANSCRIPTI; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8020, DOI 10.1021/bi00487a004; WHARTON RP, 1987, NATURE, V326, P888, DOI 10.1038/326888a0; WICK KL, 1991, J BIOL CHEM, V266, P6106	30	79	83	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 15	1992	359	6396					650	652		10.1038/359650a0	http://dx.doi.org/10.1038/359650a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	1406998				2022-12-28	WOS:A1992JT82400062
J	BERTHJONES, J; BOURKE, J; BAILEY, K; GRAHAMBROWN, RAC; HUTCHINSON, PE				BERTHJONES, J; BOURKE, J; BAILEY, K; GRAHAMBROWN, RAC; HUTCHINSON, PE			GENERALIZED PUSTULAR PSORIASIS - RESPONSE TO TOPICAL CALCIPOTRIOL	BRITISH MEDICAL JOURNAL			English	Article											BERTHJONES, J (corresponding author), LEICESTER ROYAL INFIRM,DEPT DERMATOL,LEICESTER LE1 5WW,ENGLAND.							BERTHJONES J, IN PRESS BR J DERMAT; DWYER C, 1991, LANCET, V338, P764, DOI 10.1016/0140-6736(91)91493-E; RYAN TJ, 1971, BRIT J DERMATOL, V85, P407	3	18	20	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					868	869		10.1136/bmj.305.6858.868	http://dx.doi.org/10.1136/bmj.305.6858.868			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422400	Green Submitted, Green Published, Bronze			2022-12-28	WOS:A1992JT77700025
J	CLARK, MR; CAMPBELL, KS; KAZLAUSKAS, A; JOHNSON, SA; HERTZ, M; POTTER, TA; PLEIMAN, C; CAMBIER, JC				CLARK, MR; CAMPBELL, KS; KAZLAUSKAS, A; JOHNSON, SA; HERTZ, M; POTTER, TA; PLEIMAN, C; CAMBIER, JC			THE B-CELL ANTIGEN RECEPTOR COMPLEX - ASSOCIATION OF IG-ALPHA AND IG-BETA WITH DISTINCT CYTOPLASMIC EFFECTORS	SCIENCE			English	Article							PROTEIN TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCTION; LYMPHOCYTES-B; PDGF RECEPTOR; MEMBRANE IMMUNOGLOBULIN; KINASE; STIMULATION; ANTIIMMUNOGLOBULIN; GENE	The B cell antigen receptor complex is a hetero-oligomeric structure composed of antigen binding, membrane immunoglobulin, and transducer-transporter substructures. The transducer-transporter substructure is composed of disulfide-linked dimers of immunoglobulin (Ig)-alpha and Ig-beta/gamma subunits that are products of the mb-1(alpha) and B29 (beta/gamma) genes. Although the receptor complex associates with Src family kinases that are activated after receptor ligation, the site of interaction of these and other cytoplasmic effector molecules with receptor subunits is unknown. The cytoplasmic tails of Ig-alpha and Ig-beta chains were found to associate with distinct sets of effector molecules. The Ig-alpha chain cytoplasmic domain bound to the Src family kinases Lyn and Fyn, phosphatidylinositol-3 kinase (PI-3 kinase), and an unidentified 38-kilodalton phosphoprotein; the cytoplasmic tail of Ig-beta bound PI-3 kinase and unidentified 40- and 42-kilodalton phosphoproteins. Binding activity was found to occur within a 26-amino acid sequence of Ig-alpha and Ig-beta that contains a motif [(Asp or Glu)-(any amino acid)7-(Asp or Glu)-Tyr-(any amino acid)3-Leu-(any amino acid)7-Tyr-(any amino acid)2-(Leu or Ile)] previously implicated in signal transduction via other receptors including the Fc(epsilon) receptor I and the T cell antigen receptor. These findings indicate that the subunits act independently to activate distinct second messenger pathways.	NATL JEWISH CTR IMMUNOL & RESP MED,DIV BASIC SCI,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,DENVER,CO 80206	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver			Campbell, Kerry S./T-1381-2019	Cambier, John/0000-0002-7803-242X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020519, R01AI021768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001864] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20519, AI21768] Funding Source: Medline; NIAMS NIH HHS [AR01864] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; CAMBIER JC, IN PRESS CURR OPIN I; CAMPBELL K, UNPUB; CAMPBELL KS, 1990, EMBO J, V9, P441, DOI 10.1002/j.1460-2075.1990.tb08129.x; CAMPBELL KS, 1991, P NATL ACAD SCI USA, V88, P3982, DOI 10.1073/pnas.88.9.3982; CAMPBELL KS, 1990, LIGANDS RECEPTORS SI, pCH1; CAMPBELL MA, 1990, EMBO J, V9, P2125, DOI 10.1002/j.1460-2075.1990.tb07381.x; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2745, DOI 10.1073/pnas.88.7.2745; CHIEN N, UNPUB; CLARK MW, UNPUB; COGGESHALL KM, IN PRESS P NATL ACAD; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COUGHLIN SR, 1989, SCIENCE, V243, P1191; FINKEL TH, 1991, IMMUNOL TODAY, V12, P79, DOI 10.1016/0167-5699(91)90162-M; GOLD MR, 1990, NATURE, V345, P810, DOI 10.1038/345810a0; GOLD MR, 1992, J IMMUNOL, V148, P2012; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; JENSEN W, UNPUB J C CAMBIER; JULIUS MH, 1984, EUR J IMMUNOL, V14, P753, DOI 10.1002/eji.1830140816; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KAWAKAMI T, 1988, P NATL ACAD SCI USA, V85, P3870, DOI 10.1073/pnas.85.11.3870; KAZLAUSKAS A, 1991, CELL REGUL, V2, P413, DOI 10.1091/mbc.2.6.413; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; PLEIMAN CM, UNPUB; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RETH M, 1991, IMMUNOL TODAY, V12, P196, DOI 10.1016/0167-5699(91)90053-V; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118	38	301	312	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 2	1992	258	5079					123	126		10.1126/science.1439759	http://dx.doi.org/10.1126/science.1439759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ619	1439759				2022-12-28	WOS:A1992JQ61900033
J	KRETSINGER, RH				KRETSINGER, RH			CALMODULIN AND MYOSIN LIGHT CHAIN KINASE - HOW HELICES ARE BENT	SCIENCE			English	Editorial Material							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; MONOPHOSPHATE				KRETSINGER, RH (corresponding author), UNIV VIRGINIA,DEPT BIOL,CHARLOTTESVILLE,VA 22901, USA.							IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KRETSINGER RH, 1975, BIOCHIM BIOPHYS ACTA, V405, P40, DOI 10.1016/0005-2795(75)90312-8; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; Raghunathan S., UNPUB	8	22	22	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 2	1992	258	5079					50	51		10.1126/science.1439768	http://dx.doi.org/10.1126/science.1439768			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ619	1439768				2022-12-28	WOS:A1992JQ61900023
J	VOLLRATH, D; FOOTE, S; HILTON, A; BROWN, LG; BEERROMERO, P; BOGAN, JS; PAGE, DC				VOLLRATH, D; FOOTE, S; HILTON, A; BROWN, LG; BEERROMERO, P; BOGAN, JS; PAGE, DC			THE HUMAN Y-CHROMOSOME - A 43-INTERVAL MAP BASED ON NATURALLY-OCCURRING DELETIONS	SCIENCE			English	Article							HUMAN X-CHROMOSOME; CONTIGUOUS GENE SYNDROMES; SEX-DETERMINING REGION; DISTAL SHORT ARM; ENZYMATIC AMPLIFICATION; MOLECULAR-DETECTION; TURNER SYNDROME; PAIRING REGION; DNA-SEQUENCES; HUMAN GENOME	A deletion map of the human Y chromosome was constructed by testing 96 individuals with partial Y chromosomes for the presence or absence of many DNA loci. The individuals studied included XX males, XY females, and persons in whom chromosome banding had revealed translocated, deleted, isodicentric, or ring Y chromosomes. Most of the 132 Y chromosomal loci mapped were sequence-tagged sites, detected by means of the polymerase chain reaction. These studies resolved the euchromatic region (short arm, centromere, and proximal long arm) of the Y chromosome into 43 ordered intervals, all defined by naturally occurring chromosomal breakpoints and averaging less than 800 kilobases in length. This deletion map should be useful in identifying Y chromosomal genes, in exploring the origin of chromosomal disorders, and in tracing the evolution of the Y chromosome.	MIT, DEPT BIOL, CAMBRIDGE, MA 02142 USA	Massachusetts Institute of Technology (MIT)	VOLLRATH, D (corresponding author), MIT, WHITEHEAD INST, HOWARD HUGHES RES LABS, 9 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA.		Foote, Simon J/F-2802-2013; Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466; Foote, Simon/0000-0002-9142-2107				AFFARA NA, 1987, NUCLEIC ACIDS RES, V15, P7325, DOI 10.1093/nar/15.18.7325; AFFARA NA, 1986, NUCLEIC ACIDS RES, V14, P5353, DOI 10.1093/nar/14.13.5353; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ALVESALO L, 1981, ANN HUM GENET, V45, P49, DOI 10.1111/j.1469-1809.1981.tb00305.x; ANDERSSON M, 1988, HUM GENET, V79, P2, DOI 10.1007/BF00291700; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; BARDONI B, 1991, GENOMICS, V11, P443, DOI 10.1016/0888-7543(91)90153-6; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; BLAGOWIDOW N, 1989, AM J MED GENET, V34, P159, DOI 10.1002/ajmg.1320340204; BORGAONKAR DS, 1985, Y CHROMOSOME B, P15; BROWN CJ, 1990, AM J HUM GENET, V46, P273; BUHLER EM, 1980, HUM GENET, V55, P145, DOI 10.1007/BF00291764; CANTRELL MA, 1992, GENOMICS, V13, P1255, DOI 10.1016/0888-7543(92)90043-R; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; COOKE HJ, 1984, NATURE, V311, P259, DOI 10.1038/311259a0; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; DAVIS RM, 1981, J MED GENET, V18, P161, DOI 10.1136/jmg.18.3.161; DISTECHE CM, 1986, P NATL ACAD SCI USA, V83, P7841, DOI 10.1073/pnas.83.20.7841; DISTECHE CM, 1986, HUM GENET, V74, P372, DOI 10.1007/BF00280488; FERGUSONSMITH MA, 1987, DEVELOPMENT, V101, P41; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FOOTE S, 1992, GENOMICS, V258, P60; FUSCOE JC, 1986, CYTOGENET CELL GENET, V43, P79, DOI 10.1159/000132301; GOULMY E, 1983, IMMUNOGENETICS, V17, P523, DOI 10.1007/BF00696875; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GREEN ED, 1991, GENOMICS, V11, P548, DOI 10.1016/0888-7543(91)90062-J; GRIFO JA, 1992, JAMA-J AM MED ASSOC, V268, P727, DOI 10.1001/jama.268.6.727; GUIOLI S, 1992, NAT GENET, V1, P337, DOI 10.1038/ng0892-337; INCERTI B, UNPUB NATURE GENET; JACOBS PA, 1966, NATURE, V210, P352, DOI 10.1038/210352a0; KOENIG M, 1985, NUCLEIC ACIDS RES, V13, P5485, DOI 10.1093/nar/13.15.5485; KOTECKI M, 1991, HUM GENET, V87, P234, DOI 10.1007/BF00204192; LINCOLN S, COMMUNICATION; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; MARCUS M, 1976, NATURE, V262, P63, DOI 10.1038/262063a0; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; MULLER U, 1990, HUM GENET, V85, P205; MUNKE M, 1988, HUM GENET, V80, P219, DOI 10.1007/BF01790089; NAKAHORI Y, 1991, GENOMICS, V9, P765, DOI 10.1016/0888-7543(91)90373-M; NUSSBAUM RL, 1986, AM J MED GENET, V23, P457, DOI 10.1002/ajmg.1320230137; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; OREILLY AM, UNPUB; PAGE DC, 1987, DEVELOPMENT, V101, P151; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; PAGE DC, 1990, NATURE, V346, P279, DOI 10.1038/346279a0; PAGE DC, 1986, COLD SPRING HARB SYM, V51, P229, DOI 10.1101/SQB.1986.051.01.028; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHARP CB, 1990, HUM GENET, V85, P330; SILVER J, 1987, MOL CELL BIOL, V7, P1559, DOI 10.1128/MCB.7.4.1559; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; SIMPSON E, 1987, NATURE, V326, P876, DOI 10.1038/326876a0; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SKARE J, 1990, AM J MED GENET, V36, P394, DOI 10.1002/ajmg.1320360405; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; VOGT P, 1991, HUM GENET, V86, P341; WEISSENBACH J, 1991, CYTOGENET CELL GENET, V58, P967, DOI 10.1159/000133184; YEN PH, 1991, P NATL ACAD SCI USA, V88, P8944, DOI 10.1073/pnas.88.20.8944	61	416	456	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	1992	258	5079					52	59		10.1126/science.1439769	http://dx.doi.org/10.1126/science.1439769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ619	1439769				2022-12-28	WOS:A1992JQ61900024
J	BARRETT, JA				BARRETT, JA			ABC OF COLORECTAL DISEASES - COLORECTAL DISORDERS IN ELDERLY PEOPLE	BRITISH MEDICAL JOURNAL			English	Article											BARRETT, JA (corresponding author), CLATTERBRIDGE HOSP,GERIATR MED & REHABIL,WIRRAL,ENGLAND.								0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1992	305	6856					764	766		10.1136/bmj.305.6856.764	http://dx.doi.org/10.1136/bmj.305.6856.764			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ520	1422335	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JQ52000029
J	LEDGER, WJ				LEDGER, WJ			TREATMENT OF PRETERM LABOR WITH THE BETA-ADRENERGIC AGONIST RITODRINE	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											LEDGER, WJ (corresponding author), CORNELL UNIV,MED CTR,NEW YORK HOSP,NEW YORK,NY 10021, USA.								0	0	0	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	1992	327	24					1758	1759						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA897	1435925				2022-12-28	WOS:A1992KA89700019
J	KROENKE, K; LUCAS, CA; ROSENBERG, ML; SCHEROKMAN, B; HERBERS, JE; WEHRLE, PA; BOGGI, JO				KROENKE, K; LUCAS, CA; ROSENBERG, ML; SCHEROKMAN, B; HERBERS, JE; WEHRLE, PA; BOGGI, JO			CAUSES OF PERSISTENT DIZZINESS - A PROSPECTIVE-STUDY OF 100 PATIENTS IN AMBULATORY CARE	ANNALS OF INTERNAL MEDICINE			English	Article						DIZZINESS; AMBULATORY CARE; VESTIBULAR DISEASES; VERTIGO; PSYCHIATRIC STATUS RATING SCALES	DIAGNOSTIC INTERVIEW SCHEDULE; DIZZY PATIENT; GENERAL-POPULATION; MEDICAL OUTCOMES; CLINICAL METHODS; RELIABILITY; SYMPTOMS; VALIDITY; THERAPY; HYPERVENTILATION	Objective: To determine the causes of persistent dizziness in outpatients. Design: Consecutive adult outpatients presenting with a chief complaint of dizziness. Setting: Four clinics (internal medicine, walk-in, emergency room, and neurology) in a teaching hospital. Patients: Of 185 patients presenting during the 10-month study period, 51 (28%) had minimal or no dizziness at 2-week follow-up. Of the remaining 134 patients, 100 completed the study protocol (mean age, 62 years; range, 20 to 85 years). Measurements: Evaluation included a detailed study questionnaire, standardized physical examination, vestibular testing by a neuro-ophthalmologist, laboratory tests, audiometry, and a structured psychiatric interview. Data were abstracted onto a standard form and reviewed by three raters. Raters independently assigned diagnoses using explicit criteria, with the final cause determined by consensus. Results: Primary causes of dizziness included vestibular disorders (54 patients), psychiatric disorders (16 patients), presyncope (6 patients), dysequilibrium (2 patients), and hyperventilation (1 patient); dizziness was multicausal in 13 patients and of unknown cause in 8 patients. Many of those with a single primary cause, however, had at least one other condition contributing to their dizziness; only 52% of patients had a single "pure" cause. Thirty patients had a potentially treatable primary cause, the most common being benign positional vertigo (BPV) (16%) and psychiatric disorders (6%). Central vestibulopathies detected in 10 patients were presumably vascular or idiopathic in origin. No brain tumors or cardiac arrhythmias were found. Conclusions: Vestibular disease and psychiatric disorders are the most common causes of persistent dizziness in outpatients. In about 50% of patients with dizziness, more than one factor causes or aggravates symptoms. Life-threatening causes were rare, even in our elderly population.	UNIFORMED SERV UNIV HLTH SCI, DEPT NEUROL, BETHESDA, MD 20814 USA; WALTER REED ARMY MED CTR, WASHINGTON, DC 20307 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	KROENKE, K (corresponding author), UNIFORMED SERV UNIV HLTH SCI, DEPT MED, 4301 JONES BRIDGE RD, BETHESDA, MD 20814 USA.			Kroenke, Kurt/0000-0002-0114-4669				AFZELIUS LE, 1980, LARYNGOSCOPE, V90, P649; Baloh R.W., 1990, CLIN NEUROPHYSIOL; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; BRANDT T, 1980, ARCH OTOLARYNGOL, V106, P484; Brandt T., 1991, VERTIGO ITS MULTISEN; CLARK PI, 1980, CHEST, V77, P722, DOI 10.1378/chest.77.6.722; DRACHMAN DA, 1972, NEUROLOGY, V22, P323, DOI 10.1212/WNL.22.4.323; FEINSTEIN AR, 1985, J CHRON DIS, V38, P619, DOI 10.1016/0021-9681(85)90016-5; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; HELZER JE, 1985, ARCH GEN PSYCHIAT, V42, P657; HELZER JE, 1987, ARCH GEN PSYCHIAT, V44, P1069; HERR RD, 1989, ANN EMERG MED, V18, P664, DOI 10.1016/S0196-0644(89)80524-4; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; HOLT PE, 1989, BEHAV RES THER, V27, P453, DOI 10.1016/0005-7967(89)90016-8; JOHNSON JE, 1988, MIL MED, V153, P21; KORAN LM, 1975, NEW ENGL J MED, V293, P695, DOI 10.1056/NEJM197510022931405; KORAN LM, 1975, NEW ENGL J MED, V293, P642, DOI 10.1056/NEJM197509252931307; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; KROENKE K, 1990, ARCH INTERN MED, V150, P1685, DOI 10.1001/archinte.150.8.1685; KROENKE K, 1991, CLIN RES, V39, pA579; KROENKE K, 1989, JAMA-J AM MED ASSOC, V262, P914; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MADLONKAY DJ, 1985, J FAM PRACTICE, V21, P109; MAGARIAN GJ, 1982, MEDICINE, V61, P219, DOI 10.1097/00005792-198207000-00002; NEDZELSKI JM, 1986, J OTOLARYNGOL, V15, P101; OJALA M, 1988, ACTA NEUROL SCAND, V78, P26, DOI 10.1111/j.1600-0404.1988.tb03614.x; REILLY BM, 1991, PRACTICAL STRATEGIES, P162; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; ROBINS LN, PSYCHIATRIC DISORDER, P991; SKIENDZIELEWSKI JJ, 1980, ANN EMERG MED, V9, P353, DOI 10.1016/S0196-0644(80)80111-9; SLOANE P, 1989, J AM GERIATR SOC, V37, P101, DOI 10.1111/j.1532-5415.1989.tb05867.x; SLOANE PD, 1989, J FAM PRACTICE, V29, P33; Spitzer R., 1988, STRUCTURED CLIN INTE; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914	36	187	192	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					898	904		10.7326/0003-4819-117-11-898	http://dx.doi.org/10.7326/0003-4819-117-11-898			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443950				2022-12-28	WOS:A1992JZ27600004
J	DONALDSON, JG; FINAZZI, D; KLAUSNER, RD				DONALDSON, JG; FINAZZI, D; KLAUSNER, RD			BREFELDIN-A INHIBITS GOLGI MEMBRANE-CATALYZED EXCHANGE OF GUANINE-NUCLEOTIDE ONTO ARF PROTEIN	NATURE			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING-PROTEIN; TRANSPORT; APPARATUS; VESICLES; COFACTOR; COMPLEX; COP	THE fungal metabolite brefeldin A is a powerful tool for investigating membrane traffic in eukaryotic cells1. The effects of brefeldin A on traffic are partly explained by its ability to prevent binding of cytosolic coat proteins onto membranes2-5. The non-clathrin coatomer complex6,7 binds reversibly to Golgi membranes in a GTP-controlled cycle8-10. The low-molecular-mass GTP-binding protein ADP-ribosylation factor (ARF), which also associates reversibly with Golgi membranes11,12, is required for coatomer binding13 and probably accounts for the control by guanine nucleotide of the coatomer-membrane interaction. Brefeldin A prevents the assembly of coatomer onto the membrane by inhibiting the GTP-dependent interaction of ARF with the Golgi membrane13, but the nature of this interaction has not been established. Here we demonstrate that Golgi membranes can specifically catalyse the exchange of GTP onto ARF and that brefeldin A prevents this function.			DONALDSON, JG (corresponding author), NICHHD, CELL BIOL & METAB BRANCH, BETHESDA, MD 20892 USA.		finazzi, dario/GYV-1567-2022	Finazzi, Dario/0000-0001-5176-2839				BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; BALCH WE, 1992, J BIOL CHEM, V267, P13053; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; KAHN RA, 1991, METHOD ENZYMOL, V195, P233; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KIKUCHI A, 1992, J BIOL CHEM, V267, P14611; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; NARULA N, 1992, J CELL BIOL, V117, P27, DOI 10.1083/jcb.117.1.27; ORCI L, 1991, CELL, V64, P1183; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; TAYLOR TC, 1992, CELL, V70, P69, DOI 10.1016/0092-8674(92)90534-J; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WEISS O, 1989, J BIOL CHEM, V264, P21066	26	638	648	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	1992	360	6402					350	352		10.1038/360350a0	http://dx.doi.org/10.1038/360350a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448151				2022-12-28	WOS:A1992JZ63000053
J	AKSEL, S				AKSEL, S			IMMUNOLOGICAL ASPECTS OF REPRODUCTIVE DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HISTOCOMPATIBILITY COMPLEX ANTIGENS; SPERM ANTIBODIES; UNEXPLAINED INFERTILITY; AUTOIMMUNE-DISEASE; WOMEN; AUTOANTIBODIES; PREGNANCY; TROPHOBLAST; ENDOMETRIOSIS; ABORTION				AKSEL, S (corresponding author), UNIV SO ALABAMA,COLL MED,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,MOBILE,AL 36688, USA.							BEER AE, 1981, AM J OBSTET GYNECOL, V141, P987; BEER AE, 1988, IMMUNOLOGICAL DISEAS, P329; BRONSON RA, 1982, FERTIL STERIL, V38, P724; BULMER JN, 1985, PLACENTA, V6, P127, DOI 10.1016/S0143-4004(85)80063-1; COULAM CB, 1988, AM J OBSTET GYNECOL, V158, P1374, DOI 10.1016/0002-9378(88)90370-5; COWCHOCK S, 1984, AM J OBSTET GYNECOL, V150, P367, DOI 10.1016/S0002-9378(84)80140-4; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; ELROEIY A, 1988, AM J OBSTET GYNECOL, V158, P596, DOI 10.1016/0002-9378(88)90037-3; GIMOVSKY ML, 1984, OBSTET GYNECOL, V63, P686; GLEICHER N, 1989, AM J OBSTET GYNECOL, V160, P1376, DOI 10.1016/0002-9378(89)90858-2; GLEICHER N, 1987, OBSTET GYNECOL, V70, P115; HEAD JR, 1986, AM J REPROD IMMUNOL, V10, P76; MATHUR S, 1983, FERTIL STERIL, V39, P343; MCINTYRE JA, 1986, CLIN OBSTET GYNECOL, V29, P976, DOI 10.1097/00003081-198612000-00021; MEYER WR, 1990, OBSTET GYNECOL, V75, P795; MONCAYO H, 1989, J CLIN INVEST, V84, P1857, DOI 10.1172/JCI114372; MOWBRAY JF, 1985, CLIN EXP IMMUNOL, V60, P1; OOSTERLYNCK DJ, 1991, FERTIL STERIL, V56, P45; PRESTI ME, 1989, ANN ALLERGY, V63, P477; REDMAN CWG, 1984, IMMUNOLOGY, V52, P457; REDMAN CWG, 1983, AM J REPROD IMMUNOL, V3, P175, DOI 10.1111/j.1600-0897.1983.tb00241.x; ROGER JC, 1985, TRANSPLANTATION, V40, P372; SACHS ES, 1985, OBSTET GYNECOL, V65, P375; SCOTT JR, 1987, OBSTET GYNECOL, V70, P645; STEELE RW, 1984, AM J REPROD IMMUNOL, V6, P33, DOI 10.1111/j.1600-0897.1984.tb00106.x; SUCIUFOCA N, 1983, P NATL ACAD SCI-BIOL, V80, P830, DOI 10.1073/pnas.80.3.830; TAYLOR PV, 1989, AM J OBSTET GYNECOL, V161, P377, DOI 10.1016/0002-9378(89)90524-3; TEZON JG, 1985, BIOL REPROD, V32, P591, DOI 10.1095/biolreprod32.3.591; WITKIN SS, 1988, AM J OBSTET GYNECOL, V158, P59, DOI 10.1016/0002-9378(88)90776-4	29	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2930	2934		10.1001/jama.268.20.2930	http://dx.doi.org/10.1001/jama.268.20.2930			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433710				2022-12-28	WOS:A1992JY66800019
J	GU, Y; NAKAMURA, T; ALDER, H; PRASAD, R; CANAANI, O; CIMINO, G; CROCE, CM; CANAANI, E				GU, Y; NAKAMURA, T; ALDER, H; PRASAD, R; CANAANI, O; CIMINO, G; CROCE, CM; CANAANI, E			THE T(4-11) CHROMOSOME-TRANSLOCATION OF HUMAN ACUTE LEUKEMIAS FUSES THE ALL-1 GENE, RELATED TO DROSOPHILA-TRITHORAX, TO THE AF-4 GENE	CELL			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; FUSION MESSENGER-RNA; DNA-BINDING DOMAIN; TRANSCRIPTION FACTOR; BITHORAX COMPLEX; BCR SEQUENCES; CELL-LINE; RAR-ALPHA; EXPRESSION; LOCUS	The ALL-1 gene located at human chromosome 11 band q23 is rearranged in acute leukemias with interstitial deletions or reciprocal translocations between this region and chromosomes 1, 4, 6, 9, 10, or 19. The gene spans approximately 100 kb of DNA and contains at least 21 exons. It encodes a protein of more than 3910 amino acids containing three regions with homology to sequences within the Drosophila trithorax gene, including cysteine-rich regions that can be folded into six zinc finger-like domains. The breakpoint cluster region within ALL-1 spans 8 kb and encompasses several small exons, most of which begin in the same phase of the open reading frame. The t(4;11) chromosome translocation results in two reciprocal fusion products coding for chimeric proteins derived from ALL-1 and from a gene on chromosome 4. This suggests that each 11q23 abnormality gives rise to a specific oncogenic fusion protein.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19107	Jefferson University	GU, Y (corresponding author), THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON CANC INST,JEFFERSON CANC CTR,PHILADELPHIA,PA 19107, USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; CIMINO, Giuseppe/0000-0002-7781-0816	NATIONAL CANCER INSTITUTE [R35CA039860] Funding Source: NIH RePORTER; NCI NIH HHS [CA39860] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS MD, 1992, NATURE, V355, P6322; CAPDEVILA MP, 1981, ROUX ARCH DEV BIOL, V190, P339, DOI 10.1007/BF00863271; CHU ML, 1990, EMBO J, V9, P985; CIMINO G, 1992, CANCER RES, V52, P3811; CIMINO G, 1991, CANCER RES, V51, P6712; COHEN A, 1991, BLOOD, V78, P94; CROCE CM, 1987, CELL, V49, P155, DOI 10.1016/0092-8674(87)90552-6; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; ERIKSON J, 1986, P NATL ACAD SCI USA, V83, P1807, DOI 10.1073/pnas.83.6.1807; GALE RP, 1984, P NATL ACAD SCI-BIOL, V81, P5648, DOI 10.1073/pnas.81.18.5648; GU Y, 1992, P NATL ACAD SCI USA, V89, P10464, DOI 10.1073/pnas.89.21.10464; HEIM S, 1987, CANCER CYTOGENETICS; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; INGHAM PW, 1985, COLD SPRING HARB SYM, V50, P201, DOI 10.1101/SQB.1985.050.01.026; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; LANGE B, 1987, BLOOD, V70, P192; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MCKEON J, 1991, ROUX ARCH DEV BIOL, V199, P387, DOI 10.1007/BF01705848; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553, DOI 10.1128/MCB.11.3.1553; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MOZER BA, 1989, P NATL ACAD SCI USA, V86, P3738, DOI 10.1073/pnas.86.10.3738; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; RABBITT RH, 1991, CELL, V67, P641; ROWLEY JD, 1990, P NATL ACAD SCI USA, V87, P9358, DOI 10.1073/pnas.87.23.9358; SAITO H, 1983, P NATL ACAD SCI-BIOL, V80, P7476, DOI 10.1073/pnas.80.24.7476; SAVAGE PD, 1988, CYTOGENET CELL GENET, V49, P289, DOI 10.1159/000132680; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; STONG RC, 1985, BLOOD, V66, P439; STONG RC, 1986, BLOOD, V67, P391; VONLINDERN M, 1990, MOL CELL BIOL, V10, P4016, DOI 10.1128/MCB.10.8.4016; WEDEEN C, 1986, CELL, V44, P739, DOI 10.1016/0092-8674(86)90840-8; WEI S, 1990, CANCER GENET CYTOGEN, V46, P1, DOI 10.1016/0165-4608(90)90002-R; YUNIS JJ, 1989, GENOMICS, V5, P84, DOI 10.1016/0888-7543(89)90090-6; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	39	832	876	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					701	708		10.1016/0092-8674(92)90603-A	http://dx.doi.org/10.1016/0092-8674(92)90603-A			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423625				2022-12-28	WOS:A1992JY67600017
J	HANDELI, S; WEINTRAUB, H				HANDELI, S; WEINTRAUB, H			THE TS41 MUTATION IN CHINESE-HAMSTER CELLS LEADS TO SUCCESSIVE S PHASES IN THE ABSENCE OF INTERVENING G2, M, AND G1	CELL			English	Article							RETINOBLASTOMA GENE-PRODUCT; DNA-REPLICATION; PROTEIN-KINASE; NEGATIVE CONTROL; FISSION YEAST; CYCLE CONTROL; MITOSIS; COMPLEX; CHECKPOINTS; EXPRESSION	The ts41 mutation of Chinese hamster cells was first isolated and characterized by Hirschberg and Marcus (1982) who showed that at nonpermissive temperature, cells accumulate up to 16C equivalents of DNA. Here we show that the mutation is recessive and at nonpermissive temperature, cells replicate their genome normally, but instead of going on into G2, M, and G1, they pass directly into a second S phase. Entry into a second S phase does not require serum nor is it inhibited by G2 checkpoints or mitotic inhibitors. Temperature-shift experiments suggest that the ts41 gene product participates in two functions in the cell cycle: entry into mitosis and inhibition of entry into S phase. The ts41 mutation seems to define a class of cell cycle mutant that couples the sequential events of DNA replication and mitosis.			HANDELI, S (corresponding author), FRED HUTCHINSON CANC RES CTR,HOWARD HUGHES MED INST LAB,SEATTLE,WA 98104, USA.							ANDEREASSEN PR, 1991, J CELL SCI, V100, P299; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; BEACH D, 1982, NATURE, V300, P706, DOI 10.1038/300706a0; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BREWER EN, 1968, EXP CELL RES, V49, P79, DOI 10.1016/0014-4827(68)90521-1; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; CHARRON M, 1990, BIOCHEMISTRY-US, V29, P9531, DOI 10.1021/bi00493a006; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CROSS F, 1989, ANNU REV CELL BIOL, V5, P341; CROSS FR, 1990, MOL CELL BIOL, V10, P6482, DOI 10.1128/MCB.10.12.6482; DAS M, 1981, P NATL ACAD SCI-BIOL, V78, P5677, DOI 10.1073/pnas.78.9.5677; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P271, DOI 10.1007/BF01538965; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DRAETTA G, 1989, J CELL SCI S, V12, P21; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; FAINSOD A, 1987, MOL CELL BIOL, V7, P775, DOI 10.1128/MCB.7.2.775; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FORSBURG SL, 1991, NATURE, V351, P245, DOI 10.1038/351245a0; FREEMAN M, 1987, GENE DEV, V1, P924, DOI 10.1101/gad.1.9.924; HAND R, 1978, CELL, V15, P317, DOI 10.1016/0092-8674(78)90001-6; HANKS SK, 1980, J CELL BIOL, V87, P285, DOI 10.1083/jcb.87.1.285; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HIRAI K, 1971, J VIROL, V8, P828, DOI 10.1128/JVI.8.6.828-835.1971; HIRSCHBERG J, 1982, J CELL PHYSIOL, V113, P159, DOI 10.1002/jcp.1041130125; HOLLIDAY R, 1990, New Biologist, V2, P719; HORAN PK, 1974, INT J CANCER, V14, P514, DOI 10.1002/ijc.2910140411; HOWE JA, 1992, VIROLOGY, V186, P15, DOI 10.1016/0042-6822(92)90057-V; HUNT T, 1991, NATURE, V350, P462, DOI 10.1038/350462a0; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; KLEVECZ RR, 1982, EXP CELL RES, V140, P307, DOI 10.1016/0014-4827(82)90119-7; KULKA RG, 1988, J BIOL CHEM, V263, P15726; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; LEHMAN JM, 1970, J VIROL, V6, P738, DOI 10.1128/JVI.6.6.738-749.1970; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; MORAN B, 1988, MOL CELL BIOL, V8, P1756, DOI 10.1128/MCB.8.4.1756; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; ORNITZ DM, 1987, SCIENCE, V238, P188, DOI 10.1126/science.2821617; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; RAO AP, 1976, J NATL CANCER I, V57, P11399; Rao P.N., 1982, PREMATURE CHROMOSOME, P1; REED SI, 1980, GENETICS, V95, P561; ROBERTS JM, 1986, CELL, V46, P741, DOI 10.1016/0092-8674(86)90350-8; ROBERTS JM, 1988, CELL, V52, P397, DOI 10.1016/S0092-8674(88)80032-1; SHAMANSKI FL, 1991, CELL, V66, P1289, DOI 10.1016/0092-8674(91)90050-9; SHERLINE P, 1984, EXP CELL RES, V153, P109, DOI 10.1016/0014-4827(84)90453-1; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; SMITH AV, 1991, DEVELOPMENT, V112, P997; USUI T, 1991, J CELL BIOL, V115, P1275, DOI 10.1083/jcb.115.5.1275; VARSHAVSKY A, 1983, MECHANISMS DNA REPLI, P463; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; ZETTERBERG A, 1991, COLD SH Q B, V56, P137	59	87	89	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					599	611		10.1016/0092-8674(92)90594-3	http://dx.doi.org/10.1016/0092-8674(92)90594-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423617				2022-12-28	WOS:A1992JY67600008
J	RAMACHANDRAN, VS; ROGERSRAMACHANDRAN, D; STEWART, M				RAMACHANDRAN, VS; ROGERSRAMACHANDRAN, D; STEWART, M			PERCEPTUAL CORRELATES OF MASSIVE CORTICAL REORGANIZATION	SCIENCE			English	Article											RAMACHANDRAN, VS (corresponding author), UNIV CALIF SAN DIEGO,DEPT PSYCHOL,BRAIN & PERCEPT LAB,LA JOLLA,CA 92093, USA.							MELZACK R, 1992, SCI AM, V266, P120, DOI 10.1038/scientificamerican0492-120; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; RAMACHANDRAN VS, IN PRESS SOC NEUR AB; WALL PD, 1977, PHILOS T R SOC B, V278, P361, DOI 10.1098/rstb.1977.0048	6	301	319	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1159	1160		10.1126/science.1439826	http://dx.doi.org/10.1126/science.1439826			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439826	Green Submitted			2022-12-28	WOS:A1992JX85200035
J	OKSENBERG, D; MARSTERS, SA; ODOWD, BF; JIN, H; HAVLIK, S; PEROUTKA, SJ; ASHKENAZI, A				OKSENBERG, D; MARSTERS, SA; ODOWD, BF; JIN, H; HAVLIK, S; PEROUTKA, SJ; ASHKENAZI, A			A SINGLE AMINO-ACID DIFFERENCE CONFERS MAJOR PHARMACOLOGICAL VARIATION BETWEEN HUMAN AND RODENT 5-HT(1B) RECEPTORS	NATURE			English	Article							<H-3>5-HYDROXYTRYPTAMINE BINDING-SITES; RAT-BRAIN; I125 IODOCYANOPINDOLOL; CLONING; GENE	NEUROPSYCHIATRIC disorders such as anxiety, depression, migraine, vasospasm and epilepsy may involve different subtypes of the 5-hydroxytryptamine (5-HT) receptor1,2. The 1B subtype, which has a unique pharmacology, was first identified in rodent brain3-7. But a similar receptor could not be detected in human brain6, suggesting the absence in man of a receptor with equivalent function. Recently a human receptor gene was isolated (designated 5-HT1B receptor8,9, 5-HT1Dbeta receptor10,11, or S12 receptor12) which shares 93% identity of the deduced protein sequence with rodent 5-HT1B receptors13-15. Although this receptor is identical to rodent 5-HT1B receptors in binding to 5-HT, it differs profoundly in binding to many drugs. Here we show that replacement of a single amino acid in the human receptor (threonine at residue 355) with a corresponding asparagine found in rodent 5-HT1B receptors renders the pharmacology of the receptors essentially identical. This demonstrates that the human gene does indeed encode a 1B receptor, which is likely to have the same biological functions as the rodent 5-HT1B receptor. In addition, these findings show that minute sequence differences between homologues of the same receptor from different species can cause large pharmacological variation. Thus, drug-receptor interactions should not be extrapolated from animal to human species without verification.	GENENTECH INC,DEPT NEUROSCI,SAN FRANCISCO,CA 94080; STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROL,STANFORD,CA 94305; UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A8,ONTARIO,CANADA	Roche Holding; Genentech; Stanford University; University of Toronto	OKSENBERG, D (corresponding author), GENENTECH INC,DEPT PULM RES & GENE THERAPY,460 POINT SAN BRUNO BLVD,SAN FRANCISCO,CA 94080, USA.		Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				ADHAM N, 1992, MOL PHARMACOL, V41, P1; ALBERT PR, 1990, J BIOL CHEM, V265, P5825; ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; DEMCHYSHYN L, 1992, P NATL ACAD SCI USA, V89, P5522, DOI 10.1073/pnas.89.12.5522; FARGIN A, 1989, J BIOL CHEM, V264, P14848; FINDLAY J, 1990, TRENDS PHARMACOL SCI, V11, P492, DOI 10.1016/0165-6147(90)90050-I; GUAN XM, 1992, MOL PHARMACOL, V41, P695; HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143; HAMBLIN MW, 1992, BIOCHEM BIOPH RES CO, V184, P752, DOI 10.1016/0006-291X(92)90654-4; HARTIG P, 1990, NEUROPSYCHOPHARMACOL, V3, P335; HOYER D, 1989, TRENDS PHARMACOL SCI, V10, P130, DOI 10.1016/0165-6147(89)90159-4; HOYER D, 1985, EUR J PHARMACOL, V118, P13, DOI 10.1016/0014-2999(85)90658-2; HOYER D, 1985, EUR J PHARMACOL, V118, P1, DOI 10.1016/0014-2999(85)90657-0; JIN H, 1992, J BIOL CHEM, V267, P5735; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; MAROTEAUX L, 1992, P NATL ACAD SCI USA, V89, P3020, DOI 10.1073/pnas.89.7.3020; MCPHERSON GA, 1983, COMPUT PROG BIOMED, V17, P107, DOI 10.1016/0010-468X(83)90031-4; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; OLAVLEVY F, 1992, J BIOL CHEM, V267, P7553; PEDIGO NW, 1981, J NEUROCHEM, V36, P220, DOI 10.1111/j.1471-4159.1981.tb02397.x; PEROUTKA S, 1992, J NEUROPHARMACOLOGY, V31, P609; SCHNELLMANN RG, 1984, J NEUROCHEM, V42, P65, DOI 10.1111/j.1471-4159.1984.tb09699.x; SURYANARAYANA A, 1991, J BIOL CHEM, V266, P5488; VOIGT MM, 1991, EMBO J, V10, P4017, DOI 10.1002/j.1460-2075.1991.tb04977.x; WEINSHANK RL, 1992, P NATL ACAD SCI USA, V89, P3630, DOI 10.1073/pnas.89.8.3630	25	288	308	1	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 12	1992	360	6400					161	163		10.1038/360161a0	http://dx.doi.org/10.1038/360161a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX752	1436092				2022-12-28	WOS:A1992JX75200060
J	STRICKLAND, S; RICHARDS, WG				STRICKLAND, S; RICHARDS, WG			INVASION OF THE TROPHOBLASTS	CELL			English	Review							PLASMINOGEN-ACTIVATOR; ALPHA-2-MACROGLOBULIN RECEPTOR; EXPRESSION; INHIBITOR; IMPLANTATION; PROTEOLYSIS; MOLECULE; EMBRYOS		SUNY STONY BROOK,PROGRAM GENET,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	STRICKLAND, S (corresponding author), SUNY STONY BROOK,DEPT PHARMACOL,STONY BROOK,NY 11794, USA.							AXELROD HR, 1985, DEV BIOL, V108, P185, DOI 10.1016/0012-1606(85)90021-1; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; BRENNER CA, 1989, GENE DEV, V3, P848, DOI 10.1101/gad.3.6.848; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; FLAUMENHAFT R, 1992, J CELL BIOL, V118, P901, DOI 10.1083/jcb.118.4.901; GRAHAM CH, 1992, BIOL REPROD, V46, P5631; HERZ J, 1991, J BIOL CHEM, V266, P21232; HERZ J, 1992, TRENDS BIOCHEM SCI, V17, P72; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LAIHO M, 1989, CANCER RES, V49, P2533; LALA PK, 1990, CANCER METAST REV, V9, P369, DOI 10.1007/BF00049525; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MANOVA K, 1992, MECH DEVELOP, V36, P141, DOI 10.1016/0925-4773(92)90065-R; MULLINS DE, 1980, CELL, V20, P865, DOI 10.1016/0092-8674(80)90333-5; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; POLLARD JW, 1991, DEV BIOL, V148, P273, DOI 10.1016/0012-1606(91)90336-2; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; SAPPINO AP, 1989, J CELL BIOL, V109, P2471, DOI 10.1083/jcb.109.5.2471; SMITH AG, 1992, DEV BIOL, V151, P339, DOI 10.1016/0012-1606(92)90174-F; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; STRICKLAND S, 1976, CELL, V9, P231, DOI 10.1016/0092-8674(76)90114-8; TESTA JE, 1990, CANCER METAST REV, V9, P353, DOI 10.1007/BF00049524; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; ZINI JM, 1992, BLOOD, V79, P2917	27	293	301	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					355	357		10.1016/0092-8674(92)90503-5	http://dx.doi.org/10.1016/0092-8674(92)90503-5			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423599				2022-12-28	WOS:A1992JW43500001
J	ILIFFE, S; TAI, SS; HAINES, A; GALLIVAN, S; GOLDENBERG, E; BOOROFF, A; MORGAN, P				ILIFFE, S; TAI, SS; HAINES, A; GALLIVAN, S; GOLDENBERG, E; BOOROFF, A; MORGAN, P			ARE ELDERLY PEOPLE LIVING ALONE AN AT RISK GROUP	BRITISH MEDICAL JOURNAL			English	Article								Objective-To test the hypothesis that elderly people living alone are an at risk group with a high level of morbidity that makes high demands on health and social services. Design-Secondary analysis of data from a community survey of 239 people aged 75 and over, identified from general practitioners' age-sex registers. Setting-Nine practices in the London boroughs of Brent and Islington. Main outcome measures-Scores on the minimental state examination; stated satisfaction with life; assessment of mobility; numbers of diagnoses of major physical problems; numbers of prescribed drugs taken; urinary incontinence; alcohol consumption; contacts with general practitioners and hospital outpatient and inpatient services; contact with community health and social services. Results-There were significantly more women among those living alone (93/120 (78%) v 63/119 (53%); p<0.0005) and the median age of elderly people living alone was higher (81 v 80; p<0.04). Those living alone and those living with others showed no significant differences in measures of cognitive impairment, numbers of major physical diagnoses, impaired mobility, or use of general practitioner or hospital services. Stated satisfaction with life was somewhat higher in those living alone. Elderly people living alone were significantly more likely to have contact with chiropody, home help, and meals on wheels services and less likely to have someone they could contact in an emergency or at night. Living alone increased the likelihood of contact with one or more community health professionals (district nurses, health visitors, or chiropodists) considered as a group and also increased the likelihood of contact with social services as a whole. There was a tendency for more of those living alone than those living with others to have home visits from their general practitioners, but there were no significant differences in contact with hospital services between the two groups. Conclusions-Elderly people living alone do not have an excess of morbidity compared with those living with others and do not seem to be an at risk group requiring specifically targeted assessments. More help is needed to provide elderly people living alone with a point of contact in case of emergency.	UNIV COLL & MIDDLESEX SCH MED,DEPT PRIMARY HLTH CARE,LONDON,ENGLAND; UNIV LONDON UNIV COLL,CLIN OPERAT RES UNIT,LONDON WC1E 6BT,ENGLAND	University of London; University College London; University of London; University College London			Iliffe, Steve/L-8379-2019	Haines, Andy/0000-0002-8053-4605; Iliffe, Stephen/0000-0003-2806-3997				Altman DG, 1991, PRACTICAL STATISTICS; ARMITAGE P, 1991, STATISTICAL METHODS; BEBBINGTON AC, 1980, SOC POLICY ADMIN, V13, P114; CARRHILL RA, 1991, BRIT MED J, V302, P393, DOI 10.1136/bmj.302.6773.393; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HUNT A, 1978, ELDERLY HOME; ILIFFE S, 1990, BRIT J GEN PRACT, V40, P277; JARMAN B, 1983, BRIT MED J, V286, P1705, DOI 10.1136/bmj.286.6379.1705; JARMAN B, 1990, 22 IMP COLL SCI TECH; LEVIN E, 1989, FAMILIES SERVICES CO; OCONNOR DW, 1991, ACTA PSYCHIAT SCAND, V83, P41, DOI 10.1111/j.1600-0447.1991.tb05509.x; PERKINS ER, 1989, PREVENTIVE CARE ELDE; POWER M, 1979, USE VOLUNTEERS HOME, P69; QURESHI H, 1987, AGEING SOCIAL POLICY; TAYLOR RC, 1983, J ROY COLL GEN PRACT, V33, P699; TAYLOR RC, 1987, 35 ROYAL COLL GEN PR; TINKER A, 1984, ELDERLY MODERN SOC; TUNSTALL J, 1966, OLD ALONE; VICTOR CR, 1991, HLTH HLTH CARE LATER; WALLACE P, 1985, BRIT MED J, V290, P1949, DOI 10.1136/bmj.290.6486.1949; 1990, RCGP45 ROYAL COLL GE; 1990, NEW CONTRACT GENERAL; 1989, GENERAL HOUSEHOLD SU; 1977, PREVENTION MENTAL DI	24	51	52	1	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 24	1992	305	6860					1001	1004		10.1136/bmj.305.6860.1001	http://dx.doi.org/10.1136/bmj.305.6860.1001			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JV776	1458108	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JV77600034
J	DERRICK, JP; WIGLEY, DB				DERRICK, JP; WIGLEY, DB			CRYSTAL-STRUCTURE OF A STREPTOCOCCAL PROTEIN-G DOMAIN BOUND TO AN FAB FRAGMENT	NATURE			English	Article							BINDING DOMAIN; IGG; RECOGNITION; REFINEMENT; SITES	PROTEIN G is a cell-surface protein from Streptococcus1,2 which binds to IgG molecules from a wide range of species with an affinity comparable to that of antigen3,4. The high affinity of protein G for the Fab portion of IgG poses a particular challenge in molecular recognition, given the variability of heavy chain subclass, light chain type and complementarity-determining regions. Here we report the crystal structure of a complex between a protein G domain and an immunoglobulin Fab fragment. An outer beta-strand in the protein G domain forms an antiparallel interaction with the last beta-strand in the constant heavy chain domain of the immunoglobulin, thus extending the beta-sheet into the protein G. The interaction between secondary structural elements in Fab and protein G provides an ingenious solution to the problem of maintaining a high affinity for many different IgG molecules. The structure also contrasts with Fab-antigen complexes, in which all contacts with antigen are mediated by the variable regions of the antibody, and to our knowledge provides the first details of interaction of the constant regions of Fab with another protein.	UNIV YORK, DEPT CHEM, YORK YO1 5DD, N YORKSHIRE, ENGLAND	University of York - UK	DERRICK, JP (corresponding author), UNIV LEICESTER, DEPT BIOCHEM, LEICESTER LE1 7RH, ENGLAND.			Derrick, Jeremy/0000-0002-4350-5354	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BJORCK L, 1990, P113; BJORCK L, 1984, J IMMUNOL, V133, P969; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1990, X PLOR MANUAL VERSIO; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DERRICK JP, 1992, J MOL BIOL, V227, P1253, DOI 10.1016/0022-2836(92)90535-R; FAHNESTOCK SR, 1990, BACTERIAL IMMUNOGLOB, V1, P133; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Hendrickson W. A., 1981, BIOMOLECULAR STRUCTU, V1, P43; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES AT, 1978, J APPL CRYSTALLOGR A, V43, P489; LIAN LY, 1991, BIOCHEMISTRY-US, V30, P5335, DOI 10.1021/bi00236a002; MYHRE E B, 1990, P243; SAWYER JR, 1991, PROTEIN ENG, V4, P947, DOI 10.1093/protein/4.8.947; SKERRA A, 1991, PROTEIN ENG, V4, P971, DOI 10.1093/protein/4.8.971; STONE GC, 1989, J IMMUNOL, V143, P565	19	153	167	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	1992	359	6397					752	754		10.1038/359752a0	http://dx.doi.org/10.1038/359752a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436040				2022-12-28	WOS:A1992JU65000064
J	BUSH, G; CLINTON, B				BUSH, G; CLINTON, B			SCIENCE POLICY - THE CANDIDATES RESPONSE	SCIENCE			English	Editorial Material									OFF GOVERNOR,LITTLE ROCK,AR										0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					384	&						0	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411532				2022-12-28	WOS:A1992JT77500009
J	MCCARTHY, M				MCCARTHY, M			DO CYCLE HELMETS PREVENT SERIOUS HEAD-INJURY - CYCLING WITHOUT HELMETS	BRITISH MEDICAL JOURNAL			English	Article							BICYCLE				MCCARTHY, M (corresponding author), BLOOMSBURY & ISLINGTON HLTH AUTHOR,PUBL HLTH,LONDON NW1 2LJ,ENGLAND.		McCarthy, Mark/C-1117-2009					ADAMS M, 1990, CAPITAL KILLER AIR P; BULL JP, 1988, BRIT MED J, V296, P1144, DOI 10.1136/bmj.296.6630.1144; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; HAMMER M, 1987, WHEELS WHEELS STUDY; MCCARTHY M, 1991, PUBLIC HEALTH, V105, P327, DOI 10.1016/S0033-3506(05)80218-5; Rogers R, 1992, NEW LONDON; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; 1991, HLTH MOVE POLICIES P; 1991, ROAD ACCIDENTS GREAT; 1990, CATALOGUE, P328; 1992, CYCLING HLTH SAFETY; 1988, LANCET, V1, P159	12	23	23	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					881	882		10.1136/bmj.305.6858.881	http://dx.doi.org/10.1136/bmj.305.6858.881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422407	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JT77700035
J	CHUMAKOV, I; RIGAULT, P; GUILLOU, S; OUGEN, P; BILLAUT, A; GUASCONI, G; GERVY, P; LEGALL, I; SOULARUE, P; GRINAS, L; BOUGUELERET, L; BELLANNECHANTELOT, C; LACROIX, B; BARILLOT, E; GESNOUIN, P; POOK, S; VAYSSEIX, G; FRELAT, G; SCHMITZ, A; SAMBUCY, JL; BOSCH, A; ESTIVILL, X; WEISSENBACH, J; VIGNAL, A; RIETHMAN, H; COX, D; PATTERSON, D; GARDINER, K; HATTORI, M; SAKAKI, Y; ICHIKAWA, H; OHKI, M; LEPASLIER, D; HEILIG, R; ANTONARAKIS, S; COHEN, D				CHUMAKOV, I; RIGAULT, P; GUILLOU, S; OUGEN, P; BILLAUT, A; GUASCONI, G; GERVY, P; LEGALL, I; SOULARUE, P; GRINAS, L; BOUGUELERET, L; BELLANNECHANTELOT, C; LACROIX, B; BARILLOT, E; GESNOUIN, P; POOK, S; VAYSSEIX, G; FRELAT, G; SCHMITZ, A; SAMBUCY, JL; BOSCH, A; ESTIVILL, X; WEISSENBACH, J; VIGNAL, A; RIETHMAN, H; COX, D; PATTERSON, D; GARDINER, K; HATTORI, M; SAKAKI, Y; ICHIKAWA, H; OHKI, M; LEPASLIER, D; HEILIG, R; ANTONARAKIS, S; COHEN, D			CONTINUUM OF OVERLAPPING CLONES SPANNING THE ENTIRE HUMAN CHROMOSOME-21Q	NATURE			English	Article							GENETIC-LINKAGE MAP; HUMAN GENOME; PHYSICAL MAP; YEAST; DNA; HYBRIDIZATION; CONSTRUCTION; MARKERS; BANDS	A continuous array of overlapping clones covering the entire human chromosome 21q was constructed from human yeast artificial chromosome libraries using sequence-tagged sites as landmarks specifically detected by polymerase chain reaction. The yeast artificial chromosome contiguous unit starts with pericentromeric and ends with subtelomeric loci of 21q. The resulting order of sequence-tagged sites is consistent with other physical and genetic mapping data. This set of overlapping clones will promote our knowledge of the structure of this chromosome and the function of its genes.	CTR ETUD POLYMORPHISME HUMAIN,27 RUE JULIETTE DODU,F-75010 PARIS,FRANCE; GENETHON,F-91002 EVRY,FRANCE; CEA,F-92260 FONTENAY ROSES,FRANCE; HOSP DURAN & REYNALS,INST RECERCA ONCOL,E-08907 BARCELONA,SPAIN; INST PASTEUR,CNRS,URA 1445,F-75724 PARIS,FRANCE; UNIV CALIF SAN FRANCISCO,NEUROGENET LAB,SAN FRANCISCO,CA 94143; ELEANOR ROOSEVELT INST,DENVER,CO 80206; WISTAR INST,PHILADELPHIA,PA 19104; UNIV TOKYO,INST MED SCI,TOKYO 108,JAPAN; LAB GENET MOLEC EUCARYOTES,INSERM,U184,STRASBOURG,FRANCE; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205; SAITAMA CANC CTR,RES INST,INA,SAITAMA 362,JAPAN	CEA; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California San Francisco; The Wistar Institute; University of Tokyo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University			Bosch, Assumpcio/C-7593-2015; Antonarakis, Stylianos E/N-8866-2014; Hattori, Masahira/C-6958-2016; Vignal, Alain/I-6253-2017; Estivill, Xavier/A-3125-2013; Hattori, Masahira/AAD-3785-2019	Bosch, Assumpcio/0000-0002-7205-2796; Antonarakis, Stylianos E/0000-0001-8907-5823; Hattori, Masahira/0000-0001-9467-0344; Vignal, Alain/0000-0002-6797-2125; Estivill, Xavier/0000-0002-0723-2256; Le Paslier, Denis/0000-0003-4335-9956; BARILLOT, Emmanuel/0000-0003-2724-2002; Schmitz, Annette/0000-0002-1610-2525				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P4325; ASSUM G, 1991, GENOMICS, V11, P397, DOI 10.1016/0888-7543(91)90148-8; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; COX DR, 1991, CYTOGENET CELL GENET, V58, P800, DOI 10.1159/000133181; CRAIG AG, 1990, NUCLEIC ACIDS RES, V18, P2653; EVANS GA, 1989, P NATL ACAD SCI USA, V86, P5030, DOI 10.1073/pnas.86.13.5030; GARDINER K, 1988, SOMAT CELL MOLEC GEN, V14, P623, DOI 10.1007/BF01535316; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; Green E D, 1991, PCR Methods Appl, V1, P77; ICHIKAWA H, 1992, P NATL ACAD SCI USA, V89, P23, DOI 10.1073/pnas.89.1.23; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; MONTANARO V, 1991, AM J HUM GENET, V48, P183; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; OLSON M, 1986, P NATL ACAD SCI USA, V832, P7826; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; RIETHMAN H, 1989, P NATL ACAD SCI USA, V86, P991; RIGAULT P, IN PRESS INT J GENOM; SCHLESSINGER D, 1991, GENOMICS, V11, P783, DOI 10.1016/0888-7543(91)90001-U; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; TANZI RE, IN PRESS GENOMICS; VANKEUREN M, 1989, AM J MED GENET, V38, P793; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6	28	481	494	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 1	1992	359	6394					380	387		10.1038/359380a0	http://dx.doi.org/10.1038/359380a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406950	Bronze			2022-12-28	WOS:A1992JQ62400045
J	LEWIS, SJ; DAVIDSON, RN; ROSS, EJ; HALL, AP				LEWIS, SJ; DAVIDSON, RN; ROSS, EJ; HALL, AP			SEVERITY OF IMPORTED FALCIPARUM-MALARIA - EFFECT OF TAKING ANTIMALARIAL PROPHYLAXIS	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAVELERS	Objective-To investigate the effects of antimalarial chemoprophylaxis and other variables on the severity of falciparum malaria. Design-Review of consecutive malaria cases between 1987 and 1991. Setting-The Hospital for Tropical Diseases, London. Subjects-250 consecutive cases of mild and 51 consecutive cases of severe falciparum malaria. Results-Prophylaxis was taken in 52.4% (131/250) of the cases of mild malaria and 21.6% (11/51) of cases of severe malaria. Severe malaria was more common in white patients than in those of African origin and was also seen more commonly in people returning from central, southern, and east Africa than in those returning from west Africa. Patients with severe malaria presented sooner than patients with mild malaria. Conclusions-Prior chemoprophylaxis led to a reduction in the severity of falciparum malaria. Ethnic origin, time to presentation, and sex were also associated with the severity of malaria.	HOSP TROP DIS, LONDON NW1 0PE, ENGLAND; MIDDLESEX HOSP, ACAD DEPT GENITOURINARY MED, LONDON NW1, ENGLAND	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London								BEHRENS RH, 1991, IN PRESS 2ND P INT C; BRADLEY DJ, 1989, J ROY SOC MED, V82, P8; GREENBERG AE, 1990, ANN INTERN MED, V113, P326, DOI 10.7326/0003-4819-113-4-326; HALL AP, 1972, P HELM SOC WASH, V39, P66; LACKRITZ EM, 1991, JAMA-J AM MED ASSOC, V265, P383, DOI 10.1001/jama.265.3.383; PHILLIPSHOWARD PA, 1990, BMJ-BRIT MED J, V300, P499, DOI 10.1136/bmj.300.6723.499; WESTEYN JCF, 1985, B WORLD HEALTH ORGAN, V63, P101; [No title captured]	8	61	62	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 26	1992	305	6856					741	743		10.1136/bmj.305.6856.741	http://dx.doi.org/10.1136/bmj.305.6856.741			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ520	1422328	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JQ52000019
J	SUNDT, TM				SUNDT, TM			SURGERY FOR INTRACEREBRAL HEMORRHAGE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											SUNDT, TM (corresponding author), MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905, USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3248	3248						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433770				2022-12-28	WOS:A1992KA65400035
J	BLOCK, SM				BLOCK, SM			MAKING LIGHT WORK WITH OPTICAL TWEEZERS	NATURE			English	Article							INFRARED-LASER BEAMS; MEMBRANE-GLYCOPROTEINS; FORCE; MANIPULATION; TRAP; PARTICLES; FIELDS		HARVARD UNIV, DEPT CELLULAR & DEV BIOL, CAMBRIDGE, MA 02138 USA	Harvard University	BLOCK, SM (corresponding author), ROWLAND INST SCI INC, 100 CAMBRIDGE PKWY, CAMBRIDGE, MA 02142 USA.							ASHKIN A, 1992, BIOPHYS J, V61, P569, DOI 10.1016/S0006-3495(92)81860-X; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; ASHKIN A, 1989, P NATL ACAD SCI USA, V86, P7914, DOI 10.1073/pnas.86.20.7914; ASHKIN A, 1989, BER BUNSEN PHYS CHEM, V93, P254, DOI 10.1002/bbpc.19890930308; BARTON JP, 1989, J APPL PHYS, V66, P2800, DOI 10.1063/1.344207; BARTON JP, 1989, J APPL PHYS, V66, P4594, DOI 10.1063/1.343813; BARTON JP, 1988, J APPL PHYS, V64, P1632, DOI 10.1063/1.341811; Bems M. W., 1991, INT REV CYTOL, V129, P1; BEMS MW, 1989, P NATL ACAD SCI USA, V86, P4539; BEMS MW, 1992, EXP CELL RES, V198, P375; BERG HC, 1976, J THEOR BIOL, V56, P269, DOI 10.1016/S0022-5193(76)80074-4; BLOCK SM, 1991, CYTOMETRY, V12, P492, DOI 10.1002/cyto.990120605; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BLOCK SM, 1990, NONINVASIVE TECHNIQU, V9, P375; BURNS MM, 1990, SCIENCE, V249, P749, DOI 10.1126/science.249.4970.749; CHARON NW, 1992, J BACTERIOL, V174, P832, DOI 10.1128/jb.174.3.832-840.1992; CHU S, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0292-70; DENK W, 1990, APPL OPTICS, V29, P2382, DOI 10.1364/AO.29.002382; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; HONG LA, 1991, EXP CELL RES, V197, P21, DOI 10.1016/0014-4827(91)90475-A; KUCIK DF, 1991, J CELL BIOL, V114, P1029, DOI 10.1083/jcb.114.5.1029; Kuo S C, 1992, Trends Cell Biol, V2, P116, DOI 10.1016/0962-8924(92)90016-G; KUO SC, 1990, BIOPHYS J, V57, pA399; MISAWA H, 1992, APPL PHYS LETT, V60, P310, DOI 10.1063/1.106695; SATO S, 1991, OPT LETT, V16, P282, DOI 10.1364/OL.16.000282; SCHUT TCB, 1991, CYTOMETRY, V12, P479, DOI 10.1002/cyto.990120603; SEEGER S, 1991, CYTOMETRY, V12, P497, DOI 10.1002/cyto.990120606; SHEPHERD GMG, 1990, P NATL ACAD SCI USA, V87, P8627, DOI 10.1073/pnas.87.21.8627; SIMMONS RM, 1992, MECHANISM MYOFILAMEN; SIMON A, 1992, PHYS REV LETT, V68, P3375, DOI 10.1103/PhysRevLett.68.3375; STEUBING RW, 1991, CYTOMETRY, V12, P505, DOI 10.1002/cyto.990120607; SVOBODA K, 1992, BIOPHYS J, V63, P784, DOI 10.1016/S0006-3495(92)81644-2; TADIR Y, 1990, FERTIL STERIL, V53, P944; VISSCHER K, 1992, OPTIK, V90, P57; VISSCHER K, 1992, J OPTIK, V89, P174; WAYNE D B, 1991, Journal of Cell Biology, V115, p102A; WEBER G, 1992, INT REV CYTOL, V133, P1, DOI 10.1016/S0074-7696(08)61857-4; WRIGHT WH, 1990, IEEE J QUANTUM ELECT, V26, P2148, DOI 10.1109/3.64351	42	139	149	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	1992	360	6403					493	495		10.1038/360493a0	http://dx.doi.org/10.1038/360493a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448176				2022-12-28	WOS:A1992KA79700071
J	FIGUEROA, ML; ROSENBLOOM, BE; KAY, AC; GARVER, P; THURSTON, DW; KOZIOL, JA; GELBART, T; BEUTLER, E				FIGUEROA, ML; ROSENBLOOM, BE; KAY, AC; GARVER, P; THURSTON, DW; KOZIOL, JA; GELBART, T; BEUTLER, E			A LESS COSTLY REGIMEN OF ALGLUCERASE TO TREAT GAUCHERS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; ENZYME-REPLACEMENT THERAPY	Background. Alglucerase (Ceredase) provides effective enzyme-replacement treatment for patients with Gaucher's disease, but at the usually recommended dose of 60 U per kilogram of body weight every two weeks (130 U per kilogram per month), it costs $382,200 per year for a 70-kg patient. Theoretical considerations suggest that more frequent administration would be more efficient. Methods. Fourteen patients with type 1 Gaucher's disease that was moderately severe to severe were given 30 U of alglucerase per kilogram per month, in divided doses given either daily or three times weekly, or 120 U given three times weekly. The effect of the treatment on the size of the liver and spleen and on blood counts was compared with published data on patients who received a total dose four to five times as large as the lower dose we used and who received treatment every two weeks. Results. The response to 30 U of alglucerase per kilogram per month, fractionated into three or seven doses weekly, was approximately the same as that reported after the administration every two weeks of a dose four or five times as large, given in the large infusions usually recommended. A fourfold increase in the dose given three times weekly, from 2.3 to 9.2 U per kilogram, did not substantially increase the rate of improvement. Conclusions. The treatment of Gaucher's disease with smaller total doses of alglucerase given more frequently yields satisfactory results. A dose of 2.3 U per kilogram three times weekly yields major financial benefits with no sacrifice of therapeutic effect. Even taking into account the increased ancillary costs of more frequent administration, this method of administering alglucerase reduces the annual cost of the drug for a 70-kg patient to about $100,000.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, DIV HEMATOL, LA JOLLA, CA 92037 USA; SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, DIV BIOMATH, LA JOLLA, CA 92037 USA; SCRIPPS CLIN & RES FDN, MED GRP, LA JOLLA, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute				Gelbart, Terri/0000-0002-7863-1262	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036639] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NIDDK NIH HHS [DK36639] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTON NW, 1992, J PEDIATR-US, V120, P277, DOI 10.1016/S0022-3476(05)80444-5; BARTON NW, 1991, NEW ENGL J MED, V325, P1811; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BEUTLER E, 1992, BLOOD, V79, P1662; BEUTLER E, 1970, LANCET, V1, P612; BEUTLER E, 1991, BLOOD, V78, P1183; BEUTLER E, 1991, NEW ENGL J MED, V325, P1809; FALLET S, 1992, PEDIATR RES, V31, P496, DOI 10.1203/00006450-199205000-00018; HEYMSFIELD SB, 1979, ANN INTERN MED, V90, P185, DOI 10.7326/0003-4819-90-2-185; HOBBS JR, 1987, LANCET, V1, P1111; KAY AC, 1991, T ASSOC AM PHYSICIAN, V104, P258; RAPPEPORT JM, 1984, NEW ENGL J MED, V311, P84, DOI 10.1056/NEJM198407123110203; SVENNERHOLML, 1991, DEV NEUROSCI, V13, P345; TSAI P, 1992, PEDIATR RES, V31, P503, DOI 10.1203/00006450-199205000-00019; ZIMRAN A, 1992, MEDICINE, V71, P337, DOI 10.1097/00005792-199211000-00002; 1991, WALL STREET J   1224, pA2; 1992, NY TIMES        0122, pC19	17	133	134	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 3	1992	327	23					1632	1636		10.1056/NEJM199212033272304	http://dx.doi.org/10.1056/NEJM199212033272304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA260	1435900				2022-12-28	WOS:A1992KA26000004
J	PRESTON, DS; STERN, RS				PRESTON, DS; STERN, RS			NONMELANOMA CANCERS OF THE SKIN	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BASAL-CELL-CARCINOMA; MICROSCOPICALLY CONTROLLED EXCISION; SUPPRESSOR LYMPHOCYTES-T; SQUAMOUS-CELL; ULTRAVIOLET-RADIATION; SOLAR KERATOSES; BOWENS DISEASE; XERODERMA PIGMENTOSUM; RISK-FACTORS; PHOTODYNAMIC THERAPY		BETH ISRAEL HOSP, DEPT DERMATOL, 330 BROOKLINE AVE, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, DEPT DERMATOL, BOSTON, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School					NIADDK NIH HHS [N01-AM-3-2252] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBRIGHT SD, 1982, J AM ACAD DERMATOL, V7, P143, DOI 10.1016/S0190-9622(82)70105-7; ALCALAY J, 1990, J INVEST DERMATOL, V95, P506, DOI 10.1111/1523-1747.ep12504707; ALTMAN A, 1987, J AM ACAD DERMATOL, V17, P741, DOI 10.1016/S0190-9622(87)70256-4; AMES FC, 1982, SOUTH MED J, V75, P932; AMES RC, 1982, SO MED J, V75, P920; AMONETTE RA, 1981, J DERMATOL SURG ONC, V7, P397, DOI 10.1111/j.1524-4725.1981.tb00663.x; ARBESMAN H, 1987, JAMA-J AM MED ASSOC, V257, P516, DOI 10.1001/jama.257.4.516; ASHTON H, 1970, BRIT J DERMATOL, V82, P539; AUBRY F, 1985, CANCER-AM CANCER SOC, V55, P907, DOI 10.1002/1097-0142(19850215)55:4<907::AID-CNCR2820550433>3.0.CO;2-5; BANG KM, 1987, J NATL MED ASSOC, V79, P51; BARR BBB, 1989, LANCET, V1, P124; BART RS, 1978, ARCH DERMATOL, V114, P739, DOI 10.1001/archderm.114.5.739; BAVINCK JNB, 1991, NEW ENGL J MED, V325, P843, DOI 10.1056/NEJM199109193251203; BORING CC, 1991, CA-CANCER J CLIN, V41, P19, DOI 10.3322/canjclin.41.1.19; BOYLE J, 1984, LANCET, V1, P702; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; BREUNINGER H, 1991, J DERMATOL SURG ONC, V17, P574, DOI 10.1111/j.1524-4725.1991.tb03655.x; BREUNINGER H, 1990, AM J CLIN PATHOL, V94, P624, DOI 10.1093/ajcp/94.5.624; BRUNNER R, 1985, LASER SURG MED, V5, P105, DOI 10.1002/lsm.1900050205; BRUYNEELRAPP F, 1988, J AM ACAD DERMATOL, V18, P1030, DOI 10.1016/S0190-9622(88)70100-0; BRUYNZEEL I, 1991, BRIT J DERMATOL, V124, P49, DOI 10.1111/j.1365-2133.1991.tb03281.x; BRYSK MM, 1992, J INVEST DERMATOL, V98, P45, DOI 10.1111/1523-1747.ep12494210; BURNS FJ, 1989, ARCH DERMATOL, V125, P979, DOI 10.1001/archderm.125.7.979; CHERNOSKY ME, 1978, SOUTH MED J, V71, P802, DOI 10.1097/00007611-197807000-00019; CHUANG TY, 1988, J AM ACAD DERMATOL, V19, P47, DOI 10.1016/S0190-9622(88)70150-4; CHUANG TY, 1990, J AM ACAD DERMATOL, V22, P413, DOI 10.1016/0190-9622(90)70056-N; CHUTE CG, 1991, JAMA-J AM MED ASSOC, V266, P816, DOI 10.1001/jama.266.6.816; COEBERGH JWW, 1991, BRIT J DERMATOL, V125, P353, DOI 10.1111/j.1365-2133.1991.tb14171.x; COHEN C, 1980, ARCH DERMATOL, V116, P687, DOI 10.1001/archderm.116.6.687; COLE CA, 1986, PHOTOCHEM PHOTOBIOL, V43, P275, DOI 10.1111/j.1751-1097.1986.tb05605.x; CONWAY H, 1966, SURGERY TUMORS SKIN; CORNELL RC, 1990, J AM ACAD DERMATOL, V23, P694, DOI 10.1016/0190-9622(90)70276-N; COY JA, 1989, CPT PHYSICIANS CURRE; CRISTOFOLINI M, 1984, J DERMATOL SURG ONC, V10, P778, DOI 10.1111/j.1524-4725.1984.tb01181.x; CULLEN SI, 1979, J AM GERIATR SOC, V27, P529, DOI 10.1111/j.1532-5415.1979.tb01247.x; DABSKI K, 1986, J SURG ONCOL, V32, P233, DOI 10.1002/jso.2930320412; DAVIS MM, 1989, J AM ACAD DERMATOL, V20, P608, DOI 10.1016/S0190-9622(89)70072-4; DEAU MC, 1991, VIROLOGY, V184, P492, DOI 10.1016/0042-6822(91)90419-C; DEGRUIJL FR, 1991, CANCER RES, V51, P979; DELLON AL, 1984, J SURG ONCOL, V25, P92, DOI 10.1002/jso.2930250208; DINEHART SM, 1989, J AM ACAD DERMATOL, V21, P241, DOI 10.1016/S0190-9622(89)70168-7; DINEHART SM, 1990, J DERMATOL SURG ONC, V16, P271, DOI 10.1111/j.1524-4725.1990.tb03963.x; DOUGHERTY TJ, 1981, J INVEST DERMATOL, V77, P122, DOI 10.1111/1523-1747.ep12479341; DUBIN N, 1983, ARCH DERMATOL, V119, P373, DOI 10.1001/archderm.119.5.373; DZUBOW LM, 1982, ARCH DERMATOL, V118, P900, DOI 10.1001/archderm.118.11.900; EAGLSTEIN WH, 1970, ARCH DERMATOL, V101, P132; EDENS BL, 1983, J AM ACAD DERMATOL, V9, P383, DOI 10.1016/S0190-9622(83)70145-3; EDWARDS L, 1990, J AM ACAD DERMATOL, V22, P496, DOI 10.1016/0190-9622(90)70070-X; EDWARDS MJ, 1989, ARCH SURG-CHICAGO, V124, P115; EMMETT AJJ, 1981, AUST NZ J SURG, V51, P576, DOI 10.1111/j.1445-2197.1981.tb05258.x; EMMETT AJJ, 1990, AUST NZ J SURG, V60, P855, DOI 10.1111/j.1445-2197.1990.tb07489.x; EPSTEIN E, 1973, ARCH DERMATOL, V108, P798, DOI 10.1001/archderm.108.6.798; FEARS TR, 1983, CANCER INVEST, V1, P119; FISHER ER, 1972, CANCER, V29, P1387, DOI 10.1002/1097-0142(197205)29:5<1387::AID-CNCR2820290541>3.0.CO;2-K; FISHER MS, 1982, SCIENCE, V216, P1133, DOI 10.1126/science.6210958; FITZPATRICK TB, 1985, NEW ENGL J MED, V313, P818, DOI 10.1056/NEJM198509263131310; FLEMING ID, 1975, CANCER, V35, P600, DOI 10.1002/1097-0142(197503)35:3<600::AID-CNCR2820350309>3.0.CO;2-3; FRENTZ G, 1988, CANCER, V61, P294, DOI 10.1002/1097-0142(19880115)61:2<294::AID-CNCR2820610218>3.0.CO;2-8; FRENTZ G, 1989, J AM ACAD DERMATOL, V21, P475, DOI 10.1016/S0190-9622(89)70210-3; FRIEDMAN HI, 1985, CANCER-AM CANCER SOC, V56, P1099, DOI 10.1002/1097-0142(19850901)56:5<1099::AID-CNCR2820560524>3.0.CO;2-R; GALLAGHER RP, 1990, J AM ACAD DERMATOL, V23, P413, DOI 10.1016/0190-9622(90)70234-9; GILES GG, 1988, BRIT MED J, V296, P13, DOI 10.1136/bmj.296.6614.13; GLASS AG, 1989, JAMA-J AM MED ASSOC, V262, P2097, DOI 10.1001/jama.262.15.2097; GOLDBERG LH, 1989, POSTGRAD MED, V85, P57; GOSAIN A, 1991, ANN PLAS SURG, V26, P279, DOI 10.1097/00000637-199103000-00011; GREENBERG ER, 1990, NEW ENGL J MED, V323, P789, DOI 10.1056/NEJM199009203231204; GREENWAY HT, 1990, ARCH DERMATOL, V126, P1080, DOI 10.1001/archderm.126.8.1080; GRIMWOOD RE, 1988, J DERMATOL SURG ONC, V14, P59, DOI 10.1111/j.1524-4725.1988.tb03341.x; GRIMWOOD RE, 1985, CANCER, V56, P519, DOI 10.1002/1097-0142(19850801)56:3<519::AID-CNCR2820560319>3.0.CO;2-W; GROB JJ, 1988, LANCET, V1, P878; HALL VL, 1986, CLIN RADIOL, V37, P33, DOI 10.1016/S0009-9260(86)80161-1; HARTEVELT MM, 1990, TRANSPLANTATION, V49, P506, DOI 10.1097/00007890-199003000-00006; HENDEE WR, 1989, JAMA-J AM MED ASSOC, V262, P380; HENRIKSEN T, 1990, PHOTOCHEM PHOTOBIOL, V51, P579, DOI 10.1111/j.1751-1097.1990.tb01968.x; HO T, 1991, ARCH DERMATOL, V127, P1167, DOI 10.1001/archderm.127.8.1167; HOGAN DJ, 1989, INT J DERMATOL, V28, P591, DOI 10.1111/j.1365-4362.1989.tb02534.x; HUGHES BR, 1988, J AM ACAD DERMATOL, V18, P522, DOI 10.1016/S0190-9622(88)70075-4; Hunter David J., 1990, Annals of Epidemiology, V1, P13; IKIC D, 1991, INT J DERMATOL, V30, P58, DOI 10.1111/j.1365-4362.1991.tb05884.x; IMMERMAN SC, 1983, CANCER, V51, P1537, DOI 10.1002/1097-0142(19830415)51:8<1537::AID-CNCR2820510830>3.0.CO;2-E; KAIDBEY KH, 1979, J AM ACAD DERMATOL, V1, P249, DOI 10.1016/S0190-9622(79)70018-1; KAIDBEY KH, 1978, ARCH DERMATOL, V114, P46, DOI 10.1001/archderm.114.1.46; KANITAKIS J, 1992, CANCER, V69, P2937, DOI 10.1002/1097-0142(19920615)69:12<2937::AID-CNCR2820691212>3.0.CO;2-Q; KARAGAS MR, 1992, JAMA-J AM MED ASSOC, V267, P3305, DOI 10.1001/jama.267.24.3305; KARJALAINEN S, 1989, INT J DERMATOL, V28, P445, DOI 10.1111/j.1365-4362.1989.tb02503.x; KELFKENS G, 1990, PHOTOCHEM PHOTOBIOL, V52, P819, DOI 10.1111/j.1751-1097.1990.tb08687.x; KELFKENS G, 1991, CARCINOGENESIS, V12, P1377, DOI 10.1093/carcin/12.8.1377; KLEIN E, 1969, J AMER MED ASSOC, V207, P959; KLIGMAN LH, 1987, PHOTODERMATOLOGY, V4, P88; KOPF AW, 1977, ARCH DERMATOL, V113, P439, DOI 10.1001/archderm.113.4.439; KOPLIN L, 1980, PLAST RECONSTR SURG, V65, P656, DOI 10.1097/00006534-198005000-00017; KOZLOV AP, 1980, CANCER, V46, P2172, DOI 10.1002/1097-0142(19801115)46:10<2172::AID-CNCR2820461013>3.0.CO;2-L; KRAEMER KH, 1988, NEW ENGL J MED, V318, P1633, DOI 10.1056/NEJM198806233182501; KRAEMER KH, 1987, DERMATOLOGY GENERAL, V2, P1791; KRICKER A, 1990, MED J AUSTRALIA, V152, P399, DOI 10.5694/j.1326-5377.1990.tb125266.x; KRIPKE ML, 1986, J AM ACAD DERMATOL, V14, P149, DOI 10.1016/S0190-9622(86)70017-0; KRUTMANN J, 1988, PHOTOCHEM PHOTOBIOL, V48, P787, DOI 10.1111/j.1751-1097.1988.tb02894.x; LANE RJ, 1987, LASER SURG MED, V6, P504, DOI 10.1002/lsm.1900060605; LANG PG, 1986, J AM ACAD DERMATOL, V14, P186, DOI 10.1016/S0190-9622(86)70020-0; LEAF A, 1989, NEW ENGL J MED, V321, P1577, DOI 10.1056/NEJM198912073212305; LEFFELL DJ, 1991, ARCH DERMATOL, V127, P1663, DOI 10.1001/archderm.127.11.1663; LEONG GKP, 1987, J AM ACAD DERMATOL, V17, P233, DOI 10.1016/S0190-9622(87)70197-2; LEVINE H, 1983, LARYNGOSCOPE, V93, P87; LEVINE N, 1991, JAMA-J AM MED ASSOC, V266, P2730, DOI 10.1001/jama.266.19.2730; LIDDINGTON M, 1989, BRIT J SURG, V76, P1002, DOI 10.1002/bjs.1800761005; LINDELOF B, 1991, LANCET, V338, P91, DOI 10.1016/0140-6736(91)90083-2; LYNCH HT, 1981, LANCET, V2, P1230; MAGNUS K, 1991, INT J CANCER, V47, P12, DOI 10.1002/ijc.2910470104; MARCUS SL, 1992, P IEEE, V80, P869, DOI 10.1109/5.149450; MARKS R, 1986, BRIT J DERMATOL, V115, P649, DOI 10.1111/j.1365-2133.1986.tb06644.x; MARKS R, 1989, MED J AUSTRALIA, V150, P475, DOI 10.5694/j.1326-5377.1989.tb136588.x; MARKS R, 1985, CANCER, V56, P2332; MARKS R, 1991, ARCH DERMATOL, V127, P1031, DOI 10.1001/archderm.127.7.1031; MARKS R, 1988, ARCH DERMATOL, V124, P1039, DOI 10.1001/archderm.124.7.1039; MARKS R, 1988, LANCET, V1, P795, DOI 10.1016/s0140-6736(88)91658-3; MARKS R, 1990, MED J AUSTRALIA, V153, P505, DOI 10.5694/j.1326-5377.1990.tb126185.x; MARKS R, 1990, BRIT J DERMATOL, V122, P49, DOI 10.1111/j.1365-2133.1990.tb16125.x; MARTIN H, 1970, CANCER, V25, P61, DOI 10.1002/1097-0142(197001)25:1<61::AID-CNCR2820250110>3.0.CO;2-W; MCCAUGHAN JS, 1989, ARCH SURG-CHICAGO, V124, P211; MCINTOSH GS, 1983, POSTGRAD MED J, V59, P698, DOI 10.1136/pgmj.59.697.698; MIHARA M, 1990, ARCH DERMATOL, V126, P1107, DOI 10.1001/archderm.1990.01670320131032; MILLER SJ, 1991, J AM ACAD DERMATOL, V24, P161, DOI 10.1016/0190-9622(91)70022-T; Mohs F E, 1978, J Dermatol Surg Oncol, V4, P41; MOLLER R, 1979, ARCH DERMATOL, V115, P703, DOI 10.1001/archderm.115.6.703; MORA RG, 1981, J AM ACAD DERMATOL, V5, P535, DOI 10.1016/S0190-9622(81)70113-0; MORA RG, 1981, CANCER, V47, P1436, DOI 10.1002/1097-0142(19810315)47:6<1436::AID-CNCR2820470632>3.0.CO;2-B; PEARL DK, 1986, INT J EPIDEMIOL, V15, P502, DOI 10.1093/ije/15.4.502; PENNINGTON DG, 1988, PLAST RECONSTR SURG, V82, P1067, DOI 10.1097/00006534-198812000-00021; PETROVICH Z, 1987, AM J SURG, V154, P447, DOI 10.1016/0002-9610(89)90022-6; PIERCEALL WE, 1991, J INVEST DERMATOL, V97, P880, DOI 10.1111/1523-1747.ep12491612; POTT P, 1775, CHIRURGICAL WORKS P, V5; RASZEWSKI RL, 1990, ANN PLAS SURG, V24, P170, DOI 10.1097/00000637-199002000-00012; RIEFKOHL R, 1984, ANN PLAS SURG, V13, P525, DOI 10.1097/00000637-198412000-00010; ROBBINS JH, 1988, JAMA-J AM MED ASSOC, V260, P384; ROBERTS DL, 1990, BRIT J DERMATOL, V122, P399, DOI 10.1111/j.1365-2133.1990.tb08289.x; Robins P, 1975, J Dermatol Surg, V1, P49; ROBINSON JK, 1987, CANCER, V60, P118, DOI 10.1002/1097-0142(19870701)60:1<118::AID-CNCR2820600122>3.0.CO;2-1; ROENIGK RK, 1986, J DERMATOL SURG ONC, V12, P860, DOI 10.1111/j.1524-4725.1986.tb01993.x; ROWE DE, 1989, J DERMATOL SURG ONC, V15, P315, DOI 10.1111/j.1524-4725.1989.tb03166.x; RUNDEL RD, 1983, PHOTOCHEM PHOTOBIOL, V38, P569, DOI 10.1111/j.1751-1097.1983.tb03385.x; SADAMORI N, 1990, J RADIAT RES, V31, P280, DOI 10.1269/jrr.31.280; SALASCHE SJ, 1981, J DERMATOL SURG ONC, V7, P387, DOI 10.1111/j.1524-4725.1981.tb00662.x; SANDERS GH, 1982, ANN PLAS SURG, V9, P306, DOI 10.1097/00000637-198210000-00006; SCANLON EF, 1980, J SURG ONCOL, V15, P171, DOI 10.1002/jso.2930150208; SCHNUR PL, 1978, PLAST RECONSTR SURG, V62, P258, DOI 10.1097/00006534-197808000-00016; SCHREIBER MM, 1971, ARCH DERMATOL, V104, P124, DOI 10.1001/archderm.104.2.124; SCHREIBER MM, 1990, J AM ACAD DERMATOL, V23, P1114, DOI 10.1016/0190-9622(90)70343-G; SCOTTO J, 1974, CANCER, V34, P1333, DOI 10.1002/1097-0142(197410)34:4<1333::AID-CNCR2820340447>3.0.CO;2-A; SCOTTO J, 1983, NIH832433 PUBL; SERRANO H, 1991, J AM ACAD DERMATOL, V24, P574, DOI 10.1016/0190-9622(91)70086-H; SHORE RE, 1990, INT J RADIAT BIOL, V57, P809, DOI 10.1080/09553009014550951; SILVERMAN MK, 1991, J DERMATOL SURG ONC, V17, P713, DOI 10.1111/j.1524-4725.1991.tb03424.x; SILVERMAN MK, 1991, J DERMATOL SURG ONC, V17, P720, DOI 10.1111/j.1524-4725.1991.tb03425.x; SITZ KV, 1987, JAMA-J AM MED ASSOC, V257, P340, DOI 10.1001/jama.257.3.340; SLOANE JP, 1977, BRIT J DERMATOL, V96, P127, DOI 10.1111/j.1365-2133.1977.tb12533.x; SMITH JM, 1983, ANN PLAS SURG, V11, P551, DOI 10.1097/00000637-198312000-00017; SMITH PJ, 1982, PHOTOCHEM PHOTOBIOL, V36, P333, DOI 10.1111/j.1751-1097.1982.tb04383.x; STELL JS, 1966, ARCH DERMATOL, V93, P338, DOI 10.1001/archderm.93.3.338; STENBECK KD, 1990, MED J AUSTRALIA, V153, P511, DOI 10.5694/j.1326-5377.1990.tb126188.x; STERN RS, 1986, ARCH DERMATOL, V122, P537, DOI 10.1001/archderm.122.5.537; STERN RS, 1990, NEW ENGL J MED, V322, P1093, DOI 10.1056/NEJM199004193221601; STERN RS, 1988, J INVEST DERMATOL, V91, P120, DOI 10.1111/1523-1747.ep12464137; STERN RS, 1989, J INVEST DERMATOL, V92, P300; STERN RS, 1988, DRUG INF J, V22, P471; STRICKLAND PT, 1986, J INVEST DERMATOL, V87, P272, DOI 10.1111/1523-1747.ep12696669; STURM HM, 1979, J AM ACAD DERMATOL, V1, P513, DOI 10.1016/S0190-9622(79)80095-X; SWANSON NA, 1983, ARCH DERMATOL, V119, P761, DOI 10.1001/archderm.119.9.761; TAKEMIYA M, 1990, Journal of Dermatology (Tokyo), V17, P342; TANGREA JA, 1992, JNCI-J NATL CANCER I, V84, P328, DOI 10.1093/jnci/84.5.328; THIELMANN HW, 1987, J CANCER RES CLIN, V113, P171, DOI 10.1007/BF00391441; TROMOVITCH TA, 1974, ARCH DERMATOL, V110, P231, DOI 10.1001/archderm.110.2.231; URBACH F, 1989, PHOTOCHEM PHOTOBIOL, V50, P507, DOI 10.1111/j.1751-1097.1989.tb05556.x; VANWEELDEN H, 1988, ARCH DERMATOL RES, V280, P300, DOI 10.1007/BF00440604; VITALIANO PP, 1980, ARCH DERMATOL, V116, P454, DOI 10.1001/archderm.116.4.454; VONDOMARUS H, 1984, J AM ACAD DERMATOL, V10, P1043; WALDOW SM, 1987, LASER SURG MED, V7, P451, DOI 10.1002/lsm.1900070602; WALLBERG P, 1901, ACTA DERM-VENEREOL, V71, P134; WATSON AB, 1986, CANCER DETECT PREV, V9, P161; Weimar V M, 1979, J Dermatol Surg Oncol, V5, P609; WEINSTOCK MA, 1991, ARCH DERMATOL, V127, P1194, DOI 10.1001/archderm.127.8.1194; WEINSTOCK MA, 1989, JAMA-J AM MED ASSOC, V262, P2138, DOI 10.1001/jama.262.15.2138; WHEELAND RG, 1987, J DERMATOL SURG ONC, V13, P119, DOI 10.1111/j.1524-4725.1987.tb00509.x; WHELAN CS, 1981, CANCER-AM CANCER SOC, V47, P2280, DOI 10.1002/1097-0142(19810501)47:9<2280::AID-CNCR2820470930>3.0.CO;2-U; WICKRAMASINGHE L, 1989, J AM ACAD DERMATOL, V20, P71, DOI 10.1016/S0190-9622(89)70009-8; WILDER RB, 1991, ARCH DERMATOL, V127, P1668, DOI 10.1001/archderm.127.11.1668; WOLF DJ, 1987, ARCH DERMATOL, V123, P340, DOI 10.1001/archderm.123.3.340; YU RCH, 1991, BRIT J DERMATOL, V124, P449, DOI 10.1111/j.1365-2133.1991.tb00624.x; YUSPA SH, 1976, J INVEST DERMATOL, V67, P199, DOI 10.1111/1523-1747.ep12513040; ZACARIAN SA, 1975, CUTIS, V16, P449; 1987, DHHS FDA878270 DEP H; 1991, FED REGISTER, V56, P59635	191	408	420	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	1992	327	23					1649	1662		10.1056/NEJM199212033272307	http://dx.doi.org/10.1056/NEJM199212033272307			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA260	1435901				2022-12-28	WOS:A1992KA26000007
J	STACPOOLE, PW; WRIGHT, EC; BAUMGARTNER, TG; BERSIN, RM; BUCHALTER, S; CURRY, SH; DUNCAN, CA; HARMAN, EM; HENDERSON, GN; JENKINSON, S; LACHIN, JM; LORENZ, A; SCHNEIDER, SH; SIEGEL, JH; SUMMER, WR; THOMPSON, D; WOLFE, CL; ZOROVICH, B				STACPOOLE, PW; WRIGHT, EC; BAUMGARTNER, TG; BERSIN, RM; BUCHALTER, S; CURRY, SH; DUNCAN, CA; HARMAN, EM; HENDERSON, GN; JENKINSON, S; LACHIN, JM; LORENZ, A; SCHNEIDER, SH; SIEGEL, JH; SUMMER, WR; THOMPSON, D; WOLFE, CL; ZOROVICH, B			A CONTROLLED CLINICAL-TRIAL OF DICHLOROACETATE FOR TREATMENT OF LACTIC-ACIDOSIS IN ADULTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OXYGEN-CONSUMPTION; SAMPLE-SIZE; DELIVERY; SEPSIS; POWER; SHOCK	Background. Mortality is very high in lactic acidosis, and there is no satisfactory treatment other than treatment of the underlying cause. Uncontrolled studies have suggested that dichloroacetate, which stimulates the oxidation of lactate to acetyl-coenzyme A and carbon dioxide, might reduce morbidity and improve survival among patients with this condition. Methods. We conducted a placebo-controlled, randomized trial of intravenous sodium dichloroacetate therapy in 252 patients with lactic acidosis; 126 were assigned to receive dichloroacetate and 126 to receive placebo. The entry criteria included an arterial-blood lactate concentration of greater-than-or-equal-to 5.0 mmol per liter and either an arterial-blood pH of less-than-or-equal-to 7.35 or a base deficit of greater-than-or-equal-to 6 mmol per liter. The mean (+/-SD) arterial-blood lactate concentrations before treatment were 11.6+/-7.0 mmol per liter in the dichloroacetate-treated patients and 10.4+/-5.5 mmol per liter in the placebo group, and the mean initial arterial-blood pH values were 7.24+/-0.12 and 7.24+/-0.13, respectively. Eighty-six percent of the patients required mechanical ventilation, and 74 percent required pressor agents, inotropic drugs, or both because of hypotension. Results. The arterial-blood lactate concentration decreased 20 percent or more in 83 (66 percent) of the 126 patients who received dichloroacetate and 45 (36 percent) of the 126 patients who received placebo (P = 0.001). The arterial-blood pH also increased more in the dichloroacetate-treated patients (P = 0.005). The absolute magnitude of the differences was small, however, and they were not associated with improvement in hemodynamics or survival. Only 12 percent of the dichloroacetate-treated patients and 17 percent of the placebo patients survived to be discharged from the hospital. Conclusions. Dichloroacetate treatment of patients with severe lactic acidosis results in statistically significant but clinically unimportant changes in arterial-blood lactate concentrations and pH and fails to alter either hemodynamics or survival.	UNIV FLORIDA, COLL MED, DEPT MED & BIOCHEM, GAINESVILLE, FL 32611 USA; UNIV FLORIDA, COLL MED, DEPT MOLEC BIOL, GAINESVILLE, FL 32611 USA; GEORGE WASHINGTON UNIV, CTR BIOSTAT, WASHINGTON, DC 20052 USA; UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA; UNIV TEXAS, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA; UNIV ALABAMA, SCH MED, BIRMINGHAM, AL 35233 USA; ROBERT WOOD JOHNSON SCH MED, NEW BRUNSWICK, NJ USA; LOUISIANA STATE UNIV, MED CTR, SCH MED, NEW ORLEANS, LA 70112 USA; UNIV MARYLAND, SCH MED, MARYLAND INST EMERGENCY MED SERV, BALTIMORE, MD 21201 USA; UNIV TORONTO, SCH MED, ST JOSEPHS HLTH CTR, TORONTO M5S 1A1, ONTARIO, CANADA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; George Washington University; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; University of Alabama System; University of Alabama Birmingham; Rutgers State University New Brunswick; Rutgers State University Medical Center; Louisiana State University System; University System of Maryland; University of Maryland Baltimore; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario)				Lachin, John/0000-0001-9838-2841				BLACKSHEAR PJ, 1982, DIABETES CARE, V5, P391, DOI 10.2337/diacare.5.4.391; BURNS AH, 1991, AM J PHYSIOL, V260, pH516, DOI 10.1152/ajpheart.1991.260.2.H516; Cochran W.G, 1957, STAT METHODS, V6th ed; CUNNION RE, 1987, CRITICALLY ILL IMMUN, P3; CURRY SH, 1991, BIOPHARM DRUG DISPOS, V12, P375, DOI 10.1002/bdd.2510120507; CURRY SH, 1985, CLIN PHARMACOL THER, V37, P89, DOI 10.1038/clpt.1985.17; FENWICK JC, 1990, J CRIT CARE, V5, P81, DOI 10.1016/0883-9441(90)90052-B; GANZ W, 1972, AM J CARDIOL, V29, P241, DOI 10.1016/0002-9149(72)90635-2; GILBERT EM, 1986, AM REV RESPIR DIS, V134, P873, DOI 10.1164/arrd.1986.134.5.873; HAUPT MT, 1985, AM REV RESPIR DIS, V131, P912; HEARD SO, 1991, CRIT CARE MED, V19, P271, DOI 10.1097/00003246-199102000-00025; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; KREISBERG RA, 1980, ANN INTERN MED, V92, P227, DOI 10.7326/0003-4819-92-2-227; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; MADIAS NE, 1986, KIDNEY INT, V29, P752, DOI 10.1038/ki.1986.62; MCVEIGH JJ, 1990, AM J PHYSIOL, V259, pH1079, DOI 10.1152/ajpheart.1990.259.4.H1079; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Searle S.R., 1971, LINEAR MODELS; SEVERINGHAUS JW, 1976, ANESTHESIOLOGY, V45, P539; STACPOOLE PW, 1983, NEW ENGL J MED, V309, P390, DOI 10.1056/NEJM198308183090702; STACPOOLE PW, 1988, ANN INTERN MED, V108, P58, DOI 10.7326/0003-4819-108-1-58; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; STACPOOLE PW, IN PRESS ENDOCRINOL; TEASDALE G, 1974, LANCET, V2, P81; VARY TC, 1988, CIRC SHOCK, V24, P3; WEI LJ, 1988, CONTROL CLIN TRIALS, V9, P345, DOI 10.1016/0197-2456(88)90048-7; WEI LJ, 1989, CONTROL CLIN TRIALS, V10, P127; WEIL MH, 1988, HEART DISEASE TXB CA, V1, P561; WELLS PG, 1980, DIABETOLOGIA, V19, P109, DOI 10.1007/BF00421855; WOLFF SM, 1982, NEW ENGL J MED, V307, P1267, DOI 10.1056/NEJM198211113072010; 1985, SAS USERS GUIDE BASI	35	222	229	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1564	1569		10.1056/NEJM199211263272204	http://dx.doi.org/10.1056/NEJM199211263272204			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435883	Bronze			2022-12-28	WOS:A1992JZ43200004
J	KIRKPATRICK, CH; ROWLANDS, DT				KIRKPATRICK, CH; ROWLANDS, DT			TRANSPLANTATION IMMUNOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VERSUS-HOST DISEASE; BONE-MARROW TRANSPLANTATION; LIVER-TRANSPLANTATION; LUNG TRANSPLANTATION; KIDNEY-TRANSPLANTS; RENAL-ALLOGRAFTS; TRANSFUSION; RECIPIENTS; GENE; MHC		UNIV COLORADO, HLTH SCI CTR, DEPT MED, DENVER, CO 80262 USA; LIFELINK FDN TISSUE BANK, TAMPA, FL USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	KIRKPATRICK, CH (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, DIV ALLERGY & CLIN IMMUNOL, DENVER, CO 80206 USA.							ANDERSON KC, 1990, NEW ENGL J MED, V323, P315; Auchincloss H., 1989, FUNDAMENTAL IMMUNOLO, P889; BIDWELL J, 1988, IMMUNOL TODAY, V9, P18, DOI 10.1016/0167-5699(88)91351-5; BILOUS RW, 1989, NEW ENGL J MED, V321, P80, DOI 10.1056/NEJM198907133210204; BORTIN MM, 1986, TRANSPLANTATION, V42, P229, DOI 10.1097/00007890-198609000-00001; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; CLAMAN HN, 1986, J IMMUNOL, V137, P2009; CLAY TM, 1991, LANCET, V337, P1049, DOI 10.1016/0140-6736(91)91704-X; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; FESTENSTEIN H, 1986, NEW ENGL J MED, V314, P7, DOI 10.1056/NEJM198601023140102; FISCHER A, 1990, LANCET, V336, P850, DOI 10.1016/0140-6736(90)92348-L; GEIGER MJ, 1991, J IMMUNOL, V147, P2082; GILKS WR, 1987, TRANSPLANTATION, V43, P669, DOI 10.1097/00007890-198705000-00013; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337; GROSSMAN RF, 1990, NEW ENGL J MED, V322, P727, DOI 10.1056/NEJM199003153221104; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; KORNGOLD R, 1987, TRANSPLANTATION, V44, P335, DOI 10.1097/00007890-198709000-00002; KRENSKY AM, 1990, NEW ENGL J MED, V322, P510, DOI 10.1056/NEJM199002223220805; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; NAJARIAN JS, 1991, TRANSPLANT P, V23, P2075; OPELZ G, 1981, LANCET, V1, P1223; OPELZ G, 1973, TRANSPLANT P, V5, P253; PARHAM P, 1990, NATURE, V348, P674, DOI 10.1038/348674a0; PENN I, 1990, NEW ENGL J MED, V323, P1767, DOI 10.1056/NEJM199012203232510; PERSIJN GG, 1986, LANCET, V2, P915; ROOT RK, 1988, WESTERN J MED, V149, P316; STARZL TE, 1989, NEW ENGL J MED, V321, P1014, DOI 10.1056/NEJM198910123211505; STARZL TE, 1989, NEW ENGL J MED, V321, P1092, DOI 10.1056/NEJM198910193211606; SWINNEN LJ, 1990, NEW ENGL J MED, V323, P1723, DOI 10.1056/NEJM199012203232502; THEODORE J, 1990, NEW ENGL J MED, V322, P772, DOI 10.1056/NEJM199003153221110; THOMSON AW, 1990, TRANSPLANT REV, V4, P1; URYU N, 1990, TISSUE ANTIGENS, V35, P20, DOI 10.1111/j.1399-0039.1990.tb01751.x; VANTWUYVER E, 1991, NEW ENGL J MED, V325, P1210, DOI 10.1056/NEJM199110243251704; WEIMAR W, 1988, TRANSPLANT P, V20, P96; 1990, LANCET, V335, P1371	36	1	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2952	2958						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433714				2022-12-28	WOS:A1992JY66800023
J	RICHARDSON, MA; GERLITZ, B; GRINNELL, BW				RICHARDSON, MA; GERLITZ, B; GRINNELL, BW			ENHANCING PROTEIN-C INTERACTION WITH THROMBIN RESULTS IN A CLOT-ACTIVATED ANTICOAGULANT	NATURE			English	Article							THROMBOMODULIN; COAGULATION; EXPRESSION; SUBSTITUTION; INHIBITION; INFUSION; SEQUENCE; MODEL	HUMAN protein C is a vitamin K-dependent plasma glycoprotein that circulates as an inactive zymogen. At the endothelial cell surface, thrombin in complex with the integral membrane protein thrombomodulin converts protein C to its active form by specific cleavage of an activation peptide1-3. The activated form of protein C has potent anticoagulant activity as a feedback regulator of thrombin generation (reviewed in refs 4-6), and also has profibrinolytic7-10, anti-ischaemic11 and anti-inflammatory properties12. Protein C is effective in the treatment of model and human thrombotic diseases4,13-16 but, except when it has been used to treat genetic or acquired deficiencies and microvascular thrombosis, it is administered as the activated enzyme, which has a short biological half-life. We have altered two putative inhibitory acidic residues near the thrombin cleavage site, which results in a 30-fold increase in substrate utilization by alpha-thrombin. We combined these changes with a genetically altered glycoform to generate a zymogen protein C with a 60-fold increased cleavage rate by free alpha-thrombin, independent of its cofactor thrombomodulin. We show that this 'proform' of protein C, unlike the natural circulating zymogen, can be activated by thrombin generated in clotting human plasma, resulting in an inhibition of further clot formation. Our data therefore show that we have engineered a site-activated agent, which only has anticoagulant activity when significant amounts of thrombin are being generated.	ELI LILLY & CO, LILLY RES LAB, LILLY CORP CTR, DEPT CARDIOVASC RES, INDIANAPOLIS, IN 46285 USA	Eli Lilly								BECKMANN RJ, 1985, NUCLEIC ACIDS RES, V13, P5233, DOI 10.1093/nar/13.14.5233; CHANG JY, 1985, EUR J BIOCHEM, V151, P271; CLOUSE LH, 1986, NEW ENGL J MED, V314, P1298, DOI 10.1056/NEJM198605153142006; COMP PC, 1981, J CLIN INVEST, V68, P1221, DOI 10.1172/JCI110368; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DREYFUS M, 1991, NEW ENGL J MED, V325, P1565, DOI 10.1056/NEJM199111283252207; EHRLICH HJ, 1989, J BIOL CHEM, V264, P14298; EHRLICH HJ, 1990, EMBO J, V9, P2367, DOI 10.1002/j.1460-2075.1990.tb07411.x; EMERICK SC, 1987, PHARM TOXICOLOGY PRO, P351; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; ESMON CT, 1991, THROMB HAEMOSTASIS, V66, P160; ESMON CT, 1989, J BIOL CHEM, V264, P4743; ESMON NL, 1989, PROG HEMOST THROMB, V9, P29; ESMON NL, 1982, J BIOL CHEM, V257, P859; FENG FN, 1989, BIOCHEMISTRY-US, V28, P3094; GARDNER JE, 1983, HUMAN PROTEIN C THRO, P265; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; GRINNELL BW, 1987, BIO-TECHNOL, V5, P1189, DOI 10.1038/nbt1187-1189; GRINNELL BW, 1990, PROTEIN C RELATED AN, P13; GRUBER A, 1991, CIRCULATION, V84, P2454, DOI 10.1161/01.CIR.84.6.2454; GRUBER A, 1992, BLOOD, V79, P2340; GRUBER A, 1989, BLOOD, V73, P639; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; OKAJIMA K, 1990, AM J HEMATOL, V33, P277, DOI 10.1002/ajh.2830330413; PARKINSON JF, 1990, J BIOL CHEM, V265, P12602; ROMISCH J, 1991, FIBRINOLYSIS, V5, P191, DOI 10.1016/0268-9499(91)90023-W; SNOW TR, 1991, CIRCULATION, V84, P293, DOI 10.1161/01.CIR.84.1.293; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; YE J, 1991, J BIOL CHEM, V266, P23016; ZOLTON R P, 1973, Thrombosis Research, V3, P23, DOI 10.1016/0049-3848(73)90123-0	33	47	52	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	1992	360	6401					261	264		10.1038/360261a0	http://dx.doi.org/10.1038/360261a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY960	1436107				2022-12-28	WOS:A1992JY96000052
J	FULLER, MT; WILSON, PG				FULLER, MT; WILSON, PG			FORCE AND COUNTERFORCE IN THE MITOTIC SPINDLE	CELL			English	Review							CYTOPLASMIC DYNEIN; ANAPHASE-B; KINESIN; PROTEIN; MOTOR; MICROTUBULE; KINETOCHORES; POLEWARD; GENE; DROSOPHILA		STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305	Stanford University	FULLER, MT (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305, USA.			Fuller, Margaret T/0000-0002-3804-4987				AIST JR, 1991, J CELL SCI, V100, P279; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; GORBSKY GJ, 1987, J CELL BIOL, V104, P9, DOI 10.1083/jcb.104.1.9; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HOGAN CJ, 1990, CELL MOTIL CYTOSKEL, V16, P99, DOI 10.1002/cm.970160203; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HYMAN AA, 1991, NATURE, V351, P209; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; LEGUELLEC R, 1991, MOL CELL BIOL, V11, P3395, DOI 10.1128/MCB.11.6.3395; LESLIE RJ, 1983, J CELL BIOL, V96, P548, DOI 10.1083/jcb.96.2.548; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCINTOSH JR, 1991, J CELL BIOL, V115, P577, DOI 10.1083/jcb.115.3.577; MCNEILL PA, 1981, J CELL BIOL, V88, P543, DOI 10.1083/jcb.88.3.543; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; NICKLAS RB, 1989, J CELL BIOL, V109, P2245, DOI 10.1083/jcb.109.5.2245; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1991, CURR OPIN CELL BIOL, V3, P59, DOI 10.1016/0955-0674(91)90166-V; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; ROOF DM, 1991, COLD SPRING HARB SYM, V55, P693; SALMON ED, 1989, MITOSIS MOL MECHANIS, P118; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; VALE RD, 1990, CELL, V60, P883, DOI 10.1016/0092-8674(90)90334-B; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332	28	27	27	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					547	550		10.1016/0092-8674(92)90587-3	http://dx.doi.org/10.1016/0092-8674(92)90587-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423613				2022-12-28	WOS:A1992JY67600002
J	GOODRICH, DW; LEE, WH				GOODRICH, DW; LEE, WH			ABROGATION BY C-MYC OF G1 PHASE ARREST INDUCED BY RB PROTEIN BUT NOT BY P53	NATURE			English	Article							RETINOBLASTOMA GENE-PRODUCT; CELL-CYCLE; BINDING; DIFFERENTIATION; MICROINJECTION; TRANSFORMATION; SUPPRESSION; ONCOGENE; DOMAINS; GROWTH	INACTIVATING mutations of the retinoblastoma gene (RB) are found in a wide variety of tumour cells1. Replacement of wild-type RB can suppress the tumorigenicity of some of these cells, suggesting that the RB protein (Rb) may negatively regulate cell growth2-4. As activation of c-myc expression promotes cell proliferation and blocks differentiation, it may positively regulate cell growth5-9. The c-myc protein is localized in the nucleus and can physically associate with RB protein in vitro10, hence c-myc may functionally antagonize RB function. Microinjection of Rb in G1 phase reversibly arrests cell-cycle progression11. Here we co-inject RB protein with c-myc, EJ-ras, c-fos or c-jun protein. Co-injection of c-myc, but not EJ-ras, c-fos or c-jun, inhibits the ability of Rb to arrest the cell cycle. The c-myc does not inhibit the activity of another tumour supressor, p53 (ref. 12). Thus, c-myc and RB specifically antagonize one another in the cell.			GOODRICH, DW (corresponding author), UNIV TEXAS,HLTH SCI CTR,INST BIOTECHNOL,CTR MOLEC MED,15355 LAMBDA DR,SAN ANTONIO,TX 78245, USA.							BARNER M, 1992, CELL GROWTH DIFFER, V3, P183; Bishop JM, 1982, RNA TUMOR VIRUSES, P999; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; BOOKSTEIN R, 1991, Critical Reviews in Oncogenesis, V2, P211; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COPOLLA JS, 1986, NATURE, V320, P760; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; GOIODRICH DW, 1992, CAN RES, V52, P1968; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; HUANG S, 1991, NATURE, V350, P160, DOI 10.1038/350160a0; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KAMATA T, 1990, MOL CELL BIOL, V10, P880, DOI 10.1128/MCB.10.3.880; KUME TU, 1988, J MOL BIOL, V202, P779, DOI 10.1016/0022-2836(88)90558-X; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE WH, 1991, COLD SH Q B, V56, P211; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MILLER CW, 1990, CANCER RES, V50, P7950; PIETENPOL JA, 1991, P NATL ACAD SCI USA, V88, P10227, DOI 10.1073/pnas.88.22.10227; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; PREDERGAST GC, 1992, TRENDS GENET, V8, P91; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x	33	107	110	1	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 12	1992	360	6400					177	179		10.1038/360177a0	http://dx.doi.org/10.1038/360177a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX752	1436095				2022-12-28	WOS:A1992JX75200066
J	BROWN, CJ; HENDRICH, BD; RUPERT, JL; LAFRENIERE, RG; XING, Y; LAWRENCE, J; WILLARD, HF				BROWN, CJ; HENDRICH, BD; RUPERT, JL; LAFRENIERE, RG; XING, Y; LAWRENCE, J; WILLARD, HF			THE HUMAN XIST GENE - ANALYSIS OF A 17 KB INACTIVE X-SPECIFIC RNA THAT CONTAINS CONSERVED REPEATS AND IS HIGHLY LOCALIZED WITHIN THE NUCLEUS	CELL			English	Article							CHROMOSOME INACTIVATION; BITHORAX COMPLEX; DNA METHYLATION; BARR BODY; H19 GENE; MOUSE; TRANSCRIPTS; MECHANISMS; REGION; ORGANIZATION	X chromosome inactivation in mammalian females results in the cis-limited transcriptional inactivity of most of the genes on one X chromosome. The XIST gene is unique among X-linked genes in being expressed exclusively from the inactive X chromosome. Human XIST cDNAs containing at least eight exons and totaling 17 kb have been isolated and sequenced within the region on the X chromosome known to contain the X inactivation center. The XIST gene includes several tandem repeats, the most 5' of which are evolutionarily conserved. The gene does not contain any significant conserved ORFs and thus does not appear to encode a protein, suggesting that XIST may function as a structural RNA within the nucleus. Consistent with this, fluorescence in situ hybridization experiments demonstrate localization of XIST RNA within the nucleus to a position indistinguishable from the X inactivation-associated Barr body.	STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; UNIV MASSACHUSETTS,SCH MED,DEPT CELL BIOL,WORCESTER,MA 01655	Stanford University; University of Massachusetts System; University of Massachusetts Worcester			Hendrich, Brian/AAG-5898-2020; Brown, Carolyn J/A-5159-2014	Hendrich, Brian/0000-0002-0231-3073; Brown, Carolyn J/0000-0002-8959-0101; Lawrence, Jeanne/0000-0001-6572-3128	NHGRI NIH HHS [HG 00251, HG 00013] Funding Source: Medline; NIGMS NIH HHS [GM 45441] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000251, K01HG000013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; BARR ML, 1962, ACTA CYTOL, V6, P34; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BLAKE C, 1983, NATURE, V306, P535, DOI 10.1038/306535a0; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, IN PRESS ADV DEV BIO; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; CATTANACH BM, 1969, GENET RES, V14, P223, DOI 10.1017/S0016672300002068; CATTANACH BM, 1975, ANNU REV GENET, V9, P1, DOI 10.1146/annurev.ge.09.120175.000245; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLEMAN J R, 1991, Journal of Cell Biology, V115, p454A; COMINGS DE, 1967, AM J HUM GENET, V23, P440; CORBIN V, 1989, NATURE, V337, P279, DOI 10.1038/337279a0; CUMBERLEDGE S, 1990, P NATL ACAD SCI USA, V87, P3259, DOI 10.1073/pnas.87.9.3259; DALY RF, 1977, AM J HUM GENET, V29, P83; Deininger PL, 1989, MOBILE DNA, P619; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEY EG, 1986, J CELL BIOL, V102, P1654, DOI 10.1083/jcb.102.5.1654; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; GRUMBACH MM, 1963, P NATL ACAD SCI USA, V49, P581, DOI 10.1073/pnas.49.5.581; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; JOHNSTON CV, 1991, METHOD CELL BIOL, V25, P73; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; KEER JT, 1990, GENOMICS, V7, P566, DOI 10.1016/0888-7543(90)90200-E; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KORNELUK RG, 1985, GENE, V40, P317, DOI 10.1016/0378-1119(85)90055-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAWRENCE JB, 1990, SCIENCE, V249, P928, DOI 10.1126/science.2203143; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LEHRACH H., 1990, GENOME ANAL, P39; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; LYON MF, 1962, AM J HUM GENET, V14, P135; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maniatis T., 1982, MOL CLONING; MATTEI MG, 1981, HUM GENET, V56, P401, DOI 10.1007/BF00274702; MCBURNEY MW, 1988, BIOESSAYS, V9, P85, DOI 10.1002/bies.950090211; Mohandas T, 1977, P NATL ACAD SCI USA, V77, P6759; MORISHIMA A, 1962, P NATL ACAD SCI USA, V48, P756, DOI 10.1073/pnas.48.5.756; PFEIFER GP, 1990, GENE DEV, V4, P1277, DOI 10.1101/gad.4.8.1277; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; RIGGS AD, 1990, AUST J ZOOL, V37, P419, DOI 10.1071/ZO9890419; RIGGS AD, 1990, PHILOS T R SOC B, V326, P285, DOI 10.1098/rstb.1990.0012; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; THERMAN E, 1974, CHROMOSOMA, V44, P361; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11262; WALKER CL, 1991, P NATL ACAD SCI USA, V88, P6191, DOI 10.1073/pnas.88.14.6191; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; WILLARD HF, 1976, AM J HUM GENET, V28, P213; YEN PH, 1992, HUM MOL GENET, V1, P47	71	990	1031	4	82	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					527	542		10.1016/0092-8674(92)90520-M	http://dx.doi.org/10.1016/0092-8674(92)90520-M			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423611				2022-12-28	WOS:A1992JW43500017
J	GIBBS, RA; TAYLOR, S; BENKOVIC, SJ				GIBBS, RA; TAYLOR, S; BENKOVIC, SJ			ANTIBODY-CATALYZED REARRANGEMENT OF THE PEPTIDE-BOND	SCIENCE			English	Article							PROTEINS; DEAMIDATION; ASPARAGINYL; RESIDUES	The generation of antibodies from a bifunctional cyclic phosphinate transition-state analog provided agents capable of efficiently catalyzing both steps of the overall conversion of a substrate containing an asparaginyl-glycyl sequence through a succinimide intermediate to the products aspartyl-glycyl and the rearranged isoaspartyl-glycyl sequence. This reaction provides a potential means in addition to amide cleavage for the deactivation of protein or peptide biological functions in vivo.			GIBBS, RA (corresponding author), PENN STATE UNIV,DEPT CHEM,152 DAVEY LAB,UNIV PK,PA 16802, USA.							AHERN TJ, 1985, SCIENCE, V228, P1280, DOI 10.1126/science.4001942; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; GIBBS RB, UNPUB; JANDA KD, 1989, SCIENCE, V244, P437, DOI 10.1126/science.2717936; KOSSIAKOFF AA, 1988, SCIENCE, V240, P191, DOI 10.1126/science.3353715; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERNER RA, 1991, SCIENCE, V252, P659, DOI 10.1126/science.2024118; MODRITZER K, 1975, SYN REACT INORG MET, V5, P45; NAPPER AD, 1987, SCIENCE, V237, P1041, DOI 10.1126/science.3616626; NIMAN HL, 1980, P NATL ACAD SCI-BIOL, V77, P4524, DOI 10.1073/pnas.77.8.4524; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; POLLACK SJ, 1989, J AM CHEM SOC, V111, P5961, DOI 10.1021/ja00197a078; Quin L. D., 1981, HETEROCYCLIC CHEM PH; ROGERS SW, 1988, J BIOL CHEM, V263, P19850; TOMAZIC SJ, 1988, J BIOL CHEM, V263, P3092; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; YUAN PM, 1981, MECH AGEING DEV, V17, P151, DOI 10.1016/0047-6374(81)90081-6	17	35	36	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					803	805		10.1126/science.1439788	http://dx.doi.org/10.1126/science.1439788			3	Multidisciplinary Sciences	Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439788				2022-12-28	WOS:A1992JV69200039
J	GAO, JL; XIA, XF				GAO, JL; XIA, XF			A PRIORI EVALUATION OF AQUEOUS POLARIZATION EFFECTS THROUGH MONTE-CARLO QM-MM SIMULATIONS	SCIENCE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; REACTION FIELD-THEORY; FREE-ENERGY; ELECTRONIC-PROPERTIES; COMPUTER-SIMULATION; POTENTIAL FUNCTIONS; LIQUID WATER; SOLVATION; MODEL; PROTEINS	A Monte Carlo quantum mechanical-molecular mechanical (QM-MM) simulation method was used to determine the contributions of the solvent polarization effect to the total interaction energies between solute and solvent for amino acid side chains and nucleotide bases in aqueous solution. In the present AM1-TIP3P approach, the solute molecule is characterized by valence electrons and nucleus cores with Hartree-Fock theory incorporating explicit solvent effects into the total Hamiltonian, while the solvent is approximated by the three-point charge TIP3P model. The polarization energy contributes 10 to 20 percent of the total electrostatic energy in these systems. The performance of the hybrid AM1-TIP3P model was further validated by consideration of bimolecular complexes with water and by computation of the free energies of solvation of organic molecules using statistical perturbation theory. Excellent agreement with ab initio 6-31G(d) results and experimental solvation free energies was obtained.			GAO, JL (corresponding author), SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214, USA.							Allen M.P., 1987, COMPUTER SIMULATION, DOI [10.2307/2938686, DOI 10.2307/2938686]; BARNES P, 1979, NATURE, V282, P459, DOI 10.1038/282459a0; BASH PA, 1991, BIOCHEMISTRY-US, V30, P5826, DOI 10.1021/bi00238a003; BASH PA, 1987, J AM CHEM SOC, V109, P8192; BENNAIM A, 1984, J CHEM PHYS, V81, P2016, DOI 10.1063/1.447824; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; BOTTCHER CJF, 1973, THEORY ELECTRIC POLA; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CEPERLEY D, 1986, SCIENCE, V231, P555, DOI 10.1126/science.231.4738.555; CRAMER CJ, 1991, J AM CHEM SOC, V113, P8305, DOI 10.1021/ja00022a017; CRAMER CJ, 1992, SCIENCE, V256, P213, DOI 10.1126/science.256.5054.213; CRAMER CJ, 1991, J AM CHEM SOC, V113, P8552, DOI 10.1021/ja00022a069; DANG LX, 1991, J AM CHEM SOC, V113, P2481, DOI 10.1021/ja00007a021; DEWAR MJS, 1990, J COMPUT CHEM, V11, P541, DOI 10.1002/jcc.540110413; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; FLORIS F, 1989, J COMPUT CHEM, V10, P616, DOI 10.1002/jcc.540100504; GAO J, 1989, SCIENCE, V244, P1069, DOI 10.1126/science.2727695; GAO J, 1992, MCQUB; GAO JL, 1992, J AM CHEM SOC, V114, P1912, DOI 10.1021/ja00031a073; GAO JL, 1992, J PHYS CHEM-US, V96, P537, DOI 10.1021/j100181a009; Hehre W. J., 1986, AB INITIO MOL ORBITA; HWANG JK, 1988, J AM CHEM SOC, V110, P5297, DOI 10.1021/ja00224a011; JORGENSEN WL, 1989, ACCOUNTS CHEM RES, V22, P184, DOI 10.1021/ar00161a004; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; JORGENSEN WL, 1991, BOSS; KARELSON MM, 1989, J ORG CHEM, V54, P6030, DOI 10.1021/jo00287a012; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Kirkwood JG, 1934, J CHEM PHYS, V2, DOI 10.1063/1.1749489; KOLLMAN PA, 1990, ACCOUNTS CHEM RES, V23, P246, DOI 10.1021/ar00176a002; LUZHKOV V, 1992, J COMPUT CHEM, V13, P199, DOI 10.1002/jcc.540130212; McCammon JA., 1987, DYNAMICS PROTEINS NU; MCCREERY JH, 1976, J AM CHEM SOC, V98, P7191, DOI 10.1021/ja00439a015; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; MURRAY TJ, 1992, J AM CHEM SOC, V114, P4010, DOI 10.1021/ja00036a079; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; PEARSON RG, 1986, J AM CHEM SOC, V108, P6109, DOI 10.1021/ja00280a002; PERUTZ MF, 1990, MECHANISMS COOPERATI; PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0; Pople JA., 1970, APPROXIMATE MOL ORBI; PRANATA J, 1991, J AM CHEM SOC, V113, P2810, DOI 10.1021/ja00008a002; SHARP K, 1992, J PHYS CHEM-US, V96, P3822, DOI 10.1021/j100188a047; SMYTH CP, 1955, DIELECTRIC BEHAVIOR; STEWART JJP, 1990, J COMPUT CHEM, V11, P543, DOI 10.1002/jcc.540110414; STEWART JJP, 1986, MOPAC VERSION 5 QCPE, V6, P455; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; TAPIA O, 1990, J CHIM PHYS PCB, V87, P875, DOI 10.1051/jcp/1990870875; TAPIA O, 1980, J PHYS CHEM-US, V84, P2646, DOI 10.1021/j100457a034; THOLE BT, 1982, CHEM PHYS, V71, P211, DOI 10.1016/0301-0104(82)87020-1; VANBELLE D, 1987, J MOL BIOL, V198, P721, DOI 10.1016/0022-2836(87)90213-0; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; WAHSHEL A, 1972, J AM CHEM SOC, V94, P5612; WANG ISY, 1973, J AM CHEM SOC, V95, P8160, DOI 10.1021/ja00805a033; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1984, Q REV BIOPHYS, V17, P283, DOI 10.1017/S0033583500005333; Warshel A, 1991, COMPUTER MODELING CH; WASZKOWYCZ B, 1991, J CHEM SOC PERK T 2, P225, DOI 10.1039/p29910000225; WEINER SJ, 1986, P NATL ACAD SCI USA, V83, P649, DOI 10.1073/pnas.83.3.649; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; WONG MW, 1991, J AM CHEM SOC, V113, P4776, DOI 10.1021/ja00013a010; ZHENG C, 1988, NATURE, V334, P726, DOI 10.1038/334726a0; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	65	584	589	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 23	1992	258	5082					631	635		10.1126/science.1411573	http://dx.doi.org/10.1126/science.1411573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU745	1411573				2022-12-28	WOS:A1992JU74500052
J	GAVIS, ER; LEHMANN, R				GAVIS, ER; LEHMANN, R			LOCALIZATION OF NANOS RNA CONTROLS EMBRYONIC POLARITY	CELL			English	Article							POSTERIOR DETERMINANT NANOS; SEGMENTATION GENE HUNCHBACK; EARLY DROSOPHILA EMBRYO; MATERNAL MESSENGER-RNA; ABDOMINAL SEGMENTATION; ANTERIOR LOCALIZATION; SEQUENCE SIMILARITY; PATTERN-FORMATION; BICOID PROTEIN; KRUPPEL GENE	Anterior-posterior polarity of the Drosophila embryo is initiated during oogenesis through differential maternal RNA localization. The RNA of the anterior morphogen bicoid is localized to the anterior pole of the embryo, where bicoid protein controls head and thorax development. The RNA of the posterior morphogen nanos is localized to the posterior pole, where nanos protein is required for abdomen formation. Here we show that the nanos 3' untranslated region, like that of the bicoid RNA, is sufficient for RNA localization. We have used the bicoid RNA localization signal to mislocalize nanos, producing embryos with two sources of nanos protein. Such embryos form two abdomens with mirror image symmetry. Embryos with nanos RNA localized only to the anterior have greater nanos gene activity than embryos with nanos RNA localized posteriorly. We propose a role for RNA localization in regulating nanos activity.			GAVIS, ER (corresponding author), MIT, DEPT BIOL, HOWARD HUGHES MED INST, WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02139 USA.			Gavis, Elizabeth/0000-0003-0251-0760				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BLACKMAN RK, 1986, J MOL BIOL, V188, P499, DOI 10.1016/S0022-2836(86)80001-8; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; BULL AL, 1966, J EXP ZOOL, V161, P221, DOI 10.1002/jez.1401610207; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; ELDON ED, 1991, DEVELOPMENT, V111, P367; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; FROHNHOFER HG, 1987, GENE DEV, V1, P880, DOI 10.1101/gad.1.8.880; FROHNHOIFER HG, 1987, THESIS EBERHARD KARL; GAUL U, 1987, CELL, V51, P549, DOI 10.1016/0092-8674(87)90124-3; GAUL U, 1989, DEVELOPMENT, V107, P651; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; HULSKAMP M, 1989, NATURE, V338, P629, DOI 10.1038/338629a0; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; KAUFMAN PD, 1989, CELL, V59, P359, DOI 10.1016/0092-8674(89)90297-3; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KRAUT R, 1991, DEVELOPMENT, V111, P601; KRAUT R, 1991, DEVELOPMENT, V111, P611; LANTZ V, 1992, DEVELOPMENT, V115, P75; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LEHMANN R, 1989, DEVELOPMENT, V107, P21; LEHMANN R, 1991, DEVELOPMENT, V112, P679; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Lindsley D.L., 1992, GENOME DROSOPHILA ME; Lipshitz HD, 1991, CURR OPIN CELL BIOL, V3, P966, DOI 10.1016/0955-0674(91)90115-F; MACDONALD PM, 1990, DEVELOPMENT, V110, P161; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; MISMER D, 1987, GENETICS, V116, P565; MOHLER J, 1986, GENETICS, V112, P803; MOWRY KL, 1992, SCIENCE, V255, P991, DOI 10.1126/science.1546297; NAUBER U, 1988, NATURE, V336, P489, DOI 10.1038/336489a0; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; NUSSLEINVOLHARD C, 1977, ROUX ARCH DEV BIOL, V183, P249, DOI 10.1007/BF00867325; PIGNONI F, 1992, DEVELOPMENT, V115, P239; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; RAFF JW, 1990, DEVELOPMENT, V110, P1249; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; Sambrook J, 1989, MOL CLONING LABORATO; SANDER K, 1988, NATURE, V335, P68, DOI 10.1038/335068a0; SCHUPBACH T, 1986, ROUX ARCH DEV BIOL, V195, P302, DOI 10.1007/BF00376063; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; STJOHNSTON D, 1992, CELL, V68, P201; STRUHL G, 1989, NATURE, V338, P741, DOI 10.1038/338741a0; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wieschaus E., 1986, P199; ZALOKAR M, 1976, J MICROSC BIOL CELL, V25, P97	66	310	315	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	1992	71	2					301	313		10.1016/0092-8674(92)90358-J	http://dx.doi.org/10.1016/0092-8674(92)90358-J			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423595				2022-12-28	WOS:A1992JU39500015
J	SEIDLER, H; BERNHARD, W; TESCHLERNICOLA, M; PLATZER, W; NEDDEN, DZ; HENN, R; OBERHAUSER, A; SJOVOLD, T				SEIDLER, H; BERNHARD, W; TESCHLERNICOLA, M; PLATZER, W; NEDDEN, DZ; HENN, R; OBERHAUSER, A; SJOVOLD, T			SOME ANTHROPOLOGICAL ASPECTS OF THE PREHISTORIC TYROLEAN ICE MAN	SCIENCE			English	Article								The corpse of a Late Neolithic individual found in a glacier in Oetztal is unusual because of the intact nature of all body parts that resulted from the characteristics of its mummification process and its protected geographical position with regard to glacier flow. Anthropological data indicate that the man was 25 to 40 years old, was between 156 and 160 centimeters in stature, had a cranial capacity of between 1500 and 1560 cubic centimeters, and likely died of exhaustion.	UNIV MAINZ,INST ANTHROPOL,W-6500 MAINZ,GERMANY; NAT HIST MUSEUM,ANTHROPOL ABT,A-1010 VIENNA,AUSTRIA; UNIV INNSBRUCK,INST ANAT,A-6010 INNSBRUCK,AUSTRIA; UNIV INNSBRUCK,INST GERICHTLICHE MED,A-6020 INNSBRUCK,AUSTRIA; UNIV KLIN INNSBRUCK,RONGENDIAGNOST & COMP TOMOG ABT,A-6020 INNSBRUCK,AUSTRIA; UNIV STOCKHOLM,OSTEOL RES LAB,S-17171 SOLNA,SWEDEN	Johannes Gutenberg University of Mainz; University of Innsbruck; University of Innsbruck; Medical University of Innsbruck; Stockholm University	SEIDLER, H (corresponding author), UNIV WIEN,INST HUMAN BIOL,ATHANSTR 14,A-1091 VIENNA,AUSTRIA.			Teschler-Nicola, Maria Eva/0000-0003-3080-3085				BONANI G, 1992, VEROFFENTLICHUNGEN U, V187; NEDDEN DZ, 1992, 2ND EUR SCI US C SOM; NEUGEBAUERMARES.C, 1988, MITT ANTHR GES WIEN, V118, P101; OLIVIER G, 1978, J HUM EVOL, V7, P513, DOI 10.1016/S0047-2484(78)80020-7; Sjovold T., 1990, HUMAN EVOLUTION, V5, P431, DOI DOI 10.1007/BF02435593; TESCHLERNICOLA M, UNPUB; TESCHLERNICOLA M, 1984, ANN NATURHIST MUS WI, V86, P431; TRAINDLPROHAZKA M, 1991, ANN NATURHIST MUS WI, V92, P143; ZISSERNIG G, 1992, VEROFFENTLICHUNGEN U, V187; [No title captured]	10	73	73	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					455	457		10.1126/science.1411539	http://dx.doi.org/10.1126/science.1411539			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	JT775	1411539				2022-12-28	WOS:A1992JT77500032
J	WAKABAYASHI, K; TOKUNAGA, M; KOHNO, I; SUGIMOTO, Y; HAMANAKA, T; TAKEZAWA, Y; WAKABAYASHI, T; AMEMIYA, Y				WAKABAYASHI, K; TOKUNAGA, M; KOHNO, I; SUGIMOTO, Y; HAMANAKA, T; TAKEZAWA, Y; WAKABAYASHI, T; AMEMIYA, Y			SMALL-ANGLE SYNCHROTRON X-RAY-SCATTERING REVEALS DISTINCT SHAPE CHANGES OF THE MYOSIN HEAD DURING HYDROLYSIS OF ATP	SCIENCE			English	Article							ADENOSINE-TRIPHOSPHATASE; ACTIN-FILAMENTS; SKELETAL-MUSCLE; SUBFRAGMENT-1; SITE; EQUILIBRIUM; COMPLEXES; RADIATION; DOMAINS; ION	In the energy transduction of muscle contraction, it is important to know the nature and extent of conformational changes of the head portion of the myosin molecules. In the presence of magnesium adenosine triphosphate (MgATP), fairly large conformational changes of the myosin head [subfragment-1 (S1)] in solution were observed by small-angle x-ray scattering with the use of synchrotron radiation as an intense and stable x-ray source. The presence of MgATP reduced the radius of gyration of the molecule by about 3 angstrom units and the maximum chord length by about 10 angstroms, showing that the shape of S1 becomes more compact or round during hydrolysis of MgATP. Comparison with various nucleotide-bound S1 complexes that correspond to the known intermediate states during ATP hydrolysis indicates that the shape of S1 in a key intermediate state, S1-bound adenosine diphosphate (ADP) and phosphate [S1**.ADP.P(i)], differs significantly from the shape in the other intermediate states of the Sl adenosine triphosphatase cycle as well as that of nucleotide-free S1.	UNIV TOKYO, FAC SCI, DEPT PHYS, BUNKYO KU, TOKYO 113, JAPAN; NATL LAB HIGH ENERGY PHYS, PHOTON FACTORY, TSUKUBA, IBARAKI 305, JAPAN	University of Tokyo; High Energy Accelerator Research Organization (KEK)	WAKABAYASHI, K (corresponding author), OSAKA UNIV, FAC ENGN SCI, DEPT BIOPHYS ENGN, TOYONAKA, OSAKA 560, JAPAN.		Amemiya, Yoshiyuki/M-7147-2018	Amemiya, Yoshiyuki/0000-0003-3306-3772; Tokunaga, Makio/0000-0003-4586-8922				AGUIRRE R, 1989, BIOCHEMISTRY-US, V28, P799, DOI 10.1021/bi00428a058; AMEMIYA Y, 1988, TOP CURR CHEM, V147, P121, DOI 10.1007/3-540-19040-6_13; AMEMIYA Y, 1983, NUCL INSTRUM METHODS, V208, P471, DOI 10.1016/0167-5087(83)91170-5; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Bevington P. R, 1969, DATA REDUCTION ERROR; CRAIG R, 1985, P NATL ACAD SCI USA, V82, P3247, DOI 10.1073/pnas.82.10.3247; CURMI PMG, 1988, J MOL BIOL, V203, P781, DOI 10.1016/0022-2836(88)90209-4; ELLIOTT A, 1978, J MOL BIOL, V123, P505, DOI 10.1016/0022-2836(78)90204-8; Feigin L.A., 1987, STRUCTURE ANAL SMALL; GEEVES MA, 1982, BIOCHEMISTRY-US, V21, P2782, DOI 10.1021/bi00540a032; GLATTER O, 1981, SMALL ANGLE SCATTERI, P119; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GOODY R S, 1980, Journal of Muscle Research and Cell Motility, V1, P101, DOI 10.1007/BF00711928; Guinier A., 1955, SMALL ANGLE SCATTERI; HARADA Y, 1987, NATURE, V326, P805, DOI 10.1038/326805a0; HIGHSMITH S, 1990, BIOCHEMISTRY-US, V29, P4087, DOI 10.1021/bi00469a010; IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0; KATAYAMA E, 1989, J BIOCHEM-TOKYO, V106, P751, DOI 10.1093/oxfordjournals.jbchem.a122928; KRETZSCHMAR KM, 1978, BIOCHEMISTRY-US, V17, P2314, DOI 10.1021/bi00605a009; MAITA T, 1991, J BIOCHEM, V110, P75, DOI 10.1093/oxfordjournals.jbchem.a123546; MARGOSSIAN SS, 1981, BIOCHEMISTRY-US, V20, P2151, DOI 10.1021/bi00511a012; MENDELSON R, 1980, BIOCHEMISTRY-US, V19, P4103, DOI 10.1021/bi00558a031; MENDELSON RA, 1991, ADV BIOPHYS, V27, P145; SHRIVER JW, 1984, TRENDS BIOCHEM SCI, V9, P322, DOI 10.1016/0968-0004(84)90303-7; SHRIVER JW, 1981, BIOCHEMISTRY-US, V20, P2004, DOI 10.1021/bi00510a041; STONE DB, 1986, BIOPHYS J, V49, pA444; Tokunaga M, 1991, Adv Biophys, V27, P157, DOI 10.1016/0065-227X(91)90015-6; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; VIBERT P, 1988, J MUSCLE RES CELL M, V9, P296, DOI 10.1007/BF01773873; WAKABAYASHI K, 1991, HDB SYNCHROTRON RAD, V4, P597; WALKER M, 1988, J MUSCLE RES CELL M, V9, P359, DOI 10.1007/BF01773879; WELLS C, 1984, J MUSCLE RES CELL M, V5, P97, DOI 10.1007/BF00713154; WELLS JA, 1982, METHOD ENZYMOL, V85, P93; WINKELMANN DA, 1991, J CELL BIOL, V114, P701, DOI 10.1083/jcb.114.4.701	34	140	140	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	1992	258	5081					443	447		10.1126/science.1411537	http://dx.doi.org/10.1126/science.1411537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411537				2022-12-28	WOS:A1992JT77500029
J	ZAPATA, E; ORWIN, A				ZAPATA, E; ORWIN, A			SEVERE HYPERTENSION AND BRONCHOSPASM DURING DISULFIRAM-ETHANOL TEST REACTION	BRITISH MEDICAL JOURNAL			English	Letter											ZAPATA, E (corresponding author), WOODBOURNE CLIN,BIRMINGHAM B17 8BY,ENGLAND.							FOURRIER A, 1973, LILLE MED, V18, P146; LAKE CR, 1977, AM J PSYCHIAT, V134, P1411; VOLICER L, 1984, ARCH INTERN MED, V144, P1294, DOI 10.1001/archinte.144.6.1294	3	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					870	870		10.1136/bmj.305.6858.870-a	http://dx.doi.org/10.1136/bmj.305.6858.870-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422404	Green Published, Green Submitted			2022-12-28	WOS:A1992JT77700028
J	OROURKE, NA; DAILEY, ME; SMITH, SJ; MCCONNELL, SK				OROURKE, NA; DAILEY, ME; SMITH, SJ; MCCONNELL, SK			DIVERSE MIGRATORY PATHWAYS IN THE DEVELOPING CEREBRAL-CORTEX	SCIENCE			English	Article							VISUAL CORTICAL-NEURONS; FETAL MONKEY NEOCORTEX; GLIAL-CELLS; CULTURES; TRANSFORMATION; NEUROGENESIS; ASTROCYTES; ORIGIN; FERRET; BRAIN	During early development of the mammalian cerebral cortex, young neurons migrate outward from the site of their final mitosis in the ventricular zone into the cortical plate, where they form the adult cortex. Time-lapse confocal microscopy was used to observe directly the dynamic behaviors of migrating cells in living slices of developing cortex. The majority of cells migrated along a radial pathway, consistent with the view that cortical neurons migrate along radial glial fibers. A fraction of cells, however, turned within the intermediate zone and migrated orthogonal to the radial fibers. This orthogonal migration may contribute to the tangential dispersion of clonally related cortical neurons.	STANFORD UNIV,SCH MED,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305	Stanford University	OROURKE, NA (corresponding author), STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305, USA.				NEI NIH HHS [EY06314] Funding Source: Medline; NINDS NIH HHS [NS28587, NS09027] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; COOPER M W, 1989, Society for Neuroscience Abstracts, V15, P808; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Fishell G., 1992, Society for Neuroscience Abstracts, V18, P926; GADISSEUX JF, 1989, DEV BRAIN RES, V50, P55, DOI 10.1016/0165-3806(89)90126-0; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; JACKSON CA, 1989, J NEUROSCI, V9, P1242; KATZ LC, 1987, J NEUROSCI, V7, P1223; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; ROBERTS JS, IN PRESS DEV BIOL; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SHOUKIMAS GM, 1978, J COMP NEUROL, V179, P795, DOI 10.1002/cne.901790407; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SMITH SJ, 1990, BIOL MEMORY, V23, P49; STENSAAS LJ, 1967, J COMP NEUROL, V131, P423, DOI 10.1002/cne.901310403; STENSAAS LJ, 1967, J COMP NEUROL, V131, P409, DOI 10.1002/cne.901310402; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; 1970, ANAT REC, V166, P257	33	385	386	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					299	302		10.1126/science.1411527	http://dx.doi.org/10.1126/science.1411527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	1411527				2022-12-28	WOS:A1992JR86000034
J	HE, YY; MCNALLY, T; MANFIELD, I; NAVRATIL, O; OLD, IG; PHILLIPS, SEV; SAINTGIRONS, I; STOCKLEY, PG				HE, YY; MCNALLY, T; MANFIELD, I; NAVRATIL, O; OLD, IG; PHILLIPS, SEV; SAINTGIRONS, I; STOCKLEY, PG			PROBING MET REPRESSOR OPERATOR RECOGNITION IN SOLUTION	NATURE			English	Article							PROTEIN; DNA	THE three-dimensional crystal structure of the Escherichia coli methionine repressor, MetJ, complexed with a DNA operator fragment is described in an accompanying article1. The complex exhibits several novel features of DNA-protein interaction. DNA sequence recognition is achieved largely by hydrogen-bond contacts between the bases and amino-acid side chains located on a beta-ribbon, a mode of recognition previously hypothesized on the basis of modelling of idealized beta-strands and DNA2, and mutagenesis of the Salmonella phage P22 repressors Arc and Mnt3. The complex comprises a pair of MetJ repressor dimers which bind to adjacent met-box sites on the DNA, and contact each other by means of a pair of antiparallel alpha-helices. Here we assess the importance of these contacts, and also of contacts that would be made between the C-helices of the protein and DNA in a previous model of the complex4, by studying mutations aimed at disrupting them. The role of the carboxy-terminal helix face in operator binding was unclear, but we demonstrate that recognition of operator sequences occurs through side chains in the beta-strand motif and that dimer-dimer interactions are required for effective repression.	UNIV LEEDS,DEPT GENET,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND; INST PASTEUR,DEPT BACTERIOL & MYCOL,UNITE BACTERIOL MOLEC & MED,F-75724 PARIS 15,FRANCE; UNIV LEEDS,DEPT BIOCHEM & MOLEC BIOL,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND	University of Leeds; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Leeds			Navratil, Oldrich/G-3090-2014	Stockley, Peter/0000-0002-1360-2751				CHURCH GM, 1977, P NATL ACAD SCI USA, V74, P1458, DOI 10.1073/pnas.74.4.1458; DAVIDSON BE, 1989, MOL MICROBIOL, V3, P1639, DOI 10.1111/j.1365-2958.1989.tb00149.x; KNIGHT KL, 1989, J BIOL CHEM, V264, P3639; PHILLIPS SEV, 1989, NATURE, V341, P710; RAFFERTY JB, 1989, NATURE, V341, P705, DOI 10.1038/341705a0; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0	6	29	32	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 1	1992	359	6394					431	433		10.1038/359431a0	http://dx.doi.org/10.1038/359431a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406957				2022-12-28	WOS:A1992JQ62400062
J	THORPEBEESTON, JG; BANFIELD, PJ; SAUNDERS, NJS				THORPEBEESTON, JG; BANFIELD, PJ; SAUNDERS, NJS			OUTCOME OF BREECH DELIVERY AT TERM	BRITISH MEDICAL JOURNAL			English	Article							CESAREAN-SECTION; RANDOMIZED MANAGEMENT; MODE	Objective-To compare neonatal mortality and morbidity in term infants presenting by the breech and delivered vaginally or by caesarean section. Design-Population based comparison of outcomes. Data derived from the St Mary's maternity information system. Setting-North West Thames Regional Health Authority, 1988-90. Subjects-3447 singleton fetuses presenting by the breech at term. Main outcome measures-Intrapartum and neonatal mortality, low Apgar scores, intubation at birth, and admission to special care baby units. Results-After the exclusion of babies with congenital anomalies the incidence of intrapartum and neonatal death associated with vaginal birth was 8/961 (0.83%) compared with 1/2486 (0.03%) in babies born by caesarean section (relative risk 20, 95% confidence interval 2.5 to 163). The numbers of low Apgar scores and neonatal intubation were doubled in babies born vaginally or by emergency caesarean section compared with those delivered by elective operation. Conclusions-The good neonatal outcome associated with elective caesarean delivery of the term breech fetus may influence the decision of women and their obstetricians about mode of delivery.	ST MARYS HOSP,DEPT OBSTET,LONDON W2 1PG,ENGLAND	Imperial College London								BINGHAM P, 1987, OBSTET GYNECOL, V69, P965; BINGHAM P, 1987, BRIT J OBSTET GYNAEC, V94, P746, DOI 10.1111/j.1471-0528.1987.tb03720.x; BITHELL JF, 1975, BRIT J CANCER, V31, P271, DOI 10.1038/bjc.1975.62; CHRISTIAN SS, 1990, AM J OBSTET GYNECOL, V163, P848; COLLEA JV, 1980, AM J OBSTET GYNECOL, V137, P235, DOI 10.1016/0002-9378(80)90780-2; FELDMAN GB, 1985, NEW ENGL J MED, V312, P1264, DOI 10.1056/NEJM198505093121926; GARDNER MJ, 1989, BMJ; GIMOVSKY ML, 1983, AM J OBSTET GYNECOL, V146, P34, DOI 10.1016/0002-9378(83)90923-7; HYTTEN FE, 1982, BRIT J OBSTET GYNAEC, V89, P879, DOI 10.1111/j.1471-0528.1982.tb05049.x; KIELY JL, 1991, BRIT J OBSTET GYNAEC, V98, P898, DOI 10.1111/j.1471-0528.1991.tb13512.x; PATERSON CM, 1991, BRIT MED J, V303, P818, DOI 10.1136/bmj.303.6806.818; REDIE D, 1967, BRIT J RADIOL, V40, P489; ROSEN MG, 1990, OBSTET GYNECOL, V76, P865, DOI 10.1097/00006250-199011000-00029; SACHS BP, 1983, JAMA-J AM MED ASSOC, V250, P2157, DOI 10.1001/jama.250.16.2157	14	85	86	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1992	305	6856					746	747		10.1136/bmj.305.6856.746	http://dx.doi.org/10.1136/bmj.305.6856.746			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ520	1422330	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JQ52000021
J	CHAIT, BT; KENT, SBH				CHAIT, BT; KENT, SBH			WEIGHING NAKED PROTEINS - PRACTICAL, HIGH-ACCURACY MASS MEASUREMENT OF PEPTIDES AND PROTEINS	SCIENCE			English	Article							ASSISTED LASER-DESORPTION; ELECTROSPRAY-IONIZATION; CONFORMATIONAL-CHANGES; PLASMINOGEN-ACTIVATOR; NUCLEOTIDE-SEQUENCE; RECOMBINANT-DNA; SPECTROMETRY; MATRIX; SPECTRA; LIPOPROTEINS	Two new technologies have made the study of proteins by mass spectrometry straight-forward. Proteins with molecular masses of up to more than 100 kilodaltons can be analyzed at picomole sensitivities to give simple mass spectra corresponding to the intact molecule. This development has allowed unprecedented accuracy in the determination of the molecular weights of proteins. A number of "case studies" are used to present the revolutionary impact that these powerful new ways of looking at proteins are having on biological research.	SCRIPPS RES INST, LA JOLLA, CA 92037 USA	Scripps Research Institute	CHAIT, BT (corresponding author), ROCKEFELLER UNIV, NEW YORK, NY 10021 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038274] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00862] Funding Source: Medline; NIGMS NIH HHS [GM38274] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN MH, 1992, J AM SOC MASS SPECTR, V3, P18, DOI 10.1016/1044-0305(92)85014-B; ALPIN RT, 1990, FEBS LETT, V277, P212; ANNAN RS, 1992, RAPID COMMUN MASS SP, V6, P298, DOI 10.1002/rcm.1290060415; ASHTON DS, 1991, FEBS LETT, V292, P201, DOI 10.1016/0014-5793(91)80867-3; BACA M, 1992, J AM CHEM SOC, V114, P3992, DOI 10.1021/ja00036a066; BALDWIN M, UNPUB; BAPTISTA GB, 1991, RAPID COMMUN MASS SP, V5, P632, DOI 10.1002/rcm.1290051214; Barber M, 1987, Rapid Commun Mass Spectrom, V1, P80, DOI 10.1002/rcm.1290010505; BARBER M, 1981, J CHEM SOC CHEM COMM, P325, DOI 10.1039/c39810000325; BEAVIS R, UNPUB; Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P432, DOI 10.1002/rcm.1290031207; Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P233, DOI 10.1002/rcm.1290030708; BEAVIS RC, 1991, CHEM PHYS LETT, V181, P479, DOI 10.1016/0009-2614(91)90384-L; BEAVIS RC, 1990, ANAL CHEM, V62, P1836, DOI 10.1021/ac00216a020; BEAVIS RC, 1990, P NATL ACAD SCI USA, V87, P6873, DOI 10.1073/pnas.87.17.6873; BEAVIS RC, 1992, ORG MASS SPECTROM, V27, P156, DOI 10.1002/oms.1210270217; BEAVIS RC, 1991, NATO ASI SERIES B, V209; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; BIEMANN K, 1987, SCIENCE, V237, P992, DOI 10.1126/science.3303336; BIER ME, IN PRESS 40TH P ASMS; BOARD PG, 1986, GENE, V44, P127, DOI 10.1016/0378-1119(86)90051-X; BURLINGAME AL, 1992, ANAL CHEM, V64, pR467, DOI 10.1021/ac00036a025; CAPRIOLI RM, 1991, TECHNIQUES PROTEIN C, V2, P497; CASTRO JA, 1992, RAPID COMMUN MASS SP, V6, P239, DOI 10.1002/rcm.1290060403; CHAIT BT, IN PRESS 40TH P ASMS; CHOLOUPEK RC, 1989, J CHROMATOGR, V463, P375; CHOWDHURY SK, 1990, RAPID COMMUN MASS SP, V4, P81, DOI 10.1002/rcm.1290040305; CHOWDHURY SK, 1990, J AM CHEM SOC, V112, P9012, DOI 10.1021/ja00180a074; CHRIVIA JC, 1988, J BIOL CHEM, V263, P5739; COLLEN D, 1984, J PHARMACOL EXP THER, V231, P146; COTTER RJ, 1988, ANAL CHEM, V60, pA781, DOI 10.1021/ac00164a002; Covey T R, 1988, Rapid Commun Mass Spectrom, V2, P249, DOI 10.1002/rcm.1290021111; COX KA, 1992, BIOL MASS SPECTROM, V21, P226, DOI 10.1002/bms.1200210503; Dawson P. H, 1995, QUADRUPOLE MASS SPEC; DEEB SS, 1991, J BIOL CHEM, V266, P13654; DELAETER JR, 1988, J PHYS CHEM REF DATA, V17, P1791, DOI 10.1063/1.555816; DESIDERIO DM, 1991, MASS SPECTROMETRY PE; EHRING H, 1992, ORG MASS SPECTROM, V27, P472, DOI 10.1002/oms.1210270419; Elder J. H., UNPUB; FALICK AM, IN PRESS 40TH P ASMS; FENG R, IN PRESS ANAL CHEM; FENN JB, 1990, MASS SPECTROM REV, V9, P37, DOI 10.1002/mas.1280090103; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; FOWLER VM, 1990, J CELL BIOL, V111, P471, DOI 10.1083/jcb.111.2.471; GANEM B, 1991, J AM CHEM SOC, V113, P7818, DOI 10.1021/ja00020a085; GANEM B, 1991, J AM CHEM SOC, V113, P6294, DOI 10.1021/ja00016a069; GANGULY AK, 1992, J AM CHEM SOC, V114, P6559, DOI 10.1021/ja00042a046; GIMON ME, 1992, ORG MASS SPECTROM, V27, P827, DOI 10.1002/oms.1210270711; GUEVREMONT R, 1992, J AM SOC MASS SPECTR, V3, P216, DOI 10.1016/1044-0305(92)87005-J; HENDERSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P339, DOI 10.1073/pnas.80.2.339; HENRY KD, 1991, J AM CHEM SOC, V113, P5447, DOI 10.1021/ja00014a043; HERBERG F, UNPUB; HILL JA, 1991, RAPID COMMUN MASS SP, V5, P395, DOI 10.1002/rcm.1290050905; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; HORIUCHI A, 1990, J BIOL CHEM, V265, P9576; HOU J, IN PRESS BIOCHEMISTR; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; KARAS M, 1991, MASS SPECTROM REV, V10, P335, DOI 10.1002/mas.1280100503; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; KATTA V, 1991, J AM CHEM SOC, V113, P8534, DOI 10.1021/ja00022a058; KATTA V, 1991, RAPID COMMUN MASS SP, V5, P214, DOI 10.1002/rcm.1290050415; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LEBLANC JCY, 1991, ORG MASS SPECTROM, V26, P831; LING V, 1991, ANAL CHEM, V63, P2909, DOI 10.1021/ac00024a020; Loo J.A., 1988, RAPID COMMUN MASS SP, V2, P207; LOO JA, 1991, RAPID COMMUN MASS SP, V5, P101, DOI 10.1002/rcm.1290050303; MACFARLANE RD, 1976, SCIENCE, V191, P920, DOI 10.1126/science.1251202; MANN M, 1989, ANAL CHEM, V61, P1702, DOI 10.1021/ac00190a023; MCCLOSKEY JA, 1990, METHODS ENZYMOLOGY, V193; MCEWEN CN, 1992, RAPID COMMUN MASS SP, V6, P173, DOI 10.1002/rcm.1290060304; MENARD R, 1991, FEBS LETT, V295, P27, DOI 10.1016/0014-5793(91)81376-J; MENG CK, 1988, Z PHYS D ATOM MOL CL, V10, P361, DOI 10.1007/BF01384871; MIRZA UA, UNPUB; NELSON RW, 1990, RAPID COMMUN MASS SP, V4, P348, DOI 10.1002/rcm.1290040911; PALEZEWSKI K, UNPUB; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; REINHOLD BB, 1992, J AM SOC MASS SPECTR, V3, P207, DOI 10.1016/1044-0305(92)87004-I; SCHAR M, 1991, RAPID COMMUN MASS SP, V5, P319, DOI 10.1002/rcm.1290050705; SCHMID K, 1973, BIOCHEMISTRY-US, V12, P2711, DOI 10.1021/bi00738a026; SEE YP, 1990, PROTEIN STRUCTURE PR; SEPNGLER B, 1992, ANALYSIS, V20, P91; SMITH RD, 1990, J AM SOC MASS SPECTR, V1, P53, DOI 10.1016/1044-0305(90)80006-9; SMITH RD, 1991, MASS SPECTROM REV, V10, P359, DOI 10.1002/mas.1280100504; SPENGLER B, 1991, RAPID COMMUN MASS SP, V5, P198, DOI 10.1002/rcm.1290050412; STRUPAT K, 1991, INT J MASS SPECTROM, V111, P89, DOI 10.1016/0168-1176(91)85050-V; SUNG LA, 1992, J BIOL CHEM, V267, P2616; TALBOTT RL, 1989, P NATL ACAD SCI USA, V86, P5743, DOI 10.1073/pnas.86.15.5743; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/RCM.1290020802, DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; VANBERKEL GJ, 1990, ANAL CHEM, V62, P1284, DOI 10.1021/ac00212a016; WHITEHOUSE CM, 1985, ANAL CHEM, V57, P675, DOI 10.1021/ac00280a023; WILKENS CL, IN PRESS 40TH P ASMS; WILKINS CL, IN PRESS 40TH P ASMS; YONEMOTO W, UNPUB	95	408	425	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 25	1992	257	5078					1885	1894		10.1126/science.1411504	http://dx.doi.org/10.1126/science.1411504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP594	1411504				2022-12-28	WOS:A1992JP59400020
J	PUGLIANO, N; SAYKALLY, RJ				PUGLIANO, N; SAYKALLY, RJ			MEASUREMENT OF QUANTUM TUNNELING BETWEEN CHIRAL ISOMERS OF THE CYCLIC WATER TRIMER	SCIENCE			English	Article							VANDERWAALS COMPLEXES; SPECTROSCOPY; DYNAMICS; CLUSTERS	A detailed experimental study of the water trimer is reported. A vibration-rotation-tunneling band of the perdeuterated cluster has been measured near 89.6 wavenumbers by tunable far infrared laser absorption spectroscopy. The data indicate a chiral six-membered ring structure with rapid quantum tunneling occurring between the enantiomers. The observed vibration involves torsional motion of the water subunits about each hydrogen bond axis. It is speculated that larger water clusters would also exhibit transient chirality and that similar effects may be found in liquid water.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720	University of California System; University of California Berkeley				SAYKALLY, RICHARD/0000-0001-8942-3656	NCRR NIH HHS [850RR05651A] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BALASUBRAMANIAN K, 1984, J PHYS CHEM-US, V88, P4688, DOI 10.1021/j150664a049; BLAKE GA, 1991, REV SCI INSTRUM, V62, P1701, DOI 10.1063/1.1142410; COHEN RC, 1992, J PHYS CHEM-US, V96, P1024, DOI 10.1021/j100182a006; COHEN RC, 1991, ANNU REV PHYS CHEM, V42, P369, DOI 10.1146/annurev.physchem.42.1.369; FRANKS F, 1976, WATER COMPREHENSIVE; FRASER GT, 1991, INT REV PHYS CHEM, V10, P189, DOI 10.1080/01442359109353257; HALLER EE, 1985, INFRARED PHYS, V25, P257, DOI 10.1016/0020-0891(85)90088-0; HONEGGER E, 1988, J CHEM PHYS, V88, P2582, DOI 10.1063/1.454038; HUTSON JM, 1990, ANNU REV PHYS CHEM, V41, P123, DOI 10.1146/annurev.pc.41.100190.001011; LOESER JG, IN PRESS J CHEM PHYS; OWICKI JC, 1975, J PHYS CHEM-US, V79, P1794, DOI 10.1021/j100584a010; PUGLIANO N, 1992, J CHEM PHYS, V96, P1832, DOI 10.1063/1.462084	12	397	403	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 25	1992	257	5078					1937	1940		10.1126/science.1411509	http://dx.doi.org/10.1126/science.1411509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP594	1411509				2022-12-28	WOS:A1992JP59400029
J	NIXON, PA; ORENSTEIN, DM; KELSEY, SF; DOERSHUK, CF				NIXON, PA; ORENSTEIN, DM; KELSEY, SF; DOERSHUK, CF			THE PROGNOSTIC VALUE OF EXERCISE TESTING IN PATIENTS WITH CYSTIC-FIBROSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUSCLE FATIGUE; FITNESS; MODELS; ADULTS	Background. Previous studies have shown female sex, impaired pulmonary function, older age, malnutrition, and colonization of the respiratory tract by Pseudomonas cepacia to be associated with a poor prognosis in patients with cystic fibrosis. We sought to determine the prognostic value of exercise testing in addition to the other prognostic factors. Methods. A total of 109 patients with cystic fibrosis, 7 to 35 years old, underwent pulmonary-function and exercise testing in the late 1970s. They were followed for eight years to determine the factors associated with subsequent mortality. Survival rates were calculated with standard life-table methods. Cox proportional-hazards regression models were used to determine crude relative risks of mortality and relative risks adjusted tor age, sex, body-mass index, forced expiratory volume in one second (FEV1), end-tidal partial pressure of carbon dioxide (PCO2) at peak exercise, and oxygen consumption at peak exercise (V(O2peak)). Results. Patients with the highest levels of aerobic fitness (V(O2peak), greater-than-or-equal-to 82 percent of predicted) had a survival rate of 83 percent at eight years, as compared with rates of 51 percent and 28 percent for patients with middle (V(O2peak), 59 to 81 percent of predicted) and lowest (V(O2peak), less-than-or-equal-to 58 percent of predicted) levels of fitness, respectively. After adjustment for other risk factors, patients with higher levels of aerobic fitness were more than three times as likely to survive than patients with lower levels of fitness. Colonization by P. cepacia was associated with a risk of dying that was increased fivefold. Age, sex, body-mass index, FEV1, and end-tidal PCO2 at peak exercise were not independently correlated with mortality. Conclusions. Higher levels of aerobic fitness in patients with cystic fibrosis are associated with a significantly lower risk of dying. Although better aerobic fitness may simply be a marker for less severe illness, measurement Of V(O2peak) appears to be valuable for predicting prognosis. Further research is warranted to determine whether improving aerobic fitness through exercise programs will result in a better prognosis.	UNIV PITTSBURGH, DEPT PEDIAT, DIV PULMONOL, PITTSBURGH, PA 15260 USA; CASE WESTERN RESERVE UNIV, DEPT PEDIAT, DIV PULMONOL & CYST FIBROSIS, CLEVELAND, OH 44106 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL35334] Funding Source: Medline; NIDDK NIH HHS [DK27651] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1979, AM REV RESPIR DIS, V119, P831; BACEVICE AE, 1976, 29TH P ANN C ENG MED, V18, P39; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Boat T.J., 1989, METABOLIC BASIS INHE, P2649; Bouchard C., 1986, SPORT HUMAN GENETICS, P59; COHEN CA, 1982, AM J MED, V73, P308, DOI 10.1016/0002-9343(82)90711-2; COX DR, 1972, J R STAT SOC B, V34, P187; FLEISS JL, 1981, STATISTICAL METHODS, P138; GASKIN K, 1982, J PEDIATR-US, V100, P857, DOI 10.1016/S0022-3476(82)80501-5; GODFREY S, 1974, EXERCISE TESTING CHI, P30; HUANG NN, 1987, AM J MED, V82, P871, DOI 10.1016/0002-9343(87)90147-1; ISSEKUTZ B, 1962, J APPL PHYSIOL, V17, P47, DOI 10.1152/jappl.1962.17.1.47; KAHN HA, 1989, MONOGRAPHS EPIDEMIOL, V12, P168; KRAEMER R, 1978, ACTA PAEDIATR SCAND, V67, P33, DOI 10.1111/j.1651-2227.1978.tb16273.x; MACKLEM PT, 1977, CLIN SCI MOL MED, V53, P419, DOI 10.1042/cs0530419; MACLEAN GL, 1985, S AFR J WILDL RES, V15, P1; MURCIANO D, 1984, NEW ENGL J MED, V311, P349, DOI 10.1056/NEJM198408093110601; ORENSTEIN D M, 1991, Respiratory Care, V36, P746; ORENSTEIN DM, 1981, CHEST, V80, P392, DOI 10.1378/chest.80.4.392; ORENSTEIN DM, 1989, CHEST, V95, P344, DOI 10.1378/chest.95.2.344; ORENSTEIN DM, IN PRESS HUMAN KINET; SALH W, 1989, THORAX, V44, P1006, DOI 10.1136/thx.44.12.1006; TABLAN OC, 1985, J PEDIATR-US, V107, P382, DOI 10.1016/S0022-3476(85)80511-4; WAGENER JS, 1989, PERSPECTIVES CYSTIC, P236; ZINMAN R, 1989, J PEDIATR-US, V114, P368, DOI 10.1016/S0022-3476(89)80553-0	25	472	475	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	1992	327	25					1785	1788		10.1056/NEJM199212173272504	http://dx.doi.org/10.1056/NEJM199212173272504			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB975	1435933				2022-12-28	WOS:A1992KB97500004
J	SHAPIRO, ED; GERBER, MA; HOLABIRD, NB; BERG, AT; FEDER, HM; BELL, GL; RYS, PN; PERSING, DH				SHAPIRO, ED; GERBER, MA; HOLABIRD, NB; BERG, AT; FEDER, HM; BELL, GL; RYS, PN; PERSING, DH			A CONTROLLED TRIAL OF ANTIMICROBIAL PROPHYLAXIS FOR LYME-DISEASE AFTER DEER-TICK BITES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE CHAIN-REACTION; BORRELIA-BURGDORFERI; IXODES-DAMMINI; TRANSMISSION; ATTACHMENT; DURATION	Background. Borrelia burgdorferi, which causes Lyme disease, is transmitted by deer ticks (Ixodes dammini) in the northeastern and midwestern United States. Although deer-tick bites are common in areas in which the disease is endemic, there is uncertainty about how to manage the care of persons who are bitten. Methods. To assess the risk of infection with B. burgdorferi and the efficacy of prophylactic antimicrobial treatment after a deer-tick bite, we conducted a double-blind, placebo-controlled trial in an area of southeastern Connecticut in which Lyme disease is endemic. Children and adults who had been bitten by deer ticks were randomly assigned to receive either amoxicillin or placebo for 10 days. Subjects were followed for one year for clinical manifestations of Lyme disease. Serum samples obtained at enrollment and six weeks and three months later were tested for antibodies against B. burgdorferi. Results. Of the 387 subjects, 205 (53 percent) were assigned to receive amoxicillin and 182 (47 percent) to receive placebo. Of 344 deer ticks submitted and analyzed by the polymerase chain reaction, 15 percent were infected with B. burgdorferi. Erythema migrans developed in two subjects, both of whom had received placebo. There were no asymptomatic seroconversions and no late manifestations of Lyme disease. The risk of infection with B. burgdorferi in the placebo-treated subjects was 1.2 percent (95 percent confidence interval, 0.1 to 4.1 percent), which was not significantly different (P = 0.22) from the risk in the amoxicillin-treated subjects (0 percent; 95 percent confidence interval, 0 to 1.5 percent). Conclusions. Even in an area in which Lyme disease is endemic, the risk of infection with B. burgdorferi after a recognized deer-tick bite is so low that prophylactic antimicrobial treatment is not routinely indicated.	YALE UNIV,SCH MED,DEPT EPIDEMIOL,NEW HAVEN,CT 06510; UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06032; UNIV CONNECTICUT,CTR HLTH,DEPT FAMILY MED,FARMINGTON,CT 06032; MAYO CLIN & MAYO FDN,CLIN MICROBIOL SECT,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,INFECT DIS SECT,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,EXPTL PATHOL SECT,ROCHESTER,MN 55905	Yale University; University of Connecticut; University of Connecticut; Mayo Clinic; Mayo Clinic; Mayo Clinic	SHAPIRO, ED (corresponding author), YALE UNIV,SCH MED,DEPT PEDIAT,333 CEDAR ST,NEW HAVEN,CT 06510, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041497, R01AR040451] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI32403] Funding Source: Medline; NIAMS NIH HHS [R01-AR41497, R01-AR40451] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AGRE F, 1991, AM J DIS CHILD, V145, P391; ANDERSON JF, 1987, J CLIN MICROBIOL, V25, P1564, DOI 10.1128/JCM.25.8.1564-1566.1987; BARBOUR AG, 1983, INFECT IMMUN, V41, P795, DOI 10.1128/IAI.41.2.795-804.1983; BENACH JL, 1987, J INFECT DIS, V155, P1300, DOI 10.1093/infdis/155.6.1300; COSTELLO CM, 1989, J INFECT DIS, V159, P136, DOI 10.1093/infdis/159.1.136; DATTWYLER RJ, 1990, LANCET, V336, P1404, DOI 10.1016/0140-6736(90)93103-V; FALCO RC, 1992, 5TH INT C LYM BORR A, pA46; GRODZICKI RL, 1988, J INFECT DIS, V157, P790, DOI 10.1093/infdis/157.4.790; HANRAHAN JP, 1984, J INFECT DIS, V150, P489, DOI 10.1093/infdis/150.4.489; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; MAGID D, 1992, NEW ENGL J MED, V327, P534, DOI 10.1056/NEJM199208203270806; MAGNARELLI LA, 1988, AM J EPIDEMIOL, V127, P818, DOI 10.1093/oxfordjournals.aje.a114864; MALAWISTA SE, 1992, ARTHRITIS RHEUM, V35, P246, DOI 10.1002/art.1780350220; MARKOWITZ M, 1968, PEDIATRICS, V41, P151; MATUSCHKA FR, 1992, NEW ENGL J MED, V327, P542, DOI 10.1056/NEJM199208203270807; MEHTA C, 1991, STATXACT STATISTICAL; NADELMAN RB, 1992, 5TH INT C LYM BORR A, pA60; PERSING DH, 1990, SCIENCE, V249, P1420, DOI 10.1126/science.2402635; PERSING DH, 1990, J CLIN MICROBIOL, V28, P566, DOI 10.1128/JCM.28.3.566-572.1990; PERSING DH, 1991, J CLIN MICROBIOL, V29, P1281, DOI 10.1128/JCM.29.7.1281-1285.1991; PIESMAN J, 1991, J INFECT DIS, V163, P895, DOI 10.1093/infdis/163.4.895; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; PIESMAN J, 1992, 5TH INT C LYM BORR A, pA46; RAHN DW, 1991, ANN INTERN MED, V114, P472, DOI 10.7326/0003-4819-114-6-472; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1986, J INFECT DIS, V154, P295, DOI 10.1093/infdis/154.2.295; 1991, CONNECTCUT EPIDE JUN, V11, P14	28	159	165	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	1992	327	25					1769	1773		10.1056/NEJM199212173272501	http://dx.doi.org/10.1056/NEJM199212173272501			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB975	1435930				2022-12-28	WOS:A1992KB97500001
J	CAMPBELL, NRC; HASINOFF, BB; STALTS, H; RAO, B; WONG, NCW				CAMPBELL, NRC; HASINOFF, BB; STALTS, H; RAO, B; WONG, NCW			FERROUS SULFATE REDUCES THYROXINE EFFICACY IN PATIENTS WITH HYPOTHYROIDISM	ANNALS OF INTERNAL MEDICINE			English	Article						FERROUS COMPOUNDS; HYPOTHYROIDISM; THYROXINE; IRON; DRUG INTERACTIONS	METHYLDOPA ABSORPTION; IRON; MECHANISM; THERAPY	Objective: To determine whether simultaneous ingestion of ferrous sulfate and thyroxine reduces the efficacy of thyroid hormone in patients with primary hypothyroidism. Design: Uncontrolled clinical trial. Setting: Outpatient research clinic of a tertiary care center. Patients: Fourteen patients with established primary hypothyroidism on stable thyroxine replacement. Intervention: All patients were instructed to ingest simultaneously, a 300-mg ferrous sulfate tablet and their usual thyroxine dose every day for 12 weeks. Results: After 12 weeks of ferrous sulfate ingestion with thyroxine, the mean level of serum thyrotropin (thyroid stimulating hormone, TSH) rose from 1.6 +/- 0.4 to 5.4 +/- 2.8 mU/L (P < 0.01), but the free thyroxine index did not change significantly. Subjective evaluation using a clinical score showed that nine patients had an increase in symptoms and signs of hypothyroidism; the mean score for the 14 patients changed from 0 to 1.3 +/- 0.4 (P = 0.011). When iron and thyroxine were mixed together in vitro, a poorly soluble purple complex appeared that indicated the binding of iron to thyroxine. Conclusions. Simultaneous ingestion of ferrous sulfate and thyroxine causes a variable reduction in thyroxine efficacy that is clinically significant in some patients. The interaction is probably caused by the binding of iron to thyroxine.	UNIV MANITOBA, WINNIPEG R3T 2N2, MANITOBA, CANADA	University of Manitoba	CAMPBELL, NRC (corresponding author), UNIV CALGARY, FAC MED, DEPT MED, 3330 HOSP DR NW, CALGARY T2N 1N4, ALBERTA, CANADA.							BAYER MF, 1991, MED CLIN N AM, V75, P1; CAMPBELL N, 1988, CLIN PHARMACOL THER, V43, P381, DOI 10.1038/clpt.1988.47; CAMPBELL NRC, 1990, CLIN INVEST MED, V13, P329; CAMPBELL NRC, 1989, CLIN PHARMACOL THER, V45, P220, DOI 10.1038/clpt.1989.21; CAMPBELL NRC, 1990, BRIT J CLIN PHARMACO, V30, P599, DOI 10.1111/j.1365-2125.1990.tb03819.x; CAMPBELL NRC, 1992, BRIT J CLIN PHARMACO, V33, P115, DOI 10.1111/j.1365-2125.1992.tb04010.x; CAMPBELL NRC, 1991, BRIT J CLIN PHARMACO, V31, P251, DOI 10.1111/j.1365-2125.1991.tb05525.x; CAMPBELL RRA, 1990, CAN J PHYSIOL PHARM, V68, P603, DOI 10.1139/y90-087; COLLANGE E, 1983, B SOC CHEM, V1, P44; HELFAND M, 1990, ANN INTERN MED, V113, P450, DOI 10.7326/0003-4819-113-6-450; KARA M, 1991, BRIT J CLIN PHARMACO, V31, P257, DOI 10.1111/j.1365-2125.1991.tb05526.x; NEUVONEN PJ, 1970, BMJ-BRIT MED J, V4, P532, DOI 10.1136/bmj.4.5734.532; OSMAN MA, 1983, CLIN PHARMACOL THER, V33, P465, DOI 10.1038/clpt.1983.63; Simonsen L. La Piana, 1990, PHARM TIMES, V56, P56; TOFT AD, 1988, MAYO CLIN PROC, V63, P1035, DOI 10.1016/S0025-6196(12)64921-0; UTIGER RD, 1990, NEW ENGL J MED, V323, P126; ZAND R, 1967, BIOCHEMISTRY-US, V6, P999, DOI 10.1021/bi00856a007	17	147	150	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1992	117	12					1010	1013		10.7326/0003-4819-117-12-1010	http://dx.doi.org/10.7326/0003-4819-117-12-1010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB980	1443969				2022-12-28	WOS:A1992KB98000006
J	FAY, WP; SHAPIRO, AD; SHIH, JL; SCHLEEF, RR; GINSBURG, D				FAY, WP; SHAPIRO, AD; SHIH, JL; SCHLEEF, RR; GINSBURG, D			BRIEF REPORT - COMPLETE DEFICIENCY OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 DUE TO A FRAME-SHIFT MUTATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							POLYMERASE CHAIN-REACTION; ENDOTHELIAL-CELLS; VONWILLEBRAND DISEASE; PLASMA; GENE; BINDING; SYSTEM; LOCUS		UNIV MICHIGAN, MED CTR,SCH MED,DEPT INTERNAL MED,4520 MSRB 1, 1150 W MED CTR DR, ANN ARBOR, MI 48109 USA; ANN ARBOR VET AFFAIRS HOSP, DIV CARDIOL, ANN ARBOR, MI USA; ANN ARBOR VET AFFAIRS HOSP, RES SERV, ANN ARBOR, MI USA; INDIANA UNIV, MED CTR, INDIANAPOLIS, IN 46204 USA; SCRIPPS RES INST, COMM VASC BIOL, LA JOLLA, CA USA; UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48104 USA; UNIV MICHIGAN, SCH MED, HOWARD HUGHES MED INST, ANN ARBOR, MI 48104 USA	University of Michigan System; University of Michigan; Indiana University System; Indiana University-Purdue University Indianapolis; Scripps Research Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045954, R01HL039137] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-39137, HL-45954] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOSMA PJ, 1988, J BIOL CHEM, V263, P9129; BRODBECK RM, 1992, J BIOL CHEM, V267, P294; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CARRELL RW, 1989, MOL BIOL MED, V6, P35; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; COONEY KA, 1991, J CLIN INVEST, V87, P1227, DOI 10.1172/JCI115123; DAWSON S, 1991, ARTERIOSCLER THROMB, V11, P183, DOI 10.1161/01.ATV.11.1.183; DIEVAL J, 1991, BLOOD, V77, P528; ERICKSON LA, 1985, P NATL ACAD SCI USA, V82, P8710, DOI 10.1073/pnas.82.24.8710; ERICKSON LA, 1990, NATURE, V346, P74, DOI 10.1038/346074a0; GINSBURG D, 1986, J CLIN INVEST, V78, P1673, DOI 10.1172/JCI112761; GINSBURG D, 1989, P NATL ACAD SCI USA, V86, P3723, DOI 10.1073/pnas.86.10.3723; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; HANSON CA, 1990, AM J PATHOL, V137, P1; LIU YX, 1991, EUR J BIOCHEM, V195, P549, DOI 10.1111/j.1432-1033.1991.tb15736.x; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; ROTH MS, 1990, TRANSPLANTATION, V49, P714, DOI 10.1097/00007890-199004000-00012; Sambrook J, 1989, MOL CLONING LABORATO; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; SCHLEEF RR, 1989, J CLIN INVEST, V83, P1747, DOI 10.1172/JCI114076; SCHLEEF RR, 1985, J LAB CLIN MED, V106, P408; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SHERMAN PM, 1992, J BIOL CHEM, V267, P7588; SORDAT B, 1990, CELL DIFFER DEV, V32, P277, DOI 10.1016/0922-3371(90)90040-4; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; WIMAN B, 1985, J LAB CLIN MED, V105, P265	28	219	228	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	1992	327	24					1729	1733		10.1056/NEJM199212103272406	http://dx.doi.org/10.1056/NEJM199212103272406			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA897	1435917	Bronze			2022-12-28	WOS:A1992KA89700006
J	PLEHN, JF; SOUTHWORTH, J; CORNWELL, GG				PLEHN, JF; SOUTHWORTH, J; CORNWELL, GG			ATRIAL SYSTOLIC FAILURE IN PRIMARY AMYLOIDOSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							SPONTANEOUS ECHO CONTRAST; MITRAL-VALVE DISEASE; CARDIAC AMYLOIDOSIS; CONSTRICTIVE PERICARDITIS; MUSCULAR-DYSTROPHY; DIASTOLIC FUNCTION; CARDIOMYOPATHY; FIBRILLATION; CONDUCTION; STANDSTILL		DARTMOUTH COLL,HITCHCOCK MED CTR,DEPT MED,HEMATOL ONCOL SECT,HANOVER,NH 03756	Dartmouth College	PLEHN, JF (corresponding author), DARTMOUTH COLL,HITCHCOCK MED CTR,DEPT MED,CARDIOL SECT,1 MED CTR DR,HANOVER,NH 03756, USA.							BALDWIN BJ, 1973, AM J CARDIOL, V31, P649, DOI 10.1016/0002-9149(73)90337-8; BEPPU S, 1985, J AM COLL CARDIOL, V6, P744, DOI 10.1016/S0735-1097(85)80476-9; BLACK IW, 1991, J AM COLL CARDIOL, V18, P398, DOI 10.1016/0735-1097(91)90592-W; CHEW C, 1975, AM J CARDIOL, V36, P438, DOI 10.1016/0002-9149(75)90891-7; DANIEL WG, 1988, J AM COLL CARDIOL, V11, P1204, DOI 10.1016/0735-1097(88)90283-5; FALK RH, 1987, AM J CARDIOL, V59, P418, DOI 10.1016/0002-9149(87)90948-9; GREENBERG B, 1979, AM HEART J, V98, P742, DOI 10.1016/0002-8703(79)90473-3; GUNNAR RM, 1955, CIRCULATION, V12, P827, DOI 10.1161/01.CIR.12.5.827; HOSENPUD JD, 1991, CIRCULATION, V84, P338; JOSSELSON AJ, 1952, AMA ARCH PATHOL, V54, P359; KLEIN AL, 1991, CIRCULATION, V83, P808, DOI 10.1161/01.CIR.83.3.808; KLEIN AL, 1989, J AM COLL CARDIOL, V13, P1017, DOI 10.1016/0735-1097(89)90254-4; MAEDA S, 1988, BRIT HEART J, V59, P498; MEANEY E, 1976, AM J CARDIOL, V38, P547, DOI 10.1016/S0002-9149(76)80001-X; PERLOFF JK, 1984, J AM COLL CARDIOL, V3, P1263, DOI 10.1016/S0735-1097(84)80186-2; PLEHN JF, 1986, CIRCULATION, V74, P451; PLEHN JF, 1986, J AM COLL CARDIOL, V7, pA97; ROBERTS WC, 1983, AM J CARDIOL, V52, P137, DOI 10.1016/0002-9149(83)90084-X; ROBINSON K, 1990, J AM COLL CARDIOL, V15, P1279, DOI 10.1016/S0735-1097(10)80014-2; ROKAS S, 1990, INT J CARDIOL, V26, P75, DOI 10.1016/0167-5273(90)90250-9; RUFF P, 1979, AM HEART J, V98, P413, DOI 10.1016/0002-8703(79)90245-X; SIMPSON RJ, 1982, AM J CARDIOL, V50, P1331, DOI 10.1016/0002-9149(82)90471-4; SWANTON RH, 1977, AM J CARDIOL, V39, P658, DOI 10.1016/S0002-9149(77)80125-2; TYBERG TI, 1981, AM J CARDIOL, V47, P791, DOI 10.1016/0002-9149(81)90175-2; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; WOOLLISCROFT J, 1982, AM J CARDIOL, V49, P2037, DOI 10.1016/0002-9149(82)90226-0	26	56	57	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1570	1573		10.1056/NEJM199211263272205	http://dx.doi.org/10.1056/NEJM199211263272205			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435884	Bronze			2022-12-28	WOS:A1992JZ43200005
J	CRETICOS, PS				CRETICOS, PS			IMMUNOTHERAPY WITH ALLERGENS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLLEN HAY-FEVER; RAGWEED-POLLEN; DOUBLE-BLIND; NASAL CHALLENGE; SEASONAL ASTHMA; RINKEL METHOD; FACTOR HRF; HISTAMINE; RESPONSES; MEDIATORS				CRETICOS, PS (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DIV ALLERGY CLIN IMMUNOL,BALTIMORE,MD 21205, USA.							ALAM R, 1987, J ALLERGY CLIN IMMUN, V79, P103, DOI 10.1016/S0091-6749(87)80023-4; BOUSQUET J, 1985, J ALLERGY CLIN IMMUN, V76, P734, DOI 10.1016/0091-6749(85)90680-3; BUSH RK, 1991, ALLERGEN IMMUNOTHERA, P25; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; CRETICOS PS, 1985, J CLIN INVEST, V76, P2247, DOI 10.1172/JCI112233; CRETICOS PS, 1989, J ALLERGY CLIN IMMUN, V84, P197, DOI 10.1016/0091-6749(89)90325-4; CRETICOS PS, 1987, JAMA-J AM MED ASSOC, V258, P2874, DOI 10.1001/jama.258.20.2874; CRETICOS PS, 1989, J ALLERGY CLIN IMMUN, V83, P554, DOI 10.1016/0091-6749(89)90037-7; CRETICOS PS, 1992, J ALLERGY CLIN IMMUN, V12, P13; EVANS R, 1976, J CLIN INVEST, V57, P1378, DOI 10.1172/JCI108406; FRANKLIN W, 1967, JAMA-J AM MED ASSOC, V201, P95; FURIN MJ, 1991, J ALLERGY CLIN IMMUN, V88, P27, DOI 10.1016/0091-6749(91)90297-2; ILIOPOULOS O, 1991, J ALLERGY CLIN IMMUN, V87, P855, DOI 10.1016/0091-6749(91)90134-A; ISHIZAKA K, 1968, J ALLERGY, V42, P330, DOI 10.1016/0021-8707(68)90095-6; KING TP, 1962, BIOCHEMISTRY-US, V1, P709, DOI 10.1021/bi00910a027; KUNA P, 1989, J ALLERGY CLIN IMMUN, V83, P816, DOI 10.1016/0091-6749(89)90020-1; LICHTENSTEIN LM, 1971, ANN INTERN MED, V75, P663, DOI 10.7326/0003-4819-75-5-663; Loveless MH, 1943, J IMMUNOL, V47, P165; LOWELL FC, 1963, J ALLERGY, V34, P165, DOI 10.1016/0021-8707(63)90069-8; MAJCHEL AM, IN PRESS J ALLERGY C; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; NORMAN PS, 1968, J ALLERGY, V42, P93, DOI 10.1016/0021-8707(68)90139-1; NORMAN PS, 1990, J ALLERGY CLIN IMMUN, V85, P88, DOI 10.1016/0091-6749(90)90227-U; NORMAN PS, 1978, J ALLERGY CLIN IMMUN, V61, P370, DOI 10.1016/0091-6749(78)90116-1; NORMAN PS, 1990, RESPIR ALLERGY, V2, P3; OHMAN JL, 1991, ALLERGEN IMMUNOTHERA, P209; PLATTSMILLS TAE, 1976, J CLIN INVEST, V57, P1041, DOI 10.1172/JCI108346; REID MJ, 1986, J ALLERGY CLIN IMMUN, V78, P590, DOI 10.1016/0091-6749(86)90076-X; ROCKLIN RE, 1974, J CLIN INVEST, V53, P735, DOI 10.1172/JCI107612; SUNDIN B, 1986, J ALLERGY CLIN IMMUN, V77, P478, DOI 10.1016/0091-6749(86)90183-1; TAYLOR WW, 1978, J ALLERGY CLIN IMMUN, V61, P283, DOI 10.1016/0091-6749(78)90048-9; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; VANMETRE TE, 1980, J ALLERGY CLIN IMMUN, V65, P288, DOI 10.1016/0091-6749(80)90158-X; VANMETRE TE, 1980, J ALLERGY CLIN IMMUN, V66, P500, DOI 10.1016/0091-6749(80)90012-3	34	46	48	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2834	2839		10.1001/jama.268.20.2834	http://dx.doi.org/10.1001/jama.268.20.2834			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433698				2022-12-28	WOS:A1992JY66800006
J	LOCKEY, RF				LOCKEY, RF			FUTURE-TRENDS IN ALLERGY AND IMMUNOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL IMMUNOLOGY		JAMES A HALEY VET ADM HOSP,ALLERGY & IMMUNOL SECT,TAMPA,FL	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	LOCKEY, RF (corresponding author), UNIV S FLORIDA,COLL MED,DIV ALLERGY IMMUNOL,TAMPA,FL 33612, USA.							DOLOVICH J, 1989, PRACTITIONER, V233, P551; Flexner A, 1910, MED ED US CANADA, P85; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; NOSSAL GJV, 1988, IMMUNOL TODAY, V9, P286, DOI 10.1016/0167-5699(88)91316-3; POPE BL, 1989, CAN J PHYSIOL PHARM, V67, P537, DOI 10.1139/y89-087; ROGERS DJ, 1987, MED LAB SCI, V44, P376; SALVAGGIO JE, 1987, JAMA-J AM MED ASSOC, V258, P3032; SAMTER M, 1987, POSTGRAD MED, V82, P147, DOI 10.1080/00325481.1987.11700003; STROBER W, 1991, J ALLERGY CLIN IMMUN, V88, P815, DOI 10.1016/0091-6749(91)90190-Y; 1991, US MED SCH FINANCE 1; 1991, US MED SCH FINANCE 2; IN PRESS SURVEY ALLE; 1987, CLIN EXP IMMUNOL, V70, P664	13	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2991	2992						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433718				2022-12-28	WOS:A1992JY66800027
J	HENDRIX, RW; DUDA, RL				HENDRIX, RW; DUDA, RL			BACTERIOPHAGE-LAMBDA PAPA - NOT THE MOTHER OF ALL LAMBDA-PHAGES	SCIENCE			English	Article							EVEN-TYPE BACTERIOPHAGES; TAIL FIBER PROTEIN; ESCHERICHIA-COLI; RECEPTOR; COMPONENT; SEQUENCE; ENCODES; GENOME; GENE	The common laboratory strain of bacteriophage lambda-lambda wild type or lambdaPaP-carries a frameshift mutation relative to Ur-lambda, the original isolate. The Ur-lambda virions have thin, jointed tail fibers that are absent from lambda wild type. Two novel proteins of Ur-lambda constitute the fibers: the product of stf, the gene that is disrupted in lambda wild type by the frameshift mutation, and the product of gene tfa, a protein that is implicated in facilitating tail fiber assembly. Relative to lambda wild type, Ur-lambda has expanded receptor specificity and adsorbs to Escherichia coli cells more rapidly.			HENDRIX, RW (corresponding author), UNIV PITTSBURGH, DEPT BIOL SCI, PITTSBURGH, PA 15260 USA.			Duda, Robert/0000-0002-9517-2731	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047795] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47795, R01 GM047795] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; DICKSON RC, 1973, J MOL BIOL, V79, P633, DOI 10.1016/0022-2836(73)90068-5; DOVE WF, 1969, VIROLOGY, V38, P349, DOI 10.1016/0042-6822(69)90378-X; DREXLER K, 1991, J MOL BIOL, V219, P655, DOI 10.1016/0022-2836(91)90662-P; GEORGE DG, 1983, BIOCHEM BIOPH RES CO, V115, P1061, DOI 10.1016/S0006-291X(83)80043-6; HAGGARDLJUNGQUIST E, 1992, J BACTERIOL, V174, P1462, DOI 10.1128/jb.174.5.1462-1477.1992; Hendrix R. W., 1971, BACTERIOPHAGE LAMBDA, P355; HENDRIX RW, UNPUB; IIDA S, 1984, VIROLOGY, V134, P421, DOI 10.1016/0042-6822(84)90309-X; JACOB F, 1954, ANN I PASTEUR PARIS, V87, P653; KAISER AD, 1957, VIROLOGY, V3, P42, DOI 10.1016/0042-6822(57)90022-3; KAISER AD, COMMUNICATION; KAR S, 1983, THESIS U PITTSBURGH; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; KOCH C, 1987, PHAGE MU, P75; LEDERBERG EM, 1951, GENETICS, V36, P560; MICHEL CJ, 1986, GENE, V44, P147, DOI 10.1016/0378-1119(86)90055-7; MONTAG D, 1987, J BACTERIOL, V169, P5884, DOI 10.1128/jb.169.12.5884-5886.1987; MONTAG D, 1987, J MOL BIOL, V196, P165, DOI 10.1016/0022-2836(87)90519-5; MONTAG D, 1989, J BACTERIOL, V171, P4378, DOI 10.1128/JB.171.8.4378-4384.1989; MOUNT DWA, 1968, VIROLOGY, V35, P134, DOI 10.1016/0042-6822(68)90313-9; POPA MP, 1991, J VIROL, V65, P3227, DOI 10.1128/JVI.65.6.3227-3237.1991; RANDALLH.L, 1973, J BACTERIOL, V116, P1436, DOI 10.1128/JB.116.3.1436-1446.1973; REEVE JN, 1979, MOL GEN GENET, V172, P243, DOI 10.1007/BF00271723; RIEDE I, 1987, J MOL BIOL, V194, P23, DOI 10.1016/0022-2836(87)90712-1; SAIGO K, 1978, VIROLOGY, V85, P422, DOI 10.1016/0042-6822(78)90449-X; SANDMEIER H, 1992, J BACTERIOL, V174, P3936, DOI 10.1128/jb.174.12.3936-3944.1992; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SHINAGAW.H, 1966, BIKEN J, V9, P135; THIRION JP, 1972, GENETICS, V71, P207; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; WARD S, 1971, J MOL BIOL, V62, P479, DOI 10.1016/0022-2836(71)90149-5; WOOD WB, 1983, BACTERIOPHAGE T4, P259; [No title captured]	34	98	102	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	1992	258	5085					1145	1148		10.1126/science.1439823	http://dx.doi.org/10.1126/science.1439823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439823				2022-12-28	WOS:A1992JX85200031
J	WILLIAMS, JW; SIMEL, DL; ROBERTS, L; SAMSA, GP				WILLIAMS, JW; SIMEL, DL; ROBERTS, L; SAMSA, GP			CLINICAL-EVALUATION FOR SINUSITIS - MAKING THE DIAGNOSIS BY HISTORY AND PHYSICAL-EXAMINATION	ANNALS OF INTERNAL MEDICINE			English	Article						SINUSITIS; TRANSILLUMINATION; RHINITIS; DIAGNOSIS, DIFFERENTIAL; TOOTHACHE	ACUTE MAXILLARY SINUSITIS; BACTERIAL SINUSITIS	Objective: To identify the most useful clinical examination findings for the diagnosis of acute and subacute sinusitis. Design: Prospective comparison of clinical findings with radiographs. Setting: General medicine clinics at a university-affiliated Veterans Affairs Medical Center. Patients: Two hundred forty-seven consecutive adult men with rhinorrhea (51%), facial pain (22%), or self-suspected sinusitis (27%) (median age, 50 years; median duration of symptoms, 11.5 days). Measurements: Patients were examined by a principal investigator (86%) or by a staff general internist, internal medicine resident (postgraduate year 2 or 3), or physician assistant, all blinded to radiographic results. All examiners recorded the presence or absence of 16 historical items, 5 physical examination items, and the clinical impression for sinusitis (high, intermediate, or low probability). The criterion standard was paranasal sinus radiographs (4 views), which were interpreted by radiologists blinded to clinical findings. Results: Thirty-eight percent of patients meeting entrance criteria had sinusitis. Sensitivity, specificity, and likelihood ratios were measured for clinical items. Logistic regression analysis showed five independent predictors of sinusitis: maxillary toothache (odds ratio, 2.9), transillumination (odds ratio, 2.7), poor response to nasal decongestants or antihistamines (odds ratio, 2.4), colored nasal discharge reported by the patient (odds ratio, 2.2), or mucopurulence seen during examination (odds ratio, 2.9). The overall clinical impression was more accurate than any single finding: high probability (likelihood ratio, 4.7), intermediate (likelihood ratio, 1.4), low probability (likelihood ratio, 0.4). Conclusions: General internists, focusing on five clinical findings and their overall clinical impression, can effectively stratify male patients with sinus symptoms as having a high, intermediate, or low probability of sinusitis.	VET ADM MED CTR, DURHAM, NC 27705 USA; DUKE UNIV, MED CTR, DURHAM, NC 27710 USA; UNIV TEXAS, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; University of Texas System; University of Texas Health San Antonio	WILLIAMS, JW (corresponding author), AUDIE L MURPHY MEM VET ADM MED CTR, 11C, 7400 MERTON MINTER BLVD, SAN ANTONIO, TX 78284 USA.		Williams, John/AAM-4572-2020; Williams, John W/A-3696-2008	Williams, John/0000-0002-5267-5558; Williams, John W/0000-0002-5267-5558				AXELSSON A, 1970, ACTA OTO-LARYNGOL, V69, P302, DOI 10.3109/00016487009123368; AXELSSON A, 1970, ACTA OTO-LARYNGOL, V70, P71, DOI 10.3109/00016487009181861; AXELSSON A, 1976, ORL J OTO-RHINO-LARY, V38, P298, DOI 10.1159/000275288; AXELSSON A, 1983, ANN OTO RHINOL LARYN, V92, P75, DOI 10.1177/000348948309200118; AXELSSON A, 1974, AM J ROENTGENOL, V122, P621, DOI 10.2214/ajr.122.3.621; BALLINGER PW, 1991, MERRILLS ATLAS RADIO, P364; BATES B, 1991, PHYSICAL EXAMINATION, P189; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; EVANS FO, 1975, NEW ENGL J MED, V293, P735, DOI 10.1056/NEJM197510092931502; FLEISS JL, 1981, STATISTICAL METHODS, P112; GLECKMAN RA, 1986, HOSP PRACT, V21, P92; GLECKMAN RA, 1986, HOSPITAL PRACT, V21, P100; HAMORY BH, 1979, J INFECT DIS, V139, P197, DOI 10.1093/infdis/139.2.197; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1990, SAS STAT USERS GUIDE, P175; HARVEY BS, 1987, PRIMARY CARE MED, P883; HAVAS TE, 1988, ARCH OTOLARYNGOL, V114, P856; Hosmer D., 1989, APPL LOGISTIC REGRES, P82; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MEYERS BR, 1984, J FAM PRACTICE, V18, P117; NORRBY R, 1983, SCAND J INFECT DIS, P14; Ramsey P G, 1985, Emerg Med Clin North Am, V3, P143; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; SIMEL DL, 1987, MED DECIS MAKING, V7, P107, DOI 10.1177/0272989X8700700208; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; WALD ER, 1986, PEDIATRICS, V77, P795; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; WILLIAMS JW, 1992, IN PRESS J GEN INTER, P6; YARINGTON CT, 1979, OTOLARYNG CLIN N AM, V12, P447	32	180	184	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					705	710		10.7326/0003-4819-117-9-705	http://dx.doi.org/10.7326/0003-4819-117-9-705			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416571				2022-12-28	WOS:A1992JV42400001
J	BROCKDORFF, N; ASHWORTH, A; KAY, GF; MCCABE, VM; NORRIS, DP; COOPER, PJ; SWIFT, S; RASTAN, S				BROCKDORFF, N; ASHWORTH, A; KAY, GF; MCCABE, VM; NORRIS, DP; COOPER, PJ; SWIFT, S; RASTAN, S			THE PRODUCT OF THE MOUSE XIST GENE IS A 15 KB INACTIVE X-SPECIFIC TRANSCRIPT CONTAINING NO CONSERVED ORF AND LOCATED IN THE NUCLEUS	CELL			English	Article							POSITION-EFFECT VARIEGATION; CPG-RICH ISLANDS; CHROMOSOME INACTIVATION; MESSENGER-RNA; CONTROLLING ELEMENTS; H19 GENE; DNA; METHYLATION; EXPRESSION; REGION	The Xist gene maps to the X inactivation center region in both mouse and human, and previous analysis of the 3' end of the gene has demonstrated inactive X-specific expression, suggesting a possible role in X inactivation. We have now analyzed the entire mouse Xist gene. The mature inactive X-specific transcript is 15 kb in length and contains no conserved ORF. The Xist sequence contains a number of regions comprised of tandem repeats. Comparison with the human XIST gene demonstrates significant conservation of sequence and gene structure. Xist RNA is not associated with the translational machinery of the cell and is located almost exclusively in the nucleus. Together with conservation of inactive X-specific expression, these findings support a role for Xist in X inactivation, possibly as a functional RNA or as a chromatin organizer region.	INST CANC RES,CHESTER BEATTY LABS,LONDON SW3 6JB,ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	BROCKDORFF, N (corresponding author), MRC,CTR CLIN RES,COMPARAT BIOL SECT,HARROW HA1 3UJ,MIDDX,ENGLAND.		Kay, Graham F/A-4130-2011	Brockdorff, Neil/0000-0003-4838-2653				ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1989, NUCLEIC ACIDS RES, V17, P1315, DOI 10.1093/nar/17.4.1315; BROCKDORFF N, 1991, GENOMICS, V10, P17, DOI 10.1016/0888-7543(91)90478-W; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BROWN CJ, 1990, AM J HUM GENET, V46, P273; Cattanach B. M., 1989, MOUSE NEWS LETT, V83, P165; CATTANACH BM, 1981, GENET RES, V38, P57, DOI 10.1017/S0016672300020401; CATTANACH BM, 1983, MOUSE NEWS LETT, V69, P24; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; CHARTIER FL, 1992, NAT GENET, V1, P132, DOI 10.1038/ng0592-132; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOVER GA, 1989, TRENDS GENET, V5, P100, DOI 10.1016/0168-9525(89)90038-3; FINI ME, 1989, J CELL BIOL, V6, P2045; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; GOMEZMARQUEZ J, 1985, J BIOL CHEM, V260, P3490; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; HERMAN GE, 1991, GENOMICS, V10, P961, DOI 10.1016/0888-7543(91)90186-I; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; KANDA N, 1973, EXP CELL RES, V80, P463, DOI 10.1016/0014-4827(73)90324-8; KLEENE KC, 1984, DEV BIOL, V105, P71, DOI 10.1016/0012-1606(84)90262-8; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LEE SY, 1971, BIOCHEMISTRY-US, V10, P510, DOI 10.1021/bi00779a025; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; LIEBOVITCH MP, 1991, BIOCHEM BIOPH RES CO, V180, P1241; LYON MF, 1961, NATURE, V190, P373; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; PARO R, 1990, TRENDS GENET, V6, P416, DOI 10.1016/0168-9525(90)90303-N; PFEIFER GP, 1990, GENE DEV, V4, P1277, DOI 10.1101/gad.4.8.1277; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; POIRIER F, 1991, DEVELOPMENT, V113, P1105; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; RASTAN S, 1990, GENET RES, V56, P99, DOI 10.1017/S0016672300035163; RASTAN S, 1980, NATURE, V288, P172, DOI 10.1038/288172a0; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHERER SE, 1988, NUCLEIC ACIDS RES, V16, P1593, DOI 10.1093/nar/16.4.1593; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11262; VANDEPUTTE P, 1980, NATURE, V286, P218, DOI 10.1038/286218a0; WELLS RD, 1988, J BIOL CHEM, V263, P1095; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	59	817	858	4	48	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					515	526		10.1016/0092-8674(92)90519-I	http://dx.doi.org/10.1016/0092-8674(92)90519-I			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423610				2022-12-28	WOS:A1992JW43500016
J	FISHMANLOBELL, J; HABER, JE				FISHMANLOBELL, J; HABER, JE			REMOVAL OF NONHOMOLOGOUS DNA ENDS IN DOUBLE-STRAND BREAK RECOMBINATION - THE ROLE OF THE YEAST ULTRAVIOLET REPAIR GENE RAD1	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXCISION; INCISION; LOCUS	Double-strand breaks (DSBs) in Saccharomyces cerevisiae can be repaired by gene conversions or by deletions resulting from single-strand annealing between direct repeats of homologous sequences. Although rad1 mutants are resistant to x-rays and can complete DSB-mediated mating-type switching, they could not complete recombination when the ends of the break contained approximately 60 base pairs of nonhomology. Recombination was restored when the ends of the break were made homologous to donor sequences. Additionally, the absence of RAD1 led to the frequent appearance of a previously unobserved type of recombination product. These data suggest RAD1 is required to remove nonhomologous DNA from the 3' ends of recombining DNA, a process analogous to the excision of photodimers during repair of ultraviolet-damaged DNA.	BRANDEIS UNIV,ROSENSTIEL BASIC MED SCI RES CTR,WALTHAM,MA 02254; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254	Brandeis University; Brandeis University				Haber, James/0000-0002-1878-0610	NIGMS NIH HHS [GM20056, GM01722] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R37GM020056] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; FISHMANLOBELL J, UNPUB; FISHMANLOBELL J, 1992, THESIS BRANDEIS U; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; KLEIN HL, 1988, GENETICS, V120, P367; KOSTRIKEN R, 1984, COLD SPRING HARB SYM, V49, P89, DOI 10.1101/SQB.1984.049.01.012; KOSTRIKEN R, 1983, CELL, V35, P167, DOI 10.1016/0092-8674(83)90219-2; MILLER RD, 1982, MOL CELL BIOL, V2, P939, DOI 10.1128/MCB.2.8.939; RAY BL, 1991, MOL CELL BIOL, V11, P5372, DOI 10.1128/MCB.11.10.5372; REYNOLDS RJ, 1981, J BACTERIOL, V146, P692, DOI 10.1128/JB.146.2.692-704.1981; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; RUDIN N, 1989, GENETICS, V122, P519; SCHIESTL RH, 1988, MOL CELL BIOL, V8, P3619, DOI 10.1128/MCB.8.9.3619; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P6516; SNOW R, 1968, MUTAT RES, V6, P409, DOI 10.1016/0027-5107(68)90058-4; SOKAL RR, 1969, BIOMETRY, P599; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; THOMAS BJ, 1989, GENETICS, V123, P725; WEIFFENBACH B, 1983, P NATL ACAD SCI-BIOL, V80, P3401, DOI 10.1073/pnas.80.11.3401; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; WILCOX DR, 1981, J BACTERIOL, V148, P618, DOI 10.1128/JB.148.2.618-623.1981; ZEHFUS BR, 1990, GENETICS, V126, P41	24	314	324	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					480	484		10.1126/science.1411547	http://dx.doi.org/10.1126/science.1411547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411547				2022-12-28	WOS:A1992JT77500041
J	LUO, Y; FUJII, H; GERSTER, T; ROEDER, RG				LUO, Y; FUJII, H; GERSTER, T; ROEDER, RG			A NOVEL B-CELL DERIVED COACTIVATOR POTENTIATES THE ACTIVATION OF IMMUNOGLOBULIN PROMOTERS BY OCTAMER-BINDING TRANSCRIPTION FACTORS	CELL			English	Article							HEAVY-CHAIN PROMOTER; POU-DOMAIN; GENE-TRANSCRIPTION; PROTEIN-BINDING; HELA-CELLS; EXPRESSION; OCT-1; DNA; ELEMENTS; INVITRO	A novel B cell-restricted activity, required for high levels of octamer/Oct-dependent transcription from an immunoglobulin heavy chain (IgH) promoter, was detected in an in vitro system consisting of HeLa cell-derived extracts complemented with fractionated B cell nuclear proteins. The factor responsible for this activity was designated Oct coactivator from B cells (OCA-B). OCA-B stimulates the transcription from an IgH promoter in conjunction with either Oct-1 or Oct-2 but shows no significant effect on the octamer/Oct-dependent transcription of the ubiquitously expressed histone H2B promoter and the transcription of USF- and Sp1-regulated promoters. Taken together, our results suggest that OCA-B is a tissue-, promoter-, and factor-specific coactivator and that OCA-B may be a major determinant for B cell-specific activation of immunoglobulin promoters. In light of the evidence showing physical and functional interactions between Oct factors and OCA-B, we propose a mechanism of action for OCA-B and discuss the implications of OCA-B for the transcriptional regulation of other tissue-specific promoters.			LUO, Y (corresponding author), ROCKEFELLER UNIV, BIOCHEM & MOLEC BIOL LAB, NEW YORK, NY 10021 USA.							COCKERILL PN, 1990, MOL CELL BIOL, V10, P1293, DOI 10.1128/MCB.10.3.1293; DEFRANCO AL, 1987, ANNU REV CELL BIOL, V3, P143; DENTE L, 1985, DNA CLONING PRACTICA, V1, P101; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GERSTER T, 1987, EMBO J, V6, P1323, DOI 10.1002/j.1460-2075.1987.tb02371.x; GERSTER T, 1990, EMBO J, V9, P1635, DOI 10.1002/j.1460-2075.1990.tb08283.x; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; HARVEY RP, 1982, NUCLEIC ACIDS RES, V10, P7851, DOI 10.1093/nar/10.23.7851; HATZOPOULOS AK, 1990, DEVELOPMENT, V109, P349; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HIMMELFARB HJ, 1990, CELL, V63, P1299, DOI 10.1016/0092-8674(90)90425-E; JENUWEIN T, 1991, GENE DEV, V5, P932, DOI 10.1101/gad.5.6.932; JOHNSON DG, 1990, MOL CELL BIOL, V10, P982, DOI 10.1128/MCB.10.3.982; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LANDOLFI NF, 1986, NATURE, V323, P548, DOI 10.1038/323548a0; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LUO Y, 1991, MOL CELL BIOL, V11, P3660, DOI 10.1128/MCB.11.7.3660; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; MIZUSHIMASUGANO J, 1986, P NATL ACAD SCI USA, V83, P8511, DOI 10.1073/pnas.83.22.8511; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; MULLERIMMERGLUCK MM, 1990, EMBO J, V9, P1625, DOI 10.1002/j.1460-2075.1990.tb08282.x; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; OHARE P, 1988, CELL, V52, P435, DOI 10.1016/S0092-8674(88)80036-9; PARRY HD, 1989, TRENDS BIOCHEM SCI, V14, P15, DOI 10.1016/0968-0004(89)90083-2; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; POELLINGER L, 1989, NATURE, V337, P573, DOI 10.1038/337573a0; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STUNNENBERG HG, 1988, NUCLEIC ACIDS RES, V16, P2431, DOI 10.1093/nar/16.6.2431; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; WIRTH T, 1991, NUCLEIC ACIDS RES, V19, P43, DOI 10.1093/nar/19.1.43; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; YAMAMOTO T, 1992, P NATL ACAD SCI USA, V89, P2844, DOI 10.1073/pnas.89.7.2844	49	247	251	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	1992	71	2					231	241		10.1016/0092-8674(92)90352-D	http://dx.doi.org/10.1016/0092-8674(92)90352-D			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423591				2022-12-28	WOS:A1992JU39500009
J	KOBAYASHI, T; STORRIE, B; SIMONS, K; DOTTI, CG				KOBAYASHI, T; STORRIE, B; SIMONS, K; DOTTI, CG			A FUNCTIONAL BARRIER TO MOVEMENT OF LIPIDS IN POLARIZED NEURONS	NATURE			English	Article							DEPENDENT SODIUM-CHANNELS; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; EPITHELIAL-CELL; INFLUENZA-VIRUS; TIGHT JUNCTIONS; GOLGI-APPARATUS; MAMMALIAN SPERM; MDCK CELLS; DOMAINS	IN polarized neurons, axons and dendrites perform different functions, which are reflected in their different molecular organization. Studies on the sorting of viral and endogenous glycoproteins in epithelial cells and hippocampal neurons suggest that there may be similarities in the mechanism of sorting in these two cell types1-3. The mechanisms that maintain the distinct composition of the two plasma membrane domains in these two cell types must, however, be different. We have proposed the existence of a functional barrier at the axonal hillock/initial segment which prevents the intermixing of membrane constituents1,2. Here we test this hypothesis by fusing liposomes containing fluorescent phospholipids into the plasma membrane of polarized hippocampal cells in culture. Fusion was induced by lowering the pH and mediated by influenza virus haemagglutinin expressed on the axonal surface of neurons infected with fowl plague virus. Labelling was found exclusively on axons after fusion. Although the fused lipids were mobile on the axonal membrane, no labelling was detected on the cell body and dendritic surfaces. These results suggest that there is a diffusion barrier at the axonal hillock/initial segment which maintains the compositional differences between the axonal and somatodendritic domains.	EUROPEAN MOLEC BIOL LAB, CELL BIOL PROGRAM, POSTFACH 102209, W-6900 HEIDELBERG, GERMANY; VIRGINIA POLYTECH INST & STATE UNIV, DEPT BIOCHEM, BLACKSBURG, VA 24061 USA	European Molecular Biology Laboratory (EMBL); Virginia Polytechnic Institute & State University			KOBAYASHI, TOSHIHIDE/S-8313-2019; Dotti, Carlos G/I-5533-2015; Kobayashi, Toshihide/B-6298-2015	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Dotti, Carlos G/0000-0003-4052-1719; Kobayashi, Toshihide/0000-0002-4811-7270; Simons, Kai/0000-0002-9231-9996				ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; Banker G., 1991, CULTURING NERVE CELL; COWAN AE, 1987, J CELL BIOL, V104, P917, DOI 10.1083/jcb.104.4.917; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; FRIEND DS, 1974, J CELL BIOL, V63, P641, DOI 10.1083/jcb.63.2.641; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; GUMBINER B, 1987, AM J PHYSIOL, V253, pC749, DOI 10.1152/ajpcell.1987.253.6.C749; HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605; KOBAYASHI T, 1988, CELL, V55, P797, DOI 10.1016/0092-8674(88)90135-3; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; NELSON WJ, 1989, J CELL BIOL, V108, P893, DOI 10.1083/jcb.108.3.893; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; PAGANO RE, 1989, METHOD CELL BIOL, V29, P75; Peters A., 1991, FINE STRUCTURE NERVO; POWELL SK, 1991, NATURE, V353, P76, DOI 10.1038/353076a0; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; VAN MEER G, 1985, BIOCHEMISTRY-US, V24, P3593, DOI 10.1021/bi00335a030; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; WEISS RL, 1977, J CELL BIOL, V72, P133, DOI 10.1083/jcb.72.1.133; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; WHITE J, 1982, EMBO J, V1, P217, DOI 10.1002/j.1460-2075.1982.tb01150.x	25	127	129	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	1992	359	6396					647	650		10.1038/359647a0	http://dx.doi.org/10.1038/359647a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	1406997				2022-12-28	WOS:A1992JT82400061
J	LANDIS, SE; SCHOENBACH, VJ; WEBER, DJ; MITTAL, M; KRISHAN, B; LEWIS, K; KOCH, GG				LANDIS, SE; SCHOENBACH, VJ; WEBER, DJ; MITTAL, M; KRISHAN, B; LEWIS, K; KOCH, GG			RESULTS OF A RANDOMIZED TRIAL OF PARTNER NOTIFICATION IN CASES OF HIV-INFECTION IN NORTH-CAROLINA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONORRHEA; COMMUNITY	Background. We sought to compare two methods of notifying sex partners of subjects infected with the human immunodeficiency virus (HIV) or persons who had shared needles with them (needle-sharing partners): "patient referral," in which the responsibility for notifying partners was left to the patient, and "provider referral," in which providers attempted to notify partners. Methods. Names of sex partners and needle-sharing partners and information on how to locate them were obtained from consenting HIV-infected subjects identified in the HIV-testing programs at three public health departments in North Carolina. The subjects were randomly assigned to a patient-referral group (in which patients had the initial responsibility for notifying their partners) or a provider-referral group (in which the study counselor notified the partners). The success of attempts to notify partners was monitored by means of interviews with counselors conducted both in the field and at the health department. Results. Of 534 HIV-positive persons identified at the health departments, 247 (46 percent) did not return for counseling after the test, 8 were counseled outside the study, and 117 (22 percent) were ineligible. Of the 162 invited to participate, 88 (54 percent) declined and 74 (46 percent) agreed. The subjects were mostly male (69 percent), black (87 percent), homosexual or bisexual (76 percent of the men), and had a median age of 30 years. Thirty-nine were assigned to the provider-referral group and 35 to the patient-referral group. In the provider-referral group 78 of 157 partners (50 percent) were successfully notified, whereas in the patient-referral group only 10 of 153 (7 percent) were notified. Of the partners notified by the counselors, 94 percent were not aware that they had been exposed to HIV. Overall, 23 percent of the partners notified and tested were HIV-positive. Conclusions. In this trial, leaving the notification of partners up to the subjects (patient referral) was quite ineffective, despite the North Carolina law requiring that partners be notified. Partner notification by public health counselors (provider referral) was significantly more effective. Although the effectiveness of notification procedures is constrained by the accuracy of the information provided by HIV-infected patients, counselors who notify the partners of an infected patient can refer them to educational, medical, and support services targeted to persons at high risk for HIV infection and may encourage the adoption of less-risky behavior.	UNIV N CAROLINA,SCH PUBL HLTH,DEPT EPIDEMIOL,CHAPEL HILL,NC 27514; UNIV N CAROLINA,SCH PUBL HLTH,DEPT BIOSTAT,CHAPEL HILL,NC 27514; UNIV N CAROLINA,SCH MED,DEPT MED,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine					NIAID NIH HHS [5 U01 AI25868] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI025868] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDRUS JK, 1990, ANN INTERN MED, V112, P539, DOI 10.7326/0003-4819-112-7-539; ANGELL M, 1991, NEW ENGL J MED, V324, P1498, DOI 10.1056/NEJM199105233242110; BRANDT A, 1987, NO MAGIC BULLET; BRANDT AM, 1990, ANN INTERN MED, V112, P481, DOI 10.7326/0003-4819-112-7-481; CATES W, 1989, AM J PUBLIC HEALTH, V79, P871, DOI 10.2105/AJPH.79.7.871; CATES W, 1988, AM J PUBLIC HEALTH, V78, P1533, DOI 10.2105/AJPH.78.12.1533; CLUMECK N, 1989, NEW ENGL J MED, V321, P1460, DOI 10.1056/NEJM198911233212107; Cochran W.G., 2007, SAMPLING TECHNIQUES; DUNLOP EMC, 1971, BRIT J VENER DIS, V47, P192; FARUKI H, 1985, NEW ENGL J MED, V313, P607, DOI 10.1056/NEJM198509053131004; FEHRS LJ, 1988, LANCET, V2, P379; GIESECKE J, 1989, 5TH INT C AIDS MONTR; GUADALUPE R, 1990, 6TH INT C AIDS SAN F; HENDERSON RH, 1977, BRIT J VENER DIS, V53, P211; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; JONES B, 1990, 6TH INT C AIDS SAN F, V3, P253; JUDSON FN, 1990, HOSP PRACT, V25, P63; KEGELES SM, 1988, JAMA-J AM MED ASSOC, V259, P216, DOI 10.1001/jama.259.2.216; KOCH GG, 1975, INT STAT REV, V43, P59, DOI 10.2307/1402660; LANDIS SE, IN PRESS AIDS ED PRE; MARKS G, 1991, AM J PUBLIC HEALTH, V81, P1321, DOI 10.2105/AJPH.81.10.1321; PETERSEN H, 1989, 5TH INT C AIDS MONTR; PHILLIPS L, 1980, AM J PUBLIC HEALTH, V70, P705, DOI 10.2105/AJPH.70.7.705; RAMSTEDT K, 1990, SEX TRANSM DIS, V17, P37, DOI 10.1097/00007435-199017010-00008; ROTHENBERG RB, 1990, SEXUALLY TRANSMITTED, P1081; STLAWRENCE JS, 1989, PUBLIC HEALTH REP, V104, P391; TOOMEY KE, 1989, AIDS, V3, pS57, DOI 10.1097/00002030-198901001-00009; TOOMEY KE, 1989, 5TH INT C AIDS MONTR; WOODHOUSE D, 1990, 6TH INT C AIDS SAN F, V3, P258; WOODHOUSE DE, 1985, PUBLIC HEALTH REP, V100, P61; WOODRUFF RS, 1971, J AM STAT ASSOC, V66, P411, DOI 10.2307/2283947; WYKOFF RF, 1988, JAMA-J AM MED ASSOC, V259, P3563, DOI 10.1001/jama.259.24.3563; 1991, MMWR, V40, P77; 1991, HIV AIDS SURVEILLANC; 1988, MMWR, V37, P393; 1989, LANCET, V1, P396; 1988, GUIDE PUBLIC HLTH PR; 1989, J ACQ IMMUN DEF SYND, V2, P248; 1988, MMWR, V37, P401	39	139	141	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	1992	326	2					101	106		10.1056/NEJM199201093260205	http://dx.doi.org/10.1056/NEJM199201093260205			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY045	1445500	Green Published			2022-12-28	WOS:A1992GY04500005
J	BENEDETTI, TJ				BENEDETTI, TJ			TREATMENT OF PRETERM LABOR WITH THE BETA-ADRENERGIC AGONIST RITODRINE	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											BENEDETTI, TJ (corresponding author), UNIV WASHINGTON,MED CTR,SEATTLE,WA 98195, USA.			caritis, steve/0000-0002-2169-0712				BENEDETTI TJ, 1983, AM J OBSTET GYNECOL, V145, P1; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; LEVENO KJ, 1992, NEW ENGL J MED, V327, P349, DOI 10.1056/NEJM199207303270510; 1992, NEW ENGL J MED, V327, P308	4	9	9	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	1992	327	24					1758	1758						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA897	1435923				2022-12-28	WOS:A1992KA89700017
J	DAVIES, K				DAVIES, K			IMPRINTING AND SPLICING JOIN TOGETHER	NATURE			English	Editorial Material																		BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; FISHER EM, 1991, CELL, V63, P1205; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEFF SE, 1992, NATURE, V2, P265; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	12	4	4	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 3	1992	360	6403					492	492		10.1038/360492a0	http://dx.doi.org/10.1038/360492a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448175	Bronze			2022-12-28	WOS:A1992KA79700070
J	ZATORRE, RJ; JONESGOTMAN, M; EVANS, AC; MEYER, E				ZATORRE, RJ; JONESGOTMAN, M; EVANS, AC; MEYER, E			FUNCTIONAL LOCALIZATION AND LATERALIZATION OF HUMAN OLFACTORY CORTEX	NATURE			English	Article							POSITRON EMISSION TOMOGRAPHY; TEMPORAL LOBECTOMY; BLOOD-FLOW; DISCRIMINATION; DEFICITS	ANATOMICAL and physiological investigations in monkeys indicate that olfaction is subserved by several cortical regions1,2. But the areas implicated in the human olfactory system have not been definitively identified by functional criteria. Behavioural evidence3,4 has suggested that laterally specialized mechanisms for odour processing may exist, but the neuroanatomical substrate remains unknown. We used positron emission tomography to study the cortical representation of human olfactory processing by comparing cerebral blood flow changes evoked during olfactory stimulation with those of a control task. We report here significant cerebral blood flow increases at the junction of the inferior frontal and temporal lobes bilaterally, corresponding to the piriform cortex, and unilaterally, in the right orbitofrontal cortex. The results complement and extend previous data implicating these regions in olfactory processing, and indicate that a functional asymmetry exists in the human brain favouring the right orbitofrontal area in olfaction.	MCGILL UNIV, DEPT NEUROL & NEUROSURG, MONTREAL H3A 2B4, QUEBEC, CANADA	McGill University	ZATORRE, RJ (corresponding author), MONTREAL NEUROL HOSP & INST, MCCONNELL BRAIN IMAGING CTR, MONTREAL H3A 2B4, QUEBEC, CANADA.							EICHENBAUM H, 1983, BRAIN, V106, P459, DOI 10.1093/brain/106.2.459; ENGEN T, 1965, J EXP PSYCHOL, V70, P611, DOI 10.1037/h0022685; ESKENAZI B, 1983, NEUROPSYCHOLOGIA, V21, P365, DOI 10.1016/0028-3932(83)90023-4; ESKENAZI B, 1986, NEUROPSYCHOLOGIA, V24, P553, DOI 10.1016/0028-3932(86)90099-0; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; EVANS AC, 1991, J CEREBR BLOOD F MET, V11, pA69, DOI 10.1038/jcbfm.1991.40; EVANS AC, 1991, IEEE T MED IMAGING, V10, P90, DOI 10.1109/42.75615; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; Mesulam M-M., 1985, CEREB CORTEX, P179, DOI DOI 10.1007/978-1-4757-9619-3_5; POTTER H, 1979, NEUROSCIENCE, V4, P361, DOI 10.1016/0306-4522(79)90099-X; PRICE JL, 1991, OLFACTION, P101; RAICHLE ME, 1983, J NUCL MED, V24, P790; TAKAGI SF, 1991, CEREB CORTEX, V9, P133; TALAIIRACH J, 1988, COPLANAR STEREOTAXIC; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZATORRE RJ, 1990, PERCEPT PSYCHOPHYS, V47, P526, DOI 10.3758/BF03203105; ZATORRE RJ, 1991, BRAIN, V114, P71	23	529	532	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	1992	360	6402					339	340		10.1038/360339a0	http://dx.doi.org/10.1038/360339a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448149				2022-12-28	WOS:A1992JZ63000049
J	HERBERMAN, RB				HERBERMAN, RB			TUMOR IMMUNOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY		UNIV PITTSBURGH, SCH MED, DEPT MED & PATHOL, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	HERBERMAN, RB (corresponding author), UNIV PITTSBURGH, SCH MED, PITTSBURGH CANC INST, PITTSBURGH, PA 15261 USA.							BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; GATTI RA, 1971, CANCER-AM CANCER SOC, V28, P89, DOI 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO;2-Q; HANTO DW, 1985, TRANSPLANTATION, V39, P461, DOI 10.1097/00007890-198505000-00001; HERBERMAN RB, 1983, ADV HOST DEFENSE MEC, V2, P241; Herberman RB, 1982, NATURAL KILLER CELLS; HERBERMAN RB, 1977, MECHANISMS TUMOR IMM, P175; KLEIN G, 1977, TRANSPLANT P, V9, P1095; PREHN RT, 1957, J NATL CANCER I, V18, P769; WHITESIDE TL, 1989, CLIN IMMUNOL IMMUNOP, V53, P1, DOI 10.1016/0090-1229(89)90096-2	10	15	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2935	2939		10.1001/jama.268.20.2935	http://dx.doi.org/10.1001/jama.268.20.2935			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433711				2022-12-28	WOS:A1992JY66800020
J	WILSON, CB				WILSON, CB			IMMUNOLOGICAL ASPECTS OF RENAL DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GOODPASTURE ANTIGEN; IV COLLAGEN; GLOMERULONEPHRITIS; NEPHRITIS; INJURY; MECHANISMS; ANTIBODIES; MOLECULES				WILSON, CB (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.				NIA NIH HHS [AGO4342] Funding Source: Medline; NIDDK NIH HHS [DK20043, DK40251] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020043, R01DK020043, R01DK040251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BRENTJENS JR, 1989, KIDNEY INT, V35, P954, DOI 10.1038/ki.1989.79; BRINKMAN K, 1990, IMMUNOL TODAY, V11, P232, DOI 10.1016/0167-5699(90)90095-Q; BUTKOWSKI RJ, 1985, J BIOL CHEM, V260, P3739; COUSER WG, 1990, J AM SOC NEPHROL, V1, P13; GABBAI FB, 1991, SEMIN NEPHROL, V11, P367; Glassock RJ, 1991, KIDNEY, V4th, P1182; HOEDEMAEKER PJ, 1989, KIDNEY INT, V35, P1015, DOI 10.1038/ki.1989.85; HORII Y, 1989, J IMMUNOL, V143, P3949; JENNETTE JC, 1990, AM J KIDNEY DIS, V15, P517, DOI 10.1016/S0272-6386(12)80521-X; JOHNSON JP, 1985, MEDICINE, V64, P219, DOI 10.1097/00005792-198507000-00003; KELLY CJ, 1991, KIDNEY INT, V39, P518, DOI 10.1038/ki.1991.60; KERJASCHKI D, 1990, VIRCHOWS ARCH B, V58, P253; KLEPPEL MM, 1989, LAB INVEST, V61, P278; POBER JS, 1991, LAB INVEST, V64, P301; SALANT DJ, 1989, KIDNEY INT, V35, P976, DOI 10.1038/ki.1989.81; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAVAGE COS, 1986, BRIT MED J, V292, P301, DOI 10.1136/bmj.292.6516.301; SHEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547; WILSON CB, 1991, KIDNEY INT, V39, P501, DOI 10.1038/ki.1991.59; WILSON CB, 1990, THERAPY RENAL DISEAS, P333; WILSON CB, IN PRESS MOL PATHOLO; WILSON CB, 1991, KIDNEY, P1062; WOLF G, 1991, KIDNEY INT, V39, P401, DOI 10.1038/ki.1991.52	24	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2904	2909						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433707				2022-12-28	WOS:A1992JY66800015
J	LERNER, RA; KANG, AS; BAIN, JD; BURTON, DR; BARBAS, CF				LERNER, RA; KANG, AS; BAIN, JD; BURTON, DR; BARBAS, CF			ANTIBODIES WITHOUT IMMUNIZATION	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; VARIABLE DOMAINS; PHAGE SURFACES; LIBRARY; GENERATION; REPERTOIRE; CLONING; LIGANDS; HEAVY		Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA; SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	LERNER, RA (corresponding author), SCRIPPS RES INST, DEPT CHEM, LA JOLLA, CA 92037 USA.			Kang, Angray/0000-0002-4672-4114				BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P4457, DOI 10.1073/pnas.89.10.4457; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; BETTER M, 1988, SCIENCE, V240, P1041, DOI 10.1126/science.3285471; BOSS MA, 1984, NUCLEIC ACIDS RES, V12, P3791, DOI 10.1093/nar/12.9.3791; BURTON DR, 1991, TRENDS BIOTECHNOL, V9, P169, DOI 10.1016/0167-7799(91)90055-M; CABILLY S, 1984, P NATL ACAD SCI-BIOL, V81, P3273, DOI 10.1073/pnas.81.11.3273; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; KANG AS, 1991, P NATL ACAD SCI USA, V88, P4363, DOI 10.1073/pnas.88.10.4363; KANG AS, 1991, P NATL ACAD SCI USA, V88, P11120, DOI 10.1073/pnas.88.24.11120; LARRICK JW, 1988, IN VITRO IMMUNIZATIO, V5, P231; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; SASTRY L, 1989, P NATL ACAD SCI USA, V86, P5728, DOI 10.1073/pnas.86.15.5728; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0	18	84	129	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 20	1992	258	5086					1313	1314		10.1126/science.1455226	http://dx.doi.org/10.1126/science.1455226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455226				2022-12-28	WOS:A1992JY95800024
J	KATZ, DA; LITTENBERG, B; CRONENWETT, JL				KATZ, DA; LITTENBERG, B; CRONENWETT, JL			MANAGEMENT OF SMALL ABDOMINAL AORTIC-ANEURYSMS - EARLY SURGERY VS WATCHFUL WAITING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACTORS AFFECTING SURVIVAL; CORONARY-ARTERY DISEASE; EXPANSION RATE; NATURAL-HISTORY; RISK-FACTORS; MORTALITY; RUPTURE; EXPERIENCE; VARIABLES; COMPLICATIONS	Objective.-To compare two clinical strategies for the management of small abdominal aortic aneurysms (AAAs) less than 5 cm in diameter: early surgery (repair small AAAs when diagnosed) and watchful waiting (measure AAA size every 6 months and repair when the diameter reaches 5 cm). Data Sources.-We reviewed data from an earlier longitudinal study of patients with small AAAs to estimate incidence rates of rupture or acute expansion. Estimates for other parameters in the model were obtained by searching the medical literature (MEDLINE, 1966 to present). Data Synthesis.-We constructed a Markov decision tree to compare early surgery with watchful waiting in patients with asymptomatic AAAs less than 5 cm in diameter, with respect to long-term survival in quality-adjusted life years. The average annual rates of rupture or acute expansion for AAAs with a maximal transverse diameter of less than 4.0, 4.0 to 4.9, and at least 5.0 cm, are 0, 3.3, and 14.4 events per 100 patient-years of observation, respectively. At an average rupture rate of 3.3 events per 100 patient-years and an average operative risk for elective surgery (4.6%, 30-day mortality), our model predicts that early surgery improves survival in patients who present with a 4-cm AAA. The benefit of early surgery decreases with increased age at presentation. If the average rupture rate for AAAs less than 5 cm is assumed to be low (eg, 0.4 event per 100 patient-years), watchful waiting is favored, particularly as operative risk increases. The decision in this subgroup, however, is sensitive to possible future increases in operative risk. Conclusions.-In the majority of scenarios that we examined, early surgery is preferred to watchful waiting for patients with AAAs less than 5 cm in diameter. Watchful waiting is generally favored, however, for patients with a low risk of AAA rupture or acute expansion, including those patients who present with very small AAAs (eg, <4 cm). More accurate data concerning the rupture risk of AAAs less than 5 cm would improve clinical decision making.	DARTMOUTH COLL,HITCHCOCK MED CTR,DEPT MED,TECHNOL ASSESSMENT PROGRAM,HANOVER,NH 03756; DARTMOUTH COLL,HITCHCOCK MED CTR,VASC SURG SECT,HANOVER,NH 03756	Dartmouth College; Dartmouth College	KATZ, DA (corresponding author), VET ADM MED CTR,DEPT MED 111B,WHITE RIVER JCT,VT 05001, USA.			Katz, David/0000-0001-5348-6532; Littenberg, Benjamin/0000-0002-7647-1808				ABERNATHY CM, 1986, JAMA-J AM MED ASSOC, V256, P597; Amundsen S, 1989, Eur J Vasc Surg, V3, P405, DOI 10.1016/S0950-821X(89)80046-5; BAIRD RJ, 1978, CAN MED ASSOC J, V118, P1229; BALLARD DJ, 1990, ABDOMINAL AORTIC ANE, P1; BECK JR, 1983, MED DECIS MAKING, V3, P411; BERGQVIST D, 1990, ACTA CHIR SCAND, V156, P63; Berne T V, 1969, Am Surg, V35, P36; BERNSTEIN EF, 1984, ANN SURG, V200, P255, DOI 10.1097/00000658-198409000-00003; BICKERSTAFF LK, 1984, J VASC SURG, V1, P6, DOI 10.1067/mva.1984.avs0010006; BODILY KC, 1985, AM J SURG, V149, P580, DOI 10.1016/S0002-9610(85)80129-X; BRECKWOLDT WL, 1991, J VASC SURG, V13, P798, DOI 10.1016/0741-5214(91)90044-U; BUTLER MJ, 1978, BRIT J SURG, V65, P839, DOI 10.1002/bjs.1800651204; COLLIN J, 1990, ANGIOLOGY, V41, P53, DOI 10.1177/000331979004100108; CRONENWETT JL, 1985, SURGERY, V98, P472; CRONENWETT JL, 1990, J VASC SURG, V11, P260; DARLING RC, 1977, CIRCULATION, V56, P161; DEBAKEY ME, 1964, ANN SURG, V160, P622, DOI 10.1097/00000658-196410000-00007; DENT A, 1986, BRIT J SURG, V73, P318; DIEHL JT, 1983, ANN SURG, V197, P49, DOI 10.1097/00000658-198301001-00008; DONALDSON MC, 1985, J VASC SURG, V2, P564; FIELDING JWL, 1981, BRIT MED J, V283, P355, DOI 10.1136/bmj.283.6287.355; FOSTER JH, 1969, SURG GYNECOL OBSTETR, V129, P1; Glimaker H, 1991, Eur J Vasc Surg, V5, P125, DOI 10.1016/S0950-821X(05)80675-9; GUIRGUIS EM, 1991, AM J SURG, V162, P481, DOI 10.1016/0002-9610(91)90266-G; HOLLIER LH, 1984, J VASC SURG, V1, P290, DOI 10.1067/mva.1984.avs0010290; INGOLDBY CJH, 1986, BRIT J SURG, V73, P551, DOI 10.1002/bjs.1800730711; JOHANSEN K, 1991, J VASC SURG, V13, P240, DOI 10.1016/0741-5214(91)90216-H; Johansson G, 1990, Eur J Vasc Surg, V4, P497, DOI 10.1016/S0950-821X(05)80791-1; JOHANSSON G, 1986, BRIT J SURG, V73, P101, DOI 10.1002/bjs.1800730205; JOHNSON G, 1980, ARCH SURG-CHICAGO, V115, P51; JOHNSTON KW, 1989, J VASC SURG, V9, P437, DOI 10.1067/mva.1989.vs0090437; KASSIRER JP, 1981, NEW ENGL J MED, V305, P1467; KREMER H, 1984, KLIN WOCHENSCHR, V62, P1120, DOI 10.1007/BF01782469; LAWRIE GM, 1979, SURGERY, V85, P483; LEDERLE FA, 1988, ARCH INTERN MED, V148, P1753, DOI 10.1001/archinte.148.8.1753; LIMET R, 1991, J VASC SURG, V14, P540, DOI 10.1016/0741-5214(91)90249-T; LITTOOY FN, 1989, ARCH SURG-CHICAGO, V124, P419; MCCABE CJ, 1981, ARCH SURG-CHICAGO, V116, P1025; MCNEIL BJ, 1981, NEW ENGL J MED, V305, P982, DOI 10.1056/NEJM198110223051704; MURPHY JL, 1990, CAN J SURG, V33, P201; NEVITT MP, 1989, NEW ENGL J MED, V321, P1009, DOI 10.1056/NEJM198910123211504; Olsen P S, 1990, Ann Vasc Surg, V4, P580, DOI 10.1016/S0890-5096(06)60843-1; OLSEN PS, 1991, J CARDIOVASC SURG, V32, P636; OURIEL K, 1990, J VASC SURG, V11, P493, DOI 10.1067/mva.1990.18639; PILCHER DB, 1980, AM J SURG, V139, P487, DOI 10.1016/0002-9610(80)90325-6; PLATE G, 1985, ARCH SURG-CHICAGO, V120, P590; PLATE G, 1988, ACTA CHIR SCAND, V154, P25; QUILL DS, 1989, SURG CLIN N AM, V69, P713; ROGER VL, 1989, J AM COLL CARDIOL, V14, P1245, DOI 10.1016/0735-1097(89)90423-3; SACCO RL, 1982, STROKE, V13, P290, DOI 10.1161/01.STR.13.3.290; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; SHACKLETON CR, 1987, J VASC SURG, V6, P583, DOI 10.1067/mva.1987.avs0060583; STERPETTI AV, 1991, SURG GYNECOL OBSTET, V173, P175; STERPETTI AV, 1985, AM J SURG, V150, P772, DOI 10.1016/0002-9610(85)90427-1; SULLIVAN CA, 1990, J VASC SURG, V11, P799; SZILAGYI DE, 1966, ANN SURG, V164, P678, DOI 10.1097/00000658-196610000-00014; SZILAGYI DE, 1972, ARCH SURG-CHICAGO, V104, P600; THOMAS PRS, 1988, BRIT J SURG, V75, P733, DOI 10.1002/bjs.1800750804; 1987, VITAL STATISTICS US; 1990, USRDS1990 US REN DAT, P33	60	109	110	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	1992	268	19					2678	2686		10.1001/jama.268.19.2678	http://dx.doi.org/10.1001/jama.268.19.2678			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX680	1433687				2022-12-28	WOS:A1992JX68000030
J	SWERDLOW, DL; WOODRUFF, BA; BRADY, RC; GRIFFIN, PM; TIPPEN, S; DONNELL, HD; GELDREICH, E; PAYNE, BJ; MEYER, A; WELLS, JG; GREENE, KD; BRIGHT, M; BEAN, NH; BLAKE, PA				SWERDLOW, DL; WOODRUFF, BA; BRADY, RC; GRIFFIN, PM; TIPPEN, S; DONNELL, HD; GELDREICH, E; PAYNE, BJ; MEYER, A; WELLS, JG; GREENE, KD; BRIGHT, M; BEAN, NH; BLAKE, PA			A WATERBORNE OUTBREAK IN MISSOURI OF ESCHERICHIA-COLI-O157-H7 ASSOCIATED WITH BLOODY DIARRHEA AND DEATH	ANNALS OF INTERNAL MEDICINE			English	Article						ESCHERICHIA-COLI INFECTIONS; MISSOURI; DIARRHEA; WATER SUPPLY	ESCHERICHIA-COLI O157-H7; HEMOLYTIC-UREMIC SYNDROME; SHIGA-LIKE TOXIN; HEMORRHAGIC COLITIS; MONOCLONAL-ANTIBODIES; SEROTYPE O157-H7; NURSING-HOME; INFECTIONS; 0157-H7	Objective: To describe and determine the source of a large outbreak of Escherichia coli O157:H7 (ECO157) infections in Missouri. Design: A case-control study and a household survey. Setting: A small city in a rural Missouri township that had an unchlorinated water supply. Patients: Case patients were residents of or visitors to Burdine Township with bloody diarrhea or diarrhea and abdominal cramps occurring between 15 December 1989 and 20 January 1990. Measurements: Escherichia coli O157 was isolated from 21 stool specimens. All isolates were resistant to sulfisoxazole, tetracycline, and streptomycin; produced Shiga-like toxins I and II; and had one 60-megadalton plasmid. Results: Among the 243 case patients, 86 had bloody stools, 32 were hospitalized, 4 died, and 2 had the hemolytic uremic syndrome. In the case-control study, no food was associated with illness, but ill persons had drunk more municipal water than had controls (P = 0.04). The survey showed that, during the peak of the outbreak, bloody diarrhea was 18.2 times more likely to occur in persons living inside the city and using municipal water than in persons living outside the city and using private well water (P = 0.001). Shortly before the peak of the outbreak, 45 water meters were replaced, and two water mains ruptured. The number of new cases declined rapidly after residents were ordered to boil water and after chlorination of the water supply. Conclusions: This was the largest outbreak of ECO157 infections, the first due to a multiply resistant organism, and the first shown to be transmitted by water. System-wide chlorination as well as hyperchlorination during repairs might have prevented this outbreak. Both bloody and nonbloody diarrhea may be common manifestations of this infection, which is probably underdiagnosed because of the failure of routine stool cultures to identify the organism. Cities with deteriorating water systems using untreated water risk widespread illness from contaminated drinking water.	MISSOURI STATE DEPT HLTH, JEFFERSON CITY, MO 65102 USA; US EPA, RISK REDUCT ENGN LAB, CINCINNATI, OH 45268 USA	United States Environmental Protection Agency	SWERDLOW, DL (corresponding author), CTR DIS CONTROL, ENTER DIS BRANCH, MAILSTOP C-09, ATLANTA, GA 30333 USA.							[Anonymous], 1989, STANDARD METHODS EXA, V17th; Barry A., 1985, MANUAL CLIN MICROBIO, V4th; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOPP CA, 1987, J CLIN MICROBIOL, V25, P1486, DOI 10.1128/JCM.25.8.1486-1489.1987; CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; DEV VJ, 1991, LANCET, V337, P1412, DOI 10.1016/0140-6736(91)93092-N; DOWNES FP, 1988, INFECT IMMUN, V56, P1926, DOI 10.1128/IAI.56.8.1926-1933.1988; Duncan L., 1987, Canada Diseases Weekly Report, V13, P5; GELDREICH EE, 1992, WATER RES, V26, P1127, DOI 10.1016/0043-1354(92)90150-3; GREENE KD, 1991, 91ST ANN M AM SOC MI, P374; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; MCGOWAN KL, 1989, LANCET, V1, P967; MEYERS JA, 1976, J BACTERIOL, V127, P1529, DOI 10.1128/JB.127.3.1529-1537.1976; NAYLOR GRE, 1983, LANCET, V1, P864; NEILL MA, 1985, ARCH INTERN MED, V145, P2215, DOI 10.1001/archinte.145.12.2215; OSTROFF SM, 1990, AM J EPIDEMIOL, V132, P239, DOI 10.1093/oxfordjournals.aje.a115653; PAVIA AT, 1990, J PEDIATR-US, V116, P544, DOI 10.1016/S0022-3476(05)81600-2; RADETSKY M, 1986, PEDIATR INFECT DIS J, V5, P230, DOI 10.1097/00006454-198603000-00015; RAGHUBEER EV, 1990, J CLIN MICROBIOL, V28, P803, DOI 10.1128/JCM.28.4.803-805.1990; RATNAM S, 1988, J CLIN MICROBIOL, V26, P2006, DOI 10.1128/JCM.26.10.2006-2012.1988; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; ROSE JB, 1990, INVESTIGATION PREVEN, P223; RYAN CA, 1986, J INFECT DIS, V154, P631, DOI 10.1093/infdis/154.4.631; SPIKA JS, 1986, J PEDIATR-US, V109, P287, DOI 10.1016/S0022-3476(86)80386-9; STROCKBINE NA, 1985, INFECT IMMUN, V50, P695, DOI 10.1128/IAI.50.3.695-700.1985; WELLS JG, 1983, J CLIN MICROBIOL, V18, P512, DOI 10.1128/JCM.18.3.512-520.1983	29	374	386	3	56	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					812	819		10.7326/0003-4819-117-10-812	http://dx.doi.org/10.7326/0003-4819-117-10-812			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416555				2022-12-28	WOS:A1992JX83800003
J	NELSON, WJ				NELSON, WJ			REGULATION OF CELL-SURFACE POLARITY FROM BACTERIA TO MAMMALS	SCIENCE			English	Article							DARBY CANINE KIDNEY; PLASMA-MEMBRANE PROTEINS; INTESTINAL EPITHELIAL-CELLS; TRANSFECTED MDCK CELLS; GTP-BINDING-PROTEINS; BUD SITE SELECTION; SACCHAROMYCES-CEREVISIAE; GENE-PRODUCT; CYTOPLASMIC DOMAIN; CAULOBACTER-CRESCENTUS	The generation of unique domains on the cell, cell surface polarity, is critical for differentiation into the diversity of cell structures and functions found in a wide variety of organisms and cells, including the bacterium Caulobacter crescentus, the budding yeast Saccharomyces cerevisiae, and mammalian polarized epithelial cells. Comparison of the mechanisms for establishing polarity in these cells indicates that restricted membrane protein distributions are generated by selective protein targeting to, and selective protein retention at, the cell surface. Initiation of these mechanisms involves reorientation of components of the cytoskeleton and protein transport pathways toward restricted sites at the cell surface and formation of a targeting patch at those sites for selective recruitment and retention of proteins.			NELSON, WJ (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.							ACHLER C, 1989, J CELL BIOL, V109, P179, DOI 10.1083/jcb.109.1.179; AGABIAN N, 1979, J CELL BIOL, V81, P123, DOI 10.1083/jcb.81.1.123; ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; BACON RA, 1989, J CELL BIOL, V109, P105; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BANSAL G, 1991, CELL, V67, P1203; Barnes G, 1990, CURR OPIN CELL BIOL, V2, P109, DOI 10.1016/S0955-0674(05)80040-7; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BOLL W, 1991, P NATL ACAD SCI USA, V88, P8592, DOI 10.1073/pnas.88.19.8592; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BREITFELD PP, 1990, J CELL BIOL, V111, P2365, DOI 10.1083/jcb.111.6.2365; BREWER CB, 1991, J CELL BIOL, V114, P413, DOI 10.1083/jcb.114.3.413; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CAHAMBERS A, 1987, J MOL BIOL, V194, P71; CASANOVA JE, 1991, J BIOL CHEM, V266, P24428; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHENEVERT J, 1992, NATURE, V356, P77, DOI 10.1038/356077a0; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CROSS F, 1988, ANNU REV CELL BIOL, V4, P429, DOI 10.1146/annurev.cb.04.110188.002241; DAVIS JQ, 1990, J BIOL CHEM, V265, P17252; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; EKBLOM P, 1986, ANNU REV CELL BIOL, V2, P27, DOI 10.1146/annurev.cb.02.110186.000331; EVINGER M, 1979, P NATL ACAD SCI USA, V76, P175, DOI 10.1073/pnas.76.1.175; FATH KR, IN PRESS J CELL BIOL; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FLEMING TP, 1988, ANNU REV CELL BIOL, V4, P459, DOI 10.1146/annurev.cellbio.4.1.459; FREI T, 1992, J CELL BIOL, V118, P177, DOI 10.1083/jcb.118.1.177; FREIFELDER D, 1960, J BACTERIOL, V80, P567, DOI 10.1128/JB.80.4.567-568.1960; GILBERT T, 1991, J CELL BIOL, V113, P275, DOI 10.1083/jcb.113.2.275; Gober JW, 1991, CURR OPIN GENET DEV, V1, P324, DOI 10.1016/S0959-437X(05)80295-3; GOBER JW, 1991, CELL, V64, P381, DOI 10.1016/0092-8674(91)90646-G; GOMES SL, 1984, J MOL BIOL, V177, P551; GOUD B, 1991, Current Opinion in Cell Biology, V3, P626, DOI 10.1016/0955-0674(91)90033-U; GRAVOTTA D, 1990, J CELL BIOL, V111, P2893, DOI 10.1083/jcb.111.6.2893; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; HANNAN LA, 1991, J CELL BIOL, V115, pS194; HANZEL D, 1992, SEMIN CELL BIOL, V2, P341; HARTWELL L, 1991, NATURE, V352, P663, DOI 10.1038/352663a0; HIRSCH JP, 1992, BIOESSAYS, V14, P367, DOI 10.1002/bies.950140604; HUBER LA, 1992, EUR J CELL BIOL S, V36, P35; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; HUGUENEL ED, 1982, DIFFERENTIATION, V21, P71, DOI 10.1111/j.1432-0436.1982.tb01199.x; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; HUNZIKER W, 1990, EMBO J, V9, P3515, DOI 10.1002/j.1460-2075.1990.tb07560.x; HUNZIKER W, 1992, SEM CELL BIOL, V2, P397; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; KOOB R, 1987, European Journal of Cell Biology, V45, P230; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; LAGENAUR C, 1978, J BACTERIOL, V135, P1062, DOI 10.1128/JB.135.3.1062-1069.1978; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; LILLIE SH, 1992, NATURE, V356, P358, DOI 10.1038/356358a0; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1990, P NATL ACAD SCI USA, V87, P7419, DOI 10.1073/pnas.87.19.7419; LIU JD, 1991, J BACTERIOL, V173, P4941, DOI 10.1128/jb.173.16.4941-4951.1991; MACALISTER TJ, 1983, P NATL ACAD SCI-BIOL, V80, P1372, DOI 10.1073/pnas.80.5.1372; MADDOCK J, UNPUB; MARCH L, 1991, ANN REV CELL BIOL, V7, P699; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MATTER K, 1990, EMBO J, V9, P3163, DOI 10.1002/j.1460-2075.1990.tb07514.x; MAYER A, 1992, MOL BIOL CELL, V3, pA307; MCCLOSKEY M, 1984, INT REV CYTOL, V87, P19, DOI 10.1016/S0074-7696(08)62439-0; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; MOOSEKER MS, 1989, J CELL BIOL, V108, P2395, DOI 10.1083/jcb.108.6.2395; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; Mostov K, 1991, Semin Cell Biol, V2, P411; MOSTOV K, 1992, IN PRESS J CELL BIOL, V116, P577; NASYMTH K, 1987, SCIENCE, V237, P1162; Nelson W J, 1990, Semin Cell Biol, V1, P359; NELSON WJ, 1987, J CELL BIOL, V104, P1527, DOI 10.1083/jcb.104.6.1527; NELSON WJ, 1989, J CELL BIOL, V108, P893, DOI 10.1083/jcb.108.3.893; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; NELSON WJ, 1992, SEM CELL BIOL, V2, P375; NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0; OHYA Y, 1991, J BIOL CHEM, V266, P12356; OSLEY MA, 1977, CELL, V12, P393, DOI 10.1016/0092-8674(77)90115-5; PARCZYK K, 1989, J BIOL CHEM, V264, P16837; Park h, COMMUNICATION; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Pringle J. R., 1986, YEAST CELL BIOL, P47; READ EB, 1992, MOL BIOL CELL, V3, P429, DOI 10.1091/mbc.3.4.429; RINDLER MJ, 1987, J CELL BIOL, V104, P231, DOI 10.1083/jcb.104.2.231; ROBERTS SJ, 1992, J CELL BIOL, V118, P1359, DOI 10.1083/jcb.118.6.1359; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SALIMEN A, 1989, J CELL BIOL, V109, P10236; SALIMEN A, 1987, CELL, V49, P527; SCHELL MJ, IN PRESS J CELL BIOL; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SHAPIRO L, 1985, ANNU REV CELL BIOL, V1, P173, DOI 10.1146/annurev.cb.01.110185.001133; Shattil SJ, 1991, CURR OPIN CELL BIOL, V3, P869, DOI 10.1016/0955-0674(91)90062-4; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; SMITH PR, 1991, P NATL ACAD SCI USA, V88, P6971, DOI 10.1073/pnas.88.16.6971; SNYDER M, 1991, J CELL BIOL, V114, P515, DOI 10.1083/jcb.114.3.515; SNYDER M, 1989, J CELL BIOL, V108, P1419, DOI 10.1083/jcb.108.4.1419; SOOLE KL, 1992, J CELL SCI, V102, P495; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STRATHERN JN, 1979, CELL, V17, P371, DOI 10.1016/0092-8674(79)90163-6; SWOBODA KK, 1982, J GEN MICROBIOL, V128, P279; THOMPSON TE, 1985, ANNU REV BIOPHYS BIO, V14, P361, DOI 10.1146/annurev.biophys.14.1.361; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; VANDERSLUIJS P, 1990, J CELL SCI, V95, P545; VANMEER G, 1988, BIOCHEMISTRY-US, V27, P6197; VANTHOF W, 1990, J CELL BIOL, V111, P977, DOI 10.1083/jcb.111.3.977; VANZEIJL MJAH, 1990, CELL REGUL, V1, P921, DOI 10.1091/mbc.1.12.921; VEGASALAS DE, 1987, J CELL BIOL, V104, P905, DOI 10.1083/jcb.104.4.905; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; WEISZ OA, IN PRESS J CELL BIOL; WOLLNER DA, 1992, J CELL BIOL, V116, P889, DOI 10.1083/jcb.116.4.889; YOKODE M, 1992, IN PRESS J CELL BIOL, V117, P39	131	197	200	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 6	1992	258	5084					948	955		10.1126/science.1439806	http://dx.doi.org/10.1126/science.1439806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439806				2022-12-28	WOS:A1992JW79600024
J	WETTERAU, JR; AGGERBECK, LP; BOUMA, ME; EISENBERG, C; MUNCK, A; HERMIER, M; SCHMITZ, J; GAY, G; RADER, DJ; GREGG, RE				WETTERAU, JR; AGGERBECK, LP; BOUMA, ME; EISENBERG, C; MUNCK, A; HERMIER, M; SCHMITZ, J; GAY, G; RADER, DJ; GREGG, RE			ABSENCE OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IN INDIVIDUALS WITH ABETALIPOPROTEINEMIA	SCIENCE			English	Article							APOLIPOPROTEIN-B GENE; CHOLESTERYL ESTER; DISULFIDE ISOMERASE; HYPOBETALIPOPROTEINEMIA; TRIACYLGLYCEROL; COMPLEX; DISEASE; CELLS	Abetalipoproteinemia is a human genetic disease that is characterized by a defect in the assembly or secretion of plasma very low density lipoproteins and chylomicrons. The microsomal triglyceride transfer protein (MTP), which is located in the lumen of microsomes isolated from the liver and intestine, has been proposed to function in lipoprotein assembly. MTP activity and the 88-kilodalton component of MTP were present in intestinal biopsy samples from eight control individuals but were absent in four abetalipoproteinemic subjects. This finding suggests that a defect in MTP is the basis for abetalipoproteinemia and that MTP is indeed required for lipoprotein assembly.	CNRS,CTR GENET MOLEC,F-91198 GIF SUR YVETTE,FRANCE; UNIV PARIS 07,INSERM,U327,F-75018 PARIS,FRANCE; HOP ST NICOLAS,SERV MED INTERNE,F-55107 VERDUN,FRANCE; HOP EDOUARD HERRIOT,MED INFANTILE CLIN B,F-69437 LYON,FRANCE; HOP ROBERT DEBRE,SERV GASTROENTEROL NUTR PEDIAT,F-75019 PARIS,FRANCE; HOP NECKER ENFANTS MALAD,DEPT PEDIAT,F-75730 PARIS 15,FRANCE; NHLBI,MOLEC DIS BRANCH,BETHESDA,MD 20892	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	WETTERAU, JR (corresponding author), BRISTOL MYERS SQUIBB,DEPT METABOL DIS,PRINCETON,NJ 08543, USA.				NHLBI NIH HHS [HL18577] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018577] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOSTROM K, 1988, J BIOL CHEM, V263, P4434; BOUMA ME, 1986, J CLIN INVEST, V78, P398, DOI 10.1172/JCI112590; GAY G, 1990, REV MED INTERNE, V11, P273, DOI 10.1016/S0248-8663(05)80857-4; HIGGINS JA, 1984, J LIPID RES, V25, P1295; HUANG LS, 1990, AM J HUM GENET, V46, P1141; IHM J, 1982, J BIOL CHEM, V257, P4818; JANERO DR, 1983, J BIOL CHEM, V258, P4496; Kane J.B., 1989, METABOLIC BASIS INHE, P1139; LACAILLE F, 1989, ARCH FR PEDIATR, V46, P491; LACKNER KJ, 1986, J CLIN INVEST, V78, P1707, DOI 10.1172/JCI112766; LOWRY OH, 1951, J BIOL CHEM, V193, P265; SCOAZEC JY, 1992, GUT, V33, P414, DOI 10.1136/gut.33.3.414; TALMUD PJ, 1988, J CLIN INVEST, V82, P1803, DOI 10.1172/JCI113795; WETTERAU J, UNPUB; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; WETTERAU JR, 1986, BIOCHIM BIOPHYS ACTA, V875, P610, DOI 10.1016/0005-2760(86)90084-6; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P4406, DOI 10.1021/bi00232a006	19	598	625	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 6	1992	258	5084					999	1001						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439810				2022-12-28	WOS:A1992JW79600036
J	DAVIDSON, BL; ELLIOTT, CG; LENSING, AWA				DAVIDSON, BL; ELLIOTT, CG; LENSING, AWA			LOW ACCURACY OF COLOR DOPPLER ULTRASOUND IN THE DETECTION OF PROXIMAL LEG VEIN-THROMBOSIS IN ASYMPTOMATIC HIGH-RISK PATIENTS	ANNALS OF INTERNAL MEDICINE			English	Article						ULTRASONICS; THROMBOPHLEBITIS; PHLEBOGRAPHY; PHLEBITIS	B-MODE ULTRASONOGRAPHY; DEEP VENOUS THROMBOSIS; ELECTIVE HIP-SURGERY; IMPEDANCE PLETHYSMOGRAPHY; VENOGRAPHY; DIAGNOSIS	Objective: To evaluate the ability of color Doppler ultrasound to detect proximal deep venous thrombosis (DVT) in asymptomatic high-risk patients who subsequently underwent contrast venography. Design: Prospective cohort study using blinded observers, with contrast venography as the comparison standard. Setting: Seven medical centers (university and community hospitals) participating in a clinical trial of low-molecular-weight heparin for prevention of DVT. Patients: A total of 385 consecutive patients undergoing elective unilateral hip or knee replacement. Measurements: Ten days after surgery or before hospital discharge (whichever occurred first), patients had bilateral color Doppler ultrasound examinations of the proximal veins of the lower extremities. Subsequently, a contrast venogram of the operated leg was obtained. Results: Color Doppler ultrasound studies and venograms were both evaluable in 319 of the 385 patients. Deep venous thrombosis was identified by contrast venography in 80 patients (prevalence, 25%; 95% Cl, 20% to 30%) and involved the proximal veins in 21 patients (prevalence, 7%; Cl, 4% to 10%). For proximal DVT, color Doppler ultrasound showed poor sensitivity (38%; Cl, 18% to 62%), moderately good specificity (92%; Cl, 89% to 95%), and a poor positive predictive value for this population (26%). Conclusion: Color Doppler ultrasound examinations are insensitive to proximal DVT in asymptomatic high-risk patients and should not be substituted for venography for identifying proximal DVT in such patients.	UNIV PENN, GRAD HOSP, SCH MED, PHILADELPHIA, PA 19104 USA; LATTER DAY ST HOSP, SALT LAKE CITY, UT 84143 USA; UNIV UTAH, MED CTR, SALT LAKE CITY, UT 84112 USA; HAMILTON CIVIC HOSP, HAMILTON, ONTARIO, CANADA	University of Pennsylvania; Utah System of Higher Education; University of Utah; McMaster University	DAVIDSON, BL (corresponding author), WYETH AYERST RES, POB 8299, PHILADELPHIA, PA 19101 USA.							BARNES RW, 1989, J VASC SURG, V9, P251, DOI 10.1067/mva.1989.vs0090251; BAXTER GM, 1990, CLIN RADIOL, V42, P32, DOI 10.1016/S0009-9260(05)81618-6; BORRIS LC, 1989, THROMB HAEMOSTASIS, V61, P363; CRUICKSHANK MK, 1989, THROMB HAEMOSTASIS, V62, P830; FROEHLICH JA, 1989, J BONE JOINT SURG AM, V71A, P249, DOI 10.2106/00004623-198971020-00012; GINSBERG JS, 1991, RADIOLOGY, V181, P651, DOI 10.1148/radiology.181.3.1947076; HEIT J, 1991, BLOOD S, V78, pA187; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; LEVINE MN, 1991, ANN INTERN MED, V114, P545, DOI 10.7326/0003-4819-114-7-545; MATTOS MA, 1992, J VASC SURG, V15, P366, DOI 10.1016/0741-5214(92)90258-A; MONREAL M, 1989, ANGIOLOGY, V40, P527, DOI 10.1177/000331978904000603; POLAK JF, 1989, RADIOLOGY, V171, P481, DOI 10.1148/radiology.171.2.2649923; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; ROBIN ED, 1987, ARCH INTERN MED, V147, P1704, DOI 10.1001/archinte.147.10.1704; ROSE SC, 1990, RADIOLOGY, V175, P639, DOI 10.1148/radiology.175.3.2188293	15	202	207	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					735	738		10.7326/0003-4819-117-9-735	http://dx.doi.org/10.7326/0003-4819-117-9-735			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416575				2022-12-28	WOS:A1992JV42400005
J	GORLICH, D; PREHN, S; HARTMANN, E; KALIES, KU; RAPOPORT, TA				GORLICH, D; PREHN, S; HARTMANN, E; KALIES, KU; RAPOPORT, TA			A MAMMALIAN HOMOLOG OF SEC61P AND SECYP IS ASSOCIATED WITH RIBOSOMES AND NASCENT POLYPEPTIDES DURING TRANSLOCATION	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; INTEGRAL MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM MEMBRANE; ESCHERICHIA-COLI; MICROSOMAL-MEMBRANES; SEQUENCE RECEPTOR; SECRETORY PROTEIN; ROUGH MICROSOMES; BINDING-ACTIVITY; 4.5S RNA	SEC61p is essential for protein translocation across the endoplasmic reticulum membrane of S. cerevisiae. We have found a mammalian homolog that shows more than 50% sequence identity with the yeast protein. Moreover, several regions of SEC61p have significant similarities with corresponding ones of SecYp of bacteria, indicating a strong evolutionary conservation of the mechanism of protein translocation. Mammalian Sec61p, like the yeast protein, is located in the immediate vicinity of nascent polypeptides during their membrane passage. It is tightly associated with membrane-bound ribosomes, suggesting that the nascent chain passes directly from the ribosome into a protein-conducting channel. These results define Sec61p as a ubiquitous key component of the protein translocation apparatus.	HUMBOLDT UNIV,INST BIOCHEM,O-1040 BERLIN,GERMANY	Humboldt University of Berlin	GORLICH, D (corresponding author), MAX DELBRUCK CTR MOLEC MED,ROBERT ROSSLE STR 10,O-1115 BERLIN,GERMANY.		Hartmann, Enno/C-5687-2013; Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210				ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; ARNDT E, 1992, BIOCHIM BIOPHYS ACTA, V1130, P13; AUER J, 1991, BIOCHIMIE, V73, P683, DOI 10.1016/0300-9084(91)90048-6; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1976, BIOCHEM BIOPH RES CO, V68, P1, DOI 10.1016/0006-291X(76)90001-2; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BORGESE N, 1974, J MOL BIOL, V88, P559, DOI 10.1016/0022-2836(74)90408-2; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CERRETTI DP, 1983, NUCLEIC ACIDS RES, V11, P2599, DOI 10.1093/nar/11.9.2599; COLLINS PG, 1991, J CELL BIOL, V114, P639, DOI 10.1083/jcb.114.4.639; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; DOUGLAS SE, 1992, FEBS LETT, V298, P93, DOI 10.1016/0014-5793(92)80029-G; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; GARDEL C, 1990, EMBO J, V9, P3209, DOI 10.1002/j.1460-2075.1990.tb07519.x; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; GORLICH D, 1990, J CELL BIOL, V111, P2283, DOI 10.1083/jcb.111.6.2283; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HIGH S, 1991, J CELL BIOL, V113, P35, DOI 10.1083/jcb.113.1.35; ITO K, 1983, CELL, V32, P789, DOI 10.1016/0092-8674(83)90065-X; KELLARIS KV, 1991, J CELL BIOL, V114, P21, DOI 10.1083/jcb.114.1.21; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KOIVULA T, 1991, FEBS LETT, V288, P114, DOI 10.1016/0014-5793(91)81015-Z; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MEYER DI, 1982, NATURE, V297, P503; MICHALOWSKI CB, 1990, MOL GEN GENET, V224, P222, DOI 10.1007/BF00271555; MIGLIACCIO G, 1992, J CELL BIOL, V117, P15, DOI 10.1083/jcb.117.1.15; MUSCH A, 1992, CELL, V69, P343, DOI 10.1016/0092-8674(92)90414-8; NAKAMURA K, 1990, J BIOCHEM-TOKYO, V107, P603; NUNNARI JM, 1991, NATURE, V352, P638, DOI 10.1038/352638a0; OHKUBO S, 1987, MOL GEN GENET, V210, P314, DOI 10.1007/BF00325700; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; PREHN S, 1990, EUR J BIOCHEM, V188, P439, DOI 10.1111/j.1432-1033.1990.tb15421.x; RAPOPORT TA, 1991, FASEB J, V5, P2792, DOI 10.1096/fasebj.5.13.1916103; RIBES V, 1990, CELL, V63, P591, DOI 10.1016/0092-8674(90)90454-M; ROTHBLATT JA, 1987, EMBO J, V6, P3455, DOI 10.1002/j.1460-2075.1987.tb02669.x; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; SHELNESS GS, 1990, J BIOL CHEM, V265, P9512; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; TAZAWA S, 1991, J BIOCHEM-TOKYO, V109, P89; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; TSCHAUDER S, 1992, IN PRESS MOL GEN GEN; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WIEDMANN M, 1987, NATURE, V328, P830, DOI 10.1038/328830a0; ZIMMERMANN R, 1986, TRENDS BIOCHEM SCI, V11, P512, DOI 10.1016/0968-0004(86)90085-X	56	381	388	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					489	503		10.1016/0092-8674(92)90517-G	http://dx.doi.org/10.1016/0092-8674(92)90517-G			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423609				2022-12-28	WOS:A1992JW43500014
J	GODLEE, F				GODLEE, F			JUNIORS HOURS - IS THE END IN SIGHT	BRITISH MEDICAL JOURNAL			English	Article								The question of how to reduce junior doctors' hours has taxed the government and hospital managers for nearly two decades. Now regional task forces are being asked to get them down to a maximum of 83 a week by 1 April next year. From a comparison of the way in which two different task forces (Northern and North West Thames) have responded to the challenge it emerges that most units will probably meet the 83 hour deadline by making simple rationalisations. Meeting the next deadline-of a 72 hour maximum by December 1996-will, however, require radical restructuring of working patterns.										Limb M, 1992, Health Serv J, V102, P33; 1991, JUNIOR DOCTORS NEW D; 1986, HOSPITAL STAFF ACHIE	3	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 17	1992	305	6859					937	940		10.1136/bmj.305.6859.937	http://dx.doi.org/10.1136/bmj.305.6859.937			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JU649	1458076	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JU64900025
J	TYTGAT, J; HESS, P				TYTGAT, J; HESS, P			EVIDENCE FOR COOPERATIVE INTERACTIONS IN POTASSIUM CHANNEL GATING	NATURE			English	Article							XENOPUS-OOCYTES; SHAKER; DROSOPHILA; EXPRESSION; CDNA	CLONING and expression of voltage-activated potassium ionchannel complementary DNAs1-4 has confirmed that these channels are composed of four identical subunits5, each containing a voltage sensor. It has been generally accepted that the voltage sensors must reach a permissive state through one or more conformational ('gating') transitions before the channel can open6,7. To test whether each subunit gates independently, we have constructed cDNAs encoding four subunits on a single polypeptide chain, enabling us to specify the subunit stoichiometry. The gating of heterotetramers made up from combinations of subunits with different gating phenotypes strongly suggests that individual subunits gate cooperatively, rather than independently8. Nonindependent subunit gating is consistent with measurements of the kinetics of K+-channel gating currents9-13 and in line with the widespread subunit cooperativity observed in other multisubunit proteins14.	HARVARD UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School			Tytgat, Jan/F-1560-2010	Tytgat, Jan/0000-0003-1778-6022				BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; GILLY WF, 1982, J GEN PHYSIOL, V79, P965, DOI 10.1085/jgp.79.6.965; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HILLE B, 1992, IONIC CHANNELS EXCIT, P1; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HURST R S, 1992, Biophysical Journal, V61, pA425; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; STUHMER W, 1991, PFLUG ARCH EUR J PHY, V418, P423, DOI 10.1007/BF00550881; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TYTGAT J, 1992, Biophysical Journal, V61, pA426; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	26	126	126	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	1992	359	6394					420	423		10.1038/359420a0	http://dx.doi.org/10.1038/359420a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406954				2022-12-28	WOS:A1992JQ62400058
J	MITCHELL, ABS				MITCHELL, ABS			MRC TRIAL OF TREATING HYPERTENSION IN OLDER ADULTS	BRITISH MEDICAL JOURNAL			English	Letter											MITCHELL, ABS (corresponding author), ST ANNS HOSP,N LONDON POSTGRAD MED CTR,LONDON N15 3TH,ENGLAND.							BEARD K, 1992, BMJ-BRIT MED J, V304, P412, DOI 10.1136/bmj.304.6824.412; CARLSEN JE, 1990, BRIT MED J, V300, P975, DOI 10.1136/bmj.300.6730.975; HAND CH, 1992, BMJ-BRIT MED J, V304, P639, DOI 10.1136/bmj.304.6827.639-a; JOHNSTON GD, 1992, BMJ-BRIT MED J, V304, P639, DOI 10.1136/bmj.304.6827.639-b; KENDALL MJ, 1992, BMJ-BRIT MED J, V304, P639, DOI 10.1136/bmj.304.6827.639; 1992, BMJ, V304, P405	6	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 20	1992	304	6842					1631	1631		10.1136/bmj.304.6842.1631	http://dx.doi.org/10.1136/bmj.304.6842.1631			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA436	1445573	Green Published			2022-12-28	WOS:A1992JA43600046
J	DALAKAS, MC				DALAKAS, MC			ELEVATED CREATINE-KINASE LEVEL IN POSTPOLIO SYNDROME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							NEUROMUSCULAR SYMPTOMS				DALAKAS, MC (corresponding author), NIH,BETHESDA,MD 20892, USA.							DALAKAS M, 1991, ADV NEUROL, V56, P495; DALAKAS MC, 1986, NEW ENGL J MED, V314, P959, DOI 10.1056/NEJM198604103141505; DALAKAS MC, 1988, NEUROLOGY, V38, P99, DOI 10.1212/WNL.38.1.99; DALAKAS MC, 1984, REV INFECT DIS S2, V6, P562; DALAKAS MC, 1988, ADV CONT NEUROLOGY, P51; DRACHMAN DB, 1967, ARCH NEUROL-CHICAGO, V16, P14, DOI 10.1001/archneur.1967.00470190018002	6	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3248	3248						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433769				2022-12-28	WOS:A1992KA65400036
J	KOEHLER, JE; QUINN, FD; BERGER, TG; LEBOIT, PE; TAPPERO, JW				KOEHLER, JE; QUINN, FD; BERGER, TG; LEBOIT, PE; TAPPERO, JW			ISOLATION OF ROCHALIMAEA SPECIES FROM CUTANEOUS AND OSSEOUS LESIONS OF BACILLARY ANGIOMATOSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAT-SCRATCH DISEASE; ACQUIRED IMMUNODEFICIENCY SYNDROME; EPITHELIOID ANGIOMATOSIS; INFECTION; AGENT; DNA; AMPLIFICATION; POLYMERASE; PATHOGENS; CULTURE	Background. Bacillary angiomatosis is characterized by vascular lesions, which occur usually in patients infected with the human immunodeficiency virus (HIV). A newly described gram-negative organism, Rochalimaea henselae, has been associated with cutaneous bacillary angiomatosis, but no organism has been isolated and cultivated directly from cutaneous tissue. Methods. We used two methods to isolate the infecting bacterium from four HIV-infected patients with cutaneous lesions suggestive of bacillary angiomatosis: cultivation with eukaryotic tissue-culture monolayers and direct plating of homogenized tissue onto agar. The patients' blood was cultured with the lysis-centrifugation method. Isolates recovered from skin and blood were identified by sequencing all or part of the 16S ribosomal RNA gene amplified with the polymerase chain reaction. Results. R. quintana, historically known as the agent of trench fever, was isolated from cutaneous lesions in three patients, after tissue homogenates were cultivated with endothelial-cell monolayers; R. henselae was isolated from a cutaneous lesion in one patient. In two patients, R. quintana was isolated from both cutaneous tissue and blood; in one patient it was also isolated from bone. Conclusions. In bacillary angiomatosis, either of two species of rochalimaea - R. quintana or R. henselae - can be isolated from cutaneous lesions or blood, providing an additional method of diagnosis.	UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV BACTERIAL & MYCOT DIS,ATLANTA,GA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA	KOEHLER, JE (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MED,BOX 1204,SAN FRANCISCO,CA 94143, USA.				NIAMS NIH HHS [AR07175-15] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007175] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BERGER TG, 1989, ARCH DERMATOL, V125, P1543, DOI 10.1001/archderm.125.11.1543; BIRKNESS KA, 1992, INFECT IMMUN, V60, P2281, DOI 10.1128/IAI.60.6.2281-2287.1992; BRENNER DJ, 1991, J CLIN MICROBIOL, V29, P2450, DOI 10.1128/JCM.29.11.2450-2460.1991; COCKERELL CJ, 1991, J INVEST DERMATOL, V97, P812, DOI 10.1111/1523-1747.ep12487507; ENGLISH CK, 1988, JAMA-J AM MED ASSOC, V259, P1347, DOI 10.1001/jama.259.9.1347; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; KEMPER CA, 1990, AM J MED, V89, P216, DOI 10.1016/0002-9343(90)90301-S; KOEHLER JE, 1988, ANN INTERN MED, V109, P449, DOI 10.7326/0003-4819-109-6-449; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; KWOK S, 1989, NATURE, V339, P4890; LEBOIT PE, 1989, AM J SURG PATHOL, V13, P909, DOI 10.1097/00000478-198911000-00001; LEBOIT PE, 1988, LANCET, V1, P960; LUCEY D, 1992, CLIN INFECT DIS, V14, P683, DOI 10.1093/clinids/14.3.683; MCNEE UW, 1916, BRIT MED J, V1, P225; MYERS WF, 1984, ANTIMICROB AGENTS CH, V25, P690, DOI 10.1128/AAC.25.6.690; OCONNOR SP, 1991, J CLIN MICROBIOL, V29, P2144, DOI 10.1128/JCM.29.10.2144-2150.1991; REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; RYAN US, 1978, TISSUE CELL, V10, P535, DOI 10.1016/S0040-8166(16)30347-0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLATER LN, 1990, NEW ENGL J MED, V323, P1587, DOI 10.1056/NEJM199012063232303; SLATER LN, 1992, ARCH INTERN MED, V152, P602, DOI 10.1001/archinte.152.3.602; STOLER MH, 1983, AM J CLIN PATHOL, V80, P714, DOI 10.1093/ajcp/80.5.714; TAPPERO JW, 1991, 7TH INT C AIDS FLOR, V1, P340; VINSON JW, 1969, AM J TROP MED HYG, V18, P713, DOI 10.4269/ajtmh.1969.18.713; WEAR DJ, 1983, SCIENCE, V221, P1403, DOI 10.1126/science.6612349; WEISBURG WG, 1985, SCIENCE, V230, P556, DOI 10.1126/science.3931222; WELCH DF, 1992, J CLIN MICROBIOL, V30, P275, DOI 10.1128/JCM.30.2.275-280.1992; WILSON KH, 1991, J CLIN MICROBIOL, V29, P666; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; WOODWARD TE, 1991, FEVER BASIC MECHANIS, P95; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153	33	364	379	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 3	1992	327	23					1625	1631		10.1056/NEJM199212033272303	http://dx.doi.org/10.1056/NEJM199212033272303			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA260	1435899	Bronze			2022-12-28	WOS:A1992KA26000003
J	AYUS, JC; WHEELER, JM; ARIEFF, AI				AYUS, JC; WHEELER, JM; ARIEFF, AI			POSTOPERATIVE HYPONATREMIC ENCEPHALOPATHY IN MENSTRUANT WOMEN	ANNALS OF INTERNAL MEDICINE			English	Article						HYPONATREMIA; ENCEPHALOPATHY, HYPONATREMIC; POSTOPERATIVE COMPLICATIONS; MENSTRUATION	HYPERTONIC SALINE; BRAIN-DAMAGE; WATER; SEIZURES; SURGERY; ARREST; RAT	Objectives: To determine factors associated with the development of encephalopathy and with its clinical course in patients with postoperative hyponatremia. Setting: Consultation and referral services of two university medical centers and community hospitals. Design: Case-control study (risk factors for encephalopathy) and cohort study (clinical course among patients with encephalopathy). Patients: Case patients included 65 adults with postoperative hyponatremic encephalopathy; controls included 674 adult patients who had postoperative hyponatremia without encephalopathy and who were selected from 76 678 consecutive adult surgical inpatients. Measurements: Age, gender, menstrual status, neurologic symptoms, time to development and degree of hyponatremia, arterial blood gas determinations, serum chemistries, morbidity and mortality. Results: Case patients included 40 women (62%) and 25 men (38%) (P > 0.05); controls included 367 women (54%) and 307 men (46%) (P > 0.1). Of the 34 case patients who developed permanent brain damage or died, 33 (97%) were women (P < 0.001). Among the women with brain damage, 25 (76%) were menstruant (P < 0.001). The relative risk for death or permanent brain damage from hyponatremic encephalopathy in women compared with men was 28 (95% CI, 5 to 141) and in menstruant women compared with postmenopausal women, 26 (CI, 11 to 62). Arterial PO2 at diagnosis was significantly lower in female than in male case patients (34 +/- 5 compared with 91 +/- 3 mm Hg; P < 0.001). Further, of the 38 case patients who had respiratory arrest before the diagnosis of hyponatremic encephalopathy, 36 (95%) were women. Extent of or time to development of hyponatremia did not correlate with subsequent brain damage (P > 0.1). Conclusions: Women and men are equally likely to develop hyponatremia and hyponatremic encephalopathy after surgery. However, when hyponatremic encephalopathy develops, menstruant women are about 25 times more likely to die or have permanent brain damage compared with either men or postmenopausal women.	BAYLOR COLL MED, HOUSTON, TX 77030 USA; UNIV CALIF SAN FRANCISCO, SCH MED, SAN FRANCISCO, CA 94143 USA; VET AFFAIRS MED CTR, SAN FRANCISCO, CA USA	Baylor College of Medicine; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)					NATIONAL INSTITUTE ON AGING [R01AG008575] Funding Source: NIH RePORTER; NIA NIH HHS [R01AG08575] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDREOLI TE, 1992, CECIL TXB MED, P499; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; ARIEFF AI, 1976, MEDICINE, V55, P121, DOI 10.1097/00005792-197603000-00002; ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; AYUS JC, 1987, NEW ENGL J MED, V317, P1190, DOI 10.1056/NEJM198711053171905; AYUS JC, 1982, AM J MED, V72, P43, DOI 10.1016/0002-9343(82)90575-7; AYUS JC, 1992, CLIN RES, V40, pA223; CHARLTON AJ, 1980, ANAESTHESIA, V35, P804, DOI 10.1111/j.1365-2044.1980.tb03922.x; CHUNG HM, 1986, ARCH INTERN MED, V146, P333, DOI 10.1001/archinte.146.2.333; DEUTSCH S, 1966, ANESTHESIOLOGY, V27, P250, DOI 10.1097/00000542-196627030-00003; FRASER CL, 1989, AM J PHYSIOL, V257, pE284, DOI 10.1152/ajpendo.1989.257.2.E284; FRASER CL, 1990, ANN INTERN MED, V112, P113, DOI 10.7326/0003-4819-112-2-113; FRASER CL, IN PRESS CLIN DISORD; GARCIA JH, 1980, BRAIN EDEMA PATHOLOG, P147; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; GUY AJ, 1987, BRIT J SURG, V74, P1027, DOI 10.1002/bjs.1800741123; HARRISON RH, 1956, J UROLOGY, V75, P95, DOI 10.1016/S0022-5347(17)66783-1; Helwig FC, 1935, J AMER MED ASSOC, V104, P1569, DOI 10.1001/jama.1935.02760180001001; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; KEATING JP, 1991, AM J DIS CHILD, V145, P985, DOI 10.1001/archpedi.1991.02160090037018; KOZAK LJ, 1989, DHHS PHS891250 DEP H; LEVINSKY NG, 1991, HARRISONS PRINCIPLES, P278; MELTON JE, 1983, AM J PHYSIOL, V244, pR724, DOI 10.1152/ajpregu.1983.244.5.R724; MORAN WH, 1964, SURGERY, V56, P99; NARINS RG, 1990, INTERNAL MED, P832; NATTIE EE, 1981, J APPL PHYSIOL, V51, P1086, DOI 10.1152/jappl.1981.51.5.1086; OELZ O, 1990, HYPOXIA ADAPTATIONS, P206; ROSOMOFF HL, 1963, ARCH NEUROL-CHICAGO, V9, P26, DOI 10.1001/archneur.1963.00460070036003; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P174; RYDER KW, 1984, J UROLOGY, V132, P995, DOI 10.1016/S0022-5347(17)49984-8; SARNAIK AP, 1991, CRIT CARE MED, V19, P758, DOI 10.1097/00003246-199106000-00005; SCOTT JC, 1965, OBSTET GYNECOL, V26, P168; SHIMOJYO S, 1968, NEUROLOGY, V18, P127, DOI 10.1212/WNL.18.2.127; TIEN R, 1992, AM J MED, V92, P513, DOI 10.1016/0002-9343(92)90748-Z; VEXLER ZS, 1992, CLIN RES, V40, pA306; WORTHLEY LIG, 1986, BRIT MED J, V292, P168, DOI 10.1136/bmj.292.6514.168; ZIMMERMANN B, 1952, SURGERY, V31, P654; 1990, HLTH NUTRITION, P110; 1985, SAS USERS GUIDE BASI, P1290	39	328	334	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					891	897		10.7326/0003-4819-117-11-891	http://dx.doi.org/10.7326/0003-4819-117-11-891			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443949				2022-12-28	WOS:A1992JZ27600003
J	FENDRICH, R; WESSINGER, CM; GAZZANIGA, MS				FENDRICH, R; WESSINGER, CM; GAZZANIGA, MS			RESIDUAL VISION IN A SCOTOMA - IMPLICATIONS FOR BLINDSIGHT	SCIENCE			English	Article							VISUAL FUNCTION; SUPERIOR COLLICULUS; STRIATE CORTEX; FIELD; DISCRIMINATION	Blindsight, the ability of some blind patients to describe attributes of stimuli they have no conscious awareness of seeing, has been attributed to a secondary (retinotectal) visual pathway. However, it has also been proposed that blindsight could be due to residual function within the primary (geniculostriate) visual pathway. Data have now been obtained that support the second alternative. With an image stabilizer ensuring the accurate retinal placement of stimuli, dense visual field mapping was carried out with a hemianopic patient. This perimetry revealed, embedded in the patient's scotoma, an isolated 1-degree island of residual vision that was not disclosed by conventional perimetric methods. Stimuli presented to this island could be detected and discriminated, although the subject reported he did not see them. The existence of this island of vision implies a corresponding island of functioning cortex within the patient's lesion. Other instances of blindsight may be mediated by similar islands of functioning cortex.			FENDRICH, R (corresponding author), UNIV CALIF DAVIS, CTR NEUROSCI, DAVIS, CA 95616 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001778] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS1778-10] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARBUR JL, 1980, BRAIN, V103, P905, DOI 10.1093/brain/103.4.905; CAMPION J, 1983, BEHAV BRAIN SCI, V6, P423, DOI 10.1017/S0140525X00016861; COWEY A, 1991, TRENDS NEUROSCI, V14, P140, DOI 10.1016/0166-2236(91)90085-9; CRANE HD, 1978, APPL OPTICS, V17, P691, DOI 10.1364/AO.17.000691; CRANE HD, 1978, APPL OPTICS, V17, P706, DOI 10.1364/AO.17.000706; GROSS CG, 1991, NEUROPSYCHOLOGIA, V29, P497, DOI 10.1016/0028-3932(91)90007-U; Jouandet M L, 1989, J Cogn Neurosci, V1, P88, DOI 10.1162/jocn.1989.1.1.88; MACMILLAN NA, 1991, DETECTION THEORY, P117; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; PASIK P, 1982, CONTRIBUTIONS SENSOR, V7, P147; PERENIN MT, 1978, NEUROPSYCHOLOGIA, V16, P1, DOI 10.1016/0028-3932(78)90037-4; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; PTITO A, 1991, BRAIN, V114, P497, DOI 10.1093/brain/114.1.497; RAFAL R, 1990, SCIENCE, V250, P118, DOI 10.1126/science.2218503; STOERIG P, 1987, BRAIN, V110, P869, DOI 10.1093/brain/110.4.869; STOERIG P, 1989, NATURE, V342, P916, DOI 10.1038/342916a0; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 1990, PROC R SOC SER B-BIO, V239, P247, DOI 10.1098/rspb.1990.0016; WEISKRANTZ L, 1987, BRAIN, V110, P77, DOI 10.1093/brain/110.1.77; ZIHL J, 1980, BEHAV BRAIN RES, V1, P287	20	171	172	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	1992	258	5087					1489	1491		10.1126/science.1439839	http://dx.doi.org/10.1126/science.1439839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ625	1439839				2022-12-28	WOS:A1992JZ62500030
J	KALINER, M; LEMANSKE, R				KALINER, M; LEMANSKE, R			RHINITIS AND ASTHMA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORTICOSTEROID-DEPENDENT ASTHMA; ALLERGIC RHINITIS; BRONCHIAL-ASTHMA; DRUG-THERAPY; DOUBLE-BLIND; TROLEANDOMYCIN; METHOTREXATE; MECHANISMS		UNIV WISCONSIN,SCH MED,DEPT MED,MADISON,WI 53706; UNIV WISCONSIN,SCH MED,DEPT PEDIAT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	KALINER, M (corresponding author), NIAID,ALLERG DIS SECT,BETHESDA,MD 20892, USA.							Anderson SD, 1988, ALLERGY PRINCIPLES P, P1156; BERNSTEIN DI, 1988, J ALLERGY CLIN IMMUN, V81, P6, DOI 10.1016/0091-6749(88)90213-8; BERNSTEIN DI, 1988, ALLERGY PRINCIPLES P, P1197; BIANCO S, 1989, NEW ENGL J MED, V321, P1069, DOI 10.1056/NEJM198910193211602; BLUESTONE CD, 1988, ALLERGY PRINCIPLES P, P1305; CHANYEUNG M, 1982, J ALLERGY CLIN IMMUN, V70, P32, DOI 10.1016/0091-6749(82)90198-1; CHAROUS BL, 1990, ANN ALLERGY, V65, P53; CHECK WA, 1990, AM REV RESPIR DIS, V141, pS44; CHURCH MK, 1990, ASTHMA ITS PATHOLOGY, P561; COSTA JJ, IN PRESS MAST CELLS; DELOHERY J, 1984, AM REV RESPIR DIS, V130, P1027; DRUCE HM, 1989, CURRENT THERAPY RESP, P16; ELLIS EF, 1988, ALLERGY PRINCIPLES P, P1037; ERZURUM SC, 1991, ANN INTERN MED, V114, P353, DOI 10.7326/0003-4819-114-5-353; GROSS NJ, 1988, NEW ENGL J MED, V319, P486; KALINER M, 1985, J ALLERGY CLIN IMMUN, V76, P321, DOI 10.1016/0091-6749(85)90648-7; KALINER M, 1986, AM REV RESPIR DIS, V134, P612; KALINER M, 1987, JAMA-J AM MED ASSOC, V258, P2851, DOI 10.1001/jama.258.20.2851; KALINER MA, 1991, AM REV RESPIR DIS, V144, pS52, DOI 10.1164/ajrccm/144.3_pt_2.S52; KATZ P, 1988, IMMUNOLOGICAL DIS, P1417; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; KERREBIJN KF, 1990, ASTHMA ITS PATHOLOGY, P523; LAITINEN LA, 1990, ASTHMA ITS PATHOLOGY, P103; LEMANSKE RF, IN PRESS ALLERGY PRI; MANSFIELD LE, 1989, ANN ALLERGY, V62, P158; MATHEWS KP, 1985, ALLERGY, P331; MATHISON DA, 1989, PROVOCATIVE CHALLENG, P519; MAZER BD, 1991, J ALLERGY CLIN IMMUN, V87, P976, DOI 10.1016/0091-6749(91)90420-S; MCFADDEN ER, 1988, ASTHMA PRINCIPLES PR, P1018; MULLARKEY MF, 1980, J ALLERGY CLIN IMMUN, V65, P122, DOI 10.1016/0091-6749(80)90196-7; MULLARKEY MF, 1988, NEW ENGL J MED, V318, P603, DOI 10.1056/NEJM198803103181004; NACLERIO RM, 1991, NEW ENGL J MED, V325, P860; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NELSON C, 1988, PHS881754 US DEP HLT; OERTEL HL, 1981, J IMMUNOL, V127, P1398; PAUWELS R, 1990, ASTHMA ITS PATHOLOGY, P503; PETTY TL, 1989, AM REV RESPIR DIS, V139, P694, DOI 10.1164/ajrccm/139.3.694; RAPHAEL GD, 1991, J ALLERGY CLIN IMMUN, V87, P457, DOI 10.1016/0091-6749(91)90001-5; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; SCHATZ M, 1988, ALLERGY PRINCIPLES P, P1093; SCHLEIMER RP, 1988, ALLERGY PRINCIPLES P, P739; SCHWARTZ LB, IN PRESS MAST CELLS; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SHEFFER AL, 1991, NIH913042 US DEP HLT; SLAVIN RG, 1988, ALLERGY PRINCIPLES P, P1291; SMITH JM, 1988, ALLERGY PRINCIPLES P, P891; Solomon W. R., 1988, ALLERGY PRINCIPLES P, P312; SOLOMON WR, 1989, PROVOCATIVE CHALLENG, P569; SPECTOR SL, 1989, PROVOCATIVE CHALLENG, P293; TOOGOOD JH, 1990, AM REV RESPIR DIS, V141, pS89; VANMETRE TE, 1988, J ALLERGY CLIN IMMUN, V82, P1055, DOI 10.1016/0091-6749(88)90144-3; VENGE P, 1990, ASTHMA ITS PATHOLOGY, P477; WALD JA, 1986, J ALLERGY CLIN IMMUN, V78, P36, DOI 10.1016/0091-6749(86)90112-0; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; WEISS KB, 1990, 912414 US DEP HLTH H; WHITE MV, IN PRESS MAST CELLS; WHITE MV, 1990, ASTHMA ITS PATHOLOGY, P409; WHITE MV, 1991, LUNG SCI F, P927; ZEIGER RS, 1980, J ALLERGY CLIN IMMUN, V66, P438, DOI 10.1016/0091-6749(80)90003-2; ZEISS CR, 1982, J ALLERGY CLIN IMMUN, V70, P15, DOI 10.1016/0091-6749(82)90195-6	60	54	55	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2807	2829		10.1001/jama.268.20.2807	http://dx.doi.org/10.1001/jama.268.20.2807			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433696				2022-12-28	WOS:A1992JY66800004
J	SINGH, S; RICHTER, JE; HEWSON, EG; SINCLAIR, JW; HACKSHAW, BT				SINGH, S; RICHTER, JE; HEWSON, EG; SINCLAIR, JW; HACKSHAW, BT			THE CONTRIBUTION OF GASTROESOPHAGEAL REFLUX TO CHEST PAIN IN PATIENTS WITH CORONARY-ARTERY DISEASE	ANNALS OF INTERNAL MEDICINE			English	Article						CORONARY DISEASE; GASTROESOPHAGEAL REFLUX; CHEST PAIN; ELECTROCARDIOGRAPHY, AMBULATORY	GASTRO-ESOPHAGEAL REFLUX; PH; NIFEDIPINE; DIAGNOSIS; MOTILITY; SYMPTOMS; ANGINA	Objective: To describe the effectiveness of investigating and treating the cause of refractory chest pain in patients with coronary artery disease who are receiving optimal antianginal therapy. Design: Cohort study. Setting: Tertiary referral center. Patients: Between January 1988 and December 1989, 34 patients were identified as having angiographically proven coronary artery disease and atypical chest pain symptoms despite their having received aggressive medical or surgical antianginal therapy, or both. Intervention: Patients with confirmed acid-related symptoms were treated with high-dose histamine-2 (H-2) blockers or omeprazole for 8 weeks in an open-label study. Measurements: Esophageal manometry and simultaneous 24-hour pH and Holter studies; global improvement in or disappearance of chest pain. Results: Of the 34 patients, 30 (88%) experienced their identical chest pain symptoms during the study. A total of 164 pain episodes was recorded: 38 (23.2%) correlated with acid reflux; 6 (3.7%) were related to cardiac ischemia; and the remaining 120 (73.2%) had no identifiable cause. Of these 30 patients, 20 (67%) had some of their episodes of chest pain (range, 14% to 100%) secondary to acid reflux. After 8 weeks of vigorous acid suppression, 13 of these 20 patients had marked improvement or resolution of chest pain. Four other patients had ischemia-related episodes of chest pain that responded to more aggressive antianginal therapy. No episodes of acid reflux were clearly followed by ischemic chest pain. One patient had both acid- and ischemic-related episodes of chest pain that were indistinguishable. Overall, 24 of 34 (71%) patients had a definite cause of chest pain identified by combined pH and Holter monitoring. Conclusions: Gastroesophageal reflux disease is a common, treatable cause of chest pain in patients with coronary artery disease who have atypical symptoms and remain symptomatic despite aggressive antianginal therapy. Combined Holter and 24-hour esophageal pH studies are complementary investigations for elucidating the cause of chest pain in these patients.	UNIV ALABAMA, DIV GASTROENTEROL, UAB STN, ZEIGLER BLDG 635, BIRMINGHAM, AL 35294 USA; WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DIV GASTROENTEROL, WINSTON SALEM, NC 27103 USA	University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest Baptist Medical Center								ALLEN M, 1987, Alimentary Pharmacology and Therapeutics, V1, P153; BORTOLOTTI M, 1990, Gastroenterology, V98, pA24; BRAND DC, 1988, DIGEST DIS SCI, V22, P300; DAVIES HA, 1982, JAMA-J AM MED ASSOC, V248, P2274, DOI 10.1001/jama.248.18.2274; DEARFIELD JE, 1984, AM J CARDIOL, V54, P1195; DECAESTECKER JS, 1985, LANCET, V2, P1143; GARCIAPULIDO J, 1990, CHEST, V98, P806, DOI 10.1378/chest.98.4.806; GELFOND M, 1982, GASTROENTEROLOGY, V83, P963; HEWSON EG, 1991, AM J MED, V90, P576; HEWSON EG, 1990, ARCH INTERN MED, V150, P965, DOI 10.1001/archinte.150.5.965; JANSSENS J, 1986, GASTROENTEROLOGY, V90, P1978, DOI 10.1016/0016-5085(86)90270-2; JENKINSON LR, 1988, ALIMENT PHARM THERAP, V2, P337; JOHNSON LF, 1974, AM J GASTROENTEROL, V62, P325; JOHNSSON F, 1987, SCAND J GASTROENTERO, V22, P714, DOI 10.3109/00365528709011148; KATZ PO, 1987, ANN INTERN MED, V106, P593, DOI 10.7326/0003-4819-106-4-593; KIKENDALL JW, 1980, GASTROENTEROLOGY, V79, P703; MATTOX HE, 1990, AM J MED, V89, P345, DOI 10.1016/0002-9343(90)90348-H; MELLOW MH, 1983, GASTROENTEROLOGY, V85, P306; MOCK MB, 1991, CARDIOLOGY FUNDAMENT, P349; MURPHY DW, 1989, DIGEST DIS SCI, V34, P649, DOI 10.1007/BF01540333; PETERS L, 1988, GASTROENTEROLOGY, V94, P878, DOI 10.1016/0016-5085(88)90542-2; RICHTER JE, 1987, GASTROENTEROLOGY, V93, P21, DOI 10.1016/0016-5085(87)90308-8; RICHTER JE, 1992, DIGEST DIS SCI, V37, P849, DOI 10.1007/BF01300382; RICHTER JE, 1987, DIGEST DIS SCI, V32, P583, DOI 10.1007/BF01296157; RICHTER JE, 1989, ANN INTERN MED, V110, P66, DOI 10.7326/0003-4819-110-1-66; SCHOFIELD PM, 1987, BMJ-BRIT MED J, V294, P1459, DOI 10.1136/bmj.294.6585.1459; SOBEL BE, 1992, CECIL TXB MED, P304; SVENSSON O, 1978, ACTA MED SCAND, V204, P173; TIBBLING L, 1976, ACTA MED SCAND, V200, P391; WANI M, 1990, GUT, V31, P127, DOI 10.1136/gut.31.2.127; WARD BW, 1986, J CLIN GASTROENTEROL, V8, P59; WIENER GJ, 1988, AM J GASTROENTEROL, V83, P358	32	102	102	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					824	830		10.7326/0003-4819-117-10-824	http://dx.doi.org/10.7326/0003-4819-117-10-824			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416557				2022-12-28	WOS:A1992JX83800005
J	LUNA, EJ; HITT, AL				LUNA, EJ; HITT, AL			CYTOSKELETON PLASMA-MEMBRANE INTERACTIONS	SCIENCE			English	Article							ACTIN-BINDING-PROTEIN; ADHERENS-TYPE JUNCTIONS; CELL-ADHESION; DICTYOSTELIUM-DISCOIDEUM; BUNDLING PROTEIN; SMOOTH-MUSCLE; TYROSINE PHOSPHORYLATION; ERYTHROCYTE ADDUCIN; EPITHELIAL-CELLS; SKELETAL-MUSCLE	Proteins at the boundary between the cytoskeleton and the plasma membrane control cell shape, delimit specialized membrane domains, and stabilize attachments to other cells and to the substrate. These proteins also regulate cell locomotion and cytoplasmic responses to growth factors and other external stimuli. This diversity of cellular functions is matched by the large number of biochemical mechanisms that mediate the connections between membrane proteins and the underlying cytoskeleton, the so-called membrane skeleton. General organizational themes are beginning to emerge from examination of this biochemical diversity.			LUNA, EJ (corresponding author), WORCESTER FDN EXPTL BIOL INC, CELL BIOL GRP, SHREWSBURY, MA 01545 USA.		Luna, Elizabeth/B-4364-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033048] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM033048] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam G., 1968, STRUCTURAL CHEM MOL, P198; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amos LA, 1991, MOL CYTOSKELETON; ANDREWS RK, 1991, J BIOL CHEM, V266, P7144; ANDREWS RK, 1992, J BIOL CHEM, V267, P18605; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BEARER EL, 1992, J NEUROSCI, V12, P750; BEARER EL, 1990, ANAT REC, V227, P1, DOI 10.1002/ar.1092270102; BECKERLE MC, 1990, CELL MOTIL CYTOSKEL, V16, P7, DOI 10.1002/cm.970160103; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; BENZEEV A, 1979, CELL, V17, P859, DOI 10.1016/0092-8674(79)90326-X; BLOCH R J, 1992, Trends in Cell Biology, V2, P186, DOI 10.1016/0962-8924(92)90231-B; BOURGUIGNON LYW, 1992, MOL CELL BIOL, V12, P4464, DOI 10.1128/MCB.12.10.4464; BOURGUIGNON LYW, 1992, ENCY IMMUNOLOGY, P1044; Bray D., 1992, CELL MOVEMENTS; BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cb.07.110191.002005; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BURRIDGE K, 1990, ADV CELL BIOL, V3, P95; BURRIDGE K, 1992, P NATL ACAD SCI USA, V89, P8487; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; BUTLER J A, 1989, Journal of Cell Biology, V109, p172A; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; BYERS TJ, 1991, J CELL BIOL, V115, P411, DOI 10.1083/jcb.115.2.411; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; CARRAWAY KL, 1989, BIOCHIM BIOPHYS ACTA, V988, P147, DOI 10.1016/0304-4157(89)90017-8; CARTAUD A, 1990, J CELL BIOL, V111, P581, DOI 10.1083/jcb.111.2.581; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHRISTIAN JL, 1991, CURR TOP MEMBR, V38, P99; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; COHEN CM, 1992, SEMIN HEMATOL, V29, P244; COLEMAN TR, 1989, CELL MOTIL CYTOSKEL, V12, P225, DOI 10.1002/cm.970120405; CONDEELIS J, 1992, CELL MOTIL CYTOSKEL, V22, P1, DOI 10.1002/cm.970220102; COOPER JA, 1991, ANNU REV PHYSIOL, V53, P585, DOI 10.1146/annurev.ph.53.030191.003101; COULTER S, 1992, P NATL ACAD SCI USA, V89, P5842, DOI 10.1073/pnas.89.13.5842; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DAVIS LH, 1992, J BIOL CHEM, V267, P18966; DAVIS S, 1991, SCIENCE, V252, P712, DOI 10.1126/science.1708917; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DELISI C, 1981, MOL IMMUNOL, V18, P507, DOI 10.1016/0161-5890(81)90128-0; DEPASQUALE JA, 1991, J CELL BIOL, V113, P1351, DOI 10.1083/jcb.113.6.1351; DRENCKHAHN T, 1992, PROG CELL RES, V2, P263; Dubreuil R.R., 1992, P59; EDIDIN M, IN PRESS TRENDS CELL; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FECHHEIMER M, 1987, J CELL BIOL, V104, P1539, DOI 10.1083/jcb.104.6.1539; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; FERNANDEZ JLR, 1992, CELL MOTIL CYTOSKEL, V22, P127, DOI 10.1002/cm.970220206; FISHKIND DJ, 1990, DEV BIOL, V142, P453, DOI 10.1016/0012-1606(90)90367-R; FOWLER VM, IN PRESS J CELL BIOL; FOX JEB, 1988, BIOESSAYS, V8, P14, DOI 10.1002/bies.950080105; FRIEDERICH E, 1990, BIOESSAYS, V12, P403, DOI 10.1002/bies.950120902; FRIEDRICHS B, 1989, EUR J CELL BIOL, V48, P121; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; FUKUI Y, IN PRESS INT REV CYT; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; GEIGER B, 1991, CELL MOTIL CYTOSKEL, V20, P1, DOI 10.1002/cm.970200102; GIUDICE GJ, 1991, J CLIN INVEST, V87, P734, DOI 10.1172/JCI115054; GOLDMANN WH, 1991, BIOCHEM BIOPH RES CO, V178, P718, DOI 10.1016/0006-291X(91)90167-6; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; GOLDSCHMIDTCLERMONT PJ, 1991, CELL, V66, P419, DOI 10.1016/0092-8674(81)90002-7; GOODMAN SR, 1988, CRIT REV BIOCHEM MOL, V23, P171, DOI 10.3109/10409238809088319; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; GREEN KJ, 1992, INT J BIOL MACROMOL, V14, P145, DOI 10.1016/S0141-8130(05)80004-2; GREGORIO CC, 1992, P NATL ACAD SCI USA, V89, P4947, DOI 10.1073/pnas.89.11.4947; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HARTMAN DS, 1991, J CELL BIOL, V115, P165, DOI 10.1083/jcb.115.1.165; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; Hartwig JH, 1991, CURR OPIN CELL BIOL, V3, P87, DOI 10.1016/0955-0674(91)90170-4; HEINTZELMAN MB, 1992, CURR TOP DEV BIOL, V26, P93, DOI 10.1016/S0070-2153(08)60442-1; HEMPHILL A, 1992, J CELL BIOL, V117, P95, DOI 10.1083/jcb.117.1.95; HEMPHILL A, 1991, J STRUCT BIOL, V107, P211, DOI 10.1016/1047-8477(91)90046-Y; HIEDA Y, 1989, J CELL BIOL, V109, P1511, DOI 10.1083/jcb.109.4.1511; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HOCK RS, 1990, BIOCHEMISTRY-US, V29, P9441, DOI 10.1021/bi00492a019; HOFFMAN EP, 1991, CURR TOP MEMBR, V38, P113; HOLIFIELD BF, 1990, J CELL BIOL, V111, P2499, DOI 10.1083/jcb.111.6.2499; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; HOPKINSON SB, 1991, EXP CELL RES, V194, P139; HU RJ, 1992, J BIOL CHEM, V267, P18715; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; HUSAINCHISHTI A, 1989, J BIOL CHEM, V264, P8985; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; ISENBERG G, 1991, J MUSCLE RES CELL M, V12, P136, DOI 10.1007/BF01774032; ISHIURA S, 1990, J BIOCHEM-TOKYO, V107, P510, DOI 10.1093/oxfordjournals.jbchem.a123076; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; JESAITIS AJ, 1992, COMMENTS MOL CELL BI, V8, P97; JOCKUSCH BM, 1991, J CELL SCI, P41; JOHNS JA, 1988, CELL MOTIL CYTOSKEL, V9, P205, DOI 10.1002/cm.970090303; Jones JCR, 1991, CURR OPIN CELL BIOL, V3, P127, DOI 10.1016/0955-0674(91)90175-X; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; KAUFMANN S, 1991, FEBS LETT, V284, P187, DOI 10.1016/0014-5793(91)80681-R; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; Kiehart D.P., 1990, Seminars in Cell Biology, V1, P325; KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOCH PJ, 1992, P NATL ACAD SCI USA, V89, P353, DOI 10.1073/pnas.89.1.353; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; LAZARIDES E, 1989, ANNU REV CELL BIOL, V5, P427; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LEE CC, 1991, NATURE, V349, P334, DOI 10.1038/349334a0; LEMAIRE C, 1988, EMBO J, V7, P4157, DOI 10.1002/j.1460-2075.1988.tb03311.x; LEWIS AK, IN PRESS J CELL BIOL; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; LIU YC, 1989, J BIOL CHEM, V264, P1208; LOKESHWAR VB, 1992, J BIOL CHEM, V267, P22073; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LUNA EJ, 1990, DEV GENET, V11, P354, DOI 10.1002/dvg.1020110506; Luna EJ, 1991, CURR OPIN CELL BIOL, V3, P120, DOI 10.1016/0955-0674(91)90174-W; Magee AI, 1991, CURR OPIN CELL BIOL, V3, P854, DOI 10.1016/0955-0674(91)90060-C; MARRS JA, 1992, J CELL BIOL, V118, P1465, DOI 10.1083/jcb.118.6.1465; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; MILLER M, 1992, NEURON, V8, P25, DOI 10.1016/0896-6273(92)90106-N; MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837; MOSS DJ, 1992, EUR J CELL BIOL, V57, P59; MUSACCHIO A, 1992, FEBS LETT, V307, P55, DOI 10.1016/0014-5793(92)80901-R; NACHMIAS VT, 1988, ADV CELL BIOL, V2, P181; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; NIGGLI V, 1987, J MEMBRANE BIOL, V100, P97, DOI 10.1007/BF02209144; NORMAN NJ, 1992, NEW ENGL J MED, V321, P631; NUCKOLLS GH, 1992, J CELL SCI, V102, P753; OGIHARA S, 1988, DEV GENET, V9, P505, DOI 10.1002/dvg.1020090427; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; OHTA Y, 1991, CELL, V67, P275, DOI 10.1016/0092-8674(91)90179-3; OSTER G, 1988, CELL MOTIL CYTOSKEL, V10, P164, DOI 10.1002/cm.970100121; OTTO JJ, 1990, CELL MOTIL CYTOSKEL, V16, P1, DOI 10.1002/cm.970160102; PALEK J, 1992, BLOOD, V80, P1; PASDAR M, 1991, J CELL BIOL, V113, P645, DOI 10.1083/jcb.113.3.645; PAVALKO FM, 1989, J CELL SCI, V94, P109; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; PODOLSKI JL, 1990, J BIOL CHEM, V265, P1312; PORTER GA, 1992, J CELL BIOL, V117, P997, DOI 10.1083/jcb.117.5.997; Quaranta V, 1991, Trends Cell Biol, V1, P2, DOI 10.1016/0962-8924(91)90046-C; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; RESH MD, 1990, ONCOGENE, V5, P1437; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; ROSIERE TK, 1990, J CELL BIOL, V110, P1077, DOI 10.1083/jcb.110.4.1077; ROULIER EM, 1992, J CELL BIOL, V116, P911, DOI 10.1083/jcb.116.4.911; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; SATO N, 1992, J CELL SCI, V103, P131; SAUTERER RA, 1991, J BIOL CHEM, V266, P24533; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHEEL J, 1989, J BIOL CHEM, V264, P2832; SCHULTHEISS T, 1992, P NATL ACAD SCI USA, V89, P9282, DOI 10.1073/pnas.89.19.9282; SCHWARTZ M A, 1992, Trends in Cell Biology, V2, P304, DOI 10.1016/0962-8924(92)90120-C; SCHWARZ MA, 1990, ANNU REV CELL BIOL, V6, P461, DOI 10.1146/annurev.cb.06.110190.002333; SHARIFF A, 1992, SCIENCE, V256, P245, DOI 10.1126/science.1373523; SHEETZ MP, 1990, CELL, V61, P231, DOI 10.1016/0092-8674(90)90804-N; SHEETZ MP, 1992, CELL MOTIL CYTOSKEL, V22, P160, DOI 10.1002/cm.970220303; SIMON KO, 1991, CURR TOP MEMBR, V38, P57; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; SMALL JV, 1981, COLD SPRING HARB SYM, V46, P599, DOI 10.1101/SQB.1982.046.01.056; SOBUE K, 1991, J BIOL CHEM, V266, P12115; STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197; STRITTMATTER SM, 1991, J CELL SCI, P27; SUZUKI S, 1991, CELL REGUL, V2, P261, DOI 10.1091/mbc.2.4.261; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TERMAN N, 1991, J CELL BIOL, V115, P1695; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Theriot Julie A., 1992, Trends in Cell Biology, V2, P219, DOI 10.1016/0962-8924(92)90298-2; TIDBALL JG, 1991, AM J PATHOL, V138, P17; TILNEY LG, 1982, J CELL BIOL, V93, P820, DOI 10.1083/jcb.93.3.820; TSAI MH, 1990, SCIENCE, V250, P982, DOI 10.1126/science.2237442; TSUKITA S, 1991, J CELL BIOL, V113, P867, DOI 10.1083/jcb.113.4.867; TSUKITA S, IN PRESS CURR OPIN C; Turner CE, 1991, CURR OPIN CELL BIOL, V3, P849, DOI 10.1016/0955-0674(91)90059-8; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; VIRATA MLA, 1992, P NATL ACAD SCI USA, V89, P544, DOI 10.1073/pnas.89.2.544; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; VOLBERG T, 1991, CELL REGUL, V2, P105, DOI 10.1091/mbc.2.2.105; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WARREN RH, 1985, EUR J CELL BIOL, V38, P245; WASEEM A, 1990, J CELL SCI, V96, P93; WAY M, 1992, PFEBS LETT, V301, P243; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; WHITE RA, 1992, NAT GENET, V2, P80, DOI 10.1038/ng0992-80; WITKE W, 1992, CELL, V68, P53, DOI 10.1016/0092-8674(92)90205-Q; YAMADA KM, IN PRESS COLD SPRING; YIN HL, 1990, FEBS LETT, V264, P78, DOI 10.1016/0014-5793(90)80769-F; YU J, 1973, Journal of Supramolecular Structure, V1, P233, DOI 10.1002/jss.400010308	199	743	753	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	1992	258	5084					955	963		10.1126/science.1439807	http://dx.doi.org/10.1126/science.1439807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439807				2022-12-28	WOS:A1992JW79600025
J	KEATING, HJ				KEATING, HJ			INTUITION OF A CLINICAL SORT	ANNALS OF INTERNAL MEDICINE			English	Editorial Material						PHYSICIAN-PATIENT RELATIONS; KNOWLEDGE, ATTITUDES, PRACTICE		A physician has a retired pediatrician for a patient, and each time he comes for a visit, the physician learns something new about being a doctor. The story concerns an encounter in which a critical question is raised: What makes a good doctor?			KEATING, HJ (corresponding author), VET AFFAIRS MED CTR, MED SERV 111, DES MOINES, IA 50310 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					785	785		10.7326/0003-4819-117-9-785	http://dx.doi.org/10.7326/0003-4819-117-9-785			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416581				2022-12-28	WOS:A1992JV42400014
J	IRWIN, MJ; HUDSON, KR; FRASER, JD; GASCOIGNE, NRJ				IRWIN, MJ; HUDSON, KR; FRASER, JD; GASCOIGNE, NRJ			ENTEROTOXIN RESIDUES DETERMINING T-CELL RECEPTOR V-BETA BINDING-SPECIFICITY	NATURE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN; STIMULATION; SUPERANTIGENS; MOLECULE; CHAIN	SUPERANTIGENS such as the staphylococcal enterotoxins bind to major histocompatibility complex (MHC) class II molecules and activate T cells through a specific interaction between the Vbeta region of the T-cell antigen receptor (TCR) and the toxin1-4. The TCR beta-chain alone is sufficient to produce the interaction with the enterotoxin-class II complex5. Identification of the regions of enterotoxins that interact with TCR has so far proved equivocal because of difficulties in distinguishing between direct effects on T-cell recognition and indirect effects resulting from alteration of binding to class II. For example, amino-terminal truncations of SEB abrogated T-cell stimulation whereas carboxy-terminal truncation of SEA stopped its mitogenic activity10,11. The most comprehensive study to date, accounting for both enterotoxin binding to class II and enterotoxin interactions with the TCR, identified two functionally important regions for SEB binding to TCR12. Although the amino-acid sequences of staphylococcal enterotoxins A and E are 82% identical6, they activate T cells bearing different Vbeta elements. We have assayed the binding of cells coated with these enterotoxins to soluble secreted TCR beta-chain protein and find that Vbeta3 binds enterotoxin A but not E, whereas Vbeta11 binds enterotoxin but not A. To map the amino-acid residues responsible for these different binding specificities, we prepared a series of hybrids between the two staphylococcal enterotoxins. We report that just two amino-acid residues near the carboxy terminus of the enterotoxins are responsible for the discrimination between these molecules by Vbeta3 and Vbeta11. The crystal structure of staphylococcal enterotoxin B (ref. 12) indicates that these form part of the outer rim of the site recognizing TCR.	Scripps Res Inst, DEPT IMMUNOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA; UNIV AUCKLAND, DEPT MOLEC MED, AUCKLAND, NEW ZEALAND	Scripps Research Institute; University of Auckland								BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BUELOW R, 1992, J IMMUNOL, V148, P1; CALLAHAN JE, 1990, J IMMUNOL, V144, P2473; COUCH JL, 1988, J BACTERIOL, V170, P2954, DOI 10.1128/jb.170.7.2954-2960.1988; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; GASCOIGNE NR, IN PRESS J SEMIN IMM; GASCOIGNE NRJ, 1990, J BIOL CHEM, V265, P9296; GASCOIGNE NRJ, 1991, P NATL ACAD SCI USA, V88, P613, DOI 10.1073/pnas.88.2.613; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; HUFNAGLE WO, 1991, INFECT IMMUN, V59, P2126, DOI 10.1128/IAI.59.6.2126-2134.1991; JOHNSON HM, 1991, FASEB J, V5, P2706, DOI 10.1096/fasebj.5.12.1916093; KANAGAWA O, 1989, CELL IMMUNOL, V119, P412, DOI 10.1016/0008-8749(89)90255-4; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; KUBO RT, 1989, J IMMUNOL, V142, P2736; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; PALMER MS, 1989, NUCLEIC ACIDS RES, V17, P2353, DOI 10.1093/nar/17.6.2353; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; SINGH BR, 1989, J BIOL CHEM, V264, P4404; SMITH HP, 1992, J IMMUNOL, V149, P887; Summers MD, 1987, TEXAS AGR EXPT STATI; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; TAKIMOTO H, 1990, EUR J IMMUNOL, V20, P617, DOI 10.1002/eji.1830200323; VACCHIO MS, 1992, J EXP MED, V175, P1405, DOI 10.1084/jem.175.5.1405	23	77	80	1	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 29	1992	359	6398					841	843		10.1038/359841a0	http://dx.doi.org/10.1038/359841a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV777	1436060				2022-12-28	WOS:A1992JV77700067
J	STRYNADKA, NCJ; ADACHI, H; JENSEN, SE; JOHNS, K; SIELECKI, A; BETZEL, C; SUTOH, K; JAMES, MNG				STRYNADKA, NCJ; ADACHI, H; JENSEN, SE; JOHNS, K; SIELECKI, A; BETZEL, C; SUTOH, K; JAMES, MNG			MOLECULAR-STRUCTURE OF THE ACYL-ENZYME INTERMEDIATE IN BETA-LACTAM HYDROLYSIS AT 1.7 ANGSTROM RESOLUTION	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; BACILLUS-LICHENIFORMIS 749/C; REFINED CRYSTAL-STRUCTURE; MECHANISM; PENICILLIN; CATALYSIS; MUTANTS; RESISTANCE; SINGLE; PC1	The X-ray crystal structure of the molecular complex of penicillin G with a deacylation-defective mutant of the RTEM-1 beta-lactamase from Escherichia coli shows how these antibiotics are recognized and destroyed. Penicillin G is covalently bound to Ser 70 O(gamma) as an acyl-enzyme intermediate. The deduced catalytic mechanism uses Ser 70 O(gamma) as the attacking nucleophile during acylation. Lys 73 N(zeta) acts as a general base in abstracting a proton from Ser 70 and transferring it to the thiazolidine ring nitrogen atom via Ser 130 O(gamma). Deacylation is accomplished by nucleophilic attack on the penicilloyl carbonyl carbon by a water molecule assisted by the general base, Glu 166.	UNIV ALBERTA, DEPT BIOCHEM, MRC, PROT STRUCT & FUNCT GRP, EDMONTON T6G 2H7, ALBERTA, CANADA; DESY, EUROPEAN MOLEC BIOL LAB, W-2000 HAMBURG 52, GERMANY; UNIV ALBERTA, DEPT MICROBIOL, EDMONTON T6G 2E9, ALBERTA, CANADA; UNIV TOKYO, COLL ARTS & SCI, DEPT PURE & APPL SCI, MEGURO KU, TOKYO 153, JAPAN	University of Alberta; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Alberta; University of Tokyo			Jensen, Susan/C-8701-2013; Betzel, Christian/G-8105-2018	Betzel, Christian/0000-0002-3879-5019				Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; ADACHI H, 1991, J BIOL CHEM, V266, P3186; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; CARTWRIGHT SJ, 1989, BIOCHEM J, V263, P905, DOI 10.1042/bj2630905; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; Crowfoot D., 1949, CHEM PENICILLIN, P310; DALBADIEMCFARLAND G, 1986, BIOCHEMISTRY-US, V25, P332, DOI 10.1021/bi00350a008; DEXTER DD, 1978, J CHEM SOC, V185, P110; ELLERBY LM, 1990, BIOCHEMISTRY-US, V29, P5797, DOI 10.1021/bi00476a022; ESCOBAR WA, 1991, BIOCHEMISTRY-US, V30, P10783, DOI 10.1021/bi00108a025; FISHER J, 1980, BIOCHEMISTRY-US, V19, P2895, DOI 10.1021/bi00554a012; FRERE JM, 1985, CRC CR REV MICROBIOL, V11, P299; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; GIBSON RM, 1990, BIOCHEM J, V272, P613, DOI 10.1042/bj2720613; GREEN DW, 1954, PROC R SOC LON SER-A, V225, P287, DOI 10.1098/rspa.1954.0203; HAMLIN R, 1985, METHOD ENZYMOL, V114, P416; HEALEY WJ, 1989, PROTEINS, V6, P275, DOI 10.1002/prot.340060310; HENDERSON R, 1970, Journal of Molecular Biology, V54, P341, DOI 10.1016/0022-2836(70)90434-1; Hendrickson W. A., 1980, COMPUTING CRYSTALLOG; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; HERZBERG O, 1991, J MOL BIOL, V217, P701, DOI 10.1016/0022-2836(91)90527-D; Herzberg O, 1991, CURR OPIN STRUC BIOL, V1, P946, DOI 10.1016/0959-440X(91)90090-G; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; JACOB F, 1990, PROTEIN ENG, V4, P79, DOI 10.1093/protein/4.1.79; JACOB F, 1990, BIOCHEM J, V271, P399, DOI 10.1042/bj2710399; JAMES MNG, 1968, NATURE, V220, P168, DOI 10.1038/220168a0; JELSCH C, 1992, FEBS LETT, V299, P135, DOI 10.1016/0014-5793(92)80232-6; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KNAP AK, 1991, BIOCHEM J, V273, P85, DOI 10.1042/bj2730085; KNOWLES JR, 1985, ACCOUNTS CHEM RES, V18, P97, DOI 10.1021/ar00112a001; KNOX JR, 1991, J MOL BIOL, V220, P435, DOI 10.1016/0022-2836(91)90023-Y; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; LESLIE AGW, 1986, CCP4 NEWSLETTER, V18, P33; MARTIN MT, 1988, BIOCHEM J, V254, P923, DOI 10.1042/bj2540923; MATTHEW M, 1976, J BACTERIOL, V125, P713, DOI 10.1128/JB.125.2.713-718.1976; MOEWS PC, 1990, PROTEINS, V7, P156, DOI 10.1002/prot.340070205; NAVAZA J, 1990, ACTA CRYSTALLOGR A, V46, P619, DOI 10.1107/S0108767390000290; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; OTWINOWSKI Z, 1990, AM CRYSTALLOGR ASS A; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; ROSSMAN MG, 1972, INT SCI REV, V13; SWEET RM, 1970, J AM CHEM SOC, V92, P5489, DOI 10.1021/ja00721a032; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VIRDEN R, 1990, BIOCHEMISTRY-US, V29, P145, DOI 10.1021/bi00453a018; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016	49	541	546	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	1992	359	6397					700	705		10.1038/359700a0	http://dx.doi.org/10.1038/359700a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436034				2022-12-28	WOS:A1992JU65000046
J	HAENEY, MR				HAENEY, MR			ANGIOEDEMA AND URTICARIA ASSOCIATED WITH OMEPRAZOLE	BRITISH MEDICAL JOURNAL			English	Letter							SAFETY				HAENEY, MR (corresponding author), HOPE HOSP,SALFORD M6 8HD,LANCS,ENGLAND.							NELIS GF, 1989, DIGESTION, V44, P68, DOI 10.1159/000200106; SOLVELL L, 1989, SCAND J GASTROENTERO, V24, P106, DOI 10.3109/00365528909091255	2	38	39	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					870	870		10.1136/bmj.305.6858.870-c	http://dx.doi.org/10.1136/bmj.305.6858.870-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422401	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JT77700030
J	YEN, TJ; LI, G; SCHAAR, BT; SZILAK, I; CLEVELAND, DW				YEN, TJ; LI, G; SCHAAR, BT; SZILAK, I; CLEVELAND, DW			CENP-E IS A PUTATIVE KINETOCHORE MOTOR THAT ACCUMULATES JUST BEFORE MITOSIS	NATURE			English	Article							KINESIN HEAVY-CHAIN; PROTEIN; SEQUENCE; GENE; ENCODES; DOMAINS	THE mechanics of chromosome movement, mitotic spindle assembly and spindle elongation have long been central questions of cell biology1. After attachment in prometaphase of a microtubule from one pole, duplicated chromosome pairs travel towards the pole in a rapid but discontinuous motion2,3. This is followed by a slower congression towards the midplate as the chromosome pair orients with each kinetochore attached to the microtubules f rom the nearest pole. The pairs disjoin at anaphase and translocate to opposite poles and the interpolar distance increases. Here we identify CENP-E as a kinesin-like motor protein (M(r) 312,000) that accumulates in the G2 phase of the cell cycle. CENP-E associates with kinetochores during congression, relocates to the spindle midzone at anaphase, and is quantitatively discarded at the end of the cell division. CENP-E is likely to be one of the motors responsible for mammalian chromosome movement and/or spindle elongation.	UNIV PENN,CELL BIOL GRAD GRP,PHILADELPHIA,PA 19104; JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL SCI,BALTIMORE,MD 21205	University of Pennsylvania; Johns Hopkins University	YEN, TJ (corresponding author), FOX CHASE CANC CTR,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.		Cleveland, Don/AAN-9783-2021	Yen, Tim/0000-0003-2159-0997; Cleveland, Don/0000-0002-1934-3682				CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; ENDOW SA, 1991, TRENDS BIOCHEM SCI, V16, P221, DOI 10.1016/0968-0004(91)90089-E; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KOSIK KS, 1990, J BIOL CHEM, V265, P3278; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; LEGUELLEC R, 1991, MOL CELL BIOL, V11, P3395, DOI 10.1128/MCB.11.6.3395; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MACDONALD HB, 1990, CELL, V61, P991; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; van Beneden E., 1883, ARCH BIOL, V4, P265; WRIGHT BD, 1991, J CELL BIOL, V113, P817, DOI 10.1083/jcb.113.4.817; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x	21	351	363	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 8	1992	359	6395					536	539		10.1038/359536a0	http://dx.doi.org/10.1038/359536a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406971				2022-12-28	WOS:A1992JR85900060
J	SANO, T; SMITH, CL; CANTOR, CR				SANO, T; SMITH, CL; CANTOR, CR			IMMUNO-PCR - VERY SENSITIVE ANTIGEN-DETECTION BY MEANS OF SPECIFIC ANTIBODY-DNA CONJUGATES	SCIENCE			English	Article							POLYMERASE CHAIN-REACTION; CATALYTIC ANTIBODIES; ESCHERICHIA-COLI; AMPLIFICATION; MOLECULES; CHEMISTRY	An antigen detection system, termed immuno-polymerase chain reaction (immuno-PCR), was developed in which a specific DNA molecule is used as the marker. A streptavidin-protein A chimera that possesses tight and specific binding affinity both for biotin and immunoglobulin G was used to attach a biotinylated DNA specifically to antigen-monoclonal antibody complexes that had been immobilized on microtiter plate wells. Then, a segment of the attached DNA was amplified by PCR. Analysis of the PCR products by agarose gel electrophoresis after staining with ethidium bromide allowed as few as 580 antigen molecules (9.6 x 10(-22) moles) to be readily and reproducibly detected. Direct comparison with enzyme-linked immunosorbent assay with the use of a chimera-alkaline phosphatase conjugate demonstrates that enhancement (approximately x 10(5)) in detection sensitivity was obtained with the use of immuno-PCR. Given the enormous amplification capability and specificity of PCR, this immuno-PCR technology has a sensitivity greater than any existing antigen detection system and, in principle, could be applied to the detection of single antigen molecules.	LAWRENCE BERKELEY LAB, DIV STRUCT BIOL, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	SANO, T (corresponding author), UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA.		Abrams, William R/A-5782-2008	Smith, Cassandra/0000-0002-0346-8907	NCI NIH HHS [CA39782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA039782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENKOVIC SJ, 1990, SCIENCE, V250, P1135, DOI 10.1126/science.2251500; BLOCH W, 1991, BIOCHEMISTRY-US, V30, P2735, DOI 10.1021/bi00225a001; BOLHUIS RLH, 1991, J CELL BIOCHEM, V47, P306, DOI 10.1002/jcb.240470404; CHISWELL DJ, 1992, TRENDS BIOTECHNOL, V10, P80, DOI 10.1016/0167-7799(92)90178-X; CIMINO GD, 1990, NATURE, V345, P773, DOI 10.1038/345773b0; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; FEBER JP, 1976, LANCET, V2, P406; FEBER JP, 1978, ADV CIN CHEM, V20, P129; GEISOW MJ, 1992, TRENDS BIOTECHNOL, V10, P75, DOI 10.1016/0167-7799(92)90175-U; GIBBS RA, 1990, ANAL CHEM, V62, P1202, DOI 10.1021/ac00212a004; GIBBS RA, 1991, CURR OPIN BIOTECH, V2, P69, DOI 10.1016/0958-1669(91)90063-B; Hales C N, 1980, Methods Enzymol, V70, P334; LERNER RA, 1987, TRENDS BIOCHEM SCI, V12, P427, DOI 10.1016/0968-0004(87)90208-8; LERNER RA, 1991, SCIENCE, V252, P659, DOI 10.1126/science.2024118; MORRISON SL, 1988, CLIN CHEM, V34, P1668; MORRISON SL, 1989, ADV IMMUNOL, V44, P65; NOLAN O, 1990, BIOCHIM BIOPHYS ACTA, V1040, P1, DOI 10.1016/0167-4838(90)90139-7; PLUCKTHUN A, 1990, NATURE, V347, P497, DOI 10.1038/347497a0; PLUCKTHUN A, 1991, BIO-TECHNOL, V9, P545, DOI 10.1038/nbt0691-545; REYES GR, CA39782 NIH GRANT; RODWELL JD, 1989, NATURE, V342, P99, DOI 10.1038/342099a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANO T, 1991, BIO-TECHNOL, V9, P1378, DOI 10.1038/nbt1291-1378; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; SCHULTZ PG, 1988, SCIENCE, V240, P426, DOI 10.1126/science.2833815; SHOKAT KM, 1990, ANNU REV IMMUNOL, V8, P335; VANVUNAKIS H, 1980, METHOD ENZYMOL, V770, P201; WAGNER MF, 1991, TRENDS BIOTECHNOL, V3, P375; WETZEL R, 1991, PROTEIN ENG, V4, P371, DOI 10.1093/protein/4.4.371; WHITE TJ, 1989, TRENDS GENET, V5, P185, DOI 10.1016/0168-9525(89)90073-5; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0	31	640	853	9	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	1992	258	5079					120	122		10.1126/science.1439758	http://dx.doi.org/10.1126/science.1439758			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ619	1439758				2022-12-28	WOS:A1992JQ61900032
J	HAAS, OA; ARGYRIOUTIRITA, A; LION, T				HAAS, OA; ARGYRIOUTIRITA, A; LION, T			PARENTAL ORIGIN OF CHROMOSOMES INVOLVED IN THE TRANSLOCATION T(9 22)	NATURE			English	Article							NUCLEOLUS ORGANIZER REGIONS; DNA METHYLATION; HUMAN LEUKEMIA; GENE ACTIVITY; WILMS-TUMOR; ALLELES; CANCER; TRANSGENES	FUNCTIONALLY equivalent genetic material can be labelled by an epigenetic marking process and used differentially depending on whether its origin is maternal or paternal1. This phenomenon is known as genomic imprinting and is manifested at either the chromosomal or gene level. Genomic imprinting seems to play an important role in cancer predisposition syndromes2-5 , and phenotypic consequences are evident in constitutional deletion syndromes and uniparental disomies1. Moreover, there seems to be a preferential retention of paternal alleles in sporadic tumours such as Wilms' tumour6, rhabdomyosarcoma7, osteosarcoma8 and retinoblastoma9. To investigate whether chromosomes involved in acquired abnormalities of haematologic neoplasms show a similar 'parent of origin' bias, we studied the inheritance of the translocated chromosomes 9 and 22 in cases of Philadelphia-chromosome-positive leukaemia, using unique specific chromosome band polymorphisms. Here we show that the translocated chromosome 9 was of paternal origin, whereas the translocated chromosomes 22 were derived exclusively from the maternal copy, in 11 cases with reliable polymorphisms. Our data therefore provide evidence that imprinting phenomena may play an important role in acquired tumour-specific chromosome rearrangements.			HAAS, OA (corresponding author), ST ANNA CHILDRENS HOSP, CHILDRENS CANC RES INST, KINDERSPITALGASSE 6, A-1090 VIENNA, AUSTRIA.		Haas, Oskar/AAM-5794-2020; Lion, MD, PhD, Professor, Thomas/C-3241-2016	Lion, MD, PhD, Professor, Thomas/0000-0001-9346-0994				ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; CAMPBELL ML, 1991, ADV CANCER RES, V57, P227; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; COTE GB, 1989, ANN GENET-PARIS, V32, P69; DALEY GQ, 1991, ADV CANCER RES, V57, P151; DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521; FERGUSONSMITH AC, 1990, CANCER SURV, V9, P487; HALL JG, 1990, AM J HUM GENET, V46, P857; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4; LEACH RJ, 1990, CELL GROWTH DIFFER, V1, P401; LETTMANN C, 1991, NUCLEIC ACIDS RES, V19, P7131, DOI 10.1093/nar/19.25.7131; LION T, 1991, LEUKEMIA, V5, P156; MARKOVIC VD, 1978, HUM GENET, V41, P181, DOI 10.1007/BF00273100; MULLER H, 1975, CYTOGENET CELL GENET, V15, P239, DOI 10.1159/000130522; OLSON SB, 1988, CYTOGENETICS MAMMALI, P583; PAL N, 1990, ONCOGENE, V5, P1665; PANTHIER JJ, 1991, BIOESSAYS, V13, P351, DOI 10.1002/bies.950130709; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; REIK W, 1989, NATURE, V338, P112, DOI 10.1038/338112a0; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SAPIENZA C, 1991, BIOCHIM BIOPHYS ACTA, V1072, P51, DOI 10.1016/0304-419X(91)90006-7; SCHAEFERREGO KE, 1990, ONCOGENE, V5, P1669; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SMITH SS, 1991, MOL CARCINOGEN, V4, P91, DOI 10.1002/mc.2940040202; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; VERMA RS, 1989, HUMAN CHROMOSOMES MA; YAMADA T, 1990, LEUKEMIA, V4, P341	33	88	93	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	1992	359	6394					414	416		10.1038/359414a0	http://dx.doi.org/10.1038/359414a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406953				2022-12-28	WOS:A1992JQ62400056
J	MEADE, TW; PEART, S; BRENNAN, PJ; BROUGHTON, P; DOLLERY, C; HUDSON, MF; LEVER, AF; ROSE, GA; GREENBERG, G; POCOCK, SJ				MEADE, TW; PEART, S; BRENNAN, PJ; BROUGHTON, P; DOLLERY, C; HUDSON, MF; LEVER, AF; ROSE, GA; GREENBERG, G; POCOCK, SJ			MEDICAL-RESEARCH-COUNCIL TRIAL OF TREATMENT OF HYPERTENSION IN OLDER ADULTS - PRINCIPAL RESULTS	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH BLOOD-PRESSURE; EUROPEAN-WORKING-PARTY; ELDERLY PATIENTS; REDUCTION; MORTALITY; THERAPY; DISEASE; STROKE; SWEDEN; LEVEL	Objective - To establish whether treatment with diuretic or beta-blocker in hypertensive older adults reduces risk of stroke, coronary heart disease, and death. Design - Randomised, placebo controlled, single blind trial. Setting - 226 general practices in the MRC general practice research framework. Subjects - 4396 patients aged 65-74 randomised to receive diuretic, beta-blocker, or placebo. Patients had mean systolic pressures of 160-209 mm Hg and mean diastolic pressures < 115 mm Hg during an eight week run in and were not taking antihypertensive treatment. Intervention - Patients were randomised to atenolol 50 mg daily; hydrochlorothiazide 25 mg or 50 mg plus amiloride 2.5 mg or 5 mg daily; or placebo. The regimens were adjusted to achieve specified target pressures. Mean follow up was 5.8 years. Main outcome measures - Strokes, coronary events, and deaths from all causes. Results - Both treatments reduced blood pressure below the level in the placebo group. Compared with the placebo group, actively treated subjects (diuretic and beta-blocker groups combined) had a 25% (95% confidence interval 3% to 42%) reduction in stroke (p = 0.04), 19% (-2% to 36%) reduction in coronary events (p = 0.08), and 17% (2% to 29%) reduction in all cardiovascular events (p = 0.03). After adjusting for baseline characteristics the diuretic group had significantly reduced risks of stroke (31% (3% to 51%) p = 0.04), coronary events (44% (21% to 60%), p = 0.0009), and all cardiovascular events (35% (17% to 49%), p = 0.0005) compared with the placebo group. The beta-blocker group showed no significant reductions in these end points. The reduction in strokes was mainly in non-smokers taking the diuretic. Conclusion - Hydrochlorothiazide and amiloride reduce the risk of stroke, coronary events, and all cardiovascular events in older hypertensive adults.			MEADE, TW (corresponding author), ST BARTHOLOMEWS HOSP, COLL MED, WOLFSON INST PREVENT MED, MRC, EPIDEMIOL & MED CARE UNIT, LONDON EC1M 6BQ, ENGLAND.							AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; AMERY A, 1981, ACTA MED SCAND, V210, P221; AMERY A, 1985, LANCET, V1, P1349; [Anonymous], 1985, J Hypertens, V3, P379; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1972, CIRCULATION, V45, P991; [Anonymous], 1970, JAMA, V213, P1143; [Anonymous], 1986, Lancet, V2, P57; [Anonymous], 1976, MYOCARDIAL INFARCTIO; BIRD AS, 1990, J HYPERTENS, V8, P147, DOI 10.1097/00004872-199002000-00008; BROWN MA, 1985, BRIT HEART J, V54, P351; CARTER AB, 1970, LANCET, V1, P485; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COOPE J, 1986, BRIT MED J, V293, P1145, DOI 10.1136/bmj.293.6555.1145; CRUICKSHANK JM, 1987, LANCET, V1, P581; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DOLLERY C, 1988, AM HEART J, V115, P276, DOI 10.1016/0002-8703(88)90650-3; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; GREENBERG G, 1987, J CLIN PHARMACOL, V27, P271, DOI 10.1002/j.1552-4604.1987.tb03012.x; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; HJALMARSON A, 1985, EUR HEART J, V6, P199; KANNEL WB, 1981, JAMA-J AM MED ASSOC, V245, P1225, DOI 10.1001/jama.245.12.1225; KURAMOTO K, 1981, JPN HEART J, V22, P75; LARDINOIS CK, 1988, ARCH INTERN MED, V148, P1280, DOI 10.1001/archinte.148.6.1280; MIALL WE, 1987, MILD HYPERTENSION IS; MIALL WE, 1984, ARTERIAL DISEASE ELD, P154; MIALL WE, 1981, HYPERTENSION YOUNG O, P277; MORGAN TO, 1980, MED J AUSTRALIA, V2, P27, DOI 10.5694/j.1326-5377.1980.tb131808.x; PEART WS, 1988, BRIT MED J, V296, P1565; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; SAMUELSSON OG, 1990, J HYPERTENS, V8, P547, DOI 10.1097/00004872-199006000-00008; SEVER PS, 1990, BRIT MED J, V301, P43, DOI 10.1136/bmj.301.6742.43; SPRACKLING ME, 1981, BRIT MED J, V283, P1151, DOI 10.1136/bmj.283.6300.1151; STAESSEN J, 1989, BMJ-BRIT MED J, V298, P1552, DOI 10.1136/bmj.298.6687.1552; WILHELMSEN L, 1987, J HYPERTENS, V5, P561, DOI 10.1097/00004872-198710000-00009; 1979, JAMA-J AM MED ASSOC, V242, P2572; 1981, MED J AUSTRALIA, V2, P398; 1974, JAMA-J AM MED ASSOC, V229, P409; 1986, LANCET, V2, P79	40	1469	1498	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	1992	304	6824					405	412						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HE389	1445513				2022-12-28	WOS:A1992HE38900017
J	MOORE, K; WENDON, J; FRAZER, M; KARANI, J; WILLIAMS, R; BADR, K				MOORE, K; WENDON, J; FRAZER, M; KARANI, J; WILLIAMS, R; BADR, K			PLASMA ENDOTHELIN IMMUNOREACTIVITY IN LIVER-DISEASE AND THE HEPATORENAL-SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FUNCTIONAL RENAL-FAILURE; VASCULAR-RESPONSES; CIRRHOSIS; VASOCONSTRICTOR; PROSTAGLANDIN-E2; KIDNEY; HEMODYNAMICS; EXCRETION; ASCITES; SODIUM	Background. Severe renal vasoconstriction is central to the pathogenesis of renal failure in the hepatorenal syndrome. Endothelin-1 and endothelin-3 are potent, long-acting vasoconstrictors, and endothelin-1 has selective potency as a renal vasoconstrictor. These properties suggest a role tor endothelins in the hepatorenal syndrome. Methods. We measured plasma endothelin-1 and endothelin-3 concentrations using specific radioimmunoassays in subjects with the hepatorenal syndrome, liver disease but normal renal function, chronic renal failure, acute renal failure, liver dysfunction and renal impairment, or normal liver and kidney function. Results. The patients with the hepatorenal syndrome had markedly elevated mean (+/-SE) plasma concentrations of endothelin-1 (36+/-5 ng per liter [14.5+/-1.8 pmol per liter]) and endothelin-3 (43+/-3 ng per liter [16.3+/-1.0 pmol per liter]) as compared with the normal subjects (endothelin-1, 4+/-1 ng per liter [1.7+/-0.2 pmol per liter]; and endothelin-3, 18+/-1 ng per liter [6.8+/-0.4 pmol per liter]; P<0.001) and with the patients in the other four groups (P<0.001 to P<0.05). The plasma endothelin-1, but not endothelin-3, concentrations in these four patient groups were significantly higher than in the normal subjects (P<0.001 to P<0.05). The concentrations of endothelin-1 in renal arterial plasma and renal venous plasma, measured in five patients with the hepatorenal syndrome and three with chronic liver disease and normal renal function, were 20+/-4 ng per liter (7.9+/-1.8 pmol per liter) and 24+/-4 ng per liter (9.5+/-1.5 pmol per liter), respectively (P<0.05). Conclusions. The increase in plasma endothelin-1 and endothelin-3 concentrations in patients with the hepatorenal syndrome is consistent with the hypothesis that these substances have a role in the pathogenesis of the disease.	UNIV LONDON KINGS COLL, SCH MED & DENT, INST LIVER STUDIES, LONDON WC2R 2LS, ENGLAND; VANDERBILT UNIV, DIV NEPHROL, NASHVILLE, TN 37240 USA; VANDERBILT UNIV, CTR KIDNEY & UROL DIS, NASHVILLE, TN 37240 USA	University of London; King's College London; Vanderbilt University; Vanderbilt University	MOORE, K (corresponding author), ROYAL POSTGRAD MED SCH, DEPT CLIN PHARMACOL, DU CANE RD, LONDON W12 0NN, ENGLAND.			opoku, anita/0000-0001-7243-8157				ARROYO V, 1983, EUR J CLIN INVEST, V13, P271, DOI 10.1111/j.1365-2362.1983.tb00100.x; BADR KF, 1989, J CLIN INVEST, V83, P336, DOI 10.1172/JCI113880; BADR KF, 1989, BIOCHEM BIOPH RES CO, V161, P776, DOI 10.1016/0006-291X(89)92667-3; BOULANGER CM, 1992, CIRC RES, V70, P1191, DOI 10.1161/01.RES.70.6.1191; BRENNER BM, 1989, J CLIN INVEST, V84, P1373, DOI 10.1172/JCI114309; CLARKE JG, 1989, AM J PHYSIOL, V257, pH2033, DOI 10.1152/ajpheart.1989.257.6.H2033; EMORI T, 1991, BIOCHEM BIOPH RES CO, V174, P228, DOI 10.1016/0006-291X(91)90510-E; EPSTEIN M, 1987, HEPATOLOGY, V7, P1359, DOI 10.1002/hep.1840070629; EPSTEIN M, 1970, AM J MED, V49, P175, DOI 10.1016/S0002-9343(70)80073-0; FERNANDEZSEARA J, 1989, GASTROENTEROLOGY, V97, P1304, DOI 10.1016/0016-5085(89)91704-6; HEMSEN A, 1991, ACTA PHYSIOL SCAND, V142, P1; HIRATA Y, 1988, BIOCHEM BIOPH RES CO, V154, P868, DOI 10.1016/0006-291X(88)90220-3; KAUFMANN H, 1991, LANCET, V338, P1542, DOI 10.1016/0140-6736(91)92370-H; KON V, 1991, KIDNEY INT, V40, P1, DOI 10.1038/ki.1991.172; MOORE K, 1991, GASTROENTEROLOGY, V100, P1069, DOI 10.1016/0016-5085(91)90284-R; MOORE KP, 1990, J HEPATOL, V11, P263, DOI 10.1016/0168-8278(90)90123-9; MOREAU R, 1989, GASTROEN CLIN BIOL, V13, P978; MUNGER KA, 1991, CONT ISSUES NEPHROL, V23, P297; PERNOW J, 1990, ACTA PHYSIOL SCAND, V140, P311, DOI 10.1111/j.1748-1716.1990.tb09005.x; PERNOW J, 1988, ACTA PHYSIOL SCAND, V134, P573, DOI 10.1111/j.1365-201X.1988.tb10642.x; RIMOLA A, 1986, J HEPATOL, V3, P111, DOI 10.1016/S0168-8278(86)80154-4; RINGLARSEN H, 1977, SCAND J CLIN LAB INV, V37, P635, DOI 10.3109/00365517709100657; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; TOMITA K, 1989, NEW ENGL J MED, V321, P1127; WILKINSON SP, 1978, KIDNEY LIVER DISEASE, P113; ZIPSER RD, 1983, GASTROENTEROLOGY, V84, P697	26	319	325	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	1992	327	25					1774	1778		10.1056/NEJM199212173272502	http://dx.doi.org/10.1056/NEJM199212173272502			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB975	1435931				2022-12-28	WOS:A1992KB97500002
J	GRADY, D; RUBIN, SM; PETITTI, DB; FOX, CS; BLACK, D; ETTINGER, B; ERNSTER, VL; CUMMINGS, SR				GRADY, D; RUBIN, SM; PETITTI, DB; FOX, CS; BLACK, D; ETTINGER, B; ERNSTER, VL; CUMMINGS, SR			HORMONE-THERAPY TO PREVENT DISEASE AND PROLONG LIFE IN POSTMENOPAUSAL WOMEN	ANNALS OF INTERNAL MEDICINE			English	Review						MENOPAUSE; ESTROGEN REPLACEMENT THERAPY; OSTEOPOROSIS, POSTMENOPAUSAL; CORONARY DISEASE; PROGESTATIONAL HORMONES	ESTROGEN REPLACEMENT THERAPY; POST-MENOPAUSAL WOMEN; CORONARY HEART-DISEASE; LONG-TERM ESTROGEN; BREAST-CANCER RISK; NON-CONTRACEPTIVE ESTROGENS; DENSITY-LIPOPROTEIN SUBFRACTIONS; ACUTE MYOCARDIAL-INFARCTION; ENDOMETRIAL CANCER; EXOGENOUS ESTROGENS	Purpose:To critically review the risks and benefits of hormone therapy for asymptomatic postmenopausal women who are considering long-term hormone therapy to prevent disease or to prolong life. Data Sources: Review of the English-language literature since 1970 on the effect of estrogen therapy and estrogen plus progestin therapy on endometrial cancer, breast cancer, coronary heart disease, osteoporosis, and stroke. We used standard meta-analytic statistical methods to pool estimates from studies to determine summary relative risks for these diseases in hormone users and modified lifetable methods to estimate changes in lifetime probability and life expectancy due to use of hormone regimens. Results: There is evidence that estrogen therapy decreases risk for coronary heart disease and for hip fracture, but long-term estrogen therapy increases risk for endometrial cancer and may be associated with a small increase in risk for breast cancer. The increase in endometrial cancer risk can probably be avoided by adding a progestin to the estrogen regimen for women who have a uterus, but the effects of combination hormones on risk for other diseases has not been adequately studied. We present estimates for changes in lifetime probabilities of disease and life expectancy due to hormone therapy in women who have had a hysterectomy; with coronary heart disease; and at increased risk for coronary heart disease, hip fracture, and breast cancer. Conclusions: Hormone therapy should probably be recommended for women who have had a hysterectomy and for those with coronary heart disease or at high risk for coronary heart disease. For other women, the best course of action is unclear.	AMER COLL PHYSICIANS, SCI POLICY, PHILADELPHIA, PA 19106 USA; UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA; VET AFFAIRS MED CTR, SAN FRANCISCO, CA USA; KAISER PERMANENTE MED CTR, SAN FRANCISCO, CA USA	American College of Physicians; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Kaiser Permanente								ADAM S, 1981, BRIT MED J, V282, P1277, DOI 10.1136/bmj.282.6272.1277; ADAMI HO, 1989, INT J CANCER, V44, P833, DOI 10.1002/ijc.2910440515; ADAMS MR, 1990, ARTERIOSCLEROSIS, V10, P1051, DOI 10.1161/01.ATV.10.6.1051; [Anonymous], 1974, N Engl J Med, V290, P15; ANTUNES CMF, 1979, NEW ENGL J MED, V300, P9, DOI 10.1056/NEJM197901043000103; ARMSTRONG BK, 1988, MED J AUSTRALIA, V148, P213, DOI 10.5694/j.1326-5377.1988.tb99424.x; ARTHES FG, 1971, CANCER, V28, P1391, DOI 10.1002/1097-0142(197112)28:6<1391::AID-CNCR2820280609>3.0.CO;2-S; AVILA MH, 1990, EPIDEMIOLOGY, V1, P128; BAIN C, 1981, CIRCULATION, V64, P42, DOI 10.1161/01.CIR.64.1.42; BARRETTCONNOR E, 1989, JAMA-J AM MED ASSOC, V261, P2095, DOI 10.1001/jama.261.14.2095; BARRETTCONNOR E, 1990, SERONO S, P199; BEARD CM, 1989, MAYO CLIN PROC, V64, P1471, DOI 10.1016/S0025-6196(12)65702-4; BERGKVIST L, 1988, INT J EPIDEMIOL, V17, P732, DOI 10.1093/ije/17.4.732; BERGKVIST L, 1989, NEW ENGL J MED, V321, P293, DOI 10.1056/NEJM198908033210505; BEWTRA C, 1988, J REPROD MED, V33, P205; BHATIA NN, 1989, AM J OBSTET GYNECOL, V160, P176, DOI 10.1016/0002-9378(89)90114-2; BLAND KI, 1980, CANCER, V45, P3027, DOI 10.1002/1097-0142(19800615)45:12<3027::AID-CNCR2820451225>3.0.CO;2-2; BOURNE TH, 1990, BRIT MED J, V301, P369, DOI 10.1136/bmj.301.6748.369; BOYSEN G, 1988, STROKE, V19, P1345, DOI 10.1161/01.STR.19.11.1345; BRADLEY DD, 1978, NEW ENGL J MED, V299, P17, DOI 10.1056/NEJM197807062990104; BRINCAT M, 1983, BRIT MED J, V287, P1337, DOI 10.1136/bmj.287.6402.1337; BRINCAT M, 1985, BRIT J OBSTET GYNAEC, V92, P256, DOI 10.1111/j.1471-0528.1985.tb01091.x; BRINCAT M, 1987, OBSTET GYNECOL, V70, P123; BRINTON LA, 1986, BRIT J CANCER, V54, P825, DOI 10.1038/bjc.1986.246; BRINTON LA, 1979, J NATL CANCER I, V62, P37; BRINTON LA, 1981, CANCER-AM CANCER SOC, V47, P2517, DOI 10.1002/1097-0142(19810515)47:10<2517::AID-CNCR2820471035>3.0.CO;2-L; BROWN MA, 1989, ENERG BUILDINGS, V13, P51, DOI 10.1016/0378-7788(89)90017-0; BUCHMAN MI, 1978, OBSTET GYNECOL, V51, P339, DOI 10.1097/00006250-197803000-00018; BURCH JC, 1974, AM J OBSTET GYNECOL, V118, P778, DOI 10.1016/0002-9378(74)90487-6; BURCH JC, 1971, ANN SURG, V174, P414, DOI 10.1097/00000658-197109000-00010; BURING JE, 1987, AM J EPIDEMIOL, V125, P939, DOI 10.1093/oxfordjournals.aje.a114632; BURING JE, 1986, AM J EPIDEMIOL, V124, P434, DOI 10.1093/oxfordjournals.aje.a114414; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; BUSH TL, 1990, MENOPAUSE BIOL CLIN, P211; BYRD BF, 1977, ANN SURG, V185, P574, DOI 10.1097/00000658-197705000-00010; BYRD BF, 1973, ANN SURG, V177, P626; CAMPBELL S, 1977, CLIN OBSTET GYNAECOL, V4, P31; CAMPBELL S, 1976, MANAGEMENT MENOPAUSE, P227; CASAGRANDE J, 1976, J NATL CANCER I, V56, P839, DOI 10.1093/jnci/56.4.839; CAULEY JA, 1983, ATHEROSCLEROSIS, V49, P31, DOI 10.1016/0021-9150(83)90005-9; Chiang C., 1968, INTRO STOCHASTIC PRO; CHRISTIANSEN C, 1985, LANCET, V2, P800; CHRISTIANSEN C, 1981, LANCET, V1, P459; CHU J, 1982, AM J OBSTET GYNECOL, V143, P569, DOI 10.1016/0002-9378(82)90549-X; CLARKSON TB, 1990, OBSTET GYNECOL, V75, P217; COLDITZ GA, 1990, JAMA-J AM MED ASSOC, V264, P2648, DOI 10.1001/jama.264.20.2648; COLLINS J, 1980, LANCET, V2, P961; CRILLY RG, 1978, POSTGRAD MED J, V54, P47; CRIQUI MH, 1988, AM J EPIDEMIOL, V128, P606, DOI 10.1093/oxfordjournals.aje.a115008; CROFT P, 1989, BRIT MED J, V298, P165, DOI 10.1136/bmj.298.6667.165; CUMMINGS SR, 1990, ANN INTERN MED, V113, P565, DOI 10.7326/0003-4819-113-8-565; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; CUMMINGS SR, 1987, OSTEOPOROSIS 1987, P1193; DELIGNIERES B, 1982, MATURITAS, V4, P67, DOI 10.1016/0378-5122(82)90021-4; DENNERSTEIN L, 1986, MATURITAS, V8, P101, DOI 10.1016/0378-5122(86)90016-2; DENNERSTEIN L, 1980, OBSTET GYNECOL, V56, P316; DEQUEKER J, 1982, MATURITAS, V4, P309, DOI 10.1016/0378-5122(82)90063-9; DEVOR M, 1992, AM J MED, V92, P275, DOI 10.1016/0002-9343(92)90077-O; DITKOFF EC, 1991, OBSTET GYNECOL, V78, P991; DUPONT WD, 1991, ARCH INTERN MED, V151, P67, DOI 10.1001/archinte.151.1.67; DUPONT WD, 1989, CANCER-AM CANCER SOC, V63, P948, DOI 10.1002/1097-0142(19890301)63:5<948::AID-CNCR2820630527>3.0.CO;2-U; EAKER ED, 1987, CORONARY HEART DISEA, P122; ELWOOD JM, 1977, J NATL CANCER I, V59, P1055, DOI 10.1093/jnci/59.4.1055; ERNSTER VL, 1986, OBSTET GYNECOL, V68, P715; ETTINGER B, 1985, ANN INTERN MED, V102, P319, DOI 10.7326/0003-4819-102-3-319; ETTINGER B, 1988, MATURITAS, V10, P271, DOI 10.1016/0378-5122(88)90063-1; EWERTZ M, 1988, INT J CANCER, V42, P832, DOI 10.1002/ijc.2910420606; EWERTZ M, 1988, EUR J CANCER CLIN ON, V24, P189, DOI 10.1016/0277-5379(88)90251-9; FABER P, 1977, UROL INT, V32, P221, DOI 10.1159/000280134; FAHRAEUS L, 1986, FERTIL STERIL, V45, P503; FAHRAEUS L, 1983, J CLIN ENDOCR METAB, V56, P797, DOI 10.1210/jcem-56-4-797; FARMER ME, 1984, AM J PUBLIC HEALTH, V74, P1374, DOI 10.2105/AJPH.74.12.1374; Fedor-Freybergh P, 1977, Acta Obstet Gynecol Scand Suppl, V64, P1; FERENCZY A, 1978, CONT OB GYN, V11, P137; FINUCANE F, 1991, CIRCULATION, V83, pP23; FINUCANE F, 1993, IN PRESS ARCH INTERN; Fisher E S, 1991, Epidemiology, V2, P116, DOI 10.1097/00001648-199103000-00005; Gambrell R D Jr, 1981, Acta Obstet Gynecol Scand Suppl, V106, P37; GAMBRELL RD, 1980, OBSTET GYNECOL, V55, P732; GAMBRELL RD, 1986, MATURITAS, V8, P159, DOI 10.1016/0378-5122(86)90022-8; GAMBRELL RD, 1984, SOUTHERN MED J, V77, P1509, DOI 10.1097/00007611-198412000-00009; GAMBRELL RD, 1978, MATURITAS, V1, P107, DOI 10.1016/0378-5122(78)90017-8; GAMBRELL RD, 1982, J REPROD MED, V27, P531; GAMBRELL RD, 1984, AM J OBSTET GYNECOL, V150, P119; GAMBRELL RD, 1978, MATURITAS, V1, P99, DOI 10.1016/0378-5122(78)90016-6; GAMBRELL RD, 1983, OBSTET GYNECOL, V62, P435; GELFAND MM, 1989, OBSTET GYNECOL, V74, P398; GOLDSTEIN SR, 1990, AM J OBSTET GYNECOL, V163, P119, DOI 10.1016/S0002-9378(11)90683-8; GORDON T, 1978, ANN INTERN MED, V89, P157, DOI 10.7326/0003-4819-89-2-157; GRADY D, 1991, AM J EPIDEMIOL, V134, P1396, DOI 10.1093/oxfordjournals.aje.a116043; GRANBERG S, 1991, AM J OBSTET GYNECOL, V164, P47, DOI 10.1016/0002-9378(91)90622-X; GRAY LA, 1977, OBSTET GYNECOL, V49, P385; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; GRUCHOW HW, 1988, AM HEART J, V115, P954, DOI 10.1016/0002-8703(88)90063-4; GUSBERG SB, 1976, AM J OBSTET GYNECOL, V126, P535, DOI 10.1016/0002-9378(76)90744-4; HAMMOND CB, 1979, AM J OBSTET GYNECOL, V133, P525, DOI 10.1016/0002-9378(79)90288-6; HAMMOND CB, 1979, AM J OBSTET GYNECOL, V133, P537, DOI 10.1016/0002-9378(79)90289-8; HARGROVE JT, 1989, OBSTET GYNECOL, V73, P606; HELLBERG D, 1987, MATURITAS, V9, P103, DOI 10.1016/0378-5122(87)90058-2; HENDERSO.BE, 1974, J NATL CANCER I, V53, P609, DOI 10.1093/jnci/53.3.609; HENDERSON BE, 1988, AM J OBSTET GYNECOL, V159, P312, DOI 10.1016/S0002-9378(88)80074-7; HENDERSON BE, 1983, BRIT J CANCER, V47, P749, DOI 10.1038/bjc.1983.127; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; HIATT RA, 1984, CANCER, V54, P139, DOI 10.1002/1097-0142(19840701)54:1<139::AID-CNCR2820540128>3.0.CO;2-X; HOLST J, 1987, MATURITAS, V9, P63, DOI 10.1016/0378-5122(87)90053-3; HOLST J, 1989, MATURITAS, V11, P13, DOI 10.1016/0378-5122(89)90116-3; HOOGERLAND DL, 1978, GYNECOL ONCOL, V6, P451, DOI 10.1016/0090-8258(78)90054-9; HOOVER R, 1976, NEW ENGL J MED, V295, P401, DOI 10.1056/NEJM197608192950801; HOOVER R, 1976, LANCET, V1, P885; HOOVER R, 1981, J NATL CANCER I, V67, P815; HORWITZ RI, 1978, NEW ENGL J MED, V299, P1089, DOI 10.1056/NEJM197811162992001; HORWITZ RI, 1984, AM J MED, V76, P192, DOI 10.1016/0002-9343(84)90773-3; HULKA BS, 1982, AM J OBSTET GYNECOL, V143, P638, DOI 10.1016/0002-9378(82)90108-9; HULKA BS, 1980, AM J OBSTET GYNECOL, V137, P92, DOI 10.1016/0002-9378(80)90391-9; HULKA BS, 1980, JAMA-J AM MED ASSOC, V244, P2419; HUNT K, 1990, BRIT J OBSTET GYNAEC, V97, P1080, DOI 10.1111/j.1471-0528.1990.tb02494.x; HUNT K, 1987, BRIT J OBSTET GYNAEC, V94, P620, DOI 10.1111/j.1471-0528.1987.tb03166.x; HUTCHINSON TA, 1979, LANCET, V2, P705; Iversen O E, 1985, Obstet Gynecol Surv, V40, P14, DOI 10.1097/00006254-198501000-00002; JABER R, 1988, J FAM PRACTICE, V26, P67; JELOVSEK FR, 1980, AM J OBSTET GYNECOL, V137, P85, DOI 10.1016/0002-9378(80)90390-7; JENSEN J, 1986, BRIT J OBSTET GYNAEC, V93, P613, DOI 10.1111/j.1471-0528.1986.tb08035.x; JENSEN J, 1987, AM J OBSTET GYNECOL, V156, P66, DOI 10.1016/0002-9378(87)90204-3; JICK H, 1980, AM J EPIDEMIOL, V112, P586, DOI 10.1093/oxfordjournals.aje.a113031; JICK H, 1979, NEW ENGL J MED, V300, P218, DOI 10.1056/NEJM197902013000502; JICK H, 1978, JAMA-J AM MED ASSOC, V239, P1407, DOI 10.1001/jama.239.14.1407; JICK H, 1978, JAMA-J AM MED ASSOC, V240, P2548, DOI 10.1001/jama.240.23.2548; JOHNSON RE, 1981, AM J PUBLIC HEALTH, V71, P138, DOI 10.2105/AJPH.71.2.138; KABLE WT, 1990, J REPROD MED, V35, P512; KANNEL WB, 1987, NIH872703 PUBL; KAUFMAN DW, 1984, JAMA-J AM MED ASSOC, V252, P63, DOI 10.1001/jama.252.1.63; KAUFMAN DW, 1991, AM J EPIDEMIOL, V134, P1375, DOI 10.1093/oxfordjournals.aje.a116041; KELSEY JL, 1981, JNCI-J NATL CANCER I, V67, P327; KELSEY JL, 1982, AM J EPIDEMIOL, V116, P333, DOI 10.1093/oxfordjournals.aje.a113417; KENNEDY DL, 1985, OBSTET GYNECOL, V65, P441; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; KNOPP RH, 1988, AM J OBSTET GYNECOL, V158, P1630, DOI 10.1016/0002-9378(88)90201-3; KOSS LG, 1984, OBSTET GYNECOL, V64, P1; KRAUSS RM, 1988, AM J OBSTET GYNECOL, V158, P1606, DOI 10.1016/0002-9378(88)90198-6; KREIGER N, 1982, AM J EPIDEMIOL, V116, P141, DOI 10.1093/oxfordjournals.aje.a113388; LAFFERTY FW, 1985, MATURITAS, V7, P147, DOI 10.1016/0378-5122(85)90021-0; LAROSA JC, 1985, J REPROD MED, V30, P811; LAVECCHIA C, 1987, AM J EPIDEMIOL, V125, P832, DOI 10.1093/oxfordjournals.aje.a114599; LAVECCHIA C, 1986, BRIT J CANCER, V54, P311, DOI 10.1038/bjc.1986.178; LAVECCHIA C, 1986, INT J CANCER, V38, P853, DOI 10.1002/ijc.2910380612; LAVECCHIA C, 1984, J NATL CANCER I, V73, P667; LAWSON DH, 1981, AM J EPIDEMIOL, V114, P710, DOI 10.1093/oxfordjournals.aje.a113242; LINDSAY R, 1980, LANCET, V2, P1151; LINDSAY R, 1978, LANCET, V1, P1325; LINDSAY R, 1978, CLIN SCI MOL MED, V54, P193, DOI 10.1042/cs0540193; LUCIANO AA, 1988, OBSTET GYNECOL, V71, P39; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; MACK TM, 1976, NEW ENGL J MED, V294, P1262, DOI 10.1056/NEJM197606032942304; MACK TM, 1975, NEW ENGL J MED, V292, P1366, DOI 10.1056/NEJM197506262922603; MACMAHON B, 1978, CORONARY HEART DISEA, P197; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; MAGOS AL, 1985, OBSTET GYNECOL, V65, P496; MASHCHAK CA, 1985, J REPROD MED, V30, P805; MATTSSON LA, 1982, MATURITAS, V4, P95, DOI 10.1016/0378-5122(82)90035-4; MCBRIDE JM, 1959, J OBSTET GYN BR COMM, V54, P521; MCDONALD JA, 1986, BREAST CANCER RES TR, V7, P193, DOI 10.1007/BF01806250; MCDONALD TW, 1977, AM J OBSTET GYNECOL, V127, P572, DOI 10.1016/0002-9378(77)90351-9; MCFARLAND KF, 1989, AM HEART J, V117, P1209, DOI 10.1016/0002-8703(89)90398-0; MCGILL HC, 1989, POSTGRAD MED     APR, P64; MILLER CW, 1978, J BONE JOINT SURG AM, V60, P930, DOI 10.2106/00004623-197860070-00010; MILLER V, 1990, BIOMEDICAL ADV AGING, P531; MILLER VT, 1991, OBSTET GYNECOL, V77, P235, DOI 10.1097/00006250-199102000-00014; MILLS PK, 1989, CANCER, V64, P591, DOI 10.1002/1097-0142(19890801)64:3<591::AID-CNCR2820640305>3.0.CO;2-U; MUSIANI U, 1972, UROL INT, V27, P405, DOI 10.1159/000279809; MYERS LS, 1990, J CLIN ENDOCR METAB, V70, P1124, DOI 10.1210/jcem-70-4-1124; NACHTIGALL LE, 1979, OBSTET GYNECOL, V53, P277; NACHTIGALL LE, 1979, OBSTET GYNECOL, V54, P74, DOI 10.1097/00006250-197907000-00017; NAESSEN T, 1990, ANN INTERN MED, V113, P95, DOI 10.7326/0003-4819-113-2-95; NASRI MN, 1989, BRIT J OBSTET GYNAEC, V96, P1333, DOI 10.1111/j.1471-0528.1989.tb03233.x; NOMURA AMY, 1986, INT J CANCER, V37, P49, DOI 10.1002/ijc.2910370109; OSMERS R, 1990, LANCET, V335, P1569, DOI 10.1016/0140-6736(90)91387-P; Paganini-Hill A, 1991, Epidemiology, V2, P16; PAGANINIHILL A, 1981, ANN INTERN MED, V95, P28, DOI 10.7326/0003-4819-95-1-28; PAGANINIHILL A, 1988, BMJ-BRIT MED J, V297, P519, DOI 10.1136/bmj.297.6647.519; PAGANINIHILL A, 1989, BRIT J CANCER, V59, P445, DOI 10.1038/bjc.1989.91; PAGANINIHILL A, 1988, INT J CANCER, V42, P832; PALMER JR, 1991, AM J EPIDEMIOL, V134, P1386, DOI 10.1093/oxfordjournals.aje.a116042; PATERSON MEL, 1980, BRIT MED J, V280, P822, DOI 10.1136/bmj.280.6217.822; PERSSON I, 1989, BRIT MED J, V298, P147, DOI 10.1136/bmj.298.6667.147; PERSSON IR, 1986, ACTA OBSTET GYN SCAN, V65, P211, DOI 10.3109/00016348609155173; PETITTI DB, 1979, JAMA-J AM MED ASSOC, V242, P1150, DOI 10.1001/jama.242.11.1150; PETITTI DB, 1988, GASTROENTEROLOGY, V94, P91, DOI 10.1016/0016-5085(88)90614-2; PETITTI DB, 1987, OBSTET GYNECOL, V70, P289; PETITTI DB, 1986, NEW ENGL J MED, V315, P131; PETITTI DB, 1978, AM J EPIDEMIOL, V108, P480, DOI 10.1093/oxfordjournals.aje.a112646; PFEFFER RI, 1978, AM J EPIDEMIOL, V107, P479, DOI 10.1093/oxfordjournals.aje.a112567; PFEFFER RI, 1976, AM J EPIDEMIOL, V103, P445, DOI 10.1093/oxfordjournals.aje.a112246; PROUGH SG, 1987, AM J OBSTET GYNECOL, V157, P1449, DOI 10.1016/S0002-9378(87)80242-9; PUNNONEN R, 1981, MATURITAS, V3, P309, DOI 10.1016/0378-5122(81)90039-6; PUNNONEN R, 1984, MATURITAS, V5, P259, DOI 10.1016/0378-5122(84)90019-7; PUNNONEN R, 1987, ANN CHIR GYNAECOL FE, V76, P39; PUNNONEN R, 1972, ACTA OBSTET GYNECO S, V21, P1; RAVNIHAR B, 1979, EUR J CANCER, V15, P395, DOI 10.1016/0014-2964(79)90074-4; ROBBOY SJ, 1979, OBSTET GYNECOL, V54, P269; ROBIN JC, 1983, STEROIDS, V42, P669, DOI 10.1016/0039-128X(83)90130-7; ROHAN TE, 1988, MED J AUSTRALIA, V148, P217; ROSENBERG L, 1976, NEW ENGL J MED, V294, P1256, DOI 10.1056/NEJM197606032942302; ROSENBERG L, 1980, JAMA-J AM MED ASSOC, V244, P339, DOI 10.1001/jama.244.4.339; ROSENBERG SH, 1980, WESTERN J MED, V133, P292; ROSS RK, 1980, JAMA-J AM MED ASSOC, V243, P1635, DOI 10.1001/jama.243.16.1635; ROSS RK, 1981, LANCET, V1, P858; RUBIN GL, 1990, AM J OBSTET GYNECOL, V162, P148, DOI 10.1016/0002-9378(90)90838-X; SALKEBORN M, 1992, IN PRESS BR J OBST G, V99; Salmi T, 1980, Acta Endocrinol Suppl (Copenh), V233, P37; SARTWELL PE, 1977, JNCI-J NATL CANCER I, V59, P1589, DOI 10.1093/jnci/59.6.1589; SCHIFF I, 1982, FERTIL STERIL, V37, P79; SCHLEYERSAUNDERS E, 1976, J AM GERIATR SOC, V24, P337, DOI 10.1111/j.1532-5415.1976.tb03308.x; SELBY PL, 1985, CLIN SCI, V69, P265, DOI 10.1042/cs0690265; SHAPIRO S, 1980, NEW ENGL J MED, V303, P485, DOI 10.1056/NEJM198008283030903; SHAPIRO S, 1985, NEW ENGL J MED, V313, P969, DOI 10.1056/NEJM198510173131601; SHERMAN B, 1983, CANCER, V51, P1527, DOI 10.1002/1097-0142(19830415)51:8<1527::AID-CNCR2820510828>3.0.CO;2-T; SHERWIN BB, 1989, OBSTET GYNECOL, V73, P759; SMITH DC, 1975, NEW ENGL J MED, V293, P1164, DOI 10.1056/NEJM197512042932302; SPENGLER RF, 1981, AM J EPIDEMIOL, V114, P497, DOI 10.1093/oxfordjournals.aje.a113215; SPORRONG T, 1988, BRIT J OBSTET GYNAEC, V95, P1042, DOI 10.1111/j.1471-0528.1988.tb06511.x; STALAND B, 1981, MATURITAS, V3, P145, DOI 10.1016/0378-5122(81)90006-2; STAMPFER MJ, 1986, AM J EPIDEMIOL, V124, P520; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; STAVRAKY KM, 1981, AM J OBSTET GYNECOL, V141, P547, DOI 10.1016/S0002-9378(15)33276-2; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; SULLIVAN JM, 1990, ARCH INTERN MED, V150, P2557, DOI 10.1001/archinte.150.12.2557; SULLIVAN JM, 1988, ANN INTERN MED, V108, P358, DOI 10.7326/0003-4819-108-3-358; SZKLO M, 1984, PREV MED, V13, P510, DOI 10.1016/0091-7435(84)90019-7; TALBOTT E, 1977, AM J CARDIOL, V39, P858, DOI 10.1016/S0002-9149(77)80040-4; TELINDE RW, 1985, OPERATIVE GYNECOLOGY, P245; THOM MH, 1979, LANCET, V2, P455; THOMAS DB, 1982, JNCI-J NATL CANCER I, V69, P1017; THOMPSON SG, 1989, J EPIDEMIOL COMMUN H, V43, P173, DOI 10.1136/jech.43.2.173; TSEVAT J, 1991, CIRCULATION, V83, P1194, DOI 10.1161/01.CIR.83.4.1194; VAKIL DV, 1983, CANCER DETECT PREV, V6, P415; VARNER RE, 1991, OBSTET GYNECOL, V78, P195; VOIGT LF, 1991, LANCET, V338, P274, DOI 10.1016/0140-6736(91)90417-N; WALTER S, 1978, UROL INT, V33, P135, DOI 10.1159/000280190; WEINSTEIN L, 1987, OBSTET GYNECOL, V69, P929; WEINSTEIN L, 1990, AM J OBSTET GYNECOL, V162, P1534, DOI 10.1016/0002-9378(90)90917-V; WEISS NS, 1980, NEW ENGL J MED, V303, P1195, DOI 10.1056/NEJM198011203032102; WEISS NS, 1979, JAMA-J AM MED ASSOC, V242, P261, DOI 10.1001/jama.242.3.261; WEISS NS, 1980, MATURITAS, V2, P185, DOI 10.1016/0378-5122(80)90003-1; WEISS NS, 1983, J CHRON DIS, V36, P879, DOI 10.1016/0021-9681(83)90009-7; WHITEHEAD MI, 1987, OBSTET GYN CLIN N AM, V14, P299; WHITEHEAD MI, 1990, OBSTET GYNECOL, V75, pS59; WHITEHEAD MI, 1981, NEW ENGL J MED, V305, P1599, DOI 10.1056/NEJM198112313052701; WHITEHEAD MI, 1978, MATURITAS, V1, P87, DOI 10.1016/0378-5122(78)90015-4; WHITEHEAD MI, 1982, J REPROD MED, V27, P539; WIGLE DT, 1978, CAN MED ASSOC J, V118, P1276; WILLIAMS AR, 1982, OBSTET GYNECOL, V60, P695; WILSON PD, 1987, BRIT J OBSTET GYNAEC, V94, P568, DOI 10.1111/j.1471-0528.1987.tb03152.x; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702; WINGO PA, 1987, JAMA-J AM MED ASSOC, V257, P209, DOI 10.1001/jama.257.2.209; WOLF PH, 1991, AM J OBSTET GYNECOL, V164, P489, DOI 10.1016/S0002-9378(11)80006-2; WYNDER EL, 1978, CANCER-AM CANCER SOC, V41, P2341, DOI 10.1002/1097-0142(197806)41:6<2341::AID-CNCR2820410637>3.0.CO;2-N; YLIKORKALA O, 1987, J CLIN ENDOCR METAB, V65, P1238, DOI 10.1210/jcem-65-6-1238; ZIEL HK, 1975, NEW ENGL J MED, V293, P1167, DOI 10.1056/NEJM197512042932303; 1988, CANCER 1987 A 882789; 1992, ACOG TECHNICAL B, V166, P1; 1990, VITAL STATISTICS U A, V2	265	1975	2017	1	107	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1992	117	12					1016	1037		10.7326/0003-4819-117-12-1016	http://dx.doi.org/10.7326/0003-4819-117-12-1016			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB980	1443971				2022-12-28	WOS:A1992KB98000008
J	ARONDEL, V; LEMIEUX, B; HWANG, I; GIBSON, S; GOODMAN, HM; SOMERVILLE, CR				ARONDEL, V; LEMIEUX, B; HWANG, I; GIBSON, S; GOODMAN, HM; SOMERVILLE, CR			MAP-BASED CLONING OF A GENE CONTROLLING OMEGA-3-FATTY-ACID DESATURATION IN ARABIDOPSIS	SCIENCE			English	Article							POLYMORPHISM LINKAGE MAP; THALIANA; DNA; METABOLISM; MUTANTS; PLASMID; PLANTS	A gene from the flowering plant Arabidopsis thaliana that encodes an omega-3 desaturase was cloned on the basis of the genetic map position of a mutation affecting membrane and storage lipid fatty acid composition. Yeast artificial chromosomes covering the genetic locus were identified and used to probe a seed complementary DNA library. A complementary DNA clone for the desaturase was identified and introduced into roots of both wild-type and mutant plants by Ti plasmid-mediated transformation. Transgenic tissues of both mutant and wild-type plants had significantly increased amounts of the fatty acid produced by this desaturase.	MICHIGAN STATE UNIV, US DOE, PLANT RES LAB, E LANSING, MI 48824 USA; YORK UNIV, DEPT BIOL, N YORK M3J 1P3, ONTARIO, CANADA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, DEPT MOLEC BIOL, BOSTON, MA 02114 USA	Michigan State University; United States Department of Energy (DOE); York University - Canada; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital			Somerville, Christopher R/A-4048-2009	Somerville, Christopher R/0000-0003-4647-0094				BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; BROWSE J, COMMUNICATION; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; GRILL E, 1991, MOL GEN GENET, V226, P484, DOI 10.1007/BF00260662; HARWOOD JL, 1988, ANNU REV PLANT PHYS, V39, P101, DOI 10.1146/annurev.arplant.39.1.101; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; LEMIEUX B, 1990, THEOR APPL GENET, V80, P234, DOI 10.1007/BF00224392; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; MARTINEZZAPATER J, UNPUB; MOORE L, 1979, PLASMID, V2, P617, DOI 10.1016/0147-619X(79)90059-3; NAM HG, 1989, PLANT CELL, V1, P699, DOI 10.1105/tpc.1.7.699; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; OWENS LD, 1985, PLANT PHYSIOL, V77, P87, DOI 10.1104/pp.77.1.87; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PRUITT RE, 1986, J MOL BIOL, V187, P169, DOI 10.1016/0022-2836(86)90226-3; QUINN PJ, 1988, SYM SOC EXP BIOL, V42, P237; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; STEPONKUS PL, 1990, PHILOS T ROY SOC B, V326, P571, DOI 10.1098/rstb.1990.0032; VONHEIJNE G, 1986, J MOL BIOL, V189, P239, DOI 10.1016/0022-2836(86)90394-3; WADA H, 1990, NATURE, V347, P200, DOI 10.1038/347200a0; WARD ER, 1990, PLANT MOL BIOL, V14, P561, DOI 10.1007/BF00027501	24	388	472	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	1992	258	5086					1353	1355		10.1126/science.1455229	http://dx.doi.org/10.1126/science.1455229			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455229				2022-12-28	WOS:A1992JY95800037
J	SMITH, SB; FINZI, L; BUSTAMANTE, C				SMITH, SB; FINZI, L; BUSTAMANTE, C			DIRECT MECHANICAL MEASUREMENTS OF THE ELASTICITY OF SINGLE DNA-MOLECULES BY USING MAGNETIC BEADS	SCIENCE			English	Article							GEL-ELECTROPHORESIS; FLUORESCENCE MICROSCOPY; MANIPULATION; FLEXIBILITY; DYNAMICS; BINDING; DAPI	Single DNA molecules were chemically attached by one end to a glass surface and by their other end to a magnetic bead. Equilibrium positions of the beads were observed in an optical microscope while the beads were acted on by known magnetic and hydrodynamic forces. Extension versus force curves were obtained for individual DNA molecules at three different salt concentrations with forces between 10(-14) and 10(-11) newtons. Deviations from the force curves predicted by the freely jointed chain model suggest that DNA has significant local curvature in solution. Ethidium bromide and 4',6-diamidino-2-phenylindole had little effect on the elastic response of the molecules, but their extent of intercalation was directly measured. Conversely, the effect of bend-inducing cis-diamminedichloroplatinum (II) was large and supports the hypothesis of natural curvature in DNA.	UNIV OREGON,INST MICROBIOL,EUGENE,OR 97403; UNIV OREGON,DEPT CHEM,EUGENE,OR 97403	University of Oregon; University of Oregon				Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543, R37GM032543] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 32543] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERMAN B, 1989, BIOPOLYMERS, V28, P1541, DOI 10.1002/bip.360280906; BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; BUECHE F, 1962, PHYSICAL PROPERTIES, P37; BUSTAMANTE C, 1991, ANNU REV BIOPHYS BIO, V20, P415, DOI 10.1146/annurev.bb.20.060191.002215; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P557; CASSASA EF, 1967, POLYM LETT, V5, P773; CHU S, 1991, SCIENCE, V253, P861, DOI 10.1126/science.253.5022.861; DIMARZIO EA, 1965, J CHEM PHYS, V42, P2101, DOI 10.1063/1.1696251; Flory P, 1989, STATISTICAL MECHANIC, P307; HAGERMAN PJ, 1981, BIOPOLYMERS, V20, P1503, DOI 10.1002/bip.1981.360200710; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; HOUSEAL TW, 1989, BIOPHYS J, V56, P507, DOI 10.1016/S0006-3495(89)82697-9; Johnson N.P., 1989, PROG CLIN BIOCH MED, V10, P1, DOI [DOI 10.1007/978-3-642-74760-1, 10.1007/978-3-642-74760-1_1, DOI 10.1007/978-3-642-74760-1_1]; KASEVICH M, 1990, 12TH P INT C AT PHYS, P53; Lorentz H. A., 1907, ABHANDLUNGEN THEORET, P23; MACQUET JP, 1978, BIOCHIMIE, V60, P901, DOI 10.1016/S0300-9084(78)80574-4; MANZINI G, 1983, NUCLEIC ACIDS RES, V11, P8861, DOI 10.1093/nar/11.24.8861; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P226; SCHWARTZ DC, 1989, NATURE, V338, P520, DOI 10.1038/338520a0; SMITH SB, 1989, SCIENCE, V243, P203, DOI 10.1126/science.2911733; SOBEL ES, 1991, BIOPOLYMERS, V31, P1559, DOI 10.1002/bip.360311311; STIGTER D, 1991, BIOPOLYMERS, V31, P169, DOI 10.1002/bip.360310205; Trifonov E.N., 1987, STRUCTURE EXPRESSION, P243; VOLLENWEIDER HJ, 1978, BIOCHEMISTRY-US, V75, P710; WILSON WD, 1990, BIOCHEMISTRY-US, V29, P8452, DOI 10.1021/bi00488a036; Yanagida M, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 1, P177; ZAHN K, 1985, NATURE, V317, P451, DOI 10.1038/317451a0; ZIMM BH, IN PRESS Q REV BIOPH	28	1478	1647	7	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1122	1126		10.1126/science.1439819	http://dx.doi.org/10.1126/science.1439819			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439819				2022-12-28	WOS:A1992JX85200022
J	MACER, D				MACER, D			THE FAR-EAST OF BIOLOGICAL ETHICS	NATURE			English	Editorial Material											MACER, D (corresponding author), UNIV TSUKUBA,INST BIOL SCI,TSUKUBA,IBARAKI 305,JAPAN.			Macer, Darryl/0000-0001-9335-4235				FUJIKI N, 1992, HUMAN GENOME RES SOC; KIMURA R, 1987, J MED PHILOS, V12, P267, DOI 10.1093/jmp/12.3.267; MACER DRJ, 1992, ATTITUDES GENETIC EN; NUDESHIMA J, 1991, LANCET, V338, P1063, DOI 10.1016/0140-6736(91)91912-E; SHINAGAWA S, 1988, J AOMORI SOC OBS GYN, V3, P89; SWINBANKS D, 1992, NATURE, V356, P368, DOI 10.1038/356368b0	6	8	8	1	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 29	1992	359	6398					770	770		10.1038/359770a0	http://dx.doi.org/10.1038/359770a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JV777	1436050				2022-12-28	WOS:A1992JV77700027
J	SHELDRICK, JH; VERNON, SA; WILSON, A; READ, SJ				SHELDRICK, JH; VERNON, SA; WILSON, A; READ, SJ			DEMAND INCIDENCE AND EPISODE RATES OF OPHTHALMIC DISEASE IN A DEFINED URBAN-POPULATION	BRITISH MEDICAL JOURNAL			English	Article							EYE DISEASE; OUTPATIENT; COMMUNITY; CASUALTY	Objectives-To estimate demand incidence and episode rates of ophthalmic disease in a defined urban population over one year. Design-Study of patients presenting with eye problems to general practice and eye casualty department. Setting-General practice and ophthalmic services in west Nottingham. Subjects-36018 people from the combined practice lists of 17 Nottingham general practitioners. Main outcome measures-Ophthalmic disorder, age and sex of patient, and where presented. Results-2587 consultations were recorded for ophthalmic problems, 1771 with general practitioners and 816 with eye casualty. Most consultations to general practice were by females (1066 (60%)), whereas men aged 15-44 accounted for most work in eye casualty. These men commonly presented with trauma. Infective conjunctivitis, the commonest condition, had an episode rate of 13.5/1000 population/year. Demand incidence for cataracts was 1.9/1000 population/year. Demand incidence for chronic conditions increased with age. Conclusions-As the average age of the population increases demand for ophthalmic services will rise. Planning and provision of resources to meet this increased demand should be considered now.	UNIV NOTTINGHAM,DEPT GEN PRACTICE,NOTTINGHAM NG7 2RD,ENGLAND; UNIV NOTTINGHAM,ACAD UNIT OPHTHALMOL,NOTTINGHAM NG7 2RD,ENGLAND	University of Nottingham; University of Nottingham								BANKES JLK, 1968, BRIT MED J, V1, P791, DOI 10.1136/bmj.1.5595.791; BRENNANME, 1975, COMMUNITY HLTH, V7, P13; Brittain G P, 1988, Health Trends, V20, P43; DART JKG, 1986, BRIT MED J, V293, P1477, DOI 10.1136/bmj.293.6560.1477; DUKEELDER S, 1965, SYSTEM OPHTHALMOLOGY, V8, P444; EDWARDS RS, 1987, BRIT J OPHTHALMOL, V71, P938, DOI 10.1136/bjo.71.12.938; Fraser R C, 1981, J R Coll Gen Pract, V31, P410; GIBSON JM, 1985, T OPHTHAL SOC UK, V104, P196; HARRISON RJ, 1988, BRIT MED J, V297, P1162, DOI 10.1136/bmj.297.6657.1162; Hughes A. M., 1976, MINISTRY AGR FISHERI, V9; JAY JL, 1990, EYE, V4, P127, DOI 10.1038/eye.1990.16; JONES NP, 1986, BRIT MED J, V292, P188, DOI 10.1136/bmj.292.6514.188; KHAN HA, 1977, AM J EPIDEMIOL, V106, P17; MORRELL DC, 1971, BRIT MED J, V2, P454, DOI 10.1136/bmj.2.5759.454; PAGECHIAPELLA A, 1985, BR J OPHTHALMOL, V69, P865; PODOGOR MJ, 1983, AM J EPIDEMIOL, V118, P206; POGGIO EC, 1989, NEW ENGL J MED, V321, P779, DOI 10.1056/NEJM198909213211202; PORT MJA, 1988, OPHTHAL PHYSL OPT, V8, P323, DOI 10.1016/0275-5408(88)90182-2; SHAW DE, 1986, ARCH OPHTHALMOL-CHIC, V104, P1843; SHELDRICK JH, 1992, BRIT MED J, V304, P1096, DOI 10.1136/bmj.304.6834.1096; VERNON SA, 1983, J ROY SOC MED, V76, P279, DOI 10.1177/014107688307600408; WARDEN J, 1990, BMJ, V300, P1990; 1962, MORBIDITY STATISTICS; 1974, MORBIDITY STATISTICS; 1986, MORBIDITY STATISTICS; 1991, GLOBAL POPULATION ES, P364	26	30	33	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 17	1992	305	6859					933	936		10.1136/bmj.305.6859.933	http://dx.doi.org/10.1136/bmj.305.6859.933			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JU649	1458075	Bronze, Green Submitted, Green Published			2022-12-28	WOS:A1992JU64900024
J	AMATI, B; DALTON, S; BROOKS, MW; LITTLEWOOD, TD; EVAN, GI; LAND, H				AMATI, B; DALTON, S; BROOKS, MW; LITTLEWOOD, TD; EVAN, GI; LAND, H			TRANSCRIPTIONAL ACTIVATION BY THE HUMAN C-MYC ONCOPROTEIN IN YEAST REQUIRES INTERACTION WITH MAX	NATURE			English	Article							DNA-BINDING; PROTEIN; GENE; FOS; SEQUENCE; JUN; TRANSFORMATION; CEREVISIAE; ZIPPER; COMMON	THE c-myc protein (Myc) contains an amino-terminal transcriptional activation domain1 and a carboxy-terminal basic helix-loop-helix-leucine zipper (bHLH-Z) domain 2-5 that directs dimerization of Myc with its partner, the max protein (Max), and promotes DNA binding to sites containing a CACGTG core consensus sequence6-9. Despite these characteristics and the observation that Myc can modulate gene expression4,5,10, a direct role for Myc or Max as transcription factors has never been demonstrated. Here we use Saccharomyces cerevisiae as an in vivo model system to show that the Myc protein is a sequence-specific transcriptional activator whose DNA binding is strictly dependent on dimerization with Max. Transactivation is mediated by the amino-terminal domain of Myc. We find that Max homodimers bind to the same DNA sequence as Myc + Max but that they fail to transactivate and thus can antagonize Myc + Max function. We also show that the Max HLH-Z domain has a higher affinity for the Myc HLH-Z domain than for itself, and suggest that the heterodimeric Myc + Max activator forms preferentially at equilibrium.	IMPERIAL CANC RES FUND,GROWTH CONTROL & DEV LAB,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,TRANSCRIPTION LAB,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,BIOCHEM CELL NUCLEUS LAB,LONDON WC2A 3PX,ENGLAND	Cancer Research UK; Cancer Research UK; Cancer Research UK			Amati, Bruno/AAM-3418-2020	Amati, Bruno/0000-0002-2958-1799				BERBERICH SJ, 1992, GENE DEV, V6, P166, DOI 10.1101/gad.6.2.166; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FISHER F, 1991, ONCOGENE, V6, P1099; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LECH K, 1988, CELL, V52, P179, DOI 10.1016/0092-8674(88)90506-5; LITTLEWOOD TD, 1992, ONCOGENE, V7, P1783; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MAKELA TP, 1992, SCIENCE, V256, P373, DOI 10.1126/science.256.5055.373; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; Penn L J, 1990, Semin Cancer Biol, V1, P69; PENN LJZ, 1990, MOL CELL BIOL, V10, P4961, DOI 10.1128/MCB.10.9.4961; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; SMITH M, 1979, CELL, V16, P753, DOI 10.1016/0092-8674(79)90091-6; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4277	31	424	431	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 1	1992	359	6394					423	426		10.1038/359423a0	http://dx.doi.org/10.1038/359423a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406955				2022-12-28	WOS:A1992JQ62400059
J	AFZALPURKAR, RG; SCHILLER, LR; LITTLE, KH; SANTANGELO, WC; FORDTRAN, JS				AFZALPURKAR, RG; SCHILLER, LR; LITTLE, KH; SANTANGELO, WC; FORDTRAN, JS			THE SELF-LIMITED NATURE OF CHRONIC IDIOPATHIC DIARRHEA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL PERFUSION; INGESTION	Background. Little is known about the clinical presentation and natural history of previously healthy patients in whom chronic idiopathic diarrhea develops. Methods. We reviewed the case records of 152 patients with chronic diarrhea who had no history of gastrointestinal surgery and who were evaluated in detail as part of a chronic-diarrhea protocol from 1985 to 1990. Patients were considered to have chronic idiopathic diarrhea if they had persistently loose stools for more than four weeks, no systemic illness, and no identifiable cause of diarrhea. Results. Seventeen patients (10 men and 7 women) ranging in age from 33 to 72 years met the criteria for chronic idiopathic diarrhea. Each patient had a history of a relatively abrupt onset of symptoms, often soon after returning home from a trip, starting two to seven months before evaluation. Their diarrhea did not occur during a local outbreak of diarrhea, and other family members did not become ill. Stool frequency ranged from 5 to 25 movements per day, stool weights ranged from 417 to 1480 g per day, and fecal electrolyte and osmolality values were consistent with a diagnosis of secretory diarrhea. The results of biopsies of the small intestine and colon were normal, as were small-bowel roentgenograms. Extensive studies for infectious causes of diarrhea were negative, and no patient responded to antibiotic therapy. In every patient the diarrhea stopped without specific therapy after 7 to 31 months (mean, 15) and did not recur during a follow-up period averaging 38 months. Conclusions. Sporadic idiopathic chronic diarrhea is a recognizable syndrome that can last many months, but is self-limited.	BAYLOR UNIV,MED CTR,DEPT INTERNAL MED,3500 GASTON AVE,DALLAS,TX 75246	Baylor University; Baylor University Medical Center	FORDTRAN, JS (corresponding author), BAYLOR UNIV,MED CTR,DEPT INTERNAL MED,3500 GASTON AVE,DALLAS,TX 75246, USA.				NIDDK NIH HHS [R01-DK37172-07] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037172] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		FINE KD, 1992, GASTROENTEROLOGY, V102, P1936, DOI 10.1016/0016-5085(92)90316-Q; FINE KD, 1991, NEW ENGL J MED, V324, P1012, DOI 10.1056/NEJM199104113241502; FINE KD, 1989, GASTROINTESTINAL DIS, P290; FORDTRAN JS, 1986, CLIN GASTROENTEROL, V15, P477; GORBACH SL, 1989, GASTROINTESTINAL DIS, P1191; HAMMER HF, 1989, J CLIN INVEST, V84, P1056, DOI 10.1172/JCI114267; JANDA RC, 1991, GASTROENTEROLOGY, V100, P458, DOI 10.1016/0016-5085(91)90216-8; KREJS GJ, 1977, AM J DIG DIS, V22, P280, DOI 10.1007/BF01072184; OSTERHOLM MT, 1986, JAMA-J AM MED ASSOC, V256, P484, DOI 10.1001/jama.256.4.484; PARSONNET J, 1989, ANN INTERN MED, V110, P985, DOI 10.7326/0003-4819-110-12-985; READ NW, 1982, DIGEST DIS SCI, V27, P193, DOI 10.1007/BF01296914; Schiller LA, 1991, DIARRHEAL DISEASES, P219; TOSKES PP, 1989, GASTROINTESTINAL DIS, P1289	13	47	51	0	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	1992	327	26					1849	1852		10.1056/NEJM199212243272605	http://dx.doi.org/10.1056/NEJM199212243272605			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KD714	1448122				2022-12-28	WOS:A1992KD71400005
J	SABIA, PJ; POWERS, ER; RAGOSTA, M; SAREMBOCK, IJ; BURWELL, LR; KAUL, S				SABIA, PJ; POWERS, ER; RAGOSTA, M; SAREMBOCK, IJ; BURWELL, LR; KAUL, S			AN ASSOCIATION BETWEEN COLLATERAL BLOOD-FLOW AND MYOCARDIAL VIABILITY IN PATIENTS WITH RECENT MYOCARDIAL-INFARCTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TWO-DIMENSIONAL ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; PHASE-I THROMBOLYSIS; 12-MONTH FOLLOW-UP; CONTRAST ECHOCARDIOGRAPHY; CORONARY-ARTERY; TIMI TRIAL; REPERFUSION; SIZE; OCCLUSION	Background. We hypothesized that successful reperfusion of an occluded infarct-related coronary artery even late after acute myocardial infarction would result in improved regional wall motion and that such improvement might be related to the presence of collateral blood flow within the infarct bed. Methods. We assessed regional wall motion by two-dimensional echocardiography at base line and one month after angioplasty was attempted in the occluded infarct-related artery in 43 patients who had had a myocardial infarction two days to five weeks earlier. A wall-motion score was assigned to each patient on a five-point scale (from 1 [normal function] to 5 [dyskinesia]). The percentage of the infarct bed perfused by collateral flow was assessed with myocardial contrast echocardiography. Results. In the 41 patients who had abnormal wall motion at base line, improvement in function was noted in 25 (78 percent) of the 32 in whom angioplasty was successful, as compared with only 1 (11 percent) of the 9 in whom it was unsuccessful (P<0.001). The percentage of the infarct bed supplied by collateral flow at base line was directly correlated with wall function and inversely correlated with the wall-motion score one month after successful angioplasty (r = -0.64, P<0.001). Among the patients in whom angioplasty was successful, the 23 in whom >50 percent of the infarct bed was supplied by collateral flow had better wall motion (P<0.001) and greater improvement in wall motion at one month (P = 0.004) than the 9 in whom less-than-or-equal-to 50 percent of the bed was supplied by collateral flow. The degree of improvement in function was not influenced by the length of time between the infarction and the attempted angioplasty. Conclusions. The myocardium remains viable for a prolonged period in many patients with acute infarction and an occluded infarct-related artery. Viability appears to be associated with the presence of collateral blood flow within the infarct bed.	UNIV VIRGINIA, SCH MED, DEPT MED, DIV CARDIOL, BOX 158, CHARLOTTESVILLE, VA 22908 USA	University of Virginia	POWERS, ER (corresponding author), UNIV VIRGINIA, SCH MED, DEPT MED, DIV CARDIOL, BOX 158, CHARLOTTESVILLE, VA 22908 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038345, K08HL001833] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08-HL01833, R29-HL38345] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; CHAMBERLAIN DA, 1988, LANCET, V1, P545; Cohen M. V., 1985, CORONARY COLLATERALS, P93; COHEN MV, 1985, CORONARY COLLATERALS, P1; DALEN JE, 1988, AM J CARDIOL, V62, P179, DOI 10.1016/0002-9149(88)90208-1; FINCI L, 1990, AM J CARDIOL, V66, P660, DOI 10.1016/0002-9149(90)91125-P; FORCE T, 1988, J AM COLL CARDIOL, V11, P192, DOI 10.1016/0735-1097(88)90189-1; GENSINI GG, 1969, AM J CARDIOL, V24, P393, DOI 10.1016/0002-9149(69)90434-2; GOHLKE H, 1991, AM J CARDIOL, V67, P1165, DOI 10.1016/0002-9149(91)90920-G; Gorlin R, 1976, Major Probl Intern Med, V11, P59; GRILL HP, 1990, J AM COLL CARDIOL, V16, P1594, DOI 10.1016/0735-1097(90)90306-A; HABIB GB, 1991, CIRCULATION, V83, P739, DOI 10.1161/01.CIR.83.3.739; HOCHMAN JS, 1987, CIRCULATION, V75, P299, DOI 10.1161/01.CIR.75.1.299; KAUL S, 1989, J AM COLL CARDIOL, V13, P468, DOI 10.1016/0735-1097(89)90528-7; KAUL S, 1985, J AM COLL CARDIOL, V6, P825, DOI 10.1016/S0735-1097(85)80490-3; KAUL S, 1986, J AM COLL CARDIOL, V7, P383, DOI 10.1016/S0735-1097(86)80509-5; KAUL S, 1991, J AM COLL CARDIOL, V17, P1403, DOI 10.1016/S0735-1097(10)80154-8; KAUL S, 1987, CIRC RES, V61, P77, DOI 10.1161/01.RES.61.1.77; KELLER MW, 1988, J AM COLL CARDIOL, V12, P1039, DOI 10.1016/0735-1097(88)90474-3; KENNEDY JW, 1985, NEW ENGL J MED, V312, P1073, DOI 10.1056/NEJM198504253121701; KERSSCHOT IE, 1986, J AM COLL CARDIOL, V7, P1234, DOI 10.1016/S0735-1097(86)80141-3; LANG RM, 1986, J AM COLL CARDIOL, V8, P232, DOI 10.1016/S0735-1097(86)80118-8; LIM YJ, 1990, AM J CARDIOL, V66, P556, DOI 10.1016/0002-9149(90)90481-F; MOOD AM, 1963, INTRO THEORY STATIST; MOORE CA, 1986, J AM COLL CARDIOL, V8, P1066, DOI 10.1016/S0735-1097(86)80383-7; Mulvihill DA, 1931, NEW ENGL J MED, V204, P1032, DOI 10.1056/NEJM193105142042003; REIMER KA, 1979, LAB INVEST, V40, P633; RENTROP KP, 1989, J AM COLL CARDIOL, V14, P58, DOI 10.1016/0735-1097(89)90054-5; SABIA PJ, 1992, CIRCULATION, V85, P2080, DOI 10.1161/01.CIR.85.6.2080; SAITO Y, 1985, AM J CARDIOL, V55, P1259, DOI 10.1016/0002-9149(85)90485-0; SCHAPER W, 1979, BASIC RES CARDIOL, V74, P46, DOI 10.1007/BF01907684; SCHAPER W, 1971, COLLATERAL CIRCULATI, P155; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; SCHRODER R, 1989, AM J CARDIOL, V64, P878, DOI 10.1016/0002-9149(89)90835-7; SIMOONS ML, 1986, J AM COLL CARDIOL, V7, P717, DOI 10.1016/S0735-1097(86)80329-1; SPOTNITZ WD, 1990, AM J CARDIOL, V65, P1259, DOI 10.1016/0002-9149(90)90984-9; STAMPFER MJ, 1982, NEW ENGL J MED, V307, P1180, DOI 10.1056/NEJM198211043071904; TOPOL EJ, 1992, CIRCULATION, V85, P2090, DOI 10.1161/01.CIR.85.6.2090; TOUCHSTONE DA, 1989, J AM COLL CARDIOL, V13, P1506, DOI 10.1016/0735-1097(89)90340-9; WILCOX RG, 1988, LANCET, V2, P525; YUSUF S, 1985, EUR HEART J, V6, P556, DOI 10.1093/oxfordjournals.eurheartj.a061905	42	475	485	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	1992	327	26					1825	1831		10.1056/NEJM199212243272601	http://dx.doi.org/10.1056/NEJM199212243272601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KD714	1448120				2022-12-28	WOS:A1992KD71400001
J	BERKMAN, LF; LEOSUMMERS, L; HORWITZ, RI				BERKMAN, LF; LEOSUMMERS, L; HORWITZ, RI			EMOTIONAL SUPPORT AND SURVIVAL AFTER MYOCARDIAL-INFARCTION - A PROSPECTIVE, POPULATION-BASED STUDY OF THE ELDERLY	ANNALS OF INTERNAL MEDICINE			English	Article						MYOCARDIAL INFARCTION; SOCIAL SUPPORT; ACTIVITIES OF DAILY LIVING; OUTCOME ASSESSMENT (HEALTH CARE); COMORBIDITY	SUDDEN CARDIAC DEATH; CORONARY HEART-DISEASE; SOCIAL SUPPORT; MULTIVARIATE-ANALYSIS; MORTALITY; PROGNOSIS; HEALTH; MEN; DETERMINANTS; ATTACK	Objective: To compare the survival of elderly patients hospitalized for acute myocardial infarction who have emotional support with that of patients who lack such support, while controlling for severity of disease, comorbidity, and functional status. Design: A prospective, community-based cohort study. Setting: Two hospitals in New Haven, Connecticut. Patients: Men (n = 100) and women (n = 94) 65 years of age or more hospitalized for acute myocardial infarction between 1982 and 1988. Measurements: Social support, age, gender, race, education, marital status, living arrangements, presence of depression, smoking history, weight, and physical function were assessed prospectively using questionnaires. The presence of congestive heart failure, pulmonary edema, and cardiogenic shock; the position of infarction; in-hospital complications; and history of myocardial infarction were assessed using medical records. Comorbidity was defined using an index based on the presence of eight conditions. Results: Of 194 patients, 76 (39%) died in the first 6 months after myocardial infarction. In multiple logistic regression analyses, lack of emotional support was significantly associated with 6-month mortality (odds ratio, 2.9; 95% Cl, 1.2 to 6.9) after controlling for severity of myocardial infarction, comorbidity, risk factors such as smoking and hypertension, and sociodemographic factors. Conclusions: When emotional support was assessed before myocardial infarction, it was independently related to risk for death in the subsequent 6 months.			BERKMAN, LF (corresponding author), YALE UNIV, SCH MED, DEPT EPIDEMIOL & PUBL HLTH, 60 COLL ST, NEW HAVEN, CT 06510 USA.				NIA NIH HHS [N01-AG-02105] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [N01AG002105] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BERKMAN L, 1989, DEMOGRAPHY, V26, P661, DOI 10.2307/2061264; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; BRACKETT CD, 1988, AM J CARDIOL, V61, P979, DOI 10.1016/0002-9149(88)90110-5; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Charlson ME, 1984, J CHRON DIS, V37, P369; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; CROOG SM, 1977, HEART PATIENT RECOVE; HARRELL FE, 1986, PHGLM PROCEDURE SUGI, P437; HENNING H, 1979, CIRCULATION, V59, P1124, DOI 10.1161/01.CIR.59.6.1124; HOUSE JS, 1982, AM J EPIDEMIOL, V116, P123, DOI 10.1093/oxfordjournals.aje.a113387; KAPLAN GA, 1988, AM J EPIDEMIOL, V128, P370, DOI 10.1093/oxfordjournals.aje.a114977; KAPLAN JR, 1982, ARTERIOSCLEROSIS, V2, P359, DOI 10.1161/01.ATV.2.5.359; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; KRANTZ DS, 1980, J HUM STRESS, V6, P27, DOI 10.1080/0097840X.1980.9936096; LOWN B, 1987, CIRCULATION, V76, P186; MARKOWE HLJ, 1985, BMJ-BRIT MED J, V291, P1312, DOI 10.1136/bmj.291.6505.1312; MAYOU R, 1984, J PSYCHOSOM RES, V28, P17, DOI 10.1016/0022-3999(84)90036-9; MEDALIE JH, 1976, AM J MED, V60, P910, DOI 10.1016/0002-9343(76)90921-9; MERMELSTEIN R, 1986, J CONSULT CLIN PSYCH, V54, P447, DOI 10.1037/0022-006X.54.4.447; NEREM RM, 1980, SCIENCE, V208, P1475, DOI 10.1126/science.7384790; ORTHGOMER K, 1987, J CHRON DIS, V40, P949, DOI 10.1016/0021-9681(87)90145-7; POWELL LH, 1985, J CHRON DIS, V38, P253, DOI 10.1016/0021-9681(85)90068-2; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RUBERMAN W, 1984, NEW ENGL J MED, V311, P552, DOI 10.1056/NEJM198408303110902; RUBERMAN W, 1983, J CHRON DIS, V36, P151, DOI 10.1016/0021-9681(83)90089-9; RUBERMAN W, 1992, JAMA-J AM MED ASSOC, V267, P559, DOI 10.1001/jama.267.4.559; SANZ G, 1982, NEW ENGL J MED, V306, P1065, DOI 10.1056/NEJM198205063061801; SEEMAN TE, 1987, PSYCHOSOM MED, V49, P341, DOI 10.1097/00006842-198707000-00003; SEEMAN TE, 1987, AM J EPIDEMIOL, V126, P714, DOI 10.1093/oxfordjournals.aje.a114711; SEEMAN TE, 1988, SOC SCI MED, V26, P737, DOI 10.1016/0277-9536(88)90065-2; SEEMAN TE, IN PRESS ANN EPIDEMI; SOKOLOW M, 1987, CLIN CARDIOLOGY; WELIN L, 1985, LANCET, V1, P915; WILLIAMS RB, 1992, JAMA-J AM MED ASSOC, V267, P520, DOI 10.1001/jama.267.4.520; 1971, WHO5TH REP	38	581	586	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1992	117	12					1003	1009		10.7326/0003-4819-117-12-1003	http://dx.doi.org/10.7326/0003-4819-117-12-1003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB980	1443968				2022-12-28	WOS:A1992KB98000005
J	COLEMAN, EA; FEUER, EJ				COLEMAN, EA; FEUER, EJ			BREAST-CANCER SCREENING AMONG WOMEN FROM 65 TO 74 YEARS OF AGE IN 1987-88 AND 1991	ANNALS OF INTERNAL MEDICINE			English	Article						BREAST NEOPLASMS; MAMMOGRAPHY; BREAST SELF-EXAMINATION; MASS SCREENING; PHYSICAL EXAMINATION	OLDER WOMEN; MAMMOGRAPHY; PHYSICIANS	Objective: To compare breast cancer screening rates from the 1991 survey with data from 1987-88 for women aged 65 to 74. Design: Surveys of women from five communities. Settings: Five control communities of the National Cancer Institute's Breast Cancer Screening Consortium. Participants: White, non-Hispanic women, ages 65 to 74; 499 in 1987-88 and 2156 in 1991. Response rates for the first survey wave ranged by area from 65% to 77% and for the second survey wave, from 62% to 85%. Main Outcome Measure: Mammogram and clinical breast examination during the past year and performance of monthly breast self examination, with the screening rates in wave 2 directly standardized to the income and education distribution of wave 1 in each area. Results: Mammography use between waves increased significantly (P < 0.05 after adjusting for education, income, and age) in all but one area (from 19% to 33% in wave 1 to 35% to 59% in wave 2). Among women who had a mammogram, the percent who also had a clinical breast examination decreased between waves from 95% to 85% (P = 0.001). Conclusions: Mammography in older women increased dramatically over 3 years, although the use of clinical breast examination may be decreasing.	NIH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA	COLEMAN, EA (corresponding author), NCI, DCPC, APPL RES BRANCH, EPN 343, BETHESDA, MD 20892 USA.				DIVISION OF CANCER PREVENTION AND CONTROL [N01CN085122] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CN-85122-01] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDA RF, 1990, AM J PREV MED, V6, P123, DOI 10.1016/S0749-3797(18)31016-X; BIRD RE, 1989, RADIOLOGY, V171, P87, DOI 10.1148/radiology.171.1.2494683; Burg M A, 1990, J Aging Health, V2, P514, DOI 10.1177/089826439000200406; COLL PP, 1989, J AM GERIATR SOC, V37, P957, DOI 10.1111/j.1532-5415.1989.tb07281.x; COSTANZA ME, 1991, ARCH INTERN MED, V151, P1851, DOI 10.1001/archinte.151.9.1851; Fleiss JL, 1981, STAT METHODS RATES P; FOX SA, 1991, ARCH INTERN MED, V151, P50, DOI 10.1001/archinte.151.1.50; HARRIS RP, 1991, CANCER, V67, P2010, DOI 10.1002/1097-0142(19910401)67:7<2010::AID-CNCR2820670730>3.0.CO;2-8; LANE DS, 1992, AM J PUBLIC HEALTH, V82, P199, DOI 10.2105/AJPH.82.2.199; LERMAN C, 1990, PREV MED, V19, P279, DOI 10.1016/0091-7435(90)90028-I; MEYER JE, 1990, JAMA-J AM MED ASSOC, V263, P2341, DOI 10.1001/jama.263.17.2341; RIES LAG, 1991, NIH912789 PUB; SICKLES EA, 1990, RADIOLOGY, V175, P323, DOI 10.1148/radiology.175.2.2326455; Sloane P D, 1991, Fam Med, V23, P40; VANOORTMARSSEN GJ, 1990, CANCER-AM CANCER SOC, V66, P1601, DOI 10.1002/1097-0142(19901001)66:7<1601::AID-CNCR2820660727>3.0.CO;2-O; WEINBERGER M, 1991, J AM GERIATR SOC, V39, P22, DOI 10.1111/j.1532-5415.1991.tb05901.x; ZAPKA JG, 1989, AM J PUBLIC HEALTH, V79, P1499, DOI 10.2105/AJPH.79.11.1499; ZAPKA JG, 1990, ADV CANCER CONTROL, V339, P259; 1990, JAMA-J AM MED ASSOC, V264, P54; 1990, FED REGISTER, V55, P53510	20	71	71	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					961	966		10.7326/0003-4819-117-11-961	http://dx.doi.org/10.7326/0003-4819-117-11-961			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443958				2022-12-28	WOS:A1992JZ27600012
J	FREED, CR; BREEZE, RE; ROSENBERG, NL; SCHNECK, SA; KRIEK, E; QI, JX; LONE, T; ZHANG, YB; SNYDER, JA; WELLS, TH; RAMIG, LO; THOMPSON, L; MAZZIOTTA, JC; HUANG, SC; GRAFTON, ST; BROOKS, D; SAWLE, G; SCHROTER, G; ANSARI, AA				FREED, CR; BREEZE, RE; ROSENBERG, NL; SCHNECK, SA; KRIEK, E; QI, JX; LONE, T; ZHANG, YB; SNYDER, JA; WELLS, TH; RAMIG, LO; THOMPSON, L; MAZZIOTTA, JC; HUANG, SC; GRAFTON, ST; BROOKS, D; SAWLE, G; SCHROTER, G; ANSARI, AA			SURVIVAL OF IMPLANTED FETAL DOPAMINE CELLS AND NEUROLOGIC IMPROVEMENT 12 TO 46 MONTHS AFTER TRANSPLANTATION FOR PARKINSONS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADRENAL-MEDULLARY TRANSPLANTATION; SUBSTANTIA-NIGRA; VENTRAL MESENCEPHALON; CAUDATE-NUCLEUS; RAT MODEL; NEURONS; STRIATUM; GRAFTS; TISSUE; PRIMATES	Background and Methods. Patients with Parkinson's disease tend to have a reduced response to levodopa after 5 to 20 years of therapy, with "on-off" fluctuations consisting of dyskinesia alternating with immobility. In an effort to modify the motor disability of advanced Parkinson's disease, we implanted embryonic mesencephalic tissue containing dopamine cells into the caudate and putamen of seven patients. Two patients received unilateral grafts in the caudate and the putamen on the side opposite the side with worse symptoms. Five patients received bilateral grafts implanted in the putamen only. In six of the seven patients, the fetal tissue was obtained from a single embryo with a gestational age of seven to eight weeks. The tissue was injected by means of 10 to 14 needle passes. There were no surgical complications. Four of the seven patients underwent immunosuppression with cyclosporine and prednisone. Results. All patients reported improvement according to the Activities of Daily Living Scale when in the on state 3 to 12 months after surgery (P<0.01). Neurologic examination according to the Unified Disease Rating Scale showed that five of the seven patients improved when in the on state six months after surgery. The mean group Hoehn-Yahr score improved from 3.71 to 2.50 (P<0.01). Computer and videotape testing in the home supported these findings. Fluctuations in the patients' clinical state were moderated, and periods of dyskinesia and off episodes were shorter and less severe than before implantation. Drug doses were reduced by an average of 39 percent (P<0.01; maximum, 58 percent). The results of clinical evaluation and fluorodopa positron-emission tomography in one patient were compatible with transplant survival for as long as 46 months. Both immunosuppressed and nonimmunosuppressed patients improved. Conclusions. Fetal-tissue implants appear to off er long-term clinical benefit to some patients with advanced Parkinson's disease.	SWEDISH MED CTR, COLORADO NEUROL INST, ENGLEWOOD, CO USA; TRENT H WELLS INC, COULTERVILLE, CA USA; UNIV COLORADO, DEPT COMMUN DISORDERS & SPEECH SCI, BOULDER, CO 80309 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT RADIOL, LOS ANGELES, CA USA; REED NEUROL RES CTR, LOS ANGELES, CA USA; HAMMERSMITH HOSP, MRC, LONDON W12 0HS, ENGLAND; EMORY UNIV, SCH MED, WINSHIP CANC CTR, ATLANTA, GA 30322 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Imperial College London; Emory University	FREED, CR (corresponding author), UNIV COLORADO, HLTH SCI CTR, 4200 E 9TH AVE, C-237, DENVER, CO 80262 USA.			Brooks, David/0000-0003-2602-2518				ALLEN GS, 1989, ARCH NEUROL-CHICAGO, V46, P487, DOI 10.1001/archneur.1989.00520410021016; BAKAY RAE, 1985, APPL NEUROPHYSIOL, V48, P358; BANKIEWICZ KS, 1990, J NEUROSURG, V72, P231, DOI 10.3171/jns.1990.72.2.0231; BANKIEWICZ KS, 1991, J NEUROSURG, V74, P97, DOI 10.3171/jns.1991.74.1.0097; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BJORKLUND A, 1980, CELL TISSUE RES, V212, P39; BOHN MC, 1987, SCIENCE, V237, P913, DOI 10.1126/science.2887034; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; BRUNDIN P, 1988, EXP BRAIN RES, V70, P192; CHASE TN, 1989, NEUROLOGY, V39, P7; CHRISTIEPOPE BC, 1989, EXP NEUROL, V104, P235, DOI 10.1016/0014-4886(89)90035-6; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; DUNNETT SB, 1988, EXP BRAIN RES, V71, P411; DUNNETT SB, 1991, INTRACEREBRAL TRANSP, V4, P27; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Fahn S., 1987, RECENT DEV PARKINSON, P153; Freed C. R., 1988, PHARM FUNCTIONAL REG, P353; FREED CR, 1989, CLIN RES, V37, pA527; FREED CR, 1990, ARCH NEUROL-CHICAGO, V47, P505, DOI 10.1001/archneur.1990.00530050021007; FREED CR, 1991, INTRACEREBRAL TRANSP, V4, P69; FREED WJ, 1988, PROG BRAIN RES, V78, P233; FREEMAN TB, 1991, EXP NEUROL, V113, P344, DOI 10.1016/0014-4886(91)90025-8; GOETZ CG, 1989, NEW ENGL J MED, V320, P337, DOI 10.1056/NEJM198902093200601; HENDERSON BTH, 1991, ARCH NEUROL-CHICAGO, V48, P822, DOI 10.1001/archneur.1991.00530200062020; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; LIEBERMAN AN, 1983, EXPT THERAPEUTICS MO, V37, P95; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206; MADRAZO I, 1990, ARCH NEUROL-CHICAGO, V47, P1281, DOI 10.1001/archneur.1990.00530120025005; NAHMIAS C, 1985, J NEUROL SCI, V69, P223, DOI 10.1016/0022-510X(85)90135-2; ORahilly R, 1987, DEV STAGES HUMAN EMB; Patino P., 1992, Society for Neuroscience Abstracts, V18, P59; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; QI JX, 1991, SOC NEUR ABSTR, V17, P347; REDMOND DE, 1986, LANCET, V1, P1125; SAWLE GV, 1992, ANN NEUROL, V31, P166, DOI 10.1002/ana.410310207; STROMBERG I, 1986, NEUROSCI LETT, V71, P271, DOI 10.1016/0304-3940(86)90632-4	40	624	660	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1549	1555		10.1056/NEJM199211263272202	http://dx.doi.org/10.1056/NEJM199211263272202			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435881				2022-12-28	WOS:A1992JZ43200002
J	SILVER, ML; GUO, HC; STROMINGER, JL; WILEY, DC				SILVER, ML; GUO, HC; STROMINGER, JL; WILEY, DC			ATOMIC-STRUCTURE OF A HUMAN MHC MOLECULE PRESENTING AN INFLUENZA-VIRUS PEPTIDE	NATURE			English	Article							HISTOCOMPATIBILITY ANTIGENS; CRYSTALLOGRAPHY; RECOGNITION; SPECIFICITY; HLA-A2	INFECTION by influenza virus results in the stimulation of cytotoxic T lymphocytes specific for killing virally infected cells1. Specificity is provided by clonally distributed, hypervariable T-cell receptors on cytotoxic T lymphocytes which react with peptide fragments that are derived from viral proteins expressed in the cytoplasm and 'presented' on the surface of infected cells, bound to class I histocompatibility glycoproteins2. Here we describe the structure of the complex between the human class I histocompatibility glycoprotein HLA-Aw68 and the influenza virus nucleoprotein peptide Np 91-99 as determined by X-ray cryocrystallography. Residues at both ends of the peptide are substantially buried in the peptide binding-site, whereas those in the middle of the peptide, P4 to P8, are predominantly exposed and could be recognized directly by T-cell receptors. The extended conformation of the bound viral peptide is remarkably similar to that of a collection of endogenous peptides with a different sequence motif bound to another human allele, HLA-B27 3-5. The structure defines in atomic detail the antigenic surface constructed of major histocompatibility complex and viral peptide atoms that is recognized by T-cell receptors.	HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138	Harvard University; Howard Hughes Medical Institute	SILVER, ML (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,7 DIVIN AVE,CAMBRIDGE,MA 02138, USA.							BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BJORKMAN PJ, 1985, J MOL BIOL, V186, P205, DOI 10.1016/0022-2836(85)90271-2; BLUM M, 1987, J APPL CRYSTALLOGR, V20, P235, DOI 10.1107/S0021889887086783; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; BRUNGER AT, 1990, XPLOR VERSION 2 1; CERUNDOLO V, 1991, P ROY SOC B-BIOL SCI, V244, P169, DOI 10.1098/rspb.1991.0066; DURBIN RM, 1986, SCIENCE, V232, P1127, DOI 10.1126/science.3704639; FOX GC, 1966, ACTA CRYSTALLOGR A, V34, P517; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GUO HC, 1992, NATURE, V390, P364; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JOHNSON CK, 1965, ORTEP MANUAL; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; PARHAM P, 1988, P NATL ACAD SCI USA, V85, P4005, DOI 10.1073/pnas.85.11.4005; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SILVER ML, 1991, NATURE, V350, P619, DOI 10.1038/350619a0; SILVER ML, 1992, THESIS HARVARD U; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TURNER MJ, 1975, J BIOL CHEM, V250, P4512; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	24	261	270	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 26	1992	360	6402					367	369		10.1038/360367a0	http://dx.doi.org/10.1038/360367a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448154				2022-12-28	WOS:A1992JZ63000059
J	WALT, RP				WALT, RP			MISOPROSTOL FOR THE TREATMENT OF PEPTIC-ULCER AND ANTIINFLAMMATORY-DRUG INDUCED GASTRODUODENAL ULCERATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANTI-INFLAMMATORY DRUGS; DOUBLE-BLIND; GASTRIC-ULCER; DUODENAL-ULCERS; PROSTAGLANDIN-E1 ANALOG; CELL-PROLIFERATION; ARTHRITIC PATIENTS; BLOOD-LOSS; ASPIRIN; PLACEBO				WALT, RP (corresponding author), QUEEN ELIZABETH HOSP, DEPT MED, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND.							AGRAWAL NM, 1991, ANN INTERN MED, V115, P195, DOI 10.7326/0003-4819-115-3-195; AGRAWAL NM, 1985, DIGEST DIS SCI, V30, pS164, DOI 10.1007/BF01309404; AKDAMAR K, 1982, AM J GASTROENTEROL, V77, P902; BANK S, 1991, GUT, V32, P963, DOI 10.1136/gut.32.8.963-b; BARER D, 1983, NEW ENGL J MED, V308, P1571, DOI 10.1056/NEJM198306303082606; BEARDON PHG, 1989, Q J MED, V71, P497; BIRNIE GC, 1991, GUT, V32, pA1246; BJARNASON I, 1989, DIGEST DIS SCI, V34, P407, DOI 10.1007/BF01536263; BOLTEN W, 1989, AKTUEL RHEUMATOL, V14, P214, DOI 10.1055/s-2008-1047499; BRAND DL, 1985, DIGEST DIS SCI, V30, pS147, DOI 10.1007/BF01309402; COELHO HLL, 1991, LANCET, V338, P247, DOI 10.1016/0140-6736(91)90379-4; COHEN MM, 1985, DIGEST DIS SCI, V30, P605, DOI 10.1007/BF01308407; COLLINS PW, 1990, MED RES REV, V10, P149, DOI 10.1002/med.2610100202; COLTON DG, 1978, ARCH INT PHARMACOD T, V236, P86; DAJANI EZ, 1978, AM J DIG DIS, V23, P436, DOI 10.1007/BF01072927; DANESHMEND TK, 1992, BRIT MED J, V304, P143, DOI 10.1136/bmj.304.6820.143; DAVIS GR, 1988, DIGEST DIS SCI, V33, P298, DOI 10.1007/BF01535753; EDELSON JT, 1990, JAMA-J AM MED ASSOC, V264, P41, DOI 10.1001/jama.264.1.41; GARDNER MJ, 1989, STATISTICS CONFIDENC; GONVERS JJ, 1987, HEPATO-GASTROENTEROL, V34, P233; GOODLAD RA, 1990, DIGESTION, V46, P182, DOI 10.1159/000200384; GRAHAM D Y, 1991, Gastroenterology, V100, pA75; GRAHAM DY, 1988, LANCET, V2, P1277; GRAHAM DY, 1988, GASTROENTEROLOGY, V95, P327, DOI 10.1016/0016-5085(88)90487-8; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; HAUSKEN T, 1990, SCAND J GASTROENTERO, V25, P1028, DOI 10.3109/00365529008997630; HAWKEY CJ, 1990, BMJ-BRIT MED J, V300, P278, DOI 10.1136/bmj.300.6720.278; HAWKEY CJ, 1986, LANCET, V2, P1084; HELLER SR, 1982, BRIT MED J, V285, P167, DOI 10.1136/bmj.285.6336.167; HERTING RL, 1986, DIGEST DIS SCI, V31, pS47, DOI 10.1007/BF01309323; HERTING RL, 1985, DIGEST DIS SCI, V30, pS185, DOI 10.1007/BF01309407; HILLMAN AL, 1989, ARCH INTERN MED, V149, P2061, DOI 10.1001/archinte.149.9.2061; HUDSON N, 1991, GUT, V32, pA1256; HUNT JN, 1983, DIGEST DIS SCI, V28, P897, DOI 10.1007/BF01317040; ISENBERG JI, 1986, DIGEST DIS SCI, V31, pS130, DOI 10.1007/BF01309337; JIRANEK GC, 1989, GASTROENTEROLOGY, V96, P656, DOI 10.1016/S0016-5085(89)80062-9; KARIM A, 1987, PROSTAGLANDINS, V33, P40, DOI 10.1016/0090-6980(87)90047-5; KNILLJONES R, 1990, POSTGRAD MED J, V66, P639, DOI 10.1136/pgmj.66.778.639; KURATA JH, 1990, J CLIN GASTROENTEROL, V12, P260, DOI 10.1097/00004836-199006000-00005; LACY ER, 1982, GASTROENTEROLOGY, V83, P619; LANCASTERSMITH MJ, 1991, GUT, V32, P252, DOI 10.1136/gut.32.3.252; LANGMAN MJS, 1985, BRIT MED J, V290, P347, DOI 10.1136/bmj.290.6465.347; LANZA FL, 1986, DIGEST DIS SCI, V31, pS131, DOI 10.1007/BF01309338; LANZA FL, 1989, AM J GASTROENTEROL, V84, P633; LANZA FL, 1988, GASTROENTEROLOGY, V95, P289, DOI 10.1016/0016-5085(88)90482-9; LARKAI EN, 1987, AM J GASTROENTEROL, V82, P1153; LARKAI EN, 1989, J CLIN GASTROENTEROL, V11, P158, DOI 10.1097/00004836-198904000-00009; LEUNG FW, 1986, DIGEST DIS SCI, V31, pS86, DOI 10.1007/BF01309329; LEVI S, 1990, LANCET, V336, P840, DOI 10.1016/0140-6736(90)92341-E; MONK JP, 1987, DRUGS, V33, P1, DOI 10.2165/00003495-198733010-00001; MOORE JG, 1991, GASTROENTEROLOGY, V100, P1626, DOI 10.1016/0016-5085(91)90661-4; NICHOLSON PA, 1985, DIGEST DIS SCI, V30, pS171, DOI 10.1007/BF01309405; PORRO GB, 1991, J INTERN MED, V229, P5, DOI 10.1111/j.1365-2796.1991.tb00298.x; RACHMILEWITZ D, 1986, DIGEST DIS SCI, V31, pS75, DOI 10.1007/BF01309327; ROBINSON GC, 1991, GUT, V32, pA572; ROTH S, 1989, ARCH INTERN MED, V149, P775, DOI 10.1001/archinte.149.4.775; ROTH SH, 1986, ARCH INTERN MED, V146, P1075, DOI 10.1001/archinte.146.6.1075; RYAN JR, 1987, AM J MED, V83, P41, DOI 10.1016/0002-9343(87)90578-X; SHORROCK CJ, 1988, GASTROENTEROLOGY S, V94, pA425; SILVERSTEIN FE, 1986, DIGEST DIS SCI, V31, pS137, DOI 10.1007/BF01309339; SIMJEE AE, 1986, S AFR MED J, V70, P49; SMEDFORS B, 1986, DIGEST DIS SCI, V31, pS96, DOI 10.1007/BF01309331; TARNAWSKI A, 1985, GASTROENTEROLOGY, V88, P334, DOI 10.1016/S0016-5085(85)80188-8; WALAN A, 1989, NEW ENGL J MED, V320, P69, DOI 10.1056/NEJM198901123200201; WALT R, 1986, LANCET, V1, P489; WALT RP, 1989, TOPICS GASTROENTEROL, V16, P63; WEINSTEIN RS, 1986, DIGEST DIS SCI, V31, pS115, DOI 10.1007/BF01309334; WILSON DE, 1986, DIGEST DIS SCI, V31, pS126, DOI 10.1007/BF01309336; WILSON DE, 1987, AM J MED, V83, P2, DOI 10.1016/0002-9343(87)90571-7	69	114	114	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1575	1580						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435885				2022-12-28	WOS:A1992JZ43200007
J	ASCH, DA; ENDE, J				ASCH, DA; ENDE, J			THE DOWNSIZING OF INTERNAL-MEDICINE RESIDENCY PROGRAMS	ANNALS OF INTERNAL MEDICINE			English	Article						INTERNSHIP AND RESIDENCY; INTERNAL MEDICINE; EDUCATION, MEDICAL; FOREIGN MEDICAL GRADUATES; PHYSICIANS, FAMILY	AMBULATORY CARE; HOUSE STAFF; EDUCATION; COSTS; WILL; PAY	A variety of forces are converging to reduce the number of internal medicine residency positions offered in this country. This reduction, referred to as downsizing, has been proposed as the solution to several of the problems facing internal medicine. We examine the forces that underlie the current enthusiasm for downsizing; we consider the alternative strategies by which downsizing might be implemented; and we consider the implications of these alternatives on different groups of stakeholders. Although downsizing may represent a legitimate approach to real problems, any mechanism to reduce the number of training positions in internal medicine will have broad implications for medical education and patient care well into the next century. Special efforts must be taken to ensure that downsizing will not exacerbate the existing problems of overspecialization and limited access to care.	VET AFFAIRS MED CTR, PHILADELPHIA, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center	ASCH, DA (corresponding author), UNIV PENN, SCH MED, LEONARD DAVIS INST HLTH ECON, DIV GEN INTERNAL MED, PHILADELPHIA, PA 19104 USA.			Asch, David/0000-0002-7970-286X				ANDERSEN RM, 1992, ANN INTERN MED, V117, P243, DOI 10.7326/0003-4819-117-3-243; ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209; BABBOTT D, 1991, ANN INTERN MED, V114, P16, DOI 10.7326/0003-4819-114-1-16; BENSON JA, 1989, ABIM NEWS UPDATE WIN, V90, P1; BENTLEY JD, 1989, NEW ENGL J MED, V320, P1531, DOI 10.1056/NEJM198906083202306; CAMERON JM, 1985, NEW ENGL J MED, V312, P1233, DOI 10.1056/NEJM198505093121906; CAMPBELL CR, 1991, INQUIRY-J HEALTH CAR, V28, P288; CUSTER WS, 1991, HEALTH SERV RES, V25, P831; EISENBERG JM, 1989, NEW ENGL J MED, V320, P1525, DOI 10.1056/NEJM198906083202305; EISENBERG JM, 1990, J GEN INTERN MED, V5, pS70, DOI 10.1007/BF02600440; GEHEB MA, 1988, CAREERS INTERN MED, V4, P10; GLICKMAN R, 1992, ANN INTERN MED, V117, P259, DOI 10.7326/0003-4819-117-3-259; IGLEHART JK, 1985, NEW ENGL J MED, V312, P1000, DOI 10.1056/NEJM198504113121532; KLETKE PR, 1987, ANN INTERN MED, V107, P93, DOI 10.7326/0003-4819-107-1-93; KLETKE PR, 1987, DEMOGRAPHICS PHYSICI; LURIE N, 1989, NEW ENGL J MED, V320, P1673, DOI 10.1056/NEJM198906223202507; MCCARTY DJ, 1987, NEW ENGL J MED, V317, P567, DOI 10.1056/NEJM198708273170909; Mizrahi T., 1986, GETTING RID PATIENTS; NASH DB, 1987, ANN INTERN MED, V106, P323, DOI 10.7326/0003-4819-106-2-323; NESS R, 1989, ACAD MED, V64, P588, DOI 10.1097/00001888-198910000-00009; NORCINI JJ, 1991, ANN INTERN MED, V114, P33, DOI 10.7326/0003-4819-114-1-33; SCHWARTZ MD, 1991, ANN INTERN MED, V114, P6, DOI 10.7326/0003-4819-114-1-6; SCHWARTZ WB, 1988, NEW ENGL J MED, V318, P892, DOI 10.1056/NEJM198804073181405; SILLIMAN RA, 1987, J MED EDUC, V62, P463; SLOAN FA, 1986, UNCOMPENSATED HOSPIT, P15; THORPE KE, 1990, JAMA-J AM MED ASSOC, V263, P3177, DOI 10.1001/jama.263.23.3177; TOMFORD JW, 1984, ARCH INTERN MED, V144, P1191, DOI 10.1001/archinte.144.6.1191; WIEBE C, 1991, ACP OBSERVER, V11, P14; 1990, DIRECTORY GRADUATE M; 1981, REPORT GRADUATE MED, V1	30	13	13	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					839	844		10.7326/0003-4819-117-10-839	http://dx.doi.org/10.7326/0003-4819-117-10-839			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416560				2022-12-28	WOS:A1992JX83800008
J	TKACHUK, DC; KOHLER, S; CLEARY, ML				TKACHUK, DC; KOHLER, S; CLEARY, ML			INVOLVEMENT OF A HOMOLOG OF DROSOPHILA-TRITHORAX BY 11Q23 CHROMOSOMAL TRANSLOCATIONS IN ACUTE LEUKEMIAS	CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; DNA-BINDING PROTEIN; BITHORAX COMPLEX; HMG-I; CLONING; MOTIF; GENES; IDENTIFICATION; BREAKPOINTS	We have identified a human homolog of the Drosophila trithorax protein that is structurally altered by 11q23 translocations in acute leukemias. Human trithorax (HRX) is a predicted 431 kd protein containing two potential DNA-binding motifs consisting of zinc fingers conserved with the fly protein and nonconserved amino-terminal "AT hook" motifs related to the DNA-binding motifs in HMG proteins. 11q23 translocations disrupt the HRX gene between these two motifs, and in a t(11;19)-carrying cell line fusion transcripts are expressed from both derivative chromosomes. The more abundant derivative 11 transcript codes for a chimeric protein containing the AT hook motifs fused to a previously undescribed protein (ENL) from chromosome 19. These data suggest a novel role for a trithorax-homologous protein in multilineage human leukemias that may be mediated by DNA binding within the minor groove at AT-rich sites, implicated to play an important role in bacterial IHF-, yeast datin-, and mammalian HMG-mediated gene activation.			TKACHUK, DC (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,EXPTL ONCOL LAB,STANFORD,CA 94305, USA.				NCI NIH HHS [CA42971, CA55029] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA042971, R01CA042971, R01CA055029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASHLEY CT, 1989, J BIOL CHEM, V264, P8394; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; CASTELLIGAIR JE, 1990, EMBO J, V9, P4267, DOI 10.1002/j.1460-2075.1990.tb07875.x; CHEN CS, 1991, BLOOD, V78, P2498; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; CIMINO G, 1992, CANCER RES, V52, P3811; CIMINO G, 1991, CANCER RES, V51, P6712; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; DAS S, 1991, GENE CHROMOSOME CANC, V3, P44, DOI 10.1002/gcc.2870030108; ECKNER R, 1989, NUCLEIC ACIDS RES, V17, P5947, DOI 10.1093/nar/17.15.5947; FASHENA SJ, 1992, MOL CELL BIOL, V12, P894, DOI 10.1128/MCB.12.2.894; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; HARRIS BN, 1988, CANCER GENET CYTOGEN, V30, P171, DOI 10.1016/0165-4608(88)90108-2; HAYASHI Y, 1985, LEUKEMIA RES, V9, P1467, DOI 10.1016/0145-2126(85)90038-4; HEIM S, 1987, CANCER CYTOGENETICS; INGHAM PW, 1985, COLD SPRING HARB SYM, V50, P201, DOI 10.1101/SQB.1985.050.01.026; INGHAM PW, 1983, NATURE, V306, P591, DOI 10.1038/306591a0; JACOBS G, 1990, New Biologist, V2, P583; KANEKO Y, 1988, LEUKEMIA, V2, P672; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; MANIATIS T, 1992, TRANSCRIPTIONAL REGU; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; MITELMAN F, 1987, CATALOG CHROMOSOME A; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; PUI CH, 1989, NEW ENGL J MED, V321, P136, DOI 10.1056/NEJM198907203210302; PUI CH, 1991, NEW ENGL J MED, V325, P1682, DOI 10.1056/NEJM199112123252402; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; RAIMONDI SC, 1989, BLOOD, V73, P1627; REEVES R, 1990, J BIOL CHEM, V265, P8573; REEVES R, 1991, P NATL ACAD SCI USA, V88, P1671, DOI 10.1073/pnas.88.5.1671; ROWLEY JD, 1990, P NATL ACAD SCI USA, V87, P9358, DOI 10.1073/pnas.87.23.9358; SHIMIZU H, 1989, AM J PEDIAT HEMATOL, V11, P162; SMITH SD, 1989, BLOOD, V73, P2182; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; THOMPSON LH, 1985, SOMAT CELL MOLEC GEN, V11, P87, DOI 10.1007/BF01534738; WEGNER M, 1989, NUCLEIC ACIDS RES, V17, P9909, DOI 10.1093/nar/17.23.9909; WINTER E, 1989, EMBO J, V8, P1867, DOI 10.1002/j.1460-2075.1989.tb03583.x; YANGYEN HF, 1988, MOL CELL BIOL, V8, P3406, DOI 10.1128/MCB.8.8.3406; ZIEMINVANDERPOE.S, 1991, P NATL ACAD SCI USA, V86, P10735	46	892	932	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					691	700		10.1016/0092-8674(92)90602-9	http://dx.doi.org/10.1016/0092-8674(92)90602-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423624				2022-12-28	WOS:A1992JY67600016
J	DINGWALL, C; LASKEY, R				DINGWALL, C; LASKEY, R			THE NUCLEAR-MEMBRANE	SCIENCE			English	Article							PROTEIN-KINASE-C; RAT-LIVER NUCLEI; DNA-REPLICATION; GROWTH-FACTOR; PORE COMPLEX; XENOPUS EGGS; CELL-CYCLE; FORMATION INVITRO; TARGETING SIGNAL; PURIFIED DNA	The nuclear membrane forms a major barrier within the cell, permitting levels of regulation not found in prokaryotes. The dynamics and diverse functions of the nuclear membrane and its associated structures are considered in this review. The role of the nuclear pore complex in selective transport across the nuclear membrane has been studied to a considerable degree; however, many crucial questions remain. Components of a signal transduction mechanism are associated with the nucleus, suggesting that nuclear functions may be influenced directly by this system. The involvement of the heat shock cognate protein Hsc70 in nuclear protein import is discussed, and a specific signal-presentation role for this protein is proposed.			DINGWALL, C (corresponding author), WELLCOME CANC RES CAMPAIGN INST,TENNIS COURT RD,CAMBRIDGE CB2 1QR,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X; BERRIOS M, 1983, J BIOL CHEM, V258, P4548; BERRIOS M, 1991, P NATL ACAD SCI USA, V88, P219, DOI 10.1073/pnas.88.1.219; BLOW JJ, 1990, J CELL SCI, V95, P383; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BLOW JJ, 1987, EMBO J, V6, P1997, DOI 10.1002/j.1460-2075.1987.tb02463.x; BOMAN AL, 1992, J CELL BIOL, V116, P281, DOI 10.1083/jcb.116.2.281; BOMAN AL, 1992, NATURE, V358, P512, DOI 10.1038/358512a0; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; BUSTOS JG, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; CLEVER J, 1991, P NATL ACAD SCI USA, V88, P7333, DOI 10.1073/pnas.88.16.7333; COCCO L, 1989, BIOCHEM BIOPH RES CO, V159, P720, DOI 10.1016/0006-291X(89)90054-5; COX LS, 1992, J CELL SCI, V101, P43; DAVIS LI, 1990, CELL, V61, P965, DOI 10.1016/0092-8674(90)90062-J; DELUCA C, 1990, CELL, V62, P857; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P479; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; Ellis R J, 1990, Semin Cell Biol, V1, P1; FELDHERR CM, 1992, NUCLEAR TRAFFICKING; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; FLAJNIK MF, 1991, IMMUNOGENETICS, V33, P295, DOI 10.1007/BF00216688; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FRANKE WW, 1981, J CELL BIOL, V91, P39; GERACE L, 1982, J CELL BIOL, V95, P826, DOI 10.1083/jcb.95.3.826; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GOLDBERG MW, IN PRESS J CELL BIOL; Goldfarb D, 1991, Trends Cell Biol, V1, P20, DOI 10.1016/0962-8924(91)90065-H; GOLDFARB D S, 1991, Current Biology, V1, P212, DOI 10.1016/0960-9822(91)90059-6; GOLDFARB DS, 1992, CELL, V70, P185, DOI 10.1016/0092-8674(92)90094-S; Green MR, 1989, CURR OPIN CELL BIOL, V1, P519, DOI 10.1016/0955-0674(89)90014-8; GUDDAT U, 1990, CELL, V60, P619, DOI 10.1016/0092-8674(90)90665-2; HANOVER JA, 1991, PHYSIOL REV, V71, P909; HASLEY DL, 1987, J BIOL CHEM, V262, P2234; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HENNESSY KM, 1990, GENE DEV, V4, P2252, DOI 10.1101/gad.4.12b.2252; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; HOVECAR BA, 1991, J BIOL CHEM, V266, P28; IMAMOTO N, IN PRESS J CELL BIOL; Irvine R F, 1992, Semin Cell Biol, V3, P225, DOI 10.1016/1043-4682(92)90024-P; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; LAMOND AI, 1990, TRENDS BIOCHEM SCI, V15, P451, DOI 10.1016/0968-0004(90)90292-J; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LEACH KL, 1989, J CELL BIOL, V109, P685, DOI 10.1083/jcb.109.2.685; LENO GH, 1991, J CELL BIOL, V112, P557, DOI 10.1083/jcb.112.4.557; LENO GH, 1992, CELL, V69, P151, DOI 10.1016/0092-8674(92)90126-W; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1984, J CELL BIOL, V98, P1222, DOI 10.1083/jcb.98.4.1222; MADEN DR, 1992, CELL, V70, P1035; MAHER DW, 1989, MOL CELL BIOL, V9, P2251, DOI 10.1128/MCB.9.5.2251; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; MAUL GG, 1982, NUCLEAR ENVELOPE NUC, P1; McKeon F, 1991, CURR OPIN CELL BIOL, V3, P82, DOI 10.1016/0955-0674(91)90169-Y; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; MICHAUD N, 1992, J CELL BIOL, V116, P851, DOI 10.1083/jcb.116.4.851; MICHELL R H, 1992, Current Biology, V2, P200, DOI 10.1016/0960-9822(92)90533-G; MOORE MS, 1992, CELL, V69, P939, DOI 10.1016/0092-8674(92)90613-H; NEHRBASS U, 1990, CELL, V61, P979, DOI 10.1016/0092-8674(90)90063-K; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; NEWPORT J, 1992, J CELL BIOL, V116, P295, DOI 10.1083/jcb.116.2.295; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; NEYLON CB, 1990, AM J PHYSIOL, V259, P675; NIGG EA, 1992, SEMIN CELL BIOL, V3, P242; NIGG EA, 1991, CELL, V66, P115; Paddy M R, 1992, Semin Cell Biol, V3, P255, DOI 10.1016/1043-4682(92)90027-S; PFALLER R, 1991, CELL, V65, P209, DOI 10.1016/0092-8674(91)90155-R; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; RIPMANN F, 1991, EMBO J, V10, P1053; RIS H, 1991, EMSA B, V21, P54; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; ROBERTS B, 1989, BIOCHIM BIOPHYS ACTA, V1008, P263, DOI 10.1016/0167-4781(89)90016-X; ROGUE P, 1990, J BIOL CHEM, V265, P4161; RUBINS JB, 1990, P NATL ACAD SCI USA, V87, P7080, DOI 10.1073/pnas.87.18.7080; SCHINDLER M, 1987, J CELL BIOL, V104, P849, DOI 10.1083/jcb.104.4.849; Schmitz M L, 1991, Trends Cell Biol, V1, P130, DOI 10.1016/0962-8924(91)90118-S; SEYDEL U, 1991, J BIOL CHEM, V266, P7602; SHEEHAN MA, 1988, J CELL BIOL, V106, P1, DOI 10.1083/jcb.106.1.1; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SILVER P, 1989, CRIT REV BIOCHEM MOL, V24, P419, DOI 10.3109/10409238909082557; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; STARR CM, 1990, J CELL BIOL, V110, P1861, DOI 10.1083/jcb.110.6.1861; Stewart M, 1992, Semin Cell Biol, V3, P267, DOI 10.1016/1043-4682(92)90028-T; THOMMES P, 1992, NUCLEIC ACIDS RES, V20, P1069, DOI 10.1093/nar/20.5.1069; TOBIAN JA, 1985, CELL, V43, P415, DOI 10.1016/0092-8674(85)90171-0; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; WHITE EM, 1989, J CELL BIOL, V109, P1983, DOI 10.1083/jcb.109.5.1983; WILSON KL, 1988, J CELL BIOL, V107, P57, DOI 10.1083/jcb.107.1.57; Yamasaki L, 1992, Trends Cell Biol, V2, P123, DOI 10.1016/0962-8924(92)90083-Y; YAN H, COMMUNICATION	102	193	199	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 6	1992	258	5084					942	947		10.1126/science.1439805	http://dx.doi.org/10.1126/science.1439805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439805				2022-12-28	WOS:A1992JW79600023
J	STONE, R				STONE, R			NIH FENDS OFF CRITICS OF TAMOXIFEN STUDY	SCIENCE			English	Editorial Material																			0	13	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					734	734		10.1126/science.1439776	http://dx.doi.org/10.1126/science.1439776			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439776				2022-12-28	WOS:A1992JV69200014
J	TAN, WH; SHI, ZY; SMITH, S; BIRNBAUM, D; KOPELMAN, R				TAN, WH; SHI, ZY; SMITH, S; BIRNBAUM, D; KOPELMAN, R			SUBMICROMETER INTRACELLULAR CHEMICAL OPTICAL FIBER SENSORS	SCIENCE			English	Article								A thousandfold miniaturization of immobilized optical fiber sensors, a millionfold or more sample reduction, and at least a hundredfold shorter response time, all simultaneously, were achieved by combining nanofabricated optical fiber tips with near-field photopolymerization. Specifically, pH optical fiber sensors were prepared with internal calibration, making use of the differences in both fluorescence and absorption of the acidic and basic dye species. The submicrometer sensors have excellent detection limits, as well as photostability, reversibility, and millisecond response times. Successful applications include intracellular and intraembryonic measurements. Potential applications include spatially and temporally resolved chemical analysis and kinetics inside single biological cells and their substructures.	UNIV MICHIGAN, DEPT CHEM, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan			Tan, Weihong/A-5412-2008; Tan, Weihong/AAA-4536-2020	Tan, Weihong/0000-0002-8066-1524; 				ARNOLD MA, 1988, CRC CR REV ANAL CHEM, V20, P149, DOI 10.1080/00078988808048811; BARNARD SM, 1991, NATURE, V353, P338, DOI 10.1038/353338a0; BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468; CHRISTIAN LM, 1988, TALANTA, V35, P119, DOI 10.1016/0039-9140(88)80049-3; FANG ZL, 1984, ANAL CHIM ACTA, V164, P41; HARRIS C, 1991, TERATOLOGY, V43, P229, DOI 10.1002/tera.1420430307; KOPELMAN R, 1988, SCIENCE, V241, P1620, DOI 10.1126/science.241.4873.1620; KOPELMAN R, 1992, SPIE, V1637, P33; LEWIS A, 1991, ANAL CHEM, V63, pA625, DOI 10.1021/ac00011a002; LIEBERMAN K, 1990, SCIENCE, V247, P59, DOI 10.1126/science.247.4938.59; LUO SF, 1989, ANAL CHEM, V61, P174, DOI 10.1021/ac00177a019; MUNKHOLM C, 1986, ANAL CHEM, V58, P1427, DOI 10.1021/ac00298a602; NAU H, 1987, ARCH TOXICOL, P128; SEITZ WR, 1988, CRC CR REV ANAL CHEM, V19, P135, DOI 10.1080/10408348808542810; TAN W, 1990, DYNAMICS SMALL CONFI, P195; TAN W, IN PRESS ANAL CHEM; WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN, V1	17	248	268	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	1992	258	5083					778	781		10.1126/science.1439785	http://dx.doi.org/10.1126/science.1439785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439785				2022-12-28	WOS:A1992JV69200029
J	ARONSON, JK; HARDMAN, M				ARONSON, JK; HARDMAN, M			ABC OF MONITORING DRUG-THERAPY - PATIENT COMPLIANCE	BRITISH MEDICAL JOURNAL			English	Article									ICI PLC,DIV MED RES,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND		ARONSON, JK (corresponding author), RADCLIFFE INFIRM,CLIN PHARMACOL,OXFORD OX2 6HE,ENGLAND.							CARON HS, 1968, J AMER MED ASSOC, V203, P922, DOI 10.1001/jama.203.11.922; GRIFFITH S, 1990, BRIT J GEN PRACT, V40, P114; RASHID A, 1982, BRIT MED J, V284, P24, DOI 10.1136/bmj.284.6308.24; SACKETT DL, 1975, LANCET, V1, P1205	4	34	34	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 24	1992	305	6860					1009	1011		10.1136/bmj.305.6860.1009	http://dx.doi.org/10.1136/bmj.305.6860.1009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV776	1458110	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JV77600036
J	DAVIDSON, RA; WILCOX, CS				DAVIDSON, RA; WILCOX, CS			NEWER TESTS FOR THE DIAGNOSIS OF RENOVASCULAR DISEASE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RENAL-ARTERY STENOSIS; ANGIOTENSIN-CONVERTING ENZYME; CAPTOPRIL TEST; HYPERTENSIVE PATIENTS; VEIN RENIN; SUBTRACTION ANGIOGRAPHY; VASCULAR HYPERTENSION; SCREENING TECHNIQUE; DUPLEX ULTRASOUND; MR ANGIOGRAPHY	Objective.-To evaluate published reports of diagnostic methods for renovascular hypertension, including Doppler ultrasonography, magnetic resonance imaging, the captopril test, and captopril scanning. Data Sources.-MEDLINE and selected references from appropriate published articles. Study Selection.-Studies included those that calculated sensitivities and specificities; studies that derived diagnostic criteria without application to another population of patients were excluded. Consensus of both authors was necessary for inclusion. Data Extraction.-Articles were critically assessed independently by the authors and a consensus critique was developed. Data Synthesis.-Major sources of variability exist in the investigations of recently developed tests for renovascular hypertension. These include variability in patient populations, performance of tests, and determination of outcome measures. Conclusions.-Among the newer diagnostic tests, both magnetic resonance imaging and Doppler ultrasonography hold promise for the anatomic detection of renal artery stenosis, but clear diagnostic criteria have not been universally accepted. There is more information concerning the captopril test, which has a sufficiently high sensitivity to be useful in the screening of high-risk patients for renovascular hypertension. Scans after captopril administration, which appear to be more specific, may enable the prediction of a blood pressure response to angioplasty or surgery.	UNIV FLORIDA, COLL MED, DEPT MED, DIV NEPHROL HYPERTENS & TRANSPLANTAT, GAINESVILLE, FL 32610 USA; UNIV FLORIDA, COLL MED, CTR HYPERTENS, GAINESVILLE, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	DAVIDSON, RA (corresponding author), UNIV FLORIDA, COLL MED, DEPT MED, DIV INTERNAL MED, BOX J-277, GAINESVILLE, FL 32610 USA.				BHP HRSA HHS [D28PE14233-15] Funding Source: Medline	BHP HRSA HHS		[Anonymous], 1987, ARCH INTERN MED, V147, P820; AVASTHI PS, 1984, KIDNEY INT, V25, P824, DOI 10.1038/ki.1984.96; CARMICHAEL DJS, 1986, LANCET, V1, P667; CASE DB, 1979, ANN INTERN MED, V91, P153, DOI 10.7326/0003-4819-91-2-153; DAVIDSON R, 1991, HYPERTENSION, V18, P299, DOI 10.1161/01.HYP.18.3.299; DERKX FHM, 1987, RENOVASCULAR HYPERTE, P295; DONDI M, 1991, J NUCL MED, V32, P424; DUMOULIN CL, 1990, J COMPUT ASSIST TOMO, V14, P779, DOI 10.1097/00004728-199009000-00020; EDELMAN RR, 1989, RADIOLOGY, V172, P351, DOI 10.1148/radiology.172.2.2748814; ENGLAND WL, 1988, J GEN INTERN MED, V3, P344, DOI 10.1007/BF02595792; ERBSLOHMOLLER B, 1991, AM J MED, V90, P23, DOI 10.1016/0002-9343(91)90502-O; FINE EJ, 1990, CONTRIB NEPHROL, V79, P211; FOMMEI E, 1990, CONTRIB NEPHROL, V79, P205; FREDERICKSON ED, 1990, ARCH INTERN MED, V150, P569, DOI 10.1001/archinte.150.3.569; GAUL MK, 1989, AM J HYPERTENS, V2, P335, DOI 10.1093/ajh/2.5.335; GOSSE P, 1989, AM J HYPERTENS, V2, P191, DOI 10.1093/ajh/2.3.191; GRIM CE, 1979, ANN INTERN MED, V91, P617, DOI 10.7326/0003-4819-91-4-617; HANDA N, 1988, J HYPERTENS, V6, pS458, DOI 10.1097/00004872-198812040-00144; HANSEN PB, 1990, J INTERN MED, V228, P159, DOI 10.1111/j.1365-2796.1990.tb00210.x; HAVEY RJ, 1985, JAMA-J AM MED ASSOC, V254, P388, DOI 10.1001/jama.254.3.388; HAWKINS PG, 1989, J HYPERTENS, V7, pS184, DOI 10.1097/00004872-198900076-00088; HILLMAN BJ, 1989, AM J ROENTGENOL, V153, P5, DOI 10.2214/ajr.153.1.5; IDRISSI A, 1988, KIDNEY INT, V34, pS138; KENT KC, 1991, J VASC SURG, V13, P311, DOI 10.1016/0741-5214(91)90224-I; KIM D, 1990, RADIOLOGY, V174, P727, DOI 10.1148/radiology.174.3.2305057; KIRKENDA.WM, 1967, NEW ENGL J MED, V276, P479, DOI 10.1056/NEJM196703022760901; KLETTER K, 1990, CONTRIB NEPHROL, V79, P190; LEENEN FHH, 1973, AM J PHYSIOL, V225, P1513, DOI 10.1152/ajplegacy.1973.225.6.1513; LEWIN A, 1985, ARCH INTERN MED, V145, P424, DOI 10.1001/archinte.145.3.424; LUSCHER TF, 1981, CLIN NEPHROL, V15, P314; MANN SJ, 1991, AM J MED, V90, P30, DOI 10.1016/0002-9343(91)90503-P; Marks L S, 1975, Urol Clin North Am, V2, P311; MCCARTHY JE, 1990, ARCH INTERN MED, V150, P493, DOI 10.1001/archinte.150.3.493; MULLER FB, 1986, AM J MED, V80, P633, DOI 10.1016/0002-9343(86)90819-3; NALLY JV, 1987, J NUCL MED, V28, P1501; OSBORNE RW, 1981, SURGERY, V90, P932; PAPE JF, 1988, SCAND J UROL NEPHROL, V22, P41, DOI 10.1080/00365599.1988.11690382; PLOTH DW, 1983, AM J PHYSIOL, V245, pF131, DOI 10.1152/ajprenal.1983.245.2.F131; POHL MA, 1985, AM J KIDNEY DIS, V5, pA120, DOI 10.1016/S0272-6386(85)80074-3; POSTMA CT, 1990, ARCH INTERN MED, V150, P625, DOI 10.1001/archinte.150.3.625; POSTMA CT, 1991, ARCH INTERN MED, V151, P1531, DOI 10.1001/archinte.151.8.1531; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; RE R, 1978, NEW ENGL J MED, V298, P582, DOI 10.1056/NEJM197803162981102; ROBERTSON R, 1988, BRIT J RADIOL, V61, P196, DOI 10.1259/0007-1285-61-723-196; ROUBIDOUX MA, 1991, RADIOLOGY, V178, P819, DOI 10.1148/radiology.178.3.1994424; SELLARS L, 1985, J HYPERTENS, V3, P177, DOI 10.1097/00004872-198504000-00011; SETARO JF, 1991, HYPERTENSION, V18, P289, DOI 10.1161/01.HYP.18.3.289; SFAKIANAKIS GN, 1990, CONTRIB NEPHROL, V79, P219; SIMON N, 1972, J AMER MED ASSOC, V220, P1209, DOI 10.1001/jama.220.9.1209; SOS TA, 1983, NEW ENGL J MED, V309, P274, DOI 10.1056/NEJM198308043090504; STOCKIGT JR, 1972, LANCET, V1, P1194; STRONG CG, 1971, AM J CARDIOL, V27, P602, DOI 10.1016/0002-9149(71)90223-2; SVETKEY LP, 1989, HYPERTENSION, V14, P247, DOI 10.1161/01.HYP.14.3.247; TAYLOR DC, 1988, J VASC SURG, V7, P363, DOI 10.1067/mva.1988.avs0070363; THIBONNIER M, 1984, JAMA-J AM MED ASSOC, V251, P56, DOI 10.1001/jama.251.1.56; THORNBURY JR, 1982, AM J ROENTGENOL, V138, P43; TOMODA F, 1990, AM J HYPERTENS, V3, P918, DOI 10.1093/ajh/3.12.918; TUCKER RM, 1978, MAYO CLIN PROC, V53, P373; TUNNY TJ, 1988, J UROLOGY, V140, P713, DOI 10.1016/S0022-5347(17)41794-0; VAUGHAN ED, 1984, UROL CLIN N AM, V11, P393; VETTER W, 1979, KLIN WOCHENSCHR, V57, P863, DOI 10.1007/BF01477025; WEINBERGER MH, 1985, ARCH INTERN MED, V145, P421, DOI 10.1001/archinte.1985.00360030053009; WILCOX CS, 1988, AM J HYPERTENS, V1, pS344, DOI 10.1093/ajh/1.4.344S; WILCOX CS, 1989, CLIN NUCL MED, V14, P1, DOI 10.1097/00003072-198901000-00002; ZOLLER WG, 1990, KLIN WOCHENSCHR, V68, P830, DOI 10.1007/BF01796273	65	90	90	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3353	3358		10.1001/jama.268.23.3353	http://dx.doi.org/10.1001/jama.268.23.3353			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB732	1453529				2022-12-28	WOS:A1992KB73200029
J	SLOAN, S; RADEMAKER, AW; KAHRILAS, PJ				SLOAN, S; RADEMAKER, AW; KAHRILAS, PJ			DETERMINANTS OF GASTROESOPHAGEAL JUNCTION INCOMPETENCE - HIATAL-HERNIA, LOWER ESOPHAGEAL SPHINCTER, OR BOTH	ANNALS OF INTERNAL MEDICINE			English	Article						ESOPHAGOGASTRIC JUNCTION; HERNIA, HIATAL; GASTROESOPHAGEAL REFLUX; MANOMETRY; FLUOROSCOPY	REFLUX ESOPHAGITIS; PRESSURE; MECHANISMS; DIAPHRAGM; SMOKING	Objective: To examine the effects of hiatal hernia and lower esophageal sphincter (LES) pressure on the competence of the gastroesophageal junction under conditions of abrupt increases in intra-abdominal pressure. Design: Acute experiments. Setting: University-hospital-based gastroenterology practice. Participants: Sixteen asymptomatic volunteers and 34 patients with endoscopic findings suggestive of hiatal hernia. Intervention: A series of eight provocative maneuvers entailing abrupt changes in intra-abdominal pressure. Measurements: Five radiographic measurements relevant to the presence and extent of hiatal hernia were made from videotaped barium-swallow examinations. Lower esophageal sphincter pressure was measured immediately before each maneuver. The percentage of maneuvers that resulted in gastroesophageal reflux was calculated as the reflux score. A stepwise regression analysis was then used to model the relation between measured variables of the gastroesophageal junction (manometric and radiographic) with reflux score. Results: Patients with hiatal hernia had substantially higher reflux scores and lower LES pressures than either patients without hernias or volunteers. In diminishing order of significance, the terms in the model of susceptibility to reflux were axial length of hernia measured between swallows; LES pressure; and an interaction term in which a progressive increase occurred in the risk for reflux associated with a hypotensive lower esophageal sphincter as hernia size increased. Conclusions: Gastroesophageal junction competence during abrupt increases in intra-abdominal pressure is compromised by both hiatal hernia and low LES pressure. These factors interact with each other to determine susceptibility to reflux.	NORTHWESTERN UNIV, SCH MED,DEPT MED,SUITE 1526,WESLEY TOWERS, 250 E SUPER ST, CHICAGO, IL 60611 USA	Northwestern University					NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000669] Funding Source: NIH RePORTER; NIDCD NIH HHS [1RO1DC00669-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERSTAD A, 1986, SCAND J GASTROENTERO, V21, P55, DOI 10.3109/00365528609034622; BOYLE JT, 1987, AM J PHYSIOL, V253, pG315, DOI 10.1152/ajpgi.1987.253.3.G315; BOYLE JT, 1985, GASTROENTEROLOGY, V88, P723, DOI 10.1016/0016-5085(85)90143-X; COHEN S, 1971, NEW ENGL J MED, V284, P1053, DOI 10.1056/NEJM197105132841902; DEMEESTER TR, 1981, J THORAC CARDIOV SUR, V82, P547; DENT J, 1980, J CLIN INVEST, V65, P256, DOI 10.1172/JCI109667; DODDS WJ, 1982, NEW ENGL J MED, V307, P1547, DOI 10.1056/NEJM198212163072503; Dodds WJ, 1990, J GASTROINTEST MOTIL, V2, P79; JOHNSON LF, 1978, AM J DIG DIS, V23, P498, DOI 10.1007/BF01072693; KAHRILAS PJ, 1988, GASTROENTEROLOGY, V94, P73, DOI 10.1016/0016-5085(88)90612-9; KAHRILAS PJ, 1990, GUT, V31, P4, DOI 10.1136/gut.31.1.4; KAUL B, 1986, SCAND J GASTROENTERO, V21, P31, DOI 10.3109/00365528609034617; KLEINBAUM DG, 1988, APPLIED REGRESSION A, P88; LEVINE MS, 1989, RADIOLOGY ESOPHAGUS, P256; MITTAL RK, 1990, AM J PHYSIOL, V258, pG624, DOI 10.1152/ajpgi.1990.258.4.G624; MITTAL RK, 1988, J CLIN INVEST, V81, P1182, DOI 10.1172/JCI113433; MITTAL RK, 1989, AM J PHYSIOL, V256, pG139, DOI 10.1152/ajpgi.1989.256.1.G139; OTT DJ, 1985, GASTROINTEST RADIOL, V10, P317, DOI 10.1007/BF01893120; ROSNER B, 1986, FUNDAMENTALS BIOSTAT, P246; SLOAN S, 1991, GASTROENTEROLOGY, V100, P596, DOI 10.1016/0016-5085(91)80003-R; SONTAG SJ, 1991, J CLIN GASTROENTEROL, V13, P628, DOI 10.1097/00004836-199112000-00006; WRIGHT RA, 1979, DIGEST DIS SCI, V24, P311, DOI 10.1007/BF01296546	22	201	210	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1992	117	12					977	982		10.7326/0003-4819-117-12-977	http://dx.doi.org/10.7326/0003-4819-117-12-977			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB980	1443984				2022-12-28	WOS:A1992KB98000001
J	BREO, DL				BREO, DL			AARPS CALL TO ARMS - REFORM HEALTH-CARE - NOW	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	1992	268	19					2706	2707		10.1001/jama.268.19.2706	http://dx.doi.org/10.1001/jama.268.19.2706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX680	1433691				2022-12-28	WOS:A1992JX68000035
J	SCRUTTON, NS; DEONARAIN, MP; BERRY, A; PERHAM, RN				SCRUTTON, NS; DEONARAIN, MP; BERRY, A; PERHAM, RN			COOPERATIVITY INDUCED BY A SINGLE MUTATION AT THE SUBUNIT INTERFACE OF A DIMERIC ENZYME - GLUTATHIONE-REDUCTASE	SCIENCE			English	Article							ESCHERICHIA-COLI; ASPARTATE TRANSCARBAMOYLASE; DIRECTED MUTAGENESIS; DISULFIDE BRIDGE; RESOLUTION; DEHYDROGENASE; SPECIFICITY; COENZYME; SITE	When glycine418 of Escherichia coli glutathione reductase, which is in a closely packed region of the dimer interface, is replaced with a bulky tryptophan residue, the enzyme becomes highly cooperative (Hill coefficient 1.76) for glutathione binding. The cooperativity is lost when the mutant subunit is hybridized with a wild-type subunit to create a heterodimer. The mutation appears to disrupt atomic packing at the dimer interface, which induces a change of kinetic mechanism. A single mutation in a region of the protein remote from the active site can thus act as a molecular switch to confer cooperativity on an enzyme.	UNIV CAMBRIDGE,DEPT BIOCHEM,CAMBRIDGE CTR MOLEC RECOGNIT,CAMBRIDGE CB2 1QW,ENGLAND	University of Cambridge				Berry, Alan/0000-0003-3502-0426				BERGER SA, 1990, NATURE, V343, P575, DOI 10.1038/343575a0; BERRY A, 1989, BIOCHEMISTRY-US, V28, P1264, DOI 10.1021/bi00429a047; DEMBOWSKI NJ, 1990, BIOCHEMISTRY-US, V29, P3716, DOI 10.1021/bi00467a018; DEONARAIN MP, 1990, P ROY SOC B-BIOL SCI, V241, P179, DOI 10.1098/rspb.1990.0083; DEONARAIN MP, 1992, BIOCHEMISTRY-US, V31, P1491, DOI 10.1021/bi00120a028; DEONARAIN MP, 1992, BIOCHEMISTRY-US, V31, P1498, DOI 10.1021/bi00120a029; DEONARAIN MP, 1989, BIOCHEMISTRY-US, V28, P9601; ERMLER U, 1991, PROTEINS, V9, P174, DOI 10.1002/prot.340090303; GREER S, 1986, BIOCHEMISTRY-US, V25, P2736, DOI 10.1021/bi00357a069; HENDERSON GB, 1991, P NATL ACAD SCI USA, V88, P8769, DOI 10.1073/pnas.88.19.8769; KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUO LC, 1989, SCIENCE, V245, P522, DOI 10.1126/science.2667139; KURIYAN J, 1991, NATURE, V352, P172, DOI 10.1038/352172a0; KURIYAN J, 1991, P NATL ACAD SCI USA, V88, P8764, DOI 10.1073/pnas.88.19.8764; MATTEVI A, 1991, J MOL BIOL, V220, P975, DOI 10.1016/0022-2836(91)90367-F; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PAI EF, 1983, J BIOL CHEM, V258, P1751; PERHAM RN, 1991, BIOESSAYS, V13, P515, DOI 10.1002/bies.950131005; SCHIERING N, 1991, NATURE, V352, P168, DOI 10.1038/352168a0; SCRUTTON NS, 1988, FEBS LETT, V241, P46, DOI 10.1016/0014-5793(88)81028-7; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Segel IH, 1975, ENZYME KINETICS, P460; STEBBINS JW, 1992, BIOCHEMISTRY-US, V31, P2328, DOI 10.1021/bi00123a017; VANVLIET F, 1991, P NATL ACAD SCI USA, V88, P9180, DOI 10.1073/pnas.88.20.9180; WENTE SR, 1991, J BIOL CHEM, V266, P20833; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; WONG KK, 1988, BIOCHEMISTRY-US, V27, P7091, DOI 10.1021/bi00418a063	29	46	46	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1140	1143		10.1126/science.1439821	http://dx.doi.org/10.1126/science.1439821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439821				2022-12-28	WOS:A1992JX85200029
J	LANDSBERG, JP; MCDONALD, B; WATT, F				LANDSBERG, JP; MCDONALD, B; WATT, F			ABSENCE OF ALUMINUM IN NEURITIC PLAQUE CORES IN ALZHEIMERS-DISEASE	NATURE			English	Article							SENILE PLAQUES; DRINKING-WATER; MICROPROBE; BRAIN	CONTROVERSY exists over whether aluminium has a role in the aetiology of Alzheimer's disease. Alzheimer's disease is neuropathologically characterized by the occurrence of a minimum density of neurofibrillary tangles and neuritic plaques in the hippocampus and the association cortex of the brain1,2. The purported association of aluminium with Alzheimer's disease is based on: (1) the experimental induction of fibrillary changes in the neurons of animals by the injection of aluminium salts into brain tissue3,4; (2) reported detection of aluminium in neuritic plaques5-8 and tangle-bearing neurons9,10; (3) epidemiological studies linking aluminium levels in the environment, notably water supplies, with an increased prevalence of dementia11-14; and (4) a reported decrease in the rate of disease progression following the administration of desferroxamine, an aluminium chelator, to clinically diagnosed sufferers of Alzheimer's disease15. Here we use nuclear microscopy, a new analytical technique involving million-volt nuclear particles, to identify and analyse plaques in post-mortem tissue from patients with Alzheimer's disease without using chemical staining techniques and fail to demonstrate the presence of aluminium in plaque cores in untreated tissue.	RADCLIFFE INFIRM, DEPT NEUROPATHOL, OXFORD OX2 6HE, ENGLAND	Radcliffe Infirmary	LANDSBERG, JP (corresponding author), UNIV OXFORD, NUCL PHYS LAB, SCANNING PROTON MICROPROBE UNIT, OXFORD OX1 3RH, ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARTAXO P, 1990, NUCL INSTRUM METH B, V49, P383, DOI 10.1016/0168-583X(90)90280-8; BENCH GS, 1989, NUCL INSTRUM METH B, V40-1, P655, DOI 10.1016/0168-583X(89)91069-0; CANDY J, 1988, INTERDISCIPL TOPICS, V25, P140; CANDY JM, 1986, LANCET, V1, P354; Candy JM, 1985, SENILE DEMENTIA ALZH, P183; CHAFI AH, 1991, NEUROSCI LETT, V123, P61, DOI 10.1016/0304-3940(91)90158-P; Chu W. K., 1978, BACKSCATTERING SPECT, DOI 10.1016/B978-0-12-173850-1.50008-9; DUCKETT S, 1976, CR ACAD SCI D NAT, V282, P393; DUCKETT S, 1980, J NEUROPATH EXP NEUR, V39, P350, DOI 10.1097/00005072-198005000-00048; EDWARDSON JA, 1990, ENVIRON GEOCHEM HLTH, V12, P94, DOI 10.1007/BF01734057; FLATEN TP, 1990, ENVIRON GEOCHEM HLTH, V12, P152, DOI 10.1007/BF01734064; GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310; JACOBS RW, 1989, CAN J NEUROL SCI, V16, P498, DOI 10.1017/S0317167100029838; Johansson SAE, 1988, PIXE NOVEL TECHNIQUE, V1st; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KLATZO I, 1965, J NEUROPATH EXP NEUR, V24, P187, DOI 10.1097/00005072-196504000-00002; LANDSBERG JP, 1991, NUCL INSTRUM METH B, V54, P180, DOI 10.1016/0168-583X(91)95510-K; MARTYN CN, 1989, LANCET, V1, P59; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; MICHEL P, 1991, ALZHEIMERS DISEASE : BASIC MECHANISMS, DIAGNOSIS AND THERAPEUTIC STRATEGIES, P387; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; NERI LC, 1991, LANCET, V338, P390, DOI 10.1016/0140-6736(91)90531-S; NIKAIDO T, 1972, ARCH NEUROL-CHICAGO, V27, P549, DOI 10.1001/archneur.1972.00490180085017; PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858; SCHOFIELD RMS, 1988, NUCL INSTRUM METH B, V30, P398, DOI 10.1016/0168-583X(88)90032-8; STERN AJ, 1986, J NEUROPATH EXP NEUR, V45, P361, DOI 10.1097/00005072-198605000-00140; TERRY RD, 1965, J NEUROPATH EXP NEUR, V24, P200, DOI 10.1097/00005072-196504000-00003; WATT F, 1987, PRINCIPLES APPLICATI; WATT F, 1992, XRAY MICROANALYSIS B	30	242	245	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	1992	360	6399					65	68		10.1038/360065a0	http://dx.doi.org/10.1038/360065a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW717	1436075				2022-12-28	WOS:A1992JW71700055
J	VANHATEREN, JH				VANHATEREN, JH			REAL AND OPTIMAL NEURAL IMAGES IN EARLY VISION	NATURE			English	Article								IT has been suggested1-3 that the first steps in visual processing strive to compress as much information as possible about the outside world into the limited dynamic range of the visual channels. Here I compare measured neural images with theoretical calculations based on maximizing information, taking into account the statistical structure of natural images. Neural images were obtained by scanning an image while recording from a second-order neuron in the fly visual system. Over a 5.5-log-units-wide range of mean intensities, experiment and theory correspond well. At high mean intensities, redundancy in the image is reduced by spatial and temporal antagonism. At low mean intensities, spatial and temporal low-pass filtering combat noise and increase signal reliability.			VANHATEREN, JH (corresponding author), UNIV GRONINGEN,DEPT BIOPHYS,WESTERSINGEL 34,9718 CM GRONINGEN,NETHERLANDS.		van Hateren, J.H./ADA-8501-2022	van Hateren, J.H./0000-0002-4235-4734				Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; GOLDMAN S, 1953, INFORMATION THEORY; KRETZMER ER, 1954, BELL LAB RECORD  NOV, P401; Laughlin S.B., 1983, PHYS BIOLOGICAL PROC, P42; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; LAUGHLIN SB, 1987, TRENDS NEUROSCI, V10, P478, DOI 10.1016/0166-2236(87)90104-4; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; TSUKAMOTO Y, 1990, P NATL ACAD SCI USA, V87, P1860, DOI 10.1073/pnas.87.5.1860; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924	14	80	81	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 5	1992	360	6399					68	70		10.1038/360068a0	http://dx.doi.org/10.1038/360068a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW717	1436076				2022-12-28	WOS:A1992JW71700056
J	FANGMAN, WL; BREWER, BJ				FANGMAN, WL; BREWER, BJ			A QUESTION OF TIME - REPLICATION ORIGINS OF EUKARYOTIC CHROMOSOMES	CELL			English	Review							DNA-REPLICATION; S-PHASE; SACCHAROMYCES-CEREVISIAE; YEAST; ACTIVATION; GENES; LOCUS; CELLS				FANGMAN, WL (corresponding author), UNIV WASHINGTON,DEPT GENET SK-50,SEATTLE,WA 98195, USA.							APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BENARD M, 1992, NUCLEIC ACIDS RES, V20, P3309, DOI 10.1093/nar/20.13.3309; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; CECH TR, 1981, NUCLEIC ACIDS RES, V9, P3531, DOI 10.1093/nar/9.14.3531; DESHPANDE AM, 1992, IN PRES MOL CELL BIO; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; DIJKWEL PA, 1992, MOL CELL BIOL, V12, P3715, DOI 10.1128/MCB.12.9.3715; DROUIN R, 1990, CHROMOSOMA, V99, P273, DOI 10.1007/BF01731703; DUBEY DD, 1991, MOL CELL BIOL, V11, P5346, DOI 10.1128/MCB.11.10.5346; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GUO ZS, 1992, MOL CELL BIOL, V12, P2514, DOI 10.1128/MCB.12.6.2514; HAMLIN JL, 1992, IN PRESS BIOESSAYS; HAND R, 1975, J CELL BIOL, V64, P89, DOI 10.1083/jcb.64.1.89; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; HEINZEL SS, 1991, MOL CELL BIOL, V11, P2263, DOI 10.1128/MCB.11.4.2263; HELD PG, 1992, BIOCHIM BIOPHYS ACTA, V1130, P235, DOI 10.1016/0167-4781(92)90435-3; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; LEU TH, 1992, MOL CELL BIOL, V12, P2804, DOI 10.1128/MCB.12.6.2804; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; ORRWEAVER TL, 1991, BIOESSAYS, V13, P97, DOI 10.1002/bies.950130302; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; RIVIER DH, 1992, SCIENCE, V256, P659, DOI 10.1126/science.1585179; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; ZWEIFEL SG, 1990, YEAST, V6, P179, DOI 10.1002/yea.320060302	33	132	136	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					363	366		10.1016/0092-8674(92)90505-7	http://dx.doi.org/10.1016/0092-8674(92)90505-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423601				2022-12-28	WOS:A1992JW43500003
J	WEBB, AMC; RUSSELL, J; ELSTEIN, M				WEBB, AMC; RUSSELL, J; ELSTEIN, M			COMPARISON OF YUZPE REGIMEN, DANAZOL, AND MIFEPRISTONE (RU486) IN ORAL POSTCOITAL CONTRACEPTION	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ETHINYLESTRADIOL-NORGESTREL COMBINATION; POST-COITAL CONTRACEPTION; ETHINYL ESTRADIOL; DL-NORGESTREL; INTERCEPTION; ESTROGENS; RU-486; WOMEN	Objective-To compare the effectiveness and acceptability of three regimens of postcoital contraception. Design-Randomised group comparison of ethinyloestradiol 100 mug plus levonorgestrel 500 mug repeated after 12 hours (Yuzpe method); danazol 600 mg repeated after 12 hours; and mifepristone 600 mg single dose. Setting-Community family planning clinic. Subjects-616 consecutive women with regular cycles aged 16 to 45 years. Main outcome measures-Number of pregnancies, incidence of side effects, and timing of next period. Results-The raw pregnancy rates (with 95% confidence intervals) for the Yuzpe, danazol, and mifepristone groups were 2.62% (0.86% to 6.00%), 4.66% (2.15% to 8.67%), and 0% (0% to 1.87%) (respectively. Overall, these rates differed significantly (chi2=8.988, df=2; p=0.011). The differences between the mifepristone and Yuzpe groups and between the mifepristone and danazol groups were also significant. Side effects were more common and more severe in the Yuzpe group (133 women (70%)) than in either the danazol group (58 (30%)) or the mifepristone group (72 (37%)). The Yuzpe regimen tended to induce bleeding early but mifepristone prolonged the cycle. Three women bled more than seven days late in the Yuzpe group compared with 49 in the mifepristone group. Conclusions-Mifepristone was effective in reducing expected pregnancy rates and the Yuzpe method also had a clinical effect. Danazol had little or no effect. A further multicentre trial is needed.	UNIV HOSP S MANCHESTER, DEPT MED STAT, MANCHESTER M20 8LR, LANCS, ENGLAND; UNIV HOSP S MANCHESTER, DEPT OBSTET & GYNAECOL, MANCHESTER M20 8LR, LANCS, ENGLAND	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	WEBB, AMC (corresponding author), UNIV MANCHESTER, PALATINE CTR, DEPT OBSTET & GYNAECOL, MANCHESTER M20 9LJ, ENGLAND.			Russell, Jean Marion/0000-0002-4174-7210				BARRETT JC, 1969, POP STUD-J DEMOG, V23, P455, DOI 10.1080/00324728.1969.10405297; DHONT M, 1982, J OBSTET GYNAECOL, V2, P134; DIXON GW, 1980, JAMA-J AM MED ASSOC, V244, P1336, DOI 10.1001/jama.244.12.1336; FASOLI M, 1989, CONTRACEPTION, V39, P459, DOI 10.1016/0010-7824(89)90123-6; GARDNER MJ, 1989, STATISTICS CONFIDENC; HASPELS AA, 1976, CONTRACEPTION, V14, P375, DOI 10.1016/S0010-7824(76)80052-2; HERMANN WL, 1985, ANTIPROGESTIN STEROI, P199; LAHTEENMAKI P, 1988, FERTIL STERIL, V50, P36; NADLER RD, 1985, ANTIPROGESTIN STEROI, P169; PERCIVALSMITH RKL, 1987, CONTRACEPTION, V36, P287, DOI 10.1016/0010-7824(87)90098-9; ROWLANDS S, 1983, CONTRACEPTION, V27, P39, DOI 10.1016/0010-7824(83)90054-9; SCHWARTZ D, 1979, FERTIL STERIL, V31, P226; TIETZE C, 1960, FERTIL STERIL, V11, P485; VANSANTEN MR, 1985, FERTIL STERIL, V43, P206; VANSANTEN MR, 1987, CONTRACEPTION, V35, P423, DOI 10.1016/0010-7824(87)90078-3; VANSANTEN MR, 1987, CONTRACEPTION, V35, P433, DOI 10.1016/0010-7824(87)90079-5; Vollman RF, 1977, INT REV NATURAL FAMI, V1, P40; YUZPE AA, 1982, FERTIL STERIL, V37, P508; ZULIANI G, 1990, EUR J OBSTET GYN R B, V37, P253, DOI 10.1016/0028-2243(90)90032-V; 1990, HDB CONTRACEPTIVE PR	20	173	175	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	1992	305	6859					927	931		10.1136/bmj.305.6859.927	http://dx.doi.org/10.1136/bmj.305.6859.927			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JU649	1458074	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JU64900022
J	DASILVA, LB; TREBES, JE; BALHORN, R; MROWKA, S; ANDERSON, E; ATTWOOD, DT; BARBEE, TW; BRASE, J; CORZETT, M; GRAY, J; KOCH, JA; LEE, C; KERN, D; LONDON, RA; MACGOWAN, BJ; MATTHEWS, DL; STONE, G				DASILVA, LB; TREBES, JE; BALHORN, R; MROWKA, S; ANDERSON, E; ATTWOOD, DT; BARBEE, TW; BRASE, J; CORZETT, M; GRAY, J; KOCH, JA; LEE, C; KERN, D; LONDON, RA; MACGOWAN, BJ; MATTHEWS, DL; STONE, G			X-RAY LASER MICROSCOPY OF RAT SPERM NUCLEI	SCIENCE			English	Article								The development of high brightness and short pulse width (<200 picoseconds) x-ray lasers now offers biologists the possibility of high-resolution imaging of specimens in an aqueous environment without the blurring effects associated with natural motions and chemical erosion. As a step toward developing the capabilities of this type of x-ray microscopy, a tantalum x-ray laser at 44.83 angstrom wavelength was used together with an x-ray zone plate lens to image both unlabeled and selectively gold-labeled dried rat sperm nuclei. The observed images show approximately 500 angstrom features, illustrate the importance of x-ray microscopy in determining chemical composition, and provide information about the uniformity of sperm chromatin organization and the extent of sperm chromatin hydration.	LAWRENCE LIVERMORE NATL LAB,LIVERMORE,CA 94550; LAWRENCE BERKELEY LAB,CTR XRAY OPT,BERKELEY,CA 94720; UNIV CALIF SAN FRANCISCO,DIV MOLEC CYTOMETRY,SAN FRANCISCO,CA 94143; IBM CORP,THOMAS J WATSON RES CTR,YORKTOWN HTS,NY 10598	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; International Business Machines (IBM)	DASILVA, LB (corresponding author), UNIV CALIF BERKELEY,DEPT PHYS,BERKELEY,CA 94720, USA.		Kern, Dieter P/A-3109-2011					ALLEN MJ, 1991, J CELL BIOL, V15, P50; ALLEN MJ, 1990, J CELL BIOL, V111, P110; ANDERSON EH, 1991, XRAY MICROSCOPY, V3, P75; BALHORN R, 1977, BIOCHEMISTRY-US, V16, P4704; BARBEE TW, 1990, OPT ENG, V29, P581; DASILVA LB, 1992, OPT LETT, V17, P754, DOI 10.1364/OL.17.000754; DOOHER GB, 1973, AM J ANAT, V136, P339, DOI 10.1002/aja.1001360307; HUNT J, 1991, SPIE P, V1410, P2; JACOBSEN C, 1991, OPT COMMUN, V86, P351, DOI 10.1016/0030-4018(91)90016-7; KOEHLER J K, 1970, Journal of Ultrastructure Research, V33, P598, DOI 10.1016/S0022-5320(70)90184-X; KOEHLER JK, 1983, GAMETE RES, V8, P357, DOI 10.1002/mrd.1120080406; MacGowan B. J., 1990, X-Ray Lasers 1990. Proceedings of the 2nd International Colloquium, P221; MACGOWAN BJ, 1990, PHYS REV LETT, V65, P420, DOI 10.1103/PhysRevLett.65.420; MEYERILSE W, 1991, XRAY MICROSCOPY, V3, P284; ROSEN MD, 1985, PHYS REV LETT, V54, P106, DOI 10.1103/PhysRevLett.54.106; SKINNER CH, 1990, J MICROSC-OXFORD, V159, P51, DOI 10.1111/j.1365-2818.1990.tb03018.x; TOMIE T, 1991, SCIENCE, V252, P691, DOI 10.1126/science.2024121	17	137	137	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					269	271		10.1126/science.1411525	http://dx.doi.org/10.1126/science.1411525			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	1411525				2022-12-28	WOS:A1992JR86000025
J	KANDEL, ER; ODELL, TJ				KANDEL, ER; ODELL, TJ			ARE ADULT LEARNING-MECHANISMS ALSO USED FOR DEVELOPMENT	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; REQUIRES NEURAL ACTIVITY; 3-EYED RANA-PIPIENS; NITRIC-OXIDE; CELLULAR MECHANISM; ARACHIDONIC-ACID; DEPRESSION; HIPPOCAMPUS; ENHANCEMENT; APLYSIA		COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute	KANDEL, ER (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,722 W 168 ST,NEW YORK,NY 10032, USA.							ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; GRANT SGN, 1992, SOC NEUR ABSTR, V18, P639; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HOER M, 1992, SOC NEUR ABSTR, V18, P1311; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; IUMI Y, 1992, SCIENCE, V257, P1273; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MERZENICH MM, 1988, NEUROBIOLOGY NEOCORT, P41; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PRISKY G, 1992, SOC NEUR ABSTR, V18, P1311; RAKIC P, 1992, CURR CONTENTS   0127; REH TA, 1985, J NEUROSCI, V5, P1132; Schatz C. J., 1992, SCI AM, V267, P60; SCHMIDT JT, 1983, BRAIN RES, V269, P29, DOI 10.1016/0006-8993(83)90959-9; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SCHWATZ CJ, 1990, NEURON, V5, P745; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHUMAN EM, 1991, SCIENCE, V254, P1503; SILVA AJ, 1992, P NATL ACAD SCI USA, V257, P201; Small S. A., 1992, Society for Neuroscience Abstracts, V18, P639; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; [No title captured]	37	147	149	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					243	245		10.1126/science.1411522	http://dx.doi.org/10.1126/science.1411522			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JR860	1411522				2022-12-28	WOS:A1992JR86000020
J	BECHARA, SJ; THOMPSON, KP; WARING, GO				BECHARA, SJ; THOMPSON, KP; WARING, GO			SURGICAL-CORRECTION OF NEARSIGHTEDNESS	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CENTRAL PHOTOREFRACTIVE KERATECTOMY; RADIAL KERATOTOMY PERK; EXCIMER LASER; MYOPIC KERATOMILEUSIS; CLINICAL-TRIAL; FOLLOW-UP; SURGERY; EPIKERATOPHAKIA; APHAKIA; REFRACTION		EMORY UNIV, SCH MED, CTR EYE, DEPT OPHTHALMOL, ATLANTA, GA 30322 USA	Emory University								Alberth B, 1988, Acta Chir Hung, V29, P3; ARENASARCHILA E, 1991, J CATARACT REFR SURG, V17, P424, DOI 10.1016/S0886-3350(13)80849-8; Baikoff G, 1990, Refract Corneal Surg, V6, P252; BARRAQUER J, 1959, Trans Ophthalmol Soc U K, V79, P393; Barraquer J I, 1965, An Med Espec, V51, P66; Barraquer J.I., 1964, ARCH SOC AM OFTALMOL, V5, P27; BARRAQUER JI, 1981, OPHTHALMOLOGY, V88, P701; Bates WH., 1894, ARCH OPHTHALMOL-CHIC, V23, P9; BEDROSSIAN RH, 1979, OPHTHALMOLOGY, V86, P713; BOURQUE LB, 1984, ARCH OPHTHALMOL-CHIC, V102, P1187; Choyce DP, 1982, OPHTHALMOLOGY, V89, P55; CURTIN BJ, 1985, MYOPIAS BASIC SCI CL, P3; DOSSI F, 1987, J CATARACT REFR SURG, V13, P417, DOI 10.1016/S0886-3350(87)80042-1; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; FLEMING JF, 1987, J REFRACT SURG, V3, P227; FYODOROV SN, 1979, ANN OPHTHALMOL, V11, P1885; GOLYCHEV VN, 1989, OFTALMOL ZH, V3, P160; HANNA KD, 1989, ARCH OPHTHALMOL-CHIC, V107, P895, DOI 10.1001/archopht.1989.01070010917041; JENSEN H, 1991, ACTA OPHTHALMOL, V69, P1; KAUFMAN HE, 1980, AM J OPHTHALMOL, V89, P1; KIRKNESS CM, 1985, T OPHTHAL SOC UK, V104, P343; KOVALEVSKII EI, 1989, OFTALMOL ZH, V4, P199; KRAUSS JM, 1986, SURV OPHTHALMOL, V31, P37, DOI 10.1016/0039-6257(86)90050-0; KRUMEICH JH, 1987, AM J OPHTHALMOL, V103, P397, DOI 10.1016/S0002-9394(14)77763-3; LANE SS, 1991, INVEST OPHTH VIS SCI, V32, P921; Lans LJ, 1898, GRAEF ARCH CLIN EXP, V45, P117; Lin L L, 1988, Acta Ophthalmol Suppl, V185, P69; MACRAE S, 1989, AM J OPHTHALMOL, V107, P262, DOI 10.1016/0002-9394(89)90310-3; MCCAREY BE, 1981, INVEST OPHTH VIS SCI, V21, P107; MCDONALD MB, 1991, OPHTHALMOLOGY, V98, P1327; MCDONALD MB, 1985, OPHTHALMOLOGY, V92, P1417; MCDONALD MB, 1990, ARCH OPHTHALMOL-CHIC, V108, P40, DOI 10.1001/archopht.1990.01070030046026; MCDONALD MB, 1987, AM J OPHTHALMOL, V103, P375, DOI 10.1016/S0002-9394(14)77760-8; MCDONALD MB, 1988, J REFRACT SURG, V4, P158; MCDONNELL PJ, 1989, AM J OPHTHALMOL, V107, P42, DOI 10.1016/0002-9394(89)90813-1; Mimouni F, 1991, Refract Corneal Surg, V7, P277; NORDAN LT, 1991, INT OPHTHALMOL CLIN, V31, P7, DOI 10.1097/00004397-199103110-00004; NORDAN LT, 1986, J REFRACT SURG, V2, P124; PARSSINEN O, 1989, BRIT J OPHTHALMOL, V73, P547, DOI 10.1136/bjo.73.7.547; POLSE KA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1873; RASHID ER, 1989, SURV OPHTHALMOL, V34, P73, DOI 10.1016/0039-6257(89)90037-4; Salz J J, 1991, Refract Corneal Surg, V7, P12; SATO T, 1953, AM J OPHTHALMOL, V36, P823, DOI 10.1016/0002-9394(53)90183-4; SEILER T, 1991, OPHTHALMOLOGY, V98, P1156; SEILER T, 1992, REFRACTIVE KERATOTOM; SIMON G, 1991, INVEST OPHTH VIS SCI, V32, P921; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; Spigelman A V, 1989, Refract Corneal Surg, V5, P292; STRAMPELLI B, 1954, Ann Ottalmol Clin Ocul, V80, P75; SVEINSSON K, 1982, ACTA OPHTHALMOL, V60, P779; SVIRIN AV, 1989, VESTN OFTALMOL, P20; SWINGER CA, 1984, OPHTHALMOLOGY, V91, P785; SWINGER CA, 1981, OPHTHALMOLOGY, V88, P709; Tarutta EP, 1989, OFTALMOL ZH, V4, P204; THOMPSON KP, IN PRESS CORNEA; TREVORROPER P, 1983, BRIT MED J, V287, P1822, DOI 10.1136/bmj.287.6408.1822; TROKEL SL, 1983, AM J OPHTHALMOL, V96, P710, DOI 10.1016/S0002-9394(14)71911-7; TUFT SJ, 1989, INVEST OPHTH VIS SCI, V30, P1769; Waring G O 3rd, 1991, Refract Corneal Surg, V7, P275; WARING GO, 1985, ARCH OPHTHALMOL-CHIC, V103, P1472, DOI 10.1001/archopht.1985.01050100048016; WARING GO, 1991, AM J OPHTHALMOL, V111, P133, DOI 10.1016/S0002-9394(14)72250-0; WARING GO, 1991, OPHTHALMOLOGY, V98, P1164; WARING GO, 1985, REFRACTIVE KERATOTOM; WERBLIN TP, 1987, OPHTHALMOLOGY, V94, P926; WERBLIN TP, 1981, CURR EYE RES, V1, P123, DOI 10.3109/02713688109001817; WOO GC, 1990, OPTOMETRY VISION SCI, V67, P719, DOI 10.1097/00006324-199009000-00012; WORST JGF, 1990, DOC OPHTHALMOL, V75, P335, DOI 10.1007/BF00164848; 1990, OPHTHALMOLOGY, V97, P1225	68	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	1992	305	6857					813	817		10.1136/bmj.305.6857.813	http://dx.doi.org/10.1136/bmj.305.6857.813			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT256	1422363	Green Submitted, Bronze, Green Published			2022-12-28	WOS:A1992JT25600030
J	CUCKOW, PM				CUCKOW, PM			COST OF UROLOGY - FINANCIAL AUDIT IN A CLINICAL DEPARTMENT	BRITISH MEDICAL JOURNAL			English	Article							SURGERY	Objectives-To cost a clinical unit over one month in 1991, to cost treatment of individual patients from audit data, and to compare this costing method with the hospital charging system. Design-A financial breakdown was obtained for one month's work. Ward stay, operating time, investigations, and outpatient visits were costed and a formula (episode=days on ward+hours of operating+investigations+outpatient visits) was used to cost patient episodes from audit data. Setting-The adult urology unit in a teaching hospital. Main outcome measures-Costs for each part of patients' treatment. Results-Total cost was 147 796 Pounds for 159 admissions, 738 inpatient days, 131 operations in 29 operating lists, and 615 outpatient visits. An uncomplicated transurethral prostatectomy cost 1140 Pounds but complications increased this to 1500 Pounds in another patient. The costs of diagnostic cystoscopy were 130 Pounds in outpatients, 240 Pounds in day surgery, and 430 Pounds in inpatients. Hospital charges do not reflect the individual costs of treatment, charges being greater than costs for some patients and lower than costs for others. Conclusions-Clinicians can produce a financial analysis of their work and cost their patients' treatment. Audit is strongly advocated as a resource planning tool.			CUCKOW, PM (corresponding author), ADDENBROOKES HOSP,DEPT UROL,CAMBRIDGE CB2 2QQ,ENGLAND.							[Anonymous], 1983, NHS MANAGEMENT ENQUI; [Anonymous], 1990, SHORT CUT BETTER SER; Berry M G, 1991, Ann R Coll Surg Engl, V73, P114; BURN JMB, 1983, BRIT MED J, V286, P492, DOI 10.1136/bmj.286.6363.492; CUCKOW PM, IN PRESS ANN R COLL; ELLIS BW, 1990, BRIT MED J, V301, P159, DOI 10.1136/bmj.301.6744.159; FILER J, 1991, BRIT J OPHTHALMOL, V75, P227, DOI 10.1136/bjo.75.4.227; HALL J, 1990, MED J AUSTRALIA, V152, P29, DOI 10.5694/j.1326-5377.1990.tb124425.x; OPIT LJ, 1991, ANN ROY COLL SURG, V73, P389; 1989, RESOURCE MANAGEMENT; 1989, WORKING PATIENTS; 1989, MANAGEMENT UTILISATI; 1991, DAY SURGERY MAKING I	13	10	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1992	305	6856					743	746		10.1136/bmj.305.6856.743	http://dx.doi.org/10.1136/bmj.305.6856.743			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ520	1422329	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JQ52000020
J	MCPHEETERS, DS; ABELSON, J				MCPHEETERS, DS; ABELSON, J			MUTATIONAL ANALYSIS OF THE YEAST U2 SNRNA SUGGESTS A STRUCTURAL SIMILARITY TO THE CATALYTIC CORE OF GROUP-I INTRONS	CELL			English	Article							PRE-MESSENGER-RNA; SMALL NUCLEAR-RNA; SELF-SPLICING RNA; RIBONUCLEOPROTEIN-PARTICLES; BINDING-SITE; CONSERVED NUCLEOTIDES; TRYPANOSOMA-BRUCEI; MAMMALIAN U2; U6 SNRNA; TETRAHYMENA	We have used an in vitro reconstitution system to determine the effects of a large number of mutations in the highly conserved 5' terminal domain of the yeast U2 snRNA on pre-mRNA splicing. Whereas many mutations have little or no functional consequence, base substitutions in two regions were found to have drastic effects on pre-mRNA splicing. A previously unrecognized function for the U2 snRNA in the second step of splicing was found by alteration of the absolutely conserved sequence AGA upstream of the branch point recognition sequence. The effects of these mutations suggest the formation of a structure involving the U2 snRNA similar to the guanosine-binding site found in the catalytic core of group I introns.			MCPHEETERS, DS (corresponding author), CALTECH, DIV BIOL, PASADENA, CA 91125 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032637, R01GM032637, F32GM012544] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM12544, GM32637] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Ares M. Jr, 1989, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V94, P13; BASS BL, 1984, NATURE, V308, P820, DOI 10.1038/308820a0; BEEN MD, 1991, SCIENCE, V252, P434, DOI 10.1126/science.2017681; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; BURKE JM, 1989, FEBS LETT, V250, P129, DOI 10.1016/0014-5793(89)80704-5; BURKE JM, 1990, NATURE, V344, P80, DOI 10.1038/344080a0; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CHABOT B, 1987, MOL CELL BIOL, V7, P281, DOI 10.1128/MCB.7.1.281; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; COUTURE S, 1990, J MOL BIOL, V215, P345, DOI 10.1016/S0022-2836(05)80356-0; DATTA B, 1991, NATURE, V352, P821, DOI 10.1038/352821a0; FABRIZIO P, 1989, GENE DEV, V3, P2137, DOI 10.1101/gad.3.12b.2137; FABRIZIO P, 1992, NUCLEIC ACIDS RES, V20, P3659, DOI 10.1093/nar/20.14.3659; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; FOUSER LA, 1986, CELL, V45, P81, DOI 10.1016/0092-8674(86)90540-4; FRENDEWEY D, 1987, COLD SPRING HARB SYM, V52, P287, DOI 10.1101/SQB.1987.052.01.034; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; GUPTA S, 1991, NUCLEIC ACIDS RES, V19, P2073, DOI 10.1093/nar/19.suppl.2073; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; HAMM J, 1989, CELL, V59, P159, DOI 10.1016/0092-8674(89)90878-7; HARTSHORNE T, 1990, GENE DEV, V4, P2121, DOI 10.1101/gad.4.12a.2121; HAUSNER TP, 1990, GENE DEV, V4, P2146, DOI 10.1101/gad.4.12a.2146; JACQUIER A, 1990, TRENDS BIOCHEM SCI, V15, P351, DOI 10.1016/0968-0004(90)90075-M; KHELLIL S, 1991, NUCLEIC ACIDS RES, V19, P877, DOI 10.1093/nar/19.4.877; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAMOND AI, 1989, CELL, V58, P383, DOI 10.1016/0092-8674(89)90852-0; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; MCNEIL JB, 1985, MOL CELL BIOL, V5, P3545, DOI 10.1128/MCB.5.12.3545; MCPHEETERS DS, 1989, GENE DEV, V3, P2124, DOI 10.1101/gad.3.12b.2124; MCPHEETERS DS, 1986, NUCLEIC ACIDS RES, V14, P5813, DOI 10.1093/nar/14.14.5813; MICHEL F, 1990, GENE DEV, V4, P777, DOI 10.1101/gad.4.5.777; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MIRAGLIA L, 1991, P NATL ACAD SCI USA, V88, P7061, DOI 10.1073/pnas.88.16.7061; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; MOTTRAM J, 1989, MOL CELL BIOL, V9, P1212, DOI 10.1128/MCB.9.3.1212; NELSON KK, 1989, GENE DEV, V3, P1562, DOI 10.1101/gad.3.10.1562; NEWMAN AJ, 1985, CELL, V42, P335, DOI 10.1016/S0092-8674(85)80129-X; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; PAN ZQ, 1989, GENE DEV, V3, P1887, DOI 10.1101/gad.3.12a.1887; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; PATZELT E, 1989, MOL CELL BIOL, V9, P4291, DOI 10.1128/MCB.9.10.4291; PYLE AM, 1992, NATURE, V358, P123, DOI 10.1038/358123a0; REDDY R, 1990, NUCLEIC ACIDS RES, V18, P2231, DOI 10.1093/nar/18.suppl.2231; REDDY R, 1989, METHOD ENZYMOL, V180, P521; REICH CI, 1992, CELL, V69, P1159, DOI 10.1016/0092-8674(92)90637-R; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHUMYATSKY G, 1992, NUCLEIC ACIDS RES, V20, P2159, DOI 10.1093/nar/20.suppl.2159; SHUSTER EO, 1988, CELL, V55, P41, DOI 10.1016/0092-8674(88)90007-4; Steitz J. A., 1988, STRUCTURE FUNCTION M, P115; TSCHUDI C, 1990, GENE, V91, P71, DOI 10.1016/0378-1119(90)90164-M; TSCHUDI C, 1990, CELL, V61, P459, DOI 10.1016/0092-8674(90)90527-L; VANKAN P, 1992, EMBO J, V11, P335, DOI 10.1002/j.1460-2075.1992.tb05056.x; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; WOOLFORD JL, 1989, YEAST, V5, P439, DOI 10.1002/yea.320050604; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; WU J, 1991, NATURE, V352, P818, DOI 10.1038/352818a0; WU J, 1992, IN PRESS MOL CELL BI; YARUS M, 1989, NUCLEIC ACIDS RES, V17, P6969, DOI 10.1093/nar/17.17.6969; YARUS M, 1988, SCIENCE, V240, P1751, DOI 10.1126/science.3381099; YARUS M, 1992, J MOL BIOL, V225, P945, DOI 10.1016/0022-2836(92)90095-2; YARUS M, 1991, J MOL BIOL, V222, P995, DOI 10.1016/0022-2836(91)90590-3; YARUS M, 1991, NUCLEIC ACIDS RES, V19, P1297, DOI 10.1093/nar/19.6.1297; ZAVANELLI MI, 1991, GENE DEV, V5, P2521, DOI 10.1101/gad.5.12b.2521; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545; ZILLMANN M, 1988, MOL CELL BIOL, V8, P814, DOI 10.1128/MCB.8.2.814	70	94	95	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	1992	71	5					819	831		10.1016/0092-8674(92)90557-S	http://dx.doi.org/10.1016/0092-8674(92)90557-S			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423632				2022-12-28	WOS:A1992JZ63300011
J	HELMS, JB; ROTHMAN, JE				HELMS, JB; ROTHMAN, JE			INHIBITION BY BREFELDIN-A OF A GOLGI MEMBRANE ENZYME THAT CATALYZES EXCHANGE OF GUANINE-NUCLEOTIDE BOUND TO ARF	NATURE			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING-PROTEIN; COATED VESICLES; TRANSPORT; COMPLEX; IDENTIFICATION; PURIFICATION; ENDOSOMES; COFACTOR; CELLS	A WIDE variety of membrane transformations important in intracellular transport are inhibited by the fungal metabolite brefeldin A (refs 1-4), implying that the target for this drug is central to the formation and maintenance of subcellular compartments5. Brefeldin A added to cells causes the rapid and reversible dissociation of a Golgi-associated peripheral membrane protein (M(r) 110,000)6 which was found to be identical to one of the subunits of the coat of Golgi-derived (non-clathrin) coated vesicles, beta-COP7,8, implying that brefeldin A prevents transport by blocking the assembly of coats and thus the budding of enclosed vesicles9. In addition to the coatomer (a cytosol-derived complex of seven polypeptide chains, one of which is beta-COP10), the non-clathrin (COP) coat of Golgi-derived vesicles contains stoichiometric amounts of a small (M(r) approximately 20,000) GTP-binding protein, the ADP-ribosylation factor (ARF)11. Binding of ARF to Golgi membranes is necessary before coatomer/beta-COP can bind these membranes (ref. 12; and D. J. Palmer et al., manuscript submitted), so the primary effect of brefeldin A seems to be on the reaction responsible for ARF binding. Indeed, like beta-COP, ARF is dissociated from the Golgi complex by treatment with brefeldin A and brefeldin A prevents ARF from associating in vitro13, but the mechanism of this action by brefeldin A has been unclear. Here we report the discovery of an enzyme in a Golgi-enriched fraction that catalyses guanine nucleotide (GDP-GTP) exchange on ARF-1 protein, and which is inhibited by brefeldin A. We suggest that activation of ARF proteins for membrane localization by compartmentalized exchange enzymes is in general the first committed step in membrane transformation pathways.			HELMS, JB (corresponding author), SLOAN KETTERING MEM CANC CTR, ROCKEFELLER RES LAB, PROGRAM CELLULAR BIOCHEM & BIOPHYS, NEW YORK, NY 10021 USA.							ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; BALCH WE, 1992, J BIOL CHEM, V267, P13053; BOMAN AL, 1992, NATURE, V358, P512, DOI 10.1038/358512a0; CLARY DO, 1990, J BIOL CHEM, V265, P10109; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1986, J BIOL CHEM, V261, P7906; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; ORCI L, 1991, CELL, V64, P1183; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; RANDAZZO PA, 1991, SCIENCE, V254, P850, DOI 10.1126/science.1658935; RANDAZZO PA, 1992, SCIENCE, V257, P862, DOI 10.1126/science.1323875; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SCLEICHER M, FEBS LETT, V200, P156; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WEISS O, 1989, J BIOL CHEM, V264, P21066; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5	31	626	639	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	1992	360	6402					352	354		10.1038/360352a0	http://dx.doi.org/10.1038/360352a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448152				2022-12-28	WOS:A1992JZ63000054
J	ROSENWASSER, LJ; JOSEPH, BZ				ROSENWASSER, LJ; JOSEPH, BZ			IMMUNOHEMATOLOGIC DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IDIOPATHIC THROMBOCYTOPENIC PURPURA; EOSINOPHILIA-MYALGIA-SYNDROME; CIRCULATING IMMUNE-COMPLEXES; TRANSFUSION REACTIONS; CLINICAL-FEATURES; HEMOLYTIC-ANEMIA; MANAGEMENT; CLEARANCE; THERAPY; ERYTHROCYTES		UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	ROSENWASSER, LJ (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,DIV ALLERGY & CLIN IMMUNOL,DENVER,CO 80206, USA.							ABRAMSON N, 1970, J EXP MED, V132, P1207, DOI 10.1084/jem.132.6.1207; ADINOLFI M, 1965, IMMUNOLOGY, V9, P43; AGRE P, 1991, BLOOD, V78, P551, DOI 10.1182/blood.V78.3.551.bloodjournal783551; AHN YS, 1984, SPRINGER SEMIN IMMUN, V7, P35, DOI 10.1007/BF01891778; ANDERSON KC, 1991, BLOOD, V77, P2096; ASTER RH, 1969, BRIT J HAEMATOL, V16, P61, DOI 10.1111/j.1365-2141.1969.tb00379.x; ATKINSON JP, 1973, J CLIN INVEST, V52, P1509, DOI 10.1172/JCI107325; BALDINI MG, 1978, JAMA-J AM MED ASSOC, V239, P2477, DOI 10.1001/jama.239.23.2477; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; BARTON JC, 1981, SEMIN HEMATOL, V18, P95; Bowman J M, 1988, Transfus Med Rev, V2, P129, DOI 10.1016/S0887-7963(88)70039-5; CARSTAIRS KC, 1966, LANCET, V2, P133; DESJARDINS L, 1979, J PEDIATR-US, V95, P447, DOI 10.1016/S0022-3476(79)80533-8; DIFINO SM, 1980, AM J MED, V69, P430, DOI 10.1016/0002-9343(80)90016-9; EVANS RS, 1951, ARCH INTERN MED, V87, P48, DOI 10.1001/archinte.1951.03810010058005; FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78; FRANK MM, 1989, J ALLERGY CLIN IMMUN, V84, P411, DOI 10.1016/0091-6749(89)90350-3; GEORGE JN, 1990, BLOOD, V76, P859; GILLILAND BC, 1970, J CLIN INVEST, V49, P898, DOI 10.1172/JCI106309; GREENWALT TJ, 1981, SEMIN HEMATOL, V18, P84; HUBER H, 1968, SCIENCE, V162, P1281, DOI 10.1126/science.162.3859.1281; JAFFE CJ, 1976, J CLIN INVEST, V58, P942, DOI 10.1172/JCI108547; KARPATKIN S, 1988, SEMIN HEMATOL, V25, P219; KELTON JG, 1983, ANN INTERN MED, V99, P796, DOI 10.7326/0003-4819-99-6-796; KURATA Y, 1987, CLIN EXP IMMUNOL, V67, P293; LALEZARI P, 1976, SEMIN HEMATOL, V13, P291; LEVINE AB, 1991, SEMIN PERINATOL, V15, P35; LEVINE B, 1967, INT ARCH ALLER A IMM, V31, P594, DOI 10.1159/000229906; LOBUGLIO AF, 1967, NEW ENGL J MED, V276, P658, DOI 10.1056/NEJM196703232761203; LOBUGLIO AF, 1967, SCIENCE, V158, P1582, DOI 10.1126/science.158.3808.1582; MARTIN RW, 1990, ANN INTERN MED, V113, P124, DOI 10.7326/0003-4819-113-2-124; MCCLURE PD, 1975, PEDIATRICS, V55, P68; MINCHINTON RM, 1987, MED J AUSTRALIA, V147, P139, DOI 10.5694/j.1326-5377.1987.tb133309.x; MOLLISON PL, 1965, BRIT J HAEMATOL, V11, P461, DOI 10.1111/j.1365-2141.1965.tb06609.x; NYDEGGER UE, 1991, SEMIN HEMATOL, V28, P66; Petz L, 1985, IMMUNE HEMOLYTIC ANE, P47; PETZ LD, 1966, NEW ENGL J MED, V274, P171, DOI 10.1056/NEJM196601272740401; POLLAK AN, 1988, ARCH INTERN MED, V148, P695, DOI 10.1001/archinte.148.3.695; PURAM V, 1984, CLIN EXP IMMUNOL, V58, P672; ROELCKE D, 1974, CLIN IMMUNOL IMMUNOP, V2, P266, DOI 10.1016/0090-1229(74)90044-0; ROSSE WF, 1971, J CLIN INVEST, V50, P734, DOI 10.1172/JCI106544; SCHMIDT AP, 1969, NEW ENGL J MED, V280, P188, DOI 10.1056/NEJM196901232800404; SHULMAN NR, 1961, J CLIN INVEST, V40, P1597, DOI 10.1172/JCI104383; SOKOL RJ, 1985, CRC CR REV ONCOL-HEM, V4, P125, DOI 10.1016/S1040-8428(85)80013-5; SPATH P, 1971, J IMMUNOL, V107, P860; STIEHM ER, 1988, ADV PEDIATR, V35, P50; VANDERVEEN JPW, 1986, BRIT J HAEMATOL, V63, P161, DOI 10.1111/j.1365-2141.1986.tb07506.x; VARGA J, 1991, J RHEUMATOL, V18, P259; VINCENT PC, 1986, DRUGS, V31, P52, DOI 10.2165/00003495-198631010-00004; WORLLEDG.SM, 1965, VOX SANG, V10, P293, DOI 10.1111/j.1423-0410.1965.tb01392.x; YANKEE RA, 1969, NEW ENGL J MED, V281, P1208, DOI 10.1056/NEJM196911272812202; ZON LI, 1988, SEMIN HEMATOL, V25, P208	52	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2940	2945						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433712				2022-12-28	WOS:A1992JY66800021
J	WATKINS, DC; JOHNSON, GL; MALBON, CC				WATKINS, DC; JOHNSON, GL; MALBON, CC			REGULATION OF THE DIFFERENTIATION OF TERATOCARCINOMA CELLS INTO PRIMITIVE ENDODERM BY G-ALPHA-I2	SCIENCE			English	Article							RETINOIC ACID; G-PROTEINS; STEM-CELLS; MODULATION; EXPRESSION; INDUCTION; SEQUENCES; CYCLASE; ASSAY; GI2	The amount of the heterotrimeric G protein subunit Galpha(i2) decreases after the induction of F9 teratocarcinoma cells to become primitive endoderm in the presence of retinoic acid (RA). The reduction of the Galpha(i2) protein in F9 cells by antisense RNA expression was associated with (i) loss of receptor-mediated inhibition of adenylyl cyclase; (ii) decreased cell doubling time; (iii) induction of a primitive, endoderm-like phenotype in the absence of RA; and (iv) production of the differentiation marker tissue-type plasminogen activator. Expression of a constitutively active, mutant Galpha(i2) blocked RA-induced differentiation. These data suggest the involvement of Galpha(i2) in the control of stem cell differentiation and provide insight into the involvement of G proteins in growth regulation.	SUNY STONY BROOK, HLTH SCI CTR, DEPT PHARMACOL, STONY BROOK, NY 11794 USA; NATL JEWISH CTR IMMUNOL, DEPT PEDIAT & BASIC SCI, DENVER, CO 80206 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Jewish Health	WATKINS, DC (corresponding author), SUNY STONY BROOK, HLTH SCI CTR, DIABET & METAB DIS RES PROGRAM, STONY BROOK, NY 11794 USA.		malbon, craig/ABF-3604-2020					ANDRADEGORDON P, 1986, BIOCHEMISTRY-US, V25, P4033, DOI 10.1021/bi00362a007; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BROWN BL, 1971, BIOCHEM J, V121, P561, DOI 10.1042/bj1210561; DARROW AL, 1990, METHOD ENZYMOL, V190, P110; GALVINPARTON P, UNPUB; GALVINPARTON PA, 1990, J BIOL CHEM, V265, P17771; GILMAN AG, 1990, ADV SEC MESS PHOSPH, V24, P51; GRIEP AE, 1988, P NATL ACAD SCI USA, V85, P6806, DOI 10.1073/pnas.85.18.6806; GUPTA SK, 1992, MOL CELL BIOL, V12, P190, DOI 10.1128/MCB.12.1.190; KLEBE RJ, 1991, P NATL ACAD SCI USA, V88, P9588, DOI 10.1073/pnas.88.21.9588; LAMORTE VJ, 1992, J BIOL CHEM, V267, P691; LOWNDES JM, 1991, J BIOL CHEM, V266, P14193; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; POUYSSEGUR J, 1992, ANNU REV PHYSIOL, V54, P195, DOI 10.1146/annurev.ph.54.030192.001211; Sambrook J, 1989, MOL CLONING LABORATO; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; VANDERKROL AR, 1988, BIOTECHNIQUES, V6, P958; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; WATKINS DL, UNPUB; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0	27	101	104	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	1992	258	5086					1373	1375		10.1126/science.1455234	http://dx.doi.org/10.1126/science.1455234			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455234				2022-12-28	WOS:A1992JY95800043
J	MICHIE, CA; MCLEAN, A; ALCOCK, C; BEVERLEY, PCL				MICHIE, CA; MCLEAN, A; ALCOCK, C; BEVERLEY, PCL			LIFE-SPAN OF HUMAN LYMPHOCYTE SUBSETS DEFINED BY CD45 ISOFORMS	NATURE			English	Article							T-CELL MEMORY; EXPRESSION; UCHL1; ANTIGEN	THE lifespan of thymic-derived or T lymphocytes is of particular interest because of their central role in immunological memory. Is the recall of a vaccination or early infection, which may be demonstrated clinically up to 50 years after antigen exposure1, retained by a long-lived cell, or by its progeny? Using the observation that T lymphocyte expression of isoforms of CD45 corresponds with their ability to respond to recall antigens, we have investigated the lifespan of both CD45R0 (the subset containing responders, or 'memory' cells) and CD45RA (the unresponsive, or 'naive' subset) lymphocytes in a group of patients after radiotherapy. Here we report rapid loss of unstable chromosomes from the CD45R0 but not the CD45RA pool. Immunological memory therefore apparently resides in a population with a more rapid rate of division. Differing survival curves for the two subsets are best described by a model in which there is also reversion in vivo from the CD45R0 to the CD45RA phenotype. Expression of CD45R0 in T cells may therefore be reversible.	CHURCHILL HOSP, DEPT ONCOL & RADIOTHERAPY, OXFORD OX3 7LJ, ENGLAND; UNIV OXFORD, DEPT ZOOL, OXFORD OX1 3PS, ENGLAND	University of Oxford; University of Oxford	MICHIE, CA (corresponding author), UNIV COLL & MIDDLESEX SCH MED, HUMAN TUMOUR IMMUNOL GRP, 91 RIDING HOUSE ST, LONDON W1P 8BT, ENGLAND.			Beverley, Peter/0000-0003-0481-2180				AKBAR AN, 1988, J IMMUNOL, V140, P2171; Beverley P C, 1992, Semin Immunol, V4, P35; BEVERLEY PCL, 1990, IMMUNOL TODAY, V11, P203, DOI 10.1016/0167-5699(90)90083-L; BUCKTON KE, 1967, NATURE, V214, P470, DOI 10.1038/214470a0; BUCKTON KE, 1964, INT J RADIAT BIOL RE, V8, P439, DOI 10.1080/09553006414550551; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; ERKELLERYUKSEL FM, 1992, J PEDIATR-US, V120, P216, DOI 10.1016/S0022-3476(05)80430-5; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; HAMERTON JL, 1971, HUMAN CYTOGENETICS; HAYWARD AR, 1989, EUR J IMMUNOL, V19, P771, DOI 10.1002/eji.1830190430; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; MELCHERS F, 1990, INT CONGR SER, V862, P3; Merkenschlager M, 1989, Int Immunol, V1, P450, DOI 10.1093/intimm/1.4.450; MERKENSCHLAGER M, 1988, EUR J IMMUNOL, V18, P1653, DOI 10.1002/eji.1830181102; RALSTON ML, 1978, TECHNOMETRICS, V20, P7, DOI 10.2307/1268154; ROTHSTEIN DM, 1991, J IMMUNOL, V146, P1175; SPARSHOTT SM, 1991, EUR J IMMUNOL, V21, P993, DOI 10.1002/eji.1830210420; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; TERRY L, 1987, LEUKOCYTE TYPING, V3, P225; WARREN HS, 1991, J IMMUNOL, V74, P78	20	587	610	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	1992	360	6401					264	265		10.1038/360264a0	http://dx.doi.org/10.1038/360264a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY960	1436108				2022-12-28	WOS:A1992JY96000053
J	GEISLER, R; BERGMANN, A; HIROMI, Y; NUSSLEINVOLHARD, C				GEISLER, R; BERGMANN, A; HIROMI, Y; NUSSLEINVOLHARD, C			CACTUS, A GENE INVOLVED IN DORSOVENTRAL PATTERN-FORMATION OF DROSOPHILA, IS RELATED TO THE I-KAPPA-B GENE FAMILY OF VERTEBRATES	CELL			English	Article							P-ELEMENT TRANSPOSASE; DNA-BINDING SUBUNIT; DORSAL PROTEIN; TRANSMEMBRANE PROTEIN; EMBRYONIC POLARITY; SEQUENCE; REL; TRANSCRIPTION; TOLL; DIFFERENTIATION	Among the maternally active genes of Drosophila, cactus is the only one whose loss of function mutations specifically produce ventralized embryos. Its product inhibits nuclear translocation of the dorsal morphogen in the dorsal region of the embryo. Here we report the cloning of cactus and the sequencing of its maternal transcript. The identity of our clones was verified by induction of phenocopies with antisense RNA and rescue of the mutant phenotype with sense RNA. cactus is predicted to encode an acidic, cytoplasmic protein with seven ankyrin repeats. The sequence has similarity to the IkappaB proteins that inhibit the vertebrate transcription factor NF-kappaB. In analogy to results obtained with IkappaB and NF-kappaB, bacterially expressed cactus protein can inhibit DNA binding of dorsal protein in vitro.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	GEISLER, R (corresponding author), MAX PLANCK INST ENTWICKLUNGSBIOL,GENET ABT,SPEMANNSTR 35-III,W-7400 TUBINGEN,GERMANY.		Geisler, Robert/K-6201-2013	Geisler, Robert/0000-0002-3909-8311				ANDERSON KV, 1986, GAMETOGENESIS EARLY, P177; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; DAVIS LH, 1991, J BIOL CHEM, V266, P11163; DAVIS N, 1991, SCIENCE, V253, P1268, DOI 10.1126/science.1891714; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOYLE H, 1989, THESIS COLUMBIA U NE; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; INOUE JI, 1992, P NATL ACAD SCI USA, V89, P4333, DOI 10.1073/pnas.89.10.4333; IP YT, 1991, CELL, V64, P439; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; ISODA K, 1992, GENE DEV, V6, P619, DOI 10.1101/gad.6.4.619; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LETSOU A, 1991, P NATL ACAD SCI USA, V88, P810, DOI 10.1073/pnas.88.3.810; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; NAUBER U, 1991, ANTISENSE NUCLEIC AC, P113; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RAY RP, 1991, DEVELOPMENT, V113, P35; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; RIO DC, 1986, CELL, V44, P21, DOI 10.1016/0092-8674(86)90481-2; ROBERTSON HM, 1988, GENETICS, V118, P461; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW C, 1987, NATURE, V330, P583, DOI 10.1038/330583a0; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Sambrook J, 1989, MOL CLONING LABORATO; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SCHUPBACH T, 1989, GENETICS, V121, P101; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STEWARD R, 1988, CELL, V55, P487, DOI 10.1016/0092-8674(88)90035-9; THISSE B, 1987, GENE DEV, V1, P709, DOI 10.1101/gad.1.7.709; THISSE C, 1991, CELL, V65, P1191, DOI 10.1016/0092-8674(91)90014-P; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0	50	221	227	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					613	621		10.1016/0092-8674(92)90595-4	http://dx.doi.org/10.1016/0092-8674(92)90595-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423618				2022-12-28	WOS:A1992JY67600009
J	ROSENBERG, RL; EAST, JE				ROSENBERG, RL; EAST, JE			CELL-FREE EXPRESSION OF FUNCTIONAL SHAKER POTASSIUM CHANNELS	NATURE			English	Article							PROTEIN TRANSLOCATION; XENOPUS OOCYTES; K+ CHANNELS; RECEPTORS; GLYCOSYLATION; INACTIVATION; DROSOPHILA; REGION; LOCUS; GENE	THE functional activity of ion channels and other membrane proteins requires that the proteins be correctly assembled in a transmembrane configuration. Thus, the functional expression of ion channels, neurotransmitter receptors and complex membrane-limited signalling mechanisms from complementary DNA has required the injection of messenger RNA or transfection of DNA into Xenopus oocytes or other target cells that are capable of processing newly translated protein into the surface membrane1-4. These approaches, combined with voltage-clamp analysis of ion channel currents, have been especially powerful in the identification of structure-function relationships in ion channels5-7. But oocytes express endogenous ion channels8,9, neurotransmitter receptors10 and receptor-channel subunits11, complicating the interpretation of results in mRNA-injected eggs. Furthermore, it is difficult to control experimentally the membrane lipids and post-translational modifications that underlie the regulation and modulation of ion channels in intact cells. A cell-free system for ion channel expression is ideal for good experimental control of protein expression and modulatory processes. Here we combine cell-free protein translation, microsomal membrane processing12-14 of nascent channel proteins, and reconstitution of newly synthesized ion channels into planar lipid bilayers15 to synthesize, glycosylate, process into membranes, and record in vitro the activity of functional Shaker potassium channels.	UNIV N CAROLINA, DEPT PHYSIOL, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	ROSENBERG, RL (corresponding author), UNIV N CAROLINA, DEPT PHARMACOL, CB 7365, CHAPEL HILL, NC 27599 USA.							ALBERTS B, 1991, MOL BIOL CELL; BOURINET E, 1992, FEBS LETT, V299, P5, DOI 10.1016/0014-5793(92)80087-W; BULLER AL, 1990, MOL PHARMACOL, V37, P423; DAS RC, 1980, J BIOL CHEM, V255, P7933; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; FLUHARTY SJ, 1991, J NEUROCHEM, V56, P1307, DOI 10.1111/j.1471-4159.1991.tb11426.x; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KLAIBER K, 1990, NEURON, V5, P221, DOI 10.1016/0896-6273(90)90311-3; KOBILKA BK, 1990, J BIOL CHEM, V265, P7610; LESTER HA, 1988, SCIENCE, V241, P1057, DOI 10.1126/science.2457947; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; Miller C., 1986, ION CHANNEL RECONSTI; NUMA S, 1989, HARVEY LECT, V83, P121; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; ROSENBERG RL, 1991, J GEN PHYSIOL, V97, P1207, DOI 10.1085/jgp.97.6.1207; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; SEGEV N, 1991, SCIENCE, V252, P1553, DOI 10.1126/science.1904626; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; YANG XC, 1992, J NEUROSCI, V12, P268; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; ZONA C, 1990, PROC R SOC SER B-BIO, V239, P119, DOI 10.1098/rspb.1990.0011	30	52	53	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	1992	360	6400					166	169		10.1038/360166a0	http://dx.doi.org/10.1038/360166a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX752	1436093				2022-12-28	WOS:A1992JX75200062
J	HART, MJ; MARU, Y; LEONARD, D; WITTE, ON; EVANS, T; CERIONE, RA				HART, MJ; MARU, Y; LEONARD, D; WITTE, ON; EVANS, T; CERIONE, RA			A GDP DISSOCIATION INHIBITOR THAT SERVES AS A GTPASE INHIBITOR FOR THE RAS-LIKE PROTEIN CDC42HS	SCIENCE			English	Article							BINDING PROTEIN; REGULATORY PROTEIN; ACTIVATING PROTEIN; DEPENDENT MANNER; HUMAN ONCOGENE; BCR; GENE; IDENTIFICATION; PRODUCT; REGION	Members of the family of Ras-related guanosine triphosphate (GTP) binding proteins appear to take part in the regulation of a number of biological processes, including cell growth and differentiation. Three different classes of proteins that regulate the GTP binding and GTP hydrolytic activities of the Ras family members have been identified. These different regulatory proteins inhibit guanosine diphosphate (GDP) dissociation (designated as GDIs), stimulate GDP dissociation and GDP-GTP exchange (designated as GDSs), or stimulate GTP hydrolysis (designated as GAPs). In the case of the Ras-like protein CDC42Hs, which is the human homolog of a Saccharomyces cerevisiae cell division cycle protein, the GDI protein also inhibited both the intrinsic and GAP-stimulated hydrolysis of GTP. These findings establish an additional role for the GDI protein-namely, as a guanosine triphosphatase (GTPase) inhibitory protein for a Ras-like GTP binding protein.	CORNELL UNIV,DEPT BIOCHEM CELL & MOLEC BIOL,SCHURMAN HALL,ITHACA,NY 14853; CORNELL UNIV,DEPT PHARMACOL,ITHACA,NY 14853; UNIV CALIF LOS ANGELES,HOWARD HUGHES MED INST,DEPT MICROBIOL & MOLEC GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,HOWARD HUGHES MED INST,INST MOLEC BIOL,LOS ANGELES,CA 90024; GENENTECH INC,DEPT CELL BIOL,SAN FRANCISCO,CA 94080	Cornell University; Cornell University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Roche Holding; Genentech				Hart, Matthew/0000-0002-2683-480X				ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; ADAMS JM, 1992, ONCOGENE, V7, P611; ARAKI S, 1990, J BIOL CHEM, V265, P13007; ARBO A, 1991, J BIOL CHEM, V266, P23577; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; CERIONE RA, 1990, RECEPTOR EFFECTOR CO, P69; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; GARRETT MD, 1989, J BIOL CHEM, V264, P10; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HART MJ, 1991, J BIOL CHEM, V266, P20840; HART MJ, UNPUB; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; LEONARD D, IN PRESS J BIOL CHEM; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RON D, 1991, NEW BIOL, V3, P372; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; TSAI MH, 1990, SCIENCE, V250, P982, DOI 10.1126/science.2237442; UEDA T, 1990, J BIOL CHEM, V265, P9373	28	151	152	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					812	815		10.1126/science.1439791	http://dx.doi.org/10.1126/science.1439791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439791				2022-12-28	WOS:A1992JV69200042
J	BOGGILD, M				BOGGILD, M			INTRACEREBRAL HEMORRHAGE AFTER DERMAL NITRATE APPLICATION	BRITISH MEDICAL JOURNAL			English	Letter											BOGGILD, M (corresponding author), N STAFFORDSHIRE HOSP CTR,STOKE ON TRENT ST4 7QB,ENGLAND.							BEVAN JS, 1987, J NEUROL NEUROSUR PS, V50, P636, DOI 10.1136/jnnp.50.5.636; KISTLER JP, 1979, STROKE, V10, P26, DOI 10.1161/01.STR.10.1.26; PURVIN VA, 1981, SOUTHERN MED J, V74, P1130, DOI 10.1097/00007611-198109000-00029	3	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 24	1992	305	6860					1000	1000		10.1136/bmj.305.6860.1000-b	http://dx.doi.org/10.1136/bmj.305.6860.1000-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV776	1458106	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JV77600033
J	CAREY, JR; LIEDO, P; OROZCO, D; VAUPEL, JW				CAREY, JR; LIEDO, P; OROZCO, D; VAUPEL, JW			SLOWING OF MORTALITY-RATES AT OLDER AGES IN LARGE MEDFLY COHORTS	SCIENCE			English	Article							MEDITERRANEAN FRUIT-FLY; DROSOPHILA-MELANOGASTER; CERATITIS-CAPITATA; MORBIDITY; COMPRESSION; POPULATION; HOST	It is generally assumed for most species that mortality rates increase monotonically at advanced ages. Mortality rates were found to level off and decrease at older ages in a population of 1.2 million medflies maintained in cages of 7,200 and in a group of approximately 48,000 adults maintained in solitary confinement. Thus, life expectancy in older individuals increased rather than decreased with age. These results cast doubt on several central concepts in gerontology and the biology of aging: (i) that senescence can be characterized by an increase in age-specific mortality, (ii) that the basic pattern of mortality in nearly all species follows the same unitary pattern at older ages, and (iii) that species have absolute life-span limits.	CTR INVEST ECOL SURESTE,TAPACHULA 30700,CHIAPAS,MEXICO; PROGRAMA MOSCAMED,METAPA 30820,CHIAPAS,MEXICO; ODENSE UNIV,DK-5230 ODENSE,DENMARK; DUKE UNIV,CTR DEMOG STUDIES,DURHAM,NC 27706	University of Southern Denmark; Duke University	CAREY, JR (corresponding author), UNIV CALIF DAVIS,DEPT ENTOMOL,DAVIS,CA 95616, USA.		Orozco-Davila, Dina/B-4050-2016; Liedo, Pablo/E-9313-2010; Orozco-Davila, Dina/B-3236-2016; Orozco-Davila, Dina/AAJ-2862-2021; Orozco-Davila, Dina/T-5369-2019	Orozco-Davila, Dina/0000-0002-6806-0945; Liedo, Pablo/0000-0002-0004-1721; Orozco-Davila, Dina/0000-0002-6806-0945; Vaupel, James/0000-0003-0783-3905	NATIONAL INSTITUTE ON AGING [P01AG008761] Funding Source: NIH RePORTER; NIA NIH HHS [AG08761-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AIGAKI T, 1984, EXP GERONTOL, V19, P267, DOI 10.1016/0531-5565(84)90022-6; BEARD RE, 1971, BIOL ASPECTS DEMOGRA, P75; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; CAREY JR, 1986, ENTOMOL EXP APPL, V42, P159, DOI 10.1007/BF00343543; CAREY JR, 1992, APPLIED DEMOGRAPHY B; CHIANG CL, 1984, LIFE TABLES ITS APPL, P116; Collatz K-G., 1986, INSECT AGING STRATEG; Comfort A., 1979, BIOL SENESCENCE; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Economos A.C., 1982, ARCH GERONTOL GERIAT, V1, P3, DOI [10.1016/0167-4943(82)90003-6, DOI 10.1016/0167-4943(82)90003-6]; ECONOMOS AC, 1979, AGE, V2, P74, DOI 10.1007/BF02432250; Finch CE, 1990, LONGEVITY SENESCENCE, P12; FRIES JF, 1983, MILBANK FUND Q, V61, P397, DOI 10.2307/3349864; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; FRIES JF, 1987, GERONTOLOGICA PERSPE, V1, P5; GAVRILOV LA, 1991, BIOL LIFE SPAN QUANT, P129; GAVRILOV LA, 1991, BIOL LIFE SPAN QUANT, P128; GOMPERTZ B, 1977, MATH DEMOGRAPHY SELE, P279; HAZZARD DG, 1991, EXP GERONTOL, V26, P411, DOI 10.1016/0531-5565(91)90028-K; KANNISTO V, 1988, POP STUD-J DEMOG, V42, P389, DOI 10.1080/0032472031000143546; KRAINACKER DA, 1987, OECOLOGIA, V73, P583, DOI 10.1007/BF00379420; KRAINACKER DA, 1986, THESIS U CALIFORNIA; Leslie PH, 1940, J ANIM ECOL, V9, P27, DOI 10.2307/1425; Luckinbill LS, 1988, EVOL ECOL, V2, P85, DOI 10.1007/BF02071591; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; MERTZ DB, 1975, PHYSIOL ZOOL, V48, P1; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; Pearl R, 1927, AM NAT, V61, P289, DOI 10.1086/280154; Pearl R, 1935, Q REV BIOL, V10, P60, DOI 10.1086/394476; Pearl R, 1923, AM NAT, V57, P153, DOI 10.1086/279913; Pearl R, 1924, AM NAT, V58, P71, DOI 10.1086/279956; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; RAGLAND SS, 1973, EXP GERONTOL, V8, P135, DOI 10.1016/0531-5565(73)90003-X; ROCKSTEIN M, 1959, GERONTOLOGY, V3, P23, DOI 10.1159/000210828; ROGERS A, 1992, DEMOGRAPHY, V29, P31, DOI 10.2307/2061361; SCHWARZ AJ, 1985, FLA ENTOMOL, V68, P467, DOI 10.2307/3495135; SMITH JM, 1958, J EXP BIOL, V35, P832; SOHAL RS, 1981, EXP GERONTOL, V16, P157, DOI 10.1016/0531-5565(81)90040-1; TATAR M, UNPUB; THATCHER AR, 1982, J I ACTUARIES, V109, P346; Vargas R., 1989, FRUIT FLIES THEIR B, V3B, P141; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; VAUPEL JW, 1979, DEMOGRAPHY, V16, P3; VAUPEL JW, 1988, MATH POPUL STUD, V1, P21, DOI DOI 10.1080/08898488809525259	46	455	462	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					457	461						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411540				2022-12-28	WOS:A1992JT77500033
J	PLUMP, AS; SMITH, JD; HAYEK, T; AALTOSETALA, K; WALSH, A; VERSTUYFT, JG; RUBIN, EM; BRESLOW, JL				PLUMP, AS; SMITH, JD; HAYEK, T; AALTOSETALA, K; WALSH, A; VERSTUYFT, JG; RUBIN, EM; BRESLOW, JL			SEVERE HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS IN APOLIPOPROTEIN-E-DEFICIENT MICE CREATED BY HOMOLOGOUS RECOMBINATION IN ES CELLS	CELL			English	Article							EMBRYONIC STEM-CELLS; TRANSGENIC MICE; III HYPERLIPOPROTEINEMIA; E POLYMORPHISM; MESSENGER-RNA; STOP CODON; RAT-LIVER; A-I; MOUSE; GENE	apoE-deficient mice have been created by homologous recombination in ES cells. On a low fat, low cholesterol chow diet these animals have plasma cholesterol levels of 494 mg/dl compared with 60 mg/dl in control animals, and when challenged with a high fat Western-type diet, these animals have plasma cholesterol levels of 1821 mg/dl compared with 132 mg/dl in controls. This marked hypercholesterolemia is primarily due to elevated levels of very low and intermediate density lipoproteins. At 10 weeks of age, apoE-deficient mice have already developed atherosclerotic lesions in the aorta and coronary and pulmonary arteries. apoE-deficient mice are a promising small animal model to help understand the role of apoE in vivo and the genetic and environmental determinants of atherosclerosis.	LAWRENCE BERKELEY LAB, DIV LIFE SCI, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	PLUMP, AS (corresponding author), ROCKEFELLER UNIV, BIOCHEM GENET & METAB LAB, NEW YORK, NY 10021 USA.		Breslow, Jan L/B-7544-2008; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X	NHLBI NIH HHS [HL-33714, HL-32435] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033714, R01HL032435] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbey M., 1992, CURR OPIN LIPIDOL, V3, P12, DOI [10.1097/00041433-199202000-00003, DOI 10.1097/00041433-199202000-00003]; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BREWER HB, 1983, ANN INTERN MED, V98, P623, DOI 10.7326/0003-4819-98-5-623; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLADARAS C, 1987, J BIOL CHEM, V262, P2310; DAVIDSON NO, 1988, J BIOL CHEM, V263, P13482; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; HAVEL RJ, 1989, METABOLIC BASIS INHE, P1129; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HORIUCHI K, 1989, J BIOCHEM-TOKYO, V106, P98, DOI 10.1093/oxfordjournals.jbchem.a122828; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; KATES M, 1966, BIOCHEMISTRY-US, V5, P4092, DOI 10.1021/bi00876a044; MABUCHI H, 1989, METABOLISM, V38, P115, DOI 10.1016/0026-0495(89)90249-7; Mahley Jr RWRS, 1989, METABOLIC BASIS INHE, P1195; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; NISHINA PM, 1990, J LIPID RES, V31, P859; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; SHENG J, 1990, METABOLISM, V39, P155, DOI 10.1016/0026-0495(90)90069-O; SHIMANO H, 1992, P NATL ACAD SCI USA, V89, P1750, DOI 10.1073/pnas.89.5.1750; SMITH JD, 1990, J BIOL CHEM, V265, P14709; TENNYSON GE, 1989, P NATL ACAD SCI USA, V86, P500, DOI 10.1073/pnas.86.2.500; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; UTERMANN G, 1982, HUM GENET, V60, P344, DOI 10.1007/BF00569216; WALSH A, 1989, J BIOL CHEM, V264, P6488; WEBER K, 1969, J BIOL CHEM, V244, P4406; WEINTRAUB MS, 1987, J CLIN INVEST, V79, P1110, DOI 10.1172/JCI112926; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059; ZANNIS VI, 1982, J LIPID RES, V23, P911; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0; 1987, NATIONAL HLTH NUTRIT	43	1870	1995	2	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	1992	71	2					343	353		10.1016/0092-8674(92)90362-G	http://dx.doi.org/10.1016/0092-8674(92)90362-G			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423598				2022-12-28	WOS:A1992JU39500019
J	DEBELDER, MA; LINKER, NJ; JONES, S; CAMM, AJ; WARD, DE				DEBELDER, MA; LINKER, NJ; JONES, S; CAMM, AJ; WARD, DE			COST IMPLICATIONS OF THE BRITISH-PACING-AND-ELECTROPHYSIOLOGY-GROUPS RECOMMENDATIONS FOR PACING	BRITISH MEDICAL JOURNAL			English	Article							SICK SINUS SYNDROME; TERM FOLLOW-UP; NODE DISEASE; ATRIAL; MORBIDITY; MORTALITY	Objective-To compare present pacing practice with the recommendations recently published by the British Pacing and Electrophysiology Group and to assess the increase in annual budget required to implement these recommendations in a regional cardiothomcic unit. Design-Retrospective analysis of pacemaker implantation for 1991 with calculation of the costs required to implement the group's recommendations based on average 1991 costs of the types of pacing generators and electrode leads used. Setting-Regional cardiothoracic unit for South West Thames Health Authority. Patients-433 consecutive patients receiving permanent pacemaker generators: 76 (18%) with sinus node disease; 270 (62%) with atrioventricular block; 25 (6%) with both sinus node disease and atrioventricular block; 59 (14%) with chronic atrial fibrillation and atrioventricular block; and 3 (1%) with carotid sinus or malignant vasovagal syndromes. Results-Only 102 (24%) patients received pace-maker generators recommended by the British Pacing and Electrophysiology Group; however, 355 (82%) patients were older than 65 years, and 264 (61%) were aged 75 or over. The cost of hardware for pacing was 462 885 Pound. Using generators as recommended would have cost 810525 Pound for "optimal" systems (an increase of 75%) and 710750 Pound for "alternative" systems (an increase of 54%). These increases would have been considerably reduced by limiting the use of sophisticated pacing to younger patients (aged under 75). Further savings could be made by using the least expensive pacing models available. Conclusions-Implementing these recommendations should reduce morbidity related to bradyarrhythmia but will lead to major increases in pacing costs. Age and patients' expected activity may be used to select simple pacing systems and thus to contain cost. More research is needed to determine which patient groups will benefit most from complex pacing systems.	ST GEORGE HOSP,REG CARDIOTHORAC UNIT,LONDON SW17 0QT,ENGLAND	St Georges University London			Linker, Nicholas/AAJ-6450-2021	Linker, Nicholas/0000-0002-2592-0757				AHSAN A, 1992, LANCET, V339, P62, DOI 10.1016/0140-6736(92)90191-5; AHSAN A J, 1990, European Heart Journal, V11, P300; BIANCONI L, 1989, PACING CLIN ELECTROP, V12, pA1236; CLARKE M, 1991, BRIT HEART J, V66, P185; EBAGOSTI A, 1988, PACE, V11, P1929, DOI 10.1111/j.1540-8159.1988.tb06330.x; FITZPATRICK A, 1991, EUR HEART J, V12, P389, DOI 10.1093/oxfordjournals.eurheartj.a059906; ROSENQVIST M, 1990, CLIN CARDIOL, V13, P43, DOI 10.1002/clc.4960130108; ROSENQVIST M, 1988, AM HEART J, V116, P16, DOI 10.1016/0002-8703(88)90244-X; ROSENQVIST M, 1989, PACE, V12, P97, DOI 10.1111/pace.1989.12.p1.97; SANTINI M, 1989, PACE, V12, P1237; SASAKI Y, 1988, PACE, V11, P1575, DOI 10.1111/j.1540-8159.1988.tb06277.x; SCHULLER H, 1991, CLIN CARDIOL, V14, P336, DOI 10.1002/clc.4960140410; ZANINI R, 1990, PACE, V13, P2076, DOI 10.1111/j.1540-8159.1990.tb06945.x; 1991, LANCET, V338, P1178	14	38	38	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					861	865		10.1136/bmj.305.6858.861	http://dx.doi.org/10.1136/bmj.305.6858.861			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422398	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JT77700023
J	ROSSITER, SK				ROSSITER, SK			LESSON OF THE WEEK - PSYCHOSIS WITH DISULFIRAM PRESCRIBED UNDER PROBATION ORDER	BRITISH MEDICAL JOURNAL			English	Article											ROSSITER, SK (corresponding author), MAPPERLEY HOSP,NOTTINGHAM NG3 6AA,ENGLAND.							[Anonymous], 1937, Journal of the American Medical Association, V109, P1472; EWING JA, 1977, AM J PSYCHIAT, V134, P927; HALD J, 1948, ACTA PHARMACOL TOX, V4, P285; KNEE ST, 1974, AM J PSYCHIAT, V131, P1281; LIDDON SC, 1967, AM J PSYCHIAT, V123, P1284, DOI 10.1176/ajp.123.10.1284; NASRALLAH HA, 1979, WESTERN J MED, V130, P575; QUAIL M, 1980, S AFR MED J, V57, P551	7	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1992	305	6856					763	763		10.1136/bmj.305.6856.763	http://dx.doi.org/10.1136/bmj.305.6856.763			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JQ520	1422334	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JQ52000028
J	SIDRANSKY, D; FROST, P; VONESCHENBACH, A; OYASU, R; PREISINGER, AC; VOGELSTEIN, B				SIDRANSKY, D; FROST, P; VONESCHENBACH, A; OYASU, R; PREISINGER, AC; VOGELSTEIN, B			CLONAL ORIGIN OF BLADDER-CANCER	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL CARCINOMAS; MOLECULAR-GENETICS; X-CHROMOSOME; HUMAN-TUMORS; P53 GENE; REARRANGEMENTS; IDENTIFICATION; RETINOBLASTOMA; MUTATIONS; ALLELE	Background. Patients with cancer of the urinary bladder often present with multiple tumors, appearing at different times and at different sites in the bladder. This observation has been attributed to a "field defect" in the bladder that allows the independent transformation of epithelial cells at a number of sites. We tested this hypothesis using molecular genetic techniques. Methods. We examined 13 tumors from cystectomy specimens from four women, using a method that analyzes the pattern of X-chromosome inactivation to determine whether the tumors were derived from the same precursor cell. In addition, we analyzed allelic loss on autosomes to determine whether different tumors had the same genetic alterations. The alterations evaluated included the loss of chromosome 9q sequences (commonly found in superficial bladder tumors) and the loss of 17p and 18q sequences (usually found only in advanced tumors). Results. For each patient studied, all the tumors had inactivation of the same X chromosome, whereas normal bladder mucosa cells had random patterns of inactivation. Moreover, each tumor that could be evaluated from a given patient had lost the same allele on chromosome 9q, suggesting that the loss of this allele preceded the spread of neoplastic cells elsewhere in the bladder. The losses of chromosome 17p and 18q alleles, which are late events in tumor progression, were not common to different tumors from the same patient. Conclusions. A number of bladder tumors can arise from the uncontrolled spread of a single transformed cell. These tumors can then grow independently with variable subsequent genetic alterations.	JOHNS HOPKINS ONCOL CTR,DEPT ONCOL,424 N BOND ST,BALTIMORE,MD 21231; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT CELL BIOL,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030; NORTHWESTERN UNIV,SCH MED,DEPT PATHOL,CHICAGO,IL 60611	Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Northwestern University								ARNOLD A, 1988, NEW ENGL J MED, V318, P658, DOI 10.1056/NEJM198803173181102; ARNOLD A, 1983, NEW ENGL J MED, V309, P1593, DOI 10.1056/NEJM198312293092601; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FIALKOW PJ, 1976, BIOCHIM BIOPHYS ACTA, V458, P283, DOI 10.1016/0304-419X(76)90003-2; IP NY, 1989, NUCLEIC ACIDS RES, V17, P8404, DOI 10.1093/nar/17.20.8404; KELMAN Z, 1989, BLOOD, V74, P2318; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; LYON MF, 1990, NATURE, V348, P585, DOI 10.1038/348585a0; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P3119, DOI 10.1093/nar/16.7.3119; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P10607, DOI 10.1093/nar/15.24.10607; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P10073, DOI 10.1093/nar/15.23.10073; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9369, DOI 10.1093/nar/16.19.9369; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; PAL N, 1990, ONCOGENE, V5, P1665; PRESTI JC, 1991, CANCER RES, V51, P5405; RICHIE JP, 1989, CANCER PRINCIPLES PR, V1, P1008; SANDBERG AA, 1986, CANCER GENET CYTOGEN, V19, P163, DOI 10.1016/0165-4608(86)90384-5; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; TSAI YC, 1990, CANCER RES, V50, P44; VEENEMA RJ, 1977, CANCER RES, V37, P2836; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; VOGELSTEIN B, 1985, SCIENCE, V227, P642, DOI 10.1126/science.2982210; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WU SQ, 1991, CANCER RES, V51, P3323; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0; 1988, REPORTING MANUAL STA	34	464	474	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 12	1992	326	11					737	740		10.1056/NEJM199203123261104	http://dx.doi.org/10.1056/NEJM199203123261104			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HH064	1445507				2022-12-28	WOS:A1992HH06400004
J	SESSO, R; KLAG, MJ; ANCAO, MS; WHELTON, PK; SEIDLER, A; SIGULEM, D; RAMOS, OL				SESSO, R; KLAG, MJ; ANCAO, MS; WHELTON, PK; SEIDLER, A; SIGULEM, D; RAMOS, OL			KIDNEY-TRANSPLANTATION FROM LIVING UNRELATED DONORS	ANNALS OF INTERNAL MEDICINE			English	Article						KIDNEY TRANSPLANTATION; HAPLOTYPES; TRANSPLANTATION, HOMOLOGOUS; CADAVER; ORGAN PROCUREMENT	RENAL-TRANSPLANTATION; ORGANS; OPPORTUNITY; SHORTAGE; DONATION; THERAPY; TIME	Objective: To compare patient and graft survival of recipients of kidneys from living, unrelated donors (LUDs); cadaveric donors; and living, related donors (LRDs) matched for zero (mismatched), one, or two (identical) haplotypes. Design: Cohort study. Setting: Sixty-three renal transplantation centers affiliated with the Brazilian Transplantation Registry (accounting for more than 95% of the transplantation activity in Brazil). Patients: Patients having renal transplantation between January 1987 and March 1991. Of 2892 patients, 165 (6%) received transplants from LUDs; 964 (33%), from cadaveric donors; 183 (6%), from zero haplotype, HLA-matched LRDs; 1259 (44%) from one haplotype-matched LRDs; and 321 (11%), from two haplotype-matched LRDs. Measurements: Patient and graft survival. Patients were followed for an average of 15.8 months. Results: After adjustment for age, race, diagnosis of primary disease, history of previous transplantation, cyclosporine use, and number of transplants from LUDs per center, patient survival did not differ statistically for recipients of kidneys from LUDs and recipients of cadaveric kidneys (risk ratio [RR], 1,16; 95% Cl, 0.68 to 1.98). Little difference was seen between the adjusted death rate for recipients of zero haplotype-matched LRDs and recipients of cadaveric kidneys (RR, 1.13; Cl, 0.69 to 1.87). Similarly, in a multivariate analysis, recipients of kidneys taken from LUDs and zero haplotype-matched LRDs had a risk for graft failure that did not differ statistically from that of cadaveric kidney recipients (RR, 0.74; Cl, 0.45 to 1.22 and RR, 0.82; Cl, 0.53 to 1.25, respectively). Conclusions: Graft survival for recipients of kidneys from LUDs is similar to that from zero haplotype-matched LRDs and is at least as good as that achieved with cadaveric transplants.	JOHNS HOPKINS UNIV, BALTIMORE, MD 21218 USA	Johns Hopkins University	SESSO, R (corresponding author), ESCOLA PAULISTA MED SCH, DIV NEPHROL, RUA BOTUCATU 740, BR-04023 SAO PAULO, BRAZIL.		Ancao, Meide/D-7630-2014; Sesso, Ricardo C C/B-4767-2013	Ancao, Meide/0000-0002-0781-0191; Sesso, Ricardo/0000-0002-1062-0073				ABOUNA GM, 1988, TRANSPLANT P, V20, P802; ALBRECHTSEN D, 1990, TRANSPLANT P, V22, P1435; BART KJ, 1981, TRANSPLANTATION, V31, P379, DOI 10.1097/00007890-198105010-00015; BERLOCO P, 1991, TRANSPLANT P, V23, P912; BLAKE PG, 1989, CAN MED ASSOC J, V141, P773; BRUNNER FP, 1990, AM J KIDNEY DIS, V15, P384, DOI 10.1016/S0272-6386(12)70355-4; CAPLAN AL, 1989, CLIN TRANSPLANT, V3, P170; CHISHOLM GD, 1988, BRIT MED J, V296, P1419, DOI 10.1136/bmj.296.6634.1419; COHEN B, 1989, EUROTRANSPLANT L FEB; DOSSETOR JB, 1991, TRANSPLANT P, V23, P2508; EGGERS PW, 1988, NEW ENGL J MED, V318, P223, DOI 10.1056/NEJM198801283180406; ELICK BA, 1990, TRANSPLANT P, V22, P343; EVANS RW, 1992, JAMA-J AM MED ASSOC, V267, P239, DOI 10.1001/jama.267.2.239; FLATMARK A, 1990, TRANSPLANT INT, V3, P50; GEERLINGS W, 1989, NERPHROL DIAL TRA S4, V4, P5; HABERAL M, 1990, TRANSPLANT P, V22, P342; HELD PJ, 1988, ARCH INTERN MED, V148, P2594, DOI 10.1001/archinte.148.12.2594; HOETTE M, 1986, KIDNEY INT, V29, P430; KAUFMAN DB, 1989, TRANSPLANT P, V21, P671; LEVEY AS, 1986, NEW ENGL J MED, V314, P914, DOI 10.1056/NEJM198604033141409; MORRIS PJ, 1985, LANCET, V1, P1510; POLLAK VE, 1984, AM J KIDNEY DIS, V3, P391; SABBAGA E, 1985, TRANSPLANT P, V17, P1741; SALAHUDEEN AK, 1990, LANCET, V336, P725, DOI 10.1016/0140-6736(90)92214-3; SESSO R, 1990, NEPHROL DIAL TRANSPL, V5, P956, DOI 10.1093/ndt/5.11.956; Sesso R, 1990, Int J Technol Assess Health Care, V6, P107; SESSO R, 1990, J BRAS NEFROL, V12, P1; SMITH T, 1989, BRIT MED J, V298, P776; SOLLINGER HW, 1986, ANN SURG, V204, P315, DOI 10.1097/00000658-198609000-00010; SQUIFFLET JP, 1990, TRANSPLANT INT, V3, P32; STARZL TE, 1987, TRANSPLANT P, V19, P174; 1986, TRANSPLANTATION, V41, P1; 1990, USRDS1990 US REN DAT	33	42	42	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1992	117	12					983	989		10.7326/0003-4819-117-12-983	http://dx.doi.org/10.7326/0003-4819-117-12-983			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB980	1443985				2022-12-28	WOS:A1992KB98000002
J	HEDBERG, CW; KORLATH, JA; DAOUST, JY; WHITE, KE; SCHELL, WL; MILLER, MR; CAMERON, DN; MACDONALD, KL; OSTERHOLM, MT				HEDBERG, CW; KORLATH, JA; DAOUST, JY; WHITE, KE; SCHELL, WL; MILLER, MR; CAMERON, DN; MACDONALD, KL; OSTERHOLM, MT			A MULTISTATE OUTBREAK OF SALMONELLA-JAVIANA AND SALMONELLA-ORANIENBURG INFECTIONS DUE TO CONSUMPTION OF CONTAMINATED CHEESE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHEDDAR CHEESE	Objective.-To determine the source of an outbreak of Salmonella javiana and Salmonella oranienburg infections. Design.-Laboratory-based statewide surveillance for Salmonella infections and two separate case-control studies. Setting.-Community- and industry-based studies conducted from May through October 1989. Participants.-Thirty-one culture-confirmed outbreak-associated cases of S javiana infection and 60 community controls matched for telephone prefix, gender, and age in case-control study I; 50 cases, 100 community controls, and 64 family member controls in case-control study II. Results.-One hundred thirty-six culture-confirmed cases of S javiana infection and 11 cases of S oranienburg infection were associated with the outbreak in Minnesota. Outbreak-associated cases were also identified in Wisconsin (15 cases), and in Michigan and New York (one case each). Cases were more likely than controls to have consumed mozzarella cheese manufactured at a single cheese plant (plant X) or cheese that had been shredded at processing plants that also shredded cheese manufactured at plant X (odds ratio [OR], 7.2; 95% confidence interval [CI], 1.7 to 23.2; P<.01). The outbreak-associated strains of both serovars were isolated from two unopened 16-oz (0.45-kg) blocks of mozzarella cheese produced at plant X. The most probable numbers of Salmonella organisms in these samples were 0.36/100 g and 4.3/100 g. Conclusions.-The potential for bacterial pathogen contamination of cheese during manufacture and processing has important epidemiologic implications, particularly because cheese consumption has recently increased in the United States. Low-level contamination of a nationally distributed food product can cause geographically dispersed foodborne outbreaks that may be difficult to detect.	MINNESOTA DEPT HLTH,EPIDEMIOL FIELD SERV SECT,MINNEAPOLIS,MN; MINNESOTA DEPT HLTH,DIV PUBL HLTH LABS,MINNEAPOLIS,MN; HLTH & WELF CANADA,HLTH PROTECT BRANCH,SIR FG BANTING RES CTR,OTTAWA K1A 0L2,ONTARIO,CANADA; WISCONSIN DEPT HLTH & SOCIAL SERV,DIV HLTH,MADISON,WI; CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV BACTERIAL & MYCOT DIS,ATLANTA,GA	Minnesota Department of Health (MHD); Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA	HEDBERG, CW (corresponding author), MINNESOTA DEPT HLTH,ACUTE DIS EPIDEMIOL SECT,717 DELAWARE ST SE,MINNEAPOLIS,MN 55440, USA.							ANDREWS WH, 1984, BACTERIOLOGICAL ANAL, pCH7; BARRY AL, 1985, MANUAL CLIN MICROBIO, pCH102; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Breslow N.E., 1980, STAT METHODS CANC RE, P192; CHALKER RB, 1988, REV INFECT DIS, V10, P111; DAOUST JY, 1989, J FOOD PROTECT, V52, P906, DOI 10.4315/0362-028X-52.12.906; DAOUST JY, 1985, AM J EPIDEMIOL, V122, P717, DOI 10.1093/oxfordjournals.aje.a114151; Felip G. de, 1984, Microbiologie - Aliments - Nutrition, V2, P251; FONTAINE RE, 1980, AM J EPIDEMIOL, V111, P247, DOI 10.1093/oxfordjournals.aje.a112892; MEYERS JA, 1976, J BACTERIOL, V127, P1529, DOI 10.1128/JB.127.3.1529-1537.1976; PUTNAM AJ, 1989, USDA STATISTICAL B, V773; ROSNER B, 1986, FUNDAMENTALS BIOSTAT, P84; ROTHMAN KJ, 1979, EPIDEMIOLOGIC ANAL P, P5; 1978, MFHPB20 HLTH WELF CA, P1	14	63	63	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3203	3207		10.1001/jama.268.22.3203	http://dx.doi.org/10.1001/jama.268.22.3203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433759				2022-12-28	WOS:A1992KA65400025
J	LEONHARDT, H; PAGE, AW; WEIER, HU; BESTOR, TH				LEONHARDT, H; PAGE, AW; WEIER, HU; BESTOR, TH			A TARGETING SEQUENCE DIRECTS DNA METHYLTRANSFERASE TO SITES OF DNA-REPLICATION IN MAMMALIAN NUCLEI	CELL			English	Article							PRE-MESSENGER-RNA; MURINE ERYTHROLEUKEMIA-CELLS; INTRACELLULAR-LOCALIZATION; POLYMERASE-ALPHA; SATELLITE DNA; LIGASE-I; EXPRESSION; DOMAINS; HYBRIDIZATION; SPECIFICITY	Tissue-specific patterns of methylated deoxycytidine residues in the mammalian genome are preserved by postreplicative methylation of newly synthesized DNA. DNA methyltransferase (MTase) is here shown to associate with replication foci during S phase but to display a diffuse nucleoplasmic distribution in non-S phase cells. Analysis of DNA MTase-beta-galactosidase fusion proteins has shown that association with replication foci is mediated by a novel targeting sequence located near the N-terminus of DNA MTase. This sequence has the properties expected of a targeting sequence in that it is not required for enzymatic activity, prevents proper targeting when deleted, and, when fused to beta-galactosidase, causes the fusion protein to associate with replication foci in a cell cycle-dependent manner.	UNIV CALIF SAN FRANCISCO, DEPT LAB MED, DIV MOLEC CYTOMETRY, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	LEONHARDT, H (corresponding author), HARVARD UNIV, SCH MED, DEPT ANAT & CELLULAR BIOL, BOSTON, MA 02115 USA.		Leonhardt, Heinrich/B-2791-2014		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043565] Funding Source: NIH RePORTER; NICHD NIH HHS [HD17665] Funding Source: Medline; NIGMS NIH HHS [GM43565] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALSNER J, 1992, J BIOL CHEM, V267, P12408; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; BECK JS, 1961, LANCET, V1, P1203; BENSCH KG, 1982, J BIOL CHEM, V257, P8391; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; BESTOR TH, 1985, P NATL ACAD SCI USA, V82, P2674, DOI 10.1073/pnas.82.9.2674; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; BRANCOLINI C, 1991, P NATL ACAD SCI USA, V88, P6936, DOI 10.1073/pnas.88.16.6936; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; CARMOFONSECA M, 1991, EMBO J, V10, P195, DOI 10.1002/j.1460-2075.1991.tb07936.x; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; COOK PR, 1991, CELL, V66, P627, DOI 10.1016/0092-8674(91)90109-C; CZANK A, 1991, GENE, V109, P259, DOI 10.1016/0378-1119(91)90618-L; DANDREA AD, 1983, NUCLEIC ACIDS RES, V11, P4753, DOI 10.1093/nar/11.14.4753; FOX MH, 1991, J CELL SCI, V99, P247; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; GAUTHIERROUVIERE C, 1991, CELL REGUL, V2, P575, DOI 10.1091/mbc.2.7.575; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; KUMAR A, 1972, J MOL BIOL, V63, P233, DOI 10.1016/0022-2836(72)90372-5; LASKO DD, 1990, J BIOL CHEM, V265, P12618; LAUSTER R, 1989, J MOL BIOL, V206, P305, DOI 10.1016/0022-2836(89)90480-4; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; MEIER UT, 1992, CELL, V70, P127; MILLS AD, 1989, J CELL SCI, V94, P471; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; OTTIGER HP, 1984, P NATL ACAD SCI-BIOL, V81, P3993, DOI 10.1073/pnas.81.13.3993; PECULIS BA, 1992, J CELL BIOL, V116, P1, DOI 10.1083/jcb.116.1.1; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; ROISE D, 1988, J BIOL CHEM, V263, P4509; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS WS, 1991, J CELL BIOL, V115, P919, DOI 10.1083/jcb.115.4.919; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; TOMKINSON AE, 1990, J BIOL CHEM, V265, P12611; TUBO RA, 1987, J BIOL CHEM, V262, P1148; VISSEL B, 1989, GENOMICS, V5, P407, DOI 10.1016/0888-7543(89)90003-7; WANG J, 1991, P NATL ACAD SCI USA, V88, P7391, DOI 10.1073/pnas.88.16.7391; WEIER HU, 1991, BIOTECHNIQUES, V10, P498	52	836	853	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	1992	71	5					865	873		10.1016/0092-8674(92)90561-P	http://dx.doi.org/10.1016/0092-8674(92)90561-P			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423634	Green Published			2022-12-28	WOS:A1992JZ63300015
J	TAKAHAMA, Y; SINGER, A				TAKAHAMA, Y; SINGER, A			POSTTRANSCRIPTIONAL REGULATION OF EARLY T-CELL DEVELOPMENT BY T-CELL RECEPTOR SIGNALS	SCIENCE			English	Article							3' UNTRANSLATED REGION; CD8 GENE-EXPRESSION; MESSENGER-RNA; IMMATURE THYMOCYTES; ANTIGEN RECEPTOR; MONOCLONAL-ANTIBODY; LYMPHOCYTES-T; V(D)J RECOMBINATION; MURINE THYMOCYTES; TRANSGENIC MICE	During differentiation in the thymus, immature T cells progress through an ordered sequence of developmental stages that are best characterized by variable expression of the co-receptor molecules CD4 and CD8. Crosslinking of T cell receptor (TCR) molecules on precursor thymocytes was found to block their differentiation into CD4+CD8+ cells by eliminating messenger RNA's encoding two families of developmentally important molecules: the co-receptor molecules CD4 and CD8 and the recombination activating genes 1 and 2. TCR-induced post-transcriptional regulation in early thymocytes was specific for selective messenger RNA's, required protein synthesis, and was itself developmentally regulated. These data identify a post-transcriptional mechanism that is influenced by TCR signals and that regulates early thymocyte development.			TAKAHAMA, Y (corresponding author), NCI, EXPTL IMMUNOL BRANCH, BETHESDA, MD 20892 USA.		Takahama, Yousuke/A-5863-2010	Takahama, Yousuke/0000-0002-4992-9174				ABRAHAM KM, 1991, J EXP MED, V173, P1421, DOI 10.1084/jem.173.6.1421; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0; CHENKIANG S, 1989, METHOD ENZYMOL, V180, P82; CLEVELAND D W, 1989, New Biologist, V1, P121; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; FOWLKES BJ, 1988, NATURE, V334, P620, DOI 10.1038/334620a0; GORMAN SD, 1988, J IMMUNOL, V140, P3646; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; GUNTER KC, 1984, J EXP MED, V159, P716, DOI 10.1084/jem.159.3.716; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; HUNIG T, 1988, EUR J IMMUNOL, V18, P2089, DOI 10.1002/eji.1830181234; HUSMANN LA, 1988, J IMMUNOL, V141, P736; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; KUBO RT, 1989, J IMMUNOL, V142, P2736; LITTMAN DR, 1987, NATURE, V325, P453, DOI 10.1038/325453a0; MACDONALD HR, 1988, EUR J IMMUNOL, V18, P519, DOI 10.1002/eji.1830180405; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801; MCCONKEY DJ, 1989, J BIOL CHEM, V264, P13399; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NEVINS JR, 1987, METHOD ENZYMOL, V152, P234; NIKOLICZUGIC J, 1988, P NATL ACAD SCI USA, V85, P8633, DOI 10.1073/pnas.85.22.8633; NIKOLICZUGIC J, 1989, EUR J IMMUNOL, V19, P1957, DOI 10.1002/eji.1830191030; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PAILLARD F, 1990, EMBO J, V9, P1867, DOI 10.1002/j.1460-2075.1990.tb08312.x; PARDOLL DM, 1987, J EXP MED, V165, P1624, DOI 10.1084/jem.165.6.1624; PARNES JR, 1989, ADV IMMUNOL, V44, P265, DOI 10.1016/S0065-2776(08)60644-6; PATERSON DJ, 1987, J EXP MED, V166, P1603, DOI 10.1084/jem.166.5.1603; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PETRIE HT, 1990, EUR J IMMUNOL, V20, P2813, DOI 10.1002/eji.1830201243; RAULET DH, 1985, NATURE, V314, P103, DOI 10.1038/314103a0; ROYER HD, 1985, P NATL ACAD SCI USA, V82, P5510, DOI 10.1073/pnas.82.16.5510; Sambrook J, 1989, MOL CLONING LABORATO; SARMIENTO M, 1982, IMMUNOL REV, V68, P135, DOI 10.1111/j.1600-065X.1982.tb01063.x; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCOLLAY R, 1988, IMMUNOL REV, V104, P81, DOI 10.1111/j.1600-065X.1988.tb00760.x; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHORTMAN K, 1988, CELL IMMUNOL, V113, P462, DOI 10.1016/0008-8749(88)90042-1; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; TAKAHAMA Y, 1991, J IMMUNOL, V147, P2883; TAKAHAMA Y, UNPUB; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WILKINSON MF, 1991, MOL IMMUNOL, V28, P57, DOI 10.1016/0161-5890(91)90087-Z; Wilson A, 1989, Int Immunol, V1, P605, DOI 10.1093/intimm/1.6.605; ZAMOYSKA R, 1985, CELL, V43, P153, DOI 10.1016/0092-8674(85)90020-0	63	96	96	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	1992	258	5087					1456	1462		10.1126/science.1439838	http://dx.doi.org/10.1126/science.1439838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ625	1439838				2022-12-28	WOS:A1992JZ62500021
J	MANN, SJ; PICKERING, TG				MANN, SJ; PICKERING, TG			DETECTION OF RENOVASCULAR HYPERTENSION - STATE-OF-THE-ART - 1992	ANNALS OF INTERNAL MEDICINE			English	Review						HYPERTENSION, RENOVASCULAR; ANGIOGRAPHY; CAPTOPRIL; RADIONUCLIDE IMAGING; UROGRAPHY	CONVERTING ENZYME-INHIBITION; RENAL VASCULAR HYPERTENSION; FOLLOW-UP PROGRAM; CAPTOPRIL TEST; CURABLE HYPERTENSION; GLOMERULAR-FILTRATION; APPARENT PREVALENCE; TECHNETIUM-99M MAG3; ALDOSTERONE SYSTEM; DUPLEX ULTRASOUND	Purpose: To review recent advances in detecting renovascular hypertension. Data Sources: Original English-language reports obtained through a MEDLINE search for the years 1987 to 1991. Also, a manual search through Index Medicus as well as bibliographies of original reports and selected review articles. Study Selection and Data Extraction: Cited studies were critically reviewed with emphasis on study size, patient sample, methods, diagnostic criteria, and reproducibility of results. Where applicable, reviews that combined the results of smaller studies are cited. Results: A sensitivity of 74% and a specificity of 89% have been reported for the captopril test and of 93% and 95%, respectively, for captopril scintigraphy with diethylenetriaminepentaacetic acid (DTPA). The sensitivity and specificity of renal vein renin determination are 80% and 62%, respectively and may increase with the use of stricter technical criteria and maneuvers to stimulate renin secretion. These tests differentiate renovascular hypertension from essential hypertension more reliably than from asymmetric renal parenchymal disease; however, they do not reliably distinguish unilateral from bilateral stenosis. Other tests are less widely used. Intravenous pyelography (sensitivity, 74.5%; specificity, 86.2%) has the disadvantages of radiation and dye load exposure. Intravenous angiography is expensive and invasive and does not always enable visualization of the origin of the renal artery. The roles of duplex ultrasound and magnetic resonance angiography remain to be clarified. Conclusions: Noninvasive tests are cost effective and have a high predictive value in patients with clinical clues suggestive of renovascular hypertension. These tests are not recommended for use in patients with a low likelihood of disease.			MANN, SJ (corresponding author), CORNELL UNIV, MED CTR, NEW YORK HOSP, CTR CARDIOVASC, 525 E 68TH ST, NEW YORK, NY 10021 USA.		Mann, Samuel J./AAI-5510-2020					ALDIGIER JC, 1982, AM J CARDIOL, V49, P1447, DOI 10.1016/0002-9149(82)90359-9; ALNAHHAS AA, 1988, EUR J NUCL MED, V14, P453, DOI 10.1007/BF00252388; ANDERSON GH, 1988, AM J HYPERTENS, V1, P301, DOI 10.1093/ajh/1.3.301; [Anonymous], 1987, ARCH INTERN MED, V147, P820; BAILEY RR, 1978, J UROLOGY, V120, P21, DOI 10.1016/S0022-5347(17)57026-3; BECH K, 1975, ACTA MED SCAND, V197, P65; BERGLUND G, 1976, BRIT MED J, V2, P554, DOI 10.1136/bmj.2.6035.554; BOOKSTEI.JJ, 1968, RADIOLOGY, V90, P1073, DOI 10.1148/90.6.1073; BOOKSTEIN JJ, 1972, J AMER MED ASSOC, V220, P1218, DOI 10.1001/jama.220.9.1218; BRUNNER HR, 1972, NEW ENGL J MED, V286, P441, DOI 10.1056/NEJM197203022860901; CASE DB, 1982, AM J CARDIOL, V49, P1440, DOI 10.1016/0002-9149(82)90358-7; CHEN CC, 1990, RADIOLOGY, V176, P365, DOI 10.1148/radiology.176.2.2195592; CHUANG VP, 1979, RADIOLOGY, V130, P613, DOI 10.1148/130.3.613; CURTIS JJ, 1986, AM J KIDNEY DIS, V7, P181, DOI 10.1016/S0272-6386(86)80002-6; CURTIS JJ, 1983, NEW ENGL J MED, V308, P377, DOI 10.1056/NEJM198302173080707; DANIELSON M, 1981, ACTA MED SCAND, V209, P451; DAVIS BA, 1979, NEW ENGL J MED, V301, P1273, DOI 10.1056/NEJM197912063012307; DEAN RH, 1981, ARCH SURG-CHICAGO, V116, P1408; DEBATIN JF, 1991, AM J HYPERTENS, V4, pA38; DERKX FHM, 1987, RENOVASCULAR HYPERTE, P295; DONDI M, 1989, J NUCL MED, V30, P615; DONDI M, 1991, J NUCL MED, V32, P424; DOYLE TJ, 1975, SURGERY, V77, P53; DUBOVSKY EV, 1982, SEMIN NUCL MED, V12, P308, DOI 10.1016/S0001-2998(82)80013-5; DUNN MJ, 1974, KIDNEY INT, V5, P317, DOI 10.1038/ki.1974.47; DUNNICK NR, 1991, RADIOL CLIN N AM, V29, P497; ERBSLOHMOLLER B, 1991, AM J MED, V90, P23, DOI 10.1016/0002-9343(91)90502-O; FIORENTINI C, 1990, AM HEART J, V119, P353, DOI 10.1016/S0002-8703(05)80027-4; FOMMEI E, 1987, HYPERTENSION, V10, P212, DOI 10.1161/01.HYP.10.2.212; FOSTER JH, 1973, ANN SURG, V177, P755, DOI 10.1097/00000658-197306000-00015; FREDERICKSON ED, 1990, ARCH INTERN MED, V150, P569, DOI 10.1001/archinte.150.3.569; GAVRAS H, 1975, SCIENCE, V188, P1316, DOI 10.1126/science.1145199; GEYSKES GG, 1987, HYPERTENSION, V9, P451, DOI 10.1161/01.HYP.9.5.451; GOSSE P, 1989, AM J HYPERTENS, V2, P191, DOI 10.1093/ajh/2.3.191; GRIM CE, 1979, ANN INTERN MED, V91, P617, DOI 10.7326/0003-4819-91-4-617; HALL JE, 1977, AM J PHYSIOL, V233, pF366, DOI 10.1152/ajprenal.1977.233.5.F366; HANSEN PB, 1990, J INTERN MED, V228, P159, DOI 10.1111/j.1365-2796.1990.tb00210.x; HARVEY RJ, 1985, JAMA-J AM MED ASSOC, V254, P388; HOFFMANN U, 1991, KIDNEY INT, V39, P1232, DOI 10.1038/ki.1991.156; HORVATH JS, 1982, Q J MED, V51, P139; HRICIK DE, 1983, NEW ENGL J MED, V308, P373, DOI 10.1056/NEJM198302173080706; HRICIK DE, 1985, ANN INTERN MED, V103, P222, DOI 10.7326/0003-4819-103-2-222; HUANG WC, 1983, KIDNEY INT, V23, P816, DOI 10.1038/ki.1983.100; IDRISSI A, 1988, KIDNEY INT, V34, pS138; JACKSON B, 1984, LANCET, V1, P225; JAFRI RA, 1988, J NUCL MED, V29, P147; KENNEDY AC, 1965, LANCET, V2, P963; KORNERUP HJ, 1979, P EUR DIAL TRANSPLAN, V14, P377; LARAGH JH, 1972, AM J MED, V52, P633, DOI 10.1016/0002-9343(72)90054-X; LEWIN A, 1985, ARCH INTERN MED, V145, P424, DOI 10.1001/archinte.145.3.424; LEWIS BD, 1984, MAYO CLIN P, V643, P1158; LUSCHER TF, 1981, CLIN NEPHROL, V15, P314; LYONS DF, 1983, HYPERTENSION, V5, P615, DOI 10.1161/01.HYP.5.4.615; MANN SJ, 1991, AM J MED, V90, P30, DOI 10.1016/0002-9343(91)90503-P; Marks L S, 1975, Urol Clin North Am, V2, P311; MAXWELL MH, 1972, J AMER MED ASSOC, V220, P1195, DOI 10.1001/jama.220.9.1195; MAXWELL MH, 1975, KIDNEY INT, V8, pS153; MILLER ED, 1975, AM J PHYSIOL, V228, P448; MULLER FB, 1986, AM J MED, V80, P633, DOI 10.1016/0002-9343(86)90819-3; NALLY JV, 1987, J NUCL MED, V28, P1171; NALLY JV, 1991, AM J HYPERTENS, V4, pS749, DOI 10.1093/ajh/4.12.749S; NALLY JV, 1986, HYPERTENSION, V8, P685, DOI 10.1161/01.HYP.8.8.685; NEMOY NJ, 1973, JAMA-J AM MED ASSOC, V225, P512, DOI 10.1001/jama.225.5.512; NICHOLSON JP, 1983, LANCET, V2, P765; PAPE JF, 1988, SCAND J UROL NEPHROL, V22, P41, DOI 10.1080/00365599.1988.11690382; PICKERING TG, 1984, AM J MED, V76, P398, DOI 10.1016/0002-9343(84)90657-0; PICKERING TG, 1985, J HYPERTENS, V3, pS291; PICKERING TG, 1987, CIRCULATION, V76, P274; PLOTH DW, 1983, AM J PHYSIOL, V245, pF131, DOI 10.1152/ajprenal.1983.245.2.F131; POHL MA, 1985, AM J KIDNEY DIS, V5, pA120, DOI 10.1016/S0272-6386(85)80074-3; POLLINI J, 1979, CLIN NEPHROL, V11, P202; POSTMA CT, 1990, ARCH INTERN MED, V150, P625, DOI 10.1001/archinte.150.3.625; POUTASSE E F, 1958, Surg Forum, V9, P826; RAO TKS, 1978, ARCH INTERN MED, V138, P1236, DOI 10.1001/archinte.1978.03630330036011; RAPPELLI A, 1986, NEPHRON, V44, P12, DOI 10.1159/000184039; REAMS GP, 1986, HYPERTENSION, V8, P290, DOI 10.1161/01.HYP.8.4.290; ROBERTSON R, 1988, BRIT J RADIOL, V61, P196, DOI 10.1259/0007-1285-61-723-196; ROCCHINI AP, 1979, AM J PHYSIOL, V236, pH101, DOI 10.1152/ajpheart.1979.236.1.H101; RUDNICK MR, 1984, CONTROVERSIES NEPHRO, P123; RUSSELL CD, 1988, J NUCL MED, V29, P1189; SAINTGEORGES G, 1985, AM J ROENTGENOL, V144, P235, DOI 10.2214/ajr.144.2.235; SCHLEGEL JU, 1976, J UROLOGY, V116, P282, DOI 10.1016/S0022-5347(17)58783-2; SCHWIETZER G, 1979, KIDNEY INT, V15, P134, DOI 10.1038/ki.1979.19; SETARO JF, 1991, HYPERTENSION, V18, P289, DOI 10.1161/01.HYP.18.3.289; SFAKIANAKIS GN, 1987, J NUCL MED, V28, P1383; SIAMOPOULOS K, 1983, Q J MED, V52, P349; SIMON N, 1972, J AMER MED ASSOC, V220, P1209, DOI 10.1001/jama.220.9.1209; SMELLIE WAB, 1969, SURG GYNECOL OBSTETR, V128, P963; SMITHWICK RH, 1964, AM J SURG, V107, P104, DOI 10.1016/0002-9610(64)90246-6; SQUITIERI AP, 1974, J UROLOGY, V111, P284, DOI 10.1016/S0022-5347(17)59949-8; STRONG CG, 1971, AM J CARDIOL, V27, P602, DOI 10.1016/0002-9149(71)90223-2; SVETKEY LP, 1991, HYPERTENSION, V17, P678, DOI 10.1161/01.HYP.17.5.678; SVETKEY LP, 1989, HYPERTENSION, V14, P247, DOI 10.1161/01.HYP.14.3.247; TALIERCIO CP, 1986, ANN INTERN MED, V104, P501, DOI 10.7326/0003-4819-104-4-501; TAYLOR DC, 1988, J VASC SURG, V7, P363, DOI 10.1067/mva.1988.avs0070363; TAYLOR KJW, 1987, RADIOLOGY, V162, P31, DOI 10.1148/radiology.162.1.3538150; TEXTOR SC, 1984, AM J MED, V76, P29, DOI 10.1016/0002-9343(84)90880-5; THIBONNIER M, 1984, JAMA-J AM MED ASSOC, V251, P56, DOI 10.1001/jama.251.1.56; Thibonnier M., 1982, CARDIOVASC REV REP, V3, P1659; THIND GS, 1984, AM J CARDIOL, V53, P109, DOI 10.1016/0002-9149(84)90693-3; TILLMAN DM, 1984, J HYPERTENSION S2, V2, P93; TOMODA F, 1990, AM J HYPERTENS, V3, P918, DOI 10.1093/ajh/3.12.918; TUCKER RM, 1977, MAYO CLIN PROC, V52, P549; VAUGHAN ED, 1973, AM J MED, V55, P402, DOI 10.1016/0002-9343(73)90139-3; WENTING GJ, 1984, BMJ-BRIT MED J, V288, P886, DOI 10.1136/bmj.288.6421.886	105	177	178	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					845	853		10.7326/0003-4819-117-10-845	http://dx.doi.org/10.7326/0003-4819-117-10-845			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416561				2022-12-28	WOS:A1992JX83800009
J	COHEN, J				COHEN, J			AIDS FUNDING - MICROGENESIS VACCINE TRIAL GETS A PUBLIC PEER-REVIEW	SCIENCE			English	Editorial Material																		1992, SCIENCE, V258, P883	1	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1079	1080		10.1126/science.1439814	http://dx.doi.org/10.1126/science.1439814			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439814				2022-12-28	WOS:A1992JX85200012
J	ENZI, G; CARRARO, R; ALFIERI, P; BUSETTO, L; DIGITO, M; PAVAN, M; NEGRIN, P				ENZI, G; CARRARO, R; ALFIERI, P; BUSETTO, L; DIGITO, M; PAVAN, M; NEGRIN, P			SHOULDER GIRDLE LIPOMATOSIS	ANNALS OF INTERNAL MEDICINE			English	Note						LIPOMATOSIS; CERVICOBRACHIAL NEUROPATHY; MUSCULAR DISEASES	MULTIPLE SYMMETRIC LIPOMATOSIS	We report the clinical features of a deeply located lipomatosis observed in six female patients. This lipomatosis involved the inframuscular spaces of the shoulders and the proximal part of one arm, and manifested as an asymmetric and firm swelling of the supraclavicular, suprascapular, and deltoid regions, associated with muscular weakness of the involved arm. Computed tomography showed displacement and fatty infiltration of muscular bands of the shoulder and deltoid region. Peripheral neuropathies were present in four patients. Fat infiltration of the median nerve and arm muscles was detected at surgery in one patient. Light microscopy confirmed a massive infiltration and substitution of muscular fibers by fat cells. Respiratory disturbances were seen in two patients. Laryngeal endoscopic examination showed a fatty infiltration of the laryngeal wall. Cel[ size, lipoprotein lipase activity of lipomatous tissue (two patients), and routine biochemistry tests were all normal. Chest deformities, deep location of lipomatous tissue at the scapulohumeral girdle, muscular and neural involvement, and female sex prevalence are the hallmarks of this disease. We have termed this syndrome shoulder girdle lipomatosis.	UNIV PADUA, I-35100 PADUA, ITALY	University of Padua				Carraro, Raffaele/0000-0002-5874-8076; Busetto, Luca/0000-0003-4883-8980				DERCUM F, 1942, AM J MED SCI, V104, P521; ENZI G, 1984, MEDICINE, V63, P56, DOI 10.1097/00005792-198401000-00004; ENZI G, 1984, Q J MED, V53, P453; ENZI G, 1982, RADIOLOGY, V144, P121, DOI 10.1148/radiology.144.1.7089242; ENZI G, 1985, MEDICINE, V64, P388, DOI 10.1097/00005792-198511000-00003; ENZI G, 1985, POSTGRAD MED J, V61, P797, DOI 10.1136/pgmj.61.719.797; FAEGENBURG D, 1964, RADIOLOGY, V83, P987, DOI 10.1148/83.6.987; FOGG LB, 1968, RADIOLOGY, V90, P558, DOI 10.1148/90.3.558; PRICE JE, 1970, RADIOLOGY, V96, P497, DOI 10.1148/96.3.497	9	5	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					749	750		10.7326/0003-4819-117-9-749	http://dx.doi.org/10.7326/0003-4819-117-9-749			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416577				2022-12-28	WOS:A1992JV42400007
J	NISLOW, C; LOMBILLO, VA; KURIYAMA, R; MCINTOSH, JR				NISLOW, C; LOMBILLO, VA; KURIYAMA, R; MCINTOSH, JR			A PLUS-END-DIRECTED MOTOR ENZYME THAT MOVES ANTIPARALLEL MICROTUBULES INVITRO LOCALIZES TO THE INTERZONE OF MITOTIC SPINDLES	NATURE			English	Article							PROTEINS; KINESIN; PROGRESSION; SEQUENCE; CELLS	MITOSIS comprises a complex set of overlapping motile events, many of which involve microtubule-dependent motor enzymes1,2. Here we describe a new member of the kinesin superfamily. The protein was originally identified as a spindle antigen by the CHO1 monoclonal antibody3 and shown to be required for mitotic progression4,5. We have cloned the gene that encodes this antigen and found that its sequence contains a domain with strong sequence similarity to the motor domain of kinesin-like proteins. The product of this gene, expressed in bacteria, can cross-bridge antiparallel microtubules in vitro, and in the presence of Mg-ATP, microtubules slide over one another in a fashion reminiscent of microtubule movements during spindle elongation.	UNIV MINNESOTA,DEPT CELL BIOL & NEUROANAT,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities	NISLOW, C (corresponding author), UNIV COLORADO,DEPT MOLEC CELLULAR & DEV BIOL,BOULDER,CO 80309, USA.		McIntosh, Richard/GLN-3533-2022	Nislow, Corey/0000-0002-4016-8874				CANDE WZ, 1978, J CELL BIOL, V79, P573, DOI 10.1083/jcb.79.2.573; CANDE WZ, 1989, CELL MOVEMENT, V2, P441; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; COLE DG, 1992, J CELL SCI, V101, P291; ENDOW SA, 1991, TRENDS BIOCHEM SCI, V16, P221, DOI 10.1016/0968-0004(91)90089-E; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Goldstein L S, 1991, Trends Cell Biol, V1, P93, DOI 10.1016/0962-8924(91)90036-9; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; HEIDEMANN SR, 1980, NATURE, V286, P517, DOI 10.1038/286517a0; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; HUANG B, 1979, J BIOL CHEM, V254, P3091; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KURIYAMA R, 1992, BIOESSAYS, V14, P81, DOI 10.1002/bies.950140203; LIN KH, 1991, BIOTECHNIQUES, V11, P748; LOMBILLO VA, IN PRESS METHODS CEL; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MCINTOSH JR, 1991, J CELL BIOL, V115, P577, DOI 10.1083/jcb.115.3.577; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; NISLOW C, 1990, J CELL BIOL, V111, P511, DOI 10.1083/jcb.111.2.511; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; ROBERTS B, 1989, BIOCHIM BIOPHYS ACTA, V1008, P263, DOI 10.1016/0167-4781(89)90016-X; RODIONOV VI, 1991, P NATL ACAD SCI USA, V88, P4956, DOI 10.1073/pnas.88.11.4956; ROOF DM, 1991, COLD SPRING HARB SYM, V56, P693; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Sawin K E, 1991, Trends Cell Biol, V1, P122, DOI 10.1016/0962-8924(91)90117-R; SAWIN KE, 1992, J CELL SCI, V101, P303; SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; WILLIAMS RC, 1979, BIOCHEMISTRY-US, V18, P2499, DOI 10.1021/bi00579a010; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x	33	303	312	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 8	1992	359	6395					543	547		10.1038/359543a0	http://dx.doi.org/10.1038/359543a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406973				2022-12-28	WOS:A1992JR85900062
J	BAIRD, EA; MCHENRY, PM; MACKIE, RM				BAIRD, EA; MCHENRY, PM; MACKIE, RM			EFFECT OF MAINTENANCE CHEMOTHERAPY IN CHILDHOOD ON NUMBERS OF MELANOCYTIC NEVI	BRITISH MEDICAL JOURNAL			English	Article							MALIGNANT-MELANOMA; RISK-FACTOR; NEVI	Objective-(a) To determine whether children given chemotherapy for haematological malignancy have significantly more melanocytic naevi than age matched children in the local population; (b) to establish whether any observed variation in naevus counts from normal is seen at the start of maintenance chemotherapy. Design-Follow up of 29 consecutive children starting maintenance chemotherapy, with parental interview and count of all melanocytic naevi greater-than-or-equal-to 2 mm on the child's skin. Assessment repeated three years later after completion of maintenance chemotherapy. Other dermatological problems identified at either visit were also recorded. Setting-Royal Hospital for Sick Children, Glasgow. Results-At the start of maintenance chemotherapy all children had total body counts of melanocytic naevi within the normal range established for age matched children in the local population. Three years later total body naevus counts were significantly increased, the median increase being 66 naevi per child (95% confidence interval 57 to 94). The only other problem noted in these children was relatively poor regrowth of scalp hair. Conclusion-Children on maintenance chemotherapy for haematological malignancies develop an excessive number of melanocytic naevi. Excessive numbers of melanocytic naevi are the most important risk factor for melanoma in the general population. These children should have periodic skin examinations at their follow up visits, and both child and parent should be educated about clinical features of early melanoma.	UNIV GLASGOW,ROYAL HOSP SICK CHILDREN,DEPT DERMATOL,GLASGOW G12 8QQ,SCOTLAND	University of Glasgow								DEWIT PEJ, 1990, MED PEDIATR ONCOL, V18, P336, DOI 10.1002/mpo.2950180417; GALLAGHER RP, 1990, ARCH DERMATOL, V126, P770, DOI 10.1001/archderm.126.6.770; HOLLY EA, 1987, J AM ACAD DERMATOL, V17, P459, DOI 10.1016/S0190-9622(87)70230-8; HUGHES BR, 1989, BMJ-BRIT MED J, V299, P88, DOI 10.1136/bmj.299.6691.88; MACKIE RM, 1985, BRIT J DERMATOL, V113, P167, DOI 10.1111/j.1365-2133.1985.tb02060.x; MACKIE RM, 1989, LANCET, V2, P487; OSTERLIND A, 1988, INT J CANCER, V42, P200, DOI 10.1002/ijc.2910420210; SWERDLOW AJ, 1986, BRIT MED J, V292, P1555, DOI 10.1136/bmj.292.6535.1555	8	39	39	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 3	1992	305	6857					799	801		10.1136/bmj.305.6857.799	http://dx.doi.org/10.1136/bmj.305.6857.799			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT256	1422359	Green Submitted, Green Published, Bronze			2022-12-28	WOS:A1992JT25600019
J	KRETZNER, L; BLACKWOOD, EM; EISENMAN, RN				KRETZNER, L; BLACKWOOD, EM; EISENMAN, RN			MYC AND MAX PROTEINS POSSESS DISTINCT TRANSCRIPTIONAL ACTIVITIES	NATURE			English	Article							C-MYC; DNA-BINDING; ACTIVATES TRANSCRIPTION; GENE-EXPRESSION; CELLS; ONCOGENE; PRODUCT; SITES; RNA	THE MyC family proteins are thought to be involved in transcription1,2 because they have both a carboxy-terminal basic-helix-loop-helix-zipper (bHLH-Z) domain, common to a large class of transcription factors, and an amino-terminal fragment which, for c-Myc, has transactivating function when assayed in chimaeric constructs4. In addition, c-, N- and L-Myc proteins heterodimerize, in vitro and in vivo, with the bHLH-Z protein Max5-8. In vitro, Max homodimerizes but preferentially associates with Myc, which homodimerizes poorly5,6. Furthermore Myc-Max heterodimers specifically bind the nucleotide sequence CACGTG9 with higher affinity than either homodimer alone5. The identification of Max and the specific DNA-binding activities of Myc and Max provides an opportunity for directly testing the transcriptional activities of these proteins in mammalian cells. We report here that Myc overexpression activates, whereas Max overexpression represses, transcription of a reporter gene. Max-induced repression is relieved by overexpression of c-Myc. Repression requires the DNA-binding domain of Max, whereas relief of repression requires the dimerization and transcriptional activation activities of Myc. Both effects require Myc-Max-binding sites in the reporter gene.	UNIV WASHINGTON,SCH MED,DEPT PATHOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	KRETZNER, L (corresponding author), FRED HUTCHINSON CANC RES CTR,DIV BASIC SCI,1124 COLUMBIA ST,SEATTLE,WA 98104, USA.							BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BERBERICH SJ, 1992, GENE DEV, V6, P166, DOI 10.1101/gad.6.2.166; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; DEAN M, 1986, J BIOL CHEM, V261, P9161; GEBALLE AP, 1988, J VIROL, V62, P3334, DOI 10.1128/JVI.62.9.3334-3340.1988; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; HALAZONETIS TD, 1991, P NATL ACAD SCI USA, V88, P6162, DOI 10.1073/pnas.88.14.6162; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; HARLAND R, 1985, J CELL BIOL, V101, P1094, DOI 10.1083/jcb.101.3.1094; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; KADDURAHDAOUK R, 1987, GENE DEV, V1, P347, DOI 10.1101/gad.1.4.347; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; KINGSTON RE, 1985, CELL, V41, P3, DOI 10.1016/0092-8674(85)90049-2; NYBORG JK, 1990, J BIOL CHEM, V265, P8237; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; WATERS CM, 1991, ONCOGENE, V6, P797; WENZEL A, 1991, EMBO J, V10, P3703, DOI 10.1002/j.1460-2075.1991.tb04938.x	26	458	466	0	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 1	1992	359	6394					426	429		10.1038/359426a0	http://dx.doi.org/10.1038/359426a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406956				2022-12-28	WOS:A1992JQ62400060
J	PINES, G; DANBOLT, NC; BJORAS, M; ZHANG, YM; BENDAHAN, A; EIDE, L; KOEPSELL, H; STORMMATHISEN, J; SEEBERG, E; KANNER, BI				PINES, G; DANBOLT, NC; BJORAS, M; ZHANG, YM; BENDAHAN, A; EIDE, L; KOEPSELL, H; STORMMATHISEN, J; SEEBERG, E; KANNER, BI			CLONING AND EXPRESSION OF A RAT-BRAIN L-GLUTAMATE TRANSPORTER	NATURE			English	Article							AMINO-ACIDS; MEMBRANE-VESICLES; RNA-POLYMERASE; SODIUM; HETEROGENEITY; ASPARTATE; FAMILY; SYSTEM; SITES	SYNAPTIC transmission of most vertebrate synapses is thought to be terminated by rapid transport of the neurotransmitter into presynaptic nerve terminals or neuroglia1-5. L-Glutamate is the major excitatory transmitter in brain and its transport represents the mechanism by which it is removed from the synaptic cleft and kept below toxic levels5,6. Here we use an antibody against a glial L-glutamate transporter from rat brain7 to isolate a complementary DNA clone encoding this transporter. Expression of this cDNA in transfected HeLa cells indicates that L-glutamate accumulation requires external sodium and internal potassium and transport shows the expected stereospecificity. The cDNA sequence predicts a protein of 573 amino acids with 8-9 putative transmembrane alpha-helices. Database searches indicate that this protein is not homologous to any identified protein of mammalian origin, including the recently described superfamily of neurotransmitter transporters. This protein therefore seems to be a member of a new family of transport molecules.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT BIOCHEM,POB 1172,IL-91010 JERUSALEM,ISRAEL; UNIV OSLO,INST ANAT,N-0137 OSLO,NORWAY; UNIV OSLO,CTR BIOTECHNOL,N-0136 OSLO,NORWAY; NORWEGIAN DEF RES ESTAB,DIV ENVIRONM TOXICOL,N-2007 KJELLER,NORWAY; MAX PLANCK INST BIOPHYS,W-6000 FRANKFURT 70,GERMANY	Hebrew University of Jerusalem; University of Oslo; University of Oslo; Norwegian Defence Research Establishment; Max Planck Society			Bjørås, Magnar/N-9286-2017; Danbolt, Niels Christian/A-1907-2014	Danbolt, Niels Christian/0000-0003-4227-4520; Storm-Mathisen, Jon/0000-0002-2930-3262				BALCAR VJ, 1972, J NEUROBIOL, V3, P295, DOI 10.1002/neu.480030403; BENNETT JP, 1974, LIFE SCI, V15, P1045, DOI 10.1016/S0024-3205(74)80002-0; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; FERKANY J, 1986, J NEUROSCI RES, V16, P491, DOI 10.1002/jnr.490160305; FLETCHER EJ, 1991, J NEUROCHEM, V57, P911, DOI 10.1111/j.1471-4159.1991.tb08237.x; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; IVERSEN LL, 1973, BRIT MED BULL, V29, P130, DOI 10.1093/oxfordjournals.bmb.a070982; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MCBEAN GJ, 1985, J NEUROCHEM, V44, P247, DOI 10.1111/j.1471-4159.1985.tb07137.x; NICOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462; Perbal B., 1988, PRACTICAL GUIDE MOL; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; RADIAN R, 1985, J BIOL CHEM, V260; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; Sambrook J., 1989, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; TAXT T, 1984, NEUROSCIENCE, V11, P79, DOI 10.1016/0306-4522(84)90215-X; TOLNER B, 1992, J BACTERIOL, V174, P2391, DOI 10.1128/JB.174.7.2391-2393.1992; UHL GR, 1992, TRENDS NEUROSCI, V15, P265, DOI 10.1016/0166-2236(92)90068-J; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WILKIN GP, 1982, BRAIN RES, V244, P69, DOI 10.1016/0006-8993(82)90905-2	33	1136	1160	0	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 3	1992	360	6403					464	467		10.1038/360464a0	http://dx.doi.org/10.1038/360464a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448170				2022-12-28	WOS:A1992KA79700060
J	FAHN, S				FAHN, S			FETAL-TISSUE TRANSPLANTS IN PARKINSONS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											FAHN, S (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032, USA.							BALLARD PA, 1985, NEUROLOGY, V35, P949, DOI 10.1212/WNL.35.7.949; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; SAWLE GV, 1992, ANN NEUROL, V31, P166, DOI 10.1002/ana.410310207; SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203	7	26	29	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1589	1590		10.1056/NEJM199211263272209	http://dx.doi.org/10.1056/NEJM199211263272209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435887				2022-12-28	WOS:A1992JZ43200009
J	GARRY, DJ; CAPLAN, AL; VAWTER, DE; KEARNEY, W				GARRY, DJ; CAPLAN, AL; VAWTER, DE; KEARNEY, W			ARE THERE REALLY ALTERNATIVES TO THE USE OF FETAL TISSUE FROM ELECTIVE ABORTIONS IN TRANSPLANTATION RESEARCH	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ECTOPIC PREGNANCY; MANAGEMENT; FETUS; DEATH				GARRY, DJ (corresponding author), UNIV MINNESOTA,MINNEAPOLIS,MN 55455, USA.							BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; BRENNER PF, 1980, JAMA-J AM MED ASSOC, V243, P673, DOI 10.1001/jama.243.7.673; BUDOWICK M, 1980, FERTIL STERIL, V34, P169; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; ELIAS S, 1981, AM J OBSTET GYNECOL, V141, P698, DOI 10.1016/S0002-9378(15)33314-7; FERNANDEZ H, 1988, OBSTET GYNECOL, V71, P171; FUNG CHK, 1990, JAMA-J AM MED ASSOC, V264, P34, DOI 10.1001/jama.1990.03450010038015; KALTER H, 1987, AM J OBSTET GYNECOL, V156, P1243, DOI 10.1016/0002-9378(87)90156-6; LEACH RE, 1989, J REPROD MED, V34, P324; MARTIN JN, 1988, OBSTET GYNECOL, V71, P549; MORRISON I, 1985, AM J OBSTET GYNECOL, V152, P975, DOI 10.1016/0002-9378(85)90542-3; Nederlof K P, 1990, MMWR CDC Surveill Summ, V39, P9; NOLAN K, 1990, TRANSPLANT P, V22, P1028; PITKIN RM, 1987, AM J OBSTET GYNECOL, V157, P583, DOI 10.1016/S0002-9378(87)80011-X; POLAND BJ, 1976, TERATOLOGY, V14, P315, DOI 10.1002/tera.1420140306; RAYBURN W, 1985, OBSTET GYNECOL, V65, P637; ROCHESTER D, 1987, RADIOLOGY, V165, P843, DOI 10.1148/radiology.165.3.3317509; RUBIN GL, 1983, JAMA-J AM MED ASSOC, V249, P1725, DOI 10.1001/jama.249.13.1725; SIMPSON JL, 1982, GENETICS OBSTETRICS, P125; STAFFORD PA, 1988, AM J OBSTET GYNECOL, V159, P485, DOI 10.1016/S0002-9378(88)80115-7; STRATFORD BF, 1970, AM J OBSTET GYNECOL, V107, P1223, DOI 10.1016/S0002-9378(15)30373-2; STROBINO BA, 1987, AM J OBSTET GYNECOL, V157, P1150, DOI 10.1016/S0002-9378(87)80280-6; THORNE E D, 1989, Fetal Therapy, V4, P37; VAWTER DE, 1992, J LAB CLIN MED, V120, P30; WINTER RM, 1988, MALFORMED FETUS STIL, P14; 1985, JAMA-J AM MED ASSOC, V254, P1891; 1987, BUREAU CENSUS, P74; 1984, SPONTANEOUS ABORTION, V8, P34	28	21	21	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1592	1595		10.1056/NEJM199211263272211	http://dx.doi.org/10.1056/NEJM199211263272211			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435888				2022-12-28	WOS:A1992JZ43200011
J	FRENCH, S				FRENCH, S			CONSEQUENCES OF REPLICATION FORK MOVEMENT THROUGH TRANSCRIPTION UNITS INVIVO	SCIENCE			English	Article							ESCHERICHIA-COLI CHROMOSOME; BIOTIN HOLOENZYME SYNTHETASE; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; CELL-CYCLE; BIRA-GENE; ORGANIZATION; OPERON; VISUALIZATION	To examine the basis for the evolutionary selection for codirectionality of replication and transcription in Escherichia coli, electron microscopy was used to visualize replication from an inducible ColE1 replication origin inserted into the Escherichia coli chromosome upstream (5') or downstream (3') of rrnB, a ribosomal RNA operon. Active rrnB operons were replicated either in the same direction in which they were transcribed or in the opposite direction. In either direction, RNA polymerases were dislodged during replication. When replication and transcription were codirectional, the rate of replication fork movement was similar to that observed in nontranscribed regions. When replication and transcription occurred in opposite directions, replication fork movement was reduced.			FRENCH, S (corresponding author), UNIV VIRGINIA,DEPT BIOL,CHARLOTTESVILLE,VA 22903, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021020] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 21020] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLMAN R, 1991, J BACTERIOL, V173, P7970, DOI 10.1128/jb.173.24.7970-7974.1991; BACKMAN K, 1978, COLD SPRING HARB SYM, V43, P69; BARKER DF, 1981, J MOL BIOL, V146, P469, DOI 10.1016/0022-2836(81)90043-7; BEDINGER P, 1983, CELL, V34, P115, DOI 10.1016/0092-8674(83)90141-1; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; BREWER BJ, 1990, BACTERIAL CHROMOSOME, P61; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; COOPER S, 1985, J MOL BIOL, V163, P661; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FRENCH SL, 1989, J BACTERIOL, V171, P4207, DOI 10.1128/JB.171.8.4207-4216.1989; GOTTA S, 1991, THESIS U VIRGINIA; GOTTA SL, 1991, J BACTERIOL, V173, P6647, DOI 10.1128/jb.173.20.6647-6649.1991; HELLER K, 1985, J BACTERIOL, V161, P904, DOI 10.1128/JB.161.3.904-908.1985; HELMSTETTER CE, 1968, J MOL BIOL, V31, P507, DOI 10.1016/0022-2836(68)90424-5; HIROSE S, 1983, MOL GEN GENET, V189, P422, DOI 10.1007/BF00325904; HOFMANN S, 1977, J BACTERIOL, V132, P718, DOI 10.1128/JB.132.2.718-722.1977; HOWARD PK, 1985, GENE, V35, P321, DOI 10.1016/0378-1119(85)90011-3; INOUE N, 1991, J BACTERIOL, V173, P1208, DOI 10.1128/jb.173.3.1208-1214.1991; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LUNDRIGAN MD, 1991, P NATL ACAD SCI USA, V88, P1479, DOI 10.1073/pnas.88.4.1479; MCKNIGHT SL, 1978, THESIS U VIRGINIA; MKANIATIS T, 1982, MOL CLONING LABORATO, P68; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; OSHEIM YN, 1988, MOL CELL BIOL, V8, P2811, DOI 10.1128/MCB.8.7.2811; PANAYOTATOS N, 1984, NUCLEIC ACIDS RES, V12, P2641, DOI 10.1093/nar/12.6.2641; RAHMOUNI R, 1992, J MOL BIOL, V223, P131; SAFFER LD, 1986, MOL CELL BIOL, V6, P1148, DOI 10.1128/MCB.6.4.1148; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X	33	206	209	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 20	1992	258	5086					1362	1365		10.1126/science.1455232	http://dx.doi.org/10.1126/science.1455232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455232				2022-12-28	WOS:A1992JY95800040
J	HAYASHI, H; CZAJA, I; LUBENOW, H; SCHELL, J; WALDEN, R				HAYASHI, H; CZAJA, I; LUBENOW, H; SCHELL, J; WALDEN, R			ACTIVATION OF A PLANT GENE BY T-DNA TAGGING - AUXIN-INDEPENDENT GROWTH-INVITRO	SCIENCE			English	Article							TRANSFORMATION; EXPRESSION; PLASMID; VECTORS; SET	A transferred DNA (T-DNA) tagging vector with the potential to produce dominant mutations was used with cocultured Agrobacterium tumefaciens and protoplasts to tag genes involved in the action of the plant growth substance auxin. Transgenic calli were selected for their ability to grow in the absence of auxin in the culture media. From one experiment, 12 calli that displayed this phenotype were recovered, of which 11 were able to regenerate into plants. In one plant studied in detail, protoplast division in the absence of auxin genetically cosegregated with a single T-DNA insert. A messenger RNA encoded by a 6.4-kilobase sequence of plant genomic DNA rescued from the mutant is overexpressed relative to untransformed plants. The genomic DNA, as well as a cognate complementary DNA, once transfected into protoplasts promote growth and cell division in vitro in the absence of exogenously added auxin.	MAX PLANCK INST ZUCHTUNGSFORSCH,CARL VON LINNE WEG 10,W-5000 COLOGNE 30,GERMANY; UNIV TOKYO,FAC AGR,BUNKYO KU,TOKYO 113,JAPAN	Max Planck Society; University of Tokyo								Davies P. J., 1987, PLANT HORMONES THEIR; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DEPICKER A, 1985, MOL GEN GENET, V201, P477, DOI 10.1007/BF00331342; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Draper J., 1988, PLANT GENETIC TRANSF; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KADO CI, 1991, CRIT REV PLANT SCI, V10, P1, DOI 10.1080/07352680490273310; Kahl G., 1982, MOL BIOL PLANT TUMOR; KONCZ C, 1990, EMBO J, V9, P1337, DOI 10.1002/j.1460-2075.1990.tb08248.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; MALIGA P, 1975, NATURE, V255, P401, DOI 10.1038/255401a0; MARSH JL, 1984, GENE, V32, P481, DOI 10.1016/0378-1119(84)90022-2; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEGRUTIU I, 1987, PLANT MOL BIOL, V8, P363, DOI 10.1007/BF00015814; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; PALME K, 1991, MECH DEVELOP, V33, P97, DOI 10.1016/0925-4773(91)90076-I; Sambrook J, 1989, MOL CLONING LABORATO; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; WALDEN R, 1990, Methods in Molecular and Cellular Biology, V1, P175; WALDEN R, 1991, PLANT J, V1, P281, DOI 10.1046/j.1365-313X.1991.t01-6-00999.x; WALDEN R, 1990, EUR J BIOCHEM, V192, P563, DOI 10.1111/j.1432-1033.1990.tb19262.x; WEISING K, 1988, ANNU REV GENET, V22, P421, DOI 10.1146/annurev.ge.22.120188.002225; ZAMBRYSKI P, 1989, CELL, V56, P193, DOI 10.1016/0092-8674(89)90892-1; ZAMBRYSKI P, 1989, MOBILE DNA, P309	29	141	170	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 20	1992	258	5086					1350	1353		10.1126/science.1455228	http://dx.doi.org/10.1126/science.1455228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455228				2022-12-28	WOS:A1992JY95800036
J	BARRETTCONNOR, E				BARRETTCONNOR, E			LOWER ENDOGENOUS ANDROGEN LEVELS AND DYSLIPIDEMIA IN MEN WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS	ANNALS OF INTERNAL MEDICINE			English	Article						ANDROGENS; DIABETES-MELLITUS, NON-INSULIN-DEPENDENT; TESTOSTERONE; LIPOPROTEINS, HDL; CHOLESTEROL; TRIGLYCERIDES	DENSITY-LIPOPROTEIN CHOLESTEROL; HORMONE-BINDING GLOBULIN; PLASMA TESTOSTERONE LEVELS; SEX-HORMONES; GLUCOSE-INTOLERANCE; BOUND TESTOSTERONE; SERUM-LIPOPROTEINS; ADULT MEN; ESTRADIOL; RESISTANCE	Objective: To compare plasma androgen levels in diabetic and nondiabetic men and to determine their relation to diabetic dyslipidemia. Design: A population-based, case-control study. Setting: Community. Participants: Men 53 to 88 years of age from the Rancho Bernardo, California, cohort who were screened for diabetes using an oral glucose tolerance test. Measurements: Plasma androgen levels were compared in 44 men with untreated non-insulin-dependent diabetes mellitus and 88 age-matched men who had a normal glucose tolerance test. The relation of lipid and lipoprotein levels to androgen level and diabetic status was assessed before and after adjusting for covariates. Results: Men with diabetes had significantly lower plasma levels of free (4.96 nmol/L compared with 5.58 nmol/L) and total testosterone (14.7 nmol/L compared with 17.4 nmol/L), dihydrotestosterone (428 pg/mL compared with 533 pg/mL), and dehydroepiandrosterone sulfate (DHEA-S) (1.92 mumol/L compared with 2.42 mumol/L) than nondiabetic men. They also had significantly lower high-density lipoprotein (HDL) cholesterol and significantly higher triglyceride levels. Differences were not explained by obesity, alcohol use, or cigarette habit. Overall, the total testosterone level, but not the free testosterone level, was positively correlated with the HDL cholesterol level (P = 0.009) and negatively correlated with the triglyceride level (P = 0.0001). Similar associations were seen in analyses restricted to the men without diabetes. Conclusions: Lower levels of endogenous androgens are seen in older diabetic men, and low androgen levels are associated with diabetic dyslipidemia.			BARRETTCONNOR, E (corresponding author), UNIV CALIF SAN DIEGO, DEPT COMMUNITY & FAMILY MED, 9500 GILMAN DR, LA JOLLA, CA 92093 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG007181, R01AG007181] Funding Source: NIH RePORTER; NIA NIH HHS [AG07181] Funding Source: Medline; NIDDK NIH HHS [DK31801] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBOTT WGH, 1987, DIABETES, V36, P897, DOI 10.2337/diabetes.36.8.897; ANDERSON DC, 1976, STEROIDS, V28, P179, DOI 10.1016/0039-128X(76)90108-2; ANDO S, 1984, J ENDOCRINOL INVEST, V7, P21, DOI 10.1007/BF03348370; BARRETTCONNOR E, 1990, AM J EPIDEMIOL, V132, P895, DOI 10.1093/oxfordjournals.aje.a115732; BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278; COHEN JC, 1987, J CLIN ENDOCR METAB, V64, P960, DOI 10.1210/jcem-64-5-960; DAI WS, 1984, AM J CARDIOL, V53, P1259, DOI 10.1016/0002-9149(84)90075-4; DAI WS, 1981, AM J EPIDEMIOL, V114, P804, DOI 10.1093/oxfordjournals.aje.a113251; DUELL PB, 1990, ARCH INTERN MED, V150, P2317, DOI 10.1001/archinte.150.11.2317; FRIEDL KE, 1989, J CLIN ENDOCR METAB, V68, P971, DOI 10.1210/jcem-68-5-971; FRIEDL KE, 1990, METABOLISM, V39, P69, DOI 10.1016/0026-0495(90)90150-B; GODSLAND IF, 1986, CLIN SCI, V71, P665, DOI 10.1042/cs0710665; GUTAI J, 1981, AM J CARDIOL, V48, P897, DOI 10.1016/0002-9149(81)90356-8; HAMALAINEN E, 1986, METABOLISM, V35, P535, DOI 10.1016/0026-0495(86)90011-9; HELLER RF, 1983, ACTA ENDOCRINOL-COP, V104, P253, DOI 10.1530/acta.0.1040253; Khaw K T, 1992, Ann Epidemiol, V2, P675, DOI 10.1016/1047-2797(92)90012-F; KHAW KT, 1991, ARTERIOSCLER THROMB, V11, P489, DOI 10.1161/01.ATV.11.3.489; KIRKLAND RT, 1987, JAMA-J AM MED ASSOC, V257, P502, DOI 10.1001/jama.257.4.502; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; LASKARZEWSKI PM, 1983, METABOLISM, V32, P262, DOI 10.1016/0026-0495(83)90191-9; LICHTENSTEIN MJ, 1987, AM J EPIDEMIOL, V126, P647, DOI 10.1093/oxfordjournals.aje.a114704; LINDHOLM J, 1982, AM J MED, V73, P648, DOI 10.1016/0002-9343(82)90405-3; MANNI A, 1985, J CLIN ENDOCR METAB, V61, P705, DOI 10.1210/jcem-61-4-705; MARIN P, IN PRESS OBESITY EUR; MENDOZA SG, 1981, METABOLISM, V30, P481, DOI 10.1016/0026-0495(81)90184-0; MILLER GJ, 1985, ATHEROSCLEROSIS, V55, P251, DOI 10.1016/0021-9150(85)90104-2; MORRISON JA, 1981, CIRCULATION, V64, P113; NORDOY A, 1979, ATHEROSCLEROSIS, V34, P431, DOI 10.1016/0021-9150(79)90067-4; OSTLUND RE, 1990, NEW ENGL J MED, V322, P229, DOI 10.1056/NEJM199001253220404; REBUFFESCRIVE M, 1992, INT J OBESITY, V2, P675; SEIDELL JC, 1990, METABOLISM, V39, P897, DOI 10.1016/0026-0495(90)90297-P; SEMMENS J, 1983, METABOLISM, V32, P428, DOI 10.1016/0026-0495(83)90002-1; SIMON D, 1992, DIABETOLOGIA, V35, P173, DOI 10.1007/BF00402551; SRINIVASAN SR, 1985, METABOLISM, V34, P861, DOI 10.1016/0026-0495(85)90111-8; STEFANICK ML, 1987, J CLIN ENDOCR METAB, V64, P723, DOI 10.1210/jcem-64-4-723; THOMPSON PD, 1989, JAMA-J AM MED ASSOC, V261, P1165, DOI 10.1001/jama.261.8.1165; TREMBLAY RR, 1974, CONTRACEPTION, V10, P599, DOI 10.1016/0010-7824(74)90099-7; WILSON JD, 1980, METABOLISM, V29, P1278, DOI 10.1016/0026-0495(80)90159-6; WINGARD D L, 1990, Diabetes Care, V13, P3; WOODARD TL, 1981, J CLIN ENDOCR METAB, V53, P905, DOI 10.1210/jcem-53-5-905; ZIMMET P, 1990, DIABETES RES CLIN PR, V10, pS167, DOI 10.1016/0168-8227(90)90158-P; 1985, WHO727 STUD GROUP DI; 1974, DHEW75628 NAT HEART	43	239	243	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					807	811		10.7326/0003-4819-117-10-807	http://dx.doi.org/10.7326/0003-4819-117-10-807			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416554				2022-12-28	WOS:A1992JX83800002
J	MILLER, SK				MILLER, SK			RACIAL MODIFIERS .3. ASIAN-AMERICANS BUMP AGAINST GLASS CEILINGS	SCIENCE			English	Article											MILLER, SK (corresponding author), NEW SCIENTIST,LONDON SE1 9LS,ENGLAND.								0	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1224	&		10.1126/science.1439831	http://dx.doi.org/10.1126/science.1439831			0	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JX852	1439831				2022-12-28	WOS:A1992JX85200051
J	VASSALLO, DJ; CHANA, J; CLARK, CLI; SMITH, RE; WOOD, RFM				VASSALLO, DJ; CHANA, J; CLARK, CLI; SMITH, RE; WOOD, RFM			INTRODUCTION OF A PARTIAL SHIFT SYSTEM FOR HOUSE OFFICERS IN A TEACHING HOSPITAL	BRITISH MEDICAL JOURNAL			English	Article								Objectives-(1) To introduce a partial shift system to reduce the hours of work of preregistration house surgeons to an average of 64 a week to comply with the New Deal for junior doctors; (2) to test linking the partial shift concept to an existing structure of "on call" firms. Design-Formal assessment after three months of a pilot partial shift system for eight house surgeons on three firms instituted on 1 November 1991, followed by questionnaire and interview evaluation at three and six months of a revised system implemented on 1 February 1992. Setting-Department of general surgery at St Bartholomew's Hospital, London. Subjects-24 house surgeons attached to three surgical firms. Results-In eight weeks each house surgeon worked one week (five shifts) of night duty, one week of "cover" (afternoon and evening) duty, and six weeks of normal daytime hours. Each weekday a house surgeon from the firm on call worked an extended daytime on call shift until 10 pm. Weekend duties were split between two house surgeons from the firm on call. A computer generated graphical display of the rota was used to facilitate leave planning. Average working hours were reduced to below 64 per week, including prospective cover, without detriment to patient care and educational standards. Within the shift system individual house surgeons could be on call with their own firm by day and at weekends. Opinions were equally divided among junior staff as to their preference for either on call or partial shift systems. Conclusions-The principles of this partial shift system are generally applicable and the model can readily be adopted by district general hospitals.			VASSALLO, DJ (corresponding author), ST BARTHOLOMEWS HOSP,PROFESSORIAL SURG UNIT,LONDON EC1A 7BE,ENGLAND.		Vassallo, David J/B-4888-2013					BEECHAM L, 1992, BRIT MED J, V304, P403; DILLNER L, 1992, BRIT MED J, V304, P270, DOI 10.1136/bmj.304.6822.270; KORGAONKAR G, 1992, BRIT J HOSP MED, V47, P691; NASMYTH DG, 1991, BRIT MED J, V302, P93, DOI 10.1136/bmj.302.6768.93; ROSS APJ, 1992, BRIT MED J, V304, P385, DOI 10.1136/bmj.304.6823.385-c; 1991, JUNIOR DOCTORS NEW D; 1992, 22ND REP	7	16	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 24	1992	305	6860					1005	1008		10.1136/bmj.305.6860.1005	http://dx.doi.org/10.1136/bmj.305.6860.1005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV776	1458109	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JV77600035
J	WILLIAMS, TL				WILLIAMS, TL			PHASE COUPLING BY SYNAPTIC SPREAD IN CHAINS OF COUPLED NEURONAL OSCILLATORS	SCIENCE			English	Article							LAMPREY SPINAL-CORD; CENTRAL PATTERN GENERATOR; LOCOMOTION; INTERNEURONS; FREQUENCY; MODEL	Many neural systems behave as arrays of coupled oscillators, with characteristic phase coupling. For example, the rhythmic activation patterns giving rise to swimming in fish are characterized by a rostral-to-caudal phase delay in ventral root activity that is independent of the cycle duration. This produces a traveling wave of curvature along the body of the animal with a wavelength approximately equal to the body length. Here a simple mechanism for phase coupling in chains of equally activated oscillators is postulated: the synapses between the cells making up a "unit oscillator" are simply repeated in neighboring segments, with a reduced synaptic strength. If such coupling is asymmetric in the rostral and caudal directions, traveling waves of activity are produced. The intersegmental phase lag that develops is independent of the coupling strength over at least a tenfold range. Furthermore, for the unit oscillator believed to underlie central pattern generation in the lamprey spinal cord, such coupling can result in a phase lag that is independent of frequency.			WILLIAMS, TL (corresponding author), UNIV LONDON ST GEORGES HOSP,SCH MED,DEPT PHYSIOL,LONDON SW17 0RE,ENGLAND.							BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P948, DOI 10.1152/jn.1982.47.5.948; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P961, DOI 10.1152/jn.1982.47.5.961; BUCHANAN JT, 1987, SCIENCE, V236, P312, DOI 10.1126/science.3563512; BUCHANAN JT, 1992, BIOL CYBERN, V66, P367, DOI 10.1007/BF00203673; COHEN AH, 1982, J MATH BIOL, V13, P345, DOI 10.1007/BF00276069; COHEN AH, 1987, J NEUROSCI METH, V21, P113, DOI 10.1016/0165-0270(87)90109-9; COHEN AH, 1980, EXP BRAIN RES, V41, P11; DALE N, 1986, J NEUROSCI, V6, P2662, DOI 10.1523/jneurosci.06-09-02662.1986; EKEBERG O, 1991, BIOL CYBERN, V65, P81, DOI 10.1007/BF00202382; ERMENTROUT GB, 1984, SIAM J MATH ANAL, V15, P215, DOI 10.1137/0515019; ERMENTROUT GB, 1991, J MATH BIOL, V29, P155; GRILLNER S, 1974, EXP BRAIN RES, V20, P459; GRILLNER S, 1988, NEUROSCI LETT, V89, P31, DOI 10.1016/0304-3940(88)90476-4; Grillner S., 1976, NEURAL CONTROL LOCOM, P181; KOPELL N, 1990, SIAM J APPL MATH, V50, P1014, DOI 10.1137/0150062; KOPELL N, 1988, MATH BIOSCI, V90, P87, DOI 10.1016/0025-5564(88)90059-4; KOPELL N, 1986, COMMUN PUR APPL MATH, V39, P623, DOI 10.1002/cpa.3160390504; KOPELL N, 1991, SIAM J APPL MATH, V51, P1397, DOI 10.1137/0151070; MATSUSHIMA T, 1992, J NEUROPHYSIOL, V67, P373, DOI 10.1152/jn.1992.67.2.373; ROVAINEN CM, 1974, J COMP NEUROL, V154, P189, DOI 10.1002/cne.901540206; ROVAINEN CM, 1989, J NEUROPHYSIOL, V54, P959; Sigvardt K.A., 1992, Seminars in the Neurosciences, V4, P37, DOI 10.1016/1044-5765(92)90032-W; SIGVARDT K A, 1991, Society for Neuroscience Abstracts, V17, P122; SIGVARDT KA, 1989, AM ZOOL, V29, P19; SZEKELY G, 1965, ACTA PHYSIOL HUNG, V27, P285; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; WALLEN P, IN PRESS J NEUROPHYS; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862; WILLIAMS TL, 1989, J EXP BIOL, V143, P559; WILLIAMS TL, 1992, NEURAL COMPUT, V4, P546, DOI 10.1162/neco.1992.4.4.546	30	107	107	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 23	1992	258	5082					662	665		10.1126/science.1411575	http://dx.doi.org/10.1126/science.1411575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU745	1411575				2022-12-28	WOS:A1992JU74500061
J	ARONSON, JK; HARDMAN, M				ARONSON, JK; HARDMAN, M			ABC OF MONITORING DRUG-THERAPY - WHY MONITOR DRUG-THERAPY	BRITISH MEDICAL JOURNAL			English	Article									ICI PLC,DIV MED RES,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND		ARONSON, JK (corresponding author), RADCLIFFE INFIRM,OXFORD OX2 6HE,ENGLAND.								0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 17	1992	305	6859					947	948		10.1136/bmj.305.6859.947	http://dx.doi.org/10.1136/bmj.305.6859.947			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JU649	1458079	Green Submitted, Green Published, Bronze			2022-12-28	WOS:A1992JU64900030
J	BREWER, BJ; LOCKSHON, D; FANGMAN, WL				BREWER, BJ; LOCKSHON, D; FANGMAN, WL			THE ARREST OF REPLICATION FORKS IN THE RDNA OF YEAST OCCURS INDEPENDENTLY OF TRANSCRIPTION	CELL			English	Article							RNA POLYMERASE-I; BACILLUS-SUBTILIS CHROMOSOME; ESCHERICHIA-COLI CHROMOSOME; DNA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL DNA; TERMINATOR PROTEIN; S-PHASE; PLASMID; SEQUENCE	Replication forks, moving opposite to the direction of transcription, are arrested at the 3' ends of the 35S transcription units in the rDNA locus of S. cerevisiae. Because of its position and polarity, we tested the hypothesis that this replication fork barrier (RFB) results from the act of transcription. Three results contradict this hypothesis. First, the RFB persists in a strain containing a disruption of the gene for the 135 kd subunit of RNA polymerase I. Second, the RFB causes a polar arrest of replication forks when transplanted to a plasmid. Third, transcription by RNA polymerase II of a plasmid copy of the 35S transcription unit lacking the RFB does not generate a barrier. We propose that replication forks are arrested in a directional manner through the binding of one or more proteins to two closely spaced sites in the RFB.			BREWER, BJ (corresponding author), UNIV WASHINGTON,DEPT GENET,SK-50,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018926, R37GM018926] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER SM, 1987, MOL GEN GENET, V208, P127, DOI 10.1007/BF00330433; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; DHAR V, 1991, MOL CELL BIOL, V11, P6268, DOI 10.1128/MCB.11.12.6268; FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; HIDAKA M, 1988, CELL, V55, P467, DOI 10.1016/0092-8674(88)90033-5; HILL TM, 1988, J BACTERIOL, V170, P662, DOI 10.1128/jb.170.2.662-668.1988; HILL TM, 1989, P NATL ACAD SCI USA, V86, P1593, DOI 10.1073/pnas.86.5.1593; HILL TM, 1988, CELL, V55, P459, DOI 10.1016/0092-8674(88)90032-3; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON SP, 1989, MOL CELL BIOL, V9, P4986, DOI 10.1128/MCB.9.11.4986; KEMPERSVEENSTRA AE, 1986, EMBO J, V5, P2703, DOI 10.1002/j.1460-2075.1986.tb04554.x; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; KOBAYASHI T, 1989, EMBO J, V8, P2435, DOI 10.1002/j.1460-2075.1989.tb08374.x; KOBAYASHI T, 1992, MOL GEN GENET, V233, P355, DOI 10.1007/BF00265431; KULKENS T, 1989, CURR GENET, V16, P351, DOI 10.1007/BF00340714; LEE EH, 1989, P NATL ACAD SCI USA, V86, P9104, DOI 10.1073/pnas.86.23.9104; LEWIS PJ, 1990, J MOL BIOL, V214, P73, DOI 10.1016/0022-2836(90)90147-E; LIN YH, 1991, GENETICS, V127, P31; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Maniatis T., 1982, MOL CLONING; MORROW BE, 1989, J BIOL CHEM, V264, P9061; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; SAFFER LD, 1986, MOL CELL BIOL, V6, P1148, DOI 10.1128/MCB.6.4.1148; SANDERSON KE, 1988, MICROBIOL REV, V52, P485, DOI 10.1128/MMBR.52.4.485-532.1988; VANDERSANDE CAFM, 1989, NUCLEIC ACIDS RES, V17, P9127, DOI 10.1093/nar/17.22.9127; VOELKELMEIMAN K, 1987, CELL, V48, P1071, DOI 10.1016/0092-8674(87)90714-8; WANG HM, 1990, MOL CELL BIOL, V10, P1743, DOI 10.1128/MCB.10.4.1743; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; ZAKIAN VA, 1979, CELL, V17, P923, DOI 10.1016/0092-8674(79)90332-5; ZEIGLER DR, 1990, GENETICS, V125, P703	38	216	219	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					267	276		10.1016/0092-8674(92)90355-G	http://dx.doi.org/10.1016/0092-8674(92)90355-G			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423594				2022-12-28	WOS:A1992JU39500012
J	CREWS, CM; ALESSANDRINI, A; ERIKSON, RL				CREWS, CM; ALESSANDRINI, A; ERIKSON, RL			THE PRIMARY STRUCTURE OF MEK, A PROTEIN-KINASE THAT PHOSPHORYLATES THE ERK GENE-PRODUCT	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; FISSION YEAST; CELL-CYCLE; DIACYLGLYCEROL; RESISTANCE; CEREVISIAE; PROGRESS; CASCADES; ENCODES; FUS3	Mitogen-activated protein (MAP) kinases, also known as extracellular signal-regulated kinases (ERKs), are thought to act at an integration point for multiple biochemical signals because they are activated by a wide variety of extracellular signals, rapidly phosphorylated on threonine and tyrosine, and highly conserved. A critical protein kinase lies upstream of MAP kinase and stimulates the enzymatic activity of MAP kinase. The structure of this protein kinase, denoted MEK1, for MAP kinase or ERK kinase, was elucidated from a complementary DNA sequence an shown to be a protein of 393 amino acids (43,500 daltons) that is related most closely in size and sequence to the product encoded by the Schizosaccharomyces pombe byr1 gene. The MEK gene was highly expressed in murine brain, and the product expressed in bacteria phosphorylated the ERK gene product.			CREWS, CM (corresponding author), HARVARD UNIV,DEPT CELLULAR & DEV BIOL,16 DIVIN AVE,CAMBRIDGE,MA 02138, USA.		Crews, Craig M./ABH-9346-2020	Crews, Craig M./0000-0002-8456-2005	NCI NIH HHS [CA42580] Funding Source: Medline; NIGMS NIH HHS [GM07620-14] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042580] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ALESSANDRINI A, 1992, P NATL ACAD SCI USA, V89, P8200, DOI 10.1073/pnas.89.17.8200; Alessandrini A., UNPUB; BOGUSLAWSKI G, 1987, P NATL ACAD SCI USA, V84, P5848, DOI 10.1073/pnas.84.16.5848; CAIRNS BR, 1992, GENE DEV, V6, P1305, DOI 10.1101/gad.6.7.1305; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COURCHESNE WE, 1989, CELL, V58, P1107, DOI 10.1016/0092-8674(89)90509-6; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; CREWS CM, 1992, CELL GROWTH DIFFER, V3, P135; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; ELION EA, 1990, CELL, V60, P649, DOI 10.1016/0092-8674(90)90668-5; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; KOSAKO H, 1992, EMBO J, V11, P2903, DOI 10.1002/j.1460-2075.1992.tb05359.x; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LACAL JC, 1987, SCIENCE, V238, P533, DOI 10.1126/science.2821623; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Maniatis T., 1982, MOL CLONING; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; NADINDAVIS SA, 1988, EMBO J, V7, P985, DOI 10.1002/j.1460-2075.1988.tb02905.x; NIELSEN O, 1992, EMBO J, V11, P1391, DOI 10.1002/j.1460-2075.1992.tb05184.x; PELECH SL, 1990, BIOCHEM CELL BIOL, V68, P1297, DOI 10.1139/o90-194; SEGER R, 1992, J BIOL CHEM, V267, P14373; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; TEAGUE MA, 1986, P NATL ACAD SCI USA, V83, P7371, DOI 10.1073/pnas.83.19.7371; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; THOMAS SM, 1992, CELL, V68, P1; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; WANG Y, 1991, MOL CELL BIOL, V11, P3554, DOI 10.1128/MCB.11.7.3554; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	37	858	909	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					478	480		10.1126/science.1411546	http://dx.doi.org/10.1126/science.1411546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411546				2022-12-28	WOS:A1992JT77500040
J	ADA, G; BLANDEN, B; MULLBACHER, A				ADA, G; BLANDEN, B; MULLBACHER, A			HIV - TO VACCINATE OR NOT TO VACCINATE	NATURE			English	Editorial Material											ADA, G (corresponding author), AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,CANBERRA,ACT 2601,AUSTRALIA.							BLATTNER WA, 1991, FASEB J, V5, P2340, DOI 10.1096/fasebj.5.10.2065886; CRANAGE MP, 1992, LANCET, V339, P273, DOI 10.1016/0140-6736(92)91335-6; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; FULZ PN, 1992, SCIENCE, V256, P1687; JANEWAY CA, 1992, 8TH INT C IMM BUD; KRIEGER JN, 1991, J INFECT DIS, V163, P386, DOI 10.1093/infdis/163.2.386; SABIN AB, 1992, P NATL ACAD SCI USA, V89, P8852, DOI 10.1073/pnas.89.18.8852; SABIN AB, 1991, SCIENCE, V251, P1161, DOI 10.1126/science.2015033; WOLFS TFW, 1991, VIROLOGY, V185, P195, DOI 10.1016/0042-6822(91)90767-6; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I	10	16	16	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 15	1992	359	6396					572	572		10.1038/359572a0	http://dx.doi.org/10.1038/359572a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	1406988	Bronze			2022-12-28	WOS:A1992JT82400019
J	ILLINGWORTH, C				ILLINGWORTH, C			THE ARGUMENT FOR HELMETS	BRITISH MEDICAL JOURNAL			English	Article							BICYCLE INJURIES; CHILDREN; ACCIDENTS		CHILDRENS HOSP,PAEDIAT ACCID & EMERGENCY,SHEFFIELD S10 2TH,S YORKSHIRE,ENGLAND	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital								AHLSTROM I, 1990, HJALM ALLA; BALLANTYNE R, 1975, RICHARDS BICYCLE BOO; Bouvier R, 1984, Aust Fam Physician, V13, P287; CASS DT, 1989, AUST NZ J SURG, V59, P719, DOI 10.1111/j.1445-2197.1989.tb01664.x; GUICHON DMP, 1975, J TRAUMA, V15, P504, DOI 10.1097/00005373-197506000-00009; ILLINGWORTH CM, 1979, ACTA PAEDIATR SCAND, V68, P869; ILLINGWORTH CM, 1981, INJURY, V13, P7, DOI 10.1016/0020-1383(81)90083-8; ILLINGWORTH CM, 1985, ARCH DIS CHILD, V60, P461, DOI 10.1136/adc.60.5.461; ILLINGWORTH CM, 1984, BRIT MED J, V289, P956, DOI 10.1136/bmj.289.6450.956; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; SELBST SM, 1987, AM J DIS CHILD, V141, P140, DOI 10.1001/archpedi.1987.04460020030021; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; WILLIAMS M, 1989, PROTECTIVE PERFORMAN; 1987, AM J DIS CHILD, V141, P135; 1986, ROAD ACCIDENTS GREAT	15	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					882	883		10.1136/bmj.305.6858.882	http://dx.doi.org/10.1136/bmj.305.6858.882			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422408	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JT77700036
J	MARONE, C; QUADRI, F				MARONE, C; QUADRI, F			BEWARE OF CIPROFLOXACIN IN ACUTE OTITIS-MEDIA	BRITISH MEDICAL JOURNAL			English	Letter											MARONE, C (corresponding author), OSPED SAN GIOVANNI BELLINZONA,DEPT INTERNAL MED,CH-6500 BELLINZONA,SWITZERLAND.							BATES GJEM, 1988, BRIT MED J, V296, P532, DOI 10.1136/bmj.296.6621.532; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BLUESTONE CD, 1986, DRUGS, V31, P132, DOI 10.2165/00003495-198600313-00029; COOPER B, 1989, AM J MED, V87, P475; HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606	5	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					870	870		10.1136/bmj.305.6858.870-b	http://dx.doi.org/10.1136/bmj.305.6858.870-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422402	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JT77700029
J	RODRIGUEZ, LAG; GUTTHANN, SP; WALKER, AM; LUECK, L				RODRIGUEZ, LAG; GUTTHANN, SP; WALKER, AM; LUECK, L			THE ROLE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN ACUTE LIVER-INJURY	BRITISH MEDICAL JOURNAL			English	Article							PROGRAM	Objective-To investigate the association between use of non-steroidal anti-inflammatory drugs and serious, acute non-infectious liver injury. Design-Retrospective cohort study, cross over design. Setting-Health records from provincial database in Saskatchewan, Canada, 1982-6. Subjects-228392 adults who contributed 645456 person years. All were either using or had used non-steroidal anti-inflammatory drugs. Main outcome measures-Number and type of prescriptions for non-steroidal anti-inflammatory drugs. Admission to hospital for newly diagnosed acute liver injury. Results-There were 34 admissions to hospital; 16 among subjects currently using non-steroidal anti-inflammatory drugs and 18 among subjects who were not. The incidence rate among current users was 9 per 100 000 person years (95% confidence interval 6 to 15 per 100000 person years). Subjects currently using non-steroidal anti-inflammatory drugs had twice the risk of newly diagnosed liver injury as those not currently taking these drugs (rate ratio 2.3; 95% confidence interval 1.1 to 4.9) and an excess risk of 5 per 100000 person years. The age and sex adjusted risk ratio was 1.7 (0.8 to 3.7). The strength of the association increased when only cases with no concomitant use of other hepatotoxic drugs were considered (4.0; 0.9 to 19.0). The rate ratio for people having received one to nine prescriptions was constant. There was no increased risk with long duration of treatment (1.0; 0.3 to 3.5). Conclusions-There is a small excess risk of serious, acute non-infectious liver injury associated with the use of non-steroidal anti-inflammatory drugs.	CIBA GEIGY AG,PHARMACOEPIDEMIOL UNIT,CH-4002 BASEL,SWITZERLAND; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115; GDS & ASSOCIATES SYSTEMS LTD,REGINA,SASKATCHEWAN,CANADA	Novartis; Harvard University; Harvard T.H. Chan School of Public Health			rodriguez, luis a garcia/B-1980-2010	Perez-Gutthann, Susana/0000-0001-5798-3691				BEARD K, 1986, J CLIN PHARMACOL, V26, P633, DOI 10.1002/j.1552-4604.1986.tb02963.x; BJORNEBOE M, 1967, ACTA MED SCAND, V182, P491; Davis M., 1989, ADVERSE DRUG REACT B, V139, P520; JICK H, 1992, PHARMACOTHERAPY, V12, P207; LEWIS JH, 1984, CLIN PHARMACY, V3, P128; MARTIN D, 1991, EPIDEMIOLOGY, V2, P359, DOI 10.1097/00001648-199109000-00008; PESSAYRE D, 1988, BAILLIERE CLIN GASTR, V2, P385, DOI 10.1016/0950-3528(88)90009-7; RAVIOLO P, 1991, Recenti Progressi in Medicina, V82, P319; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; RODRIGUEZ LAG, 1992, EPIDEMIOLOGY, V3, P337, DOI 10.1097/00001648-199207000-00008; ROSS RM, 1981, AM J GASTROENTEROL, V76, P511; ROTHMAN KJ, 1988, INT J EPIDEMIOL, V17, P955, DOI 10.1093/ije/17.4.955; SANCHO CG, 1988, MED CLIN-BARCELONA, V90, P579; SHERLOCK S, 1981, DISEASES LIVER BILIA; STRAND LM, 1989, PHARMACOEPIDEM DR S, P189; STRICKER BHC, 1985, DRUG INDUCED HEPATIC; VANNESS MM, 1989, ANN INTERN MED, V111, P473, DOI 10.7326/0003-4819-111-6-473; Walker AM, 1991, OBSERVATION INFERENC; ZIMMERMAN HJ, 1981, ARCH INTERN MED, V141, P333, DOI 10.1001/archinte.141.3.333; 1990, J HEPATOL, V11, P272	20	81	84	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					865	868		10.1136/bmj.305.6858.865	http://dx.doi.org/10.1136/bmj.305.6858.865			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422399	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JT77700024
J	YATES, DW; WOODFORD, M; HOLLIS, S				YATES, DW; WOODFORD, M; HOLLIS, S			PRELIMINARY-ANALYSIS OF THE CARE OF INJURED PATIENTS IN 33 BRITISH HOSPITALS - 1ST REPORT OF THE UNITED-KINGDOM MAJOR TRAUMA OUTCOME STUDY	BRITISH MEDICAL JOURNAL			English	Article							SEVERITY SCORE	Objective-To measure the effectiveness of management of major trauma in the United Kingdom. Design-Review of the care of all seriously injured patients seen over two years. Setting-33 hospitals which receive patients who have sustained major trauma. Subjects-14 648 injured patients admitted for more than three days, transferred or admitted into an intensive care bed, or dying from their injuries. Main outcome measure-Death or survival in hospital within three months of the injury. Results-21% of seriously injured patients (1299) took longer than one hour to reach hospital. Time before arrival at hospital was not related to severity of injury. A senior house officer was in charge of initial hospital resuscitation in 57% (826/1445) of patients with an injury severity score greater-than-or-equal-to 16. More senior staff were commonly responsible for definitive operations, but only 46% (165/355) of patients judged to require early operation arrived in theatre within two hours. Mortality for 6111 patients sustaining blunt trauma and treated in the 14 busiest hospitals was significantly higher (actual 408, predicted 295.6, p<0.001) than in a comparable North American dataset. Large differences in the 14 hospitals assessed could not be explained by variations in case load or facilities. In contrast, the outcome of the 4.1% (597) of patients with penetrating injuries was better than that of a comparable group in the United States. Analysis of the 415 penetrating injuries with complete data showed that 15 patients died (19.3 predicted; p=0.04). Conclusions-The initial management of major trauma in the United Kingdom remains unsatisfactory. There are delays in providing experienced staff and timely operations. Mortality varies inexplicably between hospitals and, for blunt trauma, is generally higher than in the United States.			YATES, DW (corresponding author), UNIV MANCHESTER,HOPE HOSP,SALFORD M6 8HD,LANCS,ENGLAND.			Hollis, Sally/0000-0003-0156-9189				BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; SMITH EJ, 1990, BRIT J HOSP MED, V44, P114; YATES DW, 1990, BRIT MED J, V301, P1090, DOI 10.1136/bmj.301.6760.1090; YATES DW, 1991, ACCIDENT ANAL PREV, V23, P323, DOI 10.1016/0001-4575(91)90010-3; YATES DW, 1990, INTENS THER CLIN MON, V10, P38; 1988, REPORT WORKING PARTY; 1986, MORTALITY STATISTICS; 1991, CMD1523	12	137	138	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1992	305	6856					737	740		10.1136/bmj.305.6856.737	http://dx.doi.org/10.1136/bmj.305.6856.737			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ520	1422327	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JQ52000018
J	RADMACHER, M; TILLMANN, RW; FRITZ, M; GAUB, HE				RADMACHER, M; TILLMANN, RW; FRITZ, M; GAUB, HE			FROM MOLECULES TO CELLS - IMAGING SOFT SAMPLES WITH THE ATOMIC FORCE MICROSCOPE	SCIENCE			English	Article							LANGMUIR-BLODGETT-FILMS; SCANNING TUNNELING MICROSCOPY; RESOLUTION IMAGES; HYDRATION FORCES; MONOLAYERS; SURFACES; PROTEIN; WATER	Since its invention a few years ago, the atomic force microscope has become one of the most widely used near-field microscopes. Surfaces of hard samples are imaged routinely with atomic resolution. Soft samples, however, remain challenging. An overview is presented on the application of atomic force microscopy to organic samples ranging from thin ordered films at molecular resolution to living cells. Fundamental mechanisms of the image formation are discussed, and novel imaging modes are introduced that exploit different aspects of the tip-sample interaction for local measurements of the micromechanical properties of the sample. As examples, images of Langmuir-Blodgett films, which map the local viscoelasticity as well as the friction coefficient, are presented.	TECH UNIV MUNICH,DEPT PHYS,W-8046 GARCHING,GERMANY	Technical University of Munich			Radmacher, Manfred/A-3956-2012	Radmacher, Manfred/0000-0001-8744-4541				AKAMINE S, 1990, APPL PHYS LETT, V57, P316, DOI 10.1063/1.103677; AMER NM, 1988, B AM PHYS SOC, V33, P319; BARRETT RC, 1991, J APPL PHYS, V70, P2725, DOI 10.1063/1.349388; BASELT DR, IN PRESS J VAC SCI T; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNIG G, 1987, REV MOD PHYS, V59, P615, DOI 10.1103/RevModPhys.59.615; BINNIG G, 1986, REV SCI INSTRUM, V57, P1688, DOI 10.1063/1.1139196; BINNIG G, COMMUNICATION; BLACKMAN GS, 1990, VACUUM, V41, P1283, DOI 10.1016/0042-207X(90)93934-B; BORDIEU L, 1991, PHYS REV LETT, V67, P2029; BURNHAM NA, 1991, J VAC SCI TECHNOL A, V9, P2548, DOI 10.1116/1.577271; BUTT HJ, 1991, BIOPHYS J, V60, P777, DOI 10.1016/S0006-3495(91)82112-9; BUTT HJ, 1990, BIOPHYS J, V58, P1473, DOI 10.1016/S0006-3495(90)82492-9; DENBOEF AJ, 1991, REV SCI INSTRUM, V62, P88, DOI 10.1063/1.1142287; DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794; DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0; EGGER M, 1990, J STRUCT BIOL, V103, P89, DOI 10.1016/1047-8477(90)90089-U; ENGEL A, 1991, ANNU REV BIOPHYS BIO, V20, P79, DOI 10.1146/annurev.biophys.20.1.79; ERLANDSSON R, 1988, J CHEM PHYS, V89, P5190, DOI 10.1063/1.455608; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; FRITZ M, UNPUB; FUJII T, 1991, J VAC SCI TECHNOL B, V9, P666, DOI 10.1116/1.585483; FUJII T, 1991, STM 91; GARNAES G, 1992, NATURE, V257, P508; GAROFF S, 1986, J PHYS-PARIS, V47, P701, DOI 10.1051/jphys:01986004704070100; GOETTGENS BM, 1992, LANGMUIR, V8, P1768, DOI 10.1021/la00043a014; HABERLE W, 1992, ULTRAMICROSCOPY, V42, P1161, DOI 10.1016/0304-3991(92)90418-J; HANSMA HG, 1991, LANGMUIR, V7, P1051, DOI 10.1021/la00054a005; HANSMA HG, 1992, SCIENCE, V256, P1180, DOI 10.1126/science.256.5060.1180; HANSMA PK, 1988, SCIENCE, V242, P209, DOI 10.1126/science.3051380; HARTMANN U, 1991, PHYS REV B, V43, P2404, DOI 10.1103/PhysRevB.43.2404; HENDERSON E, 1992, SCIENCE, V257, P1944, DOI 10.1126/science.1411511; HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206; ISRAELACHVILI JN, 1983, NATURE, V306, P249, DOI 10.1038/306249a0; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; KELLER D, 1992, P SOC PHOTO-OPT INS, V1639, P91, DOI 10.1117/12.58194; KELLER DJ, 1992, SURF SCI, V268, P333, DOI 10.1016/0039-6028(92)90973-A; LINDSAY SM, 1992, BIOPHYS J, V61, P1570, DOI 10.1016/S0006-3495(92)81961-6; MAGANOV SN, IN PRESS ULTRAMICROS; Maivald P., 1991, Nanotechnology, V2, P103, DOI 10.1088/0957-4484/2/2/004; MAMIN HJ, 1992, B AM PHYS SOC, V37, P565; MANNE S, 1991, SCIENCE, V251, P183, DOI 10.1126/science.251.4990.183; MANNE S, IN PRESS J CRYST GRO; MARTI O, 1988, SCIENCE, V239, P50, DOI 10.1126/science.3336773; MEYER E, 1991, NATURE, V349, P398, DOI 10.1038/349398a0; MEYER E, 1989, THIN SOLID FILMS, V181, P527, DOI 10.1016/0040-6090(89)90522-1; MULLER O, 1991, MACROMOLECULES, V24, P3111; OUTKA DA, 1987, PHYS REV LETT, V59, P1321, DOI 10.1103/PhysRevLett.59.1321; PUTMAN CAJ, 1992, P SOC PHOTO-OPT INS, V1639, P198, DOI 10.1117/12.58191; PUTMAN CAJ, IN PRESS LANGMUIR; RABE JP, 1991, SCIENCE, V253, P424, DOI 10.1126/science.253.5018.424; RADLER J, 1992, LANGMUIR, V8, P848; RADMACHER M, 1992, ULTRAMICROSCOPY, V42, P968, DOI 10.1016/0304-3991(92)90387-Y; RADMACHER M, 1991, SCANNED PROBE MICROS, V241, P144; RADMACHER M, 1992, STRUCTURE CONFORMATI, V66, P24; RADMACHER M, UNPUB; RADMACHER M, IN PRESS PURE APPL C; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; ROHRER H, 1992, ULTRAMICROSCOPY, V42, P1, DOI 10.1016/0304-3991(92)90239-G; SWALEN JD, 1987, LANGMUIR, V3, P932, DOI 10.1021/la00078a011; TEAGUE EC, 1982, WEAR, V83, P1, DOI 10.1016/0043-1648(82)90335-0; TILLMANN RW, 1992, APPL PHYS LETT, V60, P3111, DOI 10.1063/1.106768; TSCHOEGL NW, 1989, PHENOMENOLOGICAL THE; TUNDAT T, 1992, J VAC SCI TECHNOL A, V10, P630; WEIHS TP, 1991, APPL PHYS LETT, V59, P3536, DOI 10.1063/1.105649; WEISENHORN AL, 1990, BIOPHYS J, V58, P1251, DOI 10.1016/S0006-3495(90)82465-6; WEISENHORN AL, 1991, LANGMUIR, V7, P8, DOI 10.1021/la00049a003; WICKRAMASINGHE HK, 1990, J VAC SCI TECHNOL A, V8, P363, DOI 10.1116/1.576397; WIEGRABE W, 1991, J MICROSC-OXFORD, V163, P79, DOI 10.1111/j.1365-2818.1991.tb03161.x; WORCESTER DL, 1988, J MICROSC, V152; YAMADA H, 1992, ULTRAMICROSCOPY, V42, P1037; ZANONI R, 1986, PHYS REV LETT, V57, P2838, DOI 10.1103/PhysRevLett.57.2838	72	800	819	4	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 25	1992	257	5078					1900	1905		10.1126/science.1411505	http://dx.doi.org/10.1126/science.1411505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP594	1411505				2022-12-28	WOS:A1992JP59400022
J	SEEFF, LB; BUSKELLBALES, Z; WRIGHT, EC; DURAKO, SJ; ALTER, HJ; IBER, FL; HOLLINGER, FB; GITNICK, G; KNODELL, RG; PERRILLO, RP; STEVENS, CE; HOLLINGSWORTH, CG				SEEFF, LB; BUSKELLBALES, Z; WRIGHT, EC; DURAKO, SJ; ALTER, HJ; IBER, FL; HOLLINGER, FB; GITNICK, G; KNODELL, RG; PERRILLO, RP; STEVENS, CE; HOLLINGSWORTH, CG			LONG-TERM MORTALITY AFTER TRANSFUSION-ASSOCIATED NON-A-HEPATITIS, NON-B-HEPATITIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALCOHOLIC LIVER-DISEASE; C VIRUS; HEPATOCELLULAR-CARCINOMA; POSTTRANSFUSION HEPATITIS; FOLLOW-UP; VIRAL-HEPATITIS; PREVALENCE; ANTIBODIES; CIRRHOSIS; EFFICACY	Background. Acute non-A, non-B hepatitis after blood transfusion often progresses to chronic hepatitis and sometimes culminates in cirrhosis or even hepatocellular carcinoma. However, the frequency of these sequelae and their effects on mortality are not known. Methods. We traced patients with transfusion-related non-A, non-B hepatitis who had been identified in five major prospective studies conducted in the United States between 1967 and 1980. We matched each patient with two control subjects (identified as the first and second controls) who received transfusions but who did not have hepatitis. The mortality rates in the three groups were determined with use of data from the National Death index and Social Security Death Tapes. Cause-specific mortality was determined by reviewing death certificates. Results. Vital status was established for over 94 percent of the 568 patients who had had non-A, non-B hepatitis and the two control groups (526 first controls and 458 second controls). After an average follow-up of 18 years, the estimate by life-table analysis of mortality from all causes was 51 percent for those with transfusion-associated non-A, non-B hepatitis, as compared with 52 percent for the first controls and 50 percent for the second controls. The survival curves for the three groups were virtually the same. Mortality related to liver disease was 3.3, 1.1, and 2.0 percent, respectively, among the three groups (P = 0.033 for the comparison of the group with non-A, non-B hepatitis with the combined control group). Seventy-one percent of the deaths related to liver disease occurred among patients with chronic alcoholism. Conclusions. In this long-term follow-up study, there was no increase in mortality from all causes after transfusion-associated non-A, non-B hepatitis, although there was a small but statistically significant increase in the number of deaths related to liver disease.	GEORGETOWN UNIV, SCH MED, WASHINGTON, DC USA; GEORGE WASHINGTON UNIV, CTR BIOSTAT, ROCKVILLE, MD USA; WESTAT CORP, ROCKVILLE, MD USA; NIH, BLOOD BANK, BETHESDA, MD 20892 USA; VET AFFAIRS MED CTR, HINES, IL USA; BAYLOR COLL MED, HOUSTON, TX 77030 USA; UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA USA; UNIV MARYLAND, SCH MED, BALTIMORE, MD 21201 USA; WASHINGTON UNIV, SCH MED, ST LOUIS, MO 63110 USA; NEW YORK BLOOD CTR, NEW YORK, NY 10021 USA; NHLBI, BETHESDA, MD 20892 USA	Georgetown University; George Washington University; Westat; National Institutes of Health (NIH) - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL); New York Blood Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	SEEFF, LB (corresponding author), VET AFFAIRS MED CTR, 50 IRVING ST NW, WASHINGTON, DC 20422 USA.		Hollinger, F Blaine/AAY-3323-2021		DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB087047] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HB-87047] Funding Source: Medline	DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AACH RD, 1991, NEW ENGL J MED, V325, P1325, DOI 10.1056/NEJM199111073251901; AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; ALTER HJ, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P396; Alter HJ, 1978, VIRAL HEPATITIS, P359; ALTER HJ, 1989, CURRENT PERSPECTIVES, P83; BERMAN M, 1979, ANN INTERN MED, V91, P1, DOI 10.7326/0003-4819-91-1-1; CALDWELL SH, 1991, AM J GASTROENTEROL, V86, P1219; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Cochran W.G, 1957, STAT METHODS, V6th ed; COLOMBO M, 1989, LANCET, V2, P1006; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; ECOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021; FEINSTONE SM, 1975, NEW ENGL J MED, V292, P767, DOI 10.1056/NEJM197504102921502; GILLIAM JH, 1984, ANN INTERN MED, V101, P794, DOI 10.7326/0003-4819-101-6-794; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; KNODELL RG, 1976, LANCET, V1, P557; KORETZ RL, 1985, GASTROENTEROLOGY, V88, P1251, DOI 10.1016/S0016-5085(85)80087-1; MATTSSON L, 1988, LIVER, V8, P184; MENDENHALL CL, 1991, HEPATOLOGY, V14, P581; NOGUCHI O, 1991, LIVER, V11, P225; PERCY C, 1990, PUBLIC HEALTH REP, V105, P361; PRINCE AM, 1974, LANCET, V2, P241; RAKELA J, 1979, GASTROENTEROLOGY, V77, P1200; REALDI G, 1982, GUT, V23, P270, DOI 10.1136/gut.23.4.270; SEEFF LB, 1977, GASTROENTEROLOGY, V72, P111; SEEFF LB, 1978, VIRAL HEPATITIS, P371; TANAKA K, 1991, CANCER RES, V51, P2842; WEJSTAL R, 1987, SCAND J GASTROENTERO, V22, P1115, DOI 10.3109/00365528708991968; 1978, BMJ, V2, P1063; 1985, SAS USERS GUIDE BASI	33	673	678	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	1992	327	27					1906	1911		10.1056/NEJM199212313272703	http://dx.doi.org/10.1056/NEJM199212313272703			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KE505	1454085	Bronze			2022-12-28	WOS:A1992KE50500003
J	POWER, E				POWER, E			EVALUATION OF THE OREGON MEDICAID PROPOSAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											POWER, E (corresponding author), US CONGRESS,OFF TECHNOL ASSESSMENT,HLTH PROGRAM,WASHINGTON,DC 20510, USA.							1992, EVALUATION OREGON ME	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3292	3292		10.1001/jama.268.23.3292	http://dx.doi.org/10.1001/jama.268.23.3292			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB732	1453514				2022-12-28	WOS:A1992KB73200004
J	GREEN, S				GREEN, S			A CRITIQUE OF THE RATIONALE FOR CANCER-TREATMENT WITH COFFEE ENEMAS AND DIET	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLUTATHIONE S-TRANSFERASE; IDENTIFICATION; CAFESTOL; KAHWEOL				GREEN, S (corresponding author), ZOL CONSULTANTS INC, NEW YORK, NY USA.				NATIONAL CANCER INSTITUTE [R44CA041953] Funding Source: NIH RePORTER; NCI NIH HHS [2R44CA41953-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGGARWAL BB, 1987, CIBA F SYMP, V131, P39; AISENBERG A, 1961, GLYCOLYSIS RESPIRATI, P150; ARIUS IM, 1982, LIVER BIOL PATHOBIOL, P429; BASERGA R, 1985, BIOL CELL REPRODUCTI, P179; BAUER KH, CITED DIRECTLY; BERK JE, 1985, BOCKUS GASTROENTEROL, V1, P1505; BRYSON PD, 1989, COMPREHENSIVE REV TO, P374; CAREY FA, 1987, ORGANIC CHEM, P1074; CASSILETH BR, 1984, ANN INTERN MED, V101, P105, DOI 10.7326/0003-4819-101-1-105; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; Cooley W.B., 1893, AM J MED SCI, V105, P487, DOI [10.1097/00000441-189305000-00001, DOI 10.1097/00000441-189305000-00001]; Dixon M., 1964, ENZYMES, V2nd; EISELE JW, 1980, JAMA-J AM MED ASSOC, V244, P1608, DOI 10.1001/jama.244.14.1608; GERSON M, 1978, PHYSIOL CHEM PHYS M, V10, P449; GERSON M, 1977, CANCER THERAPY RESUL, P41; GERSON M, 1977, CANCER THERAPY RESUL; GERSON M, 1977, CANCER THERAPY RESUL, P21; GINSBERG MM, 1981, MMWR-MORBID MORTAL W, V30, P294; HERBERT V, 1991, MOUNT SINAI SCH MED; HESSE CC, 1982, GERSON PRIMER; HILDENBRAND G, 1986, HEALING NEWSLETT MAY, P1; HILDENBRAND G, 1990, HEALING NEWSLETT, V6, P25; ISTRE GR, 1982, NEW ENGL J MED, V307, P339, DOI 10.1056/NEJM198208053070603; JOKLIK WK, 1984, ZINSSER MICROBIOLOGY, P367; Kabat E., 1961, EXPT IMMUNOCHEMISTRY; KLAASSEN CD, 1986, CASSARETT DOULLES TO, P50; KURTJONES EA, 1985, P NATL ACAD SCI USA, V82, P1204, DOI 10.1073/pnas.82.4.1204; LAM LKT, 1982, CANCER RES, V42, P1193; LAM LKT, 1987, J MED CHEM, V30, P1399, DOI 10.1021/jm00391a022; LECHNER P, 1984, JUN P AUSTR SOC SURG; LECHNER P, CITED INDIRECTLY; LEE MD, 1987, P NATL ACAD SCI USA, V84, P2590, DOI 10.1073/pnas.84.9.2590; LICHTENFELT H, CITED INDIRECTLY; LORAND A, CITED INDIRECTLY; MORAHAN PS, 1988, MACROPHAGES CANCER, P12; NAUTS HC, 1953, ACTA MED SCAND, V145, P276; PITOT HC, 1991, FASEB J, V5, P2280, DOI 10.1096/fasebj.5.9.1860619; SHYROCK RH, 1980, DEV MODERN MED; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; STERNSON LA, 1987, ANN NY ACAD SCI, V507, P19, DOI 10.1111/j.1749-6632.1987.tb45788.x; TRACEY KJ, 1990, ANN NY ACAD SCI, V587, P325, DOI 10.1111/j.1749-6632.1990.tb00173.x; VONBERGMANN G, CITED INDIRECTLY; WARREN RS, 1987, ARCH SURG-CHICAGO, V122, P1396; 1990, CA-CANCER J CLIN, V40, P252; [No title captured]; 1990, OTAH405 OFF TECHN AS	46	21	22	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3224	3227		10.1001/jama.268.22.3224	http://dx.doi.org/10.1001/jama.268.22.3224			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433763				2022-12-28	WOS:A1992KA65400029
J	LISKOWSKY, DR				LISKOWSKY, DR			BIOLOGICAL RHYTHMS AND SHIFT WORK	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											LISKOWSKY, DR (corresponding author), US OFF TECHNOL ASSESSMENT,BIOL APPLICAT PROGRAM,WASHINGTON,DC, USA.							1989, SCAND J WORK ENV HEA, V15, P165; 1990, OCCUP MED, V5, P273; 1991, BIOL RHYTHMS IMPLICA	3	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	1992	268	21					3047	3047		10.1001/jama.268.21.3047	http://dx.doi.org/10.1001/jama.268.21.3047			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA002	1433723				2022-12-28	WOS:A1992KA00200005
J	MATZUK, MM; FINEGOLD, MJ; SU, JGJ; HSUEH, AJW; BRADLEY, A				MATZUK, MM; FINEGOLD, MJ; SU, JGJ; HSUEH, AJW; BRADLEY, A			ALPHA-INHIBIN IS A TUMOR-SUPPRESSOR GENE WITH GONADAL SPECIFICITY IN MICE	NATURE			English	Article							MESSENGER RIBONUCLEIC-ACIDS; BETA-B; CELL TUMORS; ACTIVIN-A; SUBUNIT; EXPRESSION; HORMONE; EMBRYOGENESIS; PROLIFERATION; PROTOONCOGENE	The inhibins are alpha:beta heterodimeric growth factors that are members of the transforming growth factor-beta family. To understand the physiological roles of the inhibins in mammalian development and reproduction, a targeted deletion of the alpha-inhibin gene was generated by homologous recombination in mouse embryonic stem cells. Mice homozygous for the null allele (inhibin-deficient) initially develop normally but every mouse ultimately develops mixed or incompletely differentiated gonadal stromal tumours either unilaterally or bilaterally. Inhibin is thus a critical negative regulator of gonadal stromal cell proliferation and the first secreted protein identified to have tumour-suppressor activity.	BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; STANFORD UNIV, DEPT GYNECOL OBSTET, DIV REPROD BIOL, STANFORD, CA 94305 USA	Baylor College of Medicine; Stanford University	MATZUK, MM (corresponding author), BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA.			Bradley, Allan/0000-0002-2349-8839				BARTON DE, 1989, GENOMICS, V5, P91, DOI 10.1016/0888-7543(89)90091-8; BHASIN S, 1989, ENDOCRINOLOGY, V124, P987, DOI 10.1210/endo-124-2-987; BRADLEY A, 1992, BIO-TECHNOL, V10, P534, DOI 10.1038/nbt0592-534; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Cate R.L, 1990, PEPTIDE GROWTH FACTO, P179; CHIN TW, 1991, CANCER RES, V51, P2101; DEJONG FH, 1990, J STEROID BIOCHEM, V37, P863, DOI 10.1016/0960-0760(90)90433-L; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FRANCHIMONT P, 1981, ACTA ENDOCRINOL-COP, V98, P312, DOI 10.1530/acta.0.0980312; GALWAY AB, 1990, J CLIN ENDOCR METAB, V71, P907, DOI 10.1210/jcem-71-4-907; GARDNER WU, 1955, CANCER RES, V15, P109; HAMILTON TC, 1992, CURR PROB CANCER, V16, P5, DOI 10.1016/0147-0272(92)90047-R; HSUEH AJW, 1987, P NATL ACAD SCI USA, V84, P5082, DOI 10.1073/pnas.84.14.5082; KEENE JL, 1989, MOL ENDOCRINOL, V3, P2011, DOI 10.1210/mend-3-12-2011; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LAPPOHN RE, 1989, NEW ENGL J MED, V321, P790, DOI 10.1056/NEJM198909213211204; LYONS KM, 1991, TRENDS GENET, V7, P408, DOI 10.1016/0168-9525(91)90265-R; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MATHER JP, 1990, ENDOCRINOLOGY, V127, P3206, DOI 10.1210/endo-127-6-3206; MAYO KE, 1986, P NATL ACAD SCI USA, V83, P5849, DOI 10.1073/pnas.83.16.5849; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; MITRANI E, 1990, CELL, V63, P495, DOI 10.1016/0092-8674(90)90446-L; O WS, 1989, MOL CELL ENDOCRINOL, V62, P307; PETRAGLIA F, 1989, P NATL ACAD SCI USA, V86, P5114, DOI 10.1073/pnas.86.13.5114; PIQUETTE GN, 1990, BIOL REPROD, V43, P1050, DOI 10.1095/biolreprod43.6.1050; RABINOVICI J, 1990, J CLIN ENDOCR METAB, V71, P1396, DOI 10.1210/jcem-71-5-1396; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; ROBERTS VJ, 1991, ENDOCRINOLOGY, V128, P3122, DOI 10.1210/endo-128-6-3122; Scully R. E, 1979, TUMORS OVARY MALDEVE; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SU JGJ, 1992, BIOCHEM BIOPH RES CO, V186, P293, DOI 10.1016/S0006-291X(05)80806-X; Teilum G., 1976, SPECIAL TUMORS OVARY; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; TSUCHIYA E, 1992, CANCER RES, V52, P2478; TWOMBLY GH, 1949, CANCER, V2, P884, DOI 10.1002/1097-0142(194909)2:5<884::AID-CNCR2820020522>3.0.CO;2-2; VALE W, 1990, PEPTIDE GROWTH FACTO, V2, P211; VANDISSELEMILIANI FMF, 1989, ENDOCRINOLOGY, V125, P1899, DOI 10.1210/endo-125-4-1898; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WOODRUFF TK, 1992, ENDOCRINOLOGY, V130, P871, DOI 10.1210/en.130.2.871; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; YOUNG RH, 1987, SEMIN DIAGN PATHOL, V4, P342	45	822	873	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	1992	360	6402					313	319		10.1038/360313a0	http://dx.doi.org/10.1038/360313a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448148				2022-12-28	WOS:A1992JZ63000041
J	BALLARD, JWO; OLSEN, GJ; FAITH, DP; ODGERS, WA; ROWELL, DM; ATKINSON, PW				BALLARD, JWO; OLSEN, GJ; FAITH, DP; ODGERS, WA; ROWELL, DM; ATKINSON, PW			EVIDENCE FROM 12S RIBOSOMAL-RNA SEQUENCES THAT ONYCHOPHORANS ARE MODIFIED ARTHROPODS	SCIENCE			English	Article							MITOCHONDRIAL-DNA; MOLECULAR PHYLOGENY; ORGANIZATION; EVOLUTION; ORIGIN	The evolutionary relationships of the onychophorans (velvet worms) and the monophyly of the arthropods have generated considerable debate. Cladistic analyses of 12S ribosomal RNA sequences indicate that arthropods are monophyletic and include the onychophorans. Maximum parsimony analyses and monophyly testing within arthropods indicate that myriapods (millipedes and centipedes) form a sister group to all other assemblages, whereas crustaceans (shrimps and lobsters) plus hexapods (insects and allied groups) form a well-supported monophyletic group. Parsimony analysis further suggests that onychophorans form a sister group to chelicerates (spiders and scorpions) and crustaceans plus hexapods, but this relationship is not well supported by monophyly testing. These relationships conflict with current hypotheses of evolutionary pathways within arthropods.	CSIRO,DIV ENTOMOL,CANBERRA,ACT 2601,AUSTRALIA; UNIV ILLINOIS,DEPT MICROBIOL,URBANA,IL 61801; CSIRO,DIV WILDLIFE & ECOL,LYNEHAM,ACT 2602,AUSTRALIA; AUSTRALIAN NATL UNIV,DEPT BOT & ZOOL,CANBERRA,ACT 2601,AUSTRALIA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Illinois System; University of Illinois Urbana-Champaign; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University			Rowell, David/C-9751-2009; Ballard, John William O./ABB-2743-2020	Rowell, David/0000-0002-2077-9774; Ballard, John William O./0000-0002-2358-6003				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; CLARKE G, ORGANISM IDENTIFICAT; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; CROOM HB, 1991, J ARACHNOL, V19, P210; DYNE G, NATIONAL FOREST INVE; EMERSON MJ, 1990, SCIENCE, V250, P667, DOI 10.1126/science.250.4981.667; FAITH DP, 1991, SYST ZOOL, V40, P366, DOI 10.2307/2992329; FARRIS JS, 1988, HENNIG86 REFERENCE; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1991, PHYLOGENY INFERENCE; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; GHISELIN MT, 1988, OXFORD SURVEYS EVOLU, P66; Guilding L., 1826, ZOOLOGICAL J, V2, P437; HEWITT GM, 1991, MOL TECHNIQUES TAXON, V57, P357; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; JAMIESON BGM, 1986, ZOOL SCR, V15, P141, DOI 10.1111/j.1463-6409.1986.tb00217.x; KIDD S, 1983, CELL, V34, P421, DOI 10.1016/0092-8674(83)90376-8; KIM W, 1990, J CRUSTACEAN BIOL, V10, P1, DOI 10.2307/1548664; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kristensen N.P., 1991, P125; LAKE JA, 1990, P NATL ACAD SCI USA, V87, P763, DOI 10.1073/pnas.87.2.763; Manton S. M., 1979, ORIGIN MAJOR INVERTE, P269; MANTON SM, 1972, ZOOL J LINN SOC-LOND, V51, P203, DOI 10.1111/j.1096-3642.1972.tb02550.x; MANTON SM, 1973, J LINN SOC LOND ZOOL, V53, P257; MCALPINE J.F., 1989, RES BRANCH AGR CANAD, V3, P1397; MEGLITSCH PA, 1991, INVERTEBRATE ECOLOGY, P596; PALUMBI R, 1991, MOL MAR BIOL BIOTECH, V1, P27; Paulus H.F., 1979, P299; ROBISON RA, 1990, NATURE, V343, P163, DOI 10.1038/343163a0; ROWELL DM, UNPUB; SCHRAM F R, 1991, Memoirs of the Queensland Museum, V31, P1; SIMON C, 1990, UCLA SYM BI, V122, P235; Swofford David L., 1990, P411; SWOFFORD DL, 1992, PAUP PHYLOGENETIC AN; TAIT NN, UNPUB; TIEGS OW, 1958, BIOL REV, V33, P255, DOI 10.1111/j.1469-185X.1958.tb01258.x; TUBERVILLE JM, 1991, MOL BIOL EVOL, V8, P669; WALCOTT CD, 1931, SMITHSON MISC COLLEC, V65, P1; WALCOTT CD, 1918, SMITHSON MISC COLLEC, V63, P3; WALDOCK JM, MYRIAPODS ALLOTHEREU; WEYGOLDT P, 1986, Z ZOOL SYST EVOL, V24, P19; Weygoldt P., 1979, P107; WOOD DM, 1989, RES BRANCH AGR CANAD, V3, P1333; Woodley NE., 1989, MANUAL NEARCTIC DIPT, V3, P1371; [No title captured]; [No title captured]	48	226	234	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 20	1992	258	5086					1345	1348		10.1126/science.1455227	http://dx.doi.org/10.1126/science.1455227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455227				2022-12-28	WOS:A1992JY95800034
J	CULOTTA, E				CULOTTA, E			RACIAL MODIFIERS .2. IDENTITY CRISIS - TEACHING V RESEARCH	SCIENCE			English	Article																		CULOTTA E, 1992, SCIENCE, V258, P1217; SIMS C, 1992, SCIENCE, V258, P1185, DOI 10.1126/science.1439829	2	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1223	1224		10.1126/science.1439830	http://dx.doi.org/10.1126/science.1439830			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JX852	1439830				2022-12-28	WOS:A1992JX85200050
J	DAVIES, K				DAVIES, K			MESSAGE IN A BOTTLE	NATURE			English	Editorial Material																		COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; HASTBACKA J, 1991, GENOMICS, V11, P968, DOI 10.1016/0888-7543(91)90021-6; Luria SE, 1943, GENETICS, V28, P491	5	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 5	1992	360	6399					90	90		10.1038/360090a0	http://dx.doi.org/10.1038/360090a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW717	1436083	Bronze			2022-12-28	WOS:A1992JW71700064
J	MULTIGNER, L; GAGNON, J; VANDORSSELAER, A; JOB, D				MULTIGNER, L; GAGNON, J; VANDORSSELAER, A; JOB, D			STABILIZATION OF SEA-URCHIN FLAGELLAR MICROTUBULES BY HISTONE-H1	NATURE			English	Article							CHLAMYDOMONAS ALPHA-TUBULIN; DOUBLET MICROTUBULES; STOP PROTEIN; TAU-PROTEIN; M-PHASE; CELLS; SPERM; ORIGIN; ASSOCIATION; STABILITY	Complex microtubule assemblies are essential components of eukaryotic cilia and flagella. They are extremely stable and are not affected by agents that normally induce polymer disassembly. The molecular basis of this microtubular stability is unknown, and it is not related to any feature of the constitutive tubulin. In sea urchin sperm flagella, axonemal microtubules are found to be stabilized by a protein identical to histone H1, a result that defines a new role for this histone and provides evidence for a concerted evolution of chromatin and microtubular structures.	INST BIOL STRUCT,F-38027 GRENOBLE 1,FRANCE; FAC CHIM STRASBOURG,SPECTROMETRIE MASSE BIOORGAN LAB,F-67008 STRASBOURG,FRANCE	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	MULTIGNER, L (corresponding author), CEN,INSERM,UNITE 244,DEPT BIOL MOLEC & STRUCT,CYTOSQUELETTE LAB,BP 85X,F-38041 GRENOBLE,FRANCE.		Multigner, Luc/I-2926-2015; Multigner, Luc/AAA-6214-2020; Gagnon, Jean/C-3136-2008	Multigner, Luc/0000-0003-3205-8568; Multigner, Luc/0000-0003-3205-8568; Gagnon, Jean/0000-0002-0177-824X				Behnke O, 1970, Int Rev Exp Pathol, V9, P1; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Cavalier- Smith T, 1981, SOC GEN MICROBIOL S, V32, P33; CAVALIERSMITH T, 1988, BIOESSAYS, V9, P72, DOI 10.1002/bies.950090209; CAVALIERSMITH T, 1987, ANN NY ACAD SCI, V503, P17, DOI 10.1111/j.1749-6632.1987.tb40596.x; CAVALIERSMITH T, 1975, NATURE, V256, P463, DOI 10.1038/256463a0; DRUBIN D, 1986, ANN NY ACAD SCI, V466, P257, DOI 10.1111/j.1749-6632.1986.tb38398.x; Dustin P., 1984, MICROTUBULES; ERICKSON HP, 1976, P NATL ACAD SCI USA, V73, P2813, DOI 10.1073/pnas.73.8.2813; ESPONDA P, 1980, CELL BIOL INT REP, V4, P549, DOI 10.1016/0309-1651(80)90020-X; FARRELL KW, 1982, METHOD CELL BIOL, V24, P61; FARRELL KW, 1978, J MOL BIOL, V121, P393, DOI 10.1016/0022-2836(78)90371-6; GIBBONS IR, 1972, J CELL BIOL, V54, P365, DOI 10.1083/jcb.54.2.365; GUNDERSEN GG, 1986, EUR J CELL BIOL, V42, P288; HARRISON A, 1990, J CELL SCI, V96, P347; Hnilica L.S., 1972, STRUCTURE BIOL FUNCT; IZANT JG, 1982, NATURE, V295, P248, DOI 10.1038/295248a0; JOB D, 1985, J CELL BIOL, V101, P1680, DOI 10.1083/jcb.101.5.1680; JOHNS EW, 1964, BIOCHEM J, V92, P55, DOI 10.1042/bj0920055; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; LABBE JC, 1988, NATURE, V335, P251, DOI 10.1038/335251a0; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LEFEBVRE PA, 1986, ANNU REV CELL BIOL, V2, P517, DOI 10.1146/annurev.cb.02.110186.002505; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; LINCK RW, 1987, J CELL BIOL, V104, P1069, DOI 10.1083/jcb.104.4.1069; LINCK RW, 1976, J CELL SCI, V20, P405; MARGOLIS RL, 1990, EMBO J, V9, P4095, DOI 10.1002/j.1460-2075.1990.tb07631.x; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PATURLE L, 1989, BIOCHEMISTRY-US, V28, P2698, DOI 10.1021/bi00432a050; PIROLLET F, 1989, BIOCHEMISTRY-US, V28, P835, DOI 10.1021/bi00428a064; PIROLLET F, 1987, EMBO J, V6, P3247, DOI 10.1002/j.1460-2075.1987.tb02642.x; Revzin A., 1990, BIOL NONSPECIFIC DNA; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; STEFFEN W, 1989, CELL MOTIL CYTOSKEL, V14, P359, DOI 10.1002/cm.970140306; STEPHENS R E, 1970, Journal of Molecular Biology, V47, P353, DOI 10.1016/0022-2836(70)90307-4; STEPHENS RE, 1989, J CELL SCI, V92, P403; STEPHENS RE, 1992, J CELL SCI, V101, P837; Stollar B D, 1978, Methods Cell Biol, V18, P105; STRICKLAND WN, 1980, EUR J BIOCHEM, V104, P567, DOI 10.1111/j.1432-1033.1980.tb04460.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VACQUIER VD, 1986, METHOD CELL BIOL, V27, P15, DOI 10.1016/S0091-679X(08)60340-4	42	61	61	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 5	1992	360	6399					33	39		10.1038/360033a0	http://dx.doi.org/10.1038/360033a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW717	1436071				2022-12-28	WOS:A1992JW71700045
J	GEORGOPOULOS, K; MOORE, DD; DERFLER, B				GEORGOPOULOS, K; MOORE, DD; DERFLER, B			IKAROS, AN EARLY LYMPHOID-SPECIFIC TRANSCRIPTION FACTOR AND A PUTATIVE MEDIATOR FOR T-CELL COMMITMENT	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; CD3-DELTA GENE; YOLK-SAC; EXPRESSION; PRECURSORS; ONTOGENY; MOUSE	In a screen for transcriptional regulators that control differentiation into the T cell lineage, a complementary DNA was isolated encoding a zinc finger protein (Ikaros) related to the Drosophila gap protein Hunchback. The Ikaros protein binds to and activates the enhancer of a gene encoding an early T cell differentiation antigen, CD3delta. During development, Ikaros messenger RNA was first detected in the mouse fetal liver and the embryonic thymus when hematopoietic and lymphoid progenitors initially colonize these organs; no expression was observed in the spleen or the bone marrow. The pattern of Ikaros gene expression and its ability to stimulate CD3delta transcription support the model that Ikaros functions in the specification and maturation of the T lymphocyte.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT MOLEC BIOL,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital	GEORGOPOULOS, K (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,CUTANEOUS BIOL RES CTR,BOSTON,MA 02114, USA.							AUERBACH R, 1981, FORTS ZOOL, V26, P287; AUSSUBEL F, 1991, CURRENT PROTOCOLS MO; BARKER JE, 1968, DEV BIOL, V15, P14; CAPEL B, 1989, P NATL ACAD SCI USA, V86, P4564, DOI 10.1073/pnas.86.12.4564; FURLEY AJ, 1986, CELL, V46, P75, DOI 10.1016/0092-8674(86)90861-5; GALSON D, UNPUB; GEORGOPOULOS K, 1990, EMBO J, V9, P109, DOI 10.1002/j.1460-2075.1990.tb08086.x; GEORGOPOULOS K, 1988, EMBO J, V7, P2401, DOI 10.1002/j.1460-2075.1988.tb03085.x; GEORGOPOULOS K, 1992, MOL CELL BIOL, V12, P747, DOI 10.1128/MCB.12.2.747; GEORGOPOULOS K, UNPUB; HAYNES BF, 1989, IMMUNOL TODAY, V10, P87, DOI 10.1016/0167-5699(89)90232-6; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; LEIDEN JM, 1992, IMMUNOL TODAY, V13, P22, DOI 10.1016/0167-5699(92)90200-Q; LIU CP, 1991, DEVELOPMENT, V113, P1315; LIU CP, 1991, EUR J IMMUNOL, V21, P1849, DOI 10.1002/eji.1830210811; METCALF D, 1987, MOL CONTROL BLOOD CE; MOORE MAS, 1967, J EXP MED, V126, P715, DOI 10.1084/jem.126.4.715; Owen J J, 1981, Prog Allergy, V29, P1; RUGH R, 1991, MOUSE ITS REPRODUCTI, P272; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SZILVASSY SJ, 1989, P NATL ACAD SCI USA, V86, P8798, DOI 10.1073/pnas.86.22.8798; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.iy.06.040188.001521; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; WONG PMC, 1986, P NATL ACAD SCI USA, V83, P3851, DOI 10.1073/pnas.83.11.3851	26	374	393	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					808	812		10.1126/science.1439790	http://dx.doi.org/10.1126/science.1439790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439790				2022-12-28	WOS:A1992JV69200041
J	SHERMAN, LA; HESSE, SV; IRWIN, MJ; LAFACE, D; PETERSON, P				SHERMAN, LA; HESSE, SV; IRWIN, MJ; LAFACE, D; PETERSON, P			SELECTING T-CELL RECEPTORS WITH HIGH-AFFINITY FOR SELF-MHC BY DECREASING THE CONTRIBUTION OF CD8	SCIENCE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CYTOTOXIC LYMPHOCYTES-T; TRANSGENIC MICE; ALPHA-3 DOMAIN; ANTIGEN RECEPTOR; I MOLECULES; POSITIVE SELECTION; RECOGNITION; HLA-A2; THYMUS	Selective events during T cell repertoire development in the thymus include both the positive selection of cells whose receptors recognize self-major histocompatibility complex (MHC) molecules and negative selection (tolerance) of cells whose interaction with self-MHC is of high affinity. The affinity of T cell interactions with class I MHC molecules includes contributions by both the T cell receptor and the CD8 coreceptor. Therefore, by decreasing the affinity of the interaction with CD8, T cells whose receptors have relatively high affinities for self-MHC may survive negative selection. Such T cells were generated and those T cells reactive with self-MHC plus antigen also displayed low affinity for self.			SHERMAN, LA (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.			Sherman, Linda/0000-0001-6422-7069	NCI NIH HHS [CA 25803] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA025803] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALDRICH CJ, 1991, NATURE, V352, P718, DOI 10.1038/352718a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; CONNOLLY JM, 1988, J EXP MED, V168, P325, DOI 10.1084/jem.168.1.325; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DUKE RC, 1989, J EXP MED, V170, P59, DOI 10.1084/jem.170.1.59; ENGELHARD VH, 1991, J IMMUNOL, V146, P1226; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; INGOLD AL, 1991, NATURE, V352, P721, DOI 10.1038/352721a0; IRWIN MJ, 1989, J EXP MED, V170, P1091, DOI 10.1084/jem.170.4.1091; KALINKE U, 1990, NATURE, V348, P642, DOI 10.1038/348642a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISELOW P, 1988, NATURE, V335, P730; KOLLER BH, 1985, J IMMUNOL, V134, P2727; LAFACE D, 1992, FASEB J, V6, pA1709; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; MACDONALD HR, 1988, NATURE, V336, P73; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SAMBERG NL, 1989, EUR J IMMUNOL, V19, P2349, DOI 10.1002/eji.1830191225; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VITIELLO A, 1983, J IMMUNOL, V131, P1635; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	30	97	111	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					815	818		10.1126/science.1439792	http://dx.doi.org/10.1126/science.1439792			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439792				2022-12-28	WOS:A1992JV69200043
J	MATSUSHIME, H; EWEN, ME; STROM, DK; KATO, JY; HANKS, SK; ROUSSEL, MF; SHERR, CJ				MATSUSHIME, H; EWEN, ME; STROM, DK; KATO, JY; HANKS, SK; ROUSSEL, MF; SHERR, CJ			IDENTIFICATION AND PROPERTIES OF AN ATYPICAL CATALYTIC SUBUNIT (P34(PSK-J3)/CDK4) FOR MAMMALIAN-D TYPE-G1 CYCLINS	CELL			English	Article							STIMULATING FACTOR-I; RETINOBLASTOMA SUSCEPTIBILITY GENE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; G1 CYCLINS; M-PHASE; YEAST; EXPRESSION; FAMILY	Murine D type cyclins associate with a catalytic subunit (p34PSK-J3 with properties distinct from known cyclin-dependent kinases (cdks). Mouse p34PSK-J3 shows less than 50% amino acid identity to p34cdc2, p33cdk2, and p36cdk3, lacks a PSTAIRE motif, and does not bind to p13suc1. Cyclin D1-p34PSK-J3 complexes accumulate in macrophages during G1 and decline in S phase, whereas complexes involving cyclins D2 and D3 form in proliferating T cells. Although histone H1 kinase activity is not detected in cyclin D or PSK-J3 immunoprecipitates, cyclin D-p34PSK-J3 complexes assembled in vitro stably bind and phosphorylate the retinoblastoma gene product (pRb) and an Rb-like protein (p107) but do not interact with pRb mutants that are functionally inactive. Thus, p34PSK-J3 is a cyclin D-regulated catalytic subunit that acts as an Rb (but not H1) kinase.	ST JUDE CHILDRENS RES HOSP, DEPT TUMOR CELL BIOL, MEMPHIS, TN 38105 USA; UNIV TENNESSEE, CTR HLTH SCI, COLL MED, DEPT BIOCHEM, MEMPHIS, TN 38163 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA; VANDERBILT UNIV, MED CTR, SCH MED, NASHVILLE, TN 37232 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Vanderbilt University	MATSUSHIME, H (corresponding author), ST JUDE CHILDRENS RES HOSP, HOWARD HUGHES MED INST, MEMPHIS, TN 38105 USA.		Sherr, Charles J/N-8074-2018; Roussel, Martine F/F-1469-2016	Sherr, Charles J/0000-0002-5516-6206; Roussel, Martine F/0000-0002-1740-8139	NATIONAL CANCER INSTITUTE [R35CA047064, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038793] Funding Source: NIH RePORTER; NCI NIH HHS [R35-CA47064, P01-CA21765] Funding Source: Medline; NIGMS NIH HHS [R29-GM38793] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON SJ, 1984, J VIROL, V51, P730, DOI 10.1128/JVI.51.3.730-741.1984; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DOWNING JR, 1988, MOL CELL BIOL, V8, P1795, DOI 10.1128/MCB.8.4.1795; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; ELLEDGE SJ, 1992, P NATL ACAD SCI USA, V89, P2907, DOI 10.1073/pnas.89.7.2907; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; FAHA B, 1992, SCIENCE, V255, P87, DOI 10.1126/science.1532458; GIORDANO A, 1989, CELL, V58, P981, DOI 10.1016/0092-8674(89)90949-5; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1987, P NATL ACAD SCI USA, V84, P388, DOI 10.1073/pnas.84.2.388; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HU QJ, 1991, MOL CELL BIOL, V11, P5792, DOI 10.1128/MCB.11.11.5792; Hunt T, 1989, CURR OPIN CELL BIOL, V1, P268, DOI 10.1016/0955-0674(89)90099-9; INABA T, 1992, GENOMICS, V13, P565, DOI 10.1016/0888-7543(92)90126-D; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; LEOPOLD P, 1991, CELL, V66, P1207, DOI 10.1016/0092-8674(91)90043-X; LEW DJ, 1992, CELL, V69, P317, DOI 10.1016/0092-8674(92)90412-6; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; Maller JL, 1991, CURR OPIN CELL BIOL, V3, P269; MATSUSHIME H, 1991, COLD SPRING HARB SYM, V56, P69; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; MCGOWAN CH, 1990, MOL CELL BIOL, V10, P3847, DOI 10.1128/MCB.10.7.3847; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; NASMYTH K, 1991, CELL, V66, P995, DOI 10.1016/0092-8674(91)90444-4; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OKUDA T, 1992, IN PRESS ONCOGENE; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERR CJ, 1991, TRENDS GENET, V7, P398, DOI 10.1016/0168-9525(91)90263-P; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; Summers M.D., 1987, B TEXAS AGR EXPT STA, V1555; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; WALKER DH, 1991, NATURE, V354, P314, DOI 10.1038/354314a0; WELCH PJ, 1992, P NATL ACAD SCI USA, V89, P3093, DOI 10.1073/pnas.89.7.3093; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G	61	911	941	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	1992	71	2					323	334		10.1016/0092-8674(92)90360-O	http://dx.doi.org/10.1016/0092-8674(92)90360-O			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423597				2022-12-28	WOS:A1992JU39500017
J	RICE, NR; MACKICHAN, ML; ISRAEL, A				RICE, NR; MACKICHAN, ML; ISRAEL, A			THE PRECURSOR OF NF-KAPPA-B P50 HAS I-KAPPA-B-LIKE FUNCTIONS	CELL			English	Article							REL ONCOGENE PRODUCT; DNA-BINDING SUBUNIT; TRANSFORMED LYMPHOID-CELLS; V-REL; RETICULOENDOTHELIOSIS VIRUS; TRANSCRIPTION FACTORS; CELLULAR PROTEINS; PHORBOL ESTER; 65-KD SUBUNIT; INHIBITION	The C-terminal half of the p105 precursor of the NF-kappaB p50 subunit contains ankyrin-like repeats similar to those in IkappaB molecules, which are known to retain NF-kappaB complexes in the cytoplasm. We demonstrate that in various cell lines p105 is found associated with either c-rel or p65 in the cytoplasm and serves IkappaB-like functions. p105 retains c-rel or p65 in the cytoplasm in cotransfection experiments in COS cells. It also inhibits DNA binding by c-rel in gel retardation assays. Stable interaction of p105 with c-rel or p65 requires the putative dimerization domain in the conserved rel homology region of p105, as well as a second contact with the IkappaB-related C-terminal part of p105. Pulse-chase experiments indicate that cytoplasmic complexes of p105 with c-rel or p65 give rise to cytoplasmic as well as nuclear p50-c-rel and p50-p65, respectively, probably through processing of p105. Thus, p105, like the IkappaBs, controls the subcellular localization and hence the transcriptional activity of at least two other members of the rel/NF-kappaB family.	STANFORD UNIV,PROGRAM CANC BIOL,STANFORD,CA 94305; INST PASTEUR,UNITE BIOL MOLEC EXPRESS GENIQUE,F-75724 PARIS 15,FRANCE	Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	RICE, NR (corresponding author), FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MOLEC VIROL & CARCINOGENESIS LAB,FREDERICK,MD 21702, USA.				NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101, 5T32 CA 09302] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1088, P171; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BECKWITH M, 1990, J NATL CANCER I, V82, P501, DOI 10.1093/jnci/82.6.501; BLANK V, 1991, EMBO J, V10, P4159, DOI 10.1002/j.1460-2075.1991.tb04994.x; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; BROWNELL E, 1989, ONCOGENE, V4, P935; BULL P, 1990, MOL CELL BIOL, V10, P5473, DOI 10.1128/MCB.10.10.5473; CAPOBIANCO AJ, 1992, J VIROL, V66, P3758, DOI 10.1128/JVI.66.6.3758-3767.1992; DAVIS N, 1991, SCIENCE, V253, P1268, DOI 10.1126/science.1891714; DAVIS N, 1990, J VIROL, V64, P584, DOI 10.1128/JVI.64.2.584-591.1990; DAVIS N, 1990, ONCOGENE, V5, P1105; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; HANSEN SK, 1992, EMBO J, V11, P205, DOI 10.1002/j.1460-2075.1992.tb05043.x; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; INOUE J, 1991, P NATL ACAD SCI USA, V88, P3715, DOI 10.1073/pnas.88.9.3715; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; KERR LD, 1991, GENE DEV, V5, P1464, DOI 10.1101/gad.5.8.1464; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KOCHEL T, 1991, ONCOGENE, V6, P615; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LIM MY, 1990, VIROLOGY, V175, P149, DOI 10.1016/0042-6822(90)90195-W; LOGEAT F, 1991, EMBO J, V10, P1827, DOI 10.1002/j.1460-2075.1991.tb07708.x; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MEYER R, 1991, P NATL ACAD SCI USA, V88, P966, DOI 10.1073/pnas.88.3.966; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; MORRISON LE, 1989, ONCOGENE, V4, P677; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; RICHARDSON PM, 1991, NATURE, V350, P625; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SIMEK S, 1988, ONCOGENE RES, V2, P103; SIMEK S, 1988, J VIROL, V62, P4730, DOI 10.1128/JVI.62.12.4730-4736.1988; TUNG HYL, 1988, P NATL ACAD SCI USA, V85, P2479, DOI 10.1073/pnas.85.8.2479; URBAN MB, 1990, GENE DEV, V4, P1975, DOI 10.1101/gad.4.11.1975; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P	39	419	423	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					243	253		10.1016/0092-8674(92)90353-E	http://dx.doi.org/10.1016/0092-8674(92)90353-E			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423592				2022-12-28	WOS:A1992JU39500010
J	COOKE, MW				COOKE, MW			ARRANGEMENTS FOR ON SCENE MEDICAL-CARE AT MAJOR INCIDENTS	BRITISH MEDICAL JOURNAL			English	Article											COOKE, MW (corresponding author), DUDLEY RD GEN HOSP,DEPT ACCIDENT & EMERGENCY MED,BIRMINGHAM B18 7QH,W MIDLANDS,ENGLAND.							FISHER JM, 1990, INJURY, V21, P45, DOI 10.1016/0020-1383(90)90153-L; REDMOND AD, 1989, BRIT MED J, V298, P962, DOI 10.1136/bmj.298.6678.962; 1990, HC9025 DEP HLTH	3	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1992	305	6856					748	748		10.1136/bmj.305.6856.748	http://dx.doi.org/10.1136/bmj.305.6856.748			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ520	1422331	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JQ52000022
J	BLUMENTHAL, D				BLUMENTHAL, D			ACADEMIC-INDUSTRY RELATIONSHIPS IN THE LIFE SCIENCES - EXTENT, CONSEQUENCES, AND MANAGEMENT	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONFLICT-OF-INTEREST; BIOTECHNOLOGY; UNIVERSITIES	Academic-industry relationships in the life sciences remain controversial. The available evidence suggests that such relationships have both benefits and risks for involved parties. Benefits include additional support of academic research, income for academic health centers, the potential for increased scientific and commercial productivity in both industries and universities, and enhancement of the educational experiences of students and fellows. Risks include an increase in secrecy in academic environments and damage to public support for the life science enterprise. The balance of known benefits and risks suggests that academic-industry relationships should be permitted and even selectively promoted. However, there is also a need for enhanced vigilance on the part of academic institutions and government to reduce risks posed by certain types of arrangements, especially those involving human subjects. Enhanced vigilance should include disclosure of all academic-industry relationships by life science faculty.	HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	BLUMENTHAL, D (corresponding author), MASSACHUSETTS GEN HOSP,HLTH POLICY RES & DEV UNIT,BOSTON,MA 02114, USA.							ABELSON PH, 1991, SCIENCE, V252, P9, DOI 10.1126/science.2011755; [Anonymous], 1988, NEW DEV BIOTECHNOLOG; BLUMENTHAL D, 1986, SCIENCE, V232, P1361, DOI 10.1126/science.3715452; BLUMENTHAL D, 1986, SCIENCE, V231, P242, DOI 10.1126/science.3941897; BLUMENTHAL D, 1987, 100A83 US DEP HLTH H; CHEN PS, 1992, BIOMEDICAL RES COLLA; ETZKOWITZ H, 1989, SOC PROBL, V36, P14, DOI 10.1525/sp.1989.36.1.03a00020; ETZKOWITZ H, 1991, SEP NATO RES WORKSH; FELLER I, 1990, RES POLICY, V19, P335, DOI 10.1016/0048-7333(90)90017-Z; GLUCK ME, 1987, RES POLICY, V16, P327, DOI 10.1016/0048-7333(87)90018-7; Kenney Martin, 1986, BIOTECHNOLOGY U IND; KRIMSKY S, 1991, SCI TECHNOL HUM VAL, V16, P275, DOI 10.1177/016224399101600301; MARSHALL E, 1990, SCIENCE, V248, P152, DOI 10.1126/science.2326628; Merton Robert K., 1942, J LEGAL POLITICAL SO, V1, P15; MERVIS J, 1990, SCIENTIST       0205; PALCA J, 1991, SCIENCE, V251, P19, DOI 10.1126/science.1986407; PALCA J, 1990, SCIENCE, V249, P1237, DOI 10.1126/science.2399459; PRAMIK HJ, 1990, GENETIC ENG NEWS, V10, P1; SHAPIRO HT, 1990, DEC NAT AC ENG S ROL; SHULMAN S, 1990, NATURE, V344, P97, DOI 10.1038/344097a0; WEBSTER A, 1991, 12 SCI POL SUPP GROU; 1992, RCED92104 GEN ACC OF; 1992, FACULTY POLICIES INT; 1991, IND PERSPECTIVES INN; 1989, NIH GUIDE GRANTS CON, V18; 1990, FACULTY POLICIES	26	45	45	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3344	3349		10.1001/jama.268.23.3344	http://dx.doi.org/10.1001/jama.268.23.3344			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB732	1453527				2022-12-28	WOS:A1992KB73200027
J	BHASKAR, KR; GARIK, P; TURNER, BS; BRADLEY, JD; BANSIL, R; STANLEY, HE; LAMONT, JT				BHASKAR, KR; GARIK, P; TURNER, BS; BRADLEY, JD; BANSIL, R; STANLEY, HE; LAMONT, JT			VISCOUS FINGERING OF HCL THROUGH GASTRIC MUCIN	NATURE			English	Article							MUCUS-BICARBONATE BARRIER; MUCOSAL PROTECTION; PH GRADIENT; DIFFUSION; PATTERNS; ACID; GEL; GLYCOPROTEIN; SECRETION; VISCOSITY	THE HCl in the mammalian stomach is concentrated enough to digest the stomach itself, yet the gastric epithelium remains undamaged. One protective factor is gastric mucus, which forms a protective layer over the surface epithelium1-4 and acts as a diffusion barrier5,6 Bicarbonate ions secreted by the gastric epithelium7 are trapped in the mucus gel, establishing a gradient from pH 1-2 at the lumen to pH 6-7 at the cell surface8-10. How does HCl, secreted at the base of gastric glands by parietal cells, traverse the mucus layer without acidifying it? Here we demonstrate that injection of HCl through solutions of pig gastric mucin produces viscous fingering patterns11-18 dependent on pH, mucin concentration and acid flow rate. Above pH 4, discrete fingers are observed, whereas below pH 4, HCl neither penetrates the mucin solution nor forms fingers. Our in vitro results suggest that HCl secreted by the gastric gland can penetrate the mucus gel layer (pH 5-7) through narrow fingers, whereas HCl in the lumen (pH 2) is prevented from diffusing back to the epithelium by the high viscosity of gastric mucus gel on the luminal side.	BOSTON UNIV,CTR POLYMER STUDIES,BOSTON,MA 02215; BOSTON UNIV,DEPT PHYS,BOSTON,MA 02215	Boston University; Boston University	BHASKAR, KR (corresponding author), BOSTON UNIV HOSP,MED CTR,GASTROENTEROL SECT,88 E NEWTON ST,BOSTON,MA 02218, USA.		Bansil, Rama/ABC-4452-2020	Bansil, Rama/0000-0003-1311-1749; Stanley, H./0000-0003-2800-4495				AGREN J, 1990, ACTA PHYSL SCAND, V140, pA36; ALLEN A, 1976, NATURE, V264, P88, DOI 10.1038/264088a0; ALLEN A, 1983, TRENDS BIOCHEM SCI, V8, P169, DOI 10.1016/0968-0004(83)90166-4; ALLEN A, 1980, GUT, V21, P249, DOI 10.1136/gut.21.3.249; Allen A., 1981, PHYSL GASTROINTESTIN, P617; BENJACOB E, 1990, NATURE, V343, P523, DOI 10.1038/343523a0; BHASKAR KR, 1991, AM J PHYSIOL, V261, pG827, DOI 10.1152/ajpgi.1991.261.5.G827; BLOOM W, 1966, TXB HISTOLOGY, P433; BUKA A, 1986, NATURE, V323, P424, DOI 10.1038/323424a0; CASTELL DO, 1987, ESOPHAGEAL MOTILITY, P21; FABRY T L, 1990, Gastroenterology, V98, pA42; FLEMSTROM G, 1987, PHYSL GASTROINTESTIN, P1011; GARIK P, 1991, PHYS REV LETT, V66, P1606, DOI 10.1103/PhysRevLett.66.1606; GONG DH, 1990, AM J PHYSIOL, V259, pG681, DOI 10.1152/ajpgi.1990.259.4.G681; HEATLEY NG, 1959, GASTROENTEROLOGY, V37, P313; Hele-Shaw H. S., 1898, NATURE, V58, P34, DOI DOI 10.1038/058034A0; HOLLANDER F, 1954, ARCH INTERN MED, V93, P107, DOI 10.1001/archinte.1954.00240250117009; HOLM L, 1990, J INTERN MED, V228, P91, DOI 10.1111/j.1365-2796.1990.tb01478.x; JOSEPH DD, 1990, EUR J MECH B-FLUID, V9, P565; KERSS S, 1982, CLIN SCI, V63, P185; LAL J, 1992, PHYSICA A, V186, P88, DOI 10.1016/0378-4371(92)90367-Y; MAKHLOUF GM, 1984, PHYSL GASTROINTESTIN, V1, P551; MAY SE, 1989, PHYS REV A, V40, P1723, DOI 10.1103/PhysRevA.40.1723; MURTY VLN, 1984, BIOCHEM BIOPH RES CO, V121, P521, DOI 10.1016/0006-291X(84)90213-4; NITTMANN J, 1985, NATURE, V314, P141, DOI 10.1038/314141a0; PATRONELLA CK, 1988, GASTROENTEROLOGY, V95, P612, DOI 10.1016/S0016-5085(88)80005-2; PFEIFFER CJ, 1981, AM J PHYSIOL, V240, pG176, DOI 10.1152/ajpgi.1981.240.2.G176; SEELIG LL, 1985, AM J ANAT, V174, P15, DOI 10.1002/aja.1001740103; SELLERS LA, 1987, BIORHEOLOGY, V24, P615; TAKEUCHI K, 1983, GASTROENTEROLOGY, V84, P331; WALLACE JL, 1989, AM J PHYSIOL, V256, pG31, DOI 10.1152/ajpgi.1989.256.1.G31; WILLIAMS SE, 1981, GUT, V22, P94, DOI 10.1136/gut.22.2.94; WILLIAMS SE, 1980, GASTROENTEROLOGY, V79, P299	33	174	174	1	26	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 3	1992	360	6403					458	461		10.1038/360458a0	http://dx.doi.org/10.1038/360458a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448168				2022-12-28	WOS:A1992KA79700058
J	ZHU, WX; OLSON, DE; KARON, BL; TAJIK, AJ				ZHU, WX; OLSON, DE; KARON, BL; TAJIK, AJ			MYOCARDIAL STUNNING AFTER ELECTROCONVULSIVE-THERAPY	ANNALS OF INTERNAL MEDICINE			English	Note						ELECTROCONVULSIVE THERAPY; ADRENERGIC BETA-RECEPTOR BLOCKADERS; MYOCARDIAL CONTRACTION; LABETALOL; SYMPATHETIC NERVOUS SYSTEM	BLOCKADE	Myocardial stunning, a prolonged but reversible myocardial contractile dysfunction, has not been reported as a complication of electroconvulsive therapy (ECT). An elderly woman without a history of heart disease was admitted for treatment of depression. After the initial sessions of ECT, transient myocardial dysfunction repeatedly occurred. with reversible electrocardiographic and echocardiographic changes. Preventive therapy with labetalol attenuated the hemodynamic changes during subsequent sessions of ECT, and no immediate or delayed electrocardiographic or echocardiographic abnormalities were observed. Myocardial stunning after ECT is possibly mediated by sympathetic surge and may be prevented by alpha- and beta-adrenergic blockade.	MAYO CLIN & MAYO FDN, DEPT PSYCHIAT, 200 1ST ST SW, ROCHESTER, MN 55905 USA	Mayo Clinic								BOLLI R, 1990, CIRCULATION, V82, P723, DOI 10.1161/01.CIR.82.3.723; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; DEC GW, 1985, JAMA-J AM MED ASSOC, V253, P2525, DOI 10.1001/jama.253.17.2525; DECINA P, 1984, AM J PSYCHIAT, V141, P298; FINE D G, 1990, Journal of the American College of Cardiology, V15, p215A; GOULD L, 1983, ARCH INTERN MED, V143, P1786, DOI 10.1001/archinte.143.9.1786; GREEN R, 1955, BMJ-BRIT MED J, V1, P1503, DOI 10.1136/bmj.1.4929.1503; JONES RM, 1981, ANAESTHESIA, V36, P795, DOI 10.1111/j.1365-2044.1981.tb08818.x; SELVIN BL, 1987, ANESTHESIOLOGY, V67, P367, DOI 10.1097/00000542-198709000-00015	9	28	29	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					914	915		10.7326/0003-4819-117-11-914	http://dx.doi.org/10.7326/0003-4819-117-11-914			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443953				2022-12-28	WOS:A1992JZ27600007
J	SCHMID, A; FASCHER, KD; HORZ, W				SCHMID, A; FASCHER, KD; HORZ, W			NUCLEOSOME DISRUPTION AT THE YEAST PHO5 PROMOTER UPON PHO5 INDUCTION OCCURS IN THE ABSENCE OF DNA-REPLICATION	CELL			English	Article							RNA POLYMERASE-II; BETA-GLOBIN GENE; TRANSCRIPTIONALLY ACTIVE CHROMATIN; TUMOR VIRUS PROMOTER; SACCHAROMYCES-CEREVISIAE; ACID-PHOSPHATASE; POSITIONED NUCLEOSOMES; HYPERSENSITIVE SITES; REGULATORY PROTEINS; MAJOR LATE	Activation of the PHO5 gene in S. cerevisiae by phosphate starvation was previously shown to be accompanied by the disappearance of four positioned nucleosomes from the promoter. To investigate the mechanism, we replaced the PHO80 gene, a negative regulator of PHO5, by a temperature-sensitive allele. As a consequence, PHO5 can be activated in the presence of phosphate by a temperature shift from 24-degrees-C to 37-degrees-C. Under these conditions, the promoter undergoes the same chromatin transition as in phosphate-starved cells. Disruption of the nucleosomes by the temperature shift also occurs when DNA replication is prevented. Nucleosomes re-form when the temperature is shifted from 37-degrees-C back to 24-degrees-C in nondividing cells. Glucose is required for the disruption of the nucleosomes during the temperature upshift, not for their re-formation during the temperature downshift. These experiments prove that DNA replication is not required for the transition between the nucleosomal and the non-nucleosomal state at the PHO5 promoter.			SCHMID, A (corresponding author), UNIV MUNICH,INST PHYS CHEM,SCHILLERSTR 44,W-8000 MUNICH 2,GERMANY.							ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; BARBARIC S, 1992, NUCLEIC ACIDS RES, V20, P1031, DOI 10.1093/nar/20.5.1031; BEARD P, 1978, CELL, V15, P955, DOI 10.1016/0092-8674(78)90279-9; BECKER PB, 1991, P NATL ACAD SCI USA, V88, P4109, DOI 10.1073/pnas.88.10.4109; BERBEN G, 1990, YEAST, V6, P451, DOI 10.1002/yea.320060510; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; BRAUS G, 1989, EMBO J, V8, P939, DOI 10.1002/j.1460-2075.1989.tb03455.x; BURGLIN TR, 1988, CELL, V53, P339, DOI 10.1016/0092-8674(88)90153-5; DHAR V, 1989, MOL CELL BIOL, V9, P3524, DOI 10.1128/MCB.9.8.3524; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Elgin SCR, 1990, CURR OPIN CELL BIOL, V2, P437, DOI 10.1016/0955-0674(90)90125-X; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; EPNER E, 1988, P NATL ACAD SCI USA, V85, P8081, DOI 10.1073/pnas.85.21.8081; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; FASCHER KD, 1989, THESIS U MUNCHEN MUN; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FISHER F, 1991, ONCOGENE, V6, P1099; FOY HR, 1987, EMBO J, V6, P2321; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; GRUNSTEIN M, 1990, TRENDS GENET, V6, P395, DOI 10.1016/0168-9525(90)90299-L; HAGUENAUERTSAPIS R, 1984, MOL CELL BIOL, V4, P2668, DOI 10.1128/MCB.4.12.2668; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; HANES SD, 1986, CRC CR REV BIOCH MOL, V21, P153, DOI 10.3109/10409238609113611; HAYASHI N, 1991, MOL CELL BIOL, V11, P785, DOI 10.1128/MCB.11.2.785; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KANEKO Y, 1985, MOL CELL BIOL, V5, P248, DOI 10.1128/MCB.5.1.248; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; KNEZETIC JA, 1988, MOL CELL BIOL, V8, P3114, DOI 10.1128/MCB.8.8.3114; KOREN R, 1986, GENE, V41, P271, DOI 10.1016/0378-1119(86)90107-1; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; KULAEV IS, 1983, ADV MICROB PHYSIOL, V24, P83, DOI 10.1016/S0065-2911(08)60385-9; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; LEMIRE JM, 1985, MOL CELL BIOL, V5, P2131, DOI 10.1128/MCB.5.8.2131; LEWIN B, 1990, CELL, V61, P1161, DOI 10.1016/0092-8674(90)90675-5; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; LOSA R, 1987, CELL, V50, P801, DOI 10.1016/0092-8674(87)90338-2; LUCCHINI G, 1988, MOL GEN GENET, V212, P459, DOI 10.1007/BF00330850; MADDEN SL, 1990, MOL CELL BIOL, V10, P5950, DOI 10.1128/MCB.10.11.5950; MADDEN SL, 1988, NUCLEIC ACIDS RES, V16, P2625, DOI 10.1093/nar/16.6.2625; MATSUI T, 1987, MOL CELL BIOL, V7, P1401, DOI 10.1128/MCB.7.4.1401; MEISTERERNST M, 1990, P NATL ACAD SCI USA, V87, P9153, DOI 10.1073/pnas.87.23.9153; MENDENHALL MD, 1987, CELL, V50, P927, DOI 10.1016/0092-8674(87)90519-8; MEYHACK B, 1982, EMBO J, V1, P675, DOI 10.1002/j.1460-2075.1982.tb01229.x; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; MORSE RH, 1992, TRENDS BIOCHEM SCI, V17, P23, DOI 10.1016/0968-0004(92)90422-6; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; OGAWA N, 1990, MOL CELL BIOL, V10, P2224, DOI 10.1128/MCB.10.5.2224; Oshima Y, 1982, MOL BIOL YEAST SACCH, P159; PAVLOVIC B, 1988, MOL CELL BIOL, V8, P5513, DOI 10.1128/MCB.8.12.5513; PEDERSON DS, 1986, ANNU REV CELL BIOL, V2, P117, DOI 10.1146/annurev.cellbio.2.1.117; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; PHAM TA, 1991, J BIOL CHEM, V266, P18179; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; REIK A, 1991, EMBO J, V10, P2569, DOI 10.1002/j.1460-2075.1991.tb07797.x; ROBERGE M, 1992, MOL MICROBIOL, V6, P419, DOI 10.1111/j.1365-2958.1992.tb01485.x; RUDOLPH H, 1987, P NATL ACAD SCI USA, V84, P1340, DOI 10.1073/pnas.84.5.1340; SENGSTAG C, 1987, NUCLEIC ACIDS RES, V15, P233, DOI 10.1093/nar/15.1.233; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; SVAREN J, 1990, TRENDS GENET, V6, P52, DOI 10.1016/0168-9525(90)90074-G; TATCHELL K, 1986, J BACTERIOL, V166, P364, DOI 10.1128/jb.166.2.364-367.1986; THOMA F, 1991, TRENDS GENET, V7, P175, DOI 10.1016/0168-9525(91)90429-T; Toh-e A, 1986, Yeast, V2, P129, DOI 10.1002/yea.320020209; TOHE A, 1988, MOL GEN GENET, V214, P162, DOI 10.1007/BF00340196; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; TSCHUMPER G, 1980, GENE, V10, P157, DOI 10.1016/0378-1119(80)90133-X; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; UESONO Y, 1992, MOL GEN GENET, V231, P426, DOI 10.1007/BF00292712; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; VENTER U, 1989, NUCLEIC ACIDS RES, V17, P1353, DOI 10.1093/nar/17.4.1353; VOGEL K, 1990, MOL MICROBIOL, V4, P2013, DOI 10.1111/j.1365-2958.1990.tb00560.x; VOGEL K, 1989, MOL CELL BIOL, V9, P2050, DOI 10.1128/MCB.9.5.2050; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3; WILLS C, 1990, CRIT REV BIOCHEM MOL, V25, P245, DOI 10.3109/10409239009090611; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S; YA MB, 1991, MOL CELL BIOL, V11, P3229; YANIV M, 1986, CRIT REV BIOCHEM MOL, V21, P1, DOI 10.3109/10409238609113607; YOSHIDA K, 1989, MOL GEN GENET, V217, P40, DOI 10.1007/BF00330940	89	139	141	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 27	1992	71	5					853	864		10.1016/0092-8674(92)90560-Y	http://dx.doi.org/10.1016/0092-8674(92)90560-Y			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423633				2022-12-28	WOS:A1992JZ63300014
J	SPENCER, DD; ROBBINS, RJ; NAFTOLIN, F; MAREK, KL; VOLLMER, T; LERANTH, C; ROTH, RH; PRICE, LH; GJEDDE, A; BUNNEY, BS; SASS, KJ; ELSWORTH, JD; KIER, EL; MAKUCH, R; HOFFER, PB; REDMOND, DE				SPENCER, DD; ROBBINS, RJ; NAFTOLIN, F; MAREK, KL; VOLLMER, T; LERANTH, C; ROTH, RH; PRICE, LH; GJEDDE, A; BUNNEY, BS; SASS, KJ; ELSWORTH, JD; KIER, EL; MAKUCH, R; HOFFER, PB; REDMOND, DE			UNILATERAL TRANSPLANTATION OF HUMAN FETAL MESENCEPHALIC TISSUE INTO THE CAUDATE-NUCLEUS OF PATIENTS WITH PARKINSONS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOPAMINE NEURONS; SUBSTANTIA-NIGRA; VENTRAL MESENCEPHALON; CELL TRANSPLANTATION; NEURAL TISSUE; BRAIN GRAFTS; STRIATUM; MPTP; CRYOPRESERVATION; RECONSTRUCTION	Background. Parkinson's disease is characterized by the loss of midbrain dopamine neurons that innervate the caudate and the putamen. Studies in animals suggest that fetal dopaminergic neurons can survive transplantation and restore neurologic function. This report compares the clinical results in four case patients with severe Parkinson's disease who underwent stereotaxic implantation of human fetal ventral mesencephalic tissue in one caudate nucleus with the results in a control group of similar subjects assigned at random to a one-year delay in surgery. Methods. Each case patient received cryopreserved tissue from one fetal cadaver (gestational age, 7 to 11 weeks). Before implantation, adjacent midbrain tissue underwent microbiologic, biochemical, and viability testing. Cyclosporine was administered for six months postoperatively. Results. The procedure was well tolerated. Three case patients showed bilateral improvement on motor tasks, as assessed on videotape, and were more functional in the activities of daily living, as assessed by themselves and neurologists, during both optimal drug therapy and "drug holiday" periods. One case patient, who died after four months from continued disease progression, had striatonigral degeneration at autopsy. In the patients who received transplants, optimal control was achieved with a lower dose of antiparkinsonian medications, whereas the controls required more medication. Positron-emission tomography with [F-18]fluorodopa before and after surgery in one patient revealed a bilateral restoration of caudate dopamine synthesis to the range of normal controls, but continued bilateral deficits in the putamen. Conclusions. Although the case patients continued to be disabled by their disease, unilateral intracaudate grafts of fetal tissue containing dopamine diminished the symptoms and signs of parkinsonism during 18 months of evaluation.	MCGILL UNIV, MONTREAL NEUROL INST, MONTREAL H3A 2T5, QUEBEC, CANADA	McGill University	SPENCER, DD (corresponding author), YALE UNIV, SCH MED, NEUROSURG SECT, NEURAL TRANSPLANT PROGRAM, NEW HAVEN, CT 06510 USA.		Gjedde, Albert/U-3751-2019; Gjedde, Albert/I-2452-2019	Gjedde, Albert/0000-0002-3756-7401; Marek, Kenneth/0000-0002-4197-5627				ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BAKAY RAE, 1987, ANN NY ACAD SCI, V495, P623, DOI 10.1111/j.1749-6632.1987.tb23705.x; BANKIEWICZ KS, 1990, J NEUROSURG, V72, P231, DOI 10.3171/jns.1990.72.2.0231; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BJORKLUND A, 1984, ANNU REV NEUROSCI, V7, P279, DOI 10.1146/annurev.ne.07.030184.001431; BRUNDIN P, 1987, ANN NY ACAD SCI, V495, P476, DOI 10.1111/j.1749-6632.1987.tb23695.x; Bunney BS, 1987, PSYCHOPHARMACOLOGY 3, P113; COLLIER TJ, 1987, BRAIN RES, V436, P363, DOI 10.1016/0006-8993(87)91680-5; DETTA A, 1990, BRAIN RES, V520, P277, DOI 10.1016/0006-8993(90)91716-T; ELSWORTH JD, 1989, NEUROSCIENCE, V33, P323, DOI 10.1016/0306-4522(89)90212-1; Evans A.C., 1989, PROC SPIE, V1092, P264, DOI [10.1117/12.953267, DOI 10.1117/12.953267]; EVANS AC, 1991, J CEREBR BLOOD F MET, V11, pA69, DOI 10.1038/jcbfm.1991.40; EVANS AC, 1991, IEEE T MED IMAGING, V10, P90, DOI 10.1109/42.75615; Fahn S., 1987, RECENT DEV PARKINSON, P153; FINE A, 1988, PROG BRAIN RES, V78, P479; FREED CR, 1990, ARCH NEUROL-CHICAGO, V47, P505, DOI 10.1001/archneur.1990.00530050021007; FREED WJ, 1990, SCIENCE, V250, P1434; GEMINIANI G, 1991, MOVEMENT DISORD, V6, P330, DOI 10.1002/mds.870060411; GILL TJ, 1989, JAMA-J AM MED ASSOC, V261, P2674, DOI 10.1001/jama.261.18.2674; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; GREELY HT, 1989, NEW ENGL J MED, V320, P1093, DOI 10.1056/NEJM198904203201624; HENDERSON BTH, 1991, ARCH NEUROL-CHICAGO, V48, P822, DOI 10.1001/archneur.1991.00530200062020; HITCHCOCK ER, 1988, LANCET, V1, P1274; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HOFFER BJ, 1991, TRENDS NEUROSCI, V14, P384, DOI 10.1016/0166-2236(91)90168-T; HOSHI H, IN PRESS J CEREB BLO; Landon R M, 1986, Methods Enzymol, V124, P412; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206; LUND RD, 1989, TRANSPLANT P, V21, P3159; LUND RD, 1976, SCIENCE, V193, P582, DOI 10.1126/science.959815; Lups S, 1954, CEREBROSPINAL FLUID, P1954; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; MADRAZO I, 1990, ARCH NEUROL-CHICAGO, V47, P1281, DOI 10.1001/archneur.1990.00530120025005; MAHOWALD MB, 1987, SCIENCE, V235, P1307, DOI 10.1126/science.235.4794.1307b; MCCARTHY G, 1991, EPILEPSY SURG, P385; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; REDMOND DE, 1986, LANCET, V1, P1125; REDMOND DE, 1988, SCIENCE, V242, P768, DOI 10.1126/science.2903552; REDMOND DE, 1990, LANCET, V336, P820, DOI 10.1016/0140-6736(90)93294-Y; REDMOND DE, 1989, NEW ENGL J MED, V321, P1609; REDMOND DE, IN PRESS MOL CELLULA; REDMOND DE, 1987, NEUROL CONSULTANT, V4, P1; RICE WR, 1990, BIOMETRICS, V46, P303, DOI 10.2307/2531435; Rinne U K, 1987, Adv Neurol, V45, P519; ROBBINS RJ, 1990, EXP NEUROL, V107, P208, DOI 10.1016/0014-4886(90)90137-H; ROSENFELD JV, 1991, J NEUROSURG, V74, P157; Schwab R.S., 1969, 3 S PARK DIS, P152; SLADEK JR, 1986, BRAIN RES BULL, V17, P809, DOI 10.1016/0361-9230(86)90092-4; Spitzer R.L., 1978, SCHEDULE AFFECTIVE D; STEECECOLLIER K, 1990, EXP NEUROL, V110, P201, DOI 10.1016/0014-4886(90)90031-M; STROMBERG I, 1986, NEUROSCI LETT, V71, P271, DOI 10.1016/0304-3940(86)90632-4; TAYLOR JR, 1991, EXP BRAIN RES, V85, P335; TAYLOR JR, 1990, NEURAL TRANSPLANTATI, V82, P543; WEINER WJ, 1989, MOVEMENT DISORDERS C; WIDNER H, 1988, BRAIN RES REV, V13, P287, DOI 10.1016/0165-0173(88)90010-0; 1988, REPORT HUMAN FETAL T; 1987, 1987 1987 P S NEW HA; 1988, SAS STAT USERS GUIDE; 1987, DIAGNOSTIC STATISTIC, P65	64	431	459	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1541	1548		10.1056/NEJM199211263272201	http://dx.doi.org/10.1056/NEJM199211263272201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435880				2022-12-28	WOS:A1992JZ43200001
J	FRIEDLAENDER, MH				FRIEDLAENDER, MH			IMMUNOLOGICAL ASPECTS OF DISEASES OF THE EYE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONJUNCTIVITIS				FRIEDLAENDER, MH (corresponding author), SCRIPPS CLIN & RES FDN,DIV OPHTHALMOL,LA JOLLA,CA 92037, USA.							ALLANSMITH MR, 1976, AM J OPHTHALMOL, V81, P506, DOI 10.1016/0002-9394(76)90310-X; ARSTIKAITIS MJ, 1973, ARCH OPHTHALMOL-CHIC, V90, P376, DOI 10.1001/archopht.1973.01000050378008; CULBERTSON WW, 1989, INT OPHTHALMOL CLIN, V29, P108, DOI 10.1097/00004397-198902920-00009; Friedlaender M H, 1983, Int Ophthalmol Clin, V23, P175, DOI 10.1097/00004397-198302310-00014; Friedlaender M H, 1989, Trans Am Ophthalmol Soc, V87, P577; FRIEDLAENDER MH, 1980, ARCH OPHTHALMOL-CHIC, V98, P1211; FRIEDLAENDER MH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1198; FRIEDLAENDER MH, 1979, ALLERGY IMMUNOLOGY, P130; FRIEDLAENDER MH, 1985, CURRENT OCULAR THERA, P122; MAMO JG, 1976, ARCH OPHTHALMOL-CHIC, V94, P580, DOI 10.1001/archopht.1976.03910030274004; MICHELSON JB, 1985, OPHTHALMOLOGY, V92, P1277; PATTEN JT, 1976, AM J OPHTHALMOL, V82, P272, DOI 10.1016/0002-9394(76)90433-5; PEDERSEN NB, 1976, LANCET, V2, P1363; POLACK FM, 1962, J EXP MED, V116, P709, DOI 10.1084/jem.116.5.709; PROUD D, 1990, J ALLERGY CLIN IMMUN, V85, P896, DOI 10.1016/0091-6749(90)90075-F; SCHEIN OD, 1989, NEW ENGL J MED, V321, P773, DOI 10.1056/NEJM198909213211201; SPENCER WH, 1959, AM J OPHTHALMOL, V47, P332, DOI 10.1016/S0002-9394(14)76533-X; STERN GA, 1991, INT OPHTHALMOL CLIN, V131, P147; WINTERKORN JMS, 1990, SURV OPHTHALMOL, V35, P191, DOI 10.1016/0039-6257(90)90089-E	19	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2869	2873		10.1001/jama.268.20.2869	http://dx.doi.org/10.1001/jama.268.20.2869			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433702				2022-12-28	WOS:A1992JY66800010
J	BEVILACQUA, PC; KIERZEK, R; JOHNSON, KA; TURNER, DH				BEVILACQUA, PC; KIERZEK, R; JOHNSON, KA; TURNER, DH			DYNAMICS OF RIBOZYME BINDING OF SUBSTRATE REVEALED BY FLUORESCENCE-DETECTED STOPPED-FLOW METHODS	SCIENCE			English	Article							HELIX-COIL TRANSITION; INTERVENING SEQUENCE; RIBOSOMAL-RNA; TETRAHYMENA-THERMOPHILA; ACTIVE-SITE; KINETICS; MECHANISM; RECOGNITION; CLEAVAGE; THERMODYNAMICS	Fluorescence-detected stopped-flow and equilibrium methods have been used to study the mechanism for binding of pyrene (pyr)-labeled RNA oligomer substrates to the ribozyme (catalytic RNA) from Tetrahymena thermophila. The fluorescence of these substrates increases up to 25-fold on binding to the ribozyme. Stopped-flow experiments provide evidence that pyr experiences at least three different microenvironments during the binding process. A minimal mechanism is presented in which substrate initially base pairs to ribozyme and subsequently forms tertiary contacts in an RNA folding step. All four microscopic rate constants are measured for ribozyme binding of pyrCCUCU.	UNIV ROCHESTER, DEPT CHEM, ROCHESTER, NY 14627 USA; POLISH ACAD SCI, INST BIOORGAN CHEM, PL-60704 POZNAN, POLAND; PENN STATE UNIV, DEPT MOLEC & CELL BIOL, University Pk, PA 16802 USA	University of Rochester; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park			Schroeder, Susan/D-3946-2011	Bevilacqua, Philip/0000-0001-8074-3434; Kierzek, Ryszard/0000-0002-7644-0016	NIGMS NIH HHS [GM 22939, GM44613] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939, R01GM044613] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; BENNUN M, 1992, J PHYS CHEM-US, V96, P1523, DOI 10.1021/j100183a004; CRAIG ME, 1971, J MOL BIOL, V62, P383, DOI 10.1016/0022-2836(71)90434-7; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; HE L, 1991, BIOCHEMISTRY-US, V30, P11124, DOI 10.1021/bi00110a015; HERSCHLAG D, 1992, BIOCHEMISTRY-US, V31, P1386, DOI 10.1021/bi00120a015; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; HIROMI K, 1979, KINETICS FAST ENZYME, P258; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; JOHNSON KA, 1986, METHOD ENZYMOL, V134, P677; KIERZEK R, UNPUB; KIM SH, 1987, P NATL ACAD SCI USA, V84, P8788, DOI 10.1073/pnas.84.24.8788; LABUDA D, 1984, J MOL BIOL, V174, P587, DOI 10.1016/0022-2836(84)90085-8; LIN CT, 1976, J AM CHEM SOC, V98, P6536, DOI 10.1021/ja00437a020; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; NORTH AM, 1964, COLLISION THEORY CHE, pCH7; PETERSHEIM M, 1983, BIOCHEMISTRY-US, V22, P256, DOI 10.1021/bi00271a004; PORSCHKE D, 1973, BIOPOLYMERS, V12, P1313, DOI 10.1002/bip.1973.360120609; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; PYLE AM, 1991, NATURE, V350, P628, DOI 10.1038/350628a0; SUGIMOTO N, 1989, NUCLEIC ACIDS RES, V17, P355, DOI 10.1093/nar/17.1.355; SULLIVAN FX, 1985, CELL, V42, P639, DOI 10.1016/0092-8674(85)90121-7; Turner DH, 1990, LANDOLTBORNSTEIN N C, V1, P201; WARING RB, 1983, J MOL BIOL, V167, P595, DOI 10.1016/S0022-2836(83)80100-4; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; WILLIAMS AP, 1989, BIOCHEMISTRY-US, V28, P4283, DOI 10.1021/bi00436a025; YOON K, 1976, NUCLEIC ACIDS RES, V3, P2233, DOI 10.1093/nar/3.9.2233; YOON K, 1975, J MOL BIOL, V99, P507, DOI 10.1016/S0022-2836(75)80169-0; YUAN RC, 1979, NUCLEIC ACIDS RES, V7, P2399, DOI 10.1093/nar/7.8.2399; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	35	190	191	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	1992	258	5086					1355	1357		10.1126/science.1455230	http://dx.doi.org/10.1126/science.1455230			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455230				2022-12-28	WOS:A1992JY95800038
J	SWINDELLS, MB				SWINDELLS, MB			STRUCTURAL SIMILARITY BETWEEN TRANSFORMING GROWTH-FACTOR-BETA-2 AND NERVE GROWTH-FACTOR	SCIENCE			English	Article							CRYSTAL-STRUCTURE; RESOLUTION				SWINDELLS, MB (corresponding author), PROT ENGN RES INST,6-2-3 FURUEDAI,SUITA,OSAKA 565,JAPAN.							DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; GARRETT TPJ, 1984, J BIOL CHEM, V259, P2822; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0	4	33	35	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1160	1161		10.1126/science.1439827	http://dx.doi.org/10.1126/science.1439827			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439827				2022-12-28	WOS:A1992JX85200037
J	SZE, JY; WOONTNER, M; JAEHNING, JA; KOHLHAW, GB				SZE, JY; WOONTNER, M; JAEHNING, JA; KOHLHAW, GB			INVITRO TRANSCRIPTIONAL ACTIVATION BY A METABOLIC INTERMEDIATE - ACTIVATION BY LEU3 DEPENDS ON ALPHA-ISOPROPYLMALATE	SCIENCE			English	Article							REGULATORY GENE LEU3; YEAST LEU4; EXPRESSION; BINDING; BIOSYNTHESIS; DELETION; PROTEINS; PRODUCT; ELEMENT; REGION	In the absence of the leucine biosynthetic precursor alpha-isopropylmalate (alpha-IPM), the yeast LEU3 protein (Leu3p) binds DNA and acts as a transcriptional repressor in an in vitro extract. Addition of alpha-IPM resulted in a dramatic increase in Leu3p-dependent transcription. The presence of alpha-IPM was also required for Leu3p to compete effectively with another transcriptional activator, GAL4/VP16, for limiting transcription factors. Therefore, the addition of alpha-IPM appears to convert a transcriptional repressor into an activator. This represents an example in eukaryotes of direct transcriptional regulation by a small effector molecule.	PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907; INDIANA UNIV,INST MOLEC & CELLULAR BIOL,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT BIOL,BLOOMINGTON,IN 47405	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K04AI000874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038101] Funding Source: NIH RePORTER; NIAID NIH HHS [K04 AI 00874] Funding Source: Medline; NIGMS NIH HHS [GM15102, R01 GM38101] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAGCHI MK, 1991, MOL CELL BIOL, V11, P4998, DOI 10.1128/MCB.11.10.4998; BAI YL, 1991, NUCLEIC ACIDS RES, V19, P5991, DOI 10.1093/nar/19.21.5991; BAICHWAL VR, 1983, CURR GENET, V7, P369, DOI 10.1007/BF00445877; BELTZER JP, 1986, J BIOL CHEM, V261, P5160; BERGER SL, 1990, CELL, V61, P1199, DOI 10.1016/0092-8674(90)90684-7; BRISCO PRG, 1990, J BIOL CHEM, V265, P11667; CALVO JM, 1970, METHODS ENZYMOLOGY A, V17, P791; CHANG LFL, 1984, GENETICS, V108, P91; FRIDEN P, 1989, MOL CELL BIOL, V9, P4056, DOI 10.1128/MCB.9.9.4056; FRIDEN P, 1988, MOL CELL BIOL, V8, P2690, DOI 10.1128/MCB.8.7.2690; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; GARDNER KH, 1991, BIOCHEMISTRY-US, V30, P11292, DOI 10.1021/bi00111a015; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KOHLHAW GB, 1983, AMINO ACIDS BIOSYNTH, P285; LITSKEPETERSEN JG, 1986, NUCLEIC ACIDS RES, V14, P961; MARTINEZARIAS A, 1984, NATURE, V307, P740, DOI 10.1038/307740b0; PETERS MH, 1990, ARCH BIOCHEM BIOPHYS, V276, P294, DOI 10.1016/0003-9861(90)90041-V; POLACCO JC, 1973, GENETICS, V74, P443; SZE JY, UNPUB; WOONTNER M, UNPUB; ZHOU K, 1987, NUCLEIC ACIDS RES, V15, P5261, DOI 10.1093/nar/15.13.5261; ZHOU K, 1990, J BIOL CHEM, V265, P17409; ZHOU KM, 1990, NUCLEIC ACIDS RES, V18, P291, DOI 10.1093/nar/18.2.291	24	87	88	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1143	1145		10.1126/science.1439822	http://dx.doi.org/10.1126/science.1439822			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439822				2022-12-28	WOS:A1992JX85200030
J	DRIVER, J; BAYLIS, GC; RAFAL, RD				DRIVER, J; BAYLIS, GC; RAFAL, RD			PRESERVED FIGURE GROUND SEGREGATION AND SYMMETRY PERCEPTION IN VISUAL NEGLECT	NATURE			English	Article							SPATIAL ATTENTION; RECOGNITION; STIMULI; HUMANS; FIELD	A CENTRAL controversy in current research on visual attention is whether figures are segregated from their background preattentively1-8, or whether attention is first directed to unstructured regions of the image9-13. Here we present neurological evidence for the former view from studies of a brain-injured patient with visual neglect. His attentional impairment arises after normal segmentation of the image into figures and background has taken place. Our results indicate that information which is neglected and unavailable to higher levels of visual processing can nevertheless be processed by earlier stages in the visual system concerned with segmentation.	UNIV CALIF SAN DIEGO,DEPT PSYCHOL 0109,LA JOLLA,CA 92093; UNIV CALIF DAVIS,DEPT NEUROL,DAVIS,CA 94553; UNIV CALIF DAVIS,CTR NEUROBIOL,DAVIS,CA 94553	University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California Davis	DRIVER, J (corresponding author), UNIV CAMBRIDGE,DEPT EXPTL PSYCHOL,DOWNING ST,CAMBRIDGE CB2 3EB,ENGLAND.		Driver, Jon/A-4779-2010	BAYLIS, Gordon/0000-0002-4223-9074				BARLOW HB, 1979, VISION RES, V19, P783, DOI 10.1016/0042-6989(79)90154-8; BAYLIS GC, 1992, PERCEPT PSYCHOPHYS, V51, P145, DOI 10.3758/BF03212239; BERTI A, 1992, NEUROPSYCHOLOGIA, V30, P403, DOI 10.1016/0028-3932(92)90088-4; Bisiach E, 1988, HDB NEUROPSYCHOLOGY, V1, P195; BRUNN JL, 1991, COGNITIVE NEUROPSYCH, V8, P59, DOI 10.1080/02643299108253367; COHEN A, 1991, PSYCHOL SCI, V2, P106, DOI 10.1111/j.1467-9280.1991.tb00109.x; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DRIVER J, 1991, COGNITIVE NEUROPSYCH, V8, P475, DOI 10.1080/02643299108253384; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; FARAH MJ, 1991, NEUROPSYCHOLOGIA, V29, P949, DOI 10.1016/0028-3932(91)90059-H; Heilman K.M., 1985, INT J CLIN NEUROPSYC, V2nd, P243; JULESZ B, 1984, TRENDS NEUROSCI, V6, P41; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kanwisher N., 1992, CURR DIR PSYCHOL SCI, V1, P26; MCLEOD P, 1988, NATURE, V332, P154, DOI 10.1038/332154a0; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RAFAL R, 1990, SCIENCE, V250, P118, DOI 10.1126/science.2218503; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; Rock I., 1983, LOGIC PERCEPTION; SIEROFF E, 1988, COGNITIVE NEUROPSYCH, V5, P427, DOI 10.1080/02643298808253268; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TSAL Y, 1988, PERCEPT PSYCHOPHYS, V44, P15, DOI 10.3758/BF03207469; UMITA C, 1989, HDB NEUROPSYCHOLOGY, V1, P175; van der Heijden AHC., 1992, SELECTIVE ATTENTION; VOLPE BT, 1979, NATURE, V282, P722, DOI 10.1038/282722a0	27	219	221	0	26	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 5	1992	360	6399					73	75		10.1038/360073a0	http://dx.doi.org/10.1038/360073a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JW717	1436078				2022-12-28	WOS:A1992JW71700058
J	DUMBACHER, JP; BEEHLER, BM; SPANDE, TF; GARRAFFO, HM				DUMBACHER, JP; BEEHLER, BM; SPANDE, TF; GARRAFFO, HM			HOMOBATRACHOTOXIN IN THE GENUS PITOHUI - CHEMICAL DEFENSE IN BIRDS	SCIENCE			English	Article							COLORATION	Three passerine species in the genus Pitohui, endemic to the New Guinea subregion, contain the steroidal alkaloid homobatrachotoxin, apparently as a chemical defense. Toxin concentrations varied among species but were always highest in the skin and feathers. Homobatrachotoxin is a member of a class of compounds collectively called batrachotoxins that were previously considered to be restricted to neotropical poison-dart frogs of the genus Phyllobates. The occurrence of homobatrachotoxin in pitohuis suggests that birds and frogs independently evolved this class of alkaloids.	SMITHSONIAN INST,WILDLIFE CONSERVAT INT CONSERVAT INT,DIV BIRDS,WASHINGTON,DC 20560; NIH,BIOORGAN CHEM LAB,BETHESDA,MD 20892	Smithsonian Institution; Smithsonian National Museum of Natural History; National Institutes of Health (NIH) - USA	DUMBACHER, JP (corresponding author), UNIV CHICAGO,DEPT ECOL & EVOLUT,CHICAGO,IL 60637, USA.		Dumbacher, John/B-5280-2009	Dumbacher, John/0000-0001-8942-1554				ALBUQUERQUE EX, 1971, SCIENCE, V172, P995, DOI 10.1126/science.172.3987.995; BAKER RR, 1979, PHILOS T R SOC B, V287, P63, DOI 10.1098/rstb.1979.0053; Beehler B.M., 1986, BIRDS NEW GUINEA; DALY JW, 1980, SCIENCE, V208, P1383, DOI 10.1126/science.6246586; GUILFORD T, 1988, American Naturalist, V131, pS7, DOI 10.1086/284764; GUILFORD T, 1986, ANIM BEHAV, V34, P286, DOI 10.1016/0003-3472(86)90034-5; Majnep I.S., 1977, BIRDS MY KALAM COUNT; SCHULER W, 1985, BEHAV ECOL SOCIOBIOL, V16, P249, DOI 10.1007/BF00310988; TOKUYAMA T, 1969, J AM CHEM SOC, V91, P3931, DOI 10.1021/ja01042a042; [No title captured]	10	166	173	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					799	801		10.1126/science.1439786	http://dx.doi.org/10.1126/science.1439786			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439786				2022-12-28	WOS:A1992JV69200037
J	DAVIS, EO; JENNER, PJ; BROOKS, PC; COLSTON, MJ; SEDGWICK, SG				DAVIS, EO; JENNER, PJ; BROOKS, PC; COLSTON, MJ; SEDGWICK, SG			PROTEIN SPLICING IN THE MATURATION OF MYCOBACTERIUM-TUBERCULOSIS RECA PROTEIN - A MECHANISM FOR TOLERATING A NOVEL CLASS OF INTERVENING SEQUENCE	CELL			English	Article							ESCHERICHIA-COLI; ADENOSINE-TRIPHOSPHATASE; GENE-PRODUCT; INTRONS; SUBUNIT	The M. tuberculosis recA locus comprises an 85 kd open reading frame but produced 38 kd RecA and 47 kd products in E. coli. No RNA processing was detected; rather, an 85 kd precursor protein was spliced, releasing a 47 kd spacer protein, and joining its terminal fragments to form mature RecA protein. "Spacer" protein was also produced in M. tuberculosis and from a hybrid spacer-LacZalpha fusion molecule. Mutagenesis at codon wobble positions at one splice junction showed that protein rather than nucleotide sequence determined splicing activity. Other mutants defined additional regions needed for splicing and allowed processing to be followed. Splicing was essential for RecA activity in E. coli. The possibility that splicing is a manifestation of a novel class of genetic element is discussed.	NATL INST MED RES,YEAST GENET LAB,LONDON NW7 1AA,ENGLAND	MRC National Institute for Medical Research	DAVIS, EO (corresponding author), NATL INST MED RES,LEPROSY & MYCOBACTERIAL RES LAB,MILL HILL,LONDON NW7 1AA,ENGLAND.		Wood, David W/B-2992-2012					BELFORT M, 1991, CELL, V64, P9, DOI 10.1016/0092-8674(91)90201-9; BELFORT M, 1990, ANNU REV GENET, V24, P363; DAVIS EO, 1991, J BACTERIOL, V173, P5653, DOI 10.1128/jb.173.18.5653-5662.1991; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; HENDRIX R W, 1991, Current Biology, V1, P71, DOI 10.1016/0960-9822(91)90280-A; HIRATA R, 1990, J BIOL CHEM, V265, P6726; HUDSON L, 1989, PRACTICAL IMMUNOLOGY; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; KOSHLAND D, 1980, CELL, V20, P749, DOI 10.1016/0092-8674(80)90321-9; MANLY KF, 1969, VIROLOGY, V37, P177, DOI 10.1016/0042-6822(69)90197-4; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MILLER RV, 1990, ANNU REV MICROBIOL, V44, P365; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; SAMBROOK J, 1988, MOL CLONING LABORATO; SANCAR A, 1979, J BACTERIOL, V137, P692, DOI 10.1128/JB.137.1.692-693.1979; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YARRANTON GT, 1982, MOL GEN GENET, V185, P99, DOI 10.1007/BF00333797	21	154	173	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					201	210		10.1016/0092-8674(92)90349-H	http://dx.doi.org/10.1016/0092-8674(92)90349-H			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423588				2022-12-28	WOS:A1992JU39500006
J	RUTZ, JM; LIU, J; LYONS, JA; GORANSON, J; ARMSTRONG, SK; MCINTOSH, MA; FEIX, JB; KLEBBA, PE				RUTZ, JM; LIU, J; LYONS, JA; GORANSON, J; ARMSTRONG, SK; MCINTOSH, MA; FEIX, JB; KLEBBA, PE			FORMATION OF A GATED CHANNEL BY A LIGAND-SPECIFIC TRANSPORT PROTEIN IN THE BACTERIAL OUTER-MEMBRANE	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; FERRIC ENTEROBACTIN RECEPTOR; AFFECT VITAMIN-B12 TRANSPORT; REGION TONB BOX; SALMONELLA-TYPHIMURIUM; POINT MUTATIONS; PORIN CHANNELS; IRON TRANSPORT; ENTEROCHELIN; NUCLEOTIDE	The ferric enterobactin receptor (FepA) is a high-affinity ligand-specific transport protein in the outer membrane of Gram-negative bacteria. Deletion of the cell-surface ligand-binding peptides of FepA generated mutant proteins that were incapable of high-affinity uptake but that instead formed nonspecific, passive channels in the outer membrane. Unlike native FepA, these pores acted independently of the accessory protein TonB, which suggests that FepA is a gated porin and that TonB acts as its gatekeeper by facilitating the entry of ligands into the FepA channel. The sequence homology among TonB-dependent proteins suggests that all ligand-specific outer membrane receptors may function by this gated-porin mechanism.	MED COLL WISCONSIN,DEPT MICROBIOL,MILWAUKEE,WI 53226; MED COLL WISCONSIN,DEPT BIOPHYS,MILWAUKEE,WI 53226; E CAROLINA UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,GREENVILLE,NC 27858; UNIV MISSOURI,SCH MED,DEPT MOLEC MICROBIOL & IMMUNOL,COLUMBIA,MO 65212	Medical College of Wisconsin; Medical College of Wisconsin; University of North Carolina; East Carolina University; University of Missouri System; University of Missouri Columbia			Liu, Jun/AAC-9209-2019	Liu, Jun/0000-0002-0522-6733	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022923, R01GM022923, R01GM040565] Funding Source: NIH RePORTER; NIAID NIH HHS [AI22608] Funding Source: Medline; NIGMS NIH HHS [GM22923, GM40565] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG SK, 1990, J BIOL CHEM, V265, P14536; BAUMLER AJ, 1992, MOL MICROBIOL, V6, P1309, DOI 10.1111/j.1365-2958.1992.tb00852.x; BENSON SA, 1988, J MOL BIOL, V203, P961, DOI 10.1016/0022-2836(88)90121-0; BRAUN V, 1991, BIOL MET, V4, P14, DOI 10.1007/BF01135552; BREWER S, 1990, J MOL BIOL, V216, P883, DOI 10.1016/S0022-2836(99)80008-4; DIMASI DR, 1973, J BACTERIOL, V115, P56; ECKER DJ, 1986, J BACTERIOL, V167, P666, DOI 10.1128/jb.167.2.666-673.1986; EVANS JS, 1986, FEBS LETT, V208, P211, DOI 10.1016/0014-5793(86)81020-1; GUDMUNDSDOTTIR A, 1989, J BACTERIOL, V171, P6526, DOI 10.1128/jb.171.12.6526-6533.1989; GUTERMAN SK, 1973, J BACTERIOL, V114, P1217, DOI 10.1128/JB.114.3.1217-1224.1973; GUTERMAN SK, 1973, J BACTERIOL, V114, P1225, DOI 10.1128/JB.114.3.1225-1230.1973; HANNAVY K, 1990, J MOL BIOL, V216, P897, DOI 10.1016/S0022-2836(99)80009-6; JAP BK, 1989, J MOL BIOL, V205, P407, DOI 10.1016/0022-2836(89)90351-3; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; KOSTER W, 1986, MOL GEN GENET, V204, P435, DOI 10.1007/BF00331021; LEONG J, 1976, J BACTERIOL, V126, P823, DOI 10.1128/JB.126.2.823-830.1976; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; MCINTOSH M, UNPUB; MILLER JH, 1978, EXPT MOL GENETICS, P104; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; MURPHY CK, 1989, J BACTERIOL, V171, P5894, DOI 10.1128/jb.171.11.5894-5900.1989; NAU CD, 1989, J BACTERIOL, V171, P1041, DOI 10.1128/jb.171.2.1041-1047.1989; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NEILANDS JB, 1982, ANNU REV MICROBIOL, V36, P285, DOI 10.1146/annurev.mi.36.100182.001441; NEILANDS JB, 1981, ANNU REV NUTR, V1, P27, DOI 10.1146/annurev.nu.01.070181.000331; NEILANDS JB, 1952, J AM CHEM SOC, V74, P4846, DOI 10.1021/ja01139a033; NEILANDS JB, 1966, STRUCT BOND, V1, P59; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; OZENBERGER BA, 1987, J BACTERIOL, V169, P3638, DOI 10.1128/jb.169.8.3638-3646.1987; POSTLE K, 1979, J MOL BIOL, V131, P619, DOI 10.1016/0022-2836(79)90011-1; POSTLE K, 1990, MOL MICROBIOL, V4, P2019, DOI 10.1111/j.1365-2958.1990.tb00561.x; PUGSLEY AP, 1976, J BACTERIOL, V126, P1052, DOI 10.1128/JB.126.3.1052-1062.1976; RUTZ JM, 1991, J BACTERIOL, V173, P5694; WANG CC, 1969, J BACTERIOL, V98, P1135, DOI 10.1128/JB.98.3.1135-1141.1969; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242	42	155	160	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					471	475		10.1126/science.1411544	http://dx.doi.org/10.1126/science.1411544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411544				2022-12-28	WOS:A1992JT77500038
J	SHIVER, JW; SU, LS; HENKART, PA				SHIVER, JW; SU, LS; HENKART, PA			CYTOTOXICITY WITH TARGET DNA BREAKDOWN BY RAT BASOPHILIC LEUKEMIA-CELLS EXPRESSING BOTH CYTOLYSIN AND GRANZYME-A	CELL			English	Article							TOXIC LYMPHOCYTE-T; SERINE PROTEASE; PERFORIN; FRAGMENTATION; GRANULES; CLONING; LYSIS; ANTIBODY; BINDING; FAMILY	The noncytotoxic rat mast cell tumor line RBL was transfected with genes for the cytotoxic lymphocyte granule proteins cytolysin (perforin) and granzyme A, giving transfectants with mRNA and protein expression levels comparable with cloned cytotoxic T lymphocytes. Both RBL-cytolysin and RBL-cytolysin-granzyme A transfectants showed extremely potent killing of red cell targets and lysed 20%-60% of EL4 lymphoma targets at an effector-to-target ratio of 30. RBL transfectants expressing only granzyme A were not cytotoxic. Significant EL4 DNA breakdown accompanying lysis was observed only with RBL that was transfected with both cytolysin and granzyme A. These results support the granule-exocytosis model for lymphocyte cytotoxicity and show that effector granzyme A plays a role in target cell DNA breakdown.	NCI,EXPTL IMMUNOL BRANCH,BETHESDA,MD 20892; STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,STANFORD,CA 94305	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University								BENFEY PN, 1987, J BIOL CHEM, V262, P5377; BRUNET JF, 1988, IMMUNOL REV, V103, P21, DOI 10.1111/j.1600-065X.1988.tb00747.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COMPTON MM, 1988, ENDOCRINOLOGY, V122, P2158, DOI 10.1210/endo-122-5-2158; DUKE RC, 1989, J EXP MED, V170, P1451, DOI 10.1084/jem.170.4.1451; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; Fewtrell C, 1981, Kroc Found Ser, V14, P295; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GERSHENFELD HK, 1986, SCIENCE, V232, P854, DOI 10.1126/science.2422755; HAMEED A, 1989, J EXP MED, V169, P765, DOI 10.1084/jem.169.3.765; HAYES MP, 1989, J EXP MED, V170, P933, DOI 10.1084/jem.170.3.933; HENKART PA, 1984, J EXP MED, V160, P75, DOI 10.1084/jem.160.1.75; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; HUDIG D, 1991, J IMMUNOL, V147, P1360; ISHIKAWA H, 1989, J IMMUNOL, V143, P3069; KRAMER MD, 1987, IMMUNOL TODAY, V8, P140, DOI 10.1016/0167-5699(87)90141-1; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; LIU FT, 1980, J IMMUNOL, V124, P2728; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; MUNGER WE, 1988, IMMUNOL REV, V103, P99, DOI 10.1111/j.1600-065X.1988.tb00752.x; PASTERNACK MS, 1985, NATURE, V314, P743, DOI 10.1038/314743a0; PASTERNACK MS, 1991, J BIOL CHEM, V266, P14703; PEREZ P, 1985, NATURE, V316, P354, DOI 10.1038/316354a0; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; RUSSELL JH, 1983, IMMUNOL REV, V72, P97, DOI 10.1111/j.1600-065X.1983.tb01074.x; SELLINS KS, 1991, J IMMUNOL, V147, P795; Serafin W E, 1990, Monogr Allergy, V27, P31; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; SHIVER JW, 1991, CELL, V64, P1174; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Wyllie A H, 1980, Int Rev Cytol, V68, P251; ZUNINO SJ, 1990, J IMMUNOL, V144, P2001	35	237	240	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					315	322		10.1016/0092-8674(92)90359-K	http://dx.doi.org/10.1016/0092-8674(92)90359-K			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423596				2022-12-28	WOS:A1992JU39500016
J	ZHANG, SH; REDDICK, RL; PIEDRAHITA, JA; MAEDA, N				ZHANG, SH; REDDICK, RL; PIEDRAHITA, JA; MAEDA, N			SPONTANEOUS HYPERCHOLESTEROLEMIA AND ARTERIAL LESIONS IN MICE LACKING APOLIPOPROTEIN-E	SCIENCE			English	Article							CORONARY HEART-DISEASE; E DEFICIENCY; PLASMA-LIPOPROTEINS; ATHEROSCLEROSIS; SUSCEPTIBILITY; SERUM; HYPERLIPOPROTEINEMIA; QUANTITATION; TRANSPORT	Apolipoprotein E (apoE) is a ligand for receptors that clear remnants of chylomicrons and very low density lipoproteins. Lack of apoE is, therefore, expected to cause accumulation in plasma of cholesterol-rich remnants whose prolonged circulation should be atherogenic. ApoE-deficient mice generated by gene targeting were used to test this hypothesis and to make a mouse model for spontaneous atherosclerosis. The mutant mice had five times normal plasma cholesterol, and developed foam cell-rich depositions in their proximal aortas by age 3 months. These spontaneous lesions progressed and caused severe occlusion of the coronary artery ostium by 8 months. The severe yet viable phenotype of the mutants should make them valuable for investigating genetic and environmental factors that modify the atherogenic process.	UNIV N CAROLINA, DEPT PATHOL, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, CURRICULUM GENET, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, PROGRAM MOLEC BIOL & BIOTECHNOL, CHAPEL HILL, NC 27599 USA; TEXAS A&M UNIV SYST, DEPT VET ANAT & PUBL HLTH, COLL STN, TX 77840 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042630, R01HL042630] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL42630] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERG K, 1983, PROG MED GENET, V5, P35; BRESLOW JL, 1991, ANNU REV MED, V42, P357, DOI 10.1146/annurev.me.42.020191.002041; CAMUS MC, 1983, J LIPID RES, V24, P1210; DEMACKER PNM, 1978, CLIN CHEM, V24, P1439; FRANCE DS, 1989, J LIPID RES, V30, P1997; GETZ GS, 1988, ARCH PATHOL LAB MED, V112, P1048; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; GRUNDY SM, 1991, ARTERIOSCLER THROMB, V11, P1619, DOI 10.1161/01.ATV.11.6.1619; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; KUROSAKA D, 1991, ATHEROSCLEROSIS, V88, P15, DOI 10.1016/0021-9150(91)90252-X; LEBOEUF RC, 1983, J BIOL CHEM, V258, P5063; LUSIS AJ, 1988, J LIPID RES, V29, P397; LUSIS AJ, 1987, J BIOL CHEM, V262, P7594; MABUCHI H, 1989, METABOLISM, V38, P115, DOI 10.1016/0026-0495(89)90249-7; Mahley Jr RWRS, 1989, METABOLIC BASIS INHE, P1195; MAHLEY RW, 1984, J LIPID RES, V25, P1277; MORRISETT JD, 1982, ARTERIOSCLEROSIS, V2, P312, DOI 10.1161/01.ATV.2.4.312; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Roberts A, 1976, Adv Exp Med Biol, V67, P313; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SHENG J, 1990, METABOLISM, V39, P155, DOI 10.1016/0026-0495(90)90069-O; Utermann G, 1986, Adv Exp Med Biol, V201, P261; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WEIBUST RS, 1973, GENETICS, V73, P303; Zhang S., UNPUB	26	1836	1928	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	1992	258	5081					468	471		10.1126/science.1411543	http://dx.doi.org/10.1126/science.1411543			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411543				2022-12-28	WOS:A1992JT77500037
J	GARCIA, I; MARTINOU, I; TSUJIMOTO, Y; MARTINOU, JC				GARCIA, I; MARTINOU, I; TSUJIMOTO, Y; MARTINOU, JC			PREVENTION OF PROGRAMMED CELL-DEATH OF SYMPATHETIC NEURONS BY THE BCL-2 PROTOONCOGENE	SCIENCE			English	Article							GROWTH-FACTOR DEPRIVATION; FOLLICULAR LYMPHOMA; B-CELLS; EXPRESSION; SURVIVAL; TRANSLOCATION; ENDONUCLEASE; MOTONEURONS; ACTIVATION; DEPENDENCE	Approximately half of the neurons produced during embryogenesis normally die before adulthood. Although target-derived neurotrophic factors are known to be major determinants of programmed cell death-apoptosis-the molecular mechanisms by which trophic factors interfere with cell death regulation are largely unknown. Overexpression of the bcl-2 proto-oncogene in cultured sympathetic neurons has now been shown to prevent apoptosis normally induced by deprivation of nerve growth factor. This finding, together with the previous demonstration of bcl-2 expression in the nervous system, suggests that the Bcl-2 protein may be a major mediator of the effects of neurotrophic factors on neuronal survival.	UNIV GENEVA,MED CTR,DEPT PHARMACOL & CLIN NEUROPHYSIOL,CH-1211 GENEVA 4,SWITZERLAND; UNIV GENEVA,MED CTR,DEPT PATHOL,CH-1211 GENEVA 4,SWITZERLAND; WISTAR INST,PHILADELPHIA,PA 19104	University of Geneva; University of Geneva; The Wistar Institute				martinou, Jean-claude/0000-0002-9847-2051	NCI NIH HHS [CA-51864, CA-50551] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051864, R01CA050551] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], [No title captured]; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; BORZILLO VG, 1992, ONCOGENE, V7, P869; CHUWANG IW, 1978, J COMP NEUROL, V177, P33, DOI 10.1002/cne.901770105; COHEN JJ, 1984, J IMMUNOL, V132, P38; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GARCIA I, 1986, MOL CELL BIOL, V51, P294; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; LAZARUS KJ, 1976, BRAIN RES, V113, P159, DOI 10.1016/0006-8993(76)90013-5; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTINOU JC, 1989, J NEUROSCI, V9, P3645; MARTINOU JC, UNPUB; NEGRINI M, 1987, CELL, V49, P455, DOI 10.1016/0092-8674(87)90448-X; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PEZZELLA F, 1990, AM J PATHOL, V137, P225; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SCHWARTZ LM, 1990, P NATL ACAD SCI USA, V87, P6594, DOI 10.1073/pnas.87.17.6594; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SINGH NP, 1986, STAIN TECHNOL, V61, P315, DOI 10.3109/10520298609109959; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112	34	719	743	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					302	304		10.1126/science.1411528	http://dx.doi.org/10.1126/science.1411528			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	1411528				2022-12-28	WOS:A1992JR86000035
J	MCKEGANEY, N; BARNARD, M; LEYLAND, A; COOTE, I; FOLLET, E				MCKEGANEY, N; BARNARD, M; LEYLAND, A; COOTE, I; FOLLET, E			FEMALE STREETWORKING PROSTITUTION AND HIV-INFECTION IN GLASGOW	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE	Objectives-To identify the extent of HIV infection and injecting drug use among female street-working prostitutes in Glasgow; to estimate the size of the female streetworking prostitute population in the city; and to estimate the number of HIV positive women working as prostitutes on the streets in Glasgow. Design-Observation and interviewing of female prostitutes over seven months in red light district; analysis of sativa samples for presence of antibodies to HIV; capture-recapture approach to estimating the size of the female streetworking prostitute population. Setting-Glasgow. Subjects-206 female streetworking prostitutes. Main outcome measures-Number of women with antibodies to HIV, self reported use of injecting drugs, history of contact with 206 women. Results-Saliva samples were requested from 197 women; 159 (81%) provided samples. Four (2.5%, 95% confidence interval 0.7%-6.3%) of the samples were positive for HIV, all of which had been provided by women who injected drugs. Of the 206 streetworking women contacted 147 (71%) were injecting drug users. About 1150 women are estimated to work on the streets in Glasgow over a 12 month period. Conclusions-HIV is not as widespread among female prostitutes as many reports in the tabloid press suggest. A greater proportion of female street-working prostitutes in Glasgow are injecting drugs than has been reported for other British cities.	RUCHILL HOSP, REG VIRUS LAB, HEPATITIS HIV REFERENCE LAB, GLASGOW G20 9NB, SCOTLAND		MCKEGANEY, N (corresponding author), UNIV GLASGOW, PUBL HLTH RES UNIT, GLASGOW G12 8RZ, SCOTLAND.		Leyland, Alastair/C-6069-2011	Leyland, Alastair/0000-0003-3741-7099				BLOOR M, 1991, BRIT J ADDICT, V86, P1477; CAMERON W, 1990, HETEROSEXUAL TRANSMI; CORMACK RM, 1989, BIOMETRICS, V45, P395, DOI 10.2307/2531485; DAY S, 1988, BRIT MED J, V297, P1585, DOI 10.1136/bmj.297.6663.1585; FRISCHER M, 1991, INT J EPIDEMIOL, V20, P997, DOI 10.1093/ije/20.4.997; FRISCHER M, 1992, LANCET, V339, P995, DOI 10.1016/0140-6736(92)91577-U; HOOK EB, 1992, LANCET, V339, P742, DOI 10.1016/0140-6736(92)90639-K; KINNELL H, 1989, PROSTITUTES THEIR CL; LAPORTE RE, 1992, LANCET, V339, P494, DOI 10.1016/0140-6736(92)91103-F; LEYLAND AH, 1992, JUN INT C SOCIAL SCI; MCKEGANEY N, 1990, AIDS, V4, P1153, DOI 10.1097/00002030-199011000-00017; MCKEGANEY NP, IN PRESS AIDS CARE; PARRY JV, 1987, LANCET, V2, P72, DOI 10.1016/S0140-6736(87)92737-1; TAPPIN DM, 1991, LANCET, V337, P1565; THOMAS RM, 1989, BMJ-BRIT MED J, V299, P148, DOI 10.1136/bmj.299.6692.148; TIRELLI U, 1989, AIDS, V3, P547, DOI 10.1097/00002030-198908000-00015	16	79	80	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	1992	305	6857					801	804		10.1136/bmj.305.6857.801	http://dx.doi.org/10.1136/bmj.305.6857.801			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT256	1422360	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-28	WOS:A1992JT25600020
J	FARR, CJ; GOODFELLOW, PN				FARR, CJ; GOODFELLOW, PN			HIDDEN MESSAGES IN GENETIC MAPS	SCIENCE			English	Editorial Material											FARR, CJ (corresponding author), UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 3EH,ENGLAND.			Farr, Christine/0000-0002-5357-5962				BRENNER S, 1992, NATURE, V356, P27; COLOMBO P, 1992, P NATL ACAD SCI USA, V89, P6358, DOI 10.1073/pnas.89.14.6358; DISTECHE CM, 1992, NAT GENET, V1, P333, DOI 10.1038/ng0892-333; Fisher, 1958, GENETICAL THEORY NAT; FOSTER JW, IN PRESS NATURE; GAUNT SJ, 1991, BIOESSAYS, V13, P505, DOI 10.1002/bies.950131004; HANCOMBE O, 1991, GENE DEV, V5, P1387; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; Trowsdale J, 1992, CURR OPIN GENET DEV, V2, P492, DOI 10.1016/S0959-437X(05)80163-7; VISKOCHIL D, 1991, MOL CELL BIOL, V11, P906, DOI 10.1128/MCB.11.2.906; 1991, CYTOGENET CELL GENET, V58, P1	11	14	15	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 2	1992	258	5079					49	49		10.1126/science.1439767	http://dx.doi.org/10.1126/science.1439767			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ619	1439767				2022-12-28	WOS:A1992JQ61900022
J	BLENDON, RJ; ALTMAN, DE; BENSON, JM; TAYLOR, H; JAMES, M; SMITH, M				BLENDON, RJ; ALTMAN, DE; BENSON, JM; TAYLOR, H; JAMES, M; SMITH, M			THE IMPLICATIONS OF THE 1992 PRESIDENTIAL-ELECTION FOR HEALTH-CARE REFORM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									HARVARD UNIV,SCH PUBL HLTH,PROGRAM PUBL OPIN & HLTH CARE,BOSTON,MA 02115; HENRY J KAISER FAMILY FDN,MENLO PK,CA; LOUIS HARRIS & ASSOCIATES,NEW YORK,NY	Harvard University; Harvard T.H. Chan School of Public Health	BLENDON, RJ (corresponding author), HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,677 HUNTINGTON AVE,BOSTON,MA 02115, USA.							BLENDON RJ, 1990, NEW ENGL J MED, V323, P208, DOI 10.1056/NEJM199007193230329; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2509, DOI 10.1001/jama.267.18.2509; BLENDON RJ, 1992, AM HLTH POLICY, V2, P21; BLENDON RJ, 1989, HLTH AFF, V8, P8; SMITH MD, 1992, HEALTH AFFAIR, V11, P125, DOI 10.1377/hlthaff.11.2.125; 1992, HJ KAISER FAMILY F P; 1992, VOTER RES SURVEYS EX; 1992, L HARRIS POLL	8	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3371	3375		10.1001/jama.268.23.3371	http://dx.doi.org/10.1001/jama.268.23.3371			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KB732	1453533				2022-12-28	WOS:A1992KB73200034
J	JOHNSON, AM; WADSWORTH, J; WELLINGS, K; BRADSHAW, S; FIELD, J				JOHNSON, AM; WADSWORTH, J; WELLINGS, K; BRADSHAW, S; FIELD, J			SEXUAL LIFE-STYLES AND HIV RISK	NATURE			English	Editorial Material							BEHAVIOR		SOCIAL & COMMUNITY PLANNING RES, LONDON EC1V 0AX, ENGLAND; ST MARYS HOSP, SCH MED, ACAD DEPT PUBL HLTH, LONDON W2 1NY, ENGLAND	Imperial College London	JOHNSON, AM (corresponding author), UCL, SCH MED, ACAD DEPT GENITOURINARY MED, LONDON W1N 8AA, ENGLAND.			Johnson, Anne/0000-0003-1330-7100				ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; CARBALLO M, 1989, J SEX RES, V26, P2887; HILLIER H, 1988, SHORT TERM PREDICTIO, P48; JOHNSON AM, 1990, NATURE, V343, P109, DOI 10.1038/343109a0; MADDOX J, 1989, NATURE, V341, P181, DOI 10.1038/341181a0; RGERS SM, 1991, J SEX RES, V28, P491; SPIRA A, 1992, NATURE, V360, P407; Sundet J. M., 1988, GLOBAL IMPACT AIDS, P53; WADSWORTH J, 1991, J ROY STAT SOC A STA, V154, P367; WELLINGS K, 1990, NATURE, V348, P276, DOI 10.1038/348276a0; 1990, CDR112; 1992, HLTH NATION STRATEGY; 1991, CDR, V1, pR69; 1989, GENERAL HOUSEHOLD SU; 1992, PP2 OPCS SER, V15; 1989, SHORT TERM PREDICTIO	16	197	199	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 3	1992	360	6403					410	412		10.1038/360410a0	http://dx.doi.org/10.1038/360410a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448163				2022-12-28	WOS:A1992KA79700022
J	SPIRA, A; BAJOS, N; BEJIN, A; BELTZER, N; BOZON, M; DUCOT, B; DURANDEAU, A; FERRAND, A; GIAMI, A; GILLOIRE, A; GIRAUD, M; LERIDON, H; MESSIAH, A; LUDWIG, D; MOATTI, JP; MOUNNIER, L; OLOMUCKI, H; POPLAVSKY, J; RIANDEY, B; SPENCER, B; SZTALRYD, JM				SPIRA, A; BAJOS, N; BEJIN, A; BELTZER, N; BOZON, M; DUCOT, B; DURANDEAU, A; FERRAND, A; GIAMI, A; GILLOIRE, A; GIRAUD, M; LERIDON, H; MESSIAH, A; LUDWIG, D; MOATTI, JP; MOUNNIER, L; OLOMUCKI, H; POPLAVSKY, J; RIANDEY, B; SPENCER, B; SZTALRYD, JM			AIDS AND SEXUAL-BEHAVIOR IN FRANCE	NATURE			English	Editorial Material											SPIRA, A (corresponding author), HOP BICETRE,78 RUE GEN LECLERC,F-94275 LE KREMLIN BICETR,FRANCE.		Bajos, Nathalie/M-4170-2018; Messiah, Antoine/GLT-9598-2022; Messiah, Antoine/M-1984-2018; Giami, Alain J./G-3676-2013	Bajos, Nathalie/0000-0001-8073-9056; Messiah, Antoine/0000-0003-4457-7381; Messiah, Antoine/0000-0003-4457-7381; Giami, Alain J./0000-0001-7639-3005				ALDHOUS P, 1992, SCIENCE, V257, P225; ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; BAJOS N, 1991, A ACSF SCI SOCIALES, V9, P58; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; CZAJA R, 1988, INT Q COMMUN HLTH ED, V8, P23; FRANK O, 1990, RECHERCHES COMPORTEM; JOHNSON AM, 1992, NATURE, V360, P410, DOI 10.1038/360410a0; LAGRANGE H, 1991, POPULATION, V2, P249; LERIDON H, 1991, POPULATION, V2, P777; MCQUEEN DV, 1992, HEALTH EDUC RES, V7, P47, DOI 10.1093/her/7.1.47; MELBYE M, 1992, AM J EPIDEMIOL, V135, P593, DOI 10.1093/oxfordjournals.aje.a116338; POLLAK M, 1992, ASSESSING AIDS PREVE, P305; ROGERS SM, 1991, J SEX RES, V28, P491, DOI 10.1080/00224499109551621; Simon P, 1972, RAPPORT COMPORTEMENT; SUNDET JM, 1989, HLTH POLICY, V13, P160; UPCHURCH DM, 1991, AM J EPIDEMIOL, V134, P1159, DOI 10.1093/oxfordjournals.aje.a116019; WELLINGS K, 1990, NATURE, V348, P276, DOI 10.1038/348276a0; 1992, B METHOD SOCIOL, V35, P46; 1992, AIDS, V6, P315; 1992, AIDS, V6, P243	20	124	124	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 3	1992	360	6403					407	409						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KA797	1448162				2022-12-28	WOS:A1992KA79700021
J	STODDARD, BL; STRONG, RK; ARROTT, A; FARBER, GK				STODDARD, BL; STRONG, RK; ARROTT, A; FARBER, GK			MIR FOR THE CRYSTALLOGRAPHERS MONEY	NATURE			English	Editorial Material							PROTEIN CRYSTAL-GROWTH; SPACE-SHUTTLE; MICROGRAVITY; DIFFUSION		CALTECH,DIV BIOL,PASADENA,CA 91125; PAYLOAD SYST,CAMBRIDGE,MA 02139; PENN STATE UNIV,DAVEY LAB 152,DEPT CHEM,UNIV PK,PA 16802; PENN STATE UNIV,DAVEY LAB 152,DEPT MOLEC & CELL BIOL,UNIV PK,PA 16802	California Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	STODDARD, BL (corresponding author), FRED HUTCHINSON CANC RES CTR,1124 COLUMBIA ST,SEATTLE,WA 98104, USA.							BAIRD JK, 1986, J CRYST GROWTH, V76, P694, DOI 10.1016/0022-0248(86)90186-7; DELUCAS L J, 1990, Methods (Orlando), V1, P105, DOI 10.1016/S1046-2023(05)80153-7; DeLucas L J, 1991, Adv Space Biol Med, V1, P249; DELUCAS LJ, 1989, SCIENCE, V246, P651, DOI 10.1126/science.2510297; DELUCAS LJ, 1986, J CRYST GROWTH, V76, P681, DOI 10.1016/0022-0248(86)90185-5; DELUCAS LJ, 1991, J CRYST GROWTH, V110, P302, DOI 10.1016/0022-0248(91)90899-G; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; LITTKE W, 1986, J CRYST GROWTH, V76, P663, DOI 10.1016/0022-0248(86)90183-1; LITTKE W, 1984, SCIENCE, V225, P203, DOI 10.1126/science.225.4658.203; PLASSLINK A, 1988, J APPL MICROGRAVITY, V3, P123; SHLICHTA PJ, 1986, J CRYST GROWTH, V76, P656, DOI 10.1016/0022-0248(86)90182-X; SIBILLE L, 1991, J CRYST GROWTH, V110, P72, DOI 10.1016/0022-0248(91)90868-6; STODDARD BL, 1991, J CRYST GROWTH, V110, P312, DOI 10.1016/0022-0248(91)90900-P; STRONG RK, 1992, J CRYST GROWTH, V119, P200, DOI 10.1016/0022-0248(92)90672-6	14	14	14	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 26	1992	360	6402					293	294		10.1038/360293a0	http://dx.doi.org/10.1038/360293a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448142				2022-12-28	WOS:A1992JZ63000025
J	SIMS, C				SIMS, C			PAST IMPERFECT .2. WHAT WENT WRONG - WHY PROGRAMS FAILED	SCIENCE			English	Article											SIMS, C (corresponding author), NEW YORK TIMES CO,NEW YORK,NY 10036, USA.							Gibbons A., 1992, SCIENCE, V258, P1195	1	14	14	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 13	1992	258	5085					1185	1187		10.1126/science.1439829	http://dx.doi.org/10.1126/science.1439829			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439829				2022-12-28	WOS:A1992JX85200044
J	WHITE, JM				WHITE, JM			MEMBRANE-FUSION	SCIENCE			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; INDUCED CONFORMATIONAL CHANGE; SEMLIKI FOREST VIRUS; SUCCESSIVE GOLGI COMPARTMENTS; ADRENAL CHROMAFFIN CELLS; YEAST SECRETORY PATHWAY; PH-DEPENDENT FUSION; SEA-URCHIN EGGS; VESICULAR TRANSPORT; MAST-CELLS	Common themes are emerging from the study of viral, cell-cell, intracellular, and liposome fusion. Viral and cellular membrane fusion events are mediated by fusion proteins or fusion machines. Viral fusion proteins share important characteristics, notably a fusion peptide within a transmembrane-anchored polypeptide chain. At least one protein involved in a cell-cell fusion reaction resembles viral fusion proteins. Components of intracellular fusion machines are utilized in multiple membrane trafficking events and are conserved through evolution. Fusion pores develop during viral and intracellular fusion events suggesting similar mechanisms for many, if not all, fusion events.	UNIV CALIF SAN FRANCISCO, CELL BIOL PROGRAM, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	WHITE, JM (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA.							ABOLA EE, 1987, SCI APPLICATIONS, P107; ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; ALMERS W, 1990, ANNU REV PHYSIOL, V52, P607, DOI 10.1146/annurev.ph.52.030190.003135; ALMERS W, 1991, ANN NY ACAD SCI, V635, P318; AROETI B, 1992, J BIOL CHEM, V267, P13272; AROETI B, 1988, BIOCHEMISTRY-US, V27, P5654, DOI 10.1021/bi00415a039; ASANO K, 1988, BIOCHEMISTRY-US, V27, P1321, DOI 10.1021/bi00404a035; BALCH WE, 1989, J BIOL CHEM, V264, P16965; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENTZ J, 1990, FEBS LETT, V276, P1, DOI 10.1016/0014-5793(90)80492-2; BENTZ J, 1988, COLLOID SURFACE, V30, P65; BENTZ J, 1991, DRUG ANESTHETIC EFFE, V5, P259; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLOBEL CP, 1990, J CELL BIOL, V111, P69, DOI 10.1083/jcb.111.1.69; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BONNEMAIN H, 1992, GENETICS, V130, P461; BOSCH ML, 1989, SCIENCE, V244, P694, DOI 10.1126/science.2541505; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRAND CM, 1972, NATURE-NEW BIOL, V238, P145, DOI 10.1038/newbio238145a0; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1029, P267, DOI 10.1016/0005-2736(90)90163-I; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BROWN JC, 1988, VIROLOGY, V167, P625, DOI 10.1016/S0042-6822(88)90126-2; BRUNNER J, 1989, FEBS LETT, V257, P369, DOI 10.1016/0014-5793(89)81574-1; BRUNNER J, 1991, BIOCHEMISTRY-US, V30, P2432, DOI 10.1021/bi00223a019; BURGER KNJ, 1991, BIOCHEMISTRY-US, V30, P11173, DOI 10.1021/bi00110a022; BURGER KNJ, 1988, BIOCHIM BIOPHYS ACTA, V939, P89, DOI 10.1016/0005-2736(88)90050-8; BURGER KNJ, 1990, EXPERIENTIA, V46, P631, DOI 10.1007/BF01939702; CHANDLER DE, 1991, ANN NY ACAD SCI, V635, P234, DOI 10.1111/j.1749-6632.1991.tb36495.x; CHANDLER DE, 1980, J CELL BIOL, V86, P666, DOI 10.1083/jcb.86.2.666; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; CLAGUE MJ, 1991, J VIROL, V65, P2402, DOI 10.1128/JVI.65.5.2402-2407.1991; CLARY DO, 1990, J BIOL CHEM, V265, P10109; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; CRABB JH, 1985, J CELL BIOL, V101, P2263, DOI 10.1083/jcb.101.6.2263; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; DANIELS RS, 1987, EMBO J, V6, P1459, DOI 10.1002/j.1460-2075.1987.tb02387.x; DAVIDSON HW, 1992, J CELL BIOL, V116, P1343, DOI 10.1083/jcb.116.6.1343; DIAZ R, 1989, NATURE, V339, P398, DOI 10.1038/339398a0; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DOMS RW, 1986, J VIROL, V57, P603, DOI 10.1128/JVI.57.2.603-613.1986; DOMS RW, 1986, J VIROL, V60, P833, DOI 10.1128/JVI.60.3.833-839.1986; DOMS RW, 1985, J BIOL CHEM, V260, P2973; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; EDWARDS J, 1983, J VIROL, V45, P1090, DOI 10.1128/JVI.45.3.1090-1097.1983; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; ELLENS H, 1990, BIOCHEMISTRY-US, V29, P9697, DOI 10.1021/bi00493a027; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; GALLAHER WR, 1992, CELL, V70, P531, DOI 10.1016/0092-8674(92)90423-A; GETHING MJ, 1986, J CELL BIOL, V102, P11, DOI 10.1083/jcb.102.1.11; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GODA Y, 1991, J CELL BIOL, V112, P823, DOI 10.1083/jcb.112.5.823; GODLEY L, 1992, CELL, V68, P635, DOI 10.1016/0092-8674(92)90140-8; GOMPERTS BD, 1990, ANNU REV PHYSIOL, V52, P591; GONZALEZSCARANO F, 1985, VIROLOGY, V140, P209, DOI 10.1016/0042-6822(85)90359-9; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; GRAVES PN, 1983, VIROLOGY, V126, P106, DOI 10.1016/0042-6822(83)90465-8; GRIFF IC, 1992, J BIOL CHEM, V267, P12106; GUTMAN O, IN PRESS BIOCHEMISTR; GUY HR, 1992, BIOPHYS J, V62, P95, DOI 10.1016/S0006-3495(92)81790-3; HARTER C, 1989, J BIOL CHEM, V264, P6459; HARTER C, 1988, BIOCHEMISTRY-US, V27, P1856, DOI 10.1021/bi00406a010; HELM CA, 1992, BIOCHEMISTRY-US, V31, P1794, DOI 10.1021/bi00121a030; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; HOEKSTRA D, 1990, J BIOENERG BIOMEMBR, V22, P121, DOI 10.1007/BF00762943; HOEKSTRA D, 1989, BIOSCIENCE REP, V9, P273, DOI 10.1007/BF01114682; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; HORVATH CM, 1992, J VIROL, V66, P2443, DOI 10.1128/JVI.66.4.2443-2455.1992; HORVATH CM, 1992, J VIROL, V66, P4564, DOI 10.1128/JVI.66.7.4564-4569.1992; HOWELL TW, 1989, CELL SIGNAL, V1, P157, DOI 10.1016/0898-6568(89)90005-3; HSU M, 1982, P NATL ACAD SCI-BIOL, V79, P5862, DOI 10.1073/pnas.79.19.5862; HU XL, 1992, J VIROL, V66, P1528, DOI 10.1128/JVI.66.3.1528-1534.1992; HUI SW, 1981, SCIENCE, V212, P921, DOI 10.1126/science.7233185; JUNANKAR PR, 1986, BIOCHIM BIOPHYS ACTA, V854, P198, DOI 10.1016/0005-2736(86)90111-2; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KARLI UO, 1990, P NATL ACAD SCI USA, V87, P5912, DOI 10.1073/pnas.87.15.5912; KATOW S, 1988, J GEN VIROL, V69, P2797, DOI 10.1099/0022-1317-69-11-2797; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KEMBLE GW, 1992, J VIROL, V66, P4940, DOI 10.1128/JVI.66.8.4940-4950.1992; KIELIAN M, 1990, MOL BIOL MED, V7, P17; KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284; KIMURA T, 1988, J GEN VIROL, V69, P1247, DOI 10.1099/0022-1317-69-6-1247; KNOLL G, 1988, J CELL BIOL, V107, P2511, DOI 10.1083/jcb.107.6.2511; KNOLL G, 1991, J CELL BIOL, V113, P1295, DOI 10.1083/jcb.113.6.1295; KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121; KTISTAKIS NT, 1992, NATURE, V356, P344, DOI 10.1038/356344a0; LEAR JD, 1987, J BIOL CHEM, V262, P6500; LEIKIN SL, 1987, J THEOR BIOL, V129, P411, DOI 10.1016/S0022-5193(87)80021-8; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; LINDAU M, 1991, BIOCHIM BIOPHYS ACTA, V1071, P429, DOI 10.1016/0304-4157(91)90006-I; LINSTEDT AD, 1987, TRENDS NEUROSCI, V10, P446, DOI 10.1016/0166-2236(87)90095-6; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; MEERS P, 1991, ANN NY ACAD SCI, V635, P259; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MONCK JR, 1991, BIOPHYS J, V59, P39, DOI 10.1016/S0006-3495(91)82196-8; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; MORGAN A, 1992, NATURE, V355, P833, DOI 10.1038/355833a0; MORRIS SJ, 1989, J BIOL CHEM, V264, P3972; MORRISON T, 1991, J VIROL, V65, P813, DOI 10.1128/JVI.65.2.813-822.1991; MORRISON TG, 1988, VIRUS RES, V10, P113, DOI 10.1016/0168-1702(88)90010-X; NADIN CY, 1989, J CELL BIOL, V109, P2801, DOI 10.1083/jcb.109.6.2801; NEHER E, 1986, EMBO J, V5, P51, DOI 10.1002/j.1460-2075.1986.tb04176.x; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NESTOROWICZ A, 1985, J GEN VIROL, V66, P1687, DOI 10.1099/0022-1317-66-8-1687; NEWMAN AP, 1990, BIOESSAYS, V12, P485, DOI 10.1002/bies.950121006; NIEVA JL, 1989, BIOCHEMISTRY-US, V28, P7364, DOI 10.1021/bi00444a032; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; NOVICK SL, 1988, P NATL ACAD SCI USA, V85, P7433, DOI 10.1073/pnas.85.20.7433; NUSSBAUM O, 1987, J VIROL, V61, P2245, DOI 10.1128/JVI.61.7.2245-2252.1987; OBERHAUSER AF, 1992, BIOPHYS J, V61, P800, DOI 10.1016/S0006-3495(92)81884-2; Ohnishi Shun-Ichi, 1988, Curr Top Membr Transp, V32, P257, DOI 10.1016/S0070-2161(08)60137-9; OJCIUS DM, 1991, TRENDS BIOCHEM SCI, V16, P225, DOI 10.1016/0968-0004(91)90090-I; OMAR A, 1989, VIROLOGY, V168, P177, DOI 10.1016/0042-6822(89)90418-2; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; ORNBERG RL, 1981, J CELL BIOL, V90, P40, DOI 10.1083/jcb.90.1.40; PADFIELD PJ, 1992, P NATL ACAD SCI USA, V89, P1656, DOI 10.1073/pnas.89.5.1656; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PAPAHADJOPOULOS D, 1990, J BIOENERG BIOMEMBR, V22, P157, DOI 10.1007/BF00762944; PERSSON R, 1991, J CELL BIOL, V112, P257, DOI 10.1083/jcb.112.2.257; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PLATTNER H, 1991, EUR J CELL BIOL, V55, P3; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; POLLARD HB, 1991, ANN NY ACAD SCI, V635, P328; PRIMAKOFF P, 1987, J CELL BIOL, V104, P141, DOI 10.1083/jcb.104.1.141; PURI A, 1990, J VIROL, V64, P3824, DOI 10.1128/JVI.64.8.3824-3832.1990; RAFALSKI M, 1990, BIOCHEMISTRY-US, V29, P7917, DOI 10.1021/bi00486a020; RAFALSKI M, 1991, BIOCHEMISTRY-US, V30, P10211, DOI 10.1021/bi00106a020; RAND RP, 1988, BIOCHEMISTRY-US, V27, P7711, DOI 10.1021/bi00420a021; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; ROTHMAN JE, 1984, J CELL BIOL, V99, pA230; ROTT R, 1984, EMBO J, V3, P3329, DOI 10.1002/j.1460-2075.1984.tb02299.x; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; RUIGROK RWH, 1986, EMBO J, V5, P41, DOI 10.1002/j.1460-2075.1986.tb04175.x; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; SARKAR DP, 1989, J CELL BIOL, V109, P113, DOI 10.1083/jcb.109.1.113; SATIR B, 1972, NATURE, V235, P53, DOI 10.1038/235053a0; SATIR B, 1973, J CELL BIOL, V56, P153, DOI 10.1083/jcb.56.1.153; SATIR BH, 1989, P NATL ACAD SCI USA, V86, P930, DOI 10.1073/pnas.86.3.930; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SCHEKMAN R, 1992, Current Opinion in Cell Biology, V4, P587, DOI 10.1016/0955-0674(92)90076-O; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; SCHWEIZER FE, 1989, NATURE, V339, P709; SIEGEL DP, 1986, CHEM PHYS LIPIDS, V42, P279, DOI 10.1016/0009-3084(86)90087-3; SIEGEL DP, 1986, BIOPHYS J, V49, P1171, DOI 10.1016/S0006-3495(86)83745-6; SIEGEL DP, 1989, BIOPHYS J, V56, P161, DOI 10.1016/S0006-3495(89)82661-X; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P3703, DOI 10.1021/bi00435a012; SIEGEL DP, IN PRESS VIRAL FUSIO; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; SPEAR P, 1989, CELL BIOL VIRUS ENTR, V90, P163; SPRUCE AE, 1989, NATURE, V342, P555, DOI 10.1038/342555a0; SPRUCE AE, 1991, P NATL ACAD SCI USA, V88, P3623, DOI 10.1073/pnas.88.9.3623; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; STANLEY EF, 1991, CALCIUM ENTRY ACTION, V635; STEFFY KR, 1992, J VIROL, V66, P4532, DOI 10.1128/JVI.66.7.4532-4535.1992; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; STEGMANN T, 1985, BIOCHEMISTRY-US, V24, P3107, DOI 10.1021/bi00334a006; STEGMANN T, 1989, BIOCHEMISTRY-US, V28, P1698, DOI 10.1021/bi00430a041; STEGMANN T, 1987, EMBO J, V6, P2651, DOI 10.1002/j.1460-2075.1987.tb02556.x; STEGMANN T, 1986, J BIOL CHEM, V261, P966; STEGMANN T, 1991, J BIOL CHEM, V266, P18404; STEGMANN T, 1987, J BIOL CHEM, V262, P17744; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; STEINHAUER DA, 1991, P NATL ACAD SCI USA, V88, P11525, DOI 10.1073/pnas.88.24.11525; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TATE MW, 1991, CHEM PHYS LIPIDS, V57, P147, DOI 10.1016/0009-3084(91)90073-K; TAYLOR TC, 1992, CELL, V70, P69, DOI 10.1016/0092-8674(92)90534-J; TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6016; TOURNOIS H, 1991, CHEM PHYS LIPIDS, V57, P327, DOI 10.1016/0009-3084(91)90084-O; Tse F. W., 1992, Society for Neuroscience Abstracts, V18, P751; TSE F W, 1991, Society for Neuroscience Abstracts, V17, P1325; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; TURKEWITZ AP, 1991, EMBO J, V10, P1979, DOI 10.1002/j.1460-2075.1991.tb07727.x; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; WATTENBERG BW, 1992, J CELL BIOL, V118, P1321, DOI 10.1083/jcb.118.6.1321; WEBSTER RG, 1983, VIROLOGY, V126, P587, DOI 10.1016/S0042-6822(83)80015-4; WEIDMAN PJ, 1989, J CELL BIOL, V108, P1589, DOI 10.1083/jcb.108.5.1589; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WEIS WI, 1990, EMBO J, V9, P17, DOI 10.1002/j.1460-2075.1990.tb08075.x; WHALLEY T, 1991, J CELL BIOL, V113, P769, DOI 10.1083/jcb.113.4.769; WHARTON SA, 1986, VIROLOGY, V149, P27, DOI 10.1016/0042-6822(86)90083-8; WHARTON SA, 1988, J BIOL CHEM, V263, P4474; WHITAKER M, 1987, BIOSCIENCE REP, V7, P383, DOI 10.1007/BF01362502; WHITE J, 1982, NATURE, V300, P658, DOI 10.1038/300658a0; WHITE J, 1982, EMBO J, V1, P217, DOI 10.1002/j.1460-2075.1982.tb01150.x; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; WHITE JM, 1992, J CELL BIOCH C SJ, V16, P111; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; WHITT MA, 1990, J VIROL, V64, P4907, DOI 10.1128/JVI.64.10.4907-4913.1990; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Wilschut J, 1989, CURR OPIN CELL BIOL, V1, P639, DOI 10.1016/0955-0674(89)90028-8; Wilschut J., 1991, MEMBRANE FUSION; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; WILSON DW, 1991, TRENDS BIOCHEM SCI, V16, P334, DOI 10.1016/0968-0004(91)90138-L; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WOLFBERG T, UNPUB; YEAGLE PL, 1992, BIOCHEMISTRY-US, V31, P3177, DOI 10.1021/bi00127a019; YEWDELL JW, 1983, J VIROL, V48, P239, DOI 10.1128/JVI.48.1.239-248.1983; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; ZIESENISS E, 1985, J CELL BIOL, V103, P1279; ZIMMERBERG J, 1991, ANN NY ACAD SCI, V635, P307, DOI 10.1111/j.1749-6632.1991.tb36501.x; ZIMMERBERG J, 1987, P NATL ACAD SCI USA, V84, P1585, DOI 10.1073/pnas.84.6.1585	219	672	689	3	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	1992	258	5084					917	924		10.1126/science.1439803	http://dx.doi.org/10.1126/science.1439803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439803				2022-12-28	WOS:A1992JW79600019
J	JAIYESIMI, IA; BUZDAR, AU; SAHIN, AA; ROSS, MA				JAIYESIMI, IA; BUZDAR, AU; SAHIN, AA; ROSS, MA			CARCINOMA OF THE MALE BREAST	ANNALS OF INTERNAL MEDICINE			English	Article						BREAST NEOPLASMS; SEX FACTORS; NEOPLASM METASTASIS; TAMOXIFEN; RECEPTORS, ESTROGEN	ASPIRATION BIOPSY CYTOLOGY; ADJUVANT CHEMOTHERAPY; CANCER; TAMOXIFEN; GYNECOMASTIA; THERAPY	The natural history and current management of carcinoma of the breast in men is reviewed. Articles published from 1942 to 1992 on the natural history, clinical manifestations, diagnosis, and treatment of carcinoma of the breast in men were identified using CANCERLINE and MEDLINE. Carcinoma of the breast affects approximately 1000 men per year in the United States; 300 men per year will die of metastatic disease. The mean age at diagnosis is 59 years. The causes of breast cancer in men are unknown. The most common clinical manifestation of breast cancer in men is a painless, firm subareolar mass or a mass in the upper outer quadrant of the breast. Diagnosis can be confirmed by fine-needle aspiration or surgical biopsy. Infiltrating ductal carcinoma is the predominant histologic type. Treatment is similar to that of women with breast cancer. Men with axillary nodal metastasis should receive adjuvant systemic combination chemotherapy or tamoxifen, or both, after primary surgical treatment. Because most men with carcinoma of the breast have estrogen- and progesterone-receptor-positive tumors, distant metastatic disease should be treated initially with hormonal therapies. The epidemiology, prognostic factors, survival by stage, pattern of metastasis, and response to treatment in men are similar to those in women with breast carcinoma. The data suggest, however, that breast cancers in men are more likely to respond to hormonal manipulation.	UNIV TEXAS, MD ANDERSON CANC CTR, BREAST MED ONCOL SECT, BOX 56, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center								ABELE R, 1978, BRIT MED J, V1, P1697, DOI 10.1136/bmj.1.6128.1697-c; AISNER J, 1979, ARCH INTERN MED, V139, P480, DOI 10.1001/archinte.139.4.480; AJAYI DOS, 1982, CANCER-AM CANCER SOC, V50, P1664, DOI 10.1002/1097-0142(19821015)50:8<1664::AID-CNCR2820500834>3.0.CO;2-N; APPELQVIST P, 1982, ACTA CHIR SCAND, V148, P499; BAGLEY CS, 1987, AM J CLIN ONCOL-CANC, V10, P55, DOI 10.1097/00000421-198702000-00013; BECHER R, 1981, NEW ENGL J MED, V305, P169; BEZWODA WR, 1987, CANCER, V60, P1337, DOI 10.1002/1097-0142(19870915)60:6<1337::AID-CNCR2820600629>3.0.CO;2-C; BHAGAT P, 1990, CANCER, V65, P2338, DOI 10.1002/1097-0142(19900515)65:10<2338::AID-CNCR2820651028>3.0.CO;2-K; BORING CC, 1992, CA-CANCER J CLIN, V42, P19, DOI 10.3322/canjclin.42.1.19; BUZDAR AU, 1984, AM J CLIN ONCOL-CANC, V7, P45, DOI 10.1097/00000421-198402000-00006; CANTWELL BMJ, 1978, LANCET, V2, P583; Crichlow R W, 1974, Semin Oncol, V1, P145; CRICHLOW RW, 1990, SURG CLIN N AM, V70, P1165; CRICHLOW RW, 1972, SURG GYNECOL OBSTETR, V134, P1011; DIGENIS AG, 1990, SOUTHERN MED J, V83, P1162, DOI 10.1097/00007611-199010000-00011; DOBERAUER C, 1988, CANCER, V62, P474, DOI 10.1002/1097-0142(19880801)62:3<474::AID-CNCR2820620305>3.0.CO;2-2; DONEGAN WL, 1973, ARCH SURG-CHICAGO, V106, P273; DONEGAN WL, 1988, CANC BREAST, P716; ERLICHMAN C, 1984, J CLIN ONCOL, V2, P903, DOI 10.1200/JCO.1984.2.8.903; EVERSON RB, 1980, CANCER RES, V40, P991; EWERTZ M, 1989, INT J CANCER, V43, P27, DOI 10.1002/ijc.2910430107; FARROW JOSEPH H., 1942, SCIENCE, V95, P654, DOI 10.1126/science.95.2478.654; GIFFLER RF, 1976, AM J CLIN PATHOL, V66, P715; GUPTA N, 1980, CANCER, V46, P1781, DOI 10.1002/1097-0142(19801015)46:8<1781::AID-CNCR2820460814>3.0.CO;2-F; GUPTA RK, 1988, EUR J SURG ONCOL, V14, P317; HARRIS AL, 1986, BRIT J CANCER, V54, P657, DOI 10.1038/bjc.1986.223; HELLER KS, 1978, ANN SURG, V188, P60, DOI 10.1097/00000658-197807000-00010; HENDERSON IC, 1980, NEW ENGL J MED, V302, P78, DOI 10.1056/NEJM198001103020203; HILLIARD DA, 1984, J SURG ONCOL, V25, P42; HOLLEB A, 1963, NY STATE J MED, V68, P656; HONTTUIN E, 1967, SURG GYNECOL OBSTET, V125, P279; HORN Y, 1976, ONCOLOGY, V33, P188, DOI 10.1159/000225140; HORTOBAGYI GN, 1979, CANCER TREAT REP, V63, P539; KALISHER L, 1975, AM J ROENTGENOL, V125, P656, DOI 10.2214/ajr.125.3.656; KANTARJIAN H, 1983, ARCH INTERN MED, V143, P237, DOI 10.1001/archinte.143.2.237; KENNEDY BJ, 1972, CANCER-AM CANCER SOC, V29, P1606, DOI 10.1002/1097-0142(197206)29:6<1606::AID-CNCR2820290627>3.0.CO;2-#; KRAYBILL WG, 1981, CANCER, V47, P2185, DOI 10.1002/1097-0142(19810501)47:9<2185::AID-CNCR2820470913>3.0.CO;2-B; LEFOR AT, 1988, NEW YORK STATE J MED, V88, P293; LI MC, 1970, CANCER-AM CANCER SOC, V25, P678, DOI 10.1002/1097-0142(197003)25:3<678::AID-CNCR2820250326>3.0.CO;2-N; LIECHTY RD, 1967, CANCER, V20, P1617, DOI 10.1002/1097-0142(196710)20:10<1617::AID-CNCR2820201008>3.0.CO;2-W; LOPEZ M, 1985, CANCER, V55, P2334, DOI 10.1002/1097-0142(19850515)55:10<2334::AID-CNCR2820551006>3.0.CO;2-3; LOPEZ M, 1985, ONCOLOGY, V42, P345, DOI 10.1159/000226061; LOPEZ M, 1985, ONCOLOGY, V42, P205, DOI 10.1159/000226032; MEYSKENS FL, 1976, CANCER TREAT REV, V3, P83, DOI 10.1016/S0305-7372(76)80006-0; MICHELS LG, 1977, RADIOLOGY, V122, P117, DOI 10.1148/122.1.117; MITSUYASU R, 1981, ARCH INTERN MED, V141, P809, DOI 10.1001/archinte.141.6.809; MORGAN DAL, 1978, BRIT MED J, V2, P206, DOI 10.1136/bmj.2.6131.206-c; MORIMOTO T, 1990, J SURG ONCOL, V44, P180, DOI 10.1002/jso.2930440311; MOSELEY HS, 1974, AM J SURG, V128, P143; NORRIS HJ, 1969, CANCER, V23, P1428, DOI 10.1002/1097-0142(196906)23:6<1428::AID-CNCR2820230626>3.0.CO;2-4; OLSSON HA, 1991, P AN M AM SOC CLIN, V10, P67; OURIEL K, 1984, SURG GYNECOL OBSTET, V159, P373; PANNUTI F, 1982, CANCER TREAT REP, V66, P1763; PANTOJA E, 1976, ARCH SURG-CHICAGO, V111, P611; PATEL HZ, 1989, CANCER, V64, P1583, DOI 10.1002/1097-0142(19891015)64:8<1583::AID-CNCR2820640804>3.0.CO;2-Q; PATEL JK, 1984, CANCER, V53, P1344, DOI 10.1002/1097-0142(19840315)53:6<1344::AID-CNCR2820530621>3.0.CO;2-Q; PATTERSON JS, 1980, CANCER TREAT REP, V64, P801; Ramantanis G, 1980, World J Surg, V4, P621; RAZIS DV, 1982, P INT S MEDROXYPROGE, P237; RIBEIRO G, 1985, BRIT J CANCER, V51, P115, DOI 10.1038/bjc.1985.16; RIBEIRO GG, 1976, BRIT J CANCER, V33, P465, DOI 10.1038/bjc.1976.72; RIBEIRO GG, 1983, CLIN RADIOL, V34, P625, DOI 10.1016/S0009-9260(83)80408-5; ROBISON R, 1982, CANCER, V49, P403, DOI 10.1002/1097-0142(19820115)49:2<403::AID-CNCR2820490232>3.0.CO;2-T; RUSSIN VL, 1989, DIAGN CYTOPATHOL, V5, P243, DOI 10.1002/dc.2840050303; SAEZ RA, 1989, BREAST CANC, V1, P163; SAKAI F, 1978, J ENDOCRINOL, V76, P219, DOI 10.1677/joe.0.0760219; SANCHEZ AG, 1986, CANCER-AM CANCER SOC, V57, P1181, DOI 10.1002/1097-0142(19860315)57:6<1181::AID-CNCR2820570619>3.0.CO;2-T; SCHEIKE O, 1974, BRIT J CANCER, V30, P261, DOI 10.1038/bjc.1974.190; SCHEIKE O, 1973, BRIT J CANCER, V28, P552, DOI 10.1038/bjc.1973.185; Seitzinger J W, 1990, N J Med, V87, P803; SPENCE RAJ, 1985, CANCER, V55, P648, DOI 10.1002/1097-0142(19850201)55:3<648::AID-CNCR2820550329>3.0.CO;2-3; TIRELLI U, 1982, CANCER TREAT REP, V66, P1882; TREVES N, 1959, CANCER, V12, P820, DOI 10.1002/1097-0142(195907/08)12:4<820::AID-CNCR2820120427>3.0.CO;2-9; VERCOUTERE AL, 1984, ARCH SURG-CHICAGO, V119, P1301; VISFELDT J, 1973, CANCER-AM CANCER SOC, V32, P985, DOI 10.1002/1097-0142(197310)32:4<985::AID-CNCR2820320433>3.0.CO;2-0; VOROBIOF DA, 1987, CANCER-AM CANCER SOC, V59, P688, DOI 10.1002/1097-0142(19870215)59:4<688::AID-CNCR2820590404>3.0.CO;2-E; YAP HY, 1980, JAMA-J AM MED ASSOC, V243, P1739, DOI 10.1001/jama.243.17.1739; YAP HY, 1979, CANCER, V44, P748, DOI 10.1002/1097-0142(197908)44:2<748::AID-CNCR2820440248>3.0.CO;2-9; 1991, CANCER FACTS FIGURES, P5; [No title captured]	80	119	123	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					771	777		10.7326/0003-4819-117-9-771	http://dx.doi.org/10.7326/0003-4819-117-9-771			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416579				2022-12-28	WOS:A1992JV42400011
J	WANG, J; BEDZYK, MJ; CAFFREY, M				WANG, J; BEDZYK, MJ; CAFFREY, M			RESONANCE-ENHANCED X-RAYS IN THIN-FILMS - A STRUCTURE PROBE FOR MEMBRANES AND SURFACE-LAYERS	SCIENCE			English	Article							STANDING WAVES; INTERFACE; FLUORESCENCE; DIFFRACTION	An x-ray resonance effect in an organic thin film on an x-ray reflecting mirror is reported. The resonance effect is the result of interference between reflected and refracted x-rays at the air-organic thin film interface and occurs at incident angles slightly above the critical angle of the film. In excellent agreement with theory, the primary resonant x-ray electric field that is confined in the organic thin film is approximately 20 times as intense as the electric field of the incident beam when measured at a position close to the center of the film. Resonance-enhanced x-rays can be used to characterize the internal structure of Langmuir-Blodgett thin film membranes. This effect may also find use in x-ray-based thin film devices and in the structural analysis of adlayers and surfaces that have thus far proved difficult, if not impossible, to study because of sensitivity limitations.	OHIO STATE UNIV,CHEM PHYS PROGRAM,COLUMBUS,OH 43210; NORTHWESTERN UNIV,DEPT MAT SCI & ENGN,EVANSTON,IL 60208; ARGONNE NATL LAB,ARGONNE,IL 60439	University System of Ohio; Ohio State University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory	WANG, J (corresponding author), OHIO STATE UNIV,DEPT CHEM,COLUMBUS,OH 43210, USA.		Bedzyk, Michael J/B-7503-2009; Bedzyk, Michael J/K-6903-2013		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R23DK036849, R01DK045295, R01DK036849] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 36849, DK 45295] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECKER RS, 1983, PHYS REV LETT, V50, P153, DOI 10.1103/PhysRevLett.50.153; BEDZYK MJ, 1990, SCIENCE, V248, P52, DOI 10.1126/science.2321026; BEDZYK MJ, 1989, PHYS REV LETT, V62, P1376, DOI 10.1103/PhysRevLett.62.1376; BEDZYK MJ, 1988, SCIENCE, V241, P1788, DOI 10.1126/science.3175619; BLOCH JM, 1985, PHYS REV LETT, V54, P1039, DOI 10.1103/PhysRevLett.54.1039; BOMMARITO GM, 1987, THESIS CORNELL U ITH; Born M., 1991, PRINCIPLES OPTICS; Compton AH, 1935, XRAYS THEORY EXPT; DEBOER DKG, 1991, PHYS REV B, V44, P498, DOI 10.1103/PhysRevB.44.498; EISENBERGER P, 1981, PHYS REV LETT, V46, P1081, DOI 10.1103/PhysRevLett.46.1081; MARRA WC, 1979, J APPL PHYS, V50, P6927, DOI 10.1063/1.325845; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; WANG J, 1991, NATURE, V354, P377, DOI 10.1038/354377a0	13	127	129	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 30	1992	258	5083					775	778		10.1126/science.1439784	http://dx.doi.org/10.1126/science.1439784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439784				2022-12-28	WOS:A1992JV69200028
J	MAKITA, Z; VLASSARA, H; RAYFIELD, E; CARTWRIGHT, K; FRIEDMAN, E; RODBY, R; CERAMI, A; BUCALA, R				MAKITA, Z; VLASSARA, H; RAYFIELD, E; CARTWRIGHT, K; FRIEDMAN, E; RODBY, R; CERAMI, A; BUCALA, R			HEMOGLOBIN-AGE - A CIRCULATING MARKER OF ADVANCED GLYCOSYLATION	SCIENCE			English	Article							GLUCOSE-MODIFIED PROTEINS; DIABETES-MELLITUS; END-PRODUCTS; NONENZYMATIC GLYCOSYLATION; HUMAN COLLAGEN; AMINOGUANIDINE; TISSUE; NEPHROPATHY; RAT; FLUORESCENCE	Advanced glycosylation end products (AGEs) form spontaneously from glucose-derived Amadori products and accumulate on long-lived tissue proteins. AGEs have been implicated in the pathogenesis of several of the complications of aging and diabetes, including atherosclerosis and renal disease. With the use of recently developed AGE-specific antibodies, an AGE-modified form of human hemoglobin has been identified. Termed hemoglobin-AGE (Hb-AGE), this modified species accounts for 0.42 percent of circulating hemoglobin in normal individuals but increases to 0.75 percent in patients with diabetes-induced hyperglycemia. In a group of diabetic patients treated with the advanced glycosylation inhibitor aminoguanidine, Hb-AGE levels decreased significantly over a 1-month period. Hemoglobin-AGE measurements may provide an index of long-term tissue modification by AGEs and prove useful in assessing the contribution of advanced glycosylation to a variety of diabetic and age-related complications.	ALTEON INC, NORTHVALE, NJ 07647 USA; RUSH PRESBYTERIAN ST LUKES MED CTR, CHICAGO, IL 60612 USA; SUNY DOWNSTATE MED CTR, BROOKLYN, NY 11203 USA	Rush University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019655] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19655-15] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOOKCHIN RM, 1968, BIOCHEM BIOPH RES CO, V32, P86, DOI 10.1016/0006-291X(68)90430-0; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Bucala R, 1992, Adv Pharmacol, V23, P1; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; ELLIS EN, 1991, METABOLISM, V40, P1016, DOI 10.1016/0026-0495(91)90122-D; ESPOSITO C, 1989, J EXP MED, V170, P1387, DOI 10.1084/jem.170.4.1387; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; HOGAN M, IN PRESS J CLIN INVE; KIRSTEIN M, 1990, P NATL ACAD SCI USA, V87, P9010, DOI 10.1073/pnas.87.22.9010; KOENIG RJ, 1977, J BIOL CHEM, V252, P2992; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; KOHN RR, 1984, DIABETES, V33, P57, DOI 10.2337/diabetes.33.1.57; LARSEN ML, 1990, NEW ENGL J MED, V323, P1021, DOI 10.1056/NEJM199010113231503; LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653; LEWIS BS, 1990, EXP EYE RES, V50, P463, DOI 10.1016/0014-4835(90)90033-Q; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAKITA Z, 1991, DIABETOLOGIA, V34, P40, DOI 10.1007/BF00404023; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; MAKITA Z, UNPUB; MONNIER VM, 1984, P NATL ACAD SCI-BIOL, V81, P583, DOI 10.1073/pnas.81.2.583; NICHOLLS K, 1989, LAB INVEST, V60, P486; Njoroge F G, 1989, Prog Clin Biol Res, V304, P85; NJOROGE FG, 1988, J BIOL CHEM, V263, P10646; ODETTI PR, 1990, DIABETES, V39, P796, DOI 10.2337/diabetes.39.7.796; PETERSON CM, 1985, DIABETES ANN, V1, P178; PONGOR S, 1984, P NATL ACAD SCI-BIOL, V81, P2684, DOI 10.1073/pnas.81.9.2684; SCHNIDER SL, 1981, J CLIN INVEST, V67, P1630, DOI 10.1172/JCI110198; SELL DR, 1990, J CLIN INVEST, V85, P380, DOI 10.1172/JCI114449; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; SKOLNIK EY, 1991, J EXP MED, V174, P931, DOI 10.1084/jem.174.4.931; SOULISLIPAROTA T, 1991, DIABETES, V40, P1328, DOI 10.2337/diabetes.40.10.1328; VLASSARA H, 1985, P NATL ACAD SCI USA, V82, P5588, DOI 10.1073/pnas.82.17.5588; VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727; YAGIHASHI S, 1992, DIABETES, V41, P47, DOI 10.2337/diabetes.41.1.47	36	256	272	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	1992	258	5082					651	653		10.1126/science.1411574	http://dx.doi.org/10.1126/science.1411574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU745	1411574				2022-12-28	WOS:A1992JU74500057
J	DAN, Y; POO, MM				DAN, Y; POO, MM			QUANTAL TRANSMITTER SECRETION FROM MYOCYTES LOADED WITH ACETYLCHOLINE	NATURE			English	Article							MUSCLE-CELL MEMBRANE; NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLES; RELEASE; RECEPTORS; CULTURE; EXOCYTOSIS	IT is well known that transmitter secretion requires specialized secretory organelles, the synaptic vesicles, for the packaging, storage and exocytotic release of the transmitter1,2. Here we report that when acetylcholine (ACh) is loaded into an isolated Xenopus myocyte, there is spontaneous quantal release of ACh from the myocyte which results in activation of its own surface ACh channels and the appearance of membrane currents resembling miniature endplate currents. This myocyte secretion probably reflects Ca2+-regulated exocytosis of ACh-filled cytoplasmic compartments. Furthermore, step depolarization of the myocyte membrane triggers evoked ACh release from the myocyte with a weak excitation-secretion coupling. These findings suggest that quantal transmitter secretion does not require secretory pathways unique to neurons and that the essence of presynaptic differentiation may reside in the provision of transmitter supply and modification of the preexisting secretion pathway.	COLUMBIA UNIV, DEPT BIOL SCI, NEW YORK, NY 10027 USA	Columbia University				Dan, Yang/0000-0002-3818-877X				ADLER EM, 1991, J NEUROSCI, V11, P1496; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; ENOMOTO K, 1988, EUR J PHARMACOL, V147, P209; EVERS J, 1989, J NEUROSCI, V9, P1523; HAMILL OP, 1981, PFLUGERS ARCH, V391, P80; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; ISRAEL M, 1979, PROG NEUROBIOL, V13, P237, DOI 10.1016/0301-0082(79)90017-0; Kandel E.R., 1991, PRINC NEUROSCI, V3rd ed.; KATZ B, 1977, PROC R SOC SER B-BIO, V196, P59, DOI 10.1098/rspb.1977.0029; Katz B., 1969, RELEASE NEURAL TRANS; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; MARSHALL IG, 1990, J PHYSIOL-LONDON, V424, pP52; MARSHALL IG, 1987, TRENDS NEUROSCI, V10, P174, DOI 10.1016/0166-2236(87)90044-0; MINTA A, 1989, J BIOL CHEM, V264, P8171; MOREL N, 1978, J NEUROCHEM, V30, P1553, DOI 10.1111/j.1471-4159.1978.tb10492.x; ORIDA N, 1978, NATURE, V275, P31, DOI 10.1038/275031a0; POO MM, 1982, NATURE, V295, P332, DOI 10.1038/295332a0; POULAIN B, 1986, J PHYSIOL-PARIS, V81, P270; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SUN YA, 1985, J NEUROSCI, V5, P634; TABTI N, 1986, ACTA PHYSIOL SCAND, V128, P429, DOI 10.1111/j.1748-1716.1986.tb07996.x; Tabti N., 1991, CULTURING NERVE CELL, P137; TAKAHASHI T, 1987, J NEUROSCI, V7, P473; TRIMBLE AW, 1991, REV NEUROSCI, V14, P93; WHITTAKER VP, 1972, BIOCHEM J, V128, P833, DOI 10.1042/bj1280833; YOUNG SH, 1983, NATURE, V304, P161, DOI 10.1038/304161a0	30	81	82	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	1992	359	6397					733	736		10.1038/359733a0	http://dx.doi.org/10.1038/359733a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436036				2022-12-28	WOS:A1992JU65000057
J	CLARKE, HRG; LEIGH, JA; DOUGLAS, CJ				CLARKE, HRG; LEIGH, JA; DOUGLAS, CJ			MOLECULAR SIGNALS IN THE INTERACTIONS BETWEEN PLANTS AND MICROBES	CELL			English	Editorial Material							AGROBACTERIUM VIRULENCE GENES; LIPO-OLIGOSACCHARIDE SIGNALS; RHIZOBIUM-MELILOTI; HOST-SPECIFICITY; AVIRULENCE; PROTEIN; ALFALFA; IDENTIFICATION; EXPRESSION; MEMBRANE		UNIV BRITISH COLUMBIA,DEPT BOT,VANCOUVER V6T 1Z4,BC,CANADA	University of British Columbia	CLARKE, HRG (corresponding author), UNIV WASHINGTON,DEPT MICROBIOL,SEATTLE,WA 98195, USA.		Douglas, Carl J/B-1384-2013					BANUETT F, 1991, P NATL ACAD SCI USA, V88, P3922, DOI 10.1073/pnas.88.9.3922; BANUETT F, 1992, TRENDS GENET, V8, P174, DOI 10.1016/0168-9525(92)90091-H; BATTISTI L, 1992, P NATL ACAD SCI USA, V89, P5625, DOI 10.1073/pnas.89.12.5625; BECRAFT PW, 1992, CURR OPIN GENET DEV, V2, P751; BOLKER M, 1992, CELL, V68, P441, DOI 10.1016/0092-8674(92)90182-C; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; CHEONG JJ, 1991, PLANT CELL, V3, P137, DOI 10.1105/tpc.3.2.137; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; CORNELIS GR, 1989, MOL MICROBIOL, V3, P1455, DOI 10.1111/j.1365-2958.1989.tb00129.x; COSIO EG, 1992, EUR J BIOCHEM, V204, P1115, DOI 10.1111/j.1432-1033.1992.tb16736.x; DANGL JL, 1992, IN PRESS PLANT CELL, V4; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; GILLISSEN B, 1992, CELL, V68, P647, DOI 10.1016/0092-8674(92)90141-X; GRIMSLEY N, 1987, NATURE, V325, P177, DOI 10.1038/325177a0; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; HESS KM, 1991, P NATL ACAD SCI USA, V88, P7854, DOI 10.1073/pnas.88.17.7854; HIRSCH AM, 1989, P NATL ACAD SCI USA, V86, P1244, DOI 10.1073/pnas.86.4.1244; HOOYKAAS PJJ, 1992, PLANT MOL BIOL, V19, P15, DOI 10.1007/BF00015604; HOWARD EA, 1992, CELL, V68, P109, DOI 10.1016/0092-8674(92)90210-4; HUANG Y, 1990, J BACTERIOL, V172, P1142, DOI 10.1128/jb.172.2.1142-1144.1990; JIN SG, 1990, J BACTERIOL, V172, P525, DOI 10.1128/jb.172.2.525-530.1990; KEEN NT, 1990, ANNU REV GENET, V24, P447, DOI 10.1146/annurev.ge.24.120190.002311; KNOGGE W, 1991, Z NATURFORSCH C, V46, P969; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; MELCHERS LS, 1989, EMBO J, V8, P1919, DOI 10.1002/j.1460-2075.1989.tb03595.x; ROCHE P, 1991, CELL, V67, P1131, DOI 10.1016/0092-8674(91)90290-F; SCHERES B, 1990, CELL, V60, P281, DOI 10.1016/0092-8674(90)90743-X; SCHWEDOCK J, 1990, NATURE, V348, P644, DOI 10.1038/348644a0; SHIMODA N, 1990, P NATL ACAD SCI USA, V87, P6684, DOI 10.1073/pnas.87.17.6684; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; TRUCHET G, 1989, MOL GEN GENET, V219, P65, DOI 10.1007/BF00261158; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0; URZAINQUI A, 1992, J BACTERIOL, V174, P3403, DOI 10.1128/jb.174.10.3403-3406.1992; VANBRUSSEL AAN, 1992, SCIENCE, V257, P70, DOI 10.1126/science.257.5066.70; VANDENACKERVEKEN GFJM, 1992, PLANT J, V2, P359, DOI 10.1111/j.1365-313X.1992.00359.x; VANKAN JAL, 1991, MOL PLANT MICROBE IN, V4, P52, DOI 10.1094/MPMI-4-052; WANG L, 1992, CELL, V69, P659, DOI 10.1016/0092-8674(92)90229-6; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; WILLIS DK, 1991, MOL PLANT MICROBE IN, V4, P132, DOI 10.1094/MPMI-4-132; WINANS SC, 1989, J BACTERIOL, V171, P1616, DOI 10.1128/jb.171.3.1616-1622.1989; WINANS SC, 1992, MICROBIOL REV, V56, P12, DOI 10.1128/MMBR.56.1.12-31.1992; WINANS SC, 1991, MOL MICROBIOL, V5, P2345, DOI 10.1111/j.1365-2958.1991.tb02080.x	49	40	41	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					191	199		10.1016/0092-8674(92)90348-G	http://dx.doi.org/10.1016/0092-8674(92)90348-G			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423587				2022-12-28	WOS:A1992JU39500005
J	GOLD, LS; SLONE, TH; STERN, BR; MANLEY, NB; AMES, BN				GOLD, LS; SLONE, TH; STERN, BR; MANLEY, NB; AMES, BN			RODENT CARCINOGENS - SETTING PRIORITIES	SCIENCE			English	Article							POTENCY DATABASE; ANIMAL BIOASSAYS; CHRONOLOGICAL SUPPLEMENT; CHEMICAL CARCINOGENESIS; RISK ASSESSMENT; CAFFEIC ACID; TOTAL DIET; MICE; PESTICIDES; TUMORS	The human diet contains an enormous background of natural chemicals, such as plant pesticides and the products of cooking, that have not been a focus of carcinogenicity testing. A broadened perspective that includes these natural chemicals is necessary. A comparison of possible hazards for 80 daily exposures to rodent carcinogens from a variety of sources is presented, using an index (HERP) that relates human exposure to carcinogenic potency in rodents. A similar ordering would be expected with the use of standard risk assessment methodology for the same human exposure values. Results indicate that, when viewed against the large background of naturally occurring carcinogens in typical portions of common foods, the residues of synthetic pesticides or environmental pollutants rank low. A similar result is obtained in a separate comparison of 32 average daily exposures to natural pesticides and synthetic pesticide residues in the diet. Although the findings do not indicate that these natural dietary carcinogens are important in human cancer, they cast doubt on the relative importance for human cancer of low-dose exposures to synthetic chemicals.	UNIV CALIF BERKELEY, DIV BIOCHEM & MOLEC BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	GOLD, LS (corresponding author), LAWRENCE BERKELEY LAB, DIV LIFE SCI, BERKELEY, CA 94720 USA.				NCI NIH HHS [CA39910] Funding Source: Medline; NIEHS NIH HHS [ESO1896] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA039910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001896] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMES BN, 1991, SCIENCE, V251, P12, DOI 10.1126/science.251.4989.12; AMES BN, 1988, SCIENCE, V240, P1045, DOI 10.1126/science.240.4855.1045; AMES BN, 1987, SCIENCE, V237, P1399, DOI 10.1126/science.237.4821.1399-b; AMES BN, 1987, SCIENCE, V237, P1283, DOI 10.1126/science.237.4820.1283-a; AMES BN, 1987, SCIENCE, V237, P235; AMES BN, 1987, SCIENCE, V238, P1634, DOI 10.1126/science.238.4834.1634; AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; AMES BN, 1990, SCIENCE, V250, P1645, DOI 10.1126/science.250.4988.1645; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7772, DOI 10.1073/pnas.87.19.7772; AMES BN, 1987, SCIENCE, V236, P271, DOI 10.1126/science.3563506; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7782, DOI 10.1073/pnas.87.19.7782; AMES BN, 1991, SCIENCE, V252, P902; AMES BN, 1990, SCIENCE, V250, P1498, DOI 10.1126/science.2274775; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7777, DOI 10.1073/pnas.87.19.7777; AMES BN, 1991, SCIENCE, V251, P607, DOI 10.1126/science.251.4994.607; AMES BN, IN PRESS AGING CELLU; ARIZA RR, 1988, MUTAT RES, V201, P89, DOI 10.1016/0027-5107(88)90114-5; BENDICH A, 1991, MICRONUTRIENTS HLTH; BERNSTEIN L, 1985, FUND APPL TOXICOL, V5, P79, DOI 10.1016/0272-0590(85)90051-X; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; CLARKE RJ, 1988, COFFEE, V1; DIETRICH DR, 1991, CANCER RES, V51, P3512; Doll R, 1981, THE CAUSES OF CANCER; Flament I., 1991, VOLATILE COMPOUNDS F, P617; FRAGACG, 1991, P NATL ACAD SCI USA, V88, P11003; FUNG VA, 1988, MUTAT RES, V204, P219, DOI 10.1016/0165-1218(88)90092-4; GARTRELL MJ, 1986, J ASSOC OFF ANA CHEM, V69, P146; GAYLOR DW, 1989, REGUL TOXICOL PHARM, V9, P101, DOI 10.1016/0273-2300(89)90028-7; Gaylor DW KF, 1991, MUTAGENS FOOD DETECT, P229; GOLD LS, 1989, ENVIRON HEALTH PERSP, V81, P211, DOI 10.2307/3430831; GOLD LS, 1987, ENVIRON HEALTH PERSP, V76, P211, DOI 10.2307/3430487; GOLD LS, 1987, ENVIRON HEALTH PERSP, V74, P237, DOI 10.2307/3430454; GOLD LS, 1986, ENVIRON HEALTH PERSP, V67, P161, DOI 10.2307/3430332; GOLD LS, 1984, ENVIRON HEALTH PERSP, V58, P9, DOI 10.2307/3429857; GOLD LS, 1990, ENVIRON HEALTH PERSP, V84, P215, DOI 10.2307/3430724; GOLD LS, 1990, IN PRESS ENV HLTH PE, V84; GOLD LS, IN PRESS COMP ENV RI; GOLD LS, IN PRESS RISK ANAL; GORI GB, 1991, REGUL TOXICOL PHARM, V14, P215, DOI 10.1016/0273-2300(91)90025-Q; GUNDERSON EL, 1988, J ASSOC OFF ANA CHEM, V71, P1200; GUNDERSON EL, 1989, J ASSOC OFF ANA CHEM, V72, pA133; GUNDERSON EL, 1990, J ASSOC OFF ANA CHEM, V73, pA127; HAGIWARA A, 1991, CANCER RES, V51, P5655; HANHAM AF, 1983, MUTAT RES, V116, P333, DOI 10.1016/0165-1218(83)90071-X; Health. & N.R.C.U.C.o.D.a., 1989, DIET HLTH IMPLICATIO; HENDERSON BE, 1991, SCIENCE, V254, P1131, DOI 10.1126/science.1957166; HIGGINSON J, 1988, CANCER RES, V48, P1381; ISHIDATE M, 1988, MUTAT RES, V201, P89; KEENEY RL, 1990, RISK ANAL, V10, P147, DOI 10.1111/j.1539-6924.1990.tb01029.x; KELSEY KT, 1991, MUTAT RES, V263, P197, DOI 10.1016/0165-7992(91)90001-K; KREWSKI D, 1990, REGUL TOXICOL PHARM, V12, P13, DOI 10.1016/S0273-2300(05)80043-1; MAARSE H, 1990, VOLATILE COMPOUNDS S, V1; OOTSUYAMA A, 1991, RADIAT RES, V125, P98, DOI 10.2307/3577987; PERERA F, 1988, JNCI-J NATL CANCER I, V80, P1282, DOI 10.1093/jnci/80.16.1282; PERERA F, 1989, JNCI-J NATL CANCER I, V80, P880; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; PETO R, 1984, ENVIRON HEALTH PERSP, V58, P1, DOI 10.2307/3429856; PETO R, 1985, ASSESSMENT RISK LOW, P16; RAHN W, 1978, J HIGH RES CHROMATOG, V1022, P69; STICH HF, 1981, MUTAT RES, V90, P201, DOI 10.1016/0165-1218(81)90001-X; STOFBERG J, 1987, PERFUMER FLAVORIST, V12, P27; TOMATIS L, 1990, EXP PATHOL-JENA, V40, P251, DOI 10.1016/S0232-1513(11)80309-9; TRESSL R, 1978, Z LEBENSM UNTERS FOR, V167, P111, DOI 10.1007/BF01136139; VICUSI WK, 1992, FATAL TRADE OFFS PUB; Visscher C. A., 1989, VOLATILE COMPOUNDS F; Wildavsky AaronB., 1988, SEARCHING SAFETY; WOLFF S, 1988, INT J RADIAT BIOL, V53, P39, DOI 10.1080/09553008814550401; YAMAGAMI T, 1983, SURG NEUROL, V20, P323, DOI 10.1016/0090-3019(83)90089-7; YESS NJ, 1991, J ASSOC OFF ANA CHEM, V74, pA121; YOUNGMAN LD, IN PRESS P NATL ACAD; 1987, OVERALL EVALUATION S, V7; 1986, FED REGISTER, V51, P33997; 1987, REGULATING PESTICIDE; 1991, REGULATORY PROGRAM U	74	126	127	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	1992	258	5080					261	265		10.1126/science.1411524	http://dx.doi.org/10.1126/science.1411524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	1411524				2022-12-28	WOS:A1992JR86000023
J	SHOJI, M; GOLDE, TE; GHISO, J; CHEUNG, TT; ESTUS, S; SHAFFER, LM; CAI, XD; MCKAY, DM; TINTNER, R; FRANGIONE, B; YOUNKIN, SG				SHOJI, M; GOLDE, TE; GHISO, J; CHEUNG, TT; ESTUS, S; SHAFFER, LM; CAI, XD; MCKAY, DM; TINTNER, R; FRANGIONE, B; YOUNKIN, SG			PRODUCTION OF THE ALZHEIMER AMYLOID-BETA PROTEIN BY NORMAL PROTEOLYTIC PROCESSING	SCIENCE			English	Article							ADRDA WORK GROUP; SOLUBLE DERIVATIVES; CLINICAL-DIAGNOSIS; DISEASE; PRECURSOR; PEPTIDE; LOCALIZATION; DEGRADATION; FRAGMENTS; CRITERIA	The 4-kilodalton (39 to 43 amino acids) amyloid beta protein (betaAP), which is deposited as amyloid in the brains of patients with Alzheimer's disease, is derived from a large protein, the amyloid beta protein precursor (betaAPP). Human mononuclear leukemic (K562) cells expressing a betaAP-bearing, carboxyl-terminal betaAPP derivative released significant amounts of a soluble 4-kilodalton betaAPP derivative essentially identical to the betaAP deposited in Alzheimer's disease. Human neuroblastoma (M17) cells transfected with constructs expressing full-length betaAPP and M17 cells expressing only endogenous betaAPP also released soluble 4-kilodalton betaAP, and a similar, if not identical, fragment was readily detected in cerebrospinal fluid from individuals with Alzheimer's disease and normal individuals. Thus cells normally produce and release soluble 4-kilodalton betaAP that is essentially identical to the 4-kilodalton betaAP deposited as insoluble amyloid fibrils in Alzheimer's disease.	CASE WESTERN RESERVE UNIV,INST PATHOL,DIV NEUROPATHOL,CLEVELAND,OH 44106; UNIV TEXAS,SW MED CTR,DEPT NEUROL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,ALZHEIMERS DIS RES CTR,DALLAS,TX 75235; GUNMA UNIV,DEPT NEUROL,MAEBASHI,GUNMA 371,JAPAN; NYU MED CTR,DEPT PATHOL,NEW YORK,NY 10016; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Case Western Reserve University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Gunma University; New York University; Washington University (WUSTL)			McKay, Derek/HCH-3240-2022; Shoji, Mikio/F-2841-2013	Shoji, Mikio/0000-0003-1027-1712	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR002594, R01AR002594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005891, R01AG006656, R37AG005891] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR02594] Funding Source: Medline; NIA NIH HHS [AG06656, AG05891] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; BUKTENICA S, 1987, J BIOL CHEM, V262, P9469; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; COLE GM, 1989, NEUROCHEM RES, V14, P933, DOI 10.1007/BF00965926; COLE GM, 1990, MOL BIOL GENETICS AL, P113; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FRANGIONE B, IN PRESS ALZHEIMERS; FRUCHT SJ, 1992, J NEUROPATH EXP NEUR, V51, P369; GLENNER G, 1983, BRANBURY REPORT, V15, P137; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HAMBOR JE, 1988, P NATL ACAD SCI USA, V85, P4010, DOI 10.1073/pnas.85.11.4010; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; ISENMAN LD, 1989, J BIOL CHEM, V264, P21591; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1988, ANN NEUROL, V24, P17, DOI 10.1002/ana.410240105; PALMERT MR, 1989, BIOCHEM BIOPH RES CO, V165, P182, DOI 10.1016/0006-291X(89)91052-8; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; ROBAKIS NK, 1987, LANCET, V1, P384; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TERRY RD, 1963, BRAIN, V311, P528; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	37	1385	1453	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 2	1992	258	5079					126	129		10.1126/science.1439760	http://dx.doi.org/10.1126/science.1439760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ619	1439760				2022-12-28	WOS:A1992JQ61900034
J	DESALLE, R; GATESY, J; WHEELER, W; GRIMALDI, D				DESALLE, R; GATESY, J; WHEELER, W; GRIMALDI, D			DNA-SEQUENCES FROM A FOSSIL TERMITE IN OLIGOMIOCENE AMBER AND THEIR PHYLOGENETIC IMPLICATIONS	SCIENCE			English	Article							PLANT RESINS	DNA was extracted from the fossil termite Mastotermes electrodominicus preserved in Oligo-Miocene amber (25 million to 30 million years old). Fragments of mitochondrial [16S ribosomal DNA (rDNA)] and nuclear (18S rDNA) genes were amplified by polymerase chain reaction. Phylogenetic analysis of fossil and extant 18S rDNA confirmed morphological cladistic analyses of living dictyopterans (termites, cockroaches, and mantids). The fossil termite shares several sequence attributes with Mastotermes darwiniensis. Addition of this fossil to living-species phylogeny is required to substantiate Mastotermes monophyly and affects molecular phylogenetic hypotheses of termites in this, the oldest DNA yet characterized.	AMER MUSEUM NAT HIST, DEPT INVERTEBRATES, NEW YORK, NY 10024 USA; YALE UNIV, DEPT GEOL, NEW HAVEN, CT 06511 USA	American Museum of Natural History (AMNH); Yale University	DESALLE, R (corresponding author), AMER MUSEUM NAT HIST, DEPT ENTOMOL, NEW YORK, NY 10024 USA.							BARONIURBANI C, 1982, 9TH P CAR GEOL C SAN, P213; BROUWER SB, 1982, 9TH P CAR GEOL C SAN, P303; CANO R J, 1992, Medical Science Research, V20, P249; CHERFAS J, 1991, SCIENCE, V253, P1354, DOI 10.1126/science.1910205; DESALLE R, IN PRESS MOL PHYLOGE; EMERSON ALFRED E., 1965, AMER MUS NOVTTATES, V2236, P1; Farris, 1988, HENNIG86 PROGRAM DOC; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Frost S.H., 1974, REEF BIOFACIES TERTI; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GOLENBERG EM, 1990, NATURE, V344, P656, DOI 10.1038/344656a0; Graeser, 1987, STUTTG BEITR NATUR B, V133, P1; Harms F. J., 1990, STUTTG BEITR NATUR B, V163, P1; Hennig W., 1981, INSECT PHYLOGENY; HENWOOD A, 1992, Palaios, V7, P203, DOI 10.2307/3514931; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hurd P.D., 1962, CIENCIA, V21, P107; JARZEMBOWSKI E A, 1984, Modern Geology, V9, P71; JARZEMBOWSKI EA, 1981, SYST ENTOMOL, V6, P91, DOI 10.1111/j.1365-3113.1981.tb00018.x; KOSMOWSKACERANO.B, 1990, PR MUZ ZIEMI, V41, P143; Krishna, 1983, AM MUS NOVIT, V2767, P1; KRISHNA K, 1990, B AM MUS NAT HIST, P76; KRISHNA K, 1991, AM MUS NOVIT, P1; KRISHNA K, 1970, BIOL TERMITES, V2, P127; KRISHNAN KN, 1975, INDIAN J TECHNOL, V13, P1; KWORK S, 1990, PCR PROTOCOLS, P142; LAMBERT B, 1990, ANTI-CANCER DRUG DES, V5, P43; LANGENHEIM JH, 1990, AM SCI, V78, P16; LANGENHEIM JH, 1969, SCIENCE, V163, P1157, DOI 10.1126/science.163.3872.1157; Larsson S. G, 1978, ENTOMONOGRAPH, V1; LEE YT, 1974, U CALIF PUBL BOT, V69, P1; MARTINEZ R, 1987, STUTTG BEITR NATURKD, V28, P79; ORREGO C, 1990, PCR PROTOCOLS GUIDE, P447; Paabo S., 1990, PCR PROTOCOLS GUIDE, P159; POINAR GO, 1982, SCIENCE, V215, P1241, DOI 10.1126/science.215.4537.1241; SHEDRINSKY A, 1992, WIEN BER NATURWISS K, V6, P37; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; THORNE BL, IN PRESS SYST ENTOMO; Tomasini-Ortiz A.C., 1984, PALEONTOLOGIA MEXICA, V50, P1; WELLER M, 1984, STUTTGARTER BEITRA C, V18, P85; WHEELER W, 1992, MALIGN PROGRAM DOCUM; WHEELER WC, 1991, HEIRARCHY LIFE, P307; Wilson E.O., 1971, INSECT SOC	43	213	226	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	1992	257	5078					1933	1936		10.1126/science.1411508	http://dx.doi.org/10.1126/science.1411508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP594	1411508				2022-12-28	WOS:A1992JP59400028
J	HARDY, WD; FEINBERG, J; FINKELSTEIN, DM; POWER, ME; HE, W; KACZKA, C; FRAME, PT; HOLMES, M; WASKIN, H; FASS, RJ; POWDERLY, WG; STEIGBIGEL, RT; ZUGER, A; HOLZMAN, RS				HARDY, WD; FEINBERG, J; FINKELSTEIN, DM; POWER, ME; HE, W; KACZKA, C; FRAME, PT; HOLMES, M; WASKIN, H; FASS, RJ; POWDERLY, WG; STEIGBIGEL, RT; ZUGER, A; HOLZMAN, RS			A CONTROLLED TRIAL OF TRIMETHOPRIM SULFAMETHOXAZOLE OR AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - AIDS CLINICAL-TRIALS GROUP PROTOCOL-021	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS INFECTION; CHEMOPROPHYLAXIS; ZIDOVUDINE	Background. Pneumocystis carinii pneumonia (PCP) continues to be the most common index diagnosis in the acquired immunodeficiency syndrome (AIDS), but it is not clear which of several available agents is the most effective in preventing a recurrence of PCP. Methods. We conducted a comparative, open-label trial in 310 adults with AIDS who had recently recovered from an initial episode of PCP and had no treatment-limiting toxic effects of trimethoprim-sulfamethoxazole or pentamidine. All the patients were treated with zidovudine and were randomly assigned to receive either 800 mg of sulfamethoxazole and 160 mg of trimethoprim once daily or 300 mg of aerosolized pentamidine administered every four weeks by jet nebulizer. The participants were followed for a median of 17.4 months. Results. In the trimethoprim-sulfamethoxazole group (n = 154) there were 14 recurrences of PCP, as compared with 36 recurrences (including 1 extrapulmonary recurrence) in the aerosolized-pentamidine group (n = 156). The estimated recurrence rates at 18 months were 11.4 percent with trimethoprim-sulfamethoxazole and 27.6 percent with pentamidine (P<0.001). The risk of a recurrence (adjusted for initial CD4 cell count) was 3.25 times higher in the pentamidine group (P<0.001; 95 percent confidence interval, 1.72 to 6.16). There were no significant differences between the groups in survival or in hematologic or hepatic toxicity. Crossovers from trimethoprim-sulfamethoxazole to aerosolized pentamidine were more common than the reverse (27 vs. 4 percent), partly because of the study protocols for the management of leukopenia. There were 19 serious bacterial infections in the trimethoprim-sulfamethoxazole group and 38 in the pentamidine group. The time to a first bacterial infection was significantly greater for those assigned to trimethoprim-sulfamethoxazole (P = 0.017). Conclusions. In patients with AIDS who are receiving zidovudine, trimethoprim-sulfamethoxazole is more effective than aerosolized pentamidine in conventional doses for the prevention of recurrent pneumocystis infection.	NYU,SCH MED,DEPT MED,550 1ST AVE,NEW YORK,NY 10016; UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024; HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115; NIAID,DIV AIDS,BETHESDA,MD 20892; FRONTIER SCI TECHNOL & RES FDN,AMHERST,NY; UNIV CINCINNATI,SCH MED,DEPT MED,CINCINNATI,OH 45221; UNIV SO CALIF,DEPT MED,LOS ANGELES,CA 90089; DUKE UNIV,SCH MED,DEPT MED,DURHAM,NC 27706; OHIO STATE UNIV,COLL MED,DEPT MED,COLUMBUS,OH 43210; WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110; SUNY STONY BROOK,DEPT MED,STONY BROOK,NY 11794; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461	New York University; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Frontier Science Foundation; University System of Ohio; University of Cincinnati; University of Southern California; Duke University; University System of Ohio; Ohio State University; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yeshiva University; Albert Einstein College of Medicine	HOLZMAN, RS (corresponding author), NYU,SCH MED,DEPT MED,550 1ST AVE,NEW YORK,NY 10016, USA.			Powderly, William/0000-0001-7808-3086; feinberg, judith/0000-0003-4206-7214	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI052607, N01AI095030] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-52607, N0-AI-95030] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CASTELLANO AR, 1991, JAMA-J AM MED ASSOC, V266, P820, DOI 10.1001/jama.266.6.820; COLLIER AC, 1990, NEW ENGL J MED, V323, P1015, DOI 10.1056/NEJM199010113231502; COX DR, 1972, J R STAT SOC B, V34, P187; FAUCI AS, 1985, ANN INTERN MED, V102, P800, DOI 10.7326/0003-4819-102-6-800; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501; Fleiss JL, 1981, STAT METHODS RATES P; HARDY WD, 1987, 3RD P INT C AIDS WAS, P232; HUGHES WT, 1977, NEW ENGL J MED, V297, P1419, DOI 10.1056/NEJM197712292972602; HUGHES WT, 1987, NEW ENGL J MED, V316, P1627, DOI 10.1056/NEJM198706253162604; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LEOUNG GS, 1990, NEW ENGL J MED, V323, P769, DOI 10.1056/NEJM199009203231201; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; METROKA CE, 1989, 5TH INT C AIDS MONTR, P196; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; 1989, MMWR MORB MORTAL SS5, V38, P1	18	349	353	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	1992	327	26					1842	1848		10.1056/NEJM199212243272604	http://dx.doi.org/10.1056/NEJM199212243272604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KD714	1448121	Bronze			2022-12-28	WOS:A1992KD71400004
J	STROBER, W; JAMES, SP				STROBER, W; JAMES, SP			THE IMMUNOPATHOGENESIS OF GASTROINTESTINAL AND HEPATOBILIARY DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELIAC-DISEASE; PATHOGENESIS; HEPATITIS; ANTIBODY; VIRUS		UNIV MARYLAND, DIV GASTROENTEROL, BALTIMORE, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	STROBER, W (corresponding author), NIAID, MUCOSAL IMMUN SECT, BETHESDA, MD 20892 USA.							ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; EMANCIPATOR SN, 1989, LAB INVEST, V60, P168; FERGUSON A, 1987, IMMUNOPATHOLOGY SMAL, P225; FERREIRA RD, 1990, GASTROENTEROLOGY, V98, P1255, DOI 10.1016/0016-5085(90)90342-X; FIOCCHI C, 1991, FALK SYMP, P237; FLEMING JL, 1988, MAYO CLIN PROC, V63, P539, DOI 10.1016/S0025-6196(12)64884-8; GERSHWIN ME, 1991, GASTROENTEROLOGY, V100, P822, DOI 10.1016/0016-5085(91)80033-6; GOLDSMITH R, 1992, LANCET, V339, P328, DOI 10.1016/0140-6736(92)91647-Q; HOOFNAGLE JH, 1986, SEMIN LIVER DIS, V6, P1, DOI 10.1055/s-2008-1040787; JACOBS DH, 1984, HOSP PRACT, V20, P51; Kettlehut B., 1988, ALLERGY PRINCIPLES P, V3, P1481; LAU J Y N, 1991, Gut, pS47; PULLMAN WE, 1992, GASTROENTEROLOGY, V102, P529, DOI 10.1016/0016-5085(92)90100-D; RAMBAUD JC, 1990, SPRINGER SEMIN IMMUN, V12, P239; RELMAN DA, 1992, NEW ENGL J MED, V327, P346; SAVILAHTI E, 1984, CLIN REV ALLERG, V2, P7; SCHARSCHMIDT BF, 1984, HEPATOLOGY, V4, pS95, DOI 10.1002/hep.1840040723; SMITH PD, 1992, ANN INTERN MED, V116, P63, DOI 10.7326/0003-4819-116-1-63; SPARKLAND A, 1990, HUMAN IMMUNOLOGY, V29, P157; SPENCER J, 1991, CLIN EXP IMMUNOL, V85, P109, DOI 10.1111/j.1365-2249.1991.tb05690.x; STRICKLAND RG, 1990, SPRINGER SEMIN IMMUN, V12, P203; STROBER W, 1991, ANN ALLERGY, V66, P363; STROBER W, 1986, J CLIN IMMUNOL, V6, P415, DOI 10.1007/BF00915248; STROBER W, IN PRESS GASTROENTER; STROBER W, 1985, GASTROINTESTINAL IMM, P75; Strober W., 1991, BASIC HUMAN IMMUNOLO, P175; VOLTA U, 1991, DIGEST DIS SCI, V36, P752, DOI 10.1007/BF01311232; WIESNER RH, 1989, HEPATOLOGY, V10, P430, DOI 10.1002/hep.1840100406; ZUMBUSCHENFELDE KH, 1991, HEPATOLOGY, V12, P355	29	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2910	2917		10.1001/jama.268.20.2910	http://dx.doi.org/10.1001/jama.268.20.2910			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433708				2022-12-28	WOS:A1992JY66800016
J	LISBERGER, SG; SEJNOWSKI, TJ				LISBERGER, SG; SEJNOWSKI, TJ			MOTOR LEARNING IN A RECURRENT NETWORK MODEL BASED ON THE VESTIBULOOCULAR REFLEX	NATURE			English	Article							ELECTRO-PHYSIOLOGICAL OBSERVATIONS; TERM ADAPTIVE-CHANGES; FLOCCULUS; MONKEYS; INTEGRATION; ADAPTATION; PLASTICITY; PATHWAYS; NEURONS	MOST models of neural networks have assumed that neurons process information on a timescale of milliseconds and that the long-term modification of synaptic strengths underlies learning and memory1. But neurons also have cellular mechanisms that operate on a timescale of tens or hundreds of milliseconds, such as a gradual rise in firing rate in response to injection of constant current2 or a rapid rise followed by a slower adaptation3. These dynamic properties of neuronal responses are mediated by ion channels that are subject to modulation4. We demonstrate here how a neural network with recurrent feedback connections can convert long-term modulation of neural responses that occur over these intermediate timescales into changes in the amplitude of the steady output from the system. This general principle may be relevant to many feedback systems in the brain. Here it is applied to the vestibulo-ocular reflex, whose amplitude is subject to long-term adaptive modification by visual inputs5. The model reconciles apparently contradictory data on the neural locus of the cellular mechanisms that mediate this simple form of learning and memory.	UNIV CALIF SAN FRANCISCO,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143; HOWARD HUGHES MED INST,SALK INST BIOL SCI,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093	University of California System; University of California San Francisco; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	LISBERGER, SG (corresponding author), UNIV CALIF SAN FRANCISCO,WM KECK FDN,CTR INTEGRAT NEUROSCI,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.		Sejnowski, Terrence/AAV-5558-2021					BRADLEY K, 1961, J PHYSIOL-LONDON, V156, P75, DOI 10.1113/jphysiol.1961.sp006659; Churchland P. S., 1992, COMPUTATIONAL BRAIN, DOI 10.7551/mitpress/2010.001.0001; FUCHS AF, 1975, J NEUROPHYSIOL, V38, P1140, DOI 10.1152/jn.1975.38.5.1140; GONSHOR A, 1976, J PHYSIOL-LONDON, V256, P381, DOI 10.1113/jphysiol.1976.sp011330; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1986, J NEUROSCI, V6, P346; LISBERGER SG, 1988, SCIENCE, V242, P771, DOI 10.1126/science.3142040; LISBERGER SG, 1988, SCIENCE, V242, P728, DOI 10.1126/science.3055293; LISBERGER SG, 1992, 9201 U CAL I NEUR CO; MILES FA, 1980, J NEUROPHYSIOL, V43, P1477, DOI 10.1152/jn.1980.43.5.1477; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; STRONG JA, 1987, NEUROMODULATION BIOC; WATANABE E, 1984, BRAIN RES, V297, P169, DOI 10.1016/0006-8993(84)90555-9	16	101	101	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 12	1992	360	6400					159	161		10.1038/360159a0	http://dx.doi.org/10.1038/360159a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX752	1436091				2022-12-28	WOS:A1992JX75200059
J	HERZ, J; CLOUTHIER, DE; HAMMER, RE				HERZ, J; CLOUTHIER, DE; HAMMER, RE			LDL RECEPTOR-RELATED PROTEIN INTERNALIZES AND DEGRADES UPA-PAI-1 COMPLEXES AND IS ESSENTIAL FOR EMBRYO IMPLANTATION	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; ALPHA-2-MACROGLOBULIN RECEPTOR; PLASMINOGEN-ACTIVATOR; APOLIPOPROTEIN-E; MEDIATED INTERNALIZATION; ENDOTHELIAL-CELLS; BOUND UROKINASE; CULTURED-CELLS; HIGH-AFFINITY; STEM-CELLS	The low density lipoprotein receptor-related protein (LRP) is a large multifunctional clearance receptor that has been implicated in the hepatic uptake of chylomicron remnants and in the removal of protease-inhibitor complexes from the circulation and from the extracellular space. Disruption of the LRP gene in mice blocks development of LRP-I- embryos around the implantation stage. The expression pattern of LRP in the postimplantation stage embryo is identical to that of urokinase, a plasminogen activator that confers invasive properties to migrating cells. We demonstrate that LRP mediates uptake and degradation of urokinase-type plasminogen activator-plasminogen activator inhibitor 1 complexes and propose that the inability of the giant cells to remove the inactive protease complexes from their surfaces interferes with implantation of the embryo.	UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	HERZ, J (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.		Clouthier, David/A-7062-2009	Hammer, Robert E./0000-0001-5487-7551	NHLBI NIH HHS [HL 20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		APPELLA E, 1987, J BIOL CHEM, V262, P4437; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BROWN MS, 1991, CURR OPIN LIPIDOL, V2, P65; Brunzell JD, 1989, METABOLIC BASIS INHE, P1165; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; DAVISSON MT, 1990, CYTOGENET CELL GENET, V55, P434, DOI 10.1159/000133026; EATON GJ, 1963, GENETICA, V34, P155, DOI 10.1007/BF01664187; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; HERZ J, 1990, J BIOL CHEM, V265, P21355; HILLIKER C, 1992, GENOMICS, V13, P472, DOI 10.1016/0888-7543(92)90276-X; JENSEN PH, 1988, PLACENTA, V9, P463, DOI 10.1016/0143-4004(88)90019-7; JENSEN PH, 1990, CELL REGUL, V1, P1043, DOI 10.1091/mbc.1.13.1043; KIM HS, 1988, NUCLEIC ACIDS RES, V16, P8887, DOI 10.1093/nar/16.18.8887; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; MYKLEBOST O, 1989, GENOMICS, V5, P65, DOI 10.1016/0888-7543(89)90087-6; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; OLSON D, 1992, J BIOL CHEM, V267, P9129; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; OSSOWSKI L, 1988, J CELL BIOL, V107, P2437, DOI 10.1083/jcb.107.6.2437; OSSOWSKI L, 1991, J CELL BIOL, V115, P1107, DOI 10.1083/jcb.115.4.1107; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; PLOUG M, 1991, SEMIN THROMB HEMOST, V17, P183, DOI 10.1055/s-2007-1002608; QUAX PHA, 1991, CELL REGUL, V2, P793, DOI 10.1091/mbc.2.10.793; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Sambrook J, 1989, MOL CLONING LABORATO; SAPPINO AP, 1989, J CELL BIOL, V109, P2471, DOI 10.1083/jcb.109.5.2471; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; SHI WK, 1984, J EMBRYOL EXP MORPH, V81, P143; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; STRICKLAND S, 1976, CELL, V9, P231, DOI 10.1016/0092-8674(76)90114-8; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VANMOURIK JA, 1984, J BIOL CHEM, V259, P14914; ZHENG H, 1990, NATURE, V344, P170, DOI 10.1038/344170a0	55	534	546	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					411	421		10.1016/0092-8674(92)90511-A	http://dx.doi.org/10.1016/0092-8674(92)90511-A			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423604				2022-12-28	WOS:A1992JW43500008
J	KAYE, J; ELLENBERGER, DL				KAYE, J; ELLENBERGER, DL			DIFFERENTIATION OF AN IMMATURE T-CELL LINE - A MODEL OF THYMIC POSITIVE SELECTION	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RECEPTOR TRANSGENIC MICE; INTERCELLULAR-ADHESION MOLECULE-1; RESTRICTED ANTIGEN RECEPTOR; LYT-2 POLYPEPTIDES ARISE; NEGATIVE SELECTION; CD4+8+ THYMOCYTES; DNA FRAGMENTATION; SUSPENSION-CULTURE; MURINE THYMOCYTES	Thymocyte differentiation is dependent upon recognition of major histocompatibility complex (MHC) molecules on thymic stroma, a process called positive selection. Here we describe an immature CD4+8+ T cell line derived from a TCR transgenic mouse that differentiates into CD4+8- cells in response to antigen and nonthymic antigen-presenting cells. When injected intrathymically, these cells differentiate in the absence of antigen. The ability of immature T cells to recognize MHC molecules in the absence of foreign antigen in the thymus can thus be attributed to a unique property of thymic antigen-presenting cells. These studies also demonstrate the phenotypic and functional changes associated with TCR-mediated T cell maturation and establish an in vitro model system of positive selection.			KAYE, J (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.			Kaye, Jonathan/0000-0002-1634-9069	NHLBI NIH HHS [HLO-07195] Funding Source: Medline; NIAID NIH HHS [AI31231] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031231, R29AI031231] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTMANN DM, 1989, NATURE, V338, P512, DOI 10.1038/338512a0; BENDELAC A, 1991, NATURE, V353, P68, DOI 10.1038/353068a0; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BEVAN MJ, 1978, IMMUNOL REV, V42, P3, DOI 10.1111/j.1600-065X.1978.tb00256.x; BILL J, 1989, NATURE, V341, P649, DOI 10.1038/341649a0; BLACKMAN MA, 1989, SCIENCE, V244, P214, DOI 10.1126/science.2784868; BLUE ML, 1989, J IMMUNOL, V142, P2714; BLUESTONE JA, 1987, NATURE, V326, P82, DOI 10.1038/326082a0; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; BORN W, 1987, J IMMUNOL, V138, P999; BOYER PD, 1988, J IMMUNOL, V140, P2886; CARLOW DA, 1992, J IMMUNOL, V148, P1595; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; COHEN JJ, 1984, J IMMUNOL, V132, P38; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; CRISPE IN, 1987, J IMMUNOL, V138, P2013; CRISPE IN, 1987, J IMMUNOL, V139, P3585; DUSTIN ML, 1986, J IMMUNOL, V137, P245; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; FINE JS, 1991, J IMMUNOL, V147, P2852; FINKEL TH, 1989, CELL, V58, P1047, DOI 10.1016/0092-8674(89)90503-5; FINKEL TH, 1989, J IMMUNOL, V142, P3006; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; HARVEY JE, 1990, IMMUNOLOGY, V70, P203; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; HUNIG T, 1991, J EXP MED, V173, P561, DOI 10.1084/jem.173.3.561; JAMESON SC, 1991, J IMMUNOL, V147, P3185; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KIZAKI H, 1989, J IMMUNOL, V143, P1790; KUHLMAN P, 1991, J IMMUNOL, V146, P1773; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LEPESANT H, 1990, INT IMMUNOL, V2, P1021, DOI 10.1093/intimm/2.11.1021; MACDONALD HR, 1988, NATURE, V336, P471, DOI 10.1038/336471a0; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1988, J IMMUNOL, V140, P2508; MARRACK P, 1989, NATURE, V338, P503, DOI 10.1038/338503a0; MATHIESON BJ, 1984, IMMUNOL REV, V82, P141, DOI 10.1111/j.1600-065X.1984.tb01121.x; MCCONKEY DJ, 1990, J IMMUNOL, V145, P1227; MCCONKEY DJ, 1989, FASEB J, V3, P1843, DOI 10.1096/fasebj.3.7.2497041; MERCEP M, 1989, J IMMUNOL, V142, P4085; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; NONOYAMA S, 1989, EUR J IMMUNOL, V19, P1631, DOI 10.1002/eji.1830190917; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PULLEN AM, 1990, CELL, V61, P1365, DOI 10.1016/0092-8674(90)90700-O; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; REICHERT RA, 1986, J IMMUNOL, V136, P3521; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9; ROSENBERG SA, 1984, SCIENCE, V223, P1412, DOI 10.1126/science.6367046; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SEONG RH, 1992, NATURE, V356, P718, DOI 10.1038/356718a0; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; SINGER KH, 1990, J IMMUNOL, V144, P2931; SIU G, 1989, J IMMUNOL, V143, P3813; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SPEISER DE, 1992, J EXP MED, V175, P1277, DOI 10.1084/jem.175.5.1277; SPRENT J, 1978, J EXP MED, V147, P1838, DOI 10.1084/jem.147.6.1838; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SWAIN SL, 1991, J IMMUNOL, V147, P2991; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; TAGAWA M, 1986, P NATL ACAD SCI USA, V83, P3422, DOI 10.1073/pnas.83.10.3422; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; WANG A, 1984, SCIENCE, V224, P1431, DOI 10.1126/science.6427925; WILSON A, 1988, CELL IMMUNOL, V117, P312, DOI 10.1016/0008-8749(88)90121-9; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; XIE WQ, 1991, BIOTECHNIQUES, V11, P324; ZAMOYSKA R, 1985, CELL, V43, P153, DOI 10.1016/0092-8674(85)90020-0; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; ZUNIGAPFLUCKER JC, 1989, NATURE, V338, P76, DOI 10.1038/338076a0	94	63	63	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	1992	71	3					423	435		10.1016/0092-8674(92)90512-B	http://dx.doi.org/10.1016/0092-8674(92)90512-B			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423605				2022-12-28	WOS:A1992JW43500009
J	LJUNGDAHL, PO; GIMENO, CJ; STYLES, CA; FINK, GR				LJUNGDAHL, PO; GIMENO, CJ; STYLES, CA; FINK, GR			SHR3 - A NOVEL COMPONENT OF THE SECRETORY PATHWAY SPECIFICALLY REQUIRED FOR LOCALIZATION OF AMINO-ACID PERMEASES IN YEAST	CELL			English	Article							NITROGEN CATABOLITE REPRESSION; MEMBRANE-SPANNING PROTEINS; CYCLOPHILIN HOMOLOG NINAA; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; GENE; TRANSPORT	Mutations in SHR3 block amino acid uptake into yeast by reducing the levels of multiple amino acid permeases within the plasma membrane. SHR3 is a novel integral membrane protein component of the endoplasmic reticulum (ER). shr3 null mutants specifically accumulate amino acid permeases in the ER; other plasma membrane proteins, secretory proteins, and vacuolar proteins are processed and targeted correctly. Our findings suggest that SHR3 interacts with a structural domain shared by amino acid permeases, an interaction required for permease-specific processing and transport from the ER. Even in the presence of excess amino acids, shr3 mutants exhibit starvation responses. shr3 mutants constitutively express elevated levels of GCN4, and mutant shr3/shr3 diploids undergo dimorphic transitions that result in filamentous growth at enhanced frequencies.	MIT, DEPT BIOL, CAMBRIDGE, MA 02142 USA	Massachusetts Institute of Technology (MIT)	LJUNGDAHL, PO (corresponding author), WHITEHEAD INST BIOMED RES, 9 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA.		Ljungdahl, Per O/M-5258-2013	Ljungdahl, Per O/0000-0002-6625-3540	NIGMS NIH HHS [GM12038, GM40266, GM35010] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010, R37GM035010, R01GM040266] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COURCHESNE WE, 1983, MOL CELL BIOL, V3, P672, DOI 10.1128/MCB.3.4.672; DAVIS LI, 1990, CELL, V61, P965, DOI 10.1016/0092-8674(90)90062-J; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; FINERMOORE J, 1989, PREDICTION PROTEIN S, P719; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; GARRETT JM, 1989, J GEN MICROBIOL, V135, P2429; GIMENO CJ, 1992, SCIENCE, V257, P626, DOI 10.1126/science.1496375; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GREEN GN, 1989, J CELL SCI, P109; GREEN N, 1992, MOL CELL BIOL, V12, P276, DOI 10.1128/MCB.12.1.276; GREEN N, 1992, J CELL BIOL, V116, P597, DOI 10.1083/jcb.116.3.597; GRENSON M, 1971, J BACTERIOL, V105, P477, DOI 10.1128/JB.105.2.477-482.1971; HALTINER M, 1985, NUCLEIC ACIDS RES, V13, P1015, DOI 10.1093/nar/13.3.1015; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; HOFFMANN W, 1985, J BIOL CHEM, V260, P1831; HORAK J, 1986, BIOCHIM BIOPHYS ACTA, V864, P223, DOI 10.1016/0304-4157(86)90001-8; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; KIM JM, 1990, GENETICS, V126, P799; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981; LINK AJ, 1991, GENETICS, V127, P681; LODISH HF, 1988, J BIOL CHEM, V263, P2107; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCCUSKER JH, 1990, MOL CELL BIOL, V10, P2941, DOI 10.1128/MCB.10.6.2941; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; MUSCH A, 1992, CELL, V69, P343, DOI 10.1016/0092-8674(92)90414-8; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988; ORLEAN P, 1991, METHOD ENZYMOL, V194, P682; PORUCHYNSKY MS, 1988, J CELL BIOL, V107, P1697, DOI 10.1083/jcb.107.5.1697; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROSE M, 1981, P NATL ACAD SCI-BIOL, V78, P2460, DOI 10.1073/pnas.78.4.2460; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; ROTHBLATT J, 1989, METHOD CELL BIOL, V32, P3; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; RYTKA J, 1975, J BACTERIOL, V121, P562, DOI 10.1128/JB.121.2.562-570.1975; SADLER I, 1989, J CELL BIOL, V109, P2665, DOI 10.1083/jcb.109.6.2665; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Sherman F., 1986, METHODS YEAST GENETI; SIDDIQUI AH, 1988, MOL CELL BIOL, V8, P4634, DOI 10.1128/MCB.8.11.4634; SIKORSKI RS, 1989, GENETICS, V122, P19; SILVE S, 1991, MOL CELL BIOL, V11, P1114, DOI 10.1128/MCB.11.2.1114; SORSOLI WA, 1964, J BACTERIOL, V88, P20, DOI 10.1128/JB.88.1.20-24.1964; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; SURDIN Y, 1965, BIOCHIM BIOPHYS ACTA, V107, P546, DOI 10.1016/0304-4165(65)90199-6; TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7; VANDENBOL M, 1989, GENE, V83, P153, DOI 10.1016/0378-1119(89)90413-7; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WANG H, 1991, NATURE, V352, P729, DOI 10.1038/352729a0; WEBER E, 1988, J MOL EVOL, V27, P341, DOI 10.1007/BF02101197; WEBER E, 1990, MOL MICROBIOL, V4, P585, DOI 10.1111/j.1365-2958.1990.tb00627.x; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4	82	180	183	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	1992	71	3					463	478		10.1016/0092-8674(92)90515-E	http://dx.doi.org/10.1016/0092-8674(92)90515-E			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423607				2022-12-28	WOS:A1992JW43500012
J	SUGIMURA, T				SUGIMURA, T			MULTISTEP CARCINOGENESIS - A 1992 PERSPECTIVE	SCIENCE			English	Article							HEPATITIS-B VIRUS; HETEROCYCLIC AMINES; HEPATOCELLULAR-CARCINOMA; GENETIC ALTERATIONS; COLORECTAL CANCERS; GASTRIC-CANCER; POINT MUTATION; MODEL SYSTEM; COOKED FOOD; DNA ADDUCTS	Cancer is the leading cause of death in Japan. Recent changes in cancer incidence patterns may reflect the trend toward a more Western diet and life-style. Among the dietary factors that contribute to carcinogenesis are the heterocyclic amines, a group of mutagenic compounds present in cooked meat and fish. Carcinogenesis is a multistep process in which cells accumulate multiple genetic alterations as they progress to a more malignant phenotype. Recognition of the growing number of interacting factors that contribute to carcinogenesis may force reconsideration of current methods of risk assessment.			SUGIMURA, T (corresponding author), NATL CANC CTR, 1-1 TSUKIJI 5 CHOME, CHUO KU, TOKYO 104, JAPAN.							ADAMSON RH, 1990, JPN J CANCER RES, V81, P10, DOI 10.1111/j.1349-7006.1990.tb02500.x; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; AOYAMA T, 1989, MOL CARCINOGEN, V1, P253, DOI 10.1002/mc.2940010408; BUONARATI MH, 1990, CARCINOGENESIS, V11, P1133, DOI 10.1093/carcin/11.7.1133; DEJEAN A, 1986, NATURE, V322, P70, DOI 10.1038/322070a0; DEVERDIER MG, 1991, INT J CANCER, V49, P520, DOI 10.1002/ijc.2910490408; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; ESUMI H, 1989, JPN J CANCER RES, V80, P1176, DOI 10.1111/j.1349-7006.1989.tb01651.x; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FELTON JS, 1986, CARCINOGENESIS, V7, P1081, DOI 10.1093/carcin/7.7.1081; FRANDSEN H, 1992, CARCINOGENESIS, V13, P629, DOI 10.1093/carcin/13.4.629; GRIVAS S, 1986, FOOD CHEM, V20, P127, DOI 10.1016/0308-8146(86)90149-4; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HASHIMOTO Y, 1980, BIOCHEM BIOPH RES CO, V96, P355, DOI 10.1016/0006-291X(80)91222-X; HASHIMOTO Y, 1982, J AM CHEM SOC, V104, P7636, DOI 10.1021/ja00390a040; HINO O, 1986, P NATL ACAD SCI USA, V83, P8338, DOI 10.1073/pnas.83.21.8338; HIROHASHI S, 1991, CANCER CELL-MON REV, V3, P49; HIRONO I, 1977, J NATL CANCER I, V58, P1155, DOI 10.1093/jnci/58.4.1155; HIRONO I, 1984, GANN, V75, P833; HORII A, 1992, CANCER RES, V52, P3231; IKEDA M, 1983, JPN J CANCER RES, V74, P640; ITO N, 1991, CARCINOGENESIS, V12, P1503, DOI 10.1093/carcin/12.8.1503; JAGERSTAD M, 1984, MUTAT RES, V126, P239, DOI 10.1016/0027-5107(84)90002-2; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KATO R, 1987, JPN J CANCER RES, V78, P297; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KNIZE MG, 1990, CARCINOGENESIS, V11, P2259, DOI 10.1093/carcin/11.12.2259; KOBAYASHI Y, 1990, JPN J CLIN ONCOL, V20, P128, DOI 10.1093/oxfordjournals.jjco.a039376; KOBAYASHI Y, 1991, JPN J CLIN ONCOL, V21, P233; KOSHY R, 1989, CURR TOP MICROBIOL, V144, P265; KUDO M, 1991, MOL CARCINOGEN, V4, P36, DOI 10.1002/mc.2940040107; KUROSAKA R, 1992, JPN J CANCER RES, V83, P919, DOI 10.1111/j.1349-7006.1992.tb02000.x; LOEB LA, 1990, MUTAT RES, V238, P297, DOI 10.1016/0165-1110(90)90021-3; MAKINO H, 1992, P NATL ACAD SCI USA, V89, P4850, DOI 10.1073/pnas.89.11.4850; MAKINO H, 1992, CANCER LETT, V62, P115, DOI 10.1016/0304-3835(92)90181-T; Nagao M, 1976, Adv Cancer Res, V23, P131, DOI 10.1016/S0065-230X(08)60545-X; NAGAOKA H, 1992, JPN J CANCER RES, V83, P1025, DOI 10.1111/j.1349-7006.1992.tb02716.x; NAKAHARA W, 1957, Gan, V48, P129; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; ODA T, COMMUNICATION; OHGAKI H, 1991, MUTAT RES, V259, P399, DOI 10.1016/0165-1218(91)90130-E; OVERVIK E, 1989, CARCINOGENESIS, V10, P2293, DOI 10.1093/carcin/10.12.2293; OVERVIK E, 1991, MUTAT RES, V256, P37, DOI 10.1016/0921-8734(91)90031-6; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; REDDY BS, 1986, CANCER RES, V46, P3367; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RONAI Z, 1992, ONCOL RES, V4, P45; RONAI Z, 1991, MOL CARCINOGEN, V4, P120, DOI 10.1002/mc.2940040207; SCHIFFMAN MH, 1990, AM J EPIDEMIOL, V131, P376, DOI 10.1093/oxfordjournals.aje.a115508; SHIMIZU H, 1987, JNCI-J NATL CANCER I, V78, P223; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; SNYDERWINE EG, 1988, CARCINOGENESIS, V9, P411, DOI 10.1093/carcin/9.3.411; SNYDERWINE EG, 1988, CARCINOGENESIS, V9, P1061, DOI 10.1093/carcin/9.6.1061; SUGIMURA T, 1966, NATURE, V210, P962, DOI 10.1038/210962b0; SUGIMURA T, 1982, CANCER, V49, P1970, DOI 10.1002/1097-0142(19820515)49:10<1970::AID-CNCR2820491005>3.0.CO;2-F; SUGIMURA T, 1986, SCIENCE, V233, P312, DOI 10.1126/science.3088728; SUGIMURA T, 1967, NATURE, V216, P943, DOI 10.1038/216943a0; SUGIMURA T, 1981, CARCINOGENESIS COMPR, V6; Sugimura T., 1977, ORIGINS HUMAN CANC, P1561; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAKAYAMA K, 1989, JPN J CANCER RES, V80, P1145, DOI 10.1111/j.1349-7006.1989.tb01644.x; TAMURA G, 1991, CANCER RES, V51, P3056; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; TSUDA H, 1988, GASTROENTEROLOGY, V95, P1664, DOI 10.1016/S0016-5085(88)80093-3; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; TSUDA M, 1985, MUTAT RES, V147, P335, DOI 10.1016/0165-1161(85)90002-0; TSUGANE S, 1990, INT J CANCER, V45, P436, DOI 10.1002/ijc.2910450310; UCHINO S, 1992, CANCER RES, V52, P3099; URANO Y, 1991, CANCER RES, V51, P1460; VANDERHOEVEN JCM, 1983, CARCINOGENESIS, V4, P1587, DOI 10.1093/carcin/4.12.1587; VANEGMOND HP, 1989, FOOD ADDIT CONTAM, V6, P139, DOI 10.1080/02652038909373773; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WAKABAYASHI K, 1992, CANCER RES, V52, pS2092; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; WATANABE S, 1989, JPN J CLIN ONCOL, V19, P178; WATANABE S, 1989, JPN J CLIN ONCOL, V19, P413; WATTENBERG LW, 1983, CANCER RES, V43, P2448; YAMADA H, 1986, JPN J CANCER RES, V77, P370; YAMAGATA K, 1956, HAKKO KOGAKU ZASSHI, V34, P378; YAMAGUCHI M, 1990, JPN J CLIN ONCOL, V20, P113; YAMAGUCHI N, 1992, JPN J CANCER RES, V83, P251, DOI 10.1111/j.1349-7006.1992.tb00096.x; YAMANAKA H, 1979, MUTAT RES, V68, P211, DOI 10.1016/0165-1218(79)90152-6; YAMASHITA K, 1990, JPN J CANCER RES, V81, P470, DOI 10.1111/j.1349-7006.1990.tb02593.x; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; YOKOTA J, 1988, ONCOGENE, V2, P607; YOSHIDA D, 1978, BIOCHEM BIOPH RES CO, V83, P915, DOI 10.1016/0006-291X(78)91482-1; 1990, ANN REPORT NATIONAL; 1991, VITAL STATISTICS 199; 1986, MORTALITY STATISTICS; [No title captured]	95	249	255	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	1992	258	5082					603	607		10.1126/science.1411570	http://dx.doi.org/10.1126/science.1411570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU745	1411570				2022-12-28	WOS:A1992JU74500047
J	SWARTZ, SM; BENNETT, MB; CARRIER, DR				SWARTZ, SM; BENNETT, MB; CARRIER, DR			WING BONE STRESSES IN FREE FLYING BATS AND THE EVOLUTION OF SKELETAL DESIGN FOR FLIGHT	NATURE			English	Article							INVIVO STRESS; HORSE EQUUS; STRAIN; MECHANICS; LOCOMOTION; RADIUS; SPEED; TIBIA; GAIT	THE primary mechanical functions of limb bones are to resist deformation, and hence provide stiff levers against which muscles can act, and to be sufficiently strong to prevent breaking under static or dynamic loads which arise from normal and accidental activities1. if bones perform these functions with a minimum amount of material, the energetic costs associated with building, maintaining and transporting the skeleton will be minimized2. Appropriate skeletal architecture for minimizing mass while maximizing strength depends on forces imposed on structural elements. In the evolutionary acquisition of flight in the bat lineage, the forelimb skeleton must have come to experience locomotor-forces that differed from those engendered by the terrestrial locomotion of non-flying bat relatives. Here we successfully measure in vivo strain on the wing bones of flying mammals. Our data demonstrate that torsion and shear are unique and crucial features of skeletal biomechanics during flight, and suggest that the evolution of skeletal design in bats and other flying vertebrates may be driven b the need to resist these loads.	UNIV QUEENSLAND, DEPT ANAT SCI, BRISBANE 4072, AUSTRALIA	University of Queensland	SWARTZ, SM (corresponding author), BROWN UNIV, PROGRAM ECOL & EVOLUT BIOL, PROVIDENCE, RI 02912 USA.		Bennett, Michael/L-4483-2019; Swartz, Sharon/B-9309-2011; Bennett, Michael/A-7218-2012	Bennett, Michael/0000-0001-8051-0040; Swartz, Sharon/0000-0001-5762-7435; 				ALEXANDER RM, 1981, SCI PROGRESS-UK, V67, P109; ALEXANDER RM, 1990, J ZOOL, V222, P471, DOI 10.1111/j.1469-7998.1990.tb04045.x; BERTRAM JEA, 1988, J THEOR BIOL, V131, P75, DOI 10.1016/S0022-5193(88)80122-X; BIEWENER AA, 1986, CALCIFIED TISSUE INT, V39, P390, DOI 10.1007/BF02555177; BIEWENER AA, 1986, J EXP BIOL, V123, P383; BIEWENER AA, 1983, J ZOOL, V201, P67, DOI 10.1111/j.1469-7998.1983.tb04261.x; BIEWENER AA, 1988, J ZOOL, V214, P547, DOI 10.1111/j.1469-7998.1988.tb03759.x; CARTER DR, 1978, J BIOMECH, V11, P199, DOI 10.1016/0021-9290(78)90013-1; CURREY JD, 1985, J ZOOL, V206, P453; Lanyon L E, 1976, Acta Orthop Belg, V42 Suppl 1, P98; Nordin M, 1989, BASIC BIOMECHANICS M, P3; PENNYCUICK CJ, 1967, J EXP BIOL, V46, P219; POUGH FH, 1985, VERTEBRATE LIFE; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Rayner J.M.V., 1987, P23; RUBIN CT, 1982, J EXP BIOL, V101, P187; RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4	17	137	139	8	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	1992	359	6397					726	729		10.1038/359726a0	http://dx.doi.org/10.1038/359726a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436035				2022-12-28	WOS:A1992JU65000055
J	BOITANO, S; DIRKSEN, ER; SANDERSON, MJ				BOITANO, S; DIRKSEN, ER; SANDERSON, MJ			INTERCELLULAR PROPAGATION OF CALCIUM WAVES MEDIATED BY INOSITOL TRISPHOSPHATE	SCIENCE			English	Article							INTRACELLULAR CA-2+; GAP-JUNCTIONS; MECHANICAL STIMULATION; CILIATED CELLS; OSCILLATIONS; COMMUNICATION; THAPSIGARGIN; ACTIVATION; GENERATION; MOBILIZATION	Two types of calcium (Ca2+) signaling-propagating intercellular Ca2+ waves of increasing intracellular Ca2+ concentration ([Ca2+]i) and nonpropagating oscillations in [Ca2+]i-co-exist in a variety of cell types. To investigate this difference in Ca2+ signaling, airway epithelial cells were loaded with heparin, an inositol 1,4,5-trisphosphate (IP3) receptor antagonist, by pulsed, high-frequency electroporation. Heparin inhibited propagation of intercellular Ca2+ waves but not oscillations of [Ca2+]i. In heparin-free cells, Ca2+ waves propagated through cells displaying [Ca2+]i oscillations. Depletion of intracellular Ca2+ pools with the Ca2+-pump inhibitor thapsigargin also inhibited the propagation of Ca2+ waves. These studies demonstrate that the release of Ca2+ by IP3 is necessary for the propagation of intercellular Ca2+ waves and suggest that IP3 moves through gap junctions to communicate intercellular Ca2+ waves.	UNIV CALIF LOS ANGELES,SCH MED,DEPT ANAT & CELL BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA								BENNETT MVL, 1988, GAP JUNCTIONS, P167; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BREHM P, 1989, NEURON, V3, P191, DOI 10.1016/0896-6273(89)90032-9; CHANG DC, 1989, ELECTROPORATION ELEC, P215; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; CHARLES AC, IN PRESS GLIA; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DEMER LL, UNPUB; ELY JA, 1991, J BIOL CHEM, V266, P18635; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; FOSKETT JK, 1991, J BIOL CHEM, V266, P2778; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTHRIE SC, 1989, TRENDS NEUROSCI, V12, P12, DOI 10.1016/0166-2236(89)90150-1; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; HILL TD, 1987, BIOCHEM BIOPH RES CO, V149, P897, DOI 10.1016/0006-291X(87)90492-X; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; PETERSEN OH, 1990, J MEMBRANE BIOL, V118, P93, DOI 10.1007/BF01868467; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SANDBERG K, 1992, J CELL BIOL, V117, P157, DOI 10.1083/jcb.117.1.157; SANDBERG K, 1990, SCIENCE, V249, P298, DOI 10.1126/science.2374929; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SANDERSON MJ, 1988, AM J PHYSIOL, V254, pC63, DOI 10.1152/ajpcell.1988.254.1.C63; SANDERSON MJ, 1986, P NATL ACAD SCI USA, V83, P7302, DOI 10.1073/pnas.83.19.7302; SNEYD J, UNPUB; SPRAY DC, 1985, ANNU REV PHYSIOL, V47, P281, DOI 10.1146/annurev.ph.47.030185.001433; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THASTRUP O, 1991, J BIOL CHEM, V266, P17067; TSE A, 1992, SCIENCE, V255, P462, DOI 10.1126/science.1734523; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WONG MMY, 1991, NATURE, V254, P1014; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; ZHENG Q, 1991, BIOCHIM BIOPHYS ACTA, V1088, P104, DOI 10.1016/0167-4781(91)90158-I	39	450	455	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					292	295		10.1126/science.1411526	http://dx.doi.org/10.1126/science.1411526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	1411526				2022-12-28	WOS:A1992JR86000032
J	KEANE, DP; ECKFORD, SD; SHEPHERD, AM; ABRAMS, P				KEANE, DP; ECKFORD, SD; SHEPHERD, AM; ABRAMS, P			REFERRAL PATTERNS AND DIAGNOSES IN WOMEN ATTENDING A URODYNAMIC UNIT	BRITISH MEDICAL JOURNAL			English	Article							INCONTINENCE				KEANE, DP (corresponding author), SOUTHMEAD GEN HOSP,URODYNAM UNIT,BRISTOL BS10 5NB,AVON,ENGLAND.							ABRAMS P, 1990, BRIT J OBSTET GYN  S, V6, P1; CARTER PG, 1991, BRIT J UROL, V67, P40, DOI 10.1111/j.1464-410X.1991.tb15066.x; SORENSEN S, 1988, SCAND J UROL NEPHR S, V114, P35; THOMAS TM, 1980, BRIT MED J, V281, P1243, DOI 10.1136/bmj.281.6250.1243; VERSI E, 1991, BRIT J OBSTET GYNAEC, V98, P815, DOI 10.1111/j.1471-0528.1991.tb13488.x	5	17	17	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 3	1992	305	6857					808	808		10.1136/bmj.305.6857.808	http://dx.doi.org/10.1136/bmj.305.6857.808			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT256	1422361	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JT25600022
J	WOLFF, JO				WOLFF, JO			PARENTS SUPPRESS REPRODUCTION AND STIMULATE DISPERSAL IN OPPOSITE-SEX JUVENILE WHITE-FOOTED MICE	NATURE			English	Article							INBREEDING AVOIDANCE; PEROMYSCUS-MANICULATUS; NATAL DISPERSAL; MAMMALS; LEUCOPUS; BIRDS; COMPETITION; RELATEDNESS; HYPOTHESIS; SUCCESS	JUVENILE dispersal is sex-biased in many mammals and birds: one sex often disperses more often or farther than the other. Two hypotheses are generally presented for sex-biased dispersal. The first holds that juvenile dispersal reduces reproductive and/or resource competition between parents and same-sexed offspring1-5. If so, presence of a parent on the natal home range should both promote dispersal of same-sex offspring and suppress reproduction of those that remain. The second is that juvenile dispersal reduces matings between parents and offspring6-10, thus decreasing the likelihood of inbreeding depression11-13. If so, presence of a parent should favour dispersal and reproductive suppression of offspring of the opposite sex. Here I present evidence that juvenile dispersal in white-footed mice, Peromyscus leucopus, is due to inbreeding avoidance. When population density was high, experimental removal of one parent delayed dispersal of opposite-sexed offspring and only the presence of the parents of opposite sex suppressed juvenile reproduction.	US EPA,CORVALLIS,OR 97333	United States Environmental Protection Agency	WOLFF, JO (corresponding author), OREGON STATE UNIV,DEPT FISHERIES & WILDLIFE,NASH HALL 104,CORVALLIS,OR 97331, USA.							Anderson P.K, 1989, DISPERSAL RODENTS RE; CLUTTONBROCK TH, 1989, NATURE, V337, P70, DOI 10.1038/337070a0; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAIGH GR, 1983, J MAMMAL, V64, P48, DOI 10.2307/1380749; HARVEY PH, 1986, NATURE, V320, P675; HESTBECK JB, 1982, OIKOS, V39, P157, DOI 10.2307/3544480; HOAGLAND JL, 1979, SCIENCE, V215, P1639; HOLZENBEIN S, 1992, J WILDLIFE MANAGE, V56, P147, DOI 10.2307/3808802; KEANE B, 1990, ANIM BEHAV, V39, P264, DOI 10.1016/S0003-3472(05)80870-X; KOENIG WD, 1979, SCIENCE, V206, P1103, DOI 10.1126/science.206.4422.1103; LIBERG P, 1986, AM NAT, V126, P129; MARKS JS, 1987, AM NAT, V129, P158, DOI 10.1086/284627; MCCRAVY KW, 1992, J MAMMAL, V73, P151, DOI 10.2307/1381877; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; PACKER C, 1985, ANIM BEHAV, V33, P676, DOI 10.1016/S0003-3472(85)80096-8; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Ralls K., 1986, P35; WASER PM, 1985, ECOLOGY, V66, P1170, DOI 10.2307/1939169; Wolff J.O., 1989, P271; Wolff JO, 1991, BEHAV ECOL, V2, P38, DOI 10.1093/beheco/2.1.38; WOLFF JO, 1985, CAN J ZOOL, V63, P2657, DOI 10.1139/z85-397; WOLFF JO, 1988, ANIM BEHAV, V36, P456, DOI 10.1016/S0003-3472(88)80016-2; WOLFF JO, 1983, BEHAV ECOL SOCIOBIOL, V12, P237, DOI 10.1007/BF00290776; WOLFF JO, 1985, CAN J ZOOL, V63, P1548, DOI 10.1139/z85-230; WOLFF JO, 1986, VA J SCI, V37, P209	27	129	131	0	27	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 1	1992	359	6394					409	410		10.1038/359409a0	http://dx.doi.org/10.1038/359409a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ624	1406952				2022-12-28	WOS:A1992JQ62400053
J	ANNAS, GJ				ANNAS, GJ			ADDING INJUSTICE TO INJURY - COMPULSORY PAYMENT FOR UNWANTED TREATMENT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Annas, George/0000-0001-5836-7831				ANNAS GJ, 1988, HASTINGS CENT REP, V18, P31, DOI 10.2307/3563046; ANNAS GJ, 1991, NEW ENGL J MED, V324, P1210, DOI 10.1056/NEJM199104253241711; BELKIN L, 1992, NY TIMES        0924, pA16; MENIKOFF JA, 1992, NEW ENGL J MED, V327, P1165, DOI 10.1056/NEJM199210153271612; 1992, OTHERS MUST CHOOSE D; 1987, LIFE SUSTAINING TREA	6	3	3	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	1992	327	26					1885	1887		10.1056/NEJM199212243272615	http://dx.doi.org/10.1056/NEJM199212243272615			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KD714	1448133				2022-12-28	WOS:A1992KD71400026
J	FUGHBERMAN, A; EPSTEIN, S				FUGHBERMAN, A; EPSTEIN, S			SHOULD HEALTHY WOMEN TAKE TAMOXIFEN	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							CARDIOVASCULAR RISK; SERUM-LIPOPROTEINS		UNIV ILLINOIS,SCH PUBL HLTH,CHICAGO,IL 60612	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	FUGHBERMAN, A (corresponding author), NATL WOMENS HLTH NETWORK,WASHINGTON,DC 20005, USA.							BRUNING PF, 1988, BRIT J CANCER, V58, P497, DOI 10.1038/bjc.1988.248; BUSH TL, 1988, CLIN CHEM, V34, pB60; LOVE RR, 1991, ANN INTERN MED, V115, P860, DOI 10.7326/0003-4819-115-11-860; MCDONALD CC, 1991, BRIT MED J, V303, P435, DOI 10.1136/bmj.303.6800.435; ROSSNER S, 1984, ATHEROSCLEROSIS, V52, P339, DOI 10.1016/0021-9150(84)90064-9	5	8	8	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1596	1596						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435889				2022-12-28	WOS:A1992JZ43200012
J	ANDERSON, DC; STIEHM, ER				ANDERSON, DC; STIEHM, ER			IMMUNIZATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT PEDIAT,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles	ANDERSON, DC (corresponding author), UPJOHN CO,DISCOVERY RES,KALAMAZOO,MI 49001, USA.							[Anonymous], MMWR MORB MORTAL WKL; ELLIS EF, 1969, J ALLERGY, V43, P45, DOI 10.1016/0021-8707(69)90019-7; PETER G, 1991, REPORT COMMITTEE INF; STIEHM ER, 1992, TXB PEDIAT INFECT DI, P2261; 1989, MMWR, V38, P205; 1984, MMWR, V33, P393; 1991, MMWR, V40, P1; 1984, MMWR, V33, P24; 1990, MMWR, V40, P730; 1990, MMWR, V39, P1	10	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2959	2963		10.1001/jama.268.20.2959	http://dx.doi.org/10.1001/jama.268.20.2959			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433715				2022-12-28	WOS:A1992JY66800024
J	BOH, EE; MILLIKAN, LE				BOH, EE; MILLIKAN, LE			VESICULOBULLOUS DISEASES WITH PROMINENT IMMUNOLOGICAL FEATURES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; EPIDERMOLYSIS-BULLOSA-ACQUISITA; BASEMENT-MEMBRANE; PEMPHIGUS; ACANTHOLYSIS; PATHOGENESIS; ANTIBODIES; ERUPTION; ANTIGEN; SKIN				BOH, EE (corresponding author), TULANE UNIV, SCH MED, DEPT DERMATOL, NEW ORLEANS, LA 70112 USA.							BOH E, 1990, J AM ACAD DERMATOL, V22, P587, DOI 10.1016/0190-9622(90)70077-U; BORK K, 1988, CUTANEOUS SIDE EFFEC, P121; CAMISA C, 1988, J AM ACAD DERMATOL, V18, P93, DOI 10.1016/S0190-9622(88)70014-6; FELIX RH, 1974, BRIT MED J, V4, P321, DOI 10.1136/bmj.4.5940.321; GAMMON WR, 1985, J INVEST DERMATOL, V84, P472, DOI 10.1111/1523-1747.ep12272402; GAMMON WR, 1984, J INVEST DERMATOL, V82, P139, DOI 10.1111/1523-1747.ep12259692; GAMMON WR, 1983, J INVEST DERMATOL, V81, P320, DOI 10.1111/1523-1747.ep12519602; HALL RP, 1987, J AM ACAD DERMATOL, V16, P1129, DOI 10.1016/S0190-9622(87)70148-0; KAWANA S, 1986, J INVEST DERMATOL, V86, P29, DOI 10.1111/1523-1747.ep12283762; KETTLER AH, 1988, ARCH DERMATOL, V124, P1083, DOI 10.1001/archderm.124.7.1083; LJUNGHALL K, 1983, ARCH DERMATOL, V119, P970, DOI 10.1001/archderm.119.12.970; MARKS J, 1966, LANCET, V2, P1280; MICHEL B, 1977, BRIT J DERMATOL, V96, P295, DOI 10.1111/j.1365-2133.1977.tb06141.x; MONDINO BJ, 1972, CLIN DERMATOL, V106, P819; NEMETH AJ, 1991, ARCH DERMATOL, V127, P378, DOI 10.1001/archderm.127.3.378; ROENIGK HH, 1971, ARCH DERMATOL, V103, P1, DOI 10.1001/archderm.103.1.1; SAMS WM, 1982, J AM ACAD DERMATOL, V6, P431, DOI 10.1016/S0190-9622(82)70036-2; SCHILTZ JR, 1976, J INVEST DERMATOL, V67, P254, DOI 10.1111/1523-1747.ep12513454; SHORNICK JK, 1983, J AM ACAD DERMATOL, V8, P214, DOI 10.1016/S0190-9622(83)70027-7; SHORNICK JK, 1992, J AM ACAD DERMATOL, V26, P63, DOI 10.1016/0190-9622(92)70008-4; SHORNICK JK, 1981, J CLIN INVEST, V68, P553, DOI 10.1172/JCI110287; STANLEY R, 1986, J INVEST DERMATOL, V87, P1201; THOMSEN K, 1976, BRIT J DERMATOL, V95, P568, DOI 10.1111/j.1365-2133.1976.tb00873.x; WOODLEY DT, 1986, J INVEST DERMATOL, V86, P668, DOI 10.1111/1523-1747.ep12275978	24	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2893	2898		10.1001/jama.268.20.2893	http://dx.doi.org/10.1001/jama.268.20.2893			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433705				2022-12-28	WOS:A1992JY66800013
J	HORAN, RF; SCHNEIDER, LC; SHEFFER, AL				HORAN, RF; SCHNEIDER, LC; SHEFFER, AL			ALLERGIC SKIN DISORDERS AND MASTOCYTOSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATOPIC-DERMATITIS; DEFICIENCY; URTICARIA; INHIBITOR		BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA; NEW ENGLAND DEACONESS HOSP, ALLERGY SECT, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; CHILDRENS HOSP MED CTR, DIV IMMUNOL, ALLERGY PROGRAM, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	HORAN, RF (corresponding author), HARVARD UNIV, SCH MED, DEPT DERMATOL, BOSTON, MA 02115 USA.							ALSENZ J, 1987, NEW ENGL J MED, V316, P1360, DOI 10.1056/NEJM198705283162202; CHAMPION RH, 1988, BRIT J DERMATOL, V119, P427, DOI 10.1111/j.1365-2133.1988.tb03246.x; CHAMPION RH, 1969, BRIT J DERMATOL, V81, P588, DOI 10.1111/j.1365-2133.1969.tb16041.x; CLARK RAF, 1989, J AM ACAD DERMATOL, V21, P863, DOI 10.1016/S0190-9622(89)70269-3; CRADDOCK PR, 1977, NEW ENGL J MED, V296, P769, DOI 10.1056/NEJM197704072961401; Fisher A, 1973, CONTACT DERMATITIS; GEHA RS, 1985, NEW ENGL J MED, V312, P534, DOI 10.1056/NEJM198502283120902; GOREVIC PD, 1980, INT J DERMATOL, V19, P417, DOI 10.1111/j.1365-4362.1980.tb05893.x; HANIFIN JM, 1980, ACTA DERM-VENEREOL S, V92, P44, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]; HJORTH N, 1979, TXB DERMATOLOGY, pCH14; HORAN RF, 1991, J INVEST DERMATOL, V96, pS5, DOI 10.1111/1523-1747.ep12468899; KOHLER PF, 1973, MEDICINE, V52, P419, DOI 10.1097/00005792-197309000-00006; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; Lever W. F., 1990, HISTOPATHOLOGY SKIN; METCALFE DD, 1991, J INVEST DERMATOL, V96, pS2, DOI 10.1111/1523-1747.ep12468882; MONROE EW, 1980, MED CLIN N AM, V64, P867, DOI 10.1016/S0025-7125(16)31571-1; PARKER RI, 1991, J INVEST DERMATOL, V96, pS47, DOI 10.1111/1523-1747.ep12469034; REINHOLD U, 1989, ACTA DERM-VENEREOL, V69, P497; ROSEN FS, 1971, J CLIN INVEST, V50, P2143, DOI 10.1172/JCI106708; SAMPSON HA, 1985, J PEDIATR-US, V107, P669, DOI 10.1016/S0022-3476(85)80390-5; SHEFFER AL, 1987, J ALLERGY CLIN IMMUN, V80, P855, DOI 10.1016/S0091-6749(87)80277-4; SHEFFER AL, 1984, J ALLERGY CLIN IMMUN, V73, P699, DOI 10.1016/0091-6749(84)90309-9; SOTER NA, 1991, J INVEST DERMATOL, V96, pS32, DOI 10.1111/1523-1747.ep12468973; SOTER NA, 1977, NEW ENGL J MED, V296, P1440, DOI 10.1056/NEJM197706232962505; TRASK DM, 1988, J INVEST DERMATOL, V90, P526, DOI 10.1111/1523-1747.ep12461047; VERCELLI D, 1991, J ALLERGY CLIN IMMUN, V88, P285, DOI 10.1016/0091-6749(91)90087-5; WADE JP, 1989, PRAGUE CLIN BIOL RES, V297, P157	27	31	32	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2858	2868		10.1001/jama.268.20.2858	http://dx.doi.org/10.1001/jama.268.20.2858			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433701				2022-12-28	WOS:A1992JY66800009
J	ZWEIMAN, B; LEVINSON, AI				ZWEIMAN, B; LEVINSON, AI			IMMUNOLOGICAL ASPECTS OF NEUROLOGICAL AND NEUROMUSCULAR DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUILLAIN-BARRE-SYNDROME; POLYMYOSITIS-DERMATOMYOSITIS; MULTIPLE-SCLEROSIS; ENCEPHALITIS; COMPLEMENT; ANTIGEN; SYSTEM; CELLS; MS		UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104	University of Pennsylvania	ZWEIMAN, B (corresponding author), UNIV PENN,SCH MED,DEPT MED,DIV ALLERGY,PHILADELPHIA,PA 19104, USA.							ALBERS JW, 1989, MUSCLE NERVE, V12, P435, DOI 10.1002/mus.880120602; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; BERGER JR, 1987, ANN INTERN MED, V107, P119; CALDER V, 1989, IMMUNOL TODAY, V10, P99, DOI 10.1016/0167-5699(89)90235-1; CHUNG IY, 1990, J IMMUNOL, V144, P2999; DHIBJALBUT S, 1990, ANN ALLERGY, V64, P433; DICKEY BF, 1984, SEMIN ARTHRITIS RHEU, V14, P60, DOI 10.1016/0049-0172(84)90010-6; FONTANA A, 1987, IMMUNOL REV, V100, P185, DOI 10.1111/j.1600-065X.1987.tb00532.x; FUDMAN EJ, 1986, SEMIN ARTHRITIS RHEU, V15, P255, DOI 10.1016/0049-0172(86)90021-1; FURNEAUX HF, 1990, NEUROLOGY, V40, P1085, DOI 10.1212/WNL.40.7.1085; GRIFFIN DE, 1990, RES P ARNMD, V68, P91; GRUNWALD GB, 1987, CANCER, V60, P780, DOI 10.1002/1097-0142(19870815)60:4<780::AID-CNCR2820600413>3.0.CO;2-9; HAFLER DA, 1989, IMMUNOL TODAY, V10, P104, DOI 10.1016/0167-5699(89)90236-3; HAUPT HM, 1982, AM J CARDIOL, V50, P998, DOI 10.1016/0002-9149(82)90408-8; HOHFELD R, 1991, NEW ENGL J MED, V324, P877; JOHNSON RT, 1987, J INFECT DIS, V155, P359, DOI 10.1093/infdis/155.3.359; KALOVIDOURIS AE, 1989, ARTHRITIS RHEUM, V32, P446, DOI 10.1002/anr.1780320414; KISSEL JT, 1986, NEW ENGL J MED, V314, P329, DOI 10.1056/NEJM198602063140601; KOSKI CL, 1989, J CLIN INVEST, V84, P280, DOI 10.1172/JCI114152; LEVINSON AI, 1987, J CLIN IMMUNOL, V7, P187, DOI 10.1007/BF00915723; LUQUE FA, 1991, ANN NEUROL, V29, P241, DOI 10.1002/ana.410290303; MYERS LW, 1990, NEUROL CLIN, V8, P119, DOI 10.1016/S0733-8619(18)30376-1; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; PLOTZ PH, 1989, ANN INTERN MED, V111, P100; SAIDA T, 1982, ANN NEUROL, V11, P69, DOI 10.1002/ana.410110112; WHITAKER JN, 1972, NEW ENGL J MED, V286, P333, DOI 10.1056/NEJM197202172860701; ZWEIMAN B, 1988, J ALLERGY CLIN IMMUN, V81, P1067, DOI 10.1016/0091-6749(88)90868-8	27	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2918	2922						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433709				2022-12-28	WOS:A1992JY66800017
J	SCHARSCHMIDT, BF; HELD, MJ; HOLLANDER, HH; READ, AE; LAVINE, JE; VEEREMAN, G; MCGUIRE, RF; THALER, MM				SCHARSCHMIDT, BF; HELD, MJ; HOLLANDER, HH; READ, AE; LAVINE, JE; VEEREMAN, G; MCGUIRE, RF; THALER, MM			HEPATITIS-B IN PATIENTS WITH HIV-INFECTION - RELATIONSHIP TO AIDS AND PATIENT SURVIVAL	ANNALS OF INTERNAL MEDICINE			English	Note						HEPATITIS-B; HUMAN IMMUNODEFICIENCY VIRUS; ACQUIRED IMMUNODEFICIENCY SYNDROME	HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; HOMOSEXUAL MEN; PREVALENCE	Hepatitis B virus (HBV) infection is common in patients infected with human immunodeficiency virus (HIV). Experimental evidence suggests that chronic HBV infection may accelerate the course of HIV-related disease, but clinical data are lacking. Therefore, we assessed the relationship of serologic markers for HBV infection to the presence of AIDS and length of survival in 511 patients with HIV infection, 233 (46%) of whom had AIDS. Hepatitis B virus markers were more prevalent in patients with AIDS (89%) than in those without AIDS (80%; P < 0.02). Among the various markers, anti-HBs did not differ between the groups (62% compared with 61%), whereas HBsAg, a marker of chronic infection, was more than twice as common in the AIDS group (10.7% compared with 4.7%; P < 0.02). Survival was shorter in patients with AIDS than in patients without AIDS but was not influenced in either group by the presence of HBsAg. These findings indicate that chronic HBV infection among HIV-infected patients is more prevalent in patients with AIDS than those without AIDS, and that this association probably reflects a manifestation of AIDS rather than an effect of HBV on progression of HIV-related disease.			SCHARSCHMIDT, BF (corresponding author), UNIV CALIF SAN FRANCISCO, DIV GASTROENTEROL, 1120 HSW, SAN FRANCISCO, CA 94143 USA.				NIADDK NIH HHS [AM 26740] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		COX DR, 1972, J R STAT SOC B, V34, P187; HIRSCHMAN SZ, 1988, J MED VIROL, V26, P145, DOI 10.1002/jmv.1890260206; HOMANN C, 1991, J ACQ IMMUN DEF SYND, V4, P416; HOUGHTON J, 1989, CLIN RES, V37, pA368; OUATTARA SA, 1990, J ACQ IMMUN DEF SYND, V3, P282; PERRILLO RP, 1986, ANN INTERN MED, V105, P382, DOI 10.7326/0003-4819-105-3-382; SCHREEDER MT, 1982, J INFECT DIS, V146, P7, DOI 10.1093/infdis/146.1.7; SETO E, 1988, P NATL ACAD SCI USA, V85, P8286, DOI 10.1073/pnas.85.21.8286; TWU JS, 1989, P NATL ACAD SCI USA, V86, P5168, DOI 10.1073/pnas.86.13.5168	9	83	84	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					837	838		10.7326/0003-4819-117-10-837	http://dx.doi.org/10.7326/0003-4819-117-10-837			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416559				2022-12-28	WOS:A1992JX83800007
J	HARTWELL, L				HARTWELL, L			DEFECTS IN A CELL-CYCLE CHECKPOINT MAY BE RESPONSIBLE FOR THE GENOMIC INSTABILITY OF CANCER-CELLS	CELL			English	Review							GENE AMPLIFICATION				HARTWELL, L (corresponding author), UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195, USA.							ALAMO I, 1991, MOL CELL BIOL, V11, P1009; PARSHAD R, 1985, P NATL ACAD SCI USA, V82, P5400, DOI 10.1073/pnas.82.16.5400; PETERSON RDA, 1992, LEUKEMIA, V6, P8; REID BJ, 1992, GASTROENTEROLOGY, V102, P1212; ROWLEY R, 1992, EMBO J, V11, P1335, DOI 10.1002/j.1460-2075.1992.tb05178.x; SCHIMKE RT, 1988, J BIOL CHEM, V263, P5989; Shiloh Y, 1985, Kroc Found Ser, V19, P111; SMITH KA, 1990, CELL, V63, P1219, DOI 10.1016/0092-8674(90)90417-D; TLSTY TD, 1989, P NATL ACAD SCI USA, V86, P9441, DOI 10.1073/pnas.86.23.9441; TLSTY TD, 1992, SCIENCE, V255, P1425, DOI 10.1126/science.1542791; TOLEDO F, 1992, MUTAT RES, V276, P261, DOI 10.1016/0165-1110(92)90012-X; TOLEDO F, 1992, EMBO J, V11, P2665, DOI 10.1002/j.1460-2075.1992.tb05332.x; TRASK BJ, 1989, GENE DEV, V3, P1913, DOI 10.1101/gad.3.12a.1913; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; WRIGHT JA, 1990, P NATL ACAD SCI USA, V87, P1791, DOI 10.1073/pnas.87.5.1791; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	19	790	818	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					543	546		10.1016/0092-8674(92)90586-2	http://dx.doi.org/10.1016/0092-8674(92)90586-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423612				2022-12-28	WOS:A1992JY67600001
J	LIM, MJ; BARKAN, AL; BUDA, AJ				LIM, MJ; BARKAN, AL; BUDA, AJ			RAPID REDUCTION OF LEFT-VENTRICULAR HYPERTROPHY IN ACROMEGALY AFTER SUPPRESSION OF GROWTH-HORMONE HYPERSECRETION	ANNALS OF INTERNAL MEDICINE			English	Article						ACROMEGALY; VENTRICULAR FUNCTION, LEFT; HEART ENLARGEMENT; SOMATOTROPIN; OCTREOTIDE	M-MODE ECHOCARDIOGRAPHY; SOMATOMEDIN-C LEVELS; HYPERTENSIVE PATIENTS; HEART; PITUITARY; REGRESSION; RATS; SMS-201-995; THERAPY; TUMORS	Objective: To examine the possible role of growth hormone as a pathogenetic factor in the development of myocardial hypertrophy in acromegaly. Design: An uncontrolled clinical trial. Setting: Tertiary-care medical center. Patients: Sixteen patients with acromegaly were stratified into two groups: Group I (n = 10) had left ventricular hypertrophy (LVH), and group II (n = 6) did not have LVH. Intervention: Therapy with octreotide acetate (SMS 201-995), a long-acting somatostatin analog (mean dose, 538 mug/d), was administered for 2 months. Measurements: Plasma growth hormone and insulin-like growth factor I (IGF-I) concentrations, hand volume, and echocardiographic left ventricular dimensions and mass were measured at baseline and at 1 week and 2 months after the start of therapy. Results: Before octreotide therapy, both groups had similar hand volumes and similar growth hormone and IGF-I hypersecretion. Both groups showed a reduction in growth hormone at 2 months (mean reduction, 13.7 mug/L in patients with LVH [P < 0.01 ] and 14.1 mug/L in patients without LVH [P < 0.05]). Plasma IGF-I was also decreased (mean reduction, 305 mug/L in patients with LVH [P < 0.01] and 304 mug/L in patients without LVH [P < 0.05]). Reduction of growth hormone and IGF-I hypersecretion in patients with LVH was associated with a rapid decrease in left ventricular mass (339 g to 299 g, P < 0.01) within 1 week, which was sustained at 2 months (274 g, P < 0.04). Patients without LVH showed no statistical change in left ventricular mass. In patients with LVH, the decrease in left ventricular mass correlated with the octreotide-induced decrease in growth hormone (r = 0.79, P < 0.05) but not with blood pressure. Blood pressure, left ventricular dimensions, and percent of fractional shortening were not altered by therapy in either group. Hand volume decreased in both groups. Conclusions: Normalization of growth hormone secretion is associated with reduction of left ventricular mass in acromegalic patients with LVH within 1 week of initiating therapy with octreotide.	TULANE UNIV, SCH MED, CARDIOL SECT, 1430 TULANE AVE, NEW ORLEANS, LA 70112 USA; UNIV MICHIGAN, SCH MED, ANN ARBOR, MI 48104 USA	Tulane University; University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038449] Funding Source: NIH RePORTER; NCRR NIH HHS [5MO-1-RR-42] Funding Source: Medline; NIDDK NIH HHS [R29-DK 38449] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARKAN AL, 1988, J CLIN ENDOCR METAB, V66, P16, DOI 10.1210/jcem-66-1-16; BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X; CHANSON P, 1990, ANN INTERN MED, V113, P921, DOI 10.7326/0003-4819-113-12-921; CSANADY M, 1983, INT J CARDIOL, V2, P349, DOI 10.1016/0167-5273(83)90006-2; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DUNN FG, 1987, CIRCULATION, V76, P254, DOI 10.1161/01.CIR.76.2.254; FEEK CM, 1984, CLIN ENDOCRINOL, V20, P401, DOI 10.1111/j.1365-2265.1984.tb03435.x; FOUADTARAZI FM, 1987, HYPERTENSION, V9, P65; FURLANETTO RW, 1977, J CLIN INVEST, V60, P648, DOI 10.1172/JCI108816; GIANNELLANETO D, 1988, J ENDOCRINOL INVEST, V11, P57, DOI 10.1007/BF03350100; GILBERT PL, 1985, J MOL CELL CARDIOL, V17, P805, DOI 10.1016/S0022-2828(85)80042-0; GLASSER SP, 1989, J CLIN PHARMACOL, V29, P791, DOI 10.1002/j.1552-4604.1989.tb03421.x; JORGENSEN KD, 1987, ACTA ENDOCRINOL-COP, V114, P124; LAMBERTS SWJ, 1987, J CLIN ENDOCR METAB, V65, P703, DOI 10.1210/jcem-65-4-703; LAMBERTS SWJ, 1985, NEW ENGL J MED, V313, P1576, DOI 10.1056/NEJM198512193132504; LAMBERTS SWJ, 1988, HORM RES, V29, P115, DOI 10.1159/000180984; LAYTON MW, 1988, ARTHRITIS RHEUM, V31, P1022, DOI 10.1002/art.1780310813; LEI LQ, 1988, LAB INVEST, V59, P357; LIE JT, 1980, AM HEART J, V100, P41, DOI 10.1016/0002-8703(80)90277-X; MARTINS JB, 1977, CIRCULATION, V56, P863, DOI 10.1161/01.CIR.56.5.863; MATHER HM, 1979, BRIT HEART J, V41, P697; MCGUFFIN WL, 1974, ANN INTERN MED, V81, P11, DOI 10.7326/0003-4819-81-1-11; MELMED S, 1990, NEW ENGL J MED, V322, P966, DOI 10.1056/NEJM199004053221405; NABARRO JDN, 1987, CLIN ENDOCRINOL, V26, P481, DOI 10.1111/j.1365-2265.1987.tb00805.x; PETERSON ME, 1990, J VET INTERN MED, V4, P192, DOI 10.1111/j.1939-1676.1990.tb00897.x; PRYSORJONES RA, 1980, J ENDOCRINOL, V85, P75, DOI 10.1677/joe.0.0850075; ROSS DA, 1988, J NEUROSURG, V68, P854, DOI 10.3171/jns.1988.68.6.0854; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SASSOLAS G, 1989, HORM RES, V31, P51, DOI 10.1159/000181086; SAVAGE DD, 1979, AM J MED, V67, P823, DOI 10.1016/0002-9343(79)90742-3; SMALLRIDGE RC, 1979, AM J MED, V66, P22, DOI 10.1016/0002-9343(79)90477-7; STEVENSON JG, 1984, J AM COLL CARDIOL, V4, P1021; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; THUESEN L, 1988, ACTA MED SCAND, V223, P337; TURNER JD, 1988, AM J PHYSIOL, V255, pE513, DOI 10.1152/ajpendo.1988.255.4.E513; WASS JA, 1982, CLIN ENDOCRINOL, V96, P56; WRIGHT AD, 1970, Q J MED, V39, P1	38	87	89	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					719	726		10.7326/0003-4819-117-9-719	http://dx.doi.org/10.7326/0003-4819-117-9-719			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416573				2022-12-28	WOS:A1992JV42400003
J	FORSTER, P				FORSTER, P			SEXUAL HARASSMENT AT WORK	BRITISH MEDICAL JOURNAL			English	Article											FORSTER, P (corresponding author), BRITISH MED ASSOC,NW REG OFF,MANCHESTER M20 8RX,ENGLAND.							LEONARD A, 1991, NEW LAW J       1108, P1514; MEGRANAHAN M, 1989, COUNSELLING PRACTICA, P116; RUBENSTEIN M, 1991, PERSONNEL MANAGE FEB, P55; RUBENSTEIN M, 1988, V4121087 OFF OFF PUB; RUSENSTEIN M, 1988, COMV4121087 OFF OFF; 1992, NHS HSME ALGC292 MAN; 1988, SEXUAL HARASSMENT FE; 1992, 513 IND REL SERV IND; EC76207 DIR; 1992, SEXUAL HARASSMENT WO; 1992, NHS NHSME GC292 MAN; 1991, CA2625 EUR COMM DOC	12	3	3	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 17	1992	305	6859					944	946		10.1136/bmj.305.6859.944	http://dx.doi.org/10.1136/bmj.305.6859.944			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JU649	1458078	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JU64900027
J	GILEADI, O; FEAVER, WJ; KORNBERG, RD				GILEADI, O; FEAVER, WJ; KORNBERG, RD			CLONING OF A SUBUNIT OF YEAST RNA POLYMERASE-II TRANSCRIPTION FACTOR-B AND CTD KINASE	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; PURIFICATION; PHOSPHORYLATION; INITIATION; PROMOTER; DNA; DOMAIN; BETA	Yeast RNA polymerase II initiation factor b copurifies with three polypeptides of 85,73, and 50 kilodaltons and with a protein kinase that phosphorylates the carboxyl-terminal repeat domain (CTD) of the largest polymerase subunit. The gene that encodes the 73-kilodalton polypeptide, designated TFB1, was cloned and found to be essential for cell growth. The deduced protein sequence exhibits no similarity to those of protein kinases. However, the sequence is similar to that of the 62-kilodalton subunit of the HeLa transcription factor BTF2, suggesting that this factor is the human counterpart of yeast factor b. Immunoprecipitation experiments using antibodies to the TFB1 gene product demonstrate that the transcriptional and CTD kinase activities of factor b are closely associated with an oligomer of the three polypeptides. Photoaffinity labeling with 3'-O-(4-benzoyl)benzoyl-ATP (adenosine triphosphate) identified an ATP-binding site in the 85-kilodalton polypeptide, suggesting that the 85-kilodalton subunit contains the catalytic domain of the kinase.			GILEADI, O (corresponding author), STANFORD UNIV,MED CTR,SCH MED,SHERMAN FAIRCHILD CTR,DEPT CELL BIOL,STANFORD,CA 94305, USA.		Gileadi, Opher/F-1105-2013	Gileadi, Opher/0000-0001-6886-898X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036659, R01GM036659] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-36659] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIAS JA, 1991, J BIOL CHEM, V266, P8055; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; CONAWAY RC, 1991, P NATL ACAD SCI USA, V88, P6205, DOI 10.1073/pnas.88.14.6205; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; FEAVER WJ, 1991, J BIOL CHEM, V266, P19000; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; FISCHER L, 1992, SCIENCE, V257, P1392, DOI 10.1126/science.1529339; FLANAGAN PM, IN PRESS P NATL ACAD; GERARD M, 1991, J BIOL CHEM, V266, P20940; GILEADI O, UNPUB; HARLOW E, 1988, ANTIBODIES LABORATOR; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; LEE JM, 1991, GENE EXPRESSION, V1, P149; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; LIM R, 1990, P NATL ACAD SCI USA, V87, P5233, DOI 10.1073/pnas.87.14.5233; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SERIZAWA H, IN PRESS P NATL ACAD; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; WILLIAMS N, 1986, METHOD ENZYMOL, V126, P667	23	71	73	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 4	1992	257	5075					1389	1392		10.1126/science.1445600	http://dx.doi.org/10.1126/science.1445600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JL612	1445600				2022-12-28	WOS:A1992JL61200030
J	JONES, DJ; IRVING, MH				JONES, DJ; IRVING, MH			ABC OF COLORECTAL DISEASES - INVESTIGATION OF COLORECTAL DISORDERS	BRITISH MEDICAL JOURNAL			English	Article											JONES, DJ (corresponding author), HOPE HOSP,DEPT GEN SURG,SALFORD M6 8HD,LANCS,ENGLAND.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 11	1992	304	6832					974	977		10.1136/bmj.304.6832.974	http://dx.doi.org/10.1136/bmj.304.6832.974			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP064	1445526	Bronze, Green Published			2022-12-28	WOS:A1992HP06400030
J	LAUERSEN, NH				LAUERSEN, NH			TREATMENT OF PRETERM LABOR WITH THE BETA-ADRENERGIC AGONIST RITODRINE	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter																		LAUERSEN NH, 1977, AM J OBSTET GYNECOL, V127, P837, DOI 10.1016/0002-9378(77)90115-6; POLOWCZYK D, 1984, OBSTET GYNECOL, V64, P485	2	3	3	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	1992	327	24					1759	1759						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA897	1435926				2022-12-28	WOS:A1992KA89700020
J	BOUVIER, M; SZATKOWSKI, M; AMATO, A; ATTWELL, D				BOUVIER, M; SZATKOWSKI, M; AMATO, A; ATTWELL, D			THE GLIAL-CELL GLUTAMATE UPTAKE CARRIER COUNTERTRANSPORTS PH-CHANGING ANIONS	NATURE			English	Article							RAT-BRAIN; ASPARTATE; RECEPTORS; COTRANSPORT; CALIBRATION; CEREBELLUM; TRANSPORT; POTASSIUM; RELEASE; NEURONS	UPTAKE into glial cells helps to terminate glutamate's neurotransmitter action and to keep its extracellular concentration, [Glu]o, below neurotoxic levels. The accumulative power of the uptake carrier stems from its transport of inorganic ions such as sodium (into the cell) and potassium (out of the cell)1-3. There is controversy over whether the carrier also transports a proton (or pH-changing anion)4,5. Here we show that the carrier generates an alkalinization outside and an acidification inside glial cells, and transports anions out of the cells, suggesting that there is a carrier cycle in which two Na+ accompany each glutamate anion into the cell, while one K+ and one OH- (or HCO3-) are transported out. This stoichiometry predicts a minimum [Glu]o of 0.6 muM normally (tonically activating presynaptic autoreceptors and postsynaptic NMDA receptors), and 370 muM during brain anoxia (high enough to kill neurons). Transport of OH-/HCO3- on the uptake carrier generates significant pH changes, and may provide a mechanism for neuron-glial interaction.	IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT PHYSIOL & BIOPHYS,LONDON W2 1PG,ENGLAND	Imperial College London	BOUVIER, M (corresponding author), UNIV LONDON UNIV COLL,DEPT PHYSIOL,GOWER ST,LONDON WC1E 6BT,ENGLAND.		Attwell, David/ABE-6750-2020		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; BERGER SJ, 1977, J NEUROCHEM, V28, P149, DOI 10.1111/j.1471-4159.1977.tb07720.x; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CHAILLET JR, 1985, J GEN PHYSIOL, V86, P765, DOI 10.1085/jgp.86.6.765; CHESLER M, 1990, PROG NEUROBIOL, V34, P401, DOI 10.1016/0301-0082(90)90034-E; CHOI DW, 1987, J NEUROSCI, V7, P357; EDSALL JT, 1958, BIOPHYSICAL CHEM, P585; EIGEN M, 1958, PROC R SOC LON SER-A, V247, P505, DOI 10.1098/rspa.1958.0208; EISNER DA, 1989, PFLUG ARCH EUR J PHY, V413, P553, DOI 10.1007/BF00594188; ERECINSKA M, 1983, J BIOL CHEM, V258, P9069; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; KALIA K, 1990, J PHYSL, V427, P241; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KVAMME E, 1985, NEUROCHEM RES, V10, P993, DOI 10.1007/BF00964635; MOBBS P, 1968, BRAIN RES, V460, P235; NEWMAN EA, 1991, GLIA, V4, P424, DOI 10.1002/glia.440040411; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PUTNAM RW, 1986, J PHYSIOL-LONDON, V381, P205, DOI 10.1113/jphysiol.1986.sp016323; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SARANTIS M, 1990, BRAIN RES, V516, P322, DOI 10.1016/0006-8993(90)90935-5; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SCHOUSBOE A, 1975, J NEUROCHEM, V25, P909, DOI 10.1111/j.1471-4159.1975.tb04429.x; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Thomas RC, 1978, ION SENSITIVE INTRAC	28	344	352	0	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 3	1992	360	6403					471	474		10.1038/360471a0	http://dx.doi.org/10.1038/360471a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448171				2022-12-28	WOS:A1992KA79700062
J	DENG, XW; MATSUI, M; WEI, N; WAGNER, D; CHU, AM; FELDMANN, KA; QUAIL, PH				DENG, XW; MATSUI, M; WEI, N; WAGNER, D; CHU, AM; FELDMANN, KA; QUAIL, PH			COP1, AN ARABIDOPSIS REGULATORY GENE, ENCODES A PROTEIN WITH BOTH A ZINC-BINDING MOTIF AND A G-BETA HOMOLOGOUS DOMAIN	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; HYPOCOTYL ELONGATION; GLUCOSE REPRESSION; MOLECULAR-CLONING; SHOWS HOMOLOGY; SUBUNIT GENE; EXPRESSION; THALIANA; LIGHT; PHYTOCHROME	Plant seedling development is capable of following 1 of 2 distinct morphogenic pathways: skotomorphogenesis in darkness and photomorphogenesis in light. Dark-grown Arabidopsis seedlings with recessive mutations at the constitutively photomorphogenic (COP1) locus indicate that the wild-type COP1 protein represses photomorphogenesis in darkness and that light reverses this repressive activity. Using a T-DNA-tagged mutant, we have cloned the COP1 locus. The amino-terminal half of the encoded protein contains a conserved zinc-binding motif, whereas the carboxyl-terminal half contains a domain homologous to the WD-40 repeat motif of G(beta) proteins. The presence of both a putative DNA-binding motif and a G protein-related domain in a single polypeptide suggests that COP1 may be the first of a new class of regulatory molecules. This novel structure could endow COP1 with the capacity to function as a negative transcriptional regulator capable of direct interaction with components of the G protein signaling pathway.	UNIV CALIF BERKELEY,USDA,CTR PLANT GENE EXPRESS,ALBANY,CA 94710; UNIV ARIZONA,DEPT PLANT SCI,TUCSON,AZ 85721	United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of Arizona	DENG, XW (corresponding author), YALE UNIV,DEPT BIOL,OSBORN MEM LABS,NEW HAVEN,CT 06511, USA.		Deng, Xing Wang/ABF-4107-2020; Matsui, Minami/A-5235-2016	Matsui, Minami/0000-0001-5162-2668; Wagner, Doris/0000-0003-4656-2490	NIGMS NIH HHS [1-R29-GM47850-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047850] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUCE WB, 1991, EMBO J, V10, P3015, DOI 10.1002/j.1460-2075.1991.tb07852.x; CARLSON LM, 1991, CELL, V64, P201, DOI 10.1016/0092-8674(91)90221-J; CHORY J, 1992, DEVELOPMENT, V115, P337; CHORY J, 1989, CELL, V58, P991, DOI 10.1016/0092-8674(89)90950-1; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; CHORY J, 1990, P NATL ACAD SCI USA, V85, P6856; DALRYMPLE MA, 1989, CELL, V58, P811, DOI 10.1016/0092-8674(89)90930-6; DENG XW, 1992, PLANT J, V2, P83, DOI 10.1111/j.1365-313X.1992.00083.x; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; EARP DJ, 1990, NUCLEIC ACIDS RES, V18, P3271, DOI 10.1093/nar/18.11.3271; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; GILMARTIN PM, 1990, PLANT CELL, V2, P369, DOI 10.1105/tpc.2.5.369; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HARTLEY DA, 1988, CELL, V55, P785, DOI 10.1016/0092-8674(88)90134-1; ITOH K, 1991, J CLIN INVEST, V87, P117; JONES JS, 1988, NUCLEIC ACIDS RES, V16, P7119, DOI 10.1093/nar/16.14.7119; JORGENSEN RA, 1987, PLANT MOL BIOL, V8, P3, DOI 10.1007/BF00016429; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Kendrick RE., 2012, PHOTOMORPHOGENESIS P, P333; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; KUHLEMEIER C, 1987, ANNU REV PLANT PHYS, V38, P221; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEUTWILER LS, 1986, NUCLEIC ACIDS RES, V14, P4051, DOI 10.1093/nar/14.10.4051; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; LISCUM E, 1991, PLANT CELL, V3, P685, DOI 10.1105/tpc.3.7.685; LISSEMORE JL, 1988, MOL CELL BIOL, V8, P4840, DOI 10.1128/MCB.8.11.4840; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MOHR H, 1983, ENCY PLANT PHYSL A, V16, P24; MUKAI Y, 1991, MOL CELL BIOL, V11, P3773, DOI 10.1128/MCB.11.7.3773; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; PETERSON TA, 1984, NATURE, V309, P556, DOI 10.1038/309556a0; QUAIL PH, 1991, ANNU REV GENET, V25, P389, DOI 10.1146/annurev.ge.25.120191.002133; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHULTZ J, 1987, MOL CELL BIOL, V7, P3637, DOI 10.1128/MCB.7.10.3637; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SOMERS DE, 1991, PLANT CELL, V3, P1263, DOI 10.1105/tpc.3.12.1263; THOMPSON WF, 1991, ANNU REV PLANT PHYS, V42, P423, DOI 10.1146/annurev.pp.42.060191.002231; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; YARFITZ S, 1988, P NATL ACAD SCI USA, V85, P7134, DOI 10.1073/pnas.85.19.7134; YOCHEM J, 1987, J MOL BIOL, V195, P233, DOI 10.1016/0022-2836(87)90646-2; ZHANG M, 1991, GENE, V97, P153, DOI 10.1016/0378-1119(91)90047-F	50	475	514	4	98	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 27	1992	71	5					791	801		10.1016/0092-8674(92)90555-Q	http://dx.doi.org/10.1016/0092-8674(92)90555-Q			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423630	hybrid			2022-12-28	WOS:A1992JZ63300009
J	HADDEN, JW; SMITH, DL				HADDEN, JW; SMITH, DL			IMMUNOPHARMACOLOGY - IMMUNOMODULATION AND IMMUNOTHERAPY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CYCLOSPORINE; METHOTREXATE; ARTHRITIS		UNIV SO ALABAMA,COLL MED,DIV ALLERGY,MOBILE,AL 36688; UNIV SO ALABAMA,COLL MED,DIV CLIN IMMUNOL,MOBILE,AL 36688	University of South Alabama; University of South Alabama	HADDEN, JW (corresponding author), UNIV S FLORIDA,COLL MED,IMMUNOPHARMACOL PROGRAM,TAMPA,FL 33612, USA.							BIZZINI B, 1988, ADV IMMUNOMODULATION; BOREL JF, 1989, PHARMACOL REV, V41, P259; BRAUDE AC, 1983, LANCET, V2, P995; BROSTOFF J, 1991, CLIN IMMUNOLOGY, V27; CLAMAN HN, 1983, HOSP PRACT, V18, P123; CORRIGAN JJ, 1992, NELSON TXB PEDIATRIC, P1281; CRUSE JM, 1989, THERAPY AUTOIMMUNE D; FRIEDMAN H, 1991, DRUGS ABUSE IMMUNITY; HADDEN JW, 1991, TRENDS PHARMACOL SCI, V12, P107, DOI 10.1016/0165-6147(91)90517-V; HADDEN JW, 1989, MED ONCOL TUMOR PHAR, V12, P107; HADDEN JW, 1990, IMMUNOPHARMACOLOGY R, P1; HANDSCHUMACHER RE, 1990, PHARMACOL BASIS THER, P1264; JOHNSON WJ, 1988, J RHEUMATOL, V15, P745; KATZ P, 1988, IMMUNOLOGICAL DISEAS, P675; KEIM D, 1990, J RHEUMATOL, V17, P846; KIRKPATRICK CH, 1989, ANN ALLERGY, V62, P170; LEDERER E, 1988, ADV IMMUNOMODULATION, P9; MASIHI KN, 1990, IMMUNOTHERAPEUTIC PR; MIHICH E, 1986, ADV IMMUNOPHARMACOL, V3, P257; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; RENOUX G, 1980, DRUGS, V19, P89; SCHALLER JG, 1992, NELSON TXB PEDIAT, P629; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; STRATTA RJ, 1988, SURGERY, V104, P606; SUNDAL E, 1985, SURV IMMUNOL RES S4, V1, P1; TAYLOR CW, 1990, IMMUNOPHARMACOLOGY R, P89; TSANG KY, 1984, IMMUNE MODULATION AG, P79; WHITE WB, 1985, NEW ENGL J MED, V312, P198, DOI 10.1056/NEJM198501243120402; WINKELSTEIN A, 1992, TXB PHARM, P964	29	9	18	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2964	2969		10.1001/jama.268.20.2964	http://dx.doi.org/10.1001/jama.268.20.2964			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433716				2022-12-28	WOS:A1992JY66800025
J	BLOCKI, FA; SCHLIEVERT, PM; WACKETT, LP				BLOCKI, FA; SCHLIEVERT, PM; WACKETT, LP			RAT-LIVER PROTEIN LINKING CHEMICAL AND IMMUNOLOGICAL DETOXIFICATION SYSTEMS	NATURE			English	Article							GLUTATHIONE S-TRANSFERASES; MIGRATION INHIBITORY FACTOR; CELL HYBRIDOMA CLONE; MACROPHAGE-MIGRATION; MECHANISMS; ACID	MAMMALS have separate enzymatic and cellularly mediated detoxification systems. Glutathione S-transferases (GSTs) protect against xenobiotic chemicals which continuously enter the body, largely through mucous membranes1-5. These enzymes catalyse the conjugation of glutathione with a wide variety of electrophilic compounds rendering them non-toxic. Mammals also mount a cellular immunological response on entry of foreign cells, viruses or macromolecules into the body6-8. T lymphocytes mobilize at the site of foreign body entry and secrete protein messengers called lymphokines. Secondary to T lymphocytes, macrophages concentrate at the infection site and function in antigen processing and phagocytosis. In vitro, macrophage movement is arrested by one class of lymphokines known as macrophage migration inhibitory factors (MIFs). We report here the purification of milligram quantities of a unique multifunctional protein from rat liver which links enzymatic and immunological detoxification systems. This protein actuates both GST and MIF activity and matches the primary structure of a human MIF9 in 25 out of 26 amino-terminal amino acids. Primary structure comparisons revealed significant similarity between GSTs and MIF. The glutathione affinity chromatography purification described here yields a 100-fold increase in obtaining MIF9-11 and will aid understanding of its precise biological function.	UNIV MINNESOTA,DEPT MICROBIOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,GRAY FRESHWATER BIOL INST,NAVARRE,MN 55392; UNIV MINNESOTA,DEPT BIOCHEM,NAVARRE,MN 55392	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota System				Schlievert, Patrick/0000-0001-8314-9369				ADAMS DO, 1987, IMMUNOL REV, V97, P5, DOI 10.1111/j.1600-065X.1987.tb00514.x; AHMED AE, 1978, BIOCHEM PHARMACOL, V27, P2021, DOI 10.1016/0006-2952(78)90061-8; ALLISON AC, 1978, IMMUNOL REV, V40, P3, DOI 10.1111/j.1600-065X.1978.tb00399.x; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; BOYER TD, 1989, HEPATOLOGY, V9, P486, DOI 10.1002/hep.1840090324; BOYER TD, 1983, ZAKIM BIOCH PHARM, V32, P297; DANIELSON UH, 1985, BIOCHEM J, V231, P263, DOI 10.1042/bj2310263; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P73; DING GJF, 1985, J BIOL CHEM, V260, P3268; FJELLSTEDT TA, 1973, J BIOL CHEM, V248, P3702; GOUST JM, 1986, IMMUN SERIES, V28, P169; HARRINGTON JT, 1973, J IMMUNOL, V110, P752; HIROSE S, 1991, MICROBIOL IMMUNOL, V35, P235, DOI 10.1111/j.1348-0421.1991.tb01552.x; JAKOBY WB, 1990, GLUTATHIONE S-TRANSFERASES AND DRUG RESISTANCE, P87; KOHLERSTAUB D, 1985, J BACTERIOL, V162, P676, DOI 10.1128/JB.162.2.676-681.1985; LATHROP RH, 1989, ARIADNE MANUAL; LIU SX, 1992, J BIOL CHEM, V267, P4296; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; OKI S, 1991, LYMPHOKINE CYTOK RES, V10, P273; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; RAJAPAKSE DA, 1970, NATURE, V226, P857, DOI 10.1038/226857a0; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; SCHLIEVERT PM, 1983, J INFECT DIS, V147, P391, DOI 10.1093/infdis/147.3.391; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; ZHANG PH, 1991, J BIOL CHEM, V266, P19475	28	73	80	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 19	1992	360	6401					269	270		10.1038/360269a0	http://dx.doi.org/10.1038/360269a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY960	1436109				2022-12-28	WOS:A1992JY96000055
J	STONE, VE; SEAGE, GR; HERTZ, T; EPSTEIN, AM				STONE, VE; SEAGE, GR; HERTZ, T; EPSTEIN, AM			THE RELATION BETWEEN HOSPITAL EXPERIENCE AND MORTALITY FOR PATIENTS WITH AIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCYSTIS-CARINII PNEUMONIA; ACQUIRED IMMUNODEFICIENCY SYNDROME; PROGNOSTIC FACTORS; NEW-YORK; VOLUME; SEVERITY; QUALITY; OUTCOMES; PERFECT; ILLNESS	Objective.-To determine whether there is an association between mortality and hospital acquired immune deficiency syndrome (AIDS) experience for all AIDS-related diagnoses, and to determine whether the association is explained by differences in severity of illness, earlier discharge of terminally ill patients, or differences in resource use. Design and Setting.-Population-based statewide cohort study. All hospitalizations identified for a cohort of AIDS patients diagnosed during 1987 in 40 Massachusetts hospitals were included. Patients.-All women and all male intravenous drug users (n=151), and a random sample of all male non-intravenous drug users diagnosed with AIDS during 1987 in Massachusetts (n=149). Main Outcome Measures.-Primary end points studied were (1) inpatient mortality and (2) 30-day mortality. Length of stay, cost, and intensive care unit use were also examined. Results.-In 806 hospitalizations at 40 hospitals inpatient mortality was 13.2%. Relative risk of mortality at low AIDS experience hospitals was 2.16 (95% confidence interval, 1.43 to 3.26) compared with high AIDS experience hospitals. When logistic regression was used to control for age, sex, race, human immunodeficiency virus transmission mode, severity, payer, admission type, hospital ownership, and teaching status, low hospital experience with AIDS remained a significant predictor of inpatient mortality (relative risk, 2.92; 95% confidence interval, 1.37 to 6.22). Comparisons of 30-day mortality by hospital AIDS experience yielded similar results. Length of stay and intensive care unit use were also significantly higher at low-experience hospitals after controlling for severity of illness (P<.05). Conclusions.-We conclude that mortality of AIDS patients is higher at hospitals with less AIDS experience. This finding is not because of greater severity of illness, differences in discharge patterns of the terminally ill, or less intensive use of resources.	HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,25 SHATTUCK ST,PARCEL B,1ST FLOOR,BOSTON,MA 02115; BOSTON UNIV,BOSTON CITY HOSP,SCH MED,DEPT MED,INFECT DIS SECT,BOSTON,MA 02118; BOSTON UNIV,BOSTON CITY HOSP,SCH MED,DEPT MED,GEN INTERNAL MED SECT,BOSTON,MA 02118; BOSTON DEPT HLTH & HOSP,INST URBAN HLTH POLICY RES & EDUC,BOSTON,MA; HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BOSTON,MA 02115; BOSTON UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL & BIOSTAT,BOSTON,MA 02215; BRIGHAM & WOMENS HOSP,DIV GEN MED,HLTH SERV & POLICY RES SECT,BOSTON,MA 02115	Harvard University; Harvard Medical School; Boston Medical Center; Boston University; Boston Medical Center; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Brigham & Women's Hospital					AHRQ HHS [1 RO3HS06150-01] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; BENNETT CL, 1990, ARCH INTERN MED, V150, P1447, DOI 10.1001/archinte.150.7.1447; BRENNER M, 1987, AM REV RESPIR DIS, V136, P1199, DOI 10.1164/ajrccm/136.5.1199; COTTON DJ, 1989, JAMA-J AM MED ASSOC, V261, P3016, DOI 10.1001/jama.261.20.3016; DUBOIS RW, 1987, NEW ENGL J MED, V317, P1674, DOI 10.1056/NEJM198712243172626; ELSADR W, 1988, AM REV RESPIR DIS, V137, P1264, DOI 10.1164/ajrccm/137.6.1264; FINK A, 1989, MED CARE, V27, P315, DOI 10.1097/00005650-198904000-00001; FLOOD AB, 1984, MED CARE, V22, P115, DOI 10.1097/00005650-198402000-00003; FLOOD AB, 1984, MED CARE, V22, P98, DOI 10.1097/00005650-198402000-00002; GREEN J, 1990, JAMA-J AM MED ASSOC, V263, P241, DOI 10.1001/jama.263.2.241; GREENFIELD S, 1988, JAMA-J AM MED ASSOC, V260, P2253, DOI 10.1001/jama.260.15.2253; HARDY AM, 1987, PUBLIC HEALTH REP, V102, P386; HARTZ AJ, 1989, NEW ENGL J MED, V321, P1720, DOI 10.1056/NEJM198912213212506; HUGHES RG, 1988, MED CARE, V26, P1057, DOI 10.1097/00005650-198811000-00004; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; JUSTICE AC, 1989, NEW ENGL J MED, V320, P1388, DOI 10.1056/NEJM198905253202106; KAHN KL, 1988, JAMA-J AM MED ASSOC, V260, P3625, DOI 10.1001/jama.260.24.3625; KALES CP, 1987, ARCH INTERN MED, V147, P1413; KELLY JV, 1989, MED CARE, V27, P1085, DOI 10.1097/00005650-198912000-00001; LIPSITZ SR, 1990, COMPUT BIOMED RES, V23, P268, DOI 10.1016/0010-4809(90)90021-4; LUFT HS, 1990, JAMA-J AM MED ASSOC, V263, P2899, DOI 10.1001/jama.263.21.2899; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; LUFT HS, 1987, HEALTH SERV RES, V22, P157; MAERKI SC, 1986, MED CARE, V24, P148, DOI 10.1097/00005650-198602000-00006; MATHEWS WC, 1989, J CLIN EPIDEMIOL, V42, P421, DOI 10.1016/0895-4356(89)90131-5; MOSKOWITZ MA, 1988, J AM GERIATR SOC, V36, P860, DOI 10.1111/j.1532-5415.1988.tb04272.x; ODDLEIFSON S, 1989, 5TH INT C AIDS MONTR; PARK RE, 1990, JAMA-J AM MED ASSOC, V264, P484; ROTHMAN DJ, 1990, NEW ENGL J MED, V323, P764, DOI 10.1056/NEJM199009133231129; SHORTELL SM, 1981, MED CARE, V19, P1041, DOI 10.1097/00005650-198110000-00006; TURNER BJ, 1989, MED CARE, V27, P423, DOI 10.1097/00005650-198904000-00009; WENGER JD, 1988, J GEN INTERN MED, V3, P464, DOI 10.1007/BF02595923; ZAMAN MK, 1988, AM REV RESPIR DIS, V137, P796, DOI 10.1164/ajrccm/137.4.796; 1987, MMWR S, V36, pS1; 1991, FED REGISTER, V56, P25178; 1987, MEDICARE B	36	99	99	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	1992	268	19					2655	2661		10.1001/jama.268.19.2655	http://dx.doi.org/10.1001/jama.268.19.2655			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JX680	1433685				2022-12-28	WOS:A1992JX68000026
J	CREUTZ, CE				CREUTZ, CE			THE ANNEXINS AND EXOCYTOSIS	SCIENCE			English	Article							PROTEIN-KINASE-C; ADRENAL CHROMAFFIN CELLS; PRELIMINARY-X-RAY; PLACENTAL ANTICOAGULANT PROTEIN; PHOSPHOLIPID-BINDING-PROTEINS; CALCIUM-DEPENDENT EXOCYTOSIS; PERIPHERAL ACTIN-FILAMENTS; ROUS-SARCOMA VIRUS; I LIGHT-CHAIN; CALPACTIN-I	The annexins are a group of homologous proteins that bind phospholipids in the presence of calcium. They may provide a major pathway for communication between cellular membranes and their cytoplasmic environment. Annexins have a characteristic "bivalent" activity in the sense that they can draw two membranes together when activated by calcium. This has led to the hypothesis that certain members of this protein family may initiate contact and fusion between a secretory vesicle membrane and the plasma membrane during the process of exocytosis.			CREUTZ, CE (corresponding author), UNIV VIRGINIA,DEPT PHARMACOL,CHARLOTTESVILLE,VA 22908, USA.							ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; ALI SM, 1990, CELL SIGNAL, V2, P265, DOI 10.1016/0898-6568(90)90054-E; ANDO Y, 1989, J BIOL CHEM, V264, P6948; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BADER MF, 1986, J BIOL CHEM, V261, P5777; BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P474; BARTON GJ, 1991, EUR J BIOCHEM, V198, P749, DOI 10.1111/j.1432-1033.1991.tb16076.x; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7970, DOI 10.1021/bi00246a014; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P971, DOI 10.1021/bi00218a013; BECKER T, 1990, EMBO J, V9, P4207, DOI 10.1002/j.1460-2075.1990.tb07868.x; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BLACKBOURN HD, 1991, PLANTA, V184, P67, DOI 10.1007/BF00208238; BOSTON PF, 1982, J NEUROCHEM, V38, P1466, DOI 10.1111/j.1471-4159.1982.tb07927.x; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BRISSON A, 1991, J MOL BIOL, V220, P199, DOI 10.1016/0022-2836(91)90002-N; BROOKS JC, 1983, J NEUROCHEM, V40, P468, DOI 10.1111/j.1471-4159.1983.tb11306.x; BURGOYNE RD, 1989, CELL CALCIUM, V10, P1, DOI 10.1016/0143-4160(89)90038-9; BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449; CREUTZ CE, 1990, PROG CLIN BIOL RES, V349, P99; CREUTZ CE, 1984, MET IONS BIOL SYST, V17, P319; CREUTZ CE, 1981, BIOCHEM BIOPH RES CO, V103, P1395, DOI 10.1016/0006-291X(81)90278-3; CREUTZ CE, 1983, BIOCHEM BIOPH RES CO, V114, P355, DOI 10.1016/0006-291X(83)91635-2; CREUTZ CE, 1991, YEAST, V7, P229, DOI 10.1002/yea.320070305; CREUTZ CE, 1979, J BIOL CHEM, V254, P553; CREUTZ CE, 1981, J CELL BIOL, V91, P247, DOI 10.1083/jcb.91.1.247; CREUTZ CE, 1978, J BIOL CHEM, V253, P2858; CREUTZ CE, 1992, BIOCHEM BIOPH RES CO, V184, P347, DOI 10.1016/0006-291X(92)91199-Z; CREUTZ CE, 1983, J BIOL CHEM, V258, P4664; CREUTZ CE, 1987, J BIOL CHEM, V262, P1860; CREUTZ CE, IN PRESS J CELL SCI; CREUTZ CE, 1990, STIMULUS RESPONSE CO, P279; CROMPTON MR, 1988, CELL, V55, P1, DOI 10.1016/0092-8674(88)90002-5; CRUMPTON MJ, 1990, NATURE, V345, P212, DOI 10.1038/345212a0; CUTSFORTH GA, 1989, BIOCHEMISTRY-US, V28, P7453, DOI 10.1021/bi00444a045; DE BK, 1986, J BIOL CHEM, V261, P13782; DIAZMUNOZ M, 1990, J BIOL CHEM, V265, P15894; DORING V, 1991, J BIOL CHEM, V266, P17509; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; DUNN LA, 1983, J BIOL CHEM, V258, P4989; ERNST JD, 1991, J IMMUNOL, V146, P3110; FAVA RA, 1989, J CELL PHYSIOL, V141, P284, DOI 10.1002/jcp.1041410209; FLAHERTY MJ, 1990, J LAB CLIN MED, V115, P174; FREEMONT PS, 1990, J MOL BIOL, V216, P219, DOI 10.1016/S0022-2836(05)80310-9; FUNAKOSHI T, 1987, BIOCHEMISTRY-US, V26, P8087, DOI 10.1021/bi00399a011; GABRIEL BL, 1991, J STRUCT BIOL, V107, P29, DOI 10.1016/1047-8477(91)90028-U; GEISOW M, 1984, EMBO J, V3, P2969, DOI 10.1002/j.1460-2075.1984.tb02242.x; GEISOW MJ, 1986, NATURE, V320, P636, DOI 10.1038/320636a0; GEISOW MJ, 1986, TRENDS BIOCHEM SCI, V11, P120; GENGE BR, 1990, J BIOL CHEM, V265, P4703; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; GERKE V, 1991, J BIOL CHEM, V266, P1809; GLENNEY JR, 1987, J CELL BIOL, V104, P503, DOI 10.1083/jcb.104.3.503; GLENNEY JR, 1986, J BIOL CHEM, V261, P485; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; GREENWOOD M, 1991, BIOCHIM BIOPHYS ACTA, V1088, P429, DOI 10.1016/0167-4781(91)90137-B; HUBER R, 1992, J MOL BIOL, V223, P683, DOI 10.1016/0022-2836(92)90984-R; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; HUBER R, 1990, FEBS LETT, V275, P15, DOI 10.1016/0014-5793(90)81428-Q; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; IKEBUCHI NW, 1990, J BIOL CHEM, V265, P3392; JUNKER M, UNPUB; JUNKER M, 1992, UNPUB; KARSHIKOV A, 1992, EUR BIOPHYS J BIOPHY, V20, P337, DOI 10.1007/BF00196592; KHANNA NC, 1986, BIOCHEM BIOPH RES CO, V141, P547, DOI 10.1016/S0006-291X(86)80208-X; KLEE CB, 1988, BIOCHEMISTRY-US, V27, P6645, DOI 10.1021/bi00418a001; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KRETSINGER RH, 1986, NATURE, V320, P573, DOI 10.1038/320573a0; LEWITBENTLEY A, 1989, J MOL BIOL, V210, P875, DOI 10.1016/0022-2836(89)90115-0; LIN HC, 1992, CELL, V70, P283, DOI 10.1016/0092-8674(92)90102-I; LINDAU M, 1991, Q REV BIOPHYS, V24, P75, DOI 10.1017/S0033583500003279; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LUO X, UNPUB; MATSUSHIMA N, 1990, PROTEINS, V7, P125, DOI 10.1002/prot.340070204; MEERS P, 1988, BIOCHEMISTRY-US, V27, P4430, DOI 10.1021/bi00412a033; MICHENER ML, 1986, J BIOL CHEM, V261, P6548; MOORE PB, 1982, J BIOL CHEM, V257, P9663; MORGAN A, 1992, NATURE, V355, P833, DOI 10.1038/355833a0; MORGAN A, 1990, BIOCHEM J, V271, P571, DOI 10.1042/bj2710571; MOSSER G, 1991, J MOL BIOL, V217, P241, DOI 10.1016/0022-2836(91)90538-H; NAIR J, 1990, J CELL BIOL, V110, P1897, DOI 10.1083/jcb.110.6.1897; NAKATA T, 1990, J CELL BIOL, V110, P13, DOI 10.1083/jcb.110.1.13; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NEWMAN R, 1989, J MOL BIOL, V206, P213, DOI 10.1016/0022-2836(89)90534-2; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PARSEGIAN VA, 1977, SOC NEUROSCI S, V2, P161; PEPINSKY RB, 1988, J BIOL CHEM, V263, P10799; PFAFFLE M, 1988, EMBO J, V7, P2335, DOI 10.1002/j.1460-2075.1988.tb03077.x; POLLARD HB, 1988, P NATL ACAD SCI USA, V85, P2974, DOI 10.1073/pnas.85.9.2974; POLLARD HB, 1985, FEBS LETT, V150, P201; POWELL MA, 1987, BIOCHEM J, V247, P321, DOI 10.1042/bj2470321; RADKE K, 1980, CELL, V21, P821, DOI 10.1016/0092-8674(80)90445-6; ROJAS E, 1990, J BIOL CHEM, V265, P21207; ROSS TS, 1990, SCIENCE, V248, P605, DOI 10.1126/science.2159184; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; SARAFIAN T, 1987, J BIOL CHEM, V262, P16671; SCHLAEPFER DD, 1988, BIOCHEMISTRY-US, V27, P4253, DOI 10.1021/bi00412a008; SCHLAEPFER DD, 1987, P NATL ACAD SCI USA, V84, P6078, DOI 10.1073/pnas.84.17.6078; SCHLAEPFER DD, 1992, J BIOL CHEM, V267, P9529; SEATON BA, 1990, J BIOL CHEM, V265, P4567; SILVA FG, 1986, DIFFERENTIATION, V33, P175, DOI 10.1111/j.1432-0436.1986.tb00423.x; SMALLWOOD M, 1990, BIOCHEM J, V270, P157, DOI 10.1042/bj2700157; SMITH VL, 1990, STIMULUS RESPONSE CO, P13; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; STOLL G, 1988, NEUROSCI LETT, V86, P27, DOI 10.1016/0304-3940(88)90177-2; SUDHOF TC, 1984, BIOCHEMISTRY-US, V23, P1103; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TAIT JF, 1988, BIOCHEMISTRY-US, V27, P6268, DOI 10.1021/bi00417a011; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; TOKUMITSU H, 1992, J BIOL CHEM, V267, P8919; TOWLE CA, 1992, J BIOL CHEM, V267, P5416; TSCHOPP J, 1984, J BACTERIOL, V160, P966, DOI 10.1128/JB.160.3.966-970.1984; VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021; WAISMAN DM, 1992, BIOPHYS J, V62, pA225; WALKER JH, 1982, J NEUROCHEM, V39, P815, DOI 10.1111/j.1471-4159.1982.tb07965.x; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; WANG W, IN PRESS BIOCHEMISTR; Wang W., UNPUB; WILSON SP, 1983, J BIOL CHEM, V258, P4994; WU YN, 1991, FEBS LETT, V282, P197, DOI 10.1016/0014-5793(91)80476-J; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404; ZAKS WJ, 1991, BIOCHEMISTRY-US, V30, P9607, DOI 10.1021/bi00104a007; ZAKS WJ, 1990, BIOCHIM BIOPHYS ACTA, V1029, P149, DOI 10.1016/0005-2736(90)90448-W; ZAKS WJ, 1988, MOL MECHANISMS MEMBR, P325; ZIMMERBERG J, 1987, P NATL ACAD SCI USA, V84, P1585, DOI 10.1073/pnas.84.6.1585; ZUPAN LA, 1992, J BIOL CHEM, V267, P8707	130	540	545	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 6	1992	258	5084					924	931		10.1126/science.1439804	http://dx.doi.org/10.1126/science.1439804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439804				2022-12-28	WOS:A1992JW79600020
J	KRAUSS, S; MADEN, M; HOLDER, N; WILSON, SW				KRAUSS, S; MADEN, M; HOLDER, N; WILSON, SW			ZEBRAFISH PAX[B] IS INVOLVED IN THE FORMATION OF THE MIDBRAIN HINDBRAIN BOUNDARY	NATURE			English	Article							DEVELOPING EXCRETORY SYSTEM; BOX-CONTAINING GENE; INT-1 PROTOONCOGENE; FUSHI-TARAZU; NEURAL-TUBE; DROSOPHILA; EXPRESSION; MUTATION; PROTEIN; WNT-1	AMONG the genes thought to be involved in patterning the nervous system are a family of developmentally regulated paired box-containing (Pax) genes. Mutations in some of these Pax genes lead to severe developmental abnormalities. Zebrafish pax[b] (pax[zf-b]) is a member of the Pax gene family that is expressed in the presumptive posterior midbrain from the end of gastrulation and, at later stages, in other localized regions of the developing embryo1. Here we show that injection of antibodies raised against the pax[b] protein causes a localized malformation at the mid-brain-hinbrain boundary. In situ hybridizations demonstrate that antibody injection causes downregulation of pax[b] transcripts in the posterior midbrain and alteration of wnt-1 and eng-2 expression in this area. The data demonstrate an involvement of pax[b] in the formation of the midbrain-hindbrain junction.	UNIV LONDON KINGS COLL,RANDALL INST,DEV BIOL RES CTR,DIV BIOMED SCI,LONDON WC2B 5RL,ENGLAND	University of London; King's College London			Wilson, Stephen W/B-9404-2008	Wilson, Stephen W/0000-0002-8557-5940; Krauss, Stefan/0000-0001-6992-8091				BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; HIDALGO A, 1990, DEVELOPMENT, V110, P291; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; INGHAM PW, 1988, NATURE, V331, P73, DOI 10.1038/331073a0; JOSTES B, 1991, MECH DEVELOP, V33, P27; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MIKKOLA J, 1992, J NEUROBIOL, V23, P933; MOLVEN A, 1991, EMBO J, V10, P799, DOI 10.1002/j.1460-2075.1991.tb08012.x; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978; PLACHOV D, 1990, DEVELOPMENT, V110, P643; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; TSSEBEHJI M, 1992, NATURE, V355, P635; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435	32	122	124	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 5	1992	360	6399					87	89		10.1038/360087a0	http://dx.doi.org/10.1038/360087a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW717	1436081				2022-12-28	WOS:A1992JW71700063
J	KISHIMOTO, T; AKIRA, S; TAGA, T				KISHIMOTO, T; AKIRA, S; TAGA, T			INTERLEUKIN-6 AND ITS RECEPTOR - A PARADIGM FOR CYTOKINES	SCIENCE			English	Article							LEUKEMIA-INHIBITORY FACTOR; COLONY-STIMULATING FACTOR; CILIARY NEUROTROPHIC FACTOR; TUMOR-NECROSIS-FACTOR; B-CELL GROWTH; IL-6 SIGNAL TRANSDUCER; HUMAN NGF RECEPTOR; MOLECULAR-CLONING; TYROSINE PHOSPHORYLATION; RHEUMATOID-ARTHRITIS	Many cytokines and cytokine receptors involved in the regulation of hematopoiesis, immune responses, and inflammation have been identified and characterized at the molecular level. Several characteristic features of cytokines, such as pleiotropy and redundancy, are now more clearly understood on the basis of their molecular structures. Accumulating evidence has demonstrated an intimate link between cytokines and various diseases such as allergy, autoimmune diseases, and cancer. The pathogenesis of these diseases and therapies to treat them will be discussed based on insights derived from cytokine research.	OSAKA UNIV, INST MOLEC & CELLULAR BIOL, SUITA, OSAKA 565, JAPAN	Osaka University	KISHIMOTO, T (corresponding author), OSAKA UNIV, SCH MED, DEPT INTERNAL MED 3, OSAKA 553, JAPAN.		Kishimoto, Tadamitsu/C-8470-2009					AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; [Anonymous], PROG IMMUNOL, DOI DOI 10.1016/B978-0-12-057550-3.50033-8; ASANO S, 1990, BLOOD, V75, P1602; AUSTIN L, 1991, J NEUROL SCI, V101, P193, DOI 10.1016/0022-510X(91)90045-9; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BIRX DL, 1990, BLOOD, V76, P2303; BORTNER DM, 1991, GENE DEV, V5, P1777, DOI 10.1101/gad.5.10.1777; BREEN EC, 1990, J IMMUNOL, V144, P480; BROWN TJ, 1987, J IMMUNOL, V139, P2977; CARTER A, 1990, BRIT J HAEMATOL, V74, P424, DOI 10.1111/j.1365-2141.1990.tb06330.x; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; EASTGATE JA, 1988, LANCET, V2, P706; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; GEARING DP, 1992, NEW BIOL, V4, P61; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GOUGH NM, 1988, P NATL ACAD SCI USA, V85, P2623, DOI 10.1073/pnas.85.8.2623; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HATAKEYAMA M, 1990, HDB EXPT PHARM, V95, P523; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HILTON DJ, 1988, J BIOL CHEM, V263, P9238; HILTON DJ, 1991, J CELL BIOCHEM, V46, P21, DOI 10.1002/jcb.240460105; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; HIRANO T, 1987, P NATL ACAD SCI USA, V84, P228, DOI 10.1073/pnas.84.1.228; HONDA M, 1990, BLOOD, V145, P4059; Horn D, 1990, GROWTH FACTORS, V2, P157, DOI 10.3109/08977199009071502; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; HOWARD M, 1983, ANNU REV IMMUNOL, V1, P307, DOI 10.1146/annurev.iy.01.040183.001515; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, UNPUB; ISFORT R, 1988, J BIOL CHEM, V263, P19203; ISHIBASHI T, 1989, P NATL ACAD SCI USA, V86, P5953, DOI 10.1073/pnas.86.15.5953; ISSHIKI H, 1990, MOL CELL BIOL, V10, P2757, DOI 10.1128/MCB.10.6.2757; ISSHIKI H, 1991, NEW BIOL, V3, P63; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; IWAKURA Y, 1991, SCIENCE, V253, P1026, DOI 10.1126/science.1887217; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOURDAN M, 1990, ARTHRITIS RHEUM-US, V33, P398, DOI 10.1002/art.1780330313; KANAKURA Y, 1990, BLOOD, V76, P706; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KAWANO M, 1989, BLOOD, V73, P2145; KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0; KISHIMOTO T, 1973, J IMMUNOL, V111, P1194; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133, DOI 10.1146/annurev.iy.03.040185.001025; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KLEIN B, 1989, BLOOD, V73, P517; KLEIN B, 1991, BLOOD, V78, P1198; KOCH AE, 1991, J IMMUNOL, V147, P2187; KOYASU S, 1987, EMBO J, V6, P3979, DOI 10.1002/j.1460-2075.1987.tb02740.x; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LINNEKIN D, 1990, BIOCHEM J, V271, P317, DOI 10.1042/bj2710317; LIU JW, 1992, J BIOL CHEM, V267, P16763; LORD KA, 1991, MOL CELL BIOL, V11, P4371, DOI 10.1128/MCB.11.9.4371; MARTINEZMAZA O, IN PRESS IL 6 PHYSIO; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; MILES SA, 1992, SCIENCE, V255, P1432, DOI 10.1126/science.1542793; MILES SA, 1990, P NATL ACAD SCI USA, V87, P4068, DOI 10.1073/pnas.87.11.4068; MORLA AO, 1988, MOL CELL BIOL, V8, P2214, DOI 10.1128/MCB.8.5.2214; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, UNPUB; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; NABATA T, 1990, BIOCHEM INT, V20, P445; NAIR BC, 1992, SCIENCE, V255, P1430, DOI 10.1126/science.1542792; NAITOH Y, 1988, BIOCHEM BIOPH RES CO, V155, P1459, DOI 10.1016/S0006-291X(88)81305-6; NAKAJIMA K, 1991, MOL CELL BIOL, V11, P1409, DOI 10.1128/MCB.11.3.1409; NAKAJIMA K, 1989, J IMMUNOL, V142, P531; NAKAJIMA T, UNPUB; NATSUKA S, 1992, BLOOD, V79, P460; NEMUNAITIS J, 1989, BLOOD, V74, P1929; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0; NORDAN RP, 1987, J IMMUNOL, V139, P813; PATTHY L, 1990, CELL, V61, P13, DOI 10.1016/0092-8674(90)90208-V; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15, DOI 10.1038/newbio237015a0; SEITZ M, 1991, J CLIN INVEST, V87, P463, DOI 10.1172/JCI115018; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SPANGELO BL, 1989, ENDOCRINOLOGY, V125, P575, DOI 10.1210/endo-125-1-575; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAGA T, IN PRESS P NATL ACAD; TAKAKI S, 1990, EMBO J, V9, P4367, DOI 10.1002/j.1460-2075.1990.tb07886.x; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TOMIDA M, 1984, J BIOL CHEM, V259, P978; VANDAMME J, 1987, J EXP MED, V165, P914, DOI 10.1084/jem.165.3.914; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; VOGEL J, 1988, NATURE, V335, P606, DOI 10.1038/335606a0; WALDMANN TA, 1991, J BIOL CHEM, V266, P2681; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; YOCUM DE, 1989, CELL IMMUNOL, V122, P131, DOI 10.1016/0008-8749(89)90154-8; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818	127	841	884	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	1992	258	5082					593	597		10.1126/science.1411569	http://dx.doi.org/10.1126/science.1411569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU745	1411569				2022-12-28	WOS:A1992JU74500045
J	CHAVANET, PY; GARRY, I; CHARLIER, N; CAILLOT, D; KISTERMAN, JP; DATHIS, M; PORTIER, H				CHAVANET, PY; GARRY, I; CHARLIER, N; CAILLOT, D; KISTERMAN, JP; DATHIS, M; PORTIER, H			TRIAL OF GLUCOSE VERSUS FAT EMULSION IN PREPARATION OF AMPHOTERICIN FOR USE IN HIV INFECTED PATIENTS WITH CANDIDIASIS	BRITISH MEDICAL JOURNAL			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; B-DEOXYCHOLATE; ORAL LESIONS; INFUSION; TOXICITY; PHARMACOKINETICS; PREVALENCE; INDUCTION; MYCOSES; HUMANS	Objectives-To compare the tolerance, efficacy, and pharmokinetics of amphotericin deoxycholate (Fungizone) prepared in a parenteral fat emulsion (Intralipid 20%) or glucose in HIV patients with candidiasis. Design-Non-blind randomised controlled trial. Setting-University hospital; tertiary clinical care. Patients-22 HIV positive patients with oral candidiasis. Interventions-Amphotericin 1 mg/kg/day given on four consecutive days as a one hour infusion dissolved in either 5% glucose (amphotericin-glucose) or parenteral fat emulsion at a final concentration of 2 g/l fat emulsion (amphotericin-fat emulsion). Main outcome measures-Clinical tolerance (fever, chills, sweats, nausea, arterial pressure, and pulse rate); biological tolerance (serum creatinine, electrolyte, and magnesium values); clinical score of candidiasis; and serum concentrations of amphotericin. Results-11 patients were enrolled in each group. All the amphotericin-fat emulsion infusions were given without serious problem whereas four amphotericin-glucose infusions were stopped because of renal impairment (n=3) or severe chills (n=2), or both. For patients completing the amphotericin-glucose treatment creatine concentration increased by 42 mumol/l; four of seven patients had at least one creatinine value greater-than-or-equal-to 133 mumol/l versus one of 11 receiving amphotericin-fat emulsion. Magnesium concentration fell significantly with amphotericin-glucose but not with amphotericin-fat emulsion. Clinical side effects were noted in 36/38 infusions with amphotericin-glucose but 10/44 with amphotericin-fat emulsion. Oral candidiasis score was reduced similarly in both groups. Serum amphotericin concentrations were significantly lower and the volume of distribution of the drug higher after infusion of amphotericin-fat emulsion than after amphotericin-glucose. Conclusions-Clinical and renal toxicity of amphotericin are reduced when the drug is prepared in fat emulsion. Preparation is simple and cost effective. Its efficacy is similar to that of conventional amphotericin.			CHAVANET, PY (corresponding author), HOP BOCAGE,SERV MALAD INFECT,BP 1542,F-21034 DIJON,FRANCE.							ATKINSON AJ, 1978, ANTIMICROB AGENTS CH, V13, P271, DOI 10.1128/AAC.13.2.271; BARONE R, 1990, ORAL SURG ORAL MED O, V69, P169, DOI 10.1016/0030-4220(90)90322-J; BARREUTHER AD, 1977, DRUG INTEL CLIN PHAR, V11, P368, DOI 10.1177/106002807701100609; BINDSCHADLER DD, 1969, J INFECT DIS, V120, P427, DOI 10.1093/infdis/120.4.427; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; BRAJTBURG J, 1990, ANTIMICROB AGENTS CH, V34, P2415, DOI 10.1128/AAC.34.12.2415; BRAJTBURG J, 1990, ANTIMICROB AGENTS CH, V34, P183, DOI 10.1128/AAC.34.2.183; BRAJTBURG J, 1990, ANTIMICROB AGENTS CH, V34, P381, DOI 10.1128/AAC.34.3.381; BUTLER WT, 1964, ANN INTERN MED, V61, P175, DOI 10.7326/0003-4819-61-2-175; CASAGRANDE JT, 1978, BIOMETRICS, V34, P483, DOI 10.2307/2530613; CHAVANET P, 1992, PATHOL BIOL, V40, P507; CHIA JKS, 1990, ANTIMICROB AGENTS CH, V34, P906, DOI 10.1128/AAC.34.5.906; CHRISTIANSEN KJ, 1985, J INFECT DIS, V152, P1037, DOI 10.1093/infdis/152.5.1037; CLEARY JD, 1988, DRUG INTEL CLIN PHAR, V22, P769, DOI 10.1177/106002808802201005; COLLETTE N, 1989, ANTIMICROB AGENTS CH, V33, P362, DOI 10.1128/AAC.33.3.362; CRAVEN PC, 1985, ANTIMICROB AGENTS CH, V27, P868, DOI 10.1128/AAC.27.5.868; DEMONACO HJ, 1983, DRUG INTEL CLIN PHAR, V17, P547, DOI 10.1177/106002808301700711; DENNING DW, 1991, NEW ENGL J MED, V324, P654, DOI 10.1056/NEJM199103073241003; DIAMOND RD, 1991, REV INFECT DIS, V13, P480; DUPOUYCAMET J, 1991, LANCET, V338, P383, DOI 10.1016/0140-6736(91)90514-P; EMMINGER W, 1991, BONE MARROW TRANSPL, V7, P95; EVANS TG, 1991, J INFECT DIS, V164, P1232, DOI 10.1093/infdis/164.6.1232; FEIGAL DW, 1991, AIDS, V5, P519, DOI 10.1097/00002030-199105000-00007; FIELDS BT, 1971, APPL MICROBIOL, V22, P615, DOI 10.1128/AEM.22.4.615-617.1971; GALLIS HA, 1990, REV INFECT DIS, V12, P308; GIGLIOTTI F, 1987, J INFECT DIS, V156, P784, DOI 10.1093/infdis/156.5.784; JANOFF AS, 1988, P NATL ACAD SCI USA, V85, P6122, DOI 10.1073/pnas.85.16.6122; JARNUM S, 1981, SCAND J GASTROENTERO, V16, P903, DOI 10.3109/00365528109181821; JOLY V, 1992, ANTIMICROB AGENTS CH, V36, P262, DOI 10.1128/AAC.36.2.262; KADENDE P, 1991, Journal de Mycologie Medicale, V1, P189; KAN VL, 1991, J INFECT DIS, V164, P418, DOI 10.1093/infdis/164.2.418; KIRSH R, 1988, J INFECT DIS, V158, P1065, DOI 10.1093/infdis/158.5.1065; LEIBOVITZ E, 1991, PEDIATR INFECT DIS J, V10, P888, DOI 10.1097/00006454-199112000-00002; MESSING B, 1979, GASTROEN CLIN BIOL, V3, P719; OLFIELD E, 1990, ANTIMICROB AGENTS CH, V34, P1042; PERFECT JR, 1991, REV INFECT DIS, V13, P474; SMITH DE, 1991, AIDS, V5, P1367, DOI 10.1097/00002030-199111000-00014; TARALA RA, 1980, BRIT MED J, V281, P28, DOI 10.1136/bmj.281.6232.28; TAVITIAN A, 1986, GASTROENTEROLOGY, V90, P443, DOI 10.1016/0016-5085(86)90946-7; UTZ JP, 1964, ANN INTERN MED, V61, P334, DOI 10.7326/0003-4819-61-2-334; WARNOCK DW, 1991, J ANTIMICROB CHEMOTH, V28, P27, DOI 10.1093/jac/28.suppl_B.27	41	109	114	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 17	1992	305	6859					921	925		10.1136/bmj.305.6859.921	http://dx.doi.org/10.1136/bmj.305.6859.921			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JU649	1458072	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JU64900020
J	MURRAY, AW				MURRAY, AW			CREATIVE BLOCKS - CELL-CYCLE CHECKPOINTS AND FEEDBACK CONTROLS	NATURE			English	Review							ATAXIA-TELANGIECTASIA; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; TYROSINE PHOSPHORYLATION; CHROMOSOME CONDENSATION; CHROMATIN-CONDENSATION; MICROTUBULE FUNCTION; CANCER SYNDROME; X-IRRADIATION	Before division, cells must ensure that they finish DNA replication, DNA repair and chromosome segregation. They do so by using feedback controls which can detect the failure to complete replication, repair or spindle assembly to arrest the progress of the cell cycle at one of three checkpoints. Failures in feedback controls can contribute to the generation of cancer.			MURRAY, AW (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, BOX 0444, SAN FRANCISCO, CA 94143 USA.							AEBI M, 1990, MOL GEN GENET, V224, P72, DOI 10.1007/BF00259453; ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; AMON A, 1992, NATURE, V355, P368, DOI 10.1038/355368a0; BEGG KJ, 1991, NEW BIOL, V3, P475; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; BOGUSKI M, IN PRESS NEW BIOL; BOYNTON AL, 1974, RADIAT RES, V60, P89, DOI 10.2307/3574008; Byers B, 1981, MOL BIOL YEAST SACCH, P59; BYFIELD JE, 1981, BRIT J CANCER, V43, P669, DOI 10.1038/bjc.1981.98; CLARK KL, 1989, MOL CELL BIOL, V9, P2682, DOI 10.1128/MCB.9.6.2682; COHEN MM, 1989, ADV HUM GENET, V18, P43; CYCLE TC, 1991, COLD SPRING HARB SYM, V66, P782; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; DEBOER PAJ, 1990, ANNU REV GENET, V24, P249, DOI 10.1146/annurev.genet.24.1.249; DONACHIE WD, 1990, RES MICROBIOL, V141, P64, DOI 10.1016/0923-2508(90)90099-C; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; ENOCH T, 1991, COLD SPRING HARB SYM, V56, P409; FINGERT HJ, 1988, CANCER RES, V48, P4375; FRASCH M, 1991, EMBO J, V10, P1225, DOI 10.1002/j.1460-2075.1991.tb08064.x; FREARON ER, 1990, CELL, V61, P759; GAUDIN D, 1969, P SOC EXP BIOL MED, V131, P1413; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; Glomset J. A., 1991, CURR OPIN LIPIDOL, V2, P118; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HEPLER PK, 1989, J CELL BIOL, V109, P2567, DOI 10.1083/jcb.109.6.2567; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; KASTAN MB, 1991, CANCER RES, V51, P6304; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; KUNG AL, 1990, CANCER RES, V50, P7307; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LAU CC, 1982, P NATL ACAD SCI-BIOL, V79, P2942, DOI 10.1073/pnas.79.9.2942; LI FP, 1982, JAMA-J AM MED ASSOC, V247, P2692, DOI 10.1001/jama.247.19.2692; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LITTLE JB, 1968, NATURE, V218, P1064, DOI 10.1038/2181064a0; LORCA T, 1991, EMBO J, V10, P2087, DOI 10.1002/j.1460-2075.1991.tb07741.x; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; LUTKENHAUS J, 1990, TRENDS GENET, V6, P22, DOI 10.1016/0168-9525(90)90045-8; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NAGASAWA H, 1985, MUTAT RES, V148, P71, DOI 10.1016/0027-5107(85)90209-X; NAGASAWA H, 1984, RADIAT RES, V97, P537, DOI 10.2307/3576145; NICKLAS RB, IN PRESS J CELL SCI; NISHIMOTO T, 1978, CELL, V15, P475, DOI 10.1016/0092-8674(78)90017-X; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; OHTSUBO M, 1991, EMBO J, V10, P1265, DOI 10.1002/j.1460-2075.1991.tb08068.x; OSMANI AH, 1991, EMBO J, V10, P2669, DOI 10.1002/j.1460-2075.1991.tb07810.x; OSMANI AH, 1991, CELL; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PAINTER RB, 1975, RADIAT RES, V64, P648, DOI 10.2307/3574254; PETO R, 1975, BRIT J CANCER, V32, P411, DOI 10.1038/bjc.1975.242; ROWLEY R, 1992, EMBO J, V11, P1335, DOI 10.1002/j.1460-2075.1992.tb05178.x; ROWLEY R, 1992, EMBO J; RUDOLPH NS, 1989, MUTAT RES, V211, P31, DOI 10.1016/0027-5107(89)90104-8; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SCHIMKE RT, 1991, COLD SH Q B, V56, P417; SCHLEGEL R, 1990, CELL GROWTH DIFFER, V1, P171; SCHLEGEL R, 1987, P NATL ACAD SCI USA, V84, P9025, DOI 10.1073/pnas.84.24.9025; SLUDER G, 1986, J EXP ZOOL, V238, P325, DOI 10.1002/jez.1402380307; SMYTHE C, 1992, CELL, V68, P787, DOI 10.1016/0092-8674(92)90153-4; SORGER PK, 1992, NATURE, V355, P365, DOI 10.1038/355365a0; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; SULLIVAN W, 1990, DEVELOPMENT, V110, P311; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; WALKER GC, 1987, ESCHERICHIA COLI SAL, P1346; WATANABE N, 1991, NATURE, V352, P247, DOI 10.1038/352247a0; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	84	670	683	3	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 15	1992	359	6396					599	604		10.1038/359599a0	http://dx.doi.org/10.1038/359599a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	1406993				2022-12-28	WOS:A1992JT82400045
J	KNIGHTON, DR; PEARSON, RB; SOWADSKI, JM; MEANS, AR; TENEYCK, LF; TAYLOR, SS; KEMP, BE				KNIGHTON, DR; PEARSON, RB; SOWADSKI, JM; MEANS, AR; TENEYCK, LF; TAYLOR, SS; KEMP, BE			STRUCTURAL BASIS OF THE INTRASTERIC REGULATION OF MYOSIN LIGHT CHAIN KINASES	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; CALMODULIN BINDING; CONSERVED FEATURES; SYNTHETIC PEPTIDES; RESIDUES; SEQUENCE; PHOSPHORYLATION; DOMAIN; SITE	The smooth muscle myosin light chain kinase (smMLCK) catalytic core was modeled by using the crystallographic coordinates of the cyclic AMP-dependent protein kinase catalytic subunit (cAPK) and a bound pseudosubstrate inhibitor peptide, PKI(5-24). Despite only 30% identity in amino acid sequence, the MLCK sequence can be readily accommodated in this structure. With the exception of the short B-helix, all major elements of secondary structure in the core are very likely conserved. The active site of the modeled MLCK complements the known requirements for peptide substrate recognition. MLCK contains a pseudosubstrate sequence that overlaps the calmodulin binding domain and has been proposed to act as an intrasteric inhibitor and occupy the substrate binding site in the absence of Ca2+-calmodulin. The pseudosubstrate sequence can be modeled easily into the entire backbone of PKI(5-24). The results demonstrate that the intrasteric model for regulation of MLCK by intramolecular competitive inhibition is structurally plausible.	ST VINCENTS INST MED RES, 41 VICTORIA PARADE, FITZROY, VIC 3065, AUSTRALIA; UNIV CALIF SAN DIEGO, DEPT CHEM, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA; DUKE UNIV, DEPT PHARMACOL, DURHAM, NC 27706 USA	St. Vincent's Institute of Medical Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Duke University			Pearson, Richard Bruce/I-1451-2013; Kemp, Bruce E/L-2633-2014; Kemp, Bruce/G-9602-2019	Pearson, Richard Bruce/0000-0001-5919-5090; Kemp, Bruce E/0000-0001-6735-5082; Kemp, Bruce/0000-0001-6735-5082	NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA09523] Funding Source: Medline; NIDDK NIH HHS [T32DK07233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAGCHI IC, 1992, MOL ENDOCRINOL, V6, P621, DOI 10.1210/me.6.4.621; CHENG HC, 1986, J BIOL CHEM, V261, P989; GLASS DB, 1989, J BIOL CHEM, V264, P14579; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HERRING BP, 1991, J BIOL CHEM, V266, P11838; HERRING BP, 1990, J BIOL CHEM, V265, P16588; ITO M, 1991, BIOCHEMISTRY-US, V30, P3498, DOI 10.1021/bi00228a021; KEMP BE, 1983, P NATL ACAD SCI-BIOL, V80, P7471, DOI 10.1073/pnas.80.24.7471; KEMP BE, 1985, J BIOL CHEM, V260, P3355; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KEMP BE, 1990, PEPTIDES PROTEIN PHO; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LEACHMAN SA, 1992, J BIOL CHEM, V267, P4930; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MICHNOFF CH, 1986, J BIOL CHEM, V261, P8320; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; PEARSON RB, 1988, SCIENCE, V241, P970, DOI 10.1126/science.3406746; PEARSON RB, 1986, J BIOL CHEM, V261, P25; PEARSON RB, 1991, EUR J BIOCHEM, V200, P723, DOI 10.1111/j.1432-1033.1991.tb16237.x; PEARSON RW, UNPUB; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; SHOJI S, 1979, J BIOL CHEM, V254, P6211; SOBIESZEK A, 1991, EUR J BIOCHEM, V199, P735, DOI 10.1111/j.1432-1033.1991.tb16178.x	26	114	129	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	1992	258	5079					130	135		10.1126/science.1439761	http://dx.doi.org/10.1126/science.1439761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ619	1439761				2022-12-28	WOS:A1992JQ61900035
J	WASSARMAN, DA; STEITZ, JA				WASSARMAN, DA; STEITZ, JA			INTERACTIONS OF SMALL NUCLEAR RNAS WITH PRECURSOR MESSENGER-RNA DURING INVITRO SPLICING	SCIENCE			English	Article							PSORALEN CROSS-LINKING; GROUP-II INTRON; RIBONUCLEOPROTEIN-PARTICLES; SITE SELECTION; 2'-OME RNA; U6 SNRNA; U2 SNRNP; YEAST; U1; SPLICEOSOME	Precursor messenger RNA splicing requires multiple factors including U1, U2, U4, U5, and U6 small nuclear RNA's. The crosslinking reagent psoralen was used to analyze the interactions of these RNA's with an adenovirus precursor messenger RNA in HeLa nuclear extract. An endogenous U2-U4-U6 crosslinkable complex dissociated upon incubation with precursor messenger RNA. During splicing, U1, U2, U5, and U6 became crosslinked to precursor messenger RNA and U2, U5, and U6 became crosslinked to excised lariat intron. U2 also formed a doubly crosslinked complex with U6 and precursor messenger RNA. The U1, U5, and U6 crosslinks to the precursor messenger RNA mapped to intron sequences near the 5' splice site, whereas the U2 crosslink mapped to the branch site. The kinetics of crosslink formation and disappearance delineates a temporal pathway for the action of small RNA's in the spliceosome. Potential base pairing interactions between conserved sequences in the small nuclear RNA's and precursor messenger RNA at the sites of crosslinking suggest that the 5' splice site is defined in several steps prior to the first cleavage event.			WASSARMAN, DA (corresponding author), YALE UNIV, SCH MED, DEPT MOLEC BIOPHYS & BIOCHEM, HOWARD HUGHES MED INST, 295 CONGRESS AVE, NEW HAVEN, CT 06536 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026154, R01GM026154] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26154] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABMAYR SM, 1988, P NATL ACAD SCI USA, V85, P7216, DOI 10.1073/pnas.85.19.7216; BARABINO SML, 1989, EMBO J, V8, P4171, DOI 10.1002/j.1460-2075.1989.tb08602.x; BLACK DL, 1989, MOL CELL BIOL, V9, P3350, DOI 10.1128/MCB.9.8.3350; BLENCOWE BJ, 1989, CELL, V59, P531, DOI 10.1016/0092-8674(89)90036-6; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; BRUZIK JP, 1990, CELL, V62, P889, DOI 10.1016/0092-8674(90)90264-F; CALVET JP, 1987, J MOL BIOL, V197, P543, DOI 10.1016/0022-2836(87)90563-8; CALVET JP, 1982, SCIENCE, V217, P456, DOI 10.1126/science.6178162; CALVET JP, 1981, CELL, V26, P363, DOI 10.1016/0092-8674(81)90205-1; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; COPERTINO DW, 1991, EMBO J, V10, P433, DOI 10.1002/j.1460-2075.1991.tb07965.x; DATTA B, 1991, NATURE, V352, P821, DOI 10.1038/352821a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; England T E, 1980, Methods Enzymol, V65, P65; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; GARRETTWHEELER E, 1984, NUCLEIC ACIDS RES, V12, P3405, DOI 10.1093/nar/12.7.3405; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GOLDSCHMIDTCLERMONT M, 1991, CELL, V65, P135, DOI 10.1016/0092-8674(91)90415-U; GRABOWSKI PJ, 1986, SCIENCE, V233, P1294, DOI 10.1126/science.3638792; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GUPTA S, 1991, NUCLEIC ACIDS RES, V19, P2073, DOI 10.1093/nar/19.suppl.2073; GUTHRIE C, 1989, AM ZOOL, V29, P557; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; HAUSNER TP, 1990, GENE DEV, V4, P2146, DOI 10.1101/gad.4.12a.2146; JACQUIER A, 1991, J MOL BIOL, V219, P415, DOI 10.1016/0022-2836(91)90183-7; JACQUIER A, 1990, TRENDS BIOCHEM SCI, V15, P351, DOI 10.1016/0968-0004(90)90075-M; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; KNOOP V, 1991, EMBO J, V10, P3483, DOI 10.1002/j.1460-2075.1991.tb04912.x; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; LAMOND AI, 1989, CELL, V58, P383, DOI 10.1016/0092-8674(89)90852-0; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; LUND E, 1992, SCIENCE, V255, P327, DOI 10.1126/science.1549778; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; MADHANI HD, COMMUNICATION; MANIATIS T, 1987, NATURE, V325, P673, DOI 10.1038/325673a0; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKASHIMA K, 1980, NATURE, V286, P226, DOI 10.1038/286226a0; NEWMAN A, 1991, CELL, V65, P115, DOI 10.1016/0092-8674(91)90413-S; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; OSHIM AY, 1987, J MOL BIOL, V195, P297; PATTERSON B, 1987, CELL, V49, P613, DOI 10.1016/0092-8674(87)90537-X; REICH C, 1990, MOL CELL BIOL, V10, P5548, DOI 10.1128/MCB.10.10.5548; REICH CI, 1992, CELL, V69, P1159, DOI 10.1016/0092-8674(92)90637-R; RINKE J, 1985, J MOL BIOL, V185, P721, DOI 10.1016/0022-2836(85)90057-9; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; RUBY SW, 1991, TRENDS GENET, V7, P79; RYMOND BC, 1988, GENE DEV, V2, P428, DOI 10.1101/gad.2.4.428; RYMOND BC, 1985, NATURE, V317, P735, DOI 10.1038/317735a0; SAWA H, 1992, GENE DEV, V6, P244, DOI 10.1101/gad.6.2.244; SERAPHIN B, 1990, CELL, V63, P619, DOI 10.1016/0092-8674(90)90457-P; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; SHUSTER EO, 1990, NATURE, V345, P270, DOI 10.1038/345270a0; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SOLNICK D, 1985, CELL, V42, P157, DOI 10.1016/S0092-8674(85)80111-2; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; Steitz J. A., 1988, STRUCTURE FUNCTION M, P115; STEITZ JA, 1992, SCIENCE, V257, P888, DOI 10.1126/science.1386941; STEITZ JA, 1989, METHOD ENZYMOL, V180, P468; TANI T, 1991, GENE DEV, V5, P1022, DOI 10.1101/gad.5.6.1022; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; WASSARMAN D, UNPUB; WISSINGER B, 1991, CELL, V65, P473, DOI 10.1016/0092-8674(91)90465-B; WOLFF T, 1992, EMBO J, V11, P345, DOI 10.1002/j.1460-2075.1992.tb05057.x; WU J, 1991, NATURE, V352, P818, DOI 10.1038/352818a0; WYATT J, UNPUB; YEAN SL, 1991, MOL CELL BIOL, V11, P5571, DOI 10.1128/MCB.11.11.5571; ZAUG AJ, 1984, SCIENCE, V224, P574, DOI 10.1126/science.6200938	75	326	326	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	1992	257	5078					1918	1925		10.1126/science.1411506	http://dx.doi.org/10.1126/science.1411506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP594	1411506				2022-12-28	WOS:A1992JP59400025
J	ROBERTSON, RP				ROBERTSON, RP			SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - PANCREATIC AND ISLET TRANSPLANTATION FOR DIABETES - CURES OR CURIOSITIES	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							KIDNEY TRANSPLANTATION; INSULIN-SECRETION; GLUCOSE-TOLERANCE; MELLITUS; HYPOGLYCEMIA; ALLOGRAFTS; RECIPIENTS; PROGRESSION; RETINOPATHY; METABOLISM		UNIV MINNESOTA, SCH MED, DEPT MED, DIV ENDOCRINOL & METAB, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	ROBERTSON, RP (corresponding author), UNIV MINNESOTA, SCH MED, CTR DIABET, BOX 101 UMHC, MINNEAPOLIS, MN 55455 USA.		Roberston, R Paul/AAX-5613-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039994] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR 00400] Funding Source: Medline; NIDDK NIH HHS [R01 DK 39994] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARIDGE D, 1991, TRANSPLANT P, V23, P1670; BALLINGER WF, 1972, SURGERY, V72, P175; BENSON JW, 1977, J CLIN ENDOCR METAB, V44, P459, DOI 10.1210/jcem-44-3-459; BILOUS RW, 1989, NEW ENGL J MED, V321, P80, DOI 10.1056/NEJM198907133210204; BOHMAN SO, 1985, DIABETES, V34, P306, DOI 10.2337/diabetes.34.3.306; BOLINDER J, 1991, TRANSPLANT P, V23, P1667; BOLINDER J, 1991, Diabetologia, V34, pS76, DOI 10.1007/BF00587625; CALDARA R, 1991, CLIN TRANSPLANT, V5, P260; COTTRELL DA, 1991, DIABETES CARE, V14, P1111, DOI 10.2337/diacare.14.11.1111; DIEM P, 1990, J CLIN INVEST, V86, P2008, DOI 10.1172/JCI114936; DIEM P, 1990, DIABETES, V39, P534, DOI 10.2337/diabetes.39.5.534; Diem P, 1991, Schweiz Rundsch Med Prax, V80, P1179; ELAHI D, 1991, AM J PHYSIOL, V261, pE800, DOI 10.1152/ajpendo.1991.261.6.E800; GABER AO, 1991, TRANSPLANT P, V23, P1660; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; HOLDAAS H, 1991, Diabetologia, V34, pS68, DOI 10.1007/BF00587623; KATZ H, 1991, NEW ENGL J MED, V325, P1278, DOI 10.1056/NEJM199110313251804; KELLY WD, 1967, SURGERY, V61, P827; KENDALL DM, 1990, NEW ENGL J MED, V322, P898, DOI 10.1056/NEJM199003293221305; KENNEDY WR, 1990, NEW ENGL J MED, V322, P1031, DOI 10.1056/NEJM199004123221503; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LANDGRAF R, 1991, Diabetologia, V34, pS61, DOI 10.1007/BF00587622; LARGIADER F, 1980, TRANSPLANTATION, V29, P76, DOI 10.1097/00007890-198001000-00017; LAROCCA E, 1991, TRANSPLANT P, V23, P1672; LARSEN JL, 1992, DIABETES CARE, V15, P35, DOI 10.2337/diacare.15.1.35; LUZI L, 1990, DIABETOLOGIA, V33, P549, DOI 10.1007/BF00404143; NAJARIAN JS, 1980, ANN SURG, V192, P526, DOI 10.1097/00000658-198010000-00011; NAVARRO X, 1991, Diabetologia, V34, pS108; NAVARRO X, 1990, DIABETES, V39, P802, DOI 10.2337/diabetes.39.7.802; OSEI K, 1990, DIABETES, V39, P1235, DOI 10.2337/diabetes.39.10.1235; PETERSEN MR, 1990, OPHTHALMOLOGY, V97, P496, DOI 10.1016/S0161-6420(90)32556-3; PIEHLMEIER W, 1991, Diabetologia, V34, pS150, DOI 10.1007/BF00587644; POZZA G, 1983, DIABETOLOGIA, V24, P244; PYKE D, 1988, LANCET, V1, P816; PYZDROWSKI KL, 1992, NEW ENGL J MED, V327, P220, DOI 10.1056/NEJM199207233270402; RAMSAY RC, 1988, NEW ENGL J MED, V318, P208, DOI 10.1056/NEJM198801283180403; ROBERTSON R P, 1991, Diabetologia, V34, pS57, DOI 10.1007/BF00587621; ROBERTSON RP, 1991, DIABETES, V40, P1085, DOI 10.2337/diabetes.40.9.1085; ROBERTSON RP, 1986, DIABETES, V35, P1016, DOI 10.2337/diabetes.35.9.1016; SCHARP DW, 1990, DIABETES, V39, P515, DOI 10.2337/diabetes.39.4.515; SCHEIDER A, 1991, Diabetologia, V34, pS95, DOI 10.1007/BF00587630; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; SECCHI A, 1991, TRANSPLANT P, V23, P1658; SECCHI A, 1991, TRANSPLANTATION, V51, P625, DOI 10.1097/00007890-199103000-00016; SIBLEY RK, 1985, LAB INVEST, V53, P132; STRATTA RJ, 1991, AM J GASTROENTEROL, V86, P697; Sutherland D E, 1991, Clin Transpl, P31; SUTHERLAND DER, 1989, ANN SURG, V210, P274, DOI 10.1097/00000658-198909000-00003; TATTERSALL R, 1989, NEW ENGL J MED, V321, P112, DOI 10.1056/NEJM198907133210210; TZAKIS AG, 1990, LANCET, V336, P402, DOI 10.1016/0140-6736(90)91946-8; WARNOCK GL, 1992, DIABETOLOGIA, V35, P89, DOI 10.1007/BF00400857; WARNOCK GL, 1991, DIABETOLOGIA, V34, P55, DOI 10.1007/BF00404026; YALE JF, 1985, DIABETES, V34, P1309, DOI 10.2337/diabetes.34.12.1309; ZEHRER C L, 1991, Diabetologia, V34, pS145, DOI 10.1007/BF00587643; 1985, NIH851468 PUBL	55	98	104	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	1992	327	26					1861	1868						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KD714	1448124				2022-12-28	WOS:A1992KD71400007
J	BRADDICK, O; ATKINSON, J; HOOD, B; HARKNESS, W; JACKSON, G; VARGHAKHADEM, F				BRADDICK, O; ATKINSON, J; HOOD, B; HARKNESS, W; JACKSON, G; VARGHAKHADEM, F			POSSIBLE BLINDSIGHT IN INFANTS LACKING ONE CEREBRAL HEMISPHERE	NATURE			English	Article							VISUAL FUNCTION; FIELD; CHILDREN; NUCLEUS	PATIENTs with damage to the striate cortex have a subjectively blind region of the visual field, but may still be able to detect and localize targets within this region1,2. But the relative roles in this 'blindsight' of subcortical neural systems, and of pathways to extra-striate visual areas, have been uncertain3. Here we report results on two infants in whom one cerebral hemisphere, including both striate and extra-striate visual cortex, needed surgical removal in their first year. Single conspicuous targets in the half-field contralateral to the lesion could elicit fixations, implying detection and orienting by a subcortical system. In contrast, binocular optokinetic nystagmus (OKN), for which a subcortical pathway has often been thought adequate, showed a marked asymmetry. In normal neonates, fixation shifts and OKN have both been taken to reflect subcortical control4; our results are consistent with subcortical control for fixation but not for OKN.	INST CHILD HLTH, LONDON WC1, ENGLAND; HOSP SICK CHILDREN, LONDON WC1N 3JH, ENGLAND	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	BRADDICK, O (corresponding author), UNIV CAMBRIDGE, DEPT EXPTL PSYCHOL, VISUAL DEV UNIT, DOWNING ST, CAMBRIDGE CB2 3EB, ENGLAND.		Vargha-Khadem, Faraneh/C-2558-2008; Jackson, Graeme/AAD-9070-2019; Braddick, Oliver/O-2507-2019; Jackson, Graeme D/A-9064-2013	Jackson, Graeme/0000-0002-7917-5326; Braddick, Oliver/0000-0002-7540-171X; Jackson, Graeme D/0000-0002-7917-5326				ATKINSON J, 1984, HUM NEUROBIOL, V3, P61; ATKINSON J, 1979, DEV NEUROBIOLOGY VIS; ATKINSON J, IN PRESS J PERCEPTIO; BRONSON G, 1974, CHILD DEV, V45, P873, DOI 10.1111/j.1467-8624.1974.tb00683.x; COWEY A, 1991, TRENDS NEUROSCI, V14, P140, DOI 10.1016/0166-2236(91)90085-9; CRONE RA, 13TH ISCERG S DOC OP, V45, P9; HARRIS L, IN PRESS EXPL BRAIN; HOFFMANN KP, 1975, BRAIN RES, V99, P359, DOI 10.1016/0006-8993(75)90037-2; HOFFMANN KP, 1989, PROG BRAIN RES, V80, P173; HOOD B, 1990, DEV MED CHILD NEUROL, V32, P1067; LEWIS TL, 1985, VISION RES, V25, P943, DOI 10.1016/0042-6989(85)90205-6; MEHDORN E, 1983, INVEST OPHTH VIS SCI, V24, P23; MOHN G, 1986, DOC OPHTHALMOL, V45, P363; PERENIN MT, 1978, NEUROPSYCHOLOGIA, V16, P1, DOI 10.1016/0028-3932(78)90037-4; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; PTITO A, 1987, NEUROPSYCHOLOGIA, V25, P869, DOI 10.1016/0028-3932(87)90092-3; RAFAL R, 1990, SCIENCE, V250, P118, DOI 10.1126/science.2218503; Schiller P. H., 1984, HDB PHYSL 1, V3, P457; TERBRAAK JW, 1971, J NEUROL NEUROSUR PS, V34, P140; VANHOFVANDUIN J, 1983, BEHAV BRAIN RES, V10, P163, DOI 10.1016/0166-4328(83)90162-6; WEISKRANTZ L, 1987, BLINDSIGHT CASE STUD	21	101	102	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	1992	360	6403					461	463		10.1038/360461a0	http://dx.doi.org/10.1038/360461a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448169				2022-12-28	WOS:A1992KA79700059
J	MARINER, WK				MARINER, WK			PROBLEMS WITH EMPLOYER-PROVIDED HEALTH-INSURANCE - THE EMPLOYEE RETIREMENT INCOME SECURITY ACT AND HEALTH-CARE REFORM	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									BOSTON UNIV,SCH MED,BOSTON,MA 02118	Boston University	MARINER, WK (corresponding author), BOSTON UNIV,SCH PUBL HLTH,BOSTON,MA 02118, USA.			Mariner, Wendy/0000-0001-5176-5917				DUKAKIS MS, 1992, NEW ENGL J MED, V327, P1090, DOI 10.1056/NEJM199210083271510; FREUDENHEIM M, 1992, NY TIMES        1013, pD2; Hiam P, 1987, Law Med Health Care, V15, P212; JACKSON MH, 1992, AIDS AGENDA EMERGING, P147; KOLATA G, 1992, NY TIMES        1122, P1; LEVIN DGM, 1992, NY TIMES        0826, pD3; LUNDBERG GD, 1991, JAMA-J AM MED ASSOC, V265, P2566; MILES SH, 1992, NEW ENGL J MED, V327, P1092, DOI 10.1056/NEJM199210083271511; SULLIVAN CB, 1991, HEALTH AFFAIR, V10, P104, DOI 10.1377/hlthaff.10.2.104; 1992, WALL STREET J   0824, pA3; 1992, HLTH CARE REFORM TRA; [No title captured]; 1992, ANN INTERN MED, V117, P511; 1989, HLTH NAITON SHARED R	14	21	21	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 3	1992	327	23					1682	1686		10.1056/NEJM199212033272312	http://dx.doi.org/10.1056/NEJM199212033272312			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KA260	1435904				2022-12-28	WOS:A1992KA26000012
J	VAZEUX, R; HOFFMAN, PA; TOMITA, JK; DICKINSON, ES; JASMAN, RL; STJOHN, T; GALLATIN, WM				VAZEUX, R; HOFFMAN, PA; TOMITA, JK; DICKINSON, ES; JASMAN, RL; STJOHN, T; GALLATIN, WM			CLONING AND CHARACTERIZATION OF A NEW INTERCELLULAR-ADHESION MOLECULE ICAM-R	NATURE			English	Article							IMMUNOGLOBULIN; LFA-1; SUPERFAMILY; ACTIVATION; SEQUENCES; RECEPTOR; SYSTEM	THE human intercellular adhesion molecules ICAM-1, ICAM-2 and their counter-receptors, the beta2 or leukointegrins, mediate a variety of homotypic and heterotypic leukocyte and endothelial cell-cell adhesions central to immunocompetence1. It has been found2 that cell-cell adhesion which is dependent on expression of the leukocyte function-associated antigen LFA-1 is not always blocked completely by antibodies raised against ICAM-1 and ICAM-2. Other leukointegrin ligands therefore probably exist, such as a glycoprotein of M(r) 124K that binds LFA-1 and has been designated ICAM-3 on the basis of this function3. We have molecularly cloned a new member of the ICAM family, ICAM-R, which is related to ICAM-1 and ICAM-2. The complementary DNA encoding ICAM-R is 1,781 base pairs long and the protein has five extracellular immunoglobulin-family type domains. The mature cell-surface form of the ICAM-R protein has an M(r) which varies from 116 to 140K in a cell type-specific fashion. Overall identities in protein sequence with ICAM-1 and ICAM-2 are 48% and 31% respectively, with the degree of similarity varying between individual domains. The high level of expression of ICAM-R on resting leukocytes of all lineages and its lack of expression on either resting or cytokine-activated endothelial cells indicates a pattern of expression distinct from ICAM-1 and ICAM-2. In common with ICAM-1 and ICAM-2, ICAM-R is a ligand for the beta2-integrin CD11a/LFA-1 (CD18).	ICOS CORP, 22021 20TH AVE SE, BOTHELL, WA 98021 USA	Icos Corporation								AKELLA R, 1992, EUR J IMMUNOL, V22, P1069, DOI 10.1002/eji.1830220429; BAGNASCO M, 1990, CELL IMMUNOL, V128, P362, DOI 10.1016/0008-8749(90)90033-N; CLARK EA, 1986, HUM IMMUNOL, V16, P100, DOI 10.1016/0198-8859(86)90039-X; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MAKGOBA MW, 1988, EUR J IMMUNOL, V18, P637, DOI 10.1002/eji.1830180423; NOTTENBURG C, 1990, GENE, V95, P279, DOI 10.1016/0378-1119(90)90372-X; POBER JS, 1986, J IMMUNOL, V137, P1893; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; TOSI MF, 1992, AM J RESP CELL MOL, V7, P214, DOI 10.1165/ajrcmb/7.2.214; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	17	202	220	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	1992	360	6403					485	488		10.1038/360485a0	http://dx.doi.org/10.1038/360485a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448174				2022-12-28	WOS:A1992KA79700066
J	WENGER, NS; GREENBERG, JM; HILBORNE, LH; KUSSELING, F; MANGOTICH, M; SHAPIRO, MF				WENGER, NS; GREENBERG, JM; HILBORNE, LH; KUSSELING, F; MANGOTICH, M; SHAPIRO, MF			EFFECT OF HIV ANTIBODY TESTING AND AIDS EDUCATION ON COMMUNICATION ABOUT HIV RISK AND SEXUAL-BEHAVIOR - A RANDOMIZED, CONTROLLED TRIAL IN COLLEGE-STUDENTS	ANNALS OF INTERNAL MEDICINE			English	Article						ACQUIRED IMMUNODEFICIENCY SYNDROME; KNOWLEDGE, ATTITUDES, PRACTICE; STUDENT HEALTH SERVICES; HUMAN IMMUNODEFICIENCY VIRUS	HOMOSEXUAL MEN; KNOWLEDGE; PEOPLE; POPULATION; HEALTH	Objective: To evaluate the effects of human immunodeficiency virus (HIV) antibody testing and education about HIV infection on communication about sexual risk behaviors for HIV transmission. Design: Randomized, controlled trial with three arms. Setting: University student health center. Patients: Of 2196 heterosexual university students attending the student health clinic for medical care, 435 were interested in education about HIV and HIV testing and were randomly assigned to three groups. Follow-up at 6 months was done in 370 subjects (85%): 90 control subjects, 144 subjects who received education alone, and 136 subjects who received education plus HIV testing. Measurements and Results: Subjects who received HIV testing plus education questioned sexual partners about their HIV status more than subjects receiving education alone or those in the control group (56%, 42%, and 41% of subjects, respectively; P = 0.01). No consistent differences among groups in the number of sexual partners or in the use of condoms were found at follow-up. Conclusions. Heterosexual university students who received education about HIV infection plus HIV testing had increased communication with sexual partners about the risk for HIV infection after 6 months. Further reduction in risk behaviors for HIV transmission may require additional interventions in this population.	UNIV CALIF LOS ANGELES, HLTH SERV, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles	WENGER, NS (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DIV GEN INTERNAL MED, B-564 FACTOR BLDG, LOS ANGELES, CA 90024 USA.							BECKER MH, 1988, AM J PUBLIC HEALTH, V78, P394, DOI 10.2105/AJPH.78.4.394; BLENDON RJ, 1988, NEW ENGL J MED, V319, P1022, DOI 10.1056/NEJM198810133191522; BROOK RH, 1979, MED CARE, V17, pS1; COATES TJ, 1988, AM PSYCHOL, V43, P859, DOI 10.1037/0003-066X.43.11.859; COATES TJ, 1987, JAMA-J AM MED ASSOC, V258, P1889, DOI 10.1001/jama.1987.03400140051006; COCHRAN SD, 1990, NEW ENGL J MED, V322, P774, DOI 10.1056/NEJM199003153221111; CRAIG ME, 1989, ARCH SEX BEHAV, V18, P421, DOI 10.1007/BF01541973; DAWSON DA, 1989, 176 NAT CTR HLTH STA; FOLDSPANG A, 1990, J ACQ IMMUN DEF SYND, V3, P737; FOX R, 1987, AIDS, V1, P241; Gilliam A, 1989, J Am Coll Health, V37, P261; HEARST N, 1988, JAMA-J AM MED ASSOC, V259, P2428, DOI 10.1001/jama.259.16.2428; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; HOLMES KK, 1990, AM J PUBLIC HEALTH, V80, P858, DOI 10.2105/AJPH.80.7.858; HULL HF, 1988, JAMA-J AM MED ASSOC, V260, P935, DOI 10.1001/jama.260.7.935; KEGELES SM, 1990, AIDS, V4, P585, DOI 10.1097/00002030-199006000-00016; KELING RP, 1988, J AM COLL HEALTH, V37, P121; LANDEFELD CS, 1988, J GEN INTERN MED, V3, P161, DOI 10.1007/BF02596125; MACDONALD NE, 1990, JAMA-J AM MED ASSOC, V263, P3155, DOI 10.1001/jama.263.23.3155; Manning D T, 1989, J Am Coll Health, V37, P254; MCCUSKER J, 1988, AM J PUBLIC HEALTH, V78, P462, DOI 10.2105/AJPH.78.4.462; PERRY SW, 1990, AIDS, V4, P145, DOI 10.1097/00002030-199002000-00008; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Thurman Q C, 1990, J Am Coll Health, V38, P179; VANGRIENSVEN GJP, 1989, AM J EPIDEMIOL, V129, P596; WEINSTEIN ND, 1984, HEALTH PSYCHOL, V3, P431, DOI 10.1037/0278-6133.3.5.431; WENGER NS, 1991, AM J PUBLIC HEALTH, V81, P1580, DOI 10.2105/AJPH.81.12.1580; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; ZENILMAN JM, 1992, JAMA-J AM MED ASSOC, V267, P843, DOI 10.1001/jama.267.6.843; 1990, MMWR, V39, P137; 1990, MMWR, V39, P685; 1987, SEX DRUGS AIDS	32	62	62	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					905	911		10.7326/0003-4819-117-11-905	http://dx.doi.org/10.7326/0003-4819-117-11-905			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443951				2022-12-28	WOS:A1992JZ27600005
J	BAKER, JR				BAKER, JR			IMMUNOLOGICAL ASPECTS OF ENDOCRINE DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEPENDENT DIABETES-MELLITUS; AUTOIMMUNE THYROID-DISEASE; THYROTROPIN RECEPTOR; IMMUNE-MECHANISMS; ADDISONS-DISEASE; GRAVES-DISEASE; AUTOANTIBODIES; SUSCEPTIBILITY		UNIV MICHIGAN, SCH MED, DEPT PATHOL, ANN ARBOR, MI 48104 USA	University of Michigan System; University of Michigan	BAKER, JR (corresponding author), UNIV MICHIGAN, SCH MED, DEPT INTERNAL MED, ANN ARBOR, MI 48104 USA.							AOZASA M, 1989, CLIN IMMUNOL IMMUNOP, V52, P516, DOI 10.1016/0090-1229(89)90164-5; APPELBOOM TM, 1982, CUTIS, V30, P71; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BAHN RS, 1990, J CLIN ENDOCR METAB, V71, P559, DOI 10.1210/jcem-71-3-559; BAISCH JM, 1990, NEW ENGL J MED, V322, P1836, DOI 10.1056/NEJM199006283222602; BAKER JR, 1988, ANN INTERN MED, V108, P26, DOI 10.7326/0003-4819-108-1-26; BAKER JR, 1990, PRINCIPLES PRACTICE, P1401; BETTERLE C, 1983, LANCET, V1, P1238; BURKE CW, 1985, CLIN ENDOCRINOL META, V14, P947, DOI 10.1016/S0300-595X(85)80084-0; BURMAN KD, 1985, ENDOCR REV, V6, P183, DOI 10.1210/edrv-6-2-183; DUSSAULT JH, 1987, ENDOCRIN METAB CLIN, V16, P417, DOI 10.1016/S0889-8529(18)30487-0; GERSTEIN HC, 1990, ARCH INTERN MED, V150, P1397, DOI 10.1001/archinte.150.7.1397; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; LATINNE D, 1987, TISSUE ANTIGENS, V30, P23; LERNMARK A, 1987, DIABETES METAB REV, V3, P959, DOI 10.1002/dmr.5610030407; LIBERT F, 1991, J CLIN ENDOCR METAB, V73, P857, DOI 10.1210/jcem-73-4-857; MACKENZIE WA, 1987, J CLIN ENDOCR METAB, V64, P818, DOI 10.1210/jcem-64-4-818; MCDOUGALL IR, 1991, MED CLIN N AM, V75, P79, DOI 10.1016/S0025-7125(16)30473-4; NEUFELD M, 1980, PEDIATR ANN, V9, P43, DOI 10.3928/0090-4481-19800401-07; PARHAM P, 1990, NATURE, V345, P662, DOI 10.1038/345662a0; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; RILEY WJ, 1990, NEW ENGL J MED, V323, P1167, DOI 10.1056/NEJM199010253231704; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; WEETMAN AP, 1984, ENDOCR REV, V5, P309, DOI 10.1210/edrv-5-2-309; WILSON K, 1990, ANNU REV MED, V41, P497	25	20	21	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2899	2903		10.1001/jama.268.20.2899	http://dx.doi.org/10.1001/jama.268.20.2899			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433706				2022-12-28	WOS:A1992JY66800014
J	ROBERT, D; AMOROSO, J; HOY, RR				ROBERT, D; AMOROSO, J; HOY, RR			THE EVOLUTIONARY CONVERGENCE OF HEARING IN A PARASITOID FLY AND ITS CRICKET HOST	SCIENCE			English	Article							EUPHASIOPTERYX-OCHRACEA; SEXUAL DIFFERENCES; SENSITIVITY	Parasitism is a widespread and diverse life strategy that connects species throughout the animal kingdom. Female parasitoid flies of the genus Ormia must find a specific cricket host on which to deposit their parasitic maggots. To reproduce, female flies must perform the same task as female crickets: find a singing male cricket. These flies have evolved a unique hearing organ that allows them to detect and locate singing male crickets. Through evolutionary convergence, these flies possess a hearing organ that much more resembles a cricket's ear than a typical fly's ear, allowing these parasitoids to take advantage of the sensory ecological niche of their host.	CORNELL UNIV, NEUROBIOL & BEHAV SECT, ITHACA, NY 14853 USA; UNIV FLORIDA, DEPT ENTOMOL & NEMATOL, GAINESVILLE, FL 32611 USA	Cornell University; State University System of Florida; University of Florida					NIDCD NIH HHS [DC00103] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000103] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAILEY WJ, 1991, J COMP PHYSIOL A, V169, P349; BENNETCLARK HC, 1968, J EXP BIOL, V49, P117; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; CARDONE B, 1988, PHYSIOL ENTOMOL, V13, P9, DOI 10.1111/j.1365-3032.1988.tb00903.x; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; GRAY E. G., 1960, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V243, P75, DOI 10.1098/rstb.1960.0005; HALL JC, 1985, COMPREHENSIVE INSECT, V9, P287; LAKESHARLAN R, 1992, NATURWISSENSCHAFTEN, V79, P224, DOI 10.1007/BF01227133; MANGOLD JR, 1978, FLA ENTOMOL, V61, P57, DOI 10.2307/3494638; Michelsen A., 1985, COMPREHENSIVE INSECT, P495; MOISEFF A, 1983, J COMP PHYSIOL, V152, P155, DOI 10.1007/BF00611181; Moulins M., 1976, STRUCTURE FUNCTION P; NARINS PM, 1976, SCIENCE, V192, P378, DOI 10.1126/science.1257772; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; Sokal R. R, 1981, BIOMETRY; WALKER TJ, 1986, FLA ENTOMOL, V69, P678, DOI 10.2307/3495213; WALKER TJ, 1962, EVOLUTION, V16, P407, DOI 10.2307/2406176; YAGER DD, 1990, J ZOOL, V221, P517, DOI 10.1111/j.1469-7998.1990.tb04017.x; YAGER DD, 1986, SCIENCE, V231, P727, DOI 10.1126/science.3945806	19	148	155	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	1992	258	5085					1135	1137		10.1126/science.1439820	http://dx.doi.org/10.1126/science.1439820			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX852	1439820				2022-12-28	WOS:A1992JX85200027
J	ARNOLD, D; DRISCOLL, J; ANDROLEWICZ, M; HUGHES, E; CRESSWELL, P; SPIES, T				ARNOLD, D; DRISCOLL, J; ANDROLEWICZ, M; HUGHES, E; CRESSWELL, P; SPIES, T			PROTEASOME SUBUNITS ENCODED IN THE MHC ARE NOT GENERALLY REQUIRED FOR THE PROCESSING OF PEPTIDES BOUND BY MHC CLASS-I MOLECULES	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; LINKED LMP; GENE; HLA; EXPRESSION; REGION; HEAVY; IDENTIFICATION; TRANSPORTER; DETERMINANT	ANTIGEN processing provides major histocompatibility complex (MHC) class I molecules with short peptides, which they selectively bind and present to cytotoxic T lymphocytes1-4. The proteolytic system generating these peptides in the cytosol is unidentified, but their delivery into the endoplasmic reticulum is mediated by the TAP1-TAP2 transporter encoded in the MHC class II region5-9. Closely linked to TAP1 and TAP2 are genes for the LMP2 and LMP7 proteins10, which resemble components of proteasomes11-13, proteolytic complexes known to degrade cytosolic proteins14. This association has led to the common assumption that proteasomes function in this immunological pathway (discussed in ref. 15). We now show that the expression of stably assembled class I molecules and apparently normal peptide processing can be completely restored in the absence of LMP2 and LMP7 in the human lymphoblastoid cell line mutant 721.174 (refs 16, 17). The identity of LMP7 is directly confirmed by reconstitution of a proteasomal subunit after gene transfer. These results therefore dispute the hypothetical involvement of proteasomes in antigen processing, although a more subtle effect of LMP2 and LMP7 cannot be ruled out.	HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Yale University	ARNOLD, D (corresponding author), HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR VIROL,44 BINNEY ST,BOSTON,MA 02115, USA.			Driscoll, James/0000-0001-8364-0617				ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; Coligan JKA, 1991, CURRENT PROTOCOLS IM; DEMARS R, 1985, P NATL ACAD SCI USA, V82, P8183, DOI 10.1073/pnas.82.23.8183; DRISCOLL J, 1989, P NATL ACAD SCI USA, V86, P787, DOI 10.1073/pnas.86.3.787; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FRUH K, 1992, J BIOL CHEM, V267, P22131; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; HAYNES BF, 1982, HUM IMMUNOL, V4, P273, DOI 10.1016/0198-8859(82)90001-5; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KVIST S, 1990, NATURE, V348, P446, DOI 10.1038/348446a0; LJUNGGREN HG, 1990, NATURE, V346, P478; LONG EO, 1991, HUM IMMUNOL, V31, P229, DOI 10.1016/0198-8859(91)90092-N; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; MONACO JJ, 1982, P NATL ACAD SCI-BIOL, V79, P3001, DOI 10.1073/pnas.79.9.3001; OZATO K, 1981, J IMMUNOL, V126, P317; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; WAYS JP, 1986, J IMMUNOL, V137, P217; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928	36	221	226	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 12	1992	360	6400					171	174		10.1038/360171a0	http://dx.doi.org/10.1038/360171a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX752	1436094				2022-12-28	WOS:A1992JX75200064
J	NIKOLOV, DB; HU, SH; LIN, J; GASCH, A; HOFFMANN, A; HORIKOSHI, M; CHUA, NH; ROEDER, RG; BURLEY, SK				NIKOLOV, DB; HU, SH; LIN, J; GASCH, A; HOFFMANN, A; HORIKOSHI, M; CHUA, NH; ROEDER, RG; BURLEY, SK			CRYSTAL-STRUCTURE OF TFIID TATA-BOX BINDING-PROTEIN	NATURE			English	Article							RNA POLYMERASE-II; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; FUNCTIONAL DOMAINS; CONSERVED DOMAIN; YEAST; GENE; INITIATION; CLONING	The structure of a central component of the eukaryotic transcriptional apparatus, a TATA-box binding protein (TBP or TFIIDtau) from Arabidopsis thaliana, has been determined by X-ray crystallography at 2.6 angstrom resolution. This highly symmetric alpha/beta structure contains a new DNA-binding fold, resembling a molecular 'saddle' that sits astride the DNA. The DNA-binding surface is a curved, antiparallel beta-sheet. When bound to DNA, the convex surface of the saddle would be presented for interaction with other transcription initiation factors and regulatory proteins.	ROCKEFELLER UNIV,MOLEC BIOPHYS LABS,1230 YORK AVE,NEW YORK,NY 10021; ROCKEFELLER UNIV,PLANT MOLEC BIOL LAB,NEW YORK,NY 10021; ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021; ROCKEFELLER UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10021	Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University				Burley, Stephen K./0000-0002-2487-9713				BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BURATOWSKI S, 1988, NATURE, V334, P37, DOI 10.1038/334037a0; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CAVALLINI B, 1989, P NATL ACAD SCI USA, V86, P9803, DOI 10.1073/pnas.86.24.9803; CAVALLINI B, 1988, NATURE, V334, P77, DOI 10.1038/334077a0; CHAIT BT, 1992, SCIENCE, V257, P1885, DOI 10.1126/science.1411504; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; CORMACK BP, 1991, CELL, V65, P341, DOI 10.1016/0092-8674(91)90167-W; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; FIKES JD, 1990, NATURE, V346, P291, DOI 10.1038/346291a0; GABRIELSEN OS, 1991, TRENDS BIOCHEM SCI, V16, P412, DOI 10.1016/0968-0004(91)90166-S; GASCH A, 1990, NATURE, V346, P390, DOI 10.1038/346390a0; GILL G, 1991, CELL, V65, P333, DOI 10.1016/0092-8674(91)90166-V; HAASS MM, 1992, FEBS LETT, V301, P294, DOI 10.1016/0014-5793(92)80260-N; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HAHN S, 1989, CELL, V58, P1173, DOI 10.1016/0092-8674(89)90515-1; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; HOFFMANN A, 1990, GENE DEV, V4, P1141, DOI 10.1101/gad.4.7.1141; HOLDSWORTH MJ, 1992, PLANT MOL BIOL, V19, P455, DOI 10.1007/BF00023393; HORIKOSHI M, 1989, P NATL ACAD SCI USA, V86, P4843, DOI 10.1073/pnas.86.13.4843; HORIKOSHI M, 1989, NATURE, V341, P299, DOI 10.1038/341299a0; HORIKOSHI M, 1992, P NATL ACAD SCI USA, V89, P1060, DOI 10.1073/pnas.89.3.1060; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KATAGIRI F, 1992, TRENDS GENET, V8, P22, DOI 10.1016/0168-9525(92)90020-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; LEE DK, 1991, CELL, V67, P1241, DOI 10.1016/0092-8674(91)90300-N; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MUHICH ML, 1990, P NATL ACAD SCI USA, V87, P9148, DOI 10.1073/pnas.87.23.9148; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Phillips SEV, 1991, CURR OPIN STRUC BIOL, V1, P89, DOI 10.1016/0959-440X(91)90016-M; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; REEDER RH, 1990, TRENDS GENET, V6, P390, DOI 10.1016/0168-9525(90)90298-K; RICHARDSON JS, 1985, METHOD ENZYMOL, V115, P359; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SCHMIDT MC, 1989, P NATL ACAD SCI USA, V86, P7785, DOI 10.1073/pnas.86.20.7785; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; SENTENAC A, 1985, CRC CR REV BIOCH MOL, V18, P31, DOI 10.3109/10409238509082539; SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6; STARR DB, 1991, CELL, V67, P1231, DOI 10.1016/0092-8674(91)90299-E; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; STUCKA R, 1990, FEBS LETT, V261, P223, DOI 10.1016/0014-5793(90)80558-Z; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKADA R, IN PRESS P NATN ACAD; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WHITE RJ, 1992, TRENDS GENET, V8, P284, DOI 10.1016/0168-9525(92)90255-3; WILEY SR, 1992, P NATL ACAD SCI USA, V89, P58144; YAMAMOTO T, 1992, P NATL ACAD SCI USA, V89, P2844, DOI 10.1073/pnas.89.7.2844; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6; ZHOU Q, 1991, EMBO J, V10, P1843, DOI 10.1002/j.1460-2075.1991.tb07710.x	67	355	359	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 5	1992	360	6399					40	46		10.1038/360040a0	http://dx.doi.org/10.1038/360040a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW717	1436073				2022-12-28	WOS:A1992JW71700046
J	OWENHUGHES, TA; PAVITT, GD; SANTOS, DS; SIDEBOTHAM, JM; HULTON, CSJ; HINTON, JCD; HIGGINS, CF				OWENHUGHES, TA; PAVITT, GD; SANTOS, DS; SIDEBOTHAM, JM; HULTON, CSJ; HINTON, JCD; HIGGINS, CF			THE CHROMATIN-ASSOCIATED PROTEIN H-NS INTERACTS WITH CURVED DNA TO INFLUENCE DNA TOPOLOGY AND GENE-EXPRESSION	CELL			English	Article							HISTONE-LIKE PROTEINS; OSMOREGULATED PROU PROMOTER; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; OSMOTIC REGULATION; BINDING-PROTEIN; NUCLEOTIDE-SEQUENCE; PROLINE TRANSPORT; GLYCINE BETAINE; RNA-POLYMERASE	H-NS is an abundant structural component of bacterial chromatin and influences many cellular processes, including recombination, transposition, and transcription. We have studied the mechanism of action of H-NS at the osmotically regulated proU promoter. The interaction of H-NS with a curved DNA element located downstream of the proU promoter is required for normal regulation of expression. Heterologous curved sequences can replace the regulatory role of the proU curve. Hence, the luxAB and lacZ reporter genes, which differ in the presence or absence of a curve, can indicate very different patterns of transcription. H-NS interacts preferentially with these curved DNA elements in vitro. Furthermore, in vivo the interaction of H-NS with curved DNA participates in the control of plasmid linking number. The data suggest that H-NS-dependent changes in DNA topology play a role in the osmoregulation of proU expression.			OWENHUGHES, TA (corresponding author), UNIV OXFORD,JOHN RADCLIFFE HOSP,IMPERIAL CANC RES FUND,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND.		Santos, Diógenes/A-6647-2008; Pavitt, Graham D/A-1363-2010; Hinton, Jay C. D./B-2142-2008	Santos, Diógenes/0000-0003-4971-463X; Pavitt, Graham D/0000-0002-8593-2418; Hinton, Jay C. D./0000-0003-2671-6026; Owen-Hughes, Tom/0000-0002-0618-8185				BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; BHRIAIN NN, 1989, MOL MICROBIOL, V3, P933, DOI 10.1111/j.1365-2958.1989.tb00243.x; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; CAIRNEY J, 1985, J BACTERIOL, V164, P1224, DOI 10.1128/JB.164.3.1224-1232.1985; CALLADINE CR, 1991, J MOL BIOL, V221, P981, DOI 10.1016/0022-2836(91)80187-Y; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; COLLIS CM, 1989, NUCLEIC ACIDS RES, V17, P9447, DOI 10.1093/nar/17.22.9447; DATTANANDA CS, 1991, J BACTERIOL, V173, P7481, DOI 10.1128/jb.173.23.7481-7490.1991; DAYN A, 1991, J BACTERIOL, V173, P2658, DOI 10.1128/jb.173.8.2658-2664.1991; DIEKMANN S, 1987, NUCLEIC ACIDS RES, V15, P247, DOI 10.1093/nar/15.1.247; DORMAN CJ, 1990, NATURE, V344, P789, DOI 10.1038/344789a0; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; DRLICA K, 1992, MOL MICROBIOL, V6, P425, DOI 10.1111/j.1365-2958.1992.tb01486.x; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; DRUGERLIOTTA J, 1986, J BACTERIOL, V169, P2449; DUNLAP VJ, 1985, J BACTERIOL, V163, P296, DOI 10.1128/JB.163.1.296-304.1985; EPSTEIN W, 1965, J GEN PHYSIOL, V49, P221, DOI 10.1085/jgp.49.2.221; FALCONI M, 1988, MOL MICROBIOL, V2, P323, DOI 10.1111/j.1365-2958.1988.tb00035.x; FALCONI M, 1991, NEW BIOL, V3, P615; FIGUEROA N, 1991, EMBO J, V10, P941, DOI 10.1002/j.1460-2075.1991.tb08028.x; FORAN DR, 1988, NUCLEIC ACIDS RES, V16, P777, DOI 10.1093/nar/16.2.777; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; GOWRISHANKAR J, 1989, J BACTERIOL, V171, P1923, DOI 10.1128/jb.171.4.1923-1931.1989; GOWRISHANKAR J, 1985, J BACTERIOL, V164, P434, DOI 10.1128/JB.164.1.434-445.1985; GUALERZI CO, 1986, BACTERIAL CHROMATIN, P101; HIGGINS CF, 1990, MOL MICROBIOL, V4, P2007, DOI 10.1111/j.1365-2958.1990.tb00559.x; HIGGINS CF, 1988, CELL, V52, P569, DOI 10.1016/0092-8674(88)90470-9; HINTON JCD, 1992, MOL MICROBIOL, V6, P2327, DOI 10.1111/j.1365-2958.1992.tb01408.x; HSIEH LS, 1991, J BACTERIOL, V173, P3914, DOI 10.1128/JB.173.12.3914-3917.1991; HULTON CSJ, 1990, CELL, V63, P631, DOI 10.1016/0092-8674(90)90458-Q; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; LEJEUNE P, 1990, P NATL ACAD SCI USA, V87, P360, DOI 10.1073/pnas.87.1.360; LUCHT JM, 1991, J BACTERIOL, V173, P801, DOI 10.1128/jb.173.2.801-809.1991; MAY G, 1990, MOL GEN GENET, V224, P81, DOI 10.1007/BF00259454; MAY G, 1986, MOL GEN GENET, V205, P225, DOI 10.1007/BF00430432; MAY G, 1989, MOL MICROBIOL, V3, P1521, DOI 10.1111/j.1365-2958.1989.tb00138.x; MCCLELLAN JA, 1990, P NATL ACAD SCI USA, V87, P8373, DOI 10.1073/pnas.87.21.8373; Miller J.H., 1972, EXPT MOL GENETICS; OVERDIER DG, 1989, J BACTERIOL, V171, P4694, DOI 10.1128/jb.171.9.4694-4706.1989; OVERDIER DG, 1992, P NATL ACAD SCI USA, V89, P3140, DOI 10.1073/pnas.89.7.3140; PARK SF, 1989, MOL MICROBIOL, V3, P1011, DOI 10.1111/j.1365-2958.1989.tb00252.x; PETTIJOHN DE, 1988, J BIOL CHEM, V263, P12793; PLASKON RR, 1987, NUCLEIC ACIDS RES, V15, P785, DOI 10.1093/nar/15.2.785; RIMSKY S, 1990, BIOCHEMISTRY-US, V29, P3765, DOI 10.1021/bi00467a024; ROTH JR, 1970, METHODS ENZYMOL    A, V17, P3; Sambrook J, 1989, MOL CLONING LABORATO; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SPASSKY A, 1984, NUCLEIC ACIDS RES, V12, P5321, DOI 10.1093/nar/12.13.5321; STIRLING DA, 1989, MOL MICROBIOL, V3, P1025, DOI 10.1111/j.1365-2958.1989.tb00253.x; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TANAKA K, 1991, MOL GEN GENET, V226, P367, DOI 10.1007/BF00260648; TRAVERS A, 1987, NATURE, V327, P280, DOI 10.1038/327280a0; TRAVERS AA, 1990, CELL, V60, P177, DOI 10.1016/0092-8674(90)90729-X; Travers AA, 1991, CURR OPIN STRUC BIOL, V1, P114, DOI 10.1016/0959-440X(91)90019-P; WEREL W, 1991, EMBO J, V10, P2589, DOI 10.1002/j.1460-2075.1991.tb07800.x; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; YAMADA H, 1990, J BIOCHEM-TOKYO, V108, P420, DOI 10.1093/oxfordjournals.jbchem.a123216; ZASLOFF M, 1978, NUCLEIC ACIDS RES, V5, P1139, DOI 10.1093/nar/5.4.1139; ZINKEL SS, 1991, J MOL BIOL, V219, P201, DOI 10.1016/0022-2836(91)90562-K; ZWIEB C, 1989, GENE DEV, V3, P606, DOI 10.1101/gad.3.5.606	62	265	273	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					255	265		10.1016/0092-8674(92)90354-F	http://dx.doi.org/10.1016/0092-8674(92)90354-F			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423593				2022-12-28	WOS:A1992JU39500011
J	HARVEY, RJ; BULLOCK, T; MONTGOMERY, SA				HARVEY, RJ; BULLOCK, T; MONTGOMERY, SA			DIARRHEA DURING TREATMENT WITH CLOZAPINE - ASSOCIATION WITH LYMPHOCYTE COUNT	BRITISH MEDICAL JOURNAL			English	Letter											HARVEY, RJ (corresponding author), ST MARYS HOSP,ACAD DEPT PSYCHIAT,LONDON W2 1NY,ENGLAND.		Harvey, Richard James/AAT-4667-2020	Harvey, Richard James/0000-0001-7796-0059				BALDESSARINI RJ, 1991, NEW ENGL J MED, V324, P746; IDANPAANHEIKKILA J, 1977, EUR J CLIN PHARMACOL, V11, P193, DOI 10.1007/BF00606409	2	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 3	1992	305	6857					810	810		10.1136/bmj.305.6857.810-a	http://dx.doi.org/10.1136/bmj.305.6857.810-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT256	1422362	Bronze, Green Published, Green Submitted			2022-12-28	WOS:A1992JT25600025
J	WOOD, RC; MACDONALD, KL; OSTERHOLM, MT				WOOD, RC; MACDONALD, KL; OSTERHOLM, MT			CAMPYLOBACTER ENTERITIS OUTBREAKS ASSOCIATED WITH DRINKING RAW-MILK DURING YOUTH ACTIVITIES - A 10-YEAR REVIEW OF OUTBREAKS IN THE UNITED-STATES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							JEJUNI INFECTION; SURVEILLANCE; CONSUMPTION; DISEASE; ENGLAND	Objective.-To determine the incidence of recognized outbreaks of Campylobacter enteritis associated with drinking raw milk during youth activities. Design.-Retrospective survey of 51 state and territorial health departments. Setting.-The 50 United States and the Territory of Puerto Rico. Populations.-Persons in preschool through college. Measurement.-Information was obtained for all Campylobacter outbreaks associated with consumption of raw milk during youth activities from 1981 through 1990 that were investigated by state and territorial health departments. Results.-Twenty outbreaks were identified in 11 states. Four hundred fifty-eight outbreak-associated cases occurred among 1013 persons who drank raw milk, with an overall attack rate of 45%. At least one outbreak was reported for each year of the 10-year period. Fourteen outbreaks (70%) occurred among children in kindergarten through third grade, compared with one outbreak (5%) among fourth through sixth graders. The remaining five outbreaks (25%) occurred in mixed groups of children and teenagers. Only nine (60%) of 15 outbreaks identified from 1981 through 1988 were reported to the Campylobacter national surveillance system maintained by the Centers for Disease Control and Prevention. Conclusion.-Drinking raw milk on school field trips or other youth activities continues despite the occurrence of multiple Campylobacter outbreaks documented from this practice. Such illnesses can be prevented by educating dairy farmers and officials of schools and youth organizations about the hazards of drinking raw milk. Public health organizations need to develop and implement such educational programs.	MINNESOTA DEPT HLTH,DIV DIS PREVENT & CONTROL,ACUTE DIS EPIDEMIOL SECT,717 DELAWARE ST SE,MINNEAPOLIS,MN 55440	Minnesota Department of Health (MHD)								BIRKHEAD G, 1988, J INFECT DIS, V157, P1095, DOI 10.1093/infdis/157.5.1095; BLASER MJ, 1987, JAMA-J AM MED ASSOC, V257, P43, DOI 10.1001/jama.257.1.43; BLASER MJ, 1983, ANN INTERN MED, V98, P360, DOI 10.7326/0003-4819-98-3-360; DEMING MS, 1987, AM J EPIDEMIOL, V126, P526, DOI 10.1093/oxfordjournals.aje.a114685; FINCH MJ, 1984, ARCH INTERN MED, V144, P1610, DOI 10.1001/archinte.144.8.1610; FINCH MJ, 1985, AM J EPIDEMIOL, V122, P262, DOI 10.1093/oxfordjournals.aje.a114097; GALBRAITH NS, 1982, BMJ-BRIT MED J, V284, P1761, DOI 10.1136/bmj.284.6331.1761; HARRIS NV, 1986, AM J PUBLIC HEALTH, V76, P407, DOI 10.2105/AJPH.76.4.407; HOPKINS RS, 1984, AM J PUBLIC HEALTH, V74, P249, DOI 10.2105/AJPH.74.3.249; HUDSON SJ, 1990, LANCET, V335, P1160, DOI 10.1016/0140-6736(90)91162-4; JOSEPH C, 1990, EPIDEMIOL INFECT, V105, P419, DOI 10.1017/S0950268800048007; KLEIN BS, 1986, JAMA-J AM MED ASSOC, V255, P361, DOI 10.1001/jama.255.3.361; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; KORNBLATT AN, 1985, AM J EPIDEMIOL, V122, P884, DOI 10.1093/oxfordjournals.aje.a114171; LOVETT J, 1983, APPL ENVIRON MICROB, V46, P459, DOI 10.1128/AEM.46.2.459-462.1983; MARTIN ML, 1986, LANCET, V2, P1043; MCNAUGHTON RD, 1982, CAN MED ASSOC J, V126, P657; OSTERHOLM MT, 1986, JAMA-J AM MED ASSOC, V256, P484, DOI 10.1001/jama.256.4.484; POTTER ME, 1984, JAMA-J AM MED ASSOC, V252, P2048, DOI 10.1001/jama.252.15.2048; RILEY LW, 1985, J INFECT DIS, V151, P956, DOI 10.1093/infdis/151.5.956; ROBINSON DA, 1981, BRIT MED J, V282, P1374, DOI 10.1136/bmj.282.6273.1374; SKIRROW MB, 1990, LANCET, V336, P921, DOI 10.1016/0140-6736(90)92282-M; TACKET CO, 1985, JAMA-J AM MED ASSOC, V253, P2058, DOI 10.1001/jama.253.14.2058; TAUXE RV, 1987, AM J PUBLIC HEALTH, V77, P1219, DOI 10.2105/AJPH.77.9.1219; WALTNERTOEWS D, 1990, J FOOD PROTECT, V53, P258, DOI 10.4315/0362-028X-53.3.258; 1986, MMWR, V35, P311; 1986, MMWR, V37, P1; 1987, CAN DIS WKLY REP, V13, P5	28	43	43	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3228	3230		10.1001/jama.268.22.3228	http://dx.doi.org/10.1001/jama.268.22.3228			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433764				2022-12-28	WOS:A1992KA65400030
J	WALKER, WG; NEATON, JD; CUTLER, JA; NEUWIRTH, R; COHEN, JD				WALKER, WG; NEATON, JD; CUTLER, JA; NEUWIRTH, R; COHEN, JD			RENAL-FUNCTION CHANGE IN HYPERTENSIVE MEMBERS OF THE MULTIPLE RISK FACTOR INTERVENTION TRIAL - RACIAL AND TREATMENT EFFECTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-PRESSURE; DISEASE; PROGRESSION; MRFIT; AGE; INSUFFICIENCY; DECLINE; MEN	Objective.-To evaluate the contribution of mild to moderate hypertension to progressive loss of renal function by analysis of renal function data from the Multiple Risk Factor Intervention Trial. Design.-The cohort of men with mild to moderate hypertension (baseline diastolic blood pressure greater-than-or-equal-to 90 mm Hg), randomized to a special intervention (SI) group or usual care (UC) group, were examined for change in renal function based on individual reciprocal creatinine slopes over an average of 7 years' follow-up as the outcome measure. Contribution of blood pressure control during follow-up, age, race, and blood pressure at entry were assessed. Participants.-The cohort of 5524 (463 black, 5061 nonblack) hypertensive men receiving no therapy at entry provided the data for the present analysis. Results.-Blood pressure control was similar for black and white participants, but significant decline in reciprocal creatinine slope was found for black men (mean slope, -0.0090+/-0.0013 dL/mg/y) compared with white men (+0.0018+/-0.0004 dL/mg/y) (P<.001 for difference between blacks and whites). Decline in renal function was also greater among individuals with elevated systolic (P<.001) as well as diastolic blood pressure (P<.001), and older individuals (P<.001). No difference between the SI and UC groups was seen in reciprocal creatinine slopes, but in both groups combined, treatment that maintained diastolic blood pressure below an average value of 95 mm Hg was associated with stable or improving renal function, whereas participants whose blood pressure remained 95 mm Hg or greater continued to decline at -0.0013+/-0.0009 dL/mg/y (P=.007 for difference). Separate examination of the subset of black men (n=463) failed to show such a difference. Conclusions.-Effective blood pressure control was associated with stable or improving renal function in nonblacks but not in blacks. These findings emphasize the importance of blood pressure control to maintain adequate renal function in hypertensive white men and raise important questions about the relationship of pressure reduction and renal function change in blacks.	UNIV MINNESOTA, SCH PUBL HLTH, DIV BIOSTAT, MINNEAPOLIS, MN 55455 USA; NHLBI, DIV EPIDEMIOL & CLIN APPLICAT, BETHESDA, MD 20892 USA; ST LOUIS UNIV, MED CTR, PREVENT CARDIOL PROGRAMS, ST LOUIS, MO 63103 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Saint Louis University								[Anonymous], 1986, Am J Cardiol, V58, P1; BATTEY LL, 1988, EMORY U J MED, V2, P102; BATUMAN V, 1983, NEW ENGL J MED, V309, P17, DOI 10.1056/NEJM198307073090104; BRAZY PC, 1989, KIDNEY INT, V35, P670, DOI 10.1038/ki.1989.37; COHEN JD, 1981, PREV MED, V10, P501, DOI 10.1016/0091-7435(81)90062-1; CONNETT JE, 1984, AM HEART J, V108, P839, DOI 10.1016/0002-8703(84)90680-X; CUTLER JA, 1985, PREV MED, V14, P293, DOI 10.1016/0091-7435(85)90058-1; Eggers P W, 1984, Health Care Financ Rev, V5, P69; GRIMM RH, 1985, ARCH INTERN MED, V145, P1191, DOI 10.1001/archinte.145.7.1191; KINCAIDSMITH P, 1958, Q J MED, V27, P117; KJELSBERG MO, 1985, AM J CARDIOL, V55, P16; KJELSBERG MO, 1985, AM J CARDIOL, V55, P1; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; LEVEY AS, 1991, J AM SOC NEPHROL, V1, P1087; LEVEY AS, 1989, KIDNEY INT, V36, pS73; LINDEMAN RD, 1984, KIDNEY INT, V26, P861, DOI 10.1038/ki.1984.229; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; MACMAHON S, 1989, AM J CARDIOL, V63, P202, DOI 10.1016/0002-9149(89)90286-5; MacMahon S., 1989, HYPERTENSION S1, V13, P45; MAMDANI BH, 1974, NEW ENGL J MED, V291, P1343, DOI 10.1056/NEJM197412192912509; MCCORMACK LJ, 1958, AM J PATHOL, V34, P1011; MITCH WE, 1976, LANCET, V2, P1326; Moritz AR, 1937, AM J PATHOL, V13, P679; NEATON L, 1989, CIRCULATION S2, V80, P300; RETAN JW, 1966, ARCH INTERN MED, V118, P534, DOI 10.1001/archinte.118.6.534; ROCCELLA EJ, 1988, HLTH PSYCHOL S, V7, P293; ROSTAND SG, 1989, NEW ENGL J MED, V320, P684, DOI 10.1056/NEJM198903163201102; ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155; RUTHERFORD WE, 1977, KIDNEY INT, V11, P62, DOI 10.1038/ki.1977.8; SHERWIN R, 1981, PREV MED, V10, P402, DOI 10.1016/0091-7435(81)90058-X; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; WATKINS LO, 1986, AM J CARDIOL, V57, P538, DOI 10.1016/0002-9149(86)90831-3; WHELTON PK, 1989, HYPERTENSION S1, V13, P19, DOI DOI 10.1161/HYPERTENSIONAHA.113.02250; WIDDOWSON GM, 1986, CONTROL CLIN TRIALS, V7, pS17; WOODS JW, 1967, NEW ENGL J MED, V277, P57, DOI 10.1056/NEJM196707132770201; 1987, END STAGE RENAL DISE; 1989, USRDS1989 NIH NAT I; 1985, SAS USERS GUIDE STAT; 1991, HLTH US 1990; 1978, AM J CARDIOL, V41, P402; 1986, VITAL HLTH STATIS 11, V234; 1990, PHS NIH903032 US DEP	43	283	289	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	1992	268	21					3085	3091		10.1001/jama.268.21.3085	http://dx.doi.org/10.1001/jama.268.21.3085			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA002	1433739				2022-12-28	WOS:A1992KA00200031
J	MATTER, K; HUNZIKER, W; MELLMAN, I				MATTER, K; HUNZIKER, W; MELLMAN, I			BASOLATERAL SORTING OF LDL RECEPTOR IN MDCK CELLS - THE CYTOPLASMIC DOMAIN CONTAINS 2 TYROSINE-DEPENDENT TARGETING DETERMINANTS	CELL			English	Article							CANINE KIDNEY-CELLS; POLYMERIC IMMUNOGLOBULIN RECEPTOR; DENSITY LIPOPROTEIN RECEPTOR; PLASMA-MEMBRANE PROTEINS; INFLUENZA-VIRUS HEMAGGLUTININ; LYMPHOCYTE FC-RECEPTORS; ENDOPLASMIC-RETICULUM; INTRACELLULAR-TRANSPORT; TRANSMEMBRANE PROTEINS; MEDIATED ENDOCYTOSIS	In MDCK cells, transport of membrane proteins to the basolateral plasma membrane has been shown to require a distinct cytoplasmic domain determinant. Although the determinant is often related to signals used for localization in clathrin-coated pits, inactivation of the coated pit domain in the human LDL receptor did not affect basolateral targeting. By expressing mutant and chimeric LDL receptors, we have now identified two independently acting signals that are individually sufficient for basolateral targeting. The two determinants mediate basolateral sorting with different efficiencies, but both contain tyrosine residues critical for activity. The first determinant was colinear with, but distinct from, the coated pit domain of the receptor. The second was found in the C-terminal region of the cytoplasmic domain of the receptor and, although tyrosine-dependent, did not mediate endocytosis. The results suggest that membrane proteins can have functionally redundant signals for basolateral transport and that a tyrosine-containing motif may be a common feature of multiple intracellular sorting events.			MATTER, K (corresponding author), YALE UNIV, SCH MED, DEPT CELL BIOL, NEW HAVEN, CT 06510 USA.		Hunziker, Walter/B-3140-2010; Hunziker, Walter/GSM-8190-2022; Matter, Karl/C-4880-2008; Mellman, Ira/ABG-5896-2020	Hunziker, Walter/0000-0002-5265-4933; Matter, Karl/0000-0001-8026-7220; 				BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BREWER CB, 1991, J CELL BIOL, V114, P413, DOI 10.1083/jcb.114.3.413; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; CAPLAN M, 1989, FUNCTIONAL EPITHELIA, P71; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GREEN SA, 1985, J BIOL CHEM, V260, P9867; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Hauri H P, 1991, Semin Cell Biol, V2, P355; HUNZIKER W, 1989, J CELL BIOL, V109, P3291, DOI 10.1083/jcb.109.6.3291; Hunziker W, 1991, Semin Cell Biol, V2, P397; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; Machamer C E, 1991, Trends Cell Biol, V1, P141, DOI 10.1016/0962-8924(91)90001-P; MALLABIABARRENA A, 1992, NATURE, V357, P593, DOI 10.1038/357593a0; MATLIN KS, 1984, J CELL BIOL, V99, P2131, DOI 10.1083/jcb.99.6.2131; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MIETTINEN HM, 1992, J CELL BIOL, V116, P875, DOI 10.1083/jcb.116.4.875; MISEK DE, 1984, CELL, V39, P537, DOI 10.1016/0092-8674(84)90460-4; MOSTOV KE, 1987, J CELL BIOL, V105, P2031, DOI 10.1083/jcb.105.5.2031; PATHAK RK, 1990, J CELL BIOL, V111, P347, DOI 10.1083/jcb.111.2.347; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; RODRIGUEZBOULAN E, 1984, J CELL BIOL, V98, P308, DOI 10.1083/jcb.98.1.308; RODRIQUEZBOULAN E, 1992, IN PRESS ANN REV CEL; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VANDRIEL IR, 1987, J BIOL CHEM, V262, P16127; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987; WANDINGERNESS A, 1990, INTRACELLULAR TRAFFI, P575; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39	44	337	340	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	1992	71	5					741	753		10.1016/0092-8674(92)90551-M	http://dx.doi.org/10.1016/0092-8674(92)90551-M			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423629	hybrid			2022-12-28	WOS:A1992JZ63300005
J	CALLAHAM, M; MADSEN, CD; BARTON, CW; SAUNDERS, CE; POINTER, J				CALLAHAM, M; MADSEN, CD; BARTON, CW; SAUNDERS, CE; POINTER, J			A RANDOMIZED CLINICAL-TRIAL OF HIGH-DOSE EPINEPHRINE AND NOREPINEPHRINE VS STANDARD-DOSE EPINEPHRINE IN PREHOSPITAL CARDIAC-ARREST	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL BLOOD-FLOW; CARDIOPULMONARY-RESUSCITATION; DOGS; PHENYLEPHRINE; METHOXAMINE; IMPROVES; SURVIVAL; ASYSTOLE; SWINE; RATES	Objective.-To determine the relative efficacy of high- vs standard-dose catecholamines in initial treatment of prehospital cardiac arrest. Design.-Randomized, prospective, double-blind clinical trial. Setting.-Prehospital emergency medical system of a major US city. Patients.-All adults in nontraumatic cardiac arrest, treated by paramedics, who would receive epinephrine according to American Heart Association advanced cardiac life support guidelines. Interventions.-High-dose epinephrine (HDE, 15 mg), high-dose norepinephrine bitartrate (NE, 11 mg), or standard-dose epinephrine (SDE, 1 mg) was blindly substituted for advanced cardiac life support doses of epinephrine. Main Outcome Measures.-Restoration of spontaneous circulation in the field, admission to hospital, hospital discharge, and Cerebral Performance Category score. Results.-Of 2694 patients with cardiac arrests during the study period, resuscitation was attempted on 1062 patients. Of this total, 816 patients met study criteria and were enrolled. In the entire cardiac arrest population, 63% of the survivors were among the 11% of patients who were defibrillated by first responders. The three drug treatment groups were similar for all independent variables. Thirteen percent of patients receiving HDE regained a pulse in the field vs 8% of those receiving SDE (P=.01), and 18% of HDE patients were admitted to the hospital vs 10% of SDE patients who were admitted to the hospital (P=.02). Similar trends for NE were not significant. There were 18 survivors; 1.7% of HDE patients and 2.6% of NE patients were discharged from the hospital compared with 1.2% of SDE patients, but this was not significant (P=.37; beta=.38). There was a nonsignificant trend for Cerebral Performance Category scores to be worse for HDE (3.2) and NE patients (3.7) than for SDE patients (2.3) (P=.10; beta=.31). No significant complications were identified. High-dose epinephrine did not produce longer hospital or critical care unit stays. Conclusions.-High-dose epinephrine significantly improves the rate of return of spontaneous circulation and hospital admission in patients who are in prehospital cardiac arrest without increasing complications. However, the increase in hospital discharge rate is not statistically significant, and no significant trend could be determined for neurological outcome. No benefit of NE compared with HDE was identified. Further study is needed to determine the optimal role of epinephrine in prehospital cardiac arrest.	SAN FRANCISCO DEPT PUBL HLTH, SAN FRANCISCO, CA USA	San Francisco Department of Public Health	CALLAHAM, M (corresponding author), UNIV CALIF SAN FRANCISCO, DIV EMERGENCY MED, SAN FRANCISCO, CA 94143 USA.			Callaham, Michael/0000-0003-2284-256X				[Anonymous], 1986, Am J Emerg Med, V4, P72; [Anonymous], 1986, JAMA-J AM MED ASSOC, V255, P2905, DOI [10.1001/jama.1986.03370210073024, DOI 10.1001/JAMA.1986.03370210073024]; BARTON C, 1991, ANN EMERG MED, V20, P722, DOI 10.1016/S0196-0644(05)80830-3; BRILLMAN J, 1987, ANN EMERG MED, V16, P11, DOI 10.1016/S0196-0644(87)80278-0; BRILLMAN JA, 1985, CRIT CARE MED, V13, P912, DOI 10.1097/00003246-198511000-00013; BROWN CG, 1990, ANN EMERG MED, V19, P443, DOI 10.1016/S0196-0644(05)82370-4; BROWN CG, 1988, ANN EMERG MED, V17, P302, DOI 10.1016/S0196-0644(88)80767-4; BROWN CG, 1987, AM J EMERG MED, V5, P362, DOI 10.1016/0735-6757(87)90382-2; BROWN CG, 1987, CIRCULATION, V75, P491, DOI 10.1161/01.CIR.75.2.491; CALLAHAM M, 1991, JAMA-J AM MED ASSOC, V265, P1117, DOI 10.1001/jama.265.9.1117; CALLAHAN M, 1989, ANN EMERG MED, V18, P1011, DOI 10.1016/S0196-0644(89)80483-4; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; GOETTING MG, 1991, ANN EMERG MED, V20, P22, DOI 10.1016/S0196-0644(05)81112-6; GOETTING MG, 1989, CRIT CARE MED, V17, P1258, DOI 10.1097/00003246-198912000-00004; GONZALEZ ER, 1989, ANN EMERG MED, V18, P920, DOI 10.1016/S0196-0644(89)80453-6; HAYNES BE, 1991, JAMA-J AM MED ASSOC, V266, P545, DOI 10.1001/jama.266.4.545; LINDNER KH, 1991, ACTA ANAESTH SCAND, V35, P253, DOI 10.1111/j.1399-6576.1991.tb03283.x; LINDNER KH, 1989, CRIT CARE MED, V17, P437, DOI 10.1097/00003246-198905000-00012; LINDNER KH, 1990, CHEST, V97, P1458, DOI 10.1378/chest.97.6.1458; MARTIN D, 1990, ANN EMERG MED, V19, P322, DOI 10.1016/S0196-0644(05)82055-4; MULLIE A, 1988, LANCET, V1, P137; PARADIS NA, 1991, JAMA-J AM MED ASSOC, V265, P1139, DOI 10.1001/jama.265.9.1139; PARADIS NA, 1990, ANN EMERG MED, V19, P491; REDDING JS, 1963, ANESTHESIOLOGY, V24, P203, DOI 10.1097/00000542-196303000-00008; REDDING JS, 1968, JAMA-J AM MED ASSOC, V203, P93; ROBERTS D, 1990, CHEST, V98, P999, DOI 10.1378/chest.98.4.999; ROBINSON LA, 1989, ANN EMERG MED, V18, P336, DOI 10.1016/S0196-0644(89)80564-5; TORTOLANI AJ, 1989, CHEST, V96, P622, DOI 10.1378/chest.96.3.622; TURNER LM, 1988, ANN EMERG MED, V17, P443, DOI 10.1016/S0196-0644(88)80233-6; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101	30	217	223	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	1992	268	19					2667	2672		10.1001/jama.268.19.2667	http://dx.doi.org/10.1001/jama.268.19.2667			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX680	1433686				2022-12-28	WOS:A1992JX68000028
J	DIXON, J				DIXON, J			UNITED-STATES HEALTH-CARE .3. THE REFORM PROBLEM	BRITISH MEDICAL JOURNAL			English	Article							UNIVERSAL ACCESS; INSURANCE; PHYSICIANS; AMERICANS; BUSINESS; STRATEGY; POLITICS; VIEWS				DIXON, J (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,HLTH SERV RES UNIT,LONDON WC1E 7HT,ENGLAND.							Anderson G F, 1991, Health Care Financ Rev Annu Suppl, P35; BEAUCHAMP DE, 1990, NEW ENGL J MED, V323, P640, DOI 10.1056/NEJM199009063231005; BERGTHOLD L, 1991, ANNU REV PUBL HEALTH, V12, P157; BLENDON RJ, 1989, HEALTH AFFAIR, V8, P6, DOI 10.1377/hlthaff.8.3.6; BLENDON RJ, 1991, HEALTH AFFAIR, V10, P166, DOI 10.1377/hlthaff.10.2.166; BLUMENTHAL D, 1989, NEW ENGL J MED, V321, P908, DOI 10.1056/NEJM198909283211324; BLUMENTHAL D, 1991, NEW ENGL J MED, V325, P198, DOI 10.1056/NEJM199107183250309; BROWN LD, 1990, J HEALTH POLIT POLIC, V15, P793, DOI 10.1215/03616878-15-4-793; BUTLER SM, 1991, JAMA-J AM MED ASSOC, V265, P2541, DOI 10.1001/jama.265.19.2541; CANTOR JC, 1991, HEALTH AFFAIR, V10, P98, DOI 10.1377/hlthaff.10.1.98; CANTOR JC, 1990, J HEALTH POLIT POLIC, V15, P755, DOI 10.1215/03616878-15-4-755; DAVIS K, 1991, JAMA-J AM MED ASSOC, V265, P2525, DOI 10.1001/jama.265.19.2525; DEMKOVICH L, 1990, STATES UNINSURED SLO; DIXON J, 1991, LANCET, V337, P891, DOI 10.1016/0140-6736(91)90213-9; EDWARDS JN, 1992, HEALTH AFFAIR, V11, P164, DOI 10.1377/hlthaff.11.1.164; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; FUCHS VR, 1991, HEALTH AFFAIR, V10, P7, DOI 10.1377/hlthaff.10.4.7; GINSBURG PB, 1992, HEALTH AFFAIR, V11, P73, DOI 10.1377/hlthaff.11.2.73; GLASER WA, 1989, HEALTH AFFAIR, V8, P129, DOI 10.1377/hlthaff.8.3.129; GOLDBERGER SA, 1990, J HEALTH POLIT POLIC, V15, P857, DOI 10.1215/03616878-15-4-857; GREENBERG DS, 1992, LANCET, V339, P860, DOI 10.1016/0140-6736(92)90292-B; HALL MA, 1992, NEW ENGL J MED, V326, P565, DOI 10.1056/NEJM199202203260812; HIMMELSTEIN DU, 1989, NEW ENGL J MED, V320, P102, DOI 10.1056/NEJM198901123200206; HOARE G, 1992, HEALTH AFFAIR, V11, P212, DOI 10.1377/hlthaff.11.2.212; HOLAHAN J, 1991, HEALTH AFFAIR, V10, P45, DOI 10.1377/hlthaff.10.1.45; HOPKINS TJ, 1992, BMJ, V305, P210; JAJICHTOTH C, 1990, HEALTH AFFAIR, V9, P149, DOI 10.1377/hlthaff.9.4.149; JAJICHTOTH C, 1991, HEALTH AFFAIR, V10, P170, DOI 10.1377/hlthaff.10.2.170; MCLAUGHLIN CG, 1992, HEALTH AFFAIR, V11, P28, DOI 10.1377/hlthaff.11.2.28; PEAR R, 1990, NY TIMES        1104; SMITH MD, 1992, HEALTH AFFAIR, V11, P125, DOI 10.1377/hlthaff.11.2.125; SULLIVAN CB, 1991, HEALTH AFFAIR, V10, P104, DOI 10.1377/hlthaff.10.2.104; 1992, B CLINTONS AM HLTH C; 1991, HIAA1990 91 HLTH INS; 1992, HLTH RIGHT; 1990, DIRECT FINANCING UNC; 1992, SOURCES HLTH INSURAN	37	0	0	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 17	1992	305	6859					941	944		10.1136/bmj.305.6859.941	http://dx.doi.org/10.1136/bmj.305.6859.941			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JU649	1458077	Green Submitted, Green Published, Bronze			2022-12-28	WOS:A1992JU64900026
J	NADLER, SG; TEPPER, MA; SCHACTER, B; MAZZUCCO, CE				NADLER, SG; TEPPER, MA; SCHACTER, B; MAZZUCCO, CE			INTERACTION OF THE IMMUNOSUPPRESSANT DEOXYSPERGUALIN WITH A MEMBER OF THE HSP70 FAMILY OF HEAT-SHOCK PROTEINS	SCIENCE			English	Article							CYTOSOLIC BINDING-PROTEIN; PEPTIDYL-PROLYL ISOMERASE; CYCLOSPORIN-A; 15-DEOXYSPERGUALIN; CYCLOPHILIN; RECEPTOR; INVITRO; CELLS; LYMPHOCYTES; EXPRESSION	Deoxyspergualin (DSG) is a potent immunosuppressant whose mechanism of action remains unknown. To elucidate its mechanism of action, an intracellular DSG binding protein was identified. DSG has now been shown to bind specifically to Hsc70, the constitutive or cognate member of the heat shock protein 70 (Hsp70) protein family. The members of the Hsp70 family of heat shock proteins are important for many cellular processes, including immune responses, and this finding suggests that heat shock proteins may represent a class of immunosuppressant binding proteins, or immunophilins, distinct from the previously identified cis-trans proline isomerases. DSG may provide a tool for understanding the function of heat shock proteins in immunological processes.	BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,WALLINGFORD,CT 06492	Bristol-Myers Squibb								BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; DICKNEITE G, 1987, INT J IMMUNOPHARMACO, V9, P559, DOI 10.1016/0192-0561(87)90123-8; DWORNICZAK B, 1987, NUCLEIC ACIDS RES, V15, P5181, DOI 10.1093/nar/15.13.5181; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FUJII H, 1989, J ANTIBIOT, V42, P788, DOI 10.7164/antibiotics.42.788; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HANSEN LK, 1991, EXP CELL RES, V192, P587, DOI 10.1016/0014-4827(91)90080-E; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; ISHIBASHI M, 1989, TRANSPLANT P, V21, P1854; JIANG H, 1990, TRANSPLANT P, V22, P1633; KURTZ S, 1986, SCIENCE, V231, P1154, DOI 10.1126/science.3511530; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; MAEDA K, 1992, 3RD INT C DRUG RES I; NEMOTO K, 1987, J ANTIBIOT, V40, P561, DOI 10.7164/antibiotics.40.561; NISHIMURA K, 1989, IMMUNOLOGY, V68, P66; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SANCHEZ ER, 1990, J BIOL CHEM, V265, P22067; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; TAKAHARA S, 1992, TRANSPLANTATION, V53, P914, DOI 10.1097/00007890-199204000-00037; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TAKEUCHI T, 1981, J ANTIBIOT, V34, P1619, DOI 10.7164/antibiotics.34.1619; TEPPER MA, 1991, TRANSPLANT P, V23, P328; VANBUSKIRK A, 1989, J EXP MED, V170, P1799, DOI 10.1084/jem.170.6.1799; VANBUSKIRK AM, 1991, J IMMUNOL, V146, P500; WELCH WJ, 1986, J CELL BIOL, V103, P2035, DOI 10.1083/jcb.103.5.2035; YEM AW, 1992, J BIOL CHEM, V267, P2868	34	218	223	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					484	486		10.1126/science.1411548	http://dx.doi.org/10.1126/science.1411548			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411548				2022-12-28	WOS:A1992JT77500042
J	BEHRMANN, M; WINOCUR, G; MOSCOVITCH, M				BEHRMANN, M; WINOCUR, G; MOSCOVITCH, M			DISSOCIATION BETWEEN MENTAL-IMAGERY AND OBJECT RECOGNITION IN A BRAIN-DAMAGED PATIENT	NATURE			English	Article							VISUAL-IMAGERY; GENERATION; NEUROPSYCHOLOGY; REPRESENTATION; AGNOSIA; DEFICIT	VISUAL imagery is the creation of mental representations that share many features with veridical visual percepts. Studies of normal and brain-damaged people reinforce the view that visual imagery and visual perception are mediated by a common neural substrate and activate the same representations1-4. Thus, brain-damaged patients with intact vision who have an impairment in perception should have impaired visual imagery. Here we present evidence to the contrary from a patient with severely impaired object recognition (visual object agnosia) but with normal mental imagery. He draws objects in considerable detail from memory and uses information derived from mental images in a variety of tasks. In contrast, he cannot identify visually presented objects, even those he has drawn himself. He has normal visual acuity and intact perception of equally complex material in other domains. We conclude that rich internal representations can be activated to support visual imagery even when they cannot support visually mediated perception of objects.	UNIV TORONTO,ERINDALE COLL,DEPT PSYCHOL,MISSISSAUGA L5L 1C6,ONTARIO,CANADA; UNIV TORONTO,FAC MED,TORONTO M5G 1L4,ONTARIO,CANADA; TRENT UNIV,DEPT PSYCHOL,PETERBOROUGH K9J 7B8,ONTARIO,CANADA	University of Toronto; University Toronto Mississauga; University of Toronto; Trent University	BEHRMANN, M (corresponding author), BAYCREST CTR GERIATR CARE,ROTMAN RES INST,3560 BATHURST ST,TORONTO M6A 2E1,ONTARIO,CANADA.			Behrmann, Marlene/0000-0002-3814-1015				BENSON AL, 1983, FACIAL RECOGNITION; BROOKS LR, 1968, CAN J PSYCHOLOGY, V22, P349, DOI 10.1037/h0082775; CORBALLIS M, 1988, NEUROPSYCHOLOGIA, V26, P12; CRAIK FIM, IN PRESS PSYCHOL AGI, V7; FARAH MJ, 1988, J EXP PSYCHOL GEN, V117, P248, DOI 10.1037/0096-3445.117.3.248; FARAH MJ, 1984, COGNITION, V18, P245, DOI 10.1016/0010-0277(84)90026-X; FARAH MJ, 1988, BRAIN COGNITION, V8, P147, DOI 10.1016/0278-2626(88)90046-2; FARAH MJ, 1988, PSYCHOL REV, V95, P307, DOI 10.1037/0033-295X.95.3.307; FARAH MJ, 1988, COGNITIVE PSYCHOL, V20, P439, DOI 10.1016/0010-0285(88)90012-6; FINKE RA, 1985, PSYCHOL BULL, V98, P236, DOI 10.1037/0033-2909.98.2.236; Goodglass H., 1983, BOSTON NAMING TEST; GRAILET JM, 1990, COGNITIVE NEUROPSYCH, V7, P275, DOI 10.1080/02643299008253445; JANKOWIAK J, 1992, J COGNITIVE NEUROSCI, V4, P119, DOI 10.1162/jocn.1992.4.2.119; KOSSLYN SM, 1977, J EXP PSYCHOL GEN, V106, P341, DOI 10.1037/0096-3445.106.4.341; KOSSLYN SM, 1975, COGNITIVE PSYCHOL, V7, P341, DOI 10.1016/0010-0285(75)90015-8; KOSSLYN SM, 1985, J EXP PSYCHOL GEN, V114, P311, DOI 10.1037/0096-3445.114.3.311; RIDDOCH MJ, 1987, BRAIN, V110, P1431, DOI 10.1093/brain/110.6.1431; RIDDOCH MJ, 1990, COGNITIVE NEUROPSYCH, V7, P249, DOI 10.1080/02643299008253444; SERGENT J, 1989, J EXP PSYCHOL HUMAN, V15, P170, DOI 10.1037/0096-1523.15.1.170; VANSOMMERS P, 1989, COGNITIVE NEUROPSYCH, V6, P117, DOI 10.1080/02643298908253416	20	119	119	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 15	1992	359	6396					636	637		10.1038/359636a0	http://dx.doi.org/10.1038/359636a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JT824	1406994				2022-12-28	WOS:A1992JT82400057
J	CONVERSE, RL; JACOBSEN, TN; TOTO, RD; JOST, CMT; COSENTINO, F; FOUADTARAZI, F; VICTOR, RG				CONVERSE, RL; JACOBSEN, TN; TOTO, RD; JOST, CMT; COSENTINO, F; FOUADTARAZI, F; VICTOR, RG			SYMPATHETIC OVERACTIVITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOPAMINE-BETA-HYDROXYLASE; BLOOD-PRESSURE; ANGIOTENSIN-II; RENIN-ACTIVITY; NERVE ACTIVITY; PLASMA-RENIN; HEMODIALYSIS; NOREPINEPHRINE; HYPERTENSION; MECHANISMS	Background. Hypertension is a frequent complication of chronic renal failure, but its causes are not fully understood. There is indirect evidence that increased activity of the sympathetic nervous system might contribute to hypertension in patients with end-stage renal disease, but sympathetic-nerve discharge has not been measured directly in patients or animals with chronic renal failure. Methods. We recorded the rate of postganglionic sympathetic nerve discharge to the blood vessels in skeletal muscle by means of microelectrodes inserted into the peroneal nerve in 18 patients with native kidneys who were undergoing long-term treatment with hemodialysis (ot whom 14 had hypertension), 5 patients receiving hemodialysis who had undergone bilateral nephrectomy (of whom 1 had hypertension), and 11 normal subjects. Results. The mean (+/-SE) rate of sympathetic-nerve discharge was 2.5 times higher in the patients receiving hemodialysis who had not undergone nephrectomy than in the normal subjects (58+/-3 vs. 23+/-3 bursts per minute, P<0.01). In contrast, the rate of sympathetic-nerve discharge was similar in the patients receiving hemodialysis who had undergone bilateral nephrectomy (21+/-6 bursts per minute) and the normal subjects. The rate of sympathetic-nerve discharge in the patients receiving hemodialysis who had not undergone nephrectomy was also significantly higher (P<0.01) than that in the patients with bilateral nephrectomy, and it was accompanied in the former group by higher values for vascular resistance in the calf (45+/-4 vs. 22+/-4 units, P<0.05) and mean arterial pressure (106+/-4 vs. 76+/-14 mm Hg, P<0.05). The rate of sympathetic-nerve discharge was not correlated with either plasma norepinephrine concentrations or plasma renin activity. Conclusions. Chronic renal failure may be accompanied by reversible sympathetic activation, which appears to be mediated by an afferent signal arising in the failing kidneys.	UNIV TEXAS, SW MED CTR,DEPT INTERNAL MED,DIV CARDIOL, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA; CLEVELAND CLIN EDUC FDN, RES INST, CLEVELAND, OH 44106 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Cleveland Clinic Foundation			Toto, Robert/AAQ-3336-2021		FIC NIH HHS [1-F05-TW04494-01] Funding Source: Medline; NHLBI NIH HHS [5-T32-HL07360-13, R0-1 HL44010] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F05TW004494] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044010, T32HL007360] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON EA, 1989, HYPERTENSION, V14, P177, DOI 10.1161/01.HYP.14.2.177; BRAVO EL, 1975, NEW ENGL J MED, V292, P66, DOI 10.1056/NEJM197501092920203; CAMPESE VM, 1981, KIDNEY INT, V20, P246, DOI 10.1038/ki.1981.127; CORDER CN, 1980, NEPHRON, V25, P267, DOI 10.1159/000181855; CUCHE JL, 1986, KIDNEY INT, V30, P566, DOI 10.1038/ki.1986.222; DELIUS W, 1972, ACTA PHYSIOL SCAND, V84, P82, DOI 10.1111/j.1748-1716.1972.tb05158.x; DIBONA GF, 1982, REV PHYSIOL BIOCH P, V94, P75, DOI 10.1007/BFb0031333; ESPOSTI ED, 1985, CLIN SCI, V69, P51, DOI 10.1042/cs0690051; FABER JE, 1985, CIRC RES, V57, P676, DOI 10.1161/01.RES.57.5.676; FERRARIO CM, 1972, CIRC RES, V30, P257, DOI 10.1161/01.RES.30.3.257; Heidbreder E, 1986, Contrib Nephrol, V50, P14; HENRICH WL, 1977, KIDNEY INT, V12, P279, DOI 10.1038/ki.1977.112; Katholi R E, 1984, J Hypertens, V2, P349; KATHOLI RE, 1982, J CLIN INVEST, V69, P55, DOI 10.1172/JCI110441; LAKE CR, 1979, CARDIOVASC MED, V4, P1099; LAZARUS JM, 1973, CIRCULATION, V47, P1015, DOI 10.1161/01.CIR.47.5.1015; LILLEY JJ, 1976, J CLIN INVEST, V57, P1190, DOI 10.1172/JCI108387; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; MARK AL, 1985, CIRC RES, V57, P461, DOI 10.1161/01.RES.57.3.461; Mark AL., 1983, HDB PHYSL SECTION 2, VVol. 3 Part 2, P795; MCGRATH BP, 1977, KIDNEY INT, V12, P294, DOI 10.1038/ki.1977.114; NIES AS, 1979, J LAB CLIN MED, V94, P395; PEULER JD, 1977, LIFE SCI, V21, P625, DOI 10.1016/0024-3205(77)90070-4; RECORDATI G, 1981, J AUTONOM NERV SYST, V3, P237, DOI 10.1016/0165-1838(81)90066-7; ROSTAND SG, 1991, J AM SOC NEPHROL, V2, P1053; SCHAEFER RM, 1988, AM J NEPHROL, V8, P449, DOI 10.1159/000167652; SCHERRER U, 1990, NEW ENGL J MED, V323, P693, DOI 10.1056/NEJM199009133231101; Siggaard-Andersen J, 1970, DANISH MED B      S1, V17, P1; SMOGORZEWSKI M, 1989, KIDNEY INT, V36, P458, DOI 10.1038/ki.1989.217; STEIN RD, 1984, AM J PHYSIOL, V246, pR13, DOI 10.1152/ajpregu.1984.246.1.R13; SUZUKI H, 1983, HYPERTENSION, V5, pI139, DOI 10.1161/01.HYP.5.2_Pt_2.I139; TEXTOR SC, 1981, HYPERTENSION, V3, P294, DOI 10.1161/01.HYP.3.3.294; VALLBO AB, 1979, PHYSIOL REV, V59, P919, DOI 10.1152/physrev.1979.59.4.919; WALLIN BG, 1979, HYPERTENSION, V1, P67, DOI 10.1161/01.HYP.1.2.67; WALLIN BG, 1973, CIRC RES, V33, P9, DOI 10.1161/01.RES.33.1.9; Weidmann P, 1987, Contrib Nephrol, V54, P159; WHITE RP, 1976, T AM SOC ART INT ORG, V22, P420; ZIEGLER MG, 1990, KIDNEY INT, V37, P1357, DOI 10.1038/ki.1990.122; ZUCCHELLI P, 1988, SEMIN NEPHROL, V8, P163; ZUCCHELLI P, 1992, OXFORD TXB CLIN NEPH, V2, P1458	40	899	1021	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	1992	327	27					1912	1918		10.1056/NEJM199212313272704	http://dx.doi.org/10.1056/NEJM199212313272704			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KE505	1454086				2022-12-28	WOS:A1992KE50500004
J	GESSAIN, A; GOUT, O				GESSAIN, A; GOUT, O			CHRONIC MYELOPATHY ASSOCIATED WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I)	ANNALS OF INTERNAL MEDICINE			English	Review						PARAPARESIS, TROPICAL SPASTIC; HTLV-I; NERVOUS SYSTEM DISEASES	TROPICAL SPASTIC PARAPARESIS; CELL LEUKEMIA-VIRUS; CHRONIC PROGRESSIVE MYELOPATHY; POLYMERASE CHAIN-REACTION; BLOOD MONONUCLEAR-CELLS; NUCLEOTIDE-SEQUENCE ANALYSIS; ACTIVATED LYMPHOCYTES-T; CEREBROSPINAL-FLUID; PERIPHERAL-BLOOD; MULTIPLE-SCLEROSIS	Purpose: To review the clinical, epidemiologic, immunologic, and virologic aspects of the chronic myelopathy associated with human T-cell leukemia/lymphoma virus type I (HTLV-I), currently called tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). Data Identification: Studies done after 1985, when TSP/HAM was first recognized, were identified by a computer search using MEDLARS II and CANCERLIT. Additional information was acquired from personal files and bibliographies of existing literature. Study Selection: A total of 400 articles, 90 book chapters, and 150 abstracts from meetings covering all aspects of HTLV-I and neurologic diseases were critically analyzed, and information from 250 publications was included. Results of Data Analysis: TSP/HAM is present in most HTLV-I endemic areas, with a prevalence ranging from 5.1 to 128 per 100 000 inhabitants. Up to 20% of patients develop TSP/HAM after transfusion of HTLV-I contaminated blood. Pathologic characteristics indicate a chronic meningomyelitis. The clinical features consist of a chronic progressive spastic paraparesis or paraplegia, sphincter disturbances, and minimal sensory loss. Supraspinal and peripheral nerve involvement is sometimes observed. High titers of HTLV-I-specific antibodies are present in the serum and cerebrospinal fluid. The high level of humoral and cellular immunologic response and the association of TSP/HAM with other immunologic diseases suggest an immune-mediated process. Corticosteroids and immunosuppressor treatment usually result in only short-term improvement. Conclusion: TSP/HAM is a common neurologic disease in many parts of the world. All patients with chronic progressive myelopathies should be tested for serum and cerebrospinal fluid HTLV-I-specific antibodies. Systematic screening of blood donors for HTLV-I is necessary to help prevent the dissemination of the virus and the occurrence of post-transfusional cases.	NINCDS, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	GESSAIN, A (corresponding author), NCI, TUMOR CELL BIOL LAB, BLDG 37, ROOM 6A11, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA.							AJDUKIEWICZ A, 1989, NEW ENGL J MED, V321, P615; AKIZUKI S, 1987, LANCET, V1, P156; AKIZUKI S, 1988, HUM PATHOL, V19, P988, DOI 10.1016/S0046-8177(88)80017-0; AKIZUKI S, 1989, NEUROLOGY NEUROBIOLO, V51, P253; ANNUNZIATA P, 1987, LANCET, V2, P1393; ARAUJO ADQ, 1992, J NEUROL NEUROSUR PS, V55, P153, DOI 10.1136/jnnp.55.2.153; ARIMUA K, 1989, NEUROLOGY NEUROBIOLO, V51, P245; ARIMURA K, 1987, ARCH NEUROL-CHICAGO, V44, P609, DOI 10.1001/archneur.1987.00520180033012; ARIMURA K, 1989, NEUROLOGY NUEROBIOLO, V51, P367; ARIMURA Y, 1987, NEURO-OPHTHALMOLOGY, V7, P243, DOI 10.3109/01658108709007459; BANGHAM CRM, 1988, EMBO J, V7, P4179, DOI 10.1002/j.1460-2075.1988.tb03314.x; BARKHAUS PE, 1988, MUSCLE NERVE, V11, P380, DOI 10.1002/mus.880110415; BARTHOLOMEW C, 1986, LANCET, V2, P99; BEILKE MA, 1991, J MED VIROL, V33, P64, DOI 10.1002/jmv.1890330113; BERGER JR, 1991, NEUROLOGY, V41, P197, DOI 10.1212/WNL.41.2_Part_1.197; BERGER JR, 1991, NEUROLOGY, V41, P85, DOI 10.1212/WNL.41.1.85; BHAGAVATI S, 1988, NEW ENGL J MED, V318, P1141, DOI 10.1056/NEJM198805053181801; BHIGJEE AI, 1991, NEUROLOGY, V41, P1990, DOI 10.1212/WNL.41.12.1990; BHIGJEE AI, 1990, BRAIN, V113, P1307, DOI 10.1093/brain/113.5.1307; BLATTNER WA, 1989, VIRAL INFECTIONS HUM, P545; BOWNESS P, 1991, BRIT J RHEUMATOL, V30, P141; BUCHER B, 1990, LANCET, V336, P1135, DOI 10.1016/0140-6736(90)92617-Q; BUCHER B, 1990, REV INFECT DIS, V12, P890; BUISON G, 1990, RETROVIRUS, V6, P72; CANN AJ, 1990, VIROLOGY, P1501; CARTIERROVIROSA L, 1989, LANCET, V1, P556; CASTILLO JL, 1991, ACTA NEUROL SCAND, V83, P151, DOI 10.1111/j.1600-0404.1991.tb04667.x; CERONI M, 1988, ANN NEUROL, V23, pS188, DOI 10.1002/ana.410230742; Charcot J-M, 1865, B SOC MED HOP PAR S2, V10, P24; CHAVANCE M, 1989, CLIN EXP IMMUNOL, V77, P11; COLEMAN RJ, 1991, J NEUROL NEUROSUR PS, V54, P371, DOI 10.1136/jnnp.54.4.371; COSNETT J. E., 1965, S AFRICAN MED J, V39, P592; COUDERC LJ, 1988, ANN INTERN MED, V109, P625, DOI 10.7326/0003-4819-109-8-625; COUDERC LJ, 1990, RETROVIRUS, V3, P109; CRUICKSHANK JK, 1989, BRAIN, V112, P1057, DOI 10.1093/brain/112.4.1057; DAENKE S, 1990, J VIROL, V64, P1278, DOI 10.1128/JVI.64.3.1278-1282.1990; DAGLISH AG, 1990, HUMAN RETROVIROLOGY, P245; DALGLEISH A, 1988, AIDS RES HUM RETROV, V4, P475, DOI 10.1089/aid.1988.4.475; DAURIOL L, 1990, NOUV REV FR HEMATOL, V32, P113; DEFREITAS E, 1987, AIDS RES HUM RETROV, V3, P19, DOI 10.1089/aid.1987.3.19; DELAPORTE E, 1989, LANCET, V2, P1226; DESGRANGES C, 1990, LANCET, V336, P1517; DESGRANGES C, 1989, J INFECT DIS, V160, P162, DOI 10.1093/infdis/160.1.162; DESGROSEILLERS L, 1985, P NATL ACAD SCI USA, V82, P8818, DOI 10.1073/pnas.82.24.8818; DETHE G, 1989, J ACQ IMMUN DEF SYND, V2, P550; DIXON PS, 1990, WESTERN J MED, V152, P261; DUNCAN J, 1990, J NEUROL NEUROSUR PS, V53, P173, DOI 10.1136/jnnp.53.2.173-a; EHRLICH GD, 1991, NEUROLOGY, V41, P335, DOI 10.1212/WNL.41.3.335; Erb WH, 1875, KLIN WOCHENSCHR, V12, P357; EVANGELISTA A, 1990, MICROB PATHOGENESIS, V8, P259, DOI 10.1016/0882-4010(90)90052-R; EVANS BK, 1989, NEUROLOGY, V39, P1572, DOI 10.1212/WNL.39.12.1572; FRANCIS DA, 1989, ANN NEUROL, V25, P311, DOI 10.1002/ana.410250319; FUJIHARA K, 1991, J NEUROL SCI, V105, P99, DOI 10.1016/0022-510X(91)90125-Q; FURAKAWA Y, 1989, NEUROLOGY NEUROBIOLO, V51, P393; GARDNER MB, 1985, REV INFECT DIS, V7, P99; GESSAIN A, 1990, J GEN VIROL, V71, P333, DOI 10.1099/0022-1317-71-2-333; GESSAIN A, 1990, BLOOD, V75, P428; GESSAIN A, 1992, J VIROL, V66, P2288, DOI 10.1128/JVI.66.4.2288-2295.1992; GESSAIN A, 1985, LANCET, V2, P407; GESSAIN A, 1991, J VIROL, V65, P1628, DOI 10.1128/JVI.65.3.1628-1633.1991; GESSAIN A, 1986, LANCET, V2, P698; GESSAIN A, 1988, J INFECT DIS, V157, P1226, DOI 10.1093/infdis/157.6.1226; GESSAIN A, 1988, CR ACAD SCI III-VIE, V307, P53; GESSAIN A, 1989, INT J CANCER, V43, P327, DOI 10.1002/ijc.2910430227; GESSAIN A, 1991, P NATL ACAD SCI USA, V88, P7694, DOI 10.1073/pnas.88.17.7694; GIORDANO C, 1988, REV NEUROL-FRANCE, V144, P578; GONZALEZDUNIA D, 1992, VIROLOGY, V187, P705, DOI 10.1016/0042-6822(92)90473-3; GOUBAU P, 1991, NEUROLOGY, V41, P1158, DOI 10.1212/WNL.41.7.1158; GOUDREAU G, 1988, Neurology, V38, P206; GOUT O, 1991, J NEUROL, V238, P108, DOI 10.1007/BF00315691; GOUT O, 1990, NEW ENGL J MED, V322, P383, DOI 10.1056/NEJM199002083220607; GOUT O, 1989, ARCH NEUROL-CHICAGO, V46, P255, DOI 10.1001/archneur.1989.00520390021009; GOUT O, 1990, RETROVIRUS, V6, P75; GRACIA F, 1990, ARCH NEUROL-CHICAGO, V47, P634, DOI 10.1001/archneur.1990.00530060042014; GRAY GS, 1990, VIROLOGY, V177, P391, DOI 10.1016/0042-6822(90)90498-G; GREENBERG MK, 1991, NEUROLOGY, V41, P1517, DOI 10.1212/WNL.41.9.1517; GREENBERG SJ, 1989, J INFECT DIS, V159, P741, DOI 10.1093/infdis/159.4.741; GRIMALDI LME, 1988, ANN NEUROL, V24, P727, DOI 10.1002/ana.410240606; GROOPMAN JE, 1989, NEW ENGL J MED, V321, P663, DOI 10.1056/NEJM198909073211008; HAETTICH B, 1991, PRESSE MED, V20, P661; HARRINGTON WJ, 1991, AIDS RES HUM RETROV, V7, P1031, DOI 10.1089/aid.1991.7.1031; HERSKOVITZ S, 1990, Annals of Neurology, V28, P279; HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606; HIROSE S, 1986, LANCET, V2, P397; HIYOSHI T, 1987, Acta Medica Universitatis Kagoshimaensis, V29, P19; HONIG LS, 1991, NEUROLOGY, V41, P448, DOI 10.1212/WNL.41.3.448; HUGON J, 1990, J NEUROL NEUROSUR PS, V53, P269, DOI 10.1136/jnnp.53.3.269; HUGON J, 1987, ANN INTERN MED, V107, P111, DOI 10.7326/0003-4819-107-1-111_1; HUGON J, 1989, NEUROLOGY NEUROBIOLO, V51, P233; IJICHI S, 1990, ANN RHEUM DIS, V49, P718, DOI 10.1136/ard.49.9.718; IJICHI S, 1989, J NEUROIMMUNOL, V25, P251, DOI 10.1016/0165-5728(89)90143-4; IMAMURA J, 1988, INT J CANCER, V42, P221, DOI 10.1002/ijc.2910420213; ITOYAMA Y, 1988, NEUROLOGY, V38, P1302, DOI 10.1212/WNL.38.8.1302; ITOYAMA Y, 1988, NEUROLOGY, V38, P816, DOI 10.1212/WNL.38.5.816; ITOYAMA Y, 1989, NEUROLOGY NEUROBIOLO, V51, P209; IWASAKI Y, 1990, J NEUROL SCI, V96, P103, DOI 10.1016/0022-510X(90)90060-Z; Izumo S, 1988, NEUROLOGY S, V39, P242; JACOBSON S, 1990, ANN NEUROL, V27, P149, DOI 10.1002/ana.410270209; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; JACOBSON S, 1988, ANN NEUROL, V23, pS196, DOI 10.1002/ana.410230744; JACOBSON S, 1991, J IMMUNOL, V146, P1155; JACOBSON S, 1988, NATURE, V331, P540, DOI 10.1038/331540a0; JOHNSON RT, 1988, ANN NEUROL, V23, pS151, DOI 10.1002/ana.410230734; KAJIYAMA W, 1989, NEUROL NEUROBIOL, V51, P505; KAKIGI R, 1988, J NEUROL NEUROSUR PS, V51, P1094, DOI 10.1136/jnnp.51.8.1094; KAPLAN JE, 1991, NEUROLOGY, V41, P192, DOI 10.1212/WNL.41.2_Part_1.192; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; KAWAI H, 1989, NEUROLOGY, V39, P1129, DOI 10.1212/WNL.39.8.1129; KAYEMBE K, 1990, J NEUROL NEUROSUR PS, V53, P4, DOI 10.1136/jnnp.53.1.4; KAZADI K, 1990, LANCET, V336, P260, DOI 10.1016/0140-6736(90)91797-E; KELLY R, 1982, AFR J NEUROL SCI, V1, P5; KERMODE AG, 1990, J NEUROL NEUROSUR PS, V53, P1110, DOI 10.1136/jnnp.53.12.1110-a; KINOSHITA T, 1991, INT J CANCER, V47, P491, DOI 10.1002/ijc.2910470403; KIRA J, 1992, ANN NEUROL, V31, P39, DOI 10.1002/ana.410310108; KIRA J, 1991, ANN NEUROL, V29, P194, DOI 10.1002/ana.410290214; KIRA J, 1988, J NEUROL SCI, V87, P221, DOI 10.1016/0022-510X(88)90247-X; KIRA J, 1991, J NEUROL SCI, V106, P41, DOI 10.1016/0022-510X(91)90192-A; KITAJIMA I, 1989, ARTHRITIS RHEUM, V32, P1342, DOI 10.1002/anr.1780321030; KOMURIAN F, 1991, J VIROL, V65, P3770, DOI 10.1128/JVI.65.7.3770-3778.1991; KOPPEL BS, 1990, ANN NEUROL, V28, P252; KOPROWSKI H, 1985, NATURE, V318, P154, DOI 10.1038/318154a0; KRAMER A, 1989, LANCET, V2, P923; KURODA Y, 1991, J NEUROL SCI, V105, P61, DOI 10.1016/0022-510X(91)90119-R; KURODA Y, 1991, J NEUROL SCI, V106, P199, DOI 10.1016/0022-510X(91)90258-9; KUROSAWA M, 1991, AM J CLIN PATHOL, V95, P72, DOI 10.1093/ajcp/95.1.72; KURTZKE JF, 1980, ACTA NEUROL SCAND, V62, P65, DOI 10.1111/j.1600-0404.1980.tb03006.x; KURTZKE JF, 1973, CLIN NEUROLOGY, P1; KWOK S, 1988, J INFECT DIS, V158, P1193, DOI 10.1093/infdis/158.6.1193; LAVANCHY D, 1991, LANCET, V337, P248, DOI 10.1016/0140-6736(91)92224-P; LEE JW, 1989, ANN INTERN MED, V110, P239, DOI 10.7326/0003-4819-110-3-239; LI Q, 1990, JPN J MED, V29, P487; LIBERSKI PP, 1988, ANN NEUROL, V23, pS185, DOI 10.1002/ana.410230741; LIBERSKI PP, 1989, RETROVIRUS HUMANOS H, P133; LINK H, 1989, NEUROLOGY, V39, P1566, DOI 10.1212/WNL.39.12.1566; LUDOLPH AC, 1988, MUSCLE NERVE, V11, P392, DOI 10.1002/mus.880110417; MALONEY EM, 1991, AM J EPIDEMIOL, V133, P1125, DOI 10.1093/oxfordjournals.aje.a115825; MANI KS, 1969, J NEUROL SCI, V9, P179, DOI 10.1016/0022-510X(69)90067-7; MARSHALL J, 1955, LANCET, V1, P643; MASSON C, 1989, REV NEUROL, V145, P838; MATSUO H, 1989, LANCET, V1, P790; MATSUO H, 1988, LANCET, V2, P1109; MATSUO H, 1989, JPN J MED, V28, P328, DOI 10.2169/internalmedicine1962.28.328; MATSUSHITA S, 1987, J CLIN INVEST, V80, P394, DOI 10.1172/JCI113085; MATTSON DH, 1987, LANCET, V2, P49; MATUTES E, 1986, INT J CANCER, V38, P41, DOI 10.1002/ijc.2910380108; MCARTHUR JC, 1990, NEUROLOGY, V40, P938, DOI 10.1212/WNL.40.6.938; MCKENDALL RR, 1991, NEUROLOGY, V41, P831, DOI 10.1212/WNL.41.6.831; MCKHANN G, 1989, J INFECT DIS, V160, P371, DOI 10.1093/infdis/160.3.371; MCLEAN BN, 1989, J NEUROL, V236, P351, DOI 10.1007/BF00314379; MINATO S, 1988, J NEUROL SCI, V87, P233, DOI 10.1016/0022-510X(88)90248-1; MINATO S, 1989, ANN NEUROL, V26, P398, DOI 10.1002/ana.410260316; MIYAI I, 1987, ANN NEUROL, V22, P601, DOI 10.1002/ana.410220507; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; MOLGAARD CA, 1989, NEUROEPIDEMIOLOGY, V8, P109, DOI 10.1159/000110173; MONTGOMERY RD, 1989, T ROY SOC TROP MED H, V83, P724, DOI 10.1016/0035-9203(89)90309-X; MONTGOMERY RD, 1964, BRAIN, V87, P425, DOI 10.1093/brain/87.3.425; MOORE GRW, 1989, ANN NEUROL, V26, P523, DOI 10.1002/ana.410260405; MORA CA, 1988, ANN NEUROL, V23, pS192, DOI 10.1002/ana.410230743; MORGAN OS, 1989, LANCET, V2, P1184; MORI M, 1988, ANN NEUROL, V24, P280, DOI 10.1002/ana.410240220; MOTOMURA M, 1990, LANCET, V336, P55, DOI 10.1016/0140-6736(90)91569-V; MURPHY EL, 1991, AM J EPIDEMIOL, V133, P1114, DOI 10.1093/oxfordjournals.aje.a115824; NAGASATO K, 1991, J NEUROIMMUNOL, V32, P105, DOI 10.1016/0165-5728(91)90002-O; NAKAMURA T, 1989, ARCH NEUROL-CHICAGO, V46, P35, DOI 10.1001/archneur.1989.00520370037015; NAKAMURA T, 1990, JPN J MED, V29, P362; NEWTON M, 1987, LANCET, V1, P415; NISHIMOTO N, 1990, J NEUROL SCI, V97, P183, DOI 10.1016/0022-510X(90)90217-B; NISHIOKA K, 1989, LANCET, V1, P441; NOMOTO M, 1991, NEUROLOGY, V41, P457, DOI 10.1212/WNL.41.3.457; OHAMA E, 1990, ACTA NEUROPATHOL, V81, P78, DOI 10.1007/BF00662641; OHBO K, 1991, NEUROLOGY, V41, P594, DOI 10.1212/WNL.41.4.594; OSAME M, 1990, ANN NEUROL, V28, P50, DOI 10.1002/ana.410280110; OSAME M, 1987, ANN NEUROL, V21, P117, DOI 10.1002/ana.410210203; OSAME M, 1986, LANCET, V1, P1031; OSAME M, 1986, LANCET, V2, P104; Osame M., 1990, HEMATOL REV, V3, P271; OSAME M, 1989, NEUROLOGY NEUROBIOLO, V51, P213; PAINE E, 1991, VIROLOGY, V182, P111, DOI 10.1016/0042-6822(91)90654-T; PAQUETTE Y, 1989, P NATL ACAD SCI USA, V86, P3896, DOI 10.1073/pnas.86.10.3896; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; PATY DW, 1979, ANN NEUROL, V6, P419, DOI 10.1002/ana.410060508; PICCARDO P, 1988, ANN NEUROL, V23, pS156, DOI 10.1002/ana.410230735; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSER M, 1991, ADV NEUROL, P309; POWER C, 1989, CAN J NEUROL SCI, V16, P330, DOI 10.1017/S0317167100029176; REDDY EP, 1988, P NATL ACAD SCI USA, V85, P3599, DOI 10.1073/pnas.85.10.3599; RICHARDSON JH, 1989, LANCET, V1, P1079; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; RODGERSJOHNSON P, 1988, ANN NEUROL, V23, pS121, DOI 10.1002/ana.410230729; RODGERSJOHNSON P, 1985, LANCET, V2, P1247; RODGERSJOHNSON PE, 1988, TRENDS NEUROSCI, V11, P526, DOI 10.1016/0166-2236(88)90176-2; RODGERSJOHNSON PEB, 1990, RES P ARNMD, V68, P117; ROMAN GC, 1985, NEUROLOGY, V35, P1158, DOI 10.1212/WNL.35.8.1158; ROMAN GC, 1985, ANN NEUROL, V17, P361, DOI 10.1002/ana.410170410; ROMAN GC, 1988, LANCET, V1, P651; ROMAN GC, 1990, PROG MED VIROL, V37, P190; ROMAN GC, 1987, ARCH NEUROL-CHICAGO, V44, P605, DOI 10.1001/archneur.1987.00520180029011; ROMAN GC, 1988, ANN NEUROL, V23, pS113, DOI 10.1002/ana.410230728; ROMAN GC, 1987, NEUROLOGY, V37, P1323, DOI 10.1212/WNL.37.8.1323; ROMAN GC, 1988, J NEUROL SCI, V87, P121, DOI 10.1016/0022-510X(88)90059-7; RYBERG B, 1987, BRIT MED J, V295, P1380, DOI 10.1136/bmj.295.6610.1380-a; SAID G, 1988, ANN NEUROL, V24, P275, DOI 10.1002/ana.410240218; SAKAI Y, 1989, J NEUROL NEUROSUR PS, V52, P1445, DOI 10.1136/jnnp.52.12.1445; SALAZARGRUESO EF, 1990, NEW ENGL J MED, V323, P732, DOI 10.1056/NEJM199009133231107; SARIN PS, 1989, P NATL ACAD SCI USA, V86, P2021, DOI 10.1073/pnas.86.6.2021; SASAKI S, 1990, ACTA NEUROPATHOL, V81, P219, DOI 10.1007/BF00334512; SAWADA M, 1990, J VIROL, V64, P4002, DOI 10.1128/JVI.64.8.4002-4006.1990; SAXTON EH, 1989, NEUROLOGY, V39, P841, DOI 10.1212/WNL.39.6.841; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SHEREMATA W A, 1991, Neurology, V41, P142; SHIBASAKI H, 1988, J NEUROL SCI, V87, P15, DOI 10.1016/0022-510X(88)90050-0; SHIBASAKI H, 1989, NEUROEPIDEMIOLOGY, V8, P124, DOI 10.1159/000110174; SHIBASAKI H, 1989, NEUROLOGY NEUROBIOLO, V51, P227; SHIBAYAMA K, 1991, J NEUROL SCI, V106, P186, DOI 10.1016/0022-510X(91)90256-7; SUGIMOTO M, 1989, CHEST, V95, P708, DOI 10.1378/chest.95.3.708a; SUGIMOTO M, 1989, AM REV RESPIR DIS, V139, P1329, DOI 10.1164/ajrccm/139.6.1329; SUGIMOTO M, 1987, LANCET, V2, P1220; SUGIMURA K, 1990, NEUROLOGY, V40, P1263, DOI 10.1212/WNL.40.8.1263; Takatsuki K., 1977, TOPICS HEMATOLOGY, P73; TAKAYANAGUI OM, 1991, LANCET, V337, P309; TAKEGOSHI K, 1991, J CLIN GASTROENTEROL, V13, P202, DOI 10.1097/00004836-199104000-00017; TARRAS S, 1989, NEUROLOGY NEUROBIOLO, V51, P435; TENDLER CL, 1990, P NATL ACAD SCI USA, V87, P5218, DOI 10.1073/pnas.87.13.5218; TOMITA I, 1989, NEUROLOGY NEUROBIOLO, V51, P239; TOURNIERLASSERVE E, 1987, LANCET, V2, P49; TSUJIMOTO A, 1988, MOL BIOL MED, V5, P29; TSUKADA N, 1989, J NEUROL SCI, V90, P33, DOI 10.1016/0022-510X(89)90043-9; UGAWA Y, 1988, J NEUROL NEUROSUR PS, V51, P1069, DOI 10.1136/jnnp.51.8.1069; UNGARSARGON JY, 1980, J NEUROL SCI, V46, P1, DOI 10.1016/0022-510X(80)90039-8; USUKU K, 1988, ANN NEUROL, V23, pS143, DOI 10.1002/ana.410230733; VERNANT JC, 1989, REV NEUROL-FRANCE, V145, P260; VERNANT JC, 1987, LANCET, V2, P404; VERNANT JC, 1986, PRESSE MED, V15, P419; VERNANT JC, 1988, ANN NEUROL, V23, pS133, DOI 10.1002/ana.410230731; VERNANT JC, 1987, ANN NEUROL, V21, P123, DOI 10.1002/ana.410210204; VERNANT JC, 1989, NEUROLOGY NEUROBIOLO, V51, P99; VERNANT JC, 1989, NEUROLOGY NEUROBIOLO, V51, P361; VOGT W A, 1990, Annals of Neurology, V28, P280; VOSKUHL RR, 1991, NEUROLOGY S1, V41, pS143; WADDY H, 1990, ELECTRONECEPHALOGR C, V75, P159; WALLACE ID, 1983, S AFR MED J, V63, P689; WATABE K, 1989, J NEUROPATH EXP NEUR, V48, P610, DOI 10.1097/00005072-198911000-00003; WINDSOR IM, 1988, S AFR MED J, V74, P370; YAMADA M, 1991, J NEUROPATH EXP NEUR, V50, P97, DOI 10.1097/00005072-199103000-00001; YAMAGUCHI K, 1989, J LAB CLIN MED, V114, P407; YANAGIHARA R, 1991, AM J TROP MED HYG, V44, P122, DOI 10.4269/ajtmh.1991.44.122; YANAGIHARA R, 1991, JPN J CANCER RES, V82, P240, DOI 10.1111/j.1349-7006.1991.tb01835.x; YASUI C, 1991, J AM ACAD DERMATOL, V24, P633, DOI 10.1016/0190-9622(91)70098-M; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534; YOSHIDA M, 1989, ANN NEUROL, V26, P331, DOI 10.1002/ana.410260304; ZANINOVIC V, 1988, ANN NEUROL, V23, pS127, DOI 10.1002/ana.410230730; ZANINOVIC V, 1986, COLOMB MEDICA, V17, P2; Zaninovic V., 1981, COLOMB MEDICA, V12, P111; ZANINOVIC V, 1986, COLOMB MEDICA, V17, P101	255	154	156	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					933	946		10.7326/0003-4819-117-11-933	http://dx.doi.org/10.7326/0003-4819-117-11-933			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443956				2022-12-28	WOS:A1992JZ27600010
J	COHEN, J				COHEN, J			LEGAL LIABILITY - AIDS CLINICAL-TRIAL TO GO AHEAD	SCIENCE			English	Editorial Material																		1992, SCIENCE, V257, P316	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 20	1992	258	5086					1298	1298		10.1126/science.1455220	http://dx.doi.org/10.1126/science.1455220			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JY958	1455220				2022-12-28	WOS:A1992JY95800013
J	GHALI, JK; LIAO, YL; SIMMONS, B; CASTANER, A; CAO, GC; COOPER, RS				GHALI, JK; LIAO, YL; SIMMONS, B; CASTANER, A; CAO, GC; COOPER, RS			THE PROGNOSTIC ROLE OF LEFT-VENTRICULAR HYPERTROPHY IN PATIENTS WITH OR WITHOUT CORONARY-ARTERY DISEASE	ANNALS OF INTERNAL MEDICINE			English	Article						CORONARY DISEASE; VENTRICULAR FUNCTION, LEFT; HEART ENLARGEMENT; HYPERTENSION; ECHOCARDIOGRAPHY	HEART-DISEASE; ECHOCARDIOGRAPHIC ASSESSMENT; ESSENTIAL-HYPERTENSION; RISK-FACTORS; MASS; INFARCTION; MORTALITY; EVENTS; DEATH; SIZE	Objective: To examine the association between echocardiographically determined left ventricular hypertrophy and mortality in patients with and without coronary artery disease. Design: Cohort study with a mean follow-up period of 4 years. Setting: An inner-city public hospital in Chicago. Patients: A cohort of 785 patients, most of whom were black and had hypertension. Interventions: Coronary arteriography for presumed coronary artery disease and echocardiography. Main Outcome Measure: All-cause and cardiac mortality. Results: Left ventricular hypertrophy, based on left ventricular mass corrected for body surface area, was present in 194 of 381 patients (51%) with coronary artery disease and in 162 of 404 patients (40%) without coronary artery disease. Patients with left ventricular hypertrophy had worse survival than those without hypertrophy in both the group with coronary artery disease and the group without coronary artery disease. After adjustment was made for age at baseline, sex, and hypertension, the relative risk for death from any cause in patients with hypertrophy compared with patients without hypertrophy was 2.14 (95% Cl, 1.24 to 3.68) among those with coronary artery disease and 4.14 (Cl, 1.77 to 9.71) among those without coronary artery disease. Conclusions: Echocardiographically determined left ventricular hypertrophy is an important prognostic marker in patients with or without coronary artery disease. The effect of reversing ventricular hypertrophy in patients with and without coronary disease deserves further study.	LOYOLA UNIV, STRITCH SCH MED, DEPT PREVENT MED & EPIDEMIOL, MAYWOOD, IL 60153 USA; COOK CTY HOSP, CHICAGO, IL 60612 USA	Loyola University Chicago; John H Stroger Junior Hospital Cook County					NHLBI NIH HHS [R01HL 36723] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARONOW WS, 1991, AM J CARDIOL, V67, P295, DOI 10.1016/0002-9149(91)90562-Y; BORHANI NO, 1987, AM J CARDIOL, V60, pI13; BORHANI NO, 1986, PROG CARDIOVASC DIS, V29, P55, DOI 10.1016/0033-0620(86)90034-4; CASALE PN, 1986, ANN INTERN MED, V105, P173, DOI 10.7326/0003-4819-105-2-173; COOPER RS, 1990, AM J CARDIOL, V65, P441, DOI 10.1016/0002-9149(90)90807-D; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; DEVEREUX RB, 1987, HEART HYPERTENSION, P197; DUNN FG, 1983, J AM COLL CARDIOL, V1, P1348, DOI 10.1016/S0735-1097(83)80150-8; FROHLICH ED, 1988, J HYPERTENS, V6, pS2, DOI 10.1097/00004872-198812040-00002; FROHLICH ED, 1987, AM J CARDIOL, V59, pA91, DOI 10.1016/0002-9149(87)90183-4; GHALI JK, 1991, J AM COLL CARDIOL, V17, P1277, DOI 10.1016/S0735-1097(10)80135-4; Kannel W B, 1978, Ann N Y Acad Sci, V304, P128, DOI 10.1111/j.1749-6632.1978.tb25585.x; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; KJELSBERG MO, 1985, AM J CARDIOL, V55, P1; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; KOYANAGI S, 1982, CIRCULATION, V65, P1192, DOI 10.1161/01.CIR.65.6.1192; KOYANAGI S, 1982, CIRC RES, V50, P55, DOI 10.1161/01.RES.50.1.55; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1987, AM J CARDIOL, V59, P956, DOI 10.1016/0002-9149(87)91133-7; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7; Marcus ML, 1983, CORONARY CIRCULATION, P285; MCLENACHAN JM, 1987, NEW ENGL J MED, V317, P787, DOI 10.1056/NEJM198709243171302; MESSERLI FH, 1984, AM J MED, V77, P18, DOI 10.1016/0002-9343(84)90430-3; MOSER M, 1991, EUR HEART J, V12, P1034, DOI 10.1093/eurheartj/12.9.1034; PATTERSON JE, 1985, 1299286 DEP TREAS IN, P245; RAUTAHARJU PM, 1988, AM J CARDIOL, V62, P59, DOI 10.1016/0002-9149(88)91365-3; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SAVAGE DD, 1987, CIRCULATION, V75, P26; SAVAGE DD, 1979, CIRCULATION, V59, P623, DOI 10.1161/01.CIR.59.4.623; SCHAIBLE TF, 1986, J APPL PHYSIOL, V60, P1435, DOI 10.1152/jappl.1986.60.4.1435; TROY BL, 1972, CIRCULATION, V45, P602, DOI 10.1161/01.CIR.45.3.602; WEBER KT, 1988, J APPL CARDIOL, V3, P37; ZEHENDER M, 1992, CIRCULATION, V85, P1808, DOI 10.1161/01.CIR.85.5.1808	34	384	388	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					831	836		10.7326/0003-4819-117-10-831	http://dx.doi.org/10.7326/0003-4819-117-10-831			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416558				2022-12-28	WOS:A1992JX83800006
J	STERNBERG, EM; CHROUSOS, GP; WILDER, RL; GOLD, PW				STERNBERG, EM; CHROUSOS, GP; WILDER, RL; GOLD, PW			THE STRESS RESPONSE AND THE REGULATION OF INFLAMMATORY DISEASE	ANNALS OF INTERNAL MEDICINE			English	Article						STRESS; INFLAMMATION; ANTIDEPRESSIVE AGENTS; CYTOKINES; CORTICOTROPIN-RELEASING HORMONE	CORTICOTROPIN-RELEASING HORMONE; EOSINOPHILIA-MYALGIA-SYNDROME; PITUITARY-ADRENAL AXIS; SYSTEMIC LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; IMMUNODEFICIENCY-SYNDROME; CLINICAL IMPLICATIONS; CUSHINGS-DISEASE; NERVOUS-SYSTEM; TRYPTOPHAN USE	The molecular and biochemical bases for interactions between the immune and central nervous systems are described. Immune cytokines not only activate immune function but also recruit central stress-responsive neurotransmitter systems in the modulation of the immune response and in the activation of behaviors that may be adaptive during injury or inflammation. Peripherally generated cytokines, such as interleukin-1, signal hypothalamic corticotropin-releasing hormone (CRH) neurons to activate pituitary-adrenal counter-regulation of inflammation through the potent anti-inflammatory effects of glucocorticoids. Corticotropin-releasing hormone not only activates the pituitary-adrenal axis but also sets in motion a coordinated series of behavioral and physiologic responses, suggesting that the central nervous system may coordinate both behavioral and immunologic adaptation during stressful situations. The pathophysiologic perturbation of this feedback loop, through various mechanisms, results in the development of inflammatory syndromes, such as rheumatoid arthritis, and behavioral syndromes, such as depression. Thus, diseases characterized by both inflammatory and emotional disturbances may derive from common alterations in specific central nervous system pathways (for example, the CRH system). In addition, disruptions of this communication by genetic, infectious, toxic, or pharmacologic means can influence the susceptibility to disorders associated with both behavioral and inflammatory components and potentially alter their natural history. These concepts suggest that neuropharmacologic agents that stimulate hypothalamic CRH might potentially be adjunctive therapy for illnesses traditionally viewed as inflammatory or autoimmune.	NIAMSD, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	STERNBERG, EM (corresponding author), NIMH, BLDG 10, ROOM 3S-231, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA.							BANKS WA, 1991, J PHARMACOL EXP THER, V259, P988; BANKS WA, 1989, BRAIN RES BULL, V23, P433, DOI 10.1016/0361-9230(89)90185-8; BELLINGER DL, 1990, ANN NY ACAD SCI, V594, P17; BELONGIA EA, 1990, NEW ENGL J MED, V323, P357, DOI 10.1056/NEJM199008093230601; BERKENBOSCH F, 1987, SCIENCE, V238, P524, DOI 10.1126/science.2443979; BERNARDINI R, 1988, NEW TRENDS BRAIN FEM; BERNTON EW, 1987, SCIENCE, V238, P519, DOI 10.1126/science.2821620; BISHOP DS, 1988, J RHEUMATOL, V15, P888; BLOWERS LE, 1988, J RHEUMATOL, V15, P785; BRADY LS, 1991, J CLIN INVEST, V87, P831, DOI 10.1172/JCI115086; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; CALOGERO AE, 1988, J CLIN INVEST, V82, P839, DOI 10.1172/JCI113687; CALOGERO AE, 1990, ENDOCRINOLOGY, V126, P1888, DOI 10.1210/endo-126-4-1888; CANNON JG, 1986, J IMMUNOL, V137, P2232; CATANIA A, 1990, HORM METAB RES, V22, P597, DOI 10.1055/s-2007-1004982; COHEN JJ, 1989, ANTIINFLAMMATORY STE, P111; CROFFORD LJ, 1990, J CLIN INVEST, V86, P1757, DOI 10.1172/JCI114902; CROWN J, 1991, BLOOD, V78, P1420; CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x; DEKLOET ER, 1991, STRESS REVISITED, V1, P104; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; DUNN AJ, 1989, PHYSIOL BEHAV, V45, P591, DOI 10.1016/0031-9384(89)90078-4; EDWARDS CK, 1991, P NATL ACAD SCI USA, V88, P2274, DOI 10.1073/pnas.88.6.2274; FIECHTNER J J, 1991, Arthritis and Rheumatism, V34, pS128; FONTANA A, 1984, J IMMUNOL, V133, P1696; GALIN FS, 1990, ANN NY ACAD SCI, V594, P382; GOLD PW, 1986, NEW ENGL J MED, V314, P1329, DOI 10.1056/NEJM198605223142101; GOLD PW, 1988, NEW ENGL J MED, V319, P413, DOI 10.1056/NEJM198808183190706; GOLD PW, 1988, NEW ENGL J MED, V319, P3844; GOULDING NJ, 1989, ANN RHEUM DIS, V48, P843, DOI 10.1136/ard.48.10.843; GROTA LJ, 1990, PHARMACOL BIOCHEM BE, V37, P527, DOI 10.1016/0091-3057(90)90023-B; HASHIMOTO M, 1991, BRAIN RES, V540, P217, DOI 10.1016/0006-8993(91)90510-3; HEAGY W, 1990, J EXP MED, V171, P1625, DOI 10.1084/jem.171.5.1625; HENCH PS, 1950, ARCH INTERN MED, V85, P545, DOI 10.1001/archinte.1950.00230100002001; HERTZMAN PA, 1990, NEW ENGL J MED, V322, P869, DOI 10.1056/NEJM199003293221301; HILTZ ME, 1990, PEPTIDES, V11, P979, DOI 10.1016/0196-9781(90)90020-6; JOSEPHVANDERPOOL JR, 1991, J CLIN ENDOCR METAB, V72, P1382, DOI 10.1210/jcem-72-6-1382; KALOGERAS KT, 1990, J CLIN ENDOCR METAB, V70, P1462, DOI 10.1210/jcem-70-5-1462; KAMILARIS TC, 1991, ENDOCRINOLOGY, V128, P2567, DOI 10.1210/endo-128-5-2567; KARALIS K, 1991, SCIENCE, V254, P421, DOI 10.1126/science.1925600; KLEIN A, 1990, J RHEUMATOL, V17, P30; KLING MA, 1991, J CLIN ENDOCR METAB, V72, P260, DOI 10.1210/jcem-72-2-260; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; LOVE L A, 1991, Arthritis and Rheumatism, V34, pS131; MASON D, 1990, IMMUNOLOGY, V70, P1; MAYENO AN, 1990, SCIENCE, V250, P1707, DOI 10.1126/science.2270484; MULLER S, 1991, BRAIN BEHAV IMMUN, V5, P55, DOI 10.1016/0889-1591(91)90007-W; Munck A., 1989, ANTIINFLAMMATORY STE, P30; NEECK G, 1990, J RHEUMATOL, V17, P24; PAYAN DG, 1989, ANNU REV MED, V40, P341; SAKIMOTO K, 1990, NEW ENGL J MED, V323, P992; SAPOLSKY R, 1987, SCIENCE, V238, P522, DOI 10.1126/science.2821621; SCHALLY AV, 1981, P NATL ACAD SCI-BIOL, V78, P5197, DOI 10.1073/pnas.78.8.5197; SCHLEIMER RP, 1990, AM REV RESPIR DIS, V141, pS59; SCHLEIMER RP, 1989, J PHARMACOL EXP THER, V250, P598; SELYE H, 1950, STRESS MONTREAL ACTA; SHEEHAN HL, 1949, Q J MED, V18, P319; SHERIDAN JF, 1991, J NEUROIMMUNOL, V31, P245, DOI 10.1016/0165-5728(91)90046-A; SILVER RM, 1990, NEW ENGL J MED, V322, P874, DOI 10.1056/NEJM199003293221302; SMITH JW, 1992, J CLIN ONCOL, V10, P1141, DOI 10.1200/JCO.1992.10.7.1141; SMITH MJ, 1991, TETRAHEDRON LETT, V32, P991, DOI 10.1016/S0040-4039(00)74469-8; SNYDER DS, 1982, J IMMUNOL, V129, P1803; SPADARO F, 1990, BRAIN BEHAV IMMUN, V4, P308, DOI 10.1016/0889-1591(90)90034-N; SREEDHARAN SP, 1989, J BIOL CHEM, V264, P949; STARNES HF, 1991, SEMIN HEMATOL, V28, P34; STENBERG VI, 1990, AGENTS ACTIONS, V29, P189, DOI 10.1007/BF01966446; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P2374, DOI 10.1073/pnas.86.7.2374; STERNBERG EM, 1992, BRAIN RES, V570, P54, DOI 10.1016/0006-8993(92)90563-O; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P4771, DOI 10.1073/pnas.86.12.4771; STERNBERG EM, 1989, PROGR NEUROENDOCR IM, V2, P102; STERNBERG EM, 1991, STRESS NEUROPEPTIDES, P287; STERNBERG EM, 1988, YEAR IMMUNOLOGY, V5, P205; STERNBERG EM, 1988, LYMPHOCYTE STRUCTURE, P1; STITT JT, 1990, YALE J BIOL MED, V63, P121; SUNDAR SK, 1990, J NEUROSCI, V10, P3701; SUTTON RE, 1982, NATURE, V297, P331, DOI 10.1038/297331a0; SWYGERT LA, 1990, JAMA-J AM MED ASSOC, V264, P1698, DOI 10.1001/jama.264.13.1698; TENG CS, 1990, AIDS, V4, P1219, DOI 10.1097/00002030-199012000-00006; TOLLEFSON L, 1990, J NEUROSCI RES, V25, P20, DOI 10.1002/jnr.490250104; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; WEINSTOCK JV, 1991, EUR J CLIN INVEST, V21, P145, DOI 10.1111/j.1365-2362.1991.tb01803.x; WENGER GD, 1990, ANN NY ACAD SCI, V594, P104; WEST HF, 1957, ANN RHEUM DIS, V16, P173, DOI 10.1136/ard.16.2.173; WICK G, 1987, IMMUNOL LETT, V16, P249, DOI 10.1016/0165-2478(87)90154-4; WILDER R L, 1990, Current Opinion in Rheumatology, V2, P436; WILLIAMS TJ, 1990, AM REV RESPIR DIS, V141, pS39; WOLOSKI BMRNJ, 1985, SCIENCE, V230, P1035, DOI 10.1126/science.2997929	87	369	377	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					854	866		10.7326/0003-4819-117-10-854	http://dx.doi.org/10.7326/0003-4819-117-10-854			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416562				2022-12-28	WOS:A1992JX83800010
J	WEYAND, CM; HICOK, KC; CONN, DL; GORONZY, JJ				WEYAND, CM; HICOK, KC; CONN, DL; GORONZY, JJ			THE INFLUENCE OF HLA-DRB1 GENES ON DISEASE SEVERITY IN RHEUMATOID-ARTHRITIS	ANNALS OF INTERNAL MEDICINE			English	Article						ARTHRITIS, RHEUMATOID; HLA-DR1 ANTIGEN; RHEUMATOID NODULE; VASCULITIS	SHARED EPITOPE HYPOTHESIS; ASSOCIATION; THERAPY; SUSCEPTIBILITY; SPECIFICITIES	Objective: To explore the role of HLA-DRB1 genes in determining disease severity in rheumatoid arthritis. Design: Case series of patients with seropositive rheumatoid arthritis. Setting: The outpatient clinic of the Division of Rheumatology, Mayo Clinic. Patients: One hundred and two patients with seropositive, erosive rheumatoid arthritis and a minimum disease duration of 3 years. Measurements: Patients were genotyped for both HLA-DRB1 alleles and were categorized according to the expression of one or two disease-linked HLA-DRB1 alleles. Identification of HLA-DRB1 alleles was done by the polymerase chain reaction and subsequent oligonucleotide hybridization. Homozygosity for allelic variants was confirmed by sequence analysis. Immunogenetically defined patient subgroups were retrospectively evaluated for joint destruction and patterns of disease manifestation, including rheumatoid organ disease. Results: Of 102 patients, 98 (96%) expressed the disease-linked sequence polymorphism. Forty-seven patients (46%) carried a double dose of the relevant sequence stretch: Twenty-eight patients expressed HLA-DRB1*04 variants on both alleles, and 19 combined an HLA-DRB*04 variant with HLA-DRB1*0101 or DRB1*1402. Nodular disease was present in 100% of patients typed as HLA-DRB1*04/04 and in 59% of patients typed as HLA-DRB1 *04 and who had inherited only a single dose of the disease-linked sequence polymorphism (P < 0.0001). Major organ systems were involved in 61% and 11% of these two patient groups, respectively (P < 0.0001); and joint surgery was required in 61% and 25% (P < 0.002), respectively. Patients typed as HLA-DR*04/01 had intermediate clinical courses. Conclusion: Genotyping patients with rheumatoid arthritis for both HLA-DRB1 alleles identifies clinical subsets with distinct profiles of disease manifestations.			WEYAND, CM (corresponding author), MAYO CLIN & MAYO FDN, 401 GUGGENHEIM, 200 1ST ST SW, ROCHESTER, MN 55905 USA.		Weyand, Cornelia/AAH-3343-2021	Goronzy, Jorg/0000-0001-7670-1856				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BROOK A, 1977, ANN RHEUM DIS, V36, P71, DOI 10.1136/ard.36.1.71; FELSON DT, 1990, ARTHRITIS RHEUM, V33, P1449, DOI 10.1002/art.1780331001; FUCHS HA, 1989, J RHEUMATOL, V16, P585; GORONZY J, 1986, J CLIN INVEST, V77, P1042, DOI 10.1172/JCI112358; GORONZY JJ, 1992, J IMMUNOL, V148, P604; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; JOHNSON K, 1990, J RHEUMATOL, V17, P34; KLIPPEL JH, 1990, J RHEUMATOL, V17, P1118; KUSHNER I, 1989, J RHEUMATOL, V16, P1; MARSH SGE, 1991, IMMUNOGENETICS, V33, P321, DOI 10.1007/BF00216691; Masi A T, 1976, Semin Arthritis Rheum, V4, P299; MCCARTY DJ, 1990, J RHEUMATOL, V17, P1115; NEPOM GT, 1987, J CLIN IMMUNOL, V7, P1, DOI 10.1007/BF00915418; NEPOM GT, 1986, LANCET, V2, P1002; PINCUS T, 1988, J CLIN EPIDEMIOL, V41, P1037, DOI 10.1016/0895-4356(88)90072-8; PINCUS T, 1986, J RHEUMATOL, V13, P841; SCHIFF B, 1982, ANN RHEUM DIS, V41, P403, DOI 10.1136/ard.41.4.403; SCOTT DL, 1987, LANCET, V1, P1108; SHARP JT, 1991, ARTHRITIS RHEUM, V34, P660, DOI 10.1002/art.1780340606; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; VANZEBEN D, 1991, ARTHRITIS RHEUM, V34, P822, DOI 10.1002/art.1780340707; VOLLERTSEN RS, 1990, RHEUM DIS CLIN N AM, V16, P445; WALKER DJ, 1985, ANN RHEUM DIS, V44, P519, DOI 10.1136/ard.44.8.519; WESTEDT ML, 1986, ANN RHEUM DIS, V45, P534, DOI 10.1136/ard.45.7.534; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814; WEYAND CM, 1991, J IMMUNOL, V147, P70; WEYAND CM, 1989, IMMUNOBIOLOGY HLA IM, V2, P422; WILLKENS RF, 1991, ARTHRITIS RHEUM, V34, P43, DOI 10.1002/art.1780340107; WILSKE KR, 1990, J RHEUMATOL, V17, P4; YOUNG A, 1984, ARTHRITIS RHEUM, V27, P20, DOI 10.1002/art.1780270104	33	421	435	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1992	117	10					801	806		10.7326/0003-4819-117-10-801	http://dx.doi.org/10.7326/0003-4819-117-10-801			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX838	1416553				2022-12-28	WOS:A1992JX83800001
J	SODEINDE, OA; SUBRAHMANYAM, YVBK; STARK, K; QUAN, T; BAO, YD; GOGUEN, JD				SODEINDE, OA; SUBRAHMANYAM, YVBK; STARK, K; QUAN, T; BAO, YD; GOGUEN, JD			A SURFACE PROTEASE AND THE INVASIVE CHARACTER OF PLAGUE	SCIENCE			English	Article							PLASMINOGEN-ACTIVATOR; YERSINIA-PESTIS; VIRULENCE; UROKINASE; FIBRIN; ASSAY	A 9.5-kilobase plasmid of Yersinia pestis, the causative agent of plague, is required for high virulence when mice are inoculated with the bacterium by subcutaneous injection. Inactivation of the plasmid gene pla, which encodes a surface protease, increased the median lethal dose of the bacteria for mice by a millionfold. Moreover, cloned pla was sufficient to restore segregants lacking the entire pla-bearing plasmid to full virulence. Both pla+ strains injected subcutaneously and pla- mutants injected intravenously reached high titers in liver and spleen of infected mice, whereas pla- mutants injected subcutaneously failed to do so even though they establish a sustained local infection at the injection site. More inflammatory cells accumulated in lesions caused by the pla- mutants than in lesions produced by the pla+ parent. The Pla protease was shown to be a plasminogen activator with unusual kinetic properties. It can also cleave complement C3 at a specific site.	UNIV MASSACHUSETTS,SCH MED,DEPT MOLEC GENET & MICROBIOL,WORCESTER,MA 01655; CTR DIS CONTROL,DIV VECTOR BORNE DIS,FT COLLINS,CO 80522	University of Massachusetts System; University of Massachusetts Worcester					NIAID NIH HHS [AI22176] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022176] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEESLEY ED, 1967, J BACTERIOL, V165, P19; BERCOVIER H, 1984, BERGEYS MANUAL SYSTE, V1, P498; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BUTLER T, 1983, PLAGUE OTHER YERSINI, P118; DUNN DL, 1982, SURGERY, V92, P513; FINEGOLD MJ, 1961, AM J PATHOL, V53, P99; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; MIGNATTI P, 1986, CELL, V47, P487, DOI 10.1016/0092-8674(86)90613-6; PELTZ SW, 1982, BIOCHEMISTRY-US, V21, P2798, DOI 10.1021/bi00540a035; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0; SODEINDE OA, 1989, INFECT IMMUN, V57, P1517, DOI 10.1128/IAI.57.5.1517-1523.1989; SODEINDE OA, 1988, INFECT IMMUN, V56, P2743, DOI 10.1128/IAI.56.10.2743-2748.1988; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; VERHEIJEN JH, 1982, THROMB HAEMOSTASIS, V48, P266	16	424	436	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 6	1992	258	5084					1004	1007		10.1126/science.1439793	http://dx.doi.org/10.1126/science.1439793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439793				2022-12-28	WOS:A1992JW79600038
J	BENNISH, ML; SALAM, MA; KHAN, WA; KHAN, AM				BENNISH, ML; SALAM, MA; KHAN, WA; KHAN, AM			TREATMENT OF SHIGELLOSIS .3. COMPARISON OF ONE-DOSE OR 2-DOSE CIPROFLOXACIN WITH STANDARD 5-DAY THERAPY - A RANDOMIZED, BLINDED TRIAL	ANNALS OF INTERNAL MEDICINE			English	Article						CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSENTERY, BACILLARY; SHIGELLA-DYSENTERIAE; QUINOLONES	NALIDIXIC-ACID; DYSENTERIAE TYPE-1; RESISTANT SHIGELLA; AMPICILLIN; BANGLADESH; PIVMECILLINAM; NORFLOXACIN; ARTHROPATHY; COMMUNITY; ADULTS	Objective: To determine whether a single dose, or 2 doses, of ciprofloxacin are as effective as 5-day, 10-dose therapy for the treatment of shigellosis in adult men who are moderately to severely ill. Design: Randomized, double-blind clinical trial. Setting. A diarrhea treatment center in the capital city of a developing country, Bangladesh. Patients: A total of 128 adult men with dysentery of less than 96 hours duration. All had Shigella organisms isolated from a culture of stool. Interventions: Patients were randomly assigned to receive either a single 1 -gram dose of ciprofloxacin at admission to the study (single-dose group; n = 40), a 1-gram dose of ciprofloxacin at admission and 24 hours later (2-dose group; n = 43), or 500 mg of ciprofloxacin every 12 hours for 5 days (10 dose group; n = 35). All patients were hospitalized for 6 days. Measurements: Stools were collected individually; their character and consistency were recorded and cultured daily. A physical examination and recording of symptoms were done daily, and the temperature was measured every 4 hours. Therapy was considered to have failed in patients who did not have improvement in the signs and symptoms of dysentery after 72 hours of therapy or in patients who on study day 5 had more than nine stools, or more than two watery stools, or were febrile. Results: There were no treatment failures in the 78 patients infected with species of Shigella other than Shigella dysenteriae type 1. Among the 40 patients infected with S. dysenteriae type 1, treatment failed in 4 of the 10 patients who received single-dose therapy, 2 of the 15 patients who received 2-dose therapy, and none of the 15 patients who received 10-dose therapy (P = 0.017, single-dose therapy group compared with 10-dose group; P = 0.15 for the single-dose group compared with the 2-dose group; P > 0.2 for the 2-dose group compared with the 10-dose group). Conclusions: A single 1-gram dose of ciprofloxacin is effective therapy for patients infected with species of Shigella other than S. dysenteriae type 1. Single-dose therapy is inferior to 10-dose therapy for treating patients infected with S. dysenteriae type 1.	INT CTR DIARRHOEAL DIS RES, DHAKA 1000, BANGLADESH	International Centre for Diarrhoeal Disease Research (ICDDR)	BENNISH, ML (corresponding author), NEW ENGLAND MED CTR, 750 WASHINGTON ST, BOX 041, BOSTON, MA 02111 USA.							ALFAHAM M, 1987, BRIT MED J, V295, P699, DOI 10.1136/bmj.295.6600.699; BENNISH ML, 1990, J INFECT DIS, V162, P711, DOI 10.1093/infdis/162.3.711; BENNISH ML, 1990, J INFECT DIS, V161, P500, DOI 10.1093/infdis/161.3.500; BENNISH ML, 1992, CLIN INFECT DIS, V14, P1055, DOI 10.1093/clinids/14.5.1055; BENNISH ML, 1991, REV INFECT DIS, V13, pS245; DAVIS RL, 1985, ANTIMICROB AGENTS CH, V28, P74, DOI 10.1128/AAC.28.1.74; DEMOL P, 1987, J ANTIMICROB CHEMOTH, V19, P695, DOI 10.1093/jac/19.5.695; FONTAINE O, 1989, REV INFECT DIS, V11, pS1145; FROST JA, 1985, J HYG-CAMBRIDGE, V94, P163, DOI 10.1017/S0022172400061362; GOTUZZO E, 1989, ANTIMICROB AGENTS CH, V33, P1101, DOI 10.1128/AAC.33.7.1101; GRANT JP, 1991, STATE WORLDS CHILDRE, P112; HALTALIN KC, 1967, J PEDIATR-US, V70, P970, DOI 10.1016/S0022-3476(67)80275-0; HALTALIN KC, 1972, AM J DIS CHILD, V124, P554, DOI 10.1001/archpedi.1972.02110160092010; HOFFKEN G, 1985, ANTIMICROB AGENTS CH, V27, P375, DOI 10.1128/AAC.27.3.375; HOSSAIN MM, 1982, INT J EPIDEMIOL, V11, P402, DOI 10.1093/ije/11.4.402; HYAMS KC, 1991, NEW ENGL J MED, V325, P1423, DOI 10.1056/NEJM199111143252006; INGHAM B, 1977, TOXICOL LETT, V1, P21, DOI 10.1016/0378-4274(77)90016-9; KABIR I, 1984, ANTIMICROB AGENTS CH, V25, P643, DOI 10.1128/AAC.25.5.643; LING J, 1988, ANTIMICROB AGENTS CH, V32, P20, DOI 10.1128/AAC.32.1.20; MITRA AK, 1990, LANCET, V335, P1461, DOI 10.1016/0140-6736(90)91488-V; MUNSHI MH, 1987, LANCET, V2, P419; RIES AA, 1991, 31ST INT C ANT AG CH; ROGERIE F, 1986, ANTIMICROB AGENTS CH, V29, P883, DOI 10.1128/AAC.29.5.883; RONSMANS C, 1988, LANCET, V2, P552; RONSMANS C, 1991, REV INFECT DIS S4, V13, pS342; SALAM MA, 1988, J PEDIATR-US, V113, P901, DOI 10.1016/S0022-3476(88)80029-5; SALAM MA, 1991, REV INFECT DIS, V13, pS332; SARDER AM, 1981, SOC SCI MED-MED SOC, V15, P543, DOI 10.1016/0271-7123(81)90077-8; TAUXE RV, 1990, J INFECT DIS, V162, P1107, DOI 10.1093/infdis/162.5.1107; TONG MJ, 1970, J AMER MED ASSOC, V214, P1841, DOI 10.1001/jama.214.10.1841; 1987, MMWR, V36, P633; 1986, NEW VACCINE DEV ESTA, V2, P165; 1991, MMWR, V40, P421; 1991, MMWR, V40, P427; 1990, RATIONAL USE DRUGS M	35	76	79	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					727	734		10.7326/0003-4819-117-9-727	http://dx.doi.org/10.7326/0003-4819-117-9-727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416574				2022-12-28	WOS:A1992JV42400004
J	PAWSON, T; GISH, GD				PAWSON, T; GISH, GD			SH2 AND SH3 DOMAINS - FROM STRUCTURE TO FUNCTION	CELL			English	Review							SIGNAL TRANSDUCTION; OXIDASE; BINDING; PROTEIN; SIMILARITY				PAWSON, T (corresponding author), MT SINAI HOSP, SAMUEL LUNENFELD RES INST, DIV MOLEC & DEV BIOL, TORONTO M5G 1X5, ONTARIO, CANADA.		Pawson, Tony J/E-4578-2013; Gish, Gerald D/C-7228-2017					ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BOOKER GW, 1992, NATURE, V358, P684, DOI 10.1038/358684a0; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHENEVERT J, 1992, NATURE, V356, P77, DOI 10.1038/356077a0; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KOCH CA, 1991, SCIENCE, V252, P669; LAVAN BE, 1992, J BIOL CHEM, V267, P11631; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARENGERE L, 1992, IN PRESS J BIOL CHEM; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RODAWAY ARF, 1989, NATURE, V342, P624, DOI 10.1038/342624a0; RUSSELL RB, 1992, FEBS LETT, V304, P15, DOI 10.1016/0014-5793(92)80579-6; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SEGAL AW, 1989, J CLIN INVEST, V83, P1785, DOI 10.1172/JCI114083; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0	34	966	1016	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	1992	71	3					359	362		10.1016/0092-8674(92)90504-6	http://dx.doi.org/10.1016/0092-8674(92)90504-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423600				2022-12-28	WOS:A1992JW43500002
J	SCHELLENBERG, GD; BIRD, TD; WIJSMAN, EM; ORR, HT; ANDERSON, L; NEMENS, E; WHITE, JA; BONNYCASTLE, L; WEBER, JL; ALONSO, ME; POTTER, H; HESTON, LL; MARTIN, GM				SCHELLENBERG, GD; BIRD, TD; WIJSMAN, EM; ORR, HT; ANDERSON, L; NEMENS, E; WHITE, JA; BONNYCASTLE, L; WEBER, JL; ALONSO, ME; POTTER, H; HESTON, LL; MARTIN, GM			GENETIC-LINKAGE EVIDENCE FOR A FAMILIAL ALZHEIMERS-DISEASE LOCUS ON CHROMOSOME-14	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; C-FOS; MAMMALIAN BRAIN; MUTATION; MARKERS; HETEROGENEITY; KINDREDS; SEQUENCE; DEMENTIA; INDICATE	Linkage analysis was used to search the genome for chromosomal regions harboring familial Alzheimer's disease genes. Markers on chromosome 14 gave highly significant positive lod scores in early-onset non-Volga German kindreds; a Z(max) of 9.15 (theta = 0.01) was obtained with the marker D14S43 at 14q24.3. One early-onset family yielded a lod score of 4.89 (theta = 0.0). When no assumptions were made about age-dependent penetrance, significant results were still obtained (Z(max) = 5.94, theta = 0.0), despite the loss of power to detect linkage under these conditions. Results for the Volga German families were either negative or nonsignificant for markers in this region. Thus, evidence indicates a familial Alzheimer's disease locus on chromosome 14.	VET AFFAIRS MED CTR, DIV NEUROL, SEATTLE, WA 98108 USA; UNIV WASHINGTON, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA; MARSHFIELD MED RES FDN, MARSHFIELD, WI 54449 USA; NATL INST NEUROL & NEUROSURG, MEXICO CITY, MEXICO; WASHINGTON INST MENTAL ILLNESS RES & TRAINING, DEPT PSYCHIAT, STEILACOOM, WA 98494 USA; HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA; UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT PSYCHIAT, MINNEAPOLIS, MN 55455 USA; UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	SCHELLENBERG, GD (corresponding author), UNIV WASHINGTON, DEPT MED, DIV NEUROL, SEATTLE, WA 98195 USA.			Orr, Harry/0000-0001-6118-741X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00248] Funding Source: Medline; NIA NIH HHS [AG08017] Funding Source: Medline; NIMH NIH HHS [R01MH43240] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERGEM ALM, NEUROBIOL AGING, V13, pS66; BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; BREITNER JCS, NEUROBIOL AGING, V13, pS66; BROWN IR, 1990, J NEUROSCI RES, V27, P247, DOI 10.1002/jnr.490270302; CHARTIERHARLIN MC, 1991, NEUROSCI LETT, V129, P134, DOI 10.1016/0304-3940(91)90738-F; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; CRAWFORD F, 1991, NEUROSCI LETT, V133, P1, DOI 10.1016/0304-3940(91)90042-R; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOUDSMIT J, 1981, J NEUROL SCI, V49, P79, DOI 10.1016/0022-510X(81)90190-8; HESTON LL, 1991, AM J MED GENET, V40, P449, DOI 10.1002/ajmg.1320400415; HODGE SE, 1983, AM J HUM GENET, V35, P1139; JORDAN SA, 1959, NUCLEIC ACIDS RES, V19, P1722; KAMINO K, 1992, AM J HUM GENET, V51, P998; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MORTON NE, 1956, AM J HUM GENET, V8, P80; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; NEE LE, 1987, NEUROLOGY, V37, P359, DOI 10.1212/WNL.37.3.359; NUKIWA T, 1988, AM J HUM GENET, V43, P322; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; Ott J., 1991, ANAL HUMAN GENETIC L; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; RAPOPORT SI, 1991, NEUROLOGY, V41, P1549, DOI 10.1212/WNL.41.10.1549; RISCH N, 1991, AM J HUM GENET, V48, P1058; RUPPERT C, 1987, MOL BRAIN RES, V2, P51, DOI 10.1016/0169-328X(87)90020-9; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SCHELLENBERG G, 1992, Neurobiology of Aging, V13, pS67; SCHELLENBERG GD, 1991, AM J HUM GENET, V49, P511; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SCHELLENBERG GD, 1992, ANN NEUROL, V31, P223, DOI 10.1002/ana.410310214; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1991, J BIOL CHEM, V266, P20579; TANZI RE, 1992, AM J HUM GENET, V51, P273; VALENCIA LG, 1986, REV INVEST CLIN, V38, P261; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VANDUIJN CM, 1991, INT J EPIDEMIOL, V20, pS13, DOI 10.1093/ije/20.Supplement_2.S13; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEITKAMP LR, 1983, AM J HUM GENET, V35, P443; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z; ZHANG P, 1992, NEUROSCIENCE, V46, P9, DOI 10.1016/0306-4522(92)90004-L	55	819	847	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	1992	258	5082					668	671		10.1126/science.1411576	http://dx.doi.org/10.1126/science.1411576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU745	1411576				2022-12-28	WOS:A1992JU74500063
J	FUJIMURA, T; RIBAS, JC; MAKHOV, AM; WICKNER, RB				FUJIMURA, T; RIBAS, JC; MAKHOV, AM; WICKNER, RB			POL OF GAG-POL FUSION PROTEIN REQUIRED FOR ENCAPSIDATION OF VIRAL-RNA OF YEAST L-A-VIRUS	NATURE			English	Article							HEPATITIS-B VIRUS; SACCHAROMYCES-CEREVISIAE; GENOMIC RNA; INVITRO; REPLICATION; POLYMERASE; TRANSCRIPTION; MATURATION; PARTICLES	DOUBLE-STRANDED RNA viruses have an RNA-dependent RNA polymerase activity associated with the viral particles which is indispensable for their replication cycle. Using the yeast L-A double-stranded RNA virus we have investigated the mechanism by which the virus encapsidates its genomic RNA and RNA polymerase. The L-A gag gene encodes the principal viral coat protein and the overlapping pol gene is expressed as a gag-pol fusion protein which is formed by a -1 ribosomal frameshift1-3. Here we show that Gag alone is sufficient for virus particle formation, but that it fails to package the viral single-stranded RNA genome. Encapsidation of the viral RNA requires only a part of the Pol region (the N-terminal quarter), which is presumably distinct from the RNA polymerase domain. Given that the Pol region has single-stranded RNA-binding activity, these results are consistent with our LA virus encapsidation model1: the Pol region of the fusion protein binds specifically to the viral genome (+) strand, and the N-terminal gag-encoded region primes polymerization of Gag to form the capsid, thus ensuring the packaging of both the viral genome and the RNA polymerase.	NIDDKD,BIOCHEM PHARMACOL LAB,GENET SIMPLE EUKARYOTES SECT,BETHESDA,MD 20892; NIAMSD,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	FUJIMURA, T (corresponding author), UNIV SALAMANCA,CSIC,DEPT MICROBIOL & GENET,INST MICROBIOL BIOQUIM,E-37071 SALAMANCA,SPAIN.		Ribas, Juan C/C-9864-2015; Fujimura, Tsutomu/K-5807-2014	Ribas, Juan C/0000-0001-6430-0895; Fujimura, Tsutomu/0000-0002-9457-6769				BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; CHURCHILL MEA, 1991, TRENDS BIOCHEM SCI, V16, P92, DOI 10.1016/0968-0004(91)90040-3; COFFIN J M, 1991, P645; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; FUJIMURA T, 1992, J BIOL CHEM, V267, P2708; FUJIMURA T, 1988, CELL, V55, P663, DOI 10.1016/0092-8674(88)90225-5; FUJIMURA T, 1990, CELL, V62, P819, DOI 10.1016/0092-8674(90)90125-X; FUJIMURA T, 1986, P NATL ACAD SCI USA, V83, P4433, DOI 10.1073/pnas.83.12.4433; FUJIMURA T, 1987, MOL CELL BIOL, V7, P420, DOI 10.1128/MCB.7.1.420; HERRING AJ, 1977, NATURE, V268, P464, DOI 10.1038/268464a0; HIRSCH RC, 1990, NATURE, V344, P552, DOI 10.1038/344552a0; HOPPER JE, 1977, J BIOL CHEM, V252, P9010; ICHO T, 1989, J BIOL CHEM, V264, P6716; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; OERTLE S, 1990, J VIROL, V64, P5757, DOI 10.1128/JVI.64.12.5757-5763.1990; SCHLICHT HJ, 1989, CELL, V56, P85, DOI 10.1016/0092-8674(89)90986-0; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; VALENTINE RC, 1967, J MOL BIOL, V27, P615, DOI 10.1016/0022-2836(67)90063-0; WELSH JD, 1980, NUCLEIC ACIDS RES, V8, P2365, DOI 10.1093/nar/8.11.2365; WICKNER RB, 1991, J VIROL, V65, P155, DOI 10.1128/JVI.65.1.155-161.1991; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; WICKNER RB, 1991, MOL BIOL YEAST SACCH, V1, P263	25	71	72	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 22	1992	359	6397					746	749		10.1038/359746a0	http://dx.doi.org/10.1038/359746a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	1436038				2022-12-28	WOS:A1992JU65000062
J	SILAGY, C; MUIR, J; COULTER, A; THOROGOOD, M; YUDKIN, P; ROE, L				SILAGY, C; MUIR, J; COULTER, A; THOROGOOD, M; YUDKIN, P; ROE, L			LIFE-STYLE ADVICE IN GENERAL-PRACTICE - RATES RECALLED BY PATIENTS	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY CARE; HEALTH PROMOTION; CONTROLLED TRIAL; PRACTITIONERS; PREVENTION; SMOKING; VIEWS; AUDIT	Objective-To document how often patients with varying cardiovascular risk levels reported receiving lifestyle advice from general practice. Design-Cross sectional descriptive survey by postal questionnaire. Setting-5 general practices in Bedfordshire. Subjects-4941 people aged 35-64 years who had consulted a general practitioner at least once during the 12 months before completing the questionnaire and who subsequently attended for a health check as part of the OXCHECK trial. Main outcome measures-Report of having received advice from a general practitioner or practice nurse about smoking, alcohol consumption, exercise, or diet during the 12 months before completing the questionnaire. Cardiovascular risk assessed by a nurse during structured health check. Results-The overall reported rate of advice was 27% for smoking, 4.5% for exercise, 12% for diet, and 3% for alcohol consumption. Those with unhealthy behaviour profile or at increased cardiovascular risk received more advice-for example, 47% of smokers with a history of cardiovascular disease received advice on smoking. Among those at increased risk, men were more likely than women to receive advice about exercise (11% v 4%, p = 0.04) and alcohol consumption (10% v 4%, p = 0.007), while women received more advice about weight (17% v 23%, p < 0.001). The rate of receiving advice was unaffected by age, marital status, or social class. Conclusion-The low rate of lifestyle advice reported by patients implies that more preventive advice could be provided in primary care.	RADCLIFFE INFIRM,DEPT PUBL HLTH & PRIMARY CARE,HLTH SERV RES UNIT,OXFORD OX2 6HE,ENGLAND	Radcliffe Infirmary; University of Oxford	SILAGY, C (corresponding author), UNIV OXFORD,RADCLIFFE INFIRM,DEPT PUBL HLTH & PRIMARY CARE,OXFORD OX2 6HE,ENGLAND.		Coulter, Angela/N-6998-2019	Coulter, Angela/0000-0002-6308-8375				[Anonymous], 1980, CLASSIFICATION OCCUP; ARMITAGE P, 1987, STATISTICAL METHODS, P372; CATFORD JC, 1984, BRIT MED J, V288, P832, DOI 10.1136/bmj.288.6420.832; COULTER A, 1987, J ROY COLL GEN PRACT, V37, P533; COULTER A, 1991, BRIT J GEN PRACT, V41, P140; DICKINSON JA, 1989, MED J AUSTRALIA, V150, P420, DOI 10.5694/j.1326-5377.1989.tb136560.x; Fleming D M, 1981, J R Coll Gen Pract, V31, P615; FLEMING DM, 1983, BRIT MED J, V287, P1852, DOI 10.1136/bmj.287.6408.1852; FORD AS, 1983, SOC SCI MED, V17, P1505, DOI 10.1016/0277-9536(83)90095-3; FREELING P, 1989, MATERNAL CHILD HLTH, V14, P394; FREER C B, 1986, Health Bulletin (Edinburgh), V44, P75; FULLARD E, 1987, BRIT MED J, V294, P1080, DOI 10.1136/bmj.294.6579.1080; FULLARD E, 1984, BRIT MED J, V289, P1585, DOI 10.1136/bmj.289.6458.1585; JAMROZIK K, 1984, BRIT MED J, V288, P1499, DOI 10.1136/bmj.288.6429.1499; LAWRENCE M, 1990, BRIT MED J, V300, P1501, DOI 10.1136/bmj.300.6738.1501; ORLEANS CT, 1985, PREV MED, V14, P636, DOI 10.1016/0091-7435(85)90083-0; PILL R, 1988, J ROY COLL GEN PRACT, V38, P53; PILL RM, 1989, J ROY COLL GEN PRACT, V39, P196; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; RUSSELL MAH, 1987, BRIT MED J, V295, P1240, DOI 10.1136/bmj.295.6608.1240; STOATE HG, 1989, J ROY COLL GEN PRACT, V39, P193; STONE DH, 1987, J ROY COLL GEN PRACT, V37, P218; Stott N C, 1979, J R Coll Gen Pract, V29, P201; STOTT NCH, 1990, FAM PRACT, V7, P125, DOI 10.1093/fampra/7.2.125; TUCKETT D, 1985, M EXPERTS APPRAOCH S; WALLACE PG, 1987, BRIT MED J, V294, P940, DOI 10.1136/bmj.294.6577.940; 1989, GENERAL PRACTICE NAT; 1984, 28 COMM MED ASP FOOD; 1991, BMJ, V302, P1057; 1981, RCGP18 ROYAL COLL GE	30	83	85	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 10	1992	305	6858					871	874		10.1136/bmj.305.6858.871	http://dx.doi.org/10.1136/bmj.305.6858.871			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT777	1422405	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JT77700031
J	BISSONNETTE, RP; ECHEVERRI, F; MAHBOUBI, A; GREEN, DR				BISSONNETTE, RP; ECHEVERRI, F; MAHBOUBI, A; GREEN, DR			APOPTOTIC CELL-DEATH INDUCED BY C-MYC IS INHIBITED BY BCL-2	NATURE			English	Article							TRANSGENIC MICE; GENE-EXPRESSION; LYMPHOID-CELLS; B-CELLS; GROWTH; DIFFERENTIATION; ONCOGENE; SURVIVAL; PROTEIN; INDUCTION	APOPTOSIS is a form of physiological cell death, characterized by chromatin condensation, cytoplasmic blebbing and DNA fragmentation1, which often depends on RNA and protein synthesis by the dying cell2-4. The c-myc proto-oncogene, usually implicated in cell transformation, differentiation and cell-cycle progression5-9 also has a central role in some forms of apoptosis10-13. These opposing roles of myc in cell growth and death require that other gene products dictate the outcome of c-Myc expression on a cell. A candidate for such a modifying gene is bcl-2, whose product prolongs cell survival14-16 and blocks apoptosis in some systems17-21. Here we demonstrate that Bcl-2 prevents apoptotic death induced by c-Myc, provide a mechanism whereby cells can express c-Myc without undergoing apoptosis, and give a possible explanation for the ability of Bcl-2 to synergize with c-Myc in cell transformation21-23.			BISSONNETTE, RP (corresponding author), LA JOLLA INST ALLERGY & IMMUNOL,DIV CELLULAR IMMUNOL,11149 N TORREY PINES RD,LA JOLLA,CA 92037, USA.		Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				ASKEW DS, 1991, ONCOGENE, V6, P1915; BUKH A, 1990, J IMMUNOL, V144, P4835; COHEN JJ, 1984, J IMMUNOL, V132, P38; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; DEGOLS G, 1991, NUCLEIC ACIDS RES, V19, P945, DOI 10.1093/nar/19.4.945; DUKE RC, 1986, LYMPHOKINE RES, V5, P289; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; KACZMAREK L, 1985, SCIENCE, V228, P1313, DOI 10.1126/science.4001943; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; NUNEZ G, 1991, NATURE, V353, P71, DOI 10.1038/353071a0; NUNEZ G, 1990, J IMMUNOL, V144, P3602; ONCLERCQ R, 1989, ONCOGENE RES, V4, P293; PALLAVICINI MG, 1990, J CELL PHYSIOL, V143, P372, DOI 10.1002/jcp.1041430223; PROCHOWNIK EV, 1988, MOL CELL BIOL, V8, P3683, DOI 10.1128/MCB.8.9.3683; REED JC, 1990, P NATL ACAD SCI USA, V348, P331; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VOGT M, 1987, ONCOGENE RES, V2, P49; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; WURM FM, 1986, P NATL ACAD SCI USA, V83, P5414, DOI 10.1073/pnas.83.15.5414; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1987, BRIT J CANCER, V56, P251, DOI 10.1038/bjc.1987.186; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112	29	967	1001	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 8	1992	359	6395					552	554		10.1038/359552a0	http://dx.doi.org/10.1038/359552a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406975				2022-12-28	WOS:A1992JR85900065
J	RIBERDY, JM; NEWCOMB, JR; SURMAN, MJ; BARBOSA, JA; CRESSWELL, P				RIBERDY, JM; NEWCOMB, JR; SURMAN, MJ; BARBOSA, JA; CRESSWELL, P			HLA-DR MOLECULES FROM AN ANTIGEN-PROCESSING MUTANT-CELL LINE ARE ASSOCIATED WITH INVARIANT CHAIN PEPTIDES	NATURE			English	Article							CLASS-II MOLECULES; ALLOANTIGENS; BINDING; PROTEOLYSIS; TRANSPORT	THE invariant chain, which associates with the major histocompatibility complex (MHC) class II molecules in the endoplasmic reticulum, serves two functions important in antigen processing. First, it prevents class II molecules from binding peptides in the early stages of intracellular transport1-3. Second, it contains a cytoplasmic signal that targets the class II-invariant chain complex to an acidic endosomal compartment4-6. Proteolytic cleavage and subsequent dissociation of the invariant chain then occurs7,8, allowing peptides derived from endocytosed proteins to bind to released class II molecules before their expression at the cell surface3. Certain human cell lines that are mutant in one or more MHC-linked genes are defective in class II-restricted antigen processing9-11. Here we show that in transfectants of one of these cell lines, T2, this deficiency results in the association of a large proportion of class II molecules with a nested set of invariant-chain-derived peptides (class II-associated invariant chain peptides, or CLIP). HLA-DR3 molecules isolated from T2 transfectants can be efficiently loaded with antigenic peptides by exposure to a low pH in vitro, perhaps reflecting the in vivo conditions in which peptides associate with class II molecules12-14. Addition of synthetic CLIP inhibits the loading process, indicating that CLIP may define the region of the invariant chain responsible for obstructing the class II binding site.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,310 CEDAR ST,NEW HAVEN,CT 06510; MILES RES CTR,INST INFLAMMAT & AUTOIMMUN,DEPT PRECLIN TECHNOL,W HAVEN,CT 06516	Howard Hughes Medical Institute; Yale University								BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BILLING RJ, 1976, J IMMUNOL, V117, P1589; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CRESSWELL P, 1977, EUR J IMMUNOL, V7, P636, DOI 10.1002/eji.1830070911; GELUK A, 1992, EUR J IMMUNOL, V22, P107, DOI 10.1002/eji.1830220117; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GLIMCHER LH, 1987, J IMMUNOL, V138, P1519; HARDING CV, 1991, CELL, V64, P393, DOI 10.1016/0092-8674(91)90647-H; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JENSEN PE, 1990, J EXP MED, V171, P1779, DOI 10.1084/jem.171.5.1779; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MELLINS E, 1991, J EXP MED, V174, P1607, DOI 10.1084/jem.174.6.1607; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NEWCOMB JR, IN PRESS J IMMUN; NGUYEN QV, 1989, HUM IMMUNOL, V24, P153, DOI 10.1016/0198-8859(89)90056-6; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SPRINGER TA, 1977, J BIOL CHEM, V252, P6201; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0	29	351	356	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 3	1992	360	6403					474	477		10.1038/360474a0	http://dx.doi.org/10.1038/360474a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448172				2022-12-28	WOS:A1992KA79700063
J	DEROOK, FA; COMESS, KA; ALBERS, GW; POPP, RL				DEROOK, FA; COMESS, KA; ALBERS, GW; POPP, RL			TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN THE EVALUATION OF STROKE	ANNALS OF INTERNAL MEDICINE			English	Review						ECHOCARDIOGRAPHY; CEREBROVASCULAR DISORDERS; CEREBRAL EMBOLISM AND THROMBOSIS; CORONARY THROMBOSIS; ANTICOAGULANTS	TWO-DIMENSIONAL ECHOCARDIOGRAPHY; ATRIAL SEPTAL ANEURYSM; TRANS-ESOPHAGEAL ECHOCARDIOGRAPHY; MITRAL-VALVE PROLAPSE; CLINICAL-APPLICATIONS; SYSTEMIC EMBOLISM; CEREBROVASCULAR-DISEASE; ANATOMIC CORRELATIONS; CEREBRAL-ISCHEMIA; CARDIAC SOURCE	Objective: To review the current role of transesophageal echocardiography in the evaluation of stroke. Data Identification: Articles examining the role of transesophageal echocardiography for evaluation of patients with stroke were identified using computer and bibliography searches. Study Selection: All English-language articles that provided full details on patient selection criteria, methods, and study design were reviewed. Results of Data Analysis: Cardiogenic embolism is frequently an uncertain diagnosis merely inferred by finding a potential cardiac source. Transthoracic echocardiography has had a low yield in screening unselected patients with stroke. Several series of patients with stroke have been reported comparing transthoracic and transesophageal echocardiography. Potential cardiac sources of embolism were consistently identified in many more patients by transesophageal echocardiography. Many findings are, however, of uncertain significance; these include spontaneous echo contrast, patent foramen ovale, filamentous strands on the mitral valve, and atrial septal aneurysm. Conclusions: Transesophageal echocardiography is most helpful in patients with stroke who are less than 45 years of age and in those without clinical evidence of heart disease. The indications for its use in the evaluation of stroke remain controversial. Further studies are needed using transesophageal echocardiography in patients with stroke and in control groups, not only to determine the natural history of transesophageal, echocardiographically detected abnormalities but also to evaluate treatment options.	STANFORD UNIV, MED CTR, SCH MED, STANFORD, CA 94305 USA; PALO ALTO VET AFFAIRS HOSP, PALO ALTO, CA USA; UNIV WASHINGTON, VIRGINIA MASON CLIN, SEATTLE, WA 98195 USA	Stanford University; University of Washington; University of Washington Seattle; Virginia Mason Medical Center				Albers, Gregory/0000-0003-0263-4632				Adams R.D, 1989, PRINCIPLES NEUROLOGY; ALBERS GW, 1991, ANN INTERN MED, V115, P727, DOI 10.7326/0003-4819-115-9-727; AMARENCO P, 1992, NEW ENGL J MED, V326, P221, DOI 10.1056/NEJM199201233260402; ANGELONI U, 1990, NEUROLOGY, V40, P1196, DOI 10.1212/WNL.40.8.1196; [Anonymous], 1989, Arch Neurol, V46, P727; ASCHENBERG W, 1986, J AM COLL CARDIOL, V7, P163, DOI 10.1016/S0735-1097(86)80275-3; BAMFORD JM, 1988, STROKE, V19, P1074, DOI 10.1161/01.STR.19.9.1074; BELKIN RN, 1990, AM HEART J, V120, P948, DOI 10.1016/0002-8703(90)90214-I; BELKIN RN, 1987, STROKE, V18, P856, DOI 10.1161/01.STR.18.5.856; BEVAN H, 1990, STROKE, V21, P382, DOI 10.1161/01.STR.21.3.382; BOGOUSSLAVSKY J, 1986, ARCH NEUROL-CHICAGO, V43, P223, DOI 10.1001/archneur.1986.00520030015005; BOGOUSSLAVSKY J, 1989, ANN NEUROL, V25, P555, DOI 10.1002/ana.410250605; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; BOGOUSSLAVSKY J, 1990, AM J CARDIOL, V65, pC32; CASTELLO R, 1990, AM J CARDIOL, V65, P1149, DOI 10.1016/0002-9149(90)90330-4; COME PC, 1983, ANN NEUROL, V13, P527, DOI 10.1002/ana.410130509; CUJEC B, 1991, STROKE, V22, P727, DOI 10.1161/01.STR.22.6.727; DANIEL WG, 1991, CIRCULATION, V83, P817, DOI 10.1161/01.CIR.83.3.817; DANIEL WG, 1988, J AM COLL CARDIOL, V11, P1204, DOI 10.1016/0735-1097(88)90283-5; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; DANIEL WG, 1989, CIRCULATION S2, V80, P473; de Belder M A, 1989, J Am Soc Echocardiogr, V2, P375; DEBELDER MA, 1989, CIRCULATION S2, V80, P1; DEROOK F, 1991, J AM SOC ECHOCARDIOG, V4, P293; DEVEREUX RB, 1989, ANN INTERN MED, V111, P305, DOI 10.7326/0003-4819-111-4-305; DIPASQUALE G, 1988, STROKE, V19, P640, DOI 10.1161/01.STR.19.5.640; ERBEL R, 1986, CLIN CARDIOL, V9, P245, DOI 10.1002/clc.4960090603; ERBEL R, 1988, EUR HEART J, V9, P43; GALLET B, 1985, BRIT HEART J, V53, P292; GHIKA J, 1989, NEUROLOGY, V39, P507, DOI 10.1212/WNL.39.4.507; GREENLAND P, 1981, ANN INTERN MED, V95, P51, DOI 10.7326/0003-4819-95-1-51; GUSSENHOVEN EJ, 1986, J AM COLL CARDIOL, V8, P975, DOI 10.1016/S0735-1097(86)80444-2; HANLEY PC, 1985, J AM COLL CARDIOL, V6, P1370, DOI 10.1016/S0735-1097(85)80228-X; HARVEY JR, 1986, ANN INTERN MED, V105, P695, DOI 10.7326/0003-4819-105-5-695; HOFMANN T, 1990, LANCET, V336, P1421; KARALIS DG, 1991, J AM COLL CARDIOL, V17, P73, DOI 10.1016/0735-1097(91)90706-F; KNOPMAN DS, 1982, NEUROLOGY, V32, P1005, DOI 10.1212/WNL.32.9.1005; LANDAU WM, 1989, NEUROLOGY, V39, P725, DOI 10.1212/WNL.39.5.725; LARSON EB, 1981, ANN INTERN MED, V95, P112, DOI 10.7326/0003-4819-95-1-112; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; LEE RJ, 1991, STROKE, V22, P734, DOI 10.1161/01.STR.22.6.734; LODDER J, 1990, STROKE, V21, P375, DOI 10.1161/01.STR.21.3.375; LOVETT JL, 1981, ANN INTERN MED, V95, P1, DOI 10.7326/0003-4819-95-1-1; MARKS AR, 1989, NEW ENGL J MED, V320, P1031, DOI 10.1056/NEJM198904203201602; MATSUMOTO M, 1980, AM J CARDIOL, V46, P95, DOI 10.1016/0002-9149(80)90611-6; MATSUZAKI M, 1990, CIRCULATION, V82, P709, DOI 10.1161/01.CIR.82.3.709; MILLIKAN C, 1990, STROKE, V21, P1251, DOI 10.1161/01.STR.21.9.1251; NISHIMURA RA, 1985, NEW ENGL J MED, V313, P1305, DOI 10.1056/NEJM198511213132101; OFILI EO, 1990, AM J CARDIOL, V66, P1279, DOI 10.1016/0002-9149(90)91123-N; PEARSON AC, 1991, J AM COLL CARDIOL, V17, P66, DOI 10.1016/0735-1097(91)90705-E; POP G, 1990, STROKE, V21, P560, DOI 10.1161/01.STR.21.4.560; ROBERTS WC, 1984, AM J CARDIOL, V54, P1153, DOI 10.1016/S0002-9149(84)80172-1; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P354; SCHLUTER M, 1984, ECHOCARDIOGR-J CARD, V1, P427; SEWARD JB, 1990, MAYO CLIN PROC, V65, P1193, DOI 10.1016/S0025-6196(12)62744-X; SEWARD JB, 1988, MAYO CLIN PROC, V63, P649, DOI 10.1016/S0025-6196(12)65529-3; SHENOY MM, 1987, ARCH INTERN MED, V147, P605, DOI 10.1001/archinte.147.3.605; TEGELER CH, 1991, STROKE, V22, P1206, DOI 10.1161/01.STR.22.9.1206; TUNICK PA, 1991, ANN INTERN MED, V114, P391, DOI 10.7326/0003-4819-114-5-391; TUNICK PA, 1990, AM HEART J, V120, P658, DOI 10.1016/0002-8703(90)90024-R; TUNICK PA, 1991, ANN INTERN MED, V115, P423, DOI 10.7326/0003-4819-115-6-423; TUNICK PA, 1991, ANN INTERN MED, V115, P727; WATERSTON JA, 1990, ARCH NEUROL-CHICAGO, V47, P953, DOI 10.1001/archneur.1990.00530090023007; WEBSTER MWI, 1988, LANCET, V2, P11; ZABALGOITIA M, 1990, AM HEART J, V120, P1147, DOI 10.1016/0002-8703(90)90129-L; ZENKER G, 1988, STROKE, V19, P345, DOI 10.1161/01.STR.19.3.345	66	109	109	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					922	932		10.7326/0003-4819-117-11-922	http://dx.doi.org/10.7326/0003-4819-117-11-922			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443955				2022-12-28	WOS:A1992JZ27600009
J	ADEREM, A				ADEREM, A			THE MARCKS BROTHERS - A FAMILY OF PROTEIN-KINASE-C SUBSTRATES	CELL			English	Article							TRANSFORMED FIBROBLASTS; CELLULAR SUBSTRATE; MOLECULAR-CLONING; PHORBOL ESTERS; GROWTH-FACTORS; PHOSPHORYLATION; 80-KDA; BRAIN; CELLS; MYRISTOYLATION				ADEREM, A (corresponding author), ROCKEFELLER UNIV,SIGNAL TRANSDUCT LAB,NEW YORK,NY 10021, USA.							ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0; BLACKSHEAR PJ, 1992, J BIOL CHEM, V267, P13540; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; BROOKS SF, 1992, J BIOL CHEM, V267, P14212; ERUSALIMSKY JD, 1991, J BIOL CHEM, V266, P7073; GORDONWEEKS PR, 1989, TRENDS NEUROSCI, V12, P363, DOI 10.1016/0166-2236(89)90073-8; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; HARLAN DM, 1991, J BIOL CHEM, V266, P14399; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; JOSHI R, 1991, J CELL BIOL, V115, P665, DOI 10.1083/jcb.115.3.665; KLIGMAN D, 1986, J NEUROCHEM, V47, P298; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; SEYKORA JT, 1991, P NATL ACAD SCI USA, V88, P2505, DOI 10.1073/pnas.88.6.2505; SIMEK SL, 1989, P NATL ACAD SCI USA, V86, P7410, DOI 10.1073/pnas.86.19.7410; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; THELEN M, 1990, P NATL ACAD SCI USA, V87, P5603, DOI 10.1073/pnas.87.15.5603; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Turner CE, 1991, CURR OPIN CELL BIOL, V3, P849, DOI 10.1016/0955-0674(91)90059-8; UMEKAGE T, 1991, FEBS LETT, V286, P147, DOI 10.1016/0014-5793(91)80961-2; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; WOLFMAN A, 1987, J BIOL CHEM, V262, P16546; WU WCS, 1982, P NATL ACAD SCI-BIOL, V79, P5249, DOI 10.1073/pnas.79.17.5249	26	460	468	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 27	1992	71	5					713	716		10.1016/0092-8674(92)90546-O	http://dx.doi.org/10.1016/0092-8674(92)90546-O			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423627				2022-12-28	WOS:A1992JZ63300002
J	FUJITA, I; TANAKA, K; ITO, M; CHENG, K				FUJITA, I; TANAKA, K; ITO, M; CHENG, K			COLUMNS FOR VISUAL FEATURES OF OBJECTS IN MONKEY INFEROTEMPORAL CORTEX	NATURE			English	Article							TEMPORAL CORTEX; MACAQUE MONKEY; ORGANIZATION; NEURONS; VISION	AT early stages of the mammalian visual cortex, neurons with similar stimulus selectivities are vertically arrayed through the thickness of the cortical sheet and clustered in patches or bands across the surface. This organization, referred to as a 'column', has been found with respect to one-dimensional stimulus parameters such as orientation of stimulus contours1, eye dominance of visual inputs1, and direction of stimulus motion2. It is unclear, however, whether information with extremely high dimensions, such as visual shape, is organized in a similar columnar fashion or in a different manner in the brain. Here we report that the anterior inferotemporal area of the monkey cortex, the final station of the visual cortical stream crucial for object recognition3-8, consists of columns, each containing cells responsive to similar visual features of objects.	RIKEN INST PHYS & CHEM RES,INFORMAT SCI LAB,WAKO,SAITAMA 35101,JAPAN; RES DEV CORP JAPAN,PRECURSORY RES EMBRYON SCI & TECHNOL,WAKO,SAITAMA 35101,JAPAN	RIKEN; Japan Science & Technology Agency (JST)	FUJITA, I (corresponding author), RIKEN INST PHYS & CHEM RES,FRONTIER RES PROGRAM,NEURAL INFORMAT PROC LAB,WAKO,SAITAMA 35101,JAPAN.		Cheng, Kang/A-6448-2016; Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427				ABELES M, 1970, J NEUROPHYSIOL, V33, P172, DOI 10.1152/jn.1970.33.1.172; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; BAYLIS GC, 1987, J NEUROSCI, V7, P330; DEAN P, 1982, ANAL VISUAL BEHAVIOR, P587; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GOCHIN PM, 1991, EXPL BRAIN RES, V66, P170; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IWAI E, 1985, VISION RES, V25, P425, DOI 10.1016/0042-6989(85)90068-9; IWAI E, 1988, BRAIN RES, V444, P397, DOI 10.1016/0006-8993(88)90955-9; KAAS JH, 1990, SIGNAL SENSE LOCAL G, P67; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Mountcastle V.B., 1978, MINDFUL BRAIN CORTIC, P7; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; SAITO H, 1986, J NEUROSCI, V6, P145; VANESSEN DC, 1990, COLD SPRING HARB SYM, V55, P679; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0	22	465	467	0	24	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 26	1992	360	6402					343	346		10.1038/360343a0	http://dx.doi.org/10.1038/360343a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448150				2022-12-28	WOS:A1992JZ63000051
J	HARRIS, LJ; LARSON, SB; HASEL, KW; DAY, J; GREENWOOD, A; MCPHERSON, A				HARRIS, LJ; LARSON, SB; HASEL, KW; DAY, J; GREENWOOD, A; MCPHERSON, A			THE 3-DIMENSIONAL STRUCTURE OF AN INTACT MONOCLONAL-ANTIBODY FOR CANINE LYMPHOMA	NATURE			English	Article							SEGMENTAL FLEXIBILITY; CRYSTALLOGRAPHIC REFINEMENT; IMMUNOELECTRON MICROSCOPY; ROTATIONAL FLEXIBILITY; IMMUNOGLOBULIN-G; ATOMIC MODELS; MOLECULE KOL; FC FRAGMENT; FAB REGIONS; RESOLUTION	CRYSTAL structures of Fab antibody fragments determined by X-ray diffraction characteristically feature four-domain, beta-barrel arrangements1-3. A human antibody Fc fragment has also been found to have four beta-barrel domains4. The structures of a few intact antibodies have been solved5-8: in two myeloma proteins, the flexible hinge regions that connect the Fc to the Fab segments were deleted5,6 so the molecules were non-functional, structurally restrained, T-shaped antibodies; a third antibody, Kol, had no hinge residues missing but the Fc region was sufficiently disordered that it was not possible to relate its disposition accurately with respect to the Fab components7,8. Here we report the structure at 3.5 angstrom resolution of an IgG2a antitumour monoclonal antibody which contains an intact hinge region and was solved in a triclinic crystal by molecular replacement using known Fc and Fab fragments. The antibody is asymmetric, reflecting its dynamic character. There are two local, apparently independent, dyads in the molecule. One relates the heavy chains in the Fc, the other relates the constant domains of the Fabs. The variable domains are not related by this 2-fold axis because of the different Fab elbow angles of 159-degrees and 143-degrees. The Fc has assumed an asymmetric, oblique orientation with respect to loosely tethered yet almost collinear Fabs. Our study enables the two antigen-binding segments as well as the Fc portion of a functional molecule to be visualized and illustrates the flexibility of these immune response proteins.	IMMUNOPHARMACEUT INC, SAN DIEGO, CA 92127 USA		HARRIS, LJ (corresponding author), UNIV CALIF RIVERSIDE, DEPT BIOCHEM, RIVERSIDE, CA 92521 USA.							ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BRUNGER AT, 1991, ANNU REV PHYS CHEM, V42, P197, DOI 10.1146/annurev.pc.42.100191.001213; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; COLMAN PM, 1976, J MOL BIOL, V100, P257, DOI 10.1016/S0022-2836(76)80062-9; Crowther R. A., 1972, MOL REPLACEMENT METH, P173; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; JEGLUM KA, 1989, 7TH P ACVIM FOR SAN, P922; JONES TA, 1982, COMPUTATIONAL CRYSTA, P307; LAMY J, 1985, BIOCHEMISTRY-US, V24, P5532, DOI 10.1021/bi00341a038; LARSON S, 1991, J MOL BIOL, V222, P17, DOI 10.1016/0022-2836(91)90731-K; MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1; OI VT, 1984, NATURE, V307, P136, DOI 10.1038/307136a0; RAJAN SS, 1983, MOL IMMUNOL, V20, P797; ROSALES C, 1988, CELL IMMUNOL, V115, P420, DOI 10.1016/0008-8749(88)90194-3; ROUX KH, 1984, EUR J IMMUNOL, V14, P459, DOI 10.1002/eji.1830140514; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SCHNEIDER WP, 1988, P NATL ACAD SCI USA, V85, P2509, DOI 10.1073/pnas.85.8.2509; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140; STEPLEWSKI Z, 1987, CANCER IMMUNOL IMMUN, V24, P197; WADE RH, 1989, J MOL BIOL, V206, P349, DOI 10.1016/0022-2836(89)90484-1; WILSON IA, 1991, METHOD ENZYMOL, V203, P153; WRIGLEY NG, 1983, J MOL BIOL, V169, P771, DOI 10.1016/S0022-2836(83)80170-3	29	182	188	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	1992	360	6402					369	372		10.1038/360369a0	http://dx.doi.org/10.1038/360369a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448155				2022-12-28	WOS:A1992JZ63000060
J	PANDIT, J; BOHM, A; JANCARIK, J; HALENBECK, R; KOTHS, K; KIM, SH				PANDIT, J; BOHM, A; JANCARIK, J; HALENBECK, R; KOTHS, K; KIM, SH			3-DIMENSIONAL STRUCTURE OF DIMERIC HUMAN RECOMBINANT MACROPHAGE COLONY-STIMULATING FACTOR	SCIENCE			English	Article							GROWTH-FACTOR; MACROMOLECULAR CRYSTALLOGRAPHY; WEISSENBERG CAMERA; MOLECULAR-CLONING; FACTOR CSF-1; RECEPTOR; PROTEIN	Macrophage colony-stimulating factor (M-CSF) triggers the development of cells of the monocyte-macrophage lineage and has a variety of stimulatory effects on mature cells of this class. The biologically active form of M-CSF is a disulfide-linked dimer that activates an intrinsic tyrosine kinase activity on the M-CSF receptor by inducing dimerization of the receptor molecules. The structure of a recombinant human M-CSF dimer, determined at 2.5 angstroms by x-ray crystallography, contains two bundles of four alpha helices laid end-to-end, with an interchain disulfide bond. Individual monomers of M-CSF show a close structural similarity to the cytokines granulocyte-macrophage colony-stimulating factor and human growth hormone. Both of these cytokines are monomeric in their active form, and their specific receptors lack intrinsic tyrosine kinase activity. The similarity of these structures suggests that the receptor binding determinants for all three cytokines may be similar.	LAWRENCE BERKELEY LAB, DIV STRUCT BIOL, 1 CYCLOTRON RD, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, DEPT CHEM, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, BIOPHYS GRAD GRP, BERKELEY, CA 94720 USA; CHIRON CORP, DEPT BIOL THERAPEUT, EMERYVILLE, CA 94608 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Novartis				Pandit, Jayvardhan/0000-0001-6128-7779				ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; BRUNGER AT, 1990, XPLOR SYSTEM CRYSTAL; CERRETTI DP, 1988, MOL IMMUNOL, V25, P761, DOI 10.1016/0161-5890(88)90112-5; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; COX JM, 1967, J MOL BIOL, V28, P151, DOI 10.1016/S0022-2836(67)80083-4; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DIEDERICHS K, 1991, SCIENCE, V254, P1779, DOI 10.1126/science.1837174; DOVER GA, 1991, CELL, V65, P9, DOI 10.1016/0092-8674(91)90401-J; HALENBECK R, 1989, BIO-TECHNOL, V7, P710, DOI 10.1038/nbt0789-710; HALENBECK R, UNPUB; HIGASHI T, 1989, J APPL CRYSTALLOGR, V22, P9, DOI 10.1107/S0021889888009562; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kawasaki E S, 1990, Immunol Ser, V49, P155; KAWASAKI ES, 1985, SCIENCE, V230, P291, DOI 10.1126/science.2996129; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45; POWERS R, 1992, SCIENCE, V256, P1673, DOI 10.1126/science.256.5064.1673; PRESNELL SR, 1989, P NATL ACAD SCI USA, V86, P6592, DOI 10.1073/pnas.86.17.6592; RALPH P, 1986, IMMUNOBIOLOGY, V172, P194, DOI 10.1016/S0171-2985(86)80099-7; SAKABE N, 1983, J APPL CRYSTALLOGR, V16, P542, DOI 10.1107/S0021889883010973; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; STEIGEMANN W, 1974, THESIS TU MUNCHEN; STEIN J, 1990, BLOOD, V76, P1308, DOI 10.1182/blood.V76.7.1308.bloodjournal7671308; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WONG GG, 1987, SCIENCE, V235, P1504, DOI 10.1126/science.3493529; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	31	167	186	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	1992	258	5086					1358	1362		10.1126/science.1455231	http://dx.doi.org/10.1126/science.1455231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455231	Green Submitted			2022-12-28	WOS:A1992JY95800039
J	UPTON, C; MOSSMAN, K; MCFADDEN, G				UPTON, C; MOSSMAN, K; MCFADDEN, G			ENCODING OF A HOMOLOG OF THE IFN-GAMMA RECEPTOR BY MYXOMA VIRUS	SCIENCE			English	Article							SHOPE FIBROMA VIRUS; VACCINIA VIRUS; INTERFERON-GAMMA; MOLECULAR CHARACTERIZATION; CYTOKINE RECEPTORS; IMMUNE INTERFERON; POXVIRUSES; PROTEINS; CLONING; PATHOGENESIS	Many poxvirus-encoded virulence factors have been identified as proteins that are secreted from infected cells. The major secreted protein (37 kilodaltons) from cells infected with myxoma virus is encoded by the M-T7 open reading frame. This protein has significant sequence similarity to the human and mouse receptors for interferon-gamma (IFN-gamma). Furthermore, the myxoma M-T7 protein specifically binds rabbit IFN-gamma and inhibits the biological activity of extracellular IFN-gamma, one of the key regulatory cytokines in the host immune response against viral infections.	UNIV ALBERTA, DEPT BIOCHEM, EDMONTON T6G 2H7, ALBERTA, CANADA	University of Alberta			Upton, Chris/A-4670-2008	Upton, Chris/0000-0002-9019-8967				AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; BILLIAU A, 1990, BIOCHEM PHARMACOL, V40, P1433, DOI 10.1016/0006-2952(90)90437-P; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; DORNER F, 1973, P NATL ACAD SCI USA, V70, P1981, DOI 10.1073/pnas.70.7.1981; DOWER SK, 1990, J CLIN IMMUNOL, V10, P289, DOI 10.1007/BF00917473; FENNER F, 1965, MYXOMATOSIS; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; KOHONENCORISH MRJ, 1990, EUR J IMMUNOL, V20, P157, DOI 10.1002/eji.1830200123; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KUMAR CS, 1989, J BIOL CHEM, V264, P17939; LANGER JA, 1988, IMMUNOL TODAY, V9, P393, DOI 10.1016/0167-5699(88)91241-8; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; NOTKINS AL, 1989, CONCEPTS VIRAL PATHO, V3; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; PAOLETTI E, 1990, ANN NY ACAD SCI, V590, P309, DOI 10.1111/j.1749-6632.1990.tb42239.x; PENNINGTON TH, 1982, J GEN VIROL, V61, P115, DOI 10.1099/0022-1317-61-1-115; RASHIDBAIGI A, 1985, J BIOL CHEM, V260, P8514; RUSSELL RJ, 1989, VIROLOGY, V170, P147, DOI 10.1016/0042-6822(89)90362-0; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; SMITH CA, 1991, BIOCHEM BIOPH RES CO, V176, P335, DOI 10.1016/0006-291X(91)90929-2; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; TRAKTMAN P, 1990, CELL, V62, P621, DOI 10.1016/0092-8674(90)90106-O; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; TURNER PC, 1990, CURR TOP MICROBIOL, V163, P125; UPTON C, 1986, VIROLOGY, V152, P308, DOI 10.1016/0042-6822(86)90134-0; UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4; UPTON C, UNPUB; VANLOON APGM, 1991, J LEUKOCYTE BIOL, V49, P462, DOI 10.1002/jlb.49.5.462; WILLS A, 1983, VIROLOGY, V130, P403, DOI 10.1016/0042-6822(83)90095-8; [No title captured]	32	300	317	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	1992	258	5086					1369	1373		10.1126/science.1455233	http://dx.doi.org/10.1126/science.1455233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY958	1455233				2022-12-28	WOS:A1992JY95800042
J	THEUNISSEN, O; RUDT, F; GUDDAT, U; MENTZEL, H; PIELER, T				THEUNISSEN, O; RUDT, F; GUDDAT, U; MENTZEL, H; PIELER, T			RNA AND DNA-BINDING ZINC FINGERS IN XENOPUS TFIIIA	CELL			English	Article							TRANSCRIPTION FACTOR-IIIA; INTERNAL CONTROL REGION; 5S RIBOSOMAL-RNA; LAEVIS OOCYTES; FUNCTIONAL DOMAINS; GENE PROMOTER; 5S-RNA GENE; PROTEIN; PARTICLE; SITE	The nine tandem zinc finger repeats in the 5S gene-specific transcription factor IIIA (TFIIIA) from Xenopus mediate specific binding to 5S DNA as well as to 5S ribosomal RNA. A comparative functional analysis of a systematic set of TFIIIA zinc finger combinations reveals that most, if not all, participate in both DNA and RNA binding. Minimal sets of fingers sufficient for DNA and RNA recognition are different. In RNA binding, most finger elements are found to be functionally equivalent. However, the nonessential finger 6 exhibits RNA binding characteristics distinct from the other eight modules. The secondary/tertiary structure of the central domain in 5S RNA, not its primary sequence, is found to carry the essential structural information for TFIIIA binding in Xenopus oocytes. Taken together, our findings suggest that RNA and DNA binding are overlapping, though separable functions of the nine zinc finger elements in TFIIIA, occurring via fundamentally different molecular mechanisms.			THEUNISSEN, O (corresponding author), MAX PLANCK INST MOLEC GENET,OTTO WARBURG LAB,IHNESTR 73,W-1000 BERLIN 33,GERMANY.							BAUDIN F, 1991, J MOL BIOL, V218, P69, DOI 10.1016/0022-2836(91)90874-6; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; CHRISTENSEN JH, 1991, FEBS LETT, V281, P181, DOI 10.1016/0014-5793(91)80388-J; CHRISTIANSEN J, 1987, EMBO J, V6, P453, DOI 10.1002/j.1460-2075.1987.tb04775.x; CHURCHILL MEA, 1990, P NATL ACAD SCI USA, V87, P5528, DOI 10.1073/pnas.87.14.5528; DARBY MK, 1992, MOL CELL BIOL, V12, P3155, DOI 10.1128/MCB.12.7.3155; ELBARADI T, 1991, MECH DEVELOP, V35, P155, DOI 10.1016/0925-4773(91)90015-X; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; FAIRALL L, 1986, J MOL BIOL, V192, P577, DOI 10.1016/0022-2836(86)90278-0; GINSBERG AM, 1984, CELL, V39, P479, DOI 10.1016/0092-8674(84)90455-0; GUDDAT U, 1990, CELL, V60, P619, DOI 10.1016/0092-8674(90)90665-2; HONDA BM, 1980, CELL, V22, P119, DOI 10.1016/0092-8674(80)90160-9; HUBER PW, 1986, P NATL ACAD SCI USA, V83, P1593, DOI 10.1073/pnas.83.6.1593; JOHO KE, 1990, CELL, V61, P293, DOI 10.1016/0092-8674(90)90809-S; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KOSTER M, 1991, EMBO J, V10, P3087, DOI 10.1002/j.1460-2075.1991.tb07861.x; KRAMER A, 1983, J BIOL CHEM, V258, P1915; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIAO XB, 1992, J MOL BIOL, V223, P857, DOI 10.1016/0022-2836(92)90248-I; MAJOWSKI K, 1987, EMBO J, V6, P3057, DOI 10.1002/j.1460-2075.1987.tb02612.x; Maniatis T, 1989, DECONTAMINATION DILU; MARKMEYER P, 1990, GENE, V93, P129, DOI 10.1016/0378-1119(90)90146-I; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; NIETFELD W, 1989, J MOL BIOL, V208, P639, DOI 10.1016/0022-2836(89)90155-1; NIETFELD W, 1990, EMBO J, V9, P399; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PICARD B, 1979, P NATL ACAD SCI USA, V76, P241, DOI 10.1073/pnas.76.1.241; PIELER T, 1983, FEBS LETT, V157, P283, DOI 10.1016/0014-5793(83)80562-6; PIELER T, 1985, EMBO J, V4, P1847, DOI 10.1002/j.1460-2075.1985.tb03859.x; PIELER T, 1985, EMBO J, V4, P3751, DOI 10.1002/j.1460-2075.1985.tb04144.x; PIELER T, 1987, CELL, V48, P91, DOI 10.1016/0092-8674(87)90359-X; PIELER T, 1984, NUCLEIC ACIDS RES, V12, P8393, DOI 10.1093/nar/12.22.8393; ROMANIUK PJ, 1987, NUCLEIC ACIDS RES, V15, P2737, DOI 10.1093/nar/15.6.2737; ROMANIUK PJ, 1985, NUCLEIC ACIDS RES, V13, P5369, DOI 10.1093/nar/13.14.5369; SAKONJU S, 1981, CELL, V23, P665, DOI 10.1016/0092-8674(81)90429-3; SAKONJU S, 1982, CELL, V31, P395, DOI 10.1016/0092-8674(82)90133-7; SANDS MS, 1991, NUCLEIC ACIDS RES, V19, P1797, DOI 10.1093/nar/19.8.1797; SANDS MS, 1987, MOL CELL BIOL, V7, P3985, DOI 10.1128/MCB.7.11.3985; SANDS MS, 1991, NUCLEIC ACIDS RES, V19, P1791, DOI 10.1093/nar/19.8.1791; SMITH DR, 1984, CELL, V37, P645, DOI 10.1016/0092-8674(84)90396-9; VRANA KE, 1988, MOL CELL BIOL, V8, P1684, DOI 10.1128/MCB.8.4.1684; YOU QM, 1991, BIOCHEMISTRY-US, V30, P2495, DOI 10.1021/bi00223a028	43	148	149	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					679	690		10.1016/0092-8674(92)90601-8	http://dx.doi.org/10.1016/0092-8674(92)90601-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423623				2022-12-28	WOS:A1992JY67600015
J	COHEN, J				COHEN, J			AIDS VACCINES - ARMY INVESTIGATES RESEARCHERS REPORT OF CLINICAL-TRIAL DATA	SCIENCE			English	Editorial Material																		1992, SCIENCE, V258, P536	1	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 6	1992	258	5084					883	884		10.1126/science.1439797	http://dx.doi.org/10.1126/science.1439797			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW796	1439797				2022-12-28	WOS:A1992JW79600009
J	BURGOYNE, PS; MAHADEVAIAH, SK; SUTCLIFFE, MJ; PALMER, SJ				BURGOYNE, PS; MAHADEVAIAH, SK; SUTCLIFFE, MJ; PALMER, SJ			FERTILITY IN MICE REQUIRES X-Y PAIRING AND A Y-CHROMOSOMAL SPERMIOGENESIS GENE-MAPPING TO THE LONG ARM	CELL			English	Article							SEX-REVERSED MICE; SXR MALE-MICE; AUTOSOME REARRANGEMENT; CYTOLOGICAL EVIDENCE; DETERMINING REGION; PARTIAL DELETION; MALE-STERILITY; MOUSE; SPERMATOGENESIS; ANTIGEN	There is accumulating evidence that the mammalian Y chromosome, in addition to its testis-determining function, may have other male limited functions, particularly in spermatogenesis. We have previously shown that the short arm of the mouse Y carries information needed for spermatogonial proliferation. This information, together with the testis-determining gene Sry, is contained within the Y-derived sex reversal factor Sxr(a). XO males carrying a copy of Sxr(a) attached to the X chromosome are nevertheless sterile owing to an almost complete arrest during the meiotic metaphase stages. Here we show that this meiotic block can be overcome by providing a meiotic pairing partner (with no Y-specific DNA) for the XSxr(a) chromosome. However, this does not restore fertility because the sperm produced all have abnormal heads. It is concluded that the Y-specific region of the mouse Y chromosome long arm includes information essential for the normal development of the sperm head.			BURGOYNE, PS (corresponding author), MRC,MAMMALIAN DEV UNIT,WOLFSON HOUSE,4 STEPHENSON WAY,LONDON NW1 2HE,ENGLAND.		Palmer, Stephen/F-2822-2013	Palmer, Stephen/0000-0002-4907-4719				BISHOP CE, 1987, NUCLEIC ACIDS RES, V15, P2959, DOI 10.1093/nar/15.7.2959; BURGOYNE PS, 1986, NATURE, V320, P170, DOI 10.1038/320170a0; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; BURGOYNE PS, 1984, CONTROLLING EVENTS M, P349; CATTANACH BM, 1990, GENET RES, V56, P121, DOI 10.1017/S0016672300035199; CATTANACH BM, 1971, CYTOGENETICS, V10, P318, DOI 10.1159/000130151; CHANDLEY AC, 1980, CHROMOSOMA, V81, P9, DOI 10.1007/BF00292419; CHANDLEY AC, 1987, CHROMOSOMA, V95, P345, DOI 10.1007/BF00293181; EICHER EM, 1991, CYTOGENET CELL GENET, V57, P221, DOI 10.1159/000133152; EICHER EM, 1983, RECOMBINANT DNA MED, P57; EVANS EP, 1980, CHROMOSOMA, V81, P19, DOI 10.1007/BF00292420; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; EVANS EP, 1975, NATURE, V256, P40, DOI 10.1038/256040a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HALE DW, 1991, CYTOGENET CELL GENET, V57, P231, DOI 10.1159/000133153; HANNAPPEL E, 1979, HORM METAB RES, V11, P682, DOI 10.1055/s-0028-1092800; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; KOT MC, 1990, J EXP ZOOL, V256, P92, DOI 10.1002/jez.1402560112; KRZANOWSKA H, 1969, GENET RES, V13, P17, DOI 10.1017/S0016672300002706; KRZANOWSKA H, 1986, J REPROD FERTIL, V77, P265, DOI 10.1530/jrf.0.0770265; KRZANOWSKA H, 1976, GENET RES, V28, P189, DOI 10.1017/S0016672300016864; LEVY ER, 1986, CYTOGENET CELL GENET, V42, P159, DOI 10.1159/000132269; MAHADEVAIAH S, 1986, CYTOGENET CELL GENET, V41, P169, DOI 10.1159/000132222; MAHADEVAIAH S, 1988, CHROMOSOMA, V97, P145, DOI 10.1007/BF00327371; MAHADEVAIAH SK, 1993, IN PRESS J REPROD FE; MATSUDA Y, 1991, P NATL ACAD SCI USA, V88, P4850, DOI 10.1073/pnas.88.11.4850; MCLAREN A, 1988, P NATL ACAD SCI USA, V85, P6442, DOI 10.1073/pnas.85.17.6442; MCLAREN A, 1982, NATURE, V300, P446, DOI 10.1038/300446a0; MCLAREN A, 1983, GENET RES, V42, P345, DOI 10.1017/S0016672300021820; MCLAREN A, 1984, NATURE, V312, P552, DOI 10.1038/312552a0; MIKLOS GLG, 1974, CYTOGENET CELL GENET, V13, P558, DOI 10.1159/000130307; MONK M, 1987, P139; ROBERTS C, 1988, P NATL ACAD SCI USA, V85, P6446, DOI 10.1073/pnas.85.17.6446; SEARLE AG, 1974, MUTAT RES, V22, P63, DOI 10.1016/0027-5107(74)90009-8; STYRNA J, 1991, J REPROD FERTIL, V92, P187, DOI 10.1530/jrf.0.0920187; STYRNA J, 1991, GENET RES, V57, P195, DOI 10.1017/S0016672300029268; SUTCLIFFE MJ, 1991, MOL REPROD DEV, V30, P81, DOI 10.1002/mrd.1080300202; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; TEASE C, 1989, CHROMOSOMA, V97, P390, DOI 10.1007/BF00292766	39	157	159	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					391	398		10.1016/0092-8674(92)90509-B	http://dx.doi.org/10.1016/0092-8674(92)90509-B			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423603				2022-12-28	WOS:A1992JW43500006
J	BURATOWSKI, S; ZHOU, H				BURATOWSKI, S; ZHOU, H			A SUPPRESSOR OF TBP MUTATIONS ENCODES AN RNA POLYMERASE-III TRANSCRIPTION FACTOR WITH HOMOLOGY TO TFIIB	CELL			English	Article							TATA-BINDING-PROTEIN; WHOLE-CELL EXTRACT; HUMAN U6 GENE; SACCHAROMYCES-CEREVISIAE; ACCURATE INITIATION; ESCHERICHIA-COLI; YEAST; DNA; ACTIVATION; COMPLEXES	The TDS4 gene of S. cerevisiae was isolated as an allele-specific high copy suppressor of mutations within the basic region of the TATA-binding protein (TBP). The gene is essential for viability and encodes a 596 aa protein. The first 300 aa of the TDS4 protein exhibit significant sequence similarity to the RNA polymerase II transcription factor TFIIB. However, TDS4 is required for RNA polymerase III transcription in vivo and in vitro. Antibodies specific for TDS4 or TBP react with the TFIIIB complex, indicating that both proteins are components of the RNA polymerase III initiation complex. These findings suggest that the RNA polymerase II and III initiation mechanisms are extremely similar, and they explain how the TATA-binding protein can function in both systems.			BURATOWSKI, S (corresponding author), WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142, USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARNDT KM, 1992, MOL CELL BIOL, V12, P2372, DOI 10.1128/MCB.12.5.2372; Ausubel FM., 2006, ENZYMATIC MANIPULATI; BARTHOLOMEW B, 1991, MOL CELL BIOL, V11, P5181, DOI 10.1128/MCB.11.10.5181; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; BURATOWSKI S, 1988, NATURE, V334, P37, DOI 10.1038/334037a0; BURATOWSKI S, 1992, SCIENCE, V255, P1130, DOI 10.1126/science.1546314; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CAVALLINI B, 1988, NATURE, V334, P77, DOI 10.1038/334077a0; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; DALBERG JE, 1991, SCIENCE, V254, P1462; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; GUTHRIE C, 1991, METH ENZYMOL, V194; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; KASSAVETIS GA, 1991, P NATL ACAD SCI USA, V88, P7308, DOI 10.1073/pnas.88.16.7308; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KLEKAMP MS, 1982, J BIOL CHEM, V257, P8432; KLEKAMP MS, 1986, J BIOL CHEM, V261, P2819; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; LEWIN B, 1990, CELL, V61, P1161, DOI 10.1016/0092-8674(90)90675-5; LOBO SM, 1991, GENE DEV, V5, P1477, DOI 10.1101/gad.5.8.1477; LOPEZDELEON A, 1992, CELL, V71, P211, DOI 10.1016/0092-8674(92)90350-L; LUE NF, 1990, J BIOL CHEM, V265, P18091; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; MARGOTTIN F, 1991, SCIENCE, V251, P424, DOI 10.1126/science.1989075; MONCOLLIN V, 1992, P NATL ACAD SCI USA, V89, P397, DOI 10.1073/pnas.89.1.397; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; PUGH BF, 1992, J BIOL CHEM, V267, P679; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; SCHULTZ MC, 1991, P NATL ACAD SCI USA, V88, P1004, DOI 10.1073/pnas.88.3.1004; SHARP PA, 1991, NATURE, V351, P16, DOI 10.1038/351016d0; SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMMEN KA, 1991, EMBO J, V10, P1853, DOI 10.1002/j.1460-2075.1991.tb07711.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; WHITE RJ, 1992, P NATL ACAD SCI USA, V89, P1949, DOI 10.1073/pnas.89.5.1949; WILLIS I, 1989, EMBO J, V8, P4281, DOI 10.1002/j.1460-2075.1989.tb08614.x; WOONTNER M, 1990, J BIOL CHEM, V265, P8979	52	141	142	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					221	230		10.1016/0092-8674(92)90351-C	http://dx.doi.org/10.1016/0092-8674(92)90351-C			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423590				2022-12-28	WOS:A1992JU39500008
J	FOSTER, JW; BRENNAN, FE; HAMPIKIAN, GK; GOODFELLOW, PN; SINCLAIR, AH; LOVELLBADGE, R; SELWOOD, L; RENFREE, MB; COOPER, DW; GRAVES, JAM				FOSTER, JW; BRENNAN, FE; HAMPIKIAN, GK; GOODFELLOW, PN; SINCLAIR, AH; LOVELLBADGE, R; SELWOOD, L; RENFREE, MB; COOPER, DW; GRAVES, JAM			EVOLUTION OF SEX DETERMINATION AND THE Y-CHROMOSOME - SRY-RELATED SEQUENCES IN MARSUPIALS	NATURE			English	Article							DETERMINING REGION; DETERMINING GENE; PROTEIN; ENCODES	IN mammals, testis determination is under the control of the testis-determining factor borne by the Y chromosome1,2. SRY, a gene cloned from the sex-determining region of the human Y chromosome, has been equated with the testis-determining factor in man3-5 and mouse6,7. We have used a human SRY probe to identify and clone related genes from the Y chromosome of two marsupial species. Comparisons of eutherian and metatherian Y-located SRY sequences suggest rapid evolution of these genes, especially outside the region encoding the DNA-binding HMG box. The SRY homologues, together with the mouse Ube1y homologues8, are the first genes to be identified on the marsupial Y chromosome.	LA TROBE UNIV,DEPT GENET & HUMAN VARIAT,BUNDOORA,VIC 3083,AUSTRALIA; IMPERIAL CANC RES FUND,HUMAN MOLEC GENET LAB,LONDON WC2A 3PX,ENGLAND; NATL INST MED RES,MRC,EUKARYOT MOLEC GENET LAB,LONDON NW7 1AA,ENGLAND; LA TROBE UNIV,DEPT ZOOL,BUNDOORA,VIC 3083,AUSTRALIA; UNIV MELBOURNE,DEPT ZOOL,PARKVILLE,VIC 3052,AUSTRALIA; MACQUARIE UNIV,SCH BIOL SCI,N RYDE,NSW 2109,AUSTRALIA	La Trobe University; Cancer Research UK; MRC National Institute for Medical Research; La Trobe University; University of Melbourne; Macquarie University			Graves, Jennifer A.M./A-1387-2008; Sinclair, Andrew H/A-3598-2010	Sinclair, Andrew H/0000-0003-2741-7992; Graves, Jennifer/0000-0001-6480-7856; Renfree, Marilyn/0000-0002-4589-0436; Lovell-Badge, Robin/0000-0001-9364-4179	Medical Research Council [MC_U117562207] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; DENNY P, 1992, NUCLEIC ACIDS RES, V20, P2887, DOI 10.1093/nar/20.11.2887; FORD CE, 1959, LANCET, V1, P711; GRIFFITHS R, 1991, P ROY SOC B-BIOL SCI, V244, P123, DOI 10.1098/rspb.1991.0060; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; HOPE R, 1990, AUST J ZOOL, V37, P289; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; Jost A., 1973, Recent Progress Hormone Res, V29, P1; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; MITCHELL MJ, 1992, NATURE, V359; NASRIN N, 1991, NATURE, V354, P317, DOI 10.1038/354317a0; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHARMAN GB, 1990, AUST J ZOOL, V37, P451; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SINCLAIR AH, 1988, NATURE, V336, P780, DOI 10.1038/336780a0; WAISUM O, 1988, NATURE, V331, P716	20	204	211	2	21	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 8	1992	359	6395					531	533		10.1038/359531a0	http://dx.doi.org/10.1038/359531a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406969				2022-12-28	WOS:A1992JR85900058
J	MALONEY, JV				MALONEY, JV			THE RESOURCE-BASED RELATIVE VALUE SCALE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											MALONEY, JV (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT SURG,DIV CARDIOTHORAC SURG,10883 LE CONTE AVE,LOS ANGELES,CA 90024, USA.							CHURCH CF, 1992, JAMA-J AM MED ASSOC, V267, P2894, DOI 10.1001/jama.1992.03480210051024; CLARK L, 1990, MED ECON, V67, P85; FLEISCHER AB, 1992, JAMA-J AM MED ASSOC, V267, P2893; GILLETTE RD, 1992, JAMA-J AM MED ASSOC, V267, P2894, DOI 10.1001/jama.1992.03480210051026; HSIAO W, 1992, JAMA-J AM MED ASSOC, V267, P1822, DOI 10.1001/jama.267.13.1822; HSIAO WC, 1988, NEW ENGL J MED, V319, P881, DOI 10.1056/NEJM198809293191330; HSIAO WC, 1988, NATIONAL STUDY RESOU, V2; HSIAO WC, 1988, NATIONAL STUDY RESOU, V1; MALONEY JV, 1991, JAMA-J AM MED ASSOC, V266, P3453; MALONEY JV, 1992, JAMA-J AM MED ASSOC, V267, P2896; MENDENHALL RC, 1981, LCCCN8280671 RW JOHN; MORRIS CR, 1992, JAMA-J AM MED ASSOC, V267, P2896, DOI 10.1001/jama.1992.03480210051029; PHIBBS CS, 1992, JAMA-J AM MED ASSOC, V267, P2894, DOI 10.1001/jama.1992.03480210051025; RADECKI SE, 1992, JAMA-J AM MED ASSOC, V267, P1824, DOI 10.1001/jama.267.13.1824; RAMSEY DM, 1992, JAMA-J AM MED ASSOC, V267, P2895, DOI 10.1001/jama.1992.03480210051028; ROPER WL, 1988, JAMA-J AM MED ASSOC, V260, P2444, DOI 10.1001/jama.260.16.2444; ROWLETT JD, 1992, JAMA-J AM MED ASSOC, V267, P2895, DOI 10.1001/jama.1992.03480210051027; TRONCALE JA, 1992, JAMA-J AM MED ASSOC, V267, P2896, DOI 10.1001/jama.1992.03480210051030; 1991, FED REG         1125, V56, P59501	19	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	1992	268	23					3363	3365		10.1001/jama.268.23.3363	http://dx.doi.org/10.1001/jama.268.23.3363			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB732	1453530				2022-12-28	WOS:A1992KB73200031
J	GUO, HC; JARDETZKY, TS; GARRETT, TPJ; LANE, WS; STROMINGER, JL; WILEY, DC				GUO, HC; JARDETZKY, TS; GARRETT, TPJ; LANE, WS; STROMINGER, JL; WILEY, DC			DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE	NATURE			English	Article							SELF-PEPTIDES; VIRAL PEPTIDES; LYMPHOCYTES-T; ANTIGENS; CRYSTALLOGRAPHY; SPECIFICITY; MOLECULES; HLA-B27; PROTEIN; CHAINS	WE report here the determination and refinement to 1.9 angstrom resolution by X-ray cryo-crystallography the structure of HLA-Aw68. The averaged image from the collection of bound, endogenous peptides clearly shows the atomic structure at the first three and last two amino acids in the peptides but no connected electron density in between. This suggests that bound peptides, held at both ends, take alternative pathways and could be of different lengths by bulging out in the middle. Peptides eluted from HLA-Aw68 include peptides of 9, 10 and 11 amino acids, a direct indication of the length heterogeneity of tightly bound peptides. Peptide sequencing shows relatively conserved 'anchor' residues at position 2 and the carboxy-terminal residue. Conserved binding sites for the peptide N and C termini at the ends of the class I major histocompatibility complex binding groove are apparently dominant in producing the long half-lives of peptide binding and the peptide-dependent stabilization of the class I molecule's structure.	HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138; HARVARD MICROCHEM FACIL,CAMBRIDGE,MA 02138	Harvard University; Howard Hughes Medical Institute; Harvard University	GUO, HC (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,7 DIVIN AVE,CAMBRIDGE,MA 02138, USA.							BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BLUM M, 1987, J APPL CRYSTALLOGR, V20, P235, DOI 10.1107/S0021889887086783; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1990, XPLOR MANUAL; CERUNDOLO V, 1991, P ROY SOC B-BIOL SCI, V244, P169, DOI 10.1098/rspb.1991.0066; DERES K, 1992, EUR J IMMUNOL, V22, P1603, DOI 10.1002/eji.1830220638; DURBIN RM, 1986, SCIENCE, V232, P1127, DOI 10.1126/science.3704639; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; PECCOUD J, 1990, EMBO J, V9, P4215, DOI 10.1002/j.1460-2075.1990.tb07869.x; ROBBINS PA, 1989, J IMMUNOL, V143, P4098; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; ROTZSCHKE O, 1991, IMMUNOL TODAY, V12, P447, DOI 10.1016/0167-5699(91)90018-O; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SILVER ML, 1991, NATURE, V350, P619, DOI 10.1038/350619a0; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; VANBLEEK GM, 1991, P NATL ACAD SCI USA, V88, P11032, DOI 10.1073/pnas.88.24.11032; VANBLEEK GM, 1990, NATURE, V348, P213; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	31	404	444	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 26	1992	360	6402					364	366		10.1038/360364a0	http://dx.doi.org/10.1038/360364a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ630	1448153				2022-12-28	WOS:A1992JZ63000058
J	KASTAN, MB; ZHAN, QM; ELDEIRY, WS; CARRIER, F; JACKS, T; WALSH, WV; PLUNKETT, BS; VOGELSTEIN, B; FORNACE, AJ				KASTAN, MB; ZHAN, QM; ELDEIRY, WS; CARRIER, F; JACKS, T; WALSH, WV; PLUNKETT, BS; VOGELSTEIN, B; FORNACE, AJ			A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA	CELL			English	Article							HUMAN PAPILLOMAVIRUS TYPE-16; DNA DAMAGE; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; PROTEIN; GENE; CANCER; INDUCTION; REPLICATION; DEGRADATION	Cell cycle checkpoints can enhance cell survival and limit mutagenic events following DNA damage. Primary murine fibroblasts became deficient in a G1 checkpoint activated by ionizing radiation (IR) when both wild-type p53 alleles were disrupted. In addition, cells from patients with the radiosensitive, cancer-prone disease ataxia-telangiectasia (AT) lacked the IR-induced increase in p53 protein levels seen in normal cells. Finally, IR induction of the human GADD45 gene, an induction that is also defective in AT cells, was dependent on wild-type p53 function. Wild-type but not mutant p53 bound strongly to a conserved element in the GADD45 gene, and a p53-containing nuclear factor, which bound this element, was detected in extracts from irradiated cells. Thus, we identified three participants (AT gene(s), p53, and GADD45) in a signal transduction pathway that controls cell cycle arrest following DNA damage; abnormalities in this pathway probably contribute to tumor development.	NCI,MOLEC PHARMACOL LAB,BETHESDA,MD 20892; MIT,CTR CANC RES,CAMBRIDGE,MA 02139	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Massachusetts Institute of Technology (MIT)	KASTAN, MB (corresponding author), JOHNS HOPKINS ONCOL CTR,600 N WOLFE ST,BALTIMORE,MD 21287, USA.		El-Deiry, Wafik/AAJ-6080-2020; Fornace, Albert J/A-7407-2008; Carrier, France/C-3063-2008	El-Deiry, Wafik/0000-0002-9577-8266; Fornace, Albert J/0000-0001-9695-085X; Carrier, France/0000-0002-5517-5284	NCI NIH HHS [CA 09071, CA 43460] Funding Source: Medline; NIEHS NIH HHS [ES 05777] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009071, R01CA043460, R37CA043460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005777, R01ES005777] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; BUCHMAN VL, 1988, GENE, V70, P245, DOI 10.1016/0378-1119(88)90196-5; CARRIER F, 1992, MOL CELL BIOL, V12, P1856, DOI 10.1128/MCB.12.4.1856; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doll R, 1981, J NATL CANCER I, V66, P1192; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; FORNACE AJ, 1989, EXP CELL RES, V182, P61, DOI 10.1016/0014-4827(89)90279-6; FORNACE AJ, 1991, RADIAT RES, P213; FORNACE AJ, 1992, IN PRESS ANN NY ACAD; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GIRARDI AJ, 1966, ANN MED EXP BIOL FEN, V44, P242; HARTWELL LH, 1989, SCIENCE, V246, P6229; HECHT F, 1990, CANCER GENET CYTOGEN, V46, P9, DOI 10.1016/0165-4608(90)90003-S; HOLBROOK NJ, 1991, NEW BIOL, V3, P825; HOLLANDER MC, 1990, BIOTECHNIQUES, V9, P174; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; KASTAN MB, 1991, CANCER RES, V51, P6304; KAUFMANN WK, 1991, MOL CELL BIOL, V11, P3711, DOI 10.1128/MCB.11.7.3711; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAU CC, 1982, P NATL ACAD SCI-BIOL, V79, P2942, DOI 10.1073/pnas.79.9.2942; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MCKINNON PJ, 1987, HUM GENET, V75, P197, DOI 10.1007/BF00281059; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MORRELL D, 1986, J NATL CANCER I, V77, P89; MURAKAMI Y, 1990, ONCOGENE, V5, P5; NAGASAWA H, 1985, MUTAT RES, V148, P71, DOI 10.1016/0027-5107(85)90209-X; OCONNOR PM, 1992, CELL GROWTH DIFFER, V3, P43; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PAPATHANASIOU MA, 1991, MOL CELL BIOL, V11, P1009, DOI 10.1128/MCB.11.2.1009; RUDOLPH NS, 1989, MUTAT RES, V211, P31, DOI 10.1016/0027-5107(89)90104-8; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TOLMACH LJ, 1977, RADIAT RES, V71, P653, DOI 10.2307/3574633; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1990, MOL CELL BIOL, V10, P6554, DOI 10.1128/MCB.10.12.6554; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; YUNIS JJ, 1990, ADV ONCOL, V6, P3; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651	56	3151	3237	1	137	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					587	597		10.1016/0092-8674(92)90593-2	http://dx.doi.org/10.1016/0092-8674(92)90593-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423616				2022-12-28	WOS:A1992JY67600007
J	HENRY, DH; BEALL, GN; BENSON, CA; CAREY, J; CONE, LA; ERON, LJ; FIALA, M; FISCHL, MA; GABIN, SJ; GOTTLIEB, MS; GALPIN, JE; GROOPMAN, JE; HOOTON, TM; JEMSEK, JG; LEVINE, RL; MILES, SA; RINEHART, JJ; RIOS, A; ROBBINS, WJ; RUCKDESCHEL, JC; SMITH, JA; SPRUANCE, SL; STARRETT, B; TONEY, J; ZALUSKY, R; ABELS, RI; BRYANT, EC; LARHOLT, KM; SAMPSON, AR; RUDNICK, SA				HENRY, DH; BEALL, GN; BENSON, CA; CAREY, J; CONE, LA; ERON, LJ; FIALA, M; FISCHL, MA; GABIN, SJ; GOTTLIEB, MS; GALPIN, JE; GROOPMAN, JE; HOOTON, TM; JEMSEK, JG; LEVINE, RL; MILES, SA; RINEHART, JJ; RIOS, A; ROBBINS, WJ; RUCKDESCHEL, JC; SMITH, JA; SPRUANCE, SL; STARRETT, B; TONEY, J; ZALUSKY, R; ABELS, RI; BRYANT, EC; LARHOLT, KM; SAMPSON, AR; RUDNICK, SA			RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION AND ZIDOVUDINE THERAPY - OVERVIEW OF 4 CLINICAL-TRIALS	ANNALS OF INTERNAL MEDICINE			English	Article						HUMAN IMMUNODEFICIENCY VIRUS; ZIDOVUDINE; ACQUIRED IMMUNODEFICIENCY SYNDROME; ERYTHROPOIETIN; ANEMIA	BLOOD-TRANSFUSIONS; CANCER; AIDS	Objective: To assess the effect of recombinant human erythropoietin (r-HuEPO) on anemia in patients with the acquired immunodeficiency syndrome (AIDS) who are receiving zidovudine therapy. Design: Combined analysis of four 12-week, randomized, double-blind, controlled clinical trials. Setting: Multiple centers in the United States. Patients: Two hundred and ninety-seven anemic (hematocrit < 30%) patients with AIDS who were receiving zidovudine therapy. Of the 297 patients, 255 were evaluable for efficacy, but all patients were included in analysis of safety. Intervention: Patients were randomly assigned to receive either r-HuEPO (100 to 200 U/kg body weight) or placebo, intravenously or subcutaneously, three times per week for up to 12 weeks. Measurements: Changes in mean hematocrit, transfusion requirement, and quality of life. Results: Sixty-nine percent of patients had endogenous serum erythropoietin levels less than or equal to 500 IU/L, and 31 % had erythropoietin levels greater than 500 IU/L. In patients with low erythropoietin levels (less-than-or-equal-to 500 IU/L), r-HuEPO therapy decreased the mean number of units of blood transfused per patient when compared with placebo (3.2 units and 5.3 units, respectively; P = 0.003) and increased the mean hematocrit from the baseline level (4.6 percentage points and 0.5 percentage points, respectively; P < 0.001). Overall quality of life improved in patients on r-HuEPO therapy (P = 0.13). Patients with erythropoietin levels greater than 500 IU/L showed no benefit from r-HuEPO in any outcome variable. Placebo and r-HuEPO recipients did not differ in the incidence of adverse effects or opportunistic infections. Conclusion: Therapy with r-HuEPO can increase the mean hematocrit and decrease the mean transfusion requirement in anemic patients with AIDS who are receiving zidovudine and have endogenous low erythropoietin levels (less-than-or-equal-to 500 IU/L). Such therapy is of no apparent benefit in patients whose endogenous erythropoietin levels are higher than 500 IU/L.	UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, DIV ALLERGY & CLIN IMMUNOL, TORRANCE, CA 90509 USA; UNIV HOSP CLEVELAND, DEPT INFECT DIS, CLEVELAND, OH 44106 USA; EISENHOWER MED CTR, RANCHO MIRAGE, CA 92270 USA; INFECT DIS PHYSICANS INC, ANNANDALE, VA 22003 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA 90024 USA; UNIV MIAMI, SCH MED, MIAMI, FL 33101 USA; GOTTLIEB MED GRP, SHERMAN OAKS, CA 91403 USA; NEW ENGLAND DEACONESS HOSP, BOSTON, MA 02215 USA; UNIV WASHINGTON, HARBORVIEW MED CTR, DEPT MED, SEATTLE, WA 98104 USA; NALLE CLIN, CHARLOTTE, NC 28207 USA; ROOSEVELT HOSP, TRANSFUS SERV, NEW YORK, NY 10019 USA; UNIV CALIF LOS ANGELES, CARE CTR, LOS ANGELES, CA 90024 USA; SCOTT & WHITE MEM HOSP & CLIN, TEMPLE, TX 76508 USA; LEE MOFFITT CANC CTR, TAMPA, FL 33612 USA; UNIV TEXAS, HLTH SCI CTR, DIV INFECT DIS, SAN ANTONIO, TX 78284 USA; UNIV UTAH, SCH MED, DIV INFECT DIS, SALT LAKE CITY, UT 84132 USA; UNIV S FLORIDA, DIV INFECT & TROP DIS, TAMPA, FL 33612 USA; BETH ISRAEL MED CTR, NEW YORK, NY 10003 USA; RW JOHNSON PHARMACEUT RES INST, RARITAN, NJ 08869 USA; UNIV PITTSBURGH, DEPT MATH & STAT, PITTSBURGH, PA 15260 USA; CELLULAR TRANSPLANTS INC, PROVIDENCE, RI 02906 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University Hospitals of Cleveland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Miami; Harborview Medical Center; University of Washington; University of Washington Seattle; Mount Sinai West; University of California System; University of California Los Angeles; Scott & White Medical Center; H Lee Moffitt Cancer Center & Research Institute; University of Texas System; University of Texas Health San Antonio; Utah System of Higher Education; University of Utah; State University System of Florida; University of South Florida; Harvard University; Beth Israel Deaconess Medical Center; Johnson & Johnson; Johnson & Johnson USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	HENRY, DH (corresponding author), GRAD HOSP PHILADELPHIA, TUTTLEMAN CTR, 1840 SOUTH ST, PHILADELPHIA, PA 19146 USA.		Ruckdeschel, John/AAU-2137-2020; Henry, David/AAU-4650-2020	Ruckdeschel, John/0000-0002-7977-4257; Henry, David/0000-0001-7169-7704				COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FISCHL M, 1990, NEW ENGL J MED, V322, P1488, DOI 10.1056/NEJM199005243222103; FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501; Fleiss JL, 1981, STAT METHODS RATES P; GASCON P, 1984, ANN INTERN MED, V100, P173, DOI 10.7326/0003-4819-100-2-173; GOODMAN SN, 1991, ANN INTERN MED, V114, P244, DOI 10.7326/0003-4819-114-3-244; HEDL A, 1988, 4TH INT C AIDS STOCK; KAPLAN J, 1984, BLOOD, V64, P308; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; MILLER CB, 1990, NEW ENGL J MED, V322, P1689, DOI 10.1056/NEJM199006143222401; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; SMITH MD, 1981, TRANSPLANT P, V13, P181; SPIVAK JL, 1989, JAMA-J AM MED ASSOC, V261, P3104, DOI 10.1001/jama.261.21.3104; WARD JW, 1989, NEW ENGL J MED, V321, P947, DOI 10.1056/NEJM198910053211406; ZON LI, 1988, SEMIN HEMATOL, V25, P208	16	175	179	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1992	117	9					739	748		10.7326/0003-4819-117-9-739	http://dx.doi.org/10.7326/0003-4819-117-9-739			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV424	1416576				2022-12-28	WOS:A1992JV42400006
J	FERGUSON, EL; ANDERSON, KV				FERGUSON, EL; ANDERSON, KV			DECAPENTAPLEGIC ACTS AS A MORPHOGEN TO ORGANIZE DORSAL-VENTRAL PATTERN IN THE DROSOPHILA EMBRYO	CELL			English	Article							CELL-SHAPE CHANGES; GENE-PRODUCT; ACTIVIN-A; PROTEIN; MELANOGASTER; POLARITY; HOMOLOG; FATE; AXIS; GASTRULATION	Zygotic expression of the Drosophila TGFbeta family member decapentaplegic (dpp) is required for the development of the dorsal embryonic structures. By injecting dpp transcripts into young embryos, we find that 2- to 4-fold increases in the concentration of injected RNA elicit progressively more dorsal cell fates: only low levels of dpp permit development of ventral ectoderm, intermediate dpp levels drive dorsal epidermal development, and high dpp levels drive cells to differentiate as the most dorsal pattern element, the amnioserosa. Localized dpp RNA injections into embryos that lack all known maternal and zygotic dorsal-ventral polarity indicate that dpp can both define embryonic polarity and organize detailed patterning within the ectoderm. We infer that dpp acts as an extracellular morphogen and that the graded activity of dpp specifies the pattern of ectodermal cell fates in the Drosophila embryo.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV GENET, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				Ferguson, Edwin/0000-0003-4125-4253	NICHD NIH HHS [HD07299] Funding Source: Medline; NIGMS NIH HHS [GM 35437] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035437] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; ANDERSON KV, 1986, GAMETOGENESIS EARLY, P174; ANDERSON KV, 1989, GENES EMBRYOS, P1; ARORA K, 1992, DEVELOPMENT, V114, P1003; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FERGUSON EL, 1991, CURR TOP DEV BIOL, V25, P17; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; IP YT, 1991, CELL, V64, P439; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LEPTIN M, 1990, DEVELOPMENT, V110, P73; LOHSSCHARDIN M, 1979, DEV BIOL, V73, P239, DOI 10.1016/0012-1606(79)90065-4; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; PANGANIBAN GEF, 1990, DEVELOPMENT, V110, P1041; POSAKONY LG, 1990, MECH DEVELOP, V33, P69, DOI 10.1016/0925-4773(90)90136-A; RAY RP, 1991, DEVELOPMENT, V113, P35; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW C, 1987, NATURE, V330, P583, DOI 10.1038/330583a0; RUSHLOW C, 1987, GENE DEV, V1, P1268, DOI 10.1101/gad.1.10.1268; Rushlow C, 1990, Adv Genet, V27, P277; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SCHUPBACH T, 1989, GENETICS, V121, P101; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THISSE B, 1987, GENE DEV, V1, P709, DOI 10.1101/gad.1.7.709; THISSE C, 1991, CELL, V65, P1191, DOI 10.1016/0092-8674(91)90014-P; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; Wieschaus E., 1986, P199; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; ZUSMAN SB, 1988, DEV BIOL, V129, P417, DOI 10.1016/0012-1606(88)90389-2	40	429	437	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	1992	71	3					451	461		10.1016/0092-8674(92)90514-D	http://dx.doi.org/10.1016/0092-8674(92)90514-D			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423606				2022-12-28	WOS:A1992JW43500011
J	HABAZETTL, J; GONDOL, D; WILTSCHECK, R; OTLEWSKI, J; SCHLEICHER, M; HOLAK, TA				HABAZETTL, J; GONDOL, D; WILTSCHECK, R; OTLEWSKI, J; SCHLEICHER, M; HOLAK, TA			STRUCTURE OF HISACTOPHILIN IS SIMILAR TO INTERLEUKIN-1-BETA AND FIBROBLAST GROWTH-FACTOR	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; 3-DIMENSIONAL NMR-SPECTROSCOPY; NOE-NOE SPECTROSCOPY; TRYPSIN-INHIBITOR; RESOLUTION; PROTEINS; DICTYOSTELIUM; ACTIN	THE fast reaction of the actin-based cytoskeleton in motile cells after stimulation with a chemoattractant requires a signal-transduction chain that creates a very specific environment at distinct regions beneath the plasma membrane1. Dictyostelium hisactophilin, a unique actin-binding protein, is a submembranous pH sensor that signals slight changes of the H+ concentration to actin by inducing actin polymerization and binding to microfilaments only at pH values below seven2. It has a relative molecular mass of 13.5K and its most unusual feature is the presence of 31 histidine residues among its total of 118 amino acids. The transduction of an external signal from the plasma membrane to the cytoskeleton is poorly understood. Here we report the protein's structure in solution determined by nuclear magnetic resonance spectroscopy. The nuclear Overhauser effect intensities of the three-dimensional nuclear Overhauser spectra3,4 were used directly in the calculations5. The overall folding of hisactophilin is similar to that of interleukin-1beta6-9 and fibroblast growth factor10, but the primary amino-acid sequence of hisactophilin is unrelated to these two proteins.	MAX PLANCK INST BIOCHEM,DEPT STRUCT RES,W-8033 MARTINSRIED,GERMANY; MAX PLANCK INST BIOCHEM,DEPT CELL BIOL,W-8033 MARTINSRIED,GERMANY	Max Planck Society; Max Planck Society			Otlewski, Jacek/B-6340-2008					BOELENS R, 1989, J AM CHEM SOC, V111, P8525, DOI 10.1021/ja00204a039; BREG JN, 1990, J MAGN RESON, V87, P646, DOI 10.1016/0022-2364(90)90324-3; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P2315, DOI 10.1021/bi00223a005; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; FESIK SW, 1990, Q REV BIOPHYS, V23, P97, DOI 10.1017/S0033583500005515; FINZEL BC, 1989, J MOL BIOL, V209, P779, DOI 10.1016/0022-2836(89)90606-2; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; HABAZETTL J, IN PRESS J MOL BIOL; HOLAK TA, 1991, J AM CHEM SOC, V113, P3196, DOI 10.1021/ja00008a072; HOLAK TA, 1989, J MOL BIOL, V210, P635, DOI 10.1016/0022-2836(89)90137-X; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; PRIESTLE JP, 1989, P NATL ACAD SCI USA, V86, P9667, DOI 10.1073/pnas.86.24.9667; ROSS A, 1991, J MAGN RESON, V95, P567, DOI 10.1016/0022-2364(91)90170-X; SCHEEL J, 1989, J BIOL CHEM, V264, P2832; VEERAPANDIAN B, 1992, PROTEINS, V12, P10, DOI 10.1002/prot.340120103; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wuthrich K., 1986, NMR PROTEINS NUCL AC; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	20	84	87	1	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 29	1992	359	6398					855	858		10.1038/359855a0	http://dx.doi.org/10.1038/359855a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV777	1436061				2022-12-28	WOS:A1992JV77700072
J	WEINSTEIN, JN; KOHN, KW; GREVER, MR; VISWANADHAN, VN; RUBINSTEIN, LV; MONKS, AP; SCUDIERO, DA; WELCH, L; KOUTSOUKOS, AD; CHIAUSA, AJ; PAULL, KD				WEINSTEIN, JN; KOHN, KW; GREVER, MR; VISWANADHAN, VN; RUBINSTEIN, LV; MONKS, AP; SCUDIERO, DA; WELCH, L; KOUTSOUKOS, AD; CHIAUSA, AJ; PAULL, KD			NEURAL COMPUTING IN CANCER DRUG DEVELOPMENT - PREDICTING MECHANISM OF ACTION	SCIENCE			English	Article							TUMOR-CELL-LINES; ARTIFICIAL-INTELLIGENCE; NETWORKS; DIAGNOSIS; RECOGNITION; FEASIBILITY; BINDING; ERRORS; SITES; ASSAY	Described here are neural networks capable of predicting a drug's mechanism of action from its pattern of activity against a panel of 60 malignant cell lines in the National Cancer Institute's drug screening program. Given six possible classes of mechanism, the network misses the correct category for only 12 out of 141 agents (8.5 percent), whereas linear discriminant analysis, a standard statistical technique, misses 20 out of 141 (14.2 percent). The success of the neural net indicates several things. (i) The cell line response patterns are rich in information about mechanism. (ii) Appropriately designed neural networks can make effective use of that information. (iii) Trained networks can be used to classify prospectively the more than 10,000 agents per year tested by the screening program. Related networks, in combination with classical statistical tools, will help in a variety of ways to move new anticancer agents through the pipeline from in vitro studies to clinical application.	NCI,DIV CANC BIOL DIAG & CTR,MATH BIOL LAB,BETHESDA,MD 20892; NCI,DIV CANC TREATMENT,CANC THERAPY EVALUAT PROGRAM,BIOMETR RES BRANCH,BETHESDA,MD 20892; NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,FREDERICK,MD 21702; NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,INFORMAT TECHNOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	WEINSTEIN, JN (corresponding author), NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,MOLEC PHARMACOL LAB,BLDG 37,ROOM 5C-25,BETHESDA,MD 20892, USA.			Weinstein, John/0000-0001-9401-6908; Rubinstein, Lawrence/0000-0002-9720-9737				ALLEY MC, 1988, CANCER RES, V48, P589; ASADA N, 1990, RADIOLOGY, V177, P857, DOI 10.1148/radiology.177.3.2244001; BAI R, 1991, J BIOL CHEM, V266, P15882; BOONE JM, 1990, MED PHYS, V17, P234, DOI 10.1118/1.596501; Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1; BRUNAK S, 1990, NUCLEIC ACIDS RES, V18, P4797, DOI 10.1093/nar/18.16.4797; DAPONTE JS, 1991, COMPUT MED IMAG GRAP, V15, P3, DOI 10.1016/0895-6111(91)90100-A; Dayhoff Judith E., 1990, NEURAL NETWORK ARCHI; DEMELER B, 1991, NUCLEIC ACIDS RES, V19, P1593, DOI 10.1093/nar/19.7.1593; DYTCH HE, 1990, ANAL QUANT CYTOL, V12, P379; Hand D. J, 1981, WILEY SERIES PROBABI; HOLLEY LH, 1989, P NATL ACAD SCI USA, V86, P152, DOI 10.1073/pnas.86.1.152; JAYARAM HN, 1992, BIOCHEM BIOPH RES CO, V186, P1600, DOI 10.1016/S0006-291X(05)81591-8; KHANNA T, 1991, F NEURAL NETWORKS; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; KUROGI S, 1991, BIOL CYBERN, V64, P243, DOI 10.1007/BF00201985; LUKASHIN AV, 1989, J BIOMOL STRUCT DYN, V6, P1123, DOI 10.1080/07391102.1989.10506540; MANN NH, 1991, ORTHOP CLIN N AM, V22, P303; MCGREGOR MJ, 1989, PROTEIN ENG, V2, P521, DOI 10.1093/protein/2.7.521; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; ONEILL MC, 1991, NUCLEIC ACIDS RES, V19, P313, DOI 10.1093/nar/19.2.313; PAULL KD, 1988, P AM ASSOC CANC RES, V29, P488; PAULL KD, 1992, CANCER RES, V52, P3892; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; PAULL KD, IN PRESS CANCER CHEM; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SCUDIERO DA, 1988, CANCER RES, V48, P4827; SHOEMAKER RH, 1988, PREDICTION RESPONSE, P265; Szu H. H., 1990, Telematics and Informatics, V7, P403, DOI 10.1016/S0736-5853(05)80017-6; WIED GL, 1990, ANAL QUANT CYTOL, V12, P417; WOLBERG WH, 1990, ANAL QUANT CYTOL, V12, P314; 1990, STATISTICAL ANAL SYS, V1	34	253	263	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					447	451		10.1126/science.1411538	http://dx.doi.org/10.1126/science.1411538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411538				2022-12-28	WOS:A1992JT77500030
J	THOMPSON, LT; MOSKAL, JR; DISTERHOFT, JF				THOMPSON, LT; MOSKAL, JR; DISTERHOFT, JF			HIPPOCAMPUS-DEPENDENT LEARNING FACILITATED BY A MONOCLONAL-ANTIBODY OR D-CYCLOSERINE	NATURE			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM POTENTIATION; NICTITATING-MEMBRANE RESPONSE; RAT-BRAIN; ALZHEIMERS-DISEASE; MODULATORY SITE; PARTIAL AGONIST; GLYCINE; RABBITS; COMPLEX	PERSISTENT neuronal plasticity, including that observed at some hippocampal synapses, requires N-methyl-D-aspartate (NMDA)-mediated transmission. NMDA receptor activation may be necessary for hippocampus-dependent learning as antagonists block acquisition in many such tasks. The behavioural effects of NMDA agonists are less well defined. We have shown that a monoclonal antibody (B6B21) displaced [H-3]-glycine that was bound specifically to the NMDA receptor, and enhanced the opening of its integral cation channel in a glycine-like fashion, effects that were competitively antagonized by 7-chlorokynurenic acid1. B6B21 also enhanced long-term potentiation in hippocampal slices1. We report here that intraventricular infusions of B6B21 significantly enhances acquisition rates in hippocampus-dependent trace eye blink conditioning in rabbits, halving the number of trials required to reach a criterion of 80% conditioned responses. Peripheral injections Of D-cycloserine, a partial agonist of the glycine site on the NMDA receptor which crosses the blood-brain barrier, also doubles rabbits' learning rates. Pseudoconditioning control experiments indicated a lack of nonspecific behavioural sensitization effects. Our data suggest that enhanced activation of the glycine coagonist site on the NMDA receptor/channel complex facilitates one form of associative learning and may be used in other learning tasks.	CHICAGO INST NEUROSURG & NEURORES,CHICAGO,IL 60614		THOMPSON, LT (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT CELL MOLEC & STRUCT BIOL,303 E CHICAGO AVE,CHICAGO,IL 60611, USA.		Moskal, Joseph/B-7628-2009; Thompson, Lucien/F-3496-2012; moskal, joseph/K-8431-2014	Thompson, Lucien/0000-0001-8878-0221; Disterhoft, John/0000-0002-8817-7913				ANDERSON P, 1991, EXCITATORY AMINO ACI, P463; BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONTRERAS PC, 1990, NEUROPHARMACOLOGY, V29, P291, DOI 10.1016/0028-3908(90)90015-J; DEDRICK RL, 1989, IMMUNITY CANCER, V2, P429; DEJONGE MC, 1990, EXP BRAIN RES, V80, P456, DOI 10.1007/BF00227987; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; DISTERHOFT JF, 1986, P NATL ACAD SCI USA, V83, P2733, DOI 10.1073/pnas.83.8.2733; FOSTER AC, 1990, EUR J NEUROSCI, V2, P270, DOI 10.1111/j.1460-9568.1990.tb00418.x; GAFFAN D, 1991, BRAIN, V114, P2611, DOI 10.1093/brain/114.6.2611; GOLUB ES, 1987, IMMUNOLOGY SYNTHESIS; Hanngren H, 1961, ANTIBIOT CHEMOTHER, V12, P46; HARING R, 1991, J NEUROCHEM, V57, P323, DOI 10.1111/j.1471-4159.1991.tb02131.x; HOOD WF, 1989, NEUROSCI LETT, V98, P91, DOI 10.1016/0304-3940(89)90379-0; MIYOSHI R, 1990, SYNAPSE, V6, P338, DOI 10.1002/syn.890060405; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MONAHAN JB, 1989, PHARMACOL BIOCHEM BE, V34, P649, DOI 10.1016/0091-3057(89)90571-6; MONAHAN JB, 1989, J NEUROCHEM, V53, P370; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MOSKAL JR, 1986, J NEUROSCI, V6, P2045; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; NAPIER RM, 1992, J EXP PSYCHOL ANIM B, V18, P182, DOI 10.1037/0097-7403.18.2.182; OLIVER MW, 1990, SYNAPSE, V5, P265, DOI 10.1002/syn.890050403; PATEL J, 1990, J NEUROCHEM, V54, P849, DOI 10.1111/j.1471-4159.1990.tb02329.x; PROCTER AW, 1989, NEUROSCI LETT, V101, P62, DOI 10.1016/0304-3940(89)90441-2; ROBINSON GS, 1989, PSYCHOBIOLOGY, V17, P156; SARAGOVI HU, 1991, SCIENCE, V253, P792, DOI 10.1126/science.1876837; SCHWARTZ BL, 1991, NEUROLOGY, V41, P1341, DOI 10.1212/WNL.41.9.1341; SOLOMON PR, 1991, NEUROBIOL AGING, V12, P283, DOI 10.1016/0197-4580(91)90004-4; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Squire L. R., 1987, MEMORY BRAIN; THIELS E, 1992, NEUROSCIENCE, V46, P501, DOI 10.1016/0306-4522(92)90139-S; THOMSON AM, 1989, NATURE, V338, P422, DOI 10.1038/338422a0; VARTANIAN MG, 1991, NEUROSCI LETT, V133, P109, DOI 10.1016/0304-3940(91)90069-6; WATSON GB, 1990, BRAIN RES, V510, P158, DOI 10.1016/0006-8993(90)90745-W; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; WOODRUFFPAK DS, 1988, PSYCHOL AGING, V3, P219, DOI 10.1037/0882-7974.3.3.219	37	154	174	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 15	1992	359	6396					638	641		10.1038/359638a0	http://dx.doi.org/10.1038/359638a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	1406995				2022-12-28	WOS:A1992JT82400058
J	COHEN, J				COHEN, J			AIDS FUNDING - DID POLITICAL CLOUT WIN VACCINE TRIAL FOR MICROGENESYS	SCIENCE			English	Editorial Material																			0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					211	211		10.1126/science.1411518	http://dx.doi.org/10.1126/science.1411518			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JR860	1411518				2022-12-28	WOS:A1992JR86000009
J	DIXON, J				DIXON, J			UNITED-STATES HEALTH-CARE .1. THE ACCESS PROBLEM	BRITISH MEDICAL JOURNAL			English	Article							HOSPITAL PATIENTS; INSURANCE				DIXON, J (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,HLTH SERV RES UNIT,LONDON WC1E 7HT,ENGLAND.							BILLINGS J, 1990, HEALTH AFFAIR, V9, P158, DOI 10.1377/hlthaff.9.4.158; BODENHEIMER T, 1992, NEW ENGL J MED, V327, P274, DOI 10.1056/NEJM199207233270412; BRAVEMAN PA, 1991, JAMA-J AM MED ASSOC, V266, P3300, DOI 10.1001/jama.266.23.3300; Brozan Nadine, 1991, N Y Times Web, pB3; BURWELL BO, 1987, HEALTH AFFAIR, V6, P30, DOI 10.1377/hlthaff.6.4.30; COLWILL JM, 1992, NEW ENGL J MED, V326, P387, DOI 10.1056/NEJM199202063260606; COTTON P, 1991, JAMA-J AM MED ASSOC, V265, P2451; DAVIS K, 1983, MILBANK FUND Q, V61, P149, DOI 10.2307/3349903; DAVIS K, 1991, MILBANK Q, V69, P253, DOI 10.2307/3350204; DIXON J, IN PRESS BMJ; FEDER J, 1990, J HEALTH POLIT POLIC, V15, P259, DOI 10.1215/03616878-15-2-259; FEDER J, 1985, HOSPITALS UNINSURED, P3; FRIEDMAN E, 1991, JAMA-J AM MED ASSOC, V265, P2491, DOI 10.1001/jama.265.19.2491; GOODWIN E, 1989, POVERTY HLTH NEW YOR, P105; HADLEY J, 1991, JAMA-J AM MED ASSOC, V265, P374, DOI 10.1001/jama.265.3.374; Hilts P., 1991, NY TIMES, pA17; KRAMON G, 1991, NY TIMES        0307, pF5; LEWIN T, 1991, NY TIMES        0323, pA1; LUNDBERG GD, 1991, JAMA-J AM MED ASSOC, V265, P2566; MARMOR TR, 1977, NEW HUMAN RIGHTS SOC, P157; MARTIN D, 1991, NY TIMES        0306, pB1; PEAR R, 1991, NY TIMES        0813, pA14; PEAR R, 1991, NY TIMES        1118, pA1; ROSENTHAL E, 1990, NY TIMES        1224, pA9; ROSENTHAL E, 1990, NY TIMES        1224, pA1; ROWLAND D, 1988, ANNU REV PUBL HEALTH, V9, P427; SCHLESINGER M, 1990, HEALTH AFFAIR, V9, P91, DOI 10.1377/hlthaff.9.4.91; SCHWARTZ A, 1991, HEALTH AFFAIR, V10, P131, DOI 10.1377/hlthaff.10.1.131; WEISSMAN J, 1989, JAMA-J AM MED ASSOC, V261, P3572, DOI 10.1001/jama.261.24.3572; 1991, PRIVATE HLTH INSURAN; 1988, HLTH INSURANCE UNINS; 1990, PRESCRIPTION MEDICAL; 1989, HLTH INSURANCE OVERV; 1992, SOURCES HLTH INSURAN	34	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 3	1992	305	6857					817	819		10.1136/bmj.305.6857.817	http://dx.doi.org/10.1136/bmj.305.6857.817			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JT256	1422364	Green Published, hybrid, Green Submitted			2022-12-28	WOS:A1992JT25600031
J	TAYLOR, P				TAYLOR, P			HOW TO IMPLEMENT A NO SMOKING POLICY	BRITISH MEDICAL JOURNAL			English	Article											TAYLOR, P (corresponding author), BRITISH MED ASSOC,TAVISTOCK SQ,LONDON WC1H 9JP,ENGLAND.							JENKINS M, 1987, SMOKING POLICIES WOR; 1988, 4TH IND SCI COMM SMO; 1986, HLTH CONSEQUENCES IN; 1992, TOBACCO FREE WORKPLA; 1992, 506 IND REL SERV REV	5	0	0	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 3	1992	305	6857					823	825		10.1136/bmj.305.6857.823	http://dx.doi.org/10.1136/bmj.305.6857.823			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT256	1422365	Green Published, Bronze, Green Submitted			2022-12-28	WOS:A1992JT25600033
J	MCFADDEN, ER; GILBERT, IA				MCFADDEN, ER; GILBERT, IA			ASTHMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							STEROID-DEPENDENT ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; LONG-TERM TREATMENT; NEUTROPHIL CHEMOTACTIC ACTIVITY; DOSE INHALED CORTICOSTEROIDS; ALLERGEN-INDUCED INCREASE; MAST-CELL MEDIATORS; BRONCHIAL-ASTHMA; BECLOMETHASONE DIPROPIONATE; MILD ASTHMA		CASE WESTERN RESERVE UNIV, SCH MED, CTR AIRWAY DIS, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, SCH MED, DEPT MED, CLEVELAND, OH 44106 USA	Case Western Reserve University; Case Western Reserve University					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL037117] Funding Source: NIH RePORTER; NCRR NIH HHS [MOI RR 00080] Funding Source: Medline; NHLBI NIH HHS [HL-37117] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADELROTH E, 1990, AM REV RESPIR DIS, V142, P91; AGIUS RM, 1985, THORAX, V40, P760, DOI 10.1136/thx.40.10.760; ALLEN MB, 1988, THORAX, V43, pP845; AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; BARNES PJ, 1991, AM REV RESPIR DIS, V143, pS28, DOI 10.1164/ajrccm/143.3_Pt_2.S28; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BEL EH, 1991, AM REV RESPIR DIS, V143, P109, DOI 10.1164/ajrccm/143.1.109; BERNSTEIN DI, 1988, J ALLERGY CLIN IMMUN, V81, P6, DOI 10.1016/0091-6749(88)90213-8; BERNSTEIN IL, 1982, CHEST, V81, P20, DOI 10.1378/chest.81.1.20; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BRESLIN FJ, 1980, AM REV RESPIR DIS, V122, P11; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; BROGDEN RN, 1984, DRUGS, V28, P99, DOI 10.2165/00003495-198428020-00002; BROGDEN RN, 1975, DRUGS, V10, P166, DOI 10.2165/00003495-197510030-00002; BROWN PJ, 1984, THORAX, V39, P131, DOI 10.1136/thx.39.2.131; BRUSASCO V, 1990, J APPL PHYSIOL, V69, P2209, DOI 10.1152/jappl.1990.69.6.2209; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; BUTCHER BT, 1979, J ALLERGY CLIN IMMUN, V64, P146, DOI 10.1016/0091-6749(79)90049-6; CAPEWELL S, 1990, BRIT MED J, V300, P1548, DOI 10.1136/bmj.300.6739.1548; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; CASALE TB, 1987, J CLIN INVEST, V80, P1507, DOI 10.1172/JCI113234; CASALE TB, 1987, J CLIN INVEST, V79, P1197, DOI 10.1172/JCI112937; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; CHURCH MK, 1987, BRIT J PHARMACOL, V90, P421, DOI 10.1111/j.1476-5381.1987.tb08972.x; CLISSOLD SP, 1984, DRUGS, V28, P485, DOI 10.2165/00003495-198428060-00001; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; DEAL EC, 1980, AM REV RESPIR DIS, V121, P621; DEBAETS FM, 1990, AM REV RESPIR DIS, V142, P581, DOI 10.1164/ajrccm/142.3.581; DEBLAQUIERE P, 1989, AM REV RESPIR DIS, V140, P910, DOI 10.1164/ajrccm/140.4.910; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DIAZ P, 1984, J ALLERGY CLIN IMMUN, V74, P41, DOI 10.1016/0091-6749(84)90085-X; DIAZ P, 1989, AM REV RESPIR DIS, V139, P1383, DOI 10.1164/ajrccm/139.6.1383; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P863, DOI 10.1164/ajrccm/142.4.863; DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; DRAZEN JM, 1987, AM REV RESPIR DIS, V136, P985, DOI 10.1164/ajrccm/136.4.985; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; DUTOIT JI, 1987, AM REV RESPIR DIS, V136, P1174, DOI 10.1164/ajrccm/136.5.1174; DYER PD, 1991, J ALLERGY CLIN IMMUN, V88, P208, DOI 10.1016/0091-6749(91)90330-Q; ERZURUM SC, 1991, ANN INTERN MED, V114, P353, DOI 10.7326/0003-4819-114-5-353; EVANS R, 1987, CHEST, V91, pS65, DOI 10.1378/chest.91.6_Supplement.65S; FLINT KC, 1985, BRIT MED J, V291, P923, DOI 10.1136/bmj.291.6500.923; FORESI A, 1990, CHEST, V98, P528, DOI 10.1378/chest.98.3.528; FRIGAS E, 1981, MAYO CLIN PROC, V56, P345; GEORAS SN, 1992, AM J RESP CELL MOL, V7, P261, DOI 10.1165/ajrcmb/7.3.261; GODARD P, 1987, B EUR PHYSIOPATH RES, V23, P73; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HOAG JE, 1991, ANN ALLERGY, V66, P53; HOLTZMAN MJ, 1979, AM REV RESPIR DIS, V120, P1059; HOWELL CJ, 1989, AM REV RESPIR DIS, V140, P1340, DOI 10.1164/ajrccm/140.5.1340; JACKSON R, 1988, CHEST, V94, P914, DOI 10.1378/chest.94.5.914; JARJOUR NN, 1991, AM REV RESPIR DIS, V144, P83, DOI 10.1164/ajrccm/144.1.83; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; JENKINS CR, 1988, THORAX, V43, P378, DOI 10.1136/thx.43.5.378; JOHNSON AJ, 1984, BRIT MED J, V288, P1870, DOI 10.1136/bmj.288.6434.1870; JUNIPER EF, 1990, AM REV RESPIR DIS, V142, P832, DOI 10.1164/ajrccm/142.4.832; JUNIPER EF, 1991, J ALLERGY CLIN IMMUN, V87, P483, DOI 10.1016/0091-6749(91)90006-A; KALINER M, 1989, J ALLERGY CLIN IMMUN, V83, P510, DOI 10.1016/0091-6749(89)90031-6; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; KELLEY J, 1990, AM REV RESPIR DIS, V141, P765, DOI 10.1164/ajrccm/141.3.765; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; KEWLEY GD, 1980, AUST PAEDIATR J, V16, P117; KIRBY JG, 1987, AM REV RESPIR DIS, V136, P379, DOI 10.1164/ajrccm/136.2.379; KLAUSTERMEYER WB, 1987, J ALLERGY CLIN IMMUN, V79, P720, DOI 10.1016/0091-6749(87)90202-8; KRAAN J, 1988, AM REV RESPIR DIS, V137, P44, DOI 10.1164/ajrccm/137.1.44; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LAM S, 1988, J ALLERGY CLIN IMMUN, V81, P711, DOI 10.1016/0091-6749(88)91043-3; LAW CM, 1986, LANCET, V1, P942; LEE TH, 1983, NEW ENGL J MED, V308, P1502, DOI 10.1056/NEJM198306233082504; LEFF AR, 1991, AM J PHYSIOL, V260, pL189, DOI 10.1152/ajplung.1991.260.4.L189; LIU MC, 1990, AM REV RESPIR DIS, V142, P126, DOI 10.1164/ajrccm/142.1.126; LOZEWICZ S, 1990, THORAX, V45, P12, DOI 10.1136/thx.45.1.12; LOZEWICZ S, 1988, BRIT MED J, V297, P1515, DOI 10.1136/bmj.297.6662.1515; MALO JL, 1989, AM REV RESPIR DIS, V140, P624, DOI 10.1164/ajrccm/140.3.624; MARTIN RJ, 1991, AM REV RESPIR DIS, V143, P351, DOI 10.1164/ajrccm/143.2.351; MCFADDEN ER, 1991, CHRONIC OBSTRUCTIVE, P90; MCFADDEN ER, 1988, ALLERGY PRINCIPLES P, V2, P1018; MELTZER EO, 1982, PEDIATRICS, V69, P340; MESSER JW, 1960, DIS CHEST, V38, P616, DOI 10.1378/chest.38.6.616; METZGER WJ, 1986, CHEST, V89, P477, DOI 10.1378/chest.89.4.477; MOLEMA J, 1989, EUR RESPIR J, V2, P308; MULLARKEY MF, 1988, NEW ENGL J MED, V318, P603, DOI 10.1056/NEJM198803103181004; MURANAKA M, 1978, ANN ALLERGY, V40, P132; MURPHY S, 1987, DRUG INTEL CLIN PHAR, V21, P22, DOI 10.1177/10600280870211P102; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; NADEL JA, 1991, AM REV RESPIR DIS, V143, pS33, DOI 10.1164/ajrccm/143.3_Pt_2.S33; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; NICKLAS RA, 1990, J ALLERGY CLIN IMMUN, V85, P959, DOI 10.1016/0091-6749(90)90084-H; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; OCONNOR BJ, 1992, NEW ENGL J MED, V327, P1204, DOI 10.1056/NEJM199210223271704; OLLERENSHAW SL, 1992, AM REV RESPIR DIS, V145, P922, DOI 10.1164/ajrccm/145.4_Pt_1.922; OREHEK J, 1976, J CLIN INVEST, V57, P301, DOI 10.1172/JCI108281; PAGGIARO P, 1990, CHEST, V98, P536, DOI 10.1378/chest.98.3.536; POUW EM, 1991, BRIT MED J, V302, P627, DOI 10.1136/bmj.302.6777.627; RAFFERTY P, 1985, BRIT J DIS CHEST, V79, P244; REPSHER LH, 1984, CHEST, V85, P34, DOI 10.1378/chest.85.1.34; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROSSI GA, 1991, AM REV RESPIR DIS, V144, P379, DOI 10.1164/ajrccm/144.2.379; SALMERON S, 1989, AM REV RESPIR DIS, V140, P167, DOI 10.1164/ajrccm/140.1.167; SEARS MR, 1986, BRIT MED J, V293, P1342, DOI 10.1136/bmj.293.6558.1342; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SHAPIRO GG, 1991, J ALLERGY CLIN IMMUN, V88, P742, DOI 10.1016/0091-6749(91)90181-M; SHAW NJ, 1986, ARCH DIS CHILD, V61, P788, DOI 10.1136/adc.61.8.788; SHEPPARD D, 1981, AM REV RESPIR DIS, V124, P257; SHINER RJ, 1990, LANCET, V336, P137, DOI 10.1016/0140-6736(90)91659-X; SLAVIN RG, 1980, J ALLERGY CLIN IMMUN, V66, P379, DOI 10.1016/0091-6749(80)90117-7; SMITH JM, 1988, ALLERGY PRINCIPLES P, V2, P891; SMITH MJ, 1987, DRUGS, V33, P423, DOI 10.2165/00003495-198733050-00001; SMITH MJ, 1983, THORAX, V38, P676, DOI 10.1136/thx.38.9.676; SOLOPERTO M, 1991, AM J PHYSIOL, V260, pL530, DOI 10.1152/ajplung.1991.260.6.L530; SOTER NA, 1980, NEW ENGL J MED, V302, P604, DOI 10.1056/NEJM198003133021104; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; STENTON SC, 1990, EUR RESPIR J, V3, P408; SVENDSEN UG, 1987, J ALLERGY CLIN IMMUN, V80, P68; TATTERSFIELD AE, 1985, B EUR PHYSIOPATH RES, V21, pS1; THORPE JE, 1987, CHEST, V91, P21, DOI 10.1378/chest.91.1.21; TOBIN MJ, 1982, AM REV RESPIR DIS, V126, P670; TOMIOKA M, 1984, AM REV RESPIR DIS, V129, P1000; TOOGOOD JH, 1980, J ALLERGY CLIN IMMUN, V65, P145, DOI 10.1016/0091-6749(80)90200-6; TOOGOOD JH, 1989, J ALLERGY CLIN IMMUN, V83, P528, DOI 10.1016/0091-6749(89)90034-1; TURNERWARWICK M, 1988, AM J MED, V85, P6, DOI 10.1016/0002-9343(88)90231-8; VANSCHAYCK CP, 1990, J ALLERGY CLIN IMMUN, V86, P793, DOI 10.1016/S0091-6749(05)80185-X; VATHENEN AS, 1991, AM REV RESPIR DIS, V143, P1317, DOI 10.1164/ajrccm/143.6.1317; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; WARDLAW AJ, 1986, CLIN ALLERGY, V16, P163, DOI 10.1111/j.1365-2222.1986.tb00760.x; WASSERMAN SI, 1977, J CLIN INVEST, V60, P189, DOI 10.1172/JCI108756; WASSERMAN SI, 1983, J ALLERGY CLIN IMMUN, V72, P101, DOI 10.1016/0091-6749(83)90512-2; WEBER RW, 1982, J ALLERGY CLIN IMMUN, V70, P417, DOI 10.1016/0091-6749(82)90003-3; WEISS KB, 1990, JAMA-J AM MED ASSOC, V264, P1683, DOI 10.1001/jama.264.13.1683; WENZEL SE, 1989, AM REV RESPIR DIS, V139, P450, DOI 10.1164/ajrccm/139.2.450; WESTCOTT JY, 1991, AM REV RESPIR DIS, V143, P1322, DOI 10.1164/ajrccm/143.6.1322; WIEBICKE W, 1990, J ALLERGY CLIN IMMUN, V86, P915, DOI 10.1016/S0091-6749(05)80155-1; WILLIAMS AJ, 1983, THORAX, V38, P813, DOI 10.1136/thx.38.11.813; WILLIAMS MH, 1974, AM REV RESPIR DIS, V109, P538; WOLTHERS OD, 1991, BMJ-BRIT MED J, V303, P163, DOI 10.1136/bmj.303.6795.163; ZAWADSKI DK, 1988, J APPL PHYSIOL, V64, P812, DOI 10.1152/jappl.1988.64.2.812; ZEHR BB, 1989, CHEST, V95, P1059, DOI 10.1378/chest.95.5.1059; 1972, BMJ, V4, P383; 1991, NIH913042 DEP HLTH H, P35; 1990, AM REV RESPIR DIS S, V141, pS169	147	273	277	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	1992	327	27					1928	1937		10.1056/NEJM199212313272708	http://dx.doi.org/10.1056/NEJM199212313272708			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KE505	1454088				2022-12-28	WOS:A1992KE50500008
J	CRAWSHAW, R				CRAWSHAW, R			LASTING IMPRESSIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	1992	268	22					3247	3247		10.1001/jama.268.22.3247	http://dx.doi.org/10.1001/jama.268.22.3247			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA654	1433768				2022-12-28	WOS:A1992KA65400034
J	LU, ZL; WILLIAMSON, SJ; KAUFMAN, L				LU, ZL; WILLIAMSON, SJ; KAUFMAN, L			BEHAVIORAL LIFETIME OF HUMAN AUDITORY SENSORY MEMORY PREDICTED BY PHYSIOLOGICAL MEASURES	SCIENCE			English	Article								Noninvasive magnetoencephalography makes it possible to identify the cortical area in the human brain whose activity reflects the decay of passive sensory storage of information about auditory stimuli (echoic memory). The lifetime for decay of the neuronal activation trace in primary auditory cortex was found to predict the psychophysically determined duration of memory for the loudness of a tone. Although memory for the loudness of a specific tone is lost, the remembered loudness decays toward the global mean of all of the loudnesses to which a subject is exposed in a series of trials.	NYU,DEPT PHYS,NEW YORK,NY 10003; NYU,CTR NEURAL SCI,NEW YORK,NY 10003; NYU,DEPT PSYCHOL,NEW YORK,NY 10003	New York University; New York University; New York University								BERLINER JE, 1967, J ACOUST SOC AM, V61, P1577; CONRAD R, 1964, BRIT J PSYCHOL, V55, P75, DOI 10.1111/j.2044-8295.1964.tb00899.x; Crowder R.G., 1976, PRINCIPLES LEARNING; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; HARI R, 1980, EXP BRAIN RES, V40, P237, DOI 10.1007/BF00237543; HELSON H, 1964, ADAPTATION LEVEL THE; Hollingworth H. L., 1910, J PHILOS PSYCHOL SCI, V7, P461, DOI [10.2307/2012819, DOI 10.2307/2012819]; IPSEN G, 1926, NEUE PSYCHOL STUD, V1, P279; IPSEN G, 1926, NEUE PSYCHOL STUD, V1, P171; KAUFMAN L, 1992, ELECTROEN CLIN NEURO, V82, P266, DOI 10.1016/0013-4694(92)90107-S; Lauenstein O, 1933, PSYCHOL FORSCH, V17, P130, DOI 10.1007/BF02411957; Lu Z., UNPUB; LU ZL, 1992, BRAIN RES, V572, P236, DOI 10.1016/0006-8993(92)90475-O; MASSARO DW, 1970, J EXP PSYCHOL, V85, P411, DOI 10.1037/h0029712; MASSARO DW, 1975, EXPT PSYCHOL INFORMA; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MURDOCK BB, 1969, J VERB LEARN VERB BE, V8, P665, DOI 10.1016/S0022-5371(69)80120-9; Needham JG, 1935, J EXP PSYCHOL, V18, P530, DOI 10.1037/h0056775; Neisser U., 1967, COGNITIVE PSYCHOL; PISONI DB, 1973, PERCEPT PSYCHOPHYS, V13, P253, DOI 10.3758/BF03214136; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; TREISMAN A, 1964, J VERB LEARN VERB BE, V3, P449, DOI 10.1016/S0022-5371(64)80015-3; WEINBERGER NM, 1987, PROG NEUROBIOL, V29, P1, DOI 10.1016/0301-0082(87)90014-1; WEINBERGER NM, 1990, CONCEPTS NEUROSCIENC, V1, P91; WESTENBERG IS, 1976, ELECTROEN CLIN NEURO, V40, P337, DOI 10.1016/0013-4694(76)90186-3; WICKELGR.WA, 1969, J MATH PSYCHOL, V6, P13, DOI 10.1016/0022-2496(69)90028-5; WILLIAMSON S J, 1991, Brain Topography, V4, P169, DOI 10.1007/BF01132773; Woodrow H, 1933, AM J PSYCHOL, V45, P391, DOI 10.2307/1415039; Woodworth R.S., 1938, EXP PSYCHOL	29	207	208	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 4	1992	258	5088					1668	1670		10.1126/science.1455246	http://dx.doi.org/10.1126/science.1455246			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KA896	1455246				2022-12-28	WOS:A1992KA89600043
J	CLAMAN, HN				CLAMAN, HN			THE BIOLOGY OF THE IMMUNE-RESPONSE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							T-CELL RECEPTOR				CLAMAN, HN (corresponding author), UNIV COLORADO, HLTH SCI CTR, DEPT MED, DIV ALLERGY & CLIN IMMUNOL, DENVER, CO 80262 USA.							ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BIENENSTOCK J, 1984, ANNU REV MED, V35, P49, DOI 10.1146/annurev.me.35.020184.000405; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Demaeyer E., 1988, INTERFERONS OTHER RE; FAIRCHILD RL, 1988, J IMMUNOL, V141, P3342; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; JERNE NK, 1984, IMMUNOL REV, V79, P5, DOI 10.1111/j.1600-065X.1984.tb00484.x; MARRACK P, 1990, SCIENCE, V162, P493; PORCELLI S, 1991, IMMUNOL REV, V120, P137, DOI 10.1111/j.1600-065X.1991.tb00591.x; SHORTER RG, 1982, ADV INTERNAL MED, V27, P247; STREILEIN JW, 1983, J INVEST DERMATOL, V80, pS12, DOI 10.1111/1523-1747.ep12536743; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2	14	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2790	2796		10.1001/jama.268.20.2790	http://dx.doi.org/10.1001/jama.268.20.2790			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433694				2022-12-28	WOS:A1992JY66800002
J	VALENTINE, MD				VALENTINE, MD			ANAPHYLAXIS AND STINGING INSECT HYPERSENSITIVITY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IDIOPATHIC ANAPHYLAXIS; IMMUNOTHERAPY; VENOM				VALENTINE, MD (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DIV ALLERGY, BALTIMORE, MD 21205 USA.							DESHAZO RD, 1990, NEW ENGL J MED, V323, P462, DOI 10.1056/NEJM199008163230707; GOLDEN DBK, 1989, J ALLERGY CLIN IMMUN, V84, P162, DOI 10.1016/0091-6749(89)90320-5; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; GOLDEN DBK, 1983, J CLIN IMMUNOASSAY, V6, P172; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; Portier P, 1902, CR SEANC SOC BIOL, V54, P170; Schick B., 1905, SERUM SICKNESS; SCHWARTZ LB, 1990, J ALLERGY CLIN IMMUN, V86, P594, DOI 10.1016/S0091-6749(05)80222-2; SHEFFER AL, 1984, J ALLERGY CLIN IMMUN, V73, P699, DOI 10.1016/0091-6749(84)90309-9; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936; TOOGOOD JH, 1988, J ALLERGY CLIN IMMUN, V81, P1, DOI 10.1016/0091-6749(88)90212-6; VALENTINE MD, 1990, NEW ENGL J MED, V323, P1601, DOI 10.1056/NEJM199012063232305; VALENTINE MD, 1979, HDB SERIES CLIN LA F, VF, P71; WIGGINS CA, 1988, J ALLERGY CLIN IMMUN, V82, P849, DOI 10.1016/0091-6749(88)90089-9; WONG S, 1991, ANN INTERN MED, V114, P133, DOI 10.7326/0003-4819-114-2-133	15	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	1992	268	20					2830	2833		10.1001/jama.268.20.2830	http://dx.doi.org/10.1001/jama.268.20.2830			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JY668	1433697				2022-12-28	WOS:A1992JY66800005
J	PERERA, FP; HEMMINKI, K; GRYZBOWSKA, E; MOTYKIEWICZ, G; MICHALSKA, J; SANTELLA, RM; YOUNG, TL; DICKEY, C; BRANDTRAUF, P; DEVIVO, I; BLANER, W; TSAI, WY; CHORAZY, M				PERERA, FP; HEMMINKI, K; GRYZBOWSKA, E; MOTYKIEWICZ, G; MICHALSKA, J; SANTELLA, RM; YOUNG, TL; DICKEY, C; BRANDTRAUF, P; DEVIVO, I; BLANER, W; TSAI, WY; CHORAZY, M			MOLECULAR AND GENETIC-DAMAGE IN HUMANS FROM ENVIRONMENTAL-POLLUTION IN POLAND	NATURE			English	Article							LUNG-CANCER; DNA ADDUCTS; BINDING	EXTREME environmental pollution such as that found in the highly industrialized Silesian region of Poland has been associated with increased risk of cancer and adverse reproductive outcomes1,2. Among the most prevalent carcinogenic and mutagenic air pollutants in Silesia are the polycyclic aromatic hydrocarbons (PAH) which are largely produced by industrial and residential combustion of coal1. Molecular epidemiology aims to prevent disease by using biological markers to identify risks well before clinicai onset to allow effective intervention3-7. Here, we use a battery of biological markers to measure molecular and genetic damage in peripheral blood samples from residents of Silesia and from persons living in a rural, less polluted area of Poland. The results show that their exposure to environmental pollution is associated with significant increases in carcinogen-DNA adducts (PAH-DNA and aromatic adducts), in sister chromatid exchange including high-frequency cells, and in chromosomal aberrations as well as a doubling in the frequency of ras oncogene overexpression. We found that aromatic adducts on DNA were significantly correlated with chromosomal mutation, providing us with a molecular link between environmental exposure and a genetic alteration relevant to cancer and reproductive risk.	KAROLINSKA INST,CNT,S-14152 HUDDINGE,SWEDEN; INST ONCOL,DEPT TUMOR BIOL,PL-44100 GLIWICE,POLAND; COLUMBIA UNIV,INST HUMAN NUTR,NEW YORK,NY 10032; COLUMBIA UNIV,DIV BIOSTAT,NEW YORK,NY 10032	Karolinska Institutet; Maria Sklodowska-Curie National Research Institute of Oncology; Columbia University; Columbia University	PERERA, FP (corresponding author), COLUMBIA UNIV,SCH PUBL HLTH,DIV ENVIRONM SCI,60 HAVEN AVE,B1-109,NEW YORK,NY 10032, USA.			Perera, Frederica/0000-0002-1364-9250				BARTSCH H, 1988, METHODS DETECTING DN; BIERI JG, 1979, AM J CLIN NUTR, V32, P2500; BRANDTRAUF PW, 1992, FORD INT J CANCER, V51, P1; BRANDTRAUF PW, 1990, CURRENT ISSUES RESPI, V3, P4; CARRANO AV, 1988, MUTAT RES, V204, P379, DOI 10.1016/0165-1218(88)90036-5; FAORO R, 1991, AEROMETRIC INFORMATI; FRIEDMAN GD, 1986, AM J EPIDEMIOL, V123, P781, DOI 10.1093/oxfordjournals.aje.a114307; FUKINO H, 1982, MUTAT RES, V102, P237, DOI 10.1016/0165-1218(82)90133-1; HEMMINKI K, 1990, CARCINOGENESIS, V11, P1229, DOI 10.1093/carcin/11.7.1229; HENNEKENS CH, 1984, CANCER DETECT PREV, V7, P147; HERTZMAN C, 1990, HLTH POLICY RES UNIT, V90, pD2; Hulka BS., 1990, BIOL MARKERS EPIDEMI, P3; JEDRYCHOWSKI W, 1990, J EPIDEMIOL COMMUN H, V44, P114, DOI 10.1136/jech.44.2.114; MAYER JL, IN PRESS MUTATION RE; MOON TE, NUTRITION CANCER PRE; MOORE DH, 1984, SISTER CHROMATID EXC, P469; MOTYKIEWICZ G, 1989, MUTAT RES, V223, P243, DOI 10.1016/0165-1218(89)90052-9; PERERA FP, 1988, CANCER RES, V48, P2288; PERERA FP, 1990, CA A CANCER J CLIN, V40, P227; PERERA FP, IN PRESS MOL EPIDEMI; PEZZUTO JM, 1986, P AM ASSOC CANC RES, V27, P126; WEI LJ, 1983, J AM STAT ASSOC, V78, P725; IN PRESS MONOGRAPH I	23	255	258	0	35	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 19	1992	360	6401					256	258		10.1038/360256a0	http://dx.doi.org/10.1038/360256a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY960	1436106				2022-12-28	WOS:A1992JY96000050
J	BERRIEN, R				BERRIEN, R			OUTSIDE IN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	1992	268	19					2616	2616						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JX680	1433673				2022-12-28	WOS:A1992JX68000001
J	JOHNSON, RS; SPIEGELMAN, BM; PAPAIOANNOU, V				JOHNSON, RS; SPIEGELMAN, BM; PAPAIOANNOU, V			PLEIOTROPIC EFFECTS OF A NULL MUTATION IN THE C-FOS PROTOONCOGENE	CELL			English	Article							TRANSFORMED-CELL LINE; EMBRYONIC STEM-CELLS; ANTISENSE RNA; DNA-BINDING; GENE-EXPRESSION; TRANSGENIC MICE; GLUCOCORTICOID RECEPTOR; TARGETED DISRUPTION; MOLECULAR-CLONING; NERVOUS-SYSTEM	The c-fos proto-oncogene has been implicated as a central regulatory component of the nuclear response to mitogens and other extracellular stimuli. Embryonic stem cells targeted at the c-fos locus have been used to generate chimeric mice that have transmitted the mutated allele through the germline. Homozygous mutants show reduced placental and fetal weights and significant loss of viability at birth. Approximately 40% of the homozygous mutants survive and grow at normal rates until severe osteopetrosis, characterized by foreshortening of the long bones, ossification of the marrow space, and absence of tooth eruption, begins to develop at approximately 11 days. Among other abnormalities, these mice show delayed or absent gametogenesis, lymphopenia, and altered behavior. Despite these defects, many live as long as their wild-type or heterozygous littermates (currently 7 months). These data indicate that c-fos is not required for the growth of most cell types but is involved in the development and function of several distinct tissues.	TUFTS UNIV, SCH VET MED, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02111 USA; HARVARD UNIV, SCH MED, DEPT BIOL CHEM & MOLEC PHARMACOL, BOSTON, MA 02115 USA	Tufts University; Tufts University; Harvard University; Harvard Medical School	JOHNSON, RS (corresponding author), HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA.		Johnson, Randall/AAM-1189-2021	Johnson, Randall/0000-0002-4084-6639; Papaioannou, Virginia/0000-0001-7558-8601	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024926, R01HD027295] Funding Source: NIH RePORTER; NICHD NIH HHS [HD27295, HD24926] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; ADAMSON ED, 1985, EMBO J, V4, P941, DOI 10.1002/j.1460-2075.1985.tb03722.x; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BARKA T, 1989, EXP CELL RES, V185, P419, DOI 10.1016/0014-4827(89)90312-1; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BIGGERS JD, 1991, J IN VITRO FERTIL EM, V8, P352, DOI 10.1007/BF01133028; CAUBET JF, 1989, MOL CELL BIOL, V9, P2269, DOI 10.1128/MCB.9.5.2269; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; Distel R J, 1990, Adv Cancer Res, V55, P37, DOI 10.1016/S0065-230X(08)60467-4; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DOUCAS V, 1991, EMBO J, V10, P2237, DOI 10.1002/j.1460-2075.1991.tb07760.x; EDWARDS SA, 1988, DEV BIOL, V129, P91, DOI 10.1016/0012-1606(88)90164-9; FARRAR WL, 1989, CRIT REV THER DRUG, V5, P229; FIELD SJ, 1992, P NATL ACAD SCI USA, V89, P9306, DOI 10.1073/pnas.89.19.9306; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; JENUWEIN T, 1985, CELL, V41, P629, DOI 10.1016/S0092-8674(85)80035-0; JOHNSON RS, 1989, SCIENCE, V245, P1234, DOI 10.1126/science.2506639; KASIK JW, 1987, MOL CELL BIOL, V7, P3349, DOI 10.1128/MCB.7.9.3349; KOUSVELARI E, 1988, EXP CELL RES, V179, P194, DOI 10.1016/0014-4827(88)90358-8; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; LEDWITH BJ, 1990, MOL CELL BIOL, V10, P1545, DOI 10.1128/MCB.10.4.1545; LEVI BZ, 1988, GENE DEV, V2, P554, DOI 10.1101/gad.2.5.554; LEVI BZ, 1988, CELL DIFFER DEV, V25, P95, DOI 10.1016/0922-3371(88)90105-0; LEVI BZ, 1989, P NATL ACAD SCI USA, V86, P2262, DOI 10.1073/pnas.86.7.2262; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; MERCOLA D, 1987, BIOCHEM BIOPH RES CO, V147, P288, DOI 10.1016/S0006-291X(87)80119-5; MERCOLA D, 1988, GENE, V72, P253, DOI 10.1016/0378-1119(88)90151-5; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; MULLER R, 1983, NATURE, V304, P454, DOI 10.1038/304454a0; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; OKUNO H, 1991, ONCOGENE, V6, P1491; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; Robertson E. J., 1987, TERATOCARCINOMAS EMB; RUTHER U, 1989, ONCOGENE, V4, P861; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; RUTHER U, 1988, CELL, V53, P847, DOI 10.1016/S0092-8674(88)90289-9; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCANLON KJ, 1991, P NATL ACAD SCI USA, V88, P10591, DOI 10.1073/pnas.88.23.10591; SCHILLING K, 1991, P NATL ACAD SCI USA, V88, P5665, DOI 10.1073/pnas.88.13.5665; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SEARLE AG, 1954, J GENET, V52, P68, DOI 10.1007/BF02981491; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHERR CJ, 1991, TRENDS GENET, V7, P398, DOI 10.1016/0168-9525(91)90263-P; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; WANG ZQ, 1991, EMBO J, V10, P2437, DOI 10.1002/j.1460-2075.1991.tb07783.x; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; ZARBL H, 1987, CELL, V51, P357, DOI 10.1016/0092-8674(87)90632-5	61	581	591	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	1992	71	4					577	586		10.1016/0092-8674(92)90592-Z	http://dx.doi.org/10.1016/0092-8674(92)90592-Z			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423615				2022-12-28	WOS:A1992JY67600006
J	MAIN, AL; HARVEY, TS; BARON, M; BOYD, J; CAMPBELL, ID				MAIN, AL; HARVEY, TS; BARON, M; BOYD, J; CAMPBELL, ID			THE 3-DIMENSIONAL STRUCTURE OF THE 10TH TYPE-III MODULE OF FIBRONECTIN - AN INSIGHT INTO RGD-MEDIATED INTERACTIONS	CELL			English	Article							CELL-BINDING DOMAIN; NUCLEAR-MAGNETIC-RESONANCE; SITE-DIRECTED MUTAGENESIS; PROTEIN STRUCTURES; ADHESIVE FUNCTION; CRYSTAL-STRUCTURE; HUMAN CD4; SPECTROSCOPY; RECOGNITION; SEQUENCES	The solution structure of the tenth type III module of fibronectin has been determined using nuclear magnetic resonance techniques. The molecule has a fold similar to that of immunoglobulin domains, with seven beta strands forming two antiparallel beta sheets, which pack against each other. Both beta sheets contribute conserved hydrophobic residues to a compact core. The topology is more similar to that of domain 2 of CD4, PapD, and the extracellular domain of the human growth hormone receptor than to that of immunoglobulin C domains. The module contains an Arg-Gly-Asp sequence known to be involved in cell adhesion. This tripeptide is solvent exposed and lies on a conformationally mobile loop between strands F and G, consistent with its cell adhesion function.			MAIN, AL (corresponding author), UNIV OXFORD, DEPT BIOCHEM, S PARKS RD, OXFORD OX1 3QU, ENGLAND.		Harvey, Timothy S/F-9863-2013	Harvey, Timothy S/0000-0001-6270-1943				ADLER M, 1991, SCIENCE, V253, P445, DOI 10.1126/science.1862345; AOTA S, 1991, J BIOL CHEM, V266, P15938; BARON M, 1992, BIOCHEMISTRY-US, V31, P2068, DOI 10.1021/bi00122a025; BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; BARTON GJ, 1990, METHOD ENZYMOL, V183, P403; BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, XPLOR MANUAL; CONSTANTINE KL, 1991, BIOCHEMISTRY-US, V30, P1663, DOI 10.1021/bi00220a032; DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DOWNING AK, 1992, J MOL BIOL, V225, P821, DOI 10.1016/0022-2836(92)90403-7; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; HOLMGREN A, 1989, NATURE, V342, P248, DOI 10.1038/342248a0; HOMMEL U, 1992, IN PRESS J MOL BIOL; Hynes RO, 1990, FIBRONECTINS; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; MARION D, 1988, J MAGN RESON, V80, P528, DOI 10.1016/0022-2364(88)90250-8; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Mosher DF, 1989, FIBRONECTIN; MUELLER L, 1987, J MAGN RESON, V72, P191, DOI 10.1016/0022-2364(87)90188-0; NAGAI T, 1991, J CELL BIOL, V114, P1295, DOI 10.1083/jcb.114.6.1295; NILGES M, 1990, BIOPOLYMERS, V29, P813, DOI 10.1002/bip.360290415; NILGES M, 1991, NATO ADV SCI I A-LIF, V225, P451; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; PASCARELLA S, 1992, PROTEIN ENG, V5, P121, DOI 10.1093/protein/5.2.121; Patthy L, 1991, CURR OPIN STRUC BIOL, V1, P351, DOI 10.1016/0959-440X(91)90033-P; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; WANG HM, 1992, J BIOL CHEM, V267, P979; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; Wuthrich K., 1986, NMR PROTEINS NUCL AC; YAMADA KM, 1991, J BIOL CHEM, V266, P12809	51	450	487	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	1992	71	4					671	678		10.1016/0092-8674(92)90600-H	http://dx.doi.org/10.1016/0092-8674(92)90600-H			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423622				2022-12-28	WOS:A1992JY67600014
J	BALASUBRAMANIAN, MK; HELFMAN, DM; HEMMINGSEN, SM				BALASUBRAMANIAN, MK; HELFMAN, DM; HEMMINGSEN, SM			A NEW TROPOMYOSIN ESSENTIAL FOR CYTOKINESIS IN THE FISSION YEAST S-POMBE	NATURE			English	Article							CELL-DIVISION CYCLE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; GENETIC-CONTROL; F-ACTIN; PROTEINS; MUSCLE	MUTATIONS in the Schizosaccharomyces pombe cdc8 gene impair cytokinesis1. Here we clone cdc8+ and find that it encodes a novel tropomyosin. Gene disruption results in lethal arrest of the cell cycle, but spore germination, cell growth, DNA replication and mitosis are all unaffected. Haploid cdc8 gene disruptants are rescued by expression of a fibroblast tropomyosin complementary DNA. Immunofluorescence microscopy of wild type and cdc8 gene distruptants indicates that cdc8 tropomyosin is present in two distinct cellular distributions: in dispersed patches, and during cytokinesis as a transient medial band. Collectively these results indicate that cdc8 tropomyosin has a specialized role which, we suggest, is to form part of the F-actin contractile ring at cytokinesis. These results establish the basis for further genetic studies of cytokinesis and of contractile protein function in S. pombe.	NATL RES COUNCIL CANADA, INST PLANT BIOTECHNOL, SASKATOON S7N 0W9, SASKATCHEWAN, CANADA; UNIV SASKATCHEWAN, DEPT MICROBIOL, SASKATOON S7N 0W0, SASKATCHEWAN, CANADA	National Research Council Canada; University of Saskatchewan			Helfman, David M./C-2058-2011	Balasubramanian, Mohan/0000-0002-1292-8602				ALFA CE, 1990, J CELL SCI, V96, P71; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; COTE GP, 1983, MOL CELL BIOCHEM, V57, P127, DOI 10.1007/BF00849190; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOODWIN LO, 1991, J BIOL CHEM, V266, P8408; HAGAN IM, 1988, J CELL SCI, V89, P343; JOCHOVA J, 1991, CELL BIOL INT REP, V15, P607, DOI 10.1016/0309-1651(91)90007-6; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6; LIU HP, 1989, P NATL ACAD SCI USA, V86, P90, DOI 10.1073/pnas.86.1.90; MARKS J, 1992, J CELL SCI, V101, P801; MARKS J, 1985, EUR J CELL BIOL, V39, P27; MINET M, 1979, J BACTERIOL, V137, P440, DOI 10.1128/JB.137.1.440-446.1979; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; SCHROEDER TE, 1990, ANN NY ACAD SCI, V582, P78; SCHWOB E, 1992, NATURE, V355, P179, DOI 10.1038/355179a0; SMILLIE LB, 1979, TRENDS BIOCHEM SCI, V4, P151, DOI 10.1016/0968-0004(79)90003-3; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; WATTS FZ, 1987, EMBO J, V6, P3499, DOI 10.1002/j.1460-2075.1987.tb02675.x; WRIGHT A, 1986, PLASMID, V15, P156, DOI 10.1016/0147-619X(86)90051-X	22	204	205	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	1992	360	6399					84	87		10.1038/360084a0	http://dx.doi.org/10.1038/360084a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW717	1436080				2022-12-28	WOS:A1992JW71700062
J	BRAUN, T; RUDNICKI, MA; ARNOLD, HH; JAENISCH, R				BRAUN, T; RUDNICKI, MA; ARNOLD, HH; JAENISCH, R			TARGETED INACTIVATION OF THE MUSCLE REGULATORY GENE MYF-5 RESULTS IN ABNORMAL RIB DEVELOPMENT AND PERINATAL DEATH	CELL			English	Article							MYOGENIC DETERMINATION FACTORS; LOOP-HELIX PROTEINS; MYOSIN HEAVY-CHAIN; MOUSE EMBRYO; SKELETAL-MUSCLE; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; EXTRACELLULAR-MATRIX; ALPHA-ACTIN; MYOD FAMILY	The Myf-5 gene, a member of the myogenic basic HLH factor family, has been inactivated in mice after homologous recombination in ES cells. Mice lacking Myf-5 were unable to breathe and died immediately after birth, owing to the absence of the major distal part of the ribs. Other skeletal abnormalities, except for complete ossification of the sternum, were not apparent. Histological examination of skeletal muscle from newborn mice revealed no morphological abnormalities. Northern blot analysis demonstrated normal levels of muscle-specific mRNAs including MyoD, myogenin, and Myf-6. However, the appearance of myotomal cells in early somites was delayed by several days. These results suggest that while Myf-5 plays a crucial role in the formation of lateral sclerotome derivatives, Myf-5 is dispensable for the development of skeletal muscle, perhaps because other members of the myogenic HLH family substitute for Myf-5 activity.	MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	BRAUN, T (corresponding author), UNIV HAMBURG,SCH MED,DEPT TOXICOL,GRINDELALLEE 117,W-2000 HAMBURG 13,GERMANY.		Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804	NCI NIH HHS [R35 CA 44339-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA044339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARNOLD HH, 1992, ADV DEV BIOCHM; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Bancroft JD, 1990, THEORY PRACTICE HIST; BENFIELD PA, 1984, J BIOL CHEM, V259, P4979; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; BRADLEY A, 1987, PRODUCTION ANAL CHIM; BRAUN T, 1990, NATURE, V346, P663, DOI 10.1038/346663a0; BRAUN T, 1992, GENE DEV, V6, P888, DOI 10.1101/gad.6.5.888; BRAUN T, 1991, EUR J BIOCHEM, V198, P187, DOI 10.1111/j.1432-1033.1991.tb16000.x; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRAUN T, 1991, NUCLEIC ACIDS RES, V19, P5645, DOI 10.1093/nar/19.20.5645; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P5675, DOI 10.1073/pnas.88.13.5675; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; CHAKRABORTY T, 1991, J BIOL CHEM, V266, P2878; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DELABROUSSE FC, 1990, GENE DEV, V4, P567, DOI 10.1101/gad.4.4.567; DRAKE CJ, 1991, DEV BIOL, V143, P418, DOI 10.1016/0012-1606(91)90092-H; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Emerson CP, 1990, CURR OPIN CELL BIOL, V2, P1065, DOI 10.1016/0955-0674(90)90157-A; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517; GARFINKEL LI, 1982, J BIOL CHEM, V257, P1078; Hall BK, 1977, ADV ANATOMY EMBRYOLO, V53, P1; HAUB O, 1991, DEVELOPMENT, V112, P397; HOFFMANN E, 1988, NUCLEIC ACIDS RES, V16, P2353, DOI 10.1093/nar/16.5.2353; Holtzer H., 1968, EPITHELIAL MESENCHYM, P152; HU MCT, 1986, MOL CELL BIOL, V6, P15, DOI 10.1128/MCB.6.1.15; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEMISCHKA IR, 1981, J MOL BIOL, V151, P101, DOI 10.1016/0022-2836(81)90223-0; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LYONS KM, 1990, DEVELOPMENT, V109, P833; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V20, P5755; Miller J B, 1991, Neuromuscul Disord, V1, P7, DOI 10.1016/0960-8966(91)90038-T; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; MILLER JB, 1992, CELL, V69, P1, DOI 10.1016/0092-8674(92)90111-O; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MONTARRAS D, 1991, NEW BIOL, V3, P592; NISWANDER L, 1992, DEVELOPMENT, V114, P755; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OTT MO, 1991, DEVELOPMENT, V111, P1097; PETTE D, 1985, MUSCLE NERVE, V8, P676, DOI 10.1002/mus.880080810; POWNALL ME, 1992, DEV BIOL, V151, P67, DOI 10.1016/0012-1606(92)90214-2; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RONG PM, 1992, DEVELOPMENT, V115, P657; ROSENTHAL N, 1990, NUCLEIC ACIDS RES, V18, P6239, DOI 10.1093/nar/18.21.6239; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1988, MOL CELL BIOL, V8, P406, DOI 10.1128/MCB.8.1.406; RUGH R, 1990, MOUSE ITS REPRODUCTI; SALMINEN A, 1991, J CELL BIOL, V115, P905, DOI 10.1083/jcb.115.4.905; Sambrook J, 1989, MOL CLONING LABORATO; SANDERS EJ, 1988, DIFFERENTIATION, V39, P34, DOI 10.1111/j.1432-0436.1988.tb00078.x; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; SCHWARZ JJ, 1992, MOL CELL BIOL, V12, P266, DOI 10.1128/MCB.12.1.266; SEIDEL U, 1989, J BIOL CHEM, V264, P16109; SOLURSH M, 1979, J EMBRYOL EXP MORPH, V54, P75; TEILLET MA, 1983, DEV BIOL, V98, P192, DOI 10.1016/0012-1606(83)90349-4; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242; WINTER B, 1992, EMBO J, V11, P1843, DOI 10.1002/j.1460-2075.1992.tb05236.x; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Wright WE, 1992, CURR OPIN GENET DEV, V2, P243, DOI 10.1016/S0959-437X(05)80280-1; YUTZEY KE, 1990, MOL CELL BIOL, V10, P3934, DOI 10.1128/MCB.10.8.3934; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	71	577	592	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					369	382		10.1016/0092-8674(92)90507-9	http://dx.doi.org/10.1016/0092-8674(92)90507-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423602				2022-12-28	WOS:A1992JW43500004
J	LEONE, G; MAYBAUM, L; LEE, PWK				LEONE, G; MAYBAUM, L; LEE, PWK			THE REOVIRUS CELL ATTACHMENT PROTEIN POSSESSES 2 INDEPENDENTLY ACTIVE TRIMERIZATION DOMAINS - BASIS OF DOMINANT NEGATIVE EFFECTS	CELL			English	Article							HEPTAD REPEAT REGION; WILD-TYPE P53; MUTANT P53; FUNCTIONAL DOMAINS; COLON CANCER; COILED-COIL; 3 SEROTYPES; SIGMA-1; IDENTIFICATION; GENE	The reovirus cell attachment protein, sigma1, is a homotrimer with an N-terminal fibrous tail and a C-terminal globular head. By cotranslating full-length and various truncated sigma1 proteins in vitro, we show that the N- and C-terminal halves of sigma1 possess independent trimerization and folding domains. Trimerization of sigma1 is initiated at the N-terminus by the formation of a "loose," protease-sensitive, three-stranded, alpha-helical coiled coil. This serves to bring the three unfolded C-termini into close proximity to one another, facilitating their subsequent trimerization and cooperative folding. Concomitant with, but independent of, this latter process, the N-terminal fiber further matures into a more stable and protease-resistant structure. The coordinated folding of sigma1 trimers exemplifies the dominant negative effects of mutant subunits in oligomeric complexes.			LEONE, G (corresponding author), UNIV CALGARY,HLTH SCI CTR,DEPT MICROBIOL & INFECT DIS,CALGARY T2N 4N1,ALBERTA,CANADA.		Giuseppe Leone, Full Professor/I-9166-2019	Giuseppe Leone, Full Professor/0000-0002-7812-5300				ARMSTRONG GD, 1984, VIROLOGY, V138, P37, DOI 10.1016/0042-6822(84)90145-4; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BANERJEA AC, 1988, VIROLOGY, V167, P601, DOI 10.1016/0042-6822(88)90123-7; BANERJEA AC, 1990, VIROLOGY, V179, P460, DOI 10.1016/0042-6822(90)90315-I; BASSELDUBY R, 1985, NATURE, V315, P421, DOI 10.1038/315421a0; BOURNE HR, 1991, NATURE, V353, P696, DOI 10.1038/353696b0; BOURNE HR, 1991, NATURE, V351, P188, DOI 10.1038/351188a0; BURSTIN SJ, 1982, VIROLOGY, V117, P146, DOI 10.1016/0042-6822(82)90514-1; CASHDOLLAR LW, 1985, P NATL ACAD SCI USA, V82, P24, DOI 10.1073/pnas.82.1.24; CASHDOLLAR LW, 1989, VIROLOGY, V168, P183, DOI 10.1016/0042-6822(89)90420-0; COOHAN JP, 1992, VIROLOGY, V186, P409; DUNCAN R, 1990, VIROLOGY, V174, P399, DOI 10.1016/0042-6822(90)90093-7; DUNCAN R, 1991, VIROLOGY, V182, P810, DOI 10.1016/0042-6822(91)90622-I; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRASER RDB, 1990, J VIROL, V64, P2990, DOI 10.1128/JVI.64.6.2990-3000.1990; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; GANNON JV, 1990, EMBO J, V9, P1591; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; LEONE G, 1991, VIROLOGY, V182, P346, DOI 10.1016/0042-6822(91)90678-5; LEONE G, 1991, VIROLOGY, V182, P336, DOI 10.1016/0042-6822(91)90677-4; LEONE G, 1991, VIROLOGY, V184, P758, DOI 10.1016/0042-6822(91)90447-J; MAH DCW, 1990, VIROLOGY, V179, P95, DOI 10.1016/0042-6822(90)90278-Y; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; NAGATA L, 1987, VIROLOGY, V160, P162, DOI 10.1016/0042-6822(87)90056-0; NAGATA L, 1984, NUCLEIC ACIDS RES, V12, P8699, DOI 10.1093/nar/12.22.8699; NIBERT ML, 1990, J VIROL, V64, P2976, DOI 10.1128/JVI.64.6.2976-2989.1990; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; PAUL RW, 1987, VIROLOGY, V159, P94, DOI 10.1016/0042-6822(87)90351-5; ROVINSKI B, 1988, ONCOGENE, V2, P445; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; SHARPE AH, 1985, NEW ENGL J MED, V312, P486, DOI 10.1056/NEJM198502213120806; STRONG JE, 1991, VIROLOGY, V184, P23, DOI 10.1016/0042-6822(91)90818-V; TURNER DL, 1992, VIROLOGY, V186, P219, DOI 10.1016/0042-6822(92)90076-2; WEINER HL, 1978, VIROLOGY, V86, P581, DOI 10.1016/0042-6822(78)90099-5; YEUNG MC, 1989, VIROLOGY, V170, P62, DOI 10.1016/0042-6822(89)90352-8; YEUNG MC, 1987, VIROLOGY, V156, P377, DOI 10.1016/0042-6822(87)90417-X	45	39	42	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 30	1992	71	3					479	488		10.1016/0092-8674(92)90516-F	http://dx.doi.org/10.1016/0092-8674(92)90516-F			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JW435	1423608				2022-12-28	WOS:A1992JW43500013
J	KOHLMEIER, L; ARMINGER, G; BARTOLOMEYCIK, S; BELLACH, B; REHM, J; THAMM, M				KOHLMEIER, L; ARMINGER, G; BARTOLOMEYCIK, S; BELLACH, B; REHM, J; THAMM, M			PET BIRDS AS AN INDEPENDENT RISK FACTOR FOR LUNG-CANCER - CASE-CONTROL STUDY	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPERSENSITIVITY PNEUMONITIS; FANCIERS LUNG; OCCUPATION; PATHOLOGY; BREEDERS; SMOKING	Objective-To test the hypothesis that exposure to pct birds increases risk of developing lung cancer. Design-Case-control study. Computerised interviews were used to assess previous exposure to pets and other risk factors for lung cancer. Setting-Three major hospitals treating respiratory disease in former West Berlin. Subjects-All people newly diagnosed as having primary malignant neoplasm of the trachea, bronchi, or lung who were 65 or younger and control subjects matched for age and sex from the general population of former West Berlin. 279 cases and 635 controls qualified for the study; 239 cases and 429 controls participated. Main outcome measures-Odds ratio of developing lung cancer according to whether or not pet birds were kept and the duration of keeping pet birds. Results-In addition to the risk of lung cancer imposed by smoking, passive smoking, and occupational exposure to carcinogens, an increased relative risk of 2.14 (95% confidence interval 1.35 to 3.40) was found among people exposed to pet birds. The adjusted odds ratio for exposures longer than 10 years was 3.19 (1.48 to 8.21). Conclusions-Avian exposure seems to carry a risk of lung cancer. Until the pathogenesis is understood, long term exposure to pet birds in living areas should be avoided, especially among people at high risk of developing lung cancer.	UNIV GESAMTHSCH WUPPERTAL, W-5600 WUPPERTAL 1, GERMANY	University of Wuppertal	KOHLMEIER, L (corresponding author), BUNDESGESUNDHEITSAMT, INST SOCIAL MED & EPIDEMIOL, POSTFACH 330013, W-1000 BERLIN 33, GERMANY.		Rem, Jürgen/H-1309-2011					ALLEN DH, 1976, AM REV RESPIR DIS, V114, P555; [Anonymous], 1986, ENV TOBACCO SMOKE ME; AXELSON O, 1990, ANN NY ACAD SCI, V609, P165; BALASUBRAMANIAM SK, 1987, CLIN PEDIATR, V26, P174, DOI 10.1177/000992288702600402; BOURKE SJ, 1989, CLIN EXP ALLERGY, V19, P629, DOI 10.1111/j.1365-2222.1989.tb02758.x; BOURKE SJ, 1990, AM REV RESPIR DIS, V142, P1168, DOI 10.1164/ajrccm/142.5.1168; CARSTENSEN JM, 1990, ANN NY ACAD SCI, V609, P159; FEHR R, 1983, BERUFSSPEZIFISCHE KR, P137; FINK JN, 1968, ANN INTERN MED, V68, P1205, DOI 10.7326/0003-4819-68-6-1205; GRAMMER LC, 1990, J ALLERGY CLIN IMMUN, V85, P655, DOI 10.1016/0091-6749(90)90107-F; HAGMAR L, 1990, AM J IND MED, V17, P77; HOLST PA, 1988, BRIT MED J, V297, P1319, DOI 10.1136/bmj.297.6659.1319; JAMES JM, 1987, CLIN EXP IMMUNOL, V68, P397; KELLER RH, 1984, AM REV RESPIR DIS, V130, P766; MENCK HR, 1976, J OCCUP ENVIRON MED, V18, P797, DOI 10.1097/00043764-197612000-00005; MILNE KL, 1983, AM J IND MED, V4, P565, DOI 10.1002/ajim.4700040410; OSTERGAARD JR, 1989, ACTA PAEDIATR SCAND, V78, P145, DOI 10.1111/j.1651-2227.1989.tb10906.x; PUKKALA E, 1983, INT J EPIDEMIOL, V12, P290, DOI 10.1093/ije/12.3.290; REED CE, 1965, J AMER MED ASSOC, V193, P261, DOI 10.1001/jama.1965.03090040005001; ROSENSTOCK L, 1986, CLIN OCCUPATIONAL ME; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SCHLUETER DP, 1969, ANN INTERN MED, V70, P457, DOI 10.7326/0003-4819-70-3-457; SCHMIDT CD, 1988, CHEST, V93, P359, DOI 10.1378/chest.93.2.359; SMITH JH, 1990, J PARASITOL, V76, P59, DOI 10.2307/3282628; Staib F, 1986, Prax Klin Pneumol, V40, P86; Staib F., 1987, AIDS-Forschung, V2, P363; Staib F, 1968, Mykosen, V11, P619; Staib F., 1989, AIDS-Forschung, V4, P649; STAIB F, 1985, ZBL BAKT MIK HYG B, V180, P567; STAIB F, 1987, INDOOR AIR 87, V1, P694; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; WEGENER HH, 1983, ZBL BAKT-INT J MED M, V256, P231; 1991, EGRET, P1; 1988, HLTH RISKS RADON OTH; 1989, GESUNDHEITSWESEN F 4; 1988, INT KLASSIFIKATION K; 1984, ABESTIFORM FIBERS NO	37	31	31	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	1992	305	6860					986	989		10.1136/bmj.305.6860.986	http://dx.doi.org/10.1136/bmj.305.6860.986			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV776	1458145	Green Published, Green Submitted, Bronze			2022-12-28	WOS:A1992JV77600025
J	MERBS, SL; NATHANS, J				MERBS, SL; NATHANS, J			ABSORPTION-SPECTRA OF THE HYBRID PIGMENTS RESPONSIBLE FOR ANOMALOUS COLOR-VISION	SCIENCE			English	Article							MOLECULAR-GENETICS; GENES; GREEN; BLUE; XQ28	Unequal homologous recombination events between green and red cone pigment genes produce the red-green or green-red hybrid pigment genes found in many individuals with variant color vision. Photobleaching difference absorption spectroscopy of hybrid pigments produced in cultured cells shows that the spectral sensitivity of each hybrid pigment is intermediate between the parental green and red pigment sensitivities. Amino acids encoded by exons 2, 3, 4, and 5 produce spectral shifts at the wavelength of maximal absorbance of 0 to 4, 0 to 4, 3 to 4, and 15 to 21 nanometers, respectively, the exact value depending on the identities ot amino acids elsewhere in the hybrid.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University	MERBS, SL (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.			Nathans, Jeremy/0000-0001-8106-5460				ALPERN M, 1979, J PHYSIOL-LONDON, V288, P85; ALPERN M, 1977, J PHYSIOL-LONDON, V266, P613, DOI 10.1113/jphysiol.1977.sp011785; ALPERN M, 1977, J PHYSIOL-LONDON, V266, P595, DOI 10.1113/jphysiol.1977.sp011784; ALPERN M, 1977, J PHYSIOL-LONDON, V266, P647, DOI 10.1113/jphysiol.1977.sp011786; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; CHAN T, 1992, J BIOL CHEM, V267, P9478; Dartnall H.J.A., 1983, COLOUR VISION PHYSL, P69; DEEB SS, IN PRESS AM J HUM GE; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; MERBS SL, UNPUB; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ J, 1989, NATURE, V342, P679, DOI 10.1038/342679a0; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; PIANTANIDA TP, 1973, VISION RES, V13, P2049, DOI 10.1016/0042-6989(73)90181-8; PIANTANIDA TP, 1973, VISION RES, V13, P2033, DOI 10.1016/0042-6989(73)90180-6; POKORNY J., 1979, CONGENITAL ACQUIRED; RUSHTON W A H, 1972, Journal of Physiology (Cambridge), V220, P1; RUSHTON WAH, 1973, VISION RES, V13, P2017, DOI 10.1016/0042-6989(73)90179-X; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WILLIAMS AJ, 1992, EMBO J, V11, P2039, DOI 10.1002/j.1460-2075.1992.tb05261.x; WINDERICKX J, 1992, NATURE, V356, P431, DOI 10.1038/356431a0	27	148	151	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					464	466		10.1126/science.1411542	http://dx.doi.org/10.1126/science.1411542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411542				2022-12-28	WOS:A1992JT77500035
J	KLEINERT, HD; ROSENBERG, SH; BAKER, WR; STEIN, HH; KLINGHOFER, V; BARLOW, J; SPINA, K; POLAKOWSKI, J; KOVAR, P; COHEN, J; DENISSEN, J				KLEINERT, HD; ROSENBERG, SH; BAKER, WR; STEIN, HH; KLINGHOFER, V; BARLOW, J; SPINA, K; POLAKOWSKI, J; KOVAR, P; COHEN, J; DENISSEN, J			DISCOVERY OF A PEPTIDE-BASED RENIN INHIBITOR WITH ORAL BIOAVAILABILITY AND EFFICACY	SCIENCE			English	Article							CONVERTING-ENZYME; BLOOD-PRESSURE; BIOLOGICAL-ACTIVITY; DIPEPTIDE ANALOGS; PROFILE; POTENT; HYPERTENSION; RO-42-5892; ENALKIREN; SITE	Peptidic renin inhibitors have been poorly absorbed across the intestine or rapidly eliminated by the liver and have been reported to have oral bioavailabilities of less than 2%. A peptide-based renin inhibitor, A-72517 (molecular mass of 706 daltons), was devised that has oral bioavailabilities of 8, 24, 32, and 53% in the monkey, rat, ferret, and dog, respectively. Dose-related reductions in blood pressure, plasma renin activity, and plasma angiotensin II in parallel with increased plasma drug concentrations were observed after oral administration of A-72517 to conscious, salt-depleted dogs. Thus, peptide-based molecules of sizable molecular mass can be absorbed intact into the systemic circulation of animals. These findings support the potential of peptide-based drugs for oral administration.			KLEINERT, HD (corresponding author), ABBOTT LABS, ABBOTT PK, IL 60064 USA.							ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; BLAINE EH, 1984, HYPERTENSION, V6, pI111, DOI 10.1161/01.HYP.6.2_Pt_2.I111; BOGER J, 1983, NATURE, V303, P81, DOI 10.1038/303081a0; BRUNNER HR, 1979, ANN INTERN MED, V90, P19, DOI 10.7326/0003-4819-90-1-19; BRUNNER HR, 1972, NEW ENGL J MED, V286, P441, DOI 10.1056/NEJM197203022860901; BUHLMAYER P, 1988, J MED CHEM, V31, P1839; CAMENZIND E, 1991, J CARDIOVASC PHARM, V18, P299, DOI 10.1097/00005344-199109000-00001; CAVANAUGH J, 1989, J CLIN PHARMACOL, V29, P861; CODY RJ, 1985, AM J CARDIOL, V55, pA36, DOI 10.1016/0002-9149(85)90794-5; CUMIN F, 1990, DRUG METAB DISPOS, V18, P831; DEGASPARO M, 1989, BRIT J CLIN PHARMACO, V27, P587; ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363; FISCHLI W, 1991, HYPERTENSION, V18, P22, DOI 10.1161/01.HYP.18.1.22; GLASSMAN HN, 1990, J CARDIOVASC PHARM, V16, pS76, DOI 10.1097/00005344-199016004-00016; JEUNEMAITRE X, 1989, AM J HYPERTENS, V2, P819, DOI 10.1093/ajh/2.11.819; KLEINERT H, UNPUB; Kleinert H D, 1991, Adv Pharmacol, V22, P207, DOI 10.1016/S1054-3589(08)60036-8; KLEINERT HD, 1988, FEBS LETT, V230, P38, DOI 10.1016/0014-5793(88)80637-9; KLEINERT HD, 1990, CARDIOVASC DRUG REV, V8, P203, DOI 10.1111/j.1527-3466.1990.tb00393.x; LULY Jr, 1988, J MED CHEM, V31, P2264, DOI 10.1021/jm00120a005; NEUBERG GW, 1991, AM J CARDIOL, V67, P63, DOI 10.1016/0002-9149(91)90101-P; PALS DT, 1986, HYPERTENSION, V8, P1105, DOI 10.1161/01.HYP.8.12.1105; PANEK RL, 1991, CLIN EXP HYPERTENS A, V13, P1395, DOI 10.3109/10641969109048801; PLATTNER JJ, 1988, J MED CHEM, V31, P2277, DOI 10.1021/jm00120a006; PLATTNER JJ, 1990, DRUG DISCOVERY TECHN, pCH5; ROSENBERG SH, 1989, J MED CHEM, V32, P1371, DOI 10.1021/jm00126a038; RUSH BD, 1991, INT J PHARM, V73, P231, DOI 10.1016/0378-5173(91)90415-K; SCHAFFER LW, 1990, J HYPERTENS, V8, P251; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCROOP GC, 1968, NATURE, V220, P1331, DOI 10.1038/2201331a0; SLATER EE, 1988, JAMA-J AM MED ASSOC, V260, P967, DOI 10.1001/jama.260.7.967; SZELKE M, 1982, NATURE, V299, P555, DOI 10.1038/299555a0; VERBURG KM, 1989, HYPERTENSION, V13, P262, DOI 10.1161/01.HYP.13.3.262; Waeber BNJ, 1990, HYPERTENSION PATHOPH, P2209; WEISSMAN J, 1985, J MED CHEM, V28, P997, DOI 10.1021/jm00146a005; WONG PC, 1990, J PHARMACOL EXP THER, V252, P719; WOOD JM, 1989, J CARDIOVASC PHARM, V14, P221, DOI 10.1097/00005344-198908000-00006	37	105	107	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	1992	257	5078					1940	1943		10.1126/science.1411510	http://dx.doi.org/10.1126/science.1411510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP594	1411510				2022-12-28	WOS:A1992JP59400030
J	LICHTMAN, SW; PISARSKA, K; BERMAN, ER; PESTONE, M; DOWLING, H; OFFENBACHER, E; WEISEL, H; HESHKA, S; MATTHEWS, DE; HEYMSFIELD, SB				LICHTMAN, SW; PISARSKA, K; BERMAN, ER; PESTONE, M; DOWLING, H; OFFENBACHER, E; WEISEL, H; HESHKA, S; MATTHEWS, DE; HEYMSFIELD, SB			DISCREPANCY BETWEEN SELF-REPORTED AND ACTUAL CALORIC-INTAKE AND EXERCISE IN OBESE SUBJECTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLY-LABELED-WATER; ENERGY-EXPENDITURE; BODY-WEIGHT; SMALL EATERS; HUMANS; WOMEN; VALIDATION; ADULTS; FOOD; MEN	Background and Methods. Some obese subjects repeatedly fail to lose weight even though they report restricting their caloric intake to less than 1200 kcal per day. We studied two explanations for this apparent resistance to diet - low total energy expenditure and underreporting of caloric intake - in 224 consecutive obese subjects presenting for treatment. Group 1 consisted of nine women and one man with a history of diet resistance in whom we evaluated total energy expenditure and its main thermogenic components and actual energy intake for 14 days by indirect calorimetry and analysis of body composition. Group 2, subgroups of which served as controls in the various evaluations, consisted of 67 women and 13 men with no history of diet resistance. Results. Total energy expenditure and resting metabolic rate in the subjects with diet resistance (group 1) were within 5 percent of the predicted values for body composition, and there was no significant difference between groups 1 and 2 in the thermic effects of food and exercise. Low energy expenditure was thus excluded as a mechanism of self-reported diet resistance. In contrast, the subjects in group 1 underreported their actual food intake by an average (+/-SD) of 47+/-16 percent and overreported their physical activity by 51+/-75 percent. Although the subjects in group 1 had no distinct psychopathologic characteristics, they perceived a genetic cause for their obesity, used thyroid medication at a high frequency, and described their eating behavior as relatively normal (all P<0.05 as compared with group 2). Conclusions. The failure ot some obese subjects to lose weight while eating a diet they report as low in calories is due to an energy intake substantially higher than reported and an overestimation ot physical activity, not to an abnormality in thermogenesis.	COLUMBIA UNIV COLL PHYS & SURG, ST LUKES ROOSEVELT HOSP CTR, OBES RES CTR, DEPT MED, NEW YORK, NY 10032 USA; CORNELL UNIV, MED CTR, NEW YORK HOSP, DEPT MED, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, NEW YORK HOSP, DEPT SURG, NEW YORK, NY 10021 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital			González, Adela M Gómez/D-2863-2012; Heymsfield, Steven B/N-1968-2017	Heymsfield, Steven B/0000-0003-1127-9425	NCRR NIH HHS [RR00047] Funding Source: Medline; NIDDK NIH HHS [DK-26687, P01-DK42618] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P01DK042618] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANDINI LG, 1990, AM J CLIN NUTR, V52, P421, DOI 10.1093/ajcn/52.3.421; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; CLARK D, 1992, BRIT J NUTR, V68, P31, DOI 10.1079/BJN19920064; DIEM K, 1962, DOCUMENTA GEIGY SCI, P631; Dwyer JT., 1988, MODERN NUTR HLTH DIS, V7, P887; GAESSER GA, 1975, J APPL PHYSIOL, V38, P1132, DOI 10.1152/jappl.1975.38.6.1132; GEORGE V, 1989, INT J OBESITY, V13, P43; GEORGE V, 1991, AM J CLIN NUTR, V53, P425, DOI 10.1093/ajcn/53.2.425; GOLDMAN RF, 1961, TECHNIQUES MEASURING, P79; Graham J.R., 1987, MMPI PRACTICAL GUIDE; HADIGAN CM, 1992, INT J EAT DISORDER, V12, P107, DOI 10.1002/1098-108X(199207)12:1&lt;107::AID-EAT2260120115&gt;3.0.CO;2-Y; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; KUSHNER RF, 1990, AM J CLIN NUTR, V52, P219, DOI 10.1093/ajcn/52.2.219; LUSK G, 1928, ELEMENTS SCI NUTRITI; MERTZ W, 1991, AM J CLIN NUTR, V54, P291, DOI 10.1093/ajcn/54.2.291; Newburgh LH, 1930, ANN INTERN MED, V3, P815, DOI 10.7326/0003-4819-3-8-815; PRENTICE AM, 1986, BRIT MED J, V292, P983, DOI 10.1136/bmj.292.6526.983; PRENTICE AM, 1985, LANCET, V1, P1419; PRENTICE AM, 1988, P NUTR SOC, V47, P259, DOI 10.1079/PNS19880043; PRENTICE AM, 1990, IDECG WORKING GROUP; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; RAVUSSIN E, 1989, AM J CLIN NUTR, V49, P968, DOI 10.1093/ajcn/49.5.968; ROBERTS SB, 1988, NEW ENGL J MED, V318, P461, DOI 10.1056/NEJM198802253180801; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; SCHOELLER DA, 1991, ANNU REV NUTR, V11, P355, DOI 10.1146/annurev.nu.11.070191.002035; SEGAL KR, 1985, J CLIN INVEST, V76, P1107, DOI 10.1172/JCI112065; SEGAL KR, 1990, METABOLISM, V39, P985, DOI 10.1016/0026-0495(90)90312-Z; Siri WE., 1956, ADV BIOL MED PHYS, V4, P239, DOI DOI 10.1016/B978-1-4832-3110-5.50011-X; Spitzer RL, 1990, STRUCTURED CLIN INTE; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WELLE S, 1992, AM J CLIN NUTR, V55, P14, DOI 10.1093/ajcn/55.1.14; YELLOWLEES PM, 1988, BRIT MED J, V296, P1689, DOI 10.1136/bmj.296.6638.1689; 1987, DSM3R AM PSYCH ASS; 1985, ANN INTERN MED, V103, P977	38	942	948	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	1992	327	27					1893	1898		10.1056/NEJM199212313272701	http://dx.doi.org/10.1056/NEJM199212313272701			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KE505	1454084	Bronze			2022-12-28	WOS:A1992KE50500001
J	FAWCETT, J; HOLNESS, CLL; NEEDHAM, LA; TURLEY, H; GATTER, KC; MASON, DY; SIMMONS, DL				FAWCETT, J; HOLNESS, CLL; NEEDHAM, LA; TURLEY, H; GATTER, KC; MASON, DY; SIMMONS, DL			MOLECULAR-CLONING OF ICAM-3, A 3RD LIGAND FOR LFA-1, CONSTITUTIVELY EXPRESSED ON RESTING LEUKOCYTES	NATURE			English	Article							ADHESION LIGAND; SITES; IMMUNOGLOBULIN; RECEPTOR	THE co-ordinated function of effector and accessory cells in the immune system is assisted by adhesion molecules on the cell surface that stabilize interactions between different cell types1. Leukocyte function-associated antigen 1 (LFA-1) is expressed on the surface of all white blood cells2 and is a receptor for intercellular adhesion molecules (ICAM) 1 and 2 (ref. 3) which are members of the immunoglobulin superfamily4-6. The interaction of LFA-1 with ICAMs 1 and 2 provides essential accessory adhesion signals in many immune interactions, including those between T and B lymphocytes7 and cytotoxic T cells and their targets8,9. In addition, both ICAMs are expressed at low levels on resting vascular endothelium10; ICAM-1 is strongly upregulated by cytokine stimulation and plays a key role in the arrest of leukocytes in blood vessels at sites of inflammation and injury. Recent work has indicated that resting leukocytes express a third ligand, ICAM-3, for LFA-1 (refs 11, 12). ICAM-3 is potentially the most important ligand for LFA-1 in the initiation of the immune response because the expression of ICAM-1 on resting leukocytes is low. We report the expression cloning of a complementary DNA, pICAM-3, encoding a protein constitutively expressed on all leukocytes, which binds LFA-1. ICAM-3 is closely related to ICAM-1, consists of five immunoglobulin domains, and binds LFA-1 through its two N-terminal domains.	UNIV OXFORD,INST MOLEC MED,IMPERIAL CANC RES FUND LABS,OXFORD OX3 9DU,ENGLAND; BRITISH BIOTECHNOL,OXFORD OX4 5LY,ENGLAND; JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL,OXFORD OX3 9DU,ENGLAND	Cancer Research UK; University of Oxford; University of Oxford								ALTMANN DM, 1989, NATURE, V338, P521; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; COSIMI AB, 1990, J IMMUNOL, V144, P4604; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DRANSFIELD I, 1992, J CELL BIOL, V116, P1527, DOI 10.1083/jcb.116.6.1527; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FLAVIN T, 1991, TRANSPLANT P, V23, P533; KNAPP W, 1989, LEUCOCYTE TYPING, V4; LEHMAN J, 1990, P NATL ACAD SCI USA, V86, P9891; MAKGOBA MW, 1988, EUR J IMMUNOL, V18, P637, DOI 10.1002/eji.1830180423; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MOY VT, 1992, J EXP MED, V175, P1, DOI 10.1084/jem.175.1.1; NEEDHAM L, 1991, VASCULAR ENDOTHELIUM, P61; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEED B, 1987, P NATL ACAD SCI USA, V84, P8573; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SIMMONS DL, 1991, VASCULAR ENDOTHELIUM, P1; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Uciechowski P., 1989, LEUCOCYTE TYPING, P543; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	26	324	348	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 3	1992	360	6403					481	484		10.1038/360481a0	http://dx.doi.org/10.1038/360481a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA797	1448173				2022-12-28	WOS:A1992KA79700065
J	BRANCATI, FL; WHITTLE, JC; WHELTON, PK; SEIDLER, AJ; KLAG, MJ				BRANCATI, FL; WHITTLE, JC; WHELTON, PK; SEIDLER, AJ; KLAG, MJ			THE EXCESS INCIDENCE OF DIABETIC END-STAGE RENAL-DISEASE AMONG BLACKS - A POPULATION-BASED STUDY OF POTENTIAL EXPLANATORY FACTORS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESSENTIAL-HYPERTENSION; RACIAL-DIFFERENCES; BLOOD-PRESSURE; MARYLAND; MELLITUS; FAILURE; RACE; RISK	Objective.-To investigate whether the excess incidence of diabetic end-stage renal disease (ESRD) among African Americans could be explained by racial differences in putative ESRD risk factors. Design.-Population-based, ecologic study using the 1981 and 1982 Maryland Statewide Household Hypertension Survey for data on risk factor prevalence. Participants.-A total of 2.1 million adults residing within the boundaries of the Maryland Regional ESRD Registry, grouped by race and ZIP code into 26 subpopulations. Main Outcome Measure.-Incidence rates of treatment for diabetic ESRD between 1980 and 1985 from the Maryland Regional ESRD Registry by subpopulation. Results.-Between 1980 and 1985, 442 persons entered treatment for diabetic ESRD. At the level of the subpopulation, diabetic ESRD incidence was positively associated with black race (relative risk [RR], 3.42; 95% confidence interval [Cl], 2.84 to 4.13), prevalence of diabetes (RR, 2.35; 95% Cl, 1.92 to 2.87), prevalence of poorly controlled hypertension (RR, 1.80; 95% Cl, 1.45 to 1.86), lack of a regular source of health care (RR, 1.82; 95% Cl, 1.62 to 2.05), and lower socioeconomic status as indicated by lack of college education (RR, 1.41; 95% Cl, 1.32 to 1.52) (all, P<.0001). After adjusting for these risk factors, black race remained strongly associated with the overall incidence of diabetic ESRD (RR, 2.70; 95% Cl, 1.89 to 3.86; P<.0001). Further analyses suggested that this excess risk among blacks was confined to ESRD related to non-insulin-dependent diabetes (RR, 4.80; 95% Cl, 3.09 to 7.46; P<.0001); blacks were at no higher risk than were whites for ESRD related to insulin-dependent diabetes (RR, 0.90; 95% Cl, 0.52 to 1.55; P=.70). Conclusions.-These data suggest that the excess incidence of diabetic ESRD among blacks is not fully explained by a higher prevalence of diabetes or hypertension in blacks or by racial differences in age, socioeconomic status, or access to health care. Instead, they suggest an increased susceptibility to ESRD resulting from non-insulin-dependent diabetes among blacks as compared with whites.			BRANCATI, FL (corresponding author), JOHNS HOPKINS MED INST,WELCH CTR PREVENT EPIDEMIOL & CLIN RES,CARNEGIE 2,600 N WOLFE ST,BALTIMORE,MD 21287, USA.			Whittle, Jeff/0000-0002-9544-838X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722, M01RR000035] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01RR00722, 5M01RR00035] Funding Source: Medline; NHLBI NIH HHS [HL07180] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON RM, 1991, DIABETES CARE, V14, P605, DOI 10.2337/diacare.14.7.605; APOSTOLIDES AY, 1980, P SECTION SURVEY RES, V1, P692; BRESLOW NE, 1989, DESIGN ANAL COHORT S, V2, P119; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; DRIZD T, 1986, VITAL HLTH STAT, V234, P10; EBERHARDT MS, 1990, DIABETES S1, V39, pA205; ENTWISLE G, 1983, PREV MED, V12, P695, DOI 10.1016/0091-7435(83)90227-X; FERGUSON R, 1988, J CLIN EPIDEMIOL, V41, P1189, DOI 10.1016/0895-4356(88)90023-6; FROHLICH ED, 1984, MINER ELECTROL METAB, V10, P173; GOLD CH, 1982, S AFR MED J, V61, P263; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; HARRIS MI, 1985, NIH851468 PUBL, P1; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; JAMEEL N, 1990, DIABETES S1, V39, pA39; KAPPEL DF, 1986, AM J KIDNEY DIS, V8, P234, DOI 10.1016/S0272-6386(86)80031-2; LEBOVITZ HE, 1990, DIABETES CARE, V13, P1186, DOI 10.2337/diacare.13.11.1186; LEVY SB, 1978, ANN INTERN MED, V88, P12, DOI 10.7326/0003-4819-88-1-12; LILIENFELD AM, 1980, F EPIDEMIOLOGY, P290; MOORE RD, 1990, AM J HYPERTENS, V3, P1; Rettig BS, 1984, DIABETIC NEPHROPATHY, V3, P26; ROSEMAN JM, 1985, NIH851468 US DEP HLT, P1; STATIUS LW, 1988, DISEASES KIDNEY, P2561; STEWART JH, 1975, BMJ-BRIT MED J, V1, P440, DOI 10.1136/bmj.1.5955.440; TIERNEY WM, 1989, AM J KIDNEY DIS, V13, P485, DOI 10.1016/S0272-6386(89)80006-X; WARREN SE, 1980, AM J MED, V69, P425, DOI 10.1016/0002-9343(80)90015-7; WEST KM, 1978, EPIDEMIOLOGY DIABETE, P289; WHELTON PK, 1989, HYPERTENSION S1, V13, P19, DOI DOI 10.1161/HYPERTENSIONAHA.113.02250; WHITTLE JC, 1991, ARCH INTERN MED, V151, P1359, DOI 10.1001/archinte.151.7.1359; 1989, USRDS1989 NIH NAT I; 1984, ZIP CODE PROFILE RAC	30	187	187	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	1992	268	21					3079	3084		10.1001/jama.268.21.3079	http://dx.doi.org/10.1001/jama.268.21.3079			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KA002	1433738				2022-12-28	WOS:A1992KA00200030
J	NAYLOR, CD; CHEN, E; STRAUSS, B				NAYLOR, CD; CHEN, E; STRAUSS, B			MEASURED ENTHUSIASM - DOES THE METHOD OF REPORTING TRIAL RESULTS ALTER PERCEPTIONS OF THERAPEUTIC EFFECTIVENESS	ANNALS OF INTERNAL MEDICINE			English	Article						QUESTIONNAIRES; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); CLINICAL TRIALS	CORONARY HEART-DISEASE; RISK FACTOR INTERVENTION; CLINICAL-TRIALS; DECISIONS; MORTALITY	Objective: To compare clinicians' ratings of therapeutic effectiveness when different trial end points were presented as percent reductions in relative compared with absolute risk and as numbers of patients treated to avoid one adverse outcome. Design: Survey, with random allocation of two questionnaires. Setting: Toronto teaching hospitals. Respondents: Convenience sample of 100 faculty and housestaff in internal medicine and family medicine. Intervention: One questionnaire presented results for three end points of the Helsinki Heart Study as separate drug trials using only absolute differences in events; the other showed the same end points as relative differences. Both questionnaires included a fourth "trial," showing person-years of treatment needed to prevent one myocardial infarction. Main Outcome Measure: The "trials" were each rated on an 11-point scale, from treatment "harmful" to "very effective." Results: Respondents' ratings of effectiveness varied with the end point. Controlling for end point, ratings of effectiveness by the 50 participants receiving absolute event data were lower than those by 50 participants responding to relative risk reductions (P < 0.001); however, no end-point difference was more than 0.6 scale points. For a "trial" reporting that 77 persons were treated for 5 years to prevent one myocardial infarction, mean ratings were 2.3 or 1.8 scale points lower, respectively (both P < 0.001), than when the same data were shown as relative or absolute risk reductions. Conclusions: Clinicians' views of drug therapies are affected by the common use of relative risk reductions in both trial reports and advertisements, by end-point emphasis, and, above all, by underuse of summary measures that relate treatment burden to therapeutic yields in a clinically relevant manner.	SUNNYBROOK HLTH SCI CTR, N YORK, ONTARIO, CANADA; INST CLIN EVALUAT SCI, N YORK, ONTARIO, CANADA; UNIV TORONTO, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto								BASINSKI A, 1989, JAMA-J AM MED ASSOC, V261, P2953, DOI 10.1001/jama.1989.03420200042020; BRETT AS, 1989, NEW ENGL J MED, V321, P676, DOI 10.1056/NEJM198909073211009; BRETT AS, 1984, AM J MED, V76, P557, DOI 10.1016/0002-9343(84)90272-9; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; FORROW L, 1988, JAMA-J AM MED ASSOC, V259, P3161, DOI 10.1001/jama.259.21.3161; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; HOLME I, 1990, CIRCULATION, V82, P1916, DOI 10.1161/01.CIR.82.6.1916; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LAUPACIS A, 1992, ANN INTERN MED S3, V116; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; MCCORMICK JS, 1988, NEW ENGL J MED, V318, P1274; MOORE N, 1988, NEW ENGL J MED, V318, P1275; MULDOON MF, 1990, BMJ-BRIT MED J, V301, P309, DOI 10.1136/bmj.301.6747.309; NAYLOR CD, 1990, J CLIN EPIDEMIOL, V43, P607; NAYLOR CD, 1992, CHOLESTEROL CORONARY, P401; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; SIMON R, 1986, ANN INTERN MED, V105, P429, DOI 10.7326/0003-4819-105-3-429; SLOVIC P, 1982, JUDGEMENT UNCERTAINT, P478; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	21	302	304	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1992	117	11					916	921		10.7326/0003-4819-117-11-916	http://dx.doi.org/10.7326/0003-4819-117-11-916			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ276	1443954				2022-12-28	WOS:A1992JZ27600008
J	GREEN, JBA; NEW, HV; SMITH, JC				GREEN, JBA; NEW, HV; SMITH, JC			RESPONSES OF EMBRYONIC XENOPUS CELLS TO ACTIVIN AND FGF ARE SEPARATED BY MULTIPLE DOSE THRESHOLDS AND CORRESPOND TO DISTINCT AXES OF THE MESODERM	CELL			English	Article							FIBROBLAST GROWTH-FACTOR; AMPHIBIAN DEVELOPMENT; NEURAL INDUCTION; HOMEOBOX GENES; RETINOIC ACID; BODY PATTERN; LAEVIS; EXPRESSION; ORGANIZER; HOMOLOG	The potent mesoderm-inducing factors activin and FGF are present as maternally synthesized proteins in embryos of X. laevis. We show that activin can act on explanted blastomeres to induce at least five different cell states ranging from posterolateral mesoderm to dorsoanterior organizer mesoderm. Each state is induced in a narrow dose range bounded by sharp thresholds. By contrast, FGF induces only posterolateral markers and does so over relatively broad dose ranges. FGF can modulate the actions of activin, potentiating them and broadening the threshold-bounded dose windows. Our results indicate that orthogonal gradients of activin and FGF would be sufficient to specify the main elements of the body plan.			GREEN, JBA (corresponding author), NATL INST MED RES, OPHTHALMOL LAB, RIDGEWAY, MILL HILL, LONDON NW7 1AA, ENGLAND.		Green, Jeremy/F-3630-2010	Green, Jeremy/0000-0002-6102-2620; Smith, Jim/0000-0003-2413-9392				ALBANO RM, 1990, DEVELOPMENT, V110, P435; ALTABA AR, 1989, NATURE, V341, P33; ALTABA ARI, 1991, GENE DEV, V5, P175, DOI 10.1101/gad.5.2.175; ALTABA ARI, 1991, DEV GROWTH DIFFER, V33, P651; ALTABA ARI, 1989, DEVELOPMENT, V106, P173; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; ASASHIMA M, 1991, P NATL ACAD SCI USA, V88, P6511, DOI 10.1073/pnas.88.15.6511; BLUMBERG B, 1991, SCIENCE, V253, P194, DOI 10.1126/science.1677215; BOLCE ME, 1992, DEVELOPMENT, V115, P681; BOTERENBROOD EC, 1973, ROUX ARCH DEV BIOL, V173, P319, DOI 10.1007/BF00575837; CHAKRABARTI A, 1992, DEVELOPMENT, V115, P355; CHO KWY, 1990, GENE DEV, V4, P1910, DOI 10.1101/gad.4.11.1910; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; COOKE J, 1989, DEVELOPMENT, V107, P229; COOKE J, 1987, DEVELOPMENT, V101, P893; COOKE J, 1981, NATURE, V290, P775, DOI 10.1038/290775a0; COOKE J, 1985, J EMBRYOL EXP MORPH, V88, P85; Dalcq A., 1937, Archives de Biologie Liege, V48, P669; DALE L, 1985, J EMBRYOL EXP MORPH, V89, P289; DALE L, 1987, DEVELOPMENT, V100, P279; DALE L, 1992, DEVELOPMENT, V115, P573; DAWID IB, 1990, CURR TOP DEV BIOL, V24, P31; DIRKSEN ML, 1992, GENE DEV, V6, P599, DOI 10.1101/gad.6.4.599; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FRITZ A, 1988, NUCLEIC ACIDS RES, V16, P1453, DOI 10.1093/nar/16.4.1453; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GREEN JBA, 1990, DEVELOPMENT, V108, P173; GREEN JBA, 1991, TRENDS GENET, V7, P245, DOI 10.1016/0168-9525(91)90323-I; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; GURDON JB, 1984, CELL, V38, P691, DOI 10.1016/0092-8674(84)90264-2; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HAUSEN P, 1981, STAIN TECHNOL, V56, P287, DOI 10.3109/10520298109067329; JONAS EA, 1989, DEVELOPMENT, V106, P399; JONES CM, 1992, DEVELOPMENT, V115, P639; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KIMELMAN D, 1988, SCIENCE, V242, P1053, DOI 10.1126/science.3194757; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; KOSTER M, 1991, MECH DEVELOP, V33, P191, DOI 10.1016/0925-4773(91)90027-4; MOHUN T, 1988, J MOL BIOL, V202, P67, DOI 10.1016/0022-2836(88)90519-0; NIEUWKOOP P D, 1969, Wilhelm Roux' Archiv fuer Entwicklungsmechanik der Organismen, V162, P341, DOI 10.1007/BF00578701; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NUSSLEINVOLHARD C, 1989, CIBA F SYMP, V144, P37; ROSA FM, 1989, CELL, V57, P965, DOI 10.1016/0092-8674(89)90335-8; SAHA MS, 1992, NEURON, V8, P1003, DOI 10.1016/0896-6273(92)90123-U; SHIURBA RA, 1991, DEVELOPMENT, V113, P487; SLACK JMW, 1989, DEVELOPMENT, V105, P147; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SMITH JC, 1985, DIFFERENTIATION, V29, P109, DOI 10.1111/j.1432-0436.1985.tb00302.x; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SMITH JC, 1989, DEVELOPMENT, V105, P665; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; SOKOL S, 1991, NATURE, V351, P409, DOI 10.1038/351409a0; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; VIZE PD, 1991, METHOD CELL BIOL, V36, P367; WHITMAN M, 1989, ANNU REV CELL BIOL, V5, P93; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; WRIGHT CVE, 1990, DEVELOPMENT, V109, P225	64	442	449	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	1992	71	5					731	739		10.1016/0092-8674(92)90550-V	http://dx.doi.org/10.1016/0092-8674(92)90550-V			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JZ633	1423628				2022-12-28	WOS:A1992JZ63300004
J	SAITZ, R; FRIEDMANN, PD; ROBERTS, MS				SAITZ, R; FRIEDMANN, PD; ROBERTS, MS			CONTINUED ZIDOVUDINE OR DIDANOSINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											SAITZ, R (corresponding author), NEW ENGLAND DEACONESS HOSP,BOSTON,MA 02215, USA.			/0000-0002-2535-1427					0	0	0	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	1992	327	22					1598	1598						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ432	1435891				2022-12-28	WOS:A1992JZ43200017
J	KIDD, S				KIDD, S			CHARACTERIZATION OF THE DROSOPHILA CACTUS LOCUS AND ANALYSIS OF INTERACTIONS BETWEEN CACTUS AND DORSAL PROTEINS	CELL			English	Article							NF-KAPPA-B; DNA-BINDING SUBUNIT; TOLL GENE-PRODUCT; DORSOVENTRAL PATTERN; EMBRYONIC POLARITY; VENTRAL POLARITY; MESSENGER-RNA; NOTCH LOCUS; SEQUENCE; TRANSCRIPTION	An oligonucleotide based on the cdc10/SWI6 repeats of the Drosophila Notch protein was used to isolate other Drosophila genes with these repeats. One of these genes is the cactus locus, 1 of 11 genes required maternally for the establishment in embryos of a gradient of nuclear localization of dorsal protein, a rel-like transcription factor. Previous work showed that in cactus mutants more dorsal protein enters the nucleus in dorsal regions, resulting in a ventralized phenotype. It is now shown that the cactus locus produces two proteins that differ at their carboxy termini; both contain six cdc10/SWI6 repeats that are sufficient for binding to dorsal and for inhibiting the ability of dorsal to bind DNA. The site on dorsal to which cactus binds was localized to the rel homology domain, where it overlaps with, or is adjacent to, the nuclear localization signal. In vivo the bulk of the cactus protein associated with dorsal is phosphorylated. This, or the association with dorsal, appears to stabilize the maternal cactus protein.			KIDD, S (corresponding author), ROCKEFELLER UNIV,GENET LAB,NEW YORK,NY 10021, USA.				NIGMS NIH HHS [GM25103] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025103] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKUSJARVI G, 1979, CELL, V16, P841, DOI 10.1016/0092-8674(79)90099-0; ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; DAVIS LH, 1990, J BIOL CHEM, V265, P10589; DAVIS N, 1991, SCIENCE, V253, P1268, DOI 10.1126/science.1891714; GEISLER R, 1992, CELL, V71; GERTTULA S, 1988, GENETICS, V119, P123; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; GOVIND S, 1991, TRENDS GENET, V7, P119, DOI 10.1016/0168-9525(91)90456-Z; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; INOUE JI, 1992, P NATL ACAD SCI USA, V89, P4333, DOI 10.1073/pnas.89.10.4333; IP YT, 1991, CELL, V64, P439; ISODA K, 1992, GENE DEV, V6, P619, DOI 10.1101/gad.6.4.619; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KIDD S, 1983, CELL, V34, P421, DOI 10.1016/0092-8674(83)90376-8; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETSOU A, 1991, P NATL ACAD SCI USA, V88, P810, DOI 10.1073/pnas.88.3.810; LIEBER T, 1992, IN PRESS NEURON, V9; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; NORRIS JL, 1992, GENE DEV, V6, P1657; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; ROTH S, 1991, DEVELOPMENT, V112, P371; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; RUSHLOW CA, 1990, CELL BIOL, V1, P173; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHEEN JY, 1988, BIOTECHNIQUES, V6, P942; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STEWARD R, 1984, NATURE, V311, P262, DOI 10.1038/311262a0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; THISSE C, 1991, CELL, V65, P1191, DOI 10.1016/0092-8674(91)90014-P; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; WULCZYN GF, 1992, NATURE, V358, P597; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	59	220	223	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 13	1992	71	4					623	635		10.1016/0092-8674(92)90596-5	http://dx.doi.org/10.1016/0092-8674(92)90596-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JY676	1423619				2022-12-28	WOS:A1992JY67600010
J	MCGARRY, JD				MCGARRY, JD			WHAT IF MINKOWSKI HAD BEEN AGEUSIC - AN ALTERNATIVE ANGLE ON DIABETES	SCIENCE			English	Article							FREE FATTY-ACID; HEPATIC GLUCOSE-PRODUCTION; CARNITINE PALMITOYLTRANSFERASE; PLASMA-GLUCOSE; INSULIN; MELLITUS; MECHANISMS; RESISTANCE; INHIBITION; OXIDATION	Despite decades of intensive investigation, the basic pathophysiological mechanisms responsible for the metabolic derangements associated with diabetes mellitus have remained elusive. Explored here is the possibility that traditional concepts in this area might have carried the wrong emphasis. It is suggested that the phenomena of insulin resistance and hyperglycemia might be more readily understood if viewed in the context of underlying abnormalities of lipid metabolism.	UNIV TEXAS, SW MED CTR, CTR DIABET RES, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA	Diabetes & Endocrine Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	MCGARRY, JD (corresponding author), UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA.				NIDDK NIH HHS [DK11313, DK18573] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018573, R01DK011313, R37DK018573] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAILEY CJ, 1990, NEW ANTIDIABETIC DRU, P231; BALASSE EO, 1973, METABOLISM, V22, P1193, DOI 10.1016/0026-0495(73)90207-2; BALASSE EO, 1974, EUR J CLIN INVEST, V4, P247, DOI 10.1111/j.1365-2362.1974.tb02342.x; CHEN YDI, 1987, J CLIN ENDOCR METAB, V64, P17, DOI 10.1210/jcem-64-1-17; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; FALHOLT K, 1988, DIABETIC MED, V5, P27, DOI 10.1111/j.1464-5491.1988.tb00936.x; MARBAN SL, 1992, DIABETES, V41, pA145; MCGARRY D, 1979, DIABETES, V28, P517; MCGARRY JD, 1973, J CLIN INVEST, V52, P877, DOI 10.1172/JCI107252; MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; PONTIROLI AE, 1992, DIABETOLOGIA, V35, P294, DOI 10.1007/BF00400934; RANDLE PJ, 1988, DIABETES METAB REV, V4, P623, DOI 10.1002/dmr.5610040702; RATHEISER K, 1991, METABOLISM, V40, P1185, DOI 10.1016/0026-0495(91)90214-H; REAVEN GM, 1988, DIABETES, V37, P28, DOI 10.2337/diabetes.37.1.28; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; SALORANTA C, 1991, DIABETOLOGIA, V34, P409, DOI 10.1007/BF00403179; SCHUMACHER MC, 1992, DIABETES, V41, P416, DOI 10.2337/diabetes.41.4.416; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; UNGER RH, 1983, HDB EXPT PHARM, V2, P431; VAAG A, 1992, J CLIN INVEST, V89, P782, DOI 10.1172/JCI115656; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; WITITSUWANNAKUL D, 1977, J BIOL CHEM, V252, P7812; WOLF HPO, 1990, NEW ANTIDIABETIC DRU, P217; YOUNG AA, 1991, FEBS LETT, V287, P203, DOI 10.1016/0014-5793(91)80051-4; ZARJEVSKI N, 1992, ENDOCRINOLOGY, V130, P1564, DOI 10.1210/en.130.3.1564	27	545	558	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	1992	258	5083					766	770		10.1126/science.1439783	http://dx.doi.org/10.1126/science.1439783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV692	1439783				2022-12-28	WOS:A1992JV69200026
J	NOTTEBOHM, E; DAMBLYCHAUDIERE, C; GHYSEN, A				NOTTEBOHM, E; DAMBLYCHAUDIERE, C; GHYSEN, A			CONNECTIVITY OF CHEMOSENSORY NEURONS IS CONTROLLED BY THE GENE POXN IN DROSOPHILA	NATURE			English	Article							CENTRAL NERVOUS-SYSTEM; SENSORY NEURONS; TRANSFORMATION; MELANOGASTER; PROJECTIONS; CUT	THE function of the nervous system depends on the formation of a net of appropriate connections, but little is known of the genetic program underlying this process. In Drosophila two genes that specify different types of sense organs have been identified: cut (ct)1,2, which specifies the formation of external sense organs as opposed to chordotonal organs, and pox-neuro (poxn)3, which specifies the formation of poly-innervated (chemosensory) organs as opposed to mono-innervated (mechanosensory) organs. Whether these genes are also involved in specifying the connectivity of the corresponding neurons is not known. The larval sense organs are unsuitable for analysis of the axonal pathway and connections and so we have investigated the effect of poxn on the adult. Here we show that overexpression of poxn induces the morphological transformation of mechanosensory into chemosensory bristles on the legs and that the neurons innervating the morphologically transformed bristles follow pathways and establish connections that are appropriate for chemosensory bristles.			NOTTEBOHM, E (corresponding author), UNIV LIBRE BRUXELLES,NEUROBIOL & GENET LAB,67 RUE CHEVAUX,B-1640 RHODE ST GENESE,BELGIUM.							BATE CM, 1976, HDB SENSORY PHYSL, V11; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DETHIER VG, 1965, PHYSL INSECT SENSES, P126; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; GHYSEN A, 1978, NATURE, V274, P869, DOI 10.1038/274869a0; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HELD LI, 1990, ROUX ARCH DEV BIOL, V199, P31, DOI 10.1007/BF01681531; MURPHEY RK, 1989, J NEUROSCI, V9, P3209; TEUGELS E, 1983, PROG BRAIN RES, V58, P305, DOI 10.1016/S0079-6123(08)60032-1; TOBLER H, 1973, EXPERIENTIA, V29, P170; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594	13	50	50	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 29	1992	359	6398					829	832		10.1038/359829a0	http://dx.doi.org/10.1038/359829a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JV777	1436059				2022-12-28	WOS:A1992JV77700064
J	BROWN, MS; GOLDSTEIN, JL				BROWN, MS; GOLDSTEIN, JL			KOCHS POSTULATES FOR CHOLESTEROL	CELL			English	Review							OVEREXPRESSION; MICE; LDL				BROWN, MS (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.							Anitschkow N, 1967, COWDRYS ARTERIOSCLER, P21; BROWN MS, 1991, CURR OPIN LIPIDOL, V2, P65; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; HERZ J, 1992, IN PRESS CELL, V71; HOFMANN SL, 1988, SCIENCE, V239, P1277, DOI 10.1126/science.3344433; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Roberts JC, 1965, COMP ATHEROSCLEROSIS; SHIMANO H, 1992, P NATL ACAD SCI USA, V89, P1750, DOI 10.1073/pnas.89.5.1750; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210; ZHANG SH, 1992, SCIENCE, V258; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	15	62	63	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 16	1992	71	2					187	188		10.1016/0092-8674(92)90346-E	http://dx.doi.org/10.1016/0092-8674(92)90346-E			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JU395	1423585				2022-12-28	WOS:A1992JU39500003
J	CURTSINGER, JW; FUKUI, HH; TOWNSEND, DR; VAUPEL, JW				CURTSINGER, JW; FUKUI, HH; TOWNSEND, DR; VAUPEL, JW			DEMOGRAPHY OF GENOTYPES - FAILURE OF THE LIMITED LIFE-SPAN PARADIGM IN DROSOPHILA-MELANOGASTER	SCIENCE			English	Article							MORTALITY; DYNAMICS; HETEROGENEITY; COMPRESSION; LONGEVITY; SELECTION	Experimental systems that are amenable to genetic manipulation can be used to address fundamental questions about genetic and nongenetic determinants of longevity. Analysis of large cohorts of ten genotypes of Drosophila melanogaster raised under conditions that favored extended survival has revealed variation between genotypes in both the slope and location of age-specific mortality curves. More detailed examination of a single genotype showed that the mortality trajectory was best fit by a two-stage Gompertz model, with no age-specific increase in mortality rates beyond 30 days after emergence. These results are contrary to the limited life-span paradigm, which postulates well-defined, genotype-specific limits on life-span and brief periods of intense and rapidly accelerating mortality rates at the oldest ages.	ODENSE UNIV,SCH MED,DK-5230 ODENSE,DENMARK; DUKE UNIV,CTR DEMOG STUDIES,DURHAM,NC 27706	University of Southern Denmark; Duke University	CURTSINGER, JW (corresponding author), UNIV MINNESOTA,DEPT ECOL EVOLUT & BEHAV,MINNEAPOLIS,MN 55455, USA.			Vaupel, James/0000-0003-0783-3905	NIA NIH HHS [P01 AG08761] Funding Source: Medline; NICHD NIH HHS [KO4 HD 00638] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG008761] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; CRAPO LM, 1981, VITALITY AGING IMPLI; Economos A.C., 1982, ARCH GERONTOL GERIAT, V1, P3, DOI [10.1016/0167-4943(82)90003-6, DOI 10.1016/0167-4943(82)90003-6]; ECONOMOS AC, 1979, AGE, V2, P74, DOI 10.1007/BF02432250; ECONOMOS AC, 1987, ARCH GERONTOL GERIAT, V1, P3; Falconer D. S., 1981, INTRO QUANTITATIVE G; Finch CE, 1990, LONGEVITY SENESCENCE; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; FRIES JF, 1987, GERONTOL PERSPECTA, V1, P54; FRIES JF, 1987, GERONTOLOGICA PERSPE, V1, P5; Gavrilov L.A., 1991, BIOL LIFE SPAN QUANT; GURALNICK M, 1987, GERONTOL PERSPECT, V1, P65; LUCKINBILL LS, 1985, HEREDITY, V55, P9, DOI 10.1038/hdy.1985.66; LUCKINBILL LS, 1986, HEREDITY, V56, P329, DOI 10.1038/hdy.1986.54; Manton K. G., 1987, GERONTOL PERSPECTA, V1, P23; MYERS GC, 1984, GERONTOLOGIST, V24, P346, DOI 10.1093/geront/24.4.346; PARSONS PA, 1977, EXP GERONTOL, V12, P241, DOI 10.1016/0531-5565(77)90012-2; RAMLAUHANSEN H, 1983, ANN STAT, V11, P453, DOI 10.1214/aos/1176346152; RAMLAUHANSEN H, 1983, SCAND ACTUAR J, V66, P165; ROSE M. R., 1991, EVOLUTIONARY BIOL AG; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; VAUPEL JW, 1985, SOCIOLOGICAL METHODO; WITTEN M, 1988, MECH AGEING DEV, V46, P175, DOI 10.1016/0047-6374(88)90124-8	24	322	328	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					461	463		10.1126/science.1411541	http://dx.doi.org/10.1126/science.1411541			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411541				2022-12-28	WOS:A1992JT77500034
J	JENKINS, TM; SAXENA, JK; KUMAR, A; WILSON, SH; ACKERMAN, EJ				JENKINS, TM; SAXENA, JK; KUMAR, A; WILSON, SH; ACKERMAN, EJ			DNA POLYMERASE-BETA AND DNA-SYNTHESIS IN XENOPUS OOCYTES AND IN A NUCLEAR EXTRACT	SCIENCE			English	Article							TEMPLATE BINDING DOMAIN; SINGLE-STRANDED-DNA; REPAIR SYNTHESIS; HUMAN-CELLS; ALPHA; REPLICATION; LAEVIS; DELTA; EGGS; IDENTIFICATION	The identities of the DNA polymerases required for conversion of single-strand (ss) M13 DNA to double-strand (ds) M13 DNA were examined both in injected Xenopus laevis oocytes and in an oocyte nuclear extract. Inhibitors and antibodies specific to DNA polymerases alpha and beta were used. In nuclear extracts, inhibition by the antibody to polymerase beta could be reversed by purified polymerase beta. The polymerase beta inhibitors, dideoxythymidine triphosphate (ddTTP) and dideoxycytidine triphosphate (ddCTP), also blocked DNA synthesis and indicated that polymerase beta is invoLved in the conversion of ssDNA to dsDNA. These results also may have particular significance for emerging evidence of an ssDNA replication mode in eukaryotic cells.	NIDDKD,GENET & BIOCHEM BRANCH,BETHESDA,MD 20892; NCI,BIOCHEM LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293				BJURSELL G, 1979, NATURE, V280, P420, DOI 10.1038/280420a0; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUZIO LO, 1981, MOL APPROACHES GENE, P149; Colman A., 1984, TRANSCRIPTION TRANSL, P49; CORTESE R, 1980, P NATL ACAD SCI-BIOL, V77, P4147, DOI 10.1073/pnas.77.7.4147; COX LS, 1990, J CELL SCI, V97, P177; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; FORD CC, 1975, DEV BIOL, V43, P189, DOI 10.1016/0012-1606(75)90140-2; FRY M, 1986, ANIMAL CELL DNA POLY, P103; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; HAMMOND RA, 1990, BIOCHEMISTRY-US, V29, P286, DOI 10.1021/bi00453a039; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; JENKINS TC, UNPUB; JOENJE H, 1978, J BIOL CHEM, V253, P2640; KAISERMAN HB, 1990, EUKARYOTIC NUCLEUS M, V2, P783; KUMAR A, 1990, J BIOL CHEM, V265, P2124; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGERSKI RJ, 1987, MOL CELL BIOL, V7, P4317, DOI 10.1128/MCB.7.12.4317; LINN S, 1991, CELL, V66, P185, DOI 10.1016/0092-8674(91)90608-2; LINSKENS MHK, 1990, CELL, V62, P845, DOI 10.1016/0092-8674(90)90258-G; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; NELSON EM, 1983, DEV BIOL, V96, P11, DOI 10.1016/0012-1606(83)90306-8; SAXENA JK, 1990, NUCLEIC ACIDS RES, V18, P7425, DOI 10.1093/nar/18.24.7425; SWACK JA, 1985, ANAL BIOCHEM, V147, P10, DOI 10.1016/0003-2697(85)90003-X; SWEASY JB, 1992, J BIOL CHEM, V267, P1407; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERVLIET PC, 1990, EUKARYOTIC NUCLEUS, V1, P1; VARLET I, 1990, P NATL ACAD SCI USA, V87, P7883, DOI 10.1073/pnas.87.20.7883; WANG TSF, 1990, EUKARYOTIC NUCLEUS M, V1, P147; WEISER T, 1991, J BIOL CHEM, V266, P10420; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; Wilson SH, 1990, EUKARYOTIC NUCLEUS, V1, P199; WIST E, 1979, BIOCHIM BIOPHYS ACTA, V562, P62, DOI 10.1016/0005-2787(79)90126-6	39	52	53	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 16	1992	258	5081					475	478		10.1126/science.1411545	http://dx.doi.org/10.1126/science.1411545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411545				2022-12-28	WOS:A1992JT77500039
J	KUO, CF; MCREE, DE; FISHER, CL; OHANDLEY, SF; CUNNINGHAM, RP; TAINER, JA				KUO, CF; MCREE, DE; FISHER, CL; OHANDLEY, SF; CUNNINGHAM, RP; TAINER, JA			ATOMIC-STRUCTURE OF THE DNA-REPAIR [4FE-4S] ENZYME ENDONUCLEASE-III	SCIENCE			English	Article							ALDEHYDIC ABASIC SITES; ESCHERICHIA-COLI; MACROMOLECULAR CRYSTALLOGRAPHY; ELECTROSTATIC POTENTIALS; CRYSTAL-STRUCTURE; OXIDATIVE DAMAGE; APURINIC SITES; PROTEIN; BINDING; RESOLUTION	The crystal structure of the DNA repair enzyme endonuclease III, which recognizes and cleaves DNA at damaged bases, has been solved to 2.0 angstrom resolution with an R factor of 0.185. This iron-sulfur [4Fe-4S] enzyme is elongated and bilobal with a deep cleft separating two similarly sized domains: a novel, sequence-continuous, six-helix domain (residues 22 to 132) and a Greek-key, four-helix domain formed by the amino-terminal and three carboxyl-terminal helices (residues 1 to 21 and 133 to 211) together with the [4Fe-4S] cluster. The cluster is bound entirely within the carboxyl-terminal loop with a ligation pattern (Cys-X6-Cys-X2-Cys-X5-Cys) distinct from all other known [4Fe-4S] proteins. Sequence conservation and the positive electrostatic potential of conserved regions identify a surface suitable for binding duplex B-DNA across the long axis of the enzyme, matching a 46 angstrom length of protected DNA. The primary role of the [4Fe-4S] cluster appears to involve positioning conserved basic residues for interaction with the DNA phosphate backbone. The crystallographically identified inhibitor binding region, which recognizes the damaged base thymine glycol, is a seven-residue beta-hairpin (residues 113 to 119). Location and side chain orientation at the base of the inhibitor binding site implicate Glu112 in the N-glycosylase mechanism and Lys120 in the beta-elimination mechanism. Overall, the structure reveals an unusual fold and a new biological function for [4Fe-4S]clusters and provides a structural basis for studying recognition of damaged DNA and the N-glycosylase and apurinic/apyrimidinic-lyase mechanisms.	SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA; SUNY ALBANY, DEPT BIOL SCI, CTR BIOCHEM & BIOPHYS, ALBANY, NY 12222 USA	Scripps Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany			Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; O'Handley, Suzanne/0000-0001-8373-0065	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046312] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07695] Funding Source: Medline; NIGMS NIH HHS [GM 46312] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706; AHERN H, 1991, ASM NEWS, V57, P627; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; [Anonymous], 1985, DNA REPAIR; ASAHARA H, 1989, BIOCHEMISTRY-US, V28, P4444, DOI 10.1021/bi00436a048; AUGUSTINE ML, 1991, BIOCHEMISTRY-US, V30, P8052, DOI 10.1021/bi00246a025; BAILLY V, 1987, BIOCHEM J, V242, P565, DOI 10.1042/bj2420565; BEHMOARAS T, 1981, NATURE, V292, P858, DOI 10.1038/292858a0; BEINERT H, 1990, FASEB J, V4, P2483, DOI 10.1096/fasebj.4.8.2185975; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BICKELHAUPT FM, 1990, INORG CHEM, V29, P350, DOI 10.1021/ic00327a039; BOERRIGTER PM, 1988, INT J QUANTUM CHEM, V33, P87, DOI 10.1002/qua.560330204; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CAMMACK R, 1991, ADV INORG CHEM, V38, P1; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Chen J., UNPUB; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; CHURCHILL MEA, 1991, TRENDS BIOCHEM SCI, V16, P92, DOI 10.1016/0968-0004(91)90040-3; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; DAVIS ME, 1990, CHEM REV, V90, P509, DOI 10.1021/cr00101a005; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; DOETSCH PW, 1987, MOL CELL BIOL, V7, P26, DOI 10.1128/MCB.7.1.26; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; FU WG, 1992, J BIOL CHEM, V267, P16135; GOSSETT J, 1988, BIOCHEMISTRY-US, V27, P2629, DOI 10.1021/bi00407a054; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HEIZMANN CW, 1991, TRENDS BIOCHEM SCI, V16, P98, DOI 10.1016/0968-0004(91)90041-S; HELLAND DE, 1986, MOL CELL BIOL, V6, P1983, DOI 10.1128/MCB.6.6.1983; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JORGENSEN TJ, 1987, BIOCHEMISTRY-US, V26, P6436, DOI 10.1021/bi00394a021; KALNIK MW, 1989, BIOCHEMISTRY-US, V28, P3373, DOI 10.1021/bi00434a037; KATCHER HL, 1983, BIOCHEMISTRY-US, V22, P4071, DOI 10.1021/bi00286a013; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KUO CF, 1992, J MOL BIOL, V227, P347, DOI 10.1016/0022-2836(92)90703-M; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; LINDAHL T, 1990, MUTAT RES, V238, P305, DOI 10.1016/0165-1110(90)90022-4; MANNING GS, 1983, BIOPOLYMERS, V22, P689, DOI 10.1002/bip.360220211; MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MICHAELS ML, 1990, NUCLEIC ACIDS RES, V18, P3841, DOI 10.1093/nar/18.13.3841; MORIKAWA K, 1992, SCIENCE, V256, P523, DOI 10.1126/science.1575827; OHANDLEY S, UNPUB; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PASCARELLA S, 1992, PROTEIN ENG, V5, P121, DOI 10.1093/protein/5.2.121; RAVENEK W, 1989, SCI COMPUTING SUPERC, P201; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1988, PROTEINS, V4, P229, DOI 10.1002/prot.340040402; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; RICHARDSON JS, 1990, PREDICTION PROTEIN S, P2; SCHWARTZ A, 1989, J MOL BIOL, V207, P445, DOI 10.1016/0022-2836(89)90266-0; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; SWITZER R L, 1989, Biofactors, V2, P77; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P1, DOI 10.1107/S0108767387099999; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WILLIAMS TV, 1982, THESIS U N CAROLINA; WITHKA JM, 1991, BIOCHEMISTRY-US, V30, P9931, DOI 10.1021/bi00105a017	67	283	286	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	1992	258	5081					434	440		10.1126/science.1411536	http://dx.doi.org/10.1126/science.1411536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT775	1411536				2022-12-28	WOS:A1992JT77500027
J	HEATH, WR; ALLISON, J; HOFFMANN, MW; SCHONRICH, G; HAMMERLING, G; ARNOLD, B; MILLER, JFAP				HEATH, WR; ALLISON, J; HOFFMANN, MW; SCHONRICH, G; HAMMERLING, G; ARNOLD, B; MILLER, JFAP			AUTOIMMUNE DIABETES AS A CONSEQUENCE OF LOCALLY PRODUCED INTERLEUKIN-2	NATURE			English	Article							RECEPTOR TRANSGENIC MICE; VIRUS-INFECTION; T-CELLS; TOLERANCE; MOLECULES; MECHANISM; INDUCTION	DURING cell differentiation in the thymus, self-reactive T cells can be generated. The majority of these seem to be deleted after intrathymic encounter with the relevant autoantigen1. As all self antigens are unlikely to be present in the thymus, some autoreactive T cells may escape censorship. Here we study the fate of these cells using transgenic mice expressing the class I molecule H-2K(b) (K(b)) in the insulin-producing beta-cells of the pancreas2,3. These mice were crossed with mice transgenic for genes encoding a K(b)-specific T-cell antigen receptor (TCR)4 which could be detected using a clonotype-specific monoclonal antibody5. Although T cells expressing the highest level of transgenic TCR were deleted intrathymically in double-transgenic mice, K(b)-specific T cells were detected in the periphery. These cells caused the rejection of K(b)-expressing skin grafts, but ignored islet K(b) antigens even after priming. But when double-transgenic mice were crossed with transgenic mice expressing the lymphokine interleukin-2 in the pancreatic beta-cells6, there was a rapid onset of diabetes. These results indicate that autoreactive T cells that ignore self antigens may cause autoimmune diabetes when provided with exogenous 'help' in the form of interleukin-2.	ROYAL MELBOURNE HOSP, WALTER & ELIZA HALL INST MED RES, PARKVILLE, VIC 3050, AUSTRALIA; GERMAN CANC RES CTR, INST IMMUNOL & GENET, W-6900 HEIDELBERG 1, GERMANY	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Helmholtz Association; German Cancer Research Center (DKFZ)				Heath, William/0000-0001-9670-259X; Schonrich, Gunther/0000-0002-5346-5704				ALLISON J, 1992, EUR J IMMUNOL, V22, P1115, DOI 10.1002/eji.1830220503; ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; DENNERT G, 1980, CELL IMMUNOL, V53, P350, DOI 10.1016/0008-8749(80)90335-4; HUA C, 1986, J IMMUNOL, V136, P1937; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; MILLER JFAP, 1991, IMMUNOL REV, V122, P103, DOI 10.1111/j.1600-065X.1991.tb00599.x; MILLER JFAP, 1989, COLD SPRING HARB SYM, V54, P807; MORAHAN G, 1989, NATURE, V339, P622, DOI 10.1038/339622a0; MORAHAN G, 1991, P NATL ACAD SCI USA, V88, P11421, DOI 10.1073/pnas.88.24.11421; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; SCHONRICH G, 1992, INT IMMUNOL, V4, P581, DOI 10.1093/intimm/4.5.581; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531	14	243	250	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	1992	359	6395					547	549		10.1038/359547a0	http://dx.doi.org/10.1038/359547a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR859	1406974				2022-12-28	WOS:A1992JR85900063
J	HSU, T; GOGOS, JA; KIRSH, SA; KAFATOS, FC				HSU, T; GOGOS, JA; KIRSH, SA; KAFATOS, FC			MULTIPLE ZINC FINGER FORMS RESULTING FROM DEVELOPMENTALLY REGULATED ALTERNATIVE SPLICING OF A TRANSCRIPTION FACTOR GENE	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; BROAD-COMPLEX ENCODES; DNA-BINDING DOMAINS; DROSOPHILA-MELANOGASTER; MESSENGER-RNAS; C-JUN; EXPRESSION; FAMILY; PHOSPHORYLATION; INHIBITOR	Transcripts encoding the Drosophila putative transcription factor CF2 are subject to developmentally regulated alternative splicing, and they encode protein isoforms that differ in the number of zinc fingers. One testis-specific RNA encodes an isoform that includes three zinc fingers and a frame-shifted segment. Two other transcripts encode isoforms with six and seven zinc fingers which bind to distinct promoters and DNA target sequences. Thus, because of alternative splicing, a single gene appears to encode distinct DNA-binding proteins, each capable of regulating different gene sets in different tissues and developmental periods	HARVARD UNIV,DEPT CELLULAR & DEV BIOL,CAMBRIDGE,MA 02138; UNIV CRETE,FORTH,INST MOLEC BIOL & BIOTECHNOL,GR-71110 IRAKLION,GREECE; UNIV CRETE,DEPT BIOL,GR-71110 IRAKLION,GREECE	Harvard University; Foundation for Research & Technology - Hellas (FORTH); University of Crete; University of Crete				Hsu, Tien/0000-0003-2308-4297				BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; BORDEREAUX D, 1990, ONCOGENE, V5, P925; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; DIBELLO PR, 1991, GENETICS, V129, P385; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GOGOS JA, 1992, SCIENCE, V257, P1951, DOI 10.1126/science.1290524; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HINNEBUSCH AG, 1987, TRANSLATIONAL REGULA, P397; HSU T, UNPUB; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; KORNFELD K, 1989, GENE DEV, V3, P243, DOI 10.1101/gad.3.2.243; Maniatis T., 1982, MOL CLONING; MARTINEZCRUZADO JC, 1988, GENETICS, V119, P663; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MITSIALIS SA, 1985, NATURE, V317, P453, DOI 10.1038/317453a0; MOSES K, 1991, TRENDS GENET, V7, P250; MYLIN LM, 1990, MOL CELL BIOL, V10, P4623, DOI 10.1128/MCB.10.9.4623; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PICARD D, 1987, EMBO J, V6, P333; RAYCHANDHURI P, 1989, GENE DEV, V2, P1686; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; ROMAN C, 1991, SCIENCE, V254, P94, DOI 10.1126/science.1840705; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SHEA MJ, 1990, GENE DEV, V4, P1128, DOI 10.1101/gad.4.7.1128; STEINHAUER W, 1989, MOL CELL BIOL, V12, P5726; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STROEHER VL, 1988, MOL CELL BIOL, V8, P4143, DOI 10.1128/MCB.8.10.4143; SZIDONYA J, 1988, GENET RES, V51, P197, DOI 10.1017/S0016672300024290; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; TOLIAS P, UNPUB; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	40	87	94	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 25	1992	257	5078					1946	1950		10.1126/science.1411512	http://dx.doi.org/10.1126/science.1411512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP594	1411512				2022-12-28	WOS:A1992JP59400032
